PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hartshorne, JK				Hartshorne, Joshua K.			Visual Working Memory Capacity and Proactive Interference	PLOS ONE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; FIXED NUMBER; MECHANISMS; INTERNET; MIND; FAMILIARITY; RETENTION; LIMITS; WORDS	Background: Visual working memory capacity is extremely limited and appears to be relatively immune to practice effects or the use of explicit strategies. The recent discovery that visual working memory tasks, like verbal working memory tasks, are subject to proactive interference, coupled with the fact that typical visual working memory tasks are particularly conducive to proactive interference, suggests that visual working memory capacity may be systematically under-estimated. Methodology/Principal Findings: Working memory capacity was probed behaviorally in adult humans both in laboratory settings and via the Internet. Several experiments show that although the effect of proactive interference on visual working memory is significant and can last over several trials, it only changes the capacity estimate by about 15%. Conclusions/Significance: This study further confirms the sharp limitations on visual working memory capacity, both in absolute terms and relative to verbal working memory. It is suggested that future research take these limitations into account in understanding differences across a variety of tasks between human adults, prelinguistic infants and nonlinguistic animals.	[Hartshorne, Joshua K.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Hartshorne, JK (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	jharts@wjh.harvard.edu		Hartshorne, Joshua/0000-0003-1240-3598; Lauwereyns, Jan/0000-0003-0551-2550	Harvard University [start-up (seed)]	Harvard University	Funds to test participants were provided from a start-up (seed) grant to Yuhong Jiang from Harvard University. The granting organization had no further role.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD., 1990, HUMAN MEMORY THEORY; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bunting M, 2006, J EXP PSYCHOL LEARN, V32, P183, DOI 10.1037/0278-7393.32.2.183; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; CAREY S, ORIGINAL CO IN PRESS; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Davis G, 2005, MEM COGNITION, V33, P185, DOI 10.3758/BF03195307; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; ERICSSON KA, 1982, AM SCI, V70, P607; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flavell JH, 2004, MERRILL PALMER QUART, V50, P274, DOI 10.1353/mpq.2004.0018; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hedden T, 2006, NEUROPSYCHOLOGY, V20, P511, DOI 10.1037/0894-4105.20.5.511; HULME C, 1995, BRIT J PSYCHOL, V86, P527, DOI 10.1111/j.2044-8295.1995.tb02570.x; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Jarrold C, 1997, Cogn Neuropsychiatry, V2, P101, DOI 10.1080/135468097396351; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; KEPPEL G, 1962, J VERB LEARN VERB BE, V1, P153, DOI 10.1016/S0022-5371(62)80023-1; Kliegl R, 1987, COGNITION INSTRUCT; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Makovski T, 2008, MEM COGNITION, V36, P43, DOI 10.3758/MC.36.1.43; Mecklinger A, 2003, COGNITIVE BRAIN RES, V18, P26, DOI 10.1016/j.cogbrainres.2003.08.008; Meyerson P, 2003, BEHAV RES METH INS C, V35, P614, DOI 10.3758/BF03195541; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MONSELL S, 1978, COGNITIVE PSYCHOL, V10, P465, DOI 10.1016/0010-0285(78)90008-7; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2005, J EXP PSYCHOL HUMAN, V31, P889, DOI 10.1037/0096-1523.31.5.889; Olson IR, 2004, MEM COGNITION, V32, P1326, DOI 10.3758/BF03206323; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PETERSON LR, 1965, J EXP PSYCHOL, V70, P473, DOI 10.1037/h0022542; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Postle BR, 2004, COGN AFFECT BEHAV NE, V4, P379, DOI 10.3758/CABN.4.3.379; Salthouse TA, 2006, J MEM LANG, V55, P102, DOI 10.1016/j.jml.2006.03.006; Schick B, 2007, CHILD DEV, V78, P376, DOI 10.1111/j.1467-8624.2007.01004.x; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Spelke ES, 2002, LANGUAGES OF THE BRAIN, P239; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; ZHANG GJ, 1985, MEM COGNITION, V13, P193, DOI 10.3758/BF03197681	48	67	68	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2716	10.1371/journal.pone.0002716	http://dx.doi.org/10.1371/journal.pone.0002716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648493	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900003
J	Chan, WT; Sherer, NM; Uchil, PD; Novak, EK; Swank, RT; Mothes, W				Chan, Wai-Tsing; Sherer, Nathan M.; Uchil, Pradeep D.; Novak, Edward K.; Swank, Richard T.; Mothes, Walther			Murine Leukemia Virus Spreading in Mice Impaired in the Biogenesis of Secretory Lysosomes and Ca2+-Regulated Exocytosis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; REGULATES CA2+-DEPENDENT EXOCYTOSIS; INTRACELLULAR TRAFFICKING; INFECTIOUS HIV-1; PLASMA-MEMBRANE; LYTIC GRANULES; SYNDROME GENES; TYPE-1; CELLS; AP-3	Background: Retroviruses have been observed to bud intracellularly into multivesicular bodies (MVB), in addition to the plasma membrane. Release from MVB is thought to occur by Ca2+-regulated fusion with the plasma membrane. Principal Findings: To address the role of the MVB pathway in replication of the murine leukemia virus (MLV) we took advantage of mouse models for the Hermansky-Pudlak syndrome (HPS) and Griscelli syndrome. In humans, these disorders are characterized by hypopigmentation and immunological alterations that are caused by defects in the biogenesis and trafficking of MVBs and other lysosome related organelles. Neonatal mice for these disease models lacking functional AP-3, Rab27A and BLOC factors were infected with Moloney MLV and the spread of virus into bone marrow, spleen and thymus was monitored. We found a moderate reduction in MLV infection levels in most mutant mice, which differed by less than two-fold compared to wild-type mice. In vitro, MLV release form bone-marrow derived macrophages was slightly enhanced. Finally, we found no evidence for a Ca2+-regulated release pathway in vitro. Furthermore, MLV replication was only moderately affected in mice lacking Synaptotagmin VII, a Ca2+-sensor regulating lysosome fusion with the plasma membrane. Conclusions: Given that MLV spreading in mice depends on multiple rounds of replication even moderate reduction of virus release at the cellular level would accumulate and lead to a significant effect over time. Thus our in vivo and in vitro data collectively argue against an essential role for a MVB- and secretory lysosome-mediated pathway in the egress of MLV.	[Chan, Wai-Tsing; Sherer, Nathan M.; Uchil, Pradeep D.; Mothes, Walther] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Novak, Edward K.; Swank, Richard T.] Roswell Park Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY USA	Yale University; Roswell Park Cancer Institute	Chan, WT (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA.	walther.mothes@yale.edu		Uchil, Pradeep/0000-0002-7236-858X	National Institutes of Health [R21 AI065284]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health (NIH) R21 AI065284 to W.M.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 2005, TRAFFIC, V6, P243, DOI 10.1111/j.1600-0854.2005.00264.x; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clark R, 2003, CURR OPIN IMMUNOL, V15, P516, DOI 10.1016/S0952-7915(03)00113-4; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Finke D, 2001, INFEC DIS S, P125; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fontana S, 2006, BLOOD, V107, P4857, DOI 10.1182/blood-2005-11-4398; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gottlinger HG, 2001, AIDS, V15, pS13; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; JOUVENET N, 2008, NATURE; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; OTT DE, 1992, J VIROL, V66, P6107, DOI 10.1128/JVI.66.10.6107-6116.1992; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Uittenbogaart CH, 1998, J VIROL, V72, P10118, DOI 10.1128/JVI.72.12.10118-10125.1998; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2713	10.1371/journal.pone.0002713	http://dx.doi.org/10.1371/journal.pone.0002713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629000	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200056
J	Gupta, P; Ho, PC; Huq, MDM; Khan, AA; Tsai, NP; Wei, LN				Gupta, Pawan; Ho, Ping-Chih; Huq, M. D. Mostaqul; Khan, Amjad Ali; Tsai, Nien-Pei; Wei, Li-Na			PKC epsilon Stimulated Arginine Methylation of RIP140 for Its Nuclear-Cytoplasmic Export in Adipocyte Differentiation	PLOS ONE			English	Article								Background: Receptor interacting protein 140 (RIP140) is a versatile transcriptional co-repressor that plays roles in diverse metabolic processes including fat accumulation in adipocytes. Previously we identified three methylated arginine residues in RIP140, which rendered its export to the cytoplasm; but it was unclear what triggered RIP140 arginine methylation. Methodology/Principal Findings: In this study, we determined the activated PKC epsilon as the specific trigger for RIP140 arginine methylation and its subsequent export. We identified two PKC epsilon-phosphorylated residues of RIP140, Ser-102 and Ser-1003, which synergistically stimulated direct binding of RIP140 by 14-3-3 that recruited protein arginine methyl transferase 1 to methylate RIP140. The methylated RIP140 then preferentially recruited exportin 1 for nuclear export. As a result, the nuclear gene-repressive activity of RIP140 was reduced. In RIP140 null adipocyte cultures, the defect in fat accumulation was effectively rescued by the phosphoylation-deficient mutant RIP140 that resided predominantly in the nucleus, but less so by the phospho-mimetic RIP140 that was exported to the cytoplasm. Conclusions/Significance: This study uncovers a novel means, via a cascade of protein modifications, to inactivate, or suppress, the nuclear action of an important transcription coregulator RIP140, and delineates the first specific phosphorylation-arginine methylation cascade that could alter protein subcellular distribution and biological activity.	[Gupta, Pawan; Ho, Ping-Chih; Huq, M. D. Mostaqul; Khan, Amjad Ali; Tsai, Nien-Pei; Wei, Li-Na] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gupta, P (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	weixx009@umn.edu			Philip Morris USA Inc; Philip Morris International; NIH [DK54733, DK60521, K02-DA13926, DA11190]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054733, R01DK060521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, K02DA013926] Funding Source: NIH RePORTER	Philip Morris USA Inc; Philip Morris International; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part by Philip Morris USA Inc. and Philip Morris International, and by NIH grants DK54733, DK60521, K02-DA13926 and DA11190 to L.-N. Wei.	Aguilera C, 2006, J CELL SCI, V119, P3695, DOI 10.1242/jcs.03086; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; England K, 2000, BIOCHEM J, V352, P19, DOI 10.1042/0264-6021:3520019; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fleming I, 1998, BIOCHEM J, V333, P719, DOI 10.1042/bj3330719; Frevert EU, 1996, BIOCHEM J, V316, P865, DOI 10.1042/bj3160865; Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200; Gupta P, 2007, NUCLEIC ACIDS RES, V35, P2269, DOI 10.1093/nar/gkl1147; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huq MDM, 2007, NAT CHEM BIOL, V3, P161, DOI 10.1038/nchembio861; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Huq MDM, 2005, PROTEOMICS, V5, P2157, DOI 10.1002/pmic.200401090; Jang BC, 2003, J BIOL CHEM, V278, P2773, DOI 10.1074/jbc.C200620200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LHorset F, 1996, MOL CELL BIOL, V16, P6029; Li JH, 2002, J BIOL CHEM, V277, P39967, DOI 10.1074/jbc.M200840200; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Parker M, 2003, FEBS LETT, V546, P149, DOI 10.1016/S0014-5793(03)00564-7; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Robb VA, 2004, ONCOGENE, V23, P3589, DOI 10.1038/sj.onc.1207445; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Wang H E, 2000, Prehosp Emerg Care, V4, P14, DOI 10.1080/10903120090941560; Wei LN, 2001, J BIOL CHEM, V276, P16107, DOI 10.1074/jbc.M010185200; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xu TR, 2004, FEBS LETT, V570, P20, DOI 10.1016/j.febslet.2004.05.080; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/me.15.4.501; 2002, SCI STKE, pTW101	47	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2658	10.1371/journal.pone.0002658	http://dx.doi.org/10.1371/journal.pone.0002658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628823	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200004
J	Balraj, P; El Karkouri, K; Vestris, G; Espinosa, L; Raoult, D; Renesto, P				Balraj, Premanand; El Karkouri, Khalid; Vestris, Guy; Espinosa, Leon; Raoult, Didier; Renesto, Patricia			RickA Expression Is Not Sufficient to Promote Actin-Based Motility of Rickettsia raoultii	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SHIGELLA-FLEXNERI; PLAQUE-FORMATION; GENE; SEQUENCE; IDENTIFICATION; CONORII; PROTEIN; PROWAZEKII; PEACOCKII	Background: Rickettsia raoultii is a novel Rickettsia species recently isolated from Dermacentor ticks and classified within the spotted fever group (SFG). The inability of R. raoultii to spread within L929 cells suggests that this bacterium is unable to polymerize host cell actin, a property exhibited by all SFG rickettsiae except R. peacocki. This result led us to investigate if RickA, the protein thought to generate actin nucleation, was expressed within this rickettsia species. Methodology/Principal Findings: Amplification and sequencing of R. raoultii rickA showed that this gene encoded a putative 565 amino acid protein highly homologous to those found in other rickettsiae. Using immunofluorescence assays, we determined that the motility pattern (i.e. microcolonies or cell-to-cell spreading) of R. raoultii was different depending on the host cell line in which the bacteria replicated. In contrast, under the same experimental conditions, R. conorii shares the same phenotype both in L929 and in Vero cells. Transmission electron microscopy analysis of infected cells showed that non-motile bacteria were free in the cytosol instead of enclosed in a vacuole. Moreover, western-blot analysis demonstrated that the defect of R. raoultii actin-based motility within L929 cells was not related to lower expression of RickA. Conclusion/Significance: These results, together with previously published data about R. typhi, strongly suggest that another factor, apart from RickA, may be involved with be responsible for actin-based motility in bacteria from the Rickettsia genus.	[Balraj, Premanand; El Karkouri, Khalid; Vestris, Guy; Espinosa, Leon; Raoult, Didier; Renesto, Patricia] Fac Med, Unite Rickettsies, CNRS, URMITE IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Balraj, P (corresponding author), Fac Med, Unite Rickettsies, CNRS, URMITE IRD UMR 6236, Marseille, France.	patricia.renesto@medecine.univ-mrs.fr	Renesto, patricia/M-6105-2014; RAOULT, Didier/A-8434-2008; renesto, patricia/T-6446-2019; Espinosa, Leon/V-8410-2017	RAOULT, Didier/0000-0002-0633-5974; renesto, patricia/0000-0002-6749-7862; 				Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Carlsson F, 2006, J CELL PHYSIOL, V209, P288, DOI 10.1002/jcp.20721; CORY J, 1974, APPL MICROBIOL, V27, P1157, DOI 10.1128/AEM.27.6.1157-1161.1974; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Hybiske K, 2008, NAT REV MICROBIOL, V6, P99, DOI 10.1038/nrmicro1821; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; JOHNSON JW, 1978, J CLIN MICROBIOL, V7, P389; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; MEDIANNIKOV O, 2008, INT J SYST EVOL MICR; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; OGATA H, 2006, PLOS BIOL; OGATA H, 2005, PLOS BIOL; OSTERMAN JV, 1974, INFECT IMMUN, V10, P1152, DOI 10.1128/IAI.10.5.1152-1155.1974; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renesto P, 2003, J INFECT DIS, V188, P1276, DOI 10.1086/379080; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Roberts AJ, 2006, FEMS MICROBIOL LETT, V254, P300, DOI 10.1111/j.1574-6968.2005.00041.x; ROUX V, 1993, J BACTERIOL, V175, P4895, DOI 10.1128/JB.175.15.4895-4904.1993; Rydkina E, 1999, EMERG INFECT DIS, V5, P811, DOI 10.3201/eid0506.990612; Simser J. A., 1999, American Journal of Tropical Medicine and Hygiene, V61, P359; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; SMIRNOVA NS, 1986, ACTA VIROL, V30, P436; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005; WIKE DA, 1972, INFECT IMMUN, V5, P715, DOI 10.1128/IAI.5.5.715-722.1972; WISSEMAN CL, 1975, INFECT IMMUN, V11, P1391, DOI 10.1128/IAI.11.6.1391-1401.1975; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	42	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2582	10.1371/journal.pone.0002582	http://dx.doi.org/10.1371/journal.pone.0002582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612416	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800003
J	Pawar, A; Favrin, G				Pawar, Amol; Favrin, Giorgio			Finite Size Effects in Simulations of Protein Aggregation	PLOS ONE			English	Article								It is becoming increasingly clear that the soluble protofibrillar species that proceed amyloid fibril formation are associated with a range of neurodegenerative disorders such as Alzheimer's and Parkinson diseases. Computer simulations of the processes that lead to the formation of these oligomeric species are starting to make significant contributions to our understanding of the determinants of protein aggregation. We simulate different systems at constant concentration but with a different number of peptides and we study the how the finite number of proteins affects the underlying free energy of the system and therefore the relative stability of the species involved in the process. If not taken into account, this finite size effect can undermine the validity of theoretical predictions regarding the relative stability of the species involved and the rates of conversion from one to the other. We discuss the reasons that give rise to this finite size effect form both a probabilistic and energy fluctuations point of view and also how this problem can be dealt by a finite size scaling analysis.	[Pawar, Amol; Favrin, Giorgio] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Pawar, A (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gf247@cam.ac.uk		Favrin, Giorgio/0000-0002-1884-7352	EPSRC-Life Science Interface fellowship; Engineering and Physical Sciences Research Council [EP/D06693X/1] Funding Source: researchfish; EPSRC [EP/D06693X/1] Funding Source: UKRI	EPSRC-Life Science Interface fellowship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was done with the aid of the EPSRC-Life Science Interface fellowship currently held by GF. This work was described in the fellowship application but EPSRC had no role in designing and conduct of the study.	ASPELMEIER T, 2007, ARXIV07113445; Auer S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178104; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Bellesia G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2739547; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchete NV, 2005, J MOL BIOL, V353, P804, DOI 10.1016/j.jmb.2005.08.066; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cheon M, 2008, FRONT BIOSCI-LANDMRK, V13, P5614; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839; Favrin G, 2001, J CHEM PHYS, V114, P8154, DOI 10.1063/1.1364637; Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Irback A, 2005, BIOPHYS J, V88, P1560, DOI 10.1529/biophysj.104.050427; Irback A, 2004, PROTEINS, V56, P110, DOI 10.1002/prot.20157; Irback A, 2003, BIOPHYS J, V85, P1466, DOI 10.1016/S0006-3495(03)74579-2; Irback A, 2006, J COMPUT CHEM, V27, P1548, DOI 10.1002/jcc.20452; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khare SD, 2005, PLOS COMPUT BIOL, V1, P230, DOI 10.1371/journal.pcbi.0010030; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Paci E, 2004, J MOL BIOL, V340, P555, DOI 10.1016/j.jmb.2004.05.009; Parisi G., 1998, STAT FIELD THEORY, V1; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; SIMONA F, 2004, J MOL GRAPH MODEL, V263, P12; Soto P, 2007, BIOPHYS J, V93, P3015, DOI 10.1529/biophysj.107.112086; Thirumalai D, 2003, CURR OPIN STRUC BIOL, V13, P146, DOI 10.1016/S0959-440X(03)00032-0; Tiana G, 2004, J CHEM PHYS, V120, P8307, DOI 10.1063/1.1689293; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2641	10.1371/journal.pone.0002641	http://dx.doi.org/10.1371/journal.pone.0002641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612385	Green Submitted, gold, Green Published			2022-12-27	WOS:000264065800043
J	Yamaza, T; Miura, Y; Bi, YM; Liu, YZ; Akiyama, K; Sonoyama, W; Patel, V; Gutkind, S; Young, M; Gronthos, S; Le, A; Wang, CY; Chen, WJ; Shi, ST				Yamaza, Takayoshi; Miura, Yasuo; Bi, Yanming; Liu, Yongzhong; Akiyama, Kentaro; Sonoyama, Wataru; Patel, Voymesh; Gutkind, Silvio; Young, Marian; Gronthos, Stan; Le, Anh; Wang, Cun-Yu; Chen, WanJun; Shi, Songtao			Pharmacologic Stem Cell Based Intervention as a New Approach to Osteoporosis Treatment in Rodents	PLOS ONE			English	Article							BONE-MINERAL DENSITY; T-CELLS; OSTEOBLAST APOPTOSIS; STROMAL CELLS; MARROW; OSTEOCYTE; ASPIRIN; BISPHOSPHONATES; COMPLICATIONS; THERAPY	Background: Osteoporosis is the most prevalent skeletal disorder, characterized by a low bone mineral density (BMD) and bone structural deterioration, leading to bone fragility fractures. Accelerated bone resorption by osteoclasts has been established as a principal mechanism in osteoporosis. However, recent experimental evidences suggest that inappropriate apoptosis of osteoblasts/osteocytes accounts for, at least in part, the imbalance in bone remodeling as occurs in osteoporosis. The aim of this study is to examine whether aspirin, which has been reported as an effective drug improving bone mineral density in human epidemiology studies, regulates the balance between bone resorption and bone formation at stem cell levels. Methods and Findings: We found that T cell-mediated bone marrow mesenchymal stem cell (BMMSC) impairment plays a crucial role in ovariectomized-induced osteoporosis. Ex vivo mechanistic studies revealed that T cell-mediated BMMSC impairment was mainly attributed to the apoptosis of BMMSCs via the Fas/Fas ligand pathway. To explore potential of using pharmacologic stem cell based intervention as an approach for osteoporosis treatment, we selected ovariectomy (OVX)-induced ostoeporosis mouse model to examine feasibility and mechanism of aspirin-mediated therapy for osteoporosis. We found that aspirin can inhibit T cell activation and Fas ligand induced BMMSC apoptosis in vitro. Further, we revealed that aspirin increases osteogenesis of BMMSCs by aiming at telomerase activity and inhibits osteoclast activity in OVX mice, leading to ameliorating bone density. Conclusion: Our findings have revealed a novel osteoporosis mechanism in which activated T cells induce BMMSC apoptosis via Fas/Fas ligand pathway and suggested that pharmacologic stem cell based intervention by aspirin may be a new alternative in osteoporosis treatment including activated osteoblasts and inhibited osteoclasts.	[Yamaza, Takayoshi; Akiyama, Kentaro; Sonoyama, Wataru; Le, Anh; Shi, Songtao] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA; [Miura, Yasuo] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Bi, Yanming; Liu, Yongzhong; Patel, Voymesh; Gutkind, Silvio; Young, Marian; Chen, WanJun] NIH, NIDCR, Bethesda, MD USA; [Gronthos, Stan] Inst Med & Vet Sci, Div Haematol, Mesenchymal Stem Cell Grp, Adelaide, SA, Australia; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA USA	University of Southern California; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Institute Medical & Veterinary Science Australia; University of California System; University of California Los Angeles	Yamaza, T (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	wchen@mail.nih.gov; songtaos@usc.edu	Gronthos, Stan/Y-4419-2019; Sonoyama, Wataru/B-2160-2011; Gutkind, J. Silvio/J-1201-2016	Gronthos, Stan/0000-0002-6225-3084; Gutkind, J. Silvio/0000-0002-5150-4482; Young, Marian F/0000-0003-0929-8854; Miura, Yasuo/0000-0001-9654-1300; Yamaza, Takayoshi/0000-0001-7055-3370	University of Southern California School of Dentistry; NIH [R01DE17449]; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000101] Funding Source: NIH RePORTER	University of Southern California School of Dentistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by University of Southern California School of Dentistry starting fund for S.S., an extramural grant from NIH (NIDCR R01DE17449 for S.S.), and NIDCR intramural fund.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bauer DC, 1996, J BONE MINER RES, V11, P29; Bernstein CN, 2002, CURR OPIN GASTROEN, V18, P428, DOI 10.1097/00001574-200207000-00006; BERNSTEIN CN, 2006, OSTEOPOROS REP, V4, P116; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Brunner T, 2003, SEMIN IMMUNOL, V15, P167, DOI 10.1016/S1044-5323(03)00035-6; BUKOWSKI JF, 2005, BIOCHEM BIOPH RES CO, V21, P373; Carbone LD, 2003, J BONE MINER RES, V18, P1795, DOI 10.1359/jbmr.2003.18.10.1795; Chapurlat RD, 2006, NAT CLIN PRACT ENDOC, V2, P211, DOI 10.1038/ncpendmet0121; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Hock JM, 2001, J BONE MINER RES, V16, P975, DOI 10.1359/jbmr.2001.16.6.975; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kogianni G, 2004, LIFE SCI, V75, P2879, DOI 10.1016/j.lfs.2004.04.048; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Manolagas SC, 1999, ENDOCRINOLOGY, V140, P4377, DOI 10.1210/en.140.10.4377; Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; OWEN M, 1988, CIBA F SYMP, V136, P42; Pan BQ, 2004, BONE, V34, P112, DOI 10.1016/j.bone.2003.08.013; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Rothfuss KS, 2006, WORLD J GASTROENTERO, V12, P4819; Scholz M, 2005, MED RES REV, V25, P331, DOI 10.1002/med.20025; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sylvester FA, 2005, INFLAMM BOWEL DIS, V11, P1020, DOI 10.1097/01.MIB.0000188341.96726.15; Tanaka Yoshiya, 2005, Current Drug Targets - Inflammation and Allergy, V4, P325, DOI 10.2174/1568010054022015; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Whitfield JF, 2006, CURR OPIN INVEST DR, V7, P349; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072	40	138	164	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2615	10.1371/journal.pone.0002615	http://dx.doi.org/10.1371/journal.pone.0002615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612428	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800017
J	Wu, DY; Hartman, A; Ward, N; Eisen, JA				Wu, Dongying; Hartman, Amber; Ward, Naomi; Eisen, Jonathan A.			An Automated Phylogenetic Tree-Based Small Subunit rRNA Taxonomy and Alignment Pipeline (STAP)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MICROBIAL DIVERSITY; DEEP-SEA; GENES; DATABASE; GENOMES; DOMAIN; VIEW	Comparative analysis of small-subunit ribosomal RNA (ss-rRNA) gene sequences forms the basis for much of what we know about the phylogenetic diversity of both cultured and uncultured microorganisms. As sequencing costs continue to decline and throughput increases, sequences of ss-rRNA genes are being obtained at an ever-increasing rate. This increasing flow of data has opened many new windows into microbial diversity and evolution, and at the same time has created significant methodological challenges. Those processes which commonly require time-consuming human intervention, such as the preparation of multiple sequence alignments, simply cannot keep up with the flood of incoming data. Fully automated methods of analysis are needed. Notably, existing automated methods avoid one or more steps that, though computationally costly or difficult, we consider to be important. In particular, we regard both the building of multiple sequence alignments and the performance of high quality phylogenetic analysis to be necessary. We describe here our fully-automated ss-rRNA taxonomy and alignment pipeline (STAP). It generates both high-quality multiple sequence alignments and phylogenetic trees, and thus can be used for multiple purposes including phylogenetically-based taxonomic assignments and analysis of species diversity in environmental samples. The pipeline combines publicly-available packages (PHYML, BLASTN and CLUSTALW) with our automatic alignment, masking, and tree-parsing programs. Most importantly, this automated process yields results comparable to those achievable by manual analysis, yet offers speed and capacity that are unattainable by manual efforts.	[Wu, Dongying; Hartman, Amber; Eisen, Jonathan A.] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Coll Biol Sci, Sect Evol & Ecol, Davis, CA USA; [Eisen, Jonathan A.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA USA; [Ward, Naomi] Univ Wyoming, Dept Mol Biol, Laramie, WY USA; [Ward, Naomi] Ctr Marine Biotechnol, Baltimore, MD USA; [Hartman, Amber] Johns Hopkins Univ, Dept Biol, Baltimore, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Wyoming; Johns Hopkins University	Wu, DY (corresponding author), Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA.	dongyingwu1@gmail.com	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Scholz, Amber/0000-0002-3461-0881	National Science Foundation [0228651]; Gordon and Betty Moore Foundation [1660]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The National Science Foundation "Assembling the Tree of Life" Grant No. 0228651. The final work on this project was funded by the Gordon and Betty Moore Foundation (grant #1660 to Jonathan Eisen).	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Imhoff JF, 2004, INT J SYST EVOL MICR, V54, P1415, DOI 10.1099/ijs.0.03002-0; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Penn K, 2006, APPL ENVIRON MICROB, V72, P1680, DOI 10.1128/AEM.72.2.1680-1683.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Swofford David L., 1996, P407; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1989, SYST APPL MICROBIOL, V11, P128, DOI 10.1016/S0723-2020(89)80051-7; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065	46	37	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2566	10.1371/journal.pone.0002566	http://dx.doi.org/10.1371/journal.pone.0002566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596968	Green Published, gold			2022-12-27	WOS:000263288200031
J	Mahalanabis, D; Lopez, AL; Sur, D; Deen, J; Manna, B; Kanungo, S; von Seidlein, L; Carbis, R; Han, SH; Shin, SH; Attridge, S; Rao, R; Holmgren, J; Clemens, J; Bhattacharya, SK				Mahalanabis, Dilip; Lopez, Anna Lena; Sur, Dipika; Deen, Jacqueline; Manna, Byomkesh; Kanungo, Suman; von Seidlein, Lorenz; Carbis, Rodney; Han, Seung Hyun; Shin, Seong Hye; Attridge, Stephen; Rao, Raman; Holmgren, Jan; Clemens, John; Bhattacharya, Sujit K.			A Randomized, Placebo-Controlled Trial of the Bivalent Killed, Whole-Cell, Oral Cholera Vaccine in Adults and Children in a Cholera Endemic Area in Kolkata, India	PLOS ONE			English	Article							ANTIBODY-RESPONSES; PERUVIAN ADULTS; IMMUNOGENICITY; SAFETY; IMMUNITY; VIETNAM; O139	Objectives: An effective vaccine against cholera has been used for public health purposes in Vietnam since the 1990s. This vaccine was reformulated to meet WHO requirements. We assessed the safety and immunogenicity of the reformulated bivalent (Vibrio cholerae 01 and 0139) killed whole cell oral vaccine in a cholera endemic area in Kolkata, India. Design: Double-blind, randomized, placebo controlled trial Setting: The trial was conducted in the clinical trial ward of the Infectious Diseases Hospital in Kolkata, India Participants: The participants were 101 healthy adults (males and non-pregnant females) aged 18-40 years and 100 healthy children (males and non-pregnant females) aged 1-17 years. Interventions: Participants were randomized to receive either the bivalent killed whole cell oral cholera vaccine or placebo (killed oral Escherichia coli K12) Outcome Measures: For safety: proportion of subjects with adverse events during the duration of study participation. For immunogenicity: Proportion of subjects who had a >= 4-fold rise in serum vibriocidal antibody titers 14 days after the second dose of vaccine or placebo. Results: Adverse reactions were observed with similar frequency among vaccine and placebo recipients in both age groups. Among adults 4% of vaccine and 8% of placebo recipients and among children 4% of vaccine and 2% of placebo recipients had at least one adverse event within 28 days of the first dose of the vaccine. Following immunization, 53% of adult and 80% of children vaccinees showed a >= 4 fold rise in serum V. cholerae O1 vibriocidal antibody titers. A less pronounced response to V. cholerae O139 vibriocidal antibody titers post-immunization was noted among vaccinees. Conclusions: We found the vaccine to be safe and immunogenic in a cholera-endemic area in India.	[Mahalanabis, Dilip] Soc Appl Studies, Kolkata, India; [Lopez, Anna Lena; Deen, Jacqueline; von Seidlein, Lorenz; Carbis, Rodney; Han, Seung Hyun; Shin, Seong Hye; Clemens, John] Int Vaccine Inst, Seoul, South Korea; [Sur, Dipika; Manna, Byomkesh; Kanungo, Suman; Bhattacharya, Sujit K.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Rao, Raman] Shantha Biotech, Hyderabad, Andhra Pradesh, India; [Attridge, Stephen; Holmgren, Jan] Univ Gothenburg, Gothenburg, Sweden; [Han, Seung Hyun] Seoul Natl Univ, Seoul, South Korea	International Vaccine Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Sanofi-Aventis; University of Gothenburg; Seoul National University (SNU)	Mahalanabis, D (corresponding author), Soc Appl Studies, Kolkata, India.	anlopez@ivi.int	Kanungo, Sloka/HHM-7508-2022; Lopez, Anna Lena/AAF-6481-2019	Lopez, Anna Lena/0000-0003-0013-620X; Kanungo, Suman/0000-0003-4441-4443; Holmgren, Jan/0000-0003-1784-5918	International Vaccine Institute [C-8]; Swedish International Development Cooperation Agency	International Vaccine Institute; Swedish International Development Cooperation Agency	This work was supported by the Bill and Melinda Gates Foundation through the Diseases of Most Impoverished Program (grant C-8) administered by the International Vaccine Institute; and the Swedish International Development Cooperation Agency. The sponsors had no role in the design and conduct of the study, or in the analysis, interpretation of data and preparation, review or approval of the manuscript.	Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; Attridge SR, 2002, CLIN DIAGN LAB IMMUN, V9, P383, DOI 10.1128/CDLI.9.2.383-387.2002; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; GOTUZZO E, 1993, INFECT IMMUN, V61, P3994, DOI 10.1128/IAI.61.9.3994-3997.1993; JERTBORN M, 1986, J CLIN MICROBIOL, V24, P203, DOI 10.1128/JCM.24.2.203-209.1986; Losonsky GA, 1997, CLIN DIAGN LAB IMMUN, V4, P264, DOI 10.1128/CDLI.4.3.264-269.1997; Qadri F, 2005, INFECT IMMUN, V73, P6577, DOI 10.1128/IAI.73.10.6577-6583.2005; QADRI F, 1995, CLIN DIAGN LAB IMMUN, V2, P685, DOI 10.1128/CDLI.2.6.685-688.1995; Rao MR, 2002, VACCINE, V20, P3364, DOI 10.1016/S0264-410X(02)00317-1; Taylor DN, 1999, AM J TROP MED HYG, V61, P869, DOI 10.4269/ajtmh.1999.61.869; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; Trach DD, 2002, B WORLD HEALTH ORGAN, V80, P2; Trach DD, 1997, LANCET, V349, P231, DOI 10.1016/S0140-6736(96)06107-7; *WHO GLOB TASK FOR, 2002, WHO M 10 11 DEC GEN	15	80	81	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2323	10.1371/journal.pone.0002323	http://dx.doi.org/10.1371/journal.pone.0002323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523643	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300019
J	May, T; Eccleston, L; Herrmann, S; Hauser, H; Goncalves, J; Wirth, D				May, Tobias; Eccleston, Lee; Herrmann, Sabrina; Hauser, Hansjoerg; Goncalves, Jorge; Wirth, Dagmar			Bimodal and Hysteretic Expression in Mammalian Cells from a Synthetic Gene Circuit	PLOS ONE			English	Article								In order to establish cells and organisms with predictable properties, synthetic biology makes use of controllable, synthetic genetic devices. These devices are used to replace or to interfere with natural pathways. Alternatively, they may be interlinked with endogenous pathways to create artificial networks of higher complexity. While these approaches have been already successful in prokaryotes and lower eukaryotes, the implementation of such synthetic cassettes in mammalian systems and even animals is still a major obstacle. This is mainly due to the lack of methods that reliably and efficiently transduce synthetic modules without compromising their regulation properties. To pave the way for implementation of synthetic regulation modules in mammalian systems we utilized lentiviral transduction of synthetic modules. A synthetic positive feedback loop, based on the Tetracycline regulation system was implemented in a lentiviral vector system and stably integrated in mammalian cells. This gene regulation circuit yields a bimodal expression response. Based on experimental data a mathematical model based on stochasticity was developed which matched and described the experimental findings. Modelling predicted a hysteretic expression responsewhich was verified experimentally. Thereby supporting the idea that the system is driven by stochasticity. The results presented here highlight that the combination of three independent tools/methodologies facilitate the reliable installation of synthetic gene circuits with predictable expression characteristics in mammalian cells and organisms.			May, T (corresponding author), Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany.	dagmar.wirth@helmholtz-hzi.de	Goncalves, Jorge/GYD-3756-2022; Goncalves, Jorge M/GRN-8101-2022	Goncalves, Jorge M/0000-0002-5228-6165	Math-Works Scholarship; Nuffield Foundation; EPSRC; Bundesministerium fur Bildung und Forschung [0313940]; DFG [WI2648]; Helmholtz Association; EU [513769]	Math-Works Scholarship; Nuffield Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); EU(European Commission)	Lee Eccleston would like to thank The MathWorks for their funding through The Math-Works Scholarship. Jorge Goncalves would like to thank the Nuffield Foundation and EPSRC for their support and funding. The work of Tobias May, Hansjorg Hauser and Dagmar Wirth was supported by the Bundesministerium fur Bildung und Forschung (BMBF FKZ 0313940), the DFG (WI2648) and the Helmholtz Association (SBCancer). Further support was obtained from EU (Clinigene and FlpFlex (513769)).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Arkin A, 1998, GENETICS, V149, P1633; Baron U, 1999, P NATL ACAD SCI USA, V96, P1013, DOI 10.1073/pnas.96.3.1013; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hat B, 2007, J STAT PHYS, V128, P511, DOI 10.1007/s10955-006-9218-4; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Loew R, 2004, MOL THER, V9, P738, DOI 10.1016/j.ymthe.2004.02.010; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; May T, 2006, CYTOTECHNOLOGY, V50, P109, DOI 10.1007/s10616-006-9007-6; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Schucht R, 2006, MOL THER, V14, P285, DOI 10.1016/j.ymthe.2005.12.003; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wiznerowicz M, 2005, TRENDS BIOTECHNOL, V23, P42, DOI 10.1016/j.tibtech.2004.11.001; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	49	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2372	10.1371/journal.pone.0002372	http://dx.doi.org/10.1371/journal.pone.0002372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523635	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300057
J	Rogers, LJ; Vallortigara, G				Rogers, Lesley J.; Vallortigara, Giorgio			From Antenna to Antenna: Lateral Shift of Olfactory Memory Recall by Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; BRAIN; ASYMMETRY; ADVANTAGES; INPUT; SIDES; LOBES	Honeybees, Apis mellifera, readily learn to associate odours with sugar rewards and we show here that recall of the olfactory memory, as demonstrated by the bee extending its proboscis when presented with the trained odour, involves first the right and then the left antenna. At 1-2 hour after training using both antennae, recall is possible mainly when the bee uses its right antenna but by 6 hours after training a lateral shift has occurred and the memory can now be recalled mainly when the left antenna is in use. Long-term memory one day after training is also accessed mainly via the left antenna. This time-dependent shift from right to left antenna is also seen as side biases in responding to odour presented to the bee's left or right side. Hence, not only are the cellular events of memory formation similar in bees and vertebrate species but also the lateralized networks involved may be similar. These findings therefore seem to call for remarkable parallel evolution and suggest that the proper functioning of memory formation in a bilateral animal, either vertebrate or invertebrate, requires lateralization of processing.	[Rogers, Lesley J.] Univ New England, Ctr Neurosci & Anim Behav, Armidale, NSW, Australia; [Vallortigara, Giorgio] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy	University of New England; University of Trento	Rogers, LJ (corresponding author), Univ New England, Ctr Neurosci & Anim Behav, Armidale, NSW, Australia.	lrogers@une.edu.au	Rogers, Lesley J./Y-5722-2019	Rogers, Lesley J./0000-0002-9956-1769	University of New England Faculty Grant and a Project EDCBNL; Commission of the European Communities	University of New England Faculty Grant and a Project EDCBNL; Commission of the European Communities(European Commission)	This research was supported by a University of New England Faculty Grant and a Project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization - 2006/2009) Grant, supported by the Commission of the European Communities (Programme "Integrating and strengthening the European Research Area"; Initiative "What it means to be human") to G.V.	Ades C, 2002, J INSECT BEHAV, V15, P563, DOI 10.1023/A:1016337418472; Andrew RJ, 1999, BEHAV BRAIN RES, V98, P289, DOI 10.1016/S0166-4328(98)00095-3; BATSON JD, 1992, J COMP PSYCHOL, V106, P114, DOI 10.1037/0735-7036.106.2.114; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; CIPOLLANETO J, 1982, EXP BRAIN RES, V48, P22; CLAYTON N, 1993, J COMP PHYSIOL A, V171, P799, DOI 10.1007/BF00213076; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Heuts BA, 2005, BEHAV BRAIN SCI, V28, P601, DOI 10.1017/S0140525X05350102; Kells AR, 2001, J INSECT BEHAV, V14, P47, DOI 10.1023/A:1007897512570; Komischke B, 2003, BEHAV BRAIN RES, V145, P135, DOI 10.1016/S0166-4328(03)00105-0; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MOORE D, 1983, BIOL BULL, V164, P471, DOI 10.2307/1541256; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ, 2002, COMP VERTEBRATE LATE; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Zhang SW, 2006, J EXP BIOL, V209, P4420, DOI 10.1242/jeb.02522	22	107	109	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2340	10.1371/journal.pone.0002340	http://dx.doi.org/10.1371/journal.pone.0002340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523636	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300033
J	Zhang, P; Dixon, M; Zucchelli, M; Hambiliki, F; Levkov, L; Hovatta, O; Kere, J				Zhang, Pu; Dixon, Morag; Zucchelli, Marco; Hambiliki, Fredwell; Levkov, Lev; Hovatta, Outi; Kere, Juha			Expression Analysis of the NLRP Gene Family Suggests a Role in Human Preimplantation Development	PLOS ONE			English	Article								Background: The NLRP (Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing) family, also referred to as NALP family, is well known for its roles in apoptosis and inflammation. Several NLRPs have been indicated as being involved in reproduction as well. Methodology: We studied, using the unique human gametes and embryo materials, the expression of the NLRP family in human gametes and preimplantation embryos at different developmental stages, and compared the expression levels between normal and abnormal embryos using real-time PCR. Principal Findings: Among 14 members of the NLRP family, twelve were detected in human oocytes and preimplantation embryos, whereas seven were detected in spermatozoa. Eight NLRPs (NLRP4, 5, 8, 9, 11, 12, 13, and 14) showed a similar expression pattern: their expression levels were high in oocytes and then decreased progressively in embryos, resulting in a very low level in day 5 embryos. However, NLRP2 and NLRP7 showed a different expression pattern: their expression decreased from oocytes to the lowest level by day 3, but increased again by day 5. The expression levels of NLRP5, 9, and 12 were lower in day 1 abnormal embryos but higher in day3 and day5 arrested embryos, when compared with normal embryos at the same stages. NLRP7 was down-regulated in day 1 and day 5 abnormal embryos but over-expressed in day3 arrested embryos. Conclusions: According to our results, different NLRPs possibly work in a stage-dependent manner during human preimplantation development.	[Zhang, Pu; Dixon, Morag; Zucchelli, Marco; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr Novum, Huddinge, Sweden; [Hambiliki, Fredwell; Levkov, Lev; Hovatta, Outi] Karolinska Univ Hosp Huddinge, Dept Clin Sci, Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden; [Hambiliki, Fredwell] Uppsala Univ Hosp, Dept Gynecol, Ctr Reprod, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital	Zhang, P (corresponding author), Karolinska Inst, Dept Biosci & Nutr Novum, Huddinge, Sweden.	juha.kere@biosci.ki.se	Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Tolvi, Morag/B-9491-2019	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Tolvi, Morag/0000-0002-8794-6661	Swedish Research Council; Stockholm County; Karolinska University Hospital; Academy of Finland; Sigrid Juselius Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County(Stockholm County Council); Karolinska University Hospital(Karolinska Institutet); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was supported by grants from the Swedish Research Council, Stockholm County and Karolinska University Hospital (ALF), Academy of Finland and Sigrid Juselius Foundation.	Dade S, 2004, BIOCHEM BIOPH RES CO, V324, P547, DOI 10.1016/j.bbrc.2004.09.086; Dalbies-Tran R, 2005, MOL REPROD DEV, V71, P414, DOI 10.1002/mrd.20298; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Horikawa M, 2005, BIOL REPROD, V72, P879, DOI 10.1095/biolreprod.104.033753; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Ponsuksili S, 2006, BIOL REPROD, V74, P577, DOI 10.1095/biolreprod.105.045096; Qian JH, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9498; Rao KMK, 2006, J TOXICOL ENV HEAL A, V69, P481, DOI 10.1080/15287390500247025; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; ZHANG P, 2006, FERTIL STERIL	25	99	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2755	10.1371/journal.pone.0002755	http://dx.doi.org/10.1371/journal.pone.0002755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648497	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900025
J	Hao, M; Zhao, YQ; Chen, PZ; Huang, H; Liu, H; Jiang, HL; Zhang, RW; Wang, H				Hao, Miao; Zhao, Yuqing; Chen, Peizhan; Huang, He; Liu, Hong; Jiang, Hualiang; Zhang, Ruiwen; Wang, Hui			Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes	PLOS ONE			English	Article							INDIVIDUAL GINSENOSIDES; LIQUID-CHROMATOGRAPHY; ALPHA-NAPHTHOFLAVONE; ENDOGENOUS STEROIDS; CATALYTIC ACTIVITY; CYTOCHROME-P450; GINSENG; CYP3A4; TESTOSTERONE; INHIBITION	Ginseng, a traditional herbal medicine, may interact with several co-administered drugs in clinical settings, and ginsenosides, the major active components of ginseng, may be responsible for these ginseng-drug interactions (GDIs). Results from previous studies on ginsenosides' effects on human drug-metabolizing P450 enzymes are inconsistent and confusing. Herein, we first evaluated the inhibitory effects of fifteen ginsenosides and sapogenins on human CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 enzymes by using commercially available fluorescent probes. The structure-activity relationship of their effects on the P450s was also explored and a pharmacophore model was established for CYP3A4. Moreover, substrate-dependent phenomena were found in ginsenosides' effects on CYP3A4 when another fluorescent probe was used, and were further confirmed in tests with conventional drug probes and human liver microsomes. These substrate-dependent effects of the ginsenosides may provide an explanation for the inconsistent results obtained in previous GDI reports.	[Hao, Miao; Chen, Peizhan; Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Zhao, Yuqing] Shenyang Pharm Univ, Shenyang, Peoples R China; [Huang, He; Liu, Hong; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China; [Zhang, Ruiwen] Univ Alabama Birmingham, Comprehensive Canc Ctr, Div Clin Pharmacol, Dept Pharmacol & Toxicol, Birmingham, AL USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Alabama System; University of Alabama Birmingham	Hao, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	hao, miao/HII-4487-2022		Science and Technology Commission of Shanghai Municipality; Pujiang Talent Program; Ministry of Science and Technology of China (973 Program); Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS; NIH/NCI;  [06DZ19021];  [06PJ14107];  [2007CB947100];  [R01 CA112029];  [R01 CA121211]; NATIONAL CANCER INSTITUTE [R01CA121211, R01CA112029] Funding Source: NIH RePORTER	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Pujiang Talent Program; Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS(Knowledge Innovation Program of the Chinese Academy of Sciences); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant (06DZ19021) from the Science and Technology Commission of Shanghai Municipality, Pujiang Talent Program (06PJ14107), a grant (2007CB947100) from the Ministry of Science and Technology of China (973 Program) and the Knowledge Innovation Program of Chinese Academy of Sciences, Food Safety Research Center and Key Laboratory of Nutrition and Metabolism in INS. R.Z. was supported in part by NIH/NCI grants R01 CA112029 and R01 CA121211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger DL, 2005, BRIT J PHARMACOL, V145, P926, DOI 10.1038/sj.bjp.0706255; Ansede JH, 2004, J PHARM SCI-US, V93, P239, DOI 10.1002/jps.10545; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Brown HS, 2006, CLIN PHARMACOKINET, V45, P1035, DOI 10.2165/00003088-200645100-00006; Cameron MD, 2005, BIOCHEMISTRY-US, V44, P14143, DOI 10.1021/bi051689t; Chang TKH, 2002, DRUG METAB DISPOS, V30, P378, DOI 10.1124/dmd.30.4.378; Cohen LH, 2003, DRUG METAB DISPOS, V31, P1005, DOI 10.1124/dmd.31.8.1005; de Groot MJ, 2006, DRUG DISCOV TODAY, V11, P601, DOI 10.1016/j.drudis.2006.05.001; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Fuzzati N, 2004, J CHROMATOGR B, V812, P119, DOI 10.1016/j.jchromb.2004.07.039; Gurley BJ, 2002, CLIN PHARMACOL THER, V72, P276, DOI 10.1067/mcp.2002.126913; Hasegawa H, 2004, J PHARMACOL SCI, V95, P153, DOI 10.1254/jphs.FMJ04001X4; He N, 2006, CLIN EXP PHARMACOL P, V33, P813, DOI 10.1111/j.1440-1681.2006.04445.x; He Nu, 2004, Am J Ther, V11, P206, DOI 10.1097/00045391-200405000-00009; Helms Steve, 2004, Altern Med Rev, V9, P259; Henderson GL, 1999, LIFE SCI, V65, pPL209, DOI 10.1016/S0024-3205(99)00407-5; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Ji HY, 2004, J PHARMACEUT BIOMED, V35, P207, DOI 10.1016/j.jpba.2003.12.020; Jiang XM, 2004, BRIT J CLIN PHARMACO, V57, P592, DOI 10.1111/j.1365-2125.2003.02051.x; Kim MJ, 2005, RAPID COMMUN MASS SP, V19, P2651, DOI 10.1002/rcm.2110; Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164; Lu P, 2001, DRUG METAB DISPOS, V29, P1473; Marks BD, 2003, AAPS PHARMSCI, V5; Marks BD, 2004, J BIOMOL SCREEN, V9, P439, DOI 10.1177/1087057104263440; Marks BD, 2002, ASSAY DRUG DEV TECHN, V1, P73, DOI 10.1089/154065802761001329; Nakamura H, 2003, DRUG METAB DISPOS, V31, P432, DOI 10.1124/dmd.31.4.432; Nakamura H, 2002, DRUG METAB DISPOS, V30, P534, DOI 10.1124/dmd.30.5.534; Nasrallah HA, 2006, J AFFECT DISORDERS, V95, P69, DOI 10.1016/j.jad.2006.04.030; Niwa T, 2005, BIOL PHARM BULL, V28, P1805, DOI 10.1248/bpb.28.1805; Patel Jignesh, 2004, Am J Ther, V11, P262, DOI 10.1097/01.mjt.0000101827.94820.22; Peebles CT, 2000, EPILEPSY BEHAV, V1, P74, DOI 10.1006/ebeh.2000.0031; Racha Jagdish K, 2003, Drug Metab Pharmacokinet, V18, P128, DOI 10.2133/dmpk.18.128; Roberts AG, 2007, ARCH BIOCHEM BIOPHYS, V463, P89, DOI 10.1016/j.abb.2007.03.006; Sparreboom A, 2004, J CLIN ONCOL, V22, P2489, DOI 10.1200/JCO.2004.08.182; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Torimoto N, 2003, BIOCHEMISTRY-US, V42, P15068, DOI 10.1021/bi034409n; Trubetskoy O, 2005, AAPS J, V7, pE6, DOI 10.1208/aapsj070102; Trubetskoy OV, 2005, J BIOMOL SCREEN, V10, P56, DOI 10.1177/1087057104269731; Wang HL, 1999, J CHROMATOGR B, V731, P403, DOI 10.1016/S0378-4347(99)00238-8; Wang RW, 2000, DRUG METAB DISPOS, V28, P360; Wang W, 2007, CANCER CHEMOTH PHARM, V59, P589, DOI 10.1007/s00280-006-0300-z; Weaver R, 2003, DRUG METAB DISPOS, V31, P955, DOI 10.1124/dmd.31.7.955; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zhao Y, 2007, MED CHEM, V3, P51, DOI 10.2174/157340607779317508	46	55	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2697	10.1371/journal.pone.0002697	http://dx.doi.org/10.1371/journal.pone.0002697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628990	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200040
J	Qin, H; Lu, M; Goldfarb, DS				Qin, Hong; Lu, Meng; Goldfarb, David S.			Genomic Instability Is Associated with Natural Life Span Variation in Saccharomyces cerevisiae	PLOS ONE			English	Article								Increasing genomic instability is associated with aging in eukaryotes, but the connection between genomic instability and natural variation in life span is unknown. We have quantified chronological life span and loss-of-heterozygosity (LOH) in 11 natural isolates of Saccharomyces cerevisiae. We show that genomic instability increases and mitotic asymmetry breaks down during chronological aging. The age-dependent increase of genomic instability generally lags behind the drop of viability and this delay accounts for similar to 50% of the observed natural variation of replicative life span in these yeast isolates. We conclude that the abilities of yeast strains to tolerate genomic instability co-vary with their replicative life spans. To the best of our knowledge, this is the first quantitative evidence that demonstrates a link between genomic instability and natural variation in life span.	[Qin, Hong; Lu, Meng] Univ Rochester, Dept Biol, Ctr Aging & Dev Biol, Rochester, NY 14627 USA; [Goldfarb, David S.] Univ Rochester, Dept Biol, Rochester, NY USA	University of Rochester; University of Rochester	Qin, H (corresponding author), Univ Rochester, Dept Biol, Ctr Aging & Dev Biol, Rochester, NY 14627 USA.	hong.qin@tuskegee.edu		Qin, Hong/0000-0002-1060-6722	Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging; NIH/NIA [P30AG18254, R01GM67838, R03AG23270, R03MH76395]; Glenn Foundation for Medical Research through the University of Rochester [fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH076395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023270, P30AG018254] Funding Source: NIH RePORTER	Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research through the University of Rochester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is partially supported by a pilot grant to HQ from the Rochester Nathan Shock Center for Excellency in the Basic Biology of Aging (NIH/NIA P30AG18254) and a fellowship to HQ from the Glenn Foundation for Medical Research through the University of Rochester. DSG acknowledges the support of NIH grants (R01GM67838, R03AG23270, and R03MH76395).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cost GJ, 1996, YEAST, V12, P939, DOI 10.1002/(SICI)1097-0061(199608)12:10<939::AID-YEA988>3.0.CO;2-L; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Hoopes LLM, 2002, MOL CELL BIOL, V22, P4136, DOI 10.1128/MCB.22.12.4136-4146.2002; Jazwinski SM, 2000, TRENDS GENET, V16, P506, DOI 10.1016/S0168-9525(00)02119-3; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lai CY, 2002, GENETICS, V162, P73; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; MacLean M, 2001, YEAST, V18, P499, DOI 10.1002/yea.701; Madia F, 2007, MECH AGEING DEV, V128, P45, DOI 10.1016/j.mad.2006.11.009; McMurray MA, 2004, CURR OPIN MICROBIOL, V7, P673, DOI 10.1016/j.mib.2004.10.008; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park PU, 2002, METHOD ENZYMOL, V351, P468; Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x; Preston CR, 2006, CURR BIOL, V16, P2009, DOI 10.1016/j.cub.2006.08.058; Qin H, 2006, EXP GERONTOL, V41, P448, DOI 10.1016/j.exger.2006.01.007; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vettraino J, 2001, J GERONTOL A-BIOL, V56, pB415, DOI 10.1093/gerona/56.10.B415; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; WILSON DL, 1993, MECH AGEING DEV, V66, P269, DOI 10.1016/0047-6374(93)90014-I	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2670	10.1371/journal.pone.0002670	http://dx.doi.org/10.1371/journal.pone.0002670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628831	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200015
J	Yizhar, O; Ashery, U				Yizhar, Ofer; Ashery, Uri			Modulating Vesicle Priming Reveals that Vesicle Immobilization Is Necessary but not Sufficient for Fusion-Competence	PLOS ONE			English	Article								In neurons and neuroendocrine cells, docked vesicles need to undergo priming to become fusion competent. Priming is a multi-step process that was shown to be associated with vesicle immobilization. However, it is not known whether vesicle immobilization is sufficient to acquire complete fusion competence. To extend our understanding of the physical manifestation of vesicle priming, we took advantage of tomosyn, a SNARE-related protein that specifically inhibits vesicle priming, and measured its effect on vesicle dynamics in live chromaffin cells using total internal reflection fluorescence microscopy. We show here that while in control cells vesicles undergo immobilization before fusion, vesicle immobilization is attenuated in tomosyn overexpressing cells. This in turn increases the turnover rate of vesicles near the membrane and attenuates the fusion of newcomer vesicles. Moreover, the release probability of immobile vesicles in tomosyn cells is significantly reduced, suggesting that immobilization is an early and necessary step in priming but is insufficient, as further molecular processes are needed to acquire complete fusion competence. Using tomosyn as a molecular tool we provide a mechanistic link between functional docking and priming and suggest that functional docking is the first step in vesicle priming, followed by molecular modifications that do not translate into changes in vesicle mobility.	[Yizhar, Ofer; Ashery, Uri] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Yizhar, O (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	uria@post.tau.ac.il	YIZHAR, OFER/AAV-8497-2021	Ashery, Uri/0000-0001-6338-7888; Yizhar, Ofer/0000-0003-4228-1448	Israel Science Foundation [424/02-16.6, 1211/07]; Adams Supercenter for Brain Studies; National Institutes of Health [RO1 NS053978]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Adams Supercenter for Brain Studies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Israel Science Foundation (grant 424/02-16.6 and 1211/07 to U.A.), the Adams Supercenter for Brain Studies, and the National Institutes of Health (RO1 NS053978; U.A.).	Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; DEGTYAR VE, 2007, P NATL ACAD SCI US; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; GRACHEVA EO, 2007, J PHYSL; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Lonart G, 2000, J BIOL CHEM, V275, P27703; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neco P, 2002, BIOCHEM J, V368, P405, DOI 10.1042/BJ20021090; Nili U, 2006, NEUROSCIENCE, V143, P487, DOI 10.1016/j.neuroscience.2006.08.014; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; YIZHAR O, 2007, J NEUROCHEM IN PRESS; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2694	10.1371/journal.pone.0002694	http://dx.doi.org/10.1371/journal.pone.0002694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628949	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200037
J	Chen, YC; Hsu, HS; Chen, YW; Tsai, TH; How, CK; Wang, CY; Hung, SC; Chang, YL; Tsai, ML; Lee, YY; Ku, HH; Chiou, SH				Chen, Yu-Chih; Hsu, Han-Shui; Chen, Yi-Wei; Tsai, Tung-Hu; How, Chorng-Kuang; Wang, Chien-Ying; Hung, Shih-Chieh; Chang, Yuh-Lih; Tsai, Ming-Long; Lee, Yi-Yen; Ku, Hung-Hai; Chiou, Shih-Hwa			Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM; GENE-EXPRESSION; SIDE POPULATION; IDENTIFICATION; PLURIPOTENCY; CONTRIBUTE; PROMOTER; PROTEIN; TUMORS	CD133 (prominin-1), a 5-transmembrane glycoprotein, has recently been considered to be an important marker that represents the subset population of cancer stem-like cells. Herein we report the isolation of CD133-positive cells (LC-CD133(+)) and CD133-negative cells (LC-CD133(-)) from tissue samples of ten patients with non-small cell lung cancer (LC) and five LC cell lines. LC-CD133(+) displayed higher Oct-4 expressions with the ability to self-renew and may represent a reservoir with proliferative potential for generating lung cancer cells. Furthermore, LC-CD133(+), unlike LC-CD133(-), highly co-expressed the multiple drug-resistant marker ABCG2 and showed significant resistance to chemotherapy agents (i.e., cisplatin, etoposide, doxorubicin, and paclitaxel) and radiotherapy. The treatment of Oct-4 siRNA with lentiviral vector can specifically block the capability of LC-CD133(+) to form spheres and can further facilitate LC-CD133(+) to differentiate into LC-CD133(-). In addition, knock-down of Oct-4 expression in LC-CD133(+) can significantly inhibit the abilities of tumor invasion and colony formation, and increase apoptotic activities of caspase 3 and poly (ADP-ribose) polymerase ( PARP). Finally, in vitro and in vivo studies further confirm that the treatment effect of chemoradiotherapy for LC-CD133(+) can be improved by the treatment of Oct-4 siRNA. In conclusion, we demonstrated that Oct-4 expression plays a crucial role in maintaining the self-renewing, cancer stem-like, and chemoradioresistant properties of LC-CD133(+). Future research is warranted regarding the up-regulated expression of Oct-4 in LC-CD133(+) and malignant lung cancer.	[Chen, Yu-Chih; Hsu, Han-Shui; Chen, Yi-Wei; How, Chorng-Kuang; Wang, Chien-Ying; Hung, Shih-Chieh; Lee, Yi-Yen; Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Tung-Hu; Chang, Yuh-Lih] Natl Yang Ming Univ, Inst Traditional Med, Taipei, Taiwan; [Hsu, Han-Shui; How, Chorng-Kuang] Natl Yang Ming Univ, Inst Emergency & Critical Care Med, Taipei, Taiwan; [Ku, Hung-Hai] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan; [Hsu, Han-Shui] Natl Yang Ming Univ, Taipei Veterans Gen Hosp, Dept Surg, Div Thoracic Surg, Taipei, Taiwan; [Chen, Yi-Wei] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan; [How, Chorng-Kuang; Wang, Chien-Ying] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency, Taipei, Taiwan; [Hung, Shih-Chieh; Chang, Yuh-Lih; Tsai, Ming-Long; Chiou, Shih-Hwa] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Med Res & Ed, Taipei, Taiwan; [Tsai, Tung-Hu; Lee, Yi-Yen; Ku, Hung-Hai] Taipei City Hosp, Dept Med Res & Ed, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Ku, HH (corresponding author), Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan.	hhku@ym.edu.tw; shchiou@vghtpe.gov.tw	Chen, Yi/HIR-2608-2022; Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547	National Science Council [96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024]; Taipei Veterans General Hospital [V96C1-151, V96E1-004, V96ER2-016, V96E2-010]; Joint Projects of UTVGH [VGHUST96-P1-07]; Yen-Tjing-Ling Medical Foundation, Taipei City Hospital [96001-62-014, 96001-62-018, 96002-62-092]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint Projects of UTVGH; Yen-Tjing-Ling Medical Foundation, Taipei City Hospital; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024), Taipei Veterans General Hospital (V96C1-151, V96E1-004, V96ER2-016, V96E2-010), the Joint Projects of UTVGH (VGHUST96-P1-07), Yen-Tjing-Ling Medical Foundation, Taipei City Hospital (96001-62-014, 96001-62-018, 96002-62-092), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bernstein ED, 2006, ANN SURG ONCOL, V13, P291, DOI 10.1245/ASO.2006.01.015; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bruno S, 2006, AM J PATHOL, V169, P2223, DOI 10.2353/ajpath.2006.060498; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hsu HS, 2005, CLIN CANCER RES, V11, P5410, DOI 10.1158/1078-0432.CCR-05-0601; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Lamb KA, 1998, MOL REPROD DEV, V51, P218; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olempska M, 2007, HEPATOB PANCREAT DIS, V6, P92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Socinski MA, 2007, J CLIN ONCOL, V25, P4137, DOI 10.1200/JCO.2007.11.5303; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Wang PX, 2003, BIOCHEM J, V375, P199, DOI 10.1042/BJ20030579; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	362	397	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2637	10.1371/journal.pone.0002637	http://dx.doi.org/10.1371/journal.pone.0002637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612434	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800039
J	Dechartres, A; Boutron, I; Nizard, R; Poiraudeau, S; Roy, C; Baron, G; Ravaud, P; Ravaud, JF				Dechartres, Agnes; Boutron, Isabelle; Nizard, Remy; Poiraudeau, Serge; Roy, Carine; Baron, Gabriel; Ravaud, Philippe; Ravaud, Jean-Francois			Knee Arthroplasty: Disabilities in Comparison to the General Population and to Hip Arthroplasty Using a French National Longitudinal Survey	PLOS ONE			English	Article								Background: Knee arthroplasty is increasing exponentially due to the aging of the population and to the broadening of indications. We aimed to compare physical disability and its evolution over two years in people with knee arthroplasty to that in the general population. A secondary objective was to compare the level of disabilities of people with knee to people with hip arthroplasty. Methodology/Principal Findings: 16,945 people representative of the French population were selected in 1999 from the French census and interviewed about their level of disability. This sample included 815 people with lower limb arthroplasty. In 2001, 608 of them were re-interviewed, among whom 134 had knee arthroplasty. Among the other participants reinterviewed, we identified 68 who had undergone knee arthroplasty and 145 hip arthroplasty within the last two years (recent arthroplasty). People with knee arthroplasty reported significantly greater difficulties than the general population with bending forward (odds ratio [OR] = 4.7; 95% confidence interval [CI]: 1.7, 12.6), walking more than 500 meters (OR = 6.0; 95% CI: 1.5, 24.7) and carrying 5 kg kilograms for 10 meters (OR = 4.6; 95% CI: 1.3, 16.4). However, the two years evolution in disability was similar to that in the general population for most activities. The level of mobility was similar between people with recent knee arthroplasty and those with recent hip arthroplasty. Nevertheless, people with recent knee arthroplasty reported a lower level of disability than the other group for washing and bending forward (OR = 0.3; 95% CI: 0.1, 0.6 and OR = 0.4; 95% CI: 0.1, 0.9, respectively). Conclusions/Significance: People with knee arthroplasty reported a higher risk of disability than the general population for common activities of daily living but a similar evolution. There was no relevant difference between recent knee and hip arthroplasties for mobility.	[Dechartres, Agnes; Boutron, Isabelle; Roy, Carine; Baron, Gabriel; Ravaud, Philippe] INSERM, U738, Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Roy, Carine; Baron, Gabriel; Ravaud, Philippe] Univ Paris 07, UFR Med, Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Roy, Carine; Baron, Gabriel; Ravaud, Philippe] Biostat Reche Clin, Dept Epidemiol, Hop Bichat, AP HP, Paris, France; [Nizard, Remy] Assistance Publ Hop Paris AP HP, Hop Lariboisiere, Serv Orthoped, Paris, France; [Nizard, Remy] Univ Paris 07, Paris, France; [Poiraudeau, Serge] Assistance Publ Hop Paris AP HP, Hop Cochin, Serv Med Phys Readaptat, Paris, France; [Poiraudeau, Serge] Univ Paris 05, Paris, France; [Ravaud, Jean-Francois] INSERM, U750 CERMES, Paris, France; [Poiraudeau, Serge; Ravaud, Jean-Francois] Inst Federatif Rech Handicap, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dechartres, A (corresponding author), INSERM, U738, Paris, France.	isabelle.boutron@bch.aphp.fr	RAVAUD, Jean-François/F-7190-2013; Nizard, Remy/R-5845-2019; ravaud, philippe/C-1694-2009	RAVAUD, Jean-François/0000-0003-3959-4195; Poiraudeau, Serge/0000-0002-1988-9124; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was supported by a grant from INSERM to IFR 25 for the RRC-SP "endoprotheses". The funders had a role in study design and data collection but not in analysis, decision to publish, or preparation of the manuscript.	AMADIO PC, 1993, J BONE JOINT SURG AM, V75A, P1583, DOI 10.2106/00004623-199311000-00001; Bachmeier CJM, 2001, OSTEOARTHR CARTILAGE, V9, P137, DOI 10.1053/joca.2000.0369; Courpied JP, 2001, REV CHIR ORTHOP, V87, P424; Dechartres A, 2007, ARTHRIT RHEUM-ARTHR, V57, P364, DOI 10.1002/art.22607; Field RE, 2005, J BONE JOINT SURG BR, V87B, P618, DOI 10.1302/0301-620X.87B5.15390; Fitz Gerald JD, 2004, ARTHRIT RHEUM-ARTHR, V51, P100, DOI 10.1002/art.20090; FITZPATRICK R, 1992, BRIT MED J, V305, P1074, DOI 10.1136/bmj.305.6861.1074; Forrest GP, 1999, ARCH PHYS MED REHAB, V80, P192, DOI 10.1016/S0003-9993(99)90120-X; Fortin PR, 1999, ARTHRITIS RHEUM, V42, P1722, DOI 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R; Fortin PR, 2002, ARTHRITIS RHEUM, V46, P3327, DOI 10.1002/art.10631; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Jain NB, 2005, ARTHRITIS RHEUM-US, V52, P3928, DOI 10.1002/art.21420; Jones CA, 2000, J RHEUMATOL, V27, P1745; Kiebzak G M, 1997, J South Orthop Assoc, V6, P169; Kiebzak GM, 2002, AM J MANAG CARE, V8, P463; KIRWAN JR, 1994, BRIT J RHEUMATOL, V33, P357; Kreder HJ, 1997, J BONE JOINT SURG AM, V79A, P485, DOI 10.2106/00004623-199704000-00003; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Leclerc A, 2006, SPINE, V31, P479, DOI 10.1097/01.brs.0000199939.53256.e0; Mainard D, 2000, REV CHIR ORTHOP, V86, P464; March LM, 1999, MED J AUSTRALIA, V171, P235; Noble PC, 2005, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000150130.03519.fb; *OBJ SCHEM ORG COU, 1998, ENQ HID INSEE; Praemer A, 1999, MUSCULOSKELETAL COND, P119; RISSANEN P, 1995, J ARTHROPLASTY, V10, P169, DOI 10.1016/S0883-5403(05)80123-8; Rissanen P, 1996, QUAL LIFE RES, V5, P56, DOI 10.1007/BF00435969; Ritter MA, 1995, J ARTHROPLASTY, V10, P737, DOI 10.1016/S0883-5403(05)80068-3; Salmon P, 2001, ARCH PHYS MED REHAB, V82, P360, DOI 10.1053/apmr.2001.21522; Shields RK, 1999, ARCH PHYS MED REHAB, V80, P572, DOI 10.1016/S0003-9993(99)90202-2; *UN SD, 1996, MAN DEV STAT INF DIS; Walker DJ, 2002, RHEUMATOLOGY, V41, P755, DOI 10.1093/rheumatology/41.7.755; Weiss JM, 2002, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000036536.46246.d9; ZHENYI XEL, BUILDING LOGISTIC RE	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2561	10.1371/journal.pone.0002561	http://dx.doi.org/10.1371/journal.pone.0002561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596961	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200028
J	Karkan, D; Pfeifer, C; Vitalis, TZ; Arthur, G; Ujiie, M; Chen, QQ; Tsai, S; Koliatis, G; Gabathuler, R; Jefferies, WA				Karkan, Delara; Pfeifer, Cheryl; Vitalis, Timothy Z.; Arthur, Gavin; Ujiie, Maki; Chen, Qingqi; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.			A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier	PLOS ONE			English	Article							ANTITRANSFERRIN RECEPTOR ANTIBODY; MELANOMA-ASSOCIATED ANTIGEN-P97; GLYCOPROTEIN-MEDIATED EFFLUX; CENTRAL-NERVOUS-SYSTEM; 1ST TOTAL-SYNTHESIS; TRANSFERRIN RECEPTOR; ALZHEIMERS-DISEASE; DRUG-DELIVERY; IN-VITRO; P-GLYCOPROTEIN	Background: Therapeutic intervention in many neurological diseases is thwarted by the physical obstacle formed by the blood-brain barrier (BBB) that excludes most drugs from entering the brain from the blood. Thus, identifying efficacious modes of drug delivery to the brain remains a "holy grail'' in molecular medicine and nanobiotechnology. Brain capillaries, that comprise the BBB, possess an endogenous receptor that ferries an iron-transport protein, termed p97 (melanotransferrin), across the BBB. Here, we explored the hypothesis that therapeutic drugs "piggybacked'' as conjugates of p97 can be shuttled across the BBB for treatment of otherwise inoperable brain tumors. Approach: Human p97 was covalently linked with the chemotherapeutic agents paclitaxel (PTAX) or adriamycin (ADR) and following intravenous injection, measured their penetration into brain tissue and other organs using radiolabeled and fluorescent derivatives of the drugs. In order to establish efficacy of the conjugates, we used nude mouse models to assess p97-drug conjugate activity towards glioma and mammary tumors growing subcutaneously compared to those growing intracranially. Principal Findings: Bolus-injected p97-drug conjugates and unconjugated p97 traversed brain capillary endothelium within a few minutes and accumulated to 1-2% of the injected by 24 hours. Brain delivery with p97-drug conjugates was quantitatively 10 fold higher than with free drug controls. Furthermore, both free-ADR and p97-ADR conjugates equally inhibited the subcutaneous growth of gliomas growing outside the brain. Evocatively, only p97-ADR conjugates significantly prolonged the survival of animals bearing intracranial gliomas or mammary tumors when compared to similar cumulated doses of free-ADR. Significance: This study provides the initial proof of concept for p97 as a carrier capable of shuttling therapeutic levels of drugs from the blood to the brain for the treatment of neurological disorders, including classes of resident and metastatic brain tumors. It may be prudent, therefore, to consider implementation of this novel delivery platform in various clinical settings for therapeutic intervention in acute and chronic neurological diseases.	[Karkan, Delara; Vitalis, Timothy Z.; Arthur, Gavin; Chen, Qingqi; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard] BioMarin Pharmaceut Inc, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Med Genet, Michael Smith Lab, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Microbiol & Immunol, Michael Smith Lab, Vancouver, BC, Canada; [Pfeifer, Cheryl; Vitalis, Timothy Z.; Ujiie, Maki; Tsai, Sam; Koliatis, Gerrasimo; Gabathuler, Reinhard; Jefferies, Wilfred A.] Univ British Columbia, Biomed Res Ctr, Dept Zool, Michael Smith Lab, Vancouver, BC, Canada	BioMarin Pharmaceutical Inc.; University of British Columbia; University of British Columbia; University of British Columbia	Karkan, D (corresponding author), BioMarin Pharmaceut Inc, Vancouver, BC, Canada.	wilf@brc.ubc.ca		Pfeifer, Cheryl/0000-0001-8584-228X	BioMarin Pharmaceutical (Canada) Inc.; Canadian Institute of Health Research	BioMarin Pharmaceutical (Canada) Inc.; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Financial support for this study was provided by BioMarin Pharmaceutical (Canada) Inc. (Formerly Synapse Technologies Inc.) and by grants to WAJ from the Canadian Institute of Health Research. These studies were performed at BioMarin Pharmaceutical (Canada) Inc. (Formerly Synapse Technologies Inc., Vancouver, Canada) and in the laboratory of WAJ at the University of British Columbia, Canada.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Ambruosi A, 2006, J MICROENCAPSUL, V23, P582, DOI 10.1080/02652040600788080; ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607; Ayrton A, 2001, XENOBIOTICA, V31, P469, DOI 10.1080/00498250110060969; BANKS WA, 1994, J NEUROCHEM, V62, P2404; Bartus R T, 1999, Curr Opin Drug Discov Devel, V2, P152; Bicamumpaka C, 1998, ONCOL REP, V5, P1381; BLASBERG RG, 1983, ANN NEUROL, V14, P202, DOI 10.1002/ana.410140207; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P215, DOI 10.1038/jcbfm.1983.29; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Brigger I, 2004, J CONTROL RELEASE, V100, P29, DOI 10.1016/j.jconrel.2004.07.019; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; *BRIST MYERSSQUIBB, 2004, GREEN SYNTH PATHW AW; BROWN JP, 1982, NATURE, V296, P171, DOI 10.1038/296171a0; Chen Y., 2004, Current Drug Delivery, V1, P361, DOI 10.2174/1567201043334542; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Coloma MJ, 2000, PHARMACEUT RES, V17, P266, DOI 10.1023/A:1007592720793; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Demeule M, 2003, BLOOD, V102, P1723, DOI 10.1182/blood-2003-01-0166; Demeule M, 2002, J NEUROCHEM, V83, P924, DOI 10.1046/j.1471-4159.2002.01201.x; Egleton Richard D, 2005, NeuroRx, V2, P44, DOI 10.1007/BF03206641; Fillebeen C, 1999, J BIOL CHEM, V274, P7011, DOI 10.1074/jbc.274.11.7011; Fine RL, 2006, CLIN CANCER RES, V12, P5770, DOI 10.1158/1078-0432.CCR-05-2356; FOOD MR, 1994, J BIOL CHEM, V269, P3034; FORNARI FA, 1994, MOL PHARMACOL, V45, P649; FRIDEN PM, 1993, ADV EXP MED BIOL, V331, P129; Gao KP, 2006, INT J PHARMACEUT, V310, P213, DOI 10.1016/j.ijpharm.2005.11.040; Goodman J., 2001, STORY TAXOL NATURE P; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; HEIMANS JJ, 1994, ANN ONCOL, V5, P951, DOI 10.1093/oxfordjournals.annonc.a058736; HELLSTROM I, 1983, INT J CANCER, V31, P553, DOI 10.1002/ijc.2910310505; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; HOLTON RA, 1995, SCI APPL, P97; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; JEFFERIES WA, 1985, IMMUNOLOGY, V54, P333; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kas HS, 2004, ADV EXP MED BIOL, V553, P221; KAYE AH, 1986, CANCER RES, V46, P1367; KENNARD ML, 1993, BIOTECHNOL BIOENG, V42, P480, DOI 10.1002/bit.260420411; Kennard ML, 1996, NAT MED, V2, P1230, DOI 10.1038/nm1196-1230; Kim DK, 2001, NEUROPSYCHOPHARMACOL, V25, P84, DOI 10.1016/S0893-133X(00)00230-X; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; KONDO A, 1987, BRAIN RES, V412, P73, DOI 10.1016/0006-8993(87)91441-7; Kratz F, 1998, J PHARM SCI-US, V87, P338, DOI 10.1021/js970246a; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Lee HJ, 2000, J PHARMACOL EXP THER, V292, P1048; Lee HJ, 2002, J CEREBR BLOOD F MET, V22, P223, DOI 10.1097/00004647-200202000-00010; *MAYOCLINIC MICR, 2007, DOX INTR ROUT; McAllister LD, 2000, NEUROSURGERY, V46, P51, DOI 10.1093/neurosurgery/46.1.51; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Moos T, 2001, J NEUROCHEM, V79, P119, DOI 10.1046/j.1471-4159.2001.00541.x; Moroo I, 2003, MICROCIRCULATION, V10, P457, DOI 10.1038/sj.mn.7800213; NEUWELT EA, 1980, NEUROSURGERY, V6, P49, DOI 10.1227/00006123-198001000-00007; NEUWELT EA, 1979, J CLIN INVEST, V64, P684, DOI 10.1172/JCI109509; NEUWELT EA, 1980, NEUROSURGERY, V7, P44, DOI 10.1227/00006123-198007000-00007; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; OHKAWA K, 1993, CANCER RES, V53, P4238; OHNISHI T, 1995, BIOCHEM PHARMACOL, V49, P1541, DOI 10.1016/0006-2952(95)00082-B; Olivier Jean-Christophe, 2005, NeuroRx, V2, P108, DOI 10.1007/BF03206647; Pan WH, 1999, EXP NEUROL, V160, P454, DOI 10.1006/exnr.1999.7215; PAPOIAN T, 1990, AM J PATHOL, V136, P1201; Pardridge W M, 1991, Semin Cell Biol, V2, P419; PARDRIDGE WM, 1991, J PHARMACOL EXP THER, V259, P66; PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0; Pardridge WM, 1998, J NEUROCHEM, V70, P1781; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Pardridge WM., 2007, J CONTROL RELEASE; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024; Rothenberger S, 1996, BRAIN RES, V712, P117, DOI 10.1016/0006-8993(96)88505-2; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; ROYER I, 1995, RAPID COMMUN MASS SP, V9, P495, DOI 10.1002/rcm.1290090605; Saleh M, 1999, J NATL CANCER I, V91, P438, DOI 10.1093/jnci/91.5.438; Saleh M, 1997, INT J CANCER, V72, P664, DOI 10.1002/(SICI)1097-0215(19970807)72:4<664::AID-IJC19>3.3.CO;2-3; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P85, DOI 10.1046/j.1440-1681.1999.02987.x; Saunders NR, 2000, CELL MOL NEUROBIOL, V20, P29, DOI 10.1023/A:1006991809927; SELCMAN M, 1995, GLIOBLASTOMA MALIGNA, P449; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Sharma US, 1997, PHARM RES-DORDR, V14, P992, DOI 10.1023/A:1012136925030; SILBERGELD DL, 1995, ANTI-CANCER DRUG, V6, P270, DOI 10.1097/00001813-199504000-00011; Smith MW, 2006, J DRUG TARGET, V14, P191, DOI 10.1080/10611860600650086; SPARREBOOM A, 1995, J CHROMATOGR B, V664, P383, DOI 10.1016/0378-4347(94)00495-Q; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; Stewart PA, 2000, CELL MOL NEUROBIOL, V20, P149, DOI 10.1023/A:1007026504843; Strandberg JJ, 2006, TOXICOL LETT, V166, P11, DOI 10.1016/j.toxlet.2006.05.007; Takamiya Y, 1997, BRIT J CANCER, V76, P445, DOI 10.1038/bjc.1997.408; Temsamani J, 2001, EXPERT OPIN BIOL TH, V1, P773, DOI 10.1517/14712598.1.5.773; Trail PA, 1997, CANCER RES, V57, P100; Tsuji A, 1998, THER DRUG MONIT, V20, P588, DOI 10.1097/00007691-199810000-00024; Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642; UEDA F, 1993, J NEUROCHEM, V60, P106, DOI 10.1111/j.1471-4159.1993.tb05828.x; WALL ME, 1995, CANCER RES, V55, P753; Wolff JEA, 1999, J CANCER RES CLIN, V125, P481, DOI 10.1007/s004320050305; Yamada T, 1999, BRAIN RES, V845, P1, DOI 10.1016/S0006-8993(99)01767-9; Yang J, 2004, PROTEIN EXPRES PURIF, V34, P28, DOI 10.1016/j.pep.2003.09.007; Zhou QY, 2007, CLIN CANCER RES, V13, P4271, DOI 10.1158/1078-0432.CCR-07-0658; Zhou QY, 2007, J PHARMACOL EXP THER, V321, P265, DOI 10.1124/jpet.106.118265	106	71	94	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2469	10.1371/journal.pone.0002469	http://dx.doi.org/10.1371/journal.pone.0002469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575595	gold, Green Published			2022-12-27	WOS:000263288000002
J	Munson, L; Terio, KA; Kock, R; Mlengeya, T; Roelke, ME; Dubovi, E; Summers, B; Sinclair, ARE; Packer, C				Munson, Linda; Terio, Karen A.; Kock, Richard; Mlengeya, Titus; Roelke, Melody E.; Dubovi, Edward; Summers, Brian; Sinclair, Anthony R. E.; Packer, Craig			Climate Extremes Promote Fatal Co-Infections during Canine Distemper Epidemics in African Lions	PLOS ONE			English	Article							SOUTH-AFRICA; SERENGETI; MORTALITY; ECOLOGY; DISEASE; TICKS; INFECTION; PARASITES; VIRUS	Extreme climatic conditions may alter historic host-pathogen relationships and synchronize the temporal and spatial convergence of multiple infectious agents, triggering epidemics with far greater mortality than those due to single pathogens. Here we present the first data to clearly illustrate how climate extremes can promote a complex interplay between epidemic and endemic pathogens that are normally tolerated in isolation, but with co-infection, result in catastrophic mortality. A 1994 canine distemper virus (CDV) epidemic in Serengeti lions (Panthera leo) coincided with the death of a third of the population, and a second high-mortality CDV epidemic struck the nearby Ngorongoro Crater lion population in 2001. The extent of adult mortalities was unusual for CDV and prompted an investigation into contributing factors. Serological analyses indicated that at least five "silent'' CDV epidemics swept through the same two lion populations between 1976 and 2006 without clinical signs or measurable mortality, indicating that CDV was not necessarily fatal. Clinical and pathology findings suggested that hemoparsitism was a major contributing factor during fatal epidemics. Using quantitative real-time PCR, we measured the magnitude of hemoparasite infections in these populations over 22 years and demonstrated significantly higher levels of Babesia during the 1994 and 2001 epidemics. Babesia levels correlated with mortalities and extent of CDV exposure within prides. The common event preceding the two high mortality CDV outbreaks was extreme drought conditions with wide-spread herbivore die-offs, most notably of Cape buffalo (Syncerus caffer). As a consequence of high tick numbers after the resumption of rains and heavy tick infestations of starving buffalo, the lions were infected by unusually high numbers of Babesia, infections that were magnified by the immunosuppressive effects of coincident CDV, leading to unprecedented mortality. Such mass mortality events may become increasingly common if climate extremes disrupt historic stable relationships between co- existing pathogens and their susceptible hosts.	[Munson, Linda] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Terio, Karen A.] Univ Illinois, Zool Pathol Program, Maywood, IL USA; [Kock, Richard] African Union Int Bureau Anim Resources, Nairobi, Kenya; [Mlengeya, Titus; Roelke, Melody E.] Tanzania Natl Parks, Arusha, Tanzania; [Roelke, Melody E.] NCI Frederick, SAIC Frederick Inc, Lab Genom Diversity, Frederick, MD USA; [Dubovi, Edward] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Summers, Brian] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY USA; [Sinclair, Anthony R. E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Packer, Craig] Univ Minnesota, Dept Ecol, Evolut, & Behavior, St Paul, MN USA	University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Cornell University; Cornell University; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Munson, L (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	packer@umn.edu	Terio, Karen/AAC-5376-2019	Kock, Richard/0000-0002-6561-3209	Morris Foundation; NSF [DEB-0343960, DEB-9903416, BE-0308486]; Morris Animal Foundation; University of Illinois Research Board; Messerli Foundation, Zurich, Switzerland	Morris Foundation; NSF(National Science Foundation (NSF)); Morris Animal Foundation; University of Illinois Research Board; Messerli Foundation, Zurich, Switzerland	Lab assays were performed with funding from the Morris Foundation, while the field work was supported by NSF. This work was supported by the Morris Animal Foundation, University of Illinois Research Board, and National Science Foundation Grants for Ecology of Infectious Diseases (DEB-0343960), Long-Term Research in Environmental Biology (DEB-9903416) and Biocomplexity (BE-0308486), and the Messerli Foundation, Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; De Vos AJ, 1994, INFECT DIS LIVESTOCK, P278; Fosbrooke H. A., 1963, East African Wildlife Journal, V1, P124; Fyumagwa RD, 2007, S AFR J WILDL RES, V37, P79, DOI 10.3957/0379-4369-37.1.79; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; Horak IG, 2000, ONDERSTEPOORT J VET, V67, P239; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Kocan A. Alan, 2001, P524, DOI 10.1002/9780470377000.ch18b; MOLLER TAGE, 1964, PATHOL VETERINARIA, V1, P189; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Penzhorn BL, 2006, VET PARASITOL, V138, P11, DOI 10.1016/j.vetpar.2006.01.036; Penzhorn BL, 2001, J PARASITOL, V87, P681, DOI 10.1645/0022-3395(2001)087[0681:BLNSFL]2.0.CO;2; REED WM, 1985, J AM VET MED ASSOC, V187, P1264; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Soulsby E. J. L., 1982, HEALMINTHS ARTHROPOD, V7th, P456; SOULSBY EJL, 1982, HELMINTHS ARTHROPODS, P706; Stokstad E, 2007, SCIENCE, V317, P1304, DOI 10.1126/science.317.5843.1304; Tasker S, 2003, J CLIN MICROBIOL, V41, P439, DOI 10.1128/JCM.41.1.439-441.2003; VANHEERDEN J, 1989, J WILDLIFE DIS, V25, P70, DOI 10.7589/0090-3558-25.1.70; Williams Elizabeth S., 2001, P50	27	141	144	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2545	10.1371/journal.pone.0002545	http://dx.doi.org/10.1371/journal.pone.0002545			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575601	gold, Green Published, Green Accepted			2022-12-27	WOS:000263288000048
J	Hunter, MG; McLemore, M; Link, DC; Loveland, M; Copelan, A; Avalos, BR				Hunter, Melissa G.; McLemore, Morgan; Link, Daniel C.; Loveland, Megan; Copelan, Alexander; Avalos, Belinda R.			Divergent Pathways in COS-7 Cells Mediate Defective Internalization and Intracellular Routing of Truncated G-CSFR Forms in SCN/AML	PLOS ONE			English	Article								Background: Expression of truncated G-CSFR forms in patients with SCN/AML induces hyperproliferation and prolonged cell survival. Previously, we showed that ligand internalization is delayed and degradation of truncated G-CSFR forms is defective in patients with SCN/AML. Methodology/Principal Findings: In this study, we investigated the potential roles of dileucine and tyrosine-based motifs within the cytoplasmic domain of the G-CSFR in modulating ligand/receptor internalization. Using standard binding assays with radiolabeled ligand and COS-7 cells, substitutions in the dileucine motif or deletion of tyrosine residues in the G-CSFR did not alter internalization. Attachment of the transferrin receptor YTRF internalization motif to a truncated G-CSFR form from a patient with SCN/AML corrected defective internalization, but not receptor degradation suggesting that receptor internalization and degradation occur independently via distinct domains and/or processes. Conclusions: Our data suggest that distinct domains within the G-CSFR mediate separate processes for receptor internalization and degradation. Our findings using standard binding assays differ from recently published data utilizing flow cytometry.	[Hunter, Melissa G.] Ohio State Univ, Columbus, OH 43210 USA; [Hunter, Melissa G.; Avalos, Belinda R.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH USA; [McLemore, Morgan] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Link, Daniel C.] Washington Univ, Division of Bone Marrow Transplant & Stem Cell, St Louis, MO USA; [Loveland, Megan; Avalos, Belinda R.] Ohio State Univ, Div Hematol Oncol, Columbus, OH USA; [Copelan, Alexander] Johns Hopkins Univ, Baltimore, MD USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; Washington University (WUSTL); University System of Ohio; Ohio State University; Johns Hopkins University	Hunter, MG (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	Belinda.Avalos@osumc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK068639]; National Cancer Institute [R01-CA75226, R01-CA82859, P30-CA16058]; NATIONAL CANCER INSTITUTE [R01CA082859, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK068639] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R21-DK068639), and the National Cancer Institute (R01-CA75226, R01-CA82859, and P30-CA16058).	Aarts LHJ, 2004, BLOOD, V103, P571, DOI 10.1182/blood-2003-07-2250; ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; ANAGUCHI H, 1995, J BIOL CHEM, V270, P27845, DOI 10.1074/jbc.270.46.27845; Arcasoy MO, 1997, BLOOD, V89, P4628, DOI 10.1182/blood.V89.12.4628; AVALOS BR, 1995, BLOOD, V85, P3117, DOI 10.1182/blood.V85.11.3117.bloodjournal85113117; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bresciani R, 1997, BIOCHEM J, V327, P811, DOI 10.1042/bj3270811; Cassard S, 1998, J IMMUNOL, V160, P1767; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; DUQUESNOY P, 1994, EMBO J, V13, P1386, DOI 10.1002/j.1460-2075.1994.tb06392.x; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Govers P, 1998, J BIOL CHEM, V273, P16426, DOI 10.1074/jbc.273.26.16426; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Graeve L, 1996, FEBS LETT, V399, P131, DOI 10.1016/S0014-5793(96)01305-1; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamer I, 1997, J BIOL CHEM, V272, P21685, DOI 10.1074/jbc.272.35.21685; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hermans MHA, 1999, J EXP MED, V189, P683, DOI 10.1084/jem.189.4.683; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 1998, J IMMUNOL, V160, P4979; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; LARSEN A, 1990, J EXP MED, V172, P1559, DOI 10.1084/jem.172.6.1559; Link DC, 2007, BLOOD, V110, P1648, DOI 10.1182/blood-2007-03-081216; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Miura M, 1997, BIOCHEM BIOPH RES CO, V239, P182, DOI 10.1006/bbrc.1997.7449; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Patel M, 2003, J BIOL CHEM, V278, P44799, DOI 10.1074/jbc.M308982200; SORKIN A, 1993, J CELL PHYSIOL, V156, P373, DOI 10.1002/jcp.1041560221; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Szymczak AL, 2005, J IMMUNOL, V174, P4153, DOI 10.4049/jimmunol.174.7.4153; Thiel S, 1999, BIOCHEM J, V339, P15, DOI 10.1042/0264-6021:3390015; Touw IP, 1996, LEUKEMIA RES, V20, P629, DOI 10.1016/0145-2126(96)00017-3; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Welte K, 1997, SEMIN HEMATOL, V34, P267	42	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2452	10.1371/journal.pone.0002452	http://dx.doi.org/10.1371/journal.pone.0002452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560579	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700035
J	Taylor, JA; Thoroughman, KA				Taylor, Jordan A.; Thoroughman, Kurt A.			Motor Adaptation Scaled by the Difficulty of a Secondary Cognitive Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ERROR-DETECTION; VISUOMOTOR ADAPTATION; PARKINSONS-DISEASE; RESPONSE CONFLICT; FRONTAL-CORTEX; STEADY-STATE; SHORT-TERM; ATTENTION	Background: Motor learning requires evaluating performance in previous movements and modifying future movements. The executive system, generally involved in planning and decision-making, could monitor and modify behavior in response to changes in task difficulty or performance. Here we aim to identify the quantitative cognitive contribution to responsive and adaptive control to identify possible overlap between cognitive and motor processes. Methodology/Principal Findings: We developed a dual-task experiment that varied the trial-by-trial difficulty of a secondary cognitive task while participants performed a motor adaptation task. Subjects performed a difficulty-graded semantic categorization task while making reaching movements that were occasionally subjected to force perturbations. We find that motor adaptation was specifically impaired on the most difficult to categorize trials. Conclusions/Significance: We suggest that the degree of decision-level difficulty of a particular categorization differentially burdens the executive system and subsequently results in a proportional degradation of adaptation. Our results suggest a specific quantitative contribution of executive control in motor adaptation.			Taylor, JA (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	thoroughman@wustl.edu		Taylor, Jordan/0000-0001-9300-1229	McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis; National Institutes of Health [HD055851]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055851] Funding Source: NIH RePORTER	McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Jordan Taylor was supported by the McDonnell Center for Higher Brain Function through the Cognitive, Computational, and Systems Neuroscience Pathway at Washington University in St. Louis. Kurt Thoroughman was supported by the National Institutes of Health (NIH) grant HD055851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; Balota D.A., 2002, ENGLISH LEXICON PROJ; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Broadbent D. E., 1971, DECISION STRESS; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; CURRAN T, 1993, J EXP PSYCHOL LEARN, V19, P189, DOI 10.1037/0278-7393.19.1.189; DEMB JB, 1995, J NEUROSCI, V15, P5870; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Duff SV, 2007, EXP BRAIN RES, V179, P551, DOI 10.1007/s00221-006-0811-1; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Floyer-Lea A, 2004, J NEUROPHYSIOL, V92, P2405, DOI 10.1152/jn.01092.2003; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1970, AM PSYCHOL, V25, P350, DOI 10.1037/h0029456; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Grossman M, 2002, NEUROIMAGE, V17, P1549, DOI 10.1006/nimg.2002.1273; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ingram HA, 2000, EXP BRAIN RES, V132, P114, DOI 10.1007/s002219900322; Jordan M., 1999, COGNITIVE NEUROSCIEN, P601; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; Lang CE, 2002, J NEUROPHYSIOL, V87, P1336, DOI 10.1152/jn.00368.2001; LUND K, 1995, COGNITIVE SCI P, P660; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price AL, 2006, NEUROPSYCHOLOGY, V20, P249, DOI 10.1037/0894-4105.20.2.249; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; REDDING GM, 1992, J MOTOR BEHAV, V24, P238, DOI 10.1080/00222895.1992.9941619; Regnaux JP, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-19; Regnaux JP, 2005, NEUROREHAB NEURAL RE, V19, P125, DOI 10.1177/1545968305275612; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Suminski AJ, 2007, J NEUROPHYSIOL, V97, P1527, DOI 10.1152/jn.01160.2006; Taylor JA, 2007, J NEUROPHYSIOL, V98, P317, DOI 10.1152/jn.01070.2006; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wolpert DM, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P485	60	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2485	10.1371/journal.pone.0002485	http://dx.doi.org/10.1371/journal.pone.0002485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560546	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700052
J	Hatzifoti, C; Bacon, A; Marriott, H; Laing, P; Heath, AW				Hatzifoti, Caterina; Bacon, Andrew; Marriott, Helen; Laing, Peter; Heath, Andrew W.			Liposomal Co-Entrapment of CD40mAb Induces Enhanced IgG Responses against Bacterial Polysaccharide and Protein	PLOS ONE			English	Article								Background: Antibody against CD40 is effective in enhancing immune responses to vaccines when chemically conjugated to the vaccine antigen. Unfortunately the requirement for chemical conjugation presents some difficulties in vaccine production and quality control which are compounded when multivalent vaccines are required. We explore here an alternative to chemical conjugation, involving the co-encapsulation of CD40 antibody and antigens in liposomal vehicles. Methodology/Principal Findings: Anti-mouse CD40 mAb or isotype control mAb were co-entrapped individually in cationic liposomal vehicles with pneumococcal polysaccharides or diphtheria and tetanus toxoids. Retention of CD40 binding activity upon liposomal entrapment was assessed by ELISA and flow cytometry. After subcutaneous immunization of BALB/c female mice, anti-polysaccharide and DT/TT responses were measured by ELISA. Simple co-encapsulation of CD40 antibody allowed for the retention of CD40 binding on the liposome surface, and also produced vaccines with enhanced imunogenicity. Antibody responses against both co-entrapped protein in the form of tetanus toxoid, and Streptococcus pneumoniae capsular polysaccharide, were enhanced by co-encapsulation with CD40 antibody. Surprisingly, liposomal encapsulation also appeared to decrease the toxicity of high doses of CD40 antibody as assessed by the degree of splenomegaly induced. Conclusions/Significance: Liposomal co-encapsulation with CD40 antibody may represent a practical means of producing more immunogenic multivalent vaccines and inducing IgG responses against polysaccharides without the need for conjugation.	[Hatzifoti, Caterina; Heath, Andrew W.] Adjuvantix Ltd, Sheffield, S Yorkshire, England; [Bacon, Andrew; Laing, Peter] Lipoxen Ltd, London, England; [Marriott, Helen] Univ Sheffield, Unit Resp Med, Sheffield, S Yorkshire, England; [Heath, Andrew W.] Univ Sheffield, Unit Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Hatzifoti, C (corresponding author), Adjuvantix Ltd, Sheffield, S Yorkshire, England.	a.w.heath@sheffield.ac.uk		Bacon, Andrew/0000-0002-9099-9158; Marriott, Helen/0000-0003-1070-0054	BBSRC SBRI	BBSRC SBRI(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was provided to Adjuvantix Ltd and Lipoxen Ltd by a BBSRC SBRI grant. The BBSRC SBRI grant was awarded in response to an application by the two companies and the study was designed jointly by the two companies.	ALLISON AC, 1974, NATURE, V252, P252, DOI 10.1038/252252a0; Barr TA, 1999, INFECT IMMUN, V67, P3637, DOI 10.1128/IAI.67.7.3637-3640.1999; Barr TA, 2006, VACCINE, V24, P3399, DOI 10.1016/j.vaccine.2006.02.022; Barr TA, 2005, VACCINE, V23, P3477, DOI 10.1016/j.vaccine.2004.12.025; Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x; Barr TA, 2001, IMMUNOLOGY, V102, P39, DOI 10.1046/j.1365-2567.2001.01148.x; Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Carlring J, 2004, VACCINE, V22, P3323, DOI 10.1016/j.vaccine.2004.02.043; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; Garner C V, 1989, Contrib Microbiol Immunol, V10, P11; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Kirby C J, 1984, J Microencapsul, V1, P33, DOI 10.3109/02652048409031535; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LEE CJ, 1981, REV INFECT DIS, V3, P323; Presky DH, 1996, ANN NY ACAD SCI, V795, P390, DOI 10.1111/j.1749-6632.1996.tb52702.x; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Tutt AL, 2002, J IMMUNOL, V168, P2720, DOI 10.4049/jimmunol.168.6.2720; WEINBERG GA, 1988, J PEDIATR-US, V113, P621, DOI 10.1016/S0022-3476(88)80369-X; WESSELS MR, 1989, J EXP MED, V169, P2121, DOI 10.1084/jem.169.6.2121; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	21	7	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2368	10.1371/journal.pone.0002368	http://dx.doi.org/10.1371/journal.pone.0002368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523585	Green Accepted, Green Published, gold			2022-12-27	WOS:000262614300054
J	Hodge, JJ; Stanewsky, R				Hodge, James J.; Stanewsky, Ralf			Function of the Shaw Potassium Channel within the Drosophila Circadian Clock	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; PACEMAKER NEURONS; DELAYED RECTIFIER; BEHAVIORAL RHYTHMS; GENETIC-ANALYSIS; OUTPUT; CELLS; OSCILLATORS; MODULATION; EXPRESSION	Background: In addition to the molecular feedback loops, electrical activity has been shown to be important for the function of networks of clock neurons in generating rhythmic behavior. Most studies have used over-expression of foreign channels or pharmacological manipulations that alter membrane excitability. In order to determine the cellular mechanisms that regulate resting membrane potential (RMP) in the native clock of Drosophila we modulated the function of Shaw, a widely expressed neuronal potassium (K+) channel known to regulate RMP in Drosophila central neurons. Methodology/Principal Findings: We show that Shaw is endogenously expressed in clock neurons. Differential use of clock gene promoters was employed to express a range of transgenes that either increase or decrease Shaw function in different clusters of clock neurons. Under LD conditions, increasing Shaw levels in all clock neurons (LNv, LNd, DN1, DN2 and DN3), or in subsets of clock neurons (LNd and DNs or DNs alone) increases locomotor activity at night. In free-running conditions these manipulations result in arrhythmic locomotor activity without disruption of the molecular clock. Reducing Shaw in the DN alone caused a dramatic lengthening of the behavioral period. Changing Shaw levels in all clock neurons also disrupts the rhythmic accumulation and levels of Pigment Dispersing Factor (PDF) in the dorsal projections of LNv neurons. However, changing Shaw levels solely in LNv neurons had little effect on locomotor activity or rhythmic accumulation of PDF. Conclusions/Significance: Based on our results it is likely that Shaw modulates pacemaker and output neuronal electrical activity that controls circadian locomotor behavior by affecting rhythmic release of PDF. The results support an important role of the DN clock neurons in Shaw-mediated control of circadian behavior. In conclusion, we have demonstrated a central role of Shaw for coordinated and rhythmic output from clock neurons.	[Hodge, James J.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Hodge, James J.; Stanewsky, Ralf] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of Bristol; University of London; Queen Mary University London	Hodge, JJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	james.hodge@bristol.ac.uk	Stanewsky, Ralf/ABB-9193-2021	Hodge, James/0000-0003-4741-2363; Stanewsky, Ralf/0000-0001-8238-6864	EMBO [337-2006]; BBSRC [BBE0208281]; European Commission EUCLOCK Integrated Project; NIH [R01 MH067284, P30 NS045713, S10 RR16780]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E020828/1] Funding Source: researchfish; BBSRC [BB/E020828/1] Funding Source: UKRI	EMBO(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission EUCLOCK Integrated Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an EMBO short term fellowship (337-2006) to JH, BBSRC grant (BBE0208281) and a European Commission EUCLOCK Integrated Project (FP6) to RS and a grant from the NIH to Leslie Griffith (R01 MH067284) and The Brandeis Confocal Facility (supported by US NIH P30 NS045713 and S10 RR16780).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Colwell CS, 2006, NAT NEUROSCI, V9, P985, DOI 10.1038/nn0806-985; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Deng QW, 2005, J NEUROSCI, V25, P11531, DOI 10.1523/JNEUROSCI.3672-05.2005; Giordano E, 2002, GENETICS, V160, P637; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2005, NEURON, V48, P161, DOI 10.1016/j.neuron.2005.10.004; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; KYRIACOU CP, 1985, NATURE, V314, P171, DOI 10.1038/314171a0; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lundkvist GB, 2005, METHOD ENZYMOL, V393, P623, DOI 10.1016/S0076-6879(05)93033-4; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, METHOD ENZYMOL, V393, P682, DOI 10.1016/S0076-6879(05)93036-X; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; SHAFER OT, 2008, NEURON IN PRESS; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wulbeck C, 2005, GENETICS, V169, P751, DOI 10.1534/genetics.104.036244	49	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2274	10.1371/journal.pone.0002274	http://dx.doi.org/10.1371/journal.pone.0002274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509535	gold, Green Submitted, Green Published			2022-12-27	WOS:000262268500019
J	Monsuur, AJ; de Bakker, PIW; Zhernakova, A; Pinto, D; Verduijn, W; Romanos, J; Auricchio, R; Lopez, A; van Heel, DA; Crusius, JBA; Wijmenga, C				Monsuur, Alienke J.; de Bakker, Paul I. W.; Zhernakova, Alexandra; Pinto, Dalila; Verduijn, Willem; Romanos, Jihane; Auricchio, Renata; Lopez, Ana; van Heel, David A.; Crusius, J. Bart A.; Wijmenga, Cisca			Effective Detection of Human Leukocyte Antigen Risk Alleles in Celiac Disease Using Tag Single Nucleotide Polymorphisms	PLOS ONE			English	Article								Background: The HLA genes, located in the MHC region on chromosome 6p21.3, play an important role in many autoimmune disorders, such as celiac disease (CD), type 1 diabetes (T1D), rheumatoid arthritis, multiple sclerosis, psoriasis and others. Known HLA variants that confer risk to CD, for example, include DQA1*05/DQB1*02 (DQ2.5) and DQA1*03/DQB1*0302 (DQ8). To diagnose the majority of CD patients and to study disease susceptibility and progression, typing these strongly associated HLA risk factors is of utmost importance. However, current genotyping methods for HLA risk factors involve many reactions, and are complicated and expensive. We sought a simple experimental approach using tagging SNPs that predict the CD-associated HLA risk factors. Methodology: Our tagging approach exploits linkage disequilibrium between single nucleotide polymorphism (SNPs) and the CD-associated HLA risk factors DQ2.5 and DQ8 that indicate direct risk, and DQA1*0201/DQB1*0202 (DQ2.2) and DQA1*0505/DQB1*0301 (DQ7) that attribute to the risk of DQ2.5 to CD. To evaluate the predictive power of this approach, we performed an empirical comparison of the predicted DQ types, based on these six tag SNPs, with those executed with current validated laboratory typing methods of the HLA-DQA1 and -DQB1 genes in three large cohorts. The results were validated in three European celiac populations. Conclusion: Using this method, only six SNPs were needed to predict the risk types carried by >95% of CD patients. We determined that for this tagging approach the sensitivity was >0.991, specificity >0.996 and the predictive value >0.948. Our results show that this tag SNP method is very accurate and provides an excellent basis for population screening for CD. This method is broadly applicable in European populations.	[Monsuur, Alienke J.; Zhernakova, Alexandra; Pinto, Dalila; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] MIT, Broad Inst Harvard, Cambridge, MA USA; [Verduijn, Willem] Leiden Univ Med Ctr LUMC, Dept Immunohematol & Blood Transfusion, Sect Immunogenet & Transplant Immunol, Leiden, Netherlands; [Romanos, Jihane; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Genet Dept, Groningen, Netherlands; [Auricchio, Renata] Univ Federico Naples 2, Dept Pediat, European Lab Investigat Food Induced Dis, Naples, Italy; [Lopez, Ana] Fdn Investigac Hosp La Fe, Pediat Gastroenterol Unit, Valencia, Spain; [van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Crusius, J. Bart A.] Vrije Univ, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [de Bakker, Paul I. W.] Brigham and Womens Hosp, Harvard Partners Ctr Genet & Genom, Div Genet, Boston, MA USA	Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; University of Naples Federico II; University of London; Queen Mary University London; Vrije Universiteit Amsterdam; Harvard University	Monsuur, AJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	c.wijmenga@umcutrecht.nl	Zhernakova, Alexandra/ABA-9372-2020; de Bakker, Paul IW/B-8730-2009; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Romanos, Jihane/F-7372-2012; AURICCHIO, RENATA/AAC-7718-2022; Pinto, Dalila/C-4218-2016	de Bakker, Paul IW/0000-0001-7735-7858; Wijmenga, Cisca/0000-0002-5635-1614; Pinto, Dalila/0000-0002-8769-0846; van Heel, David/0000-0002-0637-2265; Zhernakova, Alexandra/0000-0002-4574-0841	Netherlands Organization for Scientific Research [902-22-094, 912-02-028]; Dutch Digestive Disease Foundation [97-44, 03-06]; KP6 EU [036383]; Coeliac Disease Consortium; Dutch government [BSIK03009]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive Disease Foundation; KP6 EU; Coeliac Disease Consortium; Dutch government	This study was supported by grants from the Netherlands Organization for Scientific Research (grants 902-22-094 and 912-02-028), the Dutch Digestive Disease Foundation (grants 97-44 and 03-06), a KP6 EU grant (036383, PREVENTCD) and the Coeliac Disease Consortium, an innovative cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch government (grant BSIK03009). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P315, DOI 10.1016/j.cgh.2005.12.011; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Koning F, 2005, GASTROENTEROLOGY, V129, P1294, DOI 10.1053/j.gastro.2005.07.030; Lie BA, 2005, CURR OPIN IMMUNOL, V17, P526, DOI 10.1016/j.coi.2005.07.001; Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Reinton N, 2006, J IMMUNOL METHODS, V316, P125, DOI 10.1016/j.jim.2006.08.008; RONNINGEN KS, 1991, TISSUE ANTIGENS, V37, P105, DOI 10.1111/j.1399-0039.1991.tb01854.x; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Van Belzen MJ, 2003, GASTROENTEROLOGY, V125, P1032, DOI 10.1016/S0016-5085(03)01205-8; van Belzen MJ, 2004, GENES IMMUN, V5, P215, DOI 10.1038/sj.gene.6364061; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Verduyn W, 1996, TISSUE ANTIGENS, V48, P80, DOI 10.1111/j.1399-0039.1996.tb02611.x; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	29	116	123	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2270	10.1371/journal.pone.0002270	http://dx.doi.org/10.1371/journal.pone.0002270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509540	Green Published, gold			2022-12-27	WOS:000262268500016
J	Witton, MP; Naish, D				Witton, Mark P.; Naish, Darren			A Reappraisal of Azhdarchid Pterosaur Functional Morphology and Paleoecology	PLOS ONE			English	Article							GIANT PTEROSAUR; CERVICAL-VERTEBRAE; BODY-MASS; FLIGHT; PTERODACTYLOIDEA; BIRDS; CHINA; ARCHOSAURIA; REPTILIA; BEHAVIOR	Azhdarchid pterosaurs were among the most widespread and successful of pterosaur clades, but their paleoecology remains controversial. Morphological features common to all azhdarchids include a long, shallow rostrum; elongate, cylindrical cervical vertebrae that formed a long and unusually inflexible neck; and proportionally short wings with an abbreviated fourth phalanx. While azhdarchids have been imagined as vulture-like scavengers, sediment probers, swimmers, waders, aerial predators, or stork-like generalists, most recent authors have regarded them as skim-feeders, trawling their lower jaws through water during flight and seizing aquatic prey from the water's surface. Although apparently widely accepted, the skim-feeding model lacks critical support from anatomy and functional morphology. Azhdarchids lack the many cranial specialisations exhibited by extant skim-feeding birds, most notably the laterally compressed lower jaw and shock absorbing apparatus required for this feeding style. Well-preserved azhdarchid skulls are rare, but their rostra and lower jaws appear to have been sub-triangular in cross-section, and thus dissimilar to those of skim-feeders and sediment probers. Taphonomic data indicates that azhdarchids predominately inhabited inland settings, and azhdarchid morphology indicates that they were poorly suited for all proposed lifestyles bar wading and terrestrial foraging. However, azhdarchid footprints show that their feet were relatively small, padded and slender, and thus not well suited for wading. We argue that azhdarchids were stork-or ground hornbill-like generalists, foraging in diverse environments for small animals and carrion. Proficient terrestrial abilities and a relatively inflexible neck are in agreement with this interpretation.	[Witton, Mark P.; Naish, Darren] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	University of Portsmouth	Witton, MP (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	Mark.Witton@port.ac.uk	Witton, Mark/B-9368-2013					Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; ARAMBOURG C, 1954, CR HEBD ACAD SCI, V238, P133; Arambourg C., 1959, NOTES MGMOIRES MOYEN, V7, P229; Arthur S. C., 1921, Auk Lancaster Pa, V38, P566; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; Atanassov Momchil N., 2002, Journal of Vertebrate Paleontology, V22, p33A; Averianov A.O., 2007, Paleontologicheskii Zhurnal, V2, P73; Averianov AO, 2005, PALEONTOL J+, V39, P433; Averianov AO, 2004, PALEONTOL J+, V38, P669; Averianov AO, 2004, PALEONTOL J+, V38, P426; Bakhurina Natalia N., 1995, Historical Biology, V10, P197; Behrensmeyer AK, 2001, PALAEOBIOLOGY, VII, P318; Bennett S. C., 2003, RIV MUSEO CIVICO SCI, V22, P9; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett S. Christopher, 1991, Records of the Western Australian Museum, V15, P435; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; BOCK WALTER J., 1960, AUK, V77, P19; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Brower J.C., 1983, Journal of Vertebrate Paleontology, V3, P84; BROWER JC, 1981, U KANSAS PALEONTOLOG, V105, P1; Buffetaut E, 2001, CR ACAD SCI II A, V333, P357, DOI 10.1016/S1251-8050(01)01630-5; Buffetaut E, 1996, B SOC GEOL FR, V167, P753; Buffetaut E, 1997, GEOL MAG, V134, P553, DOI 10.1017/S0016756897007449; Buffetaut Eric, 2003, Geological Society Special Publication, V217, P91, DOI 10.1144/GSL.SP.2003.217.01.09; Buffetaut Eric, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P289; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, V376, P1, DOI DOI 10.1130/0-8137-2376-0.1; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.3.CO;2-#; Codorniu Laura, 2007, P143; Company J, 1999, GEOL MIJNBOUW, V78, P319, DOI 10.1023/A:1003851316054; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; CURRIE PJ, 1982, CAN J EARTH SCI, V19, P894, DOI 10.1139/e82-074; FREY E, 1998, NEUES JB GEOLOGIE PA, V20, P421; Frey Eberhard, 2003, Geological Society Special Publication, V217, P267, DOI 10.1144/GSL.SP.2003.217.01.15; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 2000, Archaeopteryx, V18, P1; Frey Eberhard, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P221; Godfrey SJ, 2005, LIFE O PAST, P292; GRAF W, 1995, J ANAT, V186, P55; Hankin E. H., 1914, Aeronautical Journal, V18, P324; Harris MA, 1997, J ZOOL, V241, P381, DOI 10.1111/j.1469-7998.1997.tb01966.x; HAZLEHURST GA, 1992, PALEOBIOLOGY, V18, P447, DOI 10.1017/S009483730001099X; Henderson MD, 2006, J VERTEBR PALEONTOL, V26, P192, DOI 10.1671/0272-4634(2006)26[192:AAPCVF]2.0.CO;2; Heptonstall W.B., 1971, SCOTTISH J GEOLOGY, V7, P61, DOI [10.1144/sjg07010061, DOI 10.1144/SJG07010061]; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; HOWSE SCB, 1986, ZOOL J LINN SOC-LOND, V88, P307, DOI 10.1111/j.1096-3642.1986.tb02249.x; Humphries S, 2007, PLOS BIOL, V5, P1647, DOI 10.1371/journal.pbio.0050204; Hwang KG, 2002, GEOL MAG, V139, P421, DOI 10.1017/S0016756802006647; Ikegami Naoki, 2000, Paleontological Research, V4, P165; KAHL MP, 1987, COLON WATERBIRD, V10, P131, DOI 10.2307/1521251; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner Alexander Wilhelm Armin, 1996, American Museum Novitates, V3175, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; KELLNER AWA, 1996, J VERTEBR PALEONTOL, V16, pA45; LANGSTON W, 1981, SCI AM, V244, P92; LAWSON DA, 1975, SCIENCE, V187, P947, DOI 10.1126/science.187.4180.947; LEDERER RJ, 1972, WILSON BULL, V84, P193; LEHMAN TM, 1996, TEXAS J VERTEBRATE P, V16, pA48; Lockley Martin G., 2003, Geological Society Special Publication, V217, P297, DOI 10.1144/GSL.SP.2003.217.01.18; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P301; Lu Jun-Chang, 2002, Memoir of the Fukui Prefectural Dinosaur Museum, V1, P19; Lu Junchang, 2006, Journal of the Paleontological Society of Korea, V22, P239; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; MARDEN JH, 1994, AM J PHYSIOL, V266, pR1077, DOI 10.1152/ajpregu.1994.266.4.R1077; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill David M., 1997, Geology Today, V13, P71; Martill David M., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P57; Mateer NJ, 1975, B GEOLOGICAL I U UPP, V6, P23; Mazin Jean-Michel, 2003, Geological Society Special Publication, V217, P283, DOI 10.1144/GSL.SP.2003.217.01.17; McGowen Michael R., 2002, Paleobios, V22, P1; MONTEILLET J, 1982, CR ACAD SCI II, V295, P409; MURRY PA, 1991, J PALEONTOL, V65, P167, DOI 10.1017/S0022336000020291; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Nessov LA., 1984, PALAEONTOL Z, V1, P47; Norberg UML, 2000, J EXP BIOL, V203, P651; Obata I., 1972, Memoirs Natn Sci Mus Tokyo, VNo. 5, P213; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; PADIAN K, 1995, CR ACAD SCI II, V320, P77; PADIAN K, 1988, NAT HIST, V97, P58; Padian K., 1984, J VERTEBR PALEONTOL, V4, P516, DOI DOI 10.1080/02724634.1984.10012027; Parris DC, 2004, SE GEOLOGY, V43, P52; Paul G.S., 1991, Modern Geology, V16, P69; Paul G. S., 2002, DINOSAURS AIR EVOLUT; PAUL GS, 1987, NATURE, V328, P481, DOI 10.1038/328481a0; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P13; Pereda Suberbiola X, 2003, GEOLOGICAL SOC SPECI, V217, P79; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Potter J. K., 1932, Auk, V49, P477; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Prieto I.R., 1998, COLOQUIOS PALEONTOLO, V49, P129; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rodriguez-de la Rosa Ruben A., 2003, Geological Society Special Publication, V217, P275, DOI 10.1144/GSL.SP.2003.217.01.16; SAEGUSA H, 2004, 111 ANN M GEOL SOC J; Schumacher G. H., 1973, P101; SEAMANS TW, 1995, IBIS, V137, P424; Shelley EL, 2004, CONDOR, V106, P395, DOI 10.1650/7424; Shipman, 1998, TAKING WING ARCHAEOP; STEIN RS, 1975, J PALEONTOL, V49, P534; Storer R. W., 1971, AVIAN BIOL, P150; SUBERBIOLA XP, 2007, AZHDARCHID PTEROSAUR; Templin RJ, 2000, PROG AEROSP SCI, V36, P393, DOI 10.1016/S0376-0421(00)00007-5; TOMKINS IVAN T., 1951, AUK, V68, P236; TOMKINS IVANR, 1963, AUK, V80, P549; Travaini A, 1998, J ZOOL, V246, P175, DOI 10.1111/j.1469-7998.1998.tb00146.x; Unwin D.M., 2007, ANN REPORT FUKADA GE, V8, P149; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, P420; Unwin David M., 1997, Historical Biology, V12, P199; Unwin DM, 1996, LETHAIA, V29, P373, DOI 10.1111/j.1502-3931.1996.tb01673.x; UNWIN DM, 1994, NATURE, V371, P62, DOI 10.1038/371062a0; UNWIN DM, 1988, PAL ASS ANN C AST; Unwin DM, 1997, PALEONTOLOGICAL SOC, V2, P43, DOI [10.1080/08912969709386563, DOI 10.1080/08912969709386563]; Veldmeijer Andre J., 2003, Scripta Geologica, V125, P35; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wellnhofer P., 1988, Historical Biology, V1, P3; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Western D., 1980, P41; Wild Rupert, 1993, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V16, P95; Wilkinson MT, 2006, P ROY SOC B-BIOL SCI, V273, P119, DOI 10.1098/rspb.2005.3278; WITHERS PC, 1977, J EXP BIOL, V70, P13; WITMER LM, 1991, PALEOBIOLOGY, V17, P95, DOI 10.1017/S0094837300010435; Witmer LM., 1987, 4 S MES TERR EC SHOR, P230; Witton Mark, 2007, Geology Today, V23, P33, DOI 10.1111/j.1365-2451.2007.00596.x; Zeffer A, 2003, BIOL J LINN SOC, V79, P461, DOI 10.1046/j.1095-8312.2003.00200.x; Zusi RL, 1962, PUBLICATIONS NUTTAL, V3; [No title captured]	138	102	103	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2271	10.1371/journal.pone.0002271	http://dx.doi.org/10.1371/journal.pone.0002271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509539	Green Submitted, Green Published, gold			2022-12-27	WOS:000262268500017
J	Begley, EB; Jafa, K; Voetsch, AC; Heffelfinger, JD; Borkowf, CB; Sullivan, PS				Begley, Elin B.; Jafa, Krishna; Voetsch, Andrew C.; Heffelfinger, James D.; Borkowf, Craig B.; Sullivan, Patrick S.			Willingness of Men Who Have Sex with Men (MSM) in the United States to Be Circumcised as Adults to Reduce the Risk of HIV Infection	PLOS ONE			English	Article							CONSPIRACY BELIEFS; AFRICAN-AMERICANS; PREVENTION; HIV/AIDS; HEALTH; TRIAL; ACCEPTABILITY; CANCER; HERPES; KENYA	Background: Circumcision reduces HIV acquisition among heterosexual men in Africa, but it is unclear if circumcision may reduce HIV acquisition among men who have sex with men (MSM) in the United States, or whether MSM would be willing to be circumcised if recommended. Methods: We interviewed presumed-HIV negative MSM at gay pride events in 2006. We asked uncircumcised respondents about willingness to be circumcised if it were proven to reduce risk of HIV among MSM and perceived barriers to circumcision. Multivariate logistic regression was used to identify covariates associated with willingness to be circumcised. Results: Of 780 MSM, 133 (17%) were uncircumcised. Of these, 71 (53%) were willing to be circumcised. Willingness was associated with black race (exact odds ratio [OR]: 3.4, 95% confidence interval [CI]: 1.3-9.8), non-injection drug use (OR: 6.1, 95% CI: 1.8-23.7) and perceived reduced risk of penile cancer (OR: 4.7, 95% CI: 2.0-11.9). The most commonly endorsed concerns about circumcision were post-surgical pain and wound infection. Conclusions: Over half of uncircumcised MSM, especially black MSM, expressed willingness to be circumcised. Perceived risks and benefits of circumcision should be a part of educational materials if circumcision is recommended for MSM in the United States.	[Begley, Elin B.; Jafa, Krishna; Voetsch, Andrew C.; Heffelfinger, James D.; Borkowf, Craig B.; Sullivan, Patrick S.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Begley, EB (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA.	EQB5@cdc.gov	Voetsch, Andrew/CAF-1978-2022	Voetsch, Andrew/0000-0002-0783-1312; Sullivan, Patrick Sean/0000-0002-7728-0587				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014; BRINTON LA, 1991, INT J CANCER, V47, P504, DOI 10.1002/ijc.2910470406; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; CDC, 2007, HIV AIDS SURV REP, P1; Fink KS, 2002, J UROLOGY, V167, P2113, DOI 10.1016/S0022-5347(05)65098-7; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HUNGFU T, 2001, CANCER CAUSE CONTROL, V12, P267; Hutchinson AB, 2007, JAIDS-J ACQ IMM DEF, V45, P603, DOI 10.1097/QAI.0b013e3181151262; Kalichman SC, 2007, LANCET, V369, P1597, DOI 10.1016/S0140-6736(07)60734-X; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Millett GA, 2007, JAIDS-J ACQ IMM DEF, V46, P643, DOI 10.1097/QAI.0b013e31815b834d; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Senkul T, 2004, UROLOGY, V63, P155, DOI 10.1016/j.urology.2003.08.035; Templeton DJ, 2007, 4 INT AIDS SOC C HIV; Weiss GN, 1997, PEDIATR INFECT DIS J, V16, P727, DOI 10.1097/00006454-199708000-00002; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04	26	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2731	10.1371/journal.pone.0002731	http://dx.doi.org/10.1371/journal.pone.0002731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628946	Green Published, gold			2022-12-27	WOS:000264057200067
J	Cunha-Rodrigues, M; Portugal, S; Prudencio, M; Goncalves, LA; Casalou, C; Buger, D; Sauerwein, R; Haas, W; Mota, MM				Cunha-Rodrigues, Margarida; Portugal, Silvia; Prudencio, Miguel; Goncalves, Ligia A.; Casalou, Cristina; Buger, Dominik; Sauerwein, Robert; Haas, Werner; Mota, Maria M.			Genistein-Supplemented Diet Decreases Malaria Liver Infection in Mice and Constitutes a Potential Prophylactic Strategy	PLOS ONE			English	Article								In tropical regions millions of people still live at risk of malaria infection. Indeed the emergence of resistance to chloroquine and other drugs in use in these areas reinforces the need to implement alternative prophylactic strategies. Genistein is a naturally occurring compound that is widely used as a food supplment and is thought to be effective in countering several pathologies. Results presented here show that genistein inhibits liver infection by the Plasmodium parasite, the causative agent of malaria. In vitro, genistein decreased the infection rates of both mouse and human hepatoma cells by inhibiting the early stages of the parasite's intracellular development. Oral or intraperitoneal administration of genistein decreased the liver parasite load of P. berghei-infected mice. Moreover, mice fed on a genistein-supplemented diet showed a significant reduction in Plasmodium liver infection as well as a reduced blood parasitemia and partial protection from severe disease. Since genistein is a safe, low-cost, natural compound that can be used permanently in a diet, we propose its use as a prophylactic agent against malaria for endemic populations and long-time travelers.	[Cunha-Rodrigues, Margarida; Portugal, Silvia; Prudencio, Miguel; Mota, Maria M.] Univ Lisbon, Fac Med, Unidade Malaria, Inst Mol Med, P-1699 Lisbon, Portugal; [Cunha-Rodrigues, Margarida; Prudencio, Miguel; Goncalves, Ligia A.; Mota, Maria M.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Casalou, Cristina] Centro de Investigacao Patobiol Mol, Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; [Buger, Dominik] R&D Analytical Res Ctr, DSM Nutrition Products, Basel, Switzerland; [Sauerwein, Robert] Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Haas, Werner] Alfama, Porto Salvo, Portugal	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Portuguese Institute of Oncology; DSM NV; Radboud University Nijmegen	Cunha-Rodrigues, M (corresponding author), Univ Lisbon, Fac Med, Unidade Malaria, Inst Mol Med, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Gonçalves, Lígia Antunes/F-6242-2014; Sauerwein, Robert/C-8519-2013; Casalou, Cristina/AAU-6804-2021; Prudêncio, Miguel/ABD-9282-2021; /AAD-5368-2019; Mota, Maria/AAF-2048-2019; Prudêncio, Miguel/D-2032-2012	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Casalou, Cristina/0000-0003-3198-2783; Prudêncio, Miguel/0000-0003-1746-6029; Prudêncio, Miguel/0000-0003-1746-6029; Portugal, Silvia/0000-0003-4567-9101; Mota, Maria Manuel/0000-0002-2858-1041	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Chang HC, 2000, TOXICOL APPL PHARM, V168, P244, DOI 10.1006/taap.2000.9019; Cimino CO, 1999, CLIN CHIM ACTA, V287, P69, DOI 10.1016/S0009-8981(99)00124-2; Cunha-Rodrigues Margarido, 2006, Biotechnology Journal, V1, P321, DOI 10.1002/biot.200500038; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; DAY K P, 1991, Immunology Today, V12, pA68; Dluzewski AR, 1996, EXPERIENTIA, V52, P621, DOI 10.1007/BF01969742; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gazarini ML, 2003, BRAZ J MED BIOL RES, V36, P1465, DOI 10.1590/S0100-879X2003001100003; Holzbeierlein JM, 2005, CURR OPIN UROL, V15, P17, DOI 10.1097/00042307-200501000-00005; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Klein CB, 2007, TOXICOL APPL PHARM, V224, P1, DOI 10.1016/j.taap.2007.06.022; Kraft C, 2000, J ETHNOPHARMACOL, V73, P131, DOI 10.1016/S0378-8741(00)00285-3; Lynch A, 2003, MUTAGENESIS, V18, P345, DOI 10.1093/mutage/geg003; MARKOVITS J, 1989, CANCER RES, V49, P5111; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mezei O, 2003, J NUTR, V133, P1238; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; OKAJIMA F, 1994, BIOCHEM BIOPH RES CO, V203, P1488, DOI 10.1006/bbrc.1994.2353; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Padmanaban G, 2000, BIOCHEM BIOPH RES CO, V268, P665, DOI 10.1006/bbrc.1999.1892; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Prudencio M, 2008, CELL MICROBIOL, V10, P218, DOI 10.1111/j.1462-5822.2007.01032.x; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Setchell KDR, 2006, ENVIRON HEALTH PERSP, V114, pA332, DOI 10.1289/ehp.114-a332; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Suzuki K, 2002, INT J CANCER, V99, P846, DOI 10.1002/ijc.10428; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79	35	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2732	10.1371/journal.pone.0002732	http://dx.doi.org/10.1371/journal.pone.0002732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628947	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200068
J	Madi, A; Friedman, Y; Roth, D; Regev, T; Bransburg-Zabary, S; Ben Jacob, E				Madi, Asaf; Friedman, Yonatan; Roth, Dalit; Regev, Tamar; Bransburg-Zabary, Sharron; Ben Jacob, Eshel			Genome Holography: Deciphering Function-Form Motifs from Gene Expression Data	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CLUSTER-ANALYSIS; ORGANIZATION; SPORULATION; NETWORKS; PATTERNS; OPERON	Background: DNA chips allow simultaneous measurements of genome-wide response of thousands of genes, i.e. system level monitoring of the gene-network activity. Advanced analysis methods have been developed to extract meaningful information from the vast amount of raw gene-expression data obtained from the microarray measurements. These methods usually aimed to distinguish between groups of subjects (e. g., cancer patients vs. healthy subjects) or identifying marker genes that help to distinguish between those groups. We assumed that motifs related to the internal structure of operons and gene-networks regulation are also embedded in microarray and can be deciphered by using proper analysis. Methodology/Principal Findings: The analysis presented here is based on investigating the gene-gene correlations. We analyze a database of gene expression of Bacillus subtilis exposed to sub-lethal levels of 37 different antibiotics. Using unsupervised analysis (dendrogram) of the matrix of normalized gene-gene correlations, we identified the operons as they form distinct clusters of genes in the sorted correlation matrix. Applying dimension-reduction algorithm (Principal Component Analysis, PCA) to the matrices of normalized correlations reveals functional motifs. The genes are placed in a reduced 3-dimensional space of the three leading PCA eigen-vectors according to their corresponding eigen-values. We found that the organization of the genes in the reduced PCA space recovers motifs of the operon internal structure, such as the order of the genes along the genome, gene separation by non-coding segments, and translational start and end regions. In addition to the intra-operon structure, it is also possible to predict inter-operon relationships, operons sharing functional regulation factors, and more. In particular, we demonstrate the above in the context of the competence and sporulation pathways. Conclusions/Significance: We demonstrated that by analyzing gene-gene correlation from gene-expression data it is possible to identify operons and to predict unknown internal structure of operons and gene-networks regulation.	[Madi, Asaf; Friedman, Yonatan; Regev, Tamar; Bransburg-Zabary, Sharron; Ben Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Madi, Asaf; Roth, Dalit; Bransburg-Zabary, Sharron] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Friedman, Yonatan] MIT, Boston, MA USA; [Ben Jacob, Eshel] Univ Calif San Diego, Ctr Theoretical & Biol Phys, La Jolla, CA USA	Tel Aviv University; Tel Aviv University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Madi, A (corresponding author), Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il	Friedman, Jonathan/I-6930-2019	Friedman, Jonathan/0000-0001-8476-8030; Regev, Tamar/0000-0003-0639-0890; Madi, Asaf/0000-0003-3441-3228	Maguy-Glass Chair in Physics of Complex Systems; Tauber Fund at Tel-Aviv University; NSF [PHY-0216576, PHY-0225630]; NIMH [R01 MH066962]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066962] Funding Source: NIH RePORTER	Maguy-Glass Chair in Physics of Complex Systems; Tauber Fund at Tel-Aviv University; NSF(National Science Foundation (NSF)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been supported in part by the Maguy-Glass Chair in Physics of Complex Systems, by the Tauber Fund at Tel-Aviv University, by the NSF-sponsored Center for Theoretical Biological Physics (grant numbers PHY-0216576 and PHY-0225630), and by NIMH sponsored grant (R01 MH066962).	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Antelmann H, 2000, J BACTERIOL, V182, P4478, DOI 10.1128/JB.182.16.4478-4490.2000; AZEVEDO V, 1993, MOL MICROBIOL, V10, P397, DOI 10.1111/j.1365-2958.1993.tb02671.x; Baruchi I, 2006, CHAOS, V16, DOI 10.1063/1.2183408; Baruchi I, 2005, COMPLEXITY, V10, P38, DOI 10.1002/cplx.20065; Baruchi I, 2004, NEUROINFORMATICS, V2, P333, DOI 10.1385/NI:2:3:333; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Chander P, 2005, J BACTERIOL, V187, P1773, DOI 10.1128/JB.187.5.1773-1782.2005; CHEN NY, 1993, J BIOL CHEM, V268, P9448; DUBES R, 1980, ADV COMPUT, V19, P113; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Everitt B. S., 1993, CLUSTER ANAL; FAWCETT P, 2000, TRANSCRIPTIONAL PROF, P8064; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Gidskehaug L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-346; Golub G., 1965, SIAM J NUMER ANAL, V2, P205, DOI DOI 10.1137/0702016; GOLUB TRS, 1999, MOL CLASSIFICATION C; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartuv E, 2000, INFORM PROCESS LETT, V76, P175, DOI 10.1016/S0020-0190(00)00142-3; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; LAST M, 2006, SPRINGER STUDIES COM, V23, P319; Lee JM, 2001, J BACTERIOL, V183, P7371, DOI 10.1128/JB.183.24.7371-7380.2001; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mirkin B., 1996, MATH CLASSIFICATION; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Otnes R. K., 1978, APPL TIME SERIES ANA, V1; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Quinlan J.R., 1992, PROGRAMS MACHINE LEA; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Rokhlenko O, 2007, BIOINFORMATICS, V23, P2139, DOI 10.1093/bioinformatics/btm319; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; SIERRO N, 2007, NUCL ACIDS RES ADV A, V25, P1; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Yosef N, 2007, BIOINFORMATICS, V23, pE91, DOI 10.1093/bioinformatics/btl298	47	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2708	10.1371/journal.pone.0002708	http://dx.doi.org/10.1371/journal.pone.0002708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628959	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200051
J	Wellbrock, C; Rana, S; Paterson, H; Pickersgill, H; Brummelkamp, T; Marais, R				Wellbrock, Claudia; Rana, Sareena; Paterson, Hugh; Pickersgill, Helen; Brummelkamp, Thijn; Marais, Richard			Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF	PLOS ONE			English	Article								The Microphthalmia-associated transcription factor (MITF) is an important regulator of cell-type specific functions in melanocytic cells. MITF is essential for the survival of pigmented cells, but whereas high levels of MITF drive melanocyte differentiation, lower levels are required to permit proliferation and survival of melanoma cells. MITF is phosphorylated by ERK, and this stimulates its activation, but also targets it for degradation through the ubiquitin-proteosome pathway, coupling MITF degradation to its activation. We have previously shown that because ERK is hyper-activated in melanoma cells in which BRAF is mutated, the MITF protein is constitutively down-regulated. Here we describe another intriguing aspect of MITF regulation by oncogenic BRAF in melanoma cells. We show oncogenic BRAF up-regulates MITF transcription through ERK and the transcription factor BRN2 (N-Oct3). In contrast, we show that in melanocytes this pathway does not exist because BRN2 is not expressed, demonstrating that MITF regulation is a newly acquired function of oncogenic BRAF that is not performed by the wild-type protein. Critically, in melanoma cells MITF is required downstream of oncogenic BRAF because it regulates expression of key cell cycle regulatory proteins such as CDK2 and CDK4. Wild-type BRAF does not regulate this pathway in melanocytes. Thus, we show that oncogenic BRAF exerts exquisite control over MITF on two levels. It downregulates the protein by stimulating its degradation, but then counteracts this by increasing transcription through BRN2. Our data suggest that oncogenic BRAF plays a critical role in regulating MITF expression to ensure that its protein levels are compatible with proliferation and survival of melanoma cells. We propose that its ability to appropriate the regulation of this critical factor explains in part why BRAF is such a potent oncogene in melanoma.	[Wellbrock, Claudia; Rana, Sareena; Marais, Richard] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Signal Transduct Team, London, England; [Paterson, Hugh] Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Oncogene Team, London, England; [Pickersgill, Helen; Brummelkamp, Thijn] Whitehead Inst Biomed Res, Cambridge, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wellbrock, C (corresponding author), Canc Res UK Ctr Cell & Mol Biol, Inst Canc Res, Signal Transduct Team, London, England.	richard.marais@icr.ac.uk		Marais, Richard/0000-0001-7484-4183; Wellbrock, Claudia/0000-0002-3825-6381	Cancer Research UK [C107/A3096] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		ANGUS J, 1995, ONCOGENE, V11, P691; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Salti GI, 2000, CANCER RES, V60, P5012; Selzer E, 2002, CANCER RES, V62, P2098; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wu M, 2000, GENE DEV, V14, P301; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750	28	193	196	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2734	10.1371/journal.pone.0002734	http://dx.doi.org/10.1371/journal.pone.0002734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628967	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200070
J	Martins, LD; Leal, E; Kishino, H				Martins, Leonardo de Oliveira; Leal, Elcio; Kishino, Hirohisa			Phylogenetic Detection of Recombination with a Bayesian Prior on the Distance between Trees	PLOS ONE			English	Article								Genomic regions participating in recombination events may support distinct topologies, and phylogenetic analyses should incorporate this heterogeneity. Existing phylogenetic methods for recombination detection are challenged by the enormous number of possible topologies, even for a moderate number of taxa. If, however, the detection analysis is conducted independently between each putative recombinant sequence and a set of reference parentals, potential recombinations between the recombinants are neglected. In this context, a recombination hotspot can be inferred in phylogenetic analyses if we observe several consecutive breakpoints. We developed a distance measure between unrooted topologies that closely resembles the number of recombinations. By introducing a prior distribution on these recombination distances, a Bayesian hierarchical model was devised to detect phylogenetic inconsistencies occurring due to recombinations. This model relaxes the assumption of known parental sequences, still common in HIV analysis, allowing the entire dataset to be analyzed at once. On simulated datasets with up to 16 taxa, our method correctly detected recombination breakpoints and the number of recombination events for each breakpoint. The procedure is robust to rate and transition: transversion heterogeneities for simulations with and without recombination. This recombination distance is related to recombination hotspots. Applying this procedure to a genomic HIV-1 dataset, we found evidence for hotspots and de novo recombination.	[Martins, Leonardo de Oliveira; Kishino, Hirohisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Leal, Elcio] Univ Fed Sao Paulo, Sao Paulo, Brazil	University of Tokyo; Universidade Federal de Sao Paulo (UNIFESP)	Martins, LD (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	leo@lbm.ab.a.u-tokyo.ac.jp	Kishino, Hirohisa/U-9311-2019; Leal, Elcio/J-6236-2016; Leal, Elcio/M-5275-2019; de Oliveira Martins, Leonardo/I-4606-2013	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492; de Oliveira Martins, Leonardo/0000-0001-5247-1320	Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/10372-3, 07/52841-8]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Japan Society for the Promotion of Science (JSPS). L.O.M. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) scholarship. E.L. was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants no. 04/10372-3, 07/52841-8).	Al-Awadhi F, 2004, STAT PROBABIL LETT, V69, P189, DOI 10.1016/j.spl.2004.06.025; Allen BL, 2001, ANN COMB, V5, P1; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Awadalla P, 2003, NAT REV GENET, V4, P50, DOI 10.1038/nrg964; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fang F, 2007, BIOINFORMATICS, V23, P507, DOI 10.1093/bioinformatics/btl613; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GOLDING GB, 1984, GENETICS, V108, P257; Grassly NC, 1997, MOL BIOL EVOL, V14, P239, DOI 10.1093/oxfordjournals.molbev.a025760; GRIFFITHS RC, 1981, THEOR POPUL BIOL, V19, P169, DOI 10.1016/0040-5809(81)90016-2; Hallett MT, 2001, P 5 ANN INT C COMP B, P149, DOI [DOI 10.1145/369133.369188, 10.1145/369133.369188]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HEIN J, 1993, J MOL EVOL, V36, P396, DOI 10.1007/BF00182187; HEIN MHS, 2005, GENE GENEALOGIES VAR; Hey J, 1997, GENETICS, V145, P833; HICKEY G, 2008, EVOLUTIONARY BIOINFO, V4, P4; Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2001, GENETICS, V159, P1805; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Husmeier D, 2005, BIOINFORMATICS, V21, P166, DOI 10.1093/bioinformatics/bti1127; Husmeier D, 2001, Bioinformatics, V17 Suppl 1, pS123; Husmeier D, 2001, J COMPUT BIOL, V8, P401, DOI 10.1089/106652701752236214; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kuhner MK, 2000, GENETICS, V156, P1393; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27; McVean G, 2002, GENETICS, V160, P1231; Minin VN, 2007, GENETICS, V175, P1773, DOI 10.1534/genetics.106.066258; Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459; Nakhleh L, 2005, J COMPUT BIOL, V12, P796, DOI 10.1089/cmb.2005.12.796; Nakhleh L, 2005, LECT NOTES COMPUT SC, V3595, P84, DOI 10.1007/11533719_11; Nielsen R, 2000, GENETICS, V154, P931; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; R Core Team, 2018, R LANG ENV STAT COMP; RAJARAM ML, 2007, BIOINF BIOENG 2007 B, P707; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Song Y. S., 2003, ANN COMB, V7, P365, DOI DOI 10.1007/S00026-003-0192-0; Song YS, 2005, J COMPUT BIOL, V12, P147, DOI 10.1089/cmb.2005.12.147; Song YS, 2003, LECT N BIOINFORMAT, V2812, P287; STEEL M, 1993, INFORM PROCESS LETT, V48, P77, DOI 10.1016/0020-0190(93)90181-8; Suchard MA, 2005, GENETICS, V170, P419, DOI 10.1534/genetics.103.025692; Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929; Wiuf C, 2003, GENETICS, V164, P407; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	63	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2651	10.1371/journal.pone.0002651	http://dx.doi.org/10.1371/journal.pone.0002651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612422	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800053
J	Valbuena, A; Blanco, S; Vega, FM; Lazo, PA				Valbuena, Alberto; Blanco, Sandra; Vega, Francisco M.; Lazo, Pedro A.			The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53	PLOS ONE			English	Article								Background: The vaccinia-related kinase 1 (VRK1) protein, an activator of p53, can be proteolytically downregulated by an indirect mechanism, which requires p53-dependent transcription. Principal Findings: In this work we have biochemically characterized the contribution of several p53 transcriptional cofactors with acetyl transferase activity to the induction of VRK1 downregulation that was used as a functional assay. Downregulation of VRK1 induced by p53 is prevented in a dose dependent manner by either p300 or CBP, but not by PCAF, used as transcriptional co-activators, suggesting that p53 has a different specificity depending on the relative level of these transcriptional cofactors. This inhibition does not require p53 acetylation, since a p53 acetylation mutant also induces VRK1 downregulation. PCAF can not revert the VRK1 protection effect of p300, indicating that these two proteins do not compete for a common factor needed to induce VRK1 downregulation. The protective effect is also induced by the C/H3 domain of p300, a region implicated in binding to several transcription factors and SV40 large T antigen; but the protective effect is lost when a mutant C/H3Del33 is used. The protective effect is a consequence of direct binding of the C/H3 domain to the transactivation domain of p53. A similar downregulatory effect can also be detected with VRK2 protein. Conclusions/Significance: Specific p53-dependent effects are determined by the availability and ratios of its transcriptional cofactors. Specifically, the downregulation of VRK1/VRK2 protein levels, as a consequence of p53 accumulation, is thus dependent on the levels of the p300/CBP protein available for transcriptional complexes, since in this context this cofactor functions as a repressor of the effect. These observations point to the relevance of knowing the cofactor levels in order to determine one effect or another.	[Valbuena, Alberto; Blanco, Sandra; Vega, Francisco M.; Lazo, Pedro A.] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Valbuena, A (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc,Programa Oncol Trans, E-37008 Salamanca, Spain.	plazozbi@usal.es	Blanco, Sandra/B-2070-2017; 2008, Ibsal/A-1268-2012; Lazo, Pedro A./M-6435-2014; Vega, Francisco M./C-4678-2008; IBIS, FISIOPATOLOGIA/O-9510-2015	Blanco, Sandra/0000-0001-7352-9392; Lazo, Pedro A./0000-0001-8997-3025; Vega, Francisco M./0000-0002-9015-864X; 	Ministerio de Educacion y Ciencia [predoctoral fellowships, SAF2007-60242]; Fundacion Ramon Areces [predoctoral fellowships]; Consolider-Ingenio-2010 [CSD-2007-0017]; Junta de Castilla y Leon [CSI05A05]; Fundacion de Investigacion Medica MM; Federacion de Cajas de Ahorro de Castilla y Leon	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion Ramon Areces; Consolider-Ingenio-2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion de Investigacion Medica MM; Federacion de Cajas de Ahorro de Castilla y Leon	A.V. and S.B. have predoctoral fellowships from Ministerio de Educacion y Ciencia. F.M.V. has a predoctoral fellowship from Fundacion Ramon Areces. This work was funded by grants from Ministerio de Educacion y Ciencia (SAF2007-60242), Consolider-Ingenio-2010 (CSD-2007-0017), Junta de Castilla y Leon (CSI05A05), Fundacion de Investigacion Medica MM and Federacion de Cajas de Ahorro de Castilla y Leon.	Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boehden GS, 2003, ONCOGENE, V22, P4111, DOI 10.1038/sj.onc.1206632; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; BOURDON JC, 2005, GENES DEV; Buschmann T, 2000, CANCER RES, V60, P896; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fan SJ, 2002, CANCER RES, V62, P141; Ferrer M, 1999, ONCOGENE, V18, P2253, DOI 10.1038/sj.onc.1202551; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Liu L, 1999, MOL CELL BIOL, V19, P1202; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Moll UM, 2003, MOL CANCER RES, V1, P1001; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Patel D, 1999, EMBO J, V18, P5061, DOI 10.1093/emboj/18.18.5061; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Roemer K, 1996, ONCOGENE, V12, P2069; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883	55	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2649	10.1371/journal.pone.0002649	http://dx.doi.org/10.1371/journal.pone.0002649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612383	gold, Green Submitted, Green Published			2022-12-27	WOS:000264065800051
J	Massacand, JC; Kaiser, P; Ernst, B; Tardivel, A; Burki, K; Schneider, P; Harris, NL				Massacand, Joanna C.; Kaiser, Patrick; Ernst, Bettina; Tardivel, Aubry; Buerki, Kurt; Schneider, Pascal; Harris, Nicola L.			Intestinal Bacteria Condition Dendritic Cells to Promote IgA Production	PLOS ONE			English	Article								Immunoglobulin (Ig) A represents the predominant antibody isotype produced at the intestinal mucosa, where it plays an important role in limiting the penetration of commensal intestinal bacteria and opportunistic pathogens. We show in mice that Peyer's Patch-derived dendritic cells (PP-DC) exhibit a specialized phenotype allowing the promotion of IgA production by B2 cells. This phenotype included increased expression of the retinaldehyde dehydrogenase 1 (RALDH1), inducible nitric oxide synthase (iNOS), B cell activating factor of the tumor necrosis family (BAFF), a proliferation-inducing ligand (APRIL), and receptors for the neuropeptide vasoactive intestinal peptide (VIP). The ability of PP-DC to promote anti-CD40 dependent IgA was partially dependent on retinoic acid (RA) and transforming growth factor (TGF)-beta, whilst BAFF and APRIL signaling were not required. Signals delivered by BAFF and APRIL were crucial for CD40 independent IgA production, although the contribution of B2 cells to this pathway was minimal. The unique ability of PP-DC to instruct naive B cells to differentiate into IgA producing plasma cells was mainly imparted by the presence of intestinal commensal bacteria, and could be mimicked by the addition of LPS to the culture. These data indicate that exposure to pathogen-associated molecular patterns present on intestinal commensal bacteria condition DC to express a unique molecular footprint that in turn allows them to promote IgA production.	[Massacand, Joanna C.; Kaiser, Patrick; Harris, Nicola L.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Ernst, Bettina] Swiss Fed Inst Technol, Inst Integrative Biol, Mol Biomed, Zurich, Switzerland; [Tardivel, Aubry; Schneider, Pascal] Univ Lausanne, Dept Biochem, Epalinges, Switzerland; [Buerki, Kurt] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; University of Zurich	Massacand, JC (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	nharris@ethz.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation [310000-116498]; NCCR Molecular Oncology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	JCM and NLH were supported by the Swiss National Science Foundation (no. 310000-116498). PS was supported by grants from the Swiss National Science Foundation and the NCCR Molecular Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist P, 2006, J IMMUNOL, V177, P7772, DOI 10.4049/jimmunol.177.11.7772; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BOIRIVANT M, 1994, GASTROENTEROLOGY, V106, P576, DOI 10.1016/0016-5085(94)90688-2; BRANDTZAEG P, 1984, NATURE, V311, P71, DOI 10.1038/311071a0; Brandtzaeg P, 1994, HDB MUCOSAL IMMUNOLO, P113; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; CEBRA JJ, 1991, IMMUNOL RES, V10, P389, DOI 10.1007/BF02919727; CEBRA JJ, 1995, ADV EXP MED BIOL, V371, P429; Chorny A, 2006, ANN NY ACAD SCI, V1088, P187, DOI 10.1196/annals.1366.004; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CONLEY ME, 1987, ANN INTERN MED, V106, P892, DOI 10.7326/0003-4819-106-6-892; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; Delgado M, 2005, J IMMUNOL, V175, P7311, DOI 10.4049/jimmunol.175.11.7311; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; FIERER J, 1993, INFECT AGENT DIS, V2, P255; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Gardby E, 1998, J IMMUNOL, V161, P49; HARRIS NL, 2006, J IMMUNOL; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; Huang NN, 2005, J IMMUNOL, V175, P7125, DOI 10.4049/jimmunol.175.11.7125; HUSBAND AJ, 1978, J EXP MED, V148, P1146, DOI 10.1084/jem.148.5.1146; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansen FE, 2001, J IMMUNOL, V167, P5185, DOI 10.4049/jimmunol.167.9.5185; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; KIMATA H, 1995, BLOOD, V85, P2098, DOI 10.1182/blood.V85.8.2098.bloodjournal8582098; Kushnir N, 1998, J IMMUNOL, V160, P1774; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; MESTECKY J, 1986, CLIN IMMUNOL IMMUNOP, V40, P105, DOI 10.1016/0090-1229(86)90073-5; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Saurer L, 2007, J IMMUNOL, V179, P3504, DOI 10.4049/jimmunol.179.6.3504; SCHRADER CE, 1990, INT IMMUNOL, V2, P563, DOI 10.1093/intimm/2.6.563; SCHRADER CE, 1993, ADV EXP MED BIOL, V329, P59; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; SPALDING DM, 1984, IMMUNOBIOLOGY, V168, P380, DOI 10.1016/S0171-2985(84)80124-2; SPALDING DM, 1984, J EXP MED, V160, P941, DOI 10.1084/jem.160.3.941; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Wykes M, 1998, J IMMUNOL, V161, P1313	57	83	86	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2588	10.1371/journal.pone.0002588	http://dx.doi.org/10.1371/journal.pone.0002588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596964	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200047
J	Pechous, RD; McCarthy, TR; Mohapatra, NP; Soni, S; Penoske, RM; Salzman, NH; Frank, DW; Gunn, JS; Zahrt, TC				Pechous, Roger D.; McCarthy, Travis R.; Mohapatra, Nrusingh P.; Soni, Shilpa; Penoske, Renee M.; Salzman, Nita H.; Frank, Dara W.; Gunn, John S.; Zahrt, Thomas C.			A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge	PLOS ONE			English	Article							AEROSOL INFECTION; TULAREMIA VACCINE; VIRULENCE; CONSTRUCTION	Background: Francisella tularensis is a Gram-negative coccobacillus that causes the febrile illness tularemia. Subspecies that are pathogenic for humans include those comprising the type A (subspecies tularensis) or type B (subspecies holarctica) biovars. An attenuated live vaccine strain (LVS) developed from a type B isolate has previously been used to vaccinate at-risk individuals, but offers limited protection against high dose (> 1000 CFUs) challenge with type A strains delivered by the respiratory route. Due to differences between type A and type B F. tularensis strains at the genetic level, it has been speculated that utilization of an attenuated type A strain as a live vaccine might offer better protection against homologous respiratory challenge compared with LVS. Here, we report the construction and characterization of an unmarked Delta purMCD mutant in the highly virulent type A strain Schu S4. Methodology/Principal Findings: Growth of Schu S4 DpurMCD was severely attenuated in primary human peripheral blood monocyte-derived macrophages and in the A549 human lung epithelial cell line. The Schu S4 DpurMCD mutant was also highly attenuated in mice when delivered via either the intranasal or intradermal infection route. Mice vaccinated intranasally with Schu S4 DpurMCD were well protected against high dose intradermal challenge with virulent type A or type B strains of F. tularensis. However, intranasal vaccination with Schu S4 DpurMCD induced tissue damage in the lungs, and conferred only limited protection against high dose Schu S4 challenge delivered by the same route. The level of protection observed was similar to that conferred following vaccination with wild-type LVS or the analogous LVS DpurMCD mutant. Conclusions/Significance: Collectively, these results argue that development of the next generation live attenuated vaccine for Francisella should be based on use of the less pathogenic type B biovar rather than the more reactogenic type A biovar.	[Pechous, Roger D.; McCarthy, Travis R.; Penoske, Renee M.; Salzman, Nita H.; Frank, Dara W.; Zahrt, Thomas C.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI USA; [Mohapatra, Nrusingh P.; Soni, Shilpa; Gunn, John S.] Ohio State Univ, Dept Mol Biol, Immunol & Med Genet, Columbus, OH USA	Medical College of Wisconsin; Medical College of Wisconsin; University System of Ohio; Ohio State University	Pechous, RD (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	tzahrt@mcw.edu	Gunn, John/E-3167-2011	Salzman, Nita/0000-0003-0939-6139	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program [1-U54-AI-057153, R01-AI063441-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI063441, R01AI057757] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program. The authors also wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). D.W.F. and T.C.Z. were also supported by NIAID grant (R01-AI063441-03).	Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; BACON GA, 1950, BRIT J EXP PATHOL, V31, P714; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Cross AS, 2007, CLIN INFECT DIS, V45, pS61, DOI 10.1086/518150; Feldman KA, 2003, J AM VET MED ASSOC, V222, P725, DOI 10.2460/javma.2003.222.725; Foshay L, 1942, AM J PUBLIC HEALTH N, V32, P1131, DOI 10.2105/AJPH.32.10.1131; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Henry T, 2007, CELL MICROBIOL, V9, P2543, DOI 10.1111/j.1462-5822.2007.01022.x; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; QIN A, 2008, INFECT IMMUN; *SAS I INC, SAS 9 1 ONL DOC; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; VANMETRE TE, 1959, ANN INTERN MED, V50, P621, DOI 10.7326/0003-4819-50-3-621; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	27	60	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2487	10.1371/journal.pone.0002487	http://dx.doi.org/10.1371/journal.pone.0002487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575611	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000015
J	Poinsignon, A; Cornelie, S; Mestres-Simon, M; Lanfrancotti, A; Rossignol, M; Boulanger, D; Cisse, B; Sokhna, C; Arca, B; Simondon, F; Remoue, F				Poinsignon, Anne; Cornelie, Sylvie; Mestres-Simon, Montserrat; Lanfrancotti, Alessandra; Rossignol, Marie; Boulanger, Denis; Cisse, Badara; Sokhna, Cheikh; Arca, Bruno; Simondon, Francois; Remoue, Franck			Novel Peptide Marker Corresponding to Salivary Protein gSG6 Potentially Identifies Exposure to Anopheles Bites	PLOS ONE			English	Article							ANTIBODY-RESPONSE; ARTHROPOD SALIVA; MALARIA; ANTIGENS; GAMBIAE; TRANSCRIPTOME; MOSQUITOS; VECTORS; SIALOME; INSIGHT	Background: In order to improve malaria control, and under the aegis of WHO recommendations, many efforts are being devoted to developing new tools for identifying geographic areas with high risk of parasite transmission. Evaluation of the human antibody response to arthropod salivary proteins could be an epidemiological indicator of exposure to vector bites, and therefore to risk of pathogen transmission. In the case of malaria, which is transmitted only by anopheline mosquitoes, maximal specificity could be achieved through identification of immunogenic proteins specific to the Anopheles genus. The objective of the present study was to determine whether the IgG response to the Anopheles gambiae gSG6 protein, from its recombinant form to derived synthetic peptides, could be an immunological marker of exposure specific to Anopheles gambiae bites. Methodology/Principal Findings: Specific IgG antibodies to recombinant gSG6 protein were observed in children living in a Senegalese area exposed to malaria. With the objective of optimizing Anopheles specificity and reproducibility, we designed five gSG6-based peptide sequences using a bioinformatic approach, taking into consideration i) their potential antigenic properties and ii) the absence of cross-reactivity with protein sequences of other arthropods/organisms. The specific anti-peptide IgG antibody response was evaluated in exposed children. The five gSG6 peptides showed differing antigenic properties, with gSG6-P1 and gSG6-P2 exhibiting the highest antigenicity. However, a significant increase in the specific IgG response during the rainy season and a positive association between the IgG level and the level of exposure to Anopheles gambiae bites was significant only for gSG6-P1. Conclusions/Significance: This step-by-step approach suggests that gSG6-P1 could be an optimal candidate marker for evaluating exposure to Anopheles gambiae bites. This marker could be employed as a geographic indicator, like remote sensing techniques, for mapping the risk of malaria. It could also represent a direct criterion of efficacy in evaluation of vector control strategies.	[Poinsignon, Anne] IRD, Epidemiol & Prevent UR024, Dakar, Senegal; [Cornelie, Sylvie; Rossignol, Marie; Boulanger, Denis; Simondon, Francois; Remoue, Franck] IRD, UR024 Epidemiol Prevent, Montpellier, France; [Mestres-Simon, Montserrat; Lanfrancotti, Alessandra; Arca, Bruno] Sapienza Univ, Dept Publ Hlth, Parasitol Sect, Rome, Italy; [Cisse, Badara; Sokhna, Cheikh] Paludol Afro trop, UR077, Dakar, Senegal; [Cisse, Badara] Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal; [Arca, Bruno] Univ Federico II, Dept Structural & Funct Biol, Naples, Italy	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Sapienza University Rome; University Cheikh Anta Diop Dakar; University of Naples Federico II	Poinsignon, A (corresponding author), IRD, Epidemiol & Prevent UR024, Dakar, Senegal.	anne.poinsignon@ird.fr	BOULANGER, Denis/G-9644-2016; Arca, Bruno/C-8383-2012	BOULANGER, Denis/0000-0002-8757-0350; Arca, Bruno/0000-0002-4029-0984; Poinsignon, Anne/0000-0003-2921-4486; Simondon, Francois/0000-0003-0395-1314; cornelie, sylvie/0000-0003-3662-1450	Research Ministry of France [scholarship]; Inkerman Fundation; Compagnia di San Paolo-IMI (Torino Italy); EU-RTN [ERBFMRXCT2000-00080]; French Ministry of Research (PAL+ Program); French Ministry of Defense (Delegation Generale pour Armement); IRD; Gates Malaria Program; Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme [LSHP-CT-2004-503578]	Research Ministry of France(European Commission); Inkerman Fundation; Compagnia di San Paolo-IMI (Torino Italy)(Compagnia di San Paolo); EU-RTN; French Ministry of Research (PAL+ Program)(Ministry of Research, France); French Ministry of Defense (Delegation Generale pour Armement); IRD; Gates Malaria Program; Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme	Anne Poinsignon was supported by a scholarship provided by the Research Ministry of France. Sylvie Cornelie was supported by the Inkerman Fundation. Alessandra Lanfrancotti was supported by Compagnia di San Paolo-IMI (Torino Italy) and Montserrat Mestres-Simon by the EU-RTN Project ERBFMRXCT2000-00080. This work was supported by the French Ministry of Research (PAL+ Program), the French Ministry of Defense (Delegation Generale pour Armement) and the IRD. The malaria field study in Niakhar area was funded by the Gates Malaria Program. This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Champagne DE, 2005, PATHOPHYSIOL HAEMO T, V34, P221, DOI 10.1159/000092428; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Lombardo F., 2006, Parassitologia (Rome), V48, P573; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2007, AM J TROP MED HYG, V76, P327, DOI 10.4269/ajtmh.2007.76.327; Remoue F., 2005, Update in tropical immunology, P377; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Schonbach C, 2002, NUCLEIC ACIDS RES, V30, P226, DOI 10.1093/nar/30.1.226; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1199, DOI 10.1016/S0965-1748(02)00083-8; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; *WHO DEP RBM UNICE, 2005, WHOHTMMAL20051102 UN	36	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2472	10.1371/journal.pone.0002472	http://dx.doi.org/10.1371/journal.pone.0002472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575604	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000004
J	Beer, S; Komatsubara, K; Bellovin, DI; Kurobe, M; Sylvester, K; Felsher, DW				Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Kurobe, Masashi; Sylvester, Karl; Felsher, Dean W.			Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis	PLOS ONE			English	Article								Background: Overexpression of the human c-MYC (MYC) oncogene is one of the most frequently implicated events in the pathogenesis of hepatocellular carcinoma (HCC). Previously, we have shown in a conditional transgenic mouse model that MYC overexpression is restrained from inducing mitotic cellular division and tumorigenesis in the adult liver; whereas, in marked contrast, MYC induces robust proliferation associated with the very rapid onset of tumorigenesis in embryonic and neonatal mice. Methodology/Principal Findings: Here, we show that non-genotoxic hepatotoxins induce changes in the liver cellular context associated with increased cellular proliferation and enhanced tumorigenesis. Both 5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) and carbon tetrachloride (CCl(4)) cooperate with MYC to greatly accelerate the onset of liver cancer in an adult host to less than 7 days versus a mean latency of onset of over 35 weeks for MYC alone. These hepatotoxin-enhanced liver tumors grossly and histologically resemble embryonic and neonatal liver tumors. Importantly, we found that MYC overexpression is only capable of inducing expression of the mitotic Cyclin B1 in embryonic/neonatal hosts or adult hosts that were treated with either carcinogen. Conclusion/Significance: Our results suggest a model whereby oncogenes can remain latently activated, but exposure of the adult liver to hepatotoxins that promote hepatocyte proliferation can rapidly uncover their malignant potential.	[Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Dept Med, Ctr Clin Sci Res, Sch Med,Div Oncol, Stanford, CA 94305 USA; [Beer, Shelly; Komatsubara, Kimberly; Bellovin, David I.; Felsher, Dean W.] Stanford Univ, Ctr Clin Sci Res, Sch Med, Dept Pathol, Div Oncol, Stanford, CA USA; [Kurobe, Masashi; Sylvester, Karl] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA USA	Stanford University; Stanford University; Stanford University	Beer, S (corresponding author), Stanford Univ, Dept Med, Ctr Clin Sci Res, Sch Med,Div Oncol, Stanford, CA 94305 USA.	dfelsher@stanford.edu		Sylvester, Karl G./0000-0002-8559-0155	National Cancer Institute (NCI) [R01-CA85610, R01-CA105102, 3R01CA089305-03S1, P50, 1P20 CA112973]; National Institutes of Health (NIH) [P50, 1P20 CA112973]; Leukemia and Lymphoma Society; Burroughs Wellcome Fund; Damon Runyon Lilly Clinical Investigator Award; American College of Surgeons; American Pediatric Surgical Association Foundation; Office of Technology Licensing- Stanford University; NIH NIDDK [DK56399]; Oak Foundation; Harmon Scholarship; Packard Foundation; NATIONAL CANCER INSTITUTE [R01CA089305, R01CA105102, R01CA085610] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Lilly Clinical Investigator Award; American College of Surgeons; American Pediatric Surgical Association Foundation; Office of Technology Licensing- Stanford University; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oak Foundation; Harmon Scholarship; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI), Grants R01-CA85610, R01-CA105102, 3R01CA089305-03S1; National Institutes of Health (NIH)_NCI In Vivo Cellular and Molecular Imaging Center Grant P50; NIH_NCI Grant 1P20 CA112973; the Leukemia and Lymphoma Society; the Burroughs Wellcome Fund; and the Damon Runyon Lilly Clinical Investigator Award (to DWF). Support from the American College of Surgeons, American Pediatric Surgical Association Foundation, Office of Technology Licensing- Stanford University, NIH NIDDK (pilot grant DK56399: Digestive Disease Center at Stanford) as well as additional support from the Oak Foundation, the Harmon Scholarship, and the Packard Foundation (to KGS).	Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Bralet MP, 2002, HEPATOLOGY, V36, P623, DOI 10.1053/jhep.2002.35540; Bruccoleri A, 1997, HEPATOLOGY, V25, P133, DOI 10.1002/hep.510250125; CHANDAR N, 1989, P NATL ACAD SCI USA, V86, P2703, DOI 10.1073/pnas.86.8.2703; Chang THT, 1996, J CELL BIOCHEM, V60, P161, DOI 10.1002/(SICI)1097-4644(19960201)60:2<161::AID-JCB1>3.0.CO;2-V; Dang CV, 1999, MOL CELL BIOL, V19, P1; DUNSFORD HA, 1989, CANCER RES, V49, P4894; EDWARDS MJ, 1993, TOXICOL APPL PHARM, V119, P275, DOI 10.1006/taap.1993.1069; ENGELHARDT NV, 1990, DIFFERENTIATION, V45, P29, DOI 10.1111/j.1432-0436.1990.tb00453.x; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FARBER E, 1977, AM J PATHOL, V89, P477; FARBER JL, 1975, AM J PATHOL, V81, P237; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fickert P, 2002, AM J PATHOL, V161, P2019, DOI 10.1016/S0002-9440(10)64480-X; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRASSO P, 1991, ANNU REV PHARMACOL, V31, P253; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; KAUFMANN WK, 1995, CANCER RES, V55, P7; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; MACSWEEN RN, 1973, J CLIN PATHOL, V26, P936, DOI 10.1136/jcp.26.12.936; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; MURAKAMI H, 1993, CANCER RES, V53, P1719; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; NAGY P, 1988, CANCER RES, V48, P5522; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; PERRAUD F, 1991, EXP CELL RES, V195, P59, DOI 10.1016/0014-4827(91)90500-T; Preisegger KH, 1999, LAB INVEST, V79, P103; Rechnagel R O, 1973, CRC Crit Rev Toxicol, V2, P263, DOI 10.3109/10408447309082019; REUBER MD, 1968, ARCH PATHOL, V85, P275; Sanders S, 2000, MOL CARCINOGEN, V28, P168, DOI 10.1002/1098-2744(200007)28:3<168::AID-MC5>3.0.CO;2-E; SANDGREN EP, 1989, ONCOGENE, V4, P715; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; SantoniRugiu E, 1996, AM J PATHOL, V149, P407; SELL S, 1991, CANCER RES, V51, P1278; SELL S, 1989, AM J PATHOL, V134, P1347; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; SHIOJIRI N, 1991, CANCER RES, V51, P2611; Slagle BL, 1996, MOL CARCINOGEN, V15, P261, DOI 10.1002/(SICI)1098-2744(199604)15:4<261::AID-MC3>3.0.CO;2-J; TAKAGI H, 1993, CANCER RES, V53, P4329; WAGNER VO, 1993, ARCH ENVIRON CON TOX, V25, P260; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yamada Y, 1998, AM J PATHOL, V152, P1577; YASWEN P, 1985, MOL CELL BIOL, V5, P780, DOI 10.1128/MCB.5.4.780; Yin XY, 2001, CANCER RES, V61, P6487	47	32	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2493	10.1371/journal.pone.0002493	http://dx.doi.org/10.1371/journal.pone.0002493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560566	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700056
J	Huurman, VAL; Hilbrands, R; Pinkse, GGM; Gillard, P; Duinkerken, G; van de Linde, P; van der Meer-Prins, PMW; Maarschalk, MFJV; Verbeeck, K; Alizadeh, BZ; Mathieu, C; Gorus, FK; Roelen, DL; Claas, FHJ; Keymeulen, B; Pipeleers, DG; Roep, BO				Huurman, Volkert A. L.; Hilbrands, Robert; Pinkse, Gabrielle G. M.; Gillard, Pieter; Duinkerken, Gaby; van de Linde, Pieter; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Verbeeck, Koen; Alizadeh, Behrooz Z.; Mathieu, Chantal; Gorus, Frans K.; Roelen, Dave L.; Claas, Frans H. J.; Keymeulen, Bart; Pipeleers, Daniel G.; Roep, Bart O.			Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation	PLOS ONE			English	Article							DIABETES-MELLITUS; T-CELLS; AUTOANTIBODY; DESTRUCTION; RECURRENCE; PREVENTION; ALLOGRAFT; GRAFT; RECIPIENTS; DISEASE	Background: Islet cell transplantation can cure type 1 diabetes (T1D), but only a minority of recipients remains insulin independent in the following years. We tested the hypothesis that allograft rejection and recurrent autoimmunity contribute to this progressive loss of islet allograft function. Methodology/Principal Findings: Twenty-one T1D patients received cultured islet cell grafts prepared from multiple donors and transplanted under anti-thymocyte globulin (ATG) induction and tacrolimus plus mycophenolate mofetil (MMF) maintenance immunosuppression. Immunity against auto-and alloantigens was measured before and during one year after transplantation. Cellular auto-and alloreactivity was assessed by lymphocyte stimulation tests against autoantigens and cytotoxic T lymphocyte precursor assays, respectively. Humoral reactivity was measured by auto-and alloantibodies. Clinical outcome parameters-including time until insulin independence, insulin independence at one year, and C-peptide levels over one year-remained blinded until their correlation with immunological parameters. All patients showed significant improvement of metabolic control and 13 out of 21 became insulin-independent. Multivariate analyses showed that presence of cellular autoimmunity before and after transplantation is associated with delayed insulin-independence (p = 0.001 and p = 0.01, respectively) and lower circulating C-peptide levels during the first year after transplantation (p = 0.002 and p = 0.02, respectively). Seven out of eight patients without pre-existent T-cell autoreactivity became insulin-independent, versus none of the four patients reactive to both islet autoantigens GAD and IA-2 before transplantation. Autoantibody levels and cellular alloreactivity had no significant association with outcome. Conclusions/Significance: In this cohort study, cellular islet-specific autoimmunity associates with clinical outcome of islet cell transplantation under ATG-tacrolimus-MMF immunosuppression. Tailored immunotherapy targeting cellular islet autoreactivity may be required. Monitoring cellular immune reactivity can be useful to identify factors influencing graft survival and to assess efficacy of immunosuppression. Trial Registration: Clinicaltrials.gov NCT00623610	[Huurman, Volkert A. L.; Pinkse, Gabrielle G. M.; Duinkerken, Gaby; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Alizadeh, Behrooz Z.; Roelen, Dave L.; Claas, Frans H. J.; Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Huurman, Volkert A. L.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Hilbrands, Robert; Gillard, Pieter; Verbeeck, Koen; Gorus, Frans K.; Keymeulen, Bart; Pipeleers, Daniel G.] Brussels Free Univ VUB, Diabetes Res Ctr, Brussels, Belgium; [Gillard, Pieter; Mathieu, Chantal] Catholic Univ Leuven KUL, Univ Hosp Gasthuisberg, LEGENDO, Louvain, Belgium; [Huurman, Volkert A. L.; Hilbrands, Robert; Pinkse, Gabrielle G. M.; Gillard, Pieter; Duinkerken, Gaby; van de Linde, Pieter; van der Meer-Prins, Petronella M. W.; Maarschalk, Minke F. J. Versteeg-van der Voort; Verbeeck, Koen; Alizadeh, Behrooz Z.; Mathieu, Chantal; Gorus, Frans K.; Roelen, Dave L.; Claas, Frans H. J.; Keymeulen, Bart; Pipeleers, Daniel G.; Roep, Bart O.] JDRF Ctr Beta Cell Therapy Diabetes, Brussels, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Brussel; KU Leuven; University Hospital Leuven	Huurman, VAL (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	boroep@lumc.nl	Gillard, Pieter/AAA-9820-2020; Hilbrands, Robert/B-7561-2014; Gillard, Pieter/GPX-1490-2022; Alizadeh, Behrooz Z Ziad/J-2921-2017; Roep, Bart/AAD-7609-2021; mathieu, chantal/ABD-5505-2021; Gillard, Pieter/AAY-1483-2020	Hilbrands, Robert/0000-0003-0228-699X; Gillard, Pieter/0000-0001-9111-4561; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; mathieu, chantal/0000-0002-4055-5233; Gillard, Pieter/0000-0001-9111-4561; Pipeleers, Daniel/0000-0002-6440-2485; Gorus, Frans/0000-0002-9007-6177; Keymeulen, Bart/0000-0002-8671-4527	Juvenile Diabetes Research Foundation [4/2001/434]; Dutch Diabetes Foundation [2001.06.001]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Dutch Diabetes Foundation	This study was supported by the Juvenile Diabetes Research Foundation (grant 4/2001/434) and the Dutch Diabetes Foundation (grant 2001.06.001). These organizations had no role in the conduction of the study nor the preparation of the mansucript.	Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bartlett ST, 1997, TRANSPLANTATION, V63, P299, DOI 10.1097/00007890-199701270-00021; Bosi E, 2001, DIABETES, V50, P2464, DOI 10.2337/diabetes.50.11.2464; BOUGNERES PF, 1990, DIABETES, V39, P1264, DOI 10.2337/diabetes.39.10.1264; BOUMA GJ, 1992, HUM IMMUNOL, V35, P85, DOI 10.1016/0198-8859(92)90015-F; Braghi S, 2000, DIABETES, V49, P218, DOI 10.2337/diabetes.49.2.218; Decochez K, 2000, DIABETES CARE, V23, P838, DOI 10.2337/diacare.23.6.838; EISENBARTH GS, 1985, DIABETES RES CLIN EX, V2, P271; Goudy KS, 2005, INT REV IMMUNOL, V24, P307, DOI 10.1080/08830180500379721; Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x; Jaeger C, 1997, DIABETES, V46, P1907, DOI 10.2337/diabetes.46.11.1907; Jaeger C, 2000, EXP CLIN ENDOCR DIAB, V108, P328, DOI 10.1055/s-2000-8125; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Keymeulen B, 1998, DIABETOLOGIA, V41, P452, DOI 10.1007/s001250050929; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; Maleux G, 2005, J VASC INTERV RADIOL, V16, P1693, DOI 10.1097/01.RVI.0000182506.88739.39; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Petruzzo P, 2000, DIABETES METAB, V26, P215; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Ricordi C, 2005, TRANSPLANTATION, V79, P1298, DOI 10.1097/01.TP.0000157275.64874.84; ROEP BO, 1995, DIABETES, V44, P278, DOI 10.2337/diabetes.44.3.278; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Roep BO, 1999, DIABETOLOGIA, V42, P636; Roep BO, 1999, DIABETES, V48, P484, DOI 10.2337/diabetes.48.3.484; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sasaki TM, 1998, TRANSPLANTATION, V65, P1510, DOI 10.1097/00007890-199806150-00021; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SIBLEY RK, 1985, LAB INVEST, V53, P132; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Slover RH, 1997, ENDOCR REV, V18, P241, DOI 10.1210/er.18.2.241; Sosenko JM, 2004, DIABETES, V53, pA425; Stobbe I, 1999, DIABETOLOGIA, V42, P1379; STRIJBOSCH LWG, 1988, INT J BIOMED COMPUT, V23, P279, DOI 10.1016/0020-7101(88)90020-7; SUTHERLAND DER, 1989, DIABETES, V38, P85, DOI 10.2337/diab.38.1.S85; Sutherland DER, 2001, WORLD J SURG, V25, P487, DOI 10.1007/s002680020342; Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018; Tyden G, 1996, NEW ENGL J MED, V335, P860, DOI 10.1056/NEJM199609193351205; Uchikoshi F, 1999, DIABETES, V48, P652, DOI 10.2337/diabetes.48.3.652; van Kampen CA, 2005, TRANSPLANTATION, V80, P118, DOI 10.1097/01.TP.0000164143.22287.E3; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857	49	140	144	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2435	10.1371/journal.pone.0002435	http://dx.doi.org/10.1371/journal.pone.0002435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560516	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700020
J	Addessi, E; Mancini, A; Crescimbene, L; Padoa-Schioppa, C; Visalberghi, E				Addessi, Elsa; Mancini, Alessandra; Crescimbene, Lara; Padoa-Schioppa, Camillo; Visalberghi, Elisabetta			Preference Transitivity and Symbolic Representation in Capuchin Monkeys (Cebus apella)	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; QUANTITY; DELAY	Background: Can non-human animals comprehend and employ symbols? The most convincing empirical evidence comes from language-trained apes, but little is known about this ability in monkeys. Tokens can be regarded as symbols since they are inherently non-valuable objects that acquire an arbitrarily assigned value upon exchange with an experimenter. Recent evidence suggested that capuchin monkeys, which diverged from the human lineage 35 million years ago, can estimate, represent and combine token quantities. A fundamental and open question is whether monkeys can reason about symbols in ways similar to how they reason about real objects. Methodology/Principal Findings: Here we examined this broad question in the context of economic choice behavior. Specifically, we assessed whether, in a symbolic context, capuchins' preferences satisfy transitivity - a fundamental trait of rational decision-making. Given three options A, B and C, transitivity holds true if A >= B, B >= C and A >= C ( where >= indicates preference). In this study, we trained monkeys to exchange three types of tokens for three different foods. We then compared choices monkeys made between different types of tokens with choices monkeys made between the foods. Qualitatively, capuchins' preferences revealed by the way of tokens were similar to those measured with the actual foods. In particular, when choosing between tokens, monkeys displayed strict economic preferences and their choices satisfied transitivity. Quantitatively, however, values measured by the way of tokens differed systematically from those measured with the actual foods. In particular, for any pair of foods, the relative value of the preferred food increased when monkeys chose between the corresponding tokens. Conclusions/Significance: These results indicate that indeed capuchins are capable of treating tokens as symbols. However, as they do so, capuchins experience the cognitive burdens imposed by symbolic representation.	[Addessi, Elsa; Mancini, Alessandra; Crescimbene, Lara; Visalberghi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Mancini, Alessandra; Crescimbene, Lara] Univ Roma La Sapienza, Rome, Italy; [Padoa-Schioppa, Camillo] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Padoa-Schioppa, Camillo] Washington Univ, Sch Med, St Louis, MO USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Sapienza University Rome; Harvard University; Harvard Medical School; Washington University (WUSTL)	Addessi, E (corresponding author), CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy.	elsa.addessi@istc.cnr.it	Addessi, Elsa/B-8329-2015	Addessi, Elsa/0000-0002-5553-7732; Padoa-Schioppa, Camillo/0000-0002-7519-8790; Mancini, Alessandra/0000-0003-1139-2890; Visalberghi, Elisabetta/0000-0001-7407-5468	VI Framework, NEST Pathfinder Initiative [12984]; SEDSU [29088]	VI Framework, NEST Pathfinder Initiative; SEDSU	Funded by VI Framework, NEST Pathfinder Initiative, What it means to be human, Contract n 12984, Stages in the Evolution and Development of Sign Use - SEDSU, and Contract n 29088, Humans: The Analogy-Making Species - ANALOGY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Bates E., 1979, EMERGENCE SYMBOLS CO, P33, DOI 10.1016/B978-0-12-081540-1.50008-9; Boysen Sarah T., 2006, P489; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Brosnan SF, 2007, CURR BIOL, V17, P1704, DOI 10.1016/j.cub.2007.08.059; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; DEACON T, 1997, SYMBOLIC SPECIES COE, P527; DeLoache J. S., 2007, BLACKWELL HDB CHILDH, P206, DOI [10.1002/9780470996652.ch10, DOI 10.1002/9780470996652.CH10]; DeLoache JS, 2004, TRENDS COGN SCI, V8, P66, DOI 10.1016/j.tics.2003.12.004; DeLoache JS, 2002, MINN SYM CHILD PSYCH, V32, P73; Dubreuil D, 2006, P ROY SOC B-BIOL SCI, V273, P1223, DOI 10.1098/rspb.2005.3433; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; KREPS DM, 1990, COURSE MICROECONOMIC, P850; MISCHEL W, 1975, J PERS SOC PSYCHOL, V31, P254, DOI 10.1037/h0076272; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Peirce Charles S., 1931, COLLECTED WRITINGS; Ramseyer A, 2006, P ROY SOC B-BIOL SCI, V273, P179, DOI 10.1098/rspb.2005.3300; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; SAVAGERUMBAUGH ES, 1978, SCIENCE, V201, P641, DOI 10.1126/science.675251; SAVAGERUMBAUGH ES, 1980, SCIENCE, V210, P922, DOI 10.1126/science.7434008; SAVAGERUMBAUGH ES, 1986, APE LANGUAGE CONDITI, P433; SCHMANDTBESSERAT D, 1978, SCI AM, V238, P50, DOI 10.1038/scientificamerican0678-50; SIGEL IE, 1990, METHODS FAMILY RES B, V1, P87; Sigel IE., 1970, MIAM S PRED BEH 1968, P99; von Neumann J., 1947, THEORY GAMES EC BEHA, DOI [DOI 10.1177/1468795X06065810, 10.1177/1468795X06065810]; VONNEUMANN J, 1963, SYMBOL FORMATION ORG, P530	34	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2414	10.1371/journal.pone.0002414	http://dx.doi.org/10.1371/journal.pone.0002414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545670	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800051
J	Attardo, A; Calegari, F; Haubensak, W; Wilsch-Brauninger, M; Huttner, WB				Attardo, Alessio; Calegari, Federico; Haubensak, Wulf; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.			Live Imaging at the Onset of Cortical Neurogenesis Reveals Differential Appearance of the Neuronal Phenotype in Apical versus Basal Progenitor Progeny	PLOS ONE			English	Article								The neurons of the mammalian brain are generated by progenitors dividing either at the apical surface of the ventricular zone (neuroepithelial and radial glial cells, collectively referred to as apical progenitors) or at its basal side (basal progenitors, also called intermediate progenitors). For apical progenitors, the orientation of the cleavage plane relative to their apical-basal axis is thought to be of critical importance for the fate of the daughter cells. For basal progenitors, the relationship between cell polarity, cleavage plane orientation and the fate of daughter cells is unknown. Here, we have investigated these issues at the very onset of cortical neurogenesis. To directly observe the generation of neurons from apical and basal progenitors, we established a novel transgenic mouse line in which membrane GFP is expressed from the beta-III-tubulin promoter, an early pan-neuronal marker, and crossed this line with a previously described knock-in line in which nuclear GFP is expressed from the Tis21 promoter, a pan-neurogenic progenitor marker. Mitotic Tis21-positive basal progenitors nearly always divided symmetrically, generating two neurons, but, in contrast to symmetrically dividing apical progenitors, lacked apical-basal polarity and showed a nearly randomized cleavage plane orientation. Moreover, the appearance of beta-III-tubulin-driven GFP fluorescence in basal progenitor-derived neurons, in contrast to that in apical progenitor-derived neurons, was so rapid that it suggested the initiation of the neuronal phenotype already in the progenitor. Our observations imply that (i) the loss of apical-basal polarity restricts neuronal progenitors to the symmetric mode of cell division, and that (ii) basal progenitors initiate the expression of neuronal phenotype already before mitosis, in contrast to apical progenitors.	[Attardo, Alessio; Calegari, Federico; Haubensak, Wulf; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Attardo, A (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018; Attardo, Alessio/ABE-5208-2021; Calegari, Federico/N-7827-2019; Calegari, Federico/A-2422-2009	Attardo, Alessio/0000-0003-0665-6011; calegari, federico/0000-0002-3703-2802; Haubensak, Wulf/0000-0002-2034-9184	DFG [SPP 1109, Hu 275/7-3, SPP 1111, Hu 275/8-3, SFB/TR 13, B1, SFB 655, A2]; Fonds der Chemischen Industrie; Federal Ministry of Education and Research (BMBF) [NGFN-2, SMP RNAi, 01GR0402, PRI-S08T05]	DFG(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	W.B.H. was supported by grants from the DFG (SPP 1109, Hu 275/7-3; SPP 1111, Hu 275/8-3; SFB/TR 13, B1; SFB 655, A2), by the DFG-funded Center for Regenerative Therapies Dresden, by the Fonds der Chemischen Industrie and by the Federal Ministry of Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN-2, SMP RNAi, 01GR0402, PRI-S08T05).	Aaku-Saraste E, 1997, MECH DEVELOP, V69, P71, DOI 10.1016/S0925-4773(97)00156-1; AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; des Portes V, 1998, CELL, V92, P51; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Ishii Y, 2000, DEV BRAIN RES, V119, P307, DOI 10.1016/S0165-3806(99)00186-8; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LIU YC, 1994, J NEUROSCI, V14, P5807; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; SMART IHM, 1973, J ANAT, V116, P67; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	59	130	130	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2388	10.1371/journal.pone.0002388	http://dx.doi.org/10.1371/journal.pone.0002388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545663	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800027
J	McCaw, JM; Wood, JG; McCaw, CT; McVernon, J				McCaw, James M.; Wood, James G.; McCaw, Christopher T.; McVernon, Jodie			Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs	PLOS ONE			English	Article							A VIRUS-INFECTION; ZANAMIVIR RESISTANCE; CONTACT PATTERNS; B VIRUSES; OSELTAMIVIR; EMERGENCE; TRANSMISSION; MODEL; H5N1; HOUSEHOLD	Background: Wide-scale use of antiviral agents in the event of an influenza pandemic is likely to promote the emergence of drug resistance, with potentially deleterious effects for outbreak control. We explored factors promoting resistance within a dynamic infection model, and considered ways in which one or two drugs might be distributed to delay the spread of resistant strains or mitigate their impact. Methods and Findings: We have previously developed a novel deterministic model of influenza transmission that simulates treatment and targeted contact prophylaxis, using a limited stockpile of antiviral agents. This model was extended to incorporate subclinical infections, and the emergence of resistant virus strains under the selective pressure imposed by various uses of one or two antiviral agents. For a fixed clinical attack rate, R-0 rises with the proportion of subclinical infections thus reducing the number of infections amenable to treatment or prophylaxis. In consequence, outbreak control is more difficult, but emergence of drug resistance is relatively uncommon. Where an epidemic may be constrained by use of a single antiviral agent, strategies that combine treatment and prophylaxis are most effective at controlling transmission, at the cost of facilitating the spread of resistant viruses. If two drugs are available, using one drug for treatment and the other for prophylaxis is more effective at preventing propagation of mutant strains than either random allocation or drug cycling strategies. Our model is relatively straightforward, and of necessity makes a number of simplifying assumptions. Our results are, however, consistent with the wider body of work in this area and are able to place related research in context while extending the analysis of resistance emergence and optimal drug use within the constraints of a finite drug stockpile. Conclusions: Combined treatment and prophylaxis represents optimal use of antiviral agents to control transmission, at the cost of drug resistance. Where two drugs are available, allocating different drugs to cases and contacts is likely to be most effective at constraining resistance emergence in a pandemic scenario.	[McCaw, James M.; McCaw, Christopher T.; McVernon, Jodie] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Wood, James G.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Wood, James G.] University of Sydney, Childrens Hospital at Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine, Sydney, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; University of New South Wales Sydney; University of Sydney	McCaw, JM (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	jamesm@unimelb.edu.au		McVernon, Jodie/0000-0001-9774-1961; McCaw, James/0000-0002-2452-3098	National Health and Medical Research Council (NHMRC) [358425]; Urgent Research [410224]; Training Fellowship [359238]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Urgent Research; Training Fellowship	Funding support was provided by the National Health and Medical Research Council (NHMRC) through Capacity Building (Grant 358425), Urgent Research (Grant 410224) and Training Fellowship (J McVernon, Grant 359238) Schemes.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; ALNAKIB W, 1986, J ANTIMICROB CHEMOTH, V18, P119, DOI 10.1093/jac/18.1.119; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P149; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; *CDC, 2008, FLUVIEW WEEK 13; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; HALL CE, 1973, AM J EPIDEMIOL, V98, P365, DOI 10.1093/oxfordjournals.aje.a121566; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; HURT A, 2007, COMMUN DIS IN PRESS; Jackson D, 2005, J ANTIMICROB CHEMOTH, V55, P162, DOI 10.1093/jac/dkh528; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kawai N, 2007, J INFECTION, V55, P267, DOI 10.1016/j.jinf.2007.05.176; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lackenby A, 2008, EURO SURVEILL, V13; Langford C, 2002, MED HIST, V46, P1; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Nicoll A., 2008, EURO SURVEILL, V13; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	42	45	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2362	10.1371/journal.pone.0002362	http://dx.doi.org/10.1371/journal.pone.0002362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523549	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300049
J	Zilli, EA; Hasselmo, ME				Zilli, Eric A.; Hasselmo, Michael E.			The Influence of Markov Decision Process Structure on the Possible Strategic Use of Working Memory and Episodic Memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; HIPPOCAMPAL ACTIVITY; CONTEXT; MODEL; NEURONS; PERFORMANCE; MECHANISMS; BRAIN	Researchers use a variety of behavioral tasks to analyze the effect of biological manipulations on memory function. This research will benefit from a systematic mathematical method for analyzing memory demands in behavioral tasks. In the framework of reinforcement learning theory, these tasks can be mathematically described as partially-observable Markov decision processes. While a wealth of evidence collected over the past 15 years relates the basal ganglia to the reinforcement learning framework, only recently has much attention been paid to including psychological concepts such as working memory or episodic memory in these models. This paper presents an analysis that provides a quantitative description of memory states sufficient for correct choices at specific decision points. Using information from the mathematical structure of the task descriptions, we derive measures that indicate whether working memory (for one or more cues) or episodic memory can provide strategically useful information to an agent. In particular, the analysis determines which observed states must be maintained in or retrieved from memory to perform these specific tasks. We demonstrate the analysis on three simplified tasks as well as eight more complex memory tasks drawn from the animal and human literature (two alternation tasks, two sequence disambiguation tasks, two non-matching tasks, the 2-back task, and the 1-2-AX task). The results of these analyses agree with results from quantitative simulations of the task reported in previous publications and provide simple indications of the memory demands of the tasks which can require far less computation than a full simulation of the task. This may provide a basis for a quantitative behavioral stoichiometry of memory tasks.	[Zilli, Eric A.; Hasselmo, Michael E.] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Zilli, EA (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	zilli@bu.edu		Hasselmo, Michael/0000-0002-9925-6377	NIMH [MH71702, MH60013, MH61492]; NSF [0354378]; NIDA [DA16454]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH061492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Silvio O. Conte Center Grant NIMH MH71702, NIMH MH60013, NIMH MH61492, NSF SLC SBE 0354378 and NIDA DA16454 (part of the CRCNS program).	Agster KL, 2002, J NEUROSCI, V22, P5760; Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A. D, 1986, WORKING MEMORY; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Dayan P, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.001.2007; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fuhs MC, 2007, NEURAL COMPUT, V19, P3173, DOI 10.1162/neco.2007.19.12.3173; Fuster JM, 1995, MEMORY CEREBRAL CORT; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Hampson RE, 1996, P NATL ACAD SCI USA, V93, P13487, DOI 10.1073/pnas.93.24.13487; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kemeny J.G., 1976, MARKOV CHAINS, V6; Khatri CG, 1968, SANKHYA, V30, P167; Koene RA, 2007, CEREB CORTEX, V17, P1766, DOI 10.1093/cercor/bhl088; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Liu SZ, 1999, LINEAR ALGEBRA APPL, V289, P267, DOI 10.1016/S0024-3795(98)10209-4; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Miller EK, 1996, J NEUROSCI, V16, P5154; MONAHAN GE, 1982, MANAGE SCI, V28, P16; Moustafa AA, 2007, COGN SYST RES, V8, P262, DOI 10.1016/j.cogsys.2007.02.001; NESTOR PG, 1990, SCHIZOPHR RES, V3, P329, DOI 10.1016/0920-9964(90)90018-3; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Schacter D., 1994, MEMORY SYSTEMS; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stern CE, 2001, HIPPOCAMPUS, V11, P337; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Zilli EA, 2008, HIPPOCAMPUS, V18, P193, DOI 10.1002/hipo.20382; ZIPSER D, 1993, J NEUROSCI, V13, P3406	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2756	10.1371/journal.pone.0002756	http://dx.doi.org/10.1371/journal.pone.0002756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648498	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900026
J	Liu, YC; Li, F; Handler, J; Huang, CRL; Xiang, Y; Neretti, N; Sedivy, JM; Zeller, KI; Dang, CV				Liu, Yen-Chun; Li, Feng; Handler, Jesse; Huang, Cheng Ran Lisa; Xiang, Yan; Neretti, Nicola; Sedivy, John M.; Zeller, Karen I.; Dang, Chi V.			Global Regulation of Nucleotide Biosynthetic Genes by c-Myc	PLOS ONE			English	Article								Background: The c-Myc transcription factor is a master regulator and integrates cell proliferation, cell growth and metabolism through activating thousands of target genes. Our identification of direct c-Myc target genes by chromatin immunoprecipitation (ChIP) coupled with pair-end ditag sequencing analysis (ChIP-PET) revealed that nucleotide metabolic genes are enriched among c-Myc targets, but the role of Myc in regulating nucleotide metabolic genes has not been comprehensively delineated. Methodology/Principal Findings: Here, we report that the majority of genes in human purine and pyrimidine biosynthesis pathway were induced and directly bound by c-Myc in the P493-6 human Burkitt's lymphoma model cell line. The majority of these genes were also responsive to the ligand-activated Myc-estrogen receptor fusion protein, Myc-ER, in a Myc null rat fibroblast cell line, HO.15 MYC-ER. Furthermore, these targets are also responsive to Myc activation in transgenic mouse livers in vivo. To determine the functional significance of c-Myc regulation of nucleotide metabolism, we sought to determine the effect of loss of function of direct Myc targets inosine monophosphate dehydrogenases (IMPDH1 and IMPDH2) on c-Myc-induced cell growth and proliferation. In this regard, we used a specific IMPDH inhibitor mycophenolic acid (MPA) and found that MPA dramatically inhibits c-Myc-induced P493-6 cell proliferation through S-phase arrest and apoptosis. Conclusions/Significance: Taken together, these results demonstrate the direct induction of nucleotide metabolic genes by c-Myc in multiple systems. Our finding of an S-phase arrest in cells with diminished IMPDH activity suggests that nucleotide pool balance is essential for c-Myc's orchestration of DNA replication, such that uncoupling of these two processes create DNA replication stress and apoptosis.	[Liu, Yen-Chun; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Program Pathobiol, Baltimore, MD 21218 USA; [Li, Feng; Handler, Jesse; Xiang, Yan; Zeller, Karen I.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD USA; [Huang, Cheng Ran Lisa; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD USA; [Neretti, Nicola; Sedivy, John M.] Brown Univ, Ctr Genom & Proteom, Dept Mol Biol, Cell Biol & Biochem, Providence, RI USA; [Neretti, Nicola] Brown Univ, Inst Brain & Neural Syst, Providence, RI USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Brown University; Brown University	Liu, YC (corresponding author), Johns Hopkins Univ, Sch Med, Program Pathobiol, Baltimore, MD 21218 USA.	kzeller@jhmi.edu; cvdang@jhmi.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522; Handler, Jesse/0000-0001-5444-3905; Neretti, Nicola/0000-0002-9552-1663	NIH [CA57341, CA51497, R01 GM41690, R01 AG16694, K25 AG028753]; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA051497, R29CA051497, R37CA051497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016694, K25AG028753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was in part supported by NIH grants CA57341 and CA51497 to CVD, R01 GM41690 and R01 AG16694 to J.M.S., and grant K25 AG028753 to N.N. The sponsors have no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Burgin A, 1998, Results Probl Cell Differ, V22, P181; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cory S, 1987, Haematol Blood Transfus, V31, P248; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dang CV, 1999, MOL CELL BIOL, V19, P1; de Marval PLM, 2004, MOL CELL BIOL, V24, P7538, DOI 10.1128/MCB.24.17.7538-7547.2004; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dominguez-Sola D, 2007, NATURE; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Yu CZ, 2005, INT J MOL MED, V16, P645; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	52	195	201	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2722	10.1371/journal.pone.0002722	http://dx.doi.org/10.1371/journal.pone.0002722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628958	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200060
J	Krithika, S; Maji, S; Vasulu, TS				Krithika, S.; Maji, Suvendu; Vasulu, T. S.			A Microsatellite Guided Insight into the Genetic Status of Adi, an Isolated Hunting-Gathering Tribe of Northeast India	PLOS ONE			English	Article							15 STR LOCI; ALLELE FREQUENCY-DISTRIBUTION; ARUNACHAL-PRADESH; POPULATION-DATA; INTEGRATED SOFTWARE; PHYLOGENETIC TREES; ETHNIC POPULATIONS; HAN POPULATION; EASTERN; CHINESE	Tibeto-Burman populations of India provide an insight into the peopling of India and aid in understanding their genetic relationship with populations of East, South and Southeast Asia. The study investigates the genetic status of one such Tibeto-Burman group, Adi of Arunachal Pradesh based on 15 autosomal microsatellite markers. Further the study examines, based on 9 common microsatellite loci, the genetic relationship of Adi with 16 other Tibeto-Burman speakers of India and 28 neighboring populations of East and Southeast Asia. Overall, the results support the recent formation of the Adi sub-tribes from a putative ancestral group and reveal that geographic contiguity is a major influencing factor of the genetic affinity among the Tibeto-Burman populations of India.	[Krithika, S.; Maji, Suvendu; Vasulu, T. S.] Indian Stat Inst, Biol Anthropol Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Krithika, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Kolkata, India.	vasulu@isical.ac.in		T, VASULU/0000-0002-9084-798X	Indian Statistical Institute, Kolkata; Central Forensic Science Laboratory, Kolkata	Indian Statistical Institute, Kolkata; Central Forensic Science Laboratory, Kolkata	The funding for the work was provided by the Indian Statistical Institute, Kolkata and Central Forensic Science Laboratory, Kolkata. CFSL provided the lab infracture and other materials required for the laboratory analysis of the samples. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Bhasin MK., 2001, GENETICS CASTES TRIB; BHATTACHARJEE PN, 1954, B DEPT ANTHR, V3, P51; BLACKBURN S, 2003, EUROPEAN B HIMALAYAN, V2526, P15; Chakrabarti CS, 2002, ANN HUM GENET, V66, P361, DOI 10.1017/S000348000200132X; CHAKRABORTY R, 1994, HUM HERED, V44, P1, DOI 10.1159/000154181; CHAKRABORTY R, 1998, DNATYPE WINDOWS 95 N; Chattopadhyay P, 2001, J FORENSIC SCI, V46, P184; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Dani A.H., 1960, PREHISTORY PROTOHIST; DAS B M, 1980, Journal of the Indian Anthropological Society, V15, P153; De Ungria MCA, 2005, FORENSIC SCI INT, V152, P281, DOI 10.1016/j.forsciint.2004.09.125; DEKA R, 1988, HUM HERED, V38, P261, DOI 10.1159/000153796; *DEP PLANN GOV AR, 2006, AR PRAD HUM DEV REP; Dobashi Yuji, 2005, Legal Medicine, V7, P222, DOI 10.1016/j.legalmed.2005.04.001; Dutta R, 2002, HUM BIOL, V74, P33, DOI 10.1353/hub.2002.0002; Elwin Verrier, 1959, PHILOS NEFA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gadgil M, 1997, INDIAN HUMAN HERITAG; Gao YZ, 2005, FORENSIC SCI INT, V154, P78, DOI 10.1016/j.forsciint.2004.09.117; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hu SP, 2005, FORENSIC SCI INT, V152, P263, DOI 10.1016/j.forsciint.2004.09.119; Izuan M, 2005, J FORENSIC SCI, V50, P1225; JIAN T, 2006, J FORENSIC SCI, V51, P188; Kang LL, 2005, FORENSIC SCI INT, V155, P219, DOI 10.1016/j.forsciint.2004.12.022; Kang LL, 2007, FORENSIC SCI INT, V168, P236, DOI 10.1016/j.forsciint.2006.02.041; Kashyap VK, 2004, AM J HUM BIOL, V16, P311, DOI 10.1002/ajhb.20026; Kashyap VK, 2002, J FORENSIC SCI, V47, P1163; Kim YL, 2003, FORENSIC SCI INT, V136, P92, DOI 10.1016/S0379-0738(03)00255-X; KOLEY RN, 2007, PANGGIS IN PRESS; Kraaijenbrink T, 2007, FORENSIC SCI INT, V168, P227, DOI 10.1016/j.forsciint.2006.02.014; Kraaijenbrink T, 2007, FORENSIC SCI INT, V170, P68, DOI 10.1016/j.forsciint.2006.04.006; Krithika S, 2007, HUM BIOL, V79, P355, DOI 10.1353/hub.2007.0043; Krithika S, 2006, HUM BIOL, V78, P221, DOI 10.1353/hub.2006.0035; Krithika S., 2005, Legal Medicine, V7, P306, DOI 10.1016/j.legalmed.2005.04.002; Krithika S, 2006, ANN HUM BIOL, V33, P26, DOI 10.1080/03014460500424043; Krithika S., 2007, Legal Medicine, V9, P210, DOI 10.1016/j.legalmed.2007.01.002; Krithika S, 2007, J FORENSIC SCI, V52, P239, DOI 10.1111/j.1556-4029.2006.00347.x; KUMAR N, 1954, B DEP ANTHROP GOVT I, V3, P55; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumar V, 2004, AM J HUM BIOL, V16, P334, DOI 10.1002/ajhb.20027; Langstieh BT, 2004, HUM BIOL, V76, P569, DOI 10.1353/hub.2004.0057; LEGO N, 2005, HIST ADIS ARUNACHAL; LI KL, 2007, FORENSIC SCI INT, V169, P239; Maity B, 2003, FORENSIC SCI INT, V132, P216, DOI 10.1016/S0379-0738(02)00436-X; Maji S, 2007, HUM BIOL, V79, P321, DOI 10.1353/hub.2007.0044; Majumdar D. N., 1980, E HIMALAYAS STUDY AN; MALHOTRA KC, 1993, HUMAN POPULATION GENETICS, P207; Mastana SS, 2007, FORENSIC SCI INT, V169, P266, DOI 10.1016/j.forsciint.2006.03.019; NATH J, 2000, CULTURAL HERITAGE TR, V1; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Ota M, 2007, FORENSIC SCI INT, V169, P234, DOI 10.1016/j.forsciint.2006.03.010; Ota T, 1993, DISPAN GENETIC DISTA; Pritchard JK, 2000, GENETICS, V155, P945; RAPSON EJ, 1955, CAMBRIDGE HIST INDIA, V1, P33; Rerkamnuaychoke B, 2006, FORENSIC SCI INT, V158, P234, DOI 10.1016/j.forsciint.2005.05.020; ROYCHOUDHURY A K, 1981, Journal of the Indian Anthropological Society, V16, P153; ROYCHOUDHURY AK, 1992, ANN HUM BIOL, V19, P489, DOI 10.1080/03014469200002322; ROYCHOUDHURY AK, 1997, J INDIAN ANTHR SOC, V32, P1; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Sachin ROY, 1997, ASPECTS PADAM MINYON; Shimada I, 2002, INT J LEGAL MED, V116, P246, DOI 10.1007/s00414-002-0313-z; SINGH KS, 1998, PEOPLE INDIA INDIAS, V1; Tabi T, 2006, ADIS; Takezaki N, 1996, GENETICS, V144, P389; Tie J, 2006, J FORENSIC SCI, V51, P188, DOI 10.1111/j.1556-4029.2005.00037.x; Trivedi R, 2002, FORENSIC SCI INT, V127, P150; WALTER H, 1986, HUM HERED, V36, P388, DOI 10.1159/000153663; Wang CW, 2003, FORENSIC SCI INT, V138, P119, DOI 10.1016/j.forsciint.2003.09.006; Wang ZY, 2005, FORENSIC SCI INT, V147, P89, DOI 10.1016/j.forsciint.2004.04.008; Yan JW, 2007, FORENSIC SCI INT, V169, pE3, DOI 10.1016/j.forsciint.2007.02.008; Yang BQ, 2005, FORENSIC SCI INT, V151, P293, DOI 10.1016/j.forsciint.2005.02.001; Yong RYY, 2004, FORENSIC SCI INT, V141, P175, DOI 10.1016/j.forsciint.2004.01.004; Zeng Zhao Shu, 2007, Legal Medicine, V9, P30, DOI 10.1016/j.legalmed.2006.08.002; Zhang HJ, 2007, FORENSIC SCI INT, V171, P222, DOI 10.1016/j.forsciint.2006.05.039	78	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2549	10.1371/journal.pone.0002549	http://dx.doi.org/10.1371/journal.pone.0002549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596928	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200018
J	Hampshire, A; Thompson, R; Duncan, J; Owen, AM				Hampshire, Adam; Thompson, Russell; Duncan, John; Owen, Adrian M.			The Target Selective Neural Response - Similarity, Ambiguity, and Learning Effects	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; EVENT-RELATED FMRI; LATERAL FRONTAL-CORTEX; WORKING-MEMORY; FUNCTIONAL-ORGANIZATION; ATTENTION; MONKEY; TASK; REPRESENTATION; INFORMATION	A network of frontal and parietal brain regions is commonly recruited during tasks that require the deliberate 'top-down' control of thought and action. Previously, using simple target detection, we have demonstrated that within this frontoparietal network, the right ventrolateral prefrontal cortex (VLPFC) in particular is sensitive to the presentation of target objects. Here, we use a range of target/non-target morphs to plot the target selective response within distinct frontoparietal sub-regions in greater detail. The increased resolution allows us to examine the extent to which different cognitive factors can predict the blood oxygenation level dependent (BOLD) response to targets. Our results reveal that both probability of positive identification (similarity to target) and proximity to the 50% decision boundary (ambiguity) are significant predictors of BOLD signal change, particularly in the right VLPFC. Furthermore, the profile of target related signal change is not static, with the degree of selectivity increasing as the task becomes familiar. These findings demonstrate that frontoparietal sub-regions are recruited under increased cognitive demand and that when recruited, they adapt, using both fast and slow mechanisms, to selectively respond to those items that are of the most relevance to current intentions.	[Hampshire, Adam; Thompson, Russell; Duncan, John; Owen, Adrian M.] MRC, Cognit & Brain Sci Unit, Cambridge, Cambs, England		Hampshire, A (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, Cambs, England.	adam.hampshire@mrc-cbu.cam.ac.uk	Owen, Adrian M/B-4997-2015	Duncan, John/0000-0002-9695-2764	Medical Research Council UK.; Medical Research Council [MC_U105559847, MC_U105580448] Funding Source: researchfish; MRC [MC_U105580448, MC_U105559847] Funding Source: UKRI	Medical Research Council UK.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Reasearch funded by the Medical Research Council UK.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Bor D, 2001, SCAND J PSYCHOL, V42, P217, DOI 10.1111/1467-9450.00232; Brett M., 2002, 8 INT C FUNCT MAPP H; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Hampshire A, 2007, J NEUROSCI, V27, P6219, DOI 10.1523/JNEUROSCI.0851-07.2007; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray LJ, 2007, J NEUROSCI, V27, P5515, DOI 10.1523/JNEUROSCI.0406-07.2007; NORMAN DA, 1980, CONSCIOUSNESS SELF R; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1995, J NEUROSCI, V15, P359; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY, P59; Postle BR, 2000, PSYCHOBIOLOGY, V28, P132; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rubia K, 2001, NEUROIMAGE, V13, pS351; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	39	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2520	10.1371/journal.pone.0002520	http://dx.doi.org/10.1371/journal.pone.0002520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575585	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000036
J	Liu, WW; Goodhouse, J; Jeon, NL; Enquist, LW				Liu, Wendy W.; Goodhouse, Joseph; Jeon, Noo Li; Enquist, L. W.			A Microfluidic Chamber for Analysis of Neuron-to-Cell Spread and Axonal Transport of an Alpha-Herpesvirus	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; AUJESZKYS-DISEASE VIRUS; RAT SENSORY NEURONS; PSEUDORABIES VIRUS; VACCINE STRAINS; EPIDERMAL-CELLS; ENVELOPE GLYCOPROTEIN-GP50; ANTEROGRADE TRANSPORT; PERIPHERAL INFECTION; TRANSNEURONAL SPREAD	Alpha-herpesviruses, including herpes simplex virus and pseudorabies virus (PRV), infect the peripheral nervous system (PNS) of their hosts. Here, we describe an in vitro method for studying neuron-to-cell spread of infection as well as viral transport in axons. The method centers on a novel microfluidic chamber system that directs growth of axons into a fluidically isolated environment. The system uses substantially smaller amounts of virus inoculum and media than previous chamber systems and yet offers the flexibility of applying multiple virology and cell biology assays including live-cell optical imaging. Using PRV infection of cultured PNS neurons, we demonstrate that the microfluidic chamber recapitulates all known facets of neuron-to-cell spread demonstrated in animals and other compartmented cell systems.	[Liu, Wendy W.; Goodhouse, Joseph; Enquist, L. W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	Princeton University; University of California System; University of California Irvine	Liu, WW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	lenquist@princeton.edu		Liu, Wendy/0000-0002-1648-4068	Princeton Class of 1943 endowment funds; American Society for Microbiology [Undergraduate Research Fellowship]; NIH [RO1 33506]	Princeton Class of 1943 endowment funds; American Society for Microbiology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	WWL was supported by the Princeton Class of 1943 endowment funds and the American Society for Microbiology Undergraduate Research Fellowship. This work was supported in part by NIH RO1 33506 to LWE.	ANDERSSON H, 2004, LAB ON CHIPS CELLOMI, P1; Antinone SE, 2006, J VIROL, V80, P11235, DOI 10.1128/JVI.01441-06; BABIC N, 1993, J VIROL, V67, P4421, DOI 10.1128/JVI.67.7.4421-4426.1993; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Brideau AD, 2000, J VIROL, V74, P834, DOI 10.1128/JVI.74.2.834-845.2000; CARD JP, 1991, NEURON, V6, P957, DOI 10.1016/0896-6273(91)90236-S; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Ch'ng TH, 2006, VET MICROBIOL, V113, P193, DOI 10.1016/j.vetmic.2005.11.010; Ch'ng TH, 2005, J VIROL, V79, P10875, DOI 10.1128/JVI.79.17.10875-10889.2005; Ch'ng Toh Hean, 2005, Methods Mol Biol, V292, P299; De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004; del Rio T, 2005, J VIROL, V79, P3903, DOI 10.1128/JVI.79.7.3903-3919.2005; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Feierbach B, 2007, J VIROL, V81, P6846, DOI 10.1128/JVI.00069-07; Holland DJ, 1999, J VIROL, V73, P8503, DOI 10.1128/JVI.73.10.8503-8511.1999; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; KRITAS SK, 1994, VET MICROBIOL, V40, P323, DOI 10.1016/0378-1135(94)90120-1; LaVail JH, 2005, J VIROL, V79, P11142, DOI 10.1128/JVI.79.17.11142-11150.2005; LaVail JH, 2003, J VIROL, V77, P6117, DOI 10.1128/JVI.77.11.6117-6126.2003; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; LOMNICZI B, 1984, J VIROL, V52, P198, DOI 10.1128/JVI.52.1.198-205.1984; LOMNICZI B, 1984, J VIROL, V49, P970, DOI 10.1128/JVI.49.3.970-979.1984; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; LYCKE E, 1984, J GEN VIROL, V65, P55, DOI 10.1099/0022-1317-65-1-55; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; MARCHAND CF, 1986, BRAIN RES, V383, P262, DOI 10.1016/0006-8993(86)90024-7; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; METTENLEITER TC, 1985, J VIROL, V56, P307, DOI 10.1128/JVI.56.1.307-311.1985; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Mikloska Z, 2001, J VIROL, V75, P11821, DOI 10.1128/JVI.75.23.11821-11826.2001; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Mulder W, 1996, J VIROL, V70, P2191, DOI 10.1128/JVI.70.4.2191-2200.1996; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; PEETERS B, 1992, J VIROL, V66, P894, DOI 10.1128/JVI.66.2.894-905.1992; PEETERS B, 1993, J VIROL, V67, P170, DOI 10.1128/JVI.67.1.170-177.1993; PENFOLD MET, 1994, P NATL ACAD SCI USA, V91, P6529, DOI 10.1073/pnas.91.14.6529; PETROVSKIS EA, 1986, J VIROL, V60, P1166, DOI 10.1128/JVI.60.3.1166-1169.1986; PLATT KB, 1979, ARCH VIROL, V60, P13, DOI 10.1007/BF01318093; Potel C, 2003, J GEN VIROL, V84, P2613, DOI 10.1099/vir.0.19279-0; RAUH I, 1991, J VIROL, V65, P5348, DOI 10.1128/JVI.65.10.5348-5356.1991; Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Smith GA, 2004, P NATL ACAD SCI USA, V101, P16034, DOI 10.1073/pnas.0404686101; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Taylor Anne M., 2006, V321, P167; Tomishima MJ, 2001, J CELL BIOL, V154, P741, DOI 10.1083/jcb.200011146; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Tourovskaia A, 2005, LAB CHIP, V5, P14, DOI 10.1039/b405719h; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Yang M, 1999, J VIROL, V73, P4350, DOI 10.1128/JVI.73.5.4350-4359.1999; ZIEGLER RJ, 1981, INFECT IMMUN, V34, P588, DOI 10.1128/IAI.34.2.588-595.1981; ZIEGLER RJ, 1980, INFECT IMMUN, V28, P620	61	68	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2382	10.1371/journal.pone.0002382	http://dx.doi.org/10.1371/journal.pone.0002382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560518	gold, Green Published			2022-12-27	WOS:000263280700003
J	Preisser, EL; Bolnick, DI				Preisser, Evan L.; Bolnick, Daniel I.			The Many Faces of Fear: Comparing the Pathways and Impacts of Nonconsumptive Predator Effects on Prey Populations	PLOS ONE			English	Article							INTERSPECIFIC COMPETITION; ANTIPREDATOR BEHAVIOR; INTERTIDAL COMMUNITY; SCALE DEPENDENCE; HUNTING MODE; HABITAT USE; RISK; FOOD; RESPONSES; COSTS	Background: Most ecological models assume that predator and prey populations interact solely through consumption: predators reduce prey densities by killing and consuming individual prey. However, predators can also reduce prey densities by forcing prey to adopt costly defensive strategies. Methodology/Principal Findings: We build on a simple Lotka-Volterra predator-prey model to provide a heuristic tool for distinguishing between the demographic effects of consumption (consumptive effects) and of anti-predator defenses (nonconsumptive effects), and for distinguishing among the multiple mechanisms by which anti-predator defenses might reduce prey population growth rates. We illustrate these alternative pathways for nonconsumptive effects with selected empirical examples, and use a meta-analysis of published literature to estimate the mean effect size of each pathway. Overall, predation risk tends to have a much larger impact on prey foraging behavior than measures of growth, survivorship, or fecundity. Conclusions/Significance: While our model provides a concise framework for understanding the many potential NCE pathways and their relationships to each other, our results confirm empirical research showing that prey are able to partially compensate for changes in energy income, mitigating the fitness effects of defensive changes in time budgets. Distinguishing the many facets of nonconsumptive effects raises some novel questions, and will help guide both empirical and theoretical studies of how predation risk affects prey dynamics.	[Preisser, Evan L.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Bolnick, Daniel I.] Univ Texas Austin, Sect Integrative Biol, Austin, TX USA	University of Rhode Island; University of Texas System; University of Texas Austin	Preisser, EL (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	preisser@uri.edu	Preisser, Evan/C-3469-2013; Bolnick, Daniel I./G-4440-2015	Preisser, Evan/0000-0002-8737-5619; Bolnick, Daniel I./0000-0003-3148-6296	NSF [DEB-0089716, DEB-0072909]; University of Texas at Austin; Center for Population Biology at the University of California at Davis; University of California, Santa Barbara Campus	NSF(National Science Foundation (NSF)); University of Texas at Austin; Center for Population Biology at the University of California at Davis; University of California, Santa Barbara Campus(University of California System)	The authors were supported by NSF grant# DEB-0089716 to M. Turelli and J. Gillespie and the University of Texas at Austin (DIB) and by the Center for Population Biology at the University of California at Davis (ELP). This work was conducted as part of the "Does Fear Matter?" Working Group (headed by ELP and DIB) at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (grant# DEB-0072909), the University of California, and the Santa Barbara Campus. None of these sponsors or funders played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P610, DOI 10.2307/2265634; ABRAMS PA, 1991, OIKOS, V62, P167, DOI 10.2307/3545262; ABRAMS PA, 1990, ECOLOGY, V71, P877, DOI 10.2307/1937359; ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; ABRAMS PA, 1984, AM NAT, V124, P80, DOI 10.1086/284253; ABRAMS PA, 1982, AM NAT, V120, P382, DOI 10.1086/283996; ABRAMS PA, 1991, ECOLOGY, V72, P1242, DOI 10.2307/1941098; Abrams PA, 2007, ECOLOGY, V88, P2555, DOI 10.1890/06-1381.1; Abrams PA, 2007, AM NAT, V169, P581, DOI 10.1086/512688; BARRY MJ, 1994, OECOLOGIA, V97, P278, DOI 10.1007/BF00323161; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blaustein L, 1997, OECOLOGIA, V110, P212, DOI 10.1007/s004420050152; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Crowder LB, 1997, ECOLOGY, V78, P1796; Dahl J, 1998, OECOLOGIA, V116, P426, DOI 10.1007/s004420050606; DAYTON PK, 1973, AM NAT, V107, P662, DOI 10.1086/282865; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; Englund G, 2004, ECOLOGY, V85, P320, DOI 10.1890/03-3039; Englund G, 2001, OIKOS, V92, P501, DOI 10.1034/j.1600-0706.2001.920311.x; Fiske P, 1998, BEHAV ECOL, V9, P328, DOI 10.1093/beheco/9.4.328; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; HEIKKILA J, 1993, ANN ZOOL FENN, V30, P153; Kelly DW, 2002, FRESHWATER BIOL, V47, P1257, DOI 10.1046/j.1365-2427.2002.00864.x; Kuhara N, 1999, OIKOS, V87, P27, DOI 10.2307/3546993; Kunert G, 2003, OECOLOGIA, V135, P304, DOI 10.1007/s00442-003-1185-8; Langerhans RB, 2002, EVOL ECOL RES, V4, P857; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1986, ANIM BEHAV, V34, P536, DOI 10.1016/S0003-3472(86)80122-1; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez DA, 1995, REV CHIL HIST NAT, V68, P469; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Luttbeg B, 2003, ECOLOGY, V84, P1140, DOI 10.1890/0012-9658(2003)084[1140:PSAEDA]2.0.CO;2; McCollum EW, 1998, ECOLOGY, V79, P1980; McIntosh AR, 1999, OIKOS, V85, P554, DOI 10.2307/3546705; MCNEELY DL, 1990, OECOLOGIA, V85, P69, DOI 10.1007/BF00317344; McPeek MA, 2004, AM NAT, V163, pE88, DOI 10.1086/382755; MORAN MD, 1994, OECOLOGIA, V98, P269, DOI 10.1007/BF00324214; Morrison LW, 1999, OECOLOGIA, V121, P113, DOI 10.1007/s004420050912; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Palmer AR, 1999, AM NAT, V154, P220, DOI 10.1086/303223; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; Pusenius J, 2000, OIKOS, V91, P123, DOI 10.1034/j.1600-0706.2000.910111.x; Resetarits WJ, 2001, OECOLOGIA, V129, P155, DOI 10.1007/s004420100704; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; SCRIMGEOUR GJ, 1994, OIKOS, V69, P71, DOI 10.2307/3545285; Sih A, 1996, OECOLOGIA, V105, P179, DOI 10.1007/BF00328544; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Stoks R, 2001, OECOLOGIA, V127, P222, DOI 10.1007/s004420000595; STRONG DR, 1973, ECOLOGY, V54, P1383; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Walker SE, 2003, J ARACHNOL, V31, P425, DOI 10.1636/S02-63; WALLS M, 1991, OECOLOGIA, V87, P43, DOI 10.1007/BF00323778; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461	73	191	196	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2465	10.1371/journal.pone.0002465	http://dx.doi.org/10.1371/journal.pone.0002465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560575	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700046
J	Li, ZY; Lee, JH; Chu, FX; Burlingame, AL; Gunzl, A; Wang, CC				Li, Ziyin; Lee, Ju Huck; Chu, Feixia; Burlingame, Alma L.; Gunzl, Arthur; Wang, Ching C.			Identification of a Novel Chromosomal Passenger Complex and Its Unique Localization during Cytokinesis in Trypanosoma brucei	PLOS ONE			English	Article								Aurora B kinase is a key component of the chromosomal passenger complex (CPC), which regulates chromosome segregation and cytokinesis. An ortholog of Aurora B was characterized in Trypanosoma brucei (TbAUK1), but other conserved components of the complex have not been found. Here we identified four novel TbAUK1 associated proteins by tandem affinity purification and mass spectrometry. Among these four proteins, TbKIN-A and TbKIN-B are novel kinesin homologs, whereas TbCPC1 and TbCPC2 are hypothetical proteins without any sequence similarity to those known CPC components from yeasts and metazoans. RNAi-mediated silencing of each of the four genes led to loss of spindle assembly, chromosome segregation and cytokinesis. TbKIN-A localizes to the mitotic spindle and TbKIN-B to the spindle midzone during mitosis, whereas TbCPC1, TbCPC2 and TbAUK1 display the dynamic localization pattern of a CPC. After mitosis, the CPC disappears from the central spindle and re-localizes at a dorsal mid-point of the mother cell, where the anterior tip of the daughter cell is tethered, to start cell division toward the posterior end, indicating a most unusual CPC-initiated cytokinesis in a eukaryote.	[Li, Ziyin; Chu, Feixia; Burlingame, Alma L.; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Lee, Ju Huck; Gunzl, Arthur] Univ Connecticut Hlth Ctr, Dept Genet & Dev Biol, Farmington, CT USA	University of California System; University of California San Francisco; University of Connecticut	Li, ZY (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu		Gunzl, Arthur/0000-0002-7487-2261; Li, Ziyin/0000-0002-3960-9716	NIH [AI21786, AI059377, RR01614, RR12961, RR15804]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059377, R01AI021786] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH R01 grants AI21786 (C.C.W.) and AI059377 (A.G.) NIH grants RR01614, RR12961 and RR15804 (A.L.B.)	Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Berberich C, 1998, BBA-GENE STRUCT EXPR, V1442, P230, DOI 10.1016/S0167-4781(98)00176-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Brandenburg J, 2007, EMBO J, V26, P4856, DOI 10.1038/sj.emboj.7601905; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ploubidou A, 1999, J CELL SCI, V112, P4641; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SASSE R, 1988, J CELL SCI, V90, P577; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; STEBECK CE, 1995, MOL BIOCHEM PARASIT, V71, P1, DOI 10.1016/0166-6851(95)00022-S; Thomas S, 2007, MOL BIOL CELL, V18, P3820, DOI 10.1091/mbc.E07-03-0201; TOLSON DL, 1994, INFECT IMMUN, V62, P4893, DOI 10.1128/IAI.62.11.4893-4899.1994; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Vaughan S, 2003, J CELL SCI, V116, P757, DOI 10.1242/jcs.00287; Walczak CE, 1996, CELL, V85, P943, DOI 10.1016/S0092-8674(00)81295-7; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49	53	64	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2354	10.1371/journal.pone.0002354	http://dx.doi.org/10.1371/journal.pone.0002354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545648	gold, Green Submitted, Green Published			2022-12-27	WOS:000263248800012
J	Matigian, NA; McCurdy, RD; Feron, F; Perry, C; Smith, H; Filippich, C; McLean, D; McGrath, J; Mackay-Sim, A; Mowry, B; Hayward, NK				Matigian, Nicholas A.; McCurdy, Richard D.; Feron, Francois; Perry, Christopher; Smith, Heather; Filippich, Cheryl; McLean, Duncan; McGrath, John; Mackay-Sim, Alan; Mowry, Bryan; Hayward, Nicholas K.			Fibroblast and Lymphoblast Gene Expression Profiles in Schizophrenia: Are Non-Neural Cells Informative?	PLOS ONE			English	Article							MICROARRAY ANALYSIS; SKIN FIBROBLASTS; BIPOLAR DISORDER; ALTERED ADHESION; BLOOD; DYSFUNCTION; DISCORDANT; CULTURE	Lymphoblastoid cell lines (LCLs) and fibroblasts provide conveniently derived non-neuronal samples in which to investigate the aetiology of schizophrenia (SZ) using gene expression profiling. This assumes that heritable mechanisms associated with risk of SZ have systemic effects and result in changes to gene expression in all tissues. The broad aim of this and other similar studies is that comparison of the transcriptomes of non-neuronal tissues from SZ patients and healthy controls may identify gene/pathway dysregulation underpinning the neurobiological defects associated with SZ. Using microarrays consisting of 18,664 probes we compared gene expression profiles of LCLs from SZ cases and healthy controls. To identify robust associations with SZ that were not patient or tissue specific, we also examined fibroblasts from an independent series of SZ cases and controls using the same microarrays. In both tissue types ANOVA analysis returned approximately the number of differentially expressed genes expected by chance. No genes were significantly differentially expressed in either tissue when corrected for multiple testing. Even using relaxed parameters (p <= 0.05, without multiple testing correction) there were still no differentially expressed genes that also displayed >= 2-fold change between the groups of SZ cases and controls common to both LCLs and fibroblasts. We conclude that despite encouraging data from previous microarray studies assessing non-neural tissues, the lack of a convergent set of differentially expressed genes associated with SZ using fibroblasts and LCLs indicates the utility of non-neuronal tissues for detection of gene expression differences and/or pathways associated with SZ remains to be demonstrated.	[Matigian, Nicholas A.; Smith, Heather; Filippich, Cheryl; Mowry, Bryan; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Matigian, Nicholas A.; Smith, Heather; Filippich, Cheryl; McLean, Duncan; McGrath, John; Mowry, Bryan] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [McCurdy, Richard D.] Sick Kids Res Inst, Toronto, ON, Canada; [Feron, Francois] CNRS, UMR 6184, Marseille, France; [Perry, Christopher] Univ Queensland, Dept Surg, St Lucia, Qld, Australia; [McGrath, John; Mackay-Sim, Alan] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld, Australia; [Mowry, Bryan] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia	QIMR Berghofer Medical Research Institute; Queensland Centre for Mental Health Research; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Centre National de la Recherche Scientifique (CNRS); University of Queensland; Griffith University; University of Queensland	Matigian, NA (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	Nick.Hayward@qimr.edu.au	Mackay-Sim, Alan/C-3431-2008; hayward, nick/AAV-8802-2020; anand, amit/A-7222-2009; Feron, Francois/J-5639-2014; Matigian, Nicholas A/A-4935-2009; hayward, nicholas k/C-1367-2015; McGrath, John Joseph/G-5493-2010; Feron, François/A-3947-2010; Matigian, Nicholas/AAF-9390-2020; Mowry, Bryan/G-5046-2010	Mackay-Sim, Alan/0000-0003-4446-5371; Matigian, Nicholas A/0000-0001-7735-9415; hayward, nicholas k/0000-0003-4760-1033; McGrath, John Joseph/0000-0002-4792-6068; Matigian, Nicholas/0000-0001-7735-9415; McLean, Duncan/0000-0002-1125-8424; Mowry, Bryan/0000-0002-4115-5645	Ipswich Hospital Foundation; Garnett Passe and Rodney Williams Memorial Foundation	Ipswich Hospital Foundation; Garnett Passe and Rodney Williams Memorial Foundation	This work was supported by grants from the Ipswich Hospital Foundation and the Garnett Passe and Rodney Williams Memorial Foundation. Neither agency had any further role in study design, analysis and interpretation of data, writing of the report or decision to submit the manuscript for publication.	Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Chung C, 2003, SYNAPSE, V50, P29, DOI 10.1002/syn.10228; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Mahadik SP, 1996, J PSYCHIATR RES, V30, P421, DOI 10.1016/S0022-3956(96)00025-8; MAHADIK SP, 1991, PSYCHIAT RES, V37, P309, DOI 10.1016/0165-1781(91)90066-X; Marcotte ER, 2003, PHARMACOL THERAPEUT, V100, P63, DOI 10.1016/S0163-7258(03)00086-X; MATIGIAN N, 2007, MOL PSYCHIAT; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; McGrath J, 2002, ARCH GEN PSYCHIAT, V59, P458, DOI 10.1001/archpsyc.59.5.458; Middleton FA, 2005, AM J MED GENET B, V136B, P12, DOI 10.1002/ajmg.b.30171; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Miyamae Y, 1998, PSYCHIAT CLIN NEUROS, V52, P345, DOI 10.1046/j.1440-1819.1998.00386.x; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Pongrac J, 2002, NEUROCHEM RES, V27, P1049, DOI 10.1023/A:1020904821237; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; *SIL GEN, 2002, CROSS GEN ERR MOD; Sourlingas TG, 2003, PSYCHIAT RES, V118, P55, DOI 10.1016/S0165-1781(03)00041-6; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; Weinberger DR, 1999, BIOL PSYCHIAT, V46, P3; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	40	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2412	10.1371/journal.pone.0002412	http://dx.doi.org/10.1371/journal.pone.0002412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545665	Green Submitted, gold, Green Published			2022-12-27	WOS:000263248800049
J	Lee, JH; Culver, G; Carpenter, S; Dobbs, D				Lee, Jae-Hyung; Culver, Gloria; Carpenter, Susan; Dobbs, Drena			Analysis of the EIAV Rev-Responsive Element (RRE) Reveals a Conserved RNA Motif Required for High Affinity Rev Binding in Both HIV-1 and EIAV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SECONDARY STRUCTURE; NUCLEOTIDE-SEQUENCE; NUCLEAR EXPORT; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; STRUCTURED REGION; WEB SERVER; PROTEIN; INFORMATION	A cis-acting RNA regulatory element, the Rev-responsive element (RRE), has essential roles in replication of lentiviruses, including human immunodeficiency virus (HIV-1) and equine infection anemia virus ( EIAV). The RRE binds the viral transacting regulatory protein, Rev, to mediate nucleocytoplasmic transport of incompletely spliced mRNAs encoding viral structural genes and genomic RNA. Because of its potential as a clinical target, RRE-Rev interactions have been well studied in HIV-1; however, detailed molecular structures of Rev-RRE complexes in other lentiviruses are still lacking. In this study, we investigate the secondary structure of the EIAV RRE and interrogate regulatory protein-RNA interactions in EIAV Rev-RRE complexes. Computational prediction and detailed chemical probing and footprinting experiments were used to determine the RNA secondary structure of EIAV RRE-1, a 555 nt region that provides RRE function in vivo. Chemical probing experiments confirmed the presence of several predicted loop and stem-loop structures, which are conserved among 140 EIAV sequence variants. Footprinting experiments revealed that Rev binding induces significant structural rearrangement in two conserved domains characterized by stable stem-loop structures. Rev binding region-1 (RBR-1) corresponds to a genetically-defined Rev binding region that overlaps exon 1 of the EIAV rev gene and contains an exonic splicing enhancer (ESE). RBR-2, characterized for the first time in this study, is required for high affinity binding of EIAV Rev to the RRE. RBR-2 contains an RNA structural motif that is also found within the high affinity Rev binding site in HIV-1 (stem-loop IIB), and within or near mapped RRE regions of four additional lentiviruses. The powerful integration of computational and experimental approaches in this study has generated a validated RNA secondary structure for the EIAV RRE and provided provocative evidence that high affinity Rev binding sites of HIV-1 and EIAV share a conserved RNA structural motif. The presence of this motif in phylogenetically divergent lentiviruses suggests that it may play a role in highly conserved interactions that could be targeted in novel anti-lentiviral therapies.	[Lee, Jae-Hyung; Dobbs, Drena] Iowa State Univ, Bioinformat & Computat Biol Program, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Culver, Gloria] Univ Rochester, Dept Biol, Rochester, NY USA; [Carpenter, Susan] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA USA	Iowa State University; University of Rochester; Washington State University	Lee, JH (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	jhlee777@iastate.edu	Lee, Jae-Hyung/AAI-9813-2020; Lee, Jae-Hyung/E-6827-2011	Lee, Jae-Hyung/0000-0002-5085-6988; Dobbs, Drena/0000-0003-4404-9554	U.S. Public Health Service, National Institutes of Health [CA97936, GM066387]; National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2002-35204-12699]; Center for Integrated Animal Genomics at Iowa State University; NATIONAL CANCER INSTITUTE [R21CA097936, R01CA128568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387] Funding Source: NIH RePORTER	U.S. Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Center for Integrated Animal Genomics at Iowa State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by U.S. Public Health Service, National Institutes of Health Grants CA97936, GM066387, National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service Grant 2002-35204-12699, and the Center for Integrated Animal Genomics at Iowa State University. Sponsors played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; Belshan M, 2001, VIROLOGY, V279, P185, DOI 10.1006/viro.2000.0696; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Chaitin Gregory J., 1982, ENCY STAT SCI, V1, P38; Chung HK, 2001, J BIOL CHEM, V276, P18960, DOI 10.1074/jbc.M008996200; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Foley B. T, 2000, HIV SEQUENCE COMPEND, P35; FRIDELL RA, 1993, J VIROL, V67, P7317, DOI 10.1128/JVI.67.12.7317-7323.1993; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; GIVER L, 1993, NUCLEIC ACIDS RES, V21, P5509, DOI 10.1093/nar/21.23.5509; Gontarek RR, 1996, MOL CELL BIOL, V16, P2325; Hamm TE, 1999, J VIROL, V73, P5741, DOI 10.1128/JVI.73.7.5741-5747.1999; Han KS, 2003, NUCLEIC ACIDS RES, V31, P3432, DOI 10.1093/nar/gkg539; Harris ME, 1998, MOL CELL BIOL, V18, P3889, DOI 10.1128/MCB.18.7.3889; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; KAWAKAMI T, 1987, VIROLOGY, V158, P300, DOI 10.1016/0042-6822(87)90202-9; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; KJEMS J, 1991, HIV 1 REV CELL, V67, P169; LE SY, 1994, NUCLEIC ACIDS RES, V22, P3966, DOI 10.1093/nar/22.19.3966; LE SY, 1990, NUCLEIC ACIDS RES, V18, P1613, DOI 10.1093/nar/18.6.1613; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; LEE SW, 1994, J VIROL, V68, P8254, DOI 10.1128/JVI.68.12.8254-8264.1994; Lesnik MA, 2002, MED RES REV, V22, P617, DOI 10.1002/med.10027; Liao HJ, 2004, VIROLOGY, V323, P131, DOI 10.1016/j.virol.2003.12.028; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MARTARANO L, 1994, J VIROL, V68, P3102, DOI 10.1128/JVI.68.5.3102-3111.1994; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Mealey RH, 2004, J VIROL, V78, P9295, DOI 10.1128/JVI.78.17.9295-9305.2004; MERRYMAN C, 1998, FOOTPRINTING MODIFIC; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; Peleg O, 2002, AIDS RES HUM RETROV, V18, P867, DOI 10.1089/08892220260190353; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; POWERS T, 1995, RNA, V1, P194; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; RUSHLOW K, 1986, VIROLOGY, V155, P309, DOI 10.1016/0042-6822(86)90195-9; SALTARELLI M, 1990, VIROLOGY, V179, P347, DOI 10.1016/0042-6822(90)90303-9; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STEPHENS RM, 1990, J VIROL, V64, P3716, DOI 10.1128/JVI.64.8.3716-3725.1990; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILEY LS, 1992, J VIROL, V66, P3609, DOI 10.1128/JVI.66.6.3609-3615.1992; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2272	10.1371/journal.pone.0002272	http://dx.doi.org/10.1371/journal.pone.0002272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523581	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300004
J	Ponti, G; Peretto, P; Bonfanti, L				Ponti, Giovanna; Peretto, Paolo; Bonfanti, Luca			Genesis of Neuronal and Glial Progenitors in the Cerebellar Cortex of Peripuberal and Adult Rabbits	PLOS ONE			English	Article								Adult neurogenesis in mammals is restricted to some brain regions, in contrast with other vertebrates in which the genesis of new neurons is more widespread in different areas of the nervous system. In the mammalian cerebellum, neurogenesis is thought to be limited to the early postnatal period, coinciding with end of the granule cell genesis and disappearance of the external granule cell layer (EGL). We recently showed that in the rabbit cerebellum the EGL is replaced by a proliferative layer called 'subpial layer' (SPL) which persists beyond puberty on the cerebellar surface. Here we investigated what happens in the cerebellar cortex of peripuberal rabbits by using endogenous and exogenously-administered cell proliferation antigens in association with a cohort of typical markers for neurogenesis. We show that cortical cell progenitors extensively continue to be generated herein. Surprisingly, this neurogenic process continues to a lesser extent in the adult, even in the absence of a proliferative SPL. We describe two populations of newly generated cells, involving neuronal cells and multipolar, glia-like cells. The genesis of neuronal precursors is restricted to the molecular layer, giving rise to cells immunoreactive for GABA, and for the transcription factor Pax2, a marker for GABAergic cerebellar interneuronal precursors of neuroepithelial origin that ascend through the white matter during early postnatal development. The multipolar cells are Map5+, contain Olig2 and Sox2 transcription factors, and are detectable in all cerebellar layers. Some dividing Sox2+ cells are Bergmann glia cells. All the cortical newly generated cells are independent from the SPL and from granule cell genesis, the latter ending before puberty. This study reveals that adult cerebellar neurogenesis can exist in some mammals. Since rabbits have a longer lifespan than rodents, the protracted neurogenesis within its cerebellar parenchyma could be a suitable model for studying adult nervous tissue permissiveness in mammals.	[Ponti, Giovanna; Bonfanti, Luca] Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy; [Peretto, Paolo] Univ Turin, Dept Anim & Human Biol, Turin, Italy; [Peretto, Paolo; Bonfanti, Luca] Neurosci Inst Turin, Turin, Italy; [Bonfanti, Luca] Natl Inst Neurosci, Turin, Italy	University of Turin; University of Turin	Ponti, G (corresponding author), Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy.	luca.bonfanti@unito.it	Bonfanti, Luca/AAW-2997-2021; Ponti, Giovanna/B-7796-2013	Ponti, Giovanna/0000-0002-0911-7606; Peretto, Paolo Marcello/0000-0001-9747-6379	Compagnia di San Paolo (Progetto NEUROTRANSPLANT); Regione Piemonte; Fondazione Mariani; University of Turin	Compagnia di San Paolo (Progetto NEUROTRANSPLANT)(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte); Fondazione Mariani; University of Turin	This work was supported by Compagnia di San Paolo (Progetto NEUROTRANSPLANT), Regione Piemonte, Fondazione Mariani, and University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Altman J, 1997, DEV CEREBELLAR SYSTE; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bonfanti L, 2008, VET J, V175, P310, DOI 10.1016/j.tvjl.2007.01.023; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cheng AW, 1999, DEV BRAIN RES, V113, P107, DOI 10.1016/S0165-3806(99)00006-1; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dusart I, 1999, J COMP NEUROL, V408, P399; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jones A, 1996, J NEUROCHEM, V67, P907; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lossi L, 1995, J ANAT, V187, P709; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Luzzati F, 2007, NEURODEGENER DIS, V4, P322, DOI 10.1159/000101889; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Mellor JR, 1998, J NEUROSCI, V18, P2822; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; Ohyu J, 1997, BRAIN DEV-JPN, V19, P541, DOI 10.1016/S0387-7604(97)00075-2; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Ponti G, 2006, DEV BIOL, V294, P168, DOI 10.1016/j.ydbio.2006.02.037; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; SAFAEI R, 1989, J MOL NEUROSCI, V1, P189, DOI 10.1007/BF02918906; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SMITH KR, 1963, J COMP NEUROL, V121, P459, DOI 10.1002/cne.901210312; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; SPACEK J, 1973, J NEUROCYTOL, V2, P407, DOI 10.1007/BF01103798; Stottmann RW, 1998, J COMP NEUROL, V395, P121; Takayama C, 2004, NEUROSCI RES, V50, P447, DOI 10.1016/j.neures.2004.08.012; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; VIERECK C, 1989, J NEUROSCI, V9, P3547; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y	71	88	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2366	10.1371/journal.pone.0002366	http://dx.doi.org/10.1371/journal.pone.0002366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523645	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300052
J	Schikora, A; Carreri, A; Charpentier, E; Hirt, H				Schikora, Adam; Carreri, Alessandro; Charpentier, Emmanuelle; Hirt, Heribert			The Dark Side of the Salad: Salmonella typhimurium Overcomes the Innate Immune Response of Arabidopsis thaliana and Shows an Endopathogenic Lifestyle	PLOS ONE			English	Article							SALICYLIC-ACID; LISTERIA-MONOCYTOGENES; DEFENSE RESPONSES; MPK4 ACTIVATION; GENE; PATHOGEN; PLANTS; HOST; PSEUDOMONAS; FLAGELLIN	Salmonella enterica serovar typhimurium contaminated vegetables and fruits are considerable sources of human infections. Bacteria present in raw plant-derived nutrients cause salmonellosis, the world wide most spread food poisoning. This facultative endopathogen enters and replicates in host cells and actively suppresses host immune responses. Although Salmonella survives on plants, the underlying bacterial infection mechanisms are only poorly understood. In this report we investigated the possibility to use Arabidopsis thaliana as a genetically tractable host system to study Salmonella-plant interactions. Using green fluorescent protein (GFP) marked bacteria, we show here that Salmonella can infect various Arabidopsis tissues and proliferate in intracelullar cellular compartments. Salmonella infection of Arabidopsis cells can occur via intact shoot or root tissues resulting in wilting, chlorosis and eventually death of the infected organs. Arabidopsis reacts to Salmonella by inducing the activation of mitogen-activated protein kinase (MAPK) cascades and enhanced expression of pathogenesis related (PR) genes. The induction of defense responses fails in plants that are compromised in ethylene or jasmonic acid signaling or in the MKK3-MPK6 MAPK pathway. These findings demonstrate that Arabidopsis represents a true host system for Salmonella, offering unique possibilities to study the interaction of this human pathogen with plants at the molecular level for developing novel drug targets and addressing current safety issues in human nutrition.	[Schikora, Adam; Hirt, Heribert] Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France; [Carreri, Alessandro; Hirt, Heribert] Max F Perutz Lab, Dept Plant Mol Biol, Vienna, Austria; [Charpentier, Emmanuelle] Max F Perutz Lab, Dept Microbiol & Immunobiol, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schikora, A (corresponding author), Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France.	Heribert.Hirt@evry.inra.fr	Schikora, Adam/B-4842-2014; Hirt, Heribert/A-2061-2013	Schikora, Adam/0000-0002-0869-6423; 	Austrian Science Fund; Centre National de Recherche France	Austrian Science Fund(Austrian Science Fund (FWF)); Centre National de Recherche France	Austrian Science Fund, Centre National de Recherche France	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BECKERS GJM, 2006, FINE TUNING PLANT DE, P1; BENT AF, 1992, MOL PLANT MICROBE IN, V5, P372, DOI 10.1094/MPMI-5-372; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; HALIM VA, 2006, ROLE SALICYLIC ACID, P307; Heck S, 2003, PLANT J, V36, P342, DOI 10.1046/j.1365-313X.2003.01881.x; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Lapidot A, 2006, INT J FOOD MICROBIOL, V109, P229, DOI 10.1016/j.ijfoodmicro.2006.01.012; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; MCGRATH R, 1998, PLANT PHYSIOL BIOCH, V14, P119; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Samelis J, 2003, J APPL MICROBIOL, V95, P563, DOI 10.1046/j.1365-2672.2003.02013.x; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	46	120	125	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2279	10.1371/journal.pone.0002279	http://dx.doi.org/10.1371/journal.pone.0002279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509467	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500023
J	Titz, B; Rajagopala, SV; Goll, J; Hauser, R; McKevitt, MT; Palzkill, T; Uetz, P				Titz, Bjoern; Rajagopala, Seesandra V.; Goll, Johannes; Haeuser, Roman; McKevitt, Matthew T.; Palzkill, Timothy; Uetz, Peter			The Binary Protein Interactome of Treponema pallidum - The Syphilis Spirochete	PLOS ONE			English	Article								Protein interaction networks shed light on the global organization of proteomes but can also place individual proteins into a functional context. If we know the function of bacterial proteins we will be able to understand how these species have adapted to diverse environments including many extreme habitats. Here we present the protein interaction network for the syphilis spirochete Treponema pallidum which encodes 1,039 proteins, 726 (or 70%) of which interact via 3,649 interactions as revealed by systematic yeast two-hybrid screens. A high-confidence subset of 991 interactions links 576 proteins. To derive further biological insights from our data, we constructed an integrated network of proteins involved in DNA metabolism. Combining our data with additional evidences, we provide improved annotations for at least 18 proteins (including TP0004, TP0050, and TP0183 which are suggested to be involved in DNA metabolism). We estimate that this "minimal'' bacterium contains on the order of 3,000 protein interactions. Profiles of functional interconnections indicate that bacterial proteins interact more promiscuously than eukaryotic proteins, reflecting the non-compartmentalized structure of the bacterial cell. Using our high-confidence interactions, we also predict 417,329 homologous interactions ("interologs'') for 372 completely sequenced genomes and provide evidence that at least one third of them can be experimentally confirmed.	[Titz, Bjoern; Rajagopala, Seesandra V.; Goll, Johannes; Haeuser, Roman; Uetz, Peter] Forschungszentrum Karlsruhe, Inst Genet, Karlsburg, Germany; [Rajagopala, Seesandra V.; Uetz, Peter] Inst Genom Res, J Craig Venter Inst, Rockville, MD USA; [McKevitt, Matthew T.; Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX USA	Helmholtz Association; Karlsruhe Institute of Technology; J. Craig Venter Institute; Baylor College of Medicine	Titz, B (corresponding author), Forschungszentrum Karlsruhe, Inst Genet, Karlsburg, Germany.	uetz@jcvi.org	Titz, Bjoern/G-6317-2017; Uetz, Peter/A-7119-2012; Titz, Björn/B-9516-2008	Titz, Bjoern/0000-0003-4414-4105; Uetz, Peter/0000-0001-6194-4927; Rajagopala, Seesandra/0000-0001-7176-5770	DFG [Ue 50/4-1]; J Craig Venter Institute; NIH [AI45842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045842] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); J Craig Venter Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PU was funded by the DFG (grant Ue 50/4-1) and by the J Craig Venter Institute. Tim Palzkill was funded by NIH grant NIH AI45842. Although the project has been proposed to the funders, they have taken no subsequent role in the design, conduct, or publication of the study.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goll J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-223; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peeling RW, 2004, NAT REV MICROBIOL, V2, P448, DOI 10.1038/nrmicro911; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Titz B, 2006, J BACTERIOL, V188, P7700, DOI 10.1128/JB.00820-06; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Uchiyama I, 2007, NUCLEIC ACIDS RES, V35, pD343, DOI 10.1093/nar/gkl978; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Yoshida Y, 1999, J BIOL CHEM, V274, P16933, DOI 10.1074/jbc.274.24.16933	43	76	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2292	10.1371/journal.pone.0002292	http://dx.doi.org/10.1371/journal.pone.0002292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509523	Green Submitted, Green Published, gold			2022-12-27	WOS:000262268500032
J	Buschdorf, JP; Chew, LL; Soh, UJK; Liou, YC; Low, BC				Buschdorf, Jan Paul; Chew, Li Li; Soh, Unice Jim Kim; Liou, Yih-Cherng; Low, Boon Chuan			Nerve Growth Factor Stimulates Interaction of Cayman Ataxia Protein BNIP-H/Caytaxin with Peptidyl-Prolyl Isomerase Pin1 in Differentiating Neurons	PLOS ONE			English	Article							DEPENDENT PROLINE ISOMERIZATION; CDC42GAP HOMOLOGY/SEC14P-LIKE; SIGNALING PATHWAYS; CARBOXYL-TERMINUS; CYCLIN-E; S-ALPHA; PHOSPHORYLATION; DOMAIN; APOPTOSIS; CAYTAXIN	Mutations in ATCAY that encodes the brain-specific protein BNIP-H (or Caytaxin) lead to Cayman cerebellar ataxia. BNIP-H binds to glutaminase, a neurotransmitter-producing enzyme, and affects its activity and intracellular localization. Here we describe the identification and characterization of the binding between BNIP-H and Pin1, a peptidyl-prolyl cis/trans isomerase. BNIP-H interacted with Pin1 after nerve growth factor-stimulation and they co-localized in the neurites and cytosol of differentiating pheochromocytoma PC12 cells and the embryonic carcinoma P19 cells. Deletional mutagenesis revealed two cryptic binding sites within the C-terminus of BNIP-H such that single point mutants affecting the WW domain of Pin1 completely abolished their binding. Although these two sites do not contain any of the canonical Pin1-binding motifs they showed differential binding profiles to Pin1 WW domain mutants S16E, S16A and W34A, and the catalytically inert C113A of its isomerase domain. Furthermore, their direct interaction would occur only upon disrupting the ability of BNIP-H to form an intramolecular interaction by two similar regions. Furthermore, expression of Pin1 disrupted the BNIP-H/ glutaminase complex formation in PC12 cells under nerve growth factor-stimulation. These results indicate that nerve growth factor may stimulate the interaction of BNIP-H with Pin1 by releasing its intramolecular inhibition. Such a mechanism could provide a post-translational regulation on the cellular activity of BNIP-H during neuronal differentiation. (213 words)	[Buschdorf, Jan Paul; Chew, Li Li; Soh, Unice Jim Kim; Liou, Yih-Cherng; Low, Boon Chuan] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Buschdorf, JP (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117548, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/H-8049-2012; Low, Boon Chuan/AAU-7685-2021	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X	Young Investigator Award; Biomedical Research Council of Singapore	Young Investigator Award; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Young Investigator Award to B.C.L. and a grant from the Biomedical Research Council of Singapore.	Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Dourlen P, 2007, BBA-MOL CELL RES, V1773, P1428, DOI 10.1016/j.bbamcr.2007.05.012; Gilbert N, 2004, HUM MUTAT, V24, P9, DOI 10.1002/humu.20060; Grelle G, 2006, MOL CELL PROTEOMICS, V5, P234, DOI 10.1074/mcp.M500198-MCP200; Hayakawa Y, 2007, BRAIN RES, V1129, P100, DOI 10.1016/j.brainres.2006.10.068; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kapfhamer D, 1996, GENOMICS, V35, P533, DOI 10.1006/geno.1996.0394; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Li MG, 2008, BIOCHEMISTRY-US, V47, P292, DOI 10.1021/bi701819k; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Lua BL, 2004, MOL BIOL CELL, V15, P2873, DOI 10.1091/mbc.E04-02-0141; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xiao J, 2007, NEUROSCIENCE, V144, P439, DOI 10.1016/j.neuroscience.2006.09.042; Xiao JF, 2005, MOL BRAIN RES, V141, P181, DOI 10.1016/j.molbrainres.2005.09.009; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2006, ONCOGENE, V25, P2393, DOI 10.1038/sj.onc.1209274; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200	46	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2686	10.1371/journal.pone.0002686	http://dx.doi.org/10.1371/journal.pone.0002686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628984	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200030
J	Kamrud, KI; Alterson, KD; Andrews, C; Copp, LO; Lewis, WC; Hubby, B; Patel, D; Rayner, JO; Talarico, T; Smith, JF				Kamrud, Kurt I.; Alterson, Kim D.; Andrews, Chasity; Copp, Laura O.; Lewis, Whitney C.; Hubby, Bolyn; Patel, Deepa; Rayner, Jonathan O.; Talarico, Todd; Smith, Jonathan F.			Analysis of Venezuelan Equine Encephalitis Replicon Particles Packaged in Different Coats	PLOS ONE			English	Article							PROTECT GUINEA-PIGS; MAJOR ENVELOPE PROTEINS; ALPHA/BETA-INTERFERON; BOTULINUM NEUROTOXIN; ATTENUATED MUTANTS; IMMUNE-RESPONSES; RAPID CLEARANCE; ARTERITIS VIRUS; MARBURG VIRUS; IN-VITRO	Background: The Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein ( GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo. Methodology/Principal Findings: The VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers. Conclusions/Significance: We suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.	[Kamrud, Kurt I.; Alterson, Kim D.; Andrews, Chasity; Lewis, Whitney C.; Patel, Deepa; Talarico, Todd; Smith, Jonathan F.] AlphaVax Inc, Res Triangle Pk, NC USA; [Copp, Laura O.; Hubby, Bolyn] Liquidia Technol Inc, Res Triangle Pk, NC USA; [Rayner, Jonathan O.] Midwest Res Inst, Kansas City, MO USA		Kamrud, KI (corresponding author), AlphaVax Inc, Res Triangle Pk, NC USA.	kamrud@alphavax.com		Rayner, Jonathan/0000-0002-2091-7604	NIH [5U01AI53876-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI053876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH grant 5U01AI53876-02	Aronson JF, 2000, VIROLOGY, V270, P111, DOI 10.1006/viro.2000.0241; Balasuriya UBR, 2002, VACCINE, V20, P1609, DOI 10.1016/S0264-410X(01)00485-6; Balasuriya UBR, 2000, J VIROL, V74, P10623, DOI 10.1128/JVI.74.22.10623-10630.2000; BERGE TO, 1961, AM J HYG, V73, P209, DOI 10.1093/oxfordjournals.aje.a120178; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; DAVIS NL, 1995, VIROLOGY, V212, P102, DOI 10.1006/viro.1995.1458; Davis NL, 2002, IUBMB LIFE, V53, P209, DOI 10.1080/15216540212657; Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000; DAVIS NL, 1989, VIROLOGY, V171, P189, DOI 10.1016/0042-6822(89)90526-6; DAVIS NL, 1991, VIROLOGY, V183, P20, DOI 10.1016/0042-6822(91)90114-Q; DAVIS NL, 1994, ARCH VIROL, P99; GRIEDER FB, 1995, VIROLOGY, V206, P994, DOI 10.1006/viro.1995.1022; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; JAHRLING PB, 1977, INFECT IMMUN, V17, P356, DOI 10.1128/IAI.17.2.356-360.1977; JOHNSTON RE, 1988, VIROLOGY, V162, P437, DOI 10.1016/0042-6822(88)90484-9; Johnston RE, 2005, VACCINE, V23, P4969, DOI 10.1016/j.vaccine.2005.05.034; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; KINNEY RM, 1993, J VIROL, V67, P1269, DOI 10.1128/JVI.67.3.1269-1277.1993; Lee JS, 2006, VACCINE, V24, P6886, DOI 10.1016/j.vaccine.2006.06.004; Lee JS, 2002, J INFECT DIS, V185, P1192, DOI 10.1086/339677; Lee JS, 2003, INFECT IMMUN, V71, P1491, DOI 10.1128/IAI.71.3.1491-1496.2003; Lee JS, 2001, INFECT IMMUN, V69, P5709, DOI 10.1128/IAI.69.9.5709-5715.2001; Ludwig George V., 2001, American Journal of Tropical Medicine and Hygiene, V64, P49; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Montgomery SA, 2006, J VIROL, V80, P7729, DOI 10.1128/JVI.00425-06; Nelson EL, 2003, BREAST CANCER RES TR, V82, P169, DOI 10.1023/B:BREA.0000004373.09678.bb; NELSON EL, 2004, CANC DRUG DISC DEV, P203; Nishimoto KP, 2007, VIRAL IMMUNOL, V20, P88, DOI 10.1089/vim.2006.0090; Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003; Pushko P, 1997, VIROLOGY, V239, P389, DOI 10.1006/viro.1997.8878; Pushko P, 2001, J VIROL, V75, P11677, DOI 10.1128/JVI.75.23.11677-11685.2001; Pushko P, 2000, VACCINE, V19, P142, DOI 10.1016/S0264-410X(00)00113-4; Reap EA, 2007, CLIN VACCINE IMMUNOL, V14, P748, DOI 10.1128/CVI.00037-07; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Schultz-Cherry S, 2000, VIROLOGY, V278, P55, DOI 10.1006/viro.2000.0635; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Turell MJ, 1999, AM J TROP MED HYG, V60, P1041, DOI 10.4269/ajtmh.1999.60.1041; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Wilson JA, 2001, VIROLOGY, V286, P384, DOI 10.1006/viro.2001.1012; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001	45	7	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2709	10.1371/journal.pone.0002709	http://dx.doi.org/10.1371/journal.pone.0002709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628938	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200052
J	Paclik, D; Danese, S; Berndt, U; Wiedenmann, B; Dignass, A; Sturm, A				Paclik, Daniela; Danese, Silvio; Berndt, Uta; Wiedenmann, Bertram; Dignass, Axel; Sturm, Andreas			Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle	PLOS ONE			English	Article								Galectin-4 is a carbohydrate-binding protein belonging to the galectin family. Here we provide novel evidence that galectin-4 is selectively expressed and secreted by intestinal epithelial cells and binds potently to activated peripheral and mucosal lamina propria T-cells at the CD3 epitope. The carbohydrate-dependent binding of galectin-4 at the CD3 epitope is fully functional and inhibited T cell activation, cycling and expansion. Galectin-4 induced apoptosis of activated peripheral and mucosal lamina propria T cells via calpain-, but not caspase-dependent, pathways. Providing further evidence for its important role in regulating T cell function, galectin-4 blockade by antisense oligonucleotides reduced TNF-alpha inhibitor induced T cell death. Furthermore, in T cells, galectin-4 reduced pro-inflammatory cytokine secretion including IL-17. In a model of experimental colitis, galectin-4 ameliorated mucosal inflammation, induced apoptosis of mucosal T-cells and decreased the secretion of pro-inflammatory cytokines. Our results show that galectin-4 plays a unique role in the intestine and assign a novel role of this protein in controlling intestinal inflammation by a selective induction of T cell apoptosis and cell cycle restriction. Conclusively, after defining its biological role, we propose Galectin-4 is a novel anti-inflammatory agent that could be therapeutically effective in diseases with a disturbed T cell expansion and apoptosis such as inflammatory bowel disease.	[Paclik, Daniela; Berndt, Uta; Wiedenmann, Bertram; Sturm, Andreas] Charite, Campus Virchow Klinikum, Med Klin Ms Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Danese, Silvio] IRCCS, Ist Clin Humanitas, Div Gastroenterol, Milan, Italy; [Dignass, Axel] Markus Krankenhaus, Medizinische Klin I, Frankfurt, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Humanitas Research Hospital	Paclik, D (corresponding author), Charite, Campus Virchow Klinikum, Med Klin Ms Hepatol & Gastroenterol, D-13353 Berlin, Germany.	andreas.sturm@charite.de	Dignass, Axel/AAW-9653-2020; Dignass, Axel/V-5400-2019; Danese, Silvio/ABH-9571-2020	Dignass, Axel/0000-0002-9724-054X; Danese, Silvio/0000-0001-7341-1351; Wiedenmann, Bertram/0000-0002-7890-2552	Broad Medical Research Program of The Eli and Edythe Broad Foundation; Forschungsforderung of the Charite, Universitatsmedizin Berlin	Broad Medical Research Program of The Eli and Edythe Broad Foundation; Forschungsforderung of the Charite, Universitatsmedizin Berlin	This work was supported by a grant from the Broad Medical Research Program of The Eli and Edythe Broad Foundation (A.S.), and by the Forschungsforderung of the Charite, Universitatsmedizin Berlin (A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Baumgart DC, 2004, CURR PHARM DESIGN, V10, P4127, DOI 10.2174/1381612043382413; Baumgart DC, 2003, Z GASTROENTEROL, V41, P1017; Braat H, 2007, GUT, V56, P351, DOI 10.1136/gut.2006.099861; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; COOPER HS, 1993, LAB INVEST, V69, P238; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hlavaty T, 2007, INFLAMM BOWEL DIS, V13, P372, DOI 10.1002/ibd.20024; Hokama A, 2004, IMMUNITY, V20, P681, DOI 10.1016/j.immuni.2004.05.009; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200; Mudter J, 2007, GUT, V56, P293, DOI 10.1136/gut.2005.090464; Nio J, 2005, J HISTOCHEM CYTOCHEM, V53, P1323, DOI 10.1369/jhc.5A6685.2005; NORTON SD, 1991, J IMMUNOL, V146, P1125; Pace KE, 1999, J IMMUNOL, V163, P3801; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; RACHMILEWITZ D, 1995, GASTROENTEROLOGY, V108, pA897; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; ROTH MS, 1988, BLOOD, V71, P1744; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Schreiber S, 1999, LANCET, V353, P459, DOI 10.1016/S0140-6736(98)03339-X; Siegmund B, 2004, GUT, V53, P965, DOI 10.1136/gut.2003.027136; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Sturm A, 2002, J CLIN INVEST, V109, P1481, DOI 10.1172/JCI14967	39	83	83	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2629	10.1371/journal.pone.0002629	http://dx.doi.org/10.1371/journal.pone.0002629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612433	gold, Green Submitted, Green Published			2022-12-27	WOS:000264065800031
J	Casas, F; Pessemesse, L; Grandemange, S; Seyer, P; Gueguen, N; Baris, O; Lepourry, L; Cabello, G; Wrutniak-Cabello, C				Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal			Overexpression of the Mitochondrial T3 Receptor p43 Induces a Shift in Skeletal Muscle Fiber Types	PLOS ONE			English	Article								In previous studies, we have characterized a new hormonal pathway involving a mitochondrial T3 receptor (p43) acting as a mitochondrial transcription factor and consequently stimulating mitochondrial activity and mitochondrial biogenesis. We have established the involvement of this T3 pathway in the regulation of in vitro myoblast differentiation. We have generated mice overexpressing p43 under control of the human alpha-skeletal actin promoter. In agreement with the previous characterization of this promoter, northern-blot and western-blot experiments confirmed that after birth p43 was specifically overexpressed in skeletal muscle. As expected from in vitro studies, in 2-month old mice, p43 overexpression increased mitochondrial genes expression and mitochondrial biogenesis as attested by the increase of mitochondrial mass and mt-DNA copy number. In addition, transgenic mice had a body temperature 0.8 degrees C higher than control ones and displayed lower plasma triiodothyronine levels. Skeletal muscles of transgenic mice were redder than wild-type animals suggesting an increased oxidative metabolism. In line with this observation, in gastrocnemius, we recorded a strong increase in cytochrome oxidase activity and in mitochondrial respiration. Moreover, we observed that p43 drives the formation of oxidative fibers: in soleus muscle, where MyHC IIa fibers were partly replaced by type I fibers; in gastrocnemius muscle, we found an increase in MyHC IIa and IIx expression associated with a reduction in the number of glycolytic fibers type IIb. In addition, we found that PGC-1 alpha and PPARd, two major regulators of muscle phenotype were up regulated in p43 transgenic mice suggesting that these proteins could be downstream targets of mitochondrial activity. These data indicate that the direct mitochondrial T3 pathway is deeply involved in the acquisition of contractile and metabolic features of muscle fibers in particular by regulating PGC-1 alpha and PPAR delta.	[Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] INRA, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France; [Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] Univ Montpellier I, Montpellier, France; [Casas, Francois; Pessemesse, Laurence; Grandemange, Stephanie; Seyer, Pascal; Gueguen, Naig; Baris, Olivier; Lepourry, Laurence; Cabello, Gerard; Wrutniak-Cabello, Chantal] Univ Montpellier 2, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier	Casas, F (corresponding author), INRA, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France.	casasf@supagro.inra.fr	Grandemange, Stéphanie/G-7928-2015; Baris, Olivier R/L-3463-2016	Baris, Olivier R/0000-0003-0974-6856; Francois, Casas/0000-0002-5535-8195	Institut National de la Recherche Agronomique (INRA); Association Francaise contre les Myopathies (AFM); Ministere de la Recherche et de l'Enseignement [fellowships]; INRA [fellowships]	Institut National de la Recherche Agronomique (INRA); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de la Recherche et de l'Enseignement; INRA	This work was supported by grants from the Institut National de la Recherche Agronomique (INRA), the Association Francaise contre les Myopathies (AFM). Stephanie Grandemange, Pascal Seyer, Naig Gueguen and Olivier Baris are recipient of fellowships from, respectively, the Ministere de la Recherche et de l'Enseignement (SG and MB) and INRA (PS, NG and OB).	AUSONI S, 1990, J NEUROSCI, V10, P153; BERGMEYER HU, 1963, ENZYMES BIOL REAGENT, V1, P443; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; BUTLERBROWNE GS, 1984, FEBS LETT, V166, P71, DOI 10.1016/0014-5793(84)80047-2; Casas F, 1999, MOL CELL BIOL, V19, P7913; Casas F, 2000, FEBS LETT, V478, P4, DOI 10.1016/S0014-5793(00)01814-7; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; Gueguen N, 2005, COMP BIOCHEM PHYS B, V140, P287, DOI 10.1016/j.cbpc.2004.10.014; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; KING DB, 1987, J EXP ZOOL, P291; Kunz WS, 2000, J BIOL CHEM, V275, P27741; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Saelim N, 2004, J CELL BIOL, V167, P915, DOI 10.1083/jcb.200409011; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; SEYER PGS, 2008, MITOCHONDRIAL ACTIVI; SUGIE H, 1985, MUSCLE NERVE, V8, P654, DOI 10.1002/mus.880080805; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wharton DC., 1967, METHOD ENZYMOL, P245; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067	34	47	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2501	10.1371/journal.pone.0002501	http://dx.doi.org/10.1371/journal.pone.0002501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575627	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000023
J	Yu, KM; Ge, J; Summers, JB; Li, F; Liu, X; Ma, P; Kaminski, J; Zhuang, J				Yu, Keming; Ge, Jian; Summers, James Bradley; Li, Fan; Liu, Xuan; Ma, Ping; Kaminski, Joseph; Zhuang, Jing			TSP-1 Secreted by Bone Marrow Stromal Cells Contributes to Retinal Ganglion Cell Neurite Outgrowth and Survival	PLOS ONE			English	Article								Background: Bone marrow stromal cells (BMSCs) are pluripotent and thereby a potential candidate for cell replacement therapy for central nervous system degenerative disorders and traumatic injury. However, the mechanism of their differentiation and effect on neural tissues has not been fully elucidated. This study evaluates the effect of BMSCs on neural cell growth and survival in a retinal ganglion cell (RGCs) model by assessing the effect of changes in the expression of a BMSC-secreted protein, thrombospondin-1 (TSP-1), as a putative mechanistic agent acting on RGCs. Methods and Findings: The effect of co-culturing BMSCs and RGCs in vitro was evaluated by measuring the following parameters: neurite outgrowth, RGC survival, BMSC neural-like differentiation, and the effect of TSP-1 on both cell lines under basal secretion conditions and when TSP-1 expression was inhibited. Our data show that BMSCs improved RGC survival and neurite outgrowth. Synaptophysin, MAP-2, and TGF-beta expression are up-regulated in RGCs co-cultured with BMSCs. Interestingly, the BMSCs progressively displayed neural-like morphology over the seven-day study period. Restriction display polymerase chain reaction (RD-PCR) was performed to screen for differentially expressed genes in BMSCs cultured alone or co-cultured with RGCs. TSP-1, a multifactorial extracellular matrix protein, is critically important in the formation of neural connections during development, so its function in our co-culture model was investigated by small interfering RNA (siRNA) transfection. When TSP-1 expression was decreased with siRNA silencing, BMSCs had no impact on RGC survival, but reduced neurite outgrowth and decreased expression of synaptophysin, MAP-2 and TGF-beta in RGCs. Furthermore, the number of BMSCs with neural-like characteristics was significantly decreased by more than two-fold using siRNA silencing. Conclusions: Our data suggest that the TSP-1 signaling pathway might have an important role in neural-like differentiation in BMSCs and neurite outgrowth in RGCs. This study provides new insights into the potential reparative mechanisms of neural cell repair.	[Yu, Keming; Ge, Jian; Li, Fan; Liu, Xuan; Ma, Ping; Zhuang, Jing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Summers, James Bradley] Univ S Alabama, Dept Radiol, Mobile, AL USA; [Kaminski, Joseph] Med Coll Georgia, Dept Radiol, Augusta, GA USA	Sun Yat Sen University; University of South Alabama; University System of Georgia; Augusta University	Yu, KM (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	joseph.kaminski@gmail.com; zhuangj@mail.sysu.edu.cn	Kaminski, Joseph/AAB-6493-2020	Kaminski, Joseph/0000-0002-7518-4962	Ministry of Science and Technology of P. R. China, Guangdong Province; Ministry of Education of P. R. China [2007CB512200, 06021308, 7001573, 20070558283]	Ministry of Science and Technology of P. R. China, Guangdong Province; Ministry of Education of P. R. China(Ministry of Education, China)	This research was supported by the grants from the Ministry of Science and Technology of P. R. China, Guangdong Province and the Ministry of Education of P. R. China)(#1 2007CB512200; #2 06021308; #3 7001573;#4 20070558283).	Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adams JC, 2000, DEV DYNAM, V218, P280; ADAMS JC, 1993, J CELL SCI, V104, P1061; Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; ALDER J, 1992, SCIENCE, V257, P657, DOI 10.1126/science.1353905; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; BUEE L, 1992, AM J PATHOL, V141, P783; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Chatila Khaled, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P21; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; CHEN Y, 2006, CELL MOL, V63, P1420; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Deng ZR, 2006, INT J CARDIOL, V113, P92, DOI 10.1016/j.ijcard.2006.06.014; Dhandapani KM, 2003, CELL BIOCHEM BIOPHYS, V39, P13, DOI 10.1385/CBB:39:1:13; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hoffman JR, 1999, BRAIN RES BULL, V48, P413, DOI 10.1016/S0361-9230(99)00021-0; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOGG PJ, 1993, J BIOL CHEM, V268, P21811; Hudson JE, 2004, J NEUROSCI RES, V76, P255, DOI 10.1002/jnr.20043; Irons H, 2004, CELL TRANSPLANT, V13, P283, DOI 10.3727/000000004783983990; ISAKOVA IA, 2006, STEM CELLS, V24, P2483; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOANNE E, 2001, J CLIN INVEST, V107, P785; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Konig HG, 2005, J CELL BIOL, V168, P1077, DOI 10.1083/jcb.200407027; Koshizuka S, 2004, J NEUROPATH EXP NEUR, V63, P64, DOI 10.1093/jnen/63.1.64; Liu CH, 2003, J BIOCHEM MOL BIOL, V36, P349; Liu GZ, 2007, FOREIGN LIT STUD, V29, P80; LIU Z, 2006, J NEUROSCI RES, V83, P1485; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mizobe Takashi, 2006, Kobe Journal of Medical Sciences, V52, P119; Ono K, 2003, J NEUROSCI RES, V72, P503, DOI 10.1002/jnr.10588; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; *OS INC, PHAS 3 TRIAL GRAFT V; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Petrik JJ, 2002, BIOL REPROD, V67, P1522, DOI 10.1095/biolreprod.102.007153; Pira GL, 2006, HUM IMMUNOL, V67, P976, DOI 10.1016/j.humimm.2006.08.298; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Saumet A, 2005, BLOOD, V106, P658, DOI 10.1182/blood-2004-09-3585; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Sun ZH, 2005, WORLD J GASTROENTERO, V11, P7579, DOI 10.3748/wjg.v11.i48.7579; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Uchida H, 2005, EXP EYE RES, V80, P23, DOI 10.1016/j.exer.2004.08.004; Uno K, 2005, HISTOL HISTOPATHOL, V20, P493, DOI 10.14670/HH-20.493; Uno K, 2004, BIOCHEM BIOPH RES CO, V315, P928, DOI 10.1016/j.bbrc.2004.01.146; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yu KM, 2007, BIOCHEM BIOPH RES CO, V358, P990, DOI 10.1016/j.bbrc.2007.05.004; [余克明 Yu Keming], 2005, [中国病理生理杂志, Chinese Journal of Pathophysiology], V21, P6; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962; ZHUANG J, 2001, ACAD J SUMS, V23, P24; ZHUANG J, 2002, J HISTO CYTO, V11, P121	68	42	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2470	10.1371/journal.pone.0002470	http://dx.doi.org/10.1371/journal.pone.0002470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575624	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000003
J	Desikan, R; Horak, J; Chaban, C; Mira-Rodado, V; Witthoft, J; Elgass, K; Grefen, C; Cheung, MK; Meixner, AJ; Hooley, R; Neill, SJ; Hancock, JT; Harter, K				Desikan, Radhika; Horak, Jakub; Chaban, Christina; Mira-Rodado, Virtudes; Witthoeft, Janika; Elgass, Kirstin; Grefen, Christopher; Cheung, Man-Kim; Meixner, Alfred J.; Hooley, Richard; Neill, Steven John; Hancock, John Travers; Harter, Klaus			The Histidine Kinase AHK5 Integrates Endogenous and Environmental Signals in Arabidopsis Guard Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; INDUCED STOMATAL CLOSURE; HYDROGEN-PEROXIDE; ABSCISIC-ACID; REACTIVE OXYGEN; RESPONSE REGULATOR; FUNCTIONAL-ANALYSIS; OXIDATIVE STRESS; INNATE IMMUNITY; RECEPTOR FLS2	Background: Stomatal guard cells monitor and respond to environmental and endogenous signals such that the stomatal aperture is continually optimised for water use efficiency. A key signalling molecule produced in guard cells in response to plant hormones, light, carbon dioxide and pathogen-derived signals is hydrogen peroxide (H2O2). The mechanisms by which H2O2 integrates multiple signals via specific signalling pathways leading to stomatal closure is not known. Principal Findings: Here, we identify a pathway by which H2O2, derived from endogenous and environmental stimuli, is sensed and transduced to effect stomatal closure. Histidine kinases (HK) are part of two-component signal transduction systems that act to integrate environmental stimuli into a cellular response via a phosphotransfer relay mechanism. There is little known about the function of the HK AHK5 in Arabidopsis thaliana. Here we report that in addition to the predicted cytoplasmic localisation of this protein, AHK5 also appears to co-localise to the plasma membrane. Although AHK5 is expressed at low levels in guard cells, we identify a unique role for AHK5 in stomatal signalling. Arabidopsis mutants lacking AHK5 show reduced stomatal closure in response to H2O2, which is reversed by complementation with the wild type gene. Over-expression of AHK5 results in constitutively less stomatal closure. Abiotic stimuli that generate endogenous H2O2, such as darkness, nitric oxide and the phytohormone ethylene, also show reduced stomatal closure in the ahk5 mutants. However, ABA caused closure, dark adaptation induced H2O2 production and H2O2 induced NO synthesis in mutants. Treatment with the bacterial pathogen associated molecular pattern (PAMP) flagellin, but not elf peptide, also exhibited reduced stomatal closure and H2O2 generation in ahk5 mutants. Significance: Our findings identify an integral signalling function for AHK5 that acts to integrate multiple signals via H2O2 homeostasis and is independent of ABA signalling in guard cells.	[Desikan, Radhika] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Horak, Jakub; Chaban, Christina; Mira-Rodado, Virtudes; Witthoeft, Janika; Grefen, Christopher; Harter, Klaus] Univ Tubingen, Zentrum Molekularbiol Pflanzen Pflanzenphysiol, Tubingen, Germany; [Elgass, Kirstin; Meixner, Alfred J.] Univ Tubingen, Inst Phys & Theoretical Chem, Dept Nano Opt, Tubingen, Germany; [Hooley, Richard] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Desikan, Radhika; Cheung, Man-Kim; Neill, Steven John; Hancock, John Travers] Univ West England, Ctr Res Plant Sci, Bristol, Avon, England	Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bath; University of West England	Desikan, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England.	r.desikan@ic.ac.uk; klaus.harter@zmbp.uni-tuebingen.de	Grefen, Christopher/AAH-4512-2020; Meixner, Alfred J./P-3260-2019	Grefen, Christopher/0000-0002-5820-4466; Meixner, Alfred J./0000-0002-0187-2906	Leverhulme Trust Early Career Fellowship; BBSRC; DFG [AFGN-Ha2146/5, Ha2146/7]	Leverhulme Trust Early Career Fellowship(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DFG(German Research Foundation (DFG))	This work was funded by a Leverhulme Trust Early Career Fellowship to RD, BBSRC grant to SJN, JTH and RH and DFG grants to KH (AFGN-Ha2146/5, Ha2146/7).	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Blum C, 2001, J PHYS CHEM A, V105, P6983, DOI 10.1021/jp0031092; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; BRIGHT J, 2006, THESIS; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Desikan R, 2005, PLANT PHYSIOL, V137, P831, DOI 10.1104/pp.104.056994; Desikan R, 2004, FUNCT PLANT BIOL, V31, P913, DOI 10.1071/FP04035; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Desikan R, 1999, J EXP BOT, V50, P1863, DOI 10.1093/jexbot/50.341.1863; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Desikan R, 2005, BIOL SCI SER, P169, DOI 10.1002/9780470988565.ch7; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grefen C, 2004, PLANTA, V219, P733, DOI 10.1007/s00425-004-1316-4; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Gudesblat GE, 2007, NEW PHYTOL, V173, P713, DOI 10.1111/j.1469-8137.2006.01953.x; Gupta R, 2003, PLANT PHYSIOL, V132, P1149, DOI 10.1104/pp.103.020792; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Horak J, 2003, PLANT BIOLOGY, V5, P245, DOI 10.1055/s-2003-40789; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Hwang D, 2002, PLANT PHYSIOL, V129, P500, DOI 10.1104/pp.005504; Iwama A, 2007, PLANT CELL PHYSIOL, V48, P375, DOI 10.1093/pcp/pcl065; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Leymarie J, 1998, PLANT PHYSIOL BIOCH, V36, P539, DOI 10.1016/S0981-9428(98)80180-0; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Meinhard M, 2002, PLANTA, V214, P775, DOI 10.1007/s00425-001-0675-3; Meinhard M, 2001, FEBS LETT, V508, P443, DOI 10.1016/S0014-5793(01)03106-4; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Papon N, 2003, FEBS LETT, V537, P101, DOI 10.1016/S0014-5793(03)00102-9; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; SCHLEIFENBAUM F, 2008, J PHYS CH B IN PRESS; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang PC, 2006, J INTEGR PLANT BIOL, V48, P62, DOI 10.1111/j.1744-7909.2006.00213.x; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	98	100	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2491	10.1371/journal.pone.0002491	http://dx.doi.org/10.1371/journal.pone.0002491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560512	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700055
J	Mattson, CL; Campbell, RT; Bailey, RC; Agot, K; Ndinya-Achola, JO; Moses, S				Mattson, Christine L.; Campbell, Richard T.; Bailey, Robert C.; Agot, Kawango; Ndinya-Achola, J. O.; Moses, Stephen			Risk Compensation Is Not Associated with Male Circumcision in Kisumu, Kenya: A Multi-Faceted Assessment of Men Enrolled in a Randomized Controlled Trial	PLOS ONE			English	Article								Background: Three randomized controlled trials (RCTs) have confirmed that male circumcision ( MC) significantly reduces acquisition of HIV-1 infection among men. The objective of this study was to perform a comprehensive, prospective evaluation of risk compensation, comparing circumcised versus uncircumcised controls in a sample of RCT participants. Methods and Findings: Between March 2004 and September 2005, we systematically recruited men enrolled in a RCT of MC in Kenya. Detailed sexual histories were taken using a modified Timeline Followback approach at baseline, 6, and 12 months. Participants provided permission to obtain circumcision status and laboratory results from the RCT. We evaluated circumcised and uncircumcised men's sexual behavior using an 18-item risk propensity score and acquisition of incident infections of gonorrhea, chlamydia, and trichomoniasis. Of 1780 eligible RCT participants, 1319 enrolled (response rate = 74%). At the baseline RCT visit, men who enrolled in the sub-study reported the same sexual behaviors as men who did not. We found a significant reduction in sexual risk behavior among both circumcised and uncircumcised men from baseline to 6 (p<0.01) and 12 (p=0.05) months post-enrollment. Longitudinal analyses indicated no statistically significant differences between sexual risk propensity scores or in incident infections of gonorrhea, chlamydia, and trichomoniasis between circumcised and uncircumcised men. These results are based on the most comprehensive analysis of risk compensation yet done. Conclusion: In the context of a RCT, circumcision did not result in increased HIV risk behavior. Continued monitoring and evaluation of risk compensation associated with circumcision is needed as evidence supporting its' efficacy is disseminated and MC is widely promoted for HIV prevention.	[Mattson, Christine L.; Campbell, Richard T.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA; [Agot, Kawango] UNIM Project, Kisumu, Kenya; [Ndinya-Achola, J. O.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Moses, Stephen] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi; University of Manitoba	Mattson, CL (corresponding author), Univ Illinois, Sch Publ Hlth, Chicago, IL 60607 USA.	christine.mattson@gmail.com	Campbell, Richard/W-6933-2019		Division of AIDS, National Institute of Allergies and Infectious Disease of the United States National Institutes of Health [AI50440]; Canadian Institutes of Health Research (CIHR) [HCT 44180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergies and Infectious Disease of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant number AI50440 from the Division of AIDS, National Institute of Allergies and Infectious Disease of the United States National Institutes of Health and by grant number HCT 44180 from the Canadian Institutes of Health Research (CIHR).	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buve A, 2001, AIDS, V15, pS89, DOI 10.1097/00002030-200108004-00010; Buve A, 2001, AIDS, V15, pS79, DOI 10.1097/00002030-200108004-00009; Carey MP, 2001, INT J STD AIDS, V12, P365, DOI 10.1258/0956462011923309; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Gray R, 2004, AIDS, V18, P2428; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Junker BW, 2001, APPL PSYCH MEAS, V25, P211, DOI 10.1177/01466210122032028; Klausner Jeffrey D, 2008, Futur HIV Ther, V2, P1, DOI 10.2217/17469600.2.1.1; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; *NIH NIAID, 2006, AD MAL CIRC SIGN RED; Olsen MK, 2001, J AM STAT ASSOC, V96, P730, DOI 10.1198/016214501753168389; Pequegnat W, 2000, SEX TRANSM DIS, V27, P127, DOI 10.1097/00007435-200003000-00001; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; *SAS I, 2002, SAS VERS 8 2 9 1; SEED J, 1995, J ACQ IMMUN DEF SYND, V8, P83; Siegfried N, 2005, LANCET INFECT DIS, V5, P165, DOI 10.1016/S1473-3099(05)01309-5; SJITSMA K, 2008, QUAL LIFE RES, V17, P275; Tooze JA, 2002, STAT METHODS MED RES, V11, P341, DOI 10.1191/0962280202sm291ra; UNAIDS/WHO/UNFPA/UNICEF, 2005, PRESS STAT UNAIDS ST; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; *WHO, 2005, UNAIDS STAT S AFR TR; *WHO UNFPA UNICEF, 2006, STAT KENY UG TRIAL F; Xie Haiyi, 2004, Ment Health Serv Res, V6, P239, DOI 10.1023/B:MHSR.0000044749.39484.1b	30	94	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2443	10.1371/journal.pone.0002443	http://dx.doi.org/10.1371/journal.pone.0002443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560581	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700028
J	Muller, MS; Brennecke, JF; Porter, ET; Ottinger, MA; Anderson, DJ				Mueller, Martina S.; Brennecke, Julius F.; Porter, Elaine T.; Ottinger, Mary Ann; Anderson, David J.			Perinatal Androgens and Adult Behavior Vary with Nestling Social System in Siblicidal Boobies	PLOS ONE			English	Article							NAZCA BOOBIES; SEXUAL-DIFFERENTIATION; YOLK ANDROGENS; TESTOSTERONE; EVOLUTION; PATTERNS; SULIDAE; PLASMA; BRAIN; QUAIL	Background: Exposure to androgens early in development, while activating adaptive aggressive behavior, may also exert long-lasting effects on non-target components of phenotype. Here we compare these organizational effects of perinatal androgens in closely related Nazca (Sula granti) and blue-footed (S. nebouxii) boobies that differ in neonatal social system. The older of two Nazca booby hatchlings unconditionally attacks and ejects the younger from the nest within days of hatching, while blue-footed booby neonates lack lethal aggression. Both Nazca booby chicks facultatively upregulate testosterone (T) during fights, motivating the prediction that baseline androgen levels differ between obligately siblicidal and other species. Methodology/Principal Findings: We show that obligately siblicidal Nazca boobies hatch with higher circulating androgen levels than do facultatively siblicidal blue-footed boobies, providing comparative evidence of the role of androgens in sociality. Although androgens confer a short-term benefit of increased aggression to Nazca booby neonates, exposure to elevated androgen levels during this sensitive period in development can also induce long-term organizational effects on behavior or morphology. Adult Nazca boobies show evidence of organizational effects of early androgen exposure in aberrant adult behavior: they visit unattended non-familial chicks in the colony and direct mixtures of aggression, affiliative, and sexual behavior toward them. In a longitudinal analysis, we found that the most active Non-parental Adult Visitors (NAVs) were those with a history of siblicidal behavior as a neonate, suggesting that the tendency to show social interest in chicks is programmed, in part, by the high perinatal androgens associated with obligate siblicide. Data from closely related blue-footed boobies provide comparative support for this interpretation. Lacking obligate siblicide, they hatch with a corresponding low androgen level, and blue-footed booby adults show a much lower frequency of NAV behavior and a lower probability of behaving aggressively during NAV interactions. This species difference in adult social behavior appears to have roots in both pleiotropic and experiential effects of nestling social system. Conclusions/Significance: Our results indicate that Nazca boobies experience life-long consequences of androgenic preparation for an early battle to the death.	[Mueller, Martina S.; Porter, Elaine T.; Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Brennecke, Julius F.] Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Ottinger, Mary Ann] Univ Maryland, College Pk, MD USA	Wake Forest University; Cold Spring Harbor Laboratory; University System of Maryland; University of Maryland College Park	Muller, MS (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	da@wfu.edu	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814	National Science Foundation; Division Of Environmental Biology [0842199] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation	ADKINS E K, 1975, Journal of Comparative and Physiological Psychology, V89, P61, DOI 10.1037/h0076406; ADKINS EK, 1979, NEUROENDOCRINOLOGY, V29, P178, DOI 10.1159/000122920; ADKINSREGAN E, 1994, J NEUROBIOL, V25, P865, DOI 10.1002/neu.480250710; ANDERSON DJ, 1989, BEHAV ECOL SOCIOBIOL, V25, P363, DOI 10.1007/BF00302994; ANDERSON DJ, 1990, AM NAT, V135, P334, DOI 10.1086/285049; Anderson DJ, 2004, BEHAVIOUR, V141, P959, DOI 10.1163/1568539042360134; ANDERSON DJ, 1993, ECOLOGY, V74, P2462, DOI 10.2307/1939597; ANDERSON DJ, 1993, BIRDS N AM, V73; Apanius V., 2008, ORNITHOL MONOGR, V65; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CADIOU B, 1994, ANIM BEHAV, V47, P847, DOI 10.1006/anbe.1994.1116; Clifford LD, 2001, J ANIM ECOL, V70, P539, DOI 10.1046/j.1365-2656.2001.00521.x; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; DRUMMOND H, 1986, BEHAV ECOL SOCIOBIOL, V19, P365, DOI 10.1007/BF00295710; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Ferree ED, 2004, HORM BEHAV, V46, P655, DOI 10.1016/j.yhbeh.2004.06.009; Friesen VL, 1997, MOL PHYLOGENET EVOL, V7, P252, DOI 10.1006/mpev.1996.0397; Humphries CA, 2006, OECOLOGIA, V147, P379, DOI 10.1007/s00442-005-0264-4; Lougheed LW, 1999, BEHAV ECOL SOCIOBIOL, V45, P11, DOI 10.1007/s002650050535; Maness TJ, 2007, WATERBIRDS, V30, P10, DOI 10.1675/1524-4695(2007)030[0010:OSRVIN]2.0.CO;2; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Ottinger MA, 2001, POULTRY SCI, V80, P795, DOI 10.1093/ps/80.6.795; Pfaff D.W., 2002, HORMONES BRAIN BEHAV; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; PORTER ET, 2003, THESIS WAKE FOREST U; ROBINSON SK, 1988, ANIM BEHAV, V36, P1482, DOI 10.1016/S0003-3472(88)80219-7; Romano M, 2005, HORM BEHAV, V48, P342, DOI 10.1016/j.yhbeh.2005.03.007; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P549, DOI 10.1007/s00265-005-0080-1; Rubolini D, 2007, P ROY SOC B-BIOL SCI, V274, P137, DOI 10.1098/rspb.2006.3696; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Tarlow EM, 2003, HORM BEHAV, V43, P402, DOI 10.1016/S0018-506X(03)00011-4; Townsend HM, 2002, OECOLOGIA, V132, P419, DOI 10.1007/s00442-002-0992-7; Uller T, 2005, BEHAV ECOL SOCIOBIOL, V57, P584, DOI 10.1007/s00265-004-0886-2; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; [No title captured]	37	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2460	10.1371/journal.pone.0002460	http://dx.doi.org/10.1371/journal.pone.0002460			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560542	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000263280700041
J	Raby, E; Moyo, M; Devendra, A; Banda, J; De Haas, P; Ayles, H; Godfrey-Faussett, P				Raby, Edward; Moyo, Maureen; Devendra, Akash; Banda, Joseph; De Haas, Petra; Ayles, Helen; Godfrey-Faussett, Peter			The Effects of HIV on the Sensitivity of a Whole Blood IFN-gamma Release Assay in Zambian Adults with Active Tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; T-CELLS; PREVALENCE; INFECTION; DIAGNOSIS; METAANALYSIS; RESPONSES; DISEASES	Background: Interferon gamma release assays (IGRA) are replacing the tuberculin skin test (TST) as a diagnostic tool for Mycobacterium tuberculosis infection. However research into the test's performance in the high HIV-TB burden setting is scarce. This study aimed to define the sensitivity of an IGRA, QuantiFERON-TB (R) Gold In-Tube (QGIT), in adult Zambian patients with active smear-positive tuberculosis. Secondary outcomes focussed on the effect of HIV on the test's performance. Principal Findings: Patients attending government health clinics were recruited within 1 month of starting treatment for TB. Subjects were tested with QGIT and TST. T lymphocyte counts were estimated (CD3(+), CD4(+), CD8(+)). QGIT was performed for 112 subjects. 83/112 were QGIT positive giving an overall sensitivity of 74% [95% CI: 66,82]. A marked decrease in sensitivity was observed in HIV positive patients with 37/59 (63%) being QGIT positive compared to 31/37 (84%) HIV negative patients [chi(2) p = 0.033]. Low CD4(+) count was associated with increases in both indeterminate and false-negative results. Low CD4(+) count in combination with high/normal CD8(+) count was associated with false-negative results. TST was recorded for 92 patients, 62/92 were positive, giving a sensitivity of 67% [95% CI: 58,77]. Although there was little difference in the overall sensitivities, agreement between TST and QGIT was poor. Conclusions: QGIT was technically feasible with results in HIV negative subjects comparable to those achieved elsewhere. However, where under-treated HIV is prevalent, an increased proportion of both indeterminate and false-negative QGIT results can be expected in patients with active TB. The implications of this for the diagnosis of LTBI by QGIT is unclear. The diagnostic and prognostic relevance of IGRAs in high burden settings needs to be better characterised.	[Raby, Edward; Devendra, Akash; De Haas, Petra; Ayles, Helen; Godfrey-Faussett, Peter] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Moyo, Maureen; Banda, Joseph; De Haas, Petra; Ayles, Helen] Univ Teach Hosp, Dept Microbiol, Zambia AIDS Related TB ZAMBART Project, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine	Raby, E (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England.	Edward.Raby@lshtm.ac.uk	Raby, Edward/AAM-1815-2021	Raby, Edward/0000-0003-1671-6188; Ayles, Helen/0000-0003-4108-2842	Foundation for Innovative New Diagnostics (FIND); Bill and Melinda Gates Foundation [19790.01]; DFID via the TARGETS consortium	Foundation for Innovative New Diagnostics (FIND); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DFID via the TARGETS consortium	Financial support for the study was from the Foundation for Innovative New Diagnostics (FIND) and also included support from the Bill and Melinda Gates Foundation as part of the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) project (19790.01), and also from DFID via the TARGETS consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Arnadottir T, 1996, TUBERCLE LUNG DIS, V77, P1, DOI 10.1016/S0962-8479(96)90127-6; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; DUNCAN LE, 1995, T ROY SOC TROP MED H, V89, P37, DOI 10.1016/0035-9203(95)90649-5; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Grant AD, 2005, JAMA-J AM MED ASSOC, V293, P2719, DOI 10.1001/jama.293.22.2719; Harada Nobuyuki, 2004, Kekkaku, V79, P725; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Inokuchi N, 2003, DIAGN MICR INFEC DIS, V46, P109, DOI 10.1016/S0732-8893(03)00018-X; Laserson KF, 2007, B WORLD HEALTH ORGAN, V85, P377, DOI 10.2471/BLT.06.035329; Luetkemeyer AF, 2007, AM J RESP CRIT CARE, V175, P737, DOI 10.1164/rccm.200608-1088OC; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Rothel James S, 2005, Expert Rev Anti Infect Ther, V3, P981, DOI 10.1586/14787210.3.6.981; Soysal A, 2008, INT J TUBERC LUNG D, V12, P50; Tat D, 2005, CLIN INFECT DIS, V40, P246, DOI 10.1086/426816; Toman K., 2004, TOMANS TUBERCULOSIS, V2nd; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895; *WHO, 2004, WHO AFR REG TB COUNT; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, GLOB PLAN STOP TB 20	32	102	106	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2489	10.1371/journal.pone.0002489	http://dx.doi.org/10.1371/journal.pone.0002489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560573	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000263280700053
J	Bonevski, B; Wilson, A; Henry, DA				Bonevski, Billie; Wilson, Amanda; Henry, David A.			An Analysis of News Media Coverage of Complementary and Alternative Medicine	PLOS ONE			English	Article							NATIONAL-SURVEY; BREAST-CANCER; HEALTH; GENETICS; BENEFITS; THERAPY; STORIES; IMPACT; DRUGS	Background: To examine the accuracy and adequacy of lay media news stories about complementary and alternative medicines and therapies. Methodology/Principal Findings: A descriptive analysis of news stories about complementary and alternative medicine (CAM) in the Australian media using a national medical news monitoring website, mediadoctor.org.au. Each story was rated against 10 criteria by two individuals. Consensus scores of 222 news articles reporting therapeutic claims about complementary medicines posted on mediadoctor.org.au between 1 January 2004 and 1 September 2007 were calculated. The overall rating score for 222 CAM articles was 50% (95% CI 47% to 53%). There was a statistically significant (F = 3.68, p = 0.006) difference in cumulative mean scores according to type of therapy: biologically based practices (54%, 95% CI 50% to 58%); manipulative body based practices (46%, 95% CI 39% to 54%), whole medical systems (45%, 95% CI 32% to 58%), mind body medicine (41%, 95% CI 31% to 50%) and energy medicine (33%, 95% CI 11% to 55%). There was a statistically significant difference in cumulative mean scores (F = 3.72, p = 0.0001) according to the clinical outcome of interest with stories about cancer treatments (62%, 95% CI 54% to 70%) scoring highest and stories about treatments for children's behavioural and mental health concerns scoring lowest (31%, 95% CI 19% to 43%). Significant differences were also found in scores between media outlets. Conclusions/Significance: There is substantial variability in news reporting practices about CAM. Overall, although they may be improving, the scores remain generally low. It appears that much of the information the public receives about CAM is inaccurate or incomplete.	[Bonevski, Billie; Wilson, Amanda] Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia; [Henry, David A.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Newcastle; University of Toronto	Bonevski, B (corresponding author), Univ Newcastle, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia.	billie.bonevski@newcastle.edu.au	Bonevski, Billie/G-7298-2013; Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Bonevski, Billie/0000-0001-8505-622X; Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; Wilson, Amanda/0000-0001-5681-9611	Hunter Medical Research Institute; University of Newcastle	Hunter Medical Research Institute; University of Newcastle	This research was funded by a grant from the Hunter Medical Research Institute and a grant from the University of Newcastle.	[Anonymous], 1994, MEDIA INFORM AUSTR; *AUSTR MED ASS, 2002, COMPL MED POS STAT; Berman B M, 1997, J Altern Complement Med, V3, P191, DOI 10.1089/acm.1997.3.191; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; Caspi O, 2003, ALTERN THER HEALTH M, V9, P58; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Chapman S, 2005, MED J AUSTRALIA, V183, P247, DOI 10.5694/j.1326-5377.2005.tb07029.x; Chapman S, 2001, HEALTH PROMOT INT, V16, P137, DOI 10.1093/heapro/16.2.137; Cohen MM, 2005, J ALTERN COMPLEM MED, V11, P995, DOI 10.1089/acm.2005.11.995; *COMM AUSTR, 2003, COMPL MED AUSTR HLTH, P163; Condit CM, 1998, AM J HUM GENET, V62, P979, DOI 10.1086/301784; Dolan G, 2004, INT J CONSUM STUD, V28, P147, DOI DOI 10.1111/J.1470-6431.2003.00363.X; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, BRIT MED J, V321, P707; ERNST E, 2002, CLIN RES COMPLEMENTA, P171; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Hann D M, 2005, Integr Cancer Ther, V4, P294, DOI 10.1177/1534735405282109; Henderson L, 1999, SOCIOL HEALTH ILL, V21, P560, DOI 10.1111/1467-9566.00173; *HOUS LORDS SEL CO, 2000, SESS 1999 2000 REP C; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; Johnson T, 1998, NEW ENGL J MED, V339, P87, DOI 10.1056/NEJM199807093390206; Lupton D, 1995, AUST J PUBLIC HEALTH, V19, P501; MacLennan AH, 2002, PREV MED, V35, P166, DOI 10.1006/pmed.2002.1057; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; National Center for Complementary and Alternative Medicine, 2002, WHAT IS COMPL ALT ME; *R STARCH WORLDW I, 1997, AM TALK SCI MED NEWS; Ransohoff D F, 2001, Eff Clin Pract, V4, P185; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Shuchman M, 1997, ANN INTERN MED, V126, P976, DOI 10.7326/0003-4819-126-12-199706150-00008; Smith DE, 2005, MED J AUSTRALIA, V183, P190, DOI 10.5694/j.1326-5377.2005.tb06992.x; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Vickers A, 2000, BRIT MED J, V321, P683, DOI 10.1136/bmj.321.7262.683; Voss M, 2002, AM J PUBLIC HEALTH, V92, P1158, DOI 10.2105/AJPH.92.7.1158; Wells J, 2001, ANN INTERN MED, V135, P1029, DOI 10.7326/0003-4819-135-12-200112180-00006; Wilkes MS, 1997, J HEALTH COMMUN, V2, P3, DOI 10.1080/108107397127888; WILKES MS, 1997, J HEALTH COMMUN, V2, P61; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x; Woodward KN, 2005, HUM EXP TOXICOL, V24, P219, DOI 10.1191/0960327105ht529oa; 2001, REP GUID	44	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2406	10.1371/journal.pone.0002406	http://dx.doi.org/10.1371/journal.pone.0002406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545688	Green Published, gold			2022-12-27	WOS:000263248800044
J	Ponts, N; Yang, JF; Chung, DWD; Prudhomme, J; Girke, T; Horrocks, P; Le Roch, KG				Ponts, Nadia; Yang, Jianfeng; Chung, Duk-Won Doug; Prudhomme, Jacques; Girke, Thomas; Horrocks, Paul; Le Roch, Karine G.			Deciphering the Ubiquitin-Mediated Pathway in Apicomplexan Parasites: A Potential Strategy to Interfere with Parasite Virulence	PLOS ONE			English	Article							PROTEIN CONJUGATION SYSTEM; PLASMODIUM-FALCIPARUM; GENOME SEQUENCE; DEUBIQUITINATING ENZYME; ISOPRENOID BIOSYNTHESIS; PROTEOLYTIC PATHWAY; PROTEASOME PATHWAY; TERMINAL REGION; DRUG DISCOVERY; BOX PROTEINS	Background: Reversible modification of proteins through the attachment of ubiquitin or ubiquitin-like modifiers is an essential post-translational regulatory mechanism in eukaryotes. The conjugation of ubiquitin or ubiquitin-like proteins has been demonstrated to play roles in growth, adaptation and homeostasis in all eukaryotes, with perturbation of ubiquitin-mediated systems associated with the pathogenesis of many human diseases, including cancer and neurodegenerative disorders. Methodology/Principal Findings: Here we describe the use of an HMM search of functional Pfam domains found in the key components of the ubiquitin-mediated pathway necessary to activate and reversibly modify target proteins in eight apicomplexan parasitic protozoa for which complete or late-stage genome projects exist. In parallel, the same search was conducted on five model organisms, single-celled and metazoans, to generate data to validate both the search parameters employed and aid paralog classification in Apicomplexa. For each of the 13 species investigated, a set of proteins predicted to be involved in the ubiquitylation pathway has been identified and demonstrates increasing component members of the ubiquitylation pathway correlating with organism and genome complexity. Sequence homology and domain architecture analyses facilitated prediction of apicomplexan-specific protein function, particularly those involved in regulating cell division during these parasite's complex life cycles. Conclusions/Significance: This study provides a comprehensive analysis of proteins predicted to be involved in the apicomplexan ubiquitin-mediated pathway. Given the importance of such pathway in a wide variety of cellular processes, our data is a key step in elucidating the biological networks that, in part, direct the pathogenicity of these parasites resulting in a massive impact on global health. Moreover, apicomplexan-specific adaptations of the ubiquitylation pathway may represent new therapeutic targets for much needed drugs against apicomplexan parasites.	[Ponts, Nadia; Yang, Jianfeng; Chung, Duk-Won Doug; Prudhomme, Jacques; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Girke, Thomas] Univ Calif Riverside, Ctr Plant Cell Biol CEPCEB, Riverside, CA USA; [Horrocks, Paul] Keele Univ, Inst Sci & Technol Med, Dept Med, Keele, Staffs, England	University of California System; University of California Riverside; University of California System; University of California Riverside; Keele University	Ponts, N (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu		Girke, Thomas/0000-0003-0710-3777				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Balakirev MY, 2002, J VIROL, V76, P6323, DOI 10.1128/JVI.76.12.6323-6331.2002; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brailoiu GC, 2003, BRAIN RES, V984, P215, DOI 10.1016/S0006-8993(03)03161-5; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Doerig C, 2000, Prog Cell Cycle Res, V4, P163; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Durbin R., 1998, BIOL SEQUENCE ANAL P; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Gao R, 2007, J BACTERIOL, V189, P6048, DOI 10.1128/JB.00459-07; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; GLASSNER BJ, 1994, RADIAT RES, V139, P24, DOI 10.2307/3578728; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; GOLDFEDER MB, 2007, J BIOL CHEM; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann K, 1998, J MOL BIOL, V282, P195, DOI 10.1006/jmbi.1998.1998; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Horrocks P, 2000, MOL BIOCHEM PARASIT, V105, P115, DOI 10.1016/S0166-6851(99)00174-7; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Ju DH, 2006, BIOCHEM BIOPH RES CO, V341, P648, DOI 10.1016/j.bbrc.2006.01.013; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kipreos Edward T, 2005, WormBook, P1; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Linares GEG, 2007, CURR MED CHEM, V14, P289; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Picot S, 1997, T ROY SOC TROP MED H, V91, P590, DOI 10.1016/S0035-9203(97)90039-0; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; PRUDHOMME J, PLOS ONE IN PRESS; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Richardson Paul, 2007, Hematology Am Soc Hematol Educ Program, P317; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Srikanth M, 2008, EXPERT OPIN INV DRUG, V17, P1, DOI 10.1517/13543784.17.1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TENG Y, 2007, EMBO REP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOTINO PR, 2007, EXP PARASITOL; Uy GL, 2007, CLIN LYMPHOMA MYELOM, V7, P587, DOI 10.3816/CLM.2007.n.045; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van der Kwast TH, 2006, NAT CLIN PRACT UROL, V3, P130, DOI 10.1038/ncpuro0431; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; *WHO UNICEF, 2005, WORLD MAL REP 2005 S; Wiesner J, 2007, CURR DRUG TARGETS, V8, P3, DOI 10.2174/138945007779315551; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	127	63	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2386	10.1371/journal.pone.0002386	http://dx.doi.org/10.1371/journal.pone.0002386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545708	gold, Green Published, Green Accepted			2022-12-27	WOS:000263248800025
J	Fisher, BL; Smith, MA				Fisher, Brian L.; Smith, M. Alex			A Revision of Malagasy Species of Anochetus Mayr and Odontomachus Latreille (Hymenoptera: Formicidae)	PLOS ONE			English	Article							TAXONOMIC INFLATION; MOLECULAR EVOLUTION; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; CONSERVATION; SYSTEMATICS; DISPERSAL; SEQUENCES; BARCODES; ANTS	Species inventories are essential for documenting global diversity and generating necessary material for taxonomic study and conservation planning. However, for inventories to be immediately relevant, the taxonomic process must reduce the time to describe and identify specimens. To address these concerns for the inventory of arthropods across the Malagasy region, we present here a collaborative approach to taxonomy where collectors, morphologists and DNA barcoders using cytochrome c oxidase 1 (CO1) participate collectively in a team-driven taxonomic process. We evaluate the role of DNA barcoding as a tool to accelerate species identification and description. This revision is primarily based on arthropod surveys throughout the Malagasy region from 1992 to 2006. The revision is based on morphological and CO1 DNA barcode analysis of 500 individuals. In the region, five species of Anochetus (A. boltoni sp. nov., A. goodmani sp. nov., A. grandidieri, and A. madagascarensis from Madagascar, and A. pattersoni sp. nov. from Seychelles) and three species of Odontomachus (O. coquereli, O. troglodytes and O. simillimus) are recognized. DNA barcoding (using cytochrome c oxidase 1 (CO1)) facilitated caste association and type designation, and highlighted population structure associated with reproductive strategy, biogeographic and evolutionary patterns for future exploration This study provides an example of collaborative taxonomy, where morphology is combined with DNA barcoding. We demonstrate that CO1 DNA barcoding is a practical tool that allows formalized alpha-taxonomy at a speed, detail, precision, and scale unattainable by employing morphology alone.	[Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Smith, M. Alex] Univ Guelph, Biodiversity Inst Ontario, Guelph, ON, Canada	California Academy of Sciences; University of Guelph	Fisher, BL (corresponding author), Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA.	bfisher@calacademy.org; salex@uoguelph.ca	Fisher, Brian L./S-9374-2019; Smith, M Alex/B-4468-2013; 赵, 鹏/B-8401-2009	Smith, M Alex/0000-0002-8650-2575; Fisher, Brian/0000-0002-4653-3270	WWF-US [INT 9998672]; National Science Foundation [DEB-0344731]; Fonds quebecois de la recherche sur la nature et les technologies [postdoctoral fellowship]; Gordon and Betty Moore Foundation; Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Innovation Trust; NSERC	WWF-US; National Science Foundation(National Science Foundation (NSF)); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ontario Genomics Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for the research was provided to BLF by WWF-US and National Science Foundation under Grant No. INT 9998672 and DEB-0344731, and a Fonds quebecois de la recherche sur la nature et les technologies B3 postdoctoral fellowship to MAS. Laboratory analyses were graciously supported by grants to P.D.N. Hebert from the Gordon and Betty Moore Foundation, Genome Canada through the Ontario Genomics Institute, the Canada Foundation for Innovation, the Ontario Innovation Trust and NSERC.	ANDRE E, 1887, REV ENTOMOLOGIE CAEN, V6, P280; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BROWN W L JR, 1978, Studia Entomologica, V20, P549; BROWN W L JR, 1976, Studia Entomologica, V19, P67; Caccone A, 2001, EVOLUTION, V55, P122; Colombel P., 1971, Annales Fac Sci Univ fed Cameroun, VNo. 6,1971, P53; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; CRAWLEY WC, 1915, ANN MAG NAT HIST, V15, P232; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Doums C, 2002, MOL ECOL, V11, P2251, DOI 10.1046/j.1365-294X.2002.01619.x; EMERY C, 1898, B SOC ENTOMOLOGICA I, V31, P263; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Forel A., 1918, Bulletin de la Societe Vaudoise, V52; Forel A, 1912, T LINN SOC LOND, V15, P159, DOI DOI 10.1111/J.1096-3642.1912.TB00096.X; FOREL A, 1891, HIST PHYS NATURELLE; FOREL A, 1887, MITTEILUNGEN SCHWEIZ, V7, P381, DOI DOI 10.5962/BHL.PART.4555; Forel A ug., 1913, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V36; Giraud T, 2000, MOL ECOL, V9, P1835, DOI 10.1046/j.1365-294x.2000.01085.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAJIBABAEI M, 2005, PHILOS T ROYAL SOC B; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harris DJ, 2005, TRENDS ECOL EVOL, V20, P6, DOI 10.1016/j.tree.2004.11.004; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lou M, 2007, MOL ECOL NOTES, V7, P908, DOI 10.1111/j.1471-8286.2007.01904.x; Molet M, 2007, INSECT SOC, V54, P183, DOI 10.1007/s00040-007-0930-0; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; Polaszek A, 2005, NATURE, V437, P477, DOI 10.1038/437477a; Polaszek Andrew, 2005, Bulletin of Zoological Nomenclature, V62, P210; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGER J, 1861, BERLINER ENTOMOLOGIS, V5, P1, DOI DOI 10.5281/ZENODO.25617; Ross KG, 1997, GENETICS, V147, P643; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTSCHI F., 1928, REV ZOOL BOT AFRICAINES, V16, P54; SANTSCHI F, 1914, INSECTES HYMENOPTERE, V2, P41; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SMITH F, 1858, CATALOGUE HYMENOPT 6; SMITH F, 1860, J P LINNEAN SOC LOND, V5, P57, DOI DOI 10.1111/J.1096-3642.1860.TB01021.X; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; TAJIMA F, 1989, GENETICS, V123, P585; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P39; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; WILSON EO, 1959, B MUS COMP ZOOL HARV, V120, P483	61	104	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e1787	10.1371/journal.pone.0001787	http://dx.doi.org/10.1371/journal.pone.0001787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509544	Green Published, gold			2022-12-27	WOS:000262268500001
J	Ishak, HD; Dumbacher, JP; Anderson, NL; Keane, JJ; Valkiunas, G; Haig, SM; Tell, LA; Sehgal, RNM				Ishak, Heather D.; Dumbacher, John P.; Anderson, Nancy L.; Keane, John J.; Valkiunas, Gediminas; Haig, Susan M.; Tell, Lisa A.; Sehgal, Ravinder N. M.			Blood Parasites in Owls with Conservation Implications for the Spotted Owl (Strix occidentalis)	PLOS ONE			English	Article							MALARIA PLASMODIUM-RELICTUM; NORTH-AMERICAN BIRDS; HOST IMMUNE DEFENSE; AVIAN MALARIA; REPRODUCTIVE SUCCESS; BARRED OWL; EMBRYONIC-DEVELOPMENT; HAWAII AMAKIHI; NEW-JERSEY; HEMATOZOA	The three subspecies of Spotted Owl (Northern, Strix occidentalis caurina; California, S. o. occidentalis; and Mexican, S. o. lucida) are all threatened by habitat loss and range expansion of the Barred Owl (S. varia). An unaddressed threat is whether Barred Owls could be a source of novel strains of disease such as avian malaria (Plasmodium spp.) or other blood parasites potentially harmful for Spotted Owls. Although Barred Owls commonly harbor Plasmodium infections, these parasites have not been documented in the Spotted Owl. We screened 111 Spotted Owls, 44 Barred Owls, and 387 owls of nine other species for haemosporidian parasites (Leucocytozoon, Plasmodium, and Haemoproteus spp.). California Spotted Owls had the greatest number of simultaneous multi-species infections (44%). Additionally, sequencing results revealed that the Northern and California Spotted Owl subspecies together had the highest number of Leucocytozoon parasite lineages (n = 17) and unique lineages (n = 12). This high level of sequence diversity is significant because only one Leucocytozoon species (L. danilewskyi) has been accepted as valid among all owls, suggesting that L. danilewskyi is a cryptic species. Furthermore, a Plasmodium parasite was documented in a Northern Spotted Owl for the first time. West Coast Barred Owls had a lower prevalence of infection (15%) when compared to sympatric Spotted Owls (S. o. caurina 52%, S. o. occidentalis 79%) and Barred Owls from the historic range (61%). Consequently, Barred Owls on the West Coast may have a competitive advantage over the potentially immune compromised Spotted Owls.	[Ishak, Heather D.; Dumbacher, John P.; Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Dumbacher, John P.] Calif Acad Sci, Dept Ornithol & Mammal, San Francisco, CA USA; [Anderson, Nancy L.] Lindsay Wildlife Museum, Walnut Creek, CA USA; [Keane, John J.] USDA, Forest Serv Pacific SW Res Stn, Sierra Nevada Res Ctr, Davis, CA USA; [Valkiunas, Gediminas] Vilnius Univ, Inst Ecol, Vilnius, Lithuania; [Haig, Susan M.] USGS, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Tell, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA USA	California State University System; San Francisco State University; California Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service; Vilnius University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Ishak, HD (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	heatherishak@gmail.com	SEHGAL, Ravinder/F-9216-2010; Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554; SEHGAL, Ravinder/0000-0002-5255-4641	UC Davis [K12GM00679]; San Francisco State University [K12GM00679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000679] Funding Source: NIH RePORTER	UC Davis; San Francisco State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Ravinder N. M. Sehgal, Heather Ishak, and this research were supported in part by an NIGMS MORE Institutional Research and Academic Career Development Award to UC Davis and San Francisco State University, grant number K12GM00679.	Appleby BM, 1999, FUNCT ECOL, V13, P315, DOI 10.1046/j.1365-2435.1999.00319.x; Atkinson CT, 2001, J WILDLIFE DIS, V37, P20, DOI 10.7589/0090-3558-37.1.20; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Clarabuch Oriol, 1999, Biologia e Conservazione della Fauna, V102, P113; COURTNEY SP, 2004, SCI EVALUATION STATU, P1; Dark SJ, 1998, AUK, V115, P50, DOI 10.2307/4089110; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DASZAK P, 2003, J PARASITOL, V89, pS37; Davidar P, 2006, AUK, V123, P141, DOI 10.1642/0004-8038(2006)123[0141:AMIMSF]2.0.CO;2; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; DEREDEC A, 2001, OECOLOGIA, V126, P193; Deviche P, 2001, J EXP ZOOL, V289, P456, DOI 10.1002/jez.1027; Dulfa R, 1996, J AVIAN BIOL, V27, P83, DOI [10.2307/3676964, DOI 10.2307/3676964]; Durrant KL, 2006, ORNITHOL MONOGR, P98; Dyrcz A, 2005, AUK, V122, P558, DOI 10.1642/0004-8038(2005)122[0558:MRSICW]2.0.CO;2; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; FORRESTER DJ, 1994, J RAPTOR RES, V28, P226; FUNK CW, 2008, P ROY SOC LO B UNPUB; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Gotelli NJ, 2006, ECOSIM NULL MODELS S; GRANT JAMES, 1966, MURRELET, V47, P39, DOI 10.2307/3536439; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; GUTIERREZ RJ, 1989, J WILDLIFE DIS, V25, P614, DOI 10.7589/0090-3558-25.4.614; GUTIERREZ RJ, 2004, SCI EVALUATION STATU, P1; GUTIERREZ RJ, 1995, AM ORNITHOLOGISTS UN; Hakkarainen H, 1998, OECOLOGIA, V114, P574, DOI 10.1007/s004420050482; HART JW, 1949, J PARASITOL, V35, P79, DOI 10.2307/3273390; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; HUME M, 2007, GLOBE MAIL, pA5; Hunter DB, 1997, J WILDLIFE DIS, V33, P486, DOI 10.7589/0090-3558-33.3.486; Kilpatrick AM, 2006, AUK, V123, P764, DOI 10.1642/0004-8038(2006)123[764:EOCAMP]2.0.CO;2; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; KIRKPATRICK CE, 1985, J WILDLIFE DIS, V21, P1, DOI 10.7589/0090-3558-21.1.1; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; KORPIMAKI E, 1993, FUNCT ECOL, V7, P420, DOI 10.2307/2390029; Korpimaki E, 1995, ECOSCIENCE, V2, P335, DOI 10.1080/11956860.1995.11682301; Krone O, 2001, ACTA PROTOZOOL, V40, P281; LAHAYE W, 2004, SCI EVALUATION STATU, P2; Leppert LL, 2004, J WILDLIFE DIS, V40, P316, DOI 10.7589/0090-3558-40.2.316; Levy S, 1999, NAT HIST, V108, P28; Lierz M, 2002, BERL MUNCH TIERARZTL, V115, P43; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; MADDISON D, 2002, MACCLADE 4 03 PPC AN; Malmqvist B, 2004, P ROY SOC B-BIOL SCI, V271, pS152, DOI 10.1098/rsbl.2003.0120; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; MERINO S, 1999, P 22 INT ORN C DURB, P2158; Mikaelian I., 1991, Point Veterinaire, V22, P857; MILTGEN F, 1981, ANN PARASIT HUM COMP, V56, P123; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Monahan William B., 2007, Ornithological Monographs, V63, P55, DOI 10.1642/0078-6594(2007)63[55:DDOIAH]2.0.CO;2; Noon BR, 2002, AUK, V119, P311, DOI 10.1642/0004-8038(2002)119[0311:SRATSO]2.0.CO;2; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; OLSEN GH, 1985, J AM VET MED ASSOC, V187, P1204; Oppliger A, 1998, ECOL LETT, V1, P129; Palinauskas V, 2007, ZOOTAXA, P39, DOI 10.11646/zootaxa.1626.1.3; PEIRCE MA, 1983, AVIAN PATHOL, V12, P443, DOI 10.1080/03079458308436189; PEIRCE MA, 1983, J NAT HIST, V17, P813, DOI 10.1080/00222938300770621; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rappole JH, 2006, EMERG INFECT DIS, V12, P1486, DOI 10.3201/eid1210.051577; Remple JD, 2004, J AVIAN MED SURG, V18, P75, DOI 10.1647/2003-008; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; SACCHI L, 1984, ANN PARASIT HUM COMP, V59, P219, DOI 10.1051/parasite/1984593219; SAKAI H, 2005, PARK SCI, V24, P50; SAKAI H, 2005, PARK SCI, V24, P24; Sanz JJ, 2001, AUK, V118, P750, DOI 10.1642/0004-8038(2001)118[0750:FHIRHS]2.0.CO;2; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Seed, 2001, PARASITISM DIVERSITY; Sehgal RNM, 2006, J PARASITOL, V92, P375, DOI 10.1645/GE-656R.1; Sehgal RNM, 2005, J VET MED SCI, V67, P295, DOI 10.1292/jvms.67.295; Shea K, 2000, ECOL LETT, V3, P150, DOI 10.1046/j.1461-0248.2000.00124.x; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; TAYLOR AL, 1976, CONDOR, V78, P560, DOI 10.2307/1367110; Telford SR, 1997, J PARASITOL, V83, P932, DOI 10.2307/3284292; TELFORD SR, 1992, SYST PARASITOL, V22, P17, DOI 10.1007/BF00009632; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P418, DOI 10.1645/GE-3547RN.1; Valkiunas G, 2001, J PARASITOL, V87, P930, DOI 10.1645/0022-3395(2001)087[0930:ACOTBP]2.0.CO;2; WETMORE PSYCHE W., 1941, JOUR PARASITOL, V27, P379, DOI 10.2307/3272625; WILLIAMS NA, 1978, CAN J ZOOL, V56, P596, DOI 10.1139/z78-086; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102; YEZERINAC SM, 1995, J ANIM ECOL, V64, P528, DOI 10.2307/5655; Ziman M, 2004, J WILDLIFE DIS, V40, P137, DOI 10.7589/0090-3558-40.1.137; 1990, FED REG 6, V55, P123	100	56	58	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2304	10.1371/journal.pone.0002304	http://dx.doi.org/10.1371/journal.pone.0002304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509541	gold, Green Published			2022-12-27	WOS:000262268500039
J	Herrada, EA; Tessone, CJ; Klemm, K; Eguiluz, VM; Hernandez-Garcia, E; Duarte, CM				Herrada, E. Alejandro; Tessone, Claudio J.; Klemm, Konstantin; Eguiluz, Victor M.; Hernandez-Garcia, Emilio; Duarte, Carlos M.			Universal Scaling in the Branching of the Tree of Life	PLOS ONE			English	Article								Understanding the patterns and processes of diversification of life in the planet is a key challenge of science. The Tree of Life represents such diversification processes through the evolutionary relationships among the different taxa, and can be extended down to intra-specific relationships. Here we examine the topological properties of a large set of interspecific and intraspecific phylogenies and show that the branching patterns follow allometric rules conserved across the different levels in the Tree of Life, all significantly departing from those expected from the standard null models. The finding of non-random universal patterns of phylogenetic differentiation suggests that similar evolutionary forces drive diversification across the broad range of scales, from macro-evolutionary to micro-evolutionary processes, shaping the diversity of life on the planet.	[Herrada, E. Alejandro; Tessone, Claudio J.; Eguiluz, Victor M.; Hernandez-Garcia, Emilio] UIB, CSIC, IFISC, Palma de Mallorca, Spain; [Tessone, Claudio J.] Swiss Fed Inst Technol, Zurich, Switzerland; [Klemm, Konstantin] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Duarte, Carlos M.] CSIC UIB, Inst Mediterraneo Estudios Avanzados, IMEDEA, Esporles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Herrada, EA (corresponding author), UIB, CSIC, IFISC, Palma de Mallorca, Spain.	victor@ifisc.uib-csic.es	Hernandez-Garcia, Emilio/B-1271-2008; Klemm, Konstantin/GYU-3511-2022; Duarte, Carlos M/A-7670-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Klemm, Konstantin/L-8426-2018; Eguíluz, Víctor M./B-9655-2008	Hernandez-Garcia, Emilio/0000-0002-9568-8287; Duarte, Carlos M/0000-0002-1213-1361; Eguíluz, Víctor M./0000-0003-1133-1289; Tessone, Claudio J./0000-0001-7733-6221	MEC (Spain); FEDER; FISICOS; CSIC (Spain) [PIE 200750I016]; SBF (Switzerland) [C05.0148]; European Commission through the NEST-Complexity project EDEN	MEC (Spain)(Spanish Government); FEDER(European Commission); FISICOS; CSIC (Spain); SBF (Switzerland); European Commission through the NEST-Complexity project EDEN	We acknowledge financial support from MEC (Spain) and FEDER, project FISICOS, from CSIC (Spain) project PIE 200750I016, from SBF (Switzerland) through project C05.0148 (Physics of Risk), and from the European Commission through the NEST-Complexity project EDEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barthelemy M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/07/L07002; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caldarelli G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.035101; Camacho J, 2005, NATURE, V435, pE3, DOI 10.1038/nature03839; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cracraft J., 2004, ASSEMBLING TREE LIFE; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Erwin DH, 2000, EVOL DEV, V2, P78, DOI 10.1046/j.1525-142x.2000.00045.x; Ford, 2006, THESIS STANFORD U; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Grantham T, 2007, PALAEONTOLOGY, V50, P75, DOI 10.1111/j.1475-4983.2006.00603.x; Harding E., 1971, ADV APPL PROBAB, V3, P44, DOI DOI 10.2307/1426329; HARVEY PH, 1983, ANNU REV ECOL SYST, V14, P189, DOI 10.1146/annurev.es.14.110183.001201; Holman EW, 2005, SYSTEMATIC BIOL, V54, P895, DOI 10.1080/10635150500354696; Klemm K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.128701; Kutschera U, 2004, NATURWISSENSCHAFTEN, V91, P255, DOI 10.1007/s00114-004-0515-y; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; MAKARIEVA AM, 2005, J THEOR BIOL, V291, P1997; MAYR E, 1982, EVOLUTION, V36, P1119, DOI 10.1111/j.1558-5646.1982.tb05483.x; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; Pinelis I, 2003, P ROY SOC B-BIOL SCI, V270, P1425, DOI 10.1098/rspb.2003.2374; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rodriguez-Iturbe I., 1997, FRACTAL RIVER BASINS; Rokas A, 2006, SCIENCE, V313, P1897, DOI 10.1126/science.1134490; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; SIMON HA, 1955, BIOMETRIKA, V42, P425; SIMON HA, 2001, PHYS REV E, V64; Simons AM, 2002, J EVOLUTION BIOL, V15, P688, DOI 10.1046/j.1420-9101.2002.00437.x; Webb JK, 2002, ECOL RES, V17, P59, DOI 10.1046/j.1440-1703.2002.00463.x; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	35	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2757	10.1371/journal.pone.0002757	http://dx.doi.org/10.1371/journal.pone.0002757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648500	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900027
J	Endo, Y; Deonauth, K; Prahalad, P; Hoxter, B; Zhu, YL; Byers, SW				Endo, Yoshimi; Deonauth, Kamla; Prahalad, Priya; Hoxter, Becky; Zhu, Yuelin; Byers, Stephen W.			Role of Sox-9, ER81 and VE-Cadherin in Retinoic Acid-Mediated Trans-Differentiation of Breast Cancer Cells	PLOS ONE			English	Article								Many aspects of development, tumor growth and metastasis depend upon the provision of an adequate vasculature. This can be a result of regulated angiogenesis, recruitment of circulating endothelial progenitors and/or vascular trans-differentiation. The present study demonstrates that treatment of SKBR-3 breast cancer cells with retinoic acid (RA), an important regulator of embryogenesis, cancer and other diseases, stimulates the formation of networks in Matrigel. RA-treatment of SKBR-3 cells co-cultured with human umbilical vein endothelial cells resulted in the formation of mixed structures. RA induces expression of many endothelial genes including vascular endothelial (VE) cadherin. VE-cadherin was also induced by RA in a number of other breast cancer cells. We show that RA-induced VE-cadherin is responsible for the RA-induced morphological changes. RA rapidly induced the expression of Sox-9 and ER81, which in turn form a complex on the VE-cadherin promoter and are required to mediate the transcriptional regulation of VE-cadherin by RA. These data indicate that RA may promote the expression of endothelial genes resulting in endothelial-like differentiation, or provide a mechanism whereby circulating endothelial progenitor cells could be incorporated into a growing organ or tumor.	[Endo, Yoshimi; Deonauth, Kamla; Prahalad, Priya; Hoxter, Becky; Zhu, Yuelin; Byers, Stephen W.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Deonauth, Kamla] Howard Univ, Dept Biol, Washington, DC USA	Georgetown University; Howard University	Endo, Y (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	byerss@georgetown.edu	Zhu, Yuelin/ABD-5743-2021	Zhu, Yuelin/0000-0003-2762-0755	NIH [DK058196, U54CA100971, CA129813]; DOD [W81XWH-08-1-0103]; NATIONAL CANCER INSTITUTE [U54CA100971, R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to acknowledge the support of NIHDK058196, NIHU54CA100971 and NIH CA129813 (SWB), DOD W81XWH-08-1-0103 (PP) and the following LCCC Core Facilities: microscopy, tissue culture, macromolecular analysis and microarray.	Afonja O, 2002, ONCOGENE, V21, P7850, DOI 10.1038/sj.onc.1205985; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Birchmeier C, 1996, ACTA ANAT, V156, P217; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cavallaro U, 2006, EXP CELL RES, V312, P659, DOI 10.1016/j.yexcr.2005.09.019; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2000, BREAST CANCER RES, V2, P417, DOI 10.1186/bcr88; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Labelle M, 2008, CANCER RES, V68, P1388, DOI 10.1158/0008-5472.CAN-07-2706; LANGSTON AW, 1994, CURR OPIN GENET DEV, V4, P550, DOI 10.1016/0959-437X(94)90071-A; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lelievre E, 2001, B CANCER, V88, P137; Lelievre E, 2000, ONCOGENE, V19, P2438, DOI 10.1038/sj.onc.1203563; Liao F, 2000, CANCER RES, V60, P6805; Lionneton F, 2003, ONCOGENE, V22, P9156, DOI 10.1038/sj.onc.1207241; Montero JA, 2002, MECH DEVELOP, V118, P199, DOI 10.1016/S0925-4773(02)00249-6; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Rahkonen O, 2003, HISTOCHEM CELL BIOL, V120, P103, DOI 10.1007/s00418-003-0549-9; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shirakawa K, 2002, BRIT J CANCER, V87, P1454, DOI 10.1038/sj.bjc.6600610; Shirakawa K, 2002, CANCER RES, V62, P560; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu K, 2000, CLIN CANCER RES, V6, P3696; Zanardi S, 2006, ENDOCR-RELAT CANCER, V13, P51, DOI 10.1677/erc.1.00938; N ENGL J MED, V330, P1029	42	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2714	10.1371/journal.pone.0002714	http://dx.doi.org/10.1371/journal.pone.0002714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628953	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200057
J	Hemelrijk, CK; Wantia, J; Isler, K				Hemelrijk, Charlotte K.; Wantia, Jan; Isler, Karin			Female Dominance over Males in Primates: Self-Organisation and Sexual Dimorphism	PLOS ONE			English	Article							BONOBOS PAN-PANISCUS; AGGRESSIVE-BEHAVIOR; JAPANESE MACAQUES; ANIMAL SOCIETIES; SOCIAL-STRUCTURE; MATING SEASON; CAPTIVE GROUP; BODY-WEIGHT; MONKEYS; HIERARCHIES	The processes that underlie the formation of the dominance hierarchy in a group are since long under debate. Models of self-organisation suggest that dominance hierarchies develop by the self-reinforcing effects of winning and losing fights (the so-called winner-loser effect), but according to 'the prior attribute hypothesis', dominance hierarchies develop from pre-existing individual differences, such as in body mass. In the present paper, we investigate the relevance of each of these two theories for the degree of female dominance over males. We investigate this in a correlative study in which we compare female dominance between groups of 22 species throughout the primate order. In our study female dominance may range from 0 (no female dominance) to 1 (complete female dominance). As regards ` the prior attribute hypothesis', we expected a negative correlation between female dominance over males and species-specific sexual dimorphism in body mass. However, to our surprise we found none (we use the method of independent contrasts). Instead, we confirm the self-organisation hypothesis: our model based on the winner-loser effect predicts that female dominance over males increases with the percentage of males in the group. We confirm this pattern at several levels in empirical data (among groups of a single species and between species of the same genus and of different ones). Since the winner-loser effect has been shown to work in many taxa including humans, these results may have broad implications.	[Hemelrijk, Charlotte K.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [Wantia, Jan] Univ Zurich, Dept Informat, Zurich, Switzerland; [Isler, Karin] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland	University of Groningen; University of Zurich; University of Zurich	Hemelrijk, CK (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands.	C.K.Hemelrijk@rug.nl	Hemelrijk, Charlotte K./E-4828-2013; Isler, Karin/A-9566-2008	Hemelrijk, Charlotte K./0000-0001-6160-077X; Isler, Karin/0000-0002-2391-1523	Swiss National Science Foundation [3100-065444, 3100A0-117789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are grateful to the Swiss national Science foundation for partial support to Jan Wantia (grant no. 3100-065444) and Karin (grant no. 3100A0-117789).	Barchas P.R., 1984, SOCIAL HIERARCHIES E, P81; BEACHAM JL, 1988, ANIM BEHAV, V36, P621, DOI 10.1016/S0003-3472(88)80042-3; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; Bernstein I.S., 1983, P535; BERNSTEIN IS, 1985, INT J PRIMATOL, V6, P209; BERNSTEIN IS, 1980, ANIM BEHAV, V28, P1033, DOI 10.1016/S0003-3472(80)80092-3; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; Bout N, 2005, INT J PRIMATOL, V26, P1215, DOI 10.1007/s10764-005-8850-1; Brosnan SF, 2003, ETHOLOGY, V109, P823, DOI 10.1046/j.0179-1613.2003.00928.x; Butovskaya M, 1996, PRIMATES, V37, P261, DOI 10.1007/BF02381858; CALDECOTT JO, 1986, ANIM BEHAV, V34, P208, DOI 10.1016/0003-3472(86)90025-4; Chase ID, 2003, BEHAVIOUR, V140, P1193, DOI 10.1163/156853903771980558; CHASE ID, 1974, BEHAV SCI, V19, P374, DOI 10.1002/bs.3830190604; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; CHASE ID, 1982, SCIENCE, V216, P439, DOI 10.1126/science.216.4544.439; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Cooper MA, 2008, INT J PRIMATOL, V29, P225, DOI 10.1007/s10764-008-9236-y; DIGBY LJ, 1995, PRIMATES, V36, P361, DOI 10.1007/BF02382859; Digby LJ, 2002, PRIMATES, V43, P191, DOI 10.1007/BF02629647; DIJKSTRA PD, 2006, THESIS U GRONINGEN N; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Dugatkin LA, 1998, P ROY SOC B-BIOL SCI, V265, P433, DOI 10.1098/rspb.1998.0313; Dugatkin LA, 2001, BEHAV ECOL, V12, P348, DOI 10.1093/beheco/12.3.348; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; EATON GG, 1984, INT J PRIMATOL, V5, P145, DOI 10.1007/BF02735738; ELLIS L, 1994, SOCIAL STRATIFICATIO, V2, P145; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; ESTRADA A, 1977, Primates, V18, P647, DOI 10.1007/BF02383141; Feistner AT., 1989, THESIS U STIRLING ST; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GIROD P, 2002, SELF ORG EVOLUTION S, P115; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hemelrijk Charlotte K., 2004, Interaction Studies, V5, P131, DOI 10.1075/is.5.1.07hem; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2005, NEUROSCI BIOBEHAV R, V29, P125, DOI 10.1016/j.neubiorev.2004.07.003; Hemelrijk CK, 2005, BEHAVIOUR, V142, P1037, DOI 10.1163/156853905774405290; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1247, DOI 10.1163/156853903771980585; Hemelrijk CK, 2002, BEHAVIOUR, V139, P729, DOI 10.1163/156853902320262790; Hemelrijk CK, 1999, LECT NOTES ARTIF INT, V1674, P524; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; HEMELRIJK CK, 2004, MACAQUE SOC MODEL ST, P295; HEMELRIJK CK, 2002, PRIMATOLOGY ANTHR S1, V1, P91; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; IZAWA K, 1980, Primates, V21, P443, DOI 10.1007/BF02373834; Johnstone RA, 2000, P ROY SOC B-BIOL SCI, V267, P17, DOI 10.1098/rspb.2000.0960; JONES C B, 1980, Primates, V21, P389, DOI 10.1007/BF02390468; Kappeler Peter M., 1993, Perspectives in Ethology, V10, P143; KAPPELER PM, 1991, FOLIA PRIMATOL, V57, P132, DOI 10.1159/000156575; Kappeler PM, 1993, LEMUR SOCIAL SYSTEMS; Magnhagen C, 2006, ANIM BEHAV, V71, P879, DOI 10.1016/j.anbehav.2005.07.017; Marvan R, 2006, FOLIA PRIMATOL, V77, P364, DOI 10.1159/000093702; MASATAKA N, 1987, BEHAVIOUR, V101, P311, DOI 10.1163/156853987X00035; MEDER A, 1985, ZOO BIOL, V4, P1, DOI 10.1002/zoo.1430040102; MEHLMAN PT, 1988, PRIMATES, V29, P195, DOI 10.1007/BF02381122; MENDOZA SP, 1983, J HUM EVOL, V12, P185, DOI 10.1016/S0047-2484(83)80023-2; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Muller MN, 2007, P ROY SOC B-BIOL SCI, V274, P1009, DOI 10.1098/rspb.2006.0206; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; OI T, 1990, INT J PRIMATOL, V11, P339, DOI 10.1007/BF02193005; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Ostner J, 1999, ANIM BEHAV, V58, P1069, DOI 10.1006/anbe.1999.1222; Ostner J, 2003, NATURWISSENSCHAFTEN, V90, P141, DOI 10.1007/s00114-003-0404-9; Overdorff DJ, 2005, AM J PRIMATOL, V66, P7, DOI 10.1002/ajp.20125; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; PARISH AR, 1994, ETHOL SOCIOBIOL, V15, P157, DOI 10.1016/0162-3095(94)90038-8; Parish AR, 2000, ANN NY ACAD SCI, V907, P97; PEREIRA ME, 1990, FOLIA PRIMATOL, V55, P96, DOI 10.1159/000156505; Plavcan JM, 1997, AM J PHYS ANTHROPOL, V103, P37, DOI 10.1002/(SICI)1096-8644(199705)103:1<37::AID-AJPA4>3.0.CO;2-A; POCHRON ST, 2005, AM J PRIMATOL, V61, P173; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RHINE R J, 1972, Primates, V13, P181, DOI 10.1007/BF01840879; RHINE R J, 1972, Primates, V13, P19, DOI 10.1007/BF01757933; RHINE R J, 1973, Primates, V14, P21, DOI 10.1007/BF01730513; Rosenblum L.A., 1971, INFLUENCE HORMONES N, P388; Rowe N, 1996, PICTORIAL GUIDE LIVI; Sade D.S., 1967, P99; SADE DS, 1972, FOLIA PRIMATOL, V18, P196, DOI 10.1159/000155480; SAPOLSKY RM, 1994, AM J PRIMATOL, V32, P261, DOI 10.1002/ajp.1350320404; SAUTHER ML, 1993, LEMUR SOCIAL SYSTEMS; Setchell JM, 2006, AM J PRIMATOL, V68, P411, DOI 10.1002/ajp.20234; Smuts B.B., 1987, P400; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Soltis J, 1999, PRIMATES, V40, P453, DOI 10.1007/BF02557581; Sommer V, 2002, ANIM BEHAV, V63, P637, DOI 10.1006/anbe.2001.1897; Stanford CB, 1998, CURR ANTHROPOL, V39, P399, DOI 10.1086/204757; Sterck EHM, 1997, BEHAVIOUR, V134, P749, DOI 10.1163/156853997X00052; STRUHSAK.TT, 1967, BEHAVIOUR, V29, P83, DOI 10.1163/156853967X00073; THERAULAZ G, 1995, J THEOR BIOL, V174, P313, DOI 10.1006/jtbi.1995.0101; THIERRY B, 1990, J THEOR BIOL, V145, P511, DOI 10.1016/S0022-5193(05)80485-0; THIERRY B, 1990, INT J PRIMATOL, V11, P357, DOI 10.1007/BF02193006; Thierry Bernard, 2000, P106; VARLEY M, 1966, BEHAVIOUR, V27, P54, DOI 10.1163/156853966X00100; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; Verbeek MEM, 1999, BEHAVIOUR, V136, P23, DOI 10.1163/156853999500659; Vervaecke H, 2000, BEHAVIOUR, V137, P1463, DOI 10.1163/156853900502673; Waeber PO, 2003, BEHAVIOUR, V140, P1235, DOI 10.1163/156853903771980576; WANTIA J, 2007, THESIS RIJKS U GRONI; [No title captured]	107	54	54	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2678	10.1371/journal.pone.0002678	http://dx.doi.org/10.1371/journal.pone.0002678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628830	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200023
J	Konrad, R; Ferry, N; Gatehouse, AMR; Babendreier, D				Konrad, Roger; Ferry, Natalie; Gatehouse, Angharad M. R.; Babendreier, Dirk			Potential Effects of Oilseed Rape Expressing Oryzacystatin-1 (OC-1) and of Purified Insecticidal Proteins on Larvae of the Solitary Bee Osmia bicornis	PLOS ONE			English	Article							BT CORN POLLEN; APIS-MELLIFERA; HONEY-BEES; PROTEASE INHIBITORS; SNOWDROP LECTIN; TRANSGENE PRODUCTS; LIGNARIA HYMENOPTERA; LEARNING-ABILITIES; DIGESTIVE ENZYMES; RISK-ASSESSMENT	Despite their importance as pollinators in crops and wild plants, solitary bees have not previously been included in nontarget testing of insect-resistant transgenic crop plants. Larvae of many solitary bees feed almost exclusively on pollen and thus could be highly exposed to transgene products expressed in the pollen. The potential effects of pollen from oilseed rape expressing the cysteine protease inhibitor oryzacystatin-1 (OC-1) were investigated on larvae of the solitary bee Osmia bicornis (= O. rufa). Furthermore, recombinant OC-1 (rOC-1), the Bt toxin Cry1Ab and the snowdrop lectin Galanthus nivalis agglutinin (GNA) were evaluated for effects on the life history parameters of this important pollinator. Pollen provisions from transgenic OC-1 oilseed rape did not affect overall development. Similarly, high doses of rOC-1 and Cry1Ab as well as a low dose of GNA failed to cause any significant effects. However, a high dose of GNA (0.1%) in the larval diet resulted in significantly increased development time and reduced efficiency in conversion of pollen food into larval body weight. Our results suggest that OC-1 and Cry1Ab expressing transgenic crops would pose a negligible risk for O. bicornis larvae, whereas GNA expressing plants could cause detrimental effects, but only if bees were exposed to high levels of the protein. The described bioassay with bee brood is not only suitable for early tier non-target tests of transgenic plants, but also has broader applicability to other crop protection products.	[Konrad, Roger; Babendreier, Dirk] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Ferry, Natalie; Gatehouse, Angharad M. R.] Newcastle Univ, Sch Biol, Inst Res Env & Sustainabil, Newcastle Upon Tyne, Tyne & Wear, England	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Newcastle University - UK	Konrad, R (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	roger.konrad@art.admin.ch		Gatehouse, Angharad/0000-0002-6406-2927; Ferry, Natalie/0000-0003-3728-4302	Swiss Office for the Environment (FOEN)	Swiss Office for the Environment (FOEN)	This research was financially supported by the Swiss Office for the Environment (FOEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1987, AGR BIOL CHEM TOKYO, V51, P2763; Abel CA, 2003, J ENTOMOL SCI, V38, P545, DOI 10.18474/0749-8004-38.4.545; Babendreier D, 2004, APIDOLOGIE, V35, P293, DOI 10.1051/apido:2004016; Babendreier D, 2008, ENTOMOL EXP APPL, V126, P148, DOI 10.1111/j.1570-7458.2007.00652.x; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Bell HA, 2004, AGR FOREST ENTOMOL, V6, P215, DOI 10.1111/j.1461-9555.2004.00225.x; BELZUNCES LP, 1994, COMP BIOCHEM PHYS B, V109, P63, DOI 10.1016/0305-0491(94)90142-2; BONADEBOTTINO M, 1993, DEFENCE COLZA INSECT; Bosch J, 2006, J ECON ENTOMOL, V99, P408, DOI 10.1603/0022-0493-99.2.408; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; BOSCH J, BEE POLLINA IN PRESS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsgaard HF, 2003, APIDOLOGIE, V34, P139, DOI 10.1051/apido:2003003; Burgess EPJ, 1996, J INSECT PHYSIOL, V42, P823, DOI 10.1016/0022-1910(96)00045-5; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Cox D.R., 1990, ANAL SURVIVAL DATA; Down RE, 1996, J INSECT PHYSIOL, V42, P1035, DOI 10.1016/S0022-1910(96)00065-0; Duan JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001415; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2003, MOL ECOL, V12, P493, DOI 10.1046/j.1365-294X.2003.01736.x; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gatehouse AMR, 1997, MOL BREEDING, V3, P49, DOI 10.1023/A:1009600321838; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Girard C, 1998, TRANSGENIC RES, V7, P239, DOI 10.1023/A:1008813910751; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hanley AV, 2003, J APICULT RES, V42, P77, DOI 10.1080/00218839.2003.11101097; HILDER VA, 1995, TRANSGENIC RES, V4, P18, DOI 10.1007/BF01976497; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; HOGERVORST PAM, 2008, AGR ENTOMOL IN PRESS; HOLM S, 1979, SCAND J STAT, V6, P65; JAMES C, 2007, ISAAA BRIEF; JOUANIN L, 2000, RECOMBINANT PROTEASE, P179; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LEACH ML, 1994, J ECON ENTOMOL, V87, P311, DOI 10.1093/jee/87.2.311; Lehrman Anna, 2007, Environmental Biosafety Research, V6, P271, DOI 10.1051/ebr:2007039; MALONE LA, 1995, J ECON ENTOMOL, V88, P46, DOI 10.1093/jee/88.1.46; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; Malone LA, 1998, J INSECT PHYSIOL, V44, P141, DOI 10.1016/S0022-1910(97)00096-6; McGregor S. E., 1976, Agriculture Handbook, United States Department of Agriculture; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; O'Toole Christopher, 1993, P169; Pham-Delegue MH, 2000, ENTOMOL EXP APPL, V95, P21, DOI 10.1023/A:1003923309473; RAW A, 1972, T ROY ENT SOC LONDON, V124, P213; RAW A, 1974, OIKOS, V25, P54, DOI 10.2307/3543545; Romeis J, 2003, OECOLOGIA, V134, P528, DOI 10.1007/s00442-002-1144-9; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Roshchina VV., 1993, EXCRETORY FUNCTION H, DOI [10.1007/978-3-642-78130-8, DOI 10.1007/978-3-642-78130-8]; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sick Martina, 2004, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V14, P423; TASEI JN, 1988, APIDOLOGIE, V19, P291, DOI 10.1051/apido:19880308; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Tesoriero Donato, 2003, Bulletin of Insectology, V56, P169; Thompson HM, 1999, ECOTOXICOLOGY, V8, P147, DOI 10.1023/A:1026444029579; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; Westcott L, 2001, BEE WORLD, V82, P115, DOI 10.1080/0005772X.2001.11099514; Westerkamp C, 2000, CROP SCI, V40, P1209, DOI 10.2135/cropsci2000.4051209x; Westrich P, 1989, WILDBIENEN BADEN WUR; Wilkaniec Z, 2003, J APICULT RES, V42, P29, DOI 10.1080/00218839.2003.11101084; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x	67	33	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2664	10.1371/journal.pone.0002664	http://dx.doi.org/10.1371/journal.pone.0002664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628826	Green Published, Green Accepted, gold			2022-12-27	WOS:000264057200010
J	Long, HH; Schmidt, DD; Baldwin, IT				Long, Hoang Hoa; Schmidt, Dominik D.; Baldwin, Ian T.			Native Bacterial Endophytes Promote Host Growth in a Species-Specific Manner; Phytohormone Manipulations Do Not Result in Common Growth Responses	PLOS ONE			English	Article								Background: All plants in nature harbor a diverse community of endophytic bacteria which can positively affect host plant growth. Changes in plant growth frequently reflect alterations in phytohormone homoeostasis by plant-growth-promoting (PGP) rhizobacteria which can decrease ethylene (ET) levels enzymatically by 1-aminocyclopropane-1-carboxylate (ACC) deaminase or produce indole acetic acid (IAA). Whether these common PGP mechanisms work similarly for different plant species has not been rigorously tested. Methodology/Principal Findings: We isolated bacterial endophytes from field-grown Solanum nigrum; characterized PGP traits (ACC deaminase activity, IAA production, phosphate solubilization and seedling colonization); and determined their effects on their host, S. nigrum, as well as on another Solanaceous native plant, Nicotiana attenuata. In S. nigrum, a majority of isolates that promoted root growth were associated with ACC deaminase activity and IAA production. However, in N. attenuata, IAA but not ACC deaminase activity was associated with root growth. Inoculating N. attenuata and S. nigrum with known PGP bacteria from a culture collection (DSMZ) reinforced the conclusion that the PGP effects are not highly conserved. Conclusions/Significance: We conclude that natural endophytic bacteria with PGP traits do not have general and predictable effects on the growth and fitness of all host plants, although the underlying mechanisms are conserved.	[Long, Hoang Hoa; Schmidt, Dominik D.; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Jena, Germany	Max Planck Society	Long, HH (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society.	ABDULBAK.AA, 1973, CROP SCI, V13, P630, DOI 10.2135/cropsci1973.0011183X001300060013x; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; Bent E, 1998, CAN J MICROBIOL, V44, P980, DOI 10.1139/cjm-44-10-980; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Cakmakci R, 2007, J PLANT NUTR SOIL SC, V170, P288, DOI 10.1002/jpln.200625105; CARROLL GC, 1999, FORAGING ASCOMYCETE, P309; Chanway CP, 1997, FOREST SCI, V43, P99; Chanway CP, 2000, FOREST ECOL MANAG, V133, P81, DOI 10.1016/S0378-1127(99)00300-X; COSTA JM, 1994, MOL PLANT MICROBE IN, V7, P440, DOI 10.1094/MPMI-7-0440; Diallo MD, 2004, SYST APPL MICROBIOL, V27, P238, DOI 10.1078/072320204322881862; Domenech J, 2007, PLANT SOIL, V290, P43, DOI 10.1007/s11104-006-9089-0; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kogel KH, 2006, CURR OPIN PLANT BIOL, V9, P358, DOI 10.1016/j.pbi.2006.05.001; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Long HH, 2003, J FAC AGR KYUSHU U, V48, P21; Madhaiyan M, 2006, PLANTA, V224, P268, DOI 10.1007/s00425-005-0211-y; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Oldroyd GED, 2005, PLANT PHYSIOL, V137, P1205, DOI 10.1104/pp.104.057661; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Prayitno J, 2006, PLANT PHYSIOL, V142, P168, DOI 10.1104/pp.106.080093; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schmidt DD, 2004, MOL ECOL, V13, P981, DOI 10.1111/j.1365-294X.2004.02111.x; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sergeeva E, 2007, PLANT SOIL, V297, P1, DOI 10.1007/s11104-007-9314-5; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Verma SC, 2001, J BIOTECHNOL, V91, P127, DOI 10.1016/S0168-1656(01)00333-9; von Dahl CC, 2007, J PLANT GROWTH REGUL, V26, P201, DOI 10.1007/s00344-007-0014-4; Wakelin SA, 2004, BIOL FERT SOILS, V40, P36, DOI 10.1007/s00374-004-0750-6; Wang K, 2007, NEW PHYTOL, V174, P212, DOI 10.1111/j.1469-8137.2007.01999.x; Wold A, 1996, SEED SCI TECHNOL, V24, P95; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zinniel DK, 2002, APPL ENVIRON MICROB, V68, P2198, DOI 10.1128/AEM.68.5.2198-2208.2002	40	161	171	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2702	10.1371/journal.pone.0002702	http://dx.doi.org/10.1371/journal.pone.0002702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628963	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200045
J	Graham, LA; Lougheed, SC; Ewart, KV; Davies, PL				Graham, Laurie A.; Lougheed, Stephen C.; Ewart, K. Vanya; Davies, Peter L.			Lateral Transfer of a Lectin-Like Antifreeze Protein Gene in Fishes	PLOS ONE			English	Article							EVOLUTION; GENOME; RESISTANCE; ENHANCEMENT; SIMILARITY; ELEMENTS; REVEALS; WATER; DNA	Fishes living in icy seawater are usually protected from freezing by endogenous antifreeze proteins (AFPs) that bind to ice crystals and stop them from growing. The scattered distribution of five highly diverse AFP types across phylogenetically disparate fish species is puzzling. The appearance of radically different AFPs in closely related species has been attributed to the rapid, independent evolution of these proteins in response to natural selection caused by sea level glaciations within the last 20 million years. In at least one instance the same type of simple repetitive AFP has independently originated in two distant species by convergent evolution. But, the isolated occurrence of three very similar type II AFPs in three distantly related species (herring, smelt and sea raven) cannot be explained by this mechanism. These globular, lectin-like AFPs have a unique disulfide-bonding pattern, and share up to 85% identity in their amino acid sequences, with regions of even higher identity in their genes. A thorough search of current databases failed to find a homolog in any other species with greater than 40% amino acid sequence identity. Consistent with this result, genomic Southern blots showed the lectin-like AFP gene was absent from all other fish species tested. The remarkable conservation of both intron and exon sequences, the lack of correlation between evolutionary distance and mutation rate, and the pattern of silent vs non-silent codon changes make it unlikely that the gene for this AFP pre-existed but was lost from most branches of the teleost radiation. We propose instead that lateral gene transfer has resulted in the occurrence of the type II AFPs in herring, smelt and sea raven and allowed these species to survive in an otherwise lethal niche.	[Graham, Laurie A.; Davies, Peter L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Lougheed, Stephen C.; Davies, Peter L.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Ewart, K. Vanya; Davies, Peter L.] NRC Inst Marine Biosci, Halifax, NS, Canada	Queens University - Canada; Queens University - Canada; National Research Council Canada	Graham, LA (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca			Canadian Institutes for Health Research; Natural Sciences and Engineering Research Councils	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Councils	This work was funded by grants to P.L.D. and K.V.E. from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Councils, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Cheng CHC, 2007, PHILOS T R SOC B, V362, P2215, DOI 10.1098/rstb.2006.1946; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Cheng CHC, 1999, NATURE, V401, P443, DOI 10.1038/46721; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Davies PL, 1993, FISH BIOCH MOL BIOL, P279; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; DUNDAS IED, 1986, MAR ECOL PROG SER, V30, P287, DOI 10.3354/meps030287; Ewart K. Vanya, 1993, Molecular Marine Biology and Biotechnology, V2, P20; EWART KV, 1992, BIOCHEM BIOPH RES CO, V185, P335, DOI 10.1016/S0006-291X(05)90005-3; Ewart KV, 1996, J BIOL CHEM, V271, P16627, DOI 10.1074/jbc.271.28.16627; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 2007, J MOL EVOL, V64, P387, DOI 10.1007/s00239-005-0256-3; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; HARTLEY BS, 1965, NATURE, V207, P1157, DOI 10.1038/2071157a0; HOURSTON AS, 1976, J FISH RES BOARD CAN, V33, P1788, DOI 10.1139/f76-226; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kordis D, 1998, P NATL ACAD SCI USA, V95, P10704, DOI 10.1073/pnas.95.18.10704; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Luo HBR, 1999, RNA, V5, P893, DOI 10.1017/S1355838299990520; MADDISON DR, MACCLADE VERSION 4 0; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson J.S., 1984, FISHES WORLD, V2nd, P523; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; NG NFL, 1992, J BIOL CHEM, V267, P16069; NYLANDER JAA, 2006, MRDMODELTEST V2 2 PR; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; Patil JG, 1996, J EXP ZOOL, V274, P121, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;121::AID-JEZ5&gt;3.0.CO;2-R; PEDEN JF, 1999, THESIS U NOTTINGHAM; RAMBAUT A, 2003, TRACER VERSION 1 2 1; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTT GK, 1985, P NATL ACAD SCI USA, V82, P2613, DOI 10.1073/pnas.82.9.2613; SCOTT GK, 1986, CAN J FISH AQUAT SCI, V43, P1028, DOI 10.1139/f86-128; Smith K, 2005, BIOESSAYS, V27, P551, DOI 10.1002/bies.20211; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Venugopal T, 2004, J EXP ZOOL PART A, V301A, P477, DOI 10.1002/jez.a.78; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Yamashita Y, 2003, BIOSCI BIOTECH BIOCH, V67, P461, DOI 10.1271/bbb.67.461; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	61	63	69	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2616	10.1371/journal.pone.0002616	http://dx.doi.org/10.1371/journal.pone.0002616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612417	Green Published, gold			2022-12-27	WOS:000264065800018
J	Hojgaard, B; Gyrd-Hansen, D; Olsen, KR; Sogaard, J; Sorensen, TIA				Hojgaard, Betina; Gyrd-Hansen, Dorte; Olsen, Kim Rose; Sogaard, Jes; Sorensen, Thorkild I. A.			Waist Circumference and Body Mass Index as Predictors of Health Care Costs	PLOS ONE			English	Article								Background: In the present study we analyze the relationship between body mass index (BMI) and waist circumference (WC) and future health care costs. On the basis of the relation between these anthropometric measures and mortality, we hypothesized that for all levels of BMI increased WC implies added future health care costs (Hypothesis 1) and for given levels of WC increased BMI entails reduced future health care costs (Hypothesis 2). We furthermore assessed whether a combination of the two measures predicts health care costs better than either individual measure. Research Methodology/Principal Findings: Data were obtained from the Danish prospective cohort study Diet, Cancer and Health. The population includes 15,334 men and 16,506 women 50 to 64 years old recruited in 1996 to 1997. The relationship between future health care costs and BMI and WC in combination was analyzed by use of categorized and continuous analyses. The analysis confirms Hypothesis 1, reflecting that an increased level of abdominal fat for a given BMI gives higher health care costs. Hypothesis 2, that BMI had a protective effect for a given WC, was only confirmed in the continuous analysis and for a subgroup of women (BMI, 30 kg/m(2) and WC,88 cm). The relative magnitude of the estimates supports that the regressions including WC as an explanatory factor provide the best fit to the data. Conclusion: The study showed that WC for given levels of BMI predicts increased health costs, whereas BMI for given WC did not predict health costs except for a lower cost in non-obese women with normal WC. Combining WC and BMI does not give a better prediction of costs than WC alone.	[Hojgaard, Betina; Gyrd-Hansen, Dorte; Olsen, Kim Rose; Sogaard, Jes] Danish Inst Hlth Serv Res, Copenhagen, Denmark; [Hojgaard, Betina; Gyrd-Hansen, Dorte] Univ So Denmark, Inst Publ Hlth, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen	Hojgaard, B (corresponding author), Danish Inst Hlth Serv Res, Copenhagen, Denmark.	beh@dsi.dk	Olsen, Kim Rose/AAU-5526-2020; Gyrd-Hansen, Dorte/A-3161-2011		Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding for this work was provided by sanofi-aventis. The funders were informed and were invited to comment on the work, but had no role in decision-making about conclusions drawn from the results and the decision about how to publish and where to publish the results. The views expressed are solely those of the authors.	Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Ardern CI, 2004, OBES RES, V12, P1094, DOI 10.1038/oby.2004.137; Ardern CL, 2003, OBES RES, V11, P135, DOI 10.1038/oby.2003.22; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2004, AM J CLIN NUTR, V80, P790; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Cornier MA, 2002, OBES RES, V10, P1167, DOI 10.1038/oby.2002.158; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P2743, DOI 10.1001/jama.292.22.2743; FOLMANN NB, 2007, EC OBESITY, P319; Han TS, 2006, BMJ-BRIT MED J, V333, P695, DOI 10.1136/bmj.333.7570.695; Iwao S, 2001, OBES RES, V9, P685, DOI 10.1038/oby.2001.93; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2006, INT J OBESITY, V30, P1223, DOI 10.1038/sj.ijo.0803287; Janssen I, 2005, PEDIATRICS, V115, P1623, DOI 10.1542/peds.2004-2588; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Johnston J., 1997, ECONOMETRICS METHODS, V4th ed.; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Kuriyama S, 2002, INT J OBESITY, V26, P1069, DOI 10.1038/sj.ijo.0802021; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Pronk NP, 1999, JAMA-J AM MED ASSOC, V282, P2235, DOI 10.1001/jama.282.23.2235; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Seidell J C, 1987, World Rev Nutr Diet, V50, P57; Thompson D, 2001, OBES RES, V9, P210, DOI 10.1038/oby.2001.23; Tjonneland A M, 2000, Ugeskr Laeger, V162, P350; Wee CC, 2005, AM J PUBLIC HEALTH, V95, P159, DOI 10.2105/AJPH.2003.027946; *WHO, WHO TECH REP SER, V894, pR1; Wildman RP, 2005, AM J CLIN NUTR, V82, P1195, DOI 10.1093/ajcn/82.6.1195; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	34	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2619	10.1371/journal.pone.0002619	http://dx.doi.org/10.1371/journal.pone.0002619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612430	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800021
J	Si, XN; Gao, G; Wong, J; Wang, YH; Zhang, JC; Luo, HL				Si, Xiaoning; Gao, Guang; Wong, Jerry; Wang, Yahong; Zhang, Jingchun; Luo, Honglin			Ubiquitination Is Required for Effective Replication of Coxsackievirus B3	PLOS ONE			English	Article								Background: Protein ubiquitination and/or degradation by the ubiquitin/proteasome system (UPS) have been recognized as critical mechanisms in the regulation of numerous essential cellular functions. The importance of the UPS in viral pathogenesis has become increasingly apparent. Using murine cardiomyocytes, we have previously demonstrated that the UPS plays a key role in the replication of coxsackievirus B3 (CVB3), an important human pathogen associated with various diseases. To further elucidate the underlying mechanisms, we examined the interplay between the UPS and CVB3, focusing on the role of ubiquitination in viral lifecycle. Methodology/Principal Findings: As assessed by in situ hybridization, Western blot, and plaque assay, we showed that proteasome inhibition decreased CVB3 RNA replication, protein synthesis, and viral titers in HeLa cells. There were no apparent changes in 20S proteasome activities following CVB3 infection. However, we found viral infection led to an accumulation of protein-ubiquitin conjugates, accompanied by a decreased protein expression of free ubiquitin, implicating an important role of ubiquitination in the UPS-mediated viral replication. Using small-interfering RNA, we demonstrated that gene-silencing of ubiquitin significantly reduced viral titers, possibly through downregulation of protein ubiquitination and subsequent alteration of protein function and/or degradation. Inhibition of deubiquitinating enzymes apparently enhances the inhibitory effects of proteasome inhibitors on CVB3 replication. Finally, by immunoprecipitation, we showed that coxsackieviral polymerase 3D was post-translationally modified by ubiquitination and such modification might be a prerequisite for its function in transcriptional regulation of viral genome. Conclusion: Coxsackievirus infection promotes protein ubiquitination, contributing to effective viral replication, probably through ubiquitin modification of viral polymerase.	[Si, Xiaoning; Gao, Guang; Wong, Jerry; Wang, Yahong; Zhang, Jingchun; Luo, Honglin] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Dept Pathol & Lab Med, Providence Heart Lung Inst,St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada; [Wang, Yahong] Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Cardiol, Chinese Internal Med Lab, Beijing, Peoples R China	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Beijing University of Chinese Medicine	Si, XN (corresponding author), Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Pulm Res, Dept Pathol & Lab Med, Providence Heart Lung Inst,St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada.	hluo@mrl.ubc.ca	Wong, Tse Yuan/G-3029-2011		Canadian Institutes of Health Research (CIHR) [Post-Doctoral Fellowship, Michael Smith Fellowship, New Investigator]; Heart and Stroke Foundation of Canada (HSFC) [Post-Doctoral Fellowship, Research Fellowship, Doctoral Traineeship]; Michael Smith Foundation for Health Research (MSFHR) [Doctoral Traineeship]; St. Paul's Hospital Foundation Award [New Investigator]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); St. Paul's Hospital Foundation Award	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation of Canada (HSFC) (to HL). XS is a recipient of the CIHR/HSFC IMPACT Post-Doctoral Fellowship, CIHR Michael Smith Fellowship and the HSFC Research Fellowship. GG is a recipient of a Doctoral Traineeship from the HSFC and the MSFHR. HL is a New Investigator of the CIHR/St. Paul's Hospital Foundation Award and a Scholar of the Michael Smith Foundation for Health Research (MSFHR).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Cunningham KA, 2003, VIRUS RES, V92, P179, DOI 10.1016/S0168-1702(03)00044-3; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Fan Z, 2006, J MED VIROL, V78, P1365, DOI 10.1002/jmv.20707; Furman MH, 2002, J CLIN INVEST, V110, P875, DOI 10.1172/JCI200216831; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; Kirschner LS, 2000, BIOCHEM BIOPH RES CO, V270, P1106, DOI 10.1006/bbrc.2000.2568; Lawson TG, 1999, J BIOL CHEM, V274, P9871, DOI 10.1074/jbc.274.14.9871; Lawson TG, 2001, J BIOL CHEM, V276, P39629, DOI 10.1074/jbc.M102659200; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Losick VP, 2003, VIROLOGY, V309, P306, DOI 10.1016/S0042-6822(03)00071-0; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; Luo HL, 2003, J VIROL, V77, P1, DOI 10.1128/JVI.77.1.1-9.2003; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Opavsky MA, 2002, J CLIN INVEST, V109, P1561, DOI 10.1172/JCI200213971; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHULENBURG JM, 2000, HEPAC, V1, P2; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shackelford J, 2004, MOL CELL BIOL, V24, P5089, DOI 10.1128/MCB.24.12.5089-5093.2004; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yuan J, 2005, CELL DEATH DIFFER, V12, P1097, DOI 10.1038/sj.cdd.4401652	41	61	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2585	10.1371/journal.pone.0002585	http://dx.doi.org/10.1371/journal.pone.0002585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612413	gold, Green Published			2022-12-27	WOS:000264065800006
J	Takasuka, TE; Cioffi, A; Stein, A				Takasuka, Taichi E.; Cioffi, Alfred; Stein, Arnold			Sequence Information Encoded in DNA that May Influence Long-Range Chromatin Structure Correlates with Human Chromosome Functions	PLOS ONE			English	Article							NUCLEOSOME POSITIONING SIGNALS; ALPHA-SATELLITE DNA; RECOMBINATION RATES; ORGANIZATION; MAP; CENTROMERE; FIBERS; MOUSE; MODEL	Little is known about the possible function of the bulk of the human genome. We have recently shown that long-range regular oscillation in the motif non-T, A/T, G (VWG) existing at ten-nucleotide multiples influences large-scale nucleosome array formation. In this work, we have determined the locations of all 100 kb regions that are predicted to form distinctive chromatin structures throughout each human chromosome (except Y). Using these data, we found that a significantly greater fraction of 300 kb sequences lacked annotated transcripts in genomic DNA regions >= 300 kb that contained nearly continuous chromatin organizing signals than in control regions. We also found a relationship between the meiotic recombination frequency and the presence of strong VWG chromatin organizing signals. Large (>= 300 kb) genomic DNA regions having low average recombination frequency are enriched in chromatin organizing signals. As additional controls, we show using chromosome 1 that the VWG motif signals are not enriched in randomly selected DNA regions having the mean size of the recombination coldspots, and that non-VWG motif sets do not generate signals that are enriched in recombination coldspots. We also show that tandemly repeated alpha satellite DNA contains strong VWG signals for the formation of distinctive nucleosome arrays, consistent with the low recombination activity of centromeres. Our correlations cannot be explained simply by variations in the GC content. Our findings suggest that a specific set of periodic DNA motifs encoded in genomic DNA, which provide signals for chromatin organization, influence human chromosome function.	[Takasuka, Taichi E.; Cioffi, Alfred; Stein, Arnold] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Takasuka, TE (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	steina@purdue.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924				Baldi P, 1996, J MOL BIOL, V263, P503, DOI 10.1006/jmbi.1996.0592; BERNARDI G, 2004, N COMP BIOC, V37, P3; BROWN FL, 1979, J MOL BIOL, V131, P777, DOI 10.1016/0022-2836(79)90201-8; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Cioffi A, 2004, BIOCHEMISTRY-US, V43, P6709, DOI 10.1021/bi049717f; Cioffi A, 2006, NUCLEIC ACIDS RES, V34, P1974, DOI 10.1093/nar/gkl078; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2005, NUCLEIC ACIDS RES, V33, P934, DOI 10.1093/nar/gki224; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; FITTLER F, 1979, NUCLEIC ACIDS RES, V7, P1, DOI 10.1093/nar/7.1.1; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent AM, 2003, HUM MOL GENET, V12, P2229, DOI 10.1093/hmg/ddg220; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pearson H, 2006, NATURE, V444, P259, DOI 10.1038/444259a; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; PRUNELL A, 1982, J MOL BIOL, V154, P515, DOI 10.1016/S0022-2836(82)80010-7; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stein A, 2002, NUCLEIC ACIDS RES, V30, P5103, DOI 10.1093/nar/gkf671; Stein A, 1999, NUCLEIC ACIDS RES, V27, P848, DOI 10.1093/nar/27.3.848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE K, 1995, J BIOL CHEM, V270, P8373, DOI 10.1074/jbc.270.15.8373; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; WARBURTON PE, 1993, MOL CELL BIOL, V13, P6520, DOI 10.1128/MCB.13.10.6520; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; ZHANG XY, 1983, NUCLEIC ACIDS RES, V11, P4287, DOI 10.1093/nar/11.13.4287; ZLATANOVA J, 1994, P NATL ACAD SCI USA, V91, P5277, DOI 10.1073/pnas.91.12.5277	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2643	10.1371/journal.pone.0002643	http://dx.doi.org/10.1371/journal.pone.0002643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612465	Green Published, gold			2022-12-27	WOS:000264065800045
J	Valenzuela, MJ; Sachdev, P; Wen, W; Chen, XH; Brodaty, H				Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua; Brodaty, Henry			Lifespan Mental Activity Predicts Diminished Rate of Hippocampal Atrophy	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; COGNITIVE IMPAIRMENT; BRAIN RESERVE; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; TRANSGENIC MICE; MECHANISMS; DEMENTIA; CREATINE	Objective: Epidemiological studies suggest that complex mental activity may reduce the risk for dementia, however an underlying mechanism remains unclear. Our objective was to determine whether individual differences in lifespan complex mental activity are linked to altered rates of hippocampal atrophy independent of global measures of neurodegeneration. Methods: Thirty seven healthy older individuals had their complex mental activity levels estimated using the Lifetime of Experiences Questionnaire (LEQ) and completed serial MRI investigations at baseline and three years follow-up. Hippocampal volume and semi-automatic quantitation of whole brain volume (WBV) and white matter hyperintensities (WMHs) were compared at both time points. Results: Higher LEQ scores were correlated with hippocampal volume independent of covariates at the three year follow-up stage (r = 0.43, p = 0.012). Moreover, those with higher LEQ scores experienced less hippocampal atrophy over the follow-up period (r = 0.41, p = 0.02). High LEQ individuals had less than half the hippocampal volume decline of low LEQ individuals in a multivariate analysis (F = 4.47, p = 0.042). No parallel changes were found in measures of WBV and WMHs. Conclusions: High level of complex mental activity across the lifespan was correlated with a reduced rate of hippocampal atrophy. This finding could not be explained by general differences in intracranial volume, larger hippocampi at baseline, presence of hypertensive disease, gender or low mood. Our results suggest that neuroprotection in medial temporal lobe may be one mechanism underlying the link between mental activity and lower rates of dementia observed in population-based studies. Additional studies are required to further explore this novel finding.	[Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua; Brodaty, Henry] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Valenzuela, Michael J.; Sachdev, Perminder; Wen, Wei; Chen, Xiaohua] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia; [Brodaty, Henry] Prince Wales Hosp, Aged Care Psychiat, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Primary Dementia Collaborative Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Valenzuela, MJ (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	michaelv@unsw.edu.au	Brodaty, Henry/E-2753-2010; Sachdev, Perminder/ABC-1137-2020	Brodaty, Henry/0000-0001-9487-6617; Sachdev, Perminder/0000-0002-9595-3220; Wen, Wei/0000-0003-2753-3870; Valenzuela, Michael/0000-0001-7162-6607	National Health and Medical Research Council of Australia [350833]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a Program Grant from the National Health and Medical Research Council of Australia (ID# 350833).	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Anstey KJ, 2004, NEUROREPORT, V15, P2825; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brustovetsky N, 2001, J NEUROCHEM, V76, P425, DOI 10.1046/j.1471-4159.2001.00052.x; COYLE J, 2003, NEW ENGL J MED, V348, P25; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; ISAACS KR, 1992, J CEREBR BLOOD F MET, V12, P110, DOI 10.1038/jcbfm.1992.14; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JANOWSKY J, 2005, J NEUROSCI, V25, P5217; Kempermann G, 2006, ADULT NEUROGENESIS; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Trollor JN, 2001, AUST NZ J PSYCHIAT, V35, P788, DOI 10.1046/j.1440-1614.2001.00969.x; VALENZUELA M, 2008, AM J GERIAT IN PRESS; Valenzuela MJ, 2007, BRAIN RES REV, V56, P198, DOI 10.1016/j.brainresrev.2007.07.007; Valenzuela MJ, 2008, CURR OPIN PSYCHIATR, V21, P296, DOI 10.1097/YCO.0b013e3282f97b1f; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Valenzuela MJ, 2003, NEUROREPORT, V14, P1333, DOI 10.1097/01.wnr.0000077548.91466.05; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027	36	161	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2598	10.1371/journal.pone.0002598	http://dx.doi.org/10.1371/journal.pone.0002598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612379	Green Published, gold			2022-12-27	WOS:000264065800011
J	Esposito, I; Born, D; Bergmann, F; Longerich, T; Welsch, T; Giese, NA; Buchler, MW; Kleeff, J; Friess, H; Schirmacher, P				Esposito, Irene; Born, Diana; Bergmann, Frank; Longerich, Thomas; Welsch, Thilo; Giese, Nathalia A.; Buechler, Markus W.; Kleeff, Joerg; Friess, Helmut; Schirmacher, Peter			Autoimmune Pancreatocholangitis, Non-Autoimmune Pancreatitis and Primary Sclerosing Cholangitis: A Comparative Morphological and Immunological Analysis	PLOS ONE			English	Article								Background: Autoimmune pancreatocholangitis ( AIPC) is an emerging, not completely characterized disease. Aim of this study was the comprehensive evaluation of a series of AIPC patients, who were diagnosed and treated in a European institution between January 2003 and July 2006. Methodology/Principal Findings: Thirty-three patients with histologically confirmed AIPC were analyzed and compared to 20 patients with non-autoimmune chronic pancreatitis (CP) and 14 patients with primary sclerosing cholangitis (PSC). Clinical features and conventional histopathology were taken into account. Immunohistochemistry and real-time quantitative PCR were used for the characterization of the inflammatory infiltrate and the stromal reaction. AIPC was localized in the pancreatic head in 94% of the patients. Intra- and/or extrapancreatic biliary tract involvement was present in 64% of the cases. The number of infiltrating T-lymphocytes, macrophages and total plasma cells was significantly higher in AIPC than in CP (3-, 4- and 8-fold increase, respectively). The absolute number of IgG4-positive plasma cells was higher in AIPC than in CP and PSC (7-fold and 35-fold increase, respectively), but significance was only reached in comparison with PSC. CXCR5- and CXCL13-positive cells were almost exclusively detected in AIPC. Conclusions/Significance: AIPC is mainly a disease of the pancreatic head with possible extension into the periphery of the gland and/or into the biliary tract/gallbladder. The morphology of AIPC, as well as the immune- and stromal reaction is characteristic and comparable between cases with and without biliary tract involvement. Immunological markers (IgG4, CXCR5, CXCL13) can be of diagnostic relevance in specific settings.	[Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Esposito, Irene] Helmholtz Zentrum Munchen, Inst Pathol, Oberschleissheim, Germany; [Born, Diana; Bergmann, Frank; Longerich, Thomas; Schirmacher, Peter] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Welsch, Thilo; Giese, Nathalia A.; Buechler, Markus W.] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany; [Kleeff, Joerg; Friess, Helmut] Tech Univ Munich, Dept Surg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technical University of Munich	Esposito, I (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	irene.esposito@helmholtz-muenchen.de	Esposito, Irene/AAQ-2891-2021; Kleeff, Jorg/B-2124-2009	Kleeff, Jorg/0000-0003-3432-6669				Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Aoki S, 2005, HISTOPATHOLOGY, V47, P147, DOI 10.1111/j.1365-2559.2005.02204.x; Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Aust G, 2004, EUR J ENDOCRINOL, V150, P225, DOI 10.1530/eje.0.1500225; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bjornsson E, 2007, HEPATOLOGY, V45, P1547, DOI 10.1002/hep.21685; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Choi EK, 2007, PANCREAS, V35, P158; Church NI, 2007, AM J GASTROENTEROL, V102, P2417, DOI 10.1111/j.1572-0241.2007.01531.x; Deshpande V, 2005, ARCH PATHOL LAB MED, V129, P1148; Deshpande V, 2006, AM J SURG PATHOL, V30, P1537, DOI 10.1097/01.pas.0000213331.09864.2c; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Esposito I, 2001, HUM PATHOL, V32, P1174, DOI 10.1053/hupa.2001.28947; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hamano H, 2006, INTERNAL MED, V45, P883, DOI 10.2169/internalmedicine.45.0162; Kim KP, 2006, WORLD J GASTROENTERO, V12, P2487, DOI 10.3748/wjg.v12.i16.2487; Kleeff J, 2006, CHIRURG, V77, P154, DOI 10.1007/s00104-005-1084-0; Kojima M, 2007, AM J SURG PATHOL, V31, P521, DOI 10.1097/01.pas.0000213390.55536.47; Kwon S, 2007, PANCREAS, V34, P279, DOI 10.1097/MPA.0b013e31802eff5f; LUPARELLO C, 1991, J CELL SCI, V100, P179; Nishimori I, 2005, GUT, V54, P274, DOI 10.1136/gut.2004.049064; Nishino T, 2007, J GASTROENTEROL, V42, P550, DOI 10.1007/s00535-007-2038-8; Okazaki K, 2003, GASTROENTEROLOGY, V125, P1557, DOI 10.1016/j.gastro.2003.09.011; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Pearson RK, 2003, PANCREAS, V27, P1, DOI 10.1097/00006676-200307000-00001; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Uchida K, 2002, LAB INVEST, V82, P411, DOI 10.1038/labinvest.3780435; Van Buuren HR, 2006, SCAND J GASTROENTERO, V41, P70, DOI 10.1080/00365520600664326; Welsch T, 2006, WORLD J GASTROENTERO, V12, P5904, DOI 10.3748/wjg.v12.i36.5904; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zhang L, 2007, MODERN PATHOL, V20, P23, DOI 10.1038/modpathol.3800689	42	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2539	10.1371/journal.pone.0002539	http://dx.doi.org/10.1371/journal.pone.0002539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596913	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200011
J	Hu, J; Barlet, X; Deslandes, L; Hirsch, J; Feng, DX; Somssich, I; Marco, Y				Hu, Jian; Barlet, Xavier; Deslandes, Laurent; Hirsch, Judith; Feng, Dong Xin; Somssich, Imre; Marco, Yves			Transcriptional Responses of Arabidopsis thaliana during Wilt Disease Caused by the Soil-Borne Phytopathogenic Bacterium, Ralstonia solanacearum	PLOS ONE			English	Article							GENE-EXPRESSION; LEAF SENESCENCE; INNATE IMMUNITY; RESISTANCE; VIRULENCE; IDENTIFICATION; EFFECTORS; NETWORKS; REVEALS; MODELS	Bacterial wilt is a common disease that causes severe yield and quality losses in many plants. In the present study, we used the model Ralstonia solanacearum-Arabidopsis thaliana pathosystem to study transcriptional changes associated with wilt disease development. Susceptible Col-5 plants and RRS1-R-containing resistant Nd-1 plants were root-inoculated with R. solanacearum strains harbouring or lacking the matching PopP2 avirulence gene. Gene expression was marginally affected in leaves during the early stages of infection. Major changes in transcript levels took place between 4 and 5 days after pathogen inoculation, at the onset of appearance of wilt symptoms. Up-regulated genes in diseased plants included ABA-, senescence- and basal resistance-associated genes. The influence of the plant genetic background on disease-associated gene expression is weak although some genes appeared to be specifically up-regulated in Nd-1 plants. Inactivation of some disease-associated genes led to alterations in the plant responses to a virulent strain of the pathogen. In contrast to other pathosystems, very little overlap in gene expression was detected between the early phases of the resistance response and the late stages of disease development. This observation may be explained by the fact that above-ground tissues were sampled for profiling whereas the bacteria were applied to root tissues. This exhaustive analysis of Arabidopsis genes whose expression is modulated during bacterial wilt development paves the way for dissecting plant networks activated by recognition of R. solanacearum effectors in susceptible plants.	[Hu, Jian; Barlet, Xavier; Deslandes, Laurent; Marco, Yves] INRA, CNRS, UMR 2594 441, LIPM, Castanet Tolosan, France; [Hu, Jian] China Agr Univ, Coll Biol Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Hirsch, Judith] Campus Int Baillarguet, Interactions Riz parasites, UMR BGPI CIRAD TA A 54K, Montpellier, France; [Feng, Dong Xin] Chinese Acad Agr Sci, Dept Int Cooperat, Beijing, Peoples R China; [Somssich, Imre] Max Planck Inst Zuchtungsforschung, Abteilung Biochem, Cologne, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; China Agricultural University; CIRAD; Chinese Academy of Agricultural Sciences; Max Planck Society	Hu, J (corresponding author), INRA, CNRS, UMR 2594 441, LIPM, Castanet Tolosan, France.	yves.marco@toulouse.inra.fr	Somssich, Imre/GLT-3738-2022; Deslandes, Laurent/N-5752-2017	Somssich, Imre/0000-0003-3066-5794; Barlet, Xavier/0000-0002-9899-6859	Agence Nationale de la Recherche (ANR) [05GPLA 020]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by funding from the Agence Nationale de la Recherche (ANR), Grant ANR 05GPLA 020 (AFINDIS).	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Gentlemen R, 2005, BIOINFORMATICS COMPU; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hirsch J, 2002, PHYTOPATHOLOGY, V92, P1142, DOI 10.1094/PHYTO.2002.92.10.1142; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; LAMB CJ, 1992, BIO-TECHNOL, V10, P1436, DOI 10.1038/nbt1192-1436; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Occhialini A, 2005, MOL PLANT MICROBE IN, V18, P938, DOI 10.1094/MPMI-18-0938; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	45	69	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2589	10.1371/journal.pone.0002589	http://dx.doi.org/10.1371/journal.pone.0002589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596930	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200048
J	Juste, RA; Elguezabal, N; Garrido, JM; Pavon, A; Geijo, MV; Sevilla, I; Cabriada, JL; Tejada, A; Garcia-Campos, F; Casado, R; Ochotorena, I; Izeta, A; Greenstein, RJ				Juste, Ramon A.; Elguezabal, Natalia; Garrido, Joseba M.; Pavon, Andres; Geijo, Maria V.; Sevilla, Iker; Cabriada, Jose-Luis; Tejada, Angel; Garcia-Campos, Francisco; Casado, Roberto; Ochotorena, Itziar; Izeta, Ander; Greenstein, Robert J.			On the Prevalence of M. avium Subspecies paratuberculosis DNA in the Blood of Healthy Individuals and Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article								Background: Mycobacteria, such as M. leprae and M. tuberculosis infect billions of humans. However, because of appropriate immune responses and antibiotic therapy, overt mycobacterial diseases occur far less frequently. M. avium subspecies paratuberculosis ( MAP) causes Johne's disease in ruminants, an affliction evocative of inflammatory bowel disease (IBD). Several agents used to treat IBD (5-ASA, methotrexate, azathioprine and its metabolite 6-MP) have recently been shown to be antiMAP antibiotics. We herein evaluate the prevalence of MAP DNA in healthy individuals and compare them with IBD patients on antiMAP antibiotics. Methods: We studied 100 healthy individuals (90 blood donors) and 246 patients with IBD. IS900 MAP DNA was identified using a nested primer PCR in the buffy coat of blood. Positive signal was confirmed as MAP by DNA sequence analysis. PCR positive results frequencies were compared according to medications used. Significance was accepted at p < 0.05. Results: 47% (47/100) healthy controls and 16% (40/246) IBD patients were IS900 positive (p < 0.0001). MAP DNA was identified in 17% of 143 patients receiving mesalamine and 6% of 16 receiving sulfasalazine. None of the IBD patients receiving methotrexate (n = 9), 6-MP (n = 3), ciprofloxacin (n = 5) or Tacrolimus (R) (n = 3) had MAP DNA detectable in their blood. Discussion: We found a disquietingly large percentage of healthy individuals have MAP DNA in their blood, the significance of which remains to be determined. Counter-intuitively, the incidence of MAP DNA was significantly lower in patients with IBD. Agents with the most potent in vitro antiMAP activity were associated with clearance of blood MAP DNA. We posit that the use antiMAP antibiotics was responsible for the decreased prevalence of MAP DNA in patients with IBD.	[Juste, Ramon A.; Elguezabal, Natalia; Garrido, Joseba M.; Geijo, Maria V.; Sevilla, Iker] Inst Vasco Invest & Desarrollo Agr NEIKER Tecnlia, Dept Prod & Sanidad Anim, Derio, Bizkaia, Spain; [Pavon, Andres; Casado, Roberto; Ochotorena, Itziar; Izeta, Ander] Fdn INBIOMED, San Sebastian, Spain; [Cabriada, Jose-Luis] Hosp Galdakao, Serv Aparato Digestivo, Galdakao, Spain; [Tejada, Angel] Clin Quiron Donostia, Serv Aparato Digestivo, San Sebastian, Spain; [Garcia-Campos, Francisco] Hosp Txagorritxu, Serv Aparato Digestivo, Vitoria, Spain; [Greenstein, Robert J.] VA Med Ctr, Dept Surg, Bronx, NY USA	Galdakao Hospital; University Hospital of Araba	Juste, RA (corresponding author), Inst Vasco Invest & Desarrollo Agr NEIKER Tecnlia, Dept Prod & Sanidad Anim, Derio, Bizkaia, Spain.	rjuste@neiker.net	Izeta, Ander/ABG-8973-2020; Izeta, Ander/H-6376-2011; Juste, Ramon A./C-3570-2008; Geijo, Maria V./K-6717-2014; Elguezabal, Natalia/ABF-8199-2021; Sevilla, Iker A/O-6060-2014; GARRIDO, JOSEBA M/L-3202-2014; Geijo, Maria V./ABC-5808-2021	Izeta, Ander/0000-0003-1879-7401; Juste, Ramon A./0000-0001-6037-5873; Geijo, Maria V./0000-0002-3120-1038; Sevilla, Iker A/0000-0003-3968-3390; Geijo, Maria V./0000-0002-3120-1038; Elguezabal, Natalia/0000-0002-8765-5477; Joseba M., Garrido/0000-0002-7559-0653; Cabriada, Jose Luis/0000-0002-3068-5659	Departamento de Industria, Comercio y Turismo of the Gobierno Vasco [ETORTEK grant]; Marie Curie [MERG-CT-2004-004323]	Departamento de Industria, Comercio y Turismo of the Gobierno Vasco(Basque Government); Marie Curie(European Commission)	This work was supported by an ETORTEK grant from the Departamento de Industria, Comercio y Turismo of the Gobierno Vasco. A.I. was supported by a Marie Curie European Reintegration Grant (MERG-CT-2004-004323) within the 6th European Community RTD Framework Programme. Sponsors have not participated in the design or execution of any part of this manuscript.	[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Ayele WY, 2005, APPL ENVIRON MICROB, V71, P1210, DOI 10.1128/AEM.71.3.1210-1214.2005; BARROW WW, 1993, ANTIMICROB AGENTS CH, V37, P652, DOI 10.1128/AAC.37.4.652; BERARDI RR, 1996, TXB THERAPEUTICS DRU, P483; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; CHIODINI RJ, 1984, J CLIN MICROBIOL, V20, P966, DOI 10.1128/JCM.20.5.966-971.1984; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DALZEIL TK, 1913, BRIT MED J, V2, P1068; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Farinha NJ, 2000, J INFECTION, V41, P61, DOI 10.1053/jinf.2000.0692; Grant IR, 2002, APPL ENVIRON MICROB, V68, P602, DOI 10.1128/AEM.68.2.602-607.2002; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Ivnitski D, 2003, BIOTECHNIQUES, V35, P862, DOI 10.2144/03354ss03; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Lindler LE, 2003, MOL CELL PROBE, V17, P41, DOI 10.1016/S0890-8508(02)00111-1; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; Ramaprasad P, 1997, LEPROSY REV, V68, P301; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; Spencer CM, 1997, DRUGS, V54, P925, DOI 10.2165/00003495-199754060-00009; Stewart-Tull DES., 1982, BIOL MYCOBACTERIA, V1, P273; Svartz N, 1942, ACTA MED SCAND, V110, P577; Zanetti Stefania, 2006, Ann Clin Microbiol Antimicrob, V5, P27, DOI 10.1186/1476-0711-5-27; [No title captured], DOI DOI 10.1002/14651858.CD002244; 2003, WKLY EPIDEMIOL REC, V78, P122	34	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2537	10.1371/journal.pone.0002537	http://dx.doi.org/10.1371/journal.pone.0002537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596984	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200009
J	Sahin, A; Daignan-Fornier, B; Sagot, I				Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle			Polarized Growth in the Absence of F-Actin in Saccharomyces cerevisiae Exiting Quiescence	PLOS ONE			English	Article								Background: Polarity establishment and maintenance are crucial for morphogenesis and development. In budding yeast, these two intricate processes involve the superposition of regulatory loops between polarity landmarks, RHO GTPases, actin-mediated vesicles transport and endocytosis. Deciphering the chronology and the significance of each molecular step of polarized growth is therefore very challenging. Principal Findings: We have taken advantage of the fact that yeast quiescent cells display actin bodies, a non polarized actin structure, to evaluate the role of F-actin in bud emergence. Here we show that upon exit from quiescence, actin cables are not required for the first steps of polarized growth. We further show that polarized growth can occur in the absence of actin patch-mediated endocytosis. We finally establish, using latrunculin-A, that the first steps of polarized growth do not require any F-actin containing structures. Yet, these structures are required for the formation of a bona fide daughter cell and cell cycle completion. We propose that upon exit from quiescence in the absence of F-actin, secretory vesicles randomly reach the plasma membrane but preferentially dock and fuse where polarity cues are localized, this being sufficient to trigger polarized growth.	[Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle] Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Sahin, Annelise; Daignan-Fornier, Bertrand; Sagot, Isabelle] CNRS, UMR5095, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Sahin, A (corresponding author), Univ Bordeaux, Inst Biochim & Genet Cellulaires, Bordeaux, France.	isabelle.sagot@ibgc.u-bordeaux2.fr			Agence Nationale pour la Recherche [JC05_42065]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This worked was supported by a Young Investigator Grant from the Agence Nationale pour la Recherche JC05_42065 to I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Bettinger BT, 2007, GENETICS, V175, P1637, DOI 10.1534/genetics.106.063370; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727; Lew DJ, 2005, CURR BIOL, V15, pR994, DOI 10.1016/j.cub.2005.11.048; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; MADDEN K, 1992, MOL BIOL CELL, V3, P1025, DOI 10.1091/mbc.3.9.1025; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Sagot I, 2006, MOL BIOL CELL, V17, P4645, DOI 10.1091/mbc.E06-04-0282; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Wedlich-Soldner R, 2004, EXP CELL RES, V301, P8, DOI 10.1016/j.yexcr.2004.08.011; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	41	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2556	10.1371/journal.pone.0002556	http://dx.doi.org/10.1371/journal.pone.0002556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596916	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200023
J	Stoel, BC; Borman, TM				Stoel, Berend C.; Borman, Terry M.			A Comparison of Wood Density between Classical Cremonese and Modern Violins	PLOS ONE			English	Article							SPRUCE	Classical violins created by Cremonese masters, such as Antonio Stradivari and Giuseppe Guarneri Del Gesu, have become the benchmark to which the sound of all violins are compared in terms of their abilities of expressiveness and projection. By general consensus, no luthier since that time has been able to replicate the sound quality of these classical instruments. The vibration and sound radiation characteristics of a violin are determined by an instrument's geometry and the material properties of the wood. New test methods allow the non-destructive examination of one of the key material properties, the wood density, at the growth ring level of detail. The densities of five classical and eight modern violins were compared, using computed tomography and specially developed image-processing software. No significant differences were found between the median densities of the modern and the antique violins, however the density difference between wood grains of early and late growth was significantly smaller in the classical Cremonese violins compared with modern violins, in both the top (Spruce) and back (Maple) plates (p = 0.028 and 0.008, respectively). The mean density differential ( SE) of the top plates of the modern and classical violins was 274 (26.6) and 183 (11.7) gram/liter. For the back plates, the values were 128 (2.6) and 115 (2.0) gram/liter. These differences in density differentials may reflect similar changes in stiffness distributions, which could directly impact vibrational efficacy or indirectly modify sound radiation via altered damping characteristics. Either of these mechanisms may help explain the acoustical differences between the classical and modern violins.	[Stoel, Berend C.] Leiden Univ, Med Ctr, Div Image Proc, Dept Radiol, Leiden, Netherlands; [Borman, Terry M.] Borman Violins, Fayetteville, AR USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Stoel, BC (corresponding author), Leiden Univ, Med Ctr, Div Image Proc, Dept Radiol, Leiden, Netherlands.	B.C.Stoel@lumc.nl						BARLOW CY, 1990, J MICROSC-OXFORD, V160, P203, DOI 10.1111/j.1365-2818.1990.tb03058.x; Bucur V., 2006, ACOUSTICS WOOD, V2nd ed., P403; Butterfield BG., 2003, WOOD QUALITY ITS BIO, P30; DIBELLA A, 2002, CAS J, V4, P22; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Gattoni F, 1999, Radiol Med, V97, P170; GIORDANO G, 1971, TECNOLOGIA LEGNO; Haines D., 1979, CATGUT ACOUST SOC NE, V1, P23, DOI DOI 10.13140/2.1.5067.1369; Haines D., 1980, CATGUT ACOUST SOC NE, V33, P19; Koubaa A, 2002, ANN FOREST SCI, V59, P511, DOI 10.1051/forest:2002035; Loen JS, 2005, STRAD, V116, P9; LOEN JS, 2005, THICKNESS GRADUATION; MCINTYRE ME, 1988, ACTA METALL MATER, V36, P1397, DOI 10.1016/0001-6160(88)90209-X; Sacconi S.F, 1979, SECRETS STRADIVARI; Saranpaa P., 2003, WOOD QUALITY ITS BIO, P87; SCHELLING JC, 2007, CAS J, V8, P17; Schleske M, 1998, CATGUT ACOUST SOC J, V3, P27; Schleske M., 2002, CATGUT ACOUST SOC J, V4, P50; Sirr SA, 1997, RADIOLOGY, V203, P801, DOI 10.1148/radiology.203.3.9169708; Skolnick AA, 1997, JAMA-J AM MED ASSOC, V278, P2128, DOI 10.1001/jama.278.24.2128; Stoel BC, 2004, INVEST RADIOL, V39, P681, DOI 10.1097/00004424-200411000-00006; Wegst UGK, 2006, AM J BOT, V93, P1439, DOI 10.3732/ajb.93.10.1439; Wilhelmsson L, 2002, SCAND J FOREST RES, V17, P330, DOI 10.1080/02827580260138080; Zink-Sharp A., 2003, WOOD QUALITY ITS BIO, P197	24	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2554	10.1371/journal.pone.0002554	http://dx.doi.org/10.1371/journal.pone.0002554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596937	Green Published, gold			2022-12-27	WOS:000263288200021
J	Zwick, ME; Kiley, MP; Stewart, AC; Mateczun, A; Read, TD				Zwick, Michael E.; Kiley, Maureen P.; Stewart, Andrew C.; Mateczun, Alfred; Read, Timothy D.			Genotyping of Bacillus cereus Strains by Microarray-Based Resequencing	PLOS ONE			English	Article								The ability to distinguish microbial pathogens from closely related but nonpathogenic strains is key to understanding the population biology of these organisms. In this regard, Bacillus anthracis, the bacterium that causes inhalational anthrax, is of interest because it is closely related and often difficult to distinguish from other members of the B. cereus group that can cause diverse diseases. We employed custom-designed resequencing arrays (RAs) based on the genome sequence of Bacillus anthracis to generate 422 kb of genomic sequence from a panel of 41 Bacillus cereus sensu lato strains. Here we show that RAs represent a "one reaction'' genotyping technology with the ability to discriminate between highly similar B. anthracis isolates and more divergent strains of the B. cereus s.l. Clade 1. Our data show that RAs can be an efficient genotyping technology for pre-screening the genetic diversity of large strain collections to selected the best candidates for whole genome sequencing.	[Zwick, Michael E.; Kiley, Maureen P.; Stewart, Andrew C.; Mateczun, Alfred; Read, Timothy D.] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Zwick, Michael E.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA	United States Department of Defense; United States Navy; Emory University	Zwick, ME (corresponding author), USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA.		Read, Timothy/E-6240-2011	Read, Timothy/0000-0001-8966-9680	Defense Threat Reduction Agency (DTRA) [G.G.004_06_NM_B]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This study was supported by grant G.G.004_06_NM_B from the Defense Threat Reduction Agency (DTRA). The views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Candelon B, 2004, MICROBIOL-SGM, V150, P601, DOI 10.1099/mic.0.26870-0; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Daffonchio D, 2006, APPL ENVIRON MICROB, V72, P1295, DOI 10.1128/AEM.72.2.1295-1301.2006; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Doran M, 2007, BIOINFORMATICS, V23, P487, DOI 10.1093/bioinformatics/btl626; Dutilh BE, 2007, BIOINFORMATICS, V23, P815, DOI 10.1093/bioinformatics/btm015; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Ko KS, 2004, INFECT IMMUN, V72, P5253, DOI 10.1128/IAI.72.9.5253-5261.2004; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOURASSE NJ, 2007, NUCL ACIDS RES; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2513	10.1371/journal.pone.0002513	http://dx.doi.org/10.1371/journal.pone.0002513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596941	Green Published, gold			2022-12-27	WOS:000263288200003
J	Archange, C; Nowak, J; Garcia, S; Moutardier, V; Calvo, EL; Dagorn, JC; Iovanna, JL				Archange, Cendrine; Nowak, Jonathan; Garcia, Stephane; Moutardier, Vincent; Calvo, Ezequiel Luis; Dagorn, Jean-Charles; Iovanna, Juan Lucio			The WSB1 Gene Is Involved in Pancreatic Cancer Progression	PLOS ONE			English	Article								Background: Pancreatic cancer cells generate metastases because they can survive the stress imposed by the new environment of the host tissue. To mimic this process, pancreatic cancer cells which are not stressed in standard culture conditions are injected into nude mice. Because they develop xenografts, they should have developed adequate stress response. Characterizing that response might provide new strategies to interfere with pancreatic cancer metastasis. Methodology/Principal Findings: In the human pancreatic cancer cell lines Panc-1, Mia-PaCa2, Capan-1, Capan-2 and BxPC3, we used Affymetrix DNA microarrays to compare the expressions of 22.000 genes in vitro and in the corresponding xenografts. We identified 228 genes overexpressed in xenografts and characterized the implication of one of them, WSB1, in the control of apoptosis and cell proliferation. WSB1 generates 3 alternatively spliced transcripts encoding distinct protein isoforms. In xenografts and in human pancreatic tumors, global expression of WSB1 mRNA is modestly increased whereas isoform 3 is strongly overexpressed and isoforms 1 and 2 are down-regulated. Treating Mia-PaCa2 cells with stress-inducing agents induced similar changes. Whereas retrovirus-forced expression of WSB1 isoforms 1 and 2 promoted cell growth and sensitized the cells to gemcitabine- and doxorubicin-induced apoptosis, WSB1 isoform 3 expression reduced cell proliferation and enhanced resistance to apoptosis, showing that stress-induced modulation of WSB1 alternative splicing increases resistance to apoptosis of pancreatic cancer cells. Conclusions/Significance: Data on WSB1 regulation support the hypothesis that activation of stress-response mechanisms helps cancer cells establishing metastases and suggest relevance to cancer development of other genes overexpressed in xenografts.	[Archange, Cendrine; Nowak, Jonathan; Garcia, Stephane; Moutardier, Vincent; Dagorn, Jean-Charles; Iovanna, Juan Lucio] INSERM, U624, F-13258 Marseille, France; [Calvo, Ezequiel Luis] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Ste Foy, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Laval University	Archange, C (corresponding author), INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France.	iovanna@marseille.inserm.fr	Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237	INSERM; La Ligue; Canceropole PACA; INCA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue; Canceropole PACA(Region Grand-Est); INCA(Institut National du Cancer (INCA) France)	INSERM, La Ligue, Canceropole PACA, INCA	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Brand R, 2001, CANCER J, V7, P287; Brand RE, 2000, MED CLIN N AM, V84, P665, DOI 10.1016/S0025-7125(05)70249-2; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Ghanima A, 2002, BRAIN RES PROTOC, V9, P1, DOI 10.1016/S1385-299X(01)00123-4; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Postier RG, 2003, AM J SURG, V186, P579, DOI 10.1016/j.amjsurg.2003.08.018; Tamm E, 2001, CANCER J, V7, P298; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; Turpin E, 1999, ONCOGENE, V18, P7834, DOI 10.1038/sj.onc.1203196; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25	17	29	31	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2475	10.1371/journal.pone.0002475	http://dx.doi.org/10.1371/journal.pone.0002475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575577	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000007
J	Greenstein, RJ; Su, LY; Juste, RA; Brown, ST				Greenstein, Robert J.; Su, Liya; Juste, Ramon A.; Brown, Sheldon T.			On the Action of Cyclosporine A, Rapamycin and Tacrolimus on M. avium Including Subspecies paratuberculosis	PLOS ONE			English	Article							CROHNS-DISEASE; MYCOBACTERIUM-PARATUBERCULOSIS; IMMUNOSUPPRESSIVE DRUGS; OPEN-LABEL; PHARMACOKINETICS; METHOTREXATE; MANAGEMENT; AY-22,989; EFFICACY; THERAPY	Background: Mycobacterium avium subspecies paratuberculosis (MAP) may be zoonotic. Recently the "immuno-modulators'' methotrexate, azathioprine and 6-MP and the "anti-inflammatory'' 5-ASA have been shown to inhibit MAP growth in vitro. We concluded that their most plausible mechanism of action is as antiMAP antibiotics. The "immunosuppressants'' Cyclosporine A, Rapamycin and Tacrolimus (FK 506) treat a variety of "autoimmune'' and "inflammatory'' diseases. Rapamycin and Tacrolimus are macrolides. We hypothesized that their mode of action may simply be to inhibit MAP growth. Methodology: The effect on radiometric MAP (CO2)-C-14 growth kinetics of Cyclosporine A, Rapamycin and Tacrolimus on MAP cultured from humans (Dominic & UCF 4) or ruminants (ATCC 19698 & 303) and M. avium subspecies avium (ATCC 25291 & 101) are presented as "percent decrease in cumulative GI'' (%-Delta cGI.) Principal Findings: The positive control clofazimine has 99%-Delta cGI at 0.5 mu g/ml (Dominic). Phthalimide, a negative control has no dose dependent inhibition on any strain. Against MAP there is dose dependent inhibition by the immunosuppressants. Cyclosporine has 97%-Delta cGI by 32 mu g/ml (Dominic), Rapamycin has 74%-Delta cGI by 64 mu g/ml (UCF 4) and Tacrolimus 43%-Delta cGI by 64 mu g/ml (UCF 4) Conclusions: We show heretofore-undescribed inhibition of MAP growth in vitro by "immunosuppressants;'' the cyclic undecapeptide Cyclosporine A, and the macrolides Rapamycin and Tacrolimus. These data are compatible with our thesis that, unknowingly, the medical profession has been treating MAP infections since 1942 when 5-ASA and subsequently azathioprine, 6-MP and methotrexate were introduced in the therapy of some "autoimmune'' and "inflammatory'' diseases.	[Greenstein, Robert J.] Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] Vet Affairs Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] Vet Affairs Med Ctr, Dept Med, Bronx, NY USA; [Juste, Ramon A.] Inst Vasco Investigat Desarrollo Agrario, Derio, Spain	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)	Greenstein, RJ (corresponding author), Vet Affairs Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com	Juste, Ramon/C-3570-2008	Juste, Ramon/0000-0001-6037-5873				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Ayele WY, 2005, APPL ENVIRON MICROB, V71, P1210, DOI 10.1128/AEM.71.3.1210-1214.2005; Balfour IC, 2006, J HEART LUNG TRANSPL, V25, P518, DOI 10.1016/j.healun.2006.01.004; BARROW WW, 1993, ANTIMICROB AGENTS CH, V37, P652, DOI 10.1128/AAC.37.4.652; Baumgart DC, 2006, AM J GASTROENTEROL, V101, P1048, DOI 10.1111/j.1572-0241.2006.00524.x; BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Borody TJ, 2002, DIGEST LIVER DIS, V34, P29, DOI 10.1016/S1590-8658(02)80056-1; Bowman LJ, 2008, EXPERT OPIN PHARMACO, V9, P635, DOI 10.1517/14656566.9.4.635; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; BRYNSKOV J, 1992, SCAND J GASTROENTERO, V27, P961, DOI 10.3109/00365529209000171; BRYNSKOV J, 1991, DIGEST DIS, V9, P236, DOI 10.1159/000171308; Bull TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001229; BUSCHMAN E, 1997, NONSPECIFIC RESISTAN, P51; Caprilli R, 2005, DIGEST LIVER DIS, V37, P407, DOI 10.1016/j.dld.2004.12.013; CARLSON RP, 1993, J PHARMACOL EXP THER, V266, P1125; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; DALZEIL TK, 1913, BRIT MED J, V2, P1068; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; Dasananjali K, 1997, INT J LEPROSY, V65, P28; de Oca J, 2003, REV ESP ENFERM DIG, V95, P465; Ellingson JLE, 2005, J FOOD PROTECT, V68, P966, DOI 10.4315/0362-028X-68.5.966; Flytstrom I, 2008, BRIT J DERMATOL, V158, P116, DOI 10.1111/j.1365-2133.2007.08284.x; Foroncewicz B, 2005, TRANSPL INT, V18, P366, DOI 10.1111/j.1432-2277.2004.00070.x; Grant IR, 2002, APPL ENVIRON MICROB, V68, P602, DOI 10.1128/AEM.68.2.602-607.2002; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P646; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; Hines ME, 2007, VET MICROBIOL, V120, P261, DOI 10.1016/j.vetmic.2006.10.030; Hughes AP, 2000, JAMA-J AM MED ASSOC, V284, P1546, DOI 10.1001/jama.284.12.1546; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; KAY AB, 1994, ALLERGY PROC, V15, P147, DOI 10.2500/108854194778702838; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LINDHOLM A, 1993, CLIN PHARMACOL THER, V54, P205, DOI 10.1038/clpt.1993.132; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; LOBO AJ, 1991, J CLIN GASTROENTEROL, V13, P42, DOI 10.1097/00004836-199102000-00010; Masuda S, 2006, PHARMACOL THERAPEUT, V112, P184, DOI 10.1016/j.pharmthera.2006.04.006; MEINGASSNER JG, 1992, J INVEST DERMATOL, V98, P851, DOI 10.1111/1523-1747.ep12456939; Meng Q, 1997, ALLERGY, V52, P1095, DOI 10.1111/j.1398-9995.1997.tb00181.x; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Murphy GJ, 2003, TRANSPL INT, V16, P347, DOI 10.1111/j.1432-2277.2003.tb00311.x; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Ng SC, 2007, INFLAMM BOWEL DIS, V13, P129, DOI 10.1002/ibd.20052; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okada T, 2007, HEPATO-GASTROENTEROL, V54, P2129; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; Shin SJ, 2008, ANTIMICROB AGENTS CH, V52, P418, DOI 10.1128/AAC.00678-07; SINGH K, 1979, J ANTIBIOT, V32, P630, DOI 10.7164/antibiotics.32.630; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Spencer CM, 1997, DRUGS, V54, P925, DOI 10.2165/00003495-199754060-00009; Sugawara Y, 2002, CLIN TRANSPLANT, V16, P102, DOI 10.1034/j.1399-0012.2002.1o106.x; TAMURA F, 1990, TRANSPLANTATION, V49, P20, DOI 10.1097/00007890-199001000-00005; vanderPijl JW, 1996, TRANSPLANTATION, V62, P456, DOI 10.1097/00007890-199608270-00006; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; WERA S, 1995, FEBS LETT, V358, P158, DOI 10.1016/0014-5793(94)01416-X; Wong SHY, 2001, CLIN CHIM ACTA, V313, P241, DOI 10.1016/S0009-8981(01)00678-7; Yeager N, 2008, CANCER RES, V68, P444, DOI 10.1158/0008-5472.CAN-07-3030; Zhou JY, 2008, VACCINE	68	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2496	10.1371/journal.pone.0002496	http://dx.doi.org/10.1371/journal.pone.0002496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575598	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288000020
J	Park, S; Hwang, H; Nam, SW; Martinez, F; Austin, RH; Ryu, WS				Park, Sungsu; Hwang, Hyejin; Nam, Seong-Won; Martinez, Fernando; Austin, Robert H.; Ryu, William S.			Enhanced Caenorhabditis elegans Locomotion in a Structured Microfluidic Environment	PLOS ONE			English	Article								Background: Behavioral studies of Caenorhabditis elegans traditionally are done on the smooth surface of agar plates, but the natural habitat of C. elegans and other nematodes is the soil, a complex and structured environment. In order to investigate how worms move in such environments, we have developed a technique to study C. elegans locomotion in microstructures fabricated from agar. Methodology/Principal Findings: When placed in open, liquid-filled, microfluidic chambers containing a square array of posts, we discovered that worms are capable of a novel mode of locomotion, which combines the fast gait of swimming with the more efficient movements of crawling. When the wavelength of the worms matched the periodicity of the post array, the microstructure directed the swimming and increased the speed of C. elegans ten-fold. We found that mutants defective in mechanosensation (mec-4, mec-10) or mutants with abnormal waveforms (unc-29) did not perform this enhanced locomotion and moved much more slowly than wild-type worms in the microstructure. Conclusion/Significance: These results show that the microstructure can be used as a behavioral screen for mechanosensory and uncoordinated mutants. It is likely that worms use mechanosensation in the movement and navigation through heterogeneous environments.	[Park, Sungsu; Hwang, Hyejin; Nam, Seong-Won] Ewha Womans Univ, Div Nanosci BK21, Seoul, South Korea; [Martinez, Fernando; Austin, Robert H.] Princeton Univ, Dept Phys, Princeton, NJ USA; [Ryu, William S.] Princeton Univ, Lewis Sigler Inst Integrative Genom, Princeton, NJ USA	Ewha Womans University; Princeton University; Princeton University	Park, S (corresponding author), Ewha Womans Univ, Div Nanosci BK21, Seoul, South Korea.	wsryu@princeton.edu	Park, Sungsu/AAF-4792-2020; Park, Sungsu/L-1920-2013	Park, Sungsu/0000-0003-3062-1302; 	Nano/Bio Science & Technology Program, Ministry of Science and Technology (MOST) [M10536090002-05, N3609-00210]; SRC program of the Korea Science and Engineering Foundation (KOSEF)	Nano/Bio Science & Technology Program, Ministry of Science and Technology (MOST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); SRC program of the Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	Nano/Bio Science & Technology Program (M10536090002-05 N3609-00210) of the Ministry of Science and Technology (MOST) and the SRC program of the Korea Science and Engineering Foundation (KOSEF)	Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1985, J NEUROSCI, V5, P956; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; GRAY J, 1964, J EXP BIOL, V41, P135; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; LOCKERY SR, 2008, J NEUROPHYSIOLOGY; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	17	83	86	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2550	10.1371/journal.pone.0002550	http://dx.doi.org/10.1371/journal.pone.0002550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575618	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000051
J	Bouchez, V; Caro, V; Levillain, E; Guigon, G; Guiso, N				Bouchez, Valerie; Caro, Valerie; Levillain, Erwan; Guigon, Ghislaine; Guiso, Nicole			Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children Vaccination	PLOS ONE			English	Article								Background: The objective of the study was to analyse the evolution of Bordetella pertussis population and the influence of herd immunity in different areas of the world where newborns and infants are highly vaccinated. Methodology: The analysis was performed using DNA microarray on 15 isolates, PCR on 111 isolates as well as GS-FLX sequencing technology on 3 isolates and the B. pertussis reference strain, Tohama I. Principal Findings: Our analyses demonstrate that the current circulating isolates are continuing to lose genetic material as compared to isolates circulating during the pre-vaccine era whatever the area of the world considered. The lost genetic material does not seem to be important for virulence. Our study confirms that the use of whole cell vaccines has led to the control of isolates that were similar to vaccine strains. GS-FLX sequencing technology shows that current isolates did not acquire any additional material when compared with vaccine strains or with isolates of the pre-vaccine era and that the sequenced strain Tohama I is not representative of the isolates. Furthermore, this technology allowed us to observe that the number of Insertion Sequence elements contained in the genome of the isolates is temporally increasing or varying between isolates. Conclusions: B. pertussis adaptation to humans is still in progress by losing genetic material via Insertion Sequence elements. Furthermore, recent isolates did not acquire any additional material when compared with vaccine strains or with isolates of the pre-vaccine era. Herd immunity, following intensive vaccination of infants and children with whole cell vaccines, has controlled isolates similar to the vaccine strains without modifying significantly the virulence of the isolates. With the replacement of whole cell vaccines by subunit vaccines, containing only few bacterial antigens targeting the virulence of the bacterium, one could hypothesize the circulation of isolates expressing less or modified vaccine antigens.	[Bouchez, Valerie; Caro, Valerie; Guiso, Nicole] Inst Pasteur, CNRS, Unite Prevent & Therapie Mol Malad Humaines, URA 3012, Paris, France; [Levillain, Erwan] Inst Pasteur, Lab Etudes Transcriptom Genom Appl, UMR 8161, IFR 142, Lille, France; [Guigon, Ghislaine] Inst Pasteur, Plateforme Sante Publ, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bouchez, V (corresponding author), Inst Pasteur, CNRS, Unite Prevent & Therapie Mol Malad Humaines, URA 3012, Paris, France.	nguiso@pasteur.fr	Bouchez, Valerie/AAG-1021-2020	Bouchez, Valerie/0000-0002-5947-6383	Institut Pasteur Fondation; URA [CNRS3012]; GlaxoSmithKline laboratories; Group Malakoff	Institut Pasteur Fondation; URA; GlaxoSmithKline laboratories(GlaxoSmithKline); Group Malakoff	This work was performed with the financial help of the Institut Pasteur Fondation, URA CNRS3012, GlaxoSmithKline laboratories and the Group Malakoff.	Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Caro V, 2005, MICROBES INFECT, V7, P976, DOI 10.1016/j.micinf.2005.04.005; Caro V, 2007, VACCINE, V25, P4335, DOI 10.1016/j.vaccine.2006.08.024; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Caro V, 2006, EMERG INFECT DIS, V12, P987, DOI 10.3201/eid1206.051283; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; EDWARDS KM, 2004, VACCINES, P471; Gogol EB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-122; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Hallander H, 2007, J CLIN MICROBIOL, V45, P3257, DOI 10.1128/JCM.00864-07; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; KHELEF N, 1993, INFECT IMMUN, V61, P486, DOI 10.1128/IAI.61.2.486-490.1993; Kourova N, 2003, J CLIN MICROBIOL, V41, P3706, DOI 10.1128/JCM.41.8.3706-3711.2003; LAUTROP H, 1971, LANCET, V1, P1195; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; MOOI FR, 2007, BORDETELLA MOL MICRO, P17; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; NJAMKEPO E, 2006, BORDETELLA PERTUSSIS; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Soubeyrand B, 2002, NATURE, V417, P609, DOI 10.1038/417609b; Weber C, 2001, J CLIN MICROBIOL, V39, P4396, DOI 10.1128/JCM.39.12.4396-4403.2001; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07	27	53	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2437	10.1371/journal.pone.0002437	http://dx.doi.org/10.1371/journal.pone.0002437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560590	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700022
J	Djelouadji, Z; Arnold, C; Gharbia, S; Raoult, D; Drancourt, M				Djelouadji, Zoheira; Arnold, Catherine; Gharbia, Saheer; Raoult, Didier; Drancourt, Michel			Multispacer Sequence Typing for Mycobacterium tuberculosis Genotyping	PLOS ONE			English	Article								Background: Genotyping methods developed to survey the transmission dynamics of Mycobacterium tuberculosis currently rely on the interpretation of restriction and amplification profiles. Multispacer sequence typing (MST) genotyping is based on the sequencing of several intergenic regions selected after complete genome sequence analysis. It has been applied to various pathogens, but not to M. tuberculosis. Methods and Findings: In M. tuberculosis, the MST approach yielded eight variable intergenic spacers which included four previously described variable number tandem repeat loci, one single nucleotide polymorphism locus and three newly evaluated spacers. Spacer sequence stability was evaluated by serial subculture. The eight spacers were sequenced in a collection of 101 M. tuberculosis strains from five phylogeographical lineages, and yielded 29 genetic events including 13 tandem repeat number variations (44.82%), 11 single nucleotide mutations (37.93%) and 5 deletions (17.24%). These 29 genetic events yielded 32 spacer alleles or spacer-types (ST) with an index of discrimination of 0.95. The distribution of M. tuberculosis isolates into ST profiles correlated with their assignment into phylogeographical lineages. Blind comparison of a further 93 M. tuberculosis strains by MST and restriction fragment length polymorphism-IS6110 fingerprinting and mycobacterial interspersed repetitive units typing, yielded an index of discrimination of 0.961 and 0.992, respectively. MST yielded 41 different profiles delineating 16 related groups and proved to be more discriminatory than IS6110-based typing for isolates containing M<8 IS6110 copies (P<0.0003). MST was successfully applied to 7/10 clinical specimens exhibiting a Cts <= 42 cycles in internal transcribed spacer-real time PCR. Conclusions: These results support MST as an alternative, sequencing-based method for genotyping low IS6110 copy-number M. tuberculosis strains. The M. tuberculosis MST database is freely available (http://ifr48.timone.univ-mrs.fr/MST_MTuberculosis/mst).	[Djelouadji, Zoheira; Raoult, Didier; Drancourt, Michel] Univ Mediterranee, Fac Med, CNRS, IFR 48,Unite Rickettsies UMR6236, Marseille, France; [Arnold, Catherine; Gharbia, Saheer] Hlth Protect Agcy, Ctr Infect, Appl & Funct Genom Unit, London, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Health Protection Agency	Djelouadji, Z (corresponding author), Univ Mediterranee, Fac Med, CNRS, IFR 48,Unite Rickettsies UMR6236, Marseille, France.	Michel.Drancourt@medecine.univ-mrs.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille	l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille	This work was supported by l'Oeuvre Antituberculeuse des Bouches-du-Rhone, Marseille.	Arnold C, 2006, FEMS MICROBIOL LETT, V256, P340, DOI 10.1111/j.1574-6968.2006.00142.x; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Barlow REL, 2001, J CLIN MICROBIOL, V39, P2453, DOI 10.1128/JCM.39.7.2453-2457.2001; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Benson G, 1999, Proc Int Conf Intell Syst Mol Biol, P44; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Braden CR, 2002, EMERG INFECT DIS, V8, P1210; BRANDER E, 1992, J CLIN MICROBIOL, V30, P1972, DOI 10.1128/JCM.30.8.1972-1975.1992; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P1140, DOI 10.1164/ajrccm.155.3.9117000; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowan LS, 2002, J CLIN MICROBIOL, V40, P1592, DOI 10.1128/JCM.40.5.1592-1602.2002; de la Salmoniere YOLG, 2004, J CLIN MICROBIOL, V42, P2913, DOI 10.1128/JCM.42.7.2913-2918.2004; DJELOUADJI Z, 2008, PLOS NTD IN PRESS; Djelouagji Z, 2006, J CLIN MICROBIOL, V44, P1594, DOI 10.1128/JCM.44.4.1594-1595.2006; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Evans JT, 2004, J CLIN MICROBIOL, V42, P4175, DOI 10.1128/JCM.42.9.4175-4180.2004; Ferdinand S, 2004, RES MICROBIOL, V155, P647, DOI 10.1016/j.resmic.2004.04.013; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Foucault C, 2005, J CLIN MICROBIOL, V43, P41, DOI 10.1128/JCM.43.1.41-48.2005; Fournier PE, 2004, J CLIN MICROBIOL, V42, P5757, DOI 10.1128/JCM.42.12.5757-5766.2004; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Gutacker MM, 2002, GENETICS, V162, P1533; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kanduma E, 2003, J APPL MICROBIOL, V94, P781, DOI 10.1046/j.1365-2672.2003.01918.x; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Radhakrishnan I, 2001, J CLIN MICROBIOL, V39, P1683, DOI 10.1128/JCM.39.4.1683.2001; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Sebban M, 2002, BIOINFORMATICS, V18, P235, DOI 10.1093/bioinformatics/18.2.235; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; van Coppenraet ESB, 2004, J CLIN MICROBIOL, V42, P2644, DOI 10.1128/JCM.42.6.2644-2650.2004; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; VANSOOLINGEN D, 1993, J CLIN MICROBIOL, V31, P1987, DOI 10.1128/JCM.31.8.1987-1995.1993; VARNEROT A, 1992, FEMS MICROBIOL LETT, V98, P155; ZHANG YS, 1992, J CLIN MICROBIOL, V30, P1551, DOI 10.1128/JCM.30.6.1551-1556.1992; Zhu Y, 2005, J CLIN MICROBIOL, V43, P4708, DOI 10.1128/JCM.43.9.4708-4712.2005	51	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2433	10.1371/journal.pone.0002433	http://dx.doi.org/10.1371/journal.pone.0002433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560597	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700018
J	Kami, D; Shiojima, I; Makino, H; Matsumoto, K; Takahashi, Y; Ishii, R; Naito, AT; Toyoda, M; Saito, H; Watanabe, M; Komuro, I; Umezawa, A				Kami, Daisuke; Shiojima, Ichiro; Makino, Hatsune; Matsumoto, Kenji; Takahashi, Yoriko; Ishii, Ryuga; Naito, Atsuhiko T.; Toyoda, Masashi; Saito, Hirohisa; Watanabe, Masatoshi; Komuro, Issei; Umezawa, Akihiro			Gremlin Enhances the Determined Path to Cardiomyogenesis	PLOS ONE			English	Article								Background: The critical event in heart formation is commitment of mesodermal cells to a cardiomyogenic fate, and cardiac fate determination is regulated by a series of cytokines. Bone morphogenetic proteins (BMPs) and fibroblast growth factors have been shown to be involved in this process, however additional factors needs to be identified for the fate determination, especially at the early stage of cardiomyogenic development. Methodology/Principal Findings: Global gene expression analysis using a series of human cells with a cardiomyogenic potential suggested Gremlin (Grem1) is a candidate gene responsible for in vitro cardiomyogenic differentiation. Grem1, a known BMP antagonist, enhanced DMSO-induced cardiomyogenesis of P19CL6 embryonal carcinoma cells (CL6 cells) 10-35 fold in an area of beating differentiated cardiomyocytes. The Grem1 action was most effective at the early differentiation stage when CL6 cells were destined to cardiomyogenesis, and was mediated through inhibition of BMP2. Furthermore, BMP2 inhibited Wnt/beta-catenin signaling that promoted CL6 cardiomyogenesis. Conclusions/Significance: Grem1 enhances the determined path to cardiomyogenesis in a stage-specific manner, and inhibition of the BMP signaling pathway is involved in initial determination of Grem1-promoted cardiomyogenesis. Our results shed new light on renewal of the cardiovascular system using Grem1 in human.	[Kami, Daisuke; Makino, Hatsune; Takahashi, Yoriko; Ishii, Ryuga; Toyoda, Masashi; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Matsumoto, Kenji; Saito, Hirohisa] Natl Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Kami, Daisuke; Watanabe, Masatoshi] Yokohama Natl Univ, Grad Sch Engn, Div Mat Sci & Chem Engn, Lab Med Engn, Yokohama, Kanagawa, Japan; [Shiojima, Ichiro; Naito, Atsuhiko T.; Komuro, Issei] Chiba Univ, Grad Scht Med, Dept Cardiovasc Sci & Med, Chiba, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Yokohama National University; Chiba University	Kami, D (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Kami, Daisuke/0000-0002-9862-5513; Watanabe, Masatoshi/0000-0002-9423-0901; Saito, Hirohisa/0000-0002-6630-8337	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Health and Labor Sciences; Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation; Ministry of Health, Labor and Welfare (MHLW)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences; Japan Health Science Foundation; Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; Terumo Life Science Foundation(Terumo Life Science Foundation); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Health and Labor Sciences Research Grants; by a Research grant on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation; by the Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a grant from the Terumo Life Science Foundation; by a Research Grant for Cardiovascular Disease from the Ministry of Health, Labor and Welfare (MHLW); and by a Grant for Child Health and Development from the MHLW.	Alsan BH, 2002, DEVELOPMENT, V129, P1935; Andree B, 1998, MECH DEVELOP, V70, P119, DOI 10.1016/S0925-4773(97)00186-X; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Ariizumi T, 2003, INT J DEV BIOL, V47, P405; Chien KR, 2004, SCIENCE, V306, P239, DOI 10.1126/science.1104769; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olson EN, 2001, SCIENCE, V291, P2327, DOI 10.1126/science.1060063; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Reifers F, 2000, DEVELOPMENT, V127, P225; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; SINGH JP, 1983, J CELL BIOL, V96, P1497, DOI 10.1083/jcb.96.5.1497; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Terami H, 2004, BIOCHEM BIOPH RES CO, V325, P968, DOI 10.1016/j.bbrc.2004.10.103; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	37	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2407	10.1371/journal.pone.0002407	http://dx.doi.org/10.1371/journal.pone.0002407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545679	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800045
J	Zhang, JX; Addepalli, B; Yun, KY; Hunt, AG; Xu, RQ; Rao, S; Li, QQ; Falcone, DL				Zhang, Jingxian; Addepalli, Balasubramanyam; Yun, Kil-Young; Hunt, Arthur G.; Xu, Ruqiang; Rao, Suryadevara; Li, Qingshun Q.; Falcone, Deane L.			A Polyadenylation Factor Subunit Implicated in Regulating Oxidative Signaling in Arabidopsis thaliana	PLOS ONE			English	Article								Background: Plants respond to many unfavorable environmental conditions via signaling mediated by altered levels of various reactive oxygen species (ROS). To gain additional insight into oxidative signaling responses, Arabidopsis mutants that exhibited tolerance to oxidative stress were isolated. We describe herein the isolation and characterization of one such mutant, oxt6. Methodology/Principal Findings: The oxt6 mutation is due to the disruption of a complex gene (At1g30460) that encodes the Arabidopsis ortholog of the 30-kD subunit of the cleavage and polyadenylation specificity factor (CPSF30) as well as a larger, related 65-kD protein. Expression of mRNAs encoding Arabidopsis CPSF30 alone was able to restore wild-type growth and stress susceptibility to the oxt6 mutant. Transcriptional profiling and single gene expression studies show elevated constitutive expression of a subset of genes that encode proteins containing thioredoxin- and glutaredoxin-related domains in the oxt6 mutant, suggesting that stress can be ameliorated by these gene classes. Bulk poly(A) tail length was not seemingly affected in the oxt6 mutant, but poly(A) site selection was different, indicating a subtle effect on polyadenylation in the mutant. Conclusions/Significance: These results implicate the Arabidopsis CPSF30 protein in the posttranscriptional control of the responses of plants to stress, and in particular to the expression of a set of genes that suffices to confer tolerance to oxidative stress.	[Zhang, Jingxian; Yun, Kil-Young; Falcone, Deane L.] Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY USA; [Addepalli, Balasubramanyam; Hunt, Arthur G.; Rao, Suryadevara; Falcone, Deane L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Xu, Ruqiang; Li, Qingshun Q.] Miami Univ, Dept Bot, Oxford, OH USA; [Yun, Kil-Young; Falcone, Deane L.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA	University of Kentucky; University of Kentucky; University System of Ohio; Miami University; University of Massachusetts System; University of Massachusetts Lowell	Zhang, JX (corresponding author), Univ Kentucky, Kentucky Tobacco Res & Dev Ctr, Lexington, KY USA.	aghunt00@uky.edu; Deane_Falcone@uml.edu	Xu, Ruqiang/GWQ-6267-2022; Hunt, Arthur/A-8040-2009; Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022; Li, Qingshun/C-5603-2009	Xu, Ruqiang/0000-0002-8966-2670; Li, Qingshun/0000-0003-4105-1480; Addepalli, Balasubrahmanyam/0000-0001-6257-7700; Hunt, Arthur/0000-0002-0008-4158	USDA NRI [2001-00911, 2005-05161]; NSF [MCB-0313472]; Kentucky Tobacco Research and Development Center; Center for Bioinformatics and Functional Genomics, Miami University	USDA NRI(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Kentucky Tobacco Research and Development Center; Center for Bioinformatics and Functional Genomics, Miami University	This work was supported by USDA NRI grants 2001-00911 and 2005-05161 (DLF), NSF grant MCB-0313472 (AGH and QQL), and the Kentucky Tobacco Research and Development Center (DLF). RX was partially supported by a postdoctoral fund from the Center for Bioinformatics and Functional Genomics, Miami University.	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Anthony RG, 2006, J BIOL CHEM, V281, P37536, DOI 10.1074/jbc.M607341200; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Clayton H, 1999, PLANT J, V17, P575, DOI 10.1046/j.1365-313X.1999.00411.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Dong CH, 2006, MOL CELL BIOL, V26, P9533, DOI 10.1128/MCB.01063-06; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Evans NH, 2005, PLANT J, V41, P615, DOI 10.1111/j.1365-313X.2004.02325.x; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Jin YF, 2004, RNA, V10, P1695, DOI 10.1261/rna.7610404; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Levine A., 1999, PLANT RESPONSES ENV, P247, DOI 10.1201/9780203743157-11; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; MAY MJ, 1993, PLANT PHYSIOL, V103, P621, DOI 10.1104/pp.103.2.621; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2001, REDOX REP, V6, P69, DOI 10.1179/135100001101536067; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Ok SH, 2005, PLANT PHYSIOL, V139, P138, DOI 10.1104/pp.105.065649; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; RENNENBERG H, 1994, BIOCHEM SOC T, V22, P936, DOI 10.1042/bst0220936; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Tacahashi Y, 2003, NUCLEIC ACIDS RES, V31, P1744, DOI 10.1093/nar/gkg265; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Xu RQ, 2004, GENE, V324, P35, DOI 10.1016/j.gene.2003.09.025; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899	51	71	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2410	10.1371/journal.pone.0002410	http://dx.doi.org/10.1371/journal.pone.0002410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545667	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800047
J	Ntsekhe, M; Wiysonge, CS; Gumedze, F; Maartens, G; Commerford, PJ; Volmink, JA; Mayosi, BM				Ntsekhe, Mpiko; Wiysonge, Charles S.; Gumedze, Freedom; Maartens, Gary; Commerford, Patrick J.; Volmink, Jimmy A.; Mayosi, Bongani M.			HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study	PLOS ONE			English	Article								Background: Pericardial constriction is a serious complication of tuberculous pericardial effusion that occurs in up to a quarter of patients despite anti-tuberculosis chemotherapy. The impact of human immunodeficiency virus (HIV) infection on the incidence of constrictive pericarditis following tuberculous pericardial effusion is unknown. Methods and Results: We conducted a prospective observational study to determine the association between HIV infection and the incidence of constrictive pericarditis among 185 patients ( median age 33 years) with suspected tuberculous pericardial effusion. These patients were recruited consecutively between March and October 2004 on commencement of anti-tuberculosis treatment, from 15 hospitals in Cameroon, Nigeria and South Africa. Surviving patients (N=119) were assessed for clinical evidence of constrictive pericarditis at 3 and 6 months of follow-up. Clinical features of HIV infection were present in 42 (35.2%) of the 119 patients at enrolment into the study. 66 of the 119 (56.9%) patients consented to HIV testing at enrolment. During the 6 months of follow-up, a clinical diagnosis of constrictive pericarditis was made in 13 of the 119 patients (10.9%, 95% confidence interval [CI] 5.9-18%). Patients with clinical features of HIV infection appear less likely to develop constriction than those without (4.8% versus 14.3%; P=0.08). None of the 33 HIV seropositive patients developed constriction, but 8 (24.2%, 95% CI 11.1-42.3%) of the 33 HIV seronegative patients did (P=0.005). In a multivariate logistic regression model adjusting simultaneously for several baseline characteristics, only clinical signs of HIV infection were significantly associated with a lower risk of constriction (odd ratio 0.14, 95% CI 0.02-0.87, P=0.035). Conclusions: These data suggest that HIV infection is associated with a lower incidence of pericardial constriction in patients with presumed tuberculous pericarditis.	[Ntsekhe, Mpiko; Maartens, Gary; Commerford, Patrick J.; Mayosi, Bongani M.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Wiysonge, Charles S.; Volmink, Jimmy A.] S African Cochrane Ctr, Med Res Council, Cape Town, South Africa; [Gumedze, Freedom] Univ Cape Town, Dept Stat Sci, Cape Town, South Africa; [Volmink, Jimmy A.] Univ Stellenbosch, Fac Hlth Sci, Tygerberg, South Africa	University of Cape Town; South African Medical Research Council; University of Cape Town; Stellenbosch University	Ntsekhe, M (corresponding author), Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa.	bongani.mayosi@uct.ac.za	Maartens, Gary/S-2788-2019; Wiysonge, Charles Shey U/A-3843-2008; Maartens, Gary/F-3836-2014; ntsekhe, mpiko/AAI-8001-2021	Maartens, Gary/0000-0003-3080-6606; Wiysonge, Charles Shey U/0000-0002-1273-4779; Maartens, Gary/0000-0003-3080-6606; ntsekhe, mpiko/0000-0002-0851-7675; Mayosi, Bongani/0000-0001-6641-8950; Gumedze, Freedom N/0000-0003-4387-8844	University of Cape Town; Medical Scholarships for South African Blacks (MESAB); Medical Research Council of South Africa; National Research Foundation of South Africa	University of Cape Town; Medical Scholarships for South African Blacks (MESAB); Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was funded, in part, through research grants from the University of Cape Town, the Medical Scholarships for South African Blacks (MESAB), the Medical Research Council of South Africa, the National Research Foundation of South Africa. The funding sources had no role in the collection, analysis, interpretation, preparation, review or approval of the manuscript.	COLEBUNDERS R, 1987, LANCET, V1, P492; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Hakim JG, 2000, HEART, V84, P183, DOI 10.1136/heart.84.2.183; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Reuter H, 2006, HISTOPATHOLOGY, V48, P295, DOI 10.1111/j.1365-2559.2005.02320.x; SAGRISTASAULEDA J, 1988, J AM COLL CARDIOL, V11, P724, DOI 10.1016/0735-1097(88)90203-3; SCHRIRE V., 1959, S AFRICAN MED JOUR, V33, P810; STRANG JIG, 1984, CLIN CARDIOL, V7, P667, DOI 10.1002/clc.4960071208; STRANG JIG, 1988, LANCET, V2, P759; Wiysonge CS, 2008, INT J CARDIOL, V124, P388, DOI 10.1016/j.ijcard.2006.12.060; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Zumla A, 2000, POSTGRAD MED J, V76, P259, DOI 10.1136/pmj.76.895.259	15	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2253	10.1371/journal.pone.0002253	http://dx.doi.org/10.1371/journal.pone.0002253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523576	gold, Green Published			2022-12-27	WOS:000262614300002
J	Saint-Georges, Y; Garcia, M; Delaveau, T; Jourdren, L; Le Crom, S; Lemoine, S; Tanty, V; Devaux, F; Jacq, C				Saint-Georges, Yann; Garcia, Mathilde; Delaveau, Thierry; Jourdren, Laurent; Le Crom, Stephane; Lemoine, Sophie; Tanty, Veronique; Devaux, Frederic; Jacq, Claude			Yeast Mitochondrial Biogenesis: A Role for the PUF RNA-Binding Protein Puf3p in mRNA Localization	PLOS ONE			English	Article								The asymmetric localization of mRNA plays an important role in coordinating posttranscriptional events in eukaryotic cells. We investigated the peripheral mitochondrial localization of nuclear-encoded mRNAs (MLR) in various conditions in which the mRNA binding protein context and the translation efficiency were altered. We identified Puf3p, a Pumilio family RNA-binding protein, as the first trans-acting factor controlling the MLR phenomenon. This allowed the characterization of two classes of genes whose mRNAs are translated to the vicinity of mitochondria. Class I mRNAs (256 genes) have a Puf3p binding motif in their 3'UTR region and many of them have their MLR properties deeply affected by PUF3 deletion. Conversely, mutations in the Puf3p binding motif alter the mitochondrial localization of BCS1 mRNA. Class II mRNAs (224 genes) have no Puf3p binding site and their asymmetric localization is not affected by the absence of PUF3. In agreement with a co-translational import process, we observed that the presence of puromycin loosens the interactions between most of the MLR-mRNAs and mitochondria. Unexpectedly, cycloheximide, supposed to solidify translational complexes, turned out to destabilize a class of mRNA-mitochondria interactions. Classes I and II mRNAs, which are therefore transported to the mitochondria through different pathways, correlated with different functional modules. Indeed, Class I genes code principally for the assembly factors of respiratory chain complexes and the mitochondrial translation machinery (ribosomes and translation regulators). Class II genes encode proteins of the respiratory chain or proteins involved in metabolic pathways. Thus, MLR, which is intimately linked to translation control, and the activity of mRNA-binding proteins like Puf3p, may provide the conditions for a fine spatiotemporal control of mitochondrial protein import and mitochondrial protein complex assembly. This work therefore provides new openings for the global study of mitochondria biogenesis.	[Saint-Georges, Yann; Garcia, Mathilde; Delaveau, Thierry; Devaux, Frederic; Jacq, Claude] Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, Paris, France; [Jourdren, Laurent; Le Crom, Stephane; Lemoine, Sophie; Tanty, Veronique; Jacq, Claude] Ecole Normale Super, Plateforme Transcriptome IFR36, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Saint-Georges, Y (corresponding author), Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, Paris, France.	frederic.devaux@ens.fr; claude.jacq@ens.fr	DEVAUX, Frédéric/N-2288-2019; Saint-Georges-Chaumet, Yann/AAL-1204-2021; Le Crom, Stéphane/P-4176-2016	DEVAUX, Frédéric/0000-0002-0039-9096; Saint-Georges-Chaumet, Yann/0000-0002-1123-254X; Le Crom, Stéphane/0000-0002-0534-7797; Jourdren, Laurent/0000-0003-4253-1048	French Ministry of Research [ANR-BLAN06-1-135513]	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the French Ministry of Research grants ANR-BLAN06-1-135513 (Funding support only).	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Garcia M, 2007, MOL BIOL CELL, V18, P362, DOI 10.1091/mbc.E06-09-0827; GARCIA M, 2007, BIOL MIM, P505; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jackson JS, 2004, RNA, V10, P1625, DOI 10.1261/rna.7270204; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; KELLEMS RE, 1972, J BIOL CHEM, V247, P8043; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; KELLEMS RE, 1974, J BIOL CHEM, V249, P3304; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saint-Georges Y, 2002, J BIOL CHEM, V277, P49397, DOI 10.1074/jbc.M207219200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2; [No title captured]	35	168	170	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2293	10.1371/journal.pone.0002293	http://dx.doi.org/10.1371/journal.pone.0002293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523582	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300009
J	Majorovits, E; Nejmeddine, M; Tanaka, Y; Taylor, GP; Fuller, SD; Bangham, CRM				Majorovits, Endre; Nejmeddine, Mohamed; Tanaka, Yuetsu; Taylor, Graham P.; Fuller, Stephen D.; Bangham, Charles R. M.			Human T-Lymphotropic Virus-1 Visualized at the Virological Synapse by Electron Tomography	PLOS ONE			English	Article								Human T-lymphotropic virus 1 (HTLV-1) is transmitted directly between cells via an organized cell-cell contact called a virological synapse (VS) [1,2]. The VS has been studied by light microscopy, but the ultrastructure of the VS and the nature of the transmitted viral particle have remained unknown. Cell-free enveloped virions of HTLV-1 are undetectable in the serum of individuals infected with the human T-lymphotropic virus 1 (HTLV-1) and during in vitro culture of naturally infected lymphocytes. However, the viral envelope protein is required for infectivity of HTLV-1, suggesting that complete, enveloped HTLV-1 virions are transferred across the synapse. Here, we use electron tomography combined with immunostaining of viral protein to demonstrate the presence of enveloped HTLV-1 particles within the VS formed between naturally infected lymphocytes. We show in 3D that HTLV-1 particles can be detected in multiple synaptic clefts at different locations simultaneously within the same VS. The synaptic clefts are surrounded by the tightly apposed plasma membranes of the two cells. HTLV-1 virions can contact the recipient cell membrane before detaching from the infected cell. The results show that the HTLV-1 virological synapse that forms spontaneously between lymphocytes of HTLV-1 infected individuals allows direct cell-cell transmission of the virus by triggered, directional release of enveloped HTLV-1 particles into confined intercellular spaces.	[Majorovits, Endre; Fuller, Stephen D.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England; [Nejmeddine, Mohamed; Bangham, Charles R. M.] Imperial Coll London, Wright Fleming Inst, Dept Immunol, London, England; [Tanaka, Yuetsu] Univ Ryukyus, Grad Sch, Fac Med, Dept Immunol, Okinawa, Japan; [Taylor, Graham P.] Imperial Coll London, Wright Fleming Inst, Dept Genito Urinary GU Med & Commun Dis, London, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; University of the Ryukyus; Imperial College London	Majorovits, E (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England.	stephen@strubi.ox.ac.uk; c.bangham@imperial.ac.uk		Bangham, Charles/0000-0003-2624-3599; Nejmeddine, Mohamed/0000-0003-0160-2727	Wellcome Trust UK [H5RCYV0, 064766]; National Center for Research Resources of the National Institutes of Health [RR00592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Wellcome Trust UK(Wellcome Trust); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was funded by the Wellcome Trust UK (grant number H5RCYV0 to S.D.F.; grant number 064766 to C.R.M.B.) and supported in part by grant RR00592 from the National Center for Research Resources of the National Institutes of Health to A. Hoenger.	Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Barnard AL, 2005, BLOOD, V106, P988, DOI 10.1182/blood-2004-07-2850; BIBERFELD P, 1975, EXP CELL RES, V94, P79, DOI 10.1016/0014-4827(75)90533-9; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Delamarre L, 1999, J VIROL, V73, P9659, DOI 10.1128/JVI.73.11.9659-9663.1999; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; GESSAIN A, 1985, LANCET, V2, P407; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KIRCHHAUSEN T, 1993, J LEUKOCYTE BIOL, V53, P342, DOI 10.1002/jlb.53.3.342; KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MIYAUCHI M, 1990, J ELECTRON MICROSC, V39, P145; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; OSAME M, 1986, LANCET, V1, P1031; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; Shuh M, 1999, VIROLOGY, V262, P442, DOI 10.1006/viro.1999.9909; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; TANAKA Y, 1986, INT J CANCER, V37, P35, DOI 10.1002/ijc.2910370107; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; WEISS A, 1984, J IMMUNOL, V133, P123; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	34	72	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2251	10.1371/journal.pone.0002251	http://dx.doi.org/10.1371/journal.pone.0002251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509526	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500005
J	Saeed, M; Roeffen, W; Alexander, N; Drakeley, CJ; Targett, GAT; Sutherland, CJ				Saeed, Maha; Roeffen, Will; Alexander, Neal; Drakeley, Christopher J.; Targett, Geoffrey A. T.; Sutherland, Colin J.			Plasmodium falciparum Antigens on the Surface of the Gametocyte-Infected Erythrocyte	PLOS ONE			English	Article							MALARIA TRANSMISSION; VARIANT ANTIGENS; ANTIBODIES; CHILDREN; CHLOROQUINE; EXPRESSION; ARTESUNATE; PROTECTION; IMMUNITY; REDUCTION	Background: The asexual blood stages of the human malaria parasite Plasmodium falciparum produce highly immunogenic polymorphic antigens that are expressed on the surface of the host cell. In contrast, few studies have examined the surface of the gametocyte-infected erythrocyte. Methodology/Principal Findings: We used flow cytometry to detect antibodies recognising the surface of live cultured erythrocytes infected with gametocytes of P. falciparum strain 3D7 in the plasma of 200 Gambian children. The majority of children had been identified as carrying gametocytes after treatment for malaria, and each donated blood for mosquito-feeding experiments. None of the plasma recognised the surface of erythrocytes infected with developmental stages of gametocytes (I-IV), but 66 of 194 (34.0%) plasma contained IgG that recognised the surface of erythrocytes infected with mature (stage V) gametocytes. Thirty-four (17.0%) of 200 plasma tested recognised erythrocytes infected with trophozoites and schizonts, but there was no association with recognition of the surface of gametocyte-infected erythrocytes (odds ratio 1.08, 95% C.I. 0.434-2.57; P = 0.851). Plasma antibodies with the ability to recognise gametocyte surface antigens (GSA) were associated with the presence of antibodies that recognise the gamete antigen Pfs 230, but not Pfs48/45. Antibodies recognising GSA were associated with donors having lower gametocyte densities 4 weeks after antimalarial treatment. Conclusions/Significance: We provide evidence that GSA are distinct from antigens detected on the surface of asexual 3D7 parasites. Our findings suggest a novel strategy for the development of transmission-blocking vaccines.	[Saeed, Maha; Alexander, Neal; Drakeley, Christopher J.; Targett, Geoffrey A. T.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Roeffen, Will; Sutherland, Colin J.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen	Saeed, M (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Roeffen, W.F.G./L-4607-2015; Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407	Wellcome Trust [061910, ISRCTN11805747]; UK Medical Research Council; Gates Malaria Partnership; Council for Assisting Refugee Academics (CARA); UK Health Protection Agency; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Malaria Partnership; Council for Assisting Refugee Academics (CARA); UK Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (Project # 061910; ISRCTN11805747), the UK Medical Research Council, and the Gates Malaria Partnership. MS is supported by the Council for Assisting Refugee Academics (CARA). CJS is supported by the UK Health Protection Agency. None of these bodies played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; BRANNAN LR, 1994, P ROY SOC B-BIOL SCI, V256, P71, DOI 10.1098/rspb.1994.0051; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7; Drakeley CJ, 2006, PARASITE IMMUNOL, V28, P185, DOI 10.1111/j.1365-3024.2005.00818.x; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; GRAVES PM, 1988, INFECT IMMUN, V56, P2818, DOI 10.1128/IAI.56.11.2818-2821.1988; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; MENDIS KN, 1987, INFECT IMMUN, V55, P369, DOI 10.1128/IAI.55.2.369-372.1987; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Muhia DK, 2001, MOL MICROBIOL, V42, P553, DOI 10.1046/j.1365-2958.2001.02665.x; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, INFECT IMMUN, V63, P467, DOI 10.1128/IAI.63.2.467-471.1995; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Sharp S, 2006, EUKARYOT CELL, V5, P1206, DOI 10.1128/EC.00029-06; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015	44	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2280	10.1371/journal.pone.0002280	http://dx.doi.org/10.1371/journal.pone.0002280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509532	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000262268500024
J	Kuiper, EJ; Van Nieuwenhoven, FA; de Smet, MD; van Meurs, JC; Tanck, MW; Oliver, N; Klaassen, I; Van Noorden, CJF; Goldschmeding, R; Schlingemann, RO				Kuiper, Esther J.; Van Nieuwenhoven, Frans A.; de Smet, Marc D.; van Meurs, Jan C.; Tanck, Michael W.; Oliver, Noelynn; Klaassen, Ingeborg; Van Noorden, Cornelis J. F.; Goldschmeding, Roel; Schlingemann, Reinier O.			The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article								Background: In proliferative diabetic retinopathy (PDR), vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) cause blindness by neovascularization and subsequent fibrosis, but their relative contribution to both processes is unknown. We hypothesize that the balance between levels of pro-angiogenic VEGF and pro-fibrotic CTGF regulates angiogenesis, the angio-fibrotic switch, and the resulting fibrosis and scarring. Methods/Principal Findings: VEGF and CTGF were measured by ELISA in 68 vitreous samples of patients with proliferative DR (PDR, N = 32), macular hole (N = 13) or macular pucker (N = 23) and were related to clinical data, including degree of intra-ocular neovascularization and fibrosis. In addition, clinical cases of PDR (n = 4) were studied before and after pan-retinal photocoagulation and intra-vitreal injections with bevacizumab, an antibody against VEGF. Neovascularization and fibrosis in various degrees occurred almost exclusively in PDR patients. In PDR patients, vitreous CTGF levels were significantly associated with degree of fibrosis and with VEGF levels, but not with neovascularization, whereas VEGF levels were associated only with neovascularization. The ratio of CTGF and VEGF was the strongest predictor of degree of fibrosis. As predicted by these findings, patients with PDR demonstrated a temporary increase in intra-ocular fibrosis after anti-VEGF treatment or laser treatment. Conclusions/Significance: CTGF is primarily a pro-fibrotic factor in the eye, and a shift in the balance between CTGF and VEGF is associated with the switch from angiogenesis to fibrosis in proliferative retinopathy.	[Kuiper, Esther J.; de Smet, Marc D.; Klaassen, Ingeborg; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Ocular Angiogenesis Grp, Dept Ophthalmol, Acad Med Ctr, Amsterdam, Netherlands; [Van Nieuwenhoven, Frans A.; Goldschmeding, Roel] Academ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Meurs, Jan C.] Rotterdam Eye Hosp, Dept Ophthalmol, Rotterdam, Netherlands; [Tanck, Michael W.] Univ Amsterdam, Academ Med Ctr, Dept Clin Epidemiol Stat, Amsterdam, Netherlands; [Oliver, Noelynn] FibroGen Inc, San Francisco, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Rotterdam Eye Hospital; University of Amsterdam; Academic Medical Center Amsterdam; FibroGen	Kuiper, EJ (corresponding author), Univ Amsterdam, Ocular Angiogenesis Grp, Dept Ophthalmol, Acad Med Ctr, Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Goldschmeding, Roel/I-1723-2014; Klaassen, Ingeborg/F-7333-2015; De Smet, Marc D./E-2451-2013	De Smet, Marc D./0000-0002-9217-5603; Tanck, Michael/0000-0001-9828-4459; Klaassen, Ingeborg/0000-0003-1695-9403; van Nieuwenhoven, Frans/0000-0002-5757-0069	Diabetes Fonds Nederland [2001 042]; Edmond and Marianne Blaauw Fonds	Diabetes Fonds Nederland; Edmond and Marianne Blaauw Fonds	This study was supported by grants from the Diabetes Fonds Nederland (grant 2001 042) and by the Edmond and Marianne Blaauw Fonds.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Babic AM, 1999, MOL CELL BIOL, V19, P2958; CAMPOCHIARO PA, 2001, RETINA, P2221; Chang CC, 2006, JNCI-J NATL CANCER I, V98, P984, DOI 10.1093/jnci/djj242; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; FRANK RN, 1994, NEW ENGL J MED, V331, P1519, DOI 10.1056/NEJM199412013312212; Franklin TJ, 1997, INT J BIOCHEM CELL B, V29, P79, DOI 10.1016/S1357-2725(96)00121-5; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Goldschmeding R, 2000, NEPHROL DIAL TRANSPL, V15, P296, DOI 10.1093/ndt/15.3.296; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; He S, 2003, ARCH OPHTHALMOL-CHIC, V121, P1283, DOI 10.1001/archopht.121.9.1283; HE S, 2008, INVEST 0430 IN PRESS; Hinton DR, 2004, DIABETES CARE, V27, P758, DOI 10.2337/diacare.27.3.758; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hofman P, 2000, CURR EYE RES, V21, P637, DOI 10.1076/0271-3683(200008)21:2;1-V;FT637; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; Kita T, 2007, DIABETES, V56, P1421, DOI 10.2337/db06-1644; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Kuiper EJ, 2004, BRIT J OPHTHALMOL, V88, P1082, DOI 10.1136/bjo.2003.032045; Kuiper EJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1139, DOI 10.1369/jhc.7A7258.2007; Kuiper EJ, 2007, INVEST OPHTH VIS SCI, V48, P4267, DOI 10.1167/iovs.06-0804; Kuiper EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1457, DOI 10.1001/archopht.124.10.1457; MAGETO Y, CHEST, V126, pS773; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Schlingemann RO, 1997, BRIT J OPHTHALMOL, V81, P501, DOI 10.1136/bjo.81.6.501; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; van Nieuwenhoven FA, 2005, NEPHROL DIAL TRANSPL, V20, P6, DOI 10.1093/ndt/gfh570; Watanabe D, 2005, RETINA-J RET VIT DIS, V25, P911, DOI 10.1097/00006982-200510000-00015; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yokoi H, 2004, J AM SOC NEPHROL, V15, P1430, DOI 10.1097/01.ASN.0000130565.69170.85; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422	51	166	182	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2675	10.1371/journal.pone.0002675	http://dx.doi.org/10.1371/journal.pone.0002675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628999	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200020
J	Wang, SC; Oelze, B; Schumacher, A				Wang, Sun-Chong; Oelze, Beatrice; Schumacher, Axel			Age-Specific Epigenetic Drift in Late-Onset Alzheimer's Disease	PLOS ONE			English	Article								Despite an enormous research effort, most cases of late-onset Alzheimer's disease (LOAD) still remain unexplained and the current biomedical science is still a long way from the ultimate goal of revealing clear risk factors that can help in the diagnosis, prevention and treatment of the disease. Current theories about the development of LOAD hinge on the premise that Alzheimer's arises mainly from heritable causes. Yet, the complex, non-Mendelian disease etiology suggests that an epigenetic component could be involved. Using MALDI-TOF mass spectrometry in post-mortem brain samples and lymphocytes, we have performed an analysis of DNA methylation across 12 potential Alzheimer's susceptibility loci. In the LOAD brain samples we identified a notably age-specific epigenetic drift, supporting a potential role of epigenetic effects in the development of the disease. Additionally, we found that some genes that participate in amyloid-beta processing (PSEN1, APOE) and methylation homeostasis (MTHFR, DNMT1) show a significant interindividual epigenetic variability, which may contribute to LOAD predisposition. The APOE gene was found to be of bimodal structure, with a hypomethylated CpG-poor promoter and a fully methylated 3'-CpG-island, that contains the sequences for the epsilon 4-haplotype, which is the only undisputed genetic risk factor for LOAD. Aberrant epigenetic control in this CpG-island may contribute to LOAD pathology. We propose that epigenetic drift is likely to be a substantial mechanism predisposing individuals to LOAD and contributing to the course of disease.	[Wang, Sun-Chong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Schumacher, Axel] Klin rechts der Isar, Dept Med 2, Epigenet Lab, Munich, Germany; [Oelze, Beatrice] Sequenom GmbH, Hamburg, Germany	National Central University	Wang, SC (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	Axel.Schumacher@lrz.tu-muenchen.de			German National Genome Network (NGFN); Klinikum Rechts der Isar	German National Genome Network (NGFN); Klinikum Rechts der Isar	This work was funded in parts by the German National Genome Network (NGFN) and the Klinikum Rechts der Isar. Funders had no influence in design or conduct of the study.	Basha MR, 2005, J NEUROSCI, V25, P823, DOI 10.1523/JNEUROSCI.4335-04.2005; Bassett SS, 2006, AM J MED GENET B, V141B, P537, DOI 10.1002/ajmg.b.30350; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bird TD, 2005, NEW ENGL J MED, V352, P862, DOI 10.1056/NEJMp058027; BOTTIGLIERI T, 1990, J NEUROL NEUROSUR PS, V53, P1096, DOI 10.1136/jnnp.53.12.1096; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COOK RH, 1981, ARCH NEUROL-CHICAGO, V38, P300, DOI 10.1001/archneur.1981.00510050066011; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DOLINOY DC, 2007, PEDIAT RES; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Guidi I, 2005, NEUROBIOL AGING, V26, P789, DOI 10.1016/j.neurobiolaging.2004.07.003; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Kristiansen M, 2005, EUR J HUM GENET, V13, P599, DOI 10.1038/sj.ejhg.5201398; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Lehmann M, 1999, DEMENT GERIATR COGN, V10, P12, DOI 10.1159/000017092; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Liddell MB, 2001, BRIT J PSYCHIAT, V178, P7, DOI 10.1192/bjp.178.1.7; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; MILICI A, 1990, BIOCHEM BIOPH RES CO, V169, P46, DOI 10.1016/0006-291X(90)91430-Z; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Morrison LD, 1996, J NEUROCHEM, V67, P1328; Nee LE, 1999, DEMENT GERIATR COGN, V10, P148, DOI 10.1159/000017115; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Payao SLM, 1998, GERONTOLOGY, V44, P267; Petronis A, 2006, TRENDS GENET, V22, P347, DOI 10.1016/j.tig.2006.04.010; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Raina AK, 2001, MECH AGEING DEV, V123, P3, DOI 10.1016/S0047-6374(01)00333-5; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; ROGAEV EI, 1994, GENOMICS, V22, P340, DOI 10.1006/geno.1994.1393; SCHWOB NG, 1990, ANN NEUROL, V28, P91, DOI 10.1002/ana.410280117; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008	51	328	351	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2698	10.1371/journal.pone.0002698	http://dx.doi.org/10.1371/journal.pone.0002698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628954	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200041
J	Cohen, D; Deniau, E; Maturana, A; Tanguy, ML; Bodeau, N; Labelle, R; Breton, JJ; Guile, JM				Cohen, David; Deniau, Emmanuelle; Maturana, Alejandro; Tanguy, Marie-Laure; Bodeau, Nicolas; Labelle, Real; Breton, Jean-Jacques; Guile, Jean-Marc			Are Child and Adolescent Responses to Placebo Higher in Major Depression than in Anxiety Disorders? A Systematic Review of Placebo-Controlled Trials	PLOS ONE			English	Review							OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; DOUBLE-BLIND; FOLLOW-UP; FLUOXETINE TREATMENT; INTERPERSONAL PSYCHOTHERAPY; CLOMIPRAMINE TREATMENT; DIFFERENTIAL RESPONSE; DESIPRAMINE TREATMENT	Background: In a previous report, we hypothesized that responses to placebo were high in child and adolescent depression because of specific psychopathological factors associated with youth major depression. The purpose of this study was to compare the placebo response rates in pharmacological trials for major depressive disorder (MDD), obsessive compulsive disorder (OCD) and other anxiety disorders (AD-non-OCD). Methodology and Principal Findings: We reviewed the literature relevant to the use of psychotropic medication in children and adolescents with internalized disorders, restricting our review to double-blind studies including a placebo arm. Placebo response rates were pooled and compared according to diagnosis (MDD vs. OCD vs. AD-non-OCD), age ( adolescent vs. child), and date of publication. From 1972 to 2007, we found 23 trials that evaluated the efficacy of psychotropic medication ( mainly non-tricyclic antidepressants) involving youth with MDD, 7 pertaining to youth with OCD, and 10 pertaining to youth with other anxiety disorders (N = 2533 patients in placebo arms). As hypothesized, the placebo response rate was significantly higher in studies on MDD, than in those examining OCD and AD-non-OCD (49.6% [ range: 17-90%] vs. 31% [ range: 4-41%] vs. 39.6% [ range: 9-53], respectively, ANOVA F = 7.1, p = 0.002). Children showed a higher stable placebo response within all three diagnoses than adolescents, though this difference was not significant. Finally, no significant effects were found with respect to the year of publication. Conclusion: MDD in children and adolescents appears to be more responsive to placebo than other internalized conditions, which highlights differential psychopathology.	[Cohen, David; Deniau, Emmanuelle; Bodeau, Nicolas] Univ Paris 06, GH Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Cohen, David; Guile, Jean-Marc] CNRS, UMR 8189, Lab Psychol Neurosci Cognit, Paris, France; [Maturana, Alejandro] Univ Chile, Dept Child & Adolescent Psychiat, Santiago, Chile; [Tanguy, Marie-Laure] Univ Paris 06, Dept Biostat, Paris, France; [Labelle, Real] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Labelle, Real; Breton, Jean-Jacques; Guile, Jean-Marc] Univ Montreal, Dept Child & Adolescent Psychiat, Montreal, PQ, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universidad de Chile; UDICE-French Research Universities; Sorbonne Universite; University of Quebec; University of Quebec Montreal; Universite de Montreal	Cohen, D (corresponding author), Univ Paris 06, GH Pitie Salpetriere, AP HP, Dept Child & Adolescent Psychiat, Paris, France.	david.cohen@psl.aphp.fr			Smith Kline Beecham; Sanofi-Synthelabo	Smith Kline Beecham(GlaxoSmithKline); Sanofi-Synthelabo	DC was an investigator in two pharmaceutical trials funded by Smith Kline Beecham (2001) and Sanofi-Synthelabo (2006). He is currently the principal investigator of a trial on adolescent OCD funded by Lundbeck. Other authors have no disclosure to declare. Sponsors cited above had no influence in the design, collection, analysis and interpretation of the data.	Bender B, 1998, J ASTHMA, V35, P347, DOI 10.3109/02770909809075667; Berard R, 2006, J CHILD ADOL PSYCHOP, V16, P59, DOI 10.1089/cap.2006.16.59; BERNEY T, 1981, BRIT J PSYCHIAT, V138, P110, DOI 10.1192/bjp.138.2.110; Bernstein GA, 2000, J AM ACAD CHILD PSY, V39, P284, DOI 10.1097/00004583-200003000-00009; Bernstein GA, 2000, J AM ACAD CHILD PSY, V39, P276, DOI 10.1097/00004583-200003000-00008; BERNSTEIN GA, 1990, J AM ACAD CHILD PSY, V29, P773, DOI 10.1097/00004583-199009000-00016; Birmaher B, 1998, J AM ACAD CHILD PSY, V37, P527, DOI 10.1097/00004583-199805000-00015; Birmaher B, 2000, ARCH GEN PSYCHIAT, V57, P29, DOI 10.1001/archpsyc.57.1.29; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; BOULOS C, 1991, PSYCHOPHARMACOL BULL, V27, P59; Braconnier A, 2003, J AM ACAD CHILD PSY, V42, P22, DOI 10.1097/00004583-200301000-00007; Brent DA, 1997, ARCH GEN PSYCHIAT, V54, P877; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; BROPHY B, 1995, US NEWS WORLD REP, V13, P96; Carr A., 2015, HDB CHILD ADOLESCENT; Cohen D, 2004, J CHILD ADOL PSYCHOP, V14, P19, DOI 10.1089/104454604773840454; Cohen D, 2007, PSYCHOTHER PSYCHOSOM, V76, P5, DOI 10.1159/000096360; CROMER BA, 1989, J DEV BEHAV PEDIATR, V10, P207; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; DEVEAUGHGEISS J, 1992, J AM ACAD CHILD PSY, V31, P45, DOI 10.1097/00004583-199201000-00008; Donnelly CL, 2006, J AM ACAD CHILD PSY, V45, P1162, DOI 10.1097/01.chi.0000233204.51050.f0; Emslie GJ, 2006, J AM ACAD CHILD PSY, V45, P709, DOI 10.1097/01.chi.0000214189.73240.63; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Emslie GJ, 2004, J AM ACAD CHILD PSY, V43, P1397, DOI 10.1097/01.chi.0000140453.89323.57; Emslie GJ, 2000, PSYCHIAT CLIN N AM, V23, P813, DOI 10.1016/S0193-953X(05)70199-4; Emslie GJ, 2007, J AM ACAD CHILD PSY, V46, P479, DOI 10.1097/chi.0b013e31802f5f03; FLAMENT M, 2004, EMOTIONAL DEV; FLAMENT M, 2000, OBSESSIVE COMPULSIVE, P147; FLAMENT MF, 1990, J CHILD PSYCHOL PSYC, V31, P363, DOI 10.1111/j.1469-7610.1990.tb01575.x; Flament MF, 2001, J AM ACAD CHILD PSY, V40, P1070, DOI 10.1097/00004583-200109000-00016; FLAMENT MF, 1985, ARCH GEN PSYCHIAT, V42, P977; FRANK JD, 1995, CLIN PSYCHOL-SCI PR, V2, P90, DOI 10.1111/j.1468-2850.1995.tb00030.x; GELLER B, 1992, J AM ACAD CHILD PSY, V31, P34, DOI 10.1097/00004583-199201000-00007; GELLER B, 1990, PSYCHOPHARMACOL BULL, V26, P85; GELLER B, 1992, J AM ACAD CHILD PSY, V31, P622, DOI 10.1097/00004583-199207000-00008; GELLER B, 1987, J CLIN PSYCHOPHARM, V7, P321; GELLER B, 1989, PSYCHOPHARMACOL BULL, V25, P101; Geller DA, 2004, J AM ACAD CHILD PSY, V43, P1387, DOI 10.1097/01.chi.0000138356.29099.f1; Geller DA, 2003, AM J PSYCHIAT, V160, P1919, DOI 10.1176/appi.ajp.160.11.1919; Geller DA, 2001, J AM ACAD CHILD PSY, V40, P773, DOI 10.1097/00004583-200107000-00011; GITTELMANKLEIN R, 1973, J NERV MENT DIS, V156, P199, DOI 10.1097/00005053-197303000-00004; GRAAE F, 1994, J AM ACAD CHILD PSY, V33, P372, DOI 10.1097/00004583-199403000-00011; Hack S, 2001, J CHILD ADOL PSYCHOP, V11, P59, DOI 10.1089/104454601750143465; HAMILTON NG, 1994, AM J PSYCHOTHER, V48, P380, DOI 10.1176/appi.psychotherapy.1994.48.3.380; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Hoberman H M, 1996, Prog Behav Modif, V30, P25; HUGHES CW, 1988, PSYCHOPHARMACOL BULL, V24, P275; HUGHES CW, 1990, PSYCHOPHARMACOL BULL, V26, P235; Jaffee SR, 2002, ARCH GEN PSYCHIAT, V59, P215, DOI 10.1001/archpsyc.59.3.215; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Kapczinski F., 2003, COCHRANE DB SYST REV, V2003, DOI [DOI 10.1002/14651858.CD003592, 10.1002/14651858.CD003592]; KASHANI JH, 1984, J AM ACAD CHILD PSY, V23, P348, DOI 10.1016/S0002-7138(09)60515-X; Keck PE, 2000, BIOL PSYCHIAT, V47, P748, DOI 10.1016/S0006-3223(99)00311-X; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kirsch I., 2002, PREV TREAT, V5, P23, DOI [DOI 10.1037/1522-3736.5.1.523A, 10.1037/1522-3736.5.1.523a]; Klein R G, 1998, Depress Anxiety, V7, P15, DOI 10.1002/(SICI)1520-6394(1998)7:1<15::AID-DA3>3.0.CO;2-4; KLEIN RG, 1992, J AM ACAD CHILD PSY, V31, P21, DOI 10.1097/00004583-199201000-00005; KOVACS M, 1989, ARCH GEN PSYCHIAT, V46, P776; KRAMER AD, 1981, J AM ACAD CHILD PSY, V20, P636, DOI 10.1016/S0002-7138(09)61650-2; KUTCHER S, 1994, J AM ACAD CHILD PSY, V33, P686, DOI 10.1097/00004583-199406000-00010; Kye CH, 1996, J AM ACAD CHILD PSY, V35, P1139, DOI 10.1097/00004583-199609000-00011; LEONARD HL, 1989, ARCH GEN PSYCHIAT, V46, P1088; LEONARD HL, 1993, ARCH GEN PSYCHIAT, V50, P429; LEONARD HL, 1991, ARCH GEN PSYCHIAT, V48, P922; Liebowitz MR, 2002, J AM ACAD CHILD PSY, V41, P1431, DOI 10.1097/00004583-200212000-00014; LITT IF, 1985, PEDIATRICS, V75, P693; MANASSIS K, 1997, CANADIAN J PSYCHIAT, V42, P87; Mandoki MW, 1997, PSYCHOPHARMACOL BULL, V33, P149; MARCELLI D, 2006, ENFANCE PSYCHOPATHOL; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March J, 2003, J AM ACAD CHILD PSY, V42, P531, DOI 10.1097/01.CHI.0000046839.90931.0D; March JS, 2007, BIOL PSYCHIAT, V62, P1149, DOI 10.1016/j.biopsych.2007.02.025; March JS, 2004, JAMA-J AM MED ASSOC, V292, P1969; March JS, 1998, JAMA-J AM MED ASSOC, V280, P1752, DOI 10.1001/jama.280.20.1752; Mayes TL, 2007, CNS SPECTRUMS, V12, P147, DOI 10.1017/S1092852900020666; MILIN R, 2000, BROWN U CHILD ADOLES, V2, P5; Mufson L, 2004, ARCH GEN PSYCHIAT, V61, P577, DOI 10.1001/archpsyc.61.6.577; Mufson L, 1999, ARCH GEN PSYCHIAT, V56, P573, DOI 10.1001/archpsyc.56.6.573; Muratori F, 2003, J AM ACAD CHILD PSY, V42, P331, DOI 10.1097/00004583-200303000-00014; PETTI TA, 1982, J CLIN PSYCHOPHARM, V2, P107; PRESKORN SH, 1986, CLIN NEUROPHARMACOL, V9, P265; PRESKORN SH, 1987, PSYCHOPHARMACOL BULL, V23, P128; PRESKORN SH, 1982, J CLIN PSYCHIAT, V43, P450; PUIGANTICH J, 1987, ARCH GEN PSYCHIAT, V44, P81; RIDDLE MA, 1992, J AM ACAD CHILD PSY, V31, P1062, DOI 10.1097/00004583-199211000-00011; Riddle MA, 2001, J AM ACAD CHILD PSY, V40, P222, DOI 10.1097/00004583-200102000-00017; Ryan ND, 2005, LANCET, V366, P933, DOI 10.1016/S0140-6736(05)67321-7; Rynn M, 2006, J CHILD ADOL PSYCHOP, V16, P103, DOI 10.1089/cap.2006.16.103; Rynn MA, 2001, AM J PSYCHIAT, V158, P2008, DOI 10.1176/appi.ajp.158.12.2008; Rynn MA, 2007, AM J PSYCHIAT, V164, P290, DOI 10.1176/appi.ajp.164.2.290; Sallee FR, 1997, AM J PSYCHIAT, V154, P668; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; SIMEON JG, 1992, J AM ACAD CHILD PSY, V31, P29, DOI 10.1097/00004583-199201000-00006; Sysko R, 2007, J CLIN PSYCHIAT, V68, P1213, DOI 10.4088/JCP.v68n0807; von Knorring AL, 2006, J CLIN PSYCHOPHARM, V26, P311, DOI 10.1097/01.jcp.0000219051.40632.d5; Wagner KD, 2006, J AM ACAD CHILD PSY, V45, P280, DOI 10.1097/01.chi.0000192250.38400.9e; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wagner KD, 2004, ARCH GEN PSYCHIAT, V61, P1153, DOI 10.1001/archpsyc.61.11.1153; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; Walkup JT, 2001, NEW ENGL J MED, V344, P1279, DOI 10.1056/NEJM200104263441703; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Williamson DE, 2005, J CHILD ADOL PSYCHOP, V15, P571, DOI 10.1089/cap.2005.15.571	107	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2632	10.1371/journal.pone.0002632	http://dx.doi.org/10.1371/journal.pone.0002632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612460	Green Submitted, gold, Green Published			2022-12-27	WOS:000264065800034
J	Husain, S; Yildirim-Toruner, C; Rubio, JP; Field, J; Schwalb, M; Cook, S; Devoto, M; Vitale, E				Husain, Seema; Yildirim-Toruner, Cagri; Rubio, Justin P.; Field, Judith; Schwalb, Marvin; Cook, Stuart; Devoto, Marcella; Vitale, Emilia		So MS Genetics Consortium	Variants of ST8SIA1 Are Associated with Risk of Developing Multiple Sclerosis	PLOS ONE			English	Article								Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown etiology with both genetic and environmental factors playing a role in susceptibility. To date, the HLA DR15/DQ6 haplotype within the major histocompatibility complex on chromosome 6p, is the strongest genetic risk factor associated with MS susceptibility. Additional alleles of IL7 and IL2 have been identified as risk factors for MS with small effect. Here we present two independent studies supporting an allelic association of MS with polymorphisms in the ST8SIA1 gene, located on chromosome 12p12 and encoding ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1. The initial association was made in a single three-generation family where a single-nucleotide polymorphism (SNP) rs4762896, was segregating together with HLA DR15/DQ6 in MS patients. A study of 274 family trios (affected child and both unaffected parents) from Australia validated the association of ST8SIA1 in individuals with MS, showing transmission disequilibrium of the paternal alleles for three additional SNPs, namely rs704219, rs2041906, and rs1558793, with p = 0.001, p = 0.01 and p = 0.01 respectively. These findings implicate ST8SIA1 as a possible novel susceptibility gene for MS.	[Husain, Seema; Yildirim-Toruner, Cagri; Schwalb, Marvin; Vitale, Emilia] UMDNJ, New Jersey Med Sch, Inst Genom Med, Newark, NJ USA; [Rubio, Justin P.; Field, Judith] Univ Melbourne, Howard Florey Inst, Parkville, Vic, Australia; [Cook, Stuart] UMDNJ, New Jersey Med Sch, Dept Neurosci, Newark, NJ USA; [Devoto, Marcella] Univ Penn, Sch Med, CHOP, CCEB, Philadelphia, PA USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Vitale, Emilia] CNR Inst Cybernet, Naples, Italy	Rutgers State University New Brunswick; Rutgers State University Medical Center; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR)	Husain, S (corresponding author), UMDNJ, New Jersey Med Sch, Inst Genom Med, Newark, NJ USA.	vitaleem@umdnj.edu	vitale, emilia/A-5282-2011; Devoto, Marcella/AAP-7595-2021	Stankovich, Jim/0000-0001-9344-7749; DEVOTO, MARCELLA/0000-0002-4431-5114; Field, Judith/0000-0002-7089-0999; Vitale, Emilia/0000-0003-4651-3875; RUBIO, JUSTIN/0000-0003-3750-917X	MS National Multiple Sclerosis Society; Wadsworth Foundation for Multiple Sclerosis Research; Foundation of UMDNJ; National Health and Medical Research Council of Australia [R. D. Wright Fellow]	MS National Multiple Sclerosis Society(National Multiple Sclerosis Society); Wadsworth Foundation for Multiple Sclerosis Research; Foundation of UMDNJ; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the MS National Multiple Sclerosis Society, the Wadsworth Foundation for Multiple Sclerosis Research Grant and the Foundation of UMDNJ(E.V.) and by Segal Family, L'Hommedieu and Kushner Family Grants (S.C.). JPR is an R. D. Wright Fellow of The National Health and Medical Research Council of Australia.	Barnett MH, 2006, CURR OPIN NEUROL, V19, P242, DOI 10.1097/01.wco.0000227032.47458.cb; Bieberich E, 2002, BIOCHEMISTRY-US, V41, P11479, DOI 10.1021/bi0259958; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Compston A, 1999, PHILOS T R SOC B, V354, P1623, DOI 10.1098/rstb.1999.0507; De Stefano N, 1998, BRAIN, V121, P1469, DOI 10.1093/brain/121.8.1469; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1986, NEW ENGL J MED, V315, P1638, DOI 10.1056/NEJM198612253152603; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Herrera BM, 2007, NEUROLOGY, V69, P1208, DOI 10.1212/01.wnl.0000268486.40851.d6; Kantarci OH, 2006, NEUROLOGY, V67, P305, DOI 10.1212/01.wnl.0000225070.13682.11; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Lassmann H, 1998, MULT SCLER J, V4, P93, DOI 10.1191/135245898678909367; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Lundmark F, 2007, J NEUROIMMUNOL, V192, P171, DOI 10.1016/j.jneuroim.2007.08.015; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Marrosu MG, 2004, NEUROLOGY, V63, P1084, DOI 10.1212/01.WNL.0000138493.04890.7C; Matsuda Y, 1996, GENOMICS, V32, P137, DOI 10.1006/geno.1996.0090; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RAMAGOPALAN SV, 2007, HUM GENET; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tettamanti G, 2003, GLYCOCONJUGATE J, V20, P301, DOI 10.1023/B:GLYC.0000033627.02765.cc; Vitale E, 2002, HUM MOL GENET, V11, P295, DOI 10.1093/hmg/11.3.295	31	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2653	10.1371/journal.pone.0002653	http://dx.doi.org/10.1371/journal.pone.0002653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612409	Green Accepted, Green Published, gold			2022-12-27	WOS:000264065800055
J	Koelsch, S; Sammler, D				Koelsch, Stefan; Sammler, Daniela			Cognitive Components of Regularity Processing in the Auditory Domain	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MUSIC PERCEPTION; LANGUAGE; BRAIN; SYNTAX; MEMORY; ERP; NEGATIVITY; CHORDS; RULES	Background: Music-syntactic irregularities often co-occur with the processing of physical irregularities. In this study we constructed chord-sequences such that perceived differences in the cognitive processing between regular and irregular chords could not be due to the sensory processing of acoustic factors like pitch repetition or pitch commonality (the major component of 'sensory dissonance'). Methodology/Principal Findings: Two groups of subjects (musicians and nonmusicians) were investigated with electroencephalography (EEG). Irregular chords elicited an early right anterior negativity (ERAN) in the event-related brain potentials (ERPs). The ERAN had a latency of around 180 ms after the onset of the music-syntactically irregular chords, and had maximum amplitude values over right anterior electrode sites. Conclusions/Significance: Because irregular chords were hardly detectable based on acoustical factors (such as pitch repetition and sensory dissonance), this ERAN effect reflects for the most part cognitive (not sensory) components of regularity-based, music-syntactic processing. Our study represents a methodological advance compared to previous ERP-studies investigating the neural processing of music-syntactically irregular chords.	[Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton, E Sussex, England; [Koelsch, Stefan; Sammler, Daniela] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	University of Sussex; Max Planck Society	Koelsch, S (corresponding author), Univ Sussex, Dept Psychol, Brighton, E Sussex, England.	koelsch@cbs.mpg.de	Sammler, Daniela/V-9044-2019; Koelsch, Stefan/AAV-1556-2020	Sammler, Daniela/0000-0001-7458-0229; 				Besson M, 2001, ANN NY ACAD SCI, V930, P232, DOI 10.1111/j.1749-6632.2001.tb05736.x; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; KOELSCH S, 2005, CURRENT OPINION NEUR, V15, P1; KOELSCH S, 2008, PSYCHOPHYSI IN PRESS; KOELSCH S, 2008, SHORT TERM EFFECTS P; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; Leman M, 2000, MUSIC PERCEPT, V17, P481; LEMAN M., 2005, IPEM TOOLBOX PERCEPT; LOUI P, 2005, COG BRAIN RES, V25, P589; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Naatanen R., 2018, ATTENTION BRAIN FUNC; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel A. D., 2007, MUSIC LANGUAGE BRAIN; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Piston W., 1948, HARMONY, V5th ed.; Poulin-Charronnat B, 2006, J COGNITIVE NEUROSCI, V18, P1545, DOI 10.1162/jocn.2006.18.9.1545; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Riemann H, 1877, MUSIKALISCHE SYNTAXI; Schonberg A, 1969, STRUCTURAL FUNCTIONS; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252	35	20	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2650	10.1371/journal.pone.0002650	http://dx.doi.org/10.1371/journal.pone.0002650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612421	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800052
J	Medina, RJ; O'Neill, CL; Devine, AB; Gardiner, TA; Stitt, AW				Medina, Reinhold J.; O'Neill, Christina L.; Devine, Adrian B.; Gardiner, Tom A.; Stitt, Alan W.			The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies	PLOS ONE			English	Article								Background: Current guidelines encourage the use of statins to reduce the risk of cardiovascular disease in diabetic patients; however the impact of these drugs on diabetic retinopathy is not well defined. Moreover, pleiotropic effects of statins on the highly specialised retinal microvascular endothelium remain largely unknown. The objective of this study was to investigate the effects of clinically relevant concentrations of simvastatin on retinal endothelium in vitro and in vivo. Methods and Findings: Retinal microvascular endothelial cells (RMECs) were treated with 0.01-10 mu M simvastatin and a biphasic dose-related response was observed. Low concentrations enhanced microvascular repair with 0.1 mu M simvastatin significantly increasing proliferation (p < 0.05), and 0.01 mu M simvastatin significantly promoting migration (p < 0.05), sprouting (p < 0.001), and tubulogenesis (p < 0.001). High concentration of simvastatin (10 mu M) had the opposite effect, significantly inhibiting proliferation (p < 0.01), migration (p < 0.01), sprouting (p < 0.001), and tubulogenesis (p < 0.05). Furthermore, simvastatin concentrations higher than 1 mu M induced cell death. The mouse model of oxygen-induced retinopathy was used to investigate the possible effects of simvastatin treatment on ischaemic retinopathy. Low dose simvastatin(0.2 mg/Kg) promoted retinal microvascular repair in response to ischaemia by promoting intra-retinal revascularisation (p < 0.01). By contrast, high dose simvastatin(20 mg/Kg) significantly prevented re-vascularisation (p < 0.01) and concomitantly increased pathological neovascularisation (p < 0.01). We also demonstrated that the pro-vascular repair mechanism of simvastatin involves VEGF stimulation, Akt phosphorylation, and nitric oxide production; and the antivascular repair mechanism is driven by marked intracellular cholesterol depletion and related disorganisation of key intracellular structures. Conclusions: A beneficial effect of low-dose simvastatin on ischaemic retinopathy is linked to angiogenic repair reducing ischaemia, thereby preventing pathological neovascularisation. High-dose simvastatin may be harmful by inhibiting reparative processes and inducing premature death of retinal microvascular endothelium which increases ischaemia-induced neovascular pathology. Statin dosage should be judiciously monitored in patients who are diabetic or are at risk of developing other forms of proliferative retinopathy.	[Medina, Reinhold J.; O'Neill, Christina L.; Devine, Adrian B.; Gardiner, Tom A.; Stitt, Alan W.] Queens Univ Belfast, Ctr Vis Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Medina, RJ (corresponding author), Queens Univ Belfast, Ctr Vis Sci, Belfast, Antrim, North Ireland.	a.stitt@qub.ac.uk	Stitt, Alan/A-9842-2009; Medina, Reinhold J/A-7949-2015	Stitt, Alan/0000-0002-8647-9918; Medina, Reinhold J/0000-0003-4351-7010; Gardiner, Tom/0000-0003-4907-2630	Jules Thorn Trust; TBF Thompson Trust; Juvenile Diabetes Research Foundation; Guide Dogs for the Blind Association	Jules Thorn Trust; TBF Thompson Trust; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Guide Dogs for the Blind Association	This work was supported by the Jules Thorn Trust, the TBF Thompson Trust and the Juvenile Diabetes Research Foundation. In vitro experiments for this work were supported by the Guide Dogs for the Blind Association.	Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Badr GA, 2000, DIABETES, V49, P1016, DOI 10.2337/diabetes.49.6.1016; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Boukhtouche F, 2004, ARTERIOSCL THROM VAS, V24, P637, DOI 10.1161/01.ATV.0000119355.56036.de; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Chen SD, 2005, ANN NY ACAD SCI, V1042, P357, DOI 10.1196/annals.1338.033; Cheung BMY, 2008, LANCET, V371, P94, DOI 10.1016/S0140-6736(08)60081-1; Coleman G, 2007, GRAEF ARCH CLIN EXP, V245, P581, DOI 10.1007/s00417-006-0396-1; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Frick M, 2003, ATHEROSCLEROSIS, V170, P229, DOI 10.1016/S0021-9150(03)00299-5; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GORDON B, 1991, AM J OPHTHALMOL, V112, P385, DOI 10.1016/S0002-9394(14)76244-0; Ii M, 2007, VASC PHARMACOL, V46, P1, DOI 10.1016/j.vph.2006.06.012; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lilja JJ, 2004, BRIT J CLIN PHARMACO, V58, P56, DOI 10.1111/j.1365-2125.2004.02095.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsuno H, 2004, J CARDIOVASC PHARM, V43, P333, DOI 10.1097/00005344-200403000-00002; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Moon JC, 2006, BMJ-BRIT MED J, V332, P1344, DOI 10.1136/bmj.332.7554.1344; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; *NIH, 2006, STAT PREV CARD EV TE; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; PEDERSEN TR, 1994, LANCET, V344, P1383; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sen K, 2002, DIABETES RES CLIN PR, V56, P1, DOI 10.1016/S0168-8227(01)00341-2; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Tawfik HE, 2006, J PHARMACOL EXP THER, V319, P386, DOI 10.1124/jpet.106.106823; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Watkins PJ, 2003, BRIT MED J, V326, P924, DOI 10.1136/bmj.326.7395.924; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Zhang J, 2007, ARCH OPHTHALMOL-CHIC, V125, P1096, DOI 10.1001/archopht.125.8.1096	46	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2584	10.1371/journal.pone.0002584	http://dx.doi.org/10.1371/journal.pone.0002584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612412	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800005
J	Burz, DS; Shekhtman, A				Burz, David S.; Shekhtman, Alexander			In-Cell Biochemistry Using NMR Spectroscopy	PLOS ONE			English	Article								Biochemistry and structural biology are undergoing a dramatic revolution. Until now, mostly in vitro techniques have been used to study subtle and complex biological processes under conditions usually remote from those existing in the cell. We developed a novel in-cell methodology to post-translationally modify interactor proteins and identify the amino acids that comprise the interaction surface of a target protein when bound to the post-translationally modified interactors. Modifying the interactor proteins causes structural changes that manifest themselves on the interacting surface of the target protein and these changes are monitored using in-cell NMR. We show how Ubiquitin interacts with phosphorylated and non-phosphorylated components of the receptor tyrosine kinase (RTK) endocytic sorting machinery: STAM2 (Signal-transducing adaptor molecule), Hrs (Hepatocyte growth factor regulated substrate) and the STAM2-Hrs heterodimer. Ubiquitin binding mediates the processivity of a large network of interactions required for proper functioning of the RTK sorting machinery. The results are consistent with a weakening of the network of interactions when the interactor proteins are phosphorylated. The methodology can be applied to any stable target molecule and may be extended to include other post-translational modifications such as ubiquitination or sumoylation, thus providing a long-awaited leap to high resolution in cell biochemistry.	[Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Burz, DS (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhta@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	Career Development Award from the American Diabetes Association [1-06-CD-23]	Career Development Award from the American Diabetes Association	This work was supported by the Career Development Award from the American Diabetes Association 1-06-CD-23 (A.S.).	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Bax A, 1997, J BIOMOL NMR, V10, P289, DOI 10.1023/A:1018308717741; Burz DS, 2006, NAT PROTOC, V1, P146, DOI 10.1038/nprot.2006.23; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Clague MJ, 2001, J CELL SCI, V114, P3075; Cruzeiro-Silva C, 2006, CELL BIOCHEM BIOPHYS, V44, P497, DOI 10.1385/CBB:44:3:497; Etezady-Esfarjani T, 2006, J BIOMOL NMR, V34, P3, DOI 10.1007/s10858-005-4519-5; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200; Pielak Gary J, 2007, Biochemistry, V46, P8206; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723	25	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2571	10.1371/journal.pone.0002571	http://dx.doi.org/10.1371/journal.pone.0002571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18626516	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200036
J	Riba, J; Kramer, UM; Heldmann, M; Richter, S; Munte, TF				Riba, Jordi; Kraemer, Ulrike M.; Heldmann, Marcus; Richter, Sylvia; Muente, Thomas F.			Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity	PLOS ONE			English	Article								The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling. In a placebo-controlled double-blind study in healthy volunteers, we observed riskier choices in a lottery task after administration of the D3 receptor-preferring agonist pramipexole thus mimicking risk-taking behavior in PD. Moreover, we demonstrate decreased activation in the rostral basal ganglia and midbrain, key structures of the reward system, following unexpected high gains and therefore propose that pathological gambling in PD results from the need to seek higher rewards to overcome the blunted response in this system.	[Riba, Jordi; Kraemer, Ulrike M.; Heldmann, Marcus; Richter, Sylvia; Muente, Thomas F.] Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany; [Riba, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu Sant Pau, Serv Farmacol Clin, Inst Recerca, Barcelona, Spain; [Heldmann, Marcus] Univ Magdeburg, Dept Neurol 2, Magdeburg, Germany; [Richter, Sylvia] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Muente, Thomas F.] Ctr Behavioral Brain Sci, Magdeburg, Germany	Otto von Guericke University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Riba, J (corresponding author), Univ Magdeburg, Dept Neuropsychol, D-39106 Magdeburg, Germany.	Thomas.muente@med.uni-magdeburg.de	Münte, Thomas/C-2077-2014; Krämer, Ulrike M./A-8871-2019; Krämer, Ulrike/AAF-2966-2020	Krämer, Ulrike M./0000-0002-3841-1812; Riba, Jordi/0000-0002-9375-8421	Deutsche Forschungsgemeinschaft [SFB 779, TP A5]; BMBF; Alexander-von-Humboldt [fellowship]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Alexander-von-Humboldt(Alexander von Humboldt Foundation)	Supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A5) and the BMBF to TFM. JR was the recipient of an Alexander-von-Humboldt-fellowship. The sponsors had no role in the design, execution, analysis or interpretation of the reported research.	Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; Ashby CR, 2003, SYNAPSE, V48, P154, DOI 10.1002/syn.10188; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Di Ciano P, 2003, NEUROPSYCHOPHARMACOL, V28, P329, DOI 10.1038/sj.npp.1300148; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Thanos PK, 2005, PHARMACOL BIOCHEM BE, V81, P190, DOI 10.1016/j.pbb.2005.03.013; Voon V, 2006, NEUROLOGY, V67, P1254, DOI 10.1212/01.wnl.0000238503.20816.13; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969	18	110	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2479	10.1371/journal.pone.0002479	http://dx.doi.org/10.1371/journal.pone.0002479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575579	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000010
J	Rotolo, S; Ceccarelli, S; Romano, F; Frati, L; Marchese, C; Angeloni, A				Rotolo, Sabrina; Ceccarelli, Simona; Romano, Ferdinando; Frati, Luigi; Marchese, Cinzia; Angeloni, Antonio			Silencing of Keratinocyte Growth Factor Receptor Restores 5-Fluorouracil and Tamoxifen Efficacy on Responsive Cancer Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN BREAST-CANCER; FACTOR EXPRESSION; MCF-7 CELLS; KGF; INHIBITION; MIGRATION; APOPTOSIS; MOTILITY; DIFFERENTIATION	Background: Keratinocyte growth factor receptor (KGFR) is a splice variant of the FGFR2 gene expressed in epithelial cells. Activation of KGFR is a key factor in the regulation of physiological processes in epithelial cells such as proliferation, differentiation and wound healing. Alterations of KGFR signaling have been linked to the pathogenesis of different epithelial tumors. It has been also hypothesized that its specific ligand, KGF, might contribute to the development of resistance to 5-fluorouracil (5-FU) in epithelial cancers and tamoxifen in estrogen-positive breast cancers. Methodology/Principal Findings: Small interfering RNA was transfected into a human keratinocyte cell line (HaCaT), a breast cancer derived cell line (MCF-7) and a keratinocyte primary culture (KCs) to induce selective downregulation of KGFR expression. A strong and highly specific reduction of KGFR expression was observed at both RNA (reduction = 75.7%, P = 0.009) and protein level. KGFR silenced cells showed a reduced responsiveness to KGF treatment as assessed by measuring proliferation rate (14.2% versus 39.0% of the control cells, P<0.001) and cell migration (24.6% versus 96.4% of the control cells, P = 0.009). In mock-transfected MCF-7 cells, KGF counteracts the capacity of 5-FU to inhibit cell proliferation, whereas in KGFR silenced cells KGF weakly interferes with 5-FU antiproliferative effect (11.2% versus 28.4% of the control cells, P = 0.002). The capacity of 5-FU to induce cell death is abrogated by co-treatment with KGF, whereas in KGFR silenced cells 5-FU efficiently induces cell death even combined to KGF, as determined by evaluating cell viability. Similarly, the capacity of tamoxifen to inhibit MCF-7 and KCs proliferation is highly reduced by KGF treatment and is completely restored in KGFR silenced cells (12.3% versus 45.5% of the control cells, P<0.001). Conclusions/Significance: These findings suggest that selective inhibition of the KGF/KGFR pathway may provide a useful tool to ameliorate the efficacy of the therapeutic strategies for certain epithelial tumors.	[Rotolo, Sabrina; Ceccarelli, Simona; Romano, Ferdinando; Frati, Luigi; Marchese, Cinzia; Angeloni, Antonio] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Frati, Luigi] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy	Sapienza University Rome; IRCCS Neuromed	Rotolo, S (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy.	antonio.angeloni@uniroma1.it	Frati, Luigi/ABI-7437-2020; Ceccarelli, Simona/J-4086-2018; Angeloni, Antonio/J-9392-2018; Marchese, Cinzia/J-1323-2018	Ceccarelli, Simona/0000-0001-8789-7719; Angeloni, Antonio/0000-0003-4969-9548; MARCHESE, CINZIA/0000-0002-9280-8917	MIUR; Cofin 2005; Regione Lazio; Progetto di Ricerca Finalizzata 2005	MIUR(Ministry of Education, Universities and Research (MIUR)); Cofin 2005(Ministry of Education, Universities and Research (MIUR)); Regione Lazio(Regione Lazio); Progetto di Ricerca Finalizzata 2005	This work was partially supported by grants from the MIUR, Cofin 2005, and from Regione Lazio grant issued for Progetto di Ricerca Finalizzata 2005. Funders were not directly nor indirectly involved in designing or conducting the study in any part.	Adamo V, 2007, ANN ONCOL, V18, P53, DOI 10.1093/annonc/mdm225; Bansal GS, 1997, BRIT J CANCER, V75, P1567, DOI 10.1038/bjc.1997.269; Carstens RP, 1997, ONCOGENE, V15, P3059, DOI 10.1038/sj.onc.1201498; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Chang HL, 2006, ANTICANCER RES, V26, P1773; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Crescioli C, 2002, PROSTATE, V50, P15, DOI 10.1002/pros.10028; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farrell CL, 1998, CANCER RES, V58, P933; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Galiacy S, 2003, EXP CELL RES, V283, P215, DOI 10.1016/S0014-4827(02)00049-6; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Hines MD, 1996, J BIOL CHEM, V271, P6245, DOI 10.1074/jbc.271.11.6245; Hishikawa Y, 2004, ARCH HISTOL CYTOL, V67, P455, DOI 10.1679/aohc.67.455; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; HUSEBY RA, 1984, CANCER RES, V44, P2654; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; KOOS RD, 1993, J STEROID BIOCHEM, V45, P217, DOI 10.1016/0960-0760(93)90335-T; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lotti LV, 2007, J CELL PHYSIOL, V212, P633, DOI 10.1002/jcp.21056; Lu YB, 2003, J BIOL CHEM, V278, P10374, DOI 10.1074/jbc.M205875200; MARCHESE C, 1995, J EXP MED, V182, P1369, DOI 10.1084/jem.182.5.1369; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Matsunobu T, 2006, INT J ONCOL, V28, P307; McLeskey SW, 1998, CLIN CANCER RES, V4, P697; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Nagy N, 2006, EXP DERMATOL, V15, P596, DOI 10.1111/j.1600-0625.2006.00450.x; Nguyen TN, 2002, PHARMACOL RES, V46, P179, DOI 10.1016/S1043-6618(02)00085-3; Nurcombe V, 2000, J BIOL CHEM, V275, P30009, DOI 10.1074/jbc.M003038200; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Panici PB, 2007, HUM REPROD, V22, P2025, DOI 10.1093/humrep/dem096; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221; Shin EY, 2000, J CANCER RES CLIN, V126, P519, DOI 10.1007/s004320000128; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Tamaru N, 2004, LAB INVEST, V84, P1460, DOI 10.1038/labinvest.3700166; Tschaharganeh D, 2007, PATHOL ONCOL RES, V13, P84, DOI 10.1007/BF02893482; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Tsukioka Y, 2001, JPN J CLIN ONCOL, V31, P450, DOI 10.1093/jjco/hye091; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zang XP, 2003, ANTICANCER RES, V23, P4913; Zang XP, 2001, CLIN EXP METASTAS, V18, P573; Zhang N, 1998, ACTA PHYS SIN-OV ED, V7, P361; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P11336, DOI 10.1073/pnas.191377098	51	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2528	10.1371/journal.pone.0002528	http://dx.doi.org/10.1371/journal.pone.0002528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575591	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288000043
J	Urich, T; Lanzen, A; Qi, J; Huson, DH; Schleper, C; Schuster, SC				Urich, Tim; Lanzen, Anders; Qi, Ji; Huson, Daniel H.; Schleper, Christa; Schuster, Stephan C.			Simultaneous Assessment of Soil Microbial Community Structure and Function through Analysis of the Meta-Transcriptome	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; NITRITE REDUCTASE; DIVERSITY; ARCHAEA; GENOME; DNA; CRENARCHAEOTA; METAGENOMICS; ASSIMILATION; EXPRESSION	Background: Soil ecosystems harbor the most complex prokaryotic and eukaryotic microbial communities on Earth. Experimental approaches studying these systems usually focus on either the soil community's taxonomic structure or its functional characteristics. Many methods target DNA as marker molecule and use PCR for amplification. Methodology/Principal Findings: Here we apply an RNA-centered meta-transcriptomic approach to simultaneously obtain information on both structure and function of a soil community. Total community RNA is random reversely transcribed into cDNA without any PCR or cloning step. Direct pyrosequencing produces large numbers of cDNA rRNA-tags; these are taxonomically profiled in a binning approach using the MEGAN software and two specifically compiled rRNA reference databases containing small and large subunit rRNA sequences. The pyrosequencing also produces mRNA-tags; these provide a sequence-based transcriptome of the community. One soil dataset of 258,411 RNA-tags of similar to 98 bp length contained 193,219 rRNA-tags with valid taxonomic information, together with 21,133 mRNA-tags. Quantitative information about the relative abundance of organisms from all three domains of life and from different trophic levels was obtained in a single experiment. Less frequent taxa, such as soil Crenarchaeota, were well represented in the data set. These were identified by more than 2,000 rRNA-tags; furthermore, their activity in situ was revealed through the presence of mRNA-tags specific for enzymes involved in ammonia oxidation and CO2 fixation. Conclusions/Significance: This approach could be widely applied in microbial ecology by efficiently linking community structure and function in a single experiment while avoiding biases inherent in other methods.	[Urich, Tim; Schleper, Christa] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Urich, Tim; Schleper, Christa] Univ Vienna, Vienna Ecol Ctr, Dept Genet Ecol, Vienna, Austria; [Lanzen, Anders] Univ Bergen, Bergen Ctr Computat Sci, Computat Biol Unit, Bergen, Norway; [Qi, Ji; Schuster, Stephan C.] Penn State Univ, Ctr Comparative Genom & Bioinformat, State Coll, PA USA; [Huson, Daniel H.] Tubingen Univ, Ctr Bioinformat, Tubingen, Germany	University of Bergen; University of Vienna; University of Bergen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Eberhard Karls University of Tubingen	Urich, T (corresponding author), Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway.	Christa.Schleper@univie.ac.at; scs@bx.psu.edu	QI, JI/E-2797-2016; Lanzén, Anders/F-3818-2016; Lanzén, Anders/AAG-5048-2019; Huson, Daniel H./AAC-5494-2019; Schleper, Christa M/C-2567-2013; Urich, Tim/J-8241-2016; Urich, Tim/C-2887-2013	Lanzén, Anders/0000-0002-7138-6364; Lanzén, Anders/0000-0002-7138-6364; Urich, Tim/0000-0002-5718-1354; Schleper, Christa/0000-0002-1918-2735	EMBO [fellowship]; University of Bergen; Gordon and Betty Moore Foundation	EMBO(European Molecular Biology Organization (EMBO)); University of Bergen; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	TU was financially supported by an EMBO long-term fellowship. Part of this project was financed through funding of the University of Bergen given to CS. SCS is funded in part by the Gordon and Betty Moore Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Bremer H, 1996, ESCHERICHIA COLI SAL; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; LIU Z, 2007, NUCL ACIDS RES; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Prosser J.I., 2007, BOOKS SOILS PLANTS, V2nd Edition, P237; Pruesse E, 2007, NUCL ACIDS RES; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Quaiser A, 2002, ENVIRON MICROBIOL, V4, P603, DOI 10.1046/j.1462-2920.2002.00345.x; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHAEFER M, 1990, OECOLOGIA, V82, P128, DOI 10.1007/BF00318544; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Treusch AH, 2004, ENVIRON MICROBIOL, V6, P970, DOI 10.1111/j.1462-2920.2004.00663.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELLER R, 1989, APPL ENVIRON MICROB, V55, P1818, DOI 10.1128/AEM.55.7.1818-1822.1989	45	511	550	2	206	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2527	10.1371/journal.pone.0002527	http://dx.doi.org/10.1371/journal.pone.0002527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575584	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000042
J	Frokjaer-Jensen, C; Ailion, M; Lockery, SR				Frokjaer-Jensen, Christian; Ailion, Michael; Lockery, Shawn R.			Ammonium-Acetate Is Sensed by Gustatory and Olfactory Neurons in Caenorhabditis elegans	PLOS ONE			English	Article								Background: Caenorhabditis elegans chemosensation has been successfully studied using behavioral assays that treat detection of volatile and water soluble chemicals as separate senses, analogous to smell and taste. However, considerable ambiguity has been associated with the attractive properties of the compound ammonium-acetate (NH(4)Ac). NH(4)Ac has been used in behavioral assays both as a chemosensory neutral compound and as an attractant. Methodology/Main Findings: Here we show that over a range of concentrations NH(4)Ac can be detected both as a water soluble attractant and as an odorant, and that ammonia and acetic acid individually act as olfactory attractants. We use genetic analysis to show that NaCl and NH(4)Ac sensation are mediated by separate pathways and that ammonium sensation depends on the cyclic nucleotide gated ion channel TAX-2/TAX-4, but acetate sensation does not. Furthermore we show that sodium-acetate (NaAc) and ammonium-chloride (NH(4)Cl) are not detected as Na(+) and Cl(-) specific stimuli, respectively. Conclusions/Significance: These findings clarify the behavioral response of C. elegans to NH(4)Ac. The results should have an impact on the design and interpretation of chemosensory experiments studying detection and adaptation to soluble compounds in the nematode Caenorhabditis elegans.	[Frokjaer-Jensen, Christian; Ailion, Michael; Lockery, Shawn R.] Univ Oregon, Inst Neurosci, Eugene, OR USA	University of Oregon	Frokjaer-Jensen, C (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR USA.	shawn@chinook.uoregon.edu	Frøkjær-Jensen, Christian/ABB-4637-2020; Ailion, Michael/ABE-6210-2021	Ailion, Michael/0000-0002-8070-1362; Frokjaer-Jensen, Christian/0000-0002-3178-0906	American Heart Association Pacific Mountain Affiliate; Fonden af 17.12.1981; Helen Hay Whitney Postdoctoral Fellowship; National Institute of Health National Center for Research Resources (NCRR) [MH-051383]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051383, R01MH051383, R21MH112105] Funding Source: NIH RePORTER	American Heart Association Pacific Mountain Affiliate(American Heart Association); Fonden af 17.12.1981; Helen Hay Whitney Postdoctoral Fellowship; National Institute of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CFJ was funded by predoctoral fellowships from "American Heart Association Pacific Mountain Affiliate" and "Fonden af 17.12.1981". MA was supported by a Helen Hay Whitney Postdoctoral Fellowship. The Caenorhabditis Genetics Center supplied strains and is funded by the National Institute of Health National Center for Research Resources (NCRR). Supported by National Institute of Health MH-051383.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2004, CURR OPIN NEUROBIOL, V14, P22, DOI 10.1016/j.conb.2004.01.006; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Saeki S, 2001, J EXP BIOL, V204, P1757; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; VOWELS JJ, 1994, GENETICS, V138, P303; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686	37	15	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2467	10.1371/journal.pone.0002467	http://dx.doi.org/10.1371/journal.pone.0002467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560547	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700048
J	Prins, KW; Lowe, DA; Ervasti, JM				Prins, Kurt W.; Lowe, Dawn A.; Ervasti, James M.			Skeletal Muscle-Specific Ablation of gamma(cyto)-Actin Does Not Exacerbate the mdx Phenotype	PLOS ONE			English	Article								We previously documented a ten-fold increase in gamma(cyto)-actin expression in dystrophin-deficient skeletal muscle and hypothesized that increased gamma(cyto)-actin expression may participate in an adaptive cytoskeletal remodeling response. To explore whether increased gamma(cyto)-actin fortifies the cortical cytoskeleton in dystrophic skeletal muscle, we generated double knockout mice lacking both dystrophin and gamma(cyto)-actin specifically in skeletal muscle (ms-DKO). Surprisingly, dystrophin-deficient mdx and ms-DKO mice presented with comparable levels of myofiber necrosis, membrane instability, and deficits in muscle function. The lack of an exacerbated phenotype in ms-DKO mice suggests gamma(cyt)o-actin and dystrophin function in a common pathway. Finally, because both mdx and ms-DKO skeletal muscle showed similar levels of utrophin expression and presented with identical dystrophies, we conclude utrophin can partially compensate for the loss of dystrophin independent of a gamma(cyto)-actin-utrophin interaction.	[Prins, Kurt W.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Lowe, Dawn A.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Prins, KW (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020	Lowe, Dawn/0000-0002-5784-9289; Prins, Kurt/0000-0002-0364-6742	University of Minnesota Graduate School [Fellowship]; NIH [AR007612, AR049899]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR049899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG020990] Funding Source: NIH RePORTER	University of Minnesota Graduate School(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a University of Minnesota Graduate School Fellowship, the NIH Training Program in Muscle Research (AR007612), and a grant from the National Institutes of Health (AR049899).	Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Chung W, 1999, Mol Cell Biol Res Commun, V2, P162, DOI 10.1006/mcbr.1999.0168; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; EMERY AEH, 1993, NEUROMUSCULAR DISORD, V3, P263, DOI 10.1016/0960-8966(93)90018-F; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hodges BL, 1997, J CELL SCI, V110, P2873; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Porter JD, 1998, J CELL SCI, V111, P1801; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2002, MOL BIOL CELL, V13, P1512, DOI 10.1091/mbc.01-09-0446; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SHARP AH, 1989, J BIOL CHEM, V264, P2816; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; URAYAMA O, 1989, J BIOL CHEM, V264, P8271; Weir AP, 2004, NEUROMUSCULAR DISORD, V14, P19, DOI 10.1016/j.nmd.2003.09.004	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2419	10.1371/journal.pone.0002419	http://dx.doi.org/10.1371/journal.pone.0002419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545671	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800055
J	Dobel, C; Putsche, C; Zwitserlood, P; Junghofer, M				Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus			Early Left-Hemispheric Dysfunction of Face Processing in Congenital Prosopagnosia: An MEG Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN EXTRASTRIATE CORTEX; HUMAN FUSIFORM GYRUS; DEVELOPMENTAL PROSOPAGNOSIA; DETAILED EXPLORATION; INVERTED FACES; IMPAIRED FACE; RECOGNITION; PERCEPTION; BRAIN	Background: Congenital prosopagnosia is a severe face perception impairment which is not acquired by a brain lesion and is presumably present from birth. It manifests mostly by an inability to recognise familiar persons. Electrophysiological research has demonstrated the relevance to face processing of a negative deflection peaking around 170 ms, labelled accordingly as N170 in the electroencephalogram (EEG) and M170 in magnetoencephalography (MEG). The M170 was shown to be sensitive to the inversion of faces and to familiarity-two factors that are assumed to be crucial for congenital prosopagnosia. In order to locate the cognitive dysfunction and its neural correlates, we investigated the time course of neural activity in response to these manipulations. Methodology: Seven individuals with congenital prosopagnosia and seven matched controls participated in the experiment. To explore brain activity with high accuracy in time, we recorded evoked magnetic fields (275 channel whole head MEG) while participants were looking at faces differing in familiarity (famous vs. unknown) and orientation (upright vs. inverted). The underlying neural sources were estimated by means of the least square minimum-norm-estimation (L2-MNE) approach. Principal Findings: The behavioural data corroborate earlier findings on impaired configural processing in congenital prosopagnosia. For the M170, the overall results replicated earlier findings, with larger occipito-temporal brain responses to inverted than upright faces, and more right-than left-hemispheric activity. Compared to controls, participants with congenital prosopagnosia displayed a general decrease in brain activity, primarily over left occipitotemporal areas. This attenuation did not interact with familiarity or orientation. Conclusions: The study substantiates the finding of an early involvement of the left hemisphere in symptoms of prosopagnosia. This might be related to an efficient and overused featural processing strategy which serves as a compensation of impaired configural processing.	[Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus] Munster Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus] Westfalische Wilhelms Univ Munster, Otto Creutzfeldt Ctr, Munster, Germany; [Zwitserlood, Pienie] Westfalische Wilhelms Univ Munster, Dept Psychol, Munster, Germany	University of Munster; University of Munster; University of Munster	Dobel, C (corresponding author), Munster Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany.	cdobel@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986				Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Bobes MA, 2004, COGN NEUROPSYCHOL, V21, P691, DOI 10.1080/02643290342000258; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Collishaw SM, 2000, PERCEPTION, V29, P893, DOI 10.1068/p2949; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Farah M.J., 1990, VISUAL AGNOSIA DISOR; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; FAST K, FAMOUS FACE IN PRESS; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Marotta JJ, 2002, COGN NEUROPSYCHOL, V19, P31, DOI 10.1080/02643290143000079; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; McMullen PA, 2000, NEUROCASE, V6, P403, DOI 10.1080/13554790008402711; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Robbins R, 2003, COGNITION, V88, P79, DOI 10.1016/S0010-0277(03)00020-9; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; ROSSION B, 2000, BEHAV COGN NEUROSCI, V1, P63; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Warrington E, 1992, TESTBATTERIE VISUELL; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	67	29	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2326	10.1371/journal.pone.0002326	http://dx.doi.org/10.1371/journal.pone.0002326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523592	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300021
J	Melchior, L; Kivisild, T; Lynnerup, N; Dissing, J				Melchior, Linea; Kivisild, Toomas; Lynnerup, Niels; Dissing, Jorgen			Evidence of Authentic DNA from Danish Viking Age Skeletons Untouched by Humans for 1,000 Years	PLOS ONE			English	Article							MTDNA HAPLOGROUP-X; ANCIENT HUMAN DNA; MITOCHONDRIAL-DNA; MISCODING LESIONS; ENZYMATIC AMPLIFICATION; MOLECULAR-CLONING; HUMAN-POPULATIONS; PHASE-ANALYSIS; HUMAN REMAINS; FOSSIL BONES	Background: Given the relative abundance of modern human DNA and the inherent impossibility for incontestable proof of authenticity, results obtained on ancient human DNA have often been questioned. The widely accepted rules regarding ancient DNA work mainly affect laboratory procedures, however, pre-laboratory contamination occurring during excavation and archaeological-/anthropological handling of human remains as well as rapid degradation of authentic DNA after excavation are major obstacles. Methodology/Principal Findings: We avoided some of these obstacles by analyzing DNA from ten Viking Age subjects that at the time of sampling were untouched by humans for 1,000 years. We removed teeth from the subjects prior to handling by archaeologists and anthropologists using protective equipment. An additional tooth was removed after standard archaeological and anthropological handling. All pre-PCR work was carried out in a "clean-laboratory" dedicated solely to ancient DNA work. Mitochondrial DNA was extracted and overlapping fragments spanning the HVR-1 region as well as diagnostic sites in the coding region were PCR amplified, cloned and sequenced. Consistent results were obtained with the "unhandled" teeth and there was no indication of contamination, while the latter was the case with half of the "handled" teeth. The results allowed the unequivocal assignment of a specific haplotype to each of the subjects, all haplotypes being compatible in their character states with a phylogenetic tree drawn from present day European populations. Several of the haplotypes are either infrequent or have not been observed in modern Scandinavians. The observation of haplogroup I in the present study (<2% in modern Scandinavians) supports our previous findings of a pronounced frequency of this haplogroup in Viking and Iron Age Danes. Conclusion: The present work provides further evidence that retrieval of ancient human DNA is a possible task provided adequate precautions are taken and well-considered sampling is applied.	[Melchior, Linea; Dissing, Jorgen] Univ Copenhagen, Inst Forens Med, Res Lab, Copenhagen, Denmark; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evol Stud, Cambridge, England; [Lynnerup, Niels] Univ Copenhagen, Inst Forensic Med, Lab Biol Anthropol, Copenhagen, Denmark	University of Copenhagen; University of Cambridge; University of Copenhagen	Melchior, L (corresponding author), Univ Copenhagen, Inst Forens Med, Res Lab, Copenhagen, Denmark.	joergen.dissing@forensic.ku.dk	Kivisild, Toomas/P-5889-2017	Kivisild, Toomas/0000-0002-6297-7808	VELUX FOUNDATION	VELUX FOUNDATION(Velux Fonden)	This work was supported by external funding from the VELUX FOUNDATION. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Allard MW, 2002, J FORENSIC SCI, V47, P1215; Andreasson H, 2002, BIOTECHNIQUES, V33, P402, DOI 10.2144/02332rr07; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2004, AM J HUM GENET, V75, P919, DOI 10.1086/425180; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Buikstra J. E., 1994, STANDARDS DATA COLLE; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Dissing J, 2007, FORENSIC SCI INT, V166, P21, DOI 10.1016/j.forsciint.2006.03.020; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handt O, 1996, AM J HUM GENET, V59, P368; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; ISCAN MY, 1985, J FORENSIC SCI, V30, P853; ISCAN MY, 1984, J FORENSIC SCI, V29, P1094; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kolman CJ, 2000, AM J PHYS ANTHROPOL, V111, P5; Kuch M, 2007, AM J PHYS ANTHROPOL, V132, P594, DOI 10.1002/ajpa.20536; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Melchior L, 2008, AM J PHYS ANTHROPOL, V135, P206, DOI 10.1002/ajpa.20721; Miles A.E.W., 1963, DENT ANTHR, P191, DOI DOI 10.1016/B978-0-08-009823-4.50015-X; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1985, J ARCHAEOL SCI, V12, P411, DOI 10.1016/0305-4403(85)90002-0; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rasmussen EM, 2002, FORENSIC SCI INT, V129, P209, DOI 10.1016/S0379-0738(02)00276-1; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Topf AL, 2006, MOL BIOL EVOL, V23, P152, DOI 10.1093/molbev/msj013; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; [No title captured]	61	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2214	10.1371/journal.pone.0002214	http://dx.doi.org/10.1371/journal.pone.0002214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509537	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500002
J	Oneda, B; Lods, N; Lottaz, D; Becker-Pauly, C; Stocker, W; Pippin, J; Huguenin, M; Ambort, D; Marti, HP; Sterchi, EE				Oneda, Beatrice; Lods, Nadege; Lottaz, Daniel; Becker-Pauly, Christoph; Stoecker, Walter; Pippin, Jeffrey; Huguenin, Maya; Ambort, Daniel; Marti, Hans-Peter; Sterchi, Erwin E.			Metalloprotease Meprin beta in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis	PLOS ONE			English	Article								Meprin (EC 3.4.24.18) is an oligomeric metalloendopeptidase found in microvillar membranes of kidney proximal tubular epithelial cells. Here, we present the first report on the expression of meprin beta in rat glomerular epithelial cells and suggest a potential involvement in experimental glomerular disease. We detected meprin beta in glomeruli of immunostained rat kidney sections on the protein level and by quantitative RT-PCR of laser-capture microdissected glomeruli on the mRNA level. Using immuno-gold staining we identified the membrane of podocyte foot processes as the main site of meprin beta expression. The glomerular meprin beta expression pattern was altered in anti-Thy 1.1 and passive Heymann nephritis (PHN). In addition, the meprin beta staining pattern in the latter was reminiscent of immunostaining with the sheep anti-Fx1A antiserum, commonly used in PHN induction. Using Western blot and immunoprecipitation assays we demonstrated that meprin beta is recognized by Fx1A antiserum and may therefore represent an auto-antigen in PHN. In anti-Thy 1.1 glomerulonephritis we observed a striking redistribution of meprin beta in tubular epithelial cells from the apical to the basolateral side and the cytosol. This might point to an involvement of meprin beta in this form of glomerulonephritis.	[Oneda, Beatrice; Lods, Nadege; Lottaz, Daniel; Huguenin, Maya; Ambort, Daniel; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Becker-Pauly, Christoph; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool, Mainz, Germany; [Pippin, Jeffrey] Univ Washington, Div Nephrol, Seattle, WA USA; [Marti, Hans-Peter] Univ Bern, Div Nephrol Hypertens, Inselspital, Bern, Switzerland	University of Bern; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Bern	Oneda, B (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	erwin.sterchi@mci.unibe.ch	Stöcker, Walter/AAB-9704-2019; Becker-Pauly, Christoph/B-7569-2011	Stöcker, Walter/0000-0002-1515-6994; 	SNF [3100A0-100772, 3200B0-100429, 3200B0-114054/1]	SNF	This work was supported by grants from the SNF to EES (3100A0-100772) and HPM (No. 3200B0-100429 and 3200B0-114054/1 resp.). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2003, KIDNEY INT, V63, P764, DOI 10.1046/j.1523-1755.2003.00791.x; Akagi Y, 1996, KIDNEY INT, V50, P148, DOI 10.1038/ki.1996.297; Asanuma K, 2002, KIDNEY INT, V62, P822, DOI 10.1046/j.1523-1755.2002.00539.x; BAKER PJ, 1989, AM J PATHOL, V135, P185; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Berthier CC, 2006, KIDNEY INT, V69, P358, DOI 10.1038/sj.ki.5000049; BEYNON RJ, 1983, SCIENCE, V219, P1351, DOI 10.1126/science.6338590; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1986, CURR TOP CELL REGUL, V28, P263; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Carmago S, 2002, KIDNEY INT, V61, P959, DOI 10.1046/j.1523-1755.2002.00209.x; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HERZOG C, 2007, KIDNEY INT; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; JOHNSON RJ, 1995, KIDNEY INT, V47, P62, DOI 10.1038/ki.1995.7; KAMATA K, 1985, J IMMUNOL, V135, P2400; KERJASCHKI D, 1987, J EXP MED, V166, P109, DOI 10.1084/jem.166.1.109; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kerjaschki D, 1996, J AM SOC NEPHROL, V7, P2518; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; LE Q, 1991, AM J PHYSIOL, V260, pF555, DOI 10.1152/ajprenal.1991.260.4.F555; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; LOVETT DH, 1992, AM J PATHOL, V141, P85; MARTI HP, 1992, BIOCHEM J, V285, P899, DOI 10.1042/bj2850899; MARTI HP, 1994, AM J PATHOL, V144, P82; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; Mundel P, 1999, EXP NEPHROL, V7, P160; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Ricardo SD, 1996, AM J PHYSIOL-RENAL, V270, pF669, DOI 10.1152/ajprenal.1996.270.4.F669; Sadlier DM, 2004, J BIOL CHEM, V279, P29670, DOI 10.1074/jbc.M313408200; SALANT DJ, 1989, KIDNEY INT, V35, P976, DOI 10.1038/ki.1989.81; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Shankland SJ, 1996, KIDNEY INT, V50, P116, DOI 10.1038/ki.1996.294; Steinmann-Niggli K, 1998, J AM SOC NEPHROL, V9, P397; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P119, DOI 10.1016/0003-9861(88)90377-3; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Turck J, 1996, J BIOL CHEM, V271, P15074, DOI 10.1074/jbc.271.25.15074; Villa JP, 2003, BIOCHEM SOC SYMP, V70, P53, DOI 10.1042/bss0700053; Villa JP, 2003, J BIOL CHEM, V278, P42545, DOI 10.1074/jbc.M303718200; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	64	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2278	10.1371/journal.pone.0002278	http://dx.doi.org/10.1371/journal.pone.0002278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509531	Green Published, gold, Green Accepted			2022-12-27	WOS:000262268500022
J	Dupret, D; Revest, JM; Koehl, M; Ichas, F; De Giorgi, F; Costet, P; Abrous, DN; Piazza, PV				Dupret, David; Revest, Jean-Michel; Koehl, Muriel; Ichas, Francois; De Giorgi, Francesca; Costet, Pierre; Abrous, Djoher Nora; Piazza, Pier Vincenzo			Spatial Relational Memory Requires Hippocampal Adult Neurogenesis	PLOS ONE			English	Article							GENERATED GRANULE CELLS; DENTATE GYRUS; SYNAPTIC PLASTICITY; ENVIRONMENTAL ENRICHMENT; ENHANCES NEUROGENESIS; PATTERN SEPARATION; PLACE NAVIGATION; PROGENITOR CELLS; TRANSGENIC MICE; SWIMMING POOL	The dentate gyrus of the hippocampus is one of the few regions of the mammalian brain where new neurons are generated throughout adulthood. This adult neurogenesis has been proposed as a novel mechanism that mediates spatial memory. However, data showing a causal relationship between neurogenesis and spatial memory are controversial. Here, we developed an inducible transgenic strategy allowing specific ablation of adult-born hippocampal neurons. This resulted in an impairment of spatial relational memory, which supports a capacity for flexible, inferential memory expression. In contrast, less complex forms of spatial knowledge were unaltered. These findings demonstrate that adult-born neurons are necessary for complex forms of hippocampus-mediated learning.	[Dupret, David; Revest, Jean-Michel; Koehl, Muriel; De Giorgi, Francesca; Abrous, Djoher Nora; Piazza, Pier Vincenzo] Inst F Magendie, INSERM, U862, Bordeaux, France; [Dupret, David; Revest, Jean-Michel; Koehl, Muriel; De Giorgi, Francesca; Abrous, Djoher Nora; Piazza, Pier Vincenzo] Univ Bordeaux 2, Bordeaux, France; [Ichas, Francois] Univ Bordeaux 2, Inst Bergonie, INSERM E347, Bordeaux, France; [Costet, Pierre] Univ Bordeaux 2, Lab Transgenese, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux	Dupret, D (corresponding author), Inst F Magendie, INSERM, U862, Bordeaux, France.	abrous@bordeaux.inserm.fr; piazza@bordeaux.inserm.fr	Koehl, Muriel/C-3698-2011; Koehl, Muriel/ABI-2043-2020; Ichas, François/ABD-8277-2020; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Ichas, François/0000-0001-8184-5248; abrous, nora/0000-0002-8589-305X; Dupret, David/0000-0002-0040-1766; De Giorgi, Francesca/0000-0003-4850-3582	INSERM; Agence Nationale pour la Recherche; University of Bordeaux 2	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); University of Bordeaux 2	This work was supported by INSERM, Agence Nationale pour la Recherche (to DNA) and University of Bordeaux 2.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ABROUS DN, 2007, NEUROGENESI IN PRESS; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Desmedt A, 1998, J NEUROSCI, V18, P480; Desmedt A, 2003, EUR J NEUROSCI, V17, P1953, DOI 10.1046/j.1460-9568.2003.02615.x; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Hairston IS, 2005, J NEUROPHYSIOL, V94, P4224, DOI 10.1152/jn.00218.2005; HOFMANN SL, 1988, SCIENCE, V239, P1277, DOI 10.1126/science.3344433; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lindsten T, 2003, J NEUROSCI, V23, P11112; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MANIER M, 1991, NEUROSCIENCE, V42, P427, DOI 10.1016/0306-4522(91)90386-3; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moses SN, 2006, HIPPOCAMPUS, V16, P43, DOI 10.1002/hipo.20131; Nakayama T, 2002, PHARMACOL BIOCHEM BE, V71, P119, DOI 10.1016/S0091-3057(01)00634-7; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nolte C, 2001, GLIA, V33, P72; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE., 2007, DENTATE GYRUS COMPRE; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shastri L, 2002, TRENDS COGN SCI, V6, P162, DOI 10.1016/S1364-6613(02)01868-5; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; SUTHERLAND RJ, 1984, CAN J PSYCHOL, V38, P322, DOI 10.1037/h0080832; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WHISHAW IQ, 1986, J COMP PSYCHOL, V100, P422, DOI 10.1037/0735-7036.100.4.422; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9	81	449	462	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1959	10.1371/journal.pone.0001959	http://dx.doi.org/10.1371/journal.pone.0001959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XD	18509506	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795500029
J	Aksglaede, L; Olsen, LW; Sorensen, TIA; Juul, A				Aksglaede, Lise; Olsen, Lina W.; Sorensen, Thorkild I. A.; Juul, Anders			Forty Years Trends in Timing of Pubertal Growth Spurt in 157,000 Danish School Children	PLOS ONE			English	Article							WEIGHT HEIGHT VELOCITY; ADOLESCENT GROWTH; SECULAR TRENDS; MATHEMATICAL-MODELS; EARLIER MENARCHE; INDIAN BOYS; US GIRLS; AGE; BIRTH; MATURATION	Background: Entering puberty is an important milestone in reproductive life and secular changes in the timing of puberty may be an important indicator of the general reproductive health in a population. Too early puberty is associated with several psychosocial and health problems. The aim of our study was to determine if the age at onset of pubertal growth spurt (OGS) and at peak height velocity (PHV) during puberty show secular trends during four decades in a large cohort of school children. Methods and Findings: Annual measurements of height were available in all children born from 1930 to 1969 who attended primary school in the Copenhagen Municipality. 135,223 girls and 21,612 boys fulfilled the criteria for determining age at OGS and age at PHV. These physiological events were used as markers of pubertal development in our computerized method in order to evaluate any secular trends in pubertal maturation during the study period (year of birth 1930 to 1969). In this period, age at OGS declined statistically significantly by 0.2 and 0.4 years in girls and boys, respectively, whereas age at PHV declined statistically significantly by 0.5 and 0.3 years in girls and boys, respectively. The decline was non-linear with a levelling off in the children born between 1940 and 1955. The duration of puberty, as defined by the difference between age at OGS and age at PHV, increased slightly in boys, whereas it decreased in girls. Conclusion: Our finding of declining age at OGS and at PHV indicates a secular trend towards earlier sexual maturation of Danish children born between 1930 and 1969. Only minor changes were observed in duration of puberty assessed by the difference in ages at OGS and PHV.	[Aksglaede, Lise; Juul, Anders] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Olsen, Lina W.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Society, Inst Prevent Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Aksglaede, L (corresponding author), Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark.	ajuul@rh.dk	Aksglaede, Lise/AAI-7163-2020; Juul, Anders/F-5864-2013	Juul, Anders/0000-0002-0534-4350; Aksglaede, Lise/0000-0001-7885-7467	Danish Medical Research Council; Faculty of Health Sciences, University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Sciences, University of Copenhagen	The study was funded by grants from the Danish Medical Research Council (LWO) and the Faculty of Health Sciences, University of Copenhagen (LA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2006, HUM REPROD UPDATE, V12, P341, DOI 10.1093/humupd/dml018; ANDERSEN E, 1968, ACTA PAEDIAT SCAND S; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Angell-Andersen E, 2004, ANN HUM BIOL, V31, P342, DOI 10.1080/03014460410001685304; BAKER JL, 2008, INT J EPIDE IN PRESS; Biro FM, 2006, J PEDIATR-US, V148, P234, DOI 10.1016/j.jpeds.2005.10.020; BOJLEN K, 1954, Acta Obstet Gynecol Scand, V33, P404; Bonat S, 2002, PEDIATRICS, V110, P743, DOI 10.1542/peds.110.4.743; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FOSTER TA, 1977, AM J CLIN NUTR, V30, P582, DOI 10.1093/ajcn/30.4.582; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HAUSPIE RC, 1989, REV EPIDEMIOL SANTE, V37, P461; Helm P, 1998, ACTA OBSTET GYN SCAN, V77, P198, DOI 10.1034/j.1600-0412.1998.770213.x; HELM P, 1984, ACTA OBSTET GYN SCAN, V63, P633, DOI 10.3109/00016348409155552; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kaplowitz PB, 1999, PEDIATRICS, V104, P936, DOI 10.1542/peds.104.4.936; KAPRIO J, 1995, HUM BIOL, V67, P739; KARLBERG J, 1987, ACTA PAEDIATR SCAND, V76, P478, DOI 10.1111/j.1651-2227.1987.tb10503.x; LEE P A, 1980, Journal of Adolescent Health Care, V1, P26, DOI 10.1016/S0197-0070(80)80005-2; Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E; Martin DD, 2005, HORM RES, V63, P95, DOI 10.1159/000084156; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Papadimitriou A, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e65; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Persson I, 1999, AM J EPIDEMIOL, V150, P747; PREECE MA, 1978, ANN HUM BIOL, V5, P1, DOI 10.1080/03014467800002601; REYNOLDS EL, 1948, AM J DIS CHILD, V75, P329; SATYANARAYANA K, 1989, ANN HUM BIOL, V16, P289, DOI 10.1080/03014468900000422; Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911; TANNER J M, 1953, Lect Sci Basis Med, V1, P308; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; TANNER JM, 1976, ANN HUM BIOL, V3, P109, DOI 10.1080/03014467600001231; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Taranger J, 1976, Acta Paediatr Scand Suppl, P121; Thomis M, 2005, J PEDIATR-US, V146, P239, DOI 10.1016/j.jpeds.2004.09.026; VANNOORD PAH, 1991, ANN HUM BIOL, V18, P57, DOI 10.1080/03014469100001402; Virani N, 2005, ANN HUM BIOL, V32, P259, DOI 10.1080/03014460500068261; WEMBER T, 1992, ANN HUM BIOL, V19, P361, DOI 10.1080/03014469200002232; Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752; ZACHARIAS L, 1983, ANN HUM BIOL, V10, P209, DOI 10.1080/03014468300006381	44	128	128	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2728	10.1371/journal.pone.0002728	http://dx.doi.org/10.1371/journal.pone.0002728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628945	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200066
J	Chastagner, P; Israel, A; Brou, C				Chastagner, Patricia; Israel, Alain; Brou, Christel			AIP4/Itch Regulates Notch Receptor Degradation in the Absence of Ligand	PLOS ONE			English	Article								Background: The regulation of Notch signaling heavily relies on ubiquitination events. Drosophila Su(dx), a member of the HECT family of ubiquitin-ligases, has been described as a negative regulator of Notch signaling, acting on the post-endocytic sorting of Notch. The mammalian ortholog of Su(dx), Itch/AIP4, has been shown to have multiple substrates, including Notch, but the precise events regulated by Itch/AIP4 in the Notch pathway have not been identified yet. Methodology/ Principal Findings: Using Itch-/- fibroblasts expressing the Notch1 receptor, we show that Itch is not necessary for Notch activation, but rather for controlling the degradation of Notch in the absence of ligand. Itch is indeed required after the early steps of Notch endocytosis to target it to the lysosomes where it is degraded. Furthermore Itch/AIP4 catalyzes Notch polyubiquitination through unusual K29-linked chains. We also demonstrate that although Notch is associated with Itch/AIP4 in cells, their interaction is not detectable in vitro and thus requires either a post-translational modification, or a bridging factor that remains to be identified. Conclusions/Significance: Taken together our results identify a specific step of Notch regulation in the absence of any activation and underline differences between mammalian and Drosophila Notch pathways.	[Chastagner, Patricia; Israel, Alain; Brou, Christel] Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chastagner, P (corresponding author), Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	cbrou@pasteur.fr						Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BUSSEAU I, 1994, GENETICS, V136, P585; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Cornell M, 1999, GENETICS, V152, P567; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fostier M, 1998, GENETICS, V150, P1477; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Lallemand F, 2005, J BIOL CHEM, V280, P27645, DOI 10.1074/jbc.M500188200; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014	44	106	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2735	10.1371/journal.pone.0002735	http://dx.doi.org/10.1371/journal.pone.0002735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628966	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200071
J	Choi, SI; Han, KS; Kim, CW; Ryu, KS; Kim, BH; Kim, KH; Kim, SI; Kang, TH; Shin, HC; Lim, KH; Kim, HK; Hyun, JM; Seong, BL				Choi, Seong Il; Han, Kyoung Sim; Kim, Chul Woo; Ryu, Ki-Sun; Kim, Byung Hee; Kim, Kyun-Hwan; Kim, Seo-Il; Kang, Tae Hyun; Shin, Hang-Cheol; Lim, Keo-Heun; Kim, Hyo Kyung; Hyun, Jeong-Min; Seong, Baik L.			Protein Solubility and Folding Enhancement by Interaction with RNA	PLOS ONE			English	Article								While basic mechanisms of several major molecular chaperones are well understood, this machinery has been known to be involved in folding of only limited number of proteins inside the cells. Here, we report a chaperone type of protein folding facilitated by interaction with RNA. When an RNA-binding module is placed at the N-terminus of aggregation-prone target proteins, this module, upon binding with RNA, further promotes the solubility of passenger proteins, potentially leading to enhancement of proper protein folding. Studies on in vitro refolding in the presence of RNA, coexpression of RNA molecules in vivo and the mutants with impaired RNA binding ability suggests that RNA can exert chaperoning effect on their bound proteins. The results suggest that RNA binding could affect the overall kinetic network of protein folding pathway in favor of productive folding over off-pathway aggregation. In addition, the RNA binding-mediated solubility enhancement is extremely robust for increasing soluble yield of passenger proteins and could be usefully implemented for high-throughput protein expression for functional and structural genomic research initiatives. The RNA-mediated chaperone type presented here would give new insights into de novo folding in vivo.	[Choi, Seong Il; Seong, Baik L.] Yonsei Univ, Inst Life Sci & Biotechnol, Seoul, South Korea; [Choi, Seong Il; Han, Kyoung Sim; Kim, Chul Woo; Ryu, Ki-Sun; Kim, Byung Hee; Kim, Seo-Il; Kang, Tae Hyun; Lim, Keo-Heun; Kim, Hyo Kyung; Hyun, Jeong-Min; Seong, Baik L.] Yonsei Univ, Coll Engn, Dept Biotechnol, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Inst Biomed Sci & Technol, Ctr Diagnost Med, Sch Med, Seoul, South Korea; [Shin, Hang-Cheol] Soongsil Univ, CAMDRC, Dept Bioinformat & Life Sci, Seoul, South Korea	Yonsei University; Yonsei University; Konkuk University; Konkuk University Medical Center; Soongsil University	Choi, SI (corresponding author), Yonsei Univ, Inst Life Sci & Biotechnol, Seoul, South Korea.	blseong@yonsei.ac.kr	Kim, Chulwoo/AAL-8854-2021	Kim, Chulwoo/0000-0001-5736-8170; Kim, Kyun-Hwan/0000-0001-5266-072X	21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology, Republic of Korea [MG05-0306-3-0]; Korea Research Foundation [KRF-2004-005-C00148]	21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program, Ministry of Science & Technology (Grant MG05-0306-3-0), Republic of Korea, and by the Korea Research Foundation (Grant KRF-2004-005-C00148).	Alexandrescu AT, 1999, J MOL BIOL, V289, P1041, DOI 10.1006/jmbi.1999.2813; Braun P, 2003, TRENDS BIOTECHNOL, V21, P383, DOI 10.1016/S0167-7799(03)00189-6; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen J, 1998, BIOCHEMISTRY-US, V37, P13643, DOI 10.1021/bi981098l; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; COMMANS S, 1995, J MOL BIOL, V253, P100, DOI 10.1006/jmbi.1995.0539; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; ELLSI RJ, 1999, CURR OPIN STRUC BIOL, V9, P102; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim JM, 2005, CLIN CANCER RES, V11, P473; Kim NS, 2004, GENOMICS, V83, P1024, DOI 10.1016/j.ygeno.2003.12.002; Korber P, 1999, J BIOL CHEM, V274, P249, DOI 10.1074/jbc.274.1.249; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Lee J, 1999, BIOTECHNOL PROGR, V15, P884, DOI 10.1021/bp9900918; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; MILLER MS, 1994, INT J ONCOL, V4, P5; Moore PB, 2001, BIOCHEMISTRY-US, V40, P3243, DOI 10.1021/bi0029402; Nasoff M, 2000, METHOD ENZYMOL, V328, P515, DOI 10.1016/S0076-6879(00)28416-4; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569; Su Y, 2007, J BIOTECHNOL, V129, P373, DOI 10.1016/j.jbiotec.2007.01.015; Tickle I, 2004, CHEM SOC REV, V33, P558, DOI 10.1039/b314510g; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; WALL JG, 1995, CURR OPIN BIOTECH, V6, P507, DOI 10.1016/0958-1669(95)80084-0; Wang CC, 2000, J BIOL CHEM, V275, P17180, DOI 10.1074/jbc.M001057200; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	48	55	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2677	10.1371/journal.pone.0002677	http://dx.doi.org/10.1371/journal.pone.0002677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628952	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200022
J	Wang, R; Wan, Q; Kozhaya, L; Fujii, H; Unutmaz, D				Wang, Rui; Wan, Qi; Kozhaya, Lina; Fujii, Hodaka; Unutmaz, Derya			Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression	PLOS ONE			English	Article								Regulatory T (T-reg) cells control immune activation and maintain tolerance. How T-regs mediate their suppressive function is unclear. Here we identified a cell surface molecule, called GARP, (or LRRC32), which within T cells is specifically expressed in Tregs activated through the T cell receptor (TCR). Ectopic expression of GARP in human naive T (T-N) cells inhibited their proliferation and cytokine secretion upon TCR activation. Remarkably, GARP over-expression in T-N cells induced expression of T-reg master transcription factor Foxp3 and endowed them with a partial suppressive function. The extracellular but not the cytoplasmic region of GARP, was necessary for these functions. Silencing Foxp3 in human Treg cells reduced expression of GARP and attenuated their suppressive function. However, GARP function was not affected when Foxp3 was downregulated in GARP-overexpressing cells, while silencing GARP in Foxp3-overexpressing cells reduced their suppressive activity. These findings reveal a novel cell surface molecule-mediated regulatory mechanism, with implications for modulating aberrant immune responses.	[Wang, Rui; Wan, Qi; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY USA; [Fujii, Hodaka] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Wang, R (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY USA.	Derya@mac.com	Fujii, Hodaka/N-9792-2019; Wan, Qi/F-1694-2013; Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256; Wan, Qi/0000-0003-3726-5187; Fujii, Hodaka/0000-0003-1296-4256	NIH [R01 AI065303, R01 AI059315]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065303, R01AI059315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI065303 to Derya Unutmaz and NIH Grant R01 AI059315 to Hodaka Fujii.	Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hoshino A, 2007, FEBS LETT, V581, P975, DOI 10.1016/j.febslet.2007.01.083; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; MAHNKE K, 2007, EUR J IMMUNOL; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; OLLENDORFF V, 1992, MAMM GENOME, V2, P195, DOI 10.1007/BF00302877; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; PANDIYAN P, 2007, CD4 CD25 FOXP3 REGUL; Pugsley AP, 1990, CURR OPIN CELL BIOL, V2, P609, DOI 10.1016/0955-0674(90)90101-J; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Roubin R, 1996, INT J DEV BIOL, V40, P545; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zenclussen Ana Claudia, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000294	28	117	124	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2705	10.1371/journal.pone.0002705	http://dx.doi.org/10.1371/journal.pone.0002705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628982	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200048
J	Chae, YK; Kang, SK; Kim, MS; Woo, J; Lee, J; Chang, S; Kim, DW; Kim, M; Park, S; Kim, I; Keam, B; Rhee, J; Koo, NH; Park, G; Kim, SH; Jang, SE; Kweon, IY; Sidransky, D; Moon, C				Chae, Young Kwang; Kang, Sung Koo; Kim, Myoung Sook; Woo, Janghee; Lee, Juna; Chang, Steven; Kim, Dong-Wook; Kim, Myungshin; Park, Seonyang; Kim, Inho; Keam, Bhumsuk; Rhee, Jiyoung; Koo, Nam Hee; Park, Gyeongsin; Kim, Soo-Hyun; Jang, Se-Eun; Kweon, Il-Young; Sidransky, David; Moon, Chulso			Human AQP5 Plays a Role in the Progression of Chronic Myelogenous Leukemia (CML)	PLOS ONE			English	Article							WATER PERMEABILITY; BCR-ABL; EXPRESSION; AQUAPORIN-1; CELLS; ANGIOGENESIS; LOCALIZATION; RESISTANCE; APOPTOSIS	Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. In addition, AQP5 expression level increased with the emergence of imatinib mesylate resistance in paired samples (p = 0.047). We have found that the overexpression of AQP5 in K562 cells resulted in increased cell proliferation. In addition, small interfering RNA (siRNA) targeting AQP5 reduced the cell proliferation rate in both K562 and LAMA84 CML cells. Moreover, by immunoblotting and flow cytometry, we show that phosphorylation of BCR-ABL1 is increased in AQP5-overexpressing CML cells and decreased in AQP5 siRNA-treated CML cells. Interestingly, caspase9 activity increased in AQP5 siRNA-treated cells. Finally, FISH showed no evidence of AQP5 gene amplification in CML from bone marrow. In summary, we report for the first time that AQP5 is overexpressed in CML cells and plays a role in promoting cell proliferation and inhibiting apoptosis. Furthermore, our findings may provide the basis for a novel CML therapy targeting AQP5.	[Chae, Young Kwang; Kang, Sung Koo; Kim, Myoung Sook; Woo, Janghee; Lee, Juna; Chang, Steven; Sidransky, David; Moon, Chulso] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Lee, Juna; Moon, Chulso] Johns Hopkins Univ, Sch Med, Grad Program Human Genet, Baltimore, MD USA; [Kim, Dong-Wook; Kim, Soo-Hyun; Jang, Se-Eun; Kweon, Il-Young] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Myungshin] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Seonyang; Kim, Inho; Keam, Bhumsuk; Rhee, Jiyoung; Koo, Nam Hee] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Park, Gyeongsin; Moon, Chulso] Catholic Univ Korea, Coll Med, Dept Hosp Pathol, Seoul, South Korea; [Moon, Chulso] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Catholic University of Korea; Catholic University of Korea; Seoul National University (SNU); Catholic University of Korea; Johns Hopkins University	Chae, YK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	cmoon5@jhmi.edu	Kim, Myungshin/AAP-9262-2020; Kim, Myungshin/AAK-1544-2021; woo, janghee/CAG-2114-2022; Kim, In Ho/J-5428-2012	Kim, Myungshin/0000-0001-8632-0168; Kim, Myungshin/0000-0001-8632-0168; Rhee, Jiyoung/0000-0002-7787-4852	SPORE [P50 CA96784-01]; Pyung-Ya Foundation; Basic Research Program Grant of the Korea Science & Engineering Foundation [R21-2007-000-10041-0]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER	SPORE; Pyung-Ya Foundation; Basic Research Program Grant of the Korea Science & Engineering Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the SPORE grant (P50 CA96784-01), Cancer Research Grant from Pyung-Ya Foundation (C.M.) and the Basic Research Program Grant of the Korea Science & Engineering Foundation (R21-2007-000-10041-0, 2007) (D.K.).	Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; CHAE YK, 2008, PLOS ONE IN PRESS; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; Gresz V, 2004, AM J PHYSIOL-GASTR L, V287, pG151, DOI 10.1152/ajpgi.00480.2003; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Kageyama Y, 1996, J UROLOGY, V156, P291, DOI 10.1016/S0022-5347(01)66019-1; Kang HY, 2006, HAEMATOLOGICA, V91, P659; KANG SK, 2008, AM J PATHOL IN PRESS; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kotton DN, 2001, DEVELOPMENT, V128, P5181; Kotton DN, 2003, CYTOTHERAPY, V5, P169, DOI 10.1080/14653240310001073; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Litzow MR, 2006, ARCH PATHOL LAB MED, V130, P669; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Ravandi F, 2001, CANCER-AM CANCER SOC, V91, P1964, DOI 10.1002/1097-0142(20010601)91:11<1964::AID-CNCR1221>3.0.CO;2-B; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; WOO J, CANC LETT IN PRESS; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054	28	52	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2594	10.1371/journal.pone.0002594	http://dx.doi.org/10.1371/journal.pone.0002594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612408	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800007
J	Joseph, JM; Fey, P; Ramalingam, N; Liu, XI; Rohlfs, M; Noegel, AA; Muller-Taubenberger, A; Glockner, G; Schleicher, M				Joseph, Jayabalan M.; Fey, Petra; Ramalingam, Nagendran; Liu, Xiao I.; Rohlfs, Meino; Noegel, Angelika A.; Mueller-Taubenberger, Annette; Gloeckner, Gernot; Schleicher, Michael			The Actinome of Dictyostelium discoideum in Comparison to Actins and Actin-Related Proteins from Other Organisms	PLOS ONE			English	Article								Actin belongs to the most abundant proteins in eukaryotic cells which harbor usually many conventional actin isoforms as well as actin-related proteins (Arps). To get an overview over the sometimes confusing multitude of actins and Arps, we analyzed the Dictyostelium discoideum actinome in detail and compared it with the genomes from other model organisms. The D. discoideum actinome comprises 41 actins and actin-related proteins. The genome contains 17 actin genes which most likely arose from consecutive gene duplications, are all active, in some cases developmentally regulated and coding for identical proteins (Act8-group). According to published data, the actin fraction in a D. discoideum cell consists of more than 95% of these Act8-type proteins. The other 16 actin isoforms contain a conventional actin motif profile as well but differ in their protein sequences. Seven actin genes are potential pseudogenes. A homology search of the human genome using the most typical D. discoideum actin (Act8) as query sequence finds the major actin isoforms such as cytoplasmic beta-actin as best hit. This suggests that the Act8-group represents a nearly perfect actin throughout evolution. Interestingly, limited data from D. fasciculatum, a more ancient member among the social amoebae, show different relationships between conventional actins. The Act8-type isoform is most conserved throughout evolution. Modeling of the putative structures suggests that the majority of the actin-related proteins is functionally unrelated to canonical actin. The data suggest that the other actin variants are not necessary for the cytoskeleton itself but rather regulators of its dynamical features or subunits in larger protein complexes.	[Joseph, Jayabalan M.; Ramalingam, Nagendran; Rohlfs, Meino; Mueller-Taubenberger, Annette; Schleicher, Michael] Univ Munich, Adolf Butenandt Inst Cell Biol, Munich, Germany; [Fey, Petra] Northwestern Univ, Ctr Genet Med, Chicago, IL USA; [Liu, Xiao I.] Ludwig Maximilians Univ Munchen, Dept Biol II, Munich, Germany; [Noegel, Angelika A.] University of Cologne, CECAD, CMMC, Inst Biochem I, Cologne, Germany; [Gloeckner, Gernot] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	University of Munich; Northwestern University; University of Munich; University of Cologne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Joseph, JM (corresponding author), Univ Munich, Adolf Butenandt Inst Cell Biol, Munich, Germany.	schleicher@lrz.uni-muenchen.de	Glöckner, Gernot/A-7800-2010; Müller-Taubenberger, Annette/AAM-3671-2021; Müller-Taubenberger, Annette/AAG-8538-2020; Fey, Petra/O-5977-2015	Glöckner, Gernot/0000-0002-9061-1061; Müller-Taubenberger, Annette/0000-0003-1163-9232; Fey, Petra/0000-0002-4532-2703; Rohlfs, Meino/0000-0002-2251-2387				Booth EO, 2005, BIOINFORMATICS, V21, P4371, DOI 10.1093/bioinformatics/bti726; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Boyer LA, 2000, BIOESSAYS, V22, P666, DOI 10.1002/1521-1878(200007)22:7<666::AID-BIES9>3.0.CO;2-Y; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis Melissa B, 2004, Genome Biol, V5, P339, DOI 10.1186/gb-2004-5-8-339; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FIRTEL RA, 1981, CELL, V24, P6, DOI 10.1016/0092-8674(81)90494-3; FIRTEL RA, 1979, P NATL ACAD SCI USA, V76, P6206, DOI 10.1073/pnas.76.12.6206; Frankel S, 1996, CURR OPIN CELL BIOL, V8, P30, DOI 10.1016/S0955-0674(96)80045-7; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; Kalay E, 2007, AM J MED GENET A, V143A, P2382, DOI 10.1002/ajmg.a.31937; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KESSIN RH, 2006, SECRET LIVES DICTYOS; Kishi Y, 1998, J CELL SCI, V111, P2923; Kishi Y, 2000, EXP CELL RES, V261, P187, DOI 10.1006/excr.2000.5061; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; MCKEOWN M, 1978, CELL, V15, P789, DOI 10.1016/0092-8674(78)90264-7; MCKEOWN M, 1981, CELL, V24, P799, DOI 10.1016/0092-8674(81)90105-7; McKinney EC, 1998, GENETICS, V149, P663; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rivero F, 2007, ADV EXP MED BIOL, V607, P97; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROMANS P, 1985, J MOL BIOL, V183, P311, DOI 10.1016/0022-2836(85)90003-8; ROMANS P, 1985, J MOL BIOL, V186, P321, DOI 10.1016/0022-2836(85)90108-1; ROMANS P, 1985, J MOL BIOL, V186, P337, DOI 10.1016/0022-2836(85)90109-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUBENSTEIN P, 1981, J BIOL CHEM, V256, P8149; RUBENSTEIN P, 1979, J BIOL CHEM, V254, P1142; Sameshima M, 2002, J ELECTRON MICROSC, V51, P337, DOI 10.1093/jmicro/51.5.337; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; Sameshima M, 2000, CELL STRUCT FUNCT, V25, P291, DOI 10.1247/csf.25.291; SAMESHIMA M, 1994, CELL STRUCT FUNCT, V19, P189, DOI 10.1247/csf.19.189; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Schleicher M, 2008, HISTOCHEM CELL BIOL, V129, P695, DOI 10.1007/s00418-008-0430-y; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SCHWEIGER A, 1992, J CELL SCI, V102, P601; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; STADLER J, 1985, EMBO J, V4, P1153, DOI 10.1002/j.1460-2075.1985.tb03753.x; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VANDEKERCKHOVE J, 1980, NATURE, V284, P475, DOI 10.1038/284475a0; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	66	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2654	10.1371/journal.pone.0002654	http://dx.doi.org/10.1371/journal.pone.0002654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612387	gold, Green Published, Green Submitted			2022-12-27	WOS:000264065800056
J	Laopaiboon, M; Lumbiganon, P; McDonald, SJ; Henderson-Smart, DJ; Green, S; Crowther, CA; Laopaiboon, M; McDonald, SJ; Lumbiganon, P; Festin, MR; Ho, JJ; Hakimi, M; Henderson-Smart, DJ; Green, S; Crowther, CA; McDonald, SJ; Thomas, M; Narash, N; Ewens, M; Hakimi, M; Supriyah; Amanah, L; Lukitasari, D; Astuti, D; Amanah, L; Amanah, L; Lukitasari, D; Astuti, D; Ho, JJ; Cham, SS; Cham, SS; Aw, ET; Cham, SS; Lumbiganon, P; Khianman, B; Pharprapa, A; Nachaipet, J; Narash, N; Poombankor, R; Saenrien, B; Srisutthikamol, N; Panikom, S; Khunudom, C; Thipawat, S; Choonhapran, S; Nuanbuddee, S; Jarudphan, P; Hempira, A; Narash, N; Poombankor, R; Tharnprisan, P; Sarapon, P; Ponpun, O; Narash, N; Poombankor, R; Festin, MR; Ubaldo-Anzures, C; Canete, LN; Festin, JL; Torralba, E; Canete, LN; Magsipoc; Festin, JL; Henderson-Smart, D; Green, S; Crowther, CA; McDonald, SJ				Laopaiboon, M.; Lumbiganon, P.; McDonald, S. J.; Henderson-Smart, D. J.; Green, S.; Crowther, C. A.; Laopaiboon, M.; McDonald, S. J.; Lumbiganon, P.; Festin, M. R.; Ho, J. J.; Hakimi, M.; Henderson-Smart, D. J.; Green, S.; Crowther, C. A.; McDonald, S. J.; Thomas, M.; Narash, N.; Ewens, M.; Hakimi, M.; Supriyah; Amanah, L.; Lukitasari, D.; Astuti, D.; Amanah, L.; Amanah, L.; Lukitasari, D.; Astuti, D.; Ho, J. J.; Cham, S. S.; Cham, S. S.; Aw, E. T.; Cham, S. S.; Lumbiganon, P.; Khianman, B.; Pharprapa, A.; Nachaipet, J.; Narash, N.; Poombankor, R.; Saenrien, B.; Srisutthikamol, N.; Panikom, S.; Khunudom, C.; Thipawat, S.; Choonhapran, S.; Nuanbuddee, S.; Jarudphan, P.; Hempira, A.; Narash, N.; Poombankor, R.; Tharnprisan, P.; Sarapon, P.; Ponpun, O.; Narash, N.; Poombankor, R.; Festin, M. R.; Ubaldo-Anzures, C.; Canete, L. N.; Festin, J. L.; Torralba, E.; Canete, L. N.; Magsipoc; Festin, J. L.; Henderson-Smart, D.; Green, S.; Crowther, C. A.; McDonald, S. J.			Use of Evidence-Based Practices in Pregnancy and Childbirth: South East Asia Optimising Reproductive and Child Health in Developing Countries Project	PLOS ONE			English	Article								Background: The burden of mortality and morbidity related to pregnancy and childbirth remains concentrated in developing countries. SEA-ORCHID ( South East Asia Optimising Reproductive and Child Health In Developing countries) is evaluating whether a multifaceted intervention to strengthen capacity for research synthesis, evidence-based care and knowledge implementation improves adoption of best clinical practice recommendations leading to better health for mothers and babies. In this study we assessed current practices in perinatal health care in four South East Asian countries and determined whether they were aligned with best practice recommendations. Methodology/Principal Findings: We completed an audit of 9550 medical records of women and their 9665 infants at nine hospitals; two in each of Indonesia, Malaysia and The Philippines, and three in Thailand between January-December 2005. We compared actual clinical practices with best practice recommendations selected from the Cochrane Library and the World Health Organization Reproductive Health Library. Evidence-based components of the active management of the third stage of labour and appropriately treating eclampsia with magnesium sulphate were universally practiced in all hospitals. Appropriate antibiotic prophylaxis for caesarean section, a beneficial form of care, was practiced in less than 5% of cases in most hospitals. Use of the unnecessary practices of enema in labour ranged from 1% to 61% and rates of episiotomy for vaginal birth ranged from 31% to 95%. Other appropriate practices were commonly performed to varying degrees between countries and also between hospitals within the same country. Conclusions/Significance: Whilst some perinatal health care practices audited were consistent with best available evidence, several were not. We conclude that recording of clinical practices should be an essential step to improve quality of care. Based on these findings, the SEA-ORCHID project team has been developing and implementing interventions aimed at increasing compliance with evidence-based clinical practice recommendations to improve perinatal practice in South East Asia.					Ho, Jacqueline/E-5690-2015; Ho, Jacqueline J/AAN-4341-2020; Lumbiganon, Pisake/E-8634-2010; Hakimi, Mohammad/GOV-6587-2022; Withinunthakit, Siriporn/E-6131-2010; McDonald, Steve/AAE-1613-2020	Ho, Jacqueline/0000-0001-9939-7551; Ho, Jacqueline J/0000-0001-9939-7551; Lumbiganon, Pisake/0000-0001-9372-0071; McDonald, Steve/0000-0003-2832-5205	National Health and Medical Research Council of Australia [307703]; Wellcome Trust, United Kingdom [071672/Z/03/Z]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, United Kingdom(Wellcome Trust)	This study is jointly funded by an International Collaborative Research Grant from the National Health and Medical Research Council of Australia (No. 307703) and Wellcome Trust, United Kingdom (071672/Z/03/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basevi V, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001236; Brown H, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-7; Carroli G., 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000081, DOI 10.1002/14651858.CD000081]; *CHOIC CHALL CHANG, 2005, INT J OBSTET GYNECOL, V112, P1270; *COCHR LIB, 2004, CHICH; Cuervo L, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000330; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; C-L D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006116.pub2; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000127; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000128; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; *GLOB HLTH COUNC, 2002, MAK CHILDB SAF PROM; Henderson-Smart DJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-43; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; Khalil K, 2005, BIRTH-ISS PERINAT C, V32, P283, DOI 10.1111/j.0730-7659.2005.00385.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Qian Xu, 2001, BMC Pregnancy Childbirth, V1, P1, DOI 10.1186/1471-2393-1-1; *RES WHO DEP REPR, MAT MORT 2000 EST DE; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; *STATACORP, 2003, STAT STAT SOFTW REL; *WHO REPR HLTH LIB, 2004, UPD SOFTW, V7; S AFRICAN MED J, V94, P117	25	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2646	10.1371/journal.pone.0002646	http://dx.doi.org/10.1371/journal.pone.0002646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612381	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800048
J	Abraham, JM; Cheng, YL; Hamilton, JP; Paun, B; Jin, Z; Agarwal, R; Kan, T; David, S; Olaru, A; Yang, J; Ito, T; Selaru, FM; Mori, Y; Meltzer, SJ				Abraham, John M.; Cheng, Yulan; Hamilton, James P.; Paun, Bogdan; Jin, Zhe; Agarwal, Rachana; Kan, Takatsugu; David, Stefan; Olaru, Alexandru; Yang, Jian; Ito, Tetsuo; Selaru, Florin M.; Mori, Yuriko; Meltzer, Stephen J.			Generation of Small P-32-Labeled Peptides as a Potential Approach to Colorectal Cancer Therapy	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BREAST-CANCER; SOLID TUMORS; LOW-GRADE; RADIOIMMUNOTHERAPY; CHEMOTHERAPY; TRIAL; PLUS; TRASTUZUMAB	Cancers have been revealed to be extremely heterogenous in terms of the frequency and types of mutations present in cells from different malignant tumors. Thus, it is likely that uniform clinical treatment is not optimal for all patients, and that the development of individualized therapeutic regimens may be beneficial. We describe the generation of multiple, unique small peptides nine to thirty-four amino acids in length which, when labeled with the radioisotope P-32, bind with vastly differing efficiencies to cell lines derived from different colon adenocarcinomas. In addition, the most effective of these peptides permanently transfers the P-32 radioisotope to colorectal cancer cellular proteins within two hours at a rate that is more than 150 times higher than in cell lines derived from other cancers or from the normal tissues tested. Currently, the only two FDA-approved radioimmunotherapeutic agents in use both employ antibodies directed against the B cell marker CD20 for the treatment of non-Hodgkin's lymphoma. By using the method described herein, large numbers of different P-32-labeled peptides can be readily produced and assayed against a broad spectrum of cancer types. This report proposes the development and use of P-32-labeled peptides as potential individualized peptide-binding therapies for the treatment of colon adenocarcinoma patients.	[Abraham, John M.; Cheng, Yulan; Hamilton, James P.; Paun, Bogdan; Jin, Zhe; Agarwal, Rachana; Kan, Takatsugu; David, Stefan; Olaru, Alexandru; Yang, Jian; Ito, Tetsuo; Selaru, Florin M.; Mori, Yuriko; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehensive Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Abraham, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	Jabrah14@jhmi.edu		Selaru, Florin/0000-0001-7990-8238	National Cancer Institute [2RO1CA095323-14, 2RO1CA077057-09, 1R01CA001808-05, 7R21/R33CA106763]; NATIONAL CANCER INSTITUTE [R01CA077057, R01CA001808, R21CA106763, R01CA095323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants 2RO1CA095323-14, 2RO1CA077057-09, 1R01CA001808-05 and 7R21/R33CA106763 from the National Cancer Institute.	Abraham JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000964; Aina OH, 2005, MOL CANCER THER, V4, P806, DOI 10.1158/1535-7163.MCT-05-0029; Aina OH, 2002, BIOPOLYMERS, V66, P184, DOI 10.1002/bip.10257; Bertagnolli MM, 2005, CLIN CANCER RES, V11, P4637, DOI 10.1158/1078-0432.CCR-05-0485; Boerman OC, 2007, ANTI-CANCER AGENT ME, V7, P335, DOI 10.2174/187152007780618126; Brans B, 2006, EUR J CANCER, V42, P994, DOI 10.1016/j.ejca.2005.12.020; Cilley JC, 2007, EXPERT OPIN BIOL TH, V7, P739, DOI 10.1517/14712598.7.5.739; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; EMIR EE, 2007, CANCER RES, V67, P11896; Jain M, 2007, CLIN CANCER RES, V13, P1374, DOI 10.1158/1078-0432.CCR-06-2436; Kreitman RJ, 2003, CURR OPIN MOL THER, V5, P44; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kreitman RJ, 2006, CURR DRUG TARGETS, V7, P1301, DOI 10.2174/138945006778559139; Okarvi SM, 2004, MED RES REV, V24, P357, DOI 10.1002/med.20002; Reilly RM, 2006, J NUCL MED, V47, P196; Rini BI, 2007, CLIN CANCER RES, V13, p741S, DOI 10.1158/1078-0432.CCR-06-2110; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vose JM, 2004, ONCOLOGIST, V9, P160, DOI 10.1634/theoncologist.9-2-160; Wangler C, 2007, PROTEIN PEPTIDE LETT, V14, P273, DOI 10.2174/092986607780090874; Wiseman GA, 2001, CRIT REV ONCOL HEMAT, V39, P181, DOI 10.1016/S1040-8428(01)00107-X; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2508	10.1371/journal.pone.0002508	http://dx.doi.org/10.1371/journal.pone.0002508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575578	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000027
J	Edwards, AO; Lee, SJ; Fridley, BL; Tosakulwong, N				Edwards, Albert O.; Lee, Sung J.; Fridley, Brooke L.; Tosakulwong, Nirubol			Density of Common Complex Ocular Traits in the Aging Eye: Analysis of Secondary Traits in Genome-Wide Association Studies	PLOS ONE			English	Article								Genetic association studies are identifying genetic risks for common complex ocular traits such as age-related macular degeneration (AMD). The subjects used for discovery of these loci have been largely from clinic-based, case-control studies. Typically, only the primary phenotype (e.g., AMD) being studied is systematically documented and other complex traits (e.g., affecting the eye) are largely ignored. The purpose of this study was to characterize these other or secondary complex ocular traits present in the cases and controls of clinic-based studies being used for genetic study of AMD. The records of 100 consecutive new patients (of any diagnosis) age 60 or older for which all traits affecting the eye had been recorded systematically were reviewed. The average patient had 3.5 distinct diagnoses. A subset of 10 complex traits was selected for further study because they were common and could be reliably diagnosed. The density of these 10 complex ocular traits increased by 0.017 log-traits/year (P = 0.03), ranging from a predicted 2.74 at age 60 to 4.45 at age 90. Trait-trait association was observed only between AMD and primary vitreomacular traction (P = 0.0009). Only 1% of subjects age 60 or older had no common complex traits affecting the eye. Extrapolations suggested that a study of 2000 similar subjects would have sufficient power to detect genetic association with an odds ratio of 2.0 or less for 4 of these 10 traits. In conclusion, the high prevalence of complex traits affecting the aging eye and the inherent biases in referral patterns leads to the potential for confounding by undocumented secondary traits within case-control studies. In addition to the primary trait, other common ocular phenotypes should be systematically documented in genetic association studies so that adjustments for potential trait-trait associations and other bias can be made and genetic risk variants identified in secondary analyses.	[Edwards, Albert O.; Lee, Sung J.; Tosakulwong, Nirubol] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Fridley, Brooke L.] Mayo Clin, Div Biostat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Edwards, AO (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	edwardslab@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	Foundation Fighting Blindness, Owing Mills, MD [EY014467]; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; Mayo Clinic Foundation; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Mayo Clinic Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by EY014467, the Foundation Fighting Blindness, Owing Mills, MD, the American Health Assistance Foundation, Clarksburg, MD, unrestricted departmental grants from Research to Prevent Blindness, New York, NY, and the Mayo Clinic Foundation. The sole role of the sponsors was to provide funding.	Arnarsson A, 2007, ACTA OPHTHALMOL SCAN, V85, P822, DOI 10.1111/j.1600-0420.2007.01051.x; Black GCM, 2003, HUM MOL GENET, V12, P3269, DOI 10.1093/hmg/ddg356; Boutboul S, 2006, HUM MUTAT, V27, P553, DOI 10.1002/humu.20331; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Chen CYC, 2007, HUM GENET, V121, P511, DOI 10.1007/s00439-006-0312-0; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; EDWARDS AO, 2007, ANGIOGENESI IN PRESS; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Girmens JF, 2008, EYE, V22, P308, DOI 10.1038/sj.eye.6702672; Go SL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1237, DOI 10.1001/archopht.123.9.1237; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; He MG, 2008, INVEST OPHTH VIS SCI, V49, P81, DOI 10.1167/iovs.07-1052; Hejtmancik JF, 2004, EXP EYE RES, V79, P3, DOI 10.1016/j.exer.2004.03.014; HEJTMANCIK JF, 2008, AM J HUM GE IN PRESS; Hopper JL, 2005, LANCET, V366, P1397, DOI 10.1016/S0140-6736(05)67570-8; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Khan AO, 2006, OPHTHALMOLOGY, V113, P2374, DOI 10.1016/j.ophtha.2006.07.020; Kitagawa K, 2002, OPHTHALMIC RES, V34, P135, DOI 10.1159/000063656; Klein AP, 2005, AM J EPIDEMIOL, V161, P707, DOI 10.1093/aje/kwi102; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krebs I, 2007, AM J OPHTHALMOL, V144, P741, DOI 10.1016/j.ajo.2007.07.024; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lalin SC, 2004, AM J OPHTHALMOL, V138, P608, DOI 10.1016/j.ajo.2004.06.013; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Matsuda A, 2007, INVEST OPHTH VIS SCI, V48, P583, DOI 10.1167/iovs.06-0991; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 1997, OPHTHALMOLOGY, V104, P581, DOI 10.1016/S0161-6420(97)30266-8; Mitchell P, 1999, ARCH OPHTHALMOL-CHIC, V117, P1319, DOI 10.1001/archopht.117.10.1319; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; Ondes F, 2000, JPN J OPHTHALMOL, V44, P91, DOI 10.1016/S0021-5155(99)00174-4; Peet JA, 2007, INVEST OPHTH VIS SCI, V48, P4002, DOI 10.1167/iovs.06-1388; Rao G. Prasad, 1998, Indian Journal of Ophthalmology, V46, P145; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Schmidt JC, 2006, BRIT J OPHTHALMOL, V90, P1361, DOI 10.1136/bjo.2006.094201; Schmitz-Valckenberg S, 2006, INVEST OPHTH VIS SCI, V47, P2648, DOI 10.1167/iovs.05-0892; Scott A, 2007, AM J OPHTHALMOL, V143, P346, DOI 10.1016/j.ajo.2006.09.022; Snead MP, 2002, EYE, V16, P447, DOI 10.1038/sj.eye.6700198; SNEAD MP, 1994, EYE, V8, P204, DOI 10.1038/eye.1994.47; STRAATSMA BR, 1980, AUST J OPHTHALMOL, V8, P275, DOI 10.1111/j.1442-9071.1980.tb00283.x; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Szijarto Z, 2007, ANN OPHTHALMOL, V39, P134, DOI 10.1007/s12009-007-0014-9; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; Weber-Krause Brigitte, 1996, Ophthalmologe, V93, P660, DOI 10.1007/s003470050054; Weger M, 2005, OPHTHALMOLOGY, V112, P1910, DOI 10.1016/j.ophtha.2005.05.019; WERBLIN TP, 1981, BRIT J OPHTHALMOL, V65, P401, DOI 10.1136/bjo.65.6.401; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038; Young AL, 2004, BRIT J OPHTHALMOL, V88, P193, DOI 10.1136/bjo.2003.021816; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHU G, 2007, OPHTHALMOLOGY; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014	67	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2510	10.1371/journal.pone.0002510	http://dx.doi.org/10.1371/journal.pone.0002510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575587	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000029
J	Nosten-Bertrand, M; Kappeler, C; Dinocourt, C; Denis, C; Germain, J; Tuy, FPD; Verstraeten, S; Alvarez, C; Metin, C; Chelly, J; Giros, B; Miles, R; Depaulis, A; Francis, F				Nosten-Bertrand, Marika; Kappeler, Caroline; Dinocourt, Celine; Denis, Cecile; Germain, Johanne; Tuy, Francoise Phan Dinh; Verstraeten, Soraya; Alvarez, Chantal; Metin, Christine; Chelly, Jamel; Giros, Bruno; Miles, Richard; Depaulis, Antoine; Francis, Fiona			Epilepsy in Dcx Knockout Mice Associated with Discrete Lamination Defects and Enhanced Excitability in the Hippocampus	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; DOUBLE CORTEX SYNDROME; NEUROPEPTIDE-Y; KAINIC ACID; NEURONAL MIGRATION; SEIZURE SUSCEPTIBILITY; CORTICAL DYSPLASIA; DENTATE GYRUS; MOSSY FIBERS; ADULT-RAT	Patients with Doublecortin (DCX) mutations have severe cortical malformations associated with mental retardation and epilepsy. Dcx knockout (KO) mice show no major isocortical abnormalities, but have discrete hippocampal defects. We questioned the functional consequences of these defects and report here that Dcx KO mice are hyperactive and exhibit spontaneous convulsive seizures. Changes in neuropeptide Y and calbindin expression, consistent with seizure occurrence, were detected in a large proportion of KO animals, and convulsants, including kainate and pentylenetetrazole, also induced seizures more readily in KO mice. We show that the dysplastic CA3 region in KO hippocampal slices generates sharp wavelike activities and possesses a lower threshold for epileptiform events. Video-EEG monitoring also demonstrated that spontaneous seizures were initiated in the hippocampus. Similarly, seizures in human patients mutated for DCX can show a primary involvement of the temporal lobe. In conclusion, seizures in Dcx KO mice are likely to be due to abnormal synaptic transmission involving heterotopic cells in the hippocampus and these mice may therefore provide a useful model to further study how lamination defects underlie the genesis of epileptiform activities.	[Nosten-Bertrand, Marika; Denis, Cecile; Germain, Johanne; Verstraeten, Soraya; Giros, Bruno] Univ Paris 06, INSERM, U513, Paris, France; [Nosten-Bertrand, Marika; Denis, Cecile; Germain, Johanne; Verstraeten, Soraya; Giros, Bruno] Univ Paris 06, UMPC, Paris, France; [Kappeler, Caroline; Tuy, Francoise Phan Dinh; Chelly, Jamel; Francis, Fiona] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Kappeler, Caroline; Tuy, Francoise Phan Dinh; Chelly, Jamel; Francis, Fiona] INSERM, U567, Paris, France; [Dinocourt, Celine; Miles, Richard] CHU Pitie Salpetriere, UPMC, INSERM, U739, Paris, France; [Alvarez, Chantal; Metin, Christine] UPMC, Paris, France; [Alvarez, Chantal; Metin, Christine] Inst Fer Moulin, INSERM, U839, Paris, France; [Giros, Bruno] McGill Univ, Douglas Hosp Res Ctr, Dept Psychiat, Montreal, PQ, Canada; [Depaulis, Antoine] Univ Joseph Fourier, Grenoble Inst Neurosci, Inserm U836 UJF CEA CHU, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; McGill University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Nosten-Bertrand, M (corresponding author), Univ Paris 06, INSERM, U513, Paris, France.	francis@cochin.inserm.fr	Francis, Fiona/B-5854-2016; Metin, Christine/E-4995-2017; Depaulis, Antoine/B-6098-2012; GIROS, Bruno/ABD-5790-2021; Chelly, Jamel/J-7528-2015	Depaulis, Antoine/0000-0001-6543-6700; GIROS, Bruno/0000-0001-5876-9822; Chelly, Jamel/0000-0002-0939-8719; Francis, Fiona/0000-0001-8542-7537; Metin, Christine/0000-0002-5936-0110	INSERM; CNRS; Federation pour la Recherche sur le Cerveau; EC [EPICURE-LSH-CT-2006-037315]; Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale [fellowship]; ANR [A05183KS]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; EC(European CommissionEuropean Commission Joint Research Centre); Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR))	The contribution of the Region Ile-de-France to the Institut Cochin animal care facility is acknowledged. This work was supported by INSERM, the CNRS and the Federation pour la Recherche sur le Cerveau (awarded to FF). C. Dinocourt was supported by the EC (EPICURE-LSH-CT-2006-037315). C. Kappeler was supported by a fellowship from the Ministere de Education Nationale, de la Recherche et de la Technologie, the Fondation pour la Recherche Medicale (FRM) and the ANR (A05183KS).	Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; BACCALA LA, 2006, HDB TIME SERIES ANAL, P413; BAKKER CE, 1994, CELL, V78, P23; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; BELLMANN R, 1991, J NEUROCHEM, V56, P525, DOI 10.1111/j.1471-4159.1991.tb08181.x; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BENDOTTI C, 1991, NEUROSCI LETT, V132, P175, DOI 10.1016/0304-3940(91)90295-5; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bernasconi A, 2001, EPILEPSIA, V42, P1124, DOI 10.1046/j.1528-1157.2001.39900.x; BROWNING RA, 1985, FED PROC, V44, P2425; CAMPBELL AM, 1984, BRAIN RES, V323, P239, DOI 10.1016/0006-8993(84)90294-4; CHAFETZ RS, 1995, MOL BRAIN RES, V31, P111, DOI 10.1016/0169-328X(95)00041-P; Chevassus-au-Louis N, 1999, CELL MOL LIFE SCI, V55, P1206, DOI 10.1007/s000180050367; COHEN I, J PHYSL 2, V524, P485; Corbo JC, 2002, J NEUROSCI, V22, P7548; De Sarro G, 2004, NEUROSCI RES, V50, P37, DOI 10.1016/j.neures.2004.05.007; Deller T, 1999, EXP NEUROL, V156, P254, DOI 10.1006/exnr.1999.7021; DERIJKVANANDEL JF, 1992, NEUROPEDIATRICS, V23, P4, DOI 10.1055/s-2008-1071302; des Portes V, 1998, CELL, V92, P51; Fleck MW, 2000, J NEUROSCI, V20, P2439; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Grant AC, 2002, EPILEPSIA, V43, P403, DOI 10.1046/j.1528-1157.2002.42601.x; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Guerrini R, 2006, EXP BRAIN RES, V173, P322, DOI 10.1007/s00221-006-0501-z; Harding B, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P81; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Janzen L, 2004, EPILEPSIA, V45, P555, DOI 10.1111/j.0013-9580.2004.53203.x; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; McCarthy JB, 1998, J NEUROCHEM, V70, P1950; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; Parent JM, 2007, EPILEPSIA, V48, P69, DOI 10.1111/j.1528-1167.2007.01355.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Patrylo PR, 2006, EPILEPSIA, V47, P257, DOI 10.1111/j.1528-1167.2006.00417.x; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; PITKANEN A, 1989, NEUROPEPTIDES, V14, P197, DOI 10.1016/0143-4179(89)90045-0; Reibel S, 2001, PEPTIDES, V22, P529, DOI 10.1016/S0196-9781(01)00347-3; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Ruttimann E, 2004, BIOCHEM PHARMACOL, V68, P1613, DOI 10.1016/j.bcp.2004.07.019; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwartzkroin PA, 2004, ADV EXP MED BIOL, V548, P145; Todorova MT, 1999, EPILEPSIA, V40, P1697, DOI 10.1111/j.1528-1157.1999.tb01586.x; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wenzel HJ, 2001, J NEUROSCI, V21, P983, DOI 10.1523/JNEUROSCI.21-03-00983.2001; WHITE JD, 1987, MOL BRAIN RES, V3, P21, DOI 10.1016/0169-328X(87)90040-4; Yang Q, 1997, BRAIN RES BULL, V43, P551, DOI 10.1016/S0361-9230(97)00006-3; Yoshihara Y, 2003, NEUROSCIENCE, V117, P391, DOI 10.1016/S0306-4522(02)00876-X; Yuhas Y, 1999, INFECT IMMUN, V67, P1455, DOI 10.1128/IAI.67.3.1455-1460.1999	61	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2473	10.1371/journal.pone.0002473	http://dx.doi.org/10.1371/journal.pone.0002473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575605	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000005
J	Derivery, E; Fink, J; Martin, D; Houdusse, A; Piel, M; Stradal, TE; Louvard, D; Gautreau, A				Derivery, Emmanuel; Fink, Jenny; Martin, Davy; Houdusse, Anne; Piel, Matthieu; Stradal, Theresia E.; Louvard, Daniel; Gautreau, Alexis			Free Brick1 Is a Trimeric Precursor in the Assembly of a Functional Wave Complex	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; REGULATES ACTIN; ARP2/3 COMPLEX; WASP; SCAR; BRICK1/HSPC300; NUCLEATION; STABILITY; MIGRATION; SCAR/WAVE	Background: The Wave complex activates the Arp2/3 complex, inducing actin polymerization in lamellipodia and membrane ruffles. The Wave complex is composed of five subunits, the smallest of which, Brick1/Hspc300 (Brk1), is the least characterized. We previously reported that, unlike the other subunits, Brk1 also exists as a free form. Principal Findings: Here we report that this free form of Brk1 is composed of homotrimers. Using a novel assay in which purified free Brk1 is electroporated into HeLa cells, we were able to follow its biochemical fate in cells and to show that free Brk1 becomes incorporated into the Wave complex. Importantly, incorporation of free Brk1 into the Wave complex was blocked upon inhibition of protein synthesis and incorporated Brk1 was found to associate preferentially with neosynthesized subunits. Brk1 depleted HeLa cells were found to bleb, as were Nap1, Wave2 or ARPC2 depleted cells, suggesting that this blebbing phenotype of Brk1 depleted cells is due to an impairment of the Wave complex function rather than a specific function of free Brk1. Blebs of Brk1 depleted cells were emitted at sites where lamellipodia and membrane ruffles were normally emitted. In Brk1 depleted cells, the electroporation of free Brk1 was sufficient to restore Wave complex assembly and to rescue the blebbing phenotype. Conclusion: Together these results establish that the free form of Brk1 is an essential precursor in the assembly of a functional Wave complex.	[Derivery, Emmanuel; Louvard, Daniel; Gautreau, Alexis] Ctr Rech, Inst Curie, Morphogenesis & Cell Signal lab, Paris, France; [Fink, Jenny; Piel, Matthieu] Ctr Rech, Inst Curie, Syst Cell Biol Cell Polar & Cell Div lab, Paris, France; [Martin, Davy; Houdusse, Anne] Ctr Rech, Inst Curie, Struct Motil lab, Paris, France; [Derivery, Emmanuel; Fink, Jenny; Martin, Davy; Houdusse, Anne; Piel, Matthieu; Louvard, Daniel; Gautreau, Alexis] CNRS, UMR144, Paris, France; [Stradal, Theresia E.] HZI Helmholz Ctr Infect Res, Braunschweig, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Helmholtz Association; Helmholtz-Center for Infection Research	Derivery, E (corresponding author), Ctr Rech, Inst Curie, Morphogenesis & Cell Signal lab, Paris, France.	alexis.gautreau@lebs.cnrs-gif.fr	Gautreau, Alexis/AAT-2751-2020	Gautreau, Alexis/0000-0002-2369-4362; Martin, Davy/0000-0003-2421-716X; Stradal, Theresia/0000-0002-0352-9474	ENS-Lyon; Boehringer Ingelheim; Curie post-doctoral fellowship; DFG; Fondation pour la Recherche Medicale [INE20071110919]	ENS-Lyon; Boehringer Ingelheim(Boehringer Ingelheim); Curie post-doctoral fellowship; DFG(German Research Foundation (DFG)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	E.D. was supported by ENS-Lyon. J.F. was supported by a PhD grant from Boehringer Ingelheim. D.M. was supported by a Curie post-doctoral fellowship. TES was supported by a DFG grant. This work was supported by Fondation pour la Recherche Medicale (INE20071110919).	Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Djakovic S, 2006, DEVELOPMENT, V133, P1091, DOI 10.1242/dev.02280; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Frank MJ, 2002, CURR BIOL, V12, P849, DOI 10.1016/S0960-9822(02)00819-9; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Iwaya K, 2007, CANCER SCI, V98, P992, DOI 10.1111/j.1349-7006.2007.00488.x; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kobayashi T, 1998, J MEMBRANE SCI, V140, P1, DOI 10.1016/S0376-7388(97)00251-2; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Le J, 2006, CURR BIOL, V16, P895, DOI 10.1016/j.cub.2006.03.061; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Smith LG, 2005, ANNU REV CELL DEV BI, V21, P271, DOI 10.1146/annurev.cellbio.21.122303.114901; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yang LY, 2006, CLIN CANCER RES, V12, P5673, DOI 10.1158/1078-0432.CCR-06-0022; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zhang XG, 2005, PLANT CELL, V17, P2314, DOI 10.1105/tpc.104.028670	38	54	58	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2462	10.1371/journal.pone.0002462	http://dx.doi.org/10.1371/journal.pone.0002462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560548	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700043
J	Maitra, R; Clement, CC; Crisi, GM; Cobelli, N; Santambrogio, L				Maitra, Radhashree; Clement, Cristina C.; Crisi, Giovanna M.; Cobelli, Neil; Santambrogio, Laura			Immunogenecity of Modified Alkane Polymers Is Mediated through TLR1/2 Activation	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENE; UHMWPE; RECOGNITION; OXIDATION; TISSUE; TLR2	Background: With the advancement of biomedical technology, artificial materials have been developed to replace diseased, damaged or nonfunctional body parts. Among such materials, ultra high molecular weight alkane or modified alkyl polymers have been extensively used in heart valves, stents, pacemakers, ear implants, as well as total joint replacement devices. Although much research has been undertaken to design the most non-reactive biologically inert polyethylene derivatives, strong inflammatory responses followed by rejection and failure of the implant have been noted. Methodology/Principal Findings: Purification of the alkane polymers from the site of inflammation revealed extensive "in vivo'' oxidation as detected by fourier transformed infra-red spectroscopy. Herein, we report the novel observation that oxidized alkane polymers induced activation of TLR1/2 pathway as determined by ligand dependent changes in intrinsic tyrosine fluorescence intensity and NF-kappa B luciferase gene assays. Oxidized polymers were very effective in activating dendritic cells and inducing secretion of pro-inflammatory cytokines. Molecular docking of the oxidized alkanes designated ligand specificity and polymeric conformations fitting into the TLR1/2 binding grooves. Conclusion/Significance: This is the first report of a synthetic polymer activating immune responses through TLR binding.	[Maitra, Radhashree; Clement, Cristina C.; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [Crisi, Giovanna M.] Baystate Med Ctr, Dept Pathol, Springfield, MA USA; [Cobelli, Neil] Montefiore Med Ctr, Div Orthoped Surg, New York, NY USA	Yeshiva University; Baystate Medical Center; Montefiore Medical Center	Maitra, R (corresponding author), Albert Einstein Coll Med, Dept Pathol, New York, NY USA.	lsantamb@aecom.yu.edu	Clement, Cristina/ABG-4525-2021	Clement, Cristina/0000-0003-1464-407X	NIH [NS 07098]; Irene Diamond Professorships in Immunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Professorships in Immunology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (L.S.) and Irene Diamond Professorships in Immunology (L.S.). R.M. was supported by NIH training grant NS 07098.	Abu-Amer Y, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2170; Brach del Prever E M, 2003, Chir Organi Mov, V88, P291; Brodsky I, 2007, CELL, V130, P979, DOI 10.1016/j.cell.2007.09.009; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Chen L, 2006, AM J TRANSPLANT, V6, P2282, DOI 10.1111/j.1600-6143.2006.01489.x; Chiesa R, 2000, J BIOMED MATER RES, V50, P381, DOI 10.1002/(SICI)1097-4636(20000605)50:3<381::AID-JBM12>3.0.CO;2-P; Costa L, 1998, BIOMATERIALS, V19, P1371, DOI 10.1016/S0142-9612(98)00013-1; Fiorito S, 2001, J BIOMED MATER RES, V57, P35, DOI 10.1002/1097-4636(200110)57:1<35::AID-JBM1138>3.0.CO;2-B; Goodman S, 2005, ORTHOP CLIN N AM, V36, P41, DOI 10.1016/j.ocl.2004.06.015; Harris WH, 2004, CLIN ORTHOP RELAT R, P39, DOI 10.1097/01.blo.0000149821.72760.39; JAHAN MS, 1995, APPL RADIAT ISOTOPES, V46, P637, DOI 10.1016/0969-8043(95)00118-2; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Koseki H, 2005, J ORTHOP SCI, V10, P284, DOI 10.1007/s00776-005-0896-6; Kurella A, 2005, J BIOMATER APPL, V20, P5, DOI 10.1177/0885328205052974; Kurth M, 1988, J Biomater Appl, V3, P33, DOI 10.1177/088532828800300102; KURTZ SM, 2005, SPINE J, V5; Lee AW, 2000, BIOMATERIALS, V21, P851, DOI 10.1016/S0142-9612(99)00257-4; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Mukherjee DP, 2000, CRIT REV BIOMED ENG, V28, P445, DOI 10.1615/CritRevBiomedEng.v28.i34.160; Ren WP, 2006, BIOMATERIALS, V27, P5161, DOI 10.1016/j.biomaterials.2006.04.004; Reno F, 2003, BIOMATERIALS, V24, P2895, DOI 10.1016/S0142-9612(03)00128-5; Taddei P, 2006, BIOMACROMOLECULES, V7, P1912, DOI 10.1021/bm060007u; Trindade MCD, 1999, J BIOMED MATER RES, V48, P434, DOI 10.1002/(SICI)1097-4636(1999)48:4<434::AID-JBM6>3.3.CO;2-P; Wallace WE, 2007, CHEM COMMUN, P4525, DOI 10.1039/b711932a; Williams S, 2003, P I MECH ENG H, V217, P147, DOI 10.1243/09544110360579367; Witkiewicz H, 1993, Tech Orthop, V8, P254, DOI 10.1097/00013611-199300840-00006; Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1	29	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2438	10.1371/journal.pone.0002438	http://dx.doi.org/10.1371/journal.pone.0002438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560588	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700023
J	Poncela, J; Gomez-Gardenes, J; Floria, LM; Sanchez, A; Moreno, Y				Poncela, Julia; Gomez-Gardenes, Jesus; Floria, Luis M.; Sanchez, Angel; Moreno, Yamir			Complex Cooperative Networks from Evolutionary Preferential Attachment	PLOS ONE			English	Article								In spite of its relevance to the origin of complex networks, the interplay between form and function and its role during network formation remains largely unexplored. While recent studies introduce dynamics by considering rewiring processes of a pre-existent network, we study network growth and formation by proposing an evolutionary preferential attachment model, its main feature being that the capacity of a node to attract new links depends on a dynamical variable governed in turn by the node interactions. As a specific example, we focus on the problem of the emergence of cooperation by analyzing the formation of a social network with interactions given by the Prisoner's Dilemma. The resulting networks show many features of real systems, such as scale-free degree distributions, cooperative behavior and hierarchical clustering. Interestingly, results such as the cooperators being located mostly on nodes of intermediate degree are very different from the observations of cooperative behavior on static networks. The evolutionary preferential attachment mechanism points to an evolutionary origin of scale-free networks and may help understand similar feedback problems in the dynamics of complex networks by appropriately choosing the game describing the interaction of nodes.	[Poncela, Julia; Gomez-Gardenes, Jesus; Floria, Luis M.; Sanchez, Angel; Moreno, Yamir] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Gomez-Gardenes, Jesus] Univ Catania, Scuola Superiore Catania, Catania, Italy; [Floria, Luis M.] Univ Zaragoza, Dept Fis Mat Condensada, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos Madrid 3, Dept Matematicas, GISC, Leganes, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Theoret Phys, Zaragoza, Spain	University of Zaragoza; University of Catania; University of Zaragoza; Universidad Carlos III de Madrid; University of Zaragoza	Poncela, J (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain.	yamir@unizar.es	Floria, Luis Mario/L-7261-2014; Sánchez, Angel/A-9229-2008; Poncela-Casasnovas, Julia/H-8931-2015; Gomez-Gardenes, Jesus/A-3226-2009; Gomez-Gardenes, Jesus/M-9825-2019; Gomez-Gardeñes, Jesus/B-5818-2009; Moreno, Yamir/A-1076-2009	Floria, Luis Mario/0000-0002-1406-8810; Sánchez, Angel/0000-0003-1874-2881; Poncela-Casasnovas, Julia/0000-0003-2791-7524; Gomez-Gardenes, Jesus/0000-0001-5204-1937; Gomez-Gardeñes, Jesus/0000-0001-5204-1937; Moreno, Yamir/0000-0002-0895-1893	Ministerio de Educacion y Ciencia through the Ramon y Cajal Program [FIS-2006-12781-C02-01, FIS-2005-00337, NAN2004-9087-C03-03]; MOSAICO; Comunidad de Madrid (Spain) [SIMUMAT-CM]	Ministerio de Educacion y Ciencia through the Ramon y Cajal Program(German Research Foundation (DFG)); MOSAICO; Comunidad de Madrid (Spain)(Comunidad de Madrid)	We acknowledge support from the Ministerio de Educacion y Ciencia through the Ramon y Cajal Program (Y.M.) and grants FIS-2006-12781-C02-01, FIS-2005-00337, MOSAICO and NAN2004-9087-C03-03. A.S. is also supported by the Comunidad de Madrid (Spain) under grant SIMUMAT-CM.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Guimera R, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100082; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lozano S, 2007, JASSS-J ARTIF SOC S, V10; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; SAXENIAN A, 1996, REGIONAL ADV CULTURE, V128; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036	23	146	147	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2449	10.1371/journal.pone.0002449	http://dx.doi.org/10.1371/journal.pone.0002449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560601	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700034
J	Holt, AR; Davies, ZG; Tyler, C; Staddon, S				Holt, Alison R.; Davies, Zoe G.; Tyler, Claire; Staddon, Samantha			Meta-Analysis of the Effects of Predation on Animal Prey Abundance: Evidence from UK Vertebrates	PLOS ONE			English	Article								Background: Controlling vertebrate predators is one of the most widespread forms of wildlife management and it continues to cause conflict between stakeholders worldwide. It is important for managers and policy-makers to make decisions on this issue that are based on the best available scientific evidence. Therefore, it is first important to understand if there is indeed an impact of vertebrate predators on prey, and then to quantify this impact. Methodology/Principal Findings: Using the UK as a case study, we use a meta-analytical approach to review the available evidence to assess the effect of vertebrate predation on animal prey abundance. We find a significant effect of predators on prey abundance across our studies. On average, there is a 1.6 fold increase in prey abundance in the absence of predation. However, we show significant heterogeneity in effect sizes, and discuss how the method of predator control, whether the predator is native or non-native, and aspects of study design, may be potential causes. Conclusions/Significance: Our results allow some cautious policy recommendations to be made regarding the management of predator and prey populations. Meta-analysis is an important tool for understanding general patterns in the effect of predators on prey abundance across studies. Such an approach is especially valuable where management decisions need to be made in the absence of site-specific information.	[Holt, Alison R.] Univ Sheffield, Catchment Sci Ctr, Sheffield, S Yorkshire, England; [Davies, Zoe G.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield, S Yorkshire, England; [Tyler, Claire] Bangor Univ, Ctr Evidence Based Conservat, Sch Env & Natural Resources, Bangor, Gwynedd, Wales; [Staddon, Samantha] Univ Edinburgh, Inst Geography, Edinburgh, Midlothian, Scotland	University of Sheffield; University of Sheffield; Bangor University; University of Edinburgh	Holt, AR (corresponding author), Univ Sheffield, Catchment Sci Ctr, Sheffield, S Yorkshire, England.	a.holt@sheffield.ac.uk			NERC [NER/A/S/2002/00938]; DIVERSITAS	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DIVERSITAS	This work was supported by NERC grant (NER/A/S/2002/00938) and DIVERSITAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines D, 1996, J APPL ECOL, V33, P54, DOI 10.2307/2405015; Berger KM, 2006, CONSERV BIOL, V20, P751, DOI 10.1111/j.1523-1739.2006.00336.x; Bolton M, 2007, J APPL ECOL, V44, P534, DOI 10.1111/j.1365-2664.2007.01288.x; Clode D, 2002, BIRD STUDY, V49, P118, DOI 10.1080/00063650209461255; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; COTE IM, 1995, 144 ENGL NAT RES; Craik C, 1997, BIRD STUDY, V44, P303, DOI 10.1080/00063659709461065; Craik J.C.A., 1995, Seabird, V17, P3; CRAIK JCA, 1998, ARGYLL BIRD REPORT, V14, P98; ERRINGTON PL, 1956, SCIENCE, V124, P304, DOI 10.1126/science.124.3216.304; Ferreras P, 1999, J APPL ECOL, V36, P701, DOI 10.1046/j.1365-2664.1999.00431.x; FLETCHER K, 2005, GAME CONSERVANCY REV, V36, P64; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Gregory Richard D., 2002, British Birds, V95, P410; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; HOLM S, 1979, SCAND J STAT, V6, P65; Hone J., 1994, ANAL VERTEBRATE PEST; Jackson DB, 2004, BIOL CONSERV, V117, P151, DOI 10.1016/S0006-3207(03)00289-1; Jackson DB, 2000, BIOL CONSERV, V93, P333, DOI 10.1016/S0006-3207(99)00135-4; Kenward RE, 2001, J APPL ECOL, V38, P813, DOI 10.1046/j.1365-2664.2001.00636.x; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Messier F, 1985, OECOLOGIA, V65, P503, DOI 10.1007/BF00379664; Mitchell BR, 2004, WILDLIFE SOC B, V32, P1209, DOI 10.2193/0091-7648(2004)032[1209:CDMCMA]2.0.CO;2; Newton I., 1993, Current Ornithology, V11, P143; Newton I., 1998, POPULATION LIMITATIO; Osenberg CW, 1999, ECOLOGY, V80, P1105, DOI 10.2307/177058; PALMER AR, 1999, AM NAT, V15, P798; PARKER H, 1984, J WILDLIFE MANAGE, V48, P1197, DOI 10.2307/3801781; PARR R, 1993, BIRD STUDY, V40, P223, DOI 10.1080/00063659309477187; Perry D, 2008, CONSERV BIOL, V22, P27, DOI 10.1111/j.1523-1739.2007.00845.x; Pullin AS, 2006, CONSERV BIOL, V20, P1647, DOI 10.1111/j.1523-1739.2006.00485.x; Redpath SA, 2004, CONSERV BIOL, V18, P350, DOI 10.1111/j.1523-1739.2004.00421.x; REDPATH SM, 1991, J APPL ECOL, V28, P659, DOI 10.2307/2404574; Reynolds JC, 1996, MAMMAL REV, V26, P127, DOI 10.1111/j.1365-2907.1996.tb00150.x; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1111/j.0014-3820.2005.tb01004.x; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; ROSENZWEIG ML, 1977, Q REV BIOL, V52, P371, DOI 10.1086/410124; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; SMITH TD, 2004, SURVEY TERN PRODUCTI; *SNH, 2004, MINK CONTR PROT IMP; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; SUMMERS RW, 1995, PRODUCTIVITY CAPERCA; SUMMERS RW, 1996, CHANGES PRODUCTIVITI; TAPPER S, 1991, GAME CONSERVANCY REV, V22, P87; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; TAPPER SC, 1993, ACT C PRED GEST PRED; Thirgood SJ, 2000, P ROY SOC B-BIOL SCI, V267, P651, DOI 10.1098/rspb.2000.1051; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X	55	53	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2400	10.1371/journal.pone.0002400	http://dx.doi.org/10.1371/journal.pone.0002400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545690	Green Published, Green Accepted, gold			2022-12-27	WOS:000263248800038
J	Levy-Adam, F; Feld, S; Suss-Toby, E; Vlodavsky, I; Ilan, N				Levy-Adam, Flonia; Feld, Sari; Suss-Toby, Edith; Vlodavsky, Israel; Ilan, Neta			Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans	PLOS ONE			English	Article								Heparanase is a heparan sulfate (HS) degrading endoglycosidase participating in extracellular matrix degradation and remodeling. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Non-enzymatic activities of heparanase include enhanced adhesion of tumor-derived cells and primary T-cells. Attempting to identify functional domains of heparanase that would serve as targets for drug development, we have identified heparin binding domains of heparanase. A corresponding peptide (residues Lys(158)-Asp(171), termed KKDC) was demonstrated to physically associate with heparin and HS, and to inhibit heparanase enzymatic activity. We hypothesized that the pro-adhesive properties of heparanase are mediated by its interaction with cell surface HS proteoglycans, and utilized the KKDC peptide to examine this possibility. We provide evidence that the KKDC peptide interacts with cell membrane HS, resulting in clustering of syndecan-1 and syndecan-4. We applied classical analysis of cell morphology, fluorescent and time-lapse microscopy and demonstrated that the KKDC peptide efficiently stimulates the adhesion and spreading of various cell types, mediated by PKC, Src, and the small GTPase Rac1. These results support, and further substantiate the notion that heparanase function is not limited to its enzymatic activity.	[Levy-Adam, Flonia; Feld, Sari; Suss-Toby, Edith; Vlodavsky, Israel; Ilan, Neta] Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Ruth & Bruce Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Levy-Adam, F (corresponding author), Technion Israel Inst Technol, Canc & Vasc Biol Res Ctr, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	Vlodavsk@cc.huji.ac.il			Israel Science Foundation [549/06]; National Cancer Institute, NIH [RO1-CA106456]; Israel Cancer Research Fund; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund; Rappaport Family Institute Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (grant 549/06); National Cancer Institute, NIH (grant RO1-CA106456); the Israel Cancer Research Fund; and the Rappaport Family Institute Fund.	BARKALOW FJB, 1991, J BIOL CHEM, V266, P7812; BARNER M, 1985, INT J CANCER, V35, P483, DOI 10.1002/ijc.2910350411; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nadav L, 2006, CANCER RES, V66, P8608, DOI 10.1158/0008-5472.CAN-06-1301; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; VLODAVSKY I, 1983, CANCER RES, V43, P2704; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	60	79	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2319	10.1371/journal.pone.0002319	http://dx.doi.org/10.1371/journal.pone.0002319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545691	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800004
J	Painter, CA; Cruz, A; Lopez, GE; Stern, LJ; Zavala-Ruiz, Z				Painter, Corrie A.; Cruz, Anthony; Lopez, Gustavo E.; Stern, Lawrence J.; Zavala-Ruiz, Zarixia			Model for the Peptide-Free Conformation of Class II MHC Proteins	PLOS ONE			English	Article								Background: Major histocompatibility complex proteins are believed to undergo significant conformational changes concomitant with peptide binding, but structural characterization of these changes has remained elusive. Methodology/Principal Findings: Here we use molecular dynamics simulations and experimental probes of protein conformation to investigate the peptide-free state of class II MHC proteins. Upon computational removal of the bound peptide from HLA-DR1-peptide complex, the alpha 50-59 region folded into the P1-P4 region of the peptide binding site, adopting the same conformation as a bound peptide. Strikingly, the structure of the hydrophobic P1 pocket is maintained by engagement of the side chain of Phe alpha 54. In addition, conserved hydrogen bonds observed in crystal structures between the peptide backbone and numerous MHC side chains are maintained between the alpha 51-55 region and the rest of the molecule. The model for the peptide-free conformation was evaluated using conformationally-sensitive antibody and superantigen probes predicted to show no change, moderate change, or dramatic changes in their interaction with peptide-free DR1 and peptide-loaded DR1. The binding observed for these probes is in agreement with the movements predicted by the model. Conclusion/Significance: This work presents a molecular model for peptide-free class II MHC proteins that can help to interpret the conformational changes known to occur within the protein during peptide binding and release, and can provide insight into possible mechanisms for DM action.	[Painter, Corrie A.; Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Cruz, Anthony; Lopez, Gustavo E.] Univ Puerto Rico, Dept Chem, Mayaguez, PR USA; [Stern, Lawrence J.] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA USA; [Zavala-Ruiz, Zarixia] Univ Puerto Rico, Dept Chem, San Juan, PR USA	University of Massachusetts System; University of Massachusetts Worcester; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Massachusetts System; University of Massachusetts Worcester; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Painter, CA (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	lawrence.stern@umassmed.edu; zarixiazavala@vmail.uprrp.edu		Zavala-Ruiz, Zarixia/0000-0003-1513-5840; Painter, Corrie/0000-0001-6174-1548	NIH [AI-38996, AI-48833, 5P20RR016439]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038996, R01AI038996, R01AI048833, R56AI038996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following NIH grants: AI-38996 (LJS), AI-48833 (LJS) and 5P20RR016439 (GRL, ZZ-R).	Andersen PS, 1999, IMMUNITY, V10, P473, DOI 10.1016/S1074-7613(00)80047-3; Belmares MP, 2003, BIOCHEMISTRY-US, V42, P838, DOI 10.1021/bi020466p; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolin DR, 2000, J MED CHEM, V43, P2135, DOI 10.1021/jm000034h; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cochran JR, 2000, CHEM BIOL, V7, P683, DOI 10.1016/S1074-5521(00)00019-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; GROTENBREG GM, 2007, J BIOL CHEM; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; Kasson PM, 2000, BIOCHEMISTRY-US, V39, P1048, DOI 10.1021/bi9921337; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kony DB, 2007, PROTEIN SCI, V16, P1101, DOI 10.1110/ps.062323407; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Nojima H, 2003, CHEM PHARM BULL, V51, P923; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schmitt L, 1999, J MOL BIOL, V286, P207, DOI 10.1006/jmbi.1998.2463; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Sundberg EJ, 2003, STRUCTURE, V11, P1151, DOI 10.1016/S0969-2126(03)00187-4; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zavala-Ruiz Z, 2004, CHEM BIOL, V11, P1395, DOI 10.1016/j.chembiol.2004.08.007; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270	59	52	52	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2403	10.1371/journal.pone.0002403	http://dx.doi.org/10.1371/journal.pone.0002403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545669	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800041
J	Korukottu, J; Schneider, R; Vijayan, V; Lange, A; Pongs, O; Becker, S; Baldus, M; Zweckstetter, M				Korukottu, Jegannath; Schneider, Robert; Vijayan, Vinesh; Lange, Adam; Pongs, Olaf; Becker, Stefan; Baldus, Marc; Zweckstetter, Markus			High-Resolution 3D Structure Determination of Kaliotoxin by Solid-State NMR Spectroscopy	PLOS ONE			English	Article								High-resolution solid-state NMR spectroscopy can provide structural information of proteins that cannot be studied by X-ray crystallography or solution NMR spectroscopy. Here we demonstrate that it is possible to determine a protein structure by solid-state NMR to a resolution comparable to that by solution NMR. Using an iterative assignment and structure calculation protocol, a large number of distance restraints was extracted from H-1/H-1 mixing experiments recorded on a single uniformly labeled sample under magic angle spinning conditions. The calculated structure has a coordinate precision of 0.6 angstrom and 1.3 angstrom for the backbone and side chain heavy atoms, respectively, and deviates from the structure observed in solution. The approach is expected to be applicable to larger systems enabling the determination of high-resolution structures of amyloid or membrane proteins.	[Korukottu, Jegannath; Schneider, Robert; Vijayan, Vinesh; Lange, Adam; Becker, Stefan; Baldus, Marc; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Pongs, Olaf] Inst Neurale Signalverarbeitung, Zentrum Mol Neurobiol, Hamburg, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Korukottu, J (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	maba@mpibpc.mpg.de; mzwecks@gwdg.de	Schneider, Robert/C-1868-2013; Baldus, Marc/C-2737-2009	Schneider, Robert/0000-0003-3279-5365; Baldus, Marc/0000-0001-7068-5613; Zweckstetter, Markus/0000-0002-2536-6581; vijayan, vinesh/0000-0001-5483-1860; Lange, Adam/0000-0002-7534-5973	Max Planck society; EU-NMR; DFG;  [BA1700/5-1];  [PO137/36-1];  [ZW71/2-1];  [ZW71/3-1]	Max Planck society(Max Planck SocietyFoundation CELLEX); EU-NMR; DFG(German Research Foundation (DFG)); ; ; ; 	This work was supported by the Max Planck society, the EU through EU-NMR and the DFG through grants BA1700/5-1, PO137/36-1, ZW71/2-1 and ZW71/3-1.	ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; Andronesi OC, 2004, J BIOMOL NMR, V30, P253, DOI 10.1007/s10858-004-3452-3; Baldus M, 2007, J BIOMOL NMR, V39, P73, DOI 10.1007/s10858-007-9177-3; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fossi M, 2005, ANGEW CHEM INT EDIT, V44, P6151, DOI 10.1002/anie.200501884; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gairi M, 1997, J PEPT SCI, V3, P314, DOI 10.1002/(SICI)1099-1387(199707)3:4<314::AID-PSC117>3.0.CO;2-E; Glaubitz C, 1998, J MAGN RESON, V130, P305, DOI 10.1006/jmre.1997.1344; Griffin RG, 1998, NAT STRUCT BIOL, V5, P508, DOI 10.1038/749; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kuszewski J, 2004, J AM CHEM SOC, V126, P6258, DOI 10.1021/ja049786h; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2003, J AM CHEM SOC, V125, P12640, DOI 10.1021/ja034555g; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Luca S, 2003, ACCOUNTS CHEM RES, V36, P858, DOI 10.1021/ar020232y; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Nomura K, 1999, J AM CHEM SOC, V121, P4064, DOI 10.1021/ja984330j; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tycko R, 2001, ANNU REV PHYS CHEM, V52, P575, DOI 10.1146/annurev.physchem.52.1.575; Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128; Zhou DH, 2007, ANGEW CHEM INT EDIT, V46, P8380, DOI 10.1002/anie.200702905; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	34	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2359	10.1371/journal.pone.0002359	http://dx.doi.org/10.1371/journal.pone.0002359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523586	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300046
J	Li, HJ; Smolen, GA; Beers, LF; Xia, L; Gerald, W; Wang, J; Haber, DA; Lee, SB				Li, Hongjie; Smolen, Gromoslaw A.; Beers, Lisa F.; Xia, Li; Gerald, William; Wang, Joanne; Haber, Daniel A.; Lee, Sean Bong			Adenosine Transporter ENT4 Is a Direct Target of EWS/WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor	PLOS ONE			English	Article								Background: Desmoplastic Small Round Cell Tumor (DSRCT) is a highly aggressive malignancy that affects mainly adolescents and young adults. A defining characteristic of DSRCT is a specific chromosomal translocation, t(11;22)(p13;q12), that fuses EWS with WT1, leading to a production of two isoforms of chimeric transcription factor, EWS/WT1(-KTS) and EWS/WT1(+KTS). The chimeric proteins are thought to play critical roles in various stages of oncogenesis through aberrant transcription of different genes, but only a few of these genes have been identified. Methodology/Principal Findings: We report the identification of a new target of EWS/WT1, ENT4 (equilibrative nucleoside transporter 4) which encodes a pH-dependent adenosine transporter. ENT4 is transcriptionally activated by both isoforms of EWS/WT1 as evidenced by promoter-reporter and chromatin immunoprecipitation (ChIP) analyses. Furthermore, ENT4 is highly and specifically expressed in primary tumors of DSRCT as well as in a DSRCT cell line, JN-DSRCT-1. Treatment of JN-DSRCT1 cells with adenosine analogs, such as 2-chloro-2'-deoxyadenosine (2-CdA), resulted in an increased cytotoxic response in dose- and pH-dependent manner. Conclusions/Significance: Our detailed analyses of a novel target of EWS/WT1 in DSRCT reveal an insight into the oncogenic mechanism of EWS-fusion chromosomal translocation gene products and provide a new marker for DSRCT. Furthermore, identification of ENT4 as a highly expressed transcript in DSRCT may represent an attractive pathway for targeting chemotherapeutic drugs into DSRCT.	[Li, Hongjie; Beers, Lisa F.; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20824 USA; [Smolen, Gromoslaw A.; Haber, Daniel A.] Massachusetts Gen Hosp Canc Ctr, Harvard Med Sch, Charlestown, MA USA; [Xia, Li; Wang, Joanne] Univ Washington, Dept Pharmaceut, Seattle, WA USA; [Gerald, William] Memorial Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center	Li, HJ (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20824 USA.	seanL@intra.niddk.nih.gov		Lee, Sean/0000-0001-6211-3498	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002, ZIADK056003] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK (S.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Finkeltov I, 2002, ONCOGENE, V21, P1890, DOI 10.1038/sj.onc.1205042; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerald WL, 2005, SEMIN CANCER BIOL, V15, P197, DOI 10.1016/j.semcancer.2005.01.005; Gerald WL, 1998, J CLIN ONCOL, V16, P3028, DOI 10.1200/JCO.1998.16.9.3028; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hoffman MA, 1997, J CLIN ONCOL, V15, P1138, DOI 10.1200/JCO.1997.15.3.1138; Ito E, 2003, AM J PATHOL, V163, P2165, DOI 10.1016/S0002-9440(10)63573-0; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; Kim J, 1998, ONCOGENE, V16, P1021, DOI 10.1038/sj.onc.1201616; Kim J, 1998, ONCOGENE, V16, P1973, DOI 10.1038/sj.onc.1201716; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Kushner BH, 1996, J CLIN ONCOL, V14, P1526, DOI 10.1200/JCO.1996.14.5.1526; LADANYI M, 1994, CANCER RES, V54, P2837; Lae ME, 2002, AM J SURG PATHOL, V26, P823, DOI 10.1097/00000478-200207000-00001; Lee SB, 1997, NAT GENET, V17, P309, DOI 10.1038/ng1197-309; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; LIU SQ, 1995, NAT MED, V1, P267, DOI 10.1038/nm0395-267; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Nishio J, 2002, LAB INVEST, V82, P1175, DOI 10.1097/01.LAB.0000028059.92642.03; OHNO T, 1994, ONCOGENE, V9, P3087; Palmer RE, 2002, CANCER CELL, V2, P497, DOI 10.1016/S1535-6108(02)00205-2; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; Reynolds PA, 2003, GENE DEV, V17, P2094, DOI 10.1101/gad.1110703; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; SAVEN A, 1994, NEW ENGL J MED, V330, P691; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Wong JC, 2002, ONCOGENE, V21, P2009, DOI 10.1038/sj.onc.1205262; Xia L, 2007, AM J PHYSIOL-RENAL, V292, pF682, DOI 10.1152/ajprenal.00302.2006	45	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2353	10.1371/journal.pone.0002353	http://dx.doi.org/10.1371/journal.pone.0002353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523561	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300041
J	Petrunia, IV; Frolova, OY; Komarova, TV; Kiselev, SL; Citovsky, V; Dorokhov, YL				Petrunia, Igor V.; Frolova, Olga Y.; Komarova, Tatiana V.; Kiselev, Sergey L.; Citovsky, Vitaly; Dorokhov, Yuri L.			Agrobacterium tumefaciens-Induced Bacteraemia Does Not Lead to Reporter Gene Expression in Mouse Organs	PLOS ONE			English	Article								Agrobacterium tumefaciens is the main plant biotechnology gene transfer tool with host range which can be extended to non-plant eukaryotic organisms under laboratory conditions. Known medical cases of Agrobacterium species isolation from bloodstream infections necessitate the assessment of biosafety-related risks of A. tumefaciens encounters with mammalian organisms. Here, we studied the survival of A. tumefaciens in bloodstream of mice injected with bacterial cultures. Bacterial titers of 10 8 CFU were detected in the blood of the injected animals up to two weeks after intravenous injection. Agrobacteria carrying Cauliflower mosaic virus (CaMV) 35S promoter-based constructs and isolated from the injected mice retained their capacity to promote green fluorescent protein (GFP) synthesis in Nicotiana benthamiana leaves. To examine whether or not the injected agrobacteria are able to express in mouse organs, we used an intron-containing GFP (GFPi) reporter driven either by a cytomegalovirus (CMV) promoter or by a CaMV 35S promoter. Western and northern blot analyses as well as RT-PCR analysis of liver, spleen and lung of mice injected with A. tumefaciens detected neither GFP protein nor its transcripts. Thus, bacteraemia induced in mice by A. tumefaciens does not lead to detectible levels of genetic transformation of mouse organs.	[Petrunia, Igor V.; Frolova, Olga Y.; Komarova, Tatiana V.; Dorokhov, Yuri L.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY USA; [Kiselev, Sergey L.; Dorokhov, Yuri L.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia	Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Vavilov Institute of General Genetics	Petrunia, IV (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Komarova, Tatiana V./D-5824-2012; Kiselev, Sergey/AAO-1247-2020; Dorokhov, Yuri L/D-3565-2012	Komarova, Tatiana V./0000-0001-6558-8755; Dorokhov, Yuri L/0000-0002-4066-8940; kiselev, sergey/0000-0001-7921-6987; Citovsky, Vitaly/0000-0003-2024-6844	Russian Foundation for Basic Research [06-08-01473]; NIH; NSF; NRI USDA CSREE; BARD; BSF; CDR-USAID	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRI USDA CSREE(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); BARD; BSF(US-Israel Binational Science Foundation); CDR-USAID(United States Agency for International Development (USAID))	This work was partly supported by Russian Foundation for Basic Research (grant 06-08-01473). The work in the VC laboratory is supported by grants from NIH, NSF, NRI USDA CSREE, BARD, BSF, and CDR-USAID.	ALNOR D, 1994, CLIN INFECT DIS, V18, P914, DOI 10.1093/clinids/18.6.914; Amaya RA, 2003, PEDIATR INFECT DIS J, V22, P183; Bulgakov Victor P., 2006, Biotechnology Journal, V1, P454, DOI 10.1002/biot.200500045; Chalandon Y, 2000, BONE MARROW TRANSPL, V26, P101, DOI 10.1038/sj.bmt.1702470; Christakis GB, 2006, J MED MICROBIOL, V55, P1453, DOI 10.1099/jmm.0.46411-0; Dorokhov YL, 2006, J GEN VIROL, V87, P2693, DOI 10.1099/vir.0.82095-0; Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013; EDMOND MB, 1993, CLIN INFECT DIS, V16, P388, DOI 10.1093/clind/16.3.388; Giammanco GM, 2004, INFECT CONT HOSP EP, V25, P885, DOI 10.1086/502315; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; HULSE M, 1993, CLIN INFECT DIS, V16, P112, DOI 10.1093/clinids/16.1.112; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Manfredi R, 1999, MICROBIOLOGICA, V22, P375; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Peiris K, 2006, J HOSP INFECT, V62, P250, DOI 10.1016/j.jhin.2005.06.022; Sacchetti A, 2001, J CELL BIOCHEM, P117; Siegman-Igra Y, 2005, J HOSP INFECT, V60, P122, DOI 10.1016/j.jhin.2004.11.021; SWANN RA, 1985, J CLIN PATHOL, V38, P1293, DOI 10.1136/jcp.38.11.1293; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009	23	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2352	10.1371/journal.pone.0002352	http://dx.doi.org/10.1371/journal.pone.0002352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523638	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300040
J	Caramelli, D; Milani, L; Vai, S; Modi, A; Pecchioli, E; Girardi, M; Pilli, E; Lari, M; Lippi, B; Ronchitelli, A; Mallegni, F; Casoli, A; Bertorelle, G; Barbujani, G				Caramelli, David; Milani, Lucio; Vai, Stefania; Modi, Alessandra; Pecchioli, Elena; Girardi, Matteo; Pilli, Elena; Lari, Martina; Lippi, Barbara; Ronchitelli, Annamaria; Mallegni, Francesco; Casoli, Antonella; Bertorelle, Giorgio; Barbujani, Guido			A 28,000 Years Old Cro-Magnon mtDNA Sequence Differs from All Potentially Contaminating Modern Sequences	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NEANDERTHALS; HUMANS	Background: DNA sequences from ancient speciments may in fact result from undetected contamination of the ancient specimens by modern DNA, and the problem is particularly challenging in studies of human fossils. Doubts on the authenticity of the available sequences have so far hampered genetic comparisons between anatomically archaic (Neandertal) and early modern (Cro-Magnoid) Europeans. Methodology/Principal Findings: We typed the mitochondrial DNA (mtDNA) hypervariable region I in a 28,000 years old Cro-Magnoid individual from the Paglicci cave, in Italy (Paglicci 23) and in all the people who had contact with the sample since its discovery in 2003. The Paglicci 23 sequence, determined through the analysis of 152 clones, is the Cambridge reference sequence, and cannot possibly reflect contamination because it differs from all potentially contaminating modern sequences. Conclusions/Significance:: The Paglicci 23 individual carried a mtDNA sequence that is still common in Europe, and which radically differs from those of the almost contemporary Neandertals, demonstrating a genealogical continuity across 28,000 years, from Cro-Magnoid to modern Europeans. Because all potential sources of modern DNA contamination are known, the Paglicci 23 sample will offer a unique opportunity to get insight for the first time into the nuclear genes of early modern Europeans.	[Caramelli, David; Milani, Lucio; Vai, Stefania; Modi, Alessandra; Pilli, Elena; Lari, Martina] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy; [Vai, Stefania; Bertorelle, Giorgio; Barbujani, Guido] Univ Ferrara, Dipartimento Biol Evoluzione, Ferrara, Italy; [Pecchioli, Elena; Girardi, Matteo] Viote Monte Bondone, Ctr Ecol Alpina Fdn Edmund Mach, Trento, Italy; [Lippi, Barbara; Mallegni, Francesco] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Ronchitelli, Annamaria] Univ Siena, Dipartimento Dipartimento Sci Ambientali, Siena, Italy; [Casoli, Antonella] Univ Parma, Dipartimento Chim Gen Inorgan, Chim Fis, Parma, Italy	University of Florence; University of Ferrara; Fondazione Edmund Mach; University of Pisa; University of Siena; University of Parma	Caramelli, D (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy.	g.barbujani@unife.it	Bertorelle, Giorgio/AAE-9078-2022; Lari, Martina/A-4085-2009; casoli, antonella/H-6953-2016; Barbujani, Guido/ABE-9998-2020	casoli, antonella/0000-0002-9212-9463; Barbujani, Guido/0000-0001-7854-6669; Pilli, Elena/0000-0002-3150-5082; Caramelli, David/0000-0001-6468-1675; VAI, STEFANIA/0000-0003-3844-5147; Girardi, Matteo/0000-0002-1176-0764; Bertorelle, Giorgio/0000-0002-2498-2702	Italian Ministery of the Universities	Italian Ministery of the Universities	Study supported by funds of the Italian Ministery of the Universities (PRIN 2006). No sponsors had any role in any phase of the study, and the authors do not envisage any conflict of interests.	Abbott A, 2003, NATURE, V423, P468, DOI 10.1038/423468b; Barbujani G, 2003, NATURE, V424, P127, DOI 10.1038/424127b; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2000, SCIENCE, V289, P1139; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Gilbert MTP, 2006, INT J OSTEOARCHAEOL, V16, P156, DOI 10.1002/oa.832; Gilbert MTP, 2005, J ARCHAEOL SCI, V32, P785, DOI 10.1016/j.jas.2004.12.008; Handt O, 1996, AM J HUM GENET, V59, P368; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; MALLEGNI F, 2005, J ANTHROPOL SCI S, V84, P110; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 2008, HEREDITY, V100, P555, DOI 10.1038/hdy.2008.14; Relethford JH, 2001, AM J PHYS ANTHROPOL, V115, P95, DOI 10.1002/ajpa.1060; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TEMPLETON AR, 1992, GENETICS, V132, P619; WOLPOFF MH, 2005, ARCHAEOLOGY KEY CONC, P176; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110	33	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2700	10.1371/journal.pone.0002700	http://dx.doi.org/10.1371/journal.pone.0002700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417DX	18628960	Green Published, gold			2022-12-27	WOS:000264057200043
J	Kohler, S; Lieleg, O; Bausch, AR				Koehler, Simone; Lieleg, Oliver; Bausch, Andreas R.			Rheological Characterization of the Bundling Transition in F-Actin Solutions Induced by Methylcellulose	PLOS ONE			English	Article								In many in vitro experiments Brownian motion hampers quantitative data analysis. Therefore, additives are widely used to increase the solvent viscosity. For this purpose, methylcellulose (MC) has been proven highly effective as already small concentrations can significantly slow down diffusive processes. Beside this advantage, it has already been reported that high MC concentrations can alter the microstructure of polymer solutions such as filamentous actin. However, it remains to be shown to what extent the mechanical properties of a composite actin/MC gel depend on the MC concentration. In particular, significant alterations might occur even if the microstructure seems unaffected. Indeed, we find that the viscoelastic response of entangled F-actin solutions depends sensitively on the amount of MC added. At concentrations higher than 0.2% (w/v) MC, actin filaments are reorganized into bundles which drastically changes the viscoelastic response. At small MC concentrations the impact of MC is more subtle: the two constituents, actin and MC, contribute in an additive way to the mechanical response of the composite material. As a consequence, the effect of methylcellulose on actin solutions has to be considered very carefully when MC is used in biochemical experiments.	[Koehler, Simone; Lieleg, Oliver; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany	Technical University of Munich	Kohler, S (corresponding author), Tech Univ Munich, Lehrstuhl Biophys E27, D-8046 Garching, Germany.	abausch@ph.tum.de		Lieleg, Oliver/0000-0002-6874-7456; Kohler, Simone/0000-0002-1119-8855				Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; COOPER JA, 1987, J CELL BIOL, V104, P491, DOI 10.1083/jcb.104.3.491; El Ghzaoui A, 2001, LANGMUIR, V17, P1453, DOI 10.1021/la000516w; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gisler T, 1999, PHYS REV LETT, V82, P1606, DOI 10.1103/PhysRevLett.82.1606; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Hosek M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051907; JANMEY PA, 1986, J BIOL CHEM, V261, P8357; Kobayashi K, 1999, MACROMOLECULES, V32, P7070, DOI 10.1021/ma990242n; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.088102; LIELEG O, 2008, TRANSIENT BINDING DI; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Luan Y, 2008, BIOPHYS J, V94, P688, DOI 10.1529/biophysj.107.112417; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Popp D, 2006, BIOCHEM BIOPH RES CO, V351, P348, DOI 10.1016/j.bbrc.2006.10.041; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SCHMOLLER KM, 2008, INTERNAL STRES UNPUB; Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suzuki A, 1996, BIOCHEMISTRY-US, V35, P5238, DOI 10.1021/bi952693f; TAKIGUCHI K, 1991, J BIOCHEM-TOKYO, V109, P520, DOI 10.1093/oxfordjournals.jbchem.a123414; Tharmann R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088103; Tharmann R, 2006, BIOPHYS J, V90, P2622, DOI 10.1529/biophysj.105.070458; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103	31	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2736	10.1371/journal.pone.0002736	http://dx.doi.org/10.1371/journal.pone.0002736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629003	gold, Green Published			2022-12-27	WOS:000264057200072
J	Meis, S; Bergado-Acosta, JR; Yanagawa, Y; Obata, K; Stork, O; Munsch, T				Meis, Susanne; Bergado-Acosta, Jorge Ricardo; Yanagawa, Yuchio; Obata, Kunihiko; Stork, Oliver; Munsch, Thomas			Identification of a Neuropeptide S Responsive Circuitry Shaping Amygdala Activity via the Endopiriform Nucleus	PLOS ONE			English	Article							C-FOS; ELECTRICAL-STIMULATION; CONDITIONED FEAR; PIRIFORM CORTEX; MESSENGER-RNA; RAT-BRAIN; EXPRESSION; ORGANIZATION; PROJECTIONS; NEURONS	Neuropeptide S (NPS) and its receptor are thought to define a set of specific brain circuits involved in fear and anxiety. Here we provide evidence for a novel, NPS-responsive circuit that shapes neural activity in the mouse basolateral amygdala (BLA) via the endopiriform nucleus (EPN). Using slice preparations, we demonstrate that NPS directly activates an inward current in 20% of EPN neurons and evokes an increase of glutamatergic excitation in this nucleus. Excitation of the EPN is responsible for a modulation of BLA activity through NPS, characterized by a general increase of GABAergic inhibition and enhancement of spike activity in a subset of BLA projection neurons. Finally, local injection of NPS to the EPN interferes with the expression of contextual, but not auditory cued fear memory. Together, these data suggest the existence of a specific NPS-responsive circuitry between EPN and BLA, likely involved in contextual aspects of fear memory.	[Meis, Susanne; Bergado-Acosta, Jorge Ricardo; Stork, Oliver; Munsch, Thomas] Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany; [Bergado-Acosta, Jorge Ricardo; Stork, Oliver] Otto von Guericke Univ, Inst Biol, Abt Mol Neurobiol, Magdeburg, Germany; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; [Obata, Kunihiko] RIKEN Brain Sci Inst, Obata Res Unit, Neuronal Circuit Mechanisms Res Grp, Wako, Saitama, Japan	Otto von Guericke University; Otto von Guericke University; Gunma University; RIKEN	Meis, S (corresponding author), Otto Von Guericke Univ, Inst Physiol, Magdeburg, Germany.	thomas.munsch@med.ovgu.de		Stork, Oliver/0000-0003-4285-7507	Deutsche Forschungsgemeinschaft [SFB 426, TP B8, SFB 779, TP B5]; Land Sachsen-Anhalt; MEXT, Japan [Grant-in-Aids for Scientific Research]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Land Sachsen-Anhalt; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the Deutsche Forschungsgemeinschaft SFB 426, TP B8 (S.M.) and SFB 779, TP B5 (O.S.), Land Sachsen-Anhalt (T.M.) and Grant-in-Aids for Scientific Research from the MEXT, Japan (Y.Y., K.O.).	Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Banks MI, 1996, J NEUROSCI, V16, P3862; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; BECK CHM, 1995, J NEUROSCI, V15, P709; Behan M, 1999, J COMP NEUROL, V408, P532; Brevi S, 2001, J NEUROPHYSIOL, V85, P2076, DOI 10.1152/jn.2001.85.5.2076; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Chen FJ, 2007, NEUROSCIENCE, V144, P472, DOI 10.1016/j.neuroscience.2006.09.037; Demir R, 1999, J NEUROSCI, V19, P1294; Fu W, 2004, NEUROSCIENCE, V126, P1033, DOI 10.1016/j.neuroscience.2004.03.041; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; GEAN PW, 1992, SYNAPSE, V11, P1, DOI 10.1002/syn.890110102; Hoffman WH, 1996, J NEUROPHYSIOL, V76, P1430, DOI 10.1152/jn.1996.76.3.1430; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; KRUKOFF TL, 1992, J NEUROSCI, V12, P3582; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; Majak K, 2004, J COMP NEUROL, V476, P414, DOI 10.1002/cne.20233; Majak K, 2002, J COMP NEUROL, V451, P236, DOI 10.1002/cne.10346; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meis S, 2007, MOL CELL NEUROSCI, V35, P356, DOI 10.1016/j.mcn.2007.03.012; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Niimi M, 2006, ENDOCRINE, V30, P75, DOI 10.1385/ENDO:30:1:75; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ponomarenko AA, 2003, BEHAV BRAIN RES, V141, P123, DOI 10.1016/S0166-4328(02)00327-3; Roth AL, 2006, J BIOL CHEM, V281, P20809, DOI 10.1074/jbc.M601846200; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Smith KL, 2006, ENDOCRINOLOGY, V147, P3510, DOI 10.1210/en.2005-1280; SMITH MA, 1992, BRAIN RES, V578, P135, DOI 10.1016/0006-8993(92)90240-A; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005	37	98	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2695	10.1371/journal.pone.0002695	http://dx.doi.org/10.1371/journal.pone.0002695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628994	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200038
J	Yuhki, N; Mullikin, JC; Beck, T; Stephens, R; O'Brien, SJ				Yuhki, Naoya; Mullikin, James C.; Beck, Thomas; Stephens, Robert; O'Brien, Stephen J.			Sequences, Annotation and Single Nucleotide Polymorphism of the Major Histocompatibility Complex in the Domestic Cat	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; MHC CLASS-I; DIVERGENCE; TOOL; HLA; MAP; EXPRESSION; HAPLOTYPES; DIVERSITY	Two sequences of major histocompatibility complex (MHC) regions in the domestic cat, 2.976 and 0.362 Mbps, which were separated by an ancient chromosome break (55-80 MYA) and followed by a chromosomal inversion were annotated in detail. Gene annotation of this MHC was completed and identified 183 possible coding regions, 147 human homologues, possible functional genes and 36 pseudo/unidentified genes) by GENSCAN and BLASTN, BLASTP RepeatMasker programs. The first region spans 2.976 Mbp sequence, which encodes six classical class II antigens (three DRA and three DRB antigens) lacking the functional DP, DQ regions, nine antigen processing molecules (DOA/DOB, DMA/DMB, TAPASIN, and LMP2/LMP7, TAP1/TAP2), 52 class III genes, nineteen class I genes/gene fragments (FLAI-A to FLAI-S). Three class I genes (FLAI-H, I-K, I-E) may encode functional classical class I antigens based on deduced amino acid sequence and promoter structure. The second region spans 0.362 Mbp sequence encoding no class I genes and 18 cross-species conserved genes, excluding class I, II and their functionally related/ associated genes, namely framework genes, including three olfactory receptor genes. One previously identified feline endogenous retrovirus, a baboon retrovirus derived sequence (ECE1) and two new endogenous retrovirus sequences, similar to brown bat endogenous retrovirus (FERVmlu1, FERVmlu2) were found within a 140 Kbp interval in the middle of class I region. MHC SNPs were examined based on comparisons of this BAC sequence and MHC homozygous 1.9xWGS sequences and found that 11,654 SNPs in 2.84 Mbp (0.00411 SNP per bp), which is 2.4 times higher rate than average heterozygous region in the WGS (0.0017 SNP per bp genome), and slightly higher than the SNP rate observed in human MHC (0.00337 SNP per bp).	[Yuhki, Naoya; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Mullikin, James C.] NIH, Natl Human Genome Res Inst, Genome Technol Branch, Bethesda, MD USA; [Beck, Thomas] NCI, Lab Genom Divers, SAIC Frederick, Frederick, MD USA; [Stephens, Robert] NCI, Advanced Biomed Comp Ctr, SAIC Frederick, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yuhki, N (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21701 USA.	yuhki@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC010537] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health.	Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; ALTSCHUL SF, 1990, J MOL BIOL, V268, P78; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Beck TW, 2005, IMMUNOGENETICS, V56, P702, DOI 10.1007/s00251-004-0742-6; Beck TW, 2001, GENOMICS, V71, P282, DOI 10.1006/geno.2000.6416; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BROWN EW, 1994, J VIROL, V68, P5953, DOI 10.1128/JVI.68.9.5953-5968.1994; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carpenter MA, 1996, J VIROL, V70, P6682, DOI 10.1128/JVI.70.10.6682-6693.1996; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hardy WD, 1980, FELINE LEUKEMIA VIRU; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; KLEIN J, 1986, NATURAL HIST MAJOR H; KLEMENT V, 1972, VIROLOGY, V50, P305, DOI 10.1016/0042-6822(72)90379-0; KOLLER BH, 1988, J IMMUNOL, V141, P897; Krawczyk M, 2004, J IMMUNOL, V173, P6200, DOI 10.4049/jimmunol.173.10.6200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; NELSONRE.WA, 1973, JNCI-J NATL CANCER I, V50, P1129, DOI 10.1093/jnci/50.5.1129; NIMAN HL, 1977, NATURE, V266, P357, DOI 10.1038/266357a0; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PONTIUS J, 2007, GENOME RES UNPUB; Roca AL, 2005, J VIROL, V79, P3979, DOI 10.1128/JVI.79.7.3979-3986.2005; Roca AL, 2004, J VIROL, V78, P4370, DOI 10.1128/JVI.78.8.4370-4375.2004; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Troyer JL, 2004, J VIROL, V78, P3777, DOI 10.1128/JVI.78.7.3777-3791.2004; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wilkerson AJP, 2004, CURR BIOL, V14, pR227, DOI 10.1016/j.cub.2004.02.051; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Yuhki N, 1997, J IMMUNOL, V158, P2822; YUHKI N, 1989, J IMMUNOL, V142, P3676; YUHKI N, 1990, J EXP MED, V172, P621, DOI 10.1084/jem.172.2.621; Yuhki N, 2007, J HERED, V98, P390, DOI 10.1093/jhered/esm056	46	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2674	10.1371/journal.pone.0002674	http://dx.doi.org/10.1371/journal.pone.0002674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629345	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200019
J	Ishikawa, Y; Aonuma, H; Miura, T				Ishikawa, Yuki; Aonuma, Hitoshi; Miura, Toru			Soldier-Specific Modification of the Mandibular Motor Neurons in Termites	PLOS ONE			English	Article								Social insects exhibit a variety of caste-specific behavioral tendencies that constitute the basis of division of labor within the colony. In termites, the soldier caste display distinctive defense behaviors, such as aggressively attacking enemies with well-developed mandibles, while the other castes retreat into the colony without exhibiting any aggressive response. It is thus likely that some form of soldier-specific neuronal modification exists in termites. In this study, the authors compared the brain (cerebral ganglion) and the suboesophageal ganglion (SOG) of soldiers and pseudergates (workers) in the damp-wood termite, Hodotermopsis sjostedti. The size of the SOG was significantly larger in soldiers than in pseudergates, but no difference in brain size was apparent between castes. Furthermore, mandibular nerves were thicker in soldiers than in pseudergates. Retrograde staining revealed that the somata sizes of the mandibular motor neurons (MdMNs) in soldiers were more than twice as large as those of pseudergates. The enlargement of MdMNs was also observed in individuals treated with a juvenile hormone analogue (JHA), indicating that MdMNs become enlarged in response to juvenile hormone (JH) action during soldier differentiation. This enlargement is likely to have two functions: a behavioral function in which soldier termites will be able to defend more effectively through relatively faster and stronger mandibular movements, and a developmental function that associates with the development of soldier-specific mandibular muscle morphogenesis in termite head. The soldier-specific enlargement of mandibular motor neurons was observed in all examined species in five termite families that have different mechanisms of defense, suggesting that such neuronal modification was already present in the common ancestor of termites and is significant for soldier function.	[Ishikawa, Yuki; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Aonuma, Hitoshi] Hokkaido Univ, Res Inst Electron Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ishikawa, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	miu@ees.hokudai.ac.jp	Miura, Toru/P-2456-2019; Aonuma, Hitoshi/D-6540-2012	Miura, Toru/0000-0002-7456-4402; Aonuma, Hitoshi/0000-0001-8380-1820; Ishikawa, Yuki/0000-0002-9873-3143	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid, 15687001, 18047002, 18370007]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for the Scientific Research (Nos. 15687001, 18047002, and 18370007) of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	[Anonymous], 1971, INSECT SOC; CLAMANN HP, 1976, J NEUROPHYSIOL, V39, P844, DOI 10.1152/jn.1976.39.4.844; CRESPI BJ, 1995, BEHAV ECOL, V6, P109, DOI 10.1093/beheco/6.1.109; Eggleton P, 2001, INSECT SOC, V48, P187, DOI 10.1007/PL00001766; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Fernandes JJ, 1998, DEVELOPMENT, V125, P1769; Gillott C., 1995, ENTOMOLOGY; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harano K, 2005, NATURWISSENSCHAFTEN, V92, P310, DOI 10.1007/s00114-005-0631-3; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; Kleineidam CJ, 2005, CHEM SENSES, V30, P383, DOI 10.1093/chemse/bji033; Koshikawa S, 2002, INSECT SOC, V49, P245, DOI 10.1007/s00040-002-8309-8; Kurshan PT, 2003, J COMP NEUROL, V466, P91, DOI 10.1002/cne.10864; LUSCHER M, 1960, ANN NY ACAD SCI, V89, P549, DOI 10.1111/j.1749-6632.1960.tb27577.x; Luscher M., 1972, General and Comparative Endocrinology, P509, DOI 10.1016/0016-6480(72)90181-5; Maekawa Kiyoto, 1998, Entomological Science, V1, P561; Matsumoto T., 1985, Scientific Papers of the College of Arts and Sciences University of Tokyo, V35, P211; Miura T, 2001, INSECT SOC, V48, P216, DOI 10.1007/PL00001769; Miura T, 2004, ECOL RES, V19, P141, DOI 10.1111/j.1440-1703.2003.00618.x; Miura T, 2004, INSECT SOC, V51, P247, DOI 10.1007/s00040-003-0736-2; Miura T, 2000, ECOL RES, V15, P83, DOI 10.1046/j.1440-1703.2000.00320.x; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; NOIROT C, 1987, EXPERIENTIA, V43, P851, DOI 10.1007/BF01951642; Noirot C., 1991, MORPHOGENETIC HORMON, P295; NOIROT C, 1969, GLANDS SECRETIONS, P89; O'Donnell S, 2004, NEUROSCI LETT, V356, P159, DOI 10.1016/j.neulet.2003.11.053; OGINO K, 1993, ZOOL SCI, V10, P361; Paul J, 2002, J INSECT PHYSIOL, V48, P255, DOI 10.1016/S0022-1910(01)00171-8; RICHARD G, 1969, BIOL TERMITES, V1, P161; Sasaki K, 2002, J INSECT PHYSIOL, V48, P1075, DOI 10.1016/S0022-1910(02)00200-7; Schulz DJ, 2002, BRAIN BEHAV EVOLUT, V60, P350, DOI 10.1159/000067788; SELVERSTON AI, 1972, J NEUROPHYSIOL, V35, P797, DOI 10.1152/jn.1972.35.6.797; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stuart AM, 1969, BIOL TERMITES, P193; WEESNER FM, 1969, EXTERNAL ANATOMY, P19; Williams DW, 2005, J NEUROBIOL, V64, P24, DOI 10.1002/neu.20151; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; ZUCKER RS, 1971, SCIENCE, V173, P645, DOI 10.1126/science.173.3997.645	41	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2617	10.1371/journal.pone.0002617	http://dx.doi.org/10.1371/journal.pone.0002617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612458	Green Published, gold			2022-12-27	WOS:000264065800019
J	Xu, J; Deng, XX; Disteche, CM				Xu, Jun; Deng, Xinxian; Disteche, Christine M.			Sex-Specific Expression of the X-Linked Histone Demethylase Gene Jarid1c in Brain	PLOS ONE			English	Article								Jarid1c, an X-linked gene coding for a histone demethylase, plays an important role in brain development and function. Notably, JARID1C mutations cause mental retardation and increased aggression in humans. These phenotypes are consistent with the expression patterns we have identified in mouse brain where Jarid1c mRNA was detected in hippocampus, hypothalamus, and cerebellum. Jarid1c expression and associated active histone marks at its 5'end are high in P19 neurons, indicating that JARID1C demethylase plays an important role in differentiated neuronal cells. We found that XX mice expressed Jarid1c more highly than XY mice, independent of their gonadal types ( testes versus ovaries). This increased expression in XX mice is consistent with Jarid1c escape from X inactivation and is not compensated by expression from the Y-linked paralogue Jarid1d, which is expressed at a very low level compared to the X paralogue in P19 cells. Our observations suggest that sex-specific expression of Jarid1c may contribute to sex differences in brain function.	[Xu, Jun; Deng, Xinxian; Disteche, Christine M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Xu, Jun] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA; [Disteche, Christine M.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; Tufts University; University of Washington; University of Washington Seattle	Xu, J (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	jun.xu@tufts.edu; cdistech@u.washington.edu	Xu, Jun/B-7351-2012		NIH [HD43942, GM46883, GM79537]; Tufts University [seed grant]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD043942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046883, R01GM079537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH awards HD43942 (J. Xu), GM46883 (C.M. Disteche), GM79537 (C.M. Disteche), and a Tufts University seed grant (J. Xu). Funders played no role in conducting the study or preparing the manuscript.	AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Carrel L, 1996, HUM MOL GENET, V5, P1361, DOI 10.1093/hmg/5.9.1361; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hall NM, 2003, MAMM GENOME, V14, P437, DOI 10.1007/s00335-002-3068-4; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee N, 2007, NAT STRUCT MOL BIOL, V14, P341, DOI 10.1038/nsmb1216; Lingenfelter PA, 1998, NAT GENET, V18, P212, DOI 10.1038/ng0398-212; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Sheardown S, 1996, HUM MOL GENET, V5, P1355, DOI 10.1093/hmg/5.9.1355; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; WU JS, 1994, HUM MOL GENET, V3, P153, DOI 10.1093/hmg/3.1.153; Xu J, 2006, GENE EXPR PATTERNS, V6, P146, DOI 10.1016/j.modgep.2005.06.011; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008	30	93	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2553	10.1371/journal.pone.0002553	http://dx.doi.org/10.1371/journal.pone.0002553			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596936	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200020
J	Cornuz, J; Zwahlen, S; Jungi, WF; Osterwalder, J; Klingler, K; van Melle, G; Bangala, Y; Guessous, I; Muller, P; Willers, J; Maurer, P; Bachmann, MF; Cerny, T				Cornuz, Jacques; Zwahlen, Susanne; Jungi, Walter Felix; Osterwalder, Joseph; Klingler, Karl; van Melle, Guy; Bangala, Yolande; Guessous, Idris; Mueller, Philipp; Willers, Joerg; Maurer, Patrik; Bachmann, Martin F.; Cerny, Thomas			A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PHASE-I SAFETY; PRECLINICAL EFFICACY; ACTIVE IMMUNIZATION; CONJUGATE VACCINE; DEPENDENCE	Background: Tobacco dependence is the leading cause of preventable death and disabilities worldwide and nicotine is the main substance responsible for the addiction to tobacco. A vaccine against nicotine was tested in a 6-month randomized, double blind phase II smoking cessation study in 341 smokers with a subsequent 6-month follow-up period. Methodology/Principal Findings: 229 subjects were randomized to receive five intramuscular injections of the nicotine vaccine and 112 to receive placebo at monthly intervals. All subjects received individual behavioral smoking cessation counseling. The vaccine was safe, generally well tolerated and highly immunogenic, inducing a 100% antibody responder rate after the first injection. Point prevalence of abstinence at month 2 showed a statistically significant difference between subjects treated with Nicotine-Q beta (47.2%) and placebo (35.1%) (P = 0.036), but continuous abstinence between months 2 and 6 was not significantly different. However, in subgroup analysis of the per-protocol population, the third of subjects with highest antibody levels showed higher continuous abstinence from month 2 until month 6 (56.6%) than placebo treated participants (31.3%) (OR 2.9; P = 0.004) while medium and low antibody levels did not increase abstinence rates. After 12 month, the difference in continuous abstinence rate between subjects on placebo and those with high antibody response was maintained (difference 20.2%, P = 0.012). Conclusions: Whereas Nicotine-Q beta did not significantly increase continuous abstinence rates in the intention-to-treat population, subgroup analyses of the per-protocol population suggest that such a vaccination against nicotine can significantly increase continuous abstinence rates in smokers when sufficiently high antibody levels are achieved. Immunotherapy might open a new avenue to the treatment of nicotine addiction. Trial Registration: Swiss Medical Registry 2003DR2327; ClinicalTrials.gov NCT00369616	[Cornuz, Jacques; Bangala, Yolande; Guessous, Idris] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Cornuz, Jacques] Lausanne Univ Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Zwahlen, Susanne; Jungi, Walter Felix; Cerny, Thomas] Kantonsspital, Dept Internal Med, St Gallen, Switzerland; [Osterwalder, Joseph] Kantonsspital, Emergency Dept, St Gallen, Switzerland; [Klingler, Karl] Lung Ctr Hirslanden, Zurich, Switzerland; [van Melle, Guy] Univ Lausanne, Inst Social & Preventive Med, Lausanne, Switzerland; [Mueller, Philipp; Willers, Joerg; Maurer, Patrik; Bachmann, Martin F.] Cytos Biotechnol AG, Schlieren, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Lausanne	Cornuz, J (corresponding author), Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland.	Jacques.Cornuz@chuv.ch			Cytos Biotechnology AG	Cytos Biotechnology AG	Cytos Biotechnology AG supported this study J. Cornuz, T. Cerny, W.F. Jungi, K. Klingler, G. van Melle and J. Osterwalder report having received grants for conducting the current study or consultation fees from Cytos Biotechnology. J. Cornuz, T. Cerny, and W.F. Jungi report having received travel expenses fees from Cytos Biotechnology. Cytos Biotechnology AG supported this study.	Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Cerny EH, 2002, ONKOLOGIE, V25, P406, DOI 10.1159/000067433; Cornuz J, 2002, ANN INTERN MED, V136, P429, DOI 10.7326/0003-4819-136-6-200203190-00006; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; FIORE MC, 2000, TREATING TOBACCO USE; Hall W, 2002, LANCET, V360, P1089, DOI 10.1016/S0140-6736(02)11134-2; Haney Margaret, 2004, Expert Rev Vaccines, V3, P11, DOI 10.1586/14760584.3.1.11; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hieda Y, 1997, J PHARMACOL EXP THER, V283, P1076; Hughes J., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB2; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Keyler D E, 1999, Nicotine Tob Res, V1, P241, DOI 10.1080/14622299050011361; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Lindblom N, 2002, RESPIRATION, V69, P254, DOI 10.1159/000063629; Malin DH, 2001, PHARMACOL BIOCHEM BE, V70, P551, DOI 10.1016/S0091-3057(01)00699-2; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; Pentel PR, 2000, PHARMACOL BIOCHEM BE, V65, P191, DOI 10.1016/S0091-3057(99)00206-3; Proctor Robert N, 2004, Clin Lung Cancer, V5, P371, DOI 10.3816/CLC.2004.n.016; Vasiljeva I, 1998, FEBS LETT, V431, P7, DOI 10.1016/S0014-5793(98)00716-9; Welsch SK, 1999, EXP CLIN PSYCHOPHARM, V7, P354, DOI 10.1037/1064-1297.7.4.354	24	210	221	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2547	10.1371/journal.pone.0002547	http://dx.doi.org/10.1371/journal.pone.0002547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575629	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000050
J	Hadjantonakis, AK; Pisano, E; Papaioannou, VE				Hadjantonakis, Anna-Katerina; Pisano, Elinor; Papaioannou, Virginia E.			Tbx6 Regulates Left/Right Patterning in Mouse Embryos through Effects on Nodal Cilia and Perinodal Signaling	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; FLUORESCENT PROTEIN FUSION; T-BOX GENES; PARAXIAL MESODERM; KUPFFERS VESICLE; LATERAL PLATE; EXPRESSION; MICE; FLOW	Background: The determination of left/right body axis during early embryogenesis sets up a developmental cascade that coordinates the development of the viscera and is essential to the correct placement and alignment of organ systems and vasculature. Defective left-right patterning can lead to congenital cardiac malformations, vascular anomalies and other serious health problems. Here we describe a novel role for the T-box transcription factor gene Tbx6 in left/right body axis determination in the mouse. Results: Embryos lacking Tbx6 show randomized embryo turning and heart looping. Our results point to multiple mechanisms for this effect. First, Dll1, a direct target of Tbx6, is down regulated around the node in Tbx6 mutants and there is a subsequent decrease in nodal signaling, which is required for laterality determination. Secondly, in spite of a lack of expression of Tbx6 in the node, we document a profound effect of the Tbx6 mutation on the morphology and motility of nodal cilia. This results in the loss of asymmetric calcium signaling at the periphery of the node, suggesting that unidirectional nodal flow is disrupted. To carry out these studies, we devised a novel method for direct labeling and live imaging cilia in vivo using a genetically-encoded fluorescent protein fusion that labels tubulin, combined with laser point scanning confocal microscopy for direct visualization of cilia movement. Conclusions: We conclude that the transcription factor gene Tbx6 is essential for correct left/right axis determination in the mouse and acts through effects on notch signaling around the node as well as through an effect on the morphology and motility of the nodal cilia.	[Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Pisano, Elinor; Papaioannou, Virginia E.] Columbia Univ, Coll Physicians & Surgeons, Dept Genet & Dev, New York, NY USA	Memorial Sloan Kettering Cancer Center; Columbia University	Hadjantonakis, AK (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.	vep1@columbia.edu		Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Papaioannou, Virginia/0000-0001-7558-8601	NIH [GM60561, HD033082, HD052115]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD033082, R01HD052115] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM60561 and HD033082 (V.E.P.) and HD052115 (A.-K.H).	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brown N, 1999, HEART DEV, P447; Chapman DL, 2003, MECH DEVELOP, V120, P837, DOI 10.1016/S0925-4773(03)00066-2; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chen JN, 1997, DEVELOPMENT, V124, P4373; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Fraser ST, 2005, GENESIS, V42, P162, DOI 10.1002/gene.20139; Gourronc F, 2007, DEV DYNAM, V236, P2131, DOI 10.1002/dvdy.21249; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Karcher C, 2005, DIFFERENTIATION, V73, P425, DOI 10.1111/j.1432-0436.2005.00048.x; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nagy A., 2003, MANIPULATING MOUSE E, P764; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Norris DP, 2002, DEVELOPMENT, V129, P3455; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Oki S, 2007, DEVELOPMENT, V134, P3893, DOI 10.1242/dev.009464; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; PAPAIOANNOU V, 2000, GENE TARGETING PRACT, P133; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Papaioannou Virginia E., 2004, P686; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Przemeck GKH, 2003, DEVELOPMENT, V130, P3, DOI 10.1242/dev.00176; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; WILKINSON DG, 1992, WHOLE MOUNT SITU HYB; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	67	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2511	10.1371/journal.pone.0002511	http://dx.doi.org/10.1371/journal.pone.0002511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575602	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000030
J	Paterson, S; Wilkes, C; Bleay, C; Viney, ME				Paterson, Steve; Wilkes, Clare; Bleay, Colin; Viney, Mark E.			Immunological Responses Elicited by Different Infection Regimes with Strongyloides ratti	PLOS ONE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; GASTROINTESTINAL NEMATODES; IMMATURE PARASITES; MIGRATION ROUTES; IMMUNE-RESPONSES; CYTOKINE; CONSEQUENCES; PATHWAYS; DYNAMICS; PATTERNS	Nematode infections are a ubiquitous feature of vertebrate life. In nature, such nematode infections are acquired by continued exposure to infective stages over a prolonged period of time. By contrast, experimental laboratory infections are typically induced by the administration of a single (and often large) dose of infective stages. Previous work has shown that the size of an infection dose can have significant effects on anti-nematode immune responses. Here we investigated the effect of different infection regimes of Strongyloides ratti, comparing single and repeated dose infections, on the host immune response that was elicited. We considered and compared infections of the same size, but administered in different ways. We considered infection size in two ways: the maximum dose of worms administered and the cumulative worm exposure time. We found that both infection regimes resulted in Th2-type immune response, characterised by IL4 and IL13 produced by S. ratti stimulated mesenteric lymph node cells, anti-S. ratti IgG(1) and intestinal rat mast cell protease II (RMCPII) production. We observed some small quantitative immunological differences between different infection regimes, in which the concentration of IL4, IL13, anti-S. ratti IgG(1) and IgG(2a) and RMCPII were affected. However, these differences were quantitatively relatively modest compared with the temporal dynamics of the anti-S. ratti immune response as a whole.	[Paterson, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Wilkes, Clare; Bleay, Colin; Viney, Mark E.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Liverpool; University of Bristol	Paterson, S (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	s.paterson@liv.ac.uk	Paterson, Steve/D-2154-2009	Paterson, Steve/0000-0002-1307-2981	The Wellcome Trust, UK	The Wellcome Trust, UK(Wellcome Trust)	Funded by The Wellcome Trust, UK. The funders have had no role in the design and conduct of the study, or in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Bancroft AJ, 2001, INT J PARASITOL, V31, P1627, DOI 10.1016/S0020-7519(01)00281-8; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; BERDING C, 1986, J THEOR BIOL, V122, P459, DOI 10.1016/S0022-5193(86)80186-2; Bleay C, 2007, INT J PARASITOL, V37, P1501, DOI 10.1016/j.ijpara.2007.04.023; Crawley M. J, 2002, STAT COMPUTING INTRO; Dawkins H. J. S., 1989, Strongyloidiasis: a major roundworm infection of man., P287; Else KJ, 2005, PARASITE IMMUNOL, V27, P407, DOI 10.1111/j.1365-3024.2005.00788.x; Faulkner H, 2002, J INFECT DIS, V185, P665, DOI 10.1086/339005; FERENS WA, 1990, J PARASITOL, V76, P684, DOI 10.2307/3282983; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; GRENFELL BT, 2002, ECOLOGY INFECT DIS; Jackson JA, 2004, INT J PARASITOL, V34, P1237, DOI 10.1016/j.ijpara.2004.07.009; Jackson JA, 2004, J INFECT DIS, V190, P1804, DOI 10.1086/425014; JENKINS DC, 1971, PARASITOLOGY, V62, P457, DOI 10.1017/S003118200007760X; JENKINS DC, 1974, PARASITOLOGY, V68, P13, DOI 10.1017/S0031182000045327; JENKINS DC, 1972, INT J PARASITOL, V22, P105; KEYMER AE, 1986, PROC R SOC SER B-BIO, V229, P47, DOI 10.1098/rspb.1986.0074; Maizels RM, 1998, CURR BIOL, V8, pR711, DOI 10.1016/S0960-9822(98)70455-5; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; Medley GF, 2002, PARASITOLOGY, V125, pS61, DOI 10.1017/S0031182002002354; OGILVIE B M, 1974, P81; OGILVIE BM, 1965, PARASITOLOGY, V55, P325, DOI 10.1017/S0031182000068797; OVINGTON KS, 1986, PARASITOL RES, V72, P851; Paterson S, 2003, P ROY SOC B-BIOL SCI, V270, P1023, DOI 10.1098/rspb.2003.2346; Paterson S, 2002, PARASITOLOGY, V125, P283, DOI 10.1017/S0031182002002056; Sokal RR, 1995, BIOMETRY; TINDALL NR, 1990, PARASITOLOGY, V100, P281, DOI 10.1017/S003118200006128X; TINDALL NR, 1988, PARASITOLOGY, V96, P551, DOI 10.1017/S0031182000080185; Turner JD, 2003, J INFECT DIS, V188, P1768, DOI 10.1086/379370; Wakelin D, 1996, IMMUNITY PARASITES; Wilkes CP, 2007, PARASITE IMMUNOL, V29, P339, DOI 10.1111/j.1365-3024.2007.00945.x; Wilkes CP, 2004, PARASITOLOGY, V128, P661, DOI 10.1017/S0031182004005062; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	33	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2509	10.1371/journal.pone.0002509	http://dx.doi.org/10.1371/journal.pone.0002509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575588	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000028
J	Kucherenko, MM; Pantoja, M; Yatsenko, AS; Shcherbata, HR; Fischer, KA; Maksymiv, DV; Chernyk, YI; Ruohola-Baker, H				Kucherenko, Mariya M.; Pantoja, Mario; Yatsenko, Andriy S.; Shcherbata, Halyna R.; Fischer, Karin A.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.; Ruohola-Baker, Hannele			Genetic Modifier Screens Reveal New Components that Interact with the Drosophila Dystroglycan-Dystrophin Complex	PLOS ONE			English	Article								The Dystroglycan-Dystrophin (Dg-Dys) complex has a capacity to transmit information from the extracellular matrix to the cytoskeleton inside the cell. It is proposed that this interaction is under tight regulation; however the signaling/regulatory components of Dg-Dys complex remain elusive. Understanding the regulation of the complex is critical since defects in this complex cause muscular dystrophy in humans. To reveal new regulators of the Dg-Dys complex, we used a model organism Drosophila melanogaster and performed genetic interaction screens to identify modifiers of Dg and Dys mutants in Drosophila wing veins. These mutant screens revealed that the Dg-Dys complex interacts with genes involved in muscle function and components of Notch, TGF-beta and EGFR signaling pathways. In addition, components of pathways that are required for cellular and/or axonal migration through cytoskeletal regulation, such as Semaphorin-Plexin, Frazzled-Netrin and Slit-Robo pathways show interactions with Dys and/or Dg. These data suggest that the Dg-Dys complex and the other pathways regulating extracellular information transfer to the cytoskeletal dynamics are more intercalated than previously thought.	[Kucherenko, Mariya M.; Pantoja, Mario; Yatsenko, Andriy S.; Shcherbata, Halyna R.; Fischer, Karin A.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kucherenko, Mariya M.; Yatsenko, Andriy S.; Maksymiv, Dariya V.; Chernyk, Yaroslava I.] Ivan Franko Natl Univ Lviv, Dept Genet & Biotechnol, Lvov, Ukraine	University of Washington; University of Washington Seattle; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv	Kucherenko, MM (corresponding author), Univ Washington, Dept Biochem, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	hannele@u.washington.edu	Shcherbata, Halyna/J-5712-2017; Yatsenko, Andriy/D-1895-2018	Shcherbata, Halyna/0000-0002-3855-0345; Yatsenko, Andriy/0000-0001-8730-5744; Kucherenko, Mariya/0000-0002-8637-2037	CRDF; MDA; NIH; AHA	CRDF; MDA(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association)	CRDF for M.M.K., A.S.Y., D.V.M. and Ya.I.C.; MDA for H.R.-B.; NIH for H.R.-B.; AHA for H.R.S.	Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Alvarado D, 2004, GENETICS, V167, P187, DOI 10.1534/genetics.167.1.187; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Bier E, 2000, CURR OPIN GENET DEV, V10, P393, DOI 10.1016/S0959-437X(00)00102-7; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; CARBONETTO S, COMMUNICATION; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Deng WM, 2000, CURR BIOL, V10, P683, DOI 10.1016/S0960-9822(00)00514-5; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Guichard A, 1999, DEVELOPMENT, V126, P2663; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Johannes B, 2002, MECH DEVELOP, V115, P3, DOI 10.1016/S0925-4773(02)00083-7; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Link N, 2007, J CELL BIOL, V178, P567, DOI 10.1083/jcb.200702125; Macioce P, 2003, J CELL SCI, V116, P4847, DOI 10.1242/jcs.00805; MADHAVAN R, 1992, BIOCHEM BIOPH RES CO, V185, P753, DOI 10.1016/0006-291X(92)91690-R; Magalhaes TR, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-59; Newbell BJ, 1997, BIOCHEMISTRY-US, V36, P1295, DOI 10.1021/bi962452n; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parsons SA, 2007, J BIOL CHEM, V282, P10068, DOI 10.1074/jbc.M609368200; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Qian L, 2005, CURR BIOL, V15, P2271, DOI 10.1016/j.cub.2005.10.037; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Steinhauer J, 2006, DEV DYNAM, V235, P1455, DOI 10.1002/dvdy.20770; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; TAGHLI L, 2008, AGING CELL, V7, P237; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Tayler TD, 2004, DEVELOPMENT, V131, P5935, DOI 10.1242/dev.01465; van der Plas MC, 2007, MECH DEVELOP, V124, P617, DOI 10.1016/j.mod.2007.04.003; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; Wang Y, 2007, CURR BIOL, V17, P1349, DOI 10.1016/j.cub.2007.06.067; Wehr K, 2006, DEV BIOL, V294, P406, DOI 10.1016/j.ydbio.2006.03.002; Yatsenko AS, 2007, J BIOL CHEM, V282, P15159, DOI 10.1074/jbc.M608800200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	62	49	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2418	10.1371/journal.pone.0002418	http://dx.doi.org/10.1371/journal.pone.0002418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545683	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800054
J	Rappoport, JZ; Heyman, KP; Kemal, S; Simon, SM				Rappoport, Joshua Z.; Heyman, Katherine P.; Kemal, Shahrnaz; Simon, Sanford M.			Dynamics of Dynamin during Clathrin Mediated Endocytosis in PC12 Cells	PLOS ONE			English	Article								Background: Members of the dynamin super-family of GTPases are involved in disparate cellular pathways. Dynamin1 and dynamin2 have been implicated in clathrin-mediated endocytosis. While some models suggest that dynamin functions specifically at the point of vesicle fission, evidence also exists for a role prior to fission during vesicle formation and it is unknown if there is a role for dynamin after vesicle fission. Although dynamin2 is ubiquitously expressed, dynamin1 is restricted to the nervous system. These two structurally similar endocytic accessory proteins have not been studied in cells that endogenously express both. Methodology/Principal Findings: The present study quantitatively assesses the dynamics of dynamin1 and dynamin2 during clathrin-mediated endocytosis in PC12 cells, which endogenously express both proteins. Both dynamin isoforms co-localized with clathrin and showed sharp increases in fluorescence intensity immediately prior to internalization of the nascent clathrin-coated vesicle. The fluorescence intensity of both proteins then decreased with two time constants. The slower time constant closely matched the time constant for the decrease of clathrin intensity and likely represents vesicle movement away from the membrane. The faster rate may reflect release of dynamin at the neck of nascent vesicle following GTP hydrolysis. Conclusions/Significance: This study analyses the role of dynamin in clathrin-mediated endocytosis in a model for cellular neuroscience and these results may provide direct evidence for the existence of two populations of dynamin associated with nascent clathrin-coated vesicles.	[Rappoport, Joshua Z.; Heyman, Katherine P.; Kemal, Shahrnaz; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY USA	Rockefeller University	Rappoport, JZ (corresponding author), Rockefeller Univ, Lab Cellular Biophys, New York, NY USA.	simon@rockefeller.edu		Simon, Sanford/0000-0002-8615-4224; Saunders, Katherine/0000-0003-4154-9975	NSF [BES-0620813]; NIH [P20 GM072015, 1F32 GM069200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072015, F32GM069200] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF BES-0620813 and NIH P20 GM072015 (to SMS), and NIH 1F32 GM069200 (to JZR)	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao S, 2003, J BIOL CHEM, V278, P5894, DOI 10.1074/jbc.M212546200; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cook T, 1996, J NEUROCHEM, V67, P927; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; HOLZ RW, 2006, CELL MOL NEUROBIOL; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; LICHTE B, 1992, EMBO J, V11, P2521, DOI 10.1002/j.1460-2075.1992.tb05317.x; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Rappoport JZ, 2003, J CELL SCI, V116, P1151; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TSUBOI T, 2002, J BIOL CHEM; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; Tsuboi T, 2007, J NEUROCHEM, V100, P770, DOI 10.1111/j.1471-4159.2006.04266.x; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107	35	23	24	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2416	10.1371/journal.pone.0002416	http://dx.doi.org/10.1371/journal.pone.0002416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545672	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800053
J	Ross-Ibarra, J; Wright, SI; Foxe, JP; Kawabe, A; DeRose-Wilson, L; Gos, G; Charlesworth, D; Gaut, BS				Ross-Ibarra, Jeffrey; Wright, Stephen I.; Foxe, John Paul; Kawabe, Akira; DeRose-Wilson, Leah; Gos, Gesseca; Charlesworth, Deborah; Gaut, Brandon S.			Patterns of Polymorphism and Demographic History in Natural Populations of Arabidopsis lyrata	PLOS ONE			English	Article								Background: Many of the processes affecting genetic diversity act on local populations. However, studies of plant nucleotide diversity have largely ignored local sampling, making it difficult to infer the demographic history of populations and to assess the importance of local adaptation. Arabidopsis lyrata, a self-incompatible, perennial species with a circumpolar distribution, is an excellent model system in which to study the roles of demographic history and local adaptation in patterning genetic variation. Principal Findings: We studied nucleotide diversity in six natural populations of Arabidopsis lyrata, using 77 loci sampled from 140 chromosomes. The six populations were highly differentiated, with a median FST of 0.52, and STRUCTURE analysis revealed no evidence of admixed individuals. Average within-population diversity varied among populations, with the highest diversity found in a German population; this population harbors 3-fold higher levels of silent diversity than worldwide samples of A. thaliana. All A. lyrata populations also yielded positive values of Tajima's D. We estimated a demographic model for these populations, finding evidence of population divergence over the past 19,000 to 47,000 years involving non-equilibrium demographic events that reduced the effective size of most populations. Finally, we used the inferred demographic model to perform an initial test for local adaptation and identified several genes, including the flowering time gene FCA and a disease resistance locus, as candidates for local adaptation events. Conclusions: Our results underscore the importance of population-specific, non-equilibrium demographic processes in patterning diversity within A. lyrata. Moreover, our extensive dataset provides an important resource for future molecular population genetic studies of local adaptation in A. lyrata.	[Ross-Ibarra, Jeffrey; DeRose-Wilson, Leah; Gaut, Brandon S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Wright, Stephen I.; Foxe, John Paul; Gos, Gesseca] York Univ, Dept Biol, Toronto, ON, Canada; [Kawabe, Akira; Charlesworth, Deborah] Univ Edinburgh, Sch Biol Sci, Inst Evol Biol, Edinburgh, Midlothian, Scotland	University of California System; University of California Irvine; York University - Canada; University of Edinburgh	Ross-Ibarra, J (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	bgaut@uci.edu	Charlesworth, Deborah/F-3071-2011; Wright, Stephen I/C-3113-2008; Kawabe, Akira/W-7485-2019; Ross-Ibarra, Jeffrey/D-7782-2011	Wright, Stephen I/0000-0001-9973-9697; Kawabe, Akira/0000-0001-5770-412X; Ross-Ibarra, Jeffrey/0000-0003-1656-4954	NSF [DEB-0426166]; NSERC; Natural Environment Research Council of Great Britain [NER/A/S/2003/00329];  [Sloan fellowship]; BBSRC [BB/E020909/1, BB/E024718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E024718/1, BB/E020909/1] Funding Source: researchfish; Natural Environment Research Council [NER/A/S/2003/00329] Funding Source: researchfish	NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Environment Research Council of Great Britain(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by NSF grant (DEB-0426166) to B.S.G.; by an NSERC grant and Sloan fellowship to S.I.W; and by a Natural Environment Research Council of Great Britain grant (NER/A/S/2003/00329) to D.C.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balana-Alcaide D, 2006, MOL ECOL, V15, P2059, DOI 10.1111/j.1365-294X.2006.02918.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bergelson J, 2001, ANNU REV GENET, V35, P469, DOI 10.1146/annurev.genet.35.102401.090954; Bergelson J, 1998, GENETICS, V148, P1311; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2006, MOL ECOL, V15, P2753, DOI 10.1111/j.1365-294X.2006.02973.x; Clauss MJ, 2003, MOL ECOL, V12, P1287, DOI 10.1046/j.1365-294X.2003.01832.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fay JC, 2000, GENETICS, V155, P1405; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hamrick James L., 1996, P203; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansson B, 2006, GENET RES, V87, P75, DOI 10.1017/S0016672306008020; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ingvarsson PK, 2002, EVOLUTION, V56, P2368, DOI 10.1111/j.0014-3820.2002.tb00162.x; Innan H, 2000, GENETICS, V155, P2015; Karkkainen K, 2004, EVOLUTION, V58, P2831, DOI 10.1111/j.0014-3820.2004.tb01634.x; Kawabe A, 2006, GENETICS, V174, P2021, DOI 10.1534/genetics.106.063628; Kawabe A, 2006, GENET RES, V88, P45, DOI 10.1017/S0016672306008287; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kivimaki M, 2007, MOL ECOL, V16, P453, DOI 10.1111/j.1365-294X.2007.03109.x; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koch MA, 2007, P NATL ACAD SCI USA, V104, P6272, DOI 10.1073/pnas.0701338104; Kuittinen H, 2004, GENETICS, V168, P1575, DOI 10.1534/genetics.103.022343; LEWONTIN RC, 1973, GENETICS, V74, P175; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Li Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000105; Liu F, 1999, GENETICS, V151, P343; Liu F, 1998, P ROY SOC B-BIOL SCI, V265, P293, DOI 10.1098/rspb.1998.0295; Ma XF, 2006, MOL BIOL EVOL, V23, P807, DOI 10.1093/molbev/msj100; Mable BK, 2007, MOL ECOL, V16, P3565, DOI 10.1111/j.1365-294X.2007.03416.x; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; McVean G, 2002, GENETICS, V160, P1231; Moeller DA, 2007, GENETICS, V176, P1799, DOI 10.1534/genetics.107.070631; Muller MH, 2008, HEREDITY, V100, P47, DOI 10.1038/sj.hdy.6801057; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 1997, GENETICS, V146, P1185; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Pagnol V, 2006, GENETICS, V172, P2441, DOI 10.1534/genetics.104.040311; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Ramos-Onsins SE, 2004, GENETICS, V166, P373, DOI 10.1534/genetics.166.1.373; Riihimaki M, 2005, GENETICA, V123, P63, DOI 10.1007/s10709-003-2711-7; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandring S, 2007, J EVOLUTION BIOL, V20, P558, DOI 10.1111/j.1420-9101.2006.01260.x; Savolainen O, 2000, MOL BIOL EVOL, V17, P645, DOI 10.1093/oxfordjournals.molbev.a026343; Schlotterer C, 2002, GENETICS, V160, P753; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Touzet P, 2004, TRENDS PLANT SCI, V9, P568, DOI 10.1016/j.tplants.2004.10.001; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Wakeley J, 1997, GENETICS, V145, P847; Wakeley J, 2001, GENETICS, V159, P893; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir B. S., 1990, Genetic data analysis. Methods for discrete population genetic data.; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wright S, 1943, GENETICS, V28, P114; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wright SI, 2003, MOL ECOL, V12, P1247, DOI 10.1046/j.1365-294X.2003.01743.x; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Wright SI, 2006, GENETICS, V174, P1421, DOI 10.1534/genetics.106.062588; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	95	137	139	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2411	10.1371/journal.pone.0002411	http://dx.doi.org/10.1371/journal.pone.0002411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545707	Green Published, gold			2022-12-27	WOS:000263248800048
J	Elder, BD; Athanasiou, KA				Elder, Benjamin D.; Athanasiou, Kyriacos A.			Synergistic and Additive Effects of Hydrostatic Pressure and Growth Factors on Tissue Formation	PLOS ONE			English	Article							ARTICULAR-CARTILAGE CONSTRUCTS; INTERVERTEBRAL DISC CELLS; MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE-CELLS; IN-VITRO; II COLLAGEN; ENGINEERED CARTILAGE; CONTACT PRESSURES; MATRIX SYNTHESIS; MECHANICAL STIMULATION	Background: Hydrostatic pressure ( HP) is a significant factor in the function of many tissues, including cartilage, knee meniscus, temporomandibular joint disc, intervertebral disc, bone, bladder, and vasculature. Though studies have been performed in assessing the role of HP in tissue biochemistry, to the best of our knowledge, no studies have demonstrated enhanced mechanical properties from HP application in any tissue. Methodology/Principal Findings: The objective of this study was to determine the effects of hydrostatic pressure (HP), with and without growth factors, on the biomechanical and biochemical properties of engineered articular cartilage constructs, using a two-phased approach. In phase I, a 363 full-factorial design of HP magnitude (1, 5, 10 MPa) and frequency (0, 0.1, 1 Hz) was used, and the best two treatments were selected for use in phase II. Static HP at 5 MPa and 10 MPa resulted in significant 95% and 96% increases, respectively, in aggregate modulus (H(A)), with corresponding increases in GAG content. These regimens also resulted in significant 101% and 92% increases in Young's modulus (E(Y)), with corresponding increases in collagen content. Phase II employed a 363 full-factorial design of HP (no HP, 5 MPa static, 10 MPa static) and growth factor application (no GF, BMP-2+IGF-I, TGF-beta 1). The combination of 10 MPa static HP and TGF-beta 1 treatment had an additive effect on both H(A) and E(Y), as well as a synergistic effect on collagen content. This group demonstrated a 164% increase in H(A), a 231% increase in EY, an 85% increase in GAG/wet weight (WW), and a 173% increase in collagen/WW, relative to control. Conclusions/Significance: To our knowledge, this is the first study to demonstrate increases in the biomechanical properties of tissue from pure HP application, using a cartilage model. Furthermore, it is the only study to demonstrate additive or synergistic effects between HP and growth factors on tissue functional properties. These findings are exciting as coupling HP stimulation with growth factor application has allowed for the formation of tissue engineered constructs with biomechanical and biochemical properties spanning native tissue values.	[Elder, Benjamin D.; Athanasiou, Kyriacos A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Elder, BD (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	athanasiou@rice.edu			NIH NIAMS [R01 AR053286]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053286] Funding Source: NIH RePORTER	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was performed with funding from NIH NIAMS R01 AR053286.	AFOKE NYP, 1987, J BONE JOINT SURG BR, V69, P536, DOI 10.1302/0301-620X.69B4.3611154; Almarza AJ, 2006, TISSUE ENG, V12, P1285, DOI 10.1089/ten.2006.12.1285; ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Bachrach NM, 1998, J BIOMECH, V31, P445, DOI 10.1016/S0021-9290(98)00035-9; Benson V, 1998, Vital Health Stat 10, P1; Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072; Bonassar LJ, 2001, J ORTHOP RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8; Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029; Browning JA, 1999, ACTA PHYSIOL SCAND, V166, P39; Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192; BUCKWALTER JA, 1979, PARK RIDGE, P405; Darling EM, 2005, CELL TISSUE RES, V322, P463, DOI 10.1007/s00441-005-0020-4; Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480; Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102; Hall AC, 1999, J CELL PHYSIOL, V178, P197, DOI 10.1002/(SICI)1097-4652(199902)178:2<197::AID-JCP9>3.0.CO;2-3; HODGE WA, 1989, J BONE JOINT SURG AM, V71A, P1378, DOI 10.2106/00004623-198971090-00015; HOROWITZ SB, 1988, J CELL PHYSIOL, V135, P425, DOI 10.1002/jcp.1041350309; Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; HUBERTI HH, 1984, J BONE JOINT SURG AM, V66A, P715, DOI 10.2106/00004623-198466050-00010; Ikenoue T, 2003, J ORTHOPAED RES, V21, P110, DOI 10.1016/S0736-0266(02)00091-8; Kasra M, 2006, J ORTHOP RES, V24, P1967, DOI 10.1002/jor.20253; Khalafi A, 2007, J ORTHOP RES, V25, P293, DOI 10.1002/jor.20329; Kornblatt JA, 2002, BBA-PROTEIN STRUCT M, V1595, P30, DOI 10.1016/S0167-4838(01)00333-8; Lee MS, 2003, J RHEUMATOL, V30, P326; Lee MS, 2003, J ORTHOPAED RES, V21, P117, DOI 10.1016/S0736-0266(02)00085-2; Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304; Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Mizuno S, 2005, AM J PHYSIOL-CELL PH, V288, pC329, DOI 10.1152/ajpcell.00131.2004; Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Muller-Marschhausen K, 2008, AM J PHYSIOL-CELL PH, V294, pC324, DOI 10.1152/ajpcell.00319.2007; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062; Pietila K, 1999, CELLS TISSUES ORGANS, V164, P30, DOI 10.1159/000016640; Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Shimizu M, 1997, CELL STRUCT FUNCT, V22, P309, DOI 10.1247/csf.22.309; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Smith RL, 1996, J ORTHOP RES, V14, P53, DOI 10.1002/jor.1100140110; Smith RL, 2000, J REHABIL RES DEV, V37, P153; Stover J, 2007, ANN BIOMED ENG, V35, P1585, DOI 10.1007/s10439-007-9331-9; Suzuki T, 2006, BIORHEOLOGY, V43, P611; Takahashi A, 1997, BRAIN RES PROTOC, V1, P70, DOI 10.1016/S1385-299X(96)00013-X; TAKEMITSU Y, 1961, KYUSHU J MED SCI, P251; Toyoda T, 2003, BIORHEOLOGY, V40, P79; Toyoda T, 2003, ARTHRITIS RHEUM, V48, P2865, DOI 10.1002/art.11250; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436	55	103	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2341	10.1371/journal.pone.0002341	http://dx.doi.org/10.1371/journal.pone.0002341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523560	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300034
J	Fudge, D; Russell, D; Beriault, D; Moore, W; Lane, EB; Vogl, AW				Fudge, Douglas; Russell, David; Beriault, Dan; Moore, Whitney; Lane, E. Birgitte; Vogl, A. Wayne			The Intermediate Filament Network in Cultured Human Keratinocytes Is Remarkably Extensible and Resilient	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LIVING CELLS; MICROTUBULES; LETHALITY; KERATIN-8; INSIGHTS; FIBERS	The prevailing model of the mechanical function of intermediate filaments in cells assumes that these 10 nm diameter filaments make up networks that behave as entropic gels, with individual intermediate filaments never experiencing direct loading in tension. However, recent work has shown that single intermediate filaments and bundles are remarkably extensible and elastic in vitro, and therefore well-suited to bearing tensional loads. Here we tested the hypothesis that the intermediate filament network in keratinocytes is extensible and elastic as predicted by the available in vitro data. To do this, we monitored the morphology of fluorescently-tagged intermediate filament networks in cultured human keratinocytes as they were subjected to uniaxial cell strains as high as 133%. We found that keratinocytes not only survived these high strains, but their intermediate filament networks sustained only minor damage at cell strains as high as 100%. Electron microscopy of stretched cells suggests that intermediate filaments are straightened at high cell strains, and therefore likely to be loaded in tension. Furthermore, the buckling behavior of intermediate filament bundles in cells after stretching is consistent with the emerging view that intermediate filaments are far less stiff than the two other major cytoskeletal components F-actin and microtubules. These insights into the mechanical behavior of keratinocytes and the cytokeratin network provide important baseline information for current attempts to understand the biophysical basis of genetic diseases caused by mutations in intermediate filament genes.	[Fudge, Douglas; Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Fudge, Douglas; Beriault, Dan; Moore, Whitney] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Russell, David; Lane, E. Birgitte] Univ Dundee, Coll Life Sci, Canc Res UK Cell Structure Res Grp, Dundee, Scotland	University of British Columbia; University of Guelph; University of Dundee	Fudge, D (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	dfudge@uoguelph.ca	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC) [postdoctoral fellowship, Discovery Grant]; Cancer Research UK [C26/A6694]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research UK(Cancer Research UK)	This work was supported by a Canadian Institute of Health Research (CIHR) Operating Grant (AWV), a Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (DF), an NSERC Discovery Grant (DF), and a Cancer Research UK grant to EBL and DR (no. C26/A6694).	BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BLANK IH, 1952, J INVEST DERMATOL, V18, P433, DOI 10.1038/jid.1952.52; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Bray D, 2001, CELL MOVEMENTS MOL M; BRODLAND GW, 1990, J BIOMECH ENG-T ASME, V112, P319, DOI 10.1115/1.2891190; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fraser R.D.B., 1972, KERATINS THEIR COMPO; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Howard J., 2001, MECH MOTOR PROTEINS; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KRAUSE AW, 1984, J HISTOCHEM CYTOCHEM, V32, P1084, DOI 10.1177/32.10.6090533; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Loranger A, 1997, AM J PATHOL, V151, P1673; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Moussa M, 2006, J EQUINE VET SCI, V26, P529, DOI 10.1016/j.jevs.2006.09.009; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	29	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2327	10.1371/journal.pone.0002327	http://dx.doi.org/10.1371/journal.pone.0002327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523546	Green Submitted, gold, Green Published			2022-12-27	WOS:000262614300022
J	Mooshagian, E; Kaplan, J; Zaidel, E; Iacoboni, M				Mooshagian, Eric; Kaplan, Jonas; Zaidel, Eran; Iacoboni, Marco			Fast Visuomotor Processing of Redundant Targets: The Role of the Right Temporo-Parietal Junction	PLOS ONE			English	Article							SIMPLE REACTION-TIME; INTERHEMISPHERIC NEURAL SUMMATION; SPLIT BRAIN; DIVIDED ATTENTION; COACTIVATION; FACILITATION; NEGLECT	Parallel processing of multiple sensory stimuli is critical for efficient, successful interaction with the environment. An experimental approach to studying parallel processing in sensorimotor integration is to examine reaction times to multiple copies of the same stimulus. Reaction times to bilateral copies of light flashes are faster than to single, unilateral light flashes. These faster responses may be due to 'statistical facilitation' between independent processing streams engaged by the two copies of the light flash. On some trials, however, reaction times are faster than predicted by statistical facilitation. This indicates that a neural 'coactivation' of the two processing streams must have occurred. Here we use fMRI to investigate the neural locus of this coactivation. Subjects responded manually to the detection of unilateral light flashes presented to the left or right visual hemifield, and to the detection of bilateral light flashes. We compared the bilateral trials where subjects' reaction times exceeded the limit predicted by statistical facilitation to bilateral trials that did not exceed the limit. Activity in the right temporo-parietal junction was higher in those bilateral trials that showed coactivation than in those that did not. These results suggest the neural coactivation observed in visuomotor integration occurs at a cognitive rather than sensory or motor stage of processing.	[Mooshagian, Eric; Zaidel, Eran] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Zaidel, Eran; Iacoboni, Marco] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA USA; [Kaplan, Jonas; Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Neuropsychiat Inst, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mooshagian, E (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	emooshag@ucla.edu		Mooshagian, Eric/0000-0001-5998-8445	NIH [MH63680, RR12169, RR13642, RR00865]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, M01RR000865, P41RR013642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by NIH grant MH63680 to M.I. For generous support the authors wish to thank the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family and Northstar Fund. The project described was also supported by Grant Numbers RR12169, RR13642 and RR00865 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMH, NCRR or NIH.	BEHRENS T, 2003, HUM BRAIN MAPP; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cavina-Pratesi C, 2001, J EXP PSYCHOL HUMAN, V27, P932, DOI 10.1037//0096-1523.27.4.932; Corballis MC, 1998, BRAIN, V121, P1795, DOI 10.1093/brain/121.9.1795; Corballis MC, 2002, J COGNITIVE NEUROSCI, V14, P1151, DOI 10.1162/089892902760807168; Corballis MC, 2002, NEUROPSYCHOLOGIA, V40, P423, DOI 10.1016/S0028-3932(01)00097-5; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; GRICE GR, 1992, PERCEPT PSYCHOPHYS, V51, P437, DOI 10.3758/BF03211639; Iacoboni M, 2000, BRAIN, V123, P759, DOI 10.1093/brain/123.4.759; Iacoboni M, 2003, EUR J NEUROSCI, V17, P1981, DOI 10.1046/j.1460-9568.2003.02602.x; LUCK SJ, 2005, INTRO EVENT RELATED, pR12; Meister IG, 2006, NEUROSCIENCE, V142, P119, DOI 10.1016/j.neuroscience.2006.06.023; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Miniussi C, 1998, J COGNITIVE NEUROSCI, V10, P216, DOI 10.1162/089892998562663; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; REUTERLORENZ PA, 1995, J EXP PSYCHOL HUMAN, V21, P211, DOI 10.1037/0096-1523.21.2.211; Roser M, 2002, NEUROPSYCHOLOGIA, V40, P1300, DOI 10.1016/S0028-3932(01)00219-6; Savazzi S, 2002, CURR BIOL, V12, P403, DOI 10.1016/S0960-9822(02)00688-7; Schroter H, 2007, PSYCHON B REV, V14, P39, DOI 10.3758/BF03194025; Todd J.W., 1912, REACTION MULTIPLE ST; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2348	10.1371/journal.pone.0002348	http://dx.doi.org/10.1371/journal.pone.0002348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523591	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300039
J	Ausseil, J; Desmaris, N; Bigou, S; Attali, R; Corbineau, S; Vitry, S; Parent, M; Cheillan, D; Fuller, M; Maire, I; Vanier, MT; Heard, JM				Ausseil, Jerome; Desmaris, Nathalie; Bigou, Stephanie; Attali, Ruben; Corbineau, Sebastien; Vitry, Sandrine; Parent, Mathieu; Cheillan, David; Fuller, Maria; Maire, Irene; Vanier, Marie-Therese; Heard, Jean-Michel			Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice	PLOS ONE			English	Article								Background: In mucopolysaccharidosis type IIIB, a lysosomal storage disease causing early onset mental retardation in children, the production of abnormal oligosaccharidic fragments of heparan sulfate is associated with severe neuropathology and chronic brain inflammation. We addressed causative links between the biochemical, pathological and inflammatory disorders in a mouse model of this disease. Methodology/Principal Findings: In cell culture, heparan sulfate oligosaccharides activated microglial cells by signaling through the Toll-like receptor 4 and the adaptor protein MyD88. CD11b positive microglial cells and three-fold increased expression of mRNAs coding for the chemokine MIP1a were observed at 10 days in the brain cortex of MPSIIIB mice, but not in MPSIIIB mice deleted for the expression of Toll-like receptor 4 or the adaptor protein MyD88, indicating early priming of microglial cells by heparan sulfate oligosaccharides in the MPSIIIB mouse brain. Whereas the onset of brain inflammation was delayed for several months in doubly mutant versus MPSIIIB mice, the onset of disease markers expression was unchanged, indicating similar progression of the neurodegenerative process in the absence of microglial cell priming by heparan sulfate oligosaccharides. In contrast to younger mice, inflammation in aged MPSIIIB mice was not affected by TLR4/MyD88 deficiency. Conclusions/Significance: These results indicate priming of microglia by HS oligosaccharides through the TLR4/MyD88 pathway. Although intrinsic to the disease, this phenomenon is not a major determinant of the neurodegenerative process. Inflammation may still contribute to neurodegeneration in late stages of the disease, albeit independent of TLR4/MyD88. The results support the view that neurodegeneration is primarily cell autonomous in this pediatric disease.	[Ausseil, Jerome; Desmaris, Nathalie; Attali, Ruben; Corbineau, Sebastien; Vitry, Sandrine; Parent, Mathieu; Heard, Jean-Michel] Inst Pasteur, Dept Neurosci, INSERM, Unite Retrovirus & Transfert Genet,U622, Paris, France; [Bigou, Stephanie] Hop Paris, Assistance Publ, Hop Bicetre, INSERM U802, Serv Neurol Pediat, Le Kremlin Bicetre, France; [Cheillan, David; Maire, Irene] CBPE, Groupement Hosp Est, Bron, France; [Fuller, Maria] Children, Youth & Womens Hlth Serv, Adelaide, SA, Australia; [Vanier, Marie-Therese] Fac Med Laennec, INSERM U820, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ausseil, J (corresponding author), Inst Pasteur, Dept Neurosci, INSERM, Unite Retrovirus & Transfert Genet,U622, Paris, France.	jmheard@pasteur.fr	Ausseil, Jerome/AAA-4703-2019	Ausseil, Jerome/0000-0002-3059-9777; Vitry, Sandrine/0000-0003-4693-7694; cheillan, david/0000-0001-9535-2567; Bigou, Stephanie/0000-0002-6328-0703	Association Francaise contre les myopathies; Institut Pasteur	Association Francaise contre les myopathies(Association Francaise contre les Myopathies); Institut Pasteur(European Commission)	This work was supported by a joint program of the Association Francaise contre les myopathies and the Institut Pasteur.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; CONSTANTOPOULOS G, 1985, J NEUROCHEM, V45, P1213, DOI 10.1111/j.1471-4159.1985.tb05544.x; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Desmaris N, 2004, ANN NEUROL, V56, P68, DOI 10.1002/ana.20150; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Gieselmann V, 2003, ACTA PAEDIATR, V92, P74, DOI 10.1080/08035320310000528; Gieselmann V, 2003, ACTA PAEDIATR, V92, P45, DOI 10.1080/08035250310000537; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARSH J, 1985, CLIN GENET, V27, P258; MASUDA H, 1981, INT J BIOCHEM, V13, P603; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; PIRAUD M, 1993, CLIN CHIM ACTA, V221, P171, DOI 10.1016/0009-8981(93)90031-X; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; SAIFER A, 1974, CLIN CHEM, V20, P538; Salvetti A, 1998, HUM GENE THER, V9, P695, DOI 10.1089/hum.1998.9.5-695; Sano R, 2005, BLOOD, V106, P2259, DOI 10.1182/blood-2005-03-1189; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sheng WS, 2000, CLIN IMMUNOL, V96, P243, DOI 10.1006/clim.2000.4905; Simpson D, 2000, MOL VIS, V6, P178; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WHITLEY CB, 1989, CLIN CHEM, V35, P2074; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	54	93	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2296	10.1371/journal.pone.0002296	http://dx.doi.org/10.1371/journal.pone.0002296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509511	gold, Green Published, Green Submitted			2022-12-27	WOS:000262268500035
J	Bagci, EZ; Vodovotz, Y; Billiar, TR; Ermentrout, B; Bahar, I				Bagci, Elife Z.; Vodovotz, Yoram; Billiar, Timothy R.; Ermentrout, Bard; Bahar, Ivet			Computational Insights on the Competing Effects of Nitric Oxide in Regulating Apoptosis	PLOS ONE			English	Article								Despite the establishment of the important role of nitric oxide (NO) on apoptosis, a molecular-level understanding of the origin of its dichotomous pro- and anti-apoptotic effects has been elusive. We propose a new mathematical model for simulating the effects of nitric oxide (NO) on apoptosis. The new model integrates mitochondria-dependent apoptotic pathways with NO-related reactions, to gain insights into the regulatory effect of the reactive NO species N2O3, non-heme iron nitrosyl species (FeLnNO), and peroxynitrite (ONOO-). The biochemical pathways of apoptosis coupled with NO-related reactions are described by ordinary differential equations using mass-action kinetics. In the absence of NO, the model predicts either cell survival or apoptosis (a bistable behavior) with shifts in the onset time of apoptotic response depending on the strength of extracellular stimuli. Computations demonstrate that the relative concentrations of anti- and proapoptotic reactive NO species, and their interplay with glutathione, determine the net anti- or pro- apoptotic effects at long time points. Interestingly, transient effects on apoptosis are also observed in these simulations, the duration of which may reach up to hours, despite the eventual convergence to an anti- apoptotic state. Our computations point to the importance of precise timing of NO production and external stimulation in determining the eventual pro- or anti- apoptotic role of NO.	[Bagci, Elife Z.; Bahar, Ivet] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Computat Biol, Pittsburgh, PA 15260 USA; [Bagci, Elife Z.] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Biochem & Mol Genet, Pittsburgh, PA USA; [Vodovotz, Yoram; Billiar, Timothy R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Sch Med, Dept Surg, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammation & Regenerat Modeling, Pittsburgh, PA USA; [Ermentrout, Bard] Univ Pittsburgh, Dept Math, Arts & Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bagci, EZ (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Computat Biol, Pittsburgh, PA 15260 USA.	bahar@ccbb.pitt.edu; bard@math.pitt.edu	Bagci, Elife Zerrin/A-9660-2016; bagci, elife/B-9032-2012; Bahar, Ivet/AAH-2921-2020	Bagci, Elife/0000-0001-5920-0400	National Institutes of Health [1P20-GM065805]; NSF [DMS0513500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM065805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	IB gratefully acknowledges the support from National Institutes of Health award No. 1P20-GM065805. GBE was supported by NSF DMS0513500.	Afshar RK, 2004, INORG CHEM, V43, P5736, DOI 10.1021/ic040057c; ALBINA JE, 1993, J IMMUNOL, V150, P5080; Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buerk DG, 2001, ANNU REV BIOMED ENG, V3, P109, DOI 10.1146/annurev.bioeng.3.1.109; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Ceneviva GD, 1998, AM J PHYSIOL-LUNG C, V275, pL717, DOI 10.1152/ajplung.1998.275.4.L717; Chen T, 2005, HEPATOLOGY, V42, P598, DOI 10.1002/hep.20813; CZAPSKI G, 1995, FREE RADICAL BIO MED, V19, P785, DOI 10.1016/0891-5849(95)00081-8; De Visscher G, 2005, J NEUROTRAUM, V22, P793; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dimmeler S, 1997, CIRC RES, V81, P970; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; FIELDEN EM, 1974, BIOCHEM J, V139, P49, DOI 10.1042/bj1390049; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Gorren ACF, 1996, ARCH BIOCHEM BIOPHYS, V330, P219, DOI 10.1006/abbi.1996.0247; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Hu TM, 2006, PHARM RES-DORDR, V23, P1702, DOI 10.1007/s11095-006-9031-4; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Jones CM, 2002, FREE RADICAL BIO MED, V32, P982, DOI 10.1016/S0891-5849(02)00791-8; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Keshive M, 1996, CHEM RES TOXICOL, V9, P988, DOI 10.1021/tx960036y; Kim PKM, 2005, CELL MOL BIOL, V51, P229; Kim PKM, 2004, BIOL CHEM, V385, P11, DOI 10.1515/BC.2004.002; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 2000, J BIOL CHEM, V275, P10954, DOI 10.1074/jbc.275.15.10954; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LICHT WR, 1988, CARCINOGENESIS, V9, P365, DOI 10.1093/carcin/9.3.365; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pou S, 1999, BBA-GEN SUBJECTS, V1427, P216, DOI 10.1016/S0304-4165(99)00014-8; Pourzand C, 1999, P NATL ACAD SCI USA, V96, P6751, DOI 10.1073/pnas.96.12.6751; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Sanfilippo CM, 2003, INT REV IMMUNOL, V22, P327, DOI 10.1080/08830180305211; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Siehs C, 2002, BIOINFORMATICS, V18, P67, DOI 10.1093/bioinformatics/18.1.67; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; THOMSON L, 1995, ARCH BIOCHEM BIOPHYS, V319, P491, DOI 10.1006/abbi.1995.1321; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Tzeng E, 1997, SURGERY, V122, P255, DOI 10.1016/S0039-6060(97)90016-7; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Vodovotz Y, 2004, CURR MOL MED, V4, P753, DOI 10.2174/1566524043359944; Wang YN, 2002, ANN NY ACAD SCI, V962, P415, DOI 10.1111/j.1749-6632.2002.tb04085.x; Weller R, 2003, AM J PHYSIOL-CELL PH, V284, pC1140, DOI 10.1152/ajpcell.00462.2002; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wink David A., 1999, P245; ZHANG W, 2006, AM J PHYSL IN PRESS	78	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2249	10.1371/journal.pone.0002249	http://dx.doi.org/10.1371/journal.pone.0002249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509469	gold, Green Published, Green Submitted			2022-12-27	WOS:000262268500003
J	Guerra, L; Carr, HS; Richter-Dahlfors, A; Masucci, MG; Thelestam, M; Frost, JA; Frisan, T				Guerra, Lina; Carr, Heather S.; Richter-Dahlfors, Agneta; Masucci, Maria G.; Thelestam, Monica; Frost, Jeffrey A.; Frisan, Teresa			A Bacterial Cytotoxin Identifies the RhoA Exchange Factor Net1 as a Key Effector in the Response to DNA Damage	PLOS ONE			English	Article								Background: Exposure of adherent cells to DNA damaging agents, such as the bacterial cytolethal distending toxin (CDT) or ionizing radiations (IR), activates the small GTPase RhoA, which promotes the formation of actin stress fibers and delays cell death. The signalling intermediates that regulate RhoA activation and promote cell survival are unknown. Principal Findings: We demonstrate that the nuclear RhoA-specific Guanine nucleotide Exchange Factor (GEF) Net1 becomes dephosphorylated at a critical inhibitory site in cells exposed to CDT or IR. Expression of a dominant negative Net1 or Net1 knock down by iRNA prevented RhoA activation, inhibited the formation of stress fibers, and enhanced cell death, indicating that Net1 activation is required for this RhoA-mediated responses to genotoxic stress. The Net1 and RhoA-dependent signals involved activation of the Mitogen-Activated Protein Kinase p38 and its downstream target MAPK-activated protein kinase 2. Significance: Our data highlight the importance of Net1 in controlling RhoA and p38 MAPK mediated cell survival in cells exposed to DNA damaging agents and illustrate a molecular pathway whereby chronic exposure to a bacterial toxin may promote genomic instability.	[Guerra, Lina; Masucci, Maria G.; Thelestam, Monica; Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Richter-Dahlfors, Agneta] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Carr, Heather S.; Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrative Biol & Pharmacol, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; University of Texas System; University of Texas Health Science Center Houston	Guerra, L (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Frisan, Teresa/H-8444-2019; Masucci, Maria/AAC-6666-2019	Frisan, Teresa/0000-0002-1209-0942; Masucci, Maria/0000-0002-5541-2809; Frost, Jeffrey/0000-0001-9722-1536; Richter-Dahlfors, Agneta/0000-0002-5479-7591	Swedish Research Council; Swedish Cancer Society; Ake-Wiberg Foundation; Karolinska Institutet; European Community Integrated Project on Infection and Cancer (INCA); Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake-Wiberg Foundation; Karolinska Institutet(Karolinska Institutet); European Community Integrated Project on Infection and Cancer (INCA)(Institut National du Cancer (INCA) France); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Swedish Research Council, Swedish Cancer Society, the Ake-Wiberg Foundation, Karolinska Institutet, the European Community Integrated Project on Infection and Cancer (INCA), Susan G. Komen Breast Cancer Foundation. None of the funding agencies contributed to design, conduct or analyze the data in this study.	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Chan AML, 1996, ONCOGENE, V12, P1259; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lax AJ, 2007, TRENDS MOL MED, V13, P91, DOI 10.1016/j.molmed.2007.01.001; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	34	55	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2254	10.1371/journal.pone.0002254	http://dx.doi.org/10.1371/journal.pone.0002254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509476	Green Published, gold			2022-12-27	WOS:000262268500006
J	Shaked, M; Weissmuller, K; Svoboda, H; Hortschansky, P; Nishino, N; Wolfl, S; Tucker, KL				Shaked, Maya; Weissmueller, Kathrin; Svoboda, Hanno; Hortschansky, Peter; Nishino, Norikazu; Woelfl, Stefan; Tucker, Kerry L.			Histone Deacetylases Control Neurogenesis in Embryonic Brain by Inhibition of BMP2/4 Signaling	PLOS ONE			English	Article								Background: Histone-modifying enzymes are essential for a wide variety of cellular processes dependent upon changes in gene expression. Histone deacetylases (HDACs) lead to the compaction of chromatin and subsequent silencing of gene transcription, and they have recently been implicated in a diversity of functions and dysfunctions in the postnatal and adult brain including ocular dominance plasticity, memory consolidation, drug addiction, and depression. Here we investigate the role of HDACs in the generation of neurons and astrocytes in the embryonic brain. Principal Findings: As a variety of HDACs are expressed in differentiating neural progenitor cells, we have taken a pharmacological approach to inhibit multiple family members. Inhibition of class I and II HDACs in developing mouse embryos with trichostatin A resulted in a dramatic reduction in neurogenesis in the ganglionic eminences and a modest increase in neurogenesis in the cortex. An identical effect was observed upon pharmacological inhibition of HDACs in in vitro-differentiating neural precursors derived from the same brain regions. A reduction in neurogenesis in ganglionic eminence-derived neural precursors was accompanied by an increase in the production of immature astrocytes. We show that HDACs control neurogenesis by inhibition of the bone morphogenetic protein BMP2/4 signaling pathway in radial glial cells. HDACs function at the transcriptional level by inhibiting and promoting, respectively, the expression of Bmp2 and Smad7, an intracellular inhibitor of BMP signaling. Inhibition of the BMP2/4 signaling pathway restored normal levels of neurogenesis and astrogliogenesis to both ganglionic eminence-and cortex-derived cultures in which HDACs were inhibited. Conclusions: Our results demonstrate a transcriptionally-based regulation of BMP2/4 signaling by HDACs both in vivo and in vitro that is critical for neurogenesis in the ganglionic eminences and that modulates cortical neurogenesis. The results also suggest that HDACs may regulate the developmental switch from neurogenesis to astrogliogenesis that occurs in late gestation.	[Shaked, Maya; Weissmueller, Kathrin; Svoboda, Hanno; Tucker, Kerry L.] Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-6900 Heidelberg, Germany; [Hortschansky, Peter] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Jena, Germany; [Nishino, Norikazu] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka, Japan; [Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Hans Knoll Institute (HKI); Kyushu Institute of Technology; Ruprecht Karls University Heidelberg	Shaked, M (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-6900 Heidelberg, Germany.	kerry.tucker@urz.uni-hd.de			German Research Foundation [SFB 488]; University of Heidelberg; BMBF [0311786, 0312558]; Minerva Stiftung of the Max Planck Society; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); University of Heidelberg; BMBF(Federal Ministry of Education & Research (BMBF)); Minerva Stiftung of the Max Planck Society; Studienstiftung des deutschen Volkes	This work was funded by the German Research Foundation (DFG, SFB 488, Teilprojekt B7), the University of Heidelberg, the BMBF (Grants 0311786 & 0312558 to P.H.), the Minerva Stiftung of the Max Planck Society (M.S.), and the Studienstiftung des deutschen Volkes (H.S.).	Ajamian F, 2003, NEUROSCI LETT, V346, P57, DOI 10.1016/S0304-3940(03)00545-7; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Bayer S.A., 1991, NEOCORTICAL DEV; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brachmann I, 2007, DEV DYNAM, V236, P3514, DOI 10.1002/dvdy.21386; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Christoffels VM, 2000, DEV BIOL, V224, P263, DOI 10.1006/dbio.2000.9801; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukuda Shinji, 2005, Anatomical Science International, V80, P12; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Gulacsi A, 2003, J NEUROSCI, V23, P9862; GURLEY LR, 1974, J CELL BIOL, V60, P356, DOI 10.1083/jcb.60.2.356; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORTSCHANSKY P, 2001, Patent No. 19944626; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nervi C, 2001, CANCER RES, V61, P1247; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stowell John C., 1995, Journal of Medicinal Chemistry, V38, P1411; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Tucker KL, 2001, NEURON, V30, P649, DOI 10.1016/S0896-6273(01)00325-7; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; Wine-Lee L, 2004, DEVELOPMENT, V131, P5393, DOI 10.1242/dev.01379; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang DM, 1998, J NEUROSCI, V18, P3314	87	58	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2668	10.1371/journal.pone.0002668	http://dx.doi.org/10.1371/journal.pone.0002668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628975	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200014
J	Widschwendter, M; Apostolidou, S; Raum, E; Rothenbacher, D; Fiegl, H; Menon, U; Stegmaier, C; Jacobs, IJ; Brenner, H				Widschwendter, Martin; Apostolidou, Sophia; Raum, Elke; Rothenbacher, Dietrich; Fiegl, Heidi; Menon, Usha; Stegmaier, Christa; Jacobs, Ian J.; Brenner, Hermann			Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study	PLOS ONE			English	Article								Background: Epigenetic changes are emerging as one of the most important events in carcinogenesis. Two alterations in the pattern of DNA methylation in breast cancer (BC) have been previously reported; active estrogen receptor-a (ER-a) is associated with decreased methylation of ER-a target (ERT) genes, and polycomb group target (PCGT) genes are more likely than other genes to have promoter DNA hypermethylation in cancer. However, whether DNA methylation in normal unrelated cells is associated with BC risk and whether these imprints can be related to factors which can be modified by the environment, is unclear. Methodology/Principal Findings: Using quantitative methylation analysis in a case-control study (n = 1,083) we found that DNA methylation of peripheral blood cell DNA provides good prediction of BC risk. We also report that invasive ductal and invasive lobular BC is characterized by two different sets of genes, the latter particular by genes involved in the differentiation of the mesenchyme (PITX2, TITF1, GDNF and MYOD1). Finally we demonstrate that only ERT genes predict ER positive BC; lack of peripheral blood cell DNA methylation of ZNF217 predicted BC independent of age and family history (odds ratio 1.49; 95% confidence interval 1.12-1.97; P = 0.006) and was associated with ER-a bioactivity in the corresponding serum. Conclusion/Significance: This first large-scale epigenotyping study demonstrates that DNA methylation may serve as a link between the environment and the genome. Factors that can be modulated by the environment (like estrogens) leave an imprint in the DNA of cells that are unrelated to the target organ and indicate the predisposition to develop a cancer. Further research will need to demonstrate whether DNA methylation profiles will be able to serve as a new tool to predict the risk of developing chronic diseases with sufficient accuracy to guide preventive measures.	[Widschwendter, Martin; Apostolidou, Sophia; Fiegl, Heidi; Menon, Usha; Jacobs, Ian J.] UCL, Dept Gynecol Oncol, Inst Womens Hlth, London, England; [Raum, Elke; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Ageing Res, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany	University of London; University College London; Helmholtz Association; German Cancer Research Center (DKFZ)	Widschwendter, M (corresponding author), UCL, Dept Gynecol Oncol, Inst Womens Hlth, London, England.	M.Widschwendter@ucl.ac.uk	Menon, Usha/C-4716-2008; Brenner, Hermann/ABE-6383-2020; Jacobs, Ian J/F-1743-2013; Brenner, Hermann/B-4627-2017; Fiegl, Heidi/K-4445-2017	Menon, Usha/0000-0003-3708-1732; Brenner, Hermann/0000-0002-6129-1572; Jacobs, Ian J/0000-0002-8112-4624; Brenner, Hermann/0000-0002-6129-1572; Apostolidou, Sophia/0000-0003-2659-0451; Widschwendter, Martin/0000-0002-7778-8380; Rothenbacher, Dietrich/0000-0002-3563-2791; Fiegl, Heidi/0000-0002-1236-6806; Jacobs, Ian/0000-0002-5005-2672	The Eve Appeal; The Oak Foundation; European Union; FWF Austrian Science Fund; Baden-Wurttemberg Ministry of Research, Science and Arts	The Eve Appeal; The Oak Foundation; European Union(European Commission); FWF Austrian Science Fund(Austrian Science Fund (FWF)); Baden-Wurttemberg Ministry of Research, Science and Arts	The work described in this manuscript was supported by The Eve Appeal and The Oak Foundation and grants from the European Union and the FWF Austrian Science Fund (awarded to M. Widschwendter) and by a grant from the Baden-Wurttemberg Ministry of Research, Science and Arts (awarded to H. Brenner). The funders did not play any role in the design or conduct of the study.	Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P746, DOI 10.1111/j.1469-1809.2007.00384.x; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Hasenbrink G, 2006, FASEB J, V20, P1552, DOI 10.1096/fj.05-5413fje; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Krig SR, 2007, J BIOL CHEM, V282, P9703, DOI 10.1074/jbc.M611752200; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Nonet GH, 2001, CANCER RES, V61, P1250; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; Sievernich A, 2004, J STEROID BIOCHEM, V92, P455, DOI 10.1016/j.jsbmb.2004.09.004; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Terry P, 2002, INT J CANCER, V97, P864, DOI 10.1002/ijc.10138; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	36	115	132	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2656	10.1371/journal.pone.0002656	http://dx.doi.org/10.1371/journal.pone.0002656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628976	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200002
J	Gratwicke, B; Mills, J; Dutton, A; Gabriel, G; Long, B; Seidensticker, J; Wright, B; You, W; Zhang, L				Gratwicke, Brian; Mills, Judy; Dutton, Adam; Gabriel, Grace; Long, Barney; Seidensticker, John; Wright, Belinda; You, Wang; Zhang, Li			Attitudes Toward Consumption and Conservation of Tigers in China	PLOS ONE			English	Article								A heated debate has recently emerged between tiger farmers and conservationists about the potential consequences of lifting the ban on trade in farmed tiger products in China. This debate has caused unfounded speculation about the extent of the potential market for tiger products. To fill this knowledge gap, we surveyed 1880 residents from a total of six Chinese cities to understand Urban Chinese tiger consumption behavior, knowledge of trade issues and attitudes towards tiger conservation. We found that 43% of respondents had consumed some product alleged to contain tiger parts. Within this user-group, 71% said that they preferred wild products over farmed ones. The two predominant products used were tiger bone plasters (38%) and tiger bone wine (6.4%). 88% of respondents knew that it was illegal to buy or sell tiger products, and 93% agreed that a ban in trade of tiger parts was necessary to conserve wild tigers. These results indicate that while Urban Chinese people are generally supportive of tiger conservation, there is a huge residual demand for tiger products that could resurge if the ban on trade in tiger parts is lifted in China. We suspect that the current supply of the market is predominantly met by fakes or substitutes branded as tiger medicines, but not listing tiger as an ingredient. We suggest that the Traditional Chinese Medicine community should consider re-branding these products as bone-healing medicines in order to reduce the residual demand for real tiger parts over the long-term. The lifting of the current ban on trade in farmed tiger parts may cause a surge in demand for wild tiger parts that consumers say are better. Because of the low input costs associated with poaching, wild-sourced parts would consistently undercut the prices of farmed tigers that could easily be laundered on a legal market. We therefore recommend that the Chinese authorities maintain the ban on trade in tiger parts, and work to improve the enforcement of the existing ban.	[Gratwicke, Brian; Mills, Judy] Natl Fish & Wildlife Fdn, Save The Tiger Fund, Washington, DC 20008 USA; [Dutton, Adam] Univ Oxford, Dept Zool, Oxford, England; [Gabriel, Grace] Int Fund For Anim Welfare, Yarmouth Port, MA USA; [Long, Barney] World Wildlife Fund, Washington, DC USA; [Wright, Belinda] Wildlife Protect Soc India, New Delhi, India; [You, Wang] Horizon key, Beijing, Peoples R China; [Zhang, Li] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Seidensticker, John] Smithsonian Inst, Natl Zool Park, Washington, DC USA	University of Oxford; World Wildlife Fund; Beijing Normal University; Smithsonian Institution	Gratwicke, B (corresponding author), Natl Fish & Wildlife Fdn, Save The Tiger Fund, Washington, DC 20008 USA.	brian.gratwicke@gmail.com		Gratwicke, Brian/0000-0002-7332-4060	Rufford Foundation; Critical Ecosystem Partnership Fund; ExxonMobil Foundation	Rufford Foundation; Critical Ecosystem Partnership Fund; ExxonMobil Foundation(Exxon Mobil Corporation)	Financial support was provided by the Rufford Foundation, the Critical Ecosystem Partnership Fund and the ExxonMobil Foundation.	Banks D., 2006, SKINNING CAT CRIME P; Chen X. M, 2006, CHINA INFORM, V20, P519; *CITES, 2007, DEC C PART CITES EFF; Conrad K., 2007, TIGER CONSERVATION I; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Gratwicke B, 2008, CONSERV BIOL, V22, P222, DOI 10.1111/j.1523-1739.2007.00802.x; Hemley Ginette, 1999, P217; *IFAW, 2007, MAD CHIN FARM TIG EX; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; KISH J, 1987, STAT DESIGN RES; Mills J.A., 1994, KILLED CURE REV WORL; Nowell K., 2007, TAMING TIGER TRADE; SAMBROOK PN, 1988, ARTHRITIS RHEUM, V31, P973, DOI 10.1002/art.1780310805; Seidensticker J., 1999, RIDING TIGER TIGER C; SEIDENSTICKER J, 2007, TIGERS WORLD; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Wetton JH, 2002, FORENSIC SCI INT, V126, P137, DOI 10.1016/S0379-0738(02)00045-2; World Population Prospects, 2007, WORLD POPULATION PRO; Yonzon Prasanna S., 2006, P84; 2005, SARISKA TIGERS MISSI; 2007, NATL ACCOUNTS MAIN A; 2007, 2006 POPULATION CENS	22	64	66	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2544	10.1371/journal.pone.0002544	http://dx.doi.org/10.1371/journal.pone.0002544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596926	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200016
J	Hsiao, EC; Yoshinaga, Y; Nguyen, TD; Musone, SL; Kim, JE; Swinton, P; Espineda, I; Manalac, C; deJong, PJ; Conklin, BR				Hsiao, Edward C.; Yoshinaga, Yuko; Nguyen, Trieu D.; Musone, Stacy L.; Kim, Judy E.; Swinton, Paul; Espineda, Isidro; Manalac, Carlota; deJong, Pieter J.; Conklin, Bruce R.			Marking Embryonic Stem Cells with a 2A Self-Cleaving Peptide: A NKX2-5 Emerald GFP BAC Reporter	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FUNCTIONAL-ANALYSIS; EXPRESSION; TRANSCRIPTION; VECTORS; DIFFERENTIATION; GENERATION; PROMOTERS; TRANSGENE; CLONING	Background: Fluorescent reporters are useful for assaying gene expression in living cells and for identifying and isolating pure cell populations from heterogeneous cultures, including embryonic stem (ES) cells. Multiple fluorophores and genetic selection markers exist; however, a system for creating reporter constructs that preserve the regulatory sequences near a gene's native ATG start site has not been widely available. Methodology: Here, we describe a series of modular marker plasmids containing independent reporter, bacterial selection, and eukaryotic selection components, compatible with both Gateway recombination and lambda prophage bacterial artificial chromosome (BAC) recombineering techniques. A 2A self-cleaving peptide links the reporter to the native open reading frame. We use an emerald GFP marker cassette to create a human BAC reporter and ES cell reporter line for the early cardiac marker NKX2-5. NKX2-5 expression was detected in differentiating mouse ES cells and ES cell-derived mice. Conclusions: Our results describe a NKX2-5 ES cell reporter line for studying early events in cardiomyocyte formation. The results also demonstrate that our modular marker plasmids could be used for generating reporters from unmodified BACs, potentially as part of an ES cell reporter library.	[Hsiao, Edward C.; Nguyen, Trieu D.; Swinton, Paul; Espineda, Isidro; Manalac, Carlota; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Hsiao, Edward C.; Kim, Judy E.; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Yoshinaga, Yuko; deJong, Pieter J.] Childrens Hosp, Oakland Res Inst, Oakland, CA USA; [Musone, Stacy L.] Univ Calif San Francisco, Grad Program Pharm Sci & Pharmacogenom, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hsiao, EC (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA USA.	ehsiao@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	National Institute of Health [2T32DK07418-26, HL60664, HL66621]; California Institute of Regenerative Medicine/J. David Gladstone Institutes [T2-00003]; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664, U01HL066621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine/J. David Gladstone Institutes(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support to ECH was from a National Institute of Health Fellowship Training Grant (2T32DK07418-26) and the California Institute of Regenerative Medicine/J. David Gladstone Institutes CIRM Fellowship Program (Grant T2-00003). BRC received support from the NIH (grants HL60664 and HL66621). The Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01.	Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Chi X, 2003, GENESIS, V35, P220, DOI 10.1002/gene.10181; Chung SM, 2002, STEM CELLS, V20, P139, DOI 10.1634/stemcells.20-2-139; Conklin BR, 2007, P NATL ACAD SCI USA, V104, P4777, DOI 10.1073/pnas.0700913104; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Coyne C, 1999, DEV GENES EVOL, V209, P63, DOI 10.1007/s004270050228; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dorak M. T., 2006, REAL TIME PCR ADV ME; Douin V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-16; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; HOSLER BA, 1993, MOL CELL BIOL, V13, P2919, DOI 10.1128/MCB.13.5.2919; Jacobson KA, 2001, J MED CHEM, V44, P4125, DOI 10.1021/jm010232o; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lien CL, 1999, DEVELOPMENT, V126, P75; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Parsley TB, 2002, EUKARYOT CELL, V1, P401, DOI 10.1128/EC.1.3.401-413.2002; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TOKUNAGA T, 1992, DEV GROWTH DIFFER, V34, P561; Tomishima MJ, 2007, STEM CELLS, V25, P39, DOI 10.1634/stemcells.2006-0173; Triccas JA, 2002, RES MICROBIOL, V153, P379, DOI 10.1016/S0923-2508(02)01327-X; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	43	47	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2532	10.1371/journal.pone.0002532	http://dx.doi.org/10.1371/journal.pone.0002532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596956	gold, Green Submitted, Green Published			2022-12-27	WOS:000263288200005
J	Ngo, Y; Benhamou, Y; Thibault, V; Ingiliz, P; Munteanu, M; Lebray, P; Thabut, D; Morra, R; Messous, D; Charlotte, F; Imbert-Bismut, F; Rousselot-Bonnefont, D; Moussalli, J; Ratziu, V; Poynard, T				Ngo, Yen; Benhamou, Yves; Thibault, Vincent; Ingiliz, Patrick; Munteanu, Mona; Lebray, Pascal; Thabut, Dominique; Morra, Rachel; Messous, Djamila; Charlotte, Frederic; Imbert-Bismut, Francoise; Rousselot-Bonnefont, Dominique; Moussalli, Joseph; Ratziu, Vlad; Poynard, Thierry			An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load	PLOS ONE			English	Article								Background: The combination of transaminases (ALT), biopsy, HBeAg and viral load have classically defined the inactive status of carriers of chronic hepatitis B. The use of FibroTest (FT) and ActiTest (AT), biomarkers of fibrosis and necroinflammatory activity, has been previously validated as alternatives to biopsy. We compared the 4-year prognostic value of combining FT-AT and viral load for a better definition of the inactive carrier status. Methods and Findings: 1,300 consecutive CHB patients who had been prospectively followed since 2001 were preincluded. The main endpoint was the absence of liver-related complications, transplantation or death. We used the manufacturers' definitions of normal FT (< = 0.27), normal AT (< = 0.29) and 3 standard classes for viral load. The adjustment factors were age, sex, HBeAg, ethnic origin, alcohol consumption, HIV-Delta-HCV co-infections and treatment. Results: 1,074 patients with baseline FT-AT and viral load were included: 41 years old, 47% African, 27% Asian, 26% Caucasian. At 4 years follow-up, 50 complications occurred (survival without complications 93.4%), 36 deaths occurred (survival 95.0%), including 27 related to HBV (survival 96.1%). The prognostic value of FT was higher than those of viral load or ALT when compared using area under the ROC curves [0.89 (95% CI 0.84-0.93) vs 0.64 (0.55-0.71) vs 0.53 (0.46-0.60) all P < 0.001], survival curves and multivariate Cox model [regression coefficient 5.2 (3.5-6.9; P < 0.001) vs 0.53 (0.15-0.92; P = 0.007) vs -0.001 (-0.003-0.000; P = 0.052)] respectively. A new definition of inactive carriers was proposed with an algorithm combining "zero'' scores for FT-AT (F0 and A0) and viral load classes. This new algorithm provides a 100% negative predictive value for the prediction of liver related complications or death. Among the 275 patients with the classic definition of inactive carrier, 62 (23%) had fibrosis presumed with FT, and 3 died or had complications at 4 year. Conclusion: In patients with chronic hepatitis B, a combination of FibroTest-ActiTest and viral load testing accurately defined the prognosis and the inactive carrier status.	[Ngo, Yen; Benhamou, Yves; Ingiliz, Patrick; Lebray, Pascal; Thabut, Dominique; Morra, Rachel; Moussalli, Joseph; Ratziu, Vlad; Poynard, Thierry] Univ Paris 06, Grp Hosp Pitie Salpetriere, CNRS, Serv Hepatogastroenterol,UMR 8149, Paris, France; [Thibault, Vincent] Grp Hospp Pitie Salpetriere, Lab Virol, Paris, France; [Munteanu, Mona] Biopredictive, Paris, France; [Messous, Djamila; Imbert-Bismut, Francoise; Rousselot-Bonnefont, Dominique] Grp Hosp Pitie Salpetriere, Fed Biochim, Paris, France; [Charlotte, Frederic] Grp Hosp Pitie Salpetriere, Serv Anatom Pathol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Ngo, Y (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, CNRS, Serv Hepatogastroenterol,UMR 8149, Paris, France.	tpoynard@teaser.fr	THIBAULT, Vincent/J-7193-2015; Hug, Balthasar L./G-1568-2010; Poynard, Thierry/C-1355-2010; THIBAULT, Vincent/AAB-5241-2020	THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-3726-7230; THIBAULT, Vincent/0000-0001-6517-2901; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; Munteanu, Mona/0000-0003-4517-2757; Poynard, Thierry/0000-0002-2050-640X; Charlotte, Frederic/0000-0003-2803-6606	Association pour la Recherche sur les Maladies Hepatiques et Virales	Association pour la Recherche sur les Maladies Hepatiques et Virales	The collection of data was supported by the Association pour la Recherche sur les Maladies Hepatiques et Virales.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Cacoub P, 2008, J HEPATOL, V48, P765, DOI 10.1016/j.jhep.2008.01.025; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dong Zhong, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P129; Ederer F, 1959, INSTRUCTIONS IBM 650; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ferard G, 2006, CLIN CHEM LAB MED, V44, P400, DOI 10.1515/CCLM.2006.078; Ferard G, 2005, CLIN CHEM LAB MED, V43, P549, DOI 10.1515/CCLM.2005.095; Gigi E, 2007, J GASTROINTEST LIVER, V16, P19; HINTZE JL, 2003, NCSS 2003 USER GUIDE; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Imbert-Bismut F, 2004, CLIN CHEM LAB MED, V42, P323, DOI 10.1515/CCLM.2004.058; Kelloff GJ, 2005, EUR J CANCER, V41, P491, DOI 10.1016/j.ejca.2004.12.006; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Mahtab MA, 2007, HEPATOB PANCREAT DIS, V6, P483; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Ngo Y, 2006, CLIN CHEM, V52, P1887, DOI 10.1373/clinchem.2006.070961; Park BK, 2007, J GASTROEN HEPATOL, V22, P383, DOI 10.1111/j.1440-1746.2007.04857.x; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; Poynard T, 2007, J HEPATOL, V46, pS298; Poynard T, 2005, AM J GASTROENTEROL, V100, P1970, DOI 10.1111/j.1572-0241.2005.41957.x; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; TAKANO S, 1995, HEPATOLOGY, V21, P650; TEMPLE RJ, 1995, CLIN MEASUREMENT DRU, P1; Vallin J., 2001, TABLES MORTALITE FRA; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	42	62	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2573	10.1371/journal.pone.0002573	http://dx.doi.org/10.1371/journal.pone.0002573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596917	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200038
J	Scholl, HPN; Issa, PC; Walier, M; Janzer, S; Pollok-Kopp, B; Borncke, F; Fritsche, LG; Chong, NV; Fimmers, R; Wienker, T; Holz, FG; Weber, BHF; Oppermann, M				Scholl, Hendrik P. N.; Issa, Peter Charbel; Walier, Maja; Janzer, Stefanie; Pollok-Kopp, Beatrix; Boerncke, Florian; Fritsche, Lars G.; Chong, Ngaihang V.; Fimmers, Rolf; Wienker, Thomas; Holz, Frank G.; Weber, Bernhard H. F.; Oppermann, Martin			Systemic Complement Activation in Age-Related Macular Degeneration	PLOS ONE			English	Article								Dysregulation of the alternative pathway (AP) of complement cascade has been implicated in the pathogenesis of age-related macular degeneration (AMD), the leading cause of blindness in the elderly. To further test the hypothesis that defective control of complement activation underlies AMD, parameters of complement activation in blood plasma were determined together with disease-associated genetic markers in AMD patients. Plasma concentrations of activation products C3d, Ba, C3a, C5a, SC5b-9, substrate proteins C3, C4, factor B and regulators factor H and factor D were quantified in patients (n = 112) and controls (n = 67). Subjects were analyzed for single nucleotide polymorphisms in factor H (CFH), factor B-C2 (BF-C2) and complement C3 (C3) genes which were previously found to be associated with AMD. All activation products, especially markers of chronic complement activation Ba and C3d (p<0.001), were significantly elevated in AMD patients compared to controls. Similar alterations were observed in factor D, but not in C3, C4 or factor H. Logistic regression analysis revealed better discriminative accuracy of a model that is based only on complement activation markers Ba, C3d and factor D compared to a model based on genetic markers of the complement system within our study population. In both the controls' and AMD patients' group, the protein markers of complement activation were correlated with CFH haplotypes. This study is the first to show systemic complement activation in AMD patients. This suggests that AMD is a systemic disease with local disease manifestation at the ageing macula. Furthermore, the data provide evidence for an association of systemic activation of the alternative complement pathway with genetic variants of CFH that were previously linked to AMD susceptibility.	[Scholl, Hendrik P. N.; Issa, Peter Charbel; Janzer, Stefanie; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany; [Walier, Maja; Fimmers, Rolf; Wienker, Thomas] Univ Bonn, Inst Med Biomet, Informat & Epidemiol, Bonn, Germany; [Pollok-Kopp, Beatrix; Boerncke, Florian; Oppermann, Martin] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Fritsche, Lars G.; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Chong, Ngaihang V.] Univ Oxford, Oxford Eye Hosp, Oxford, England	University of Bonn; University of Bonn; University of Gottingen; University of Regensburg; University of Oxford	Scholl, HPN (corresponding author), Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany.	mopperm@gwdg.de	Fritsche, Lars G/AAF-9387-2019; Issa, Peter Charbel/E-8935-2018; Issa, Peter Charbel/F-9603-2011; Issa, Peter Charbel/O-2580-2019; Mohammed, Imran/J-8271-2012; Chong, Ngaihang V/A-5141-2009; Chong, Victor/Q-6565-2018	Fritsche, Lars G/0000-0002-2110-1690; Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673; Mohammed, Imran/0000-0002-8412-0768; Chong, Victor/0000-0002-7693-522X; Weber, Bernhard H.F./0000-0002-8808-7723	European Commission (EU FP6), Integrated Project "EVIGENORET" [LSHG-CT-2005-512036]; German Research Foundation (DFG) Heisenberg Fellowship [SCHO 734/2-1, HO 1926/1-3]	European Commission (EU FP6), Integrated Project "EVIGENORET"(European CommissionEuropean Commission Joint Research Centre); German Research Foundation (DFG) Heisenberg Fellowship(German Research Foundation (DFG))	Pro Retina Foundation Pro-Re/Seed/Issa.1; European Commission (EU FP6), Integrated Project "EVIGENORET" (LSHG-CT-2005-512036); German Research Foundation (DFG) Heisenberg Fellowship SCHO 734/2-1, HO 1926/1-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; BOURKE BE, 1982, CLIN EXP IMMUNOL, V48, P726; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Comitato A, 2007, HUM MOL GENET, V16, P1699, DOI 10.1093/hmg/ddm118; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DERODRIGUEZ CS, 2004, MOL IMMUNOL, V41, P355; Despriet DDG, 2007, ARCH OPHTHALMOL-CHIC, V125, P1270, DOI 10.1001/archopht.125.9.1270; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Huang SJ, 2003, RETINA-J RET VIT DIS, V23, P429, DOI 10.1097/00006982-200306000-00036; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MOLLNES TE, 1986, ARTHRITIS RHEUM, V29, P715, DOI 10.1002/art.1780290603; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; OPPERMANN M, 1991, KIDNEY INT, V40, P939, DOI 10.1038/ki.1991.298; OPPERMANN M, 1990, J IMMUNOL METHODS, V133, P181, DOI 10.1016/0022-1759(90)90358-3; OPPERMANN M, 1992, IMMUNOPHARMACOLOGY, V24, P119, DOI 10.1016/0162-3109(92)90018-8; OPPERMANN M, 1991, COMPLEMENT INFLAMMAT, V8, P13, DOI 10.1159/000463173; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Scholl HPN, 2004, OPHTHALMOLOGY, V111, P125, DOI 10.1016/j.ophtha.2003.05.003; Scholl HPN, 2003, GRAEF ARCH CLIN EXP, V241, P39, DOI 10.1007/s00417-002-0602-8; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; WURZNER R, 1991, COMPLEMENT INFLAMMAT, V8, P328; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	41	297	317	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2593	10.1371/journal.pone.0002593	http://dx.doi.org/10.1371/journal.pone.0002593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596911	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200052
J	Burgevin, A; Saveanu, L; Kim, Y; Barilleau, E; Kotturi, M; Sette, A; van Endert, P; Peters, B				Burgevin, Anne; Saveanu, Loredana; Kim, Yohan; Barilleau, Emilie; Kotturi, Maya; Sette, Alessandro; van Endert, Peter; Peters, Bjoern			A Detailed Analysis of the Murine TAP Transporter Substrate Specificity	PLOS ONE			English	Article								Background: The transporter associated with antigen processing ( TAP) supplies cytosolic peptides into the endoplasmic reticulum for binding to major histocompatibility complex (MHC) class I molecules. Its specificity therefore influences the repertoire of peptides presented by MHC molecules. Compared to human TAP, murine TAP's binding specificity has not been characterized as well, even though murine systems are widely used for basic studies of antigen processing and presentation. Methodology/Principal Findings: We performed a detailed experimental analysis of murine TAP binding specificity by measuring the binding affinities of 323 peptides. Based on this experimental data, a computational model of murine TAP specificity was constructed. The model was compared to previously generated data on human and murine TAP specificities. In addition, the murine TAP specificities for known epitopes and random peptides were predicted and compared to assess the impact of murine TAP selectivity on epitope selection. Conclusions/Significance: Comparisons to a previously constructed model of human TAP specificity confirms the well-established differences for peptide substrates with positively charged C-termini. In addition these comparisons show that several residues at the N-terminus of peptides which strongly influence binding to human TAP showed little effect on binding to murine TAP, and that the overall influence of the aminoterminal residues on peptide affinity for murine TAP is much lower than for the human transporter. Murine TAP also partly prefers different hydrophobic amino acids than human TAP in the carboxyterminal position. These species-dependent differences in specificity determined in vitro are shown to correlate with the epitope repertoire recognized in vivo. The quantitative model of binding specificity of murine TAP developed herein should be useful for interpreting epitope mapping and immunogenicity data obtained in humanized mouse models.	[Burgevin, Anne; Saveanu, Loredana; Barilleau, Emilie; van Endert, Peter] INSERM, Paris, France; [Burgevin, Anne; Saveanu, Loredana; Barilleau, Emilie; van Endert, Peter] Univ Paris 05, Fac Med Rene Descartes, Paris, France; [Kim, Yohan; Kotturi, Maya; Sette, Alessandro; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; La Jolla Institute for Immunology	Burgevin, A (corresponding author), INSERM, Paris, France.	vanendert@necker.fr; bpeters@liai.org	van Endert, Peter/R-4606-2017; Sette, Alessandro/AFO-8916-2022; SAVEANU, Loredana/Q-1241-2019; Saveanu, Loredana/K-6821-2017; Pacific-Southwest, RCE/B-6155-2009	van Endert, Peter/0000-0003-3782-0750; SAVEANU, Loredana/0000-0003-3138-7968; 	National Institutes of Health [HHSN26620040006C]; PSWRCE [U54 AI065359]; European Commission [LSHB-CT-2003-503231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSWRCE; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health contract HHSN26620040006C to AS and BP, PSWRCE grant U54 AI065359 to BP, and grant LSHB-CT-2003-503231 (Genomes to Vaccines) of the European Commission to PvE.	Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Choi C, 2005, BLOOD, V105, P2132, DOI 10.1182/blood-2004-01-0366; Daniel S, 1998, J IMMUNOL, V161, P617; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Fruci D, 2003, J IMMUNOL, V170, P2977, DOI 10.4049/jimmunol.170.6.2977; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Gubler B, 1998, MOL IMMUNOL, V35, P427, DOI 10.1016/S0161-5890(98)00059-5; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; Herberts CA, 2006, J IMMUNOL, V176, P2697, DOI 10.4049/jimmunol.176.5.2697; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Koopmann JO, 2000, IMMUNITY, V13, P117, DOI 10.1016/S1074-7613(00)00013-3; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lauvau G, 2004, EUR J IMMUNOL, V34, P913, DOI 10.1002/eji.200424944; Li Z, 2003, INFECT IMMUN, V71, P3920, DOI 10.1128/IAI.71.7.3920-3926.2003; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; PAMER EG, 1994, J IMMUNOL, V152, P686; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Peh CA, 2000, J IMMUNOL, V164, P292, DOI 10.4049/jimmunol.164.1.292; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Salerno-Goncalves R, 2004, J IMMUNOL, V173, P5852, DOI 10.4049/jimmunol.173.9.5852; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sette A, 2007, CURR OPIN IMMUNOL, V19, P106, DOI 10.1016/j.coi.2006.11.002; Sidney J, 2007, IMMUNOGENETICS, V59, P745, DOI 10.1007/s00251-007-0243-5; Swain SL, 2004, VIRAL IMMUNOL, V17, P197, DOI 10.1089/0882824041310577; Udaka K, 2002, J IMMUNOL, V169, P5744, DOI 10.4049/jimmunol.169.10.5744; Uebel S, 1997, P NATL ACAD SCI USA, V94, P8976, DOI 10.1073/pnas.94.17.8976; van Endert PM, 2002, TRENDS BIOCHEM SCI, V27, P454, DOI 10.1016/S0968-0004(02)02090-X; VANENDERT PM, 1995, J EXP MED, V182, P1883, DOI 10.1084/jem.182.6.1883; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4	47	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2402	10.1371/journal.pone.0002402	http://dx.doi.org/10.1371/journal.pone.0002402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545702	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800040
J	Cabantous, S; Rogers, Y; Terwilliger, TC; Waldo, GS				Cabantous, Stephanie; Rogers, Yvonne; Terwilliger, Thomas C.; Waldo, Geoffrey S.			New Molecular Reporters for Rapid Protein Folding Assays	PLOS ONE			English	Article								The GFP folding reporter assay [1] uses a C-terminal GFP fusion to report on the folding success of upstream fused polypeptides. The GFP folding assay is widely-used for screening protein variants with improved folding and solubility [2-8], but truncation artifacts may arise during evolution, i.e. from de novo internal ribosome entry sites [9]. One way to reduce such artifacts would be to insert target genes within the scaffolding of GFP circular permuted variants. Circular permutants of fluorescent proteins often misfold and are non-fluorescent, and do not readily tolerate fused polypeptides within the fluorescent protein scaffolding [10-12]. To overcome these limitations, and to increase the dynamic range for reporting on protein misfolding, we have created eight GFP insertion reporters with different sensitivities to protein misfolding using chimeras of two previously described GFP variants, the GFP folding reporter [1] and the robustly-folding ''superfolder'' GFP [13]. We applied this technology to engineer soluble variants of Rv0113, a protein from Mycobacterium tuberculosis initially expressed as inclusion bodies in Escherichia coli. Using GFP insertion reporters with increasing stringency for each cycle of mutagenesis and selection led to a variant that produced large amounts of soluble protein at 37 degrees C in Escherichia coli. The new reporter constructs discriminate against truncation artifacts previously isolated during directed evolution of Rv0113 using the original C-terminal GFP folding reporter. Using GFP insertion reporters with variable stringency should prove useful for engineering protein variants with improved folding and solubility, while reducing the number of artifacts arising from internal cryptic ribosome initiation sites.	[Cabantous, Stephanie; Rogers, Yvonne; Terwilliger, Thomas C.; Waldo, Geoffrey S.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Cabantous, Stephanie] Ctr Natl Rech Sci, Inst Pharmacol Biol Structurale, Toulouse, France	United States Department of Energy (DOE); Los Alamos National Laboratory; Centre National de la Recherche Scientifique (CNRS)	Cabantous, S (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	waldo@lanl.gov	Cabantous, Stephanie/M-3282-2014; Terwilliger, Thomas C/K-4109-2012; Terwilliger, Thomas/AEF-4827-2022; Terwilliger, Thomas/AAM-4079-2020; Cabantous, Stephanie/AAB-5113-2020	Cabantous, Stephanie/0000-0002-8406-9421; Terwilliger, Thomas C/0000-0001-6384-0320; Terwilliger, Thomas/0000-0001-6384-0320; Cabantous, Stephanie/0000-0002-8406-9421	NIH;  [1 U54 GM074946-01US]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grant NIH 1 U54 GM074946-01US, Integrated Center for Structure and Function Innovation, PI: Terwilliger).	ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Akemann W, 2001, PHOTOCHEM PHOTOBIOL, V74, P356, DOI 10.1562/0031-8655(2001)074<0356:FCOPEG>2.0.CO;2; Andre A, 2000, FEBS LETT, V468, P73, DOI 10.1016/S0014-5793(00)01198-4; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Baneyx Francois, 2003, Methods Mol Biol, V205, P171; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CABANTOUS S, 2007, EXPRESSION SYSTEMS M; Cabantous Stephanie, 2005, Journal of Structural and Functional Genomics, V6, P113, DOI 10.1007/s10969-005-5247-5; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11604, DOI 10.1021/bi990765n; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Heddle C, 2007, PROTEIN ENG DES SEL, V20, P327, DOI 10.1093/protein/gzm024; Ito Y, 2004, J MOL EVOL, V58, P196, DOI 10.1007/s00239-003-2542-2; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jiang SM, 2007, BIOCHEM J, V402, P429, DOI 10.1042/BJ20061457; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kawasaki M, 2001, BIOCHEM BIOPH RES CO, V280, P842, DOI 10.1006/bbrc.2000.4229; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pedelacq JD, 2002, NAT BIOTECHNOL, V20, P927, DOI 10.1038/nbt732; Roberts RW, 1999, CURR OPIN CHEM BIOL, V3, P268, DOI 10.1016/S1367-5931(99)80042-8; Sharkov NA, 2002, J BIOL CHEM, V277, P5796, DOI 10.1074/jbc.M106849200; Song LT, 2003, FASEB J, V17, P1674, DOI 10.1096/fj.03-0105com; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tur MK, 2001, BIOTECHNIQUES, V30, P404, DOI 10.2144/01302rr04; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Waldo GS, 2003, CURR OPIN CHEM BIOL, V7, P33, DOI 10.1016/S1367-5931(02)00017-0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yang JK, 2003, P NATL ACAD SCI USA, V100, P455, DOI 10.1073/pnas.0137017100; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4	39	43	48	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2387	10.1371/journal.pone.0002387	http://dx.doi.org/10.1371/journal.pone.0002387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545698	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800026
J	Hayashi, H; Kume, T				Hayashi, Hisaki; Kume, Tsutomu			Foxc Transcription Factors Directly Regulate Dll4 and Hey2 Expression by Interacting with the VEGF-Notch Signaling Pathways in Endothelial Cells	PLOS ONE			English	Article								Background: Recent studies have shown that in the developing embryo, arterial and venous identity is established by genetic mechanisms before circulation begins. Vascular endothelial growth factor (VEGF) signaling and its downstream Notch pathway play critical roles in arterial cell fate determination. We have recently shown that Foxc1 and Foxc2, two closely related Fox transcription factors, are essential for arterial cell specification during development by directly inducing the transcription of Delta-like 4 (Dll4), a ligand for Notch receptors. However, the basic mechanisms whereby the VEGF and Notch signaling pathways control transcriptional regulation of arterial-specific genes have yet to be elucidated. Methodologies/Principal Findings: In the current study, we examined whether and how Foxc transcription factors are involved in VEGF and Notch signaling in induction of Dll4 as well as the Notch target gene Hey2 in endothelial cells. We found that Foxc1 and Foxc2 directly activate the Hey2 promoter via Foxc binding elements. Significantly, Foxc2 physically and functionally interacts with a Notch transcriptional activation complex containing Su(H) and Notch intracellular domain to induce Hey2 promoter activity. Moreover, activation of the Dll4 and Hey2 promoters is induced by VEGF in conjunction with either Foxc1 or Foxc2 more than by either component alone. VEGF-activated PI3K and ERK intracellular pathways modulate the transcriptional activity of Foxc proteins in Dll4 and Hey2 induction. Conclusions/Significance: Our new findings demonstrate that Foxc transcriptional factors interact with VEGF and Notch signaling to regulate arterial gene expression in multiple steps of the VEGF-Dll4-Notch-Hey2 signaling pathway.	[Hayashi, Hisaki; Kume, Tsutomu] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA	Vanderbilt University	Hayashi, H (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37235 USA.	tsutomu.kume@vanderbilt.edu			NIH [HL67105, HL74121]; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074121, P01HL067105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the NIH to T. K. (HL67105 and HL74121).	Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Berry FB, 2006, J BIOL CHEM, V281, P10098, DOI 10.1074/jbc.M513629200; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fujita H, 2006, CIRC RES, V98, P626, DOI 10.1161/01.RES.0000207407.51752.3c; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	44	133	143	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2401	10.1371/journal.pone.0002401	http://dx.doi.org/10.1371/journal.pone.0002401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545664	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800039
J	Lefevre, E; Roussel, B; Amblard, C; Sime-Ngando, T				Lefevre, Emilie; Roussel, Balbine; Amblard, Christian; Sime-Ngando, Telesphore			The Molecular Diversity of Freshwater Picoeukaryotes Reveals High Occurrence of Putative Parasitoids in the Plankton	PLOS ONE			English	Article							VIRUS-SIZED PARTICLES; RIBOSOMAL-RNA GENE; EUKARYOTIC DIVERSITY; MICROBIAL EUKARYOTES; COASTAL SITE; FOOD-WEB; SP-NOV.; LAKE; GROWTH; PHYTOPLANKTON	Eukaryotic microorganisms have been undersampled in biodiversity studies in freshwater environments. We present an original 18S rDNA survey of freshwater picoeukaryotes sampled during spring/summer 2005, complementing an earlier study conducted in autumn 2004 in Lake Pavin (France). These studies were designed to detect the small unidentified heterotrophic flagellates (HF, 0.6-5 mu m) which are considered the main bacterivores in aquatic systems. Alveolates, Fungi and Stramenopiles represented 65% of the total diversity and differed from the dominant groups known from microscopic studies. Fungi and Telonemia taxa were restricted to the oxic zone which displayed two fold more operational taxonomic units (OTUs) than the oxycline. Temporal forcing also appeared as a driving force in the diversification within targeted organisms. Several sequences were not similar to those in databases and were considered as new or unsampled taxa, some of which may be typical of freshwater environments. Two taxa known from marine systems, the genera Telonema and Amoebophrya, were retrieved for the first time in our freshwater study. The analysis of potential trophic strategies displayed among the targeted HF highlighted the dominance of parasites and saprotrophs, and provided indications that these organisms have probably been wrongfully regarded as bacterivores in previous studies. A theoretical exercise based on a new 'parasite/saprotroph-dominated HF hypothesis' demonstrates that the inclusion of parasites and saprotrophs may increase the functional role of the microbial loop as a link for carbon flows in pelagic ecosystems. New interesting perspectives in aquatic microbial ecology are thus opened.	[Lefevre, Emilie; Roussel, Balbine; Amblard, Christian; Sime-Ngando, Telesphore] Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6023, LMGE, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Lefevre, E (corresponding author), Univ Blaise Pascal Clermont Ferrand II, CNRS, UMR 6023, LMGE, Aubiere, France.	telesphore.sime-ngando@univ-bpclermont.fr	Sime-Ngando, Télesphore/M-4134-2019	Sime-Ngando, Télesphore/0000-0002-7240-5803	French Ministere de la Recherche et de la technologie (MRT) [fellowships]; French ANR Programme Blanc DREP	French Ministere de la Recherche et de la technologie (MRT); French ANR Programme Blanc DREP(French National Research Agency (ANR))	EL and BR were supported by fellowships from the French Ministere de la Recherche et de la technologie (MRT). This study was supported by a grant from the French ANR Programme Blanc DREP: Diversite et roles des Eumycetes dans le pelagos, Coordinator TSN.	Alster A, 2007, HYDROBIOLOGIA, V578, P131, DOI 10.1007/s10750-006-0439-y; Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Arndt H, 2000, SYST ASSOC SPEC VOL, V59, P240; Auer B, 2001, FRESHWATER BIOL, V46, P959, DOI 10.1046/j.1365-2427.2001.00730.x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bass D, 2004, INT J SYST EVOL MICR, V54, P2393, DOI 10.1099/ijs.0.63229-0; Bettarel Y, 2005, AQUAT MICROB ECOL, V39, P205, DOI 10.3354/ame039205; BRUGEROLLE G, 1979, PROTISTOLOGICA, V15, P183; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Burreson EM, 2005, J EUKARYOT MICROBIOL, V52, P258, DOI 10.1111/j.1550-7408.2005.05-00035.x; Carrias JF, 2001, AQUAT MICROB ECOL, V24, P163, DOI 10.3354/ame024163; Carrias JF, 1998, FRESHWATER BIOL, V39, P91, DOI 10.1046/j.1365-2427.1998.00263.x; Cleven EJ, 2001, AQUAT MICROB ECOL, V23, P147, DOI 10.3354/ame023147; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Comte J, 2006, MICROB ECOL, V52, P72, DOI 10.1007/s00248-004-0230-4; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; DEBRES G, 1996, HELGOLAND MAR RES, V50, P497; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Domaizon I, 2003, FEMS MICROBIOL ECOL, V46, P317, DOI 10.1016/S0168-6496(03)00248-4; DUGAN CF, 2007, J EUKARYOT MICROBIOL, V54, P263; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; GASOL JM, 1993, LIMNOL OCEANOGR, V38, P657, DOI 10.4319/lo.1993.38.3.0657; Gestal C, 2006, ENVIRON MICROBIOL, V8, P1105, DOI 10.1111/j.1462-2920.2006.01008.x; GLEASON FH, 1989, MYCOLOGIA, V81, P811, DOI 10.2307/3759889; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; HAGSTROM A, 1988, MAR ECOL PROG SER, V49, P171, DOI 10.3354/meps049171; Hausner G, 2000, CAN J BOT, V78, P124, DOI 10.1139/b99-177; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Kagami M, 2004, LIMNOL OCEANOGR, V49, P680, DOI 10.4319/lo.2004.49.3.0680; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Klaveness D, 2005, INT J SYST EVOL MICR, V55, P2595, DOI 10.1099/ijs.0.63652-0; Laybourn-Parry J, 2000, SYST ASSOC SPEC VOL, V59, P216; Leander BS, 2003, J EUKARYOT MICROBIOL, V50, P334, DOI 10.1111/j.1550-7408.2003.tb00145.x; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lefranc M, 2005, APPL ENVIRON MICROB, V71, P5935, DOI 10.1128/AEM.71.10.5935-5942.2005; Letcher PM, 2006, MYCOL RES, V110, P898, DOI 10.1016/j.mycres.2006.06.011; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Myl'nikov Alexander P., 2004, Protistology, V3, P201; Nikolaev SI, 2003, ACTA PROTOZOOL, V42, P183; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Park MG, 2004, J EUKARYOT MICROBIOL, V51, P145, DOI 10.1111/j.1550-7408.2004.tb00539.x; Park MG, 2002, MAR ECOL PROG SER, V227, P281, DOI 10.3354/meps227281; PATTERSON DJ, 1993, J EUKARYOT MICROBIOL, V40, P606, DOI 10.1111/j.1550-7408.1993.tb06116.x; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; POMEROY LR, 1988, HYDROBIOLOGIA, V159, P7, DOI 10.1007/BF00007363; Richards TA, 2005, ENVIRON MICROBIOL, V7, P1413, DOI 10.1111/j.1462-2920.2005.00828.x; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Schnepf E, 2000, HELGOLAND MAR RES, V54, P18, DOI 10.1007/s101520050032; Shalchian-Tabrizi K, 2006, P ROY SOC B-BIOL SCI, V273, P1833, DOI 10.1098/rspb.2006.3515; SHERR E, 1988, LIMNOL OCEANOGR, V33, P1225, DOI 10.4319/lo.1988.33.5.1225; SHERR EB, 1988, NATURE, V335, P348, DOI 10.1038/335348a0; Sherr EB, 2007, MAR ECOL PROG SER, V352, P187, DOI 10.3354/meps07161; Siddall Mark E., 2001, American Museum Novitates, V3314, P1, DOI 10.1206/0003-0082(2001)314<0001:MDOTPP>2.0.CO;2; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Sleigh MA, 2000, SYST ASSOC SPEC VOL, V59, P147; Sonntag B, 2006, AQUAT MICROB ECOL, V43, P193, DOI 10.3354/ame043193; Soudant P, 2005, J EUKARYOT MICROBIOL, V52, P492, DOI 10.1111/j.1550-7408.2005.00058.x; Takishita K, 2005, EXTREMOPHILES, V9, P185, DOI 10.1007/s00792-005-0432-9; TRANVIK LJ, 1993, MAR ECOL PROG SER, V92, P301, DOI 10.3354/meps092301; Vickerman K, 2002, PROTIST, V153, P9, DOI 10.1078/1434-4610-00079; Wieltschnig C, 2001, MICROBIAL ECOL, V42, P159	68	117	122	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2324	10.1371/journal.pone.0002324	http://dx.doi.org/10.1371/journal.pone.0002324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545660	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800005
J	Baez, S; Collins, SL				Baez, Selene; Collins, Scott L.			Shrub Invasion Decreases Diversity and Alters Community Stability in Northern Chihuahuan Desert Plant Communities	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SPECIES-DIVERSITY; BIODIVERSITY; FACILITATION; GRASSLAND; ECOSYSTEM; DYNAMICS; PATTERNS; CARBON; INTERFERENCE	Background: Global climate change is rapidly altering species range distributions and interactions within communities. As ranges expand, invading species change interactions in communities which may reduce stability, a mechanism known to affect biodiversity. In aridland ecosystems worldwide, the range of native shrubs is expanding as they invade and replace native grassland vegetation with significant consequences for biodiversity and ecosystem functioning. Methodology: We used two long-term data sets to determine the effects of shrub encroachment by Larrea tridentata on subdominant community composition and stability in formerly native perennial grassland dominated by Bouteloua eriopoda in New Mexico, USA. Principal Findings: Our results indicated that Larrea invasion decreased species richness during the last 100 years. We also found that over shorter temporal scales species-poor subdominant communities in areas invaded by Larrea were less stable (more variable in time) compared to species rich communities in grass-dominated vegetation. Compositional stability increased as cover of Bouteloua increased and decreased as cover of Larrea increased. Significance: Changes in community stability due to altered interspecific interactions may be one mechanism by which biodiversity declines in grasslands following shrub invasion. As global warming increases, shrub encroachment into native grasslands worldwide will continue to alter species interactions and community stability both of which may lead to a decline in biodiversity.	[Baez, Selene; Collins, Scott L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Baez, S (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	sbaez@zoo.ufl.edu	Collins, Scott L/P-7742-2014	Collins, Scott L/0000-0002-0193-2892	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	National Science Foundation	AGUIAR MR, 1994, OIKOS, V70, P26, DOI 10.2307/3545695; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; BAGGS JE, 1997, ROLE BOUTELOUA ERIOP; Bhark EW, 2003, ECOSYSTEMS, V6, P185, DOI 10.1007/s10021-002-0210-9; Buonopane M, 2005, OIKOS, V110, P67, DOI 10.1111/j.0030-1299.2005.13949.x; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; CLARK CW, 1994, AM NAT, V143, P583, DOI 10.1086/285621; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Cross AF, 1999, PLANT ECOL, V145, P11, DOI 10.1023/A:1009865020145; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Fowler MS, 2002, OIKOS, V99, P511, DOI 10.1034/j.1600-0706.2002.11757.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hochstrasser T, 2004, J VEG SCI, V15, P615, DOI 10.1111/j.1654-1103.2004.tb02303.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Holzapfel C, 1999, ECOLOGY, V80, P1747, DOI 10.2307/176564; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Hubbell Stephen P., 2001, V32, pi; Huenneke LF, 2002, GLOBAL CHANGE BIOL, V8, P247, DOI 10.1046/j.1365-2486.2002.00473.x; Hughes JB, 2000, AM NAT, V155, P618, DOI 10.1086/303348; Hughes RF, 2006, GLOBAL CHANGE BIOL, V12, P1733, DOI [10.1111/j.1365-2486.2006.01210.x, 10.1111/J.1365-2486.2006.01210.x]; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2002, AM NAT, V159, P388, DOI 10.1086/338994; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; Kieft TL, 1998, ECOLOGY, V79, P671, DOI 10.2307/176962; KNAPP AK, 2008, GLOBAL CHANGE BIOL; Kokkoris GD, 2002, J ANIM ECOL, V71, P362, DOI 10.1046/j.1365-2656.2002.00604.x; Kroel-Dulay G, 2004, J VEG SCI, V15, P531, DOI 10.1111/j.1654-1103.2004.tb02292.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Lundberg P, 2000, ECOL LETT, V3, P465, DOI 10.1046/j.1461-0248.2000.00170.x; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Pockman WT, 1997, OECOLOGIA, V109, P19, DOI 10.1007/s004420050053; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Ravi S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000474; Reinhart KO, 2006, BIOL INVASIONS, V8, P231, DOI 10.1007/s10530-004-5163-9; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SHMIDA A, 1981, ECOLOGY, V62, P234, DOI 10.2307/1936684; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tielborger K, 1997, PLANT ECOL, V130, P191, DOI 10.1023/A:1009766824033; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Valone TJ, 2007, ECOLOGY, V88, P26, DOI 10.1890/0012-9658(2007)88[26:RRBDPP]2.0.CO;2; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Whitford WG, 2020, ECOLOGY OF DESERT SYSTEMS, 2ND EDITION, P1, DOI 10.1016/B978-0-12-815055-9.00001-1; Wilby A, 2004, OIKOS, V106, P209, DOI 10.1111/j.0030-1299.2004.13085.x; Yao J, 2006, LANDSCAPE ECOL, V21, P1217, DOI 10.1007/s10980-006-0025-8; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	62	95	100	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2332	10.1371/journal.pone.0002332	http://dx.doi.org/10.1371/journal.pone.0002332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523686	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300027
J	Chen, HY; Liu, B; Lukas, TJ; Neufeld, AH				Chen, Huiyi; Liu, Bin; Lukas, Thomas J.; Neufeld, Arthur H.			The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; GENOME SCAN; SUSCEPTIBILITY; GENE; DRUSEN; POLYMORPHISM; EXPRESSION; COMMON; MODEL; CFH	Background: Although the statement that age is the greatest risk factor for Age-related macular degeneration (AMD) is widely accepted, the cellular and molecular explanations for that clinical statement are not generally known. A major focus of AMD research is the retinal pigment epithelium (RPE)/choroid. The purpose of this study was to characterize the changes in the RPE/choroid with age that may provide a background for the development of AMD. Methodology/Principal Findings: We compared the transcriptional profiles, key protein levels and histology of the RPE/choroid from young and old mice. Using three statistical methods, microarray data demonstrated marked changes in the old mouse. There were 315 genes differentially expressed with age; most of these genes were related to immune responses and inflammatory activity. Canonical pathways having significant numbers of upregulated genes in aged RPE/choroid included leukocyte extravasation, complement cascades, natural killer cell signaling and IL-10 signaling. By contrast, the adjacent neural retina showed completely different age-related changes. The levels of proteins that participate in leukocyte extravasation and complement pathways were consistently increased in the normal, aged RPE/choroid. Furthermore, there was increased gene expression and protein levels of leukocyte attracting signal, chemokine ligand 2 (Ccl2) in aged RPE/choroid. In old animals, there was marked extravasation and accumulation of leukocytes from the choroidal circulation onto Bruch's membrane and into the RPE. Conclusions/Significance: These phenotypic changes indicate that the RPE/choroid in the normal, old mouse has become an immunologically active tissue. There are signals from the normal, aged RPE/choroid which recruit leukocytes from the circulation and activate the complement cascade. These age-related changes that occur in the RPE/choroid with age, to the extent that they occur in the human retina, may provide the background for an error in regulation of immunological activity to cause AMD to appear in an elderly individual.	[Chen, Huiyi; Liu, Bin; Lukas, Thomas J.; Neufeld, Arthur H.] Northwestern Univ, Sch Med, Dept Ophthalmol, Lab Invest Aging Retina, Chicago, IL 60611 USA	Northwestern University	Chen, HY (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-neufeld@northwestern.edu			NIH [EY12017]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY12017, a generous gift from the Forsythe Foundation and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burke D, 2007, BRIT J PSYCHIAT, V190, P371, DOI 10.1192/bjp.bp.106.033407; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fiotti N, 2005, GENET MED, V7, P272, DOI 10.1097/01.GIM.0000159903.69597.73; Frick C, 2005, EUR J IMMUNOL, V35, P3610, DOI 10.1002/eji.200425914; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Luckow B, 2004, EUR J IMMUNOL, V34, P2568, DOI 10.1002/eji.200324776; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murray J, 2006, J AAPOS, V10, P6, DOI 10.1016/j.jaapos.2006.01.010; Radeke MJ, 2007, EXP EYE RES, V85, P366, DOI 10.1016/j.exer.2007.05.006; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Simonelli F, 2001, OPHTHALMIC RES, V33, P325, DOI 10.1159/000055688; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	50	93	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2339	10.1371/journal.pone.0002339	http://dx.doi.org/10.1371/journal.pone.0002339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523633	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300032
J	Cohen, T; Colijn, C; Finklea, B; Wright, A; Zignol, M; Pym, A; Murray, M				Cohen, Ted; Colijn, Caroline; Finklea, Bryson; Wright, Abigail; Zignol, Matteo; Pym, Alexander; Murray, Megan			Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study	PLOS ONE			English	Article								Background: The emergence of tuberculosis resistant to multiple first- and second-line antibiotics poses challenges to a global control strategy that relies on standard drug treatment regimens. Highly drug-resistant strains of Mycobacterium tuberculosis have been implicated in outbreaks and have been found throughout the world; a comprehensive understanding the magnitude of this threat requires an accurate assessment of the worldwide burden of resistance. Unfortunately, in many settings where resistance is emerging, laboratory capacity is limited and estimates of the burden of resistance are obtained by performing drug sensitivity testing on a sample of incident cases rather than through the use of routine surveillance. Methodology/Principal Findings: Using an individual-based dynamic tuberculosis model to simulate surveillance strategies for drug resistance, we found that current surveys may underestimate the total burden of resistant tuberculosis because cases of acquired resistance are undercounted and resistance among prevalent cases is not assessed. We explored how this bias is affected by the maturity of the epidemic and by the introduction of interventions that target the emergence and spread of resistant tuberculosis. Conclusions: Estimates of drug resistant tuberculosis based on samples of incident cases should be viewed as a lower bound of the total burden of resistance.	[Cohen, Ted; Murray, Megan] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Cohen, Ted; Colijn, Caroline; Finklea, Bryson; Murray, Megan] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wright, Abigail; Zignol, Matteo] WHO, STOP TB Dept, Geneva, Switzerland; [Pym, Alexander] S African MRC, Clin & Biomed TB Res Unit, Durban, South Africa; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; South African Medical Research Council; Harvard University; Massachusetts General Hospital	Cohen, T (corresponding author), Brigham & Womens Hosp, Div Social Med & Hlth Inequal, 75 Francis St, Boston, MA 02115 USA.	tcohen@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198; Pym, Alexander/0000-0002-6260-8180	NIH [5K08AI055985-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TC is supported by an NIH grant (5K08AI055985-05). The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P387; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; COHEN T, 2008, AM J RESP C IN PRESS; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; HOLM J, 1969, DEV TUBERCULOSIS INF; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Portaels F, 1999, INT J TUBERC LUNG D, V3, P582; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; RIGOUTS L, 1994, TUBERCLE LUNG DIS, V75, P160, DOI 10.1016/0962-8479(94)90051-5; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, 2003, WHOTB2003320; *WHO, 2005, WHOHTMTB2005349; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; [No title captured]	36	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2363	10.1371/journal.pone.0002363	http://dx.doi.org/10.1371/journal.pone.0002363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523659	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300050
J	Ngumbela, KC; Ryan, KP; Sivamurthy, R; Brockman, MA; Gandhi, RT; Bhardwaj, N; Kavanagh, DG				Ngumbela, Kholiswa C.; Ryan, Kieran P.; Sivamurthy, Rohini; Brockman, Mark A.; Gandhi, Rajesh T.; Bhardwaj, Nina; Kavanagh, Daniel G.			Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells	PLOS ONE			English	Article								Background: The sequences of wild-isolate strains of Human Immunodeficiency Virus-1 (HIV-1) are characterized by low GC content and suboptimal codon usage. Codon optimization of DNA vectors can enhance protein expression both by enhancing translational efficiency, and by altering RNA stability and export. Although gag codon optimization is widely used in DNA vectors and experimental vaccines, the actual effect of altered codon usage on gag translational efficiency has not been quantified. Methodology and Principal Findings: To quantify translational efficiency of gag mRNA in live T cells, we transfected Jurkat cells with increasing doses of capped, polyadenylated synthetic mRNA corresponding to wildtype or codon-optimized gag sequences, measured Gag production by quantitative ELISA and flow cytometry, and estimated the translational efficiency of each transcript as mu g of Gag antigen produced per mg of input mRNA. We found that codon optimization yielded a small increase in gag translational efficiency (approximately 1.6 fold). In contrast when cells were transfected with DNA vectors requiring nuclear transcription and processing of gag mRNA, codon optimization resulted in a very large enhancement of Gag production. Conclusions: We conclude that suboptimal codon usage by HIV-1 results in only a slight loss of gag translational efficiency per se, with the vast majority of enhancement in protein expression from DNA vectors due to altered processing and export of nuclear RNA.	[Ngumbela, Kholiswa C.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ryan, Kieran P.; Sivamurthy, Rohini; Brockman, Mark A.; Gandhi, Rajesh T.; Bhardwaj, Nina; Kavanagh, Daniel G.] Harvard Med Sch, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Div AIDS, Boston, MA USA; [Bhardwaj, Nina] NYU, Sch Med, New York, NY USA	University of Kwazulu Natal; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University	Ngumbela, KC (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	dkavanagh@partners.org	; Brockman, Mark/D-1669-2016	Bhardwaj, Nina/0000-0003-1865-4187; Brockman, Mark/0000-0001-6432-1426	Emerald Foundation, NY; NIH [R01AI0571278-03, R01AI066992];  [R37AI044628-08];  [F32AI058457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, F32AI058457, R01AI066992] Funding Source: NIH RePORTER	Emerald Foundation, NY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Emerald Foundation, NY and NIH grants R37AI044628-08 (NB), R01AI0571278-03 (NB), and by R01AI066992 (RTG) and F32AI058457 (DGK). The funders did not particiapate in collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Freed E. O., 2001, FIELDS VIROLOGY, P1971; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Kavanagh DG, 2006, BLOOD, V107, P1963, DOI 10.1182/blood-2005-04-1513; Kofman Alexander, 2003, Tsitologiia, V45, P86; Kofman Alexander, 2003, Tsitologiia, V45, P94; Kong W, 2002, J VIROL, V76, P11434, DOI 10.1128/JVI.76.22.11434-11439.2002; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Pasquinelli AE, 1995, RNA, V1, P957; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Stepinski J, 2001, RNA, V7, P1486; Tang HL, 1999, ANNU REV GENET, V33, P133, DOI 10.1146/annurev.genet.33.1.133; Van Gulck ERA, 2006, BLOOD, V107, P1818, DOI 10.1182/blood-2005-01-0339; Vartanian JP, 2003, TRENDS MOL MED, V9, P409, DOI 10.1016/j.molmed.2003.08.008; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649	22	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2356	10.1371/journal.pone.0002356	http://dx.doi.org/10.1371/journal.pone.0002356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523584	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300043
J	Prudhomme, J; McDaniel, E; Ponts, N; Bertani, S; Fenical, W; Jensen, P; Le Roch, K				Prudhomme, Jacques; McDaniel, Eric; Ponts, Nadia; Bertani, Stephane; Fenical, William; Jensen, Paul; Le Roch, Karine			Marine Actinomycetes: A New Source of Compounds against the Human Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PROTEASOME INHIBITOR; SALINOSPORAMIDE-A; RESISTANCE; KINASE; IDENTIFICATION; MECHANISMS; DIVERSITY	Background: Malaria continues to be a devastating parasitic disease that causes the death of 2 million individuals annually. The increase in multi-drug resistance together with the absence of an efficient vaccine hastens the need for speedy and comprehensive antimalarial drug discovery and development. Throughout history, traditional herbal remedies or natural products have been a reliable source of antimalarial agents, e. g. quinine and artemisinin. Today, one emerging source of small molecule drug leads is the world's oceans. Included among the source of marine natural products are marine microorganisms such as the recently described actinomycete. Members of the genus Salinispora have yielded a wealth of new secondary metabolites including salinosporamide A, a molecule currently advancing through clinical trials as an anticancer agent. Because of the biological activity of metabolites being isolated from marine microorganisms, our group became interested in exploring the potential efficacy of these compounds against the malaria parasite. Methods: We screened 80 bacterial crude extracts for their activity against malaria growth. We established that the pure compound, salinosporamide A, produced by the marine actinomycete, Salinispora tropica, shows strong inhibitory activity against the erythrocytic stages of the parasite cycle. Biochemical experiments support the likely inhibition of the parasite 20S proteasome. Crystal structure modeling of salinosporamide A and the parasite catalytic 20S subunit further confirm this hypothesis. Ultimately we showed that salinosporamide A protected mice against deadly malaria infection when administered at an extremely low dosage. Conclusion: These findings underline the potential of secondary metabolites, derived from marine microorganisms, to inhibit Plasmodium growth. More specifically, we highlight the effect of proteasome inhibitors such as salinosporamide A on in vitro and in vivo parasite development. Salinosporamide A (NPI-0052) now being advanced to phase I trials for the treatment of refractory multiple myeloma will need to be further explored to evaluate the safety profile for its use against malaria.	[Prudhomme, Jacques; McDaniel, Eric; Ponts, Nadia; Le Roch, Karine] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bertani, Stephane] Univ Calif Riverside, Dept Biochem, Riverside, CA USA; [Fenical, William; Jensen, Paul] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanography, San Diego, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California San Diego; Scripps Institution of Oceanography	Prudhomme, J (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu	Bertani, Stephane/B-1250-2013	Bertani, Stephane/0000-0002-0398-9745; Fenical, William/0000-0002-8955-1735; jensen, paul/0000-0003-2349-1888; McDaniel, Eric/0000-0002-5985-3919	National Institutes of Health [TW007401]; Fogarty International Center [TW007401]; FOGARTY INTERNATIONAL CENTER [U01TW007401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	WF and PRJ thank the National Institutes of Health, Fogarty International Center, for funding under ICBG Grant #TW007401. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; Buchanan GN, 2005, DIS COLON RECTUM, V48, P141, DOI 10.1007/s10350-004-0752-3; Buchanan GO, 2005, ORG LETT, V7, P2731, DOI 10.1021/ol050901i; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Dorin D, 2005, MOL MICROBIOL, V55, P184, DOI 10.1111/j.1365-2958.2004.04393.x; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Ferrer-Rodriguez I, 2004, J PARASITOL, V90, P152, DOI 10.1645/GE-3225; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gontang EA, 2007, APPL ENVIRON MICROB, V73, P3272, DOI 10.1128/AEM.02811-06; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Gonzalez J, 1997, Arch Med Res, V28 Spec No, P139; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laurent D, 2006, MAR BIOTECHNOL, V8, P433, DOI 10.1007/s10126-006-6100-y; Le Roch K, 2000, J BIOL CHEM, V275, P8952, DOI 10.1074/jbc.275.12.8952; LEROCH KG, 2003, DISCOVERY GENE FUNCT; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Maldonado LA, 2005, ANTON LEEUW INT J G, V87, P11, DOI 10.1007/s10482-004-6525-0; Rao KV, 2004, J NAT PROD, V67, P1314, DOI 10.1021/np0400095; Schwartsmann G, 2003, EXPERT OPIN INV DRUG, V12, P1367, DOI 10.1517/13543784.12.8.1367; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Walker DJ, 2000, ANTIMICROB AGENTS CH, V44, P344, DOI 10.1128/AAC.44.2.344-347.2000; Wan YQ, 2004, CHEM BIOL, V11, P247, DOI 10.1016/j.chembiol.2004.01.015; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+	36	122	131	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2335	10.1371/journal.pone.0002335	http://dx.doi.org/10.1371/journal.pone.0002335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523554	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300030
J	Xing, GQ; Qualls, C; Huicho, L; River-Ch, M; Stobdan, T; Slessarev, M; Prisman, E; Ito, S; Wu, H; Norboo, A; Dolma, D; Kunzang, M; Norboo, T; Gamboa, JL; Claydon, VE; Fisher, J; Zenebe, G; Gebremedhin, A; Hainsworth, R; Verma, A; Appenzeller, O				Xing, Guoqiang; Qualls, Clifford; Huicho, Luis; River-Ch, Maria; Stobdan, Tsering; Slessarev, Marat; Prisman, Eitan; Ito, Soji; Wu, Hong; Norboo, Angchuk; Dolma, Diskit; Kunzang, Moses; Norboo, Tsering; Gamboa, Jorge L.; Claydon, Victoria E.; Fisher, Joseph; Zenebe, Guta; Gebremedhin, Amha; Hainsworth, Roger; Verma, Ajay; Appenzeller, Otto			Adaptation and Mal-Adaptation to Ambient Hypoxia; Andean, Ethiopian and Himalayan Patterns	PLOS ONE			English	Article							CHRONIC MOUNTAIN-SICKNESS; HIGH-ALTITUDE; GENE-EXPRESSION; FITNESS; LIFE	The study of the biology of evolution has been confined to laboratories and model organisms. However, controlled laboratory conditions are unlikely to model variations in environments that influence selection in wild populations. Thus, the study of "fitness'' for survival and the genetics that influence this are best carried out in the field and in matching environments. Therefore, we studied highland populations in their native environments, to learn how they cope with ambient hypoxia. The Andeans, African highlanders and Himalayans have adapted differently to their hostile environment. Chronic mountain sickness (CMS), a loss of adaptation to altitude, is common in the Andes, occasionally found in the Himalayas; and absent from the East African altitude plateau. We compared molecular signatures (distinct patterns of gene expression) of hypoxia-related genes, in white blood cells (WBC) from Andeans with (n = 10), without CMS (n = 10) and sea-level controls from Lima (n = 20) with those obtained from CMS (n = 8) and controls (n = 5) Ladakhi subjects from the Tibetan altitude plateau. We further analyzed the expression of a subset of these genes in Ethiopian highlanders (n = 8). In all subjects, we performed the studies at their native altitude and after they were rendered normoxic. We identified a gene that predicted CMS in Andeans and Himalayans (PDP2). After achieving normoxia, WBC gene expression still distinguished Andean and Himalayan CMS subjects. Remarkably, analysis of the small subset of genes (n = 8) studied in all 3 highland populations showed normoxia induced gene expression changes in Andeans, but not in Ethiopians nor Himalayan controls. This is consistent with physiologic studies in which Ethiopians and Himalayans show a lack of responsiveness to hypoxia of the cerebral circulation and of the hypoxic ventilatory drive, and with the absence of CMS on the East African altitude plateau.	[Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Qualls, Clifford] University of New Mexico, Dept Math & Statist, Albuquerque, NM USA; [Huicho, Luis] Univ Nacl Mayor San Marcos, Dept Acad Pediat, Lima, Peru; [River-Ch, Maria] Univ Peruana Cayetano Heredia, Inst Invest Altura, Fac Cienc Filos, Dept Cienc Biol, Lima, Peru; [Stobdan, Tsering; Norboo, Tsering] Ladakh Heart Fdn, Ladakh Inst Prevent, Leh, India; [Slessarev, Marat; Prisman, Eitan; Fisher, Joseph] Univ Toronto, Dept Anesthesiol, Toronto, ON, Canada; [Slessarev, Marat; Fisher, Joseph] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ito, Soji] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol, Nagoya, Aichi, Japan; [Ito, Soji] Nagoya City Univ, Grad Sch Med Sc, Dept Med Crisis Management, Nagoya, Aichi, Japan; [Wu, Hong] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD USA; [Norboo, Angchuk; Dolma, Diskit] Sonam Norboo Memorial Hosp Leh, Leh, India; [Gamboa, Jorge L.] Univ Kentucky, Dept Physiol, Louisville, KY USA; [Gamboa, Jorge L.] Univ Kentucky, Dept Neurol, Louisville, KY USA; [Claydon, Victoria E.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC, Canada; [Zenebe, Guta] Univ Addis Ababa, Yehuleshet Higher Clin, Dept Neurol, Addis Ababa, Ethiopia; [Gebremedhin, Amha] Univ Addis Ababa, Dept Med, Addis Ababa, Ethiopia; [Hainsworth, Roger] Univ Leeds, Inst Cardiovascul Res, Leeds, W Yorkshire, England; [Verma, Ajay] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD USA; [Appenzeller, Otto] New Mexico Hlth Enhancement, Marathon Clin Res Fdn, Dept Neurol, Albuquerque, NM USA	Uniformed Services University of the Health Sciences - USA; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia; University of Toronto; University of Toronto; Nagoya City University; Nagoya City University; Uniformed Services University of the Health Sciences - USA; University of Kentucky; University of Kentucky; Simon Fraser University; Addis Ababa University; Addis Ababa University; University of Leeds; Uniformed Services University of the Health Sciences - USA	Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA.	oarun@unm.edu	Gamboa, Jorge/AFM-0631-2022; Xing, Guoqiang/ABA-8450-2020; Gamboa, Jorge/AAH-3052-2022; Huicho, Luis/AAD-7353-2019; Slessarev, Marat/G-2505-2018; Gamboa, Jorge/E-5879-2010; Slessarev, Marat/I-7482-2017	Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670; Slessarev, Marat/0000-0003-1181-0706; Claydon, Victoria/0000-0002-2720-8042; Prisman, Eitan/0000-0001-7201-6181; Rivera-Chira, Maria/0000-0001-9470-6642; Huicho, Luis/0000-0002-5272-5885; Verma, Ajay/0000-0001-7715-0443	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada; NIH [Ro1 NS37814]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037814] Funding Source: NIH RePORTER	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada, NIH Ro1 NS37814 to A.V.	Appenzeller O, 2003, J NEUROL SCI, V207, P37, DOI 10.1016/S0022-510X(02)00356-8; Appenzeller O, 2006, STROKE, V37, P1754, DOI 10.1161/01.STR.0000226973.97858.0b; Appenzeller O, 2006, CLIN AUTON RES, V16, P217, DOI 10.1007/s10286-006-0338-3; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bakonyi T, 2004, J SPORT SCI MED, V3, P64; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Claydon VE, 2008, STROKE, V39, P336, DOI 10.1161/STROKEAHA.107.491498; Cohen J, 2007, SCIENCE, V317, P1315, DOI 10.1126/science.317.5843.1315; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; GILBERT DL, 1983, RESP PHYSIOL, V52, P327, DOI 10.1016/0034-5687(83)90089-0; GILBERT DL, 1983, RESP PHYSIOL, V52, P315, DOI 10.1016/0034-5687(83)90088-9; GOEBEL T, 2008, LATE PLEISTOCENE DIS, V319, P1497; Hartzell HC, 2007, SCIENCE, V317, P1331, DOI 10.1126/science.1148142; Hurtado A, 1942, J AMER MED ASSOC, V120, P1278, DOI 10.1001/jama.1942.02830510016004; Leon-Velarde F, 2003, ADV EXP MED BIOL, V543, P339; MONGE CC, 2003, RETO FISIOLOGICO VIV, V177, P435; MONGE MC, 1928, ANALES FACULTAD MED, V11, P76; Niermeyer S, 2001, LUNG BIOL HEALTH DIS, V161, P43; Pennisi E, 2008, SCIENCE, V319, P1177, DOI 10.1126/science.319.5867.1177; Sartori C, 2003, ADV EXP MED BIOL, V543, P263; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SIME F, 1975, INT J BIOMETEOROL, V19, P93, DOI 10.1007/BF01463864; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Slessarev M, 2006, CRIT CARE MED, V34, P829, DOI 10.1097/01.CCM.0000201877.82049.C3; SLESSAREV M, 2007, ADV EXPT MED BIOL, V618, P326; SLESSAREV M, 2006, ISR J EMERG MED, V6, P10; SLESSAREV M, 2007, ADV EXPT MED BIOL, V618, P328; SUTTON JR, 1983, SEMIN RESPIR MED, V5, P129, DOI 10.1055/s-2007-1011442; Thomas PK, 2000, J NEUROL NEUROSUR PS, V69, P447, DOI 10.1136/jnnp.69.4.447	36	57	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2342	10.1371/journal.pone.0002342	http://dx.doi.org/10.1371/journal.pone.0002342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523639	Green Published, gold			2022-12-27	WOS:000262614300035
J	Rojas-Galeano, S; Hsieh, E; Agranoff, D; Krishna, S; Fernandez-Reyes, D				Rojas-Galeano, Sergio; Hsieh, Emily; Agranoff, Dan; Krishna, Sanjeev; Fernandez-Reyes, Delmiro			Estimation of Relevant Variables on High-Dimensional Biological Patterns Using Iterated Weighted Kernel Functions	PLOS ONE			English	Article							CANCER CLASSIFICATION; VECTOR; PERCEPTRON	Background: The analysis of complex proteomic and genomic profiles involves the identification of significant markers within a set of hundreds or even thousands of variables that represent a high-dimensional problem space. The occurrence of noise, redundancy or combinatorial interactions in the profile makes the selection of relevant variables harder. Methodology/Principal Findings: Here we propose a method to select variables based on estimated relevance to hidden patterns. Our method combines a weighted-kernel discriminant with an iterative stochastic probability estimation algorithm to discover the relevance distribution over the set of variables. We verified the ability of our method to select predefined relevant variables in synthetic proteome-like data and then assessed its performance on biological high-dimensional problems. Experiments were run on serum proteomic datasets of infectious diseases. The resulting variable subsets achieved classification accuracies of 99% on Human African Trypanosomiasis, 91% on Tuberculosis, and 91% on Malaria serum proteomic profiles with fewer than 20% of variables selected. Our method scaled-up to dimensionalities of much higher orders of magnitude as shown with gene expression microarray datasets in which we obtained classification accuracies close to 90% with fewer than 1% of the total number of variables. Conclusions: Our method consistently found relevant variables attaining high classification accuracies across synthetic and biological datasets. Notably, it yielded very compact subsets compared to the original number of variables, which should simplify downstream biological experimentation.	[Rojas-Galeano, Sergio; Fernandez-Reyes, Delmiro] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Rojas-Galeano, Sergio; Fernandez-Reyes, Delmiro] UCL, Dept Comp Sci, London, England; [Agranoff, Dan] Imperial Coll London, Fac Med, Dept Infect Dis & Immun, London, England; [Hsieh, Emily; Krishna, Sanjeev] St Georges Univ London, Ctr Infection, Div Cell & Mol Med, London, England	MRC National Institute for Medical Research; University of London; University College London; Imperial College London; St Georges University London	Rojas-Galeano, S (corresponding author), Natl Inst Med Res, Div Parasitol, London NW7 1AA, England.	dfernan@nimr.mrc.ac.uk		Fernandez-Reyes, Delmiro/0000-0001-5070-9198; Krishna, Sanjeev/0000-0003-0066-0634	Medical Research Council, United Kingdom; MRC [MC_U117585869] Funding Source: UKRI; Medical Research Council [MC_U117585869] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by The Medical Research Council, United Kingdom. The sponsor of the study had no direct role in study design, data collection, data analysis, data interpretation, or writing of the report.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Baldi P, 2002, DNA MICROARRAYS GENE; BEDO J, 2006, EFFICIENT ALTERNATIV; Briggs T, 2005, MATLAB MEX INTERFACE; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; CONRADS T, 2004, ENDOCR RELAT CANCER, P163; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini N, 2000, INTRO SUPPORT VECTOR; DAVIES L, 1991, HDB GENETIC ALGORTIH; DAVIES S, 1994, NP COMPLETENESS SEAR; Ding YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S12; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Friedrichs F, 2005, NEUROCOMPUTING, V64, P107, DOI 10.1016/j.neucom.2004.11.022; Frohlich H., 2003, FEATURE SELECTION SU; FROHLICH H, 2004, FEATURE SUBSET SELEC, P2041; GALEANO SR, 2005, ADAPTING MULTIPLE KE; Garey M.R., 1979, COMPUTERS INTRACTABI; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; HERBSTER M, 2001, LEARNING ADDITIVE MO, P444; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Joachims T., 1999, ADV KERNEL METHODS S; Li LB, 2005, GENOMICS, V85, P16, DOI 10.1016/j.ygeno.2004.09.007; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; MERCER J, 1909, PHILOS T ROY SOC LON; Minsky M., 1969, PERCEPTRONS; NOVIKOV ABJ, 1962, P S MATH THEOR AUT, V12, P615; NUTT C, 2003, CANCER RES, P1602; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; PELIKAN P, 2006, SCALABLE OPTIMIZATIO; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; VANGESTEL T, 2001, AUTOMATIC RELEVANCE; Wagner M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-26; Wagner M, 2003, PROTEOMICS, V3, P1692, DOI 10.1002/pmic.200300519; Weston Jason, 2000, FEATURE SELECTION SV; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1806	10.1371/journal.pone.0001806	http://dx.doi.org/10.1371/journal.pone.0001806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18509521	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000260762400001
J	Friedrich, O; von Wegner, F; Chamberlain, JS; Fink, RHA; Rohrbach, P				Friedrich, Oliver; von Wegner, Frederic; Chamberlain, Jeffrey S.; Fink, Rainer H. A.; Rohrbach, Petra			L-Type Ca2+ Channel Function Is Linked to Dystrophin Expression in Mammalian Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CALCIUM LEAK CHANNELS; TRANSVERSE TUBULAR SYSTEM; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; GENE-THERAPY; MDX MICE; INTRACELLULAR CA2+; CHARGE MOVEMENT; FULL-LENGTH	Background: In dystrophic mdx skeletal muscle, aberrant Ca2+ homeostasis and fibre degeneration are found. The absence of dystrophin in models of Duchenne muscular dystrophy (DMD) has been connected to altered ion channel properties e. g. impaired L-type Ca2+ currents. In regenerating mdx muscle, 'revertant' fibres restore dystrophin expression. Their functionality involving DHPR-Ca2+- channels is elusive. Methods and Results: We developed a novel 'in-situ' confocal immuno-fluorescence and imaging technique that allows, for the first time, quantitative subcellular dystrophin-DHPR colocalization in individual, non-fixed, muscle fibres. Tubular DHPR signals alternated with second harmonic generation signals originating from myosin. Dystrophin-DHPR colocalization was substantial in wt fibres, but diminished in most mdx fibres. Mini-dystrophin (MinD) expressing fibres successfully restored colocalization. Interestingly, in some aged mdx fibres, colocalization was similar to wt fibres. Most mdx fibres showed very weak membrane dystrophin staining and were classified 'mdx-like'. Some mdx fibres, however, had strong 'wt-like' dystrophin signals and were identified as 'revertants'. Split mdx fibres were mostly 'mdx-like' and are not generally 'revertants'. Correlations between membrane dystrophin and DHPR colocalization suggest a restored putative link in 'revertants'. Using the two-micro-electrode-voltage clamp technique, Ca2+- current amplitudes (imax) showed very similar behaviours: reduced amplitudes in most aged mdx fibres (as seen exclusively in young mdx mice) and a few mdx fibres, most likely 'revertants', with amplitudes similar to wt or MinD fibres. Ca2+ current activation curves were similar in 'wt-like' and 'mdx-like' aged mdx fibres and are not the cause for the differences in current amplitudes. imax amplitudes were fully restored in MinD fibres. Conclusions: We present evidence for a direct/indirect DHPR-dystrophin interaction present in wt, MinD and 'revertant' mdx fibres but absent in remaining mdx fibres. Our imaging technique reliably detects single isolated 'revertant' fibres that could be used for subsequent physiological experiments to study mechanisms and therapy concepts in DMD.	[Friedrich, Oliver; von Wegner, Frederic; Fink, Rainer H. A.] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany; [Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA USA; [Rohrbach, Petra] Heidelberg Univ, Hyg Inst, Dept Parasitol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	Friedrich, O (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany.	oliver.friedrich@physiologie.uni-heidelberg.de	Rohrbach, Petra/F-3201-2011	Chamberlain, Jeffrey/0000-0001-5299-0059; Friedrich, Oliver/0000-0003-2238-2049				Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Allard B, 2006, J PHYSL, V575, P68; Allard B, 2006, J MUSCLE RES CELL M, V27, P367, DOI 10.1007/s10974-006-9083-4; ALMERS W, 1981, J PHYSIOL-LONDON, V312, P177, DOI 10.1113/jphysiol.1981.sp013623; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Boland BJ, 1996, PEDIATR NEUROL, V14, P7, DOI 10.1016/0887-8994(95)00251-0; Both M, 2004, J BIOMED OPT, V9, P882, DOI 10.1117/1.1783354; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Coirault C, 2002, AM J RESP CRIT CARE, V165, P250, DOI 10.1164/ajrccm.165.2.2105088; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487; Decrouy A, 1997, GENE THER, V4, P401, DOI 10.1038/sj.gt.3300407; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Divet A, 2005, ACTA PHYSIOL SCAND, V184, P173, DOI 10.1111/j.1365-201X.2005.01450.x; DULHUNTY AF, 1984, J MUSCLE RES CELL M, V5, P333, DOI 10.1007/BF00713111; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINK RHA, 1990, J PHYSIOL-LONDON, V420, P337, DOI 10.1113/jphysiol.1990.sp017916; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Francini F, 1996, J PHYSIOL-LONDON, V494, P121, DOI 10.1113/jphysiol.1996.sp021480; FRANK JS, 1994, AM J PHYSIOL-CELL PH, V267, pC1707, DOI 10.1152/ajpcell.1994.267.6.C1707; Friedrich O, 2004, J PHYSIOL-LONDON, V555, P251, DOI 10.1113/jphysiol.2003.054213; Friedrich O, 1999, J PHYSIOL-LONDON, V517, P757, DOI 10.1111/j.1469-7793.1999.0757s.x; Friedrich O, 2001, BIOPHYS J, V80, P2046, DOI 10.1016/S0006-3495(01)76178-4; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Ge Y, 2004, ELECTROPHORESIS, V25, P2576, DOI 10.1002/elps.200406013; GONZALEZSERRATOS H, 1982, NATURE, V298, P292, DOI 10.1038/298292a0; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 1997, J PHYSIOL-LONDON, V504, P425, DOI 10.1111/j.1469-7793.1997.425be.x; Launikonis BS, 2002, J PHYSIOL-LONDON, V538, P607, DOI 10.1113/jphysiol.2001.012920; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mallouk N, 2002, BIOPHYS J, V82, P3012, DOI 10.1016/S0006-3495(02)75642-7; Marchand E, 2004, EXP CELL RES, V297, P363, DOI 10.1016/j.yexcr.2004.02.032; MATSUMURA K, 1994, NEUROMUSCULAR DISORD, V4, P115, DOI 10.1016/0960-8966(94)90002-7; McCarter GC, 2000, J MEMBRANE BIOL, V176, P169, DOI 10.1007/s002320001086; Melacini P, 1996, NEUROMUSCULAR DISORD, V6, P367, DOI 10.1016/0960-8966(96)00357-4; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; Pereon Y, 1997, BBA-MOL BASIS DIS, V1362, P201, DOI 10.1016/S0925-4439(97)00079-3; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SENTER L, 1995, BIOCHEM BIOPH RES CO, V206, P57, DOI 10.1006/bbrc.1995.1009; STRAUB V, 1992, J CELL BIOL, V119, P1183, DOI 10.1083/jcb.119.5.1183; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wang ZM, 2000, BIOPHYS J, V78, P1947, DOI 10.1016/S0006-3495(00)76742-7; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Woods CE, 2005, J PHYSIOL-LONDON, V568, P867, DOI 10.1113/jphysiol.2005.089318; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Woolf PJ, 2006, AM J PHYSIOL-HEART C, V290, pH2439, DOI 10.1152/ajpheart.00844.2005; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000	76	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1762	10.1371/journal.pone.0001762	http://dx.doi.org/10.1371/journal.pone.0001762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18516256	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000016
J	Baurle, I; Dean, C				Baurle, Isabel; Dean, Caroline			Differential Interactions of the Autonomous Pathway RRM Proteins and Chromatin Regulators in the Silencing of Arabidopsis Targets	PLOS ONE			English	Article								We have recently shown that two proteins containing RRM-type RNA-binding domains, FCA and FPA, originally identified through their role in flowering time control in Arabidopsis, silence transposons and other repeated sequences in the Arabidopsis genome. In flowering control, FCA and FPA function in the autonomous pathway with conserved chromatin regulators, the histone demethylase FLD and the MSI1-homologue FVE, a conserved WD-repeat protein found in many chromatin complexes. Here, we investigate how the RRM proteins interact genetically with these chromatin regulators at a range of loci in the Arabidopsis genome. We also investigate their interaction with the DNA methylation pathway. In several cases the RRM protein activity at least partially required a chromatin regulator to effect silencing. However, the interactions of the autonomous pathway components differed at each target analysed, most likely determined by certain properties of the target loci and/or other silencing pathways. We speculate that the RNA-binding proteins FCA and FPA function as part of a transcriptome surveillance mechanism linking RNA recognition with chromatin silencing mechanisms.	[Baurle, Isabel; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baurle, I (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Bäurle, Isabel/ABD-6356-2021	Bäurle, Isabel/0000-0001-5633-8068; Dean, Caroline/0000-0002-6555-3525	BBSRC [BBS/E/J/000CA355, BB/D010799/1, BBS/E/J/000CA305, BBS/E/J/000CA344, BB/E009662/1] Funding Source: UKRI; Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA305, BBS/E/J/00000581, BB/C517633/1, BBS/E/J/000CA355, BB/G009562/1, BBS/E/J/000CA376, BB/G01406X/1, BBS/E/J/000CA378, BBS/E/J/0000A219, BBS/E/J/0000A199, BBS/E/J/000CA369, G20334, BB/E009662/1, BBS/E/J/000CA344, BB/D010799/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Henderson IR, 2005, DEVELOPMENT, V132, P3597, DOI 10.1242/dev.01924; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang D, 2007, PLANT CELL, V19, P2975, DOI 10.1105/tpc.107.052373; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Veley KM, 2008, PLANT PHYSIOL, V147, P682, DOI 10.1104/pp.108.118927; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	40	58	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2733	10.1371/journal.pone.0002733	http://dx.doi.org/10.1371/journal.pone.0002733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628965	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200069
J	Mehra, S; Charaniya, S; Takano, E; Hu, WS				Mehra, Sarika; Charaniya, Salim; Takano, Eriko; Hu, Wei-Shou			A Bistable Gene Switch for Antibiotic Biosynthesis: The Butyrolactone Regulon in Streptomyces coelicolor	PLOS ONE			English	Article							AUTOREGULATOR RECEPTOR PROTEIN; CHEMICAL REACTOR STABILITY; GAMMA-BUTYROLACTONE; SECONDARY METABOLISM; POSITIVE FEEDBACK; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; CATABOLITE REPRESSION; INDUCER EXCLUSION; GLOBAL ANALYSIS	Many microorganisms, including bacteria of the class Streptomycetes, produce various secondary metabolites including antibiotics to gain a competitive advantage in their natural habitat. The production of these compounds is highly coordinated in a population to expedite accumulation to an effective concentration. Furthermore, as antibiotics are often toxic even to their producers, a coordinated production allows microbes to first arm themselves with a defense mechanism to resist their own antibiotics before production commences. One possible mechanism of coordination among individuals is through the production of signaling molecules. The gamma-butyrolactone system in Streptomyces coelicolor is a model of such a signaling system for secondary metabolite production. The accumulation of these signaling molecules triggers antibiotic production in the population. A pair of repressor-amplifier proteins encoded by scbA and scbR mediates the production and action of one particular gamma-butyrolactone, SCB1. Based on the proposed interactions of scbA and scbR, a mathematical model was constructed and used to explore the ability of this system to act as a robust genetic switch. Stability analysis shows that the butyrolactone system exhibits bistability and, in response to a threshold SCB1 concentration, can switch from an OFF state to an ON state corresponding to the activation of genes in the cryptic type I polyketide synthase gene cluster, which are responsible for production of the hypothetical polyketide. The switching time is inversely related to the inducer concentration above the threshold, such that short pulses of low inducer concentration cannot switch on the system, suggesting its possible role in noise filtering. In contrast, secondary metabolite production can be triggered rapidly in a population of cells producing the butyrolactone signal due to the presence of an amplification loop in the system. S. coelicolor was perturbed experimentally by varying concentrations of SCB1, and the model simulations match the experimental data well. Deciphering the complexity of this butyrolactone switch will provide valuable insights into how robust and efficient systems can be designed using "simple'' two-protein networks.	[Mehra, Sarika] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Charaniya, Salim; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN USA; [Takano, Eriko] Univ Groningen, Dept Microbiol, Groningen, Netherlands	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Minnesota System; University of Minnesota Twin Cities; University of Groningen	Mehra, S (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.	acre@cems.umn.edu		Mehra, Sarika/0000-0003-3844-4726; Takano, Eriko/0000-0002-6791-3256	National Institutes of Health [GM55850]; Graduate School at University of Minnesota [dissertation fellowship]; Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School at University of Minnesota; Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay	This work was supported in part by a grant from the National Institutes of Health (GM55850). SM was supported by a dissertation fellowship from Graduate School at University of Minnesota. SM also thanks the Industrial Research and Consultancy Center at Indian Institute of Technology, Bombay, which supported part of the research.	ARIS R, 1958, CHEM ENG SCI, V7, P121, DOI 10.1016/0009-2509(58)80019-6; ARIS R, 1958, CHEM ENG SCI, V7, P132, DOI 10.1016/0009-2509(58)80020-2; Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bignell DRD, 2007, MOL MICROBIOL, V63, P838, DOI 10.1111/j.1365-2958.2006.05541.x; Butler MJ, 2003, APPL MICROBIOL BIOT, V61, P512, DOI 10.1007/s00253-003-1277-8; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Charaniya S, 2007, NUCLEIC ACIDS RES, V35, P7222, DOI 10.1093/nar/gkm501; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Choi SU, 2004, J BACTERIOL, V186, P3423, DOI 10.1128/JB.186.11.3423-3430.2004; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Folcher M, 2001, J BIOL CHEM, V276, P44297, DOI 10.1074/jbc.M101109200; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Goryachev AB, 2005, PLOS COMPUT BIOL, V1, P265, DOI 10.1371/journal.pcbi.0010037; Graumann PL, 2006, MOL MICROBIOL, V61, P560, DOI 10.1111/j.1365-2958.2006.05264.x; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Horinouchi S, 2002, FRONT BIOSCI-LANDMRK, V7, pD2045, DOI 10.2741/horinouc; Hsiao NH, 2007, MICROBIOL-SGM, V153, P1394, DOI 10.1099/mic.0.2006/004432-0; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; KIERSER T, 2000, PRACTICAL STREPTOMYC; Kim HS, 2004, ARCH MICROBIOL, V182, P44, DOI 10.1007/s00203-004-0697-x; Kinoshita H, 1997, J BACTERIOL, V179, P6986, DOI 10.1128/jb.179.22.6986-6993.1997; Kitani S, 1999, J BACTERIOL, V181, P5081, DOI 10.1128/JB.181.16.5081-5084.1999; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; Kobayashi T, 2003, J THEOR BIOL, V221, P379, DOI 10.1006/jtbi.2003.3190; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Onaka H, 1997, J BACTERIOL, V179, P2748, DOI 10.1128/jb.179.8.2748-2752.1997; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; RUENGJITCHATCHAWALYA M, 1995, J BACTERIOL, V177, P551, DOI 10.1128/jb.177.3.551-557.1995; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Takano E, 2006, CURR OPIN MICROBIOL, V9, P287, DOI 10.1016/j.mib.2006.04.003; Tian TH, 2004, J THEOR BIOL, V227, P229, DOI 10.1016/j.jtbi.2003.11.003; Vo NV, 2003, BIOCHEMISTRY-US, V42, P3798, DOI 10.1021/bi026962v; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o	54	42	42	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2724	10.1371/journal.pone.0002724	http://dx.doi.org/10.1371/journal.pone.0002724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628968	Green Submitted, Green Published, gold			2022-12-27	WOS:000264057200062
J	Thakur, AK; Rao, CM				Thakur, Abhay Kumar; Rao, Ch Mohan			UV-Light Exposed Prion Protein Fails to Form Amyloid Fibrils	PLOS ONE			English	Article								Amyloid fibril formation involves three steps; structural perturbation, nucleation and elongation. We have investigated amyloidogenesis using prion protein as a model system and UV-light as a structural perturbant. We find that UV-exposed prion protein fails to form amyloid fibrils. Interestingly, if provided with pre-formed fibrils as seeds, UV-exposed prion protein formed amyloid fibrils albeit with slightly different morphology. Atomic force microscopy and electron microscopic studies clearly show the formation of fibrils under these conditions. Circular dichroism study shows loss in helicity in UV-exposed protein. UV-exposed prion protein fails to form amyloid fibrils. However, it remains competent for fibril extension, suggesting that UV-exposure results in loss of nucleating capability. This work opens up possibility of segregating nucleation and elongation step of amyloidogenesis, facilitating screening of new drug candidates for specifically inhibiting either of these processes. In addition, the work also highlights the importance of light-induced structural and functional alterations which are important in protein based therapeutics.	[Thakur, Abhay Kumar; Rao, Ch Mohan] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Thakur, AK (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	mohan@ccmb.res.in	Thakur, Abhay/K-4167-2012		Council of Scientific and Industrial Research, New Delhi, India [Senior Research Fellowship]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Abhay Kumar Thakur acknowledges the Council of Scientific and Industrial Research, New Delhi, India for the grant of Senior Research Fellowship.	Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; AIKEN JM, 1990, J VIROL, V64, P3265, DOI 10.1128/JVI.64.7.3265-3268.1990; Andrievskaia O, 2007, ARCH BIOCHEM BIOPHYS, V460, P10, DOI 10.1016/j.abb.2007.02.001; Babcock K., 2004, PHASE IMAGING TOPOGR; Balasubramanian D, 2005, PHOTOCHEM PHOTOBIOL, V81, P498, DOI 10.1562/2004-11-01-RA-354.1; BALASUBRAMANIAN D, 1990, PHOTOCHEM PHOTOBIOL, V52, P761, DOI 10.1111/j.1751-1097.1990.tb08679.x; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BUETTNER GR, 1987, BIOCHIM BIOPHYS ACTA, V923, P501, DOI 10.1016/0304-4165(87)90060-2; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Costa D, 2007, ANAL BIOANAL CHEM, V387, P2071, DOI 10.1007/s00216-006-0998-9; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; DEVASAGAYAM TPA, 1991, J PHOTOCH PHOTOBIO B, V9, P105, DOI 10.1016/1011-1344(91)80008-6; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gobbi M, 2006, J BIOL CHEM, V281, P843, DOI 10.1074/jbc.M506164200; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; GROSSWEINER LI, 1984, CURR EYE RES, V3, P137, DOI 10.3109/02713688408997195; Guentchev M, 2002, NEUROBIOL DIS, V9, P275, DOI 10.1006/nbdi.2002.0477; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Hills RD, 2007, J MOL BIOL, V368, P894, DOI 10.1016/j.jmb.2007.02.043; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Konno T, 1999, FEBS LETT, V454, P122, DOI 10.1016/S0014-5793(99)00789-9; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RAO CM, 1987, PHOTOCHEM PHOTOBIOL, V46, P511, DOI 10.1111/j.1751-1097.1987.tb04804.x; RAO SC, 1990, PHOTOCHEM PHOTOBIOL, V51, P357, DOI 10.1111/j.1751-1097.1990.tb01722.x; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; VAN EB, 2004, ACTA NEUROPATHOL BER, V108, P194; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936; Wong BS, 1999, BIOCHEM BIOPH RES CO, V259, P352, DOI 10.1006/bbrc.1999.0802; Yun SW, 2006, EXP NEUROL, V201, P90, DOI 10.1016/j.expneurol.2006.03.025; Yutani K, 2000, BIOCHEMISTRY-US, V39, P2769, DOI 10.1021/bi991406v	53	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2688	10.1371/journal.pone.0002688	http://dx.doi.org/10.1371/journal.pone.0002688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628989	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200032
J	Davey, VJ; Glass, RJ; Min, HJ; Beyeler, WE; Glass, LM				Davey, Victoria J.; Glass, Robert J.; Min, H. Jason; Beyeler, Walter E.; Glass, Laura M.			Effective, Robust Design of Community Mitigation for Pandemic Influenza: A Systematic Examination of Proposed US Guidance	PLOS ONE			English	Article							STRATEGIES; INTERVENTIONS; SPREAD; MODEL	Background: The US government proposes pandemic influenza mitigation guidance that includes isolation and antiviral treatment of ill persons, voluntary household member quarantine and antiviral prophylaxis, social distancing of individuals, school closure, reduction of contacts at work, and prioritized vaccination. Is this the best strategy combination? Is choice of this strategy robust to pandemic uncertainties? What are critical enablers of community resilience? Methods and Findings: We systematically simulate a broad range of pandemic scenarios and mitigation strategies using a networked, agent-based model of a community of explicit, multiply-overlapping social contact networks. We evaluate illness and societal burden for alterations in social networks, illness parameters, or intervention implementation. For a 1918-like pandemic, the best strategy minimizes illness to <1% of the population and combines network-based (e. g. school closure, social distancing of all with adults' contacts at work reduced), and case-based measures (e. g. antiviral treatment of the ill and prophylaxis of household members). We find choice of this best strategy robust to removal of enhanced transmission by the young, additional complexity in contact networks, and altered influenza natural history including extended viral shedding. Administration of age-group or randomly targeted 50% effective pre-pandemic vaccine with 7% population coverage (current US H5N1 vaccine stockpile) had minimal effect on outcomes. In order, mitigation success depends on rapid strategy implementation, high compliance, regional mitigation, and rigorous rescinding criteria; these are the critical enablers for community resilience. Conclusions: Systematic evaluation of feasible, recommended pandemic influenza interventions generally confirms the US community mitigation guidance yields best strategy choices for pandemic planning that are robust to a wide range of uncertainty. The best strategy combines network-and case-based interventions; network-based interventions are paramount. Because strategies must be applied rapidly, regionally, and stringently for greatest benefit, preparation and public education is required for long-lasting, high community compliance during a pandemic.	[Davey, Victoria J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Davey, Victoria J.] Dept Vet Affairs, Vet Hlth Adm, Office Publ Hlth & Env Hazards, Washington, DC USA; [Glass, Robert J.; Min, H. Jason; Beyeler, Walter E.] Sandia Natl Labs, Natl Infrastructure Simulat & Anal Ctr, Albuquerque, NM USA; [Glass, Laura M.] Albuquerque Publ Sch Syst, Albuquerque, NM USA	Uniformed Services University of the Health Sciences - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); United States Department of Energy (DOE); Sandia National Laboratories	Davey, VJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	victoria.davey@va.gov			National Infrastructure Simulation and Analysis Center (NISAC); Department of Homeland Security's Infrastructure Protection/Risk Management Division; partnership of Sandia National Laboratories (SNL) and Los Alamos National Laboratory (LANL) [DE-AC04-94AL85000]	National Infrastructure Simulation and Analysis Center (NISAC); Department of Homeland Security's Infrastructure Protection/Risk Management Division(United States Department of Homeland Security (DHS)); partnership of Sandia National Laboratories (SNL) and Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory)	This research was supported by the National Infrastructure Simulation and Analysis Center (NISAC), a program of the Department of Homeland Security's Infrastructure Protection/Risk Management Division and comprised of a core partnership of Sandia National Laboratories (SNL) and Los Alamos National Laboratory (LANL). Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company for the United States Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, desision to publish, or preparation of the manuscript.	Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Committee on Modeling Community Containment for Pandemic Influenza and Institute of Medicine, 2006, MOD COMM CONT PAND I; Davey VJ, 2008, EMERG INFECT DIS, V14, P365, DOI 10.3201/eid1403.070673; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; *DEP HLTH HUM SERV, 2006, HHS PAND INF PLAN S, V6; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; GLASS RJ, 2007, SAND20071184P NAT IN; GLASS RJ, 2005, SAND20057955J NAT IN; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; Meltzer MI, 2008, EMERG INFECT DIS, V14, P509, DOI 10.3201/eid1403.080026; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; [No title captured]; 2008, NEJM, V358, P261	34	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2606	10.1371/journal.pone.0002606	http://dx.doi.org/10.1371/journal.pone.0002606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596963	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200059
J	Poliseno, L; Pitto, L; Simili, M; Mariani, L; Riccardi, L; Ciucci, A; Rizzo, M; Evangelista, M; Mercatanti, A; Pandolfi, PP; Rainaldi, G				Poliseno, Laura; Pitto, Letizia; Simili, Marcella; Mariani, Laura; Riccardi, Luisa; Ciucci, Alessia; Rizzo, Milena; Evangelista, Monica; Mercatanti, Alberto; Pandolfi, Pier Paolo; Rainaldi, Giuseppe			The Proto-Oncogene LRF Is under Post-Transcriptional Control of MiR-20a: Implications for Senescence	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CHROMOSOME 13Q; TUMOR; MICRORNAS; GENE; HETEROZYGOSITY; EXPRESSION; P53; ANGIOGENESIS; PROGRESSION	MicroRNAs (miRNAs) are short 20-22 nucleotide RNA molecules that act as negative regulators of gene expression via translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis. The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 3'UTR is demonstrated. To validate the interaction miR-20a/3'UTR LRF miR-20a was over-expressed, either by transient transfection or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that other targets are cooperating. As LRF down-regulation/ p19ARF induction is always accompanied by E2F1 down-regulation and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF. Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of view the discovery of new physiological "senescence inducer'' appears to be promising as this molecule could be used as anticancer drug.	[Poliseno, Laura; Pitto, Letizia; Simili, Marcella; Mariani, Laura; Ciucci, Alessia; Rizzo, Milena; Evangelista, Monica; Mercatanti, Alberto; Rainaldi, Giuseppe] CNR, Inst Clin Physiol, Lab Gene & Mol, I-56100 Pisa, Italy; [Poliseno, Laura; Riccardi, Luisa; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Poliseno, Laura; Riccardi, Luisa; Pandolfi, Pier Paolo] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Rainaldi, Giuseppe] Ist Toscano Tumori, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Poliseno, L (corresponding author), CNR, Inst Clin Physiol, Lab Gene & Mol, Via Savi 8, I-56100 Pisa, Italy.	g.rainaldi@ifc.cnr.it	Pitto, Letizia/A-3070-2014; Rizzo, Milena/L-1481-2016; Poliseno, Laura/B-5711-2012	Pitto, Letizia/0000-0002-8660-9516; Rizzo, Milena/0000-0001-5924-8615; Mercatanti, Alberto/0000-0001-5110-9688; EVANGELISTA, MONICA/0000-0002-5674-8523; Poliseno, Laura/0000-0001-6557-955X	Associazione Italiana Ricerca sul Cancro (AIRC); NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by Associazione Italiana Ricerca sul Cancro (AIRC).	Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Eiriksdottir G, 1998, EUR J CANCER, V34, P2076, DOI 10.1016/S0959-8049(98)00241-X; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Iida S, 2004, ONCOGENE, V23, P5266, DOI 10.1038/sj.onc.1207623; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Liu CJ, 2004, J BIOL CHEM, V279, P47081, DOI 10.1074/jbc.M405288200; Lloyd AC, 2002, NAT CELL BIOL, V4, pE25, DOI 10.1038/ncb0202-e25; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Mason SL, 2002, ONCOGENE, V21, P4220, DOI 10.1038/sj.onc.1205524; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Park C, 2006, INT J MOL MED, V17, P715; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shao JY, 2002, CHINESE MED J-PEKING, V115, P571; SYLVESTRE Y, 2006, J BIOL CHEM; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; Tuccoli A, 2006, CELL CYCLE, V5, P2473, DOI 10.4161/cc.5.21.3422; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; WOODS K, 2006, J BIOL CHEM; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yogev O, 2006, J BIOL CHEM, V281, P34475, DOI 10.1074/jbc.M602865200	47	66	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2542	10.1371/journal.pone.0002542	http://dx.doi.org/10.1371/journal.pone.0002542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596985	gold, Green Published			2022-12-27	WOS:000263288200014
J	Traka, M; Gasper, AV; Melchini, A; Bacon, JR; Needs, PW; Frost, V; Chantry, A; Jones, AME; Ortori, CA; Barrett, DA; Ball, RY; Mills, RD; Mithen, RF				Traka, Maria; Gasper, Amy V.; Melchini, Antonietta; Bacon, James R.; Needs, Paul W.; Frost, Victoria; Chantry, Andrew; Jones, Alexandra M. E.; Ortori, Catharine A.; Barrett, David A.; Ball, Richard Y.; Mills, Robert D.; Mithen, Richard F.			Broccoli Consumption Interacts with GSTM1 to Perturb Oncogenic Signalling Pathways in the Prostate	PLOS ONE			English	Article								Background: Epidemiological studies suggest that people who consume more than one portion of cruciferous vegetables per week are at lower risk of both the incidence of prostate cancer and of developing aggressive prostate cancer but there is little understanding of the underlying mechanisms. In this study, we quantify and interpret changes in global gene expression patterns in the human prostate gland before, during and after a 12 month broccoli-rich diet. Methods and Findings: Volunteers were randomly assigned to either a broccoli-rich or a pea-rich diet. After six months there were no differences in gene expression between glutathione S-transferase mu 1 (GSTM1) positive and null individuals on the pea-rich diet but significant differences between GSTM1 genotypes on the broccoli-rich diet, associated with transforming growth factor beta 1 (TGF beta 1) and epidermal growth factor (EGF) signalling pathways. Comparison of biopsies obtained pre and post intervention revealed more changes in gene expression occurred in individuals on a broccoli-rich diet than in those on a pea-rich diet. While there were changes in androgen signalling, regardless of diet, men on the broccoli diet had additional changes to mRNA processing, and TGFb1, EGF and insulin signalling. We also provide evidence that sulforaphane (the isothiocyanate derived from 4-methylsuphinylbutyl glucosinolate that accumulates in broccoli) chemically interacts with TGFb1, EGF and insulin peptides to form thioureas, and enhances TGF beta 1/Smad-mediated transcription. Conclusions: These findings suggest that consuming broccoli interacts with GSTM1 genotype to result in complex changes to signalling pathways associated with inflammation and carcinogenesis in the prostate. We propose that these changes may be mediated through the chemical interaction of isothiocyanates with signalling peptides in the plasma. This study provides, for the first time, experimental evidence obtained in humans to support observational studies that diets rich in cruciferous vegetables may reduce the risk of prostate cancer and other chronic disease.	[Traka, Maria; Gasper, Amy V.; Melchini, Antonietta; Bacon, James R.; Needs, Paul W.; Mithen, Richard F.] Inst Food Res, Phytochem & Hlth Programme, Norwich, Norfolk, England; [Melchini, Antonietta] Univ Messina, Sch Pharm, Dept Farm Biol, Messina, Italy; [Frost, Victoria; Chantry, Andrew] Univ E Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Jones, Alexandra M. E.] Norwich Res Park, Sainsbury Lab, Norwich, Norfolk, England; [Ortori, Catharine A.; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analytical Biosci, Nottingham, England; [Ball, Richard Y.; Mills, Robert D.] Norfolk & Norwich Univ Hosp, Dept Histopathol Cytopathol, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Messina; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Nottingham; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Traka, M (corresponding author), Inst Food Res, Phytochem & Hlth Programme, Norwich Res Pk, Norwich, Norfolk, England.	Richard.Mithen@bbsrc.ac.uk	Barrett, David A/C-9922-2011; Jones, Alexandra/B-5227-2009	Barrett, David A/0000-0001-6900-9474; Jones, Alexandra/0000-0003-2571-8708; Traka, Maria/0000-0002-6592-5691; MELCHINI, ANTONIETTA/0000-0001-5256-2724; Mithen, Richard/0000-0001-7307-4324	Biotechnology and Biological Sciences Research Council, UK	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, UK. The sponsors had no role in the design and conduct of the study, analysis and interpretation of the results and did not review the manuscript prior to publication.	Agalliu I, 2006, PROSTATE, V66, P146, DOI 10.1002/pros.20305; Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Bello-DeOcampo D, 2003, CURR DRUG TARGETS, V4, P197, DOI 10.2174/1389450033491118; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Conaway CC, 2000, NUTR CANCER, V38, P168, DOI 10.1207/S15327914NC382_5; Cornelis MC, 2007, AM J CLIN NUTR, V86, P752, DOI 10.1093/ajcn/86.3.752; Covault J, 2003, BIOTECHNIQUES, V35, P594, DOI 10.2144/03353dd02; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fleshner N, 2007, CANCER-AM CANCER SOC, V110, P1889, DOI 10.1002/cncr.23009; Fowke JH, 2003, CANCER RES, V63, P3980; Gasper AV, 2007, J NUTR, V137, P1718, DOI 10.1093/jn/137.7.1718; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Joniau S, 2007, UROLOGY, V69, P1102, DOI 10.1016/j.urology.2007.02.063; Joseph MA, 2004, NUTR CANCER, V50, P206, DOI 10.1207/s15327914nc5002_11; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kim WR, 2006, NAT CLIN PRACT GASTR, V3, P482, DOI 10.1038/ncpgasthep0558; Kirsh VA, 2007, JNCI-J NATL CANCER I, V99, P1200, DOI 10.1093/jnci/djm065; Komiya Y, 2005, J CANCER RES CLIN, V131, P238, DOI 10.1007/s00432-004-0634-z; Kristal AR, 2002, NUTR CANCER, V42, P1, DOI 10.1207/S15327914NC421_1; Lampe JW, 2000, CANCER EPIDEM BIOMAR, V9, P787; Lin HJ, 1998, CANCER EPIDEM BIOMAR, V7, P647; Lorenzo Giuseppe Di, 2003, Clin Prostate Cancer, V2, P50; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; MEYER DJ, 1995, BIOCHEM J, V306, P565, DOI 10.1042/bj3060565; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Monti S, 2007, CURR PHARM DESIGN, V13, P719, DOI 10.2174/138161207780249128; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; NIJHOFF WA, 1995, CARCINOGENESIS, V16, P955, DOI 10.1093/carcin/16.4.955; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ntais C, 2005, CANCER EPIDEM BIOMAR, V14, P176; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; R Development Core Team, 2007, R LANG ENV STAT COMP; Rawel HM, 1998, J AGR FOOD CHEM, V46, P5103, DOI 10.1021/jf980244r; Rawel HM, 1998, J AGR FOOD CHEM, V46, P5043, DOI 10.1021/jf980245j; Sarikamis G, 2006, MOL BREEDING, V18, P219, DOI 10.1007/s11032-006-9029-y; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Spitz MR, 2000, CANCER EPIDEM BIOMAR, V9, P1017; Srivastava DSL, 2005, BJU INT, V95, P170, DOI 10.1111/j.1464-410X.2005.05271.x; van Poppel G, 1999, ADV EXP MED BIOL, V472, P159; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang LI, 2004, CANCER CAUSE CONTROL, V15, P977, DOI 10.1007/s10552-004-1093-1; Zhang YS, 2002, BIOCHEM J, V364, P301, DOI 10.1042/bj3640301; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhu B, 2005, CANC TREAT, V126, P157, DOI 10.1007/0-387-24361-5_7	51	110	115	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2568	10.1371/journal.pone.0002568	http://dx.doi.org/10.1371/journal.pone.0002568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596959	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200033
J	Xu, DZ; Zhao, K; Guo, LM; Chen, XY; Wang, HF; Zhang, JM; Xie, Q; Ren, H; Wang, WX; Li, LJ; Xu, M; Liu, P; Niu, JQ; Bai, XF; Shen, XL; Yuan, ZH; Wang, XY; Wen, YM				Xu, Dao-Zhen; Zhao, Kai; Guo, Li-Min; Chen, Xin-Yue; Wang, Hui-Fen; Zhang, Ji-Ming; Xie, Qin; Ren, Hong; Wang, Wen-Xiang; Li, Lan-Juan; Xu, Min; Liu, Pei; Niu, Jun-Qi; Bai, Xue-Fan; Shen, Xin-Liang; Yuan, Zheng-Hong; Wang, Xuan-Yi; Wen, Yu-Mei			A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients	PLOS ONE			English	Article							SURFACE-ANTIGEN; IMMUNE-COMPLEXES; DENDRITIC CELLS; VIRUS-INFECTION; RESPONSES; IMMUNIZATION; PROTEINS; EFFICACY; HBV	Background: The safety of the immune complexes composed of yeast-derived hepatitis B surface antigen (HBsAg) and antibodies (abbreviated as YIC) among healthy adults and chronic hepatitis B patients has been proved in phase I and phase IIa trial. A larger number of patients for study of dosage and efficacy are therefore needed. Methods and Principal Findings: Two hundred forty two HBeAg-positive chronic hepatitis B patients were immunized with six injections of either 30 mg YIC, 60 mg of YIC or alum adjuvant as placebo at four-week intervals under code. HBV markers and HBV DNA were monitored during immunization and 24 weeks after the completion of immunization. The primary endpoint was defined as loss of HBeAg, or presence of anti-HBe antibody or suppression of HBV DNA, while the secondary endpoint was both HBeAg seroconversion and suppression of HBV DNA. Statistical significance was not reached in primary endpoints four weeks after the end of treatment among three groups, however, at the end of follow-up, HBeAg seroconversion rate was 21.8%(17/78) and 9% (7/78) in the 60 mg YIC and placebo groups respectively (p = 0.03), with 95% confidence intervals at 1.5% to 24.1%. Using generalized estimating equations (GEEs) model, a significant difference of group effects was found between 60 mg YIC and the placebo groups in terms of the primary endpoint. Eleven serious adverse events occurred, which were 5.1%, 3.6%, and 5.0% in the placebo, 30 mg YIC and 60 mg YIC groups respectively (p > 0.05). Conclusions: Though statistical differences in the preset primary and secondary endpoints among the three groups were not reached, a late and promising HBeAg seroconversion effect was shown in the 60 mg YIC immunized regimen. By increasing the number of patients and injections, the therapeutic efficacy of YIC in chronic hepatitis B patients will be further evaluated.	[Xu, Dao-Zhen; Guo, Li-Min] Ditan Hosp, Beijing, Peoples R China; [Zhao, Kai; Shen, Xin-Liang] Beijing Inst Vaccine & Biol Products, Beijing, Peoples R China; [Chen, Xin-Yue] Capital Med Univ, You An Hosp, Beijing, Peoples R China; [Wang, Hui-Fen] Mil Hosp 302, Beijing, Peoples R China; [Zhang, Ji-Ming] Fudan Univ, Hua Shan Hosp, Shanghai, Peoples R China; [Xie, Qin] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai, Peoples R China; [Ren, Hong] Chongqing Med Univ, Second affiliated hosp, Chongqing, Peoples R China; [Wang, Wen-Xiang] Chongqing Med Univ, First affiliated hosp, Chongqing, Peoples R China; [Li, Lan-Juan] Zhejiang Univ, First affiliated hosp, Hangzhou, Peoples R China; [Xu, Min] Guangzhou Eighth Hosp, Guangzhou, Peoples R China; [Liu, Pei] China Med Univ, Second Hosp Affiliated, Shenyang, Peoples R China; [Niu, Jun-Qi] Jilin Univ, First affiliated hosp, Changchun, Peoples R China; [Bai, Xue-Fan] Fourth Mil Med Univ, Tangdu Hosp, Xian, Peoples R China; [Yuan, Zheng-Hong; Wang, Xuan-Yi; Wen, Yu-Mei] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai, Peoples R China; [Wang, Xuan-Yi] Fudan Univ, Inst Biol Sci, Shanghai, Peoples R China	Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital; Fudan University; Shanghai Jiao Tong University; Chongqing Medical University; Chongqing Medical University; Zhejiang University; China Medical University; Jilin University; Air Force Military Medical University; Fudan University; Fudan University	Xu, DZ (corresponding author), Ditan Hosp, Beijing, Peoples R China.	ymwen@shmu.edu.cn	chen, xinyue/HHR-9308-2022; wen, yu/AAJ-7482-2021		State high Technology, China [2002AA2Z3303, 2004AA2Z3970]; Shanghai Municipal Government Commission of Science and Technology [G 1999054105]	State high Technology, China; Shanghai Municipal Government Commission of Science and Technology	This work was supported by grants from State high Technology Grant from China (2002AA2Z3303 and 2004AA2Z3970), Shanghai Municipal Government Commission of Science and Technology (Grant number G 1999054105).	Akbar SMF, 2004, HEPATOL RES, V29, P136, DOI 10.1016/j.hepres.2004.03.003; Bertoletti A, 2003, HEPATOLOGY, V38, P4, DOI 10.1053/jhep.2003.50310; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; BROWN SE, 1984, LANCET, V2, P184; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; COHEN J, 1994, SCIENCE, V264, P503, DOI 10.1126/science.8160009; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Heathcote J, 1999, HEPATOLOGY, V30, P531, DOI 10.1002/hep.510300208; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; Mancini M, 1996, P NATL ACAD SCI USA, V93, P12496, DOI 10.1073/pnas.93.22.12496; Mancini-Bourgine M, 2006, VACCINE, V24, P4482, DOI 10.1016/j.vaccine.2005.08.013; MICHALAK T, 1978, AM J PATHOL, V90, P619; Pancholi P, 2001, HEPATOLOGY, V33, P448, DOI 10.1053/jhep.2001.21594; POL S, 1994, LANCET, V344, P342, DOI 10.1016/S0140-6736(94)91384-6; Pol S, 2006, EXPERT REV VACCINES, V5, P707, DOI 10.1586/14760584.5.5.707; RANDALL RE, 1988, J GEN VIROL, V69, P2517, DOI 10.1099/0022-1317-69-10-2517; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Schuurhuis DH, 2006, J IMMUNOL, V176, P4573, DOI 10.4049/jimmunol.176.8.4573; Schuurhuis DH, 2002, J IMMUNOL, V168, P2240, DOI 10.4049/jimmunol.168.5.2240; Sprengers D, 2005, FUND CLIN PHARMACOL, V19, P17, DOI 10.1111/j.1472-8206.2004.00300.x; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Wen F, 2003, HEPATOLOGY, V38, p236A; Yao Guang-Bi, 2004, Hepatobiliary Pancreat Dis Int, V3, P188; Yao X, 2007, VACCINE, V25, P1771, DOI 10.1016/j.vaccine.2006.11.019; Yuen MF, 2001, HEPATOLOGY, V34, P139, DOI 10.1053/jhep.2001.25273; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zheng BJ, 2004, J VIRAL HEPATITIS, V11, P217, DOI 10.1111/j.1365-2893.2004.00497.x; Zheng BJ, 2001, VACCINE, V19, P4219, DOI 10.1016/S0264-410X(01)00158-X	30	89	106	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2565	10.1371/journal.pone.0002565	http://dx.doi.org/10.1371/journal.pone.0002565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596958	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200030
J	Janic, B; Iskander, ASM; Rad, AM; Soltanian-Zadeh, H; Arbab, AS				Janic, Branislava; Iskander, A. S. M.; Rad, Ali M.; Soltanian-Zadeh, Hamid; Arbab, Ali S.			Effects of Ferumoxides - Protamine Sulfate Labeling on Immunomodulatory Characteristics of Macrophage-like THP-1 Cells	PLOS ONE			English	Article								Superparamagnetic Iron Oxide (SPIO) complexed with cationic transfection agent is used to label various mammalian cells. Labeled cells can then be utilized as an in vivo magnetic resonance imaging (MRI) probes. However, certain number of in vivo administered labeled cells may be cleared from tissues by the host's macrophages. For successful translation to routine clinical application of SPIO labeling method it is important that this mode of in vivo clearance of iron does not elicit any diverse immunological effects. The purpose of this study was to demonstrate that SPIO agent ferumoxides-protamine sulfate (FePro) incorporation into macrophages does not alter immunological properties of these cells with regard to differentiation, chemotaxis, and ability to respond to the activation stimuli and to modulate T cell response. We used THP-1 cell line as a model for studying macrophage cell type. THP-1 cells were magnetically labeled with FePro, differentiated with 100 nM of phorbol ester, 12-Myristate-13-acetate (TPA) and stimulated with 100 ng/ml of LPS. The results showed 1) FePro labeling had no effect on the changes in morphology and expression of cell surface proteins associated with TPA induced differentiation; 2) FePro labeled cells responded to LPS with slightly higher levels of NFkB pathway activation, as shown by immunobloting; TNF-alpha secretion and cell surface expression levels of CD54 and CD83 activation markers, under these conditions, were still comparable to the levels observed in non-labeled cells; 3) FePro labeling exhibited differential, chemokine dependent, effect on THP-1 chemotaxis with a decrease in cell directional migration to MCP-1; 4) FePro labeling did not affect the ability of THP-1 cells to down-regulate T cell expression of CD4 and CD8 and to induce T cell proliferation. Our study demonstrated that intracellular incorporation of FePro complexes does not alter overall immunological properties of THP-1 cells. The described experiments provide the model for studying the effects of in vivo clearance of iron particles via incorporation into the host's macrophages that may follow after in vivo application of any type of magnetically labeled mammalian cells. To better mimic the complex in vivo scenario, this model may be further exploited by introducing additional cellular and biological, immunologically relevant, components.	[Janic, Branislava; Iskander, A. S. M.; Rad, Ali M.; Soltanian-Zadeh, Hamid; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022; Arbab, Ali/AAS-1933-2020	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; 	NIH [R01-EB002450, R21-NS058589, R01-CA122031]; NATIONAL CANCER INSTITUTE [R01CA122031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants R01-EB002450, R21-NS058589 and R01-CA122031	Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Akasaka K, 2005, J VASC SURG, V41, P517, DOI 10.1016/j.jvs.2004.12.043; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX J, 1992, LEUKEMIA RES, V16, P317, DOI 10.1016/0145-2126(92)90070-N; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Conti P, 1998, ALLERGY ASTHMA PROC, V19, P121, DOI 10.2500/108854198778604176; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Czerniecki BJ, 2001, CRIT REV IMMUNOL, V21, P157; DI MP, 1994, J EXP MED, V179, P1731; Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Hawiger J, 1999, BLOOD, V94, P1711, DOI 10.1182/blood.V94.5.1711.417k20_1711_1716; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; JAMALI I, 1992, J IMMUNOL, V148, P1613; Janic B, 2005, AM J PHYSIOL-LUNG C, V288, pL317, DOI 10.1152/ajplung.00125.2004; Jones MA, 2003, INFECT IMMUN, V71, P2626, DOI 10.1128/IAI.71.5.2626-2633.2003; Kemp K, 2001, J INTERF CYTOK RES, V21, P503, DOI 10.1089/10799900152434376; Kremlev SG, 1997, AM J PHYSIOL-LUNG C, V272, pL996, DOI 10.1152/ajplung.1997.272.5.L996; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094; POULIQUEN D, 1991, MAGN RESON IMAGING, V9, P275, DOI 10.1016/0730-725X(91)90412-F; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Raynal I, 2004, INVEST RADIOL, V39, P56, DOI 10.1097/01.rli.0000101027.57021.28; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Schwende H, 1997, ADV EXP MED BIOL, V407, P491; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; SHACKELFORD DA, 1982, IMMUNOL REV, V66, P133, DOI 10.1111/j.1600-065X.1982.tb00437.x; Siglienti I, 2006, J NEUROIMMUNOL, V173, P166, DOI 10.1016/j.jneuroim.2005.11.011; Slavik JM, 1999, IMMUNOL RES, V19, P1, DOI 10.1007/BF02786473; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; STEIN M, 1991, EUR J IMMUNOL, V21, P431, DOI 10.1002/eji.1830210227; TVEDE N, 1988, SCAND J IMMUNOL, V27, P679, DOI 10.1111/j.1365-3083.1988.tb02401.x; VanGool SW, 1996, IMMUNOL REV, V153, P47; WANG JM, 1993, J EXP MED, V177, P699, DOI 10.1084/jem.177.3.699; Yano S, 2005, ENDOCRINOLOGY, V146, P2324, DOI 10.1210/en.2005-0065; Zhang Y, 2005, APOPTOSIS, V10, P545, DOI 10.1007/s10495-005-1885-0	46	20	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2499	10.1371/journal.pone.0002499	http://dx.doi.org/10.1371/journal.pone.0002499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575575	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000022
J	Jiang, HY; Patel, JJ; Yi, M; Mu, JB; Ding, JH; Stephens, R; Cooper, RA; Ferdig, MT; Su, XZ				Jiang, Hongying; Patel, Jigar J.; Yi, Ming; Mu, Jianbing; Ding, Jinhui; Stephens, Robert; Cooper, Roland A.; Ferdig, Michael T.; Su, Xin-zhuan			Genome-Wide Compensatory Changes Accompany Drug-Selected Mutations in the Plasmodium falciparum crt Gene	PLOS ONE			English	Article							CHLOROQUINE-RESISTANCE TRANSPORTER; TRANSMEMBRANE PROTEIN PFCRT; DIGESTIVE VACUOLAR PH; MALARIA PARASITES; LINKAGE DISEQUILIBRIUM; MEFLOQUINE RESISTANCE; ANTIBIOTIC-RESISTANCE; PFMDR1 GENE; QUININE; SENSITIVITY	Mutations in PfCRT (Plasmodium falciparum chloroquine-resistant transporter), particularly the substitution at amino acid position 76, confer chloroquine (CQ) resistance in P. falciparum. Point mutations in the homolog of the mammalian multidrug resistance gene (pfmdr1) can also modulate the levels of CQ response. Moreover, parasites with the same pfcrt and pfmdr1 alleles exhibit a wide range of drug sensitivity, suggesting that additional genes contribute to levels of CQ resistance (CQR). Reemergence of CQ sensitive parasites after cessation of CQ use indicates that changes in PfCRT are deleterious to the parasite. Some CQR parasites, however, persist in the field and grow well in culture, which may reflect adaptive changes in the parasite genome to compensate for the mutations in PfCRT. Using three isogenic clones that have different drug resistance profiles corresponding to unique mutations in the pfcrt gene (106/1(K76), 106/1(76I), and 106/(76I-352K)), we investigated changes in gene expression in these parasites grown with and without CQ. We also conducted hybridizations of genomic DNA to identify copy number (CN) changes in parasite genes. RNA transcript levels from 45 genes were significantly altered in one or both mutants relative to the parent line, 106/1(K76). Most of the up-regulated genes are involved in invasion, cell growth and development, signal transduction, and transport activities. Of particular interest are genes encoding proteins involved in transport and/or regulation of cytoplasmic or compartmental pH such as the V-type H+ pumping pyrophosphatase 2 (PfVP2), Ca2+/H+ antiporter VCX1, a putative drug transporter and CN changes in pfmdr1. These changes may represent adaptations to altered functionality of PfCRT, a predicted member of drug/metabolite transporter superfamily found on the parasite food vacuole (FV) membrane. Further investigation of these genes may shed light on how the parasite compensates for functional changes accompanying drug resistance mutations in a gene coding for a membrane/drug transporter.	[Jiang, Hongying; Mu, Jianbing; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Patel, Jigar J.; Ferdig, Michael T.] Univ Notre Dame, Ctr Glob Hlth & Infect Dis, Dept Biol Sci, Notre Dame, IN USA; [Yi, Ming; Stephens, Robert] NCI Frederick, Advanced Biomed Comput Ctr, Frederick, MD USA; [Ding, Jinhui] NIH, NIA, Lab Neurogenet, Bioinformat Unit, Bethesda, MD USA; [Cooper, Roland A.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Notre Dame; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Old Dominion University	Jiang, HY (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ferdig.1@nd.edu; xsu@niaid.nih.gov	Ferdig, Michael/C-6627-2016	Su, Xinzhuan/0000-0003-3246-3248; Yi, Ming/0000-0001-9098-1364	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI071121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, R01AI071121] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. MTF and RAC are supported by NIH grant AI071121.	Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; Allen JD, 2000, CANCER RES, V60, P5761; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; BOLSTAD BM, 2005, STAT BIOL HLTH; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Chen NH, 2002, J INFECT DIS, V185, P405, DOI 10.1086/338470; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2005, MOL MICROBIOL, V57, P874, DOI 10.1111/j.1365-2958.2005.04748.x; Duraisingh MT, 2000, PARASITOLOGY, V121, P1, DOI 10.1017/S0031182099006022; Dzekunov SM, 2000, MOL BIOCHEM PARASIT, V110, P107, DOI 10.1016/S0166-6851(00)00261-9; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gaur D, 2003, INFECT IMMUN, V71, P6742, DOI 10.1128/IAI.71.12.6742-6746.2003; Gligorijevic B, 2008, MOL BIOCHEM PARASIT, V159, P7, DOI 10.1016/j.molbiopara.2007.12.014; Hastings IM, 2002, SCIENCE, V298, P74, DOI 10.1126/science.1077573; Hayton K., 2004, Current Drug Targets - Infectious Disorders, V4, P1, DOI 10.2174/1568005043480925; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Levin BR, 2000, GENETICS, V154, P985; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P355, DOI 10.1046/j.1365-2958.2002.03173.x; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; McIntosh MT, 2002, INT J PARASITOL, V32, P1, DOI 10.1016/S0020-7519(01)00325-3; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Nessler S, 2004, J BIOL CHEM, V279, P39438, DOI 10.1074/jbc.M404671200; Ouellette Marc, 1994, Trends in Microbiology, V2, P407, DOI 10.1016/0966-842X(94)90620-3; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Warhurst DC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-31; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	60	66	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2484	10.1371/journal.pone.0002484	http://dx.doi.org/10.1371/journal.pone.0002484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575593	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000014
J	Zafarmand, MH; van der Schouw, YT; Grobbee, DE; de Leeuw, PW; Bots, ML				Zafarmand, Mohammad Hadi; van der Schouw, Yvonne T.; Grobbee, Diederick E.; de Leeuw, Peter W.; Bots, Michiel L.			The M235T Polymorphism in the AGT Gene and CHD Risk: Evidence of a Hardy-Weinberg Equilibrium Violation and Publication Bias in a Meta-Analysis	PLOS ONE			English	Article								Background: The M235T polymorphism in the AGT gene has been related to an increased risk of hypertension. This finding may also suggest an increased risk of coronary heart disease (CHD). Methodology/Principal Findings: A case-cohort study was conducted in 1,732 unrelated middle-age women (210 CHD cases and 1,522 controls) from a prospective cohort of 15,236 initially healthy Dutch women. We applied a Cox proportional hazards model to study the association of the polymorphism with acute myocardial infarction (AMI) (n = 71) and CHD. In the case-cohort study, no increased risk for CHD was found under the additive genetic model (hazard ratio [HR] = 1.20; 95% confidence interval [CI], 0.86 to 1.68; P = 0.28). This result was not changed by adjustment (HR = 1.17; 95% CI, 0.83 to 1.64; P = 0.38) nor by using dominant, recessive and pairwise genetic models. Analyses for AMI risk under the additive genetic model also did not show any statistically significant association (crude HR = 1.14; 95% CI, 0.93 to 1.39; P = 0.20). To evaluate the association, a comprehensive systematic review and meta-analysis were undertaken of all studies published up to February 2007 (searched through PubMed/MEDLINE, Web of Science and EMBASE). The meta-analysis (38 studies with 13284 cases and 18722 controls) showed a per-allele odds ratio (OR) of 1.08 (95% CI, 1.01 to 1.15; P = 0.02). Moderate to large levels of heterogeneity were identified between studies. Hardy-Weinberg equilibrium (HWE) violation and the mean age of cases were statistically significant sources of the observed variation. In a stratum of non-HWE violation studies, there was no effect. An asymmetric funnel plot, the Egger's test (P = 0.066), and the Begg-Mazumdar test (P = 0.074) were all suggestive of the presence of publication bias. Conclusions/Significance: The pooled OR of the present meta-analysis, including our own data, presented evidence that there is an increase in the risk of CHD conferred by the M235T variant of the AGT gene. However, the relevance of this weakly positive overall association remains uncertain because it may be due to various residual biases, including HWE-violation and publication biases.	[Zafarmand, Mohammad Hadi] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Zafarmand, Mohammad Hadi; van der Schouw, Yvonne T.; Grobbee, Diederick E.; Bots, Michiel L.] Bushehr Univ Med Sci & Hlth Serv, Persian Gulf Hlth Res Ctr, Bushehr, Iran; [de Leeuw, Peter W.] Univ Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC)	Zafarmand, MH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.l.bots@umcutrecht.nl	de Leeuw, Peter W./J-4552-2016; Grobbee, Diederick/C-7651-2014; van der Schouw, Yvonne T./F-8327-2014	de Leeuw, Peter W./0000-0002-4949-5812; Grobbee, Diederick/0000-0003-4472-4468; van der Schouw, Yvonne T./0000-0002-4605-435X	Iranian Ministry of Health and Medical Education [FN12265]; "Europe Against Cancer" Programme of the European Commission (SANCO)	Iranian Ministry of Health and Medical Education; "Europe Against Cancer" Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre)	The first author has been supported by a grant from the Iranian Ministry of Health and Medical Education (FN12265). The Prospect-EPIC study was funded by "Europe Against Cancer" Programme of the European Commission (SANCO). There are no financial or other relationships that might lead to a conflict of interest.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; Araujo MA, 2005, INT J CARDIOL, V103, P27, DOI 10.1016/j.ijcard.2004.07.009; Batalla A, 2000, CLIN CHEM, V46, P1910; Berdeli A, 2005, CLIN CHIM ACTA, V351, P87, DOI 10.1016/j.cccn.2004.08.015; Bis JC, 2003, AM J HYPERTENS, V16, P1011, DOI 10.1016/j.amjhyper.2003.07.018; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; Buraczynska Monika, 2003, Kardiol Pol, V58, P1; CAULFIELD M, 1995, J CLIN INVEST, V96, P687, DOI 10.1172/JCI118111; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Cong ND, 1998, AM J MED SCI, V316, P339, DOI 10.1016/S0002-9629(15)40436-7; Ermis C, 2002, THROMB HAEMOSTASIS, V88, P693, DOI 10.1055/s-0037-1613281; Fatini C, 2000, EUR HEART J, V21, P633, DOI 10.1053/euhj.1999.1738; Fernandez-Arcas N, 2001, CLIN GENET, V60, P52, DOI 10.1034/j.1399-0004.2001.600108.x; Fernandez-Arcas N, 1999, ATHEROSCLEROSIS, V145, P293, DOI 10.1016/S0021-9150(99)00080-5; Fomicheva EV, 2000, MOL GENET METAB, V69, P76, DOI 10.1006/mgme.1999.2924; Frossard PM, 1998, CLIN GENET, V54, P285, DOI 10.1034/j.1399-0004.1998.5440405.x; Gardemann A, 1999, ATHEROSCLEROSIS, V145, P309, DOI 10.1016/S0021-9150(99)00082-9; Goldenberg I, 2006, HYPERTENSION, V48, P693, DOI 10.1161/01.HYP.0000239204.41079.6b; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooper WC, 2002, AM J HEMATOL, V70, P1, DOI 10.1002/ajh.10078; Ichihara S, 1997, AM HEART J, V134, P260, DOI 10.1016/S0002-8703(97)70133-9; ISHIGAMI T, 1995, CIRCULATION, V91, P951, DOI 10.1161/01.CIR.91.4.951; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Ko YL, 1997, HUM GENET, V100, P210, DOI 10.1007/s004390050492; Krizanova O, 1997, PHYSIOL RES, V46, P357; Lanz JR, 2005, CLIN CHIM ACTA, V362, P176, DOI 10.1016/j.cccn.2005.06.004; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Ludwig EH, 1997, ANN EPIDEMIOL, V7, P3, DOI 10.1016/S1047-2797(96)00105-6; Methot J, 2005, INT J CARDIOL, V105, P308, DOI 10.1016/j.ijcard.2005.02.040; Nair KG, 2003, J CLIN LAB ANAL, V17, P141, DOI 10.1002/jcla.10084; Ntzani EE, 2007, AM J EPIDEMIOL, V165, P973, DOI 10.1093/aje/kwk085; Olivieri O, 2001, J HYPERTENS, V19, P879, DOI 10.1097/00004872-200105000-00007; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Ortlepp Jan R., 2002, Eur J Intern Med, V13, P485, DOI 10.1016/S0953-6205(02)00182-6; Paillard F, 1999, HYPERTENSION, V34, P423, DOI 10.1161/01.HYP.34.3.423; Petrovic D, 2001, ANGIOLOGY, V52, P247, DOI 10.1177/000331970105200403; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Ranjith N, 2004, Cardiovasc J S Afr, V15, P22; Reinhardt D, 2000, PHARMAZIE, V55, P69; Renner W, 2005, J MOL MED, V83, P235, DOI 10.1007/s00109-004-0618-0; Rodriguez-Perez JC, 2001, J AM COLL CARDIOL, V37, P1536, DOI 10.1016/S0735-1097(01)01186-X; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Sekuri C, 2005, J RENIN-ANGIO-ALDO S, V6, P38, DOI 10.3317/jraas.2005.005; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Sethi AA, 2003, HYPERTENSION, V41, P1202, DOI 10.1161/01.HYP.0000072334.34433.17; Sethi AA, 2001, ANN INTERN MED, V134, P941, DOI 10.7326/0003-4819-134-10-200105150-00008; Sheu WHH, 1998, AM HEART J, V136, P125, DOI 10.1016/S0002-8703(98)70192-9; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; Tiret L, 1998, J HYPERTENS, V16, P37, DOI 10.1097/00004872-199816010-00007; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Tsai CT, 2007, ATHEROSCLEROSIS, V195, P172, DOI 10.1016/j.atherosclerosis.2006.09.014; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wenzel K, 1997, J MOL MED-JMM, V75, P57, DOI 10.1007/s001090050087; Wierzbicki AS, 2000, HYPERTENSION, V36, P808, DOI 10.1161/01.HYP.36.5.808; Winkelmann BR, 1999, AM HEART J, V137, P698, DOI 10.1016/S0002-8703(99)70226-7; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; YAMAKAWAKOBAYASHI K, 1995, LANCET, V346, P515, DOI 10.1016/S0140-6736(95)91369-6; Zafarmand MH, 2008, J INTERN MED, V263, P79, DOI 10.1111/j.1365-2796.2007.01876.x; Zee RYL, 2006, J THROMB HAEMOST, V4, P341, DOI 10.1111/j.1538-7836.2006.01754.x	64	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2533	10.1371/journal.pone.0002533	http://dx.doi.org/10.1371/journal.pone.0002533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575631	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000047
J	Cross, A; Collard, M; Nelson, A				Cross, Alan; Collard, Mark; Nelson, Andrew			Body Segment Differences in Surface Area, Skin Temperature and 3D Displacement and the Estimation of Heat Balance during Locomotion in Hominins	PLOS ONE			English	Article							OPEN EQUATORIAL ENVIRONMENTS; THERMOREGULATORY ADVANTAGES; WATER BUDGETS; BIPEDALISM; ENERGY; WARM	The conventional method of estimating heat balance during locomotion in humans and other hominins treats the body as an undifferentiated mass. This is problematic because the segments of the body differ with respect to several variables that can affect thermoregulation. Here, we report a study that investigated the impact on heat balance during locomotion of inter-segment differences in three of these variables: surface area, skin temperature and rate of movement. The approach adopted in the study was to generate heat balance estimates with the conventional method and then compare them with heat balance estimates generated with a method that takes into account inter-segment differences in surface area, skin temperature and rate of movement. We reasoned that, if the hypothesis that inter-segment differences in surface area, skin temperature and rate of movement affect heat balance during locomotion is correct, the estimates yielded by the two methods should be statistically significantly different. Anthropometric data were collected on seven adult male volunteers. The volunteers then walked on a treadmill at 1.2 m/s while 3D motion capture cameras recorded their movements. Next, the conventional and segmented methods were used to estimate the volunteers' heat balance while walking in four ambient temperatures. Lastly, the estimates produced with the two methods were compared with the paired t-test. The estimates of heat balance during locomotion yielded by the two methods are significantly different. Those yielded by the segmented method are significantly lower than those produced by the conventional method. Accordingly, the study supports the hypothesis that inter-segment differences in surface area, skin temperature and rate of movement impact heat balance during locomotion. This has important implications not only for current understanding of heat balance during locomotion in hominins but also for how future research on this topic should be approached.	[Cross, Alan; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada; [Nelson, Andrew] Univ Western Ontario, Dept Anthropol, London, ON, Canada	Simon Fraser University; Western University (University of Western Ontario)	Cross, A (corresponding author), Simon Fraser Univ, Dept Archaeol, Lab Human Evolutionary Studies, Burnaby, BC V5A 1S6, Canada.	agc6@sfu.ca	Nelson, Andrew J/B-9090-2015	Collard, Mark/0000-0002-2725-4989	SSHRC-CGS [766-2004-0723, 767-2006-1902]; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Simon Fraser University	SSHRC-CGS; Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University	This research was funded by SSHRC-CGS# 766-2004-0723, SSHRC-CGS# 767-2006-1902, the Canada Research Chairs Program, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University. Funding bodies had no role in the study or the preparation of the manuscript.	Anderson GS, 1999, INT J BIOMETEOROL, V43, P99, DOI 10.1007/s004840050123; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; Buono RJ, 2000, J THERM BIOL, V25, P263, DOI 10.1016/S0306-4565(99)00095-9; CHAPLIN G, 1994, J HUM EVOL, V27, P497, DOI 10.1006/jhev.1994.1066; Dennis SC, 1999, EUR J APPL PHYSIOL, V79, P280, DOI 10.1007/s004210050507; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Gordon C.C., 1989, 1988 ANTHROPOMETRIC; HOUDAS REF, 1982, HUMAN BODY TEMPERATU; Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003; Marino FE, 2000, PFLUG ARCH EUR J PHY, V441, P359, DOI 10.1007/s004240000432; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Nielsen B, 1996, MED SCI SPORT EXER, V28, P665, DOI 10.1097/00005768-199606000-00004; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; WHEELER PE, 1994, J HUM EVOL, V27, P511, DOI 10.1006/jhev.1994.1067; WHEELER PE, 1991, J HUM EVOL, V21, P107, DOI 10.1016/0047-2484(91)90002-D; WHEELER PE, 1993, J HUM EVOL, V24, P13, DOI 10.1006/jhev.1993.1003; WHEELER PE, 1994, J HUM EVOL, V26, P339, DOI 10.1006/jhev.1994.1021; WHEELER PE, 1991, J HUM EVOL, V21, P117, DOI 10.1016/0047-2484(91)90003-E; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65	19	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2464	10.1371/journal.pone.0002464	http://dx.doi.org/10.1371/journal.pone.0002464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560580	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700045
J	Dylla, SJ; Beviglia, L; Park, IK; Chartier, C; Raval, J; Ngan, L; Pickell, K; Aguilar, J; Lazetic, S; Smith-Berdan, S; Clarke, MF; Hoey, T; Lewicki, J; Gurney, AL				Dylla, Scott J.; Beviglia, Lucia; Park, In-Kyung; Chartier, Cecile; Raval, Janak; Ngan, Lucy; Pickell, Kellie; Aguilar, Jorge; Lazetic, Sasha; Smith-Berdan, Stephanie; Clarke, Michael F.; Hoey, Tim; Lewicki, John; Gurney, Austin L.			Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy	PLOS ONE			English	Article								Background: Patients generally die of cancer after the failure of current therapies to eliminate residual disease. A subpopulation of tumor cells, termed cancer stem cells (CSC), appears uniquely able to fuel the growth of phenotypically and histologically diverse tumors. It has been proposed, therefore, that failure to effectively treat cancer may in part be due to preferential resistance of these CSC to chemotherapeutic agents. The subpopulation of human colorectal tumor cells with an ESA(+) CD44(+) phenotype are uniquely responsible for tumorigenesis and have the capacity to generate heterogeneous tumors in a xenograft setting (i.e. CoCSC). We hypothesized that if non-tumorigenic cells are more susceptible to chemotherapeutic agents, then residual tumors might be expected to contain a higher frequency of CoCSC. Methods and Findings: Xenogeneic tumors initiated with CoCSC were allowed to reach,400 mm 3, at which point mice were randomized and chemotherapeutic regimens involving cyclophosphamide or Irinotecan were initiated. Data from individual tumor phenotypic analysis and serial transplants performed in limiting dilution show that residual tumors are enriched for cells with the CoCSC phenotype and have increased tumorigenic cell frequency. Moreover, the inherent ability of residual CoCSC to generate tumors appears preserved. Aldehyde dehydrogenase 1 gene expression and enzymatic activity are elevated in CoCSC and using an in vitro culture system that maintains CoCSC as demonstrated by serial transplants and lentiviral marking of single cell-derived clones, we further show that ALDH1 enzymatic activity is a major mediator of resistance to cyclophosphamide: a classical chemotherapeutic agent. Conclusions: CoCSC are enriched in colon tumors following chemotherapy and remain capable of rapidly regenerating tumors from which they originated. By focusing on the biology of CoCSC, major resistance mechanisms to specific chemotherapeutic agents can be attributed to specific genes, thereby suggesting avenues for improving cancer therapy.	[Dylla, Scott J.; Beviglia, Lucia; Park, In-Kyung; Chartier, Cecile; Raval, Janak; Ngan, Lucy; Pickell, Kellie; Aguilar, Jorge; Lazetic, Sasha; Smith-Berdan, Stephanie; Hoey, Tim; Lewicki, John; Gurney, Austin L.] OncoMed Pharmaceut Inc, Redwood City, CA USA; [Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA USA	Stanford University	Dylla, SJ (corresponding author), OncoMed Pharmaceut Inc, Redwood City, CA USA.	mnscott11@yahoo.com						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2007, CELLS TISSUES ORGANS, V185, P29, DOI 10.1159/000101300; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Boddy AV, 2000, CLIN PHARMACOKINET, V38, P291, DOI 10.2165/00003088-200038040-00001; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Corti S, 2006, HUM MOL GENET, V15, P167, DOI 10.1093/hmg/ddi446; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Fallon P, 2003, BRIT J HAEMATOL, V122, P99, DOI 10.1046/j.1365-2141.2003.04357.x; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huff CA, 2006, EUR J CANCER, V42, P1293, DOI 10.1016/j.ejca.2006.01.045; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; MAHMOUD MIE, 1993, ALCOHOL CLIN EXP RES, V17, P1223, DOI 10.1111/j.1530-0277.1993.tb05233.x; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Moreb JS, 2005, J PHARMACOL EXP THER, V312, P339, DOI 10.1124/jpet.104.072496; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Polyak K, 2007, STEM CELL REV, V3, P107, DOI 10.1007/s12015-007-0020-8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Russo J E, 1989, Prog Clin Biol Res, V290, P65; Russo JE, 1997, ADV EXP MED BIOL, V414, P217; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sladek NE, 1999, CURR PHARM DESIGN, V5, P607; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Staud F, 2005, INT J BIOCHEM CELL B, V37, P720, DOI 10.1016/j.biocel.2004.11.004; Tallman MS, 2004, SEMIN HEMATOL, V41, P27, DOI 10.1053/j.seminhematol.2004.02.004; Thompson MA, 1998, CANCER RES, V58, P5168; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023	49	455	501	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2428	10.1371/journal.pone.0002428	http://dx.doi.org/10.1371/journal.pone.0002428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560594	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700013
J	Ma, YQ; Malbon, CC; Williams, DL; Thorngate, FE				Ma, Yanqing; Malbon, Craig C.; Williams, David L.; Thorngate, Fayanne E.			Altered Gene Expression in Early Atherosclerosis Is Blocked by Low Level Apolipoprotein E	PLOS ONE			English	Article								Background: Mice deficient in apolipoprotein E (apoE(-/-)) develop atherosclerosis. The possible linkage between expression of adhesion molecules/cofactors and atherosclerosis was probed at the level of mRNA and protein expression. The hypothesis of a linkage between changes of adhesion molecules/cofactors and atherosclerosis was tested further by suppression of aortic lesion formation in apoE(-/)-mice by expression of very low levels of transgenic apolipoprotein E. Methodology/Principal Findings: We show that at 8.5 months of age, the apoE(-/)-mice display elevated expression of mRNA for LFA-1, MAC-1, VCAM-1, ICAM-1, and for CD44, as well as MCP-1, cathepsin B, and COX-2 (but not that for eNOS) in atherosclerotic aortic arches. At earlier age, (10-13 week old) apoE 2/2 mice already display elevated expression of mRNA of CD44, LFA-1, MAC-1, VCAM-1, ICAM-1, cathepsin, and of COX-2 in lesioned aortic arches. Expressing very low levels of transgenic apolipoprotein E suppresses both aortic lesions and the expression of mRNA of LFA-1, VCAM-1, MCP-1, cathepsin B, and of ICAM-1 in ApoE(-/)-mice. We tested at the level of protein, the observations obtained for mRNA expression. CD11a (a component of LFA-1), VCAM-1 and cathepsin B expression was found to be elevated in apoE 2/2 aortas at 8-9 months; low level expression of transgenic apolipoprotein E rectifies these changes. Conclusions/Significance: Atherosclerotic lesions in apoE(-/)-mice are detected as early as 4 weeks of age. Expression of low levels of apoE is shown to be both atheroprotective and to suppress these changes in key adhesion and inflammatory molecules observed in early atherosclerotic lesions.	[Ma, Yanqing; Malbon, Craig C.; Williams, David L.; Thorngate, Fayanne E.] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ma, YQ (corresponding author), SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	thorngate@pharm.stonybrook.edu	malbon, craig/ABF-3604-2020		National Institutes of Health [HL-32868]; American Heart Association [postdoctoral fellowship]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Grant HL-32868 (CCM and FET) from the National Institutes of Health and an American Heart Association postdoctoral fellowship to Yanqing Ma. Neither had any role aside from funding in the preparation of this manuscript.	Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; CURTISS LK, 1977, J IMMUNOL, V118, P648; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; HUI DY, 1980, J BIOL CHEM, V255, P1775; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MILLER BF, 1969, EXP MOL PATHOL, V10, P288, DOI 10.1016/0014-4800(69)90058-6; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; PEPE MG, 1986, J IMMUNOL, V136, P3716; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Riddell DR, 1997, J BIOL CHEM, V272, P89; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stannard AK, 2001, J BIOL CHEM, V276, P46011, DOI 10.1074/jbc.M104812200; Tertov VV, 1997, EXP MOL PATHOL, V64, P127, DOI 10.1006/exmp.1997.2216; Thorngate FE, 2000, ARTERIOSCL THROM VAS, V20, P1939, DOI 10.1161/01.ATV.20.8.1939; Thorngate FE, 2002, J LIPID RES, V43, P1920, DOI 10.1194/jlr.M200205-JLR200; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; VANDE SA, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069; Wuttge DM, 2001, MOL MED, V7, P383, DOI 10.1007/BF03402184; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zibara K, 2000, ARTERIOSCL THROM VAS, V20, P2288, DOI 10.1161/01.ATV.20.10.2288	38	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2503	10.1371/journal.pone.0002503	http://dx.doi.org/10.1371/journal.pone.0002503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560564	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700059
J	Scardigli, R; Gargioli, C; Tosoni, D; Borello, U; Sampaolesi, M; Sciorati, C; Cannata, S; Clementi, E; Brunelli, S; Cossu, G				Scardigli, Raffaella; Gargioli, Cesare; Tosoni, Daniela; Borello, Ugo; Sampaolesi, Maurilio; Sciorati, Clara; Cannata, Stefano; Clementi, Emilio; Brunelli, Silvia; Cossu, Giulio			Binding of sFRP-3 to EGF in the Extra-Cellular Space Affects Proliferation, Differentiation and Morphogenetic Events Regulated by the Two Molecules	PLOS ONE			English	Article								Background: sFRP-3 is a soluble antagonist of Wnts, widely expressed in developing embryos. The Wnt gene family comprises cysteine-rich secreted ligands that regulate cell proliferation, differentiation, organogenesis and oncogenesis of different organisms ranging from worms to mammals. In the canonical signal transduction pathway Wnt proteins bind to the extracellular domain of Frizzled receptors and consequently recruit Dishevelled (Dsh) to the cell membrane. In addition to Wnt membrane receptors belonging to the Frizzled family, several other molecules have been described which share homology in the CRD domain and lack the putative trans-membrane domain, such as sFRP molecules (soluble Frizzled Related Protein). Among them, sFRP-3 was originally isolated from bovine articular cartilage and also as a component of the Spemann organizer. sFRP-3 blocks Wnt-8 induced axis duplication in Xenopus embryos and binds to the surface of cells expressing a membrane-anchored form of Wnt-1. Injection of sFRP-3 mRNA blocks expression of XMyoD mRNA and leads to embryos with enlarged heads and shortened trunks. Methodology/Principal Findings: Here we report that sFRP-3 specifically blocks EGF-induced fibroblast proliferation and foci formation. Over-expression of sFRP-3 reverts EGF-mediated inhibition of hair follicle development in the mouse ectoderm while its ablation in Xenopus maintains EGF-mediated inhibition of ectoderm differentiation. Conversely, overexpression of EGF reverts the inhibition of somitic myogenesis and axis truncation in Xenopus and mouse embryos caused by sFRP-3. In vitro experiments demonstrated a direct binding of EGF to sFRP-3 both on heparin and on the surface of CHO cells where the molecule had been membrane anchored. Conclusions/Significance: sFRP-3 and EGF reciprocally inhibit their effects on cell proliferation, differentiation and morphogenesis and indeed are expressed in contiguous domains of the embryo, suggesting that in addition to their canonical ligands (Wnt and EGF receptor, respectively) these molecules bind to each other and regulate their activities during embryogenesis.	[Scardigli, Raffaella; Gargioli, Cesare; Cossu, Giulio] Inst Cell Biol & Tissue Engn, Dept Dev Biol, San Raffaele Biomed Sci Park Rome, Rome, Italy; [Scardigli, Raffaella; Gargioli, Cesare; Tosoni, Daniela; Borello, Ugo] Univ Roma La Sapienza, Med Sch, Dept Histol & Med Embryol, Rome, Italy; [Borello, Ugo; Sciorati, Clara; Clementi, Emilio; Brunelli, Silvia; Cossu, Giulio] Stem Cell Res Inst, Milan, Italy; [Sampaolesi, Maurilio] Univ Pavia, Dept Expt Med, Pavia, Italy; [Sampaolesi, Maurilio] Univ Hosp Gasthuisberg, Interdept Stem Cell Res Inst, Louvain, Belgium; [Cannata, Stefano] Univ Tor Vergata, Dept Biol, Rome, Italy; [Clementi, Emilio] Univ Milan, E Medea Sci Inst, Dept Preclin Sci, Milan, Italy; [Brunelli, Silvia] Univ Milano Bicocca, Dept Expt Med, Milan, Italy; [Cossu, Giulio] Univ Milan, Dept Biol, Milan, Italy	Sapienza University Rome; University of Pavia; KU Leuven; University Hospital Leuven; University of Rome Tor Vergata; University of Milan; University of Milano-Bicocca; University of Milan	Scardigli, R (corresponding author), Inst Cell Biol & Tissue Engn, Dept Dev Biol, San Raffaele Biomed Sci Park Rome, Rome, Italy.	cossu.giulio@hsr.it	Borello, Ugo/M-5213-2014; Tosoni, Daniela/K-4524-2014; Brunelli, Silvia/J-3248-2014; Sampaolesi, Maurilio/H-6509-2013; Brunelli, Silvia/P-3853-2019; sciorati, clara/K-4823-2016	Borello, Ugo/0000-0001-9812-579X; Brunelli, Silvia/0000-0003-1753-5346; Sampaolesi, Maurilio/0000-0002-2422-3757; Brunelli, Silvia/0000-0003-1753-5346; Gargioli, Cesare/0000-0003-1742-3969; sciorati, clara/0000-0003-2030-9366; Scardigli, Raffaella/0000-0003-1369-0496	AFM; MDA; Duchenne Parent Project; CARIPLO; Fondation Leducq; European Community; Italian Ministries of Health and Research	AFM(Association Francaise contre les Myopathies); MDA(Muscular Dystrophy Association); Duchenne Parent Project; CARIPLO(Fondazione Cariplo); Fondation Leducq(Leducq Foundation); European Community(European Commission); Italian Ministries of Health and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from AFM, MDA, Duchenne Parent Project, CARIPLO, Fondation Leducq, European Community, Italian Ministries of Health and Research.	Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Berghella L, 1999, HUM GENE THER, V10, P1607, DOI 10.1089/10430349950017617; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Borello U, 1999, MECH DEVELOP, V89, P173, DOI 10.1016/S0925-4773(99)00205-1; Borello U, 1999, DEVELOPMENT, V126, P4247; BRADBURY JM, 1994, ONCOGENE, V9, P2597; Brunelli S, 2003, GENE EXPR PATTERNS, V3, P755, DOI 10.1016/S1567-133X(03)00135-2; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carmena A, 1998, GENE DEV, V12, P3910, DOI 10.1101/gad.12.24.3910; Chen YJ, 2004, INT J DEV BIOL, V48, P867, DOI 10.1387/ijdb.041882yc; Chung YS, 2004, J BONE MINER RES, V19, P1395, DOI 10.1359/JBMR.040412; Clementi E, 1995, MOL PHARMACOL, V48, P1068; Cossu G, 1996, DEVELOPMENT, V122, P429; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Gargioli C, 2004, DEVELOPMENT, V131, P2669, DOI 10.1242/dev.01155; Graham NA, 2004, J BIOL CHEM, V279, P23517, DOI 10.1074/jbc.M314055200; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Kashiwagi M, 1997, DEV BIOL, V189, P22, DOI 10.1006/dbio.1997.8650; KIM SE, 2007, CELL SIGNAL; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kopp A, 1999, DEVELOPMENT, V126, P3495; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kumar JP, 2001, DEVELOPMENT, V128, P2689; LAFLAMME SE, 1990, DEV BIOL, V137, P414, DOI 10.1016/0012-1606(90)90265-K; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSE R, 1992, J STEROID BIOCHEM, V43, P9, DOI 10.1016/0960-0760(92)90181-H; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; PAN MG, 1995, ONCOGENE, V11, P2005; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SALVATORI G, 1995, J CELL SCI, V108, P2733; Schroeder JA, 2000, ONCOGENE, V19, P3193, DOI 10.1038/sj.onc.1203652; Sciorati C, 1999, J IMMUNOL, V163, P1570; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Tagliafico E, 2004, J CELL SCI, V117, P4377, DOI 10.1242/jcs.01291; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; van de Water S, 2001, DEVELOPMENT, V128, P3877; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	58	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2471	10.1371/journal.pone.0002471	http://dx.doi.org/10.1371/journal.pone.0002471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560570	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700049
J	Siroux, V; Bouzigon, E; Dizier, MH; Pin, I; Demenais, F; Kauffmann, F				Siroux, Valerie; Bouzigon, Emmanuelle; Dizier, Marie-Helene; Pin, Isabelle; Demenais, Florence; Kauffmann, Francine		EGEA Cooperative Grp	Replication of Association between ADAM33 Polymorphisms and Psoriasis	PLOS ONE			English	Article								Polymorphisms in ADAM33, the first gene identified in asthma by positional cloning, have been recently associated with psoriasis. No replication study of this association has been published so far. Data available in the French EGEA study (Epidemiological study on Genetics and Environment of Asthma, bronchial hyperresponsivensess and Atopy) give the opportunity to attempt to replicate the association between ADAM33 and psoriasis in 2002 individuals. Psoriasis (n = 150) has been assessed by questionnaire administered by an interviewer and a sub-sample of subjects with early-onset psoriasis (n = 74) has been identified based on the age of the subjects at time of interview (<40 years). Nine SNPs in ADAM33 and 11 SNPs in PSORS1 were genotyped. Association analysis was conducted by using two methods, GEE regression-based method and a likelihood-based method (LAMP program). The rs512625 SNP in ADAM33 was found associated with psoriasis at p = 0.01, the usual threshold required for replication (OR [95% CI] for heterozygotes compared to the reference group of homozygotes for the most frequent allele = 0.61 [0.42;0.89]). The rs628977 SNP, which was not in linkage disequilibrium with rs512625, was significantly associated with early-onset psoriasis (p = 0.01, OR [ 95% CI] for homozygotes for the minor allele compared to the reference group = 2.52 [1.31;4.86]). Adjustment for age, sex, asthma and a PSORS1 SNP associated with psoriasis in the EGEA data did not change the significance of these associations. This suggests independent effects of ADAM33 and PSORS1 on psoriasis. This is the first study that replicates an association between genetic variants in ADAM33 and psoriasis. Interestingly, the 2 ADAM33 SNPs associated with psoriasis in the present analysis were part of the 3-SNPs haplotypes showing the strongest associations in the initial study. The identification of a pleiotropic effect of ADAM33 on asthma and psoriasis may contribute to the understanding of these common immune-mediated diseases.	[Siroux, Valerie; Pin, Isabelle] Ctr Rech Albert Bonniot Epidemiol Canc & Affect G, INSERM, U823, La Tronche, France; [Siroux, Valerie; Pin, Isabelle] Univ Joseph Fourier, Grenoble, France; [Bouzigon, Emmanuelle; Demenais, Florence] Fdn Jean Dausset, CEPH, INSERM, U794, Paris, France; [Bouzigon, Emmanuelle; Demenais, Florence] Univ Evry, Evry, France; [Dizier, Marie-Helene] INSERM, U535, Villejuif, France; [Dizier, Marie-Helene; Kauffmann, Francine] Univ Paris Sud, IFR69, Villejuif, France; [Pin, Isabelle] CHU Grenoble, Grenoble, France; [Kauffmann, Francine] Inserm, U780, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Siroux, V (corresponding author), Ctr Rech Albert Bonniot Epidemiol Canc & Affect G, INSERM, U823, La Tronche, France.	valerie.siroux@ujf-grenoble.fr	PIN, Isabelle/N-3020-2013; Dizier, Marie-Hélène/K-8463-2018; siroux, valerie/N-1865-2013; Le Moual, Nicole/R-8976-2016; Bouzigon, Emmanuelle/L-2766-2017; Demenais, Florence/G-3298-2013; Le Moual, Nicole/GNP-5114-2022	Dizier, Marie-Hélène/0000-0001-8460-7667; siroux, valerie/0000-0001-7329-7237; Le Moual, Nicole/0000-0002-2723-5569; Bouzigon, Emmanuelle/0000-0001-5756-4286; Demenais, Florence/0000-0001-8361-0936; Le Moual, Nicole/0000-0002-2723-5569	Merck; ANR [05-SEST-020-02/05-9-97, ANR-06-CEBS]; PHRC-Paris	Merck(Merck & Company); ANR(French National Research Agency (ANR)); PHRC-Paris	Merck, ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS and PHRC-Paris	BRANDRUP F, 1981, ACTA DERM-VENEREOL, V61, P344; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Del Mastro RG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-46; Dizier MH, 2000, AM J RESP CRIT CARE, V162, P1812, DOI 10.1164/ajrccm.162.5.2002113; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gudjonsson JE, 2007, CLIN DERMATOL, V25, P535, DOI 10.1016/j.clindermatol.2007.08.007; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Holgate ST, 2006, PULM PHARMACOL THER, V19, P3, DOI 10.1016/j.pupt.2005.02.008; Iizuka H, 2004, J DERMATOL SCI, V35, P93, DOI 10.1016/j.jdermsci.2004.01.003; Ito I, 2007, J ALLERGY CLIN IMMUN, V119, P89, DOI 10.1016/j.jaci.2006.08.038; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lesueur F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000906; Lesueur F, 2007, J INVEST DERMATOL, V127, P1403, DOI 10.1038/sj.jid.5700749; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; NAIR RP, 2008, J INVEST DERMATOL; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; SIROUX V, 2006, EUR RESP J S50, V28, pS143; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094	28	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2448	10.1371/journal.pone.0002448	http://dx.doi.org/10.1371/journal.pone.0002448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560587	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700033
J	Dossin, FD; Dufour, A; Dusch, E; Siqueira-Neto, JL; Moraes, CB; Yang, GS; Cano, MI; Genovesio, A; Freitas, LH				Dossin, Fernando de M.; Dufour, Alexandre; Dusch, Elodie; Siqueira-Neto, Jair L.; Moraes, Carolina B.; Yang, Gyong Seon; Cano, Maria Isabel; Genovesio, Auguste; Freitas-Junior, Lucio H.			Automated Nuclear Analysis of Leishmania major Telomeric Clusters Reveals Changes in Their Organization during the Parasite's Life Cycle	PLOS ONE			English	Article								Parasite virulence genes are usually associated with telomeres. The clustering of the telomeres, together with their particular spatial distribution in the nucleus of human parasites such as Plasmodium falciparum and Trypanosoma brucei, has been suggested to play a role in facilitating ectopic recombination and in the emergence of new antigenic variants. Leishmania parasites, as well as other trypanosomes, have unusual gene expression characteristics, such as polycistronic and constitutive transcription of protein-coding genes. Leishmania subtelomeric regions are even more unique because unlike these regions in other trypanosomes they are devoid of virulence genes. Given these peculiarities of Leishmania, we sought to investigate how telomeres are organized in the nucleus of Leishmania major parasites at both the human and insect stages of their life cycle. We developed a new automated and precise method for identifying telomere position in the three-dimensional space of the nucleus, and we found that the telomeres are organized in clusters present in similar numbers in both the human and insect stages. While the number of clusters remained the same, their distribution differed between the two stages. The telomeric clusters were found more concentrated near the center of the nucleus in the human stage than in the insect stage suggesting reorganization during the parasite's differentiation process between the two hosts. These data provide the first 3D analysis of Leishmania telomere organization. The possible biological implications of these findings are discussed.	[Dossin, Fernando de M.; Siqueira-Neto, Jair L.; Moraes, Carolina B.; Yang, Gyong Seon; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Syst Biol Pathogens Grp, Seoul, South Korea; [Dufour, Alexandre; Dusch, Elodie; Genovesio, Auguste] Inst Pasteur Korea, Image Mining Grp, Seoul, South Korea; [Moraes, Carolina B.] Univ Fed Sao Paulo, Dept Microbiol, Imunol Parasitol, Sao Paulo, Brazil; [Cano, Maria Isabel] Univ Estadual Paulista, Inst Biocien, Dept Genet, Sao Paulo, Brazil	Institut Pasteur Korea; Institut Pasteur Korea; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista	Dossin, FD (corresponding author), Inst Pasteur Korea, Syst Biol Pathogens Grp, Seoul, South Korea.	junior@ip-korea.org	Cano, Maria Isabel/A-4020-2008; Freitas-Junior, Lucio H/C-8677-2011; Cano, Maria Isabel/M-7691-2019; GENOVESIO, Auguste/I-1656-2017; Dossin, Fernando/D-1503-2011; Moraes, Carolina Borsoi/I-4408-2014; Siqueira-Neto, Jair L/D-6040-2012; Siqueira-Neto, Jair/AAC-1173-2019	Freitas-Junior, Lucio H/0000-0002-8904-7897; Cano, Maria Isabel/0000-0001-9798-6627; Moraes, Carolina Borsoi/0000-0002-0689-2770; Siqueira-Neto, Jair L/0000-0001-9574-8174; Siqueira-Neto, Jair/0000-0001-9574-8174; Genovesio, Auguste/0000-0003-1877-5595; Dufour, Alexandre/0000-0002-9417-7389	Institut Pasteur Korea	Institut Pasteur Korea	This work was funded by Institut Pasteur Korea	BLACKBURN EH, 1990, J BIOL CHEM, V265, P5919; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Campbell DA, 2003, MICROBES INFECT, V5, P1231, DOI 10.1016/j.micinf.2003.09.005; Chuang TCY, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-12; Conte FF, 2005, INT J PARASITOL, V35, P1435, DOI 10.1016/j.ijpara.2005.05.011; CORCORAN LM, 1988, CELL, V53, P807, DOI 10.1016/0092-8674(88)90097-9; DUFOUR A, 2007, 3D AUTOMATED NUCL MO, P356; Dusch E, 2007, J MICROSC-OXFORD, V228, P132, DOI 10.1111/j.1365-2818.2007.01844.x; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Glover L, 2006, EMBO REP, V7, P93, DOI 10.1038/sj.embor.7400575; Hediger F, 2002, NAT CELL BIOL, V4, pE53, DOI 10.1038/ncb0302-e53; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kozubek S, 2000, ANAL BIOCHEM, V282, P29, DOI 10.1006/abio.2000.4538; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Navarro M, 2007, TRENDS MICROBIOL, V15, P263, DOI 10.1016/j.tim.2007.04.004; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Perez-Morga D, 2001, J EUKARYOT MICROBIOL, V48, P221, DOI 10.1111/j.1550-7408.2001.tb00306.x; Pombo A, 2007, CURR OPIN GENET DEV, V17, P451, DOI 10.1016/j.gde.2007.08.008; Ravel C, 1995, MOL BIOCHEM PARASIT, V74, P31, DOI 10.1016/0166-6851(95)02480-8; Ray A, 2000, FASEB J, V14, P1041, DOI 10.1096/fasebj.14.9.1041; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Summerton JE, 2003, LETT PEPT SCI, V10, P215, DOI 10.1007/BF02484560; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2313	10.1371/journal.pone.0002313	http://dx.doi.org/10.1371/journal.pone.0002313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545650	gold, Green Submitted, Green Published			2022-12-27	WOS:000263248800003
J	Laaksonen, T; Negro, JJ; Lyytinen, S; Valkama, J; Ots, I; Korpimaki, E				Laaksonen, Toni; Negro, Juan J.; Lyytinen, Sami; Valkama, Jari; Ots, Indrek; Korpimaki, Erkki			Effects of Experimental Brood Size Manipulation and Gender on Carotenoid Levels of Eurasian Kestrels Falco tinnunculus	PLOS ONE			English	Article							REPRODUCING GREAT TITS; HEALTH STATE INDEXES; PLASMA CAROTENOIDS; SKIN COLOR; INTERSPECIFIC VARIATION; SEXUAL DIFFERENCES; TERRITORY QUALITY; GENETIC-VARIATION; IMMUNE-RESPONSE; FOOD LIMITATION	Background: Animals use carotenoid-pigments for coloration, as antioxidants and as enhancers of the immune system. Carotenoid-dependent colours can thus signal individual quality and carotenoids have also been suggested to mediate life-history trade-offs. Methodology: To examine trade-offs in carotenoid allocation between parents and the young, or between skin coloration and plasma of the parents at different levels of brood demand, we manipulated brood sizes of Eurasian kestrels (Falco tinnunculus). Principal Findings: Brood size manipulation had no overall effect on plasma carotenoid levels or skin hue of parents, but female parents had twice the plasma carotenoid levels of males. Males work physically harder than females and they might thus also use more carotenoids against oxidative stress than females. Alternatively, females could be gaining back the carotenoid stores they depleted during egg-laying by eating primarily carotenoid-rich food items during the early nestling stage. Fledglings in enlarged broods had higher plasma carotenoid concentrations than those in reduced broods. This difference was not explained by diet. In light of recent evidence from other species, we suggest it might instead be due to fledglings in enlarged broods having higher testosterone levels, which in turn increased plasma carotenoid levels. The partial cross-foster design of our experiment revealed evidence for origin effects (genetic or maternal) on carotenoid levels of fledglings, but no origin-environment interaction. Significance: These results from wild birds differ from studies in captivity, and thus offer new insights into carotenoid physiology in relation to division of parental care and demands of the brood.	[Laaksonen, Toni; Lyytinen, Sami; Valkama, Jari; Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Laaksonen, Toni] Netherlands Inst Ecol NIOO KNAW, Dept Anim Populat Biol, Yerseke, Netherlands; [Negro, Juan J.] Estac Biol Donana, Lab Chem Ecol, Donana, Spain; [Ots, Indrek] Univ Tartu, Inst Zool & Hydrobiol, Tartu, Estonia	University of Turku; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Tartu	Laaksonen, T (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	tokrla@utu.fi	Laaksonen, Toni/B-4241-2014; Negro, Juan Jose/I-2653-2015	Laaksonen, Toni/0000-0001-9035-7131; Negro, Juan Jose/0000-0002-8697-5647; Valkama, Jari/0000-0002-0393-7320	Academy of Finland [8206140, 209198]	Academy of Finland(Academy of Finland)	Academy of Finland (grant 8206140 to EK and grant 209198 to TL). The funding organization had no involvement in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Blount JD, 2004, P ROY SOC B-BIOL SCI, V271, pS79, DOI 10.1098/rsbl.2003.0104; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; Bostrom MR, 2006, J FIELD ORNITHOL, V77, P392, DOI 10.1111/j.1557-9263.2006.00069.x; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; Casagrande S, 2007, J COMP PHYSIOL B, V177, P237, DOI 10.1007/s00360-006-0125-4; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Costantini D, 2007, J EXP BIOL, V210, P1238, DOI 10.1242/jeb.002741; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Dawson RD, 2006, NATURWISSENSCHAFTEN, V93, P597, DOI 10.1007/s00114-006-0146-6; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fargallo JA, 2003, EVOL ECOL RES, V5, P549; Fargallo JA, 2002, ECOL LETT, V5, P95, DOI 10.1046/j.1461-0248.2002.00290.x; Fargallo JA, 2007, J ANIM ECOL, V76, P201, DOI 10.1111/j.1365-2656.2006.01193.x; Figuerola J, 1998, ARDEA, V86, P245; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Hill GE, 1995, AUK, V112, P1054, DOI 10.2307/4089041; Hill GE, 1995, AUK, V112, P1057, DOI 10.2307/4089042; Horak P, 1998, FUNCT ECOL, V12, P750, DOI 10.1046/j.1365-2435.1998.00244.x; Horak P, 2004, J AVIAN BIOL, V35, P63, DOI 10.1111/j.0908-8857.2004.03167.x; Horak P, 2003, BIOESSAYS, V25, P746, DOI 10.1002/bies.10325; KORPIMAKI E, 1985, Ornis Fennica, V62, P130; Korpimaki E, 1998, OIKOS, V83, P259, DOI 10.2307/3546837; Korpimaki E, 1996, ECOSCIENCE, V3, P264, DOI 10.1080/11956860.1996.11682341; Laaksonen T, 2004, J ANIM ECOL, V73, P342, DOI 10.1111/j.0021-8790.2004.00811.x; Laaksonen T, 2004, EVOL ECOL, V18, P215, DOI 10.1023/B:EVEC.0000035081.91292.17; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Martinez-Padilla J, 2007, BIOL LETTERS, V3, P161, DOI 10.1098/rsbl.2006.0593; McGraw KJ, 2003, AUK, V120, P400, DOI 10.1642/0004-8038(2003)120[0400:DPCASC]2.0.CO;2; McGraw KJ, 2005, EVOL ECOL RES, V7, P251; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1998, GENETICS, V148, P1233; Minguez-Mosquera MI, 1997, CLOROFILAS CAROTENOI; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Mougeot F, 2007, FUNCT ECOL, V21, P886, DOI 10.1111/j.1365-2435.2007.01302.x; Mougeot F, 2006, BIOL LETTERS, V2, P173, DOI 10.1098/rsbl.2005.0434; Negro JJ, 1998, FUNCT ECOL, V12, P307, DOI 10.1046/j.1365-2435.1998.00176.x; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Negro JJ, 2001, FUNCT ECOL, V15, P297, DOI 10.1046/j.1365-2435.2001.00526.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; PALOKANGAS P, 1992, ANIM BEHAV, V43, P659, DOI 10.1016/0003-3472(92)90087-P; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Ros AFH, 2002, HORM BEHAV, V41, P334, DOI 10.1006/hbeh.2002.1768; Tella JL, 2004, J EVOLUTION BIOL, V17, P156, DOI 10.1046/j.1420-9101.2003.00634.x; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; TOLONEN P, 1994, BEHAV ECOL SOCIOBIOL, V35, P355; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Velando A, 2006, OECOLOGIA, V149, P535, DOI 10.1007/s00442-006-0457-5; Village A., 1990, THE KESTREL; Wiehn J, 1997, ECOLOGY, V78, P2043, DOI 10.1890/0012-9658(1997)078[2043:FLOBSE]2.0.CO;2; Wiehn J, 1999, OIKOS, V84, P87, DOI 10.2307/3546869; Wiehn J, 1998, P ROY SOC B-BIOL SCI, V265, P1197, DOI 10.1098/rspb.1998.0419	63	14	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2374	10.1371/journal.pone.0002374	http://dx.doi.org/10.1371/journal.pone.0002374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545646	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800015
J	Barger, JL; Kayo, T; Vann, JM; Arias, EB; Wang, JL; Hacker, TA; Wang, Y; Raederstorff, D; Morrow, JD; Leeuwenburgh, C; Allison, DB; Saupe, KW; Cartee, GD; Weindruch, R; Prolla, TA				Barger, Jamie L.; Kayo, Tsuyoshi; Vann, James M.; Arias, Edward B.; Wang, Jelai; Hacker, Timothy A.; Wang, Ying; Raederstorff, Daniel; Morrow, Jason D.; Leeuwenburgh, Christiaan; Allison, David B.; Saupe, Kurt W.; Cartee, Gregory D.; Weindruch, Richard; Prolla, Tomas A.			A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice	PLOS ONE			English	Article								Resveratrol in high doses has been shown to extend lifespan in some studies in invertebrates and to prevent early mortality in mice fed a high-fat diet. We fed mice from middle age (14-months) to old age (30-months) either a control diet, a low dose of resveratrol (4.9 mg kg(-1) day(-1)), or a calorie restricted (CR) diet and examined genome-wide transcriptional profiles. We report a striking transcriptional overlap of CR and resveratrol in heart, skeletal muscle and brain. Both dietary interventions inhibit gene expression profiles associated with cardiac and skeletal muscle aging, and prevent age-related cardiac dysfunction. Dietary resveratrol also mimics the effects of CR in insulin mediated glucose uptake in muscle. Gene expression profiling suggests that both CR and resveratrol may retard some aspects of aging through alterations in chromatin structure and transcription. Resveratrol, at doses that can be readily achieved in humans, fulfills the definition of a dietary compound that mimics some aspects of CR.	[Barger, Jamie L.; Kayo, Tsuyoshi] LifeGen Technol LLC, Madison, WI USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI USA; [Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Div Kinesiol, Ann Arbor, MI USA; [Wang, Jelai] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL USA; [Hacker, Timothy A.; Saupe, Kurt W.] Univ Wisconsin Madison, Dept Med, Madison, WI USA; [Wang, Ying; Raederstorff, Daniel] DSM Nutr Products Ltd, R&D Human Nutr & Hlth, Basel, Switzerland; [Morrow, Jason D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN USA; [Morrow, Jason D.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA; [Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Dept Aging & Geriat, Gainesville, FL USA; [Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Dept Biostat, Sect Stat Genet, Birmingham, AL USA; [Weindruch, Richard] Univ Wisconsin Madison, Vet Adm Hosp, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; DSM NV; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Barger, JL (corresponding author), LifeGen Technol LLC, Madison, WI USA.	rhweindr@wisc.edu; taprolla@wisc.edu		Leeuwenburgh, Christiaan/0000-0003-0826-4257; Allison, David/0000-0003-3566-9399; Cartee, Gregory/0000-0001-5311-1722; Barger, Jamie/0000-0001-8694-0068	NIH [AG17994, AG21042, AG-000908, GM15431, DK48831, ES13125, AG020681]; NSF [EPSCoR 05026]; DSM Nutritional Products, Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000908, R01AG021042, P30AG028740, R01AG020681, R01AG017994, K01AG000908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DSM Nutritional Products, Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CL: NIH AG17994 and AG21042, DBA: NSF EPSCoR 05026, KAS: NIH AG-000908, JDM: NIH GM15431, DK48831 and ES13125, TAP: NIH AG020681 Portions of this research were funded by DSM Nutritional Products, Ltd.; however, DSM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dunn SE, 1997, CANCER RES, V57, P4667; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; HURSTING SD, 1993, CANCER RES, V53, P2750; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KLINGE CM, 2008, FASEB J; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; PENUMATHSA SV, 2008, J CELL MOL MED; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; SELMAN C, 2007, FASEB J; Sengupta S, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-34; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Weindruch R., 1988, RETARDATION AGING DI; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	42	478	488	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2264	10.1371/journal.pone.0002264	http://dx.doi.org/10.1371/journal.pone.0002264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523577	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300003
J	Di Segni, A; Farin, K; Pinkas-Kramarski, R				Di Segni, Ayelet; Farin, Keren; Pinkas-Kramarski, Ronit			Identification of Nucleolin as New ErbB Receptors-Interacting Protein	PLOS ONE			English	Article								Background: The ErbB receptor tyrosine kinases are major contributors to malignant transformation. These receptors are frequently overexpressed in a variety of human carcinomas. The role of the ErbB receptors and their ligands in carcinomas and the mechanism by which their overexpression leads to cancer development is still unclear. Ligand binding to specific ErbB receptor is followed by receptor dimerization, phosphorylation and recruitment of SH2 containing cytoplasmic proteins, which initiate the cascade of signaling events. Nevertheless, increasing data suggest that there are non-phosphorylated receptor-substrate interactions that may affect ErbB-mediated responses. Methodology/Principal Findings: In the present study, using GST-ErbB4 fusion protein pull down assay and mass spectroscopic analysis, we have found the ErbB receptors interact with nucleolin via their cytoplasmic tail. Nucleolin is a ubiquitous, nonhistone, nucleolar, multifunctional phosphoprotein that is also overexpressed in cancer cells. Our results demonstrate that overexpression of ErbB1 and nucleolin may lead to receptor dimerization, phosphorylation and to anchorage independent growth. Conclusions/Significance: The oncogenic potential of ErbB depends on receptor levels and activation. Our results suggest that nucleolin may affect ErbB dimerization and activation leading to enhanced cell growth.	[Di Segni, Ayelet; Farin, Keren; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel	Tel Aviv University	Di Segni, A (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Cancer Biology Research Center of Tel Aviv University, Israel	Cancer Biology Research Center of Tel Aviv University, Israel	This work was supported by the Cancer Biology Research Center of Tel Aviv University, Israel.	Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; BUGLER B, 1987, J BIOL CHEM, V262, P10922; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Derenzini M, 2000, MICRON, V31, P117, DOI 10.1016/S0968-4328(99)00067-0; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; ESCANDEGERAUD ML, 1985, EXP CELL RES, V161, P353, DOI 10.1016/0014-4827(85)90092-8; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Harms G, 2001, BIOCHEM J, V360, P531, DOI 10.1042/0264-6021:3600531; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Pawson T, 2003, PHILOS T R SOC A, V361, P1251, DOI 10.1098/rsta.2003.1197; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; SLAMON DJ, 1990, CANC INVEST, V8; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; STANCOVSKI I, 1994, REGULATORY MECH BREA, P161; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo JY, 2000, BRIT J CANCER, V82, P683	48	53	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2310	10.1371/journal.pone.0002310	http://dx.doi.org/10.1371/journal.pone.0002310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523588	Green Submitted, gold, Green Published			2022-12-27	WOS:000262614300016
J	Dias, A; Dewey, ME; D'Souza, J; Dhume, R; Motghare, DD; Shaji, KS; Menon, R; Prince, M; Patel, V				Dias, Amit; Dewey, Michael E.; D'Souza, Jean; Dhume, Rajesh; Motghare, Dilip D.; Shaji, K. S.; Menon, Rajiv; Prince, Martin; Patel, Vikram			The Effectiveness of a Home Care Program for Supporting Caregivers of Persons with Dementia in Developing Countries: A Randomised Controlled Trial from Goa, India	PLOS ONE			English	Article							SPOUSE-CAREGIVERS; ALZHEIMER-DISEASE; INTERVENTION; COMMUNITY; NETWORK; PEOPLE	Objectives: To develop and evaluate the effectiveness of a home based intervention in reducing caregiver burden, promoting caregiver mental health and reducing behavioural problems in elderly persons with dementia. Methodology and Principal Findings: This was a randomised controlled trial in which the person with dementia-caregiver dyad was randomly allocated either to receive the intervention immediately or to a waiting list group which received the intervention after 6 months. It was carried out in communities based in two talukas (administrative blocks) in Goa, India. Mild to moderate cases with dementia (diagnosed using the DSM IV criteria and graded using the Clinical Dementia Rating scale) and their caregivers were included in the trial. Community based intervention provided by a team consisting of Home Care Advisors who were supervised by a counselor and a psychiatrist, focusing on supporting the caregiver through information on dementia, guidance on behaviour management, a single psychiatric assessment and psychotropic medication if needed. We measured caregiver mental health (General Health Questionnaire), caregiver burden (Zarit Burden Score), distress due to behavioural disturbances (NPI-D), behavioural problems in the subject (NPI-S) and activities of daily living in the elder with dementia (EASI). Outcome evaluations were masked to the allocation status. We analysed each outcome with a mixed effects model. 81 families enrolled in the trial; 41 were randomly allocated to the intervention. 59 completed the trial and 18 died during the trial. The intervention led to a significant reduction of GHQ (-1.12, 95% CI -2.07 to -0.17) and NPI-D scores (-1.96, 95% CI -3.51 to -0.41) and non-significant reductions in the ZBS, EASI and NPI-S scores. We also observed a non-significant reduction in the total number of deaths in people with dementia in the intervention arm (OR 0.34, 95% Cl 0.01 to 1.03). Conclusion: Home based support for caregivers of persons with dementia, which emphasizes the use of locally available, low-cost human resources, is feasible, acceptable and leads to significant improvements in caregiver mental health and burden of caring.	[Dias, Amit; Motghare, Dilip D.] Goa Med Coll, Dept Prevent & Social Med, Goa, India; [Dewey, Michael E.; Prince, Martin] Kings Coll London, Inst Psychiat, Sect Epidemiol, London, England; [D'Souza, Jean] Dementia Soc Goa, Goa, India; [Dhume, Rajesh] Directorate Hlth Serv, Goa, India; [Shaji, K. S.] Med Coll, Dept Psychiat, Trichur, India; [Menon, Rajiv] Chelsea & Westminster Hosp, Mental Hlth Ctr, London, England; [Patel, Vikram] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England	Goa Medical College & Hospital; University of London; King's College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Dias, A (corresponding author), Goa Med Coll, Dept Prevent & Social Med, Goa, India.	dr_amit_dias@yahoo.com	K.S., Shaji/J-4992-2016; Prince, Martin J/A-9170-2010; Dewey, Michael E/E-2049-2010	K.S., Shaji/0000-0002-6029-9679; Prince, Martin J/0000-0003-1379-7146; Dewey, Michael E/0000-0002-7522-3677; Patel, Vikram/0000-0003-1066-8584	World Health Organization	World Health Organization(World Health Organization)	World Health Organization	*AM PSYCH ASS, 1994, COMM NOM STAT DIAGN; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dias A, 2004, INT J GERIATR PSYCH, V19, P182, DOI 10.1002/gps.1016; ELONIEMISULKAVA U, 1999, SUPPORT PROGRAMME DE; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fillenbaum GG, 1999, AGE AGEING, V28, P161, DOI 10.1093/ageing/28.2.161; HINCHLIFFE AC, 1995, INT J GERIATR PSYCH, V10, P839, DOI 10.1002/gps.930101005; *INT I POP SCI, 2002, INT I POP SCI NAT FA; McCurry SM, 1998, J GERONTOL B-PSYCHOL, V53, pP122, DOI 10.1093/geronb/53B.2.P122; MITTELMAN MS, 1995, GERONTOLOGIST, V35, P792, DOI 10.1093/geront/35.6.792; MITTELMAN MS, 1993, GERONTOLOGIST, V33, P730, DOI 10.1093/geront/33.6.730; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prince M, 2004, INT J GERIATR PSYCH, V19, P170, DOI 10.1002/gps.1046; Prince M, 2004, INT J GERIATR PSYCH, V19, P178, DOI 10.1002/gps.1059; Prince M, 2001, INT PSYCHOGERIATR, V13, P389, DOI 10.1017/S1041610201007797; Ramos-Cerqueira ATA, 2005, J AM GERIATR SOC, V53, P1738, DOI 10.1111/j.1532-5415.2005.53553.x; Shaji KS, 2002, INT J GERIATR PSYCH, V17, P222, DOI 10.1002/gps.553; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	22	125	127	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2333	10.1371/journal.pone.0002333	http://dx.doi.org/10.1371/journal.pone.0002333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523642	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300028
J	Ross, A; Penny, M; Maire, N; Studer, A; Carneiro, I; Schellenberg, D; Greenwood, B; Tanner, M; Smith, T				Ross, Amanda; Penny, Melissa; Maire, Nicolas; Studer, Alain; Carneiro, Ilona; Schellenberg, David; Greenwood, Brian; Tanner, Marcel; Smith, Thomas			Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; DOUBLE-BLIND; ROUTINE VACCINATIONS; TANZANIAN INFANTS; EXPANDED PROGRAM; PARASITE DENSITY; INOCULATION RATE; CONTROLLED-TRIAL; CHILDREN	Background: Trials of intermittent preventive treatment against malaria in infants (IPTi) using sulphadoxine-pyrimethamine (SP) have shown a positive, albeit variable, protective efficacy against clinical malaria episodes. The impact of IPTi in different epidemiological settings and over time is unknown and predictions are hampered by the lack of knowledge about how IPTi works. We investigated mechanisms proposed for the action of IPTi and made predictions of the likely impact on morbidity and mortality. Methods/Principal Findings: We used a comprehensive, individual-based, stochastic model of malaria epidemiology to simulate recently published trials of IPTi using SP with site-specific characteristics as inputs. This baseline model was then modified to represent hypotheses concerning the duration of action of SP, the temporal pattern of fevers caused by individual infections, potential benefits of avoiding fevers on immunity and the effect of sub-therapeutic levels of SP on parasite dynamics. The baseline model reproduced the pattern of results reasonably well. None of the models based on alternative hypotheses improved the fit between the model predictions and observed data. Predictions suggest that IPTi would have a beneficial effect across a range of transmission intensities. IPTi was predicted to avert a greater number of episodes where IPTi coverage was higher, the health system treatment coverage lower, and for drugs which were more efficacious and had longer prophylactic periods. The predicted cumulative benefits were proportionately slightly greater for severe malaria episodes and malaria-attributable mortality than for acute episodes in the settings modelled. Modest increased susceptibility was predicted between doses and following the last dose, but these were outweighed by the cumulative benefits. The impact on transmission intensity was negligible. Conclusions: The pattern of trial results can be accounted for by differences between the trial sites together with known features of malaria epidemiology and the action of SP. Predictions suggest that IPTi would have a beneficial impact across a variety of epidemiological settings.	[Ross, Amanda; Penny, Melissa; Maire, Nicolas; Studer, Alain; Tanner, Marcel; Smith, Thomas] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Carneiro, Ilona; Schellenberg, David; Greenwood, Brian] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of London; London School of Hygiene & Tropical Medicine	Ross, A (corresponding author), Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.	amanda.ross@unibas.ch	Penny, Melissa A/N-6838-2015; Smith, Thomas/B-5569-2015	Penny, Melissa A/0000-0002-4972-593X; Smith, Thomas/0000-0002-3650-9381; Ross, Amanda/0000-0001-6027-5645; Schellenberg, David/0000-0001-8222-0186	The Bill and Melinda Gates Foundation	The Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by The Bill and Melinda Gates Foundation through the IPTi Consortium. The funders had no role in study design, development of the model, decision to publish, or preparation of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; BINKA FN, 1994, T ROY SOC TROP MED H, V88, P381, DOI 10.1016/0035-9203(94)90391-3; BOYD MARK F., 1940, AMER JOUR TROP MED, V20, P279; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Chandler CIR, 2006, TROP MED INT HEALTH, V11, P1178, DOI 10.1111/j.1365-3156.2006.01672.x; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; CHITNIS N, 2008, J BIOL DYNA IN PRESS; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986; DICKO A, 2004, AM J TROP MED HYG S, V71; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Gatton ML, 2004, ANTIMICROB AGENTS CH, V48, P2116, DOI 10.1128/AAC.48.6.2116-2123.2004; GLYNN JR, 1995, T ROY SOC TROP MED H, V89, P281, DOI 10.1016/0035-9203(95)90540-5; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-54; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hastings IM, 2006, TRENDS PARASITOL, V22, P71, DOI 10.1016/j.pt.2005.12.011; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; INDEPTH Network, 2002, POP HLTH SURV INDEPT; KOBBE R, 2002, MALARIA J, V6, P163; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; LINES J, 1992, PARASITOL TODAY, V8, P381, DOI 10.1016/0169-4758(92)90176-3; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; MAIRE N, 2008, DISTRIBUTED IN PRESS; Maire N, 2006, AM J TROP MED HYG, V75, P111, DOI 10.4269/ajtmh.2006.75.111; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maire N, 2006, AM J TROP MED HYG, V75, P104, DOI 10.4269/ajtmh.2006.75.104; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; O'Meara WP, 2006, PLOS MED, V3, P633, DOI 10.1371/journal.pmed.0030141; ODURO A, 2007, TROP MED INT HEALTH, V10, P279; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Ringwald P, 2005, SUSCEPTIBILITY PLASM; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Schellenberg D, 2005, LANCET, V366, P545, DOI 10.1016/S0140-6736(05)67093-6; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SMITH T, 1995, AM J TROP MED HYG, V52, P306, DOI 10.4269/ajtmh.1995.52.306; SMITH T, 2008, PARASITOL IN PRESS; Smith T, 2006, AM J TROP MED HYG, V75, P1; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Stepniewska K, 2004, ANTIMICROB AGENTS CH, V48, P4271, DOI 10.1128/AAC.48.11.4271-4280.2004; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; ter Kuile FO, 2006, J INFECT DIS, V194, P269, DOI 10.1086/505434; WALTON GA, 1947, ANN TROP MED PARASIT, V41, P380, DOI 10.1080/00034983.1947.11685341; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; 2007, IPTI CONSORTIUM STAT	67	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2661	10.1371/journal.pone.0002661	http://dx.doi.org/10.1371/journal.pone.0002661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628828	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000264057200007
J	Du, LK; Dunn-Walters, DK; Chrzanowska, KH; Stankovic, T; Kotnis, A; Li, X; Lu, JY; Eggertsen, G; Brittain, C; Popov, SW; Gennery, AR; Taylor, AMR; Pan-Hammarstrom, Q				Du, Likun; Dunn-Walters, Deborah K.; Chrzanowska, Krystyna H.; Stankovic, Tanja; Kotnis, Ashwin; Li, Xin; Lu, Jiayi; Eggertsen, Gosta; Brittain, Claire; Popov, Sergey W.; Gennery, Andrew R.; Taylor, A. Malcolm R.; Pan-Hammarstrom, Qiang			A Regulatory Role for NBS1 in Strand-Specific Mutagenesis during Somatic Hypermutation	PLOS ONE			English	Article								Activation-induced cytidine deaminase (AID) is believed to initiate somatic hypermutation (SHM) by deamination of deoxycytidines to deoxyuridines within the immunoglobulin variable regions genes. The deaminated bases can subsequently be replicated over, processed by base excision repair or mismatch repair, leading to introduction of different types of point mutations (G/C transitions, G/C transversions and A/T mutations). It is evident that the base excision repair pathway is largely dependent on uracil-DNA glycosylase (UNG) through its uracil excision activity. It is not known, however, which endonuclease acts in the step immediately downstream of UNG, i.e. that cleaves at the abasic sites generated by the latter. Two candidates have been proposed, an apurinic/apyrimidinic endonuclease (APE) and the Mre11-Rad50-NBS1 complex. The latter is intriguing as this might explain how the mutagenic pathway is primed during SHM. We have investigated the latter possibility by studying the in vivo SHM pattern in B cells from ataxia-telangiectasia-like disorder (Mre11 deficient) and Nijmegen breakage syndrome (NBS1 deficient) patients. Our results show that, although the pattern of mutations in the variable heavy chain (V-H) genes was altered in NBS1 deficient patients, with a significantly increased number of G (but not C) transversions occurring in the SHM and/or AID targeting hotspots, the general pattern of mutations in the V-H genes in Mre11 deficient patients was only slightly altered, with an increased frequency of A to C transversions. The Mre11-Rad50-NBS1 complex is thus unlikely to be the major nuclease involved in cleavage of the abasic sites during SHM, whereas NBS1 might have a specific role in regulating the strand-biased repair during phase Ib mutagenesis.	[Du, Likun; Kotnis, Ashwin; Li, Xin; Lu, Jiayi; Popov, Sergey W.; Pan-Hammarstrom, Qiang] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden; [Dunn-Walters, Deborah K.] Kings Coll London, Sch Med, Guys Hosp, Dept Immunobiol, London, England; [Chrzanowska, Krystyna H.] Childrens Memorial Hlth Inst, Dept Med Genet, Warsaw, Poland; [Stankovic, Tanja; Brittain, Claire; Taylor, A. Malcolm R.] Univ Birmingham, Med Sch Edghaston, CRC Inst Canc Stud, Birmingham, W Midlands, England; [Eggertsen, Gosta] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Gennery, Andrew R.] Newcastle Gen Hosp, Dept Pediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England	Karolinska Institutet; Karolinska University Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Children's Memorial Health Institute; University of Birmingham; Karolinska Institutet; Karolinska University Hospital; Newcastle General Hospital	Du, LK (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden.	Qiang.Pan-Hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Popov, Sergey/AAB-3225-2021	Dunn-Walters, Deborah/0000-0002-7172-3893; Du, Likun/0000-0002-8448-2187; Popov, Sergey/0000-0003-1172-3557; Stankovic, Tatjana/0000-0002-3780-274X; pan-hammarstrom, qiang/0000-0003-1990-8804; Chrzanowska, Krystyna/0000-0003-3888-0624	Swedish Research Council; Swedish Cancer Foundation; Swedish Society for Medicine; "KID" program of the Karolinska Institutet; CR-UK; Medical Research Council [G0000160] Funding Source: researchfish; MRC [G0000160] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Society for Medicine; "KID" program of the Karolinska Institutet; CR-UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swedish Research Council, the Swedish Cancer Foundation, the Swedish Society for Medicine and the "KID" program of the Karolinska Institutet. A. M. Taylor acknowledges the continuing support of CR-UK.	Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; Fernet M, 2005, HUM MOL GENET, V14, P307, DOI 10.1093/hmg/ddi027; Gennery AR, 2004, CLIN IMMUNOL, V113, P214, DOI 10.1016/j.clim.2004.03.024; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Gregorek H, 2002, CLIN EXP IMMUNOL, V130, P319, DOI 10.1046/j.1365-2249.2002.01971.x; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Hadi MZ, 2000, ENVIRON MOL MUTAGEN, V36, P312, DOI 10.1002/1098-2280(2000)36:4<312::AID-EM7>3.0.CO;2-K; Ide Y, 2004, BLOOD, V104, P4097, DOI 10.1182/blood-2004-04-1476; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2006, J EXP MED, V203, P99, DOI 10.1084/jem.20050595; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Pan-Hammarstrom Q, 2003, J IMMUNOL, V170, P3707, DOI 10.4049/jimmunol.170.7.3707; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taylor AMR, 2004, DNA REPAIR, V3, P1219, DOI 10.1016/j.dnarep.2004.04.009; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Unniraman S, 2007, SCIENCE, V317, P1227, DOI 10.1126/science.1145065; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; YAN CT, 2007, NATURE; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	62	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2482	10.1371/journal.pone.0002482	http://dx.doi.org/10.1371/journal.pone.0002482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575580	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288000012
J	Laddy, DJ; Yan, J; Kutzler, M; Kobasa, D; Kobinger, GP; Khan, AS; Greenhouse, J; Sardesai, NY; Draghia-Akli, R; Weiner, DB				Laddy, Dominick J.; Yan, Jian; Kutzler, Michele; Kobasa, Darwyn; Kobinger, Gary P.; Khan, Amir S.; Greenhouse, Jack; Sardesai, Niranjan Y.; Draghia-Akli, Ruxandra; Weiner, David B.			Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens	PLOS ONE			English	Article								Background: The persistent evolution of highly pathogenic avian influenza (HPAI) highlights the need for novel vaccination techniques that can quickly and effectively respond to emerging viral threats. We evaluated the use of optimized consensus influenza antigens to provide broad protection against divergent strains of H5N1 influenza in three animal models of mice, ferrets, and non-human primates. We also evaluated the use of in vivo electroporation to deliver these vaccines to overcome the immunogenicity barrier encountered in larger animal models of vaccination. Methods and Findings: Mice, ferrets and non-human primates were immunized with consensus plasmids expressing H5 hemagglutinin (pH5HA), N1 neuraminidase (pN1NA), and nucleoprotein antigen (pNP). Dramatic IFN-gamma-based cellular immune responses to both H5 and NP, largely dependent upon CD8+ T cells were seen in mice. Hemaggutination inhibition titers classically associated with protection (>1:40) were seen in all species. Responses in both ferrets and macaques demonstrate the ability of synthetic consensus antigens to induce antibodies capable of inhibiting divergent strains of the H5N1 subtype, and studies in the mouse and ferret demonstrate the ability of synthetic consensus vaccines to induce protection even in the absence of such neutralizing antibodies. After challenge, protection from morbidity and mortality was seen in mice and ferrets, with significant reductions in viral shedding and disease progression seen in vaccinated animals. Conclusions: By combining several consensus influenza antigens with in vivo electroporation, we demonstrate that these antigens induce both protective cellular and humoral immune responses in mice, ferrets and non-human primates. We also demonstrate the ability of these antigens to protect from both morbidity and mortality in a ferret model of HPAI, in both the presence and absence of neutralizing antibody, which will be critical in responding to the antigenic drift that will likely occur before these viruses cross the species barrier to humans.	[Laddy, Dominick J.; Yan, Jian; Kutzler, Michele; Weiner, David B.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kobasa, Darwyn] Publ Hlth Agcy Canada, Natl Microbiol Lab, Resp Viruses, Winnipeg, MB, Canada; [Kobinger, Gary P.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens, Winnipeg, MB, Canada; [Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Khan, Amir S.; Sardesai, Niranjan Y.; Draghia-Akli, Ruxandra] VGX Pharm, Blue Bell, PA USA; [Greenhouse, Jack] Bioqual Inc, Rockville, MD USA	University of Pennsylvania; Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; BIOQUAL Inc.	Laddy, DJ (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Weiner, David B/H-8579-2014; Khan, Amir Sada/Q-8429-2019	Draghia-Akli, Ruxandra/0000-0001-6372-4039; Sardesai, Niranjan/0000-0001-6920-1167; Kutzler, Michele/0000-0001-5692-5617	Wyeth; Ichor; BMS; Virxsys	Wyeth(Wyeth); Ichor; BMS(Bristol-Myers Squibb); Virxsys	DBW serves as a consultant to VGX and has sponsored research grants from Wyeth, Ichor, BMS and Virxsys.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; DRAGHIAAKLI R, 2008, VACCINE; Epstein SL, 2000, INT IMMUNOL, V12, P91, DOI 10.1093/intimm/12.1.91; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Forde GM, 2005, NAT BIOTECHNOL, V23, P1059, DOI 10.1038/nbt0905-1059; Hebel H, 2006, VACCINE, V24, P4607, DOI 10.1016/j.vaccine.2005.08.049; HIRAO LA, 2008, VACCINE; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Kadowaki S, 2000, VACCINE, V18, P2779, DOI 10.1016/S0264-410X(00)00087-6; Khan AS, 2005, DNA CELL BIOL, V24, P810, DOI 10.1089/dna.2005.24.810; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Krohn K, 2005, MICROBES INFECT, V7, P1405, DOI 10.1016/j.micinf.2005.07.023; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Laddy DJ, 2006, INT REV IMMUNOL, V25, P99, DOI 10.1080/08830180600785827; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Malm M, 2005, VIRAL IMMUNOL, V18, P678, DOI 10.1089/vim.2005.18.678; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; RENEGAR KB, 1992, LAB ANIM SCI, V42, P222; ROBERT G, 2006, MICROBE, V1, P559; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; YAN J, 2006, MOL THERAPY; Zucchelli S, 2000, J VIROL, V74, P11598, DOI 10.1128/JVI.74.24.11598-11607.2000	34	124	152	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2517	10.1371/journal.pone.0002517	http://dx.doi.org/10.1371/journal.pone.0002517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575608	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000034
J	Swaddle, JP; Calos, SE				Swaddle, John P.; Calos, Stavros E.			Increased Avian Diversity Is Associated with Lower Incidence of Human West Nile Infection: Observation of the Dilution Effect	PLOS ONE			English	Article							LYME-DISEASE; SPECIES-DIVERSITY; VIRUS-INFECTION; HOST; BIODIVERSITY; EPIDEMIOLOGY; COEXISTENCE; DENSITY; GEORGIA; BIRDS	Recent infectious disease models illustrate a suite of mechanisms that can result in lower incidence of disease in areas of higher disease host diversity-the 'dilution effect'. These models are particularly applicable to human zoonoses, which are infectious diseases of wildlife that spill over into human populations. As many recent emerging infectious diseases are zoonoses, the mechanisms that underlie the 'dilution effect' are potentially widely applicable and could contribute greatly to our understanding of a suite of diseases. The dilution effect has largely been observed in the context of Lyme disease and the predictions of the underlying models have rarely been examined for other infectious diseases on a broad geographic scale. Here, we explored whether the dilution effect can be observed in the relationship between the incidence of human West Nile virus (WNV) infection and bird (host) diversity in the eastern US. We constructed a novel geospatial contrasts analysis that compares the small differences in avian diversity of neighboring US counties (where one county reported human cases of WNV and the other reported no cases) with associated between-county differences in human disease. We also controlled for confounding factors of climate, regional variation in mosquito vector type, urbanization, and human socioeconomic factors that are all likely to affect human disease incidence. We found there is lower incidence of human WNV in eastern US counties that have greater avian (viral host) diversity. This pattern exists when examining diversity-disease relationships both before WNV reached the US (in 1998) and once the epidemic was underway ( in 2002). The robust disease-diversity relationships confirm that the dilution effect can be observed in another emerging infectious disease and illustrate an important ecosystem service provided by biodiversity, further supporting the growing view that protecting biodiversity should be considered in public health and safety plans.	[Swaddle, John P.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Swaddle, John P.; Calos, Stavros E.] Coll William & Mary, Inst Integrative Bird Behavior Stud, Biol Dept, Williamsburg, VA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; William & Mary	Swaddle, JP (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	jpswad@wm.edu			NSF [EF-0436318, DEB-0553768]; National Center for Ecological Analysis and Synthesis [Sabbatical Fellow]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); National Center for Ecological Analysis and Synthesis; University of California, Santa Barbara(University of California System); State of California	This work was funded by NSF (Grant #EF-0436318 to JPS) and partially conducted while a Sabbatical Fellow at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #DEB-0553768), the University of California, Santa Barbara, and the State of California. The funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bowen RA, 2007, CURR OPIN INFECT DIS, V20, P293, DOI 10.1097/QCO.0b013e32816b5cad; Caffrey C, 2005, CONDOR, V107, P128, DOI 10.1650/7646; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Eidson M, 2005, EMERG INFECT DIS, V11, P1370; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Garvin MC, 2004, AM J TROP MED HYG, V70, P566, DOI 10.4269/ajtmh.2004.70.566; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P57, DOI 10.1089/vbz.2006.6.57; Jourdain E, 2007, VECTOR-BORNE ZOONOT, V7, P448, DOI 10.1089/vbz.2006.0592; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2005, AM J TROP MED HYG, V73, P1031, DOI 10.4269/ajtmh.2005.73.1031; Krasnov BR, 2007, OECOLOGIA, V154, P185, DOI 10.1007/s00442-007-0824-x; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Male T, 2003, CONSERV BIOL, V17, P928, DOI 10.1046/j.1523-1739.2003.02424.x; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Roberts RS, 2006, VECTOR-BORNE ZOONOT, V6, P1, DOI 10.1089/vbz.2006.6.1; Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; SAUER JR, 2007, N AM BREEDING BIRD S; THRALL PH, 1993, AM NAT, V142, P543, DOI 10.1086/285554; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360	32	135	146	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2488	10.1371/journal.pone.0002488	http://dx.doi.org/10.1371/journal.pone.0002488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575599	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000016
J	Stjernman, M; Raberg, L; Nilsson, JA				Stjernman, Martin; Raberg, Lars; Nilsson, Jan-Ake			Maximum Host Survival at Intermediate Parasite Infection Intensities	PLOS ONE			English	Article								Background: Although parasitism has been acknowledged as an important selective force in the evolution of host life histories, studies of fitness effects of parasites in wild populations have yielded mixed results. One reason for this may be that most studies only test for a linear relationship between infection intensity and host fitness. If resistance to parasites is costly, however, fitness may be reduced both for hosts with low infection intensities (cost of resistance) and high infection intensities (cost of parasitism), such that individuals with intermediate infection intensities have highest fitness. Under this scenario one would expect a non-linear relationship between infection intensity and fitness. Methodology/Principal Findings: Using data from blue tits (Cyanistes caeruleus) in southern Sweden, we investigated the relationship between the intensity of infection of its blood parasite (Haemoproteus majoris) and host survival to the following winter. Presence and intensity of parasite infections were determined by microscopy and confirmed using PCR of a 480bp section of the cytochrome-b-gene. While a linear model suggested no relationship between parasite intensity and survival (F = 0.01, p = 0.94), a non-linear model showed a significant negative quadratic effect (quadratic parasite intensity: F = 4.65, p = 0.032; linear parasite intensity F = 4.47, p = 0.035). Visualization using the cubic spline technique showed maximum survival at intermediate parasite intensities. Conclusions/Significance: Our results indicate that failing to recognize the potential for a non-linear relationship between parasite infection intensity and host fitness may lead to the potentially erroneous conclusion that the parasite is harmless to its host. Here we show that high parasite intensities indeed reduced survival, but this effect was masked by reduced survival for birds heavily suppressing their parasite intensities. Reduced survival among hosts with low parasite intensities suggests costs of controlling parasite infections; however, the nature of such costs remains to be elucidated.	[Stjernman, Martin; Raberg, Lars; Nilsson, Jan-Ake] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	Lund University	Stjernman, M (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	martin.stjernman@zooekol.lu.se			Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Lunds Djurskyddsfond; Swedish Research Council	Royal Physiographic Society in Lund; Royal Swedish Academy of Sciences; Lunds Djurskyddsfond; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study received financial support from the Royal Physiographic Society in Lund (to MS), the Royal Swedish Academy of Sciences, and Lunds Djurskyddsfond (to MS & LR), and from the Swedish Research Council (to J-AN). None of the sponsors/funders had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; ATKINSON CT, 1988, J PARASITOL, V74, P228, DOI 10.2307/3282448; BENNETT GF, 1988, J WILDLIFE DIS, V24, P339, DOI 10.7589/0090-3558-24.2.339; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; BULL CM, 1993, OECOLOGIA, V96, P415, DOI 10.1007/BF00317513; Desser Sherwin S., 1993, P273; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Raberg L, 2003, EVOLUTION, V57, P1670, DOI 10.1554/02-417; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; RICHNER H, 1995, P NATL ACAD SCI USA, V92, P1192, DOI 10.1073/pnas.92.4.1192; Sambrook J., 2002, MOL CLONING LAB MANU; SAS Institute, 1999, SAS ONL DOC V8; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Svensson L., 1992, IDENTIFICATION GUIDE; Telfer S, 2002, J ANIM ECOL, V71, P558, DOI 10.1046/j.1365-2656.2002.00623.x; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; WEATHERHEAD PJ, 1992, CAN J ZOOL, V70, P1, DOI 10.1139/z92-001; Westneat DF, 1998, P ROY SOC B-BIOL SCI, V265, P1065, DOI 10.1098/rspb.1998.0400	27	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2463	10.1371/journal.pone.0002463	http://dx.doi.org/10.1371/journal.pone.0002463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560544	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700044
J	Wang, CH; Lee, DY; Deng, ZQ; Jeyapalan, Z; Lee, SC; Kahai, S; Lu, WY; Zhang, Y; Yang, BB				Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Lu, Wei-Yang; Zhang, Yaou; Yang, Burton B.			MicroRNA miR-328 Regulates Zonation Morphogenesis by Targeting CD44 Expression	PLOS ONE			English	Article								Morphogenesis is crucial to initiate physiological development and tumor invasion. Here we show that a microRNA controls zonation morphogenesis by targeting hyaluronan receptor CD44. We have developed a novel system to study microRNA functions by generating constructs expressing pre-miRNAs and mature miRNAs. Using this system, we have demonstrated that expression of miR-328 reduced cell adhesion, aggregation, and migration, and regulated formation of capillary structure. Protein analysis indicated that miR-328 repressed CD44 expression. Activities of luciferase constructs harboring the target site in CD44, but not the one containing mutation, were repressed by miR-328. Zonation morphogenesis appeared in cells transfected by miR-328: miR-328-transfected cells were present on the surface of zonating structures while the control cells stayed in the middle. MiR-328-mediated CD44 actions was validated by anti-CD44 antibody, hyaluronidase, CD44 siRNA, and CD44 expression constructs. In vivo experiments showed that CD44-silencing cells appeared as layers on the surfaces of nodules or zonating structures. Immuno-histochemistry also exhibited CD44-negative cells on the surface layers of normal rat livers and the internal zones of Portal veins. Our results demonstrate that miR-328 targets CD44, which is essential in regulating zonation morphogenesis: silencing of CD44 expression is essential in sealing the zonation structures to facilitate their extension and to inhibit complex expansion.	[Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Lu, Wei-Yang; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Wang, Chia-Hui; Lee, Daniel Y.; Deng, Zhaoqun; Jeyapalan, Zina; Lee, Shao-Chen; Kahai, Shireen; Yang, Burton B.] University of Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lu, Wei-Yang] Univ Toronto, Dept Anaesthesia, Toronto, ON, Canada; [Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Life Sci Div, Shenzhen, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Wang, CH (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca	Lu, Wei-Yang/K-4404-2013		Canadian Institutes of Health Research [MOP-62729]; Canadian Breast Cancer Foundation Ontario Chapter [5958]; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation Ontario Chapter; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a grant from Canadian Institutes of Health Research (MOP-62729) and a grant from Canadian Breast Cancer Foundation Ontario Chapter to Burton B. Yang who is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cullen BR, 2007, SCIENCE, V317, P329, DOI 10.1126/science.1146077; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gakunga P, 1997, DEVELOPMENT, V124, P3987; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Makunin IV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001133; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; TERPE HJ, 1993, VIRCHOWS ARCH A, V422, P219, DOI 10.1007/BF01621805; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211; YEW L, 2008, PLOS ONE, V3, pE1719; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	66	84	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2420	10.1371/journal.pone.0002420	http://dx.doi.org/10.1371/journal.pone.0002420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560585	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700007
J	Guerreiro, RJ; Schymick, JC; Crews, C; Singleton, A; Hardy, J; Traynor, BJ				Guerreiro, Rita J.; Schymick, Jennifer C.; Crews, Cynthia; Singleton, Andrew; Hardy, John; Traynor, Bryan J.			TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article								Background: TAR DNA binding protein, encoded by TARDBP, was shown to be a central component of ubiquitin-positive, tau-negative inclusions in frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS). Recently, mutations in TARDBP have been linked to familial and sporadic ALS. Methodology/Principal Findings: To further examine the frequency of mutations in TARDBP in sporadic ALS, 279 ALS cases and 806 neurologically normal control individuals of European descent were screened for sequence variants, copy number variants, genetic and haplotype association with disease. An additional 173 African samples from the Human Gene Diversity Panel were sequenced as this population had the highest likelihood of finding changes. No mutations were found in the ALS cases. Several genetic variants were identified in controls, which were considered as non-pathogenic changes. Furthermore, pathogenic structural variants were not observed in the cases and there was no genetic or haplotype association with disease status across the TARDBP locus. Conclusions: Our data indicate that genetic variation in TARDBP is not a common cause of sporadic ALS in North American.	[Guerreiro, Rita J.; Schymick, Jennifer C.; Crews, Cynthia; Singleton, Andrew; Traynor, Bryan J.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Guerreiro, Rita J.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Schymick, Jennifer C.] Univ Oxford, Dept Physiol, Anat & Genet, Oxford, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Inst, London, England; [Hardy, John] Inst Neurol, Dept Neurodegen Dis, Reta Lila Weston Inst, London, England; [Traynor, Bryan J.] NIH, NINDS, Neurogenet Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade de Coimbra; University of Oxford; University of London; University College London; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Guerreiro, RJ (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	portalegrer@nia.nih.gov	Traynor, Bryan J/G-5690-2010; Sander-Effron, Samuel/AAX-2231-2020; Singleton, Andrew B/C-3010-2009; Resource Center, NINDS Human Genetics/AGF-2474-2022; Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486	ALS Association; Packard Center for ALS Research at Hopkins; NIA [1 Z01 AG000951-06]; NINDS; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/27442/2006]; MRC [G0701075] Funding Source: UKRI; Medical Research Council [G0701075] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [Z01AG000951, ZIAAG000933, Z01AG000957] Funding Source: NIH RePORTER	ALS Association; Packard Center for ALS Research at Hopkins; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the ALS Association, the Packard Center for ALS Research at Hopkins, the intramural programs of NIA (1 Z01 AG000951-06) and NINDS and grant #SFRH/BD/27442/2006 from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI T, 2008, BIOCHEM BIOPH RES CO, V351, P602; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Cann HM, 2002, SCIENCE, V296, P261; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; GIJSELINCK I, 2007, NEUROBIOL AGING 1207; GITCHO MA, 2008, ANN NEUROL      0220; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; KABASHI E, 2008, NAT GENET       0330; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; VANDEERLIN VM, 2008, LANCET NEUROL   0404; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WINTON MJ, 2006, J BIOL CHEM     0227	30	57	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2450	10.1371/journal.pone.0002450	http://dx.doi.org/10.1371/journal.pone.0002450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545701	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800058
J	Jelluma, N; Brenkman, AB; McLeod, I; Yates, JR; Cleveland, DW; Medema, RH; Kops, GJPL				Jelluma, Nannette; Brenkman, Arjan B.; McLeod, Ian; Yates, John R., III; Cleveland, Don W.; Medema, Rene H.; Kops, Geert J. P. L.			Chromosomal Instability by Inefficient Mps1 Auto-Activation Due to a Weakened Mitotic Checkpoint and Lagging Chromosomes	PLOS ONE			English	Article								Background: Chromosomal instability (CIN), a feature widely shared by cells from solid tumors, is caused by occasional chromosome missegregations during cell division. Two of the causes of CIN are weakened mitotic checkpoint signaling and persistent merotelic attachments that result in lagging chromosomes during anaphase. Principal Findings: Here we identify an autophosphorylation event on Mps1 that is required to prevent these two causes of CIN. Mps1 is phosphorylated in mitotic cells on at least 7 residues, 4 of which by autophosphorylation. One of these, T676, resides in the activation loop of the kinase domain and a mutant that cannot be phosphorylated on T676 is less active than wild-type Mps1 but is not kinase-dead. Strikingly, cells in which endogenous Mps1 was replaced with this mutant are viable but missegregate chromosomes frequently. Anaphase is initiated in the presence of misaligned and lagging chromosomes, indicative of a weakened checkpoint and persistent merotelic attachments, respectively. Conclusions/Significance: We propose that full activity of Mps1 is essential for maintaining chromosomal stability by allowing resolution of merotelic attachments and to ensure that single kinetochores achieve the strength of checkpoint signaling sufficient to prevent premature anaphase onset and chromosomal instability. To our knowledge, phosphorylation of T676 on Mps1 is the first post-translational modification in human cells of which the absence causes checkpoint weakening and CIN without affecting cell viability.	[Jelluma, Nannette; Brenkman, Arjan B.; Kops, Geert J. P. L.] UMC Utrecht, Canc Genom Ctr, Dept Physiol Chem, Utrecht, Netherlands; [Jelluma, Nannette; Medema, Rene H.; Kops, Geert J. P. L.] UMC Utrecht, Dept Med Oncol, Lab Expt Oncol, Utrecht, Netherlands; [McLeod, Ian; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Jelluma, N (corresponding author), UMC Utrecht, Canc Genom Ctr, Dept Physiol Chem, Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl	Medema, Rene H/E-2981-2013; Cleveland, Don/AAN-9783-2021; Medema, Rene H/G-5415-2011	Medema, Rene/0000-0002-6754-0381; Cleveland, Don/0000-0002-1934-3682; Kops, Geert/0000-0003-3555-5295	EU [LSHC-CT-2004-503438];  [UU-2006-3664];  [VIDI-91776336];  [ZonMW 91846616]	EU(European Commission); ; ; 	This work was supported by grants awarded to G.J.P.L.K. (UU-2006-3664 and VIDI-91776336) and R.H.M. (ZonMW 91846616). A.B.B. was supported by a grant from the EU (LSHC-CT-2004-503438).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cheeseman I. M., 2005, SCI STKE, V2005, P11; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Doak SH, 2004, MUTAT RES-FUND MOL M, V547, P133, DOI 10.1016/j.mrfmmm.2003.12.009; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Heim S, 1995, CANC CYTOGENETICS; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weitzel DH, 2000, CELL TISSUE RES, V300, P57, DOI 10.1007/s004410000189; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044	32	63	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2415	10.1371/journal.pone.0002415	http://dx.doi.org/10.1371/journal.pone.0002415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545697	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800052
J	Martin, B; Pearson, M; Brenneman, R; Golden, E; Keselman, A; Iyun, T; Carlson, OD; Egan, JM; Becker, KG; Wood, W; Prabhu, V; de Cabo, R; Maudsley, S; Mattson, MP				Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Keselman, Alex; Iyun, Titilola; Carlson, Olga D.; Egan, Josephine M.; Becker, Kevin G.; Wood, William, III; Prabhu, Vinayakumar; de Cabo, Rafael; Maudsley, Stuart; Mattson, Mark P.			Conserved and Differential Effects of Dietary Energy Intake on the Hippocampal Transcriptomes of Females and Males	PLOS ONE			English	Article								The level of dietary energy intake influences metabolism, reproductive function, the development of age-related diseases, and even cognitive behavior. Because males and females typically play different roles in the acquisition and allocation of energy resources, we reasoned that dietary energy intake might differentially affect the brains of males and females at the molecular level. To test this hypothesis, we performed a gene array analysis of the hippocampus in male and female rats that had been maintained for 6 months on either ad libitum (control), 20% caloric restriction (CR), 40% CR, intermittent fasting (IF) or high fat/high glucose (HFG) diets. These diets resulted in expected changes in body weight, and circulating levels of glucose, insulin and leptin. However, the CR diets significantly increased the size of the hippocampus of females, but not males. Multiple genes were regulated coherently in response to energy restriction diets in females, but not in males. Functional physiological pathway analyses showed that the 20% CR diet down-regulated genes involved in glycolysis and mitochondrial ATP production in males, whereas these metabolic pathways were up-regulated in females. The 40% CR diet up-regulated genes involved in glycolysis, protein deacetylation, PGC-1 alpha and mTor pathways in both sexes. IF down-regulated many genes in males including those involved in protein degradation and apoptosis, but up-regulated many genes in females including those involved in cellular energy metabolism, cell cycle regulation and protein deacetylation. Genes involved in energy metabolism, oxidative stress responses and cell death were affected by the HFG diet in both males and females. The gender-specific molecular genetic responses of hippocampal cells to variations in dietary energy intake identified in this study may mediate differential behavioral responses of males and females to differences in energy availability.	[Martin, Bronwen; Pearson, Michele; Brenneman, Randall; Golden, Erin; Keselman, Alex; Iyun, Titilola; Maudsley, Stuart; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Carlson, Olga D.; Egan, Josephine M.] NIA, Lab Clin Invest, Intramural Res Program, Baltimore, MD USA; [Becker, Kevin G.; Wood, William, III; Prabhu, Vinayakumar] NIA, Gene Expression & Genom Unit, Intramural Res Program, Baltimore, MD USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, Intramural Res Program, Baltimore, MD USA; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Martin, B (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.	martinbro@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; de Cabo, Rafael/E-7996-2010; Maudsley, Stuart/Q-4782-2019; de Cabo, Rafael Carlos/J-5230-2016; Mattson, Mark P/F-6038-2012; de Cabo, Rafael/J-5230-2016	Maudsley, Stuart/0000-0002-1868-184X; de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000315, Z01AG000368, ZIAAG000331, Z01AG000314, Z01AG000315, Z01AG000616, ZICAG000616, ZIAAG000330, ZIAAG000314] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging.	Antunes-Martins A, 2007, LEARN MEMORY, V14, P693, DOI 10.1101/lm.640307; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; Connan F, 2006, PSYCHIAT RES-NEUROIM, V146, P117, DOI 10.1016/j.pscychresns.2005.10.006; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Ferguson GD, 2004, HIPPOCAMPUS, V14, P964, DOI 10.1002/hipo.20013; Gatward N, 2007, EUR EAT DISORD REV, V15, P1, DOI 10.1002/erv.718; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Levine AS, 1997, ANNU REV NUTR, V17, P597, DOI 10.1146/annurev.nutr.17.1.597; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mahmoud GS, 2006, J NEUROPHYSIOL, V95, P2962, DOI 10.1152/jn.00947.2005; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2002, NEUROBIOL AGING, V23, P695, DOI 10.1016/S0197-4580(02)00025-8; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perreau VM, 2004, GENE EXPRESSION, V12, P107, DOI 10.3727/000000005783992115; Phillips GR, 2004, J NEUROSCI RES, V78, P38, DOI 10.1002/jnr.20224; Ross JL, 2005, HORM RES, V64, P89, DOI 10.1159/000089323; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sprott RL, 1997, EXP GERONTOL, V32, P205, DOI 10.1016/S0531-5565(96)00065-4; STRUPP BJ, 1986, NEUROPSYCHOBIOLOGY, V15, P89, DOI 10.1159/000118248; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Weindruch R., 1988, RETARDATION AGING DI; Whitney LW, 1999, ANN NEUROL, V46, P425; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234	44	45	45	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2398	10.1371/journal.pone.0002398	http://dx.doi.org/10.1371/journal.pone.0002398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545695	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800036
J	Axe, DD; Dixon, BW; Lu, P				Axe, Douglas D.; Dixon, Brendan W.; Lu, Philip			Stylus: A System for Evolutionary Experimentation Based on a Protein/Proteome Model with Non-Arbitrary Functional Constraints	PLOS ONE			English	Article							PROTEIN EVOLUTION; SEQUENCE; SENSITIVITY; SELECTION; UNIVERSE; ORIGIN	The study of protein evolution is complicated by the vast size of protein sequence space, the huge number of possible protein folds, and the extraordinary complexity of the causal relationships between protein sequence, structure, and function. Much simpler model constructs may therefore provide an attractive complement to experimental studies in this area. Lattice models, which have long been useful in studies of protein folding, have found increasing use here. However, while these models incorporate actual sequences and structures ( albeit non-biological ones), they incorporate no actual functions-relying instead on largely arbitrary structural criteria as a proxy for function. In view of the central importance of function to evolution, and the impossibility of incorporating real functional constraints without real function, it is important that protein-like models be developed around real structure-function relationships. Here we describe such a model and introduce open-source software that implements it. The model is based on the structure-function relationship in written language, where structures are two-dimensional ink paths and functions are the meanings that result when these paths form legible characters. To capture something like the hierarchical complexity of protein structure, we use the traditional characters of Chinese origin. Twenty coplanar vectors, encoded by base triplets, act like amino acids in building the character forms. This vector-world model captures many aspects of real proteins, including life-size sequences, a life-size structural repertoire, a realistic genetic code, secondary, tertiary, and quaternary structure, structural domains and motifs, operon-like genetic structures, and layered functional complexity up to a level resembling bacterial genomes and proteomes. Stylus is a full-featured implementation of the vector world for Unix systems. To demonstrate the utility of Stylus, we generated a sample set of homologous vector proteins by evolving successive lines from a single starting gene. These homologues show sequence and structure divergence resembling those of natural homologues in many respects, suggesting that the system may be sufficiently life-like for informative comparison to biology.	[Axe, Douglas D.; Dixon, Brendan W.; Lu, Philip] Inst Biol, Redmond, WA USA		Axe, DD (corresponding author), Inst Biol, Redmond, WA USA.	daxe@biologicinstitute.org			Biologic Institute	Biologic Institute	The work was paid for by general research funds of Biologic Institute.	Axe DD, 1998, BIOCHEMISTRY-US, V37, P7157, DOI 10.1021/bi9804028; Axe DD, 2000, J MOL BIOL, V301, P585, DOI 10.1006/jmbi.2000.3997; Axe DD, 2004, J MOL BIOL, V341, P1295, DOI 10.1016/j.jmb.2004.06.058; Axe DD, 1996, P NATL ACAD SCI USA, V93, P5590, DOI 10.1073/pnas.93.11.5590; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Brenner SE, 1996, METHOD ENZYMOL, V266, P635; CHAN HS, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881371; Chan Hue Sun, 2002, Appl Bioinformatics, V1, P121; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Das S, 2000, ADV PROTEIN CHEM, V54, P159, DOI 10.1016/S0065-3233(00)54006-6; Deeds Eric J., 2007, V75, P133; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Drake JW, 1998, GENETICS, V148, P1667; EDEN M, 1967, MATH CHALLENGES NEO, P109; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hirst JD, 1999, PROTEIN ENG, V12, P721, DOI 10.1093/protein/12.9.721; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kimura M., 1983, NEUTRAL THEORY MOL E; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LEVIN BR, 1981, GENETICS, V99, P1; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHUTZENBERGER MP, 1967, MATH CHALLENGES NEO, P75; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xia Y, 2004, CURR OPIN STRUC BIOL, V14, P202, DOI 10.1016/j.sbi.2004.03.001; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P1224, DOI 10.1371/journal.pcbi.0030139	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2246	10.1371/journal.pone.0002246	http://dx.doi.org/10.1371/journal.pone.0002246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523658	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300001
J	Driemeyer, J; Boyke, J; Gaser, C; Buchel, C; May, A				Driemeyer, Joenna; Boyke, Janina; Gaser, Christian; Buechel, Christian; May, Arne			Changes in Gray Matter Induced by Learning-Revisited	PLOS ONE			English	Article								Background: Recently, activation-dependant structural brain plasticity in humans has been demonstrated in adults after three months of training a visio-motor skill. Learning three-ball cascade juggling was associated with a transient and highly selective increase in brain gray matter in the occipito-temporal cortex comprising the motion sensitive area hMT/V5 bilaterally. However, the exact time-scale of usage-dependant structural changes occur is still unknown. A better understanding of the temporal parameters may help to elucidate to what extent this type of cortical plasticity contributes to fast adapting cortical processes that may be relevant to learning. Principal Findings: Using a 3 Tesla scanner and monitoring whole brain structure we repeated and extended our original study in 20 healthy adult volunteers, focussing on the temporal aspects of the structural changes and investigated whether these changes are performance or exercise dependant. The data confirmed our earlier observation using a mean effects analysis and in addition showed that learning to juggle can alter gray matter in the occipito-temporal cortex as early as after 7 days of training. Neither performance nor exercise alone could explain these changes. Conclusion: We suggest that the qualitative change (i.e. learning of a new task) is more critical for the brain to change its structure than continued training of an already-learned task.	[Driemeyer, Joenna; Boyke, Janina; Buechel, Christian; May, Arne] Univ Hamburg UKE, Dept Syst Neurosci, Hamburg, Germany; [Gaser, Christian] Univ Jena, Dept Psychiat, Jena, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena	Driemeyer, J (corresponding author), Univ Hamburg UKE, Dept Syst Neurosci, Hamburg, Germany.	a.may@uke.uni-hamburg.de	Gaser, Christian/F-5103-2010	Gaser, Christian/0000-0002-9940-099X				ANDERSON BJ, 1994, GLIA, V11, P73, DOI 10.1002/glia.440110110; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Etgen T, 2005, NEUROIMAGE, V24, P1242, DOI 10.1016/j.neuroimage.2004.10.021; Gaser C, 2003, J NEUROSCI, V23, P9240; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Swain RA, 2003, NEUROSCIENCE, V117, P1037, DOI 10.1016/S0306-4522(02)00664-4; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720	18	318	323	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2669	10.1371/journal.pone.0002669	http://dx.doi.org/10.1371/journal.pone.0002669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648501	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900001
J	Kaplan, D; Lacetera, N; Kaplan, C				Kaplan, David; Lacetera, Nicola; Kaplan, Celia			Sample Size and Precision in NIH Peer Review	PLOS ONE			English	Article								The Working Group on Peer Review of the Advisory Committee to the Director of NIH has recommended that at least 4 reviewers should be used to assess each grant application. A sample size analysis of the number of reviewers needed to evaluate grant applications reveals that a substantially larger number of evaluators are required to provide the level of precision that is currently mandated. NIH should adjust their peer review system to account for the number of reviewers needed to provide adequate precision in their evaluations.	[Kaplan, David] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Lacetera, Nicola] Case Western Reserve Univ, Dept Econ, Cleveland, OH USA; [Kaplan, Celia] Brandeis Univ, Dept Psychol, Waltham, MA USA	Case Western Reserve University; Case Western Reserve University; Brandeis University	Kaplan, D (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	david.kaplan@case.edu		Lacetera, Nicola/0000-0002-3191-8792				Kaplan D, 2007, FASEB J, V21, P305, DOI 10.1096/fj.07-0204ufm; 2008, ENHANCING PEER REV N; 2006, CSR SCORING PROCEDUR; ENHANCING PEER REV S	4	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2761	10.1371/journal.pone.0002761	http://dx.doi.org/10.1371/journal.pone.0002761			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648494	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900031
J	Daubersies, P; Ollomo, B; Sauzet, JP; Brahimi, K; Perlaza, BL; Eling, W; Moukana, H; Rouquet, P; De Taisne, C; Druilhe, P				Daubersies, Pierre; Ollomo, Benjamin; Sauzet, Jean-Pierre; Brahimi, Karima; Perlaza, Blanca-Liliana; Eling, Wijnand; Moukana, Hubert; Rouquet, Pierre; De Taisne, Charles; Druilhe, Pierre			Genetic Immunisation by Liver Stage Antigen 3 Protects Chimpanzees against Malaria despite Low Immune Responses	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; PLASMODIUM-FALCIPARUM; DNA VACCINES; IN-VITRO; IMMUNOGENICITY; SPOROZOITE; INDUCTION; EFFICACY; HELPER; VACCINATION	Background: The true interest of genetic immunisation might have been hastily underestimated based on overall immunogenicity data in humans and lack of parallelism with other, more classical immunisation methods. Principal Findings: Using malaria Liver Stage Antigen-3 (LSA-3), we report that genetic immunization induces in chimpanzees, the closest relative of humans, immune responses which are as scarce as those reported using other DNA vaccines in humans, but which nonetheless confer strong, sterile and reproducible protection. The pattern was consistent in 3/4 immunized apes against two high dose sporozoite challenges performed as late as 98 and 238 days post-immunization and by a heterologous strain. Conclusions: These results should, in our opinion, lead to a revisiting of the value of this unusual means of immunisation, using as a model a disease, malaria, in which virulent challenges of volunteers are ethically acceptable.	[Daubersies, Pierre; Sauzet, Jean-Pierre; Brahimi, Karima; Perlaza, Blanca-Liliana; Druilhe, Pierre] Inst Pasteur, Unite Parasitol Biomed, Paris, France; [Ollomo, Benjamin; Moukana, Hubert; Rouquet, Pierre] Ctr Int Rech Med Franceville, Franceville, Gabon; [Eling, Wijnand] Univ Nijmegen, Dept Med Microbiol, Nijmegen, Netherlands; [De Taisne, Charles] Aventis Pasteur, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Radboud University Nijmegen; Sanofi-Aventis; Sanofi France	Daubersies, P (corresponding author), Inst Pasteur, Unite Parasitol Biomed, Paris, France.	druilhe@pasteur.fr			European Comission Inco-DC [CT-980387]; Centre International de Recherche Medical de Franceville; Aventis Pasteur	European Comission Inco-DC; Centre International de Recherche Medical de Franceville; Aventis Pasteur	This work received support from the European Comission Inco-DC Grant CT-980387, from the Centre International de Recherche Medical de Franceville and from Aventis Pasteur.	Alarcon JB, 1999, ADV PARASIT, V42, P343, DOI 10.1016/S0065-308X(08)60152-9; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; Bottius E, 1996, J IMMUNOL, V156, P2874; Boyer JD, 2000, J INFECT DIS, V181, P476, DOI 10.1086/315229; Brahimi K, 2001, INFECT IMMUN, V69, P3845, DOI 10.1128/IAI.69.6.3845-3952.2001; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Druilhe P., 1998, MALARIA PARASITE BIO; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hedstrom RC, 1998, INT J MOL MED, V2, P29; HERRINGTON DA, 1991, AM J TROP MED HYG, V45, P695, DOI 10.4269/ajtmh.1991.45.695; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Lema OE, 1999, AM J TROP MED HYG, V60, P177, DOI 10.4269/ajtmh.1999.60.177; Lewis PJ, 1999, ADV VIRUS RES, V54, P129, DOI 10.1016/S0065-3527(08)60367-X; MEIS JFGM, 1990, EXP PARASITOL, V70, P1, DOI 10.1016/0014-4894(90)90080-V; MELLOUK S, 1987, J IMMUNOL, V139, P4192; Perlaza BL, 1998, INFECT IMMUN, V66, P3423, DOI 10.1128/IAI.66.7.3423-3428.1998; Perlaza BL, 2003, EUR J IMMUNOL, V33, P1321, DOI 10.1002/eji.200323339; Perlaza BL, 2001, EUR J IMMUNOL, V31, P2200, DOI 10.1002/1521-4141(200107)31:7&lt;2200::AID-IMMU2200&gt;3.0.CO;2-L; PERLAZA BL, 2008, EUR J IMMUNOL UNPUB; PONNUDURAI T, 1989, T ROY SOC TROP MED H, V83, P67, DOI 10.1016/0035-9203(89)90708-6; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Sauzet JP, 2001, INFECT IMMUN, V69, P1202, DOI 10.1128/IAI.69.2.1202-1206.2001; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, J IMMUNOL, V139, P2020; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; Shi FH, 2002, VACCINE, V20, P3629, DOI 10.1016/S0264-410X(02)00398-5; Smooker Peter M, 2004, Biotechnol Annu Rev, V10, P189, DOI 10.1016/S1387-2656(04)10007-0; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 1998, INFECT IMMUN, V66, P4193; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476	35	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2659	10.1371/journal.pone.0002659	http://dx.doi.org/10.1371/journal.pone.0002659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628827	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200005
J	del Fresno, C; Gomez-Pina, V; Lores, V; Soares-Schanoski, A; Fernandez-Ruiz, I; Rojo, B; Alvarez-Sala, R; Caballero-Garrido, E; Garcia, F; Veliz, T; Arnalich, F; Fuentes-Prior, P; Garcia-Rio, F; Lopez-Collazo, E				del Fresno, Carlos; Gomez-Pina, Vanesa; Lores, Vanesa; Soares-Schanoski, Alessandra; Fernandez-Ruiz, Irene; Rojo, Blas; Alvarez-Sala, Rodolfo; Caballero-Garrido, Ernesto; Garcia, Felipe; Veliz, Tania; Arnalich, Francisco; Fuentes-Prior, Pablo; Garcia-Rio, Francisco; Lopez-Collazo, Eduardo			Monocytes from Cystic Fibrosis Patients Are Locked in an LPS Tolerance State: Down-Regulation of TREM-1 as Putative Underlying Mechanism	PLOS ONE			English	Article								Cystic Fibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene that codes for the chloride channel, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). CF patients are frequently colonized by several pathogens, but the mechanisms that allow colonization in spite of apparently functional immune systems are incompletely understood. In this paper we show that blood peripheral monocytes isolated from CF patients are found in an endotoxin tolerance state, yet this is not due to a deficient TLR activation. On the other hand, levels of the amplifier of inflammatory responses, TREM-1 (Triggering Receptor Expressed on Myeloid cells), are notably down-regulated in monocytes from patients, in comparison to those extracted from healthy volunteers. Furthermore, the soluble form of TREM-1 (sTREM-1) was not detected in the sera of patients. Additionally, and in strict contrast to patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), CF monocytes challenged ex vivo with LPS neither up-regulated membrane-anchored TREM-1 nor sTREM-1. Finally, similar levels of PGE(2) expression and p65 translocation into the nucleus were found in both patients and healthy volunteers, thus suggesting that TREM-1 regulation is neither controlled by PGE(2) levels nor by p65 activation in this case. However, PU.1 translocation into the nucleus was significantly higher in CF monocytes than in controls, suggesting a role for this transcription factor in the control of TREM-1 expression. We conclude that down-regulation of TREM-1 expression in cystic fibrosis patients is at least partly responsible for the endotoxin tolerance state in which their monocytes are locked.	[del Fresno, Carlos; Gomez-Pina, Vanesa; Soares-Schanoski, Alessandra; Fernandez-Ruiz, Irene; Caballero-Garrido, Ernesto; Lopez-Collazo, Eduardo] Hosp La Paz, Res Unit, Madrid, Spain; [Lores, Vanesa; Rojo, Blas; Alvarez-Sala, Rodolfo; Garcia-Rio, Francisco] Hosp La Paz, Serv Resp Dis, Madrid, Spain; [Garcia, Felipe] EMPIREO Mol Diagnost, Discover Unit, Madrid, Spain; [Veliz, Tania] Ist Humanitas, Rozzano, Italy; [Arnalich, Francisco] Univ Autonoma Madrid, Hosp La Paz, Med Sch, Dept Med, Emergency Serv, Madrid, Spain; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; IRCCS Humanitas Research Hospital; Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	del Fresno, C (corresponding author), Hosp La Paz, Res Unit, Madrid, Spain.	elopezc.hulp@salud.madrid.org	Del Fresno, Carlos/F-2624-2016; Arnalich, Francisco/J-8184-2017; Garcia-Rio, Francisco/AAC-9981-2020; Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/AAF-5924-2021; Caballero-Garrido, Ernesto/Q-4401-2019; Del Fresno Sánchez, CArlos/AAY-1525-2021; Del Fresno, Carlos/ABD-7766-2020; Schanoski, Alessandra/H-8144-2014; Lopez-Collazo, Eduardo/U-6634-2018	Del Fresno, Carlos/0000-0003-1771-7254; Arnalich, Francisco/0000-0003-2943-0373; Caballero-Garrido, Ernesto/0000-0002-4644-7524; Del Fresno, Carlos/0000-0003-1771-7254; Schanoski, Alessandra/0000-0002-6514-8458; Alvarez-Sala, Rodolfo/0000-0002-3442-670X; Fuentes-Prior, Pablo/0000-0002-6618-3204; Fernandez Ruiz, Irene/0000-0001-5138-1649; Garcia, Felipe/0000-0002-4099-0120; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Garcia-Rio, Francisco/0000-0002-7227-2238	MEC; FMMA	MEC(European Commission); FMMA	MEC and FMMA	Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dehus O, 2006, J ENDOTOXIN RES, V12, P171, DOI 10.1179/096805106X102156; DeKoter RP, 2007, BLOOD CELL MOL DIS, V39, P316, DOI 10.1016/j.bcmd.2007.06.004; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; DORIN JR, 1987, NATURE, V326, P614, DOI 10.1038/326614a0; ELBORN JS, 1992, AM J RESP CELL MOL, V6, P207, DOI 10.1165/ajrcmb/6.2.207; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Gibot S, 2006, CURR OPIN INVEST DR, V7, P438; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; GIBOT S, 2007, CLIN MED RES, V39, P604; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Haselmayer P, 2007, BLOOD, V110, P1029, DOI 10.1182/blood-2007-01-069195; Henkel GW, 2002, INT IMMUNOL, V14, P723, DOI 10.1093/intimm/dxf040; Hoefnagel JJ, 2006, MODERN PATHOL, V19, P1270, DOI 10.1038/modpathol.3800650; Horonenko G, 2007, CHEST, V132, P58, DOI 10.1378/chest.06-2731; How CK, 2007, INT J CLIN PRACT; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Knapp S, 2004, J IMMUNOL, V173, P7131, DOI 10.4049/jimmunol.173.12.7131; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; Liu CL, 2007, RESP MED, V101, P903, DOI 10.1016/j.rmed.2006.09.021; Lopez-Collazo E, 1998, J IMMUNOL, V160, P2889; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Massengale ARD, 1999, AM J RESP CELL MOL, V20, P1073, DOI 10.1165/ajrcmb.20.5.3243; Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06; Mouri F, 2008, EUR J HAEMATOL, V80, P10, DOI 10.1111/j.1600-0609.2007.00981.x; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; NORMAN D, 1991, THORAX, V46, P91, DOI 10.1136/thx.46.2.91; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Radsak MP, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/52040; Ramsey BW, 1996, NEW ENGL J MED, V335, P179, DOI 10.1056/NEJM199607183350307; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Richeldi L, 2004, EUR RESPIR J, V24, P247, DOI 10.1183/09031936.04.00014204; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; SCHONI MH, 1987, CELL CALCIUM, V8, P53, DOI 10.1016/0143-4160(87)90036-4; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Tejera A, 2007, CYTOKINE, V38, P117, DOI 10.1016/j.cyto.2007.05.002; WILKINSON MM, 1988, J CELL SCI, V91, P221; Xu Y, 2006, J BIOL CHEM, V281, P11279, DOI 10.1074/jbc.M512072200; Xu Y, 2003, J BIOL CHEM, V278, P7674, DOI 10.1074/jbc.M210277200; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270	58	72	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2667	10.1371/journal.pone.0002667	http://dx.doi.org/10.1371/journal.pone.0002667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628981	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200013
J	Kreijveld, E; Koenen, HJPM; van Cranenbroek, B; van Rijssen, E; Joosten, I; Hilbrands, LB				Kreijveld, Ellen; Koenen, Hans J. P. M.; van Cranenbroek, Bram; van Rijssen, Esther; Joosten, Irma; Hilbrands, Luuk B.			Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus	PLOS ONE			English	Article								Background: Transplant patients would benefit from reduction of immunosuppression providing that graft rejection is prevented. We have evaluated a number of immunological markers in blood of patients in whom tacrolimus was withdrawn after renal transplantation. The alloreactive precursor frequency of CD4+ and CD8+ T cells, the frequency of T cell subsets and the functional capacity of CD4+CD25+FoxP3+ regulatory T cells (Treg) were analyzed before transplantation and before tacrolimus reduction. In a case-control design, the results were compared between patients with (n = 15) and without (n = 28) acute rejection after tacrolimus withdrawal. Principal Findings: Prior to tacrolimus reduction, the ratio between memory CD8+ T cells and Treg was higher in rejectors compared to non-rejectors. Rejectors also had a higher ratio between memory CD4+ T cells and Treg, and ratios,20 were only observed in non-rejectors. Between the time of transplantation and the start of tacrolimus withdrawal, an increase in naive T cell frequencies and a reciprocal decrease of effector T cell percentages was observed in rejectors. The proportion of Treg within the CD4+ T cells decreased after transplantation, but anti-donor regulatory capacity of Treg remained unaltered in rejectors and non-rejectors. Conclusions: Immunological monitoring revealed an association between acute rejection following the withdrawal of tacrolimus and 1) the ratio of memory T cells and Treg prior to the start of tacrolimus reduction, and 2) changes in the distribution of naive, effector and memory T cells over time. Combination of these two biomarkers allowed highly specific identification of patients in whom immunosuppression could be safely reduced.	[Kreijveld, Ellen; Koenen, Hans J. P. M.; van Cranenbroek, Bram; van Rijssen, Esther; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Blood Transfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kreijveld, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Blood Transfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	l.hilbrands@nier.umcn.nl	Joosten, Irma/N-4418-2013; Koenen, Hans J.P.M./A-2852-2014; van Rijssen, Esther/K-1049-2016; van Cranenbroek, Bram/K-1549-2016; Hilbrands, Luuk/B-4921-2011	Joosten, Irma/0000-0003-2950-4977; van Rijssen, Esther/0000-0003-1534-5039; van Cranenbroek, Bram/0000-0001-5135-1183; Hilbrands, Luuk/0000-0002-4935-9765				Bakker RC, 2003, KIDNEY INT, V64, P1027, DOI 10.1046/j.1523-1755.2003.00175.x; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Coenen JJA, 2005, TRANSPLANTATION, V79, P147, DOI 10.1097/01.TP.0000147460.93587.87; EL EB, 2006, TRANSPLANTATION, V82, P267; Gregoor PJHS, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013298.11876.BF; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hernandez-Fuentes MP, 2003, IMMUNOL REV, V196, P247, DOI 10.1046/j.1600-065X.2003.00092.x; Hricik DE, 2003, AM J TRANSPLANT, V3, P878, DOI 10.1034/j.1600-6143.2003.00132.x; Jiang SP, 2006, HUM IMMUNOL, V67, P765, DOI 10.1016/j.humimm.2006.07.013; Kreijveld E, 2006, J IMMUNOL METHODS, V314, P103, DOI 10.1016/j.jim.2006.06.001; Lechler RI, 2003, NAT REV IMMUNOL, V3, P147, DOI 10.1038/nri1002; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Nickel P, 2004, TRANSPLANTATION, V78, P1640, DOI 10.1097/01.TP.0000144057.31799.6A; Poggio ED, 2007, TRANSPLANTATION, V83, P847, DOI 10.1097/01.tp.0000258730.75137.39; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Rocha PN, 2003, IMMUNOL REV, V196, P51, DOI 10.1046/j.1600-065X.2003.00090.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salama AD, 2003, J AM SOC NEPHROL, V14, P1643, DOI 10.1097/01.ASN.0000057540.98231.C1; Segall M, 1996, HUM IMMUNOL, V49, P49, DOI 10.1016/0198-8859(96)00055-9; SHARROCK CEM, 1990, IMMUNOL TODAY, V11, P281, DOI 10.1016/0167-5699(90)90113-N; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Solez K, 1998, TRANSPLANTATION, V66, P1736, DOI 10.1097/00007890-199812270-00029; Speiser DE, 1996, BRIT J HAEMATOL, V93, P935; STEINMANN J, 1994, J CLIN LAB ANAL, V8, P157, DOI 10.1002/jcla.1860080308; Suwelack B, 2004, AM J TRANSPLANT, V4, P655, DOI 10.1111/j.1600-6143.2004.00404.x; Tanaka Y, 2005, TRANSPLANTATION, V79, P1262, DOI 10.1097/01.TP.0000161667.99145.20; van Besouw NM, 2000, TRANSPLANTATION, V70, P136; Velthuis JHL, 2006, AM J TRANSPLANT, V6, P2955, DOI 10.1111/j.1600-6143.2006.01566.x; Weir MR, 2001, KIDNEY INT, V59, P1567, DOI 10.1046/j.1523-1755.2001.0590041567.x; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873	30	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2711	10.1371/journal.pone.0002711	http://dx.doi.org/10.1371/journal.pone.0002711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628993	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200054
J	Wilhelm, E; Pellay, FX; Benecke, A; Bell, B				Wilhelm, Emmanuelle; Pellay, Francois-Xavier; Benecke, Arndt; Bell, Brendan			TAF6 delta Controls Apoptosis and Gene Expression in the Absence of p53	PLOS ONE			English	Article								Background: Life and death decisions of metazoan cells hinge on the balance between the expression of pro-versus antiapoptotic gene products. The general RNA polymerase II transcription factor, TFIID, plays a central role in the regulation of gene expression through its core promoter recognition and co-activator functions. The core TFIID subunit TAF6 acts in vitro as an essential co-activator of transcription for the p53 tumor suppressor protein. We previously identified a splice variant of TAF6, termed TAF6 delta that can be induced during apoptosis. Methodology/Principal Findings: To elucidate the impact of TAF6d on cell death and gene expression, we have employed modified antisense oligonucleotides to enforce expression of endogenous TAF6d. The induction of endogenous TAF6d triggered apoptosis in tumor cell lines, including cells devoid of p53. Microarray experiments revealed that TAF6d activates gene expression independently of cellular p53 status. Conclusions: Our data define TAF6d as a pivotal node in a signaling pathway that controls gene expression programs and apoptosis in the absence of p53.	[Wilhelm, Emmanuelle; Bell, Brendan] Univ Sherbrooke, Fac Med & Sci Sante, RNA Grp, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada; [Pellay, Francois-Xavier; Benecke, Arndt] Univ Lille, Inst Rech Interdisciplin, Inst Hautes Etudes Sci, CNRS USR3078, Bures Sur Yvette, France	University of Sherbrooke; Universite de Lille - ISITE; Universite de Lille	Wilhelm, E (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, RNA Grp, Dept Microbiol & Infectiol, Sherbrooke, PQ J1K 2R1, Canada.	Brendan.Bell@USherbrooke.ca	Benecke, Arndt G./T-1079-2019		Nausicaa Combat Sa Leucemie association [doctoral fellowship]; European Hematology Association - Jose Carreras Foundation; French Ministry of Research; Natural Sciences and Engineering Research Council of Canada [Discovery grant]	Nausicaa Combat Sa Leucemie association; European Hematology Association - Jose Carreras Foundation; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	F.X.P. is recipient of a doctoral fellowship from the Nausicaa Combat Sa Leucemie association. A.B.'s group received funds from the European Hematology Association - Jose Carreras Foundation, and the French Ministry of Research through the "Complexite du Vivant - Action STICS-Sante" program. Work in B.B.'s laboratory was funded through a Discovery grant from Natural Sciences and Engineering Research Council of Canada. B.B. holds the Canada Research Chair in Genomic Regulation.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Aoyagi N, 2001, MOL CELL BIOL, V21, P6808, DOI 10.1128/MCB.21.20.6808-6819.2001; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; BROU C, 1993, NUCLEIC ACIDS RES, V21, P5, DOI 10.1093/nar/21.1.5; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; DEATO MD, 2007, GENES DEV; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, MOL CELL BIOL, V16, P4295; Fesus L, 1999, CELL DEATH DIFFER, V6, P1144, DOI 10.1038/sj.cdd.4400608; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kumar S, 2004, TRENDS BIOCHEM SCI, V29, P193, DOI 10.1016/j.tibs.2004.02.001; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lago C, 2005, DEV BIOL, V285, P91, DOI 10.1016/j.ydbio.2005.06.006; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MAY E, 1991, ONCOGENE, V6, P1363; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; MIYASHITA T, 1995, CELL, V80, P293; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P212, DOI 10.1016/S1672-0229(07)60002-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Purrello M, 1998, ONCOGENE, V16, P1633, DOI 10.1038/sj.onc.1201673; ROBLES LM, 2007, J EXP BOT; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang W, 2004, MOL CANCER RES, V2, P442; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; WEINZIERL ROJ, 1993, EMBO J, V12, P5303, DOI 10.1002/j.1460-2075.1993.tb06226.x; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	66	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2721	10.1371/journal.pone.0002721	http://dx.doi.org/10.1371/journal.pone.0002721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628956	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200059
J	Dressel, R; Schindehutte, J; Kuhlmann, T; Elsner, L; Novota, P; Baier, PC; Schillert, A; Bickeboller, H; Herrmann, T; Trenkwalder, C; Paulus, W; Mansouri, A				Dressel, Ralf; Schindehuette, Jan; Kuhlmann, Tanja; Elsner, Leslie; Novota, Peter; Baier, Paul Christian; Schillert, Arne; Bickeboeller, Heike; Herrmann, Thomas; Trenkwalder, Claudia; Paulus, Walter; Mansouri, Ahmed			The Tumorigenicity of Mouse Embryonic Stem Cells and In Vitro Differentiated Neuronal Cells Is Controlled by the Recipients' Immune Response	PLOS ONE			English	Article								Embryonic stem (ES) cells have the potential to differentiate into all cell types and are considered as a valuable source of cells for transplantation therapies. A critical issue, however, is the risk of teratoma formation after transplantation. The effect of the immune response on the tumorigenicity of transplanted cells is poorly understood. We have systematically compared the tumorigenicity of mouse ES cells and in vitro differentiated neuronal cells in various recipients. Subcutaneous injection of 1 x 10(6) ES or differentiated cells into syngeneic or allogeneic immunodeficient mice resulted in teratomas in about 95% of the recipients. Both cell types did not give rise to tumors in immunocompetent allogeneic mice or xenogeneic rats. However, in 61% of cyclosporine A-treated rats teratomas developed after injection of differentiated cells. Undifferentiated ES cells did not give rise to tumors in these rats. ES cells turned out to be highly susceptible to killing by rat natural killer (NK) cells due to the expression of ligands of the activating NK receptor NKG2D on ES cells. These ligands were downregulated on differentiated cells. The activity of NK cells which is not suppressed by cyclosporine A might contribute to the prevention of teratomas after injection of ES cells but not after inoculation of differentiated cells. These findings clearly point to the importance of the immune response in this process. Interestingly, the differentiated cells must contain a tumorigenic cell population that is not present among ES cells and which might be resistant to NK cell-mediated killing.	[Dressel, Ralf; Elsner, Leslie; Novota, Peter] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Schindehuette, Jan; Baier, Paul Christian; Trenkwalder, Claudia; Paulus, Walter; Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, Gottingen, Germany; [Kuhlmann, Tanja] Univ Gottingen, Dept Neuropathol, Gottingen, Germany; [Kuhlmann, Tanja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Schillert, Arne; Bickeboeller, Heike] Univ Gottingen, Dept Genet Epidemiol, Gottingen, Germany; [Schillert, Arne] Univ Lubeck, Inst Med Biomet & Stat, Lubeck, Germany; [Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Munster; University of Gottingen; University of Lubeck; University of Wurzburg; Max Planck Society	Dressel, R (corresponding author), Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany.	rdresse@gwdg.de	Herrmann, Thomas/J-4943-2012; Baier, Paul/F-9765-2010; Bickeböller, Heike/V-2318-2018; Trenkwalder, Claudia/AHD-1232-2022; Trenkwalder, Claudia/ABD-6559-2021; Dressel, Ralf/R-7065-2016; Paulus, Walter/A-3544-2009; Baier, Paul Christian/H-7919-2014	Herrmann, Thomas/0000-0002-1093-0194; Bickeböller, Heike/0000-0002-3361-5488; Trenkwalder, Claudia/0000-0001-6407-1199; Dressel, Ralf/0000-0002-1651-1214; Paulus, Walter/0000-0001-5549-8377; 	Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union [MRTN-CT-2004-512253, TRANS-NET]; Max Planck Society; German Federal Ministry for Research and Technology BMBF [01 GN 0510]; Dr. Helmut Storz and Alte Leipziger Foundation	Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union; Max Planck Society(Max Planck Society); German Federal Ministry for Research and Technology BMBF(Federal Ministry of Education & Research (BMBF)); Dr. Helmut Storz and Alte Leipziger Foundation	This work was supported by grants of the Gottingen Research Fund Medicine, Medical Faculty, University of Gottingen, the European Union (MRTN-CT-2004-512253, TRANS-NET), the Max Planck Society, the German Federal Ministry for Research and Technology BMBF (01 GN 0510), and the Dr. Helmut Storz and Alte Leipziger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2007, J IMMUNOL, V178, P3390, DOI 10.4049/jimmunol.178.6.3390; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Baier PC, 2004, STEM CELLS, V22, P396, DOI 10.1634/stemcells.22-3-396; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; BRUNNER E, 2002, NONPARAMETRIC ANAL L, P1; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dressel R, 2004, J BIOL CHEM, V279, P20200, DOI 10.1074/jbc.M313108200; Dressel R, 2000, J IMMUNOL, V164, P2362, DOI 10.4049/jimmunol.164.5.2362; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, METHOD ENZYMOL, V420, P391, DOI 10.1016/S0076-6879(06)20019-3; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Fair JH, 2005, P NATL ACAD SCI USA, V102, P2958, DOI 10.1073/pnas.0409840102; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gasser S, 2006, CANCER RES, V66, P3959, DOI 10.1158/0008-5472.CAN-05-4603; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Grinnemo KH, 2008, CELL TISSUE RES, V331, P67, DOI 10.1007/s00441-007-0486-3; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; KODAMA HA, 1982, J CELL PHYSIOL, V112, P89, DOI 10.1002/jcp.1041120114; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Thinyane K, 2005, BRAIN RES, V1045, P80, DOI 10.1016/j.brainres.2005.03.033; Tian L, 1997, BIOL REPROD, V57, P561, DOI 10.1095/biolreprod57.3.561; VANDENBRINK MRM, 1990, J EXP MED, V171, P197, DOI 10.1084/jem.171.1.197; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; WANG H, 2007, BLOOD; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	52	86	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2622	10.1371/journal.pone.0002622	http://dx.doi.org/10.1371/journal.pone.0002622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612432	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800024
J	Sendina-Nadal, I; Buldu, JM; Leyva, I; Boccaletti, S				Sendina-Nadal, Irene; Buldu, Javier M.; Leyva, Inmaculada; Boccaletti, Stefano			Phase Locking Induces Scale-Free Topologies in Networks of Coupled Oscillators	PLOS ONE			English	Article								An initial unsynchronized ensemble of networking phase oscillators is further subjected to a growing process where a set of forcing oscillators, each one of them following the dynamics of a frequency pacemaker, are added to the pristine graph. Linking rules based on dynamical criteria are followed in the attachment process to force phase locking of the network with the external pacemaker. We show that the eventual locking occurs in correspondence to the arousal of a scale-free degree distribution in the original graph.	[Sendina-Nadal, Irene; Buldu, Javier M.; Leyva, Inmaculada] Univ Rey Juan Carlos, Dept Fis, Madrid, Spain; [Boccaletti, Stefano] Embassy Italy Tel Aviv, Tel Aviv, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy	Universidad Rey Juan Carlos; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Sendina-Nadal, I (corresponding author), Univ Rey Juan Carlos, Dept Fis, Madrid, Spain.	stefano.boccaletti@isc.cnr.it	Buldu, Javier/N-5422-2014; Sendina-Nadal, Irene/M-3083-2013; Leyva, I./M-1820-2013	Buldu, Javier/0000-0002-9345-599X; Sendina-Nadal, Irene/0000-0003-0432-235X; Leyva, I./0000-0001-9634-5385	Spanish Ministry of Science and Technology [FIS2006-08525]; URJC-CM [2006-CET-0643, 2007-CET-1601]; European Project GABA	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); URJC-CM; European Project GABA	Work partly supported by the Spanish Ministry of Science and Technology under Project No. FIS2006-08525, the URJC-CM Projects Nos. 2006-CET-0643 and 2007-CET-1601, and the European Project GABA.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Ebel H, 2002, EVOLUTIONARY GAMES E; LEYVA I, UNPUB; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Stilwell DJ, 2006, SIAM J APPL DYN SYST, V5, P140, DOI 10.1137/050625229; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yin CY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.047102; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	17	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2644	10.1371/journal.pone.0002644	http://dx.doi.org/10.1371/journal.pone.0002644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612423	gold, Green Submitted, Green Published			2022-12-27	WOS:000264065800046
J	Dusek, JA; Otu, HH; Wohlhueter, AL; Bhasin, M; Zerbini, LF; Joseph, MG; Benson, H; Libermann, TA				Dusek, Jeffery A.; Otu, Hasan H.; Wohlhueter, Ann L.; Bhasin, Manoj; Zerbini, Luiz F.; Joseph, Marie G.; Benson, Herbert; Libermann, Towia A.			Genomic Counter-Stress Changes Induced by the Relaxation Response	PLOS ONE			English	Article							PERIPHERAL-BLOOD; GENE-EXPRESSION; DISEASE; MODULATION; MEDICINE	Background: Mind-body practices that elicit the relaxation response (RR) have been used worldwide for millennia to prevent and treat disease. The RR is characterized by decreased oxygen consumption, increased exhaled nitric oxide, and reduced psychological distress. It is believed to be the counterpart of the stress response that exhibits a distinct pattern of physiology and transcriptional profile. We hypothesized that RR elicitation results in characteristic gene expression changes that can be used to measure physiological responses elicited by the RR in an unbiased fashion. Methods/Principal Findings: We assessed whole blood transcriptional profiles in 19 healthy, long-term practitioners of daily RR practice (group M), 19 healthy controls (group N-1), and 20 N-1 individuals who completed 8 weeks of RR training (group N-2). 2209 genes were differentially expressed in group M relative to group N-1 (p < 0.05) and 1561 genes in group N-2 compared to group N-1 (p, 0.05). Importantly, 433 (p, 10210) of 2209 and 1561 differentially expressed genes were shared among long-term (M) and short-term practitioners (N-2). Gene ontology and gene set enrichment analyses revealed significant alterations in cellular metabolism, oxidative phosphorylation, generation of reactive oxygen species and response to oxidative stress in long-term and short-term practitioners of daily RR practice that may counteract cellular damage related to chronic psychological stress. A significant number of genes and pathways were confirmed in an independent validation set containing 5 N-1 controls, 5 N-2 short-term and 6 M long-term practitioners. Conclusions/Significance: This study provides the first compelling evidence that the RR elicits specific gene expression changes in short-term and long-term practitioners. Our results suggest consistent and constitutive changes in gene expression resulting from RR may relate to long term physiological effects. Our study may stimulate new investigations into applying transcriptional profiling for accurately measuring RR and stress related responses in multiple disease settings.	[Dusek, Jeffery A.; Wohlhueter, Ann L.; Benson, Herbert] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Chestnut Hill, MA USA; [Dusek, Jeffery A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Dusek, Jeffery A.; Otu, Hasan H.; Bhasin, Manoj; Zerbini, Luiz F.; Benson, Herbert; Libermann, Towia A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Division of Interdisciplinary Med & Biotechnol, Boston, MA USA; [Otu, Hasan H.; Bhasin, Manoj; Zerbini, Luiz F.; Joseph, Marie G.; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, BIDMC Genom Ctr, Boston, MA USA; [Benson, Herbert] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA; [Dusek, Jeffery A.] Abbott NW Hosp, Inst Hlth & Healing, Minneapolis, MN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Dusek, JA (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Chestnut Hill, MA USA.	hbenson@partners.org; tliberma@bidmc.harvard.edu	Zerbini, Luiz/B-7720-2015	Zerbini, Luiz/0000-0003-0736-9508; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X; Dusek, Jeffery/0000-0001-9581-0564; Otu, Hasan/0000-0002-9253-8152	Centers for Disease Control and Prevention (CDC) [H75/CCH 19124, H75/CCH 123424, R01 DP000339]; National Institutes of Health [M01 RR01032]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was funded by grants H75/CCH 19124, H75/CCH 123424 and R01 DP000339 (HB) from the Centers for Disease Control and Prevention (CDC) and M01 RR01032 (HB) from the National Institutes of Health (to Harvard-Thorndike BIDMC GCRC).	Astin JA, 2003, J AM BOARD FAM PRACT, V16, P131, DOI 10.3122/jabfm.16.2.131; BEARY JF, 1974, PSYCHOSOM MED, V36, P115, DOI 10.1097/00006842-197403000-00003; BENSON H, 1975, Journal of Human Stress, V1, P37; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BENSON H, 1981, J FLA MED ASSOC, V68, P265; BENSON H, 1983, TRENDS NEUROSCI, V6, P281, DOI 10.1016/0166-2236(83)90120-0; Benson H, 1978, Cardiovasc Clin, V9, P113; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Dusek JA, 2006, MED SCI MONITOR, V12, pCR1; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Escher JC, 2003, INFLAMM BOWEL DIS, V9, P34, DOI 10.1097/00054725-200301000-00006; GLASER R, 1990, ARCH GEN PSYCHIAT, V47, P707; GLASER R, 1993, BEHAV NEUROSCI, V107, P525, DOI 10.1037/0735-7044.107.3.525; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irie M, 2002, PSYCHOTHER PSYCHOSOM, V71, P90, DOI 10.1159/000049351; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacobs GD, 1996, BIOFEEDBACK SELF-REG, V21, P121, DOI 10.1007/BF02284691; KESTERSON J, 1989, AM J PHYSIOL, V256, pR632, DOI 10.1152/ajpregu.1989.256.3.R632; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Lee Norman H, 2007, Methods Mol Biol, V353, P265; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li QZ, 2005, J ALTERN COMPLEM MED, V11, P29, DOI 10.1089/acm.2005.11.29; Morita K, 2005, NEUROSCI LETT, V381, P57, DOI 10.1016/j.neulet.2005.01.081; Nakao M, 2001, BEHAV MED, V26, P169, DOI 10.1080/08964280109595764; Peng CK, 2004, INT J CARDIOL, V95, P19, DOI 10.1016/j.ijcard.2003.02.006; PLATT JE, 1995, PROG NEURO-PSYCHOPH, V19, P65, DOI 10.1016/0278-5846(94)00105-Q; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Sternberg EM, 1997, NAT MED, V3, P264, DOI 10.1038/nm0397-264; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WALLACE RK, 1971, AM J PHYSIOL, V221, P795, DOI 10.1152/ajplegacy.1971.221.3.795; WARRENBURG S, 1980, Journal of Behavioral Medicine, V3, P73, DOI 10.1007/BF00844915; Yamaguchi T, 2002, BIOCHEM BIOPH RES CO, V293, P517, DOI 10.1016/S0006-291X(02)00233-4; Zheng KC, 2007, J OCCUP HEALTH, V49, P32, DOI 10.1539/joh.49.32; Zieker J, 2007, MOL PSYCHIATR, V12, P116, DOI 10.1038/sj.mp.4001905	38	150	151	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2576	10.1371/journal.pone.0002576	http://dx.doi.org/10.1371/journal.pone.0002576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596974	Green Published, gold			2022-12-27	WOS:000263288200041
J	Perez-Mancera, PA; Bermejo-Rodriguez, C; Sanchez-Martin, M; Abollo-Jimenez, F; Pintado, B; Sanchez-Garcia, I				Perez-Mancera, Pedro A.; Bermejo-Rodriguez, Camino; Sanchez-Martin, Manuel; Abollo-Jimenez, Fernando; Pintado, Belen; Sanchez-Garcia, Isidro			FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPAR gamma and C/EBP alpha and Activating eIF4E	PLOS ONE			English	Article								Background: FUS-DDIT3 is a chimeric protein generated by the most common chromosomal translocation t( 12;16)( q13;p11) linked to liposarcomas, which are characterized by the accumulation of early adipocytic precursors. Current studies indicate that FUS-DDIT3- liposarcoma develops from uncommitted progenitors. However, the precise mechanism whereby FUS-DDIT3 contributes to the differentiation arrest remains to be elucidated. Methodology/Principal Findings: Here we have characterized the adipocyte regulatory protein network in liposarcomas of FUS-DITT3 transgenic mice and showed that PPAR gamma 2 and C/EBP alpha expression was altered. Consistent with in vivo data, FUS-DDIT3 MEFs and human liposarcoma cell lines showed a similar downregulation of both PPAR gamma 2 and C/EBP alpha expression. Complementation studies with gamma but not C/EBP alpha rescued the differentiation block in committed adipocytic precursors expressing FUS-DDIT3. Our results further show that FUS-DDIT3 interferes with the control of initiation of translation by upregulation of the eukaryotic translation initiation factors eIF2 and eIF4E both in FUS-DDIT3 mice and human liposarcomas ;cell lines, explaining the shift towards the truncated p30 isoform of C/EBP alpha in liposarcomas. Suppression of the FUS-DDIT3 transgene did rescue this adipocyte differentiation block. Moreover, eIF4E was also strongly upregulated in normal adipose tissue of FUS-DDIT3 transgenic mice, suggesting that overexpression of eIF4E may be a primary event in the initiation of liposarcomas. Reporter assays showed FUS-DDIT3 is involved in the upregulation of eIF4E in liposarcomas and that both domains of the fusion protein are required for affecting eIF4E expression. Conclusions/Significance: Taken together, this study provides evidence of the molecular mechanisms involve in the disruption of normal adipocyte differentiation program in liposarcoma harbouring the chimeric gene FUS-DDIT3.	[Perez-Mancera, Pedro A.; Bermejo-Rodriguez, Camino; Abollo-Jimenez, Fernando; Sanchez-Garcia, Isidro] Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Cancer, CSIC, E-37008 Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, Dept Med, Salamanca, Spain; [Sanchez-Martin, Manuel] Univ Salamanca, SEA, Genet Engineered Mouse Facil, Salamanca, Spain; [Pintado, Belen] CSIC, CNB, Genet Engineered Mouse Facil, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Perez-Mancera, PA (corresponding author), Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Cancer, CSIC, E-37008 Salamanca, Spain.	isg@usal.es	Sanchez-Martin, Manuel/N-5327-2016; Jimenez, Fernando A./K-3376-2014; 2008, Ibsal/A-1268-2012; Pintado, Belen/N-3233-2014; SANCHEZ-GARCIA, ISIDRO/A-5631-2019	Sanchez-Martin, Manuel/0000-0001-8370-1336; Jimenez, Fernando A./0000-0003-4363-7653; Pintado, Belen/0000-0002-8485-2520; SANCHEZ-GARCIA, ISIDRO/0000-0001-6989-9905	FEDER; MEC [SAF2006-03726, PETRI N 95-0913.OP]; Junta de Castilla y Leon [CSI03A05]; FIS [PI050087, PI050116]; Fundacion de Investigacion MMA; Federacion de Cajas de Ahorro Castilla y Leon; CDTEAM project; MEC Consolider-Ingenio 2010 [CSD2007-0017]; Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria [PI04-1271]; Fundacion Manuel Solorzano, University of Salamanca [SA085A06]	FEDER(European Commission); MEC(European Commission); Junta de Castilla y Leon(Junta de Castilla y Leon); FIS(Instituto de Salud Carlos III); Fundacion de Investigacion MMA; Federacion de Cajas de Ahorro Castilla y Leon; CDTEAM project; MEC Consolider-Ingenio 2010; Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Manuel Solorzano, University of Salamanca	Research in ISG group is supported partially by FEDER and by MEC (SAF2006-03726 and PETRI N 95-0913.OP), Junta de Castilla y Leon (CSI03A05), FIS (PI050087, PI050116), Fundacion de Investigacion MMA, Federacion de Cajas de Ahorro Castilla y Leon (I Convocatoria de Ayudas para Proyectos de Investigacion Biosanitaria con Celulas Madre), CDTEAM project (CENIT-Ingenio 2010) and MEC Consolider-Ingenio 2010 (Ref. CSD2007-0017). MSM is supported by the Ramon y Cajal Scientific Spanish Program, Fondo Investigacion Sanitaria (FIS PI04-1271), Junta de Castilla y Leon (SA085A06) and Fundacion Manuel Solorzano, University of Salamanca.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Altabef M, 1996, EMBO J, V15, P2707, DOI 10.1002/j.1460-2075.1996.tb00631.x; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Perez-Mancera PA, 2007, HUM MOL GENET, V16, P2972, DOI 10.1093/hmg/ddm278; BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goransson M, 2002, EXP CELL RES, V278, P125, DOI 10.1006/excr.2002.5566; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; MACK TM, 1995, CANCER-AM CANCER SOC, V75, P211, DOI 10.1002/1097-0142(19950101)75:1+<211::AID-CNCR2820751309>3.0.CO;2-X; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Perez-Caro M, 2007, ONCOGENE, V26, P1702, DOI 10.1038/sj.onc.1209968; Perez-Losada J, 2000, ONCOGENE, V19, P6015, DOI 10.1038/sj.onc.1204018; Perez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572; Perez-Mancera PA, 2005, HUM MOL GENET, V14, P3449, DOI 10.1093/hmg/ddi373; Perez-Mancera PA, 2005, SEMIN CANCER BIOL, V15, P206, DOI 10.1016/j.semcancer.2005.01.006; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Perez-Mancera PA, 2002, ONCOGENE, V21, P1679, DOI 10.1038/sj.onc.1205220; Perez-Mancera PA, 2007, CARCINOGENESIS, V28, P2069, DOI 10.1093/carcin/bgm107; PRASAD DDK, 1994, ONCOGENE, V9, P3717; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; Sanchez-Garcia I, 1997, ANNU REV GENET, V31, P429, DOI 10.1146/annurev.genet.31.1.429; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Thelin-Jarnum S, 1999, INT J CANCER, V83, P30, DOI 10.1002/(SICI)1097-0215(19990924)83:1<30::AID-IJC6>3.0.CO;2-4; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; *US DEP HHS, 2002, US CANC STAT 1999 IN; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	44	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2569	10.1371/journal.pone.0002569	http://dx.doi.org/10.1371/journal.pone.0002569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596980	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200034
J	Xiang, JH; McLinden, JH; Chang, Q; Jordan, EL; Stapleton, JT				Xiang, Jinhua; McLinden, James H.; Chang, Qing; Jordan, Emma L.; Stapleton, Jack T.			Characterization of a Peptide Domain within the GB Virus C NS5A Phosphoprotein that Inhibits HIV Replication	PLOS ONE			English	Article							HEPATITIS-G VIRUS; BLOOD MONONUCLEAR-CELLS; HUMAN LYMPHOID-TISSUE; TYPE-1 REPLICATION; T-LYMPHOCYTE; INFECTION; PROTEIN; EXPRESSION; SURVIVAL; SEQUENCE	Background: GBV-C infection is associated with prolonged survival in HIV-infected people and GBV-C inhibits HIV replication in co-infection models. Expression of the GBV-C nonstructural phosphoprotein 5A (NS5A) decreases surface levels of the HIV co-receptor CXCR4, induces the release of SDF-1 and inhibits HIV replication in Jurkat CD4+ T cell lines. Methodology/Principal Findings: Jurkat cell lines stably expressing NS5A protein and peptides were generated and HIV replication in these cell lines assessed. HIV replication was significantly inhibited in all cell lines expressing NS5A amino acids 152-165. Substitution of an either alanine or glycine for the serine at position 158 (S158A or S158G) resulted in a significant decrease in the HIV inhibitory effect. In contrast, substituting a phosphomimetic amino acid (glutamic acid; S158E) inhibited HIV as well as the parent peptide. HIV inhibition was associated with lower levels of surface expression of the HIV coreceptor CXCR4 and increased release of the CXCR4 ligand, SDF-1 compared to control cells. Incubation of CD4+ T cell lines with synthetic peptides containing amino acids 152-167 or the S158E mutant peptide prior to HIV infection resulted in HIV replication inhibition compared to control peptides. Conclusions/Significance: Expression of GBV-C NS5A amino acids 152 - 165 are sufficient to inhibit HIV replication in vitro, and the serine at position 158 appears important for this effect through either phosphorylation or structural changes in this peptide. The addition of synthetic peptides containing 152 - 167 or the S158E substitution to Jurkat cells resulted in HIV replication inhibition in vitro. These data suggest that GBV-C peptides or a peptide mimetic may offer a novel, cellular-based approach to antiretroviral therapy.	[Xiang, Jinhua; McLinden, James H.; Chang, Qing; Jordan, Emma L.; Stapleton, Jack T.] Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Xiang, JH (corresponding author), Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA USA.	jack-stapleton@uiowa.edu		Stapleton, Jack/0000-0002-2302-9055	Veterans Administration [Merit Review Grants]; NIH [AI-58740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058740] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Merit Review Grants from the Veterans Administration (JX and JTS), and by an NIH RO1 grant (AI-58740, JTS). The funders of this work had no input into the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Bjorkman P, 2007, AIDS, V21, P1641, DOI 10.1097/QAD.0b013e32823bc9b7; Chang Q, 2007, J GEN VIROL, V88, P3341, DOI 10.1099/vir.0.83198-0; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Feucht HH, 1997, HEPATOLOGY, V26, P491, DOI 10.1002/hep.510260234; Fogeda M, 2000, J VIROL, V74, P7936, DOI 10.1128/JVI.74.17.7936-7942.2000; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Garcia M, 2005, J VIROL, V79, P9197, DOI 10.1128/JVI.79.14.9197-9205.2005; George SL, 2006, J INFECT DIS, V193, P451, DOI 10.1086/499435; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; HERMANN B, 2007, ANTIMICROB AGENTS CH, V51, P1596; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jungbauer Alois, 2007, Biotechnology Journal, V2, P647, DOI 10.1002/biot.200790060; KENNY MT, 1970, APPL MICROBIOL, V20, P371, DOI 10.1128/AEM.20.3.371-373.1970; Khudyakov YE, 1997, J VIROL, V71, P6875, DOI 10.1128/JVI.71.9.6875-6880.1997; Leary TP, 1996, J MED VIROL, V48, P60, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;60::AID-JMV10&gt;3.0.CO;2-A; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Madejon A, 1997, GASTROENTEROLOGY, V113, P573, DOI 10.1053/gast.1997.v113.pm9247478; Okamoto T, 2008, J VIROL, V82, P3480, DOI 10.1128/JVI.02253-07; Pan Y, 2007, BIOCHEM BIOPH RES CO, V359, P70, DOI 10.1016/j.bbrc.2007.05.052; PilotMatias TJ, 1996, VIROLOGY, V225, P282, DOI 10.1006/viro.1996.0602; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Sinn PL, 2003, J VIROL, V77, P5902, DOI 10.1128/JVI.77.10.5902-5910.2003; Stapleton JT, 2004, J CLIN MICROBIOL, V42, P3915, DOI 10.1128/JCM.42.9.3915-3919.2004; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Tacke M, 1997, LANCET, V349, P318, DOI 10.1016/S0140-6736(96)06461-6; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Vanpouille C, 2007, J VIROL, V81, P12458, DOI 10.1128/JVI.00326-07; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; Xiang JH, 2005, J INFECT DIS, V192, P2147, DOI 10.1086/498170; Xiang JH, 2005, J INTERF CYTOK RES, V25, P261, DOI 10.1089/jir.2005.25.261; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Xiang WS, 2006, PESTIC BIOCHEM PHYS, V85, P1, DOI 10.1016/j.pestbp.2005.09.001; Yu YJ, 2000, NAT MED, V6, P933, DOI 10.1038/78704; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	49	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2580	10.1371/journal.pone.0002580	http://dx.doi.org/10.1371/journal.pone.0002580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596910	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200044
J	Losin, EAR; Russell, JL; Freeman, H; Meguerditchian, A; Hopkins, WD				Losin, Elizabeth A. Reynolds; Russell, Jamie L.; Freeman, Hani; Meguerditchian, Adrien; Hopkins, William D.			Left Hemisphere Specialization for Oro-Facial Movements of Learned Vocal Signals by Captive Chimpanzees	PLOS ONE			English	Article							SPECIES-SPECIFIC VOCALIZATIONS; ORIENTING ASYMMETRIES; FACIAL EXPRESSION; CEREBRAL LATERALIZATION; NEURAL LATERALIZATION; JAPANESE MACAQUES; RHESUS-MONKEYS; COMMUNICATION; HANDEDNESS; DOMINANCE	Background: The left hemisphere of the human brain is dominant in the production of speech and signed language. Whether similar lateralization of function for communicative signal production is present in other primates remains a topic of considerable debate. In the current study, we examined whether oro-facial movements associated with the production of learned attention-getting sounds are differentially lateralized compared to facial expressions associated with the production of species-typical emotional vocalizations in chimpanzees. Methodology/Principal Findings: Still images captured from digital video were used to quantify oro-facial asymmetries in the production of two attention-getting sounds and two species-typical vocalizations in a sample of captive chimpanzees. Comparisons of mouth asymmetries during production of these sounds revealed significant rightward biased asymmetries for the attention-getting sounds and significant leftward biased asymmetries for the species-typical sounds. Conclusions/Significance: These results suggest that the motor control of oro-facial movements associated with the production of learned sounds is lateralized to the left hemisphere in chimpanzees. Furthermore, the findings suggest that the antecedents for lateralization of human speech may have been present in the common ancestor of chimpanzees and humans similar to 5 mya and are not unique to the human lineage.	[Losin, Elizabeth A. Reynolds; Russell, Jamie L.; Freeman, Hani; Meguerditchian, Adrien; Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA USA; [Losin, Elizabeth A. Reynolds] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA	University of California System; University of California Los Angeles	Losin, EAR (corresponding author), Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA.	whopkin@emory.edu	Meguerditchian, Adrien/H-3047-2013; Meguerditchian, Adrien/AAB-6367-2022	Meguerditchian, Adrien/0000-0003-3754-6747; Meguerditchian, Adrien/0000-0003-3754-6747	NIH [NS-36605, NS-42867, HD-38105, HD-56232]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036605, R01NS042867] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This was was supported by NIH grants NS-36605, NS-42867, HD-38105 and HD-56232.	BAUER RH, 1993, PSYCHOBIOLOGY, V21, P243; Boesch C, 2000, CHIMPANZEES TAI FORE; Borod JC, 1997, NEUROPSYCHOL REV, V7, P41, DOI 10.1007/BF02876972; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Bradshaw John., 1998, HUMAN EVOLUTION NEUR; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Corballis MC, 2002, HAND MOUTH ORIGINS L; Corina DP, 1999, LANG SPEECH, V42, P307, DOI 10.1177/00238309990420020801; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Davidson Richard J., 1995, P361; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fernandez-Carriba S, 2002, NEUROPSYCHOLOGIA, V40, P1523, DOI 10.1016/S0028-3932(02)00028-3; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; FOUNDAS AL, 1995, ARCH NEUROL-CHICAGO, V52, P501, DOI 10.1001/archneur.1995.00540290091023; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRAVES R, 1990, INT J PSYCHOL, V25, P179, DOI 10.1080/00207599008247856; GRAVES R, 1982, NEUROPSYCHOLOGIA, V20, P371, DOI 10.1016/0028-3932(82)90037-9; Hauser M.D., 1999, DESIGN ANIMAL COMMUN; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HAUSER MD, 1993, SCIENCE, V261, P475, DOI 10.1126/science.8332914; Hausmann M, 1998, NEUROPSYCHOLOGIA, V36, P1397, DOI 10.1016/S0028-3932(98)00027-X; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Holowka S, 2002, SCIENCE, V297, P1515, DOI 10.1126/science.1074941; Hook-Costigan MA, 1998, NEUROPSYCHOLOGIA, V36, P1265, DOI 10.1016/S0028-3932(98)00037-2; Hopkins WD, 2005, PSYCHOL SCI, V16, P487; Hopkins WD, 2004, NEUROPSYCHOLOGIA, V42, P990, DOI 10.1016/j.neuropsychologia.2003.11.017; HOPKINS WD, 2007, EVOUTION HEMISPHERIC; HOPKINS WD, 2003, PRIMATE PSYCHOL; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; JURGENS U, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P199; Kay RF, 1998, P NATL ACAD SCI USA, V95, P5417, DOI 10.1073/pnas.95.9.5417; Kimura D., 1993, NEUROMOTOR MECH HUMA; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liebesman S, 2003, QUAL PROG, V36, P62; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; McGrew WC, 1997, YEARB PHYS ANTHROPOL, V40, P201; Meador KJ, 1999, NEUROLOGY, V53, P2028, DOI 10.1212/WNL.53.9.2028; Meguerditchian A, 2006, BEHAV BRAIN RES, V171, P170, DOI 10.1016/j.bbr.2006.03.018; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Provins KA, 1997, PSYCHOL REV, V104, P554, DOI 10.1037/0033-295X.104.3.554; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Rogers L, 1993, EVOLUTION LATERAL AS; Rogers LJ, 2002, COMP VERTEBRATE LATE; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Shafer Dulce D., 1993, P267; Sherwood CC, 2005, ANAT REC PART A, V287A, P1067, DOI 10.1002/ar.a.20259; Sherwood CC, 2003, ANN NY ACAD SCI, V1000, P99, DOI 10.1196/annals.1280.016; Sherwood CC, 2005, J HUM EVOL, V48, P45, DOI 10.1016/j.jhevol.2004.10.003; Suthers RA, 1999, DESIGN OF ANIMAL COMMUNICATION, P37; TAGLIALATELA JP, 2004, THESIS GEORGIA STATE, P103; TAGLIALATELA JP, 2007, EVOLUTION HEMISPHERI; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; Theall Laura A., 1999, Animal Cognition, V2, P207, DOI 10.1007/s100710050041; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807	69	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2529	10.1371/journal.pone.0002529	http://dx.doi.org/10.1371/journal.pone.0002529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575610	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000044
J	Dahiya, N; Sherman-Baust, CA; Wang, TL; Davidson, B; Shih, IM; Zhang, YQ; Wood, W; Becker, KG; Morin, PJ				Dahiya, Neetu; Sherman-Baust, Cheryl A.; Wang, Tian-Li; Davidson, Ben; Shih, Ie-Ming; Zhang, Yongqing; Wood, William, III; Becker, Kevin G.; Morin, Patrice J.			MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer	PLOS ONE			English	Article							HUMAN LUNG CANCERS; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; GENE-EXPRESSION; RISK-FACTORS; MICROARRAY; PROFILES; SURVIVAL; LET-7; DEREGULATION	Background: MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by targeting mRNAs and triggering either translation repression or RNA degradation. Emerging evidence suggests the potential involvement of altered regulation of miRNA in the pathogenesis of cancers, and these genes are thought to function as both tumor suppressors and oncogenes. Methodology/Principal Findings: Using microRNA microarrays, we identify several miRNAs aberrantly expressed in human ovarian cancer tissues and cell lines. miR-221 stands out as a highly elevated miRNA in ovarian cancer, while miR-21 and several members of the let-7 family are found downregulated. Public databases were used to reveal potential targets for the highly differentially expressed miRNAs. In order to experimentally identify transcripts whose stability may be affected by the differentially expressed miRNAs, we transfected precursor miRNAs into human cancer cell lines and used oligonucleotide microarrays to examine changes in the mRNA levels. Interestingly, there was little overlap between the predicted and the experimental targets or pathways, or between experimental targets/pathways obtained using different cell lines, highlighting the complexity of miRNA target selection. Conclusion/Significance: Our results identify several differentially expressed miRNAs in ovarian cancer and identify potential target transcripts that may be regulated by these miRNAs. These miRNAs and their targets may have important roles in the initiation and development of ovarian cancer.	[Dahiya, Neetu; Sherman-Baust, Cheryl A.; Morin, Patrice J.] Hopkins Med Inst, Cellular & Mol Biol Lab, Baltimore, MD USA; [Wang, Tian-Li; Shih, Ie-Ming; Morin, Patrice J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD USA; [Davidson, Ben] Norwegian Radium Hosp, Oslo, Norway; [Zhang, Yongqing; Wood, William, III; Becker, Kevin G.] NIA, Res Resource Branch, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Dahiya, N (corresponding author), Hopkins Med Inst, Cellular & Mol Biol Lab, Baltimore, MD USA.	morinp@grc.nia.nih.gov	sdsd, shihieih/ABE-6190-2020; Dahiya, Neetu/E-5208-2011	Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the NIH, National Institute on Aging.; NATIONAL INSTITUTE ON AGING [Z01AG000616, ZICAG000616, ZIAAG000398, Z01AG000512, Z01AG000398] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; FRANKEL LB, 2007, J BIOL CHEM; GIANNAKAKIS A, 2007, CANC BIOL THER, V7; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kitada T, 2003, HISTOPATHOLOGY, V43, P550, DOI 10.1111/j.1365-2559.2003.01733.x; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; NAKAJIMA T, 1995, CARCINOGENESIS, V16, P707, DOI 10.1093/carcin/16.4.707; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; VASUDEVAN S, 2007, SCIENCE; VISONE R, 2007, ONCOGENE; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu W, 2004, CANCER RES, V64, P1757, DOI 10.1158/0008-5472.CAN-03-2546; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	51	288	310	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2436	10.1371/journal.pone.0002436	http://dx.doi.org/10.1371/journal.pone.0002436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560586	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700021
J	Haslam, NJ; Whiteford, NE; Weber, G; Prugel-Bennett, A; Essex, JW; Neylon, C				Haslam, Niall J.; Whiteford, Nava E.; Weber, Gerald; Prugel-Bennett, Adam; Essex, Jonathan W.; Neylon, Cameron			Optimal Probe Length Varies for Targets with High Sequence Variation: Implications for Probe Library Design for Resequencing Highly Variable Genes	PLOS ONE			English	Article								Background: Sequencing by hybridisation is an effective method for obtaining large amounts of DNA sequence information at low cost. The efficiency of SBH depends on the design of the probe library to provide the maximum information for minimum cost. Long probes provide a higher probability of non-repeated sequences but lead to an increase in the number of probes required whereas short probes may not provide unique sequence information due to repeated sequences. We have investigated the effect of probe length, use of reference sequences, and thermal filtering on the design of probe libraries for several highly variable target DNA sequences. Results: We designed overlapping probe libraries for a range of highly variable drug target genes based on known sequence information and develop a formal terminology to describe probe library design. We find that for some targets these libraries can provide good coverage of a previously unseen target whereas for others the coverage is less than 30%. The optimal probe length varies from as short at 12 nt to as large as 19 nt and depends on the sequence, its variability, and the stringency of thermal filtering. It cannot be determined from inspection of an example gene sequence. Conclusions: Optimal probe length and the optimal number of reference sequences used to design a probe library are highly target specific for highly variable sequencing targets. The optimum design cannot be determined simply by inspection of input sequences or of alignments but only by detailed analysis of the each specific target. For highly variable sequences, shorter probes can in some cases provide better information than longer probes. Probe library design would benefit from a general purpose tool for analysing these issues. The formal terminology developed here and the analysis approaches it is used to describe will contribute to the development of such tools.	[Haslam, Niall J.; Whiteford, Nava E.; Weber, Gerald; Essex, Jonathan W.; Neylon, Cameron] Univ Southampton, Sch Chem, Southampton, Hants, England; [Weber, Gerald] Univ Federal Ouro Preto, Inst Ciencias Exatas Biol, Dept Fisica, Ouro Preto, Brazil; [Prugel-Bennett, Adam] Univ Southampton, Sch Engn Comp Sci, Southampton, Hants, England; [Neylon, Cameron] STFC Rutherford Appleton Lab, Harwell Sci & Innovat Campus, Didcot, Oxon, England	University of Southampton; Universidade Federal de Ouro Preto; University of Southampton; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Haslam, NJ (corresponding author), Univ Southampton, Sch Chem, Southampton, Hants, England.	haslam@embl.de	Essex, Jonathan/B-8341-2009; Weber, Gerald/A-8669-2010	Weber, Gerald/0000-0002-2935-1571; Haslam, Niall/0000-0001-7007-5137; Neylon, Cameron/0000-0002-0068-716X	Research Councils UK through the Basic Technology Programme	Research Councils UK through the Basic Technology Programme	The work was funded by the Research Councils UK through the Basic Technology Programme.	Blazewicz J, 2004, COMPUT BIOL CHEM, V28, P11, DOI 10.1016/j.compbiolchem.2003.12.002; Chan EY, 2005, MUTAT RES-FUND MOL M, V573, P13, DOI 10.1016/j.mrfmmm.2005.01.004; Chou CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-232; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Drmanac Radoje, 2002, Adv Biochem Eng Biotechnol, V77, P75; Fedrigo O, 2004, NUCLEIC ACIDS RES, V32, P1208, DOI 10.1093/nar/gkh210; Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Koehler RT, 2005, BIOINFORMATICS, V21, P3333, DOI 10.1093/bioinformatics/bti530; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; van Dam RM, 2002, GENOME RES, V12, P145, DOI 10.1101/gr.198901; WANG Z, 2002, EMERG INFECT DIS, V19, P402; Weber G, 2006, NAT PHYS, V2, P55, DOI 10.1038/nphys189; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	21	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2500	10.1371/journal.pone.0002500	http://dx.doi.org/10.1371/journal.pone.0002500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18563203	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000263280700058
J	Hemminki, K; Forsti, A; Bermejo, JL				Hemminki, Kari; Foersti, Asta; Bermejo, Justo Lorenzo			The 'Common Disease-Common Variant' Hypothesis and Familial Risks	PLOS ONE			English	Article								The recent large genotyping studies have identified a new repertoire of disease susceptibility loci of unknown function, characterized by high allele frequencies and low relative risks, lending support to the common disease-common variant (CDCV) hypothesis. The variants explain a much larger proportion of the disease etiology, measured by the population attributable fraction, than of the familial risk. We show here that if the identified polymorphisms were markers of rarer functional alleles they would explain a much larger proportion of the familial risk. For example, in a plausible scenario where the marker is 10 times more common than the causative allele, the excess familial risk of the causative allele is over 10 times higher than that of the marker allele. However, the population attributable fractions of the two alleles are equal. The penetrance mode of the causative locus may be very difficult to deduce from the apparent penetrance mode of the marker locus.	[Hemminki, Kari; Foersti, Asta; Bermejo, Justo Lorenzo] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Foersti, Asta] Karolinska Inst, Ctr Family & Community Med, Huddinge, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet	Hemminki, K (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	k.hemminki@dkfz.de		Lorenzo Bermejo, Justo/0000-0002-6568-5333	Deutsche Krebshilfe; Swedish Cancer Society; Swedish Council for Working Life and Social Research; EU [LSHC-CT-2004-503465]; BMBF; NGFN plus [FOOD-CT-2005-016320]	Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Cancer Society(Swedish Cancer Society); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); NGFN plus	Supported by Deutsche Krebshilfe, the Swedish Cancer Society, The Swedish Council for Working Life and Social Research and the EU, LSHC-CT-2004-503465, BMBF through NGFN plus and FOOD-CT-2005-016320. The financers have not influenced the contents of the paper nor yet seen it.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHANOCK S, 2008, NATURE E PUB; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HEMMINKI K, 2008, MUTAT RES REV E PUB; HEMMINKI K, 2008, BREAST CANC RES TREA; Hemminki K, 2007, CARCINOGENESIS, V28, P648, DOI 10.1093/carcin/bgl182; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Hernminki K, 2008, MUTAT RES-REV MUTAT, V658, P42, DOI 10.1016/j.mrrev.2007.07.001; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xu SZ, 2003, GENETICS, V165, P2259; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	24	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2504	10.1371/journal.pone.0002504	http://dx.doi.org/10.1371/journal.pone.0002504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560565	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700060
J	Kuhn, I; Harden, P; Bauzon, M; Chartier, C; Nye, J; Thorne, S; Reid, T; Ni, SH; Lieber, A; Fisher, K; Seymour, L; Rubanyi, GM; Harkins, RN; Hermiston, TW				Kuhn, Irene; Harden, Paul; Bauzon, Maxine; Chartier, Cecile; Nye, Julie; Thorne, Steve; Reid, Tony; Ni, Shaoheng; Lieber, Andre; Fisher, Kerry; Seymour, Len; Rubanyi, Gabor M.; Harkins, Richard N.; Hermiston, Terry W.			Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer	PLOS ONE			English	Article								Background: Viral-mediated oncolysis is a novel cancer therapeutic approach with the potential to be more effective and less toxic than current therapies due to the agents selective growth and amplification in tumor cells. To date, these agents have been highly safe in patients but have generally fallen short of their expected therapeutic value as monotherapies. Consequently, new approaches to generating highly potent oncolytic viruses are needed. To address this need, we developed a new method that we term "Directed Evolution'' for creating highly potent oncolytic viruses. Methodology/Principal Findings: Taking the "Directed Evolution'' approach, viral diversity was increased by pooling an array of serotypes, then passaging the pools under conditions that invite recombination between serotypes. These highly diverse viral pools were then placed under stringent directed selection to generate and identify highly potent agents. ColoAd1, a complex Ad3/Ad11p chimeric virus, was the initial oncolytic virus derived by this novel methodology. ColoAd1, the first described non-Ad5-based oncolytic Ad, is 2-3 logs more potent and selective than the parent serotypes or the most clinically advanced oncolytic Ad, ONYX-015, in vitro. ColoAd1's efficacy was further tested in vivo in a colon cancer liver metastasis xenograft model following intravenous injection and its ex vivo selectivity was demonstrated on surgically-derived human colorectal tumor tissues. Lastly, we demonstrated the ability to arm ColoAd1 with an exogenous gene establishing the potential to impact the treatment of cancer on multiple levels from a single agent. Conclusions/Significance: Using the "Directed Evolution'' methodology, we have generated ColoAd1, a novel chimeric oncolytic virus. In vitro, this virus demonstrated a >2 log increase in both potency and selectivity when compared to ONYX-015 on colon cancer cells. These results were further supported by in vivo and ex vivo studies. Furthermore, these results have validated this methodology as a new general approach for deriving clinically-relevant, highly potent anti-cancer virotherapies.	[Kuhn, Irene; Harden, Paul; Bauzon, Maxine; Chartier, Cecile; Nye, Julie; Rubanyi, Gabor M.; Harkins, Richard N.; Hermiston, Terry W.] Bayer Healthcare, Novel Technol, Richmond, CA USA; [Thorne, Steve; Reid, Tony] Stanford Univ, Palo Alto Vet Hosp, Palo Alto, CA USA; [Ni, Shaoheng; Lieber, Andre] Univ Washington, Dept Med, Div Med Genet, Seattle, WA USA; [Fisher, Kerry; Seymour, Len] Hybrid syst Ltd, Oxford, England	Bayer AG; Bayer Healthcare Pharmaceuticals; Stanford University; University of Washington; University of Washington Seattle	Kuhn, I (corresponding author), Bayer Healthcare, Novel Technol, Richmond, CA USA.	Terry.Hermiston@Bayer.com		Lieber, Andre/0000-0001-6742-6266; seymour, len/0000-0003-3825-0841	Bayer Healthcare Pharmaceutics	Bayer Healthcare Pharmaceutics	These studies were supported in their entirety by Bayer Healthcare Pharmaceutics.	Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; Bernal RM, 2002, CLIN CANCER RES, V8, P1915; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Branton PE, 2001, ONCOGENE, V20, P7855, DOI 10.1038/sj.onc.1204862; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Dingli D, 2003, J CELL BIOCHEM, V90, P1079, DOI 10.1002/jcb.10714; Doronin K, 2000, J VIROL, V74, P6147, DOI 10.1128/JVI.74.13.6147-6155.2000; Duque PM, 1999, CANCER GENE THER, V6, P554, DOI 10.1038/sj.cgt.7700077; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Freytag SO, 2002, CANCER RES, V62, P4968; Fuxe J, 2003, INT J CANCER, V103, P723, DOI 10.1002/ijc.10891; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gambhir SS, 2000, NEOPLASIA, V2, P118, DOI 10.1038/sj.neo.7900083; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Geoerger B, 2003, BRIT J CANCER, V89, P577, DOI 10.1038/sj.bjc.6601102; Hann Christine L, 2007, Curr Treat Options Oncol, V8, P28, DOI 10.1007/s11864-007-0024-2; Hawkins LK, 2001, GENE THER, V8, P1123, DOI 10.1038/sj.gt.3301507; Hermiston T, 2000, J CLIN INVEST, V105, P1169, DOI 10.1172/JCI9973; Hermiston T, 2002, CURR OPIN MOL THER, V4, P334; Hermiston TW, 2002, CANCER GENE THER, V9, P1022, DOI 10.1038/sj.cgt.7700542; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Jee YS, 2002, ANTICANCER RES, V22, P2629; Jin F, 2005, MOL THER, V12, P1052, DOI 10.1016/j.ymthe.2005.07.696; Kanerva A, 2005, GENE THER, V12, P87, DOI 10.1038/sj.gt.3302387; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kim M, 2003, BRIT J CANCER, V88, P1411, DOI 10.1038/sj.bjc.6600932; Kirn D, 2001, EXPERT OPIN BIOL TH, V1, P525, DOI 10.1517/14712598.1.3.525; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kretschmer PJ, 2005, MOL THER, V12, P118, DOI 10.1016/j.ymthe.2005.03.019; Kuhn I, 2007, GENE THER, V14, P180, DOI 10.1038/sj.gt.3302851; Lamfers MLM, 2002, CANCER RES, V62, P5736; Li ZY, 2004, MOL THER, V9, P650, DOI 10.1016/j.ymthe.2004.01.021; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; MCDOUGALL I, 1987, J GEN VIROL, V68, P1361, DOI 10.1099/0022-1317-68-5-1361; Mei YF, 2003, J GEN VIROL, V84, P2061, DOI 10.1099/vir.0.19178-0; Mel YF, 1998, VIROLOGY, V240, P254, DOI 10.1006/viro.1997.8904; Mi J, 2001, HUM GENE THER, V12, P1343, DOI 10.1089/104303401750270995; Miller CR, 1998, CANCER RES, V58, P5738; Molnar-Kimber KL, 1998, HUM GENE THER, V9, P2121, DOI 10.1089/hum.1998.9.14-2121; Okegawa T, 2000, CANCER RES, V60, P5031; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527; Phuong LK, 2003, CANCER RES, V63, P2462; Reid T, 2002, CANCER GENE THER, V9, P979, DOI 10.1038/sj.cgt.7700539; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rogulski KR, 2000, HUM GENE THER, V11, P67, DOI 10.1089/10430340050016166; ROSA DD, 2007, CANC TREAT REV; Sachs MD, 2002, UROLOGY, V60, P531, DOI 10.1016/S0090-4295(02)01748-X; Sauthoff H, 2000, HUM GENE THER, V11, P379, DOI 10.1089/10430340050015851; Sauthoff H, 2002, HUM GENE THER, V13, P1859, DOI 10.1089/104303402760372954; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Shabram PW, 1997, HUM GENE THER, V8, P453, DOI 10.1089/hum.1997.8.4-453; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Stone D, 2003, VIROLOGY, V309, P152, DOI 10.1016/S0042-6822(02)00085-5; TOLLEFSON A, 1999, ADENOVIRUS METHODS P; van Beusechem VW, 2002, CANCER RES, V62, P6165; Yan W, 2003, J VIROL, V77, P2640, DOI 10.1128/JVI.77.4.2640-2650.2003; YIP MCM, 1970, J BIOL CHEM, V245, P2199; Yu DC, 2002, CURR OPIN MOL THER, V4, P435; Zeimet AG, 2002, GENE THER, V9, P1093, DOI 10.1038/sj.gt.3301775	61	130	150	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2409	10.1371/journal.pone.0002409	http://dx.doi.org/10.1371/journal.pone.0002409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560559	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700005
J	Lynn, FC; Sanchez, L; Gomis, R; German, MS; Gasa, R				Lynn, Francis C.; Sanchez, Lidia; Gomis, Ramon; German, Michael S.; Gasa, Rosa			Identification of the bHLH Factor Math6 as a Novel Component of the Embryonic Pancreas Transcriptional Network	PLOS ONE			English	Article								Background: Basic helix-loop-helix (bHLH) transcription factors play important roles in differentiation processes during embryonic development of vertebrates. In the pancreas, the atonal-related bHLH gene Neurogenin3 (Neurog3) controls endocrine cell fate specification in uncommitted progenitor cells. Therefore, it is likely that Neurog3-regulated factors will have important functions during pancreatic endocrine cell differentiation. The gene for the atonal-related bHLH factor Math6 was recognized as a potential target of Neurog3 in a genomic scale profiling during endocrine differentiation. Herein we have explored the role of Math6 during endocrine pancreas development. Results: We demonstrate that the Math6 gene is a direct target of Neurog3 in vitro and that, during mouse development, Math6 is expressed in both endocrine and exocrine pancreatic precursor cells. We have investigated the role of Math6 in endocrine differentiation by over-expressing this factor in pancreatic duct cells. Math6 possesses intrinsic transcriptional repressor activity and, in contrast to Neurog3 it does not induce the endocrine differentiation program; however, it can modulate some of the pro-endocrine functions of Neurog3 in this system. In addition, we show that Math6 is broadly expressed in mouse embryonic tissues and its expression is induced by tissue-specific bHLH genes other than Neurog3. Furthermore, inactivation of the Math6 gene in the mouse results in early embryonic lethality demonstrating an essential role of this factor in organismal development. Conclusions: These data demonstrate that Math6 is a novel component of the pancreatic transcriptional network during embryonic development and suggest a potential role for Math6 as a modulator of the differentiation program initiated by the pro-endocrine factor Neurog3. Furthermore, our results demonstrate that Math6 is indispensable for early embryonic development and indicate a more widespread function for this factor in tissue-specific differentiation processes that are dependent on class II bHLH genes.	[Lynn, Francis C.; German, Michael S.] Univ Calif San Francisco, Hormone Res Inst, Ctr Diabet, San Francisco, CA 94143 USA; [Sanchez, Lidia; Gomis, Ramon; Gasa, Rosa] Univ Barcelona, Hosp Clin, IDIBAPS, Diabetes & Obesity Lab,Endocrinol & Nutr Unit, Barcelona, Spain; [Gomis, Ramon; Gasa, Rosa] CIBERDEM, Barcelona, Spain; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of California System; University of California San Francisco	Lynn, FC (corresponding author), Univ Calif San Francisco, Hormone Res Inst, Ctr Diabet, San Francisco, CA 94143 USA.	rgasa@clinic.ub.es		Lynn, Francis/0000-0001-9318-1063	Spanish Ministry of Education and Science [BFU2005-06080, SAF2006-07382]; Larry L. Hillblom Foundation [2007/1B]; National Institutes of Health [R01 DK021344, P30 DK63720]; Juvenile Diabetes Research Foundation [3-2004-276, 10-2007-86]; Ramon y Cajal program from the Ministry of Education and Science of Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344, P30DK063720] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Larry L. Hillblom Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Ramon y Cajal program from the Ministry of Education and Science of Spain; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from: Spanish Ministry of Education and Science (BFU2005-06080 and SAF2006-07382), Larry L. Hillblom Foundation (2007/1B), National Institutes of Health (R01 DK021344) and cores laboratories supported by the National Institutes of Health (P30 DK63720). FCL is a recipient of Juvenile Diabetes Research Foundation fellowship awards 3-2004-276 & 10-2007-86. RG is a recipient of the Ramon y Cajal program from the Ministry of Education and Science of Spain. CIBER de Diabetes y Enfermedades Metabolicas Asociadas is a ISCIII Project.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Brentrup D, 2000, DEVELOPMENT, V127, P4729; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Farah MH, 2000, DEVELOPMENT, V127, P693; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Petri A, 2006, J MOL ENDOCRINOL, V37, P301, DOI 10.1677/jme.1.02096; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Rovira M, 2007, CLONING STEM CELLS, V9, P327, DOI 10.1089/clo.2006.0064; Sander M, 2000, DEVELOPMENT, V127, P5533; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Smith SB, 2004, MOL ENDOCRINOL, V18, P142, DOI 10.1210/me.2003-0037; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; THAYER MJ, 1990, CELL, V63, P23, DOI 10.1016/0092-8674(90)90285-M; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; Watada H, 2000, J BIOL CHEM, V275, P34224, DOI 10.1074/jbc.M004981200; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zammit PS, 2004, DEV BIOL, V273, P454, DOI 10.1016/j.ydbio.2004.05.038; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	55	33	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2430	10.1371/journal.pone.0002430	http://dx.doi.org/10.1371/journal.pone.0002430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560595	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700015
J	Dinov, ID; Rubin, D; Lorensen, W; Dugan, J; Ma, J; Murphy, S; Kirschner, B; Bug, W; Sherman, M; Floratos, A; Kennedy, D; Jagadish, HV; Schmidt, J; Athey, B; Califano, A; Musen, M; Altman, R; Kikinis, R; Kohane, I; Delp, S; Parker, DS; Toga, AW				Dinov, Ivo D.; Rubin, Daniel; Lorensen, William; Dugan, Jonathan; Ma, Jeff; Murphy, Shawn; Kirschner, Beth; Bug, William; Sherman, Michael; Floratos, Aris; Kennedy, David; Jagadish, H. V.; Schmidt, Jeanette; Athey, Brian; Califano, Andrea; Musen, Mark; Altman, Russ; Kikinis, Ron; Kohane, Isaac; Delp, Scott; Parker, D. Stott; Toga, Arthur W.			iTools: A Framework for Classification, Categorization and Integration of Computational Biology Resources	PLOS ONE			English	Article								The advancement of the computational biology field hinges on progress in three fundamental directions - the development of new computational algorithms, the availability of informatics resource management infrastructures and the capability of tools to interoperate and synergize. There is an explosion in algorithms and tools for computational biology, which makes it difficult for biologists to find, compare and integrate such resources. We describe a new infrastructure, iTools, for managing the query, traversal and comparison of diverse computational biology resources. Specifically, iTools stores information about three types of resources - data, software tools and web-services. The iTools design, implementation and resource meta - data content reflect the broad research, computational, applied and scientific expertise available at the seven National Centers for Biomedical Computing. iTools provides a system for classification, categorization and integration of different computational biology resources across space-and-time scales, biomedical problems, computational infrastructures and mathematical foundations. A large number of resources are already iTools-accessible to the community and this infrastructure is rapidly growing. iTools includes human and machine interfaces to its resource meta-data repository. Investigators or computer programs may utilize these interfaces to search, compare, expand, revise and mine meta-data descriptions of existent computational biology resources. We propose two ways to browse and display the iTools dynamic collection of resources. The first one is based on an ontology of computational biology resources, and the second one is derived from hyperbolic projections of manifolds or complex structures onto planar discs. iTools is an open source project both in terms of the source code development as well as its meta-data content. iTools employs a decentralized, portable, scalable and lightweight framework for long-term resource management. We demonstrate several applications of iTools as a framework for integrated bioinformatics. iTools and the complete details about its specifications, usage and interfaces are available at the iTools web page http://iTools.ccb.ucla.edu.	[Dinov, Ivo D.; Ma, Jeff; Parker, D. Stott; Toga, Arthur W.] Univ Calif Los Angeles, Ctr Computat Biol, Los Angeles, CA 90095 USA; [Kirschner, Beth; Jagadish, H. V.; Athey, Brian] Univ Michigan, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI USA; [Floratos, Aris; Califano, Andrea] Columbia Univ, Natl Ctr Multi Scale Study Cellular Networks, New York, NY USA; [Rubin, Daniel; Musen, Mark] Stanford Univ, Natl Ctr Biomed Ontol, Stanford, CA USA; [Dugan, Jonathan; Sherman, Michael; Schmidt, Jeanette; Altman, Russ; Delp, Scott] Stanford Univ, Ctr Phys based Simulat Biol Structures, Stanford, CA USA; [Lorensen, William; Kikinis, Ron] Harvard Univ, Natl Alliance Med Imaging Comput, Cambridge, MA USA; [Murphy, Shawn; Kohane, Isaac] Harvard Univ, Informat Integrat Biol Bedside, Cambridge, MA USA; [Kennedy, David] Massachusetts General Hosp, Neurosci Ctr, Boston, MA USA; [Bug, William] Univ Calif San Diego, Natl Ctr Microscopy Imag Res, San Diego, CA USA	University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Columbia University; Stanford University; Stanford University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego	Dinov, ID (corresponding author), Univ Calif Los Angeles, Ctr Computat Biol, Los Angeles, CA 90095 USA.	toga@loni.ucla.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160; Athey, Brian/0000-0002-9793-535X; Califano, Andrea/0000-0003-4742-3679; Delp, Scott/0000-0002-9643-7551; Musen, Mark/0000-0003-3325-793X; Sherman, Michael/0000-0003-3345-073X; Dinov, Ivo/0000-0003-3825-4375	National Institutes of Health [U54-RR021813, U54-DA021519, U54-CA121852, U54-HG004028, U54-GM072970, U54-EB005149, U54-LM008748]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218, U54RR021813] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grants U54-RR021813 (CCB), U54-DA021519 (NCIBI), U54-CA121852 (MAGNet), U54-HG004028 (NCBO), U54-GM072970 (Simbios), U54-EB005149 (NA-MIC) and U54-LM008748 (I2B2). Information on the National Centers for Biomedical Computing can be obtained from nihroadmap.nih.gov/bioinformatics and www.NCBCs.org.	Badidi E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-63; Berge C., 1973, GRAPHS HYPERGRAPHS; Cannata N, 2005, PLOS COMPUT BIOL, V1, P531, DOI 10.1371/journal.pcbi.0010076; Curbera F, 2002, IEEE INTERNET COMPUT, V6, P86, DOI 10.1109/4236.991449; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; HOMEM M, 2004, SKELETONIZATION 2 DI; HUGHES TJR, 1977, ARCH RATION MECH AN, V63, P273, DOI 10.1007/BF00251584; Kennedy DN, 2006, NEUROINFORMATICS, V4, P263, DOI 10.1385/NI:4:3:263; KIERNAN P, 1972, T AM MATH SOC, V172, P347, DOI 10.2307/1996355; Kim YJ, 2005, NUCLEIC ACIDS RES, V33, P4335, DOI 10.1093/nar/gki739; Koike H., 1993, P 1993 IEEE S VIS LA; LAMPING J, 1994, 7 ANN ACM S US INT S, P13; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Munzner T, 2000, INTERACTIVE VISUALIZ; Neu SC, 2005, NEUROIMAGE, V24, P1170, DOI 10.1016/j.neuroimage.2004.10.035; OSHER S, 2003, GEOMETRIC LEVEL SET; PIEPER S, 2004, IEEE INT S BIOM IM M; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Richtsmeier J. T., 2001, INTER DISC; TU Z, 2008, IEEE T MED IN PRESS; Wilkinson Mark D, 2002, Brief Bioinform, V3, P331, DOI 10.1093/bib/3.4.331	24	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2265	10.1371/journal.pone.0002265	http://dx.doi.org/10.1371/journal.pone.0002265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509477	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500012
J	FitzGerald, J; Luo, M; Chaudhury, A; Berger, F				FitzGerald, Jonathan; Luo, Ming; Chaudhury, Abed; Berger, Frederic			DNA Methylation Causes Predominant Maternal Controls of Plant Embryo Growth	PLOS ONE			English	Article							SEED DEVELOPMENT; CPG METHYLATION; ARABIDOPSIS; GENE; SIZE; ENDOSPERM; ORIGIN; FERTILIZATION; MAINTENANCE; DROSOPHILA	The parental conflict hypothesis predicts that the mother inhibits embryo growth counteracting growth enhancement by the father. In plants the DNA methyltransferase MET1 is a central regulator of parentally imprinted genes that affect seed growth. However the relation between the role of MET1 in imprinting and its control of seed size has remained unclear. Here we combine cytological, genetic and statistical analyses to study the effect of MET1 on seed growth. We show that the loss of MET1 during male gametogenesis causes a reduction of seed size, presumably linked to silencing of the paternal allele of growth enhancers in the endosperm, which nurtures the embryo. However, we find no evidence for a similar role of MET1 during female gametogenesis. Rather, the reduction of MET1 dosage in the maternal somatic tissues causes seed size increase. MET1 inhibits seed growth by restricting cell division and elongation in the maternal integuments that surround the seed. Our data demonstrate new controls of seed growth linked to the mode of reproduction typical of flowering plants. We conclude that the regulation of embryo growth by MET1 results from a combination of predominant maternal controls, and that DNA methylation maintained by MET1 does not orchestrate a parental conflict.	[FitzGerald, Jonathan; Berger, Frederic] Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Chromatin & Reprod Grp, Singapore, Singapore; [Luo, Ming; Chaudhury, Abed] Black Mountain Lab, Commonwealth Sci & Indust Res Org, Canberra, ACT, Australia	National University of Singapore; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	FitzGerald, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Chromatin & Reprod Grp, Singapore, Singapore.	fred@tll.org.sg	Luo, Ming/F-4100-2010	Berger, Frederic/0000-0002-3609-8260	National University of Singapore, Temasek Life Science Laboratory; NSF [INT 0301886]; CSIRO	National University of Singapore, Temasek Life Science Laboratory(National University of Singapore); NSF(National Science Foundation (NSF)); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	F.B. and J.F.G. were supported by the Temasek Life Science Laboratory affiliated to the National University of Singapore. J.F.G. is additionally supported by NSF International Research Fellowship Program grant INT 0301886. A.C. and M.L. were supported by the CSIRO.	Adams S, 2000, DEVELOPMENT, V127, P2493; Browning H, 1996, DEVELOPMENT, V122, P391; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Ferguson-Smith AC, 2006, PLACENTA, V27, pS122, DOI 10.1016/j.placenta.2006.01.015; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Garcia D, 2003, PLANT PHYSIOL, V131, P1661, DOI 10.1104/pp.102.018762; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; KERMICLE JL, 1990, DEVELOPMENT, P9; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Spielman M, 2001, TRENDS GENET, V17, P705, DOI 10.1016/S0168-9525(01)02519-7; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849	31	42	42	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2298	10.1371/journal.pone.0002298	http://dx.doi.org/10.1371/journal.pone.0002298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509545	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500037
J	van Haperen, R; Samyn, H; Moerland, M; van Gent, T; Peeters, M; Grosveld, F; van Tol, A; de Crom, R				van Haperen, Rien; Samyn, Hannelore; Moerland, Matthijs; van Gent, Teus; Peeters, Marian; Grosveld, Frank; van Tol, Arie; de Crom, Rini			Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ADENOVIRUS-MEDIATED OVEREXPRESSION; ANTIINFLAMMATORY PROPERTIES; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; PLTP DEFICIENCY; HDL; MICE; CHOLESTEROL; INCREASES	Background: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerotic lesions, where it seems to be macrophage derived. The aim of the present study is to evaluate the atherogenic potential of macrophage derived PLTP. Methods and Findings: Here we show that macrophages from human PLTP transgenic mice secrete active PLTP. Subsequently, we performed bone marrow transplantations using either wild type mice (PLTPwt/wt), hemizygous PLTP transgenic mice (huPLTPtg/wt) or homozygous PLTP transgenic mice (huPLTPtg/tg) as donors and low density lipoprotein receptor deficient mice (LDLR-/-) as acceptors, in order to establish the role of PLTP expressed by bone marrow derived cells in diet-induced atherogenesis. Atherosclerosis was increased in the huPLTPtg/wt -> LDLR-/- mice (2.3-fold) and even further in the huPLTPtg/tg -> LDLR-/- mice (4.5-fold) compared with the control PLTPwt/wt -> LDLR-/- mice (both P<0.001). Plasma PLTP activity levels and non-HDL cholesterol were increased and HDL cholesterol decreased compared with controls (all P < 0.01). PLTP was present in atherosclerotic plaques in the mice as demonstrated by immunohistochemistry and appears to co-localize with macrophages. Isolated macrophages from PLTP transgenic mice do not show differences in cholesterol efflux or in cytokine production. Lipopolysaccharide activation of macrophages results in increased production of PLTP. This effect was strongly amplified in PLTP transgenic macrophages. Conclusions: We conclude that PLTP expression by bone marrow derived cells results in atherogenic effects on plasma lipids, increased PLTP activity, high local PLTP protein levels in the atherosclerotic lesions and increased atherosclerotic lesion size.	[van Haperen, Rien; Samyn, Hannelore; Moerland, Matthijs; van Gent, Teus; Peeters, Marian; Grosveld, Frank; van Tol, Arie; de Crom, Rini] Erasmus MC Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [de Crom, Rini] Erasmus MC Univ, Med Ctr, Dept Vascular Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Haperen, R (corresponding author), Erasmus MC Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands.	m.decrom@erasmusmc.nl			Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development [910-31-806]	Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development	Part of this work was supported by Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development (910-31-806).	Albers JJ, 2004, CURR OPIN LIPIDOL, V15, P255, DOI 10.1097/00041433-200406000-00004; ALBERS JJ, 1995, BBA-LIPID LIPID MET, V1258, P27, DOI 10.1016/0005-2760(95)00091-P; Ansell BJ, 2004, REV ENDOCR METAB DIS, V5, P351, DOI 10.1023/B:REMD.0000045107.71895.b2; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bouma G, 2005, EUR J IMMUNOL, V35, P225, DOI 10.1002/eji.200425513; Cheung MC, 2002, BBA-MOL BASIS DIS, V1587, P53, DOI 10.1016/S0925-4439(02)00054-6; CHEUNG MC, 2005, BIOCHIM BIOPHYS ACTA, V1762, P131; Colhoun HM, 2002, DIABETES, V51, P3300, DOI 10.2337/diabetes.51.11.3300; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; DAY JR, 1994, J BIOL CHEM, V269, P9388; de Vries R, 2006, DIABETOLOGIA, V49, P398, DOI 10.1007/s00125-005-0088-0; Desrumaux C, 1999, ARTERIOSCL THROM VAS, V19, P266, DOI 10.1161/01.ATV.19.2.266; Desrumaux CM, 2003, J LIPID RES, V44, P1453, DOI 10.1194/jlr.M200281-JLR200; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; Ehnholm S, 1998, J LIPID RES, V39, P1248; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Foger B, 1997, J BIOL CHEM, V272, P27393, DOI 10.1074/jbc.272.43.27393; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; Jiang XC, 2002, J BIOL CHEM, V277, P31850, DOI 10.1074/jbc.M205077200; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Karkkainen M, 2002, J BIOL CHEM, V277, P15413, DOI 10.1074/jbc.M112247200; Kaser S, 2001, DIABETOLOGIA, V44, P1111, DOI 10.1007/s001250100630; KOSTNER GM, 1995, BIOCHEM J, V305, P659, DOI 10.1042/bj3050659; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Lie J, 2004, J LIPID RES, V45, P805, DOI 10.1194/jlr.M300487-JLR200; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Lie J, 2006, BBA-MOL CELL BIOL L, V1761, P1070, DOI 10.1016/j.bbalip.2006.06.013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murdoch SJ, 2003, J LIPID RES, V44, P1705, DOI 10.1194/jlr.M300073-JLR200; Murdoch SJ, 2000, J LIPID RES, V41, P237; OBRIEN KD, 2003, CIRCULATION; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peeters M, 2005, HAEMATOLOGICA, V90, P734; Riemens SC, 1998, DIABETOLOGIA, V41, P929, DOI 10.1007/s001250051009; Rothblat G H, 1986, Methods Enzymol, V129, P628; Schlitt A, 2005, BBA-MOL CELL BIOL L, V1733, P187, DOI 10.1016/j.bbalip.2004.12.011; Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008; TALL AR, 1980, J LIPID RES, V21, P354; TALL AR, 1983, J BIOL CHEM, V258, P2174; TU AY, 1993, J BIOL CHEM, V268, P23098; Valenta DT, 2008, J LIPID RES, V49, P24, DOI 10.1194/jlr.M700228-JLR200; VALENTA DT, 2006, ARTERIOSCLER THROMB; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; van Haperen R, 2002, J BIOL CHEM, V277, P48803, DOI 10.1074/jbc.M209477200; van Haperen R, 2002, J BIOL CHEM, V277, P48938, DOI 10.1074/jbc.M209128200; van Tol A, 2002, CURR OPIN LIPIDOL, V13, P135, DOI 10.1097/00041433-200204000-00004; Vikstedt R, 2007, ARTERIOSCL THROM VAS, V27, P578, DOI 10.1161/01.ATV.0000254815.49414.be; Yan DG, 2004, J LIPID RES, V45, P1852, DOI 10.1194/jlr.M400053-JLR200	53	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2255	10.1371/journal.pone.0002255	http://dx.doi.org/10.1371/journal.pone.0002255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509527	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500007
J	Badaeva, TN; Malysheva, DN; Korchagin, VI; Ryskov, AP				Badaeva, Tatiana N.; Malysheva, Daria N.; Korchagin, Vitaly I.; Ryskov, Alexei P.			Genetic Variation and De Novo Mutations in the Parthenogenetic Caucasian Rock Lizard Darevskia unisexualis	PLOS ONE			English	Article							MICROSATELLITE LOCI; LACERTA; GERMLINE; DIVERSITY; EVOLUTION; DAHLI; AGE	Unisexual all-female lizards of the genus Darevskia that are well adapted to various habitats are known to reproduce normally by true parthenogenesis. Although they consist of unisexual lineages and lack effective genetic recombination, they are characterized by some level of genetic polymorphism. To reveal the mutational contribution to overall genetic variability, the most straightforward and conclusive way is the direct detection of mutation events in pedigree genotyping. Earlier we selected from genomic library of D. unisexualis two polymorphic microsatellite containg loci Du281 and Du215. In this study, these two loci were analyzed to detect possible de novo mutations in 168 parthenogenetic offspring of 49 D. unisexualis mothers and in 147 offspring of 50 D. armeniaca mothers. No mutant alleles were detected in D. armeniaca offspring at both loci, and in D. unisexualis offspring at the Du215 locus. There were a total of seven mutational events in the germ lines of four of the 49 D. unisexualis mothers at the Du281 locus, yielding the mutation rate of 0.1428 events per germ line tissue. Sequencing of the mutant alleles has shown that most mutations occur via deletion or insertion of single microsatellite repeat being identical in all offspring of the family. This indicates that such mutations emerge at the early stages of embryogenesis. In this study we characterized single highly unstable (GATA)(n) containing locus in parthenogenetic lizard species D. unisexualis. Besides, we characterized various types of mutant alleles of this locus found in the D. unisexualis offspring of the first generation. Our data has shown that microsatellite mutations at highly unstable loci can make a significant contribution to population variability of parthenogenetic lizards.	[Badaeva, Tatiana N.; Malysheva, Daria N.; Korchagin, Vitaly I.; Ryskov, Alexei P.] Russian Acad Sci, Lab Genome Org, Inst Gene Biol, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Badaeva, TN (corresponding author), Russian Acad Sci, Lab Genome Org, Inst Gene Biol, Moscow, Russia.	badaeva_t@mail.ru	Ryskov, Alexey/F-1179-2016; Korchagin, Vitaly/B-8635-2011	Ryskov, Alexey/0000-0002-4159-0671; Korchagin, Vitaly/0000-0003-2264-6294	Leading Scientific School and Program of President of Russian Federation [02.120.11.23498, MK-4748.2007.4, MK-2106.2008.4]	Leading Scientific School and Program of President of Russian Federation	This work was partly supported by the Leading Scientific School and Program of President of Russian Federation for financial support of young scientist 02.120.11.23498 MK-4748.2007.4. and MK-2106.2008.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Arribas Oscar J., 1999, Russian Journal of Herpetology, V6, P1; Brohede J, 2002, NUCLEIC ACIDS RES, V30, P1997, DOI 10.1093/nar/30.9.1997; Cole CJ, 1988, AM MUS NOVIT, V2905, P1; DAREVSKY IS, 1958, DOKL AKAD NAUK SSSR+, V122, P730; DAREVSKY IS, 1966, J HERPETOL, V2, P65; Darevsky IS, 1985, BIOL REPTILIA, V15, P413; Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Fu JZ, 2000, COPEIA, P432, DOI 10.1643/0045-8511(2000)000[0432:DOTCBG]2.0.CO;2; Fu JZ, 1998, J MOL EVOL, V46, P127, DOI 10.1007/PL00013146; Gardner MG, 2000, J EVOLUTION BIOL, V13, P551; Grebelnyi S. D., 2005, INVERTEBR ZOOL, V2, P79; Kan NG, 1998, MOL BIOL+, V32, P672; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Korchagin VI, 2007, GENE, V392, P126, DOI 10.1016/j.gene.2006.11.020; MacCulloch RD, 1997, BIOCHEM SYST ECOL, V25, P33, DOI 10.1016/S0305-1978(96)00085-3; MaCCulloch RD, 1995, GENOME, V38, P1057, DOI 10.1139/g95-141; MAHTANI MM, 1993, HUM MOL GENET, V2, P431, DOI 10.1093/hmg/2.4.431; Malysheva DN, 2007, RUSS J GENET+, V43, P116, DOI 10.1134/S1022795407020032; Martirosyan IA, 2002, RUSS J GENET+, V38, P691, DOI 10.1023/A:1016000219576; MITANI K, 1990, J BIOL CHEM, V265, P15203; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1992, GENETICA, V87, P53, DOI 10.1007/BF00128773; Murphy RW, 1997, GENETICA, V101, P125, DOI 10.1023/A:1018392603062; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x; PARKER ED, 1976, GENETICS, V84, P791; Primmer CR, 1996, NAT GENET, V13, P391, DOI 10.1038/ng0896-391; Ryskov AP, 2003, RUSS J GENET+, V39, P986, DOI 10.1023/A:1025762731634; Tokarskaya ON, 2004, MOL GENET GENOMICS, V270, P509, DOI 10.1007/s00438-003-0936-x; Tokarskaya ON, 2001, MOL GENET GENOMICS, V265, P812, DOI 10.1007/s004380100475; UZZELL T, 1975, COPEIA, P204; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2730	10.1371/journal.pone.0002730	http://dx.doi.org/10.1371/journal.pone.0002730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648496	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900008
J	Crossman, LC; Castillo-Ramirez, S; McAnnula, C; Lozano, L; Vernikos, GS; Acosta, JL; Ghazoui, ZF; Hernandez-Gonzalez, I; Meakin, G; Walker, AW; Hynes, MF; Young, JPW; Downie, JA; Romero, D; Johnston, AWB; Davila, G; Parkhill, J; Gonzalez, V				Crossman, Lisa C.; Castillo-Ramirez, Santiago; McAnnula, Craig; Lozano, Luis; Vernikos, Georgios S.; Acosta, Jose L.; Ghazoui, Zara F.; Hernandez-Gonzalez, Ismael; Meakin, Georgina; Walker, Alan W.; Hynes, Michael F.; Young, J. Peter W.; Downie, J. Allan; Romero, David; Johnston, Andrew W. B.; Davila, Guillermo; Parkhill, Julian; Gonzalez, Victor			A Common Genomic Framework for a Diverse Assembly of Plasmids in the Symbiotic Nitrogen Fixing Bacteria	PLOS ONE			English	Article								This work centres on the genomic comparisons of two closely-related nitrogen-fixing symbiotic bacteria, Rhizobium leguminosarum biovar viciae 3841 and Rhizobium etli CFN42. These strains maintain a stable genomic core that is also common to other rhizobia species plus a very variable and significant accessory component. The chromosomes are highly syntenic, whereas plasmids are related by fewer syntenic blocks and have mosaic structures. The pairs of plasmids p42f-pRL12, p42e-pRL11 and p42b-pRL9 as well large parts of p42c with pRL10 are shown to be similar, whereas the symbiotic plasmids ( p42d and pRL10) are structurally unrelated and seem to follow distinct evolutionary paths. Even though purifying selection is acting on the whole genome, the accessory component is evolving more rapidly. This component is constituted largely for proteins for transport of diverse metabolites and elements of external origin. The present analysis allows us to conclude that a heterogeneous and quickly diversifying group of plasmids co-exists in a common genomic framework.	[Crossman, Lisa C.; Vernikos, Georgios S.; Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Castillo-Ramirez, Santiago; Lozano, Luis; Acosta, Jose L.; Hernandez-Gonzalez, Ismael; Romero, David; Davila, Guillermo; Gonzalez, Victor] Univ Nacl Autonoma Mexico, Cuernavaca, Morelos, Mexico; [McAnnula, Craig; Downie, J. Allan] John Innes Ctr, Norwich, Norfolk, England; [Ghazoui, Zara F.; Young, J. Peter W.] Univ York, Dept Biol, York, N Yorkshire, England; [Meakin, Georgina; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Hynes, Michael F.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	Wellcome Trust Sanger Institute; Universidad Nacional Autonoma de Mexico; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of York - UK; University of East Anglia; University of Calgary	Crossman, LC (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	lcc@sanger.ac.uk; vgonzal@ccg.unam.mx	Young, Peter/C-1446-2012; González, Víctor/AAF-7035-2020; Downie, Allan/I-3487-2012; Walker, Alan W./AAE-8102-2019; Walker, Alan W/E-8055-2011; Parkhill, Julian/G-4703-2011; Johnston, Andrew W B/D-1859-2009; ACOSTA, JOSE LUIS/AAJ-6886-2020; Meakin, Georgina/AAE-6675-2021; Hynes, Michael F./C-4080-2013	Young, Peter/0000-0001-5259-4830; González, Víctor/0000-0003-4082-0022; Walker, Alan W./0000-0001-5099-8495; Parkhill, Julian/0000-0002-7069-5958; ACOSTA, JOSE LUIS/0000-0002-7009-0465; Hynes, Michael F./0000-0002-3608-2971; Downie, Allan/0000-0003-1011-4960; Romero, David/0000-0002-1685-4305; Castillo-Ramirez, Santiago/0000-0003-3922-7088; Meakin, Georgina/0000-0002-9223-3017; Crossman, Lisa/0000-0003-2390-4750	CONACyT [46333-Q]; PAPIIT-UNAM [IN223005-5]; Wellcome Trust; BBSRC [104/P16988, 208/BRE13665, 208/PRS12210]; NERC [NE/D011485/1] Funding Source: UKRI; Natural Environment Research Council [NE/D011485/1] Funding Source: researchfish	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	CONACyT 46333-Q and PAPIIT-UNAM IN223005-5 grants supported work on Rhizobium etli. Work on Rhizobium leguminosarum was supported by the Wellcome Trust and the BBSRC under grants 104/P16988, 208/BRE13665, and 208/PRS12210.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brom S, 2004, J BACTERIOL, V186, P7538, DOI 10.1128/JB.186.22.7538-7548.2004; Brom S, 2000, PLASMID, V44, P34, DOI 10.1006/plas.2000.1469; Bueno E, 2005, BIOCHEM SOC T, V33, P162, DOI 10.1042/BST0330162; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cevallos MA, 2002, PLASMID, V48, P104, DOI 10.1016/S0147-619X(02)00119-1; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Flores M, 2005, J BACTERIOL, V187, P7185, DOI 10.1128/JB.187.21.7185-7192.2005; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Girard L, 2000, MOL PLANT MICROBE IN, V13, P1283, DOI 10.1094/MPMI.2000.13.12.1283; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Gonzalez V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r36; Jumas-Bilak E, 1998, J BACTERIOL, V180, P2749, DOI 10.1128/JB.180.10.2749-2755.1998; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P225, DOI 10.1093/dnares/9.6.225; Karunakaran R, 2006, J BACTERIOL, V188, P6661, DOI 10.1128/JB.00641-06; Palacios R, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P183; Perez-Mendoza D, 2005, J BACTERIOL, V187, P7341, DOI 10.1128/JB.187.21.7341-7350.2005; Perez-Mendoza D, 2004, J BACTERIOL, V186, P5753, DOI 10.1128/JB.186.17.5753-5761.2004; REANNEY D, 1976, BACTERIOL REV, V40, P552, DOI 10.1128/MMBR.40.3.552-590.1976; Richardson JS, 2004, J BACTERIOL, V186, P8433, DOI 10.1128/JB.186.24.8433-8442.2004; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Romero D, 2004, PLASMID BIOLOGY, P271; Rosemeyer V, 1998, J BACTERIOL, V180, P815, DOI 10.1128/JB.180.4.815-821.1998; Sanchez-Contreras M, 2007, PHILOS T R SOC B, V362, P1149, DOI 10.1098/rstb.2007.2041; Sourjik V, 2000, J BACTERIOL, V182, P782, DOI 10.1128/JB.182.3.782-788.2000; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tun-Garrido C, 2003, J BACTERIOL, V185, P1681, DOI 10.1128/JB.185.5.1681-1692.2003; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yost CK, 2006, MICROBIOL-SGM, V152, P2061, DOI 10.1099/mic.0.28938-0; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	36	59	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2567	10.1371/journal.pone.0002567	http://dx.doi.org/10.1371/journal.pone.0002567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596979	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200032
J	Patel, AV; Cheng, I; Canzian, F; Le Marchand, L; Thun, MJ; Berg, CD; Buring, J; Calle, EE; Chanock, S; Clavel-Chapelon, F; Cox, DG; Dorronsoro, M; Dossus, L; Haiman, CA; Hankinson, SE; Henderson, BE; Hoover, R; Hunter, DJ; Kaaks, R; Kolonel, LN; Kraft, P; Linseisen, J; Lund, E; Manjer, J; McCarty, C; Peeters, PHM; Pike, MC; Pollak, M; Riboli, E; Stram, DO; Tjonneland, A; Travis, RC; Trichopoulos, D; Tumino, R; Yeager, M; Ziegler, RG; Feigelson, HS				Patel, Alpa V.; Cheng, Iona; Canzian, Federico; Le Marchand, Loic; Thun, Michael J.; Berg, Christine D.; Buring, Julie; Calle, Eugenia E.; Chanock, Stephen; Clavel-Chapelon, Francoise; Cox, David G.; Dorronsoro, Miren; Dossus, Laure; Haiman, Christopher A.; Hankinson, Susan E.; Henderson, Brian E.; Hoover, Robert; Hunter, David J.; Kaaks, Rudolf; Kolonel, Laurence N.; Kraft, Peter; Linseisen, Jakob; Lund, Eiliv; Manjer, Jonas; McCarty, Catherine; Peeters, Petra H. M.; Pike, Malcolm C.; Pollak, Michael; Riboli, Elio; Stram, Daniel O.; Tjonneland, Anne; Travis, Ruth C.; Trichopoulos, Dimitrios; Tumino, Rosario; Yeager, Meredith; Ziegler, Regina G.; Feigelson, Heather Spencer			IGF-1, IGFBP-1, and IGFBP-3 Polymorphisms Predict Circulating IGF Levels but Not Breast Cancer Risk: Findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)	PLOS ONE			English	Article							GROWTH-FACTOR-I; GENETIC-VARIATION; BINDING-PROTEINS; MAMMARY-GLAND; INSULIN; ASSOCIATION; GENOTYPE; ANGELES; SYSTEM; WOMEN	IGF-1 has been shown to promote proliferation of normal epithelial breast cells, and the IGF pathway has also been linked to mammary carcinogenesis in animal models. We comprehensively examined the association between common genetic variation in the IGF1, IGFBP1, and IGFBP3 genes in relation to circulating IGF-1 and IGFBP-3 levels and breast cancer risk within the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). This analysis included 6,912 breast cancer cases and 8,891 matched controls (n = 6,410 for circulating IGF-1 and 6,275 for circulating IGFBP-3 analyses) comprised primarily of Caucasian women drawn from six large cohorts. Linkage disequilibrium and haplotype patterns were characterized in the regions surrounding IGF1 and the genes coding for two of its binding proteins, IGFBP1 and IGFBP3. In total, thirty haplotype-tagging single nucleotide polymorphisms (htSNP) were selected to provide high coverage of common haplotypes; the haplotype structure was defined across four haplotype blocks for IGF1 and three for IGFBP1 and IGFBP3. Specific IGF1 SNPs individually accounted for up to 5% change in circulating IGF-1 levels and individual IGFBP3 SNPs were associated up to 12% change in circulating IGFBP-3 levels, but no associations were observed between these polymorphisms and breast cancer risk. Logistic regression analyses found no associations between breast cancer and any htSNPs or haplotypes in IGF1, IGFBP1, or IGFBP3. No effect modification was observed in analyses stratified by menopausal status, family history of breast cancer, body mass index, or postmenopausal hormone therapy, or for analyses stratified by stage at diagnosis or hormone receptor status. In summary, the impact of genetic variation in IGF1 and IGFBP3 on circulating IGF levels does not appear to substantially influence breast cancer risk substantially among primarily Caucasian postmenopausal women.	[Patel, Alpa V.; Thun, Michael J.; Calle, Eugenia E.; Feigelson, Heather Spencer] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Cheng, Iona] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, San Francisco, CA USA; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr, Epidemiol Program, Honolulu, HI USA; [Berg, Christine D.] NCI, Div Canc Prevent, Bethesda, MD USA; [Buring, Julie] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; [Chanock, Stephen; Hoover, Robert; Yeager, Meredith] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, Villejuif, France; [Cox, David G.; Hunter, David J.; Kraft, Peter] Harvard Sch Publ Hlth, Epidemiol Dept, Program Mol & Genet Epidemiol, Boston, MA USA; [Dorronsoro, Miren] Dept Publ Hlth Guipuzcoa, San Sebastian, Spain; [Dossus, Laure; Kaaks, Rudolf; Linseisen, Jakob] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Haiman, Christopher A.; Henderson, Brian E.; Pike, Malcolm C.; Stram, Daniel O.] USC, Los Angeles, CA USA; [Hankinson, Susan E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Lund, Eiliv] Univ Tromso, Inst Community Med, Tromso, Norway; [Manjer, Jonas] Malmo Univ Hosp, Dept Surg, Malmo, Sweden; [McCarty, Catherine] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Peeters, Petra H. M.; Riboli, Elio] Imperial Coll, Dept Epidemiol & Publ Hlth, London, England; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Travis, Ruth C.] Univ Oxford, Canc Res UK Epidemiol Unit, Oxford, England; [Trichopoulos, Dimitrios] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Tumino, Rosario] Canc Registry Azienda Ospedaliera Civile MP Arezzo, Ragusa, Italy; [Ziegler, Regina G.] NIH, NCI, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD USA	American Cancer Society; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Harvard University; Harvard T.H. Chan School of Public Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UiT The Arctic University of Tromso; Lund University; Skane University Hospital; Utrecht University; Utrecht University Medical Center; McGill University; Imperial College London; Danish Cancer Society; Cancer Research UK; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Civile M.P. Arezzo Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Patel, AV (corresponding author), Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA.	apatel@cancer.org	Dossus, Laure/AAW-9097-2021; Clavel-Chapelon, Francoise/G-6733-2014; Cox, David G/A-2023-2009; Pollak, Michael/G-9094-2011; Canzian, Federico/I-2804-2014; Cox, David/ABA-7454-2020; Dossus, Laure/B-2875-2013; Yeager, Meredith/AAA-5322-2020; Linseisen, Jakob/B-5353-2014	Dossus, Laure/0000-0003-2716-5748; Cox, David G/0000-0002-2152-9259; Pollak, Michael/0000-0003-3047-0604; Dossus, Laure/0000-0003-2716-5748; Linseisen, Jakob/0000-0002-9386-382X; Riboli, Elio/0000-0001-6795-6080; Lund, Eiliv/0000-0002-8071-8711; Cox, David/0000-0003-2047-4687; Tjonneland, Anne/0000-0003-4385-2097; McCarty, Catherine/0000-0003-1089-0142; Canzian, Federico/0000-0002-4261-4583; tumino, rosario/0000-0003-2666-414X	National Cancer Institute [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.; NATIONAL CANCER INSTITUTE [U01CA098216, U01CA098710, U01CA098758, U01CA098233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support from National Cancer Institute cooperative agreements U01-CA98233, U01-CA98710, U01-CA98216, and U01-CA98758 and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Allen NE, 2005, BRIT J CANCER, V92, P1283, DOI 10.1038/sj.bjc.6602471; BAXTER RC, 1994, HORM RES, V42, P140, DOI 10.1159/000184186; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P500, DOI 10.1002/cncr.10197; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Cheng I, 2006, JNCI-J NATL CANCER I, V98, P123, DOI 10.1093/jnci/djj013; Cheng I, 2006, CANCER EPIDEM BIOMAR, V15, P1993, DOI 10.1158/1055-9965.EPI-06-0361; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; DeLellis K, 2003, BRIT J CANCER, V88, P277, DOI 10.1038/sj.bjc.6600728; Feigelson HS, 2006, CANCER RES, V66, P2468, DOI 10.1158/0008-5472.CAN-05-3574; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hadsell DL, 2000, J MAMMARY GLAND BIOL, V5, P19, DOI 10.1023/A:1009559014703; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Johansson M, 2007, J CLIN ENDOCR METAB, V92, P4820, DOI 10.1210/jc.2007-0887; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Packer BR, 2004, NUCLEIC ACIDS RES, V32, pD528, DOI 10.1093/nar/gkh005; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Setiawan VW, 2006, CANCER EPIDEM BIOMAR, V15, P172, DOI 10.1158/1055-9965.EPI-05-0625; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; VERHEUS M, 2007, BREAST CANC RES TREA; Wagner WR, 2005, ACTA BIOMATER, V1, P3, DOI 10.1016/j.actbio.2004.09.010; Wood TL, 2000, J MAMMARY GLAND BIOL, V5, P1, DOI 10.1023/A:1009580913795; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	31	99	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2578	10.1371/journal.pone.0002578	http://dx.doi.org/10.1371/journal.pone.0002578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596909	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200042
J	Bafna, PA; Purohit, PG; Auerbach, A				Bafna, Pallavi A.; Purohit, Prasad G.; Auerbach, Anthony			Gating at the Mouth of the Acetylcholine Receptor Channel: Energetic Consequences of Mutations in the alpha M2-Cap	PLOS ONE			English	Article								Gating of nicotinic acetylcholine receptors from a C(losed) to an O(pen) conformation is the initial event in the postsynaptic signaling cascade at the vertebrate nerve-muscle junction. Studies of receptor structure and function show that many residues in this large, five-subunit membrane protein contribute to the energy difference between C and O. Of special interest are amino acids located at the two transmitter binding sites and in the narrow region of the channel, where C <-> O gating motions generate a low <-> high change in the affinity for agonists and in the ionic conductance, respectively. We have measured the energy changes and relative timing of gating movements for residues that lie between these two locations, in the C-terminus of the pore-lining M2 helix of the alpha subunit ('alpha M2-cap'). This region contains a binding site for noncompetitive inhibitors and a charged ring that influences the conductance of the open pore. alpha M2-cap mutations have large effects on gating but much smaller effects on agonist binding, channel conductance, channel block and desensitization. Three alpha M2-cap residues (alpha I260, alpha P265 and alpha S268) appear to move at the outset of channel-opening, about at the same time as those at the transmitter binding site. The results suggest that the alpha M2-cap changes its secondary structure to link gating motions in the extracellular domain with those in the channel that regulate ionic conductance.	[Bafna, Pallavi A.; Purohit, Prasad G.; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bafna, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	auerbach@buffalo.edu			NIH [NS-23513]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023513, R37NS023513] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH (NS-23513).	Akk G, 1996, J PHYSIOL-LONDON, V496, P185, DOI 10.1113/jphysiol.1996.sp021676; Arias HR, 1998, BBA-REV BIOMEMBRANES, V1376, P173, DOI 10.1016/S0304-4157(98)00004-5; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DILGER JP, 1992, PFLUG ARCH EUR J PHY, V420, P479, DOI 10.1007/BF00374622; DREYER EB, 1986, J BIOL CHEM, V261, P3727; Forman SA, 2007, BIOCHEMISTRY-US, V46, P11911, DOI 10.1021/bi701287a; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Ho BK, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-14; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	38	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2515	10.1371/journal.pone.0002515	http://dx.doi.org/10.1371/journal.pone.0002515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575616	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288000032
J	Garbuzova-Davis, S; Sanberg, CD; Kuzmin-Nichols, N; Willing, AE; Gemma, C; Bickford, PC; Miller, C; Rossi, R; Sanberg, PR				Garbuzova-Davis, Svitlana; Sanberg, Cyndy Davis; Kuzmin-Nichols, Nicole; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Miller, Christina; Rossi, Robert; Sanberg, Paul R.			Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose	PLOS ONE			English	Article								Background: Amyotrophic Lateral Sclerosis (ALS) is a multicausal disease characterized by motor neuron degeneration in the spinal cord and brain. Cell therapy may be a promising new treatment for this devastating disorder. We recently showed that a single low dose (10(6) cells) of mononuclear human umbilical cord blood (MNC hUCB) cells administered intravenously to G93A mice delayed symptom progression and modestly prolonged lifespan. The aim of this pre-clinical translation study is to optimize the dose of MNC hUCB cells to retard disease progression in G93A mice. Three different doses of MNC hUCB cells, 10610 6, 25610 6 and 50610 6, were administered intravenously into pre-symptomatic G93A mice. Motor function tests and various assays to determine cell effects were performed on these mice. Methodology/Principal Findings: Our results showed that a cell dose of 25 x 10(6) cells significantly increased lifespan of mice by 20-25% and delayed disease progression by 15%. The most beneficial effect on decreasing pro-inflammatory cytokines in the brain and spinal cord was found in this group of mice. Human Th2 cytokines were found in plasma of mice receiving 25 x 10(6) cells, although prevalent human Th1 cytokines were indicated in mice with 50 x 10(6) cells. High response of splenic cells to mitogen (PHA) was indicated in mice receiving 25 x 10(6) (mainly) and 10 x 10(6) cells. Significantly increased lymphocytes and decreased neutrophils in the peripheral blood were found only in animals receiving 25 x 10(6) cells. Stable reduction in microglia density in both cervical and lumbar spinal cords was also noted in mice administered with 25 x 10(6) cells. Conclusions/Significance: These results demonstrate that treatment for ALS with an appropriate dose of MNC hUCB cells may provide a neuroprotective effect for motor neurons through active involvement of these cells in modulating the host immune inflammatory system response.	[Garbuzova-Davis, Svitlana; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Miller, Christina; Rossi, Robert; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Gemma, Carmelina; Bickford, Paula C.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Willing, Alison E.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy Davis; Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Willing, Alison/AAP-7759-2021; Garbuzova-Davis, Svitlana/Q-3687-2019; Willing, Alison/I-4946-2012; Bickford, Paula C/J-5970-2012	Bickford, Paula C/0000-0001-9657-7725; Sanberg, Paul/0000-0001-9130-4592; Gemma, Carmelina/0000-0002-4480-0056	NIH STTR [IR41NS46870-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS046870] Funding Source: NIH RePORTER	NIH STTR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH STTR (Phase I) grant IR41NS46870-01A1.	Alexianu Maria E., 1995, Romanian Journal of Neurology and Psychiatry, V33, P215; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.3.CO;2-O; APPEL SH, 1994, J NEUROL SCI, V124, P14, DOI 10.1016/0022-510X(94)90171-6; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cardoso A A, 1993, J Hematother, V2, P275, DOI 10.1089/scd.1.1993.2.275; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Gemma C, 2002, J NEUROSCI, V22, P6114; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hemendinger R, 2005, EXP NEUROL, V196, P235, DOI 10.1016/j.expneurol.2005.07.025; Hensley K, 2002, J NEUROCHEM, V82, P365, DOI 10.1046/j.1471-4159.2002.00968.x; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kuzmenok OI, 2006, J NEUROIMMUNOL, V172, P132, DOI 10.1016/j.jneuroim.2005.11.015; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Miller RG, 2000, NEUROLOGY, V54, P53, DOI 10.1212/WNL.54.1.53; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Nayar B, 2002, INT J GYNECOL OBSTET, V79, P31, DOI 10.1016/S0020-7292(02)00187-X; Niebroj-Dobosz I, 1999, ACTA NEUROL SCAND, V100, P238; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; SANBERG PR, 2004, 6174 IT PLANN SOC NE; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Todaro AM, 2000, BLOOD PURIFICAT, V18, P144, DOI 10.1159/000014438; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x	43	77	84	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2494	10.1371/journal.pone.0002494	http://dx.doi.org/10.1371/journal.pone.0002494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575617	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000018
J	Gross, GG; Feldman, RMR; Ganguly, A; Wang, JH; Yu, H; Guo, M				Gross, Garrett G.; Feldman, R. M. Renny; Ganguly, Atish; Wang, Jinhui; Yu, Hong; Guo, Ming			Role of X11 and ubiquilin as In Vivo Regulators of the Amyloid Precursor Protein in Drosophila	PLOS ONE			English	Article								The Amyloid Precursor Protein (APP) undergoes sequential proteolytic cleavages through the action of beta- and gamma-secretase, which result in the generation of toxic beta- amyloid (A beta) peptides and a C-terminal fragment consisting of the intracellular domain of APP (AICD). Mutations leading to increased APP levels or alterations in APP cleavage cause familial Alzheimer's disease (AD). Thus, identification of factors that regulate APP steady state levels and/or APP cleavage by gamma-secretase is likely to provide insight into AD pathogenesis. Here, using transgenic flies that act as reporters for endogenous gamma-secretase activity and/or APP levels (GAMAREP), and for the APP intracellular domain (AICDREP), we identified mutations in X11L and ubiquilin (ubqn) as genetic modifiers of APP. Human homologs of both X11L (X11/Mint) and Ubqn (UBQLN1) have been implicated in AD pathogenesis. In contrast to previous reports, we show that overexpression of X11L or human X11 does not alter gamma-secretase cleavage of APP or Notch, another gamma-secretase substrate. Instead, expression of either X11L or human X11 regulates APP at the level of the AICD, and this activity requires the phosphotyrosine binding (PTB) domain of X11. In contrast, Ubqn regulates the levels of APP: loss of ubqn function leads to a decrease in the steady state levels of APP, while increased ubqn expression results in an increase in APP levels. Ubqn physically binds to APP, an interaction that depends on its ubiquitin-associated (UBA) domain, suggesting that direct physical interactions may underlie Ubqn-dependent regulation of APP. Together, our studies identify X11L and Ubqn as in vivo regulators of APP. Since increased expression of X11 attenuates A beta production and/or secretion in APP transgenic mice, but does not act on gamma-secretase directly, X11 may represent an attractive therapeutic target for AD.	[Gross, Garrett G.; Feldman, R. M. Renny; Ganguly, Atish; Wang, Jinhui; Yu, Hong; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pharmacol, Los Angeles, CA USA; [Gross, Garrett G.; Guo, Ming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Brain Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gross, GG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	mingfly@ucla.edu			UCLA; National Institute of Health [RO1, KO8]; Alfred P. Sloan Foundation; Alzheimer's Association; American Federation of Aging Foundation; Larry L. Hillblom Foundation; Glenn Family Foundation; Ellison Medical Foundation	UCLA(University of California System); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alzheimer's Association(Alzheimer's Association); American Federation of Aging Foundation; Larry L. Hillblom Foundation; Glenn Family Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported by a UCLA Neurobehavioral Genetics training grant to R.M.R.F., as well as grants and funds from the National Institute of Health (RO1 and KO8), the Alfred P. Sloan Foundation, the Alzheimer's Association, the American Federation of Aging Foundation, the Larry L. Hillblom Foundation, the Glenn Family Foundation and the Ellison Medical Foundation to M.G.	Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashley J, 2005, J NEUROSCI, V25, P5943, DOI 10.1523/JNEUROSCI.1144-05.2005; Bensemain F, 2006, NEUROBIOL DIS, V22, P691, DOI 10.1016/j.nbd.2006.01.007; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Biederer T, 2002, J NEUROSCI, V22, P7340; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brouwers N, 2006, NEUROSCI LETT, V392, P72, DOI 10.1016/j.neulet.2005.08.064; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo M, 2003, HUM MOL GENET, V12, P2669, DOI 10.1093/hmg/ddg292; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hase M, 2002, J NEUROCHEM, V81, P1223, DOI 10.1046/j.1471-4159.2002.00911.x; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hoareau C, 2008, NEUROBIOL AGING, V29, P542, DOI 10.1016/j.neurobiolaging.2006.11.012; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kamboh MI, 2006, MOL PSYCHIATR, V11, P273, DOI 10.1038/sj.mp.4001775; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; King GD, 2003, NEUROSCIENCE, V120, P143, DOI 10.1016/S0306-4522(03)00284-7; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li A, 2007, HUM MOL GENET, V16, P2626, DOI 10.1093/hmg/ddm219; Loewer A, 2004, EMBO REP, V5, P405, DOI 10.1038/sj.embor.7400122; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 1996, FEBS LETT, V397, P197; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slifer MA, 2006, AM J MED GENET B, V141B, P208, DOI 10.1002/ajmg.b.30298; Smemo S, 2006, ANN NEUROL, V59, P21, DOI 10.1002/ana.20673; Sumioka A, 2008, EXP CELL RES, V314, P1155, DOI 10.1016/j.yexcr.2007.12.006; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	76	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2495	10.1371/journal.pone.0002495	http://dx.doi.org/10.1371/journal.pone.0002495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575606	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000019
J	Timinszky, G; Bortfeld, M; Ladurner, AG				Timinszky, Gyula; Bortfeld, Miriam; Ladurner, Andreas G.			Repression of RNA Polymerase II Transcription by a Drosophila Oligopeptide	PLOS ONE			English	Article								Background: Germline progenitors resist signals that promote differentiation into somatic cells. This occurs through the transient repression in primordial germ cells of RNA polymerase II, specifically by disrupting Ser2 phosphorylation on its C-terminal domain. Methodology/Principal Findings: Here we show that contrary to expectation the Drosophila polar granule component (pgc) gene functions as a protein rather than a non-coding RNA. Surprisingly, pgc encodes a 71-residue, dimeric, alpha-helical oligopeptide repressor. In vivo data show that Pgc ablates Ser2 phosphorylation of the RNA polymerase II C-terminal domain and completely suppresses early zygotic transcription in the soma. Conclusions/Significance: We thus identify pgc as a novel oligopeptide that readily inhibits gene expression. Germ cell repression of transcription in Drosophila is thus catalyzed by a small inhibitor protein.	[Timinszky, Gyula; Bortfeld, Miriam; Ladurner, Andreas G.] European Mol Biol Lab, Gene Express Unit, Heidelberg, Germany; [Ladurner, Andreas G.] European Mol Biol Lab, Structural & Computat Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Timinszky, G (corresponding author), European Mol Biol Lab, Gene Express Unit, Heidelberg, Germany.	ladurner@embl.de		Timinszky, Gyula/0000-0001-6342-8985; Ladurner, Andreas/0000-0003-3835-232X	EMBL; EU; Human Frontiers Science Program [Young Investigator Award]	EMBL; EU(European Commission); Human Frontiers Science Program(Human Frontier Science Program)	A.G.L. thanks the EMBL and the EU Network of Excellence "The Epigenome" for financial support. A.G.L. is the recipient of a Young Investigator Award from the Human Frontiers Science Program.	Deshpande G, 2004, DEVELOPMENT, V131, P1247, DOI 10.1242/dev.01004; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Nakamura A, 1996, SCIENCE, V274, P2075, DOI 10.1126/science.274.5295.2075; Rothwell W.F., 2000, DROSOPHILA PROTOCOLS, P141; Till S, 2007, CELL, V131, P643, DOI 10.1016/j.cell.2007.10.044; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213	10	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2506	10.1371/journal.pone.0002506	http://dx.doi.org/10.1371/journal.pone.0002506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575576	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000025
J	Sussman, M; Willis, BL; Victor, S; Bourne, DG				Sussman, Meir; Willis, Bette L.; Victor, Steven; Bourne, David G.			Coral Pathogens Identified for White Syndrome (WS) Epizootics in the Indo-Pacific	PLOS ONE			English	Article							CHOLERAE HEMAGGLUTININ PROTEASE; PLAGUE-LIKE DISEASE; VIBRIO-SHILOI; CAUSATIVE AGENT; SP-NOV.; POCILLOPORA-DAMICORNIS; INFECTIOUS-DISEASES; OCULINA-PATAGONICA; EPITHELIAL-CELLS; SHIGA TOXIN	Background: White Syndrome (WS), a general term for scleractinian coral diseases with acute signs of advancing tissue lesions often resulting in total colony mortality, has been reported from numerous locations throughout the Indo-Pacific, constituting a growing threat to coral reef ecosystems. Methodology/Principal Findings: Bacterial isolates were obtained from corals displaying disease signs at three WS outbreak sites: Nikko Bay in the Republic of Palau, Nelly Bay in the central Great Barrier Reef (GBR) and Majuro Atoll in the Republic of the Marshall Islands, and used in laboratory-based infection trials to satisfy Henle-Koch's postulates, Evan's rules and Hill's criteria for establishing causality. Infected colonies produced similar signs to those observed in the field following exposure to bacterial concentrations of 1x10(6) cells ml(-1). Phylogenetic 16S rRNA gene analysis demonstrated that all six pathogens identified in this study were members of the gamma-Proteobacteria family Vibrionacae, each with greater than 98% sequence identity with the previously characterized coral bleaching pathogen Vibrio coralliilyticus. Screening for proteolytic activity of more than 150 coral derived bacterial isolates by a biochemical assay and specific primers for a Vibrio family zinc-metalloprotease demonstrated a significant association between the presence of isolates capable of proteolytic activity and observed disease signs. Conclusion/Significance: This is the first study to provide evidence for the involvement of a unique taxonomic group of bacterial pathogens in the aetiology of Indo-Pacific coral diseases affecting multiple coral species at multiple locations. Results from this study strongly suggest the need for further investigation of bacterial proteolytic enzymes as possible virulence factors involved in Vibrio associated acute coral infections.	[Sussman, Meir; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Sussman, Meir; Bourne, David G.] Townsville MC, Australian Inst Marine Sci, PMB3, Townsville, Qld, Australia; [Victor, Steven] Palau Int Coral Reef Ctr, Koror, Palau	James Cook University; Australian Institute of Marine Science	Sussman, M (corresponding author), James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	dsmb007@jcu.edu.au	Bourne, David G/B-5073-2008	Bourne, David G/0000-0002-1492-8710	ARC [Discovery grant]; James Cook University [CRIG grant]	ARC(Australian Research Council); James Cook University	This study was funded by an ARC Discovery grant and a James Cook University CRIG grant to BL Willis. The authors wish to thank CD Harvell, Chair of the World Bank Coral Disease Working Group, L Raymundo, University of Guam, and A Hooten from the IOC-GEF/World Bank Coral Reef Targeted Research and Capacity Building Program for contributing funding and support for travel and field work in Palau. Work on the research vessel Lady Basten and in the PC2 laboratory at Cape Ferguson was funded by the Australian Institute of Marine Science.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barash Y, 2005, AQUAT MICROB ECOL, V40, P183, DOI 10.3354/ame040183; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Ben-Haim Y, 1999, ENVIRON MICROBIOL, V1, P223, DOI 10.1046/j.1462-2920.1999.00027.x; BOOTH BA, 1986, J INFECT DIS, V154, P183, DOI 10.1093/infdis/154.1.183; Bordas MA, 1996, APPL ENVIRON MICROB, V62, P3650, DOI 10.1128/AEM.62.10.3650-3654.1996; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; BOURNE DG, 2007, IZME ONLINE; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; DANE FC, 1990, RES METHODS, P258; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Denkin SM, 1999, APPL ENVIRON MICROB, V65, P3555; Denkin SM, 2004, APPL ENVIRON MICROB, V70, P4193, DOI 10.1128/AEM.70.7.4193-4204.2004; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Dubos Ren?J., 1965, MAN ADAPTING; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Efrony R, 2007, CORAL REEFS, V26, P7, DOI 10.1007/s00338-006-0170-1; EVANS AS, 1976, YALE J BIOL MED, V49, P175; *FAO, 1995, CHALL SUST FOR MAN W, P128; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; FINKELSTEIN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1092, DOI 10.1073/pnas.80.4.1092; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; Fiorentini C, 1998, INFECT IMMUN, V66, P2660, DOI 10.1128/IAI.66.6.2660-2665.1998; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; GILAGUDELO DL, 2006, INT J TROP BIOL S3, V54, P59; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HASE CC, 1991, J BACTERIOL, V173, P3311; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hiney Maura, 1997, Bulletin of the European Association of Fish Pathologists, V17, P245; Hiney MP, 1998, AQUACULTURE, V162, P41, DOI 10.1016/S0044-8486(98)00207-5; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; KAMATA R, 1985, INFECT IMMUN, V48, P747, DOI 10.1128/IAI.48.3.747-753.1985; KEENAN KP, 1986, AM J PATHOL, V125, P69; Kim CM, 2007, FEMS MICROBIOL LETT, V269, P170, DOI 10.1111/j.1574-6968.2006.00622.x; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koch R., 1891, BAKT FORSCH VERH 10, V1, P35; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Kushmaro A, 1996, NATURE, V380, P396, DOI 10.1038/380396a0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lightner D. V., 1988, Disease diagnosis and control in North American marine aquaculture., P42; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; McCole DF, 2000, INFECT IMMUN, V68, P1710, DOI 10.1128/IAI.68.3.1710-1713.2000; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; MIYOSHI S, 1988, MICROBIOL IMMUNOL, V32, P1025, DOI 10.1111/j.1348-0421.1988.tb01467.x; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; NELSON ET, 1976, INFECT IMMUN, V14, P527, DOI 10.1128/IAI.14.2.527-547.1976; Osawa R, 2000, J MED MICROBIOL, V49, P565, DOI 10.1099/0022-1317-49-6-565; Palumbi SR, 2005, NATURE, V434, P713, DOI 10.1038/434713a; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Retief J D, 2000, Methods Mol Biol, V132, P243; Richie K., 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1994, PROCEEDINGS OF THE FIFTH SYMPOSIUM ON THE NATURAL HISTORY OF THE BAHAMAS, P75; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rosenberg E, 2004, ANNU REV MICROBIOL, V58, P143, DOI 10.1146/annurev.micro.58.030603.123610; SNIESZKO SF, 1974, J FISH BIOL, V6, P197, DOI 10.1111/j.1095-8649.1974.tb04537.x; STAINER RY, 1971, GEN MICROBIOLOGY; STELMA GN, 1992, APPL ENVIRON MICROB, V58, P2776, DOI 10.1128/AEM.58.9.2776-2782.1992; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Teo JWP, 2003, GENE, V303, P147, DOI 10.1016/S0378-1119(02)01151-4; Thomas SR, 2004, J INVERTEBR PATHOL, V85, P146, DOI 10.1016/j.jip.2004.01.006; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Thrusfield M., 2018, VET EPIDEMIOLOGY, DOI [10.1002/9781118280249, DOI 10.1002/9781118280249]; Valenti P, 1999, EXP CELL RES, V250, P197, DOI 10.1006/excr.1999.4500; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; WILESMITH JW, 1993, PREV VET MED, V18, P33, DOI 10.1016/0167-5877(93)90091-7; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Windle HJP, 1997, INFECT IMMUN, V65, P3132, DOI 10.1128/IAI.65.8.3132-3137.1997; *WORLD ORG AN HLTH, 2006, MAN DIAGN TESTS AQ A; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x	104	197	200	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2393	10.1371/journal.pone.0002393	http://dx.doi.org/10.1371/journal.pone.0002393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560584	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700004
J	Walker, S; Peto, TEA; O'Connor, L; Crook, DW; Wyllie, D				Walker, Sarah; Peto, Tim E. A.; O'Connor, Lily; Crook, Derrick W.; Wyllie, David			Are There Better Methods of Monitoring MRSA Control than Bacteraemia Surveillance? An Observational Database Study	PLOS ONE			English	Article								Background: Despite a substantial burden of non-bacteraemic methicillin resistant Staphylococcus aureus (MRSA) disease, most MRSA surveillance schemes are based on bacteraemias. Using bacteraemia as an outcome, trends at hospital level are difficult to discern, due to random variation. We investigated rates of nosocomial bacteraemic and non-bacteraemic MRSA infection as surveillance outcomes. Methods and Findings: We used microbiology and patient administration system data from an Oxford hospital to estimate monthly rates of first nosocomial MRSA bacteraemia, and nosocomial MRSA isolation from blood/respiratory/sterile site specimens ("sterile sites") or all clinical samples (screens excluded) in all patients admitted from the community for at least 2 days between April 1998 and June 2006. During this period there were 441 nosocomial MRSA bacteraemias, 1464 MRSA isolations from sterile sites, and 3450 isolations from clinical specimens (8% blood, 15% sterile site, 10% respiratory, 59% surface swabs, 8% urine) in over 2.6 million patient-days. The ratio of bacteraemias to sterile site and all clinical isolations was similar over this period (around 3 and 8-fold lower respectively), during which rates of nosocomial MRSA bacteraemia increased by 27% per year to July 2003 before decreasing by 18% per year thereafter (heterogeneity p < 0.001). Trends in sterile site and all clinical isolations were similar. Notably, a change in rate of all clinical MRSA isolations in December 2002 could first be detected with conventional statistical significance by August 2003 (p = 0.03). In contrast, when monitoring MRSA bacteraemia, identification of probable changes in trend took longer, first achieving p < 0.05 in July 2004. Conclusions: MRSA isolation from all sites of suspected infection, including bacteraemic and non-bacteraemic isolation, is a potential new surveillance method for MRSA control. It occurs about 8 times more frequently than bacteraemia, allowing robust statistical determination of changing rates over substantially shorter times or smaller areas than using bacteraemia as an outcome.	[Walker, Sarah; Peto, Tim E. A.; O'Connor, Lily; Crook, Derrick W.] John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Walker, Sarah] MRC Clin Trials Unit, London, England; [Wyllie, David] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; Medical Research Council Clinical Trials Unit; University of Oxford	Walker, S (corresponding author), John Radcliffe Hosp, Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England.	david.wyllie@ndcls.ox.ac.uk		peto, tim/0000-0003-3477-8307	Oxford Biomedical Research Centre Programme	Oxford Biomedical Research Centre Programme	Supported by the Oxford Biomedical Research Centre Programme, which is an NIHR funded Biomedical Research Centre.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Coello R, 1997, J HOSP INFECT, V37, P39, DOI 10.1016/S0195-6701(97)90071-2; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405; Loveday HP, 2006, J HOSP INFECT, V63, pS45, DOI 10.1016/j.jhin.2006.01.002; Mekontso-Dessap A, 2001, CLIN INFECT DIS, V32, P877, DOI 10.1086/319355; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pollard TCB, 2006, J HOSP INFECT, V63, P133, DOI 10.1016/j.jhin.2006.01.015; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Shorr AF, 2006, CRIT CARE MED, V34, P700, DOI 10.1097/01.CCM.0000201885.57697.21; Spiegelhalter DJ, 2005, BRIT MED J, V331, P1013, DOI 10.1136/bmj.331.7523.1013; *SURV HEALTHC ASS, 2007, SURV HEALTHC ASS INF; TAYLOR J, 2006, SURVEILLANCE SURG SI; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F; Wyllie DH, 2005, BMJ-BRIT MED J, V331, P992, DOI 10.1136/bmj.38558.453310.8F	18	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2378	10.1371/journal.pone.0002378	http://dx.doi.org/10.1371/journal.pone.0002378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545686	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800018
J	Boutsma, E; Noback, S; van Lohuizen, M				Boutsma, Erwin; Noback, Sonja; van Lohuizen, Maarten			The Polycomb Protein and E3 Ubiquitin Ligase Ring1B Harbors an IRES in its Highly Conserved 5 ' UTR	PLOS ONE			English	Article								Ring1B is an essential member of the highly conserved Polycomb group proteins, which orchestrate developmental processes, cell growth and stem cell fate by modifying local chromatin structure. Ring1B was found to be the E3 ligase that monoubiquitinates histone H2A, which adds a new level of chromatin modification to Polycomb group proteins. Here we report that Ring1B belongs to the exclusive group of proteins that for their translation depend on a stable 5' UTR sequence in their mRNA known as an Internal Ribosome Entry Site (IRES). In cell transfection assays the Ring1B IRES confers significantly higher expression levels of Ring1B than a Ring1B cDNA without the IRES. Also, dual luciferase assays show strong activity of the Ring1B IRES. Although our findings indicate Ring1B can be translated under conditions where cap-dependent translation is impaired, we found the Ring1B IRES to be cap-dependent. This raises the possibility that translational control of Ring1B is a multi-layered process and that translation of Ring1B needs to be maintained under varying conditions, which is in line with its essential role as an E3 ligase for monoubiquitination of histone H2A in the PRC1 Polycomb protein complex.	[Boutsma, Erwin; Noback, Sonja; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Boutsma, E (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl			KWF	KWF	This research was supported by grants from the Dutch cancer foundation KWF.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; BONNAL S, 2004, J BIOL CHEM; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Core N, 1997, DEVELOPMENT, V124, P721; De Quinto SL, 2001, RNA, V7, P1213, DOI 10.1017/S1355838201010433; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; HAMBIDGE SJ, 1992, P NATL ACAD SCI USA, V89, P10272, DOI 10.1073/pnas.89.21.10272; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hernandez-Munoz I, 2003, CANCER RES, V63, P4188; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI Z, 2006, J BIOL CHEM; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; MARUSHIGE Y, 1995, ANTICANCER RES, V15, P267; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Suay L, 2005, NUCLEIC ACIDS RES, V33, P4754, DOI 10.1093/nar/gki760; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tie F, 2001, DEVELOPMENT, V128, P275; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100	63	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2322	10.1371/journal.pone.0002322	http://dx.doi.org/10.1371/journal.pone.0002322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523580	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300018
J	Chen, SY; Wang, YL; Telen, MJ; Chi, JT				Chen, Shao-Yin; Wang, Yulei; Telen, Marilyn J.; Chi, Jen-Tsan			The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases	PLOS ONE			English	Article								Background: Since mature erythrocytes are terminally differentiated cells without nuclei and organelles, it is commonly thought that they do not contain nucleic acids. In this study, we have re-examined this issue by analyzing the transcriptome of a purified population of human mature erythrocytes from individuals with normal hemoglobin (HbAA) and homozygous sickle cell disease (HbSS). Methods and Findings: Using a combination of microarray analysis, real-time RT-PCR and Northern blots, we found that mature erythrocytes, while lacking ribosomal and large-sized RNAs, contain abundant and diverse microRNAs. MicroRNA expression of erythrocytes was different from that of reticulocytes and leukocytes, and contributed the majority of the microRNA expression in whole blood. When we used microRNA microarrays to analyze erythrocytes from HbAA and HbSS individuals, we noted a dramatic difference in their microRNA expression pattern. We found that miR-320 played an important role for the down-regulation of its target gene, CD71 during reticulocyte terminal differentiation. Further investigation revealed that poor expression of miR-320 in HbSS cells was associated with their defective downregulation CD71 during terminal differentiation. Conclusions: In summary, we have discovered significant microRNA expression in human mature erythrocytes, which is dramatically altered in HbSS erythrocytes and their defect in terminal differentiation. Thus, the global analysis of microRNA expression in circulating erythrocytes can provide mechanistic insights into the disease phenotypes of erythrocyte diseases.	[Chen, Shao-Yin; Chi, Jen-Tsan] Duke Univ, Sch Med, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Chen, Shao-Yin; Chi, Jen-Tsan] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA; [Wang, Yulei] Appl Biosyst Inc, Foster City, CA USA; [Telen, Marilyn J.] Duke Univ, Sch Med, Dept Med, Div Hematol, Durham, NC USA	Duke University; Duke University; Thermo Fisher Scientific; Applied Biosystems; Duke University	Chen, SY (corresponding author), Duke Univ, Sch Med, Inst Genome Sci & Policy, Durham, NC 27710 USA.	chi00002@mc.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Wang, Yulei/0000-0002-9057-9786; Telen, Marilyn/0000-0003-3809-1780				Bahou WF, 2004, SEMIN THROMB HEMOST, V30, P473, DOI 10.1055/s-2004-833482; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Browne EP, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-238; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; GIRALDEZ AJ, 2006, SCIENCE; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goh SH, 2004, NUCLEIC ACIDS RES, V32, pD572, DOI 10.1093/nar/gkh129; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hoffman R, 2004, HEMATOLOGY BASIC PRI, V4th; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LINDA G, 1986, CYTOMETRY, V7, P508; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miller JL, 2004, BLOOD CELL MOL DIS, V32, P341, DOI 10.1016/j.bcmd.2004.01.003; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rainen L, 2002, CLIN CHEM, V48, P1883; Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Skadberg Oyvind, 2003, Lab Hematol, V9, P198; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; WANG Q, 2007, BLOOD; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zen Q, 2004, AM J HEMATOL, V75, P63, DOI 10.1002/ajh.10442; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x	46	125	134	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2360	10.1371/journal.pone.0002360	http://dx.doi.org/10.1371/journal.pone.0002360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523662	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300047
J	Earnest, CP; Lavie, CJ; Blair, SN; Church, TS				Earnest, Conrad P.; Lavie, Carl J.; Blair, Steven N.; Church, Timothy S.			Heart Rate Variability Characteristics in Sedentary Postmenopausal Women Following Six Months of Exercise Training: The DREW Study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; HEALTHY; FITNESS; MEN; RISK; REST	Background: Decreased heart rate variability (HRV) is associated with a higher risk of mortality. Overall, postmenopausal women have lower levels of HRV than premenopausal women, which may be additionally complicated by lifestyle related behaviors such as physical inactivity and obesity. Though cardiorespiratory exercise training increases HRV, little is known regarding the exercise dose necessary to promote this improvement. Methodology/ Principal Findings: Our primary aim was to measure HRV in post-menopausal women following 6-months of exercise training. We examined supine resting HRV in 373 post-menopausal women (45-75 y) after 6-months of randomly assigned and double-blinded administered exercise training exercise training at 50%, 100% and 150% of the NIH Consensus Development Panel's recommended minimal physical activity level. This corresponded to 4, 8, or 12 kcal/kg per week (KKW) of energy expenditure. At baseline, we observed no significant differences in HRV or hormone replacement use between treatment groups. However, we did observe that Caucasian women and those taking antidepressant medications had lower levels of baseline HRV. After 6-months of exercise intervention, we observed a dose dependent increase in all parasympathetically derived time and frequency domain measurements across exercise groups after adjustment for age, ethnicity, antidepressants, and baseline rMSSD (all, P < 0.001). For example, the parasympathetic index rMSSD was greater than control (23.19 +/- 1.0) for the 4-KKW (25.98 +/- 0.8; P=0.14), 8-KKW (27.66 +/- 1.0; P < 0.05), and 12-KKW (27.40 +/- 0.0; P < 0.05) groups at follow-up. Conclusions/Significance: Moderate intensity exercise training exercise is sufficient to improve HRV in previously sedentary postmenopausal women in a dose-dependent manner, as 4-KKW is insufficient to improve parasympathetic indices of HRV, while 12-KKW conferred no greater improvement than 8-KKW.	[Earnest, Conrad P.; Church, Timothy S.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Lavie, Carl J.] Ochsner Hlth Syst, Dept Cardiol, New Orleans, LA USA; [Blair, Steven N.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC USA; [Blair, Steven N.] Univ N Texas, Denton, TX USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Ochsner Health System; University of South Carolina System; University of South Carolina Columbia; University of North Texas System; University of North Texas Denton	Earnest, CP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.	conrad.earnest@pbrc.edu	Earnest, Conrad P/A-7860-2009; Lavie, Carl J/A-6014-2011; Earnest, Conrad P./M-6849-2017	Earnest, Conrad P./0000-0002-6546-1268	American Heart Association Texas Affiliate award [02651404]; National Institutes of Health [HL-66262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066262] Funding Source: NIH RePORTER	American Heart Association Texas Affiliate award(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The DREW study as financially supported by in part by American Heart Association Texas Affiliate award 02651404; the National Institutes of Health grant HL-66262 and an exercise equipment donation from Life Fitness (Schiller Park, IL).	ALGRA A, 1993, CIRCULATION, V88, P180, DOI 10.1161/01.CIR.88.1.180; [Anonymous], 1996, JAMA, V276, P241; ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; BERTEL O, 1980, HYPERTENSION, V2, P130, DOI 10.1161/01.HYP.2.2.130; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Britton A, 2007, AM J CARDIOL, V100, P524, DOI 10.1016/j.amjcard.2007.03.056; Brockbank CL, 2000, EXP PHYSIOL, V85, P327; Camm AJ, 1996, EUR HEART J, V17, P354; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Davy KP, 1996, AM J PHYSIOL-HEART C, V271, pH455, DOI 10.1152/ajpheart.1996.271.2.H455; Davy KP, 1997, CLIN PHYSIOL, V17, P31, DOI 10.1046/j.1365-2281.1997.01010.x; Dickhuth H H, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS71, DOI 10.1097/00005344-198706106-00009; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.713; EAKER ED, 1993, CIRCULATION, V88, P1999, DOI 10.1161/01.CIR.88.4.1999; EKBLOM B, 1973, Scandinavian Journal of Clinical and Laboratory Investigation, V32, P251, DOI 10.3109/00365517309082468; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Fluckiger L, 1999, J GERONTOL A-BIOL, V54, pB219, DOI 10.1093/gerona/54.5.B219; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Huikuri HV, 1996, CIRCULATION, V93, P1836, DOI 10.1161/01.CIR.93.10.1836; HUIKURI HV, 1992, AM J CARDIOL, V70, P610, DOI 10.1016/0002-9149(92)90200-I; HULL SS, 1994, CIRCULATION, V89, P548, DOI 10.1161/01.CIR.89.2.548; Ito H, 2001, JPN HEART J, V42, P459, DOI 10.1536/jhj.42.459; Jones PP, 2003, CIRCULATION, V107, P1770, DOI 10.1161/01.CIR.0000057811.86187.88; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; KATONA PG, 1982, J APPL PHYSIOL, V52, P1652, DOI 10.1152/jappl.1982.52.6.1652; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; LAROVERE MT, 1992, CHEST, V101, pS299, DOI 10.1378/chest.101.5.299S; Levy WC, 1998, AM J CARDIOL, V82, P1236, DOI 10.1016/S0002-9149(98)00611-0; LEWIS SF, 1980, ACTA PHYSIOL SCAND, V109, P297, DOI 10.1111/j.1748-1716.1980.tb06600.x; Lucini D, 2002, AM HEART J, V143, P977, DOI 10.1067/mhj.2002.123117; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; Mosca L, 1997, CIRCULATION, V96, P2468; Myslivecek PR, 2002, CAN J APPL PHYSIOL, V27, P1, DOI 10.1139/h02-001; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Perini R, 2002, MED SCI SPORT EXER, V34, P700, DOI 10.1097/00005768-200204000-00022; Reland S, 2004, CLIN SCI, V107, P29, DOI 10.1042/CS20030405; Schuit AJ, 1999, MED SCI SPORT EXER, V31, P816, DOI 10.1097/00005768-199906000-00009; SCHWARTZ JB, 1991, J GERONTOL, V46, pM99, DOI 10.1093/geronj/46.3.M99; Shin K, 1997, MED SCI SPORT EXER, V29, P1482, DOI 10.1097/00005768-199711000-00015; TSUJI H, 1994, CIRCULATION, V90, P878, DOI 10.1161/01.CIR.90.2.878; Westerterp KR, 2001, J GERONTOL A-BIOL, V56, P7, DOI 10.1093/gerona/56.suppl_2.7; Yataco AR, 1997, AM J CARDIOL, V80, P1389, DOI 10.1016/S0002-9149(97)00697-8	47	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2288	10.1371/journal.pone.0002288	http://dx.doi.org/10.1371/journal.pone.0002288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523583	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300007
J	Zeng, L; Wu, GZ; Goh, KJ; Lee, YM; Ng, CC; Ben You, A; Wang, JH; Jia, DY; Hao, AJ; Yu, Q; Li, BJ				Zeng, Li; Wu, Guang-Zhi; Goh, Kim Jee; Lee, Yew Mun; Ng, Chuo Chung; Ben You, Ang; Wang, Jianhe; Jia, Deyong; Hao, Aijun; Yu, Qiang; Li, Baojie			Saturated Fatty Acids Modulate Cell Response to DNA Damage: Implication for Their Role in Tumorigenesis	PLOS ONE			English	Article								DNA damage triggers a network of signaling events that leads to cell cycle arrest or apoptosis. This DNA damage response acts as a mechanism to prevent cancer development. It has been reported that fatty acids (FAs) synthesis is increased in many human tumors while inhibition of fatty acid synthase (FASN) could suppress tumor growth. Here we report that saturated fatty acids (SFAs) play a negative role in DNA damage response. Palmitic acid, as well as stearic acid and myristic acid, compromised the induction of p21 and Bax expression in response to double stranded breaks and ssDNA, while inhibition or knockdown of FASN enhanced these cellular events. SFAs appeared to regulate p21 and Bax expression via Atr-p53 dependent and independent pathways. These effects were only observed in primary mouse embryonic fibroblasts and osteoblasts, but not in immortalized murine NIH3T3, or transformed HCT116 and MCF-7 cell lines. Accordingly, SFAs showed some positive effects on proliferation of MEFs in response to DNA damage. These results suggest that SFAs, by negatively regulating the DNA damage response pathway, might promote cell transformation, and that increased synthesis of SFAs in precancer/cancer cells might contribute to tumor progression and drug resistance.	[Zeng, Li; Wu, Guang-Zhi; Goh, Kim Jee; Lee, Yew Mun; Ng, Chuo Chung; Ben You, Ang; Wang, Jianhe; Li, Baojie] Natl Univ Singapore, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore 117548, Singapore; [Wu, Guang-Zhi] Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China; [Jia, Deyong; Hao, Aijun] Shandong Univ, Fac Med, Key Lab Expt Teratol, Minist Educ, Jinan, Peoples R China; [Yu, Qiang] Genome Inst Singapore, Lab Mol Pharmacol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Jilin University; Shandong University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zeng, L (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, Canc & Dev Biol Div, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	libj@imcb.a-star.edu.sg	Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022; Lee, Yew Mun/G-8891-2017	Jia, Deyong/0000-0003-2034-0363; Lee, Yew Mun/0000-0002-8360-7689; Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology, and Research, Signapore; Ministry of Education, China [NCET-04-0624]	Agency for Science, Technology, and Research, Signapore; Ministry of Education, China(Ministry of Education, China)	The study was supported by Agency for Science, Technology, and Research, Signapore (BL) and New Century Excellent Talents Program in University (NCET-04-0624), Ministry of Education, China (AH).	Aja S, 2008, AM J PHYSIOL-REG I, V294, pR352, DOI 10.1152/ajpregu.00862.2006; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; CHALBOS D, 1987, J BIOL CHEM, V262, P9923; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Fraser DA, 1999, RHEUMATOLOGY, V38, P948, DOI 10.1093/rheumatology/38.10.948; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Key T, 2007, BRIT MED J, V335, P897, DOI 10.1136/bmj.39373.676204.BE; Kiffmeyer T, 2007, Cancer Treat Res, V134, P275; KLEIN S, 1992, AM J PHYSIOL, V262, pE631, DOI 10.1152/ajpendo.1992.262.5.E631; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Li BJ, 2004, GENE DEV, V18, P1824, DOI 10.1101/gad.1223504; Li JN, 2001, CANCER RES, V61, P1493; Malhotra V, 2003, CANCER BIOL THER, V2, pS2; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2004, MOL CARCINOGEN, V41, P164, DOI 10.1002/mc.20054; Menendez JA, 2004, INT J ONCOL, V24, P591; Ogino S, 2007, HUM PATHOL, V38, P842, DOI 10.1016/j.humpath.2006.11.018; Pandian SS, 1999, J ROY COLL SURG EDIN, V44, P352; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pizer ES, 1996, CANCER RES, V56, P745; Prentice RL, 2007, JNCI-J NATL CANCER I, V99, P1534, DOI 10.1093/jnci/djm159; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Schmid B, 2005, BIOCHEM BIOPH RES CO, V328, P1073, DOI 10.1016/j.bbrc.2005.01.067; Slade RF, 2003, ANTICANCER RES, V23, P1235; Van de Sande T, 2002, CANCER RES, V62, P642; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Walley AJ, 2006, HUM MOL GENET, V15, pR124, DOI 10.1093/hmg/ddl215; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Zeng L, 2005, J BIOL CHEM, V280, P29374, DOI 10.1074/jbc.M503016200; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zhou WB, 2003, CANCER RES, V63, P7330	43	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2329	10.1371/journal.pone.0002329	http://dx.doi.org/10.1371/journal.pone.0002329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523653	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300024
J	Tao, R; Hancock, WW				Tao, Ran; Hancock, Wayne W.			Resistance of Foxp3+Regulatory T Cells to Nur77-Induced Apoptosis Promotes Allograft Survival	PLOS ONE			English	Article								The NR4A nuclear receptor family member Nur77 (NR4A1) promotes thymocyte apoptosis during negative selection of autoreactive thymocytes, but may also function in mature extrathymic T cells. We studied the effects of over-expression of Nur77 on the apoptosis of murine peripheral T cells, including thymic-derived Foxp3+ regulatory (Treg) cells. Overexpression of Nur77 in the T cell lineage decreased numbers of peripheral CD4 and CD8 T cells by similar to 80% compared to wild-type (WT) mice. However, the proportions of Treg cells were markedly increased in the thymus (61% of CD4+Foxp3+ singly positive thymocytes vs. 8% in WT) and secondary lymphoid organs (40-50% of CD4+ Foxp3+ T cells vs. 7-8% in WT) of Nur77 transgenic (Nur77Tg) mice, and immunoprecipitation studies showed Nur77 was associated with a recently identified HDAC7/Foxp3 transcriptional complex. Upon activation through the T cell receptor in vitro or in vivo, Nur77Tg T cells showed only marginally decreased proliferation but significantly increased apoptosis. Fully allogeneic cardiac grafts transplanted to Nur77Tg mice survived long-term with well-preserved structure, and recipient splenocytes showed markedly enhanced apoptosis and greatly reduced anti-donor recall responses. Allografts in Nur77Tg recipients had significantly increased expression of multiple Treg-associated genes, including Foxp3, Foxp1, Tip60 and HDAC9. Allograft rejection was restored by CD25 monoclonal antibody therapy, indicating that allograft acceptance was dependent upon Treg function in Nur77Tg recipients. These data show that compared to conventional CD4 and CD8 T cells, Foxp3+ Tregs are relatively resistant to Nur77-mediated apoptosis, and that tipping the balance between the numbers of Tregs and responder T cells in the early period post-transplantation can determine the fate of the allograft. Hence, induced expression of Nur77 might be a novel means to achieve long-term allograft survival.	[Tao, Ran; Hancock, Wayne W.] Childrens Hosp Philadelphia, Stokes Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Tao, R (corresponding author), Childrens Hosp Philadelphia, Stokes Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu			National Institutes of Health [1R01AI54720, 1R01AI 073938]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073938, R01AI054720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (1R01AI54720 and 1R01AI 073938) to WWH. There are no financial, personal, or professional interests that could be construed to have influenced the paper.	CALNAN BJ, 1995, IMMUNITY, V3, P273; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Dawson MI, 2001, CANCER RES, V61, P4723; De Silva S, 2005, ARTHRITIS RHEUM-US, V52, P333, DOI 10.1002/art.20736; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; DeYoung AL, 2000, J IMMUNOL, V165, P6170, DOI 10.4049/jimmunol.165.11.6170; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gennari A, 2002, TOXICOL APPL PHARM, V181, P27, DOI 10.1006/taap.2002.9357; Hancock WW, 2003, CURR OPIN IMMUNOL, V15, P479, DOI 10.1016/S0952-7915(03)00103-1; Kang HJ, 2000, EXP CELL RES, V256, P545, DOI 10.1006/excr.2000.4832; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kasprowicz DJ, 2005, EUR J IMMUNOL, V35, P3424, DOI 10.1002/eji.200526339; Kim H, 2006, BIOCHEM BIOPH RES CO, V348, P950, DOI 10.1016/j.bbrc.2006.07.167; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Toth R, 2001, EUR J IMMUNOL, V31, P1382, DOI 10.1002/1521-4141(200105)31:5<1382::AID-IMMU1382>3.0.CO;2-Y; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YAZDANBAKHSH K, 1995, P NATL ACAD SCI USA, V92, P437, DOI 10.1073/pnas.92.2.437; Zhang J, 1999, COLD SPRING HARB SYM, V64, P363, DOI 10.1101/sqb.1999.64.363; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	36	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2321	10.1371/journal.pone.0002321	http://dx.doi.org/10.1371/journal.pone.0002321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509529	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500048
J	Bai, BK; Hu, QX; Hu, H; Zhou, P; Shi, ZL; Meng, J; Lu, BJ; Huang, Y; Mao, PY; Wang, H				Bai, Bingke; Hu, Qinxue; Hu, Hui; Zhou, Peng; Shi, Zhengli; Meng, Jin; Lu, Baojing; Huang, Yi; Mao, Panyong; Wang, Hanzhong			Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SPIKE PROTEIN; TARGETED RECOMBINATION; MURINE CORONAVIRUS; IMMUNE-RESPONSES; VACCINE; GENE; IDENTIFICATION; GLYCOPROTEIN; DETERMINANT	The pathogenesis of SARS coronavirus (CoV) remains poorly understood. In the current study, two recombinant baculovirus were generated to express the spike (S) protein of SARS-like coronavirus (SL-CoV) isolated from bats (vAcBS) and the envelope (E) and membrane (M) proteins of SARS-CoV, respectively. Co-infection of insect cells with these two recombinant baculoviruses led to self-assembly of virus- like particles (BVLPs) as demonstrated by electron microscopy. Incorporation of S protein of vAcBS (BS) into VLPs was confirmed by western blot and immunogold labeling. Such BVLPs up-regulated the level of CD40, CD80, CD86, CD83, and enhanced the secretion of IL-6, IL-10 and TNF-alpha in immature dendritic cells (DCs). Immune responses were compared in immature DCs inoculated with BVLPs or with VLPs formed by S, E and M proteins of human SARS-CoV. BVLPs showed a stronger ability to stimulate DCs in terms of cytokine induction as evidenced by 2 to 6 fold higher production of IL-6 and TNF-alpha. Further study indicated that IFN-gamma+ and IL-4+ populations in CD4+ T cells increased upon co-cultivation with DCs pre-exposed with BVLPs or SARS-CoV VLPs. The observed difference in DC- stimulating activity between BVLPs and SARS CoV VLPs was very likely due to the S protein. In agreement, SL-CoV S DNA vaccine evoked a more vigorous antibody response and a stronger T cell response than SARS-CoV S DNA in mice. Our data have demonstrated for the first time that SL-CoV VLPs formed by membrane proteins of different origins, one from SL-CoV isolated from bats (BS) and the other two from human SARS-CoV (E and M), activated immature DCs and enhanced the expression of costimulatory molecules and the secretion of cytokines. Finding in this study may provide important information for vaccine development as well as for understanding the pathogenesis of SARS-like CoV.	[Bai, Bingke; Hu, Qinxue; Hu, Hui; Zhou, Peng; Shi, Zhengli; Meng, Jin; Lu, Baojing; Huang, Yi; Wang, Hanzhong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Zhou, Peng; Meng, Jin; Lu, Baojing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Bai, Bingke; Mao, Panyong] Inst Infect Dis, Dept Virol, Beijing, Peoples R China; [Bai, Bingke] Chinese Peoples Liberat Army, Postgrad Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, BK (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	wanghz@wh.iov.cn	Zhou, Peng/I-8578-2015; Shi, Zhengli/A-1013-2013	Zhou, Peng/0000-0003-1938-8255; Shi, Zhengli/0000-0001-8089-163X; Hu, Qinxue/0000-0002-4594-9215	Ministry of Science and Technology, People's Republic of China [2005CB523000, 2006CB933102]; Chinese Academy of Sciences [KSCX1-YW-R-07]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by National "973 Project" grants (2005CB523000, 2006CB933102) from the Ministry of Science and Technology, People's Republic of China and by Chinese Academy of Sciences (grant no. KSCX1-YW-R-07).	Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Bisht H, 2004, P NATL ACAD SCI USA, V101, P6641, DOI 10.1073/pnas.0401939101; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Buchholz UJ, 2004, P NATL ACAD SCI USA, V101, P9804, DOI 10.1073/pnas.0403492101; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Cui W, 2003, CLIN INFECT DIS, V37, P857, DOI 10.1086/378587; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Farcas GA, 2005, J INFECT DIS, V191, P193, DOI 10.1086/426870; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; HARRIS R, 1997, FOCUS, V19, P72; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; Ho JC, 2003, AM J RESP CRIT CARE, V168, P1449, DOI 10.1164/rccm.200306-766OC; Ho Y, 2004, BIOCHEM BIOPH RES CO, V318, P833, DOI 10.1016/j.bbrc.2004.04.111; Hsueh PR, 2004, EMERG INFECT DIS, V10, P489, DOI 10.3201/eid1003.030571; JACOBS DM, 1977, J IMMUNOL, V118, P21; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Leparc-Goffart I, 1998, J VIROL, V72, P9628, DOI 10.1128/JVI.72.12.9628-9636.1998; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu XY, 2007, IMMUNOLOGY, V122, P496, DOI 10.1111/j.1365-2567.2007.02676.x; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Nakajima N, 2003, JPN J INFECT DIS, V56, P139; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Paliard X, 2000, AIDS RES HUM RETROV, V16, P273, DOI 10.1089/088922200309368; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Ren W, 2006, J GEN VIROL, V87, P3355, DOI 10.1099/vir.0.82220-0; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanchez CM, 1999, J VIROL, V73, P7607; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Spiegel M, 2006, J GEN VIROL, V87, P1953, DOI 10.1099/vir.0.81624-0; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Ye L, 2006, VIROLOGY, V351, P260, DOI 10.1016/j.virol.2006.03.021; Zhao P, 2004, ACTA BIOCH BIOPH SIN, V36, P37, DOI 10.1093/abbs/36.1.37	49	33	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2685	10.1371/journal.pone.0002685	http://dx.doi.org/10.1371/journal.pone.0002685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628832	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200029
J	Boukal, DS; Berec, L; Krivan, V				Boukal, David S.; Berec, Ludek; Krivan, Vlastimil			Does Sex-Selective Predation Stabilize or Destabilize Predator-Prey Dynamics?	PLOS ONE			English	Article							GYPSY-MOTH LEPIDOPTERA; NATURAL ENEMIES; MATING SYSTEMS; BODY-SIZE; ALLEE; EXTINCTION; RISK; CONSEQUENCES; POPULATIONS; RATIOS	Background: Little is known about the impact of prey sexual dimorphism on predator-prey dynamics and the impact of sex-selective harvesting and trophy hunting on long-term stability of exploited populations. Methodology and Principal Findings: We review the quantitative evidence for sex-selective predation and study its long-term consequences using several simple predator-prey models. These models can be also interpreted in terms of feedback between harvesting effort and population size of the harvested species under open-access exploitation. Among the 81 predator-prey pairs found in the literature, male bias in predation is 2.3 times as common as female bias. We show that long-term effects of sex-selective predation depend on the interplay of predation bias and prey mating system. Predation on the 'less limiting' prey sex can yield a stable predator-prey equilibrium, while predation on the other sex usually destabilizes the dynamics and promotes population collapses. For prey mating systems that we consider, males are less limiting except for polyandry and polyandrogyny, and male-biased predation alone on such prey can stabilize otherwise unstable dynamics. On the contrary, our results suggest that female-biased predation on polygynous, polygynandrous or monogamous prey requires other stabilizing mechanisms to persist. Conclusions and Significance: Our modelling results suggest that the observed skew towards male-biased predation might reflect, in addition to sexual selection, the evolutionary history of predator-prey interactions. More focus on these phenomena can yield additional and interesting insights as to which mechanisms maintain the persistence of predator-prey pairs over ecological and evolutionary timescales. Our results can also have implications for long-term sustainability of harvesting and trophy hunting of sexually dimorphic species.	[Boukal, David S.] Inst Marine Res, N-5024 Bergen, Norway; [Boukal, David S.] Univ Bergen, Dept Biol, Bergen, Norway; [Boukal, David S.; Berec, Ludek; Krivan, Vlastimil] Biol Ctr AS CR, Inst Entomol, Dept Theoretical Ecol, Ceske Budejovice, Czech Republic	Institute of Marine Research - Norway; University of Bergen; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Boukal, DS (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	berec@entu.cas.cz	Krivan, Vlastimil/F-1709-2010; Krivan, Vlastimil/J-7015-2019; Berec, Ludek/G-7253-2014; Boukal, David/H-4762-2014	Krivan, Vlastimil/0000-0003-0971-1231; Krivan, Vlastimil/0000-0003-0971-1231; Berec, Ludek/0000-0002-2419-3324; Boukal, David/0000-0001-8181-7458	Institute of Entomology [Z50070508]; GA AV CR [KJB600070602, IAA100070601]; EU Research Training Network FishACE [MRTN-CT-2004-005578]; EvoFish project funded through Bergen Research Foundation	Institute of Entomology(Czech Academy of Sciences); GA AV CR(Grant Agency of the Czech Republic); EU Research Training Network FishACE; EvoFish project funded through Bergen Research Foundation	This research was supported by the Institute of Entomology (project Z50070508) and grants from GA AV CR (KJB600070602 and IAA100070601). DSB is currently supported by the EU Research Training Network FishACE (contract no. MRTN-CT-2004-005578) and by the EvoFish project funded through Bergen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Boukal DS, 2007, THEOR POPUL BIOL, V72, P136, DOI 10.1016/j.tpb.2006.12.003; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; BRITTON RH, 1982, OECOLOGIA, V53, P146, DOI 10.1007/BF00545657; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Clark C.W., 1974, MATH PROBLEMS BIOL, P29; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; DOEBELI M, 1994, P ROY SOC B-BIOL SCI, V257, P17, DOI 10.1098/rspb.1994.0088; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; Fuester RW, 1996, ENVIRON ENTOMOL, V25, P536, DOI 10.1093/ee/25.2.536; Garcia CM, 1998, J FISH BIOL, V53, P104, DOI 10.1111/j.1095-8649.1998.tb01021.x; Gotmark F, 1997, OIKOS, V80, P540, DOI 10.2307/3546627; Gwynne DT, 2002, BEHAVIOUR, V139, P1425, DOI 10.1163/15685390260514690; HAIRSTON NG, 1983, LIMNOL OCEANOGR, V28, P935, DOI 10.4319/lo.1983.28.5.0935; HICKS GRF, 1985, NEW ZEAL J MAR FRESH, V19, P227, DOI 10.1080/00288330.1985.9516089; JOHNSON D, 1991, CAN J ZOOL, P208; Kent A, 2003, ECOL MODEL, V162, P233, DOI 10.1016/S0304-3800(02)00343-5; Kokko H, 2007, EVOLUTION, V61, P1162, DOI 10.1111/j.1558-5646.2007.00090.x; KRAUSMAN PR, 1989, WILDLIFE MONOGRAPHS, V102; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; Liebhold AM, 2005, AGR FOREST ENTOMOL, V7, P179, DOI 10.1111/j.1461-9555.2005.00256.x; Lindstrom J, 1998, P ROY SOC B-BIOL SCI, V265, P483, DOI 10.1098/rspb.1998.0320; LLOYD JE, 1983, SCIENCE, V222, P634, DOI 10.1126/science.222.4624.634; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MALY EJ, 1970, LIMNOL OCEANOGR, V15, P566, DOI 10.4319/lo.1970.15.4.0566; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mooring MS, 2004, J WILDLIFE MANAGE, V68, P519, DOI 10.2193/0022-541X(2004)068[0519:VPRATA]2.0.CO;2; Murdoch WW, 1998, ECOLOGY, V79, P1339, DOI 10.2307/176747; Norrdahl K, 1998, ECOLOGY, V79, P226; Olsen JB, 2006, J FISH BIOL, V69, P140, DOI 10.1111/j.1095-8649.2006.01119.x; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; REHFELDT G, 1992, OECOLOGIA, V89, P550, DOI 10.1007/BF00317162; Reid K, 1996, MAR ECOL PROG SER, V140, P13, DOI 10.3354/meps140013; Rowe S, 2003, TRENDS ECOL EVOL, V18, P567, DOI 10.1016/j.tree.2003.09.004; Schlacher TA, 1996, MAR BIOL, V125, P241, DOI 10.1007/BF00346304; SHUSTER SM, 2003, MG BEH ECOL, pR7; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Svensson JE, 1997, HYDROBIOLOGIA, V344, P155, DOI 10.1023/A:1002966614054; Tcheslavskaia K, 2002, GREAT LAKES ENTOMOL, V35, P1; WESELOH RM, 1988, CAN ENTOMOL, V120, P873, DOI 10.4039/Ent120873-10; YEARGAN KV, 1988, OECOLOGIA, V74, P524, DOI 10.1007/BF00380049; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	51	44	44	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2687	10.1371/journal.pone.0002687	http://dx.doi.org/10.1371/journal.pone.0002687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628951	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200031
J	Riising, EM; Boggio, R; Chiocca, S; Helin, K; Pasini, D				Riising, Eva Madi; Boggio, Roberto; Chiocca, Susanna; Helin, Kristian; Pasini, Diego			The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; EZH2; PROLIFERATION; METHYLATION; NUCLEAR; GASTRULATION; LYSINE-27; PROTEINS; ENHANCER	Background: The Polycomb Repressive Complex 2 ( PRC2) functions as a transcriptional repressor through a mechanism that involves methylation of Histone H3 at lysine 27. The PRC2 complex activity is essential for cellular proliferation, development, and cell fate decisions. PRC2 target genes include important regulators of development and proliferation as well as tumor suppressor genes. Consistent with this, the activity of several Polycomb group (PcG) proteins is deregulated in human cancer suggesting an important role for PcGs in tumor development. Whereas the downstream functions of PcGs are well characterized, the mechanisms of their recruitment to target genes and the regulation of their activity are not fully understood. Principal Findings: Here we show that the two PRC2 components SUZ12 and EZH2 are sumoylated in vitro and in vivo. Among several putative sumoylation sites we have mapped the major site of SUZ12 sumoylation. Furthermore, we show that SUZ12 interacts with the E2-conjugating enzyme UBC9 both in vitro and in vivo and that mutation of the SUZ12 sumoylation site does not abolish this binding. Finally, we provide evidence that the E3-ligase PIASX beta interacts and enhances the sumoylation of SUZ12 in vivo suggesting that PIASXb could function as an E3-ligase for SUZ12. Conclusions: Taken together, our data identify sumoylation as a novel post-translational modification of components of the PRC2 complex, which could suggest a potential new mechanism to modulate PRC2 repressive activity. Further work aimed to identify the physiological conditions for these modifications will be required to understand the role of SUZ12 and EZH2 sumoylation in PcG-mediated epigenetic regulation of transcription.	[Riising, Eva Madi; Helin, Kristian; Pasini, Diego] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Riising, Eva Madi; Helin, Kristian; Pasini, Diego] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Boggio, Roberto; Chiocca, Susanna] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Copenhagen; University of Copenhagen; IRCCS European Institute of Oncology (IEO)	Riising, EM (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	kristian.helin@bric.dk	Pasini, Diego/J-9674-2012; Helin, Kristian/K-2526-2019; Chiocca, Susanna/K-5233-2016; Helin, Kristian/HDM-8306-2022; Chiocca, Susanna/AAC-8863-2019	Pasini, Diego/0000-0002-9879-6486; Chiocca, Susanna/0000-0002-9721-0850; Helin, Kristian/0000-0003-1975-6097; Madi Riising, Eva/0000-0003-3152-5769	Danish Medical Research Council [post-doctoral fellowship]; Danish Cancer Society; Novo Nordisk Foundation; Danish Natural Science Research Council; Danish National Research Foundation; International Association for Cancer Research	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Science Research Council(Danish Natural Science Research Council); Danish National Research Foundation(Danmarks Grundforskningsfond); International Association for Cancer Research	D.P. was supported by a post-doctoral fellowship from the Danish Medical Research Council. The work in the Helin lab was supported by grants from the Danish Cancer Society, the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Natural Science Research Council, the Danish National Research Foundation, and the International Association for Cancer Research.	Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jacobs, 1999, Curr Infect Dis Rep, V1, P13, DOI 10.1007/s11908-999-0004-8; Jacobs JJL, 2002, BBA-REV CANCER, V1602, P151, DOI 10.1016/S0304-419X(02)00052-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2004, CELL CYCLE, V3, P396; PASINI D, 2007, MOL CELL BIOL; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Yan W, 2003, GENE EXPR PATTERNS, V3, P301, DOI 10.1016/S1567-133X(03)00045-0; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; CELL, V121, P425	49	44	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2704	10.1371/journal.pone.0002704	http://dx.doi.org/10.1371/journal.pone.0002704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628979	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200047
J	Itrat, A; Khan, A; Javaid, S; Kamal, M; Khan, H; Javed, S; Kalia, S; Khan, AH; Sethi, MI; Jehan, I				Itrat, Ahmed; Khan, Abdullah; Javaid, Sunniya; Kamal, Mahwash; Khan, Hassan; Javed, Sannia; Kalia, Saira; Khan, Adil Haleem; Sethi, Muhammad Imran; Jehan, Imtiaz			Knowledge, Awareness and Practices Regarding Dengue Fever among the Adult Population of Dengue Hit Cosmopolitan	PLOS ONE			English	Article								Background: The World health Organization (WHO) declares dengue and dengue hemorrhagic fever to be endemic in South Asia. Despite the magnitude of problem, no documented evidence exists in Pakistan which reveals the awareness and practices of the country's adult population regarding dengue fever, its spread, symptoms, treatment and prevention. This study was conducted to assess the level of knowledge, attitudes and practices regarding dengue fever in people visiting tertiary care hospitals in Karachi, Pakistan. Methods: A cross-sectional pilot study was conducted among people visiting tertiary care hospitals in Karachi. Through convenience sampling, a pre-tested and structured questionnaire was administered through a face-to-face unprompted interview with 447 visitors. Knowledge was recorded on a scale of 1-3. Results: About 89.9% of individuals interviewed had heard of dengue fever. Sufficient knowledge about dengue was found to be in 38.5% of the sample, with 66% of these in Aga Khan University Hospital and 33% in Civil Hospital Karachi. Literate individuals were relatively more well-informed about dengue fever as compared to the illiterate people (p < 0.001). Knowledge based upon preventive measures was found to be predominantly focused towards prevention of mosquito bites (78.3%) rather than eradication of mosquito population (17.3%). Use of anti-mosquito spray was the most prevalent (48.1%) preventive measure. Television was considered as the most important and useful source of information on the disease. Conclusion: Adult population of Karachi has adequate knowledge related to the disease 'dengue' on isolated aspects, but the overall prevalence of 'sufficient knowledge' based on our criteria is poor. We demonstrated adequate prevalence of preventive practices against the disease. Further studies correlating the association between knowledge and its effectiveness against dengue will be helpful in demonstrating the implications of awareness campaigns.	[Itrat, Ahmed; Khan, Abdullah; Javaid, Sunniya; Kamal, Mahwash; Khan, Hassan; Javed, Sannia; Kalia, Saira; Khan, Adil Haleem; Sethi, Muhammad Imran] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Jehan, Imtiaz] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University; Aga Khan University	Itrat, A (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	drhasankhan@gmail.com	Khan, Hassan/D-6267-2013	Khan, Hassan/0000-0003-1468-8654				Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114; *FED BUR STAT GOV, 2003, PAK INT HLTH SURV; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Halstead SB, 1999, LANCET, V353, P1100, DOI 10.1016/S0140-6736(05)76460-6; Jamil B, 2005, T ROY SOC TROP MED H, V99, P577, DOI 10.1016/j.trstmh.2005.03.002; Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889; Khan E, 2007, T ROY SOC TROP MED H, V101, P1114, DOI 10.1016/j.trstmh.2007.06.016; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Kubik K, 2004, AM J OBSTET GYNECOL, V191, P188, DOI 10.1016/j.ajog.2004.03.084; McArthur L, 2001, INT J OBESITY, V25, P1262, DOI 10.1038/sj.ijo.0801674; Paul R E, 1998, Int J Infect Dis, V2, P197, DOI 10.1016/S1201-9712(98)90052-2; Porter KR, 2005, AM J TROP MED HYG, V72, P60, DOI 10.4269/ajtmh.2005.72.60; Potvin L, 2000, CAN MED ASSOC J, V162, pS5; Rai MA, 2007, J CLIN VIROL, V38, P269, DOI 10.1016/j.jcv.2006.12.010; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; WHO, 1997, DENG HAEM FEV DIAGN; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927	23	85	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2620	10.1371/journal.pone.0002620	http://dx.doi.org/10.1371/journal.pone.0002620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612437	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800022
J	Fishman, Y; Zlotkin, E; Sher, D				Fishman, Yelena; Zlotkin, Eliahu; Sher, Daniel			Expulsion of Symbiotic Algae during Feeding by the Green Hydra - a Mechanism for Regulating Symbiont Density?	PLOS ONE			English	Article								Background: Algal-cnidarian symbiosis is one of the main factors contributing to the success of cnidarians, and is crucial for the maintenance of coral reefs. While loss of the symbionts (such as in coral bleaching) may cause the death of the cnidarian host, over-proliferation of the algae may also harm the host. Thus, there is a need for the host to regulate the population density of its symbionts. In the green hydra, Chlorohydra viridissima, the density of symbiotic algae may be controlled through host modulation of the algal cell cycle. Alternatively, Chlorohydra may actively expel their endosymbionts, although this phenomenon has only been observed under experimentally contrived stress conditions. Principal Findings: We show, using light and electron microscopy, that Chlorohydra actively expel endosymbiotic algal cells during predatory feeding on Artemia. This expulsion occurs as part of the apocrine mode of secretion from the endodermal digestive cells, but may also occur via an independent exocytotic mechanism. Significance: Our results demonstrate, for the first time, active expulsion of endosymbiotic algae from cnidarians under natural conditions. We suggest this phenomenon may represent a mechanism whereby cnidarians can expel excess symbiotic algae when an alternative form of nutrition is available in the form of prey.	[Fishman, Yelena; Zlotkin, Eliahu; Sher, Daniel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Anim Biol, Jerusalem, Israel	Hebrew University of Jerusalem	Fishman, Y (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Anim Biol, Jerusalem, Israel.	dsher@mit.edu			Israel Science Foundation [476/01, 750/04]	Israel Science Foundation(Israel Science Foundation)	This study was supported by grants 476/01 and 750/04 from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghdasarian G, 2000, BIOL BULL-US, V199, P278, DOI 10.2307/1543184; BOSSERT P, 1986, J CELL SCI, V85, P187; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Lenhoff H.M., 1983, P29; MCAULEY PJ, 1981, J EXP ZOOL, V217, P23, DOI 10.1002/jez.1402170104; MCAULEY PJ, 1982, J CELL SCI, V58, P423; MCAULEY PJ, 1985, J CELL SCI, V77, P225; MCAULEY PJ, 1986, J CELL SCI, V85, P63; MCAULEY PJ, 1981, J CELL SCI, V47, P197; MCAULEY PJ, 1985, J CELL SCI, V77, P241; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; PARDY RL, 1983, HYDRA RES METHODS; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sher D, 2008, FASEB J, V22, P207, DOI 10.1096/fj.07-9133com	18	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2603	10.1371/journal.pone.0002603	http://dx.doi.org/10.1371/journal.pone.0002603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596972	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200056
J	Marti, D; Deco, G; Mattia, M; Gigante, G; Del Giudice, P				Marti, Daniel; Deco, Gustavo; Mattia, Maurizio; Gigante, Guido; Del Giudice, Paolo			A Fluctuation-Driven Mechanism for Slow Decision Processes in Reverberant Networks	PLOS ONE			English	Article							PERCEPTUAL DECISION; REACTION-TIMES; VISUAL-MOTION; NEURAL BASIS; AREA LIP; MODEL; NEURONS; CORTEX; INTEGRATION; POPULATION	The spike activity of cells in some cortical areas has been found to be correlated with reaction times and behavioral responses during two-choice decision tasks. These experimental findings have motivated the study of biologically plausible winner-take-all network models, in which strong recurrent excitation and feedback inhibition allow the network to form a categorical choice upon stimulation. Choice formation corresponds in these models to the transition from the spontaneous state of the network to a state where neurons selective for one of the choices fire at a high rate and inhibit the activity of the other neurons. This transition has been traditionally induced by an increase in the external input that destabilizes the spontaneous state of the network and forces its relaxation to a decision state. Here we explore a different mechanism by which the system can undergo such transitions while keeping the spontaneous state stable, based on an escape induced by finite-size noise from the spontaneous state. This decision mechanism naturally arises for low stimulus strengths and leads to exponentially distributed decision times when the amount of noise in the system is small. Furthermore, we show using numerical simulations that mean decision times follow in this regime an exponential dependence on the amplitude of noise. The escape mechanism provides thus a dynamical basis for the wide range and variability of decision times observed experimentally.	[Marti, Daniel; Deco, Gustavo] Univ Pompeu Fabra, Computat Neurosci Unit, Barcelona, Spain; [Deco, Gustavo] ICREA, Barcelona, Spain; [Mattia, Maurizio; Gigante, Guido; Del Giudice, Paolo] Ist Superiore Sanita, Dept Technol & Hlth, Rome, Italy; [Mattia, Maurizio; Del Giudice, Paolo] Ist Nazl Fis Nucl, Sezione Roma I, Rome, Italy	Pompeu Fabra University; ICREA; Istituto Superiore di Sanita (ISS); Istituto Nazionale di Fisica Nucleare (INFN)	Marti, D (corresponding author), Univ Pompeu Fabra, Computat Neurosci Unit, Barcelona, Spain.	daniel.marti@upf.edu	Mattia, Maurizio/A-4716-2011; Del Giudice, Paolo/N-4655-2015; DECO, GUSTAVO/A-6341-2008	Mattia, Maurizio/0000-0002-2356-4509; Del Giudice, Paolo/0000-0002-5633-8241; DECO, GUSTAVO/0000-0002-8995-7583; Gigante, Guido/0000-0003-1899-4579	STREP "Decisions-in-Motion" [IST-027198]; ICREA Funding Source: Custom	STREP "Decisions-in-Motion"; ICREA(ICREA)	This research has been partially supported STREP "Decisions-in-Motion" (IST-027198).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; BURBECK SL, 1982, PERCEPT PSYCHOPHYS, V32, P117, DOI 10.3758/BF03204271; Deco G, 2007, J NEUROSCI, V27, P11192, DOI 10.1523/JNEUROSCI.1072-07.2007; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; HAAKE F, 1981, PHYS REV A, V23, P3255, DOI 10.1103/PhysRevA.23.3255; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HOHLE RH, 1965, J EXP PSYCHOL, V69, P382, DOI 10.1037/h0021740; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kitano K, 2003, BIOL CYBERN, V88, P387, DOI 10.1007/s00422-002-0390-6; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce R.D., 1991, RESPONSE TIMES THEIR; Mascaro M, 1999, NETWORK-COMP NEURAL, V10, P351, DOI 10.1088/0954-898X/10/4/305; Mattia M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.052903; Mattia M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051917; Mattia M, 2000, NEURAL COMPUT, V12, P2305, DOI 10.1162/089976600300014953; Mattia M, 2003, SCI MATH JAPONICAE, V58, P335; MITZ AR, 1991, J NEUROSCI, V11, P1855; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Okamoto H, 2001, PHYS REV LETT, V86, P3919, DOI 10.1103/PhysRevLett.86.3919; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roitman JD, 2002, J NEUROSCI, V22, P9475; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Ruthruff E, 1996, PERCEPT PSYCHOPHYS, V58, P56, DOI 10.3758/BF03205475; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Spiridon M, 1999, NETWORK-COMP NEURAL, V10, P257, DOI 10.1088/0954-898X/10/3/304; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Van Zandt T, 2000, PSYCHON B REV, V7, P424, DOI 10.3758/BF03214357; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Xu XM, 2006, P NATL ACAD SCI USA, V103, P17490, DOI 10.1073/pnas.0608502103; ZIPSER D, 1993, J NEUROSCI, V13, P3406	44	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2534	10.1371/journal.pone.0002534	http://dx.doi.org/10.1371/journal.pone.0002534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596965	Green Published, gold			2022-12-27	WOS:000263288200006
J	Nishimura, T; Ishima, T; Iyo, M; Hashimoto, K				Nishimura, Tomoko; Ishima, Tamaki; Iyo, Masaomi; Hashimoto, Kenji			Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways	PLOS ONE			English	Article								Background: Selective serotonin reuptake inhibitors (SSRIs) have been widely used and are a major therapeutic advance in psychopharmacology. However, their pharmacology is quite heterogeneous. The SSRI fluvoxamine, with sigma-1 receptor agonism, is shown to potentiate nerve-growth factor (NGF)-induced neurite outgrowth in PC 12 cells. However, the precise cellular and molecular mechanisms underlying potentiation by fluvoxamine are not fully understood. In this study, we examined the roles of cellular signaling pathways in the potentiation of NGF-induced neurite outgrowth by fluvoxamine and sigma-1 receptor agonists. Methods and Findings: The effects of three SSRIs ( fluvoxamine, sertraline, paroxetine) and three sigma-1 receptor agonists (SA4503, 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), and dehydroepiandrosterone (DHEA)-sulfate) on NGF-induced neurite outgrowth in PC12 cells were examined. Also examined were the effects of the sigma-1 receptor antagonist NE-100, inositol 1,4,5-triphosphate (IP3) receptor antagonist, and specific inhibitors of signaling pathways in the potentiation of NGF-induced neurite outgrowth by selective sigma-1 receptor agonist SA4503. Fluvoxamine ( but not sertraline or paroxetine) and the sigma-1 receptor agonists SA4503, PPBP, and DHEA-sulfate significantly potentiated NGF-induced neurite outgrowth in PC12 cells in a concentration-dependent manner. The potentiation by fluvoxamine and the three sigma-1 receptor agonists was blocked by co-administration of the selective sigma-1 receptor antagonist NE-100, suggesting that sigma-1 receptors play a role in blocking the enhancement of NGF-induced neurite outgrowth. Moreover, the potentiation by SA4503 was blocked by co-administration of the IP3 receptor antagonist xestospongin C. In addition, the specific inhibitors of phospholipase C (PLC-gamma), phosphatidylinositol 3-kinase (PI3K), p38MAPK, c-Jun N-terminal kinase (JNK), and the Ras/Raf/mitogen-activated protein kinase ( MAPK) signaling pathways blocked the potentiation of NGF-induced neurite outgrowth by SA4503. Conclusion: These findings suggest that stimulation of sigma-1 receptors and subsequent interaction with IP3 receptors, PLC-gamma, PI3K, p38MAPK, JNK, and the Ras/Raf/MAPK signaling pathways are involved in the mechanisms of action of sigma-1 receptor agonists such as fluvoxamine and SA4503.	[Nishimura, Tomoko; Ishima, Tamaki; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehab, Chiba, Japan; [Nishimura, Tomoko; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University; Chiba University	Nishimura, T (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K.H.); this funding had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Bermack JE, 2005, J PHARMACOL SCI, V97, P317, DOI 10.1254/jphs.CRJ04005X; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Carrasco JL, 2005, INT J CLIN PRACT, V59, P1428, DOI 10.1111/j.1368-5031.2005.00681.x; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Goodnick PJ, 1998, J PSYCHOPHARMACOL, V12, pS5, DOI 10.1177/0269881198012003021; Goyagi T, 2001, STROKE, V32, P1613, DOI 10.1161/01.STR.32.7.1613; Harukuni I, 2000, STROKE, V31, P976, DOI 10.1161/01.STR.31.4.976; HASHIMOTO K, 1995, SYNAPSE, V20, P85, DOI 10.1002/syn.890200112; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; Hashimoto K, 2006, CURR PHARM DESIGN, V12, P3857, DOI 10.2174/138161206778559614; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2008, EXPERT OPIN THER TAR, V12, P45, DOI 10.1517/14728222.12.1.45; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ishikawa M, 2007, BIOL PSYCHIAT, V62, P878, DOI 10.1016/j.biopsych.2007.04.001; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Matsuno K, 1997, BEHAV BRAIN RES, V83, P221, DOI 10.1016/S0166-4328(97)86074-3; Matsuno Kiyoshi, 1998, CNS Drug Reviews, V4, P1, DOI 10.1111/j.1527-3458.1998.tb00038.x; Maurice T, 2001, BRIT J PHARMACOL, V134, P1731, DOI 10.1038/sj.bjp.0704355; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; Nemeroff CB, 2004, CNS SPECTRUMS, V9, P23, DOI 10.1017/S1092852900025475; Noda Y, 2000, NEUROPSYCHOPHARMACOL, V23, P276, DOI 10.1016/S0893-133X(00)00103-2; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Okuyama S., 1996, CNS DRUG REV, V2, P226, DOI 10.1111/j.1527-3458.1996.tb00299.x; Owens MJ, 2004, J CLIN PSYCHIAT, V65, P5; Price RD, 2005, EUR J PHARMACOL, V509, P11, DOI 10.1016/j.ejphar.2004.12.023; Price RD, 2003, BRIT J PHARMACOL, V140, P825, DOI 10.1038/sj.bjp.0705522; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stahl SM, 1998, J CLIN PSYCHIAT, V59, P343; Stahl SM, 1998, J CLIN PSYCHIAT, V59, P642, DOI 10.4088/JCP.v59n1201; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Su TP, 2003, CURR MED CHEM, V10, P2073, DOI 10.2174/0929867033456783; TAKAHASHI H, 1995, STROKE, V26, P1676, DOI 10.1161/01.STR.26.9.1676; Takahashi H, 1996, STROKE, V27, P2120, DOI 10.1161/01.STR.27.11.2120; Takebayashi M, 2004, PHARMACOPSYCHIATRY, V37, pS208, DOI 10.1055/s-2004-832679; Takebayashi M, 2002, J PHARMACOL EXP THER, V303, P1227, DOI 10.1124/jpet.102.041970; Urani A, 2002, PSYCHOPHARMACOLOGY, V163, P26, DOI 10.1007/s00213-002-1150-y; Westenberg HGM, 2006, INT J CLIN PRACT, V60, P482, DOI 10.1111/j.1368-5031.2006.00865.x	44	107	113	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2558	10.1371/journal.pone.0002558	http://dx.doi.org/10.1371/journal.pone.0002558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596927	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200025
J	Second, G; Rouhan, G				Second, Gerard; Rouhan, Germinal			Human-Mediated Emergence as a Weed and Invasive Radiation in the Wild of the CD Genome Allotetraploid Rice Species (Oryza, Poaceae) in the Neotropics	PLOS ONE			English	Article							PHYLOGENY; EVOLUTION; SEQUENCE; ORIGIN; WHEAT; DIVERSITY; DNA; DIVERSIFICATION; BIOGEOGRAPHY; CHLOROPLAST	Background: The genus Oryza is being used as a model in plant genomic studies although there are several issues still to be resolved regarding the spatio-temporal evolution of this ancient genus. Particularly contentious is whether undated transoceanic natural dispersal or recent human interference has been the principal agent determining its present distribution and differentiation. In this context, we studied the origin and distribution history of the allotetraploid CD rice genome. It is endemic to the Neotropics but the genus is thought to have originated in the Paleotropics, and there is relatively little genetic divergence between some orthologous sequences of the C genome component and their Old World counterparts. Methodology/Principal Findings: Because of its allotetraploidy, there are several potential pitfalls in trying to date the formation of the CD genome using molecular data and this could lead to erroneous estimates. Therefore, we rather chose to rely on historical evidence to determine whether or not the CD genome was present in the Neotropics before the arrival of Columbus. We searched early collections of herbarium specimens and studied the reports of explorers of the tropical Americas for references to rice. In spite of numerous collectors traveling inland and collecting Oryza, plants determined as CD genome species were not observed away from cultivated rice fields until 1869. Various arguments suggest that they only consisted of weedy forms until that time. Conclusions/Significance: The spatio-temporal distribution of herbarium collections fits a simple biogeographical scenario for the emergence in cultivated rice fields followed by radiation in the wild of the CD genome in the Neotropics during the last four centuries. This probably occurred from species introduced to the Americas by humans and we found no evidence that the CD genome pre-existed in the Old World. We therefore propose a new evolutionary hypothesis for such a recent origin of the CD genome. Moreover, we exemplify how an historical approach can provide potentially important information and help to disentangle the timing of evolutionary events in the history of the Oryza genomes.	[Second, Gerard] IRD, UMR DIAPC, Montpellier, France; [Rouhan, Germinal] Natl Mus Nat Hist, IRD, US84, Paris, France; [Rouhan, Germinal] Inst System Bot, New York Botanical Garden, New York, NY USA	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); New York Botanical Garden	Second, G (corresponding author), IRD, UMR DIAPC, Montpellier, France.	gerard.second@mpl.ird.fr	Rouhan, Germinal/P-4717-2019	Rouhan, Germinal/0000-0002-0751-5352	Institut de la Recherche pour le Developement (IRD)	Institut de la Recherche pour le Developement (IRD)	The Institut de la Recherche pour le Developement (IRD) entirely supported this work.	ABE Y, 2007, RIZ MAISON SCI HOMME, P588; ALADREN MPS, 2000, AGRULA NOPAL EXPEDIC, P229; ALADREN MPS, 1992, MUTIS ROYAL BOT EXPE, P221; ALLSTON RFW, 1854, ANN M HELD COL CAP S, P46; AMES GJ, 2008, GLOBE ENCOMPASSED AG, P208; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; BANCROFT J, 1884, P R SOC QLD, V1, P104; Bao Y, 2004, PLANT SYST EVOL, V249, P55, DOI 10.1007/s00606-004-0173-8; BATES HW, 1863, NATURALIST RIVER AMZ; BOXER CR, 1965, DUTCH SEABORNE EMPIR, P326; CALMANT S, 2006, CARTE FONDS OCEANIQU; CARNEY J, 2001, BLACK RICE AFRICAN O, P240; Carney Judith A., 2003, Journal of Ethnobiology, V23, P167; Carney Judith A., 2004, SLAVERY ABOLIT, V25, P1, DOI DOI 10.1080/0144039042000220900; CASCUDO LC, 1983, HIST ALIMENTACAO PES; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; Chang TT, 2002, W CROP SCI, P3; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; CHEVALIER A., 1932, Revue de Botanique Appliquee et d'Agriculture Tropicale, V12, P1014; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; COLLINGRIDGE G, 1906, 1 DISCOVERY AUSTR NE, P136; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; DASILVA P, 1974, GABRIEL SOARES SOUSA, P489; David JL, 2004, BIOL J LINN SOC, V82, P503, DOI 10.1111/j.1095-8312.2004.00336.x; DESVAUX NA, 1813, J BOT APPL AGR PHARM, V1, P63; DICIENSON J, 1996, RICHARD DPRUCE, P65; DOLL JC, 1971, FLORA BRASILINESIS, P5; DUISTERMAAT H, 1987, BLUMEA, V32, P157; Federici MT, 2002, ELECTRON J BIOTECHN, V5, P173; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; GARDNER G, 1846, TRAVELS INTERIOR BRA, P562; GARMENDIA FM, 2003, BOT SERVICIO CORONO, P220; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Gu YQ, 2006, GENETICS, V174, P1493, DOI 10.1534/genetics.106.060756; Guo YL, 2005, AM J BOT, V92, P1548, DOI 10.3732/ajb.92.9.1548; GYRORY J, 2001, GUINAA CURRENT OCEAN; HAIR PE, 1992, BARBOT GUINEA WRITIN, P916; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; HILAIRE AS, 1830, VOYAGES INTERIEIUR B; HOBSON JB, 2004, E ORIGINS W CIVILISA, P392; HOLMGREN PK, 1998, INDEX HERBARIORUM GL; Humboldt A, 1805, ESSAI GEOGRAPHIE PLA, DOI DOI 10.5962/BHL.TITLE.9309; KANNO A, 1992, THEOR APPL GENET, V83, P791, DOI 10.1007/BF00226699; KATAYAMA T, 1982, JPN J GENET, V57, P613, DOI 10.1266/jjg.57.613; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KUNTH CS, 1829, REV GRAMINEES PUBLIC, P666; KUNTH CS, 1822, SYNOPSIS PLANTOANUM; KURATA N, 2008, CHROMOSOEM GENOME EV, P235; Ledru, 1810, VOYAGE ILES TENERIFF; LEVATHES L, 1994, CHINA RULED SEAS TRE, P256; LEVISTRAUSS C, 1950, SMITHSONIAN I BUREAU, V143, P465; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Mahe L, 2007, GENOME, V50, P316, DOI 10.1139/G07-011; MARTIUS CFP, 1840, FLROA BRAISLILNISIS; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; MAURIZIO A, 1932, HIST ALIMENTATION VE, P663; MCCINTOSH B, 1984, SCIENCE, V226, P792; Metcalf Alida C., 1992, FAMILY FRONTIER COLO; Mullins IM, 2002, THEOR APPL GENET, V105, P841, DOI 10.1007/s00122-002-1056-4; Multani DS, 2003, THEOR APPL GENET, V107, P395, DOI 10.1007/s00122-003-1214-3; MUTCH TD, 1942, 1 DISCOVERY AUSTR AC, P56; NUNEZ MF, 1994, TRAS DORADO VEGETAL, P441; Oka H. I., 1988, Origin of cultivated rice.; Ozkan H, 2002, ISRAEL J PLANT SCI, V50, pS65, DOI 10.1560/E282-PV55-G4XT-DRWJ; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; PINTO E, 1958, MUXARABIS BALCOES; PORTERES R., 1960, Journal d'Agriculture tropicale, V7, P441; PORTERES R., 1956, Journal d'Agriculture tropicale, V3, P341; Prodoehl A, 1922, BOT ARCH, V1, P211; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; RAMSEY J, 1998, ANN REV ECOL SYST, V29; ROTH WE, 1901, N QUEENSLAND ETHNOGR, V3, P1; Sanchez E, 2006, REV BIOL TROP, V54, P377; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Second G., 1985, Relations evolutives chez le genre Oryzaet processus de domestication des riz.; Second G., 1992, Genetic Resources and Crop Evolution, V39, P125; SECOND G, 1991, BIOTECHNOLOGY AGR FO, V14, P469; SECOND G, 1991, RICE GENETICS, V2, P475; SHU LH, 1989, PLANT TISSUE CULTRUE, V6, P14; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SPIX JB, 1828, REISE BRAISLIEEN; SPRING A, 1871, ANN ACAD ROY BELGIQU, V37, P1; SPRUCE R, 1908, NOTES BOT AMZON ANDE; STICKNEY GP, 1896, AM ANTHROPOL, V9, P115; SWADLING P, 1996, PLUMES PARADISE TRAD, P352; TRINUS KB, 1820, FUNDAMNETA AGROFSTRH; VARNEY J, 2005, SLAVERY ABOLITION, V26, P325; Vaughan D.A., 1994, WILD RELATIVES RICE, P137; Vaughan DA, 2005, BREEDING SCI, V55, P113, DOI 10.1270/jsbbs.55.113; Vaughan Duncan A., 2008, V62, P219; Voeks RA, 1995, GEOGR REV, V85, P115, DOI 10.2307/215565; VONESENBECK CGD, 1829, AGROSTOLGOIAS BRASIL; Wallace A.R., 1853, NARRATIVE TRAVELS AM, P541; Zamora A, 2003, GENET RESOUR CROP EV, V50, P855, DOI 10.1023/A:1025998801637; Zhang LB, 2007, MOL BIOL EVOL, V24, P769, DOI 10.1093/molbev/msl204; ZOHARY D, 1962, EVOLUTION, V16, P44, DOI 10.2307/2406265; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	101	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2613	10.1371/journal.pone.0002613	http://dx.doi.org/10.1371/journal.pone.0002613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596981	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200062
J	Hennequin, M; Moysan, V; Jourdan, D; Dorin, M; Nicolas, E				Hennequin, Martine; Moysan, Veronique; Jourdan, Didier; Dorin, Martine; Nicolas, Emmanuel			Inequalities in Oral Health for Children with Disabilities: A French National Survey in Special Schools	PLOS ONE			English	Article							DOWN-SYNDROME; CEREBRAL-PALSY; CARE; PREVALENCE; FRANCE; INDIVIDUALS; ADULTS; EDUCATION; HYGIENE; PARENTS	Background: Despite wide recognition that children with disability often have poor oral health, few high quality, controlled results are available. Method: Twenty-four objective and subjective criteria covering feeding, autonomy, access to dental care, oral hygiene, oral disease, general health and behavior were evaluated in a observational cross-sectional study of 2,487 children with disability (DC group), 4,772 adolescents with disability (DA group) and 1,641 children without disability (NDC group). Five algorithms ranked the subjects according to clinical criteria in three original oral health indices: the Clinical Oral Health Index (COHI), indicating the level of oral health problems, the Clinical Oral Care Needs Index (COCNI) giving dental care need levels, and the Clinical Oral Prevention Index (COPI) determining possible needs in terms of dental education initiatives. Results: DC-group children presented poorer oral health and had greater needs in both treatment and preventive oral health actions than NDC-group children (OR = 3.97, 95% CI = 3.25-4.86 for COHI; OR = 2.01, 95% CI = 1.77-2.28 for COCNI; OR = 5.25, 95% CI = 4.55-6.02 for COPI). These conditions were worse again in the DA group comparing to the DC group (OR = 3.52, 95% CI = 2.7-4.6 for COHI; OR = 1.52, 95% CI = 1.38-1.69 for COCNI; OR = 1.53, 95% CI = 1.39-1.69 for COPI). Conclusion: Clinical indices generated by algorithmic association of various clinical indicators allow sensitive clinical measurement, and in this study demonstrated inequalities in oral health for children with disabilities schooling in institutions. Questions need now to be addressed as to the measures that could be taken to compensate for this situation.	[Hennequin, Martine; Nicolas, Emmanuel] Univ Auvergne Clermont 1, EA 3847, Clermont Ferrand, France; [Hennequin, Martine; Nicolas, Emmanuel] CHU Clermont Ferrand, Clermont Ferrand, France; [Moysan, Veronique; Dorin, Martine] CNAMTS, Paris, France; [Jourdan, Didier] Inst Univ Format Maitres, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Hennequin, M (corresponding author), Univ Auvergne Clermont 1, EA 3847, Clermont Ferrand, France.	martine.hennequin@u-clermont1.fr	Hennequin, Martine/AAB-3004-2021	Hennequin, Martine/0000-0001-8173-2606	Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Mutualite Sociale Agricole (MSA); Assurance Maladie des Professions Independantes (RSI); Auvergne region teacher training institute [JE 2432]; University of Auvergne [EA 3847]	Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Mutualite Sociale Agricole (MSA); Assurance Maladie des Professions Independantes (RSI); Auvergne region teacher training institute(Region Auvergne-Rhone-Alpes); University of Auvergne	The survey that provided the data for the DC and DA groups was given financial support by three French national health insurance schemes (the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS), the Mutualite Sociale Agricole (MSA) and the Assurance Maladie des Professions Independantes (RSI)) that had pooled their resources under a national research program (Programme National Inter Regimes 2004). The survey that provided the data for the NDC group was given financial support through two research teams: JE 2432 from the Auvergne region teacher training institute and EA 3847 from the University of Auvergne. The current analysis received financial support from the EA 3847 research team, which participated in building the methodology for both projects, designed the study, built the database, analyzed the data, wrote the paper, and managed the submission process for publication.	Adachi M, 2007, Int J Dent Hyg, V5, P69, DOI 10.1111/j.1601-5037.2007.00233.x; Allison P, 1999, J DENT RES, V78, P643, DOI 10.1177/00220345990780020301; Allison P J, 2000, Spec Care Dentist, V20, P28, DOI 10.1111/j.1754-4505.2000.tb00007.x; Donnell David O, 2002, Spec Care Dentist, V22, P231; Dos Santos MTBR, 2005, J ORAL REHABIL, V32, P880; EKSTRAND KR, 1995, CARIES RES, V29, P243, DOI 10.1159/000262076; Faulks D, 2006, NURS OUTLOOK, V54, P345, DOI 10.1016/j.outlook.2006.09.004; FISCHERBRANDIES H, 1988, EUR J ORTHODONT, V10, P255; Franklin DL, 1996, EUR J ORTHODONT, V18, P637; Frazier JB, 1996, DEV MED CHILD NEUROL, V38, P695, DOI 10.1111/j.1469-8749.1996.tb12139.x; Frenkel H, 2002, COMMUNITY DENT ORAL, V30, P91, DOI 10.1034/j.1600-0528.2002.300202.x; Glassman Paul, 2003, Spec Care Dentist, V23, P165; Gordon S M, 1998, Spec Care Dentist, V18, P88, DOI 10.1111/j.1754-4505.1998.tb00910.x; Greene JC., 1960, J AM DENT ASSOC, V61, P172, DOI 10.14219/jada.archive.1960.0177; Hennequin H, 2000, LANCET, V356, P1882, DOI 10.1016/S0140-6736(00)03259-1; Hennequin M, 2000, DEV MED CHILD NEUROL, V42, P691, DOI 10.1017/S0012162200001274; Hennequin M, 2005, J DENT RES, V84, P1057, DOI 10.1177/154405910508401117; Hennequin M, 2003, J OROFAC PAIN, V17, P347; Hennequin M, 2000, J DENT, V28, P131, DOI 10.1016/S0300-5712(99)00052-4; Hobson R S, 2005, Int J Paediatr Dent, V15, P355, DOI 10.1111/j.1365-263X.2005.00642.x; Honberg L, 2005, PEDIATRICS, V115, P1233, DOI 10.1542/peds.2004-1503; Lancashire P, 1997, J CLIN PERIODONTOL, V24, P198, DOI 10.1111/j.1600-051X.1997.tb00491.x; Locker D, 1988, Community Dent Health, V5, P3; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; MacEntee MI, 2006, COMMUNITY DENT HLTH, V23, P5; Maestre C, 1996, BRIT DENT J, V180, P297, DOI 10.1038/sj.bdj.4809068; *MIN ED NAT, 2007, REP REF STAT ENS FOR; Mojon Philippe, 2002, J Can Dent Assoc, V68, P340; MULLER M, 1988, J BIOL BUCCALE, V16, P239; Nunn J H, 1993, Community Dent Health, V10, P389; ORELAND A, 1987, SWED DENT J, V11, P103; Page LAF, 2005, J DENT RES, V84, P649, DOI 10.1177/154405910508400713; Rodriguez Vazquez Carmen, 2002, Spec Care Dentist, V22, P65, DOI 10.1111/j.1754-4505.2002.tb01164.x; Shaw M J, 1990, Community Dent Health, V7, P135; Shyama M, 2001, Spec Care Dentist, V21, P104, DOI 10.1111/j.1754-4505.2001.tb00235.x; SLADE GD, 1994, COMMUNITY DENT HLTH, V11, P3; Spender Q, 1996, DEV MED CHILD NEUROL, V38, P681, DOI 10.1111/j.1469-8749.1996.tb12138.x; Stabholz A, 1991, Spec Care Dentist, V11, P203, DOI 10.1111/j.1754-4505.1991.tb01732.x; Sullivan PB, 2000, DEV MED CHILD NEUROL, V42, P674, DOI 10.1017/S0012162200001249; Tahmassebi JF, 2003, DEV MED CHILD NEUROL, V45, P613, DOI 10.1017/S0012162203001117; Trulsson U, 2003, EUR J ORAL SCI, V111, P19, DOI 10.1034/j.1600-0722.2003.00001.x; VENHAM L, 1977, J DENT RES, V56, P454, DOI 10.1177/00220345770560050101; Waldman HB, 2006, MENT RETARD, V44, P184, DOI 10.1352/0047-6765(2006)44[184:MEODGT]2.0.CO;2; Waldman HB, 2006, J DENT CHILD, V73, P57; World Health Organization, 1993, ICD 10 INT CLASS DIS; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Young NL, 2005, DISABIL REHABIL, V27, P1455, DOI 10.1080/00222930500218946	47	58	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2564	10.1371/journal.pone.0002564	http://dx.doi.org/10.1371/journal.pone.0002564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575600	Green Published, gold			2022-12-27	WOS:000263288000054
J	Wang, T; Gong, N; Liu, JN; Kadiu, I; Kraft-Terry, SD; Mosley, RL; Volsky, DJ; Ciborowski, P; Gendelman, HE				Wang, Tong; Gong, Nan; Liu, Jianuo; Kadiu, Irena; Kraft-Terry, Stephanie D.; Mosley, R. Lee; Volsky, David J.; Ciborowski, Pawel; Gendelman, Howard E.			Proteomic Modeling for HIV-1 Infected Microglia-Astrocyte Crosstalk	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; HEAT-SHOCK PROTEINS; PRODUCTIVE INFECTION; OXIDATIVE STRESS; HIV-1 INFECTION; GENE-EXPRESSION; NERVOUS-SYSTEM; HUMAN BRAIN	Background: HIV-1-infected and immune competent brain mononuclear phagocytes (MP; macrophages and microglia) secrete cellular and viral toxins that affect neuronal damage during advanced disease. In contrast, astrocytes can affect disease by modulating the nervous system's microenvironment. Interestingly, little is known how astrocytes communicate with MP to influence disease. Methods and Findings: MP-astrocyte crosstalk was investigated by a proteomic platform analysis using vesicular stomatitis virus pseudotyped HIV infected murine microglia. The microglial-astrocyte dialogue was significant and affected microglial cytoskeleton by modulation of cell death and migratory pathways. These were mediated, in part, through F-actin polymerization and filament formation. Astrocyte secretions attenuated HIV-1 infected microglia neurotoxicity and viral growth linked to the regulation of reactive oxygen species. Conclusions: These observations provide unique insights into glial crosstalk during disease by supporting astrocyte-mediated regulation of microglial function and its influence on the onset and progression of neuroAIDS. The results open new insights into previously undisclosed pathogenic mechanisms and open the potential for biomarker discovery and therapeutics that may influence the course of HIV-1-mediated neurodegeneration.	[Wang, Tong; Gong, Nan; Liu, Jianuo; Kadiu, Irena; Kraft-Terry, Stephanie D.; Mosley, R. Lee; Ciborowski, Pawel; Gendelman, Howard E.] Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Volsky, David J.] Columbia Univ, Med Ctr, St Lukes Roosevelt Hosp Ctr, Mol Virol Div, New York, NY USA; [Wang, Tong] Jinan Univ, Inst Tissue Transplant & Immunol, Guangzhou, Peoples R China	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Jinan University	Wang, T (corresponding author), Ctr Neurovirol & Neurodegenerat Disorders, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	hegendel@unmc.edu	Wang, Tong/A-2750-2011; Gendelman, Howard E/G-8242-2012	Wang, Tong/0000-0002-5980-3380; Kraft-Terry, Stephanie/0000-0001-9838-1574	Frances and Louis Blumkin Foundation; Community Neuroscience Pride of Nebraska Research Initiative; Alan Baer Charitable Trust; NIH [5P01NS31492, DA17618, 2R37 NS36126, 2R01 NS034239, P20RR15635, U54NS43011, P01MH64570, P01 NS43985]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043985, R37NS036126, U54NS043011, R01NS034239, R01NS036126, P01NS031492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017618] Funding Source: NIH RePORTER	Frances and Louis Blumkin Foundation; Community Neuroscience Pride of Nebraska Research Initiative; Alan Baer Charitable Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Frances and Louis Blumkin Foundation, the Community Neuroscience Pride of Nebraska Research Initiative, and the Alan Baer Charitable Trust, and NIH grant 5P01NS31492 and DA17618 (to D.J.V.) and 2R37 NS36126, 2R01 NS034239, P20RR15635, U54NS43011, P01MH64570, P01 NS43985 (to H.E.G.)	Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; Adam SEI, 1999, VET HUM TOXICOL, V41, P5; Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; An SF, 1999, ACTA NEUROPATHOL, V98, P481, DOI 10.1007/s004010051113; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; BENOS DJ, 1994, P NATL ACAD SCI USA, V91, P494, DOI 10.1073/pnas.91.2.494; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blume J, 1994, Acad Radiol, V1, P253, DOI 10.1016/S1076-6332(05)80725-1; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CAIROLI E, 2008, CLIN IMMUNOL; Calabrese V, 2000, J NEUROSCI RES, V60, P613, DOI 10.1002/(SICI)1097-4547(20000601)60:5<613::AID-JNR6>3.0.CO;2-8; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng XD, 2007, DNA CELL BIOL, V26, P116, DOI 10.1089/dna.2006.0541; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Cosenza-Nashat MA, 2006, J NEUROIMMUNOL, V178, P87, DOI 10.1016/j.jneuroim.2006.05.020; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Dou HY, 2006, GLIA, V54, P81, DOI 10.1002/glia.20358; Dunfee R, 2006, CURR HIV RES, V4, P267, DOI 10.2174/157016206777709500; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; Faulkner NE, 2003, J VIROL, V77, P2276, DOI 10.1128/JVI.77.3.2276-2281.2003; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fust G, 2005, MOL IMMUNOL, V42, P79, DOI 10.1016/j.molimm.2004.07.003; Galey D, 2003, J NEUROVIROL, V9, P358, DOI 10.1080/13550280390201119; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; GENDELMAN HE, 1991, J EXP MED, V173, P277, DOI 10.1084/jem.173.1.277; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; GENDELMAN HE, 1994, RES IMMUNOL, V145, P679, DOI 10.1016/S0923-2494(05)80054-9; GENDELMAN HE, 2005, NEUROLOGY AIDS, P177; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Gorantla S, 2007, J IMMUNOL, V179, P4345, DOI 10.4049/jimmunol.179.7.4345; GRAY CW, 1995, BRAIN RES, V691, P169, DOI 10.1016/0006-8993(95)00669-H; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hadas E, 2007, AIDS, V21, P905, DOI 10.1097/QAD.0b013e3281574549; Hao HN, 1999, BRAIN RES, V823, P24, DOI 10.1016/S0006-8993(98)01371-7; Hao HN, 1997, BRAIN RES, V764, P149, DOI 10.1016/S0006-8993(97)00441-1; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kawamura K, 2004, J BIOL CHEM, V279, P54862, DOI 10.1074/jbc.M408057200; Kim SY, 2004, J NEUROIMMUNOL, V157, P17, DOI 10.1016/j.jneuroim.2004.08.032; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KURE K, 1990, ACTA NEUROPATHOL, V80, P393, DOI 10.1007/BF00307693; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; MA MH, 1994, J VIROL, V68, P6824, DOI 10.1128/JVI.68.10.6824-6828.1994; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Magrys A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/s10875-006-9065-8; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McCrossan M, 2006, BRAIN, V129, P503, DOI 10.1093/brain/awh695; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; Mosley RL, 2006, CLIN NEUROSCI RES, V6, P261, DOI 10.1016/j.cnr.2006.09.006; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nitkiewicz J, 2004, J NEUROVIROL, V10, P400, DOI 10.1080/13550280490890097; NOTTET HSLM, 1995, J IMMUNOL, V154, P3567; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; OUIMET CC, 1990, J NEUROSCI, V10, P1683; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Pentreath VW, 2000, HUM EXP TOXICOL, V19, P641, DOI 10.1191/096032700676221595; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Persidsky Y, 2006, IMMUNOL REV, V213, P180, DOI 10.1111/j.1600-065X.2006.00440.x; Pingle SC, 2007, MOL PHARMACOL, V72, P856, DOI 10.1124/mol.106.031427; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; Pocernich CB, 2005, MOL BRAIN RES, V133, P299, DOI 10.1016/j.molbrainres.2004.10.024; Polazzi E, 1999, J NEUROPATH EXP NEUR, V58, P825, DOI 10.1097/00005072-199908000-00005; Poluektova L, 2004, J IMMUNOL, V172, P7610, DOI 10.4049/jimmunol.172.12.7610; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; PULLIAM L, 1993, AIDS RES HUM RETROV, V9, P439, DOI 10.1089/aid.1993.9.439; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Sas AR, 2007, AIDS, V21, P2151, DOI 10.1097/QAD.0b013e3282f08c2f; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; Schweighardt B, 2001, AIDS RES HUM RETROV, V17, P1133, DOI 10.1089/088922201316912745; Sherry B, 2000, MOL MED, V6, P542, DOI 10.1007/BF03401793; Speth C, 2005, MOL IMMUNOL, V42, P213, DOI 10.1016/j.molimm.2004.06.018; Su ZZ, 2003, J NEUROVIROL, V9, P372, DOI 10.1080/13550280390201263; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; Wang ZY, 2004, J NEUROVIROL, V10, P25, DOI 10.1080/13550280490270851; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Willey SJ, 2003, J VIROL, V77, P6138, DOI 10.1128/JVI.77.11.6138-6152.2003; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Xie CS, 1998, FREE RADICAL BIO MED, V25, P979, DOI 10.1016/S0891-5849(98)00186-5; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zink MC, 2006, CURR HIV RES, V4, P293; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333	120	39	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2507	10.1371/journal.pone.0002507	http://dx.doi.org/10.1371/journal.pone.0002507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575609	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288000026
J	Overney, LS; Blanke, O; Herzog, MH				Overney, Leila S.; Blanke, Olaf; Herzog, Michael H.			Enhanced Temporal but Not Attentional Processing in Expert Tennis Players	PLOS ONE			English	Article							VISUAL-SEARCH STRATEGY; SKILLED PERCEPTION; KNOWLEDGE; SOCCER; DISCRIMINATION; ANTICIPATION; PERFORMANCE; LATENCY; HOCKEY; ACUITY	In tennis, as in many disciplines of sport, fine spatio-temporal resolution is required to reach optimal performance. While many studies on tennis have focused on anticipatory skills or decision making, fewer have investigated the underlying visual perception abilities. In this study, we used a battery of seven visual tests that allowed us to assess which kind of visual information processing is performed better by tennis players than other athletes (triathletes) and non-athletes. We found that certain time-related skills, such as speed discrimination, are superior in tennis players compared to non-athletes and triathletes. Such tasks might be used to improve tennis performance in the future.	[Overney, Leila S.; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland; [Overney, Leila S.; Herzog, Michael H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Psychophys, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Overney, LS (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland.	leila.overney@epfl.ch			Sport and Rehabilitation Engineering (SRE) programme at EPFL	Sport and Rehabilitation Engineering (SRE) programme at EPFL	This work was supported by the Sport and Rehabilitation Engineering (SRE) programme at EPFL. They had no role in the study or preparation of the manuscript.	ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; ABERNETHY B, 1994, APPL COGNITIVE PSYCH, V8, P185, DOI 10.1002/acp.2350080302; Abernethy B, 2001, J SPORT SCI, V19, P203, DOI 10.1080/026404101750095376; Abernethy B, 1984, AUSTR J SCI MED SPOR, V16, P2; ALLARD F, 1980, Journal of Sport Psychology, V2, P14; ALLARD F, 1980, Journal of Sport Psychology, V2, P22; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BORGEAUD P, 1987, J SPORT EXERCISE PSY, V9, P400, DOI 10.1123/jsp.9.4.400; Breitmeyer B., 2006, VISUAL MASKING; BUCKLES KM, 1991, BRAIN COGNITION, V17, P52, DOI 10.1016/0278-2626(91)90066-H; CASTIELLO U, 1992, INT J SPORT PSYCHOL, V23, P301; Clifford CWG, 1999, VISION RES, V39, P2213, DOI 10.1016/S0042-6989(98)00314-9; COFFEY B, 1995, SPORTS VISION, P158; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; Di Russo F, 2003, VISION RES, V43, P1837, DOI 10.1016/S0042-6989(03)00299-2; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Didierjean A, 2005, VIS COGN, V12, P265, DOI 10.1080/13506280444000021A; Enns JT, 1997, J EXP CHILD PSYCHOL, V64, P255, DOI 10.1006/jecp.1996.2348; Farrow D, 2002, J SPORT SCI, V20, P471, DOI 10.1080/02640410252925143; FRENCH KE, 1987, J SPORT EXERCISE PSY, V9, P15, DOI 10.1123/jsp.9.1.15; GOULET C, 1989, J SPORT EXERCISE PSY, V11, P382, DOI 10.1123/jsep.11.4.382; Helsen WF, 1999, APPL COGNITIVE PSYCH, V13, P1; Kanai R, 2004, VISION RES, V44, P2605, DOI 10.1016/j.visres.2003.10.028; KIBELE A, 2002, LEISTUNGSSPORT, V32, P56; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; LORAN DFC, 1998, SVA NEWSLETTER; McAuliffe J, 2004, J GEN PSYCHOL, V131, P426, DOI 10.3200/GENP.131.4.426-437; MCPHERSON SL, 1989, J EXP CHILD PSYCHOL, V48, P190, DOI 10.1016/0022-0965(89)90002-7; Moreno FJ, 2005, PERCEPT MOTOR SKILL, V101, P13, DOI 10.2466/pms.101.1.13-20; Morrillo M, 2006, MED SCI SPORT EXER, V38, P388, DOI 10.1249/01.mss.0000185661.01802.67; Namba J, 2004, PERCEPTION, V33, P621, DOI 10.1068/p5212; NOUGIER V, 1989, INT J SPORT PSYCHOL, V20, P205; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Schulte-Korne G, 2004, NEUROSCI LETT, V357, P207, DOI 10.1016/j.neulet.2003.12.098; Singer RN, 1996, J APPL SPORT PSYCHOL, V8, P9, DOI 10.1080/10413209608406305; STARKES J, 1994, INT J SPORT PSYCHOL, V25, P249; STARKES JL, 1987, J SPORT EXERCISE PSY, V9, P146, DOI 10.1123/jsp.9.2.146; Starkes JL, 2001, HDB SPORT PSYCHOL, P174; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Westheimer G, 2001, VISION RES, V41, P47, DOI 10.1016/S0042-6989(00)00245-5; Williams A. M., 1998, SCI RACKET SPORTS 2, P121; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Williams AM, 2002, J EXP PSYCHOL-APPL, V8, P259, DOI 10.1037/1076-898X.8.4.259; WILLIAMS AM, 1993, SCIENCE AND FOOTBALL II, P239; WILLIAMS M, 1993, PERCEPT MOTOR SKILL, V76, P579, DOI 10.2466/pms.1993.76.2.579; WILLIAMS M, 1995, J SPORT EXERCISE PSY, V17, P259, DOI 10.1123/jsep.17.3.259	47	56	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2380	10.1371/journal.pone.0002380	http://dx.doi.org/10.1371/journal.pone.0002380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545661	gold, Green Published			2022-12-27	WOS:000263248800020
J	Paffen, CLE; Naber, M; Verstraten, FAJ				Paffen, Chris L. E.; Naber, Marnix; Verstraten, Frans A. J.			The Spatial Origin of a Perceptual Transition in Binocular Rivalry	PLOS ONE			English	Article							CONTEXTUAL INFLUENCES; TRAVELING-WAVES; ATTENTION; SUPPRESSION; HIERARCHY; DOMINANCE; DYNAMICS; DEPENDS	When the left and the right eye are simultaneously presented with incompatible images at overlapping retinal locations, an observer typically reports perceiving only one of the two images at a time. This phenomenon is called binocular rivalry. Perception during binocular rivalry is not stable; one of the images is perceptually dominant for a certain duration (typically in the order of a few seconds) after which perception switches towards the other image. This alternation between perceptual dominance and suppression will continue for as long the images are presented. A characteristic of binocular rivalry is that a perceptual transition from one image to the other generally occurs in a gradual manner: the image that was temporarily suppressed will regain perceptual dominance at isolated locations within the perceived image, after which its visibility spreads throughout the whole image. These gradual transitions from perceptual suppression to perceptual dominance have been labeled as traveling waves of perceptual dominance. In this study we investigate whether stimulus parameters affect the location at which a traveling wave starts. We varied the contrast, spatial frequency or motion speed in one of the rivaling images, while keeping the same parameter constant in the other image. We used a flash-suppression paradigm to force one of the rival images into perceptual suppression. Observers waited until the suppressed image became perceptually dominant again, and indicated the position at which this breakthrough from suppression occurred. Our results show that the starting point of a traveling wave during binocular rivalry is highly dependent on local stimulus parameters. More specifically, a traveling wave most likely started at the location where the contrast of the suppressed image was higher than that of the dominant one, the spatial frequency of the suppressed image was lower than that of the dominant one, and the motion speed of the suppressed image was higher than that of the dominant one. We suggest that a breakthrough from suppression to dominance occurs at the location where salience (the degree to which a stimulus element stands out relative to neighboring elements) of the suppressed image is higher than that of the dominant one. Our results further show that stimulus parameters affecting the temporal dynamics during continuous viewing of rival images described in other studies, also affect the spatial origin of traveling waves during binocular rivalry.	[Paffen, Chris L. E.; Naber, Marnix; Verstraten, Frans A. J.] Univ Utrecht, Helmholtz Inst & Expt Psychol, Utrecht, Netherlands	Utrecht University	Paffen, CLE (corresponding author), Univ Utrecht, Helmholtz Inst & Expt Psychol, Utrecht, Netherlands.	c.l.e.paffen@uu.nl		Naber, Marnix/0000-0003-4208-8437	Netherlands Organization for Scientific Research [NWO pionier grant, NWO VENI grant]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organization for Scientific Research (NWO pionier grant to FV, and NWO VENI grant to CP).	Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Arnold DH, 2007, J VISION, V7, DOI 10.1167/7.7.7; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1985, BIOL CYBERN, V52, P391, DOI 10.1007/BF00449596; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bonneh Y, 1999, VISION RES, V39, P271, DOI 10.1016/S0042-6989(98)00112-6; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; FAHLE M, 1982, VISION RES, V22, P787, DOI 10.1016/0042-6989(82)90010-4; HOLLINS M, 1980, PERCEPT PSYCHOPHYS, V27, P550, DOI 10.3758/BF03198684; HOLLINS M, 1980, INVEST OPHTH VIS SCI, V19, P1117; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225, DOI 10.1111/j.2044-8295.1966.tb01023.x; Levelt WJM, 1965, BINOCULAR RIVALRY; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; OShea RP, 1997, VISION RES, V37, P175, DOI 10.1016/S0042-6989(96)00113-7; Paffen CLE, 2006, VISION RES, V46, P599, DOI 10.1016/j.visres.2005.05.013; ROELOFS CO, 1919, ALBRECHT GRAEFES ARC, V99, P79; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; VERSTRATEN FAJ, 1994, VISION RES, V34, P349, DOI 10.1016/0042-6989(94)90093-0; WADE NJ, 1984, PERCEPT PSYCHOPHYS, V35, P111, DOI 10.3758/BF03203891; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	39	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2311	10.1371/journal.pone.0002311	http://dx.doi.org/10.1371/journal.pone.0002311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545647	Green Submitted, gold, Green Published			2022-12-27	WOS:000263248800002
J	Soreq, L; Gilboa-Geffen, A; Berrih-Aknin, S; Lacoste, P; Darvasi, A; Soreq, E; Bergman, H; Soreq, H				Soreq, Lilach; Gilboa-Geffen, Adi; Berrih-Aknin, Sonia; Lacoste, Paul; Darvasi, Ariel; Soreq, Eyal; Bergman, Hagai; Soreq, Hermona			Identifying Alternative Hyper-Splicing Signatures in MG-Thymoma by Exon Arrays	PLOS ONE			English	Article								Background: The vast majority of human genes (> 70%) are alternatively spliced. Although alternative pre-mRNA processing is modified in multiple tumors, alternative hyper-splicing signatures specific to particular tumor types are still lacking. Here, we report the use of Affymetrix Human Exon Arrays to spot hyper-splicing events characteristic of myasthenia gravis (MG)-thymoma, thymic tumors which develop in patients with MG and discriminate them from colon cancer changes. Methodology/Principal Findings: We combined GO term to parent threshold-based and threshold-independent ad-hoc functional statistics with in-depth analysis of key modified transcripts to highlight various exon-specific changes. These denote alternative splicing in MG-thymoma tumors compared to healthy human thymus and to in-house and Affymetrix datasets from colon cancer and healthy tissues. By using both global and specific, term-to-parent Gene Ontology (GO) statistical comparisons, our functional integrative ad-hoc method allowed the detection of disease-relevant splicing events. Conclusions/Significance: Hyper-spliced transcripts spanned several categories, including the tumorogenic ERBB4 tyrosine kinase receptor and the connective tissue growth factor CTGF, as well as the immune function-related histocompatability gene HLA-DRB1 and interleukin (IL)19, two muscle-specific collagens and one myosin heavy chain gene; intriguingly, a putative new exon was discovered in the MG-involved acetylcholinesterase ACHE gene. Corresponding changes in spliceosome composition were indicated by co-decreases in the splicing factors ASF/SF(2) and SC35. Parallel tumor-associated changes occurred in colon cancer as well, but the majority of the apparent hyper-splicing events were particular to MG-thymoma and could be validated by Fluorescent In-Situ Hybridization (FISH), Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and mass spectrometry (MS) followed by peptide sequencing. Our findings demonstrate a particular alternative hyper-splicing signature for transcripts over-expressed in MG-thymoma, supporting the hypothesis that alternative hyper-splicing contributes to shaping the biological functions of these and other specialized tumors and opening new venues for the development of diagnosis and treatment approaches.	[Soreq, Lilach; Bergman, Hagai] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91010 Jerusalem, Israel; [Gilboa-Geffen, Adi; Soreq, Hermona] Hebrew Univ Jerusalem, Fac Sci, Dept Biol Chem, Jerusalem, Israel; [Berrih-Aknin, Sonia; Lacoste, Paul] Univ Paris Sud, Hop Marie Lannelongue, UMR 8162, Paris, France; [Berrih-Aknin, Sonia; Lacoste, Paul] CNRS, Paris, France; [Darvasi, Ariel] Hebrew Univ Jerusalem, Fac Sci, Dept Genet, Jerusalem, Israel; [Soreq, Eyal] Bezalel Acad Arts & Design, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hopital Marie Lannelongue; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Hebrew University of Jerusalem	Soreq, L (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91010 Jerusalem, Israel.	soreq@cc.huji.ac.il	Berrih‐Aknin, Sonia/F-8025-2013; Soreq, Lilach/AAY-7139-2020; Bergman, Hagai/AAI-4683-2021; gilboa-geffen, adi/E-3028-2013	Berrih‐Aknin, Sonia/0000-0001-9199-4175; Bergman, Hagai/0000-0002-2402-6673; Soreq, Hermona/0000-0002-0955-526X; Soreq, Lilach/0000-0002-9447-2150; gilboa-geffen, adi/0000-0001-9549-4194; Soreq, Lilach/0000-0003-2907-097X	European Alternative Splicing Network of Excellence-EURASNET; The German Israel Project; United States-Israel Binational Science Foundation; Israel Ministry of Science and Technology; Israel Science Foundation; The Eric Roland Center for neurodegenerative diseases;  [LSH-2004-1.1.5-3];  [518238];  [LSHM-CT-2006-037378];  [EU LSHG-CT-2006-037277];  [DIP-G 3.2];  [2003028-01];  [3-2589];  [399/07]	European Alternative Splicing Network of Excellence-EURASNET; The German Israel Project; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Foundation(Israel Science Foundation); The Eric Roland Center for neurodegenerative diseases; ; ; ; ; ; ; ; 	This work was supported by the European Alternative Splicing Network of Excellence-EURASNET LSH-2004-1.1.5-3 # 518238, LSHM-CT-2006-037378, EU LSHG-CT-2006-037277, The German Israel Project DIP-G 3.2, United States-Israel Binational Science Foundation (BSF No. 2003028-01), Israel Ministry of Science and Technology grant number 3-2589, Israel Science Foundation, Grant No. 399/07 and The Eric Roland Center for neurodegenerative diseases.	Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; *AFF, AFF HUM EX ARR TISS; *AFF GENECHIP EX A, 2005, GEN SIGN EST EX ARR; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai YD, 1999, NUCLEIC ACIDS RES, V27, P1126, DOI 10.1093/nar/27.4.1126; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Ben-Shaul Y, 2005, BIOINFORMATICS, V21, P1129, DOI 10.1093/bioinformatics/bti149; BENDOV C, 2007, J BIOL CHEM; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Bjarnadottir TK, 2007, GENE, V387, P38, DOI 10.1016/j.gene.2006.07.039; Brenner T, 2003, FASEB J, V17, P214, DOI 10.1096/fj.02-0609com; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Buratti E, 2005, TRENDS MOL MED, V11, P5, DOI 10.1016/j.molmed.2004.11.007; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; BUSH CR, 2007, J BIOL CHEM; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Espejo F, 2006, BIOCHEM BIOPH RES CO, V340, P860, DOI 10.1016/j.bbrc.2005.12.087; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Franciotta D, 2001, J NEUROL SCI, V190, P11, DOI 10.1016/S0022-510X(01)00573-1; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gilboa-Geffen A, 2007, BLOOD, V109, P4383, DOI 10.1182/blood-2006-07-033373; Giraud M, 2001, NEUROLOGY, V57, P1555, DOI 10.1212/WNL.57.9.1555; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gross SS, 2006, J COMPUT BIOL, V13, P379, DOI 10.1089/cmb.2006.13.379; *HLA DRB, HLADRB1002; Hoffacker V, 2000, BLOOD, V96, P3872, DOI 10.1182/blood.V96.12.3872.h8003872_3872_3879; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Ishibashi H, 2005, CLIN CANCER RES, V11, P6495, DOI 10.1158/1078-0432.CCR-04-2495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kuroda K, 1999, J INVEST DERMATOL, V112, P706, DOI 10.1046/j.1523-1747.1999.00563.x; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; LIBERMANN TA, 1984, CANCER RES, V44, P753; MAGLIETTA R, 2007, BIOINFORMATICS; Marie JC, 1999, J IMMUNOL, V162, P2103; *MATLAB, 2005, MATHW 7 0 4 365 R14; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mesnard-Rouiller L, 2004, J NEUROIMMUNOL, V148, P97, DOI 10.1016/j.jneuroim.2003.11.013; Mignone F, 2003, NUCLEIC ACIDS RES, V31, P4639, DOI 10.1093/nar/gkg483; Mio F, 2007, AM J HUM GENET, V81, P1271, DOI 10.1086/522377; Miyata Y, 2006, UROLOGY, V68, P1360, DOI 10.1016/j.urology.2006.09.035; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MOHAN S, 1994, CLIN IMMUNOL IMMUNOP, V70, P266, DOI 10.1006/clin.1994.1039; Mourra N, 2007, DIS COLON RECTUM, V50, P1881, DOI 10.1007/s10350-007-9040-3; Nerenberg Paul S., 2007, Cancer Genomics & Proteomics, V4, P319; Nilsson B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r74; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2003, GENOME RES, V13, P108, DOI 10.1101/gr.871403; Patel BB, 2007, J PROTEOME RES, V6, P2232, DOI 10.1021/pr060641e; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smit A, 1996, REPEATMASKER OPEN 30; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stremmel C, 2007, DEUT MED WOCHENSCHR, V132, P2090, DOI 10.1055/s-2007-985647; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Vaughn MW, 2005, SCIENCE, V309, P1525, DOI 10.1126/science.1117805; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; VIEIRA ML, 1993, J NEUROIMMUNOL, V47, P115, DOI 10.1016/0165-5728(93)90021-P; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang ZN, 2003, CANCER RES, V63, P655; Wu F, 2007, J IMMUNOL, V179, P6988, DOI 10.4049/jimmunol.179.10.6988; Xiong Z, 2006, J CLIN PATHOL, V59, P855, DOI 10.1136/jcp.2005.032961; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; YANG D, 2007, BIOINFORMATICS; Yang D, 2008, BIOINFORMATICS, V24, P265, DOI 10.1093/bioinformatics/btm558; YOSHIDA T, 1977, J NEUROL SCI, V32, P195, DOI 10.1016/0022-510X(77)90234-9; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; AFFYMETRIX ARRAY DES	91	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2392	10.1371/journal.pone.0002392	http://dx.doi.org/10.1371/journal.pone.0002392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545673	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800031
J	Zheng, HJ; Lu, LD; Wang, BF; Pu, SY; Zhang, XL; Zhu, GF; Shi, WL; Zhang, L; Wang, HH; Wang, SY; Zhao, GP; Zhang, Y				Zheng, Huajun; Lu, Liangdong; Wang, Bofei; Pu, Shiying; Zhang, Xianglin; Zhu, Genfeng; Shi, Wanliang; Zhang, Lu; Wang, Honghai; Wang, Shengyue; Zhao, Guoping; Zhang, Ying			Genetic Basis of Virulence Attenuation Revealed by Comparative Genomic Analysis of Mycobacterium tuberculosis Strain H37Ra versus H37Rv	PLOS ONE			English	Article								Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading infectious disease despite the availability of chemotherapy and BCG vaccine. The commonly used avirulent M. tuberculosis strain H37Ra was derived from virulent strain H37 in 1935 but the basis of virulence attenuation has remained obscure despite numerous studies. We determined the complete genomic sequence of H37Ra ATCC25177 and compared that with its virulent counterpart H37Rv and a clinical isolate CDC1551. The H37Ra genome is highly similar to that of H37Rv with respect to gene content and order but is 8,445 bp larger as a result of 53 insertions and 21 deletions in H37Ra relative to H37Rv. Variations in repetitive sequences such as IS6110 and PE/PPE/PE-PGRS family genes are responsible for most of the gross genetic changes. A total of 198 single nucleotide variations (SNVs) that are different between H37Ra and H37Rv were identified, yet 119 of them are identical between H37Ra and CDC1551 and 3 are due to H37Rv strain variation, leaving only 76 H37Ra-specific SNVs that affect only 32 genes. The biological impact of missense mutations in protein coding sequences was analyzed in silico while nucleotide variations in potential promoter regions of several important genes were verified by quantitative RT-PCR. Mutations affecting transcription factors and/or global metabolic regulations related to in vitro survival under aging stress, and mutations affecting cell envelope, primary metabolism, in vivo growth as well as variations in the PE/PPE/PE-PGRS family genes, may underlie the basis of virulence attenuation. These findings have implications not only for improved understanding of pathogenesis of M. tuberculosis but also for development of new vaccines and new therapeutic agents.	[Zheng, Huajun; Lu, Liangdong; Zhang, Lu; Wang, Honghai; Wang, Shengyue; Zhao, Guoping] Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zheng, Huajun; Wang, Bofei; Pu, Shiying; Zhang, Xianglin; Zhu, Genfeng; Wang, Shengyue; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Shi, Wanliang; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zheng, HJ (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	gpzhao@sibs.ac.cn; yzhang@jhsph.edu	Lyu, Liangdong/C-6557-2014; Zheng, Huajun/AAN-4973-2020	Lyu, Liangdong/0000-0001-6391-6030; Zhao, Guo-Ping/0000-0002-7621-6620	NIH [AI44063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI44063 to YZ.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; ALSAADI AI, 1973, AM REV RESPIR DIS, V107, P1041; Argyrou A, 2004, J BIOL CHEM, V279, P52694, DOI 10.1074/jbc.M410704200; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cardona PJ, 2006, MICROBES INFECT, V8, P183, DOI 10.1016/j.micinf.2005.06.011; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dawes SS, 2003, INFECT IMMUN, V71, P6124, DOI 10.1128/IAI.71.11.6124-6131.2003; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dubos R., 1955, S SOC GEN MICROBIOL, P103; DUBOS RJ, 1948, AM REV TUBERC PULM, V58, P698; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Fang Z, 1998, J BACTERIOL, V180, P2102, DOI 10.1128/JB.180.8.2102-2109.1998; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; HART P D, 1974, Infection and Immunity, V10, P742; HEPLAR JQ, 1954, J INFECT DIS, V94, P90, DOI 10.1093/infdis/94.1.90; Ho TBL, 2000, YEAST, V17, P272, DOI 10.1002/1097-0061(200012)17:4&lt;272::AID-YEA48&gt;3.0.CO;2-2; Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Karls RK, 2006, MICROBIOL-SGM, V152, P1591, DOI 10.1099/mic.0.28591-0; Kazakov Alexei E., 2003, In Silico Biology, V3, P3; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Lari N, 2001, J MED MICROBIOL, V50, P805, DOI 10.1099/0022-1317-50-9-805; LARSON CL, 1964, AM REV RESPIR DIS, V90, P742; Lewis Gregory S, 2003, Reprod Biol Endocrinol, V1, P117; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACKANESS GB, 1954, AM REV TUBERC PULM, V69, P479; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARSHAK A, 1951, J BACTERIOL, V61, P1; MARSHAK A, 1950, AM REV TUBERC PULM, V62, P333; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Mustafa AS, 2006, INFECT IMMUN, V74, P4566, DOI 10.1128/IAI.01660-05; PARISH T, 2001, METHODS MOL MED SERI; PASCOPELLA L, 1994, INFECT IMMUN, V62, P1313, DOI 10.1128/IAI.62.4.1313-1319.1994; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; PIERCE CH, 1953, J EXP MED, V97, P189, DOI 10.1084/jem.97.2.189; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rindi L, 1999, BIOCHEM BIOPH RES CO, V258, P94, DOI 10.1006/bbrc.1999.0591; Rivera-Marrero CA, 1998, MICROB PATHOGENESIS, V25, P307, DOI 10.1006/mpat.1998.0235; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Sirakova TD, 2003, INFECT IMMUN, V71, P3794, DOI 10.1128/IAI.71.7.3794-3801.2003; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; Steenken W, 1935, P SOC EXP BIOL MED, V33, P253; STEENKEN WILLIAM, 1938, AMER REV TUBERC, V38, P777; Sun RG, 2004, MOL MICROBIOL, V52, P25, DOI 10.1111/j.1365-2958.2003.03958.x; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; ZHANG Y, 1992, INFECT IMMUN, V60, P2160, DOI 10.1128/IAI.60.6.2160-2165.1992; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	69	163	592	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2375	10.1371/journal.pone.0002375	http://dx.doi.org/10.1371/journal.pone.0002375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18584054	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800016
J	Pogson, M; Holcombe, M; Smallwood, R; Qwarnstrom, E				Pogson, Mark; Holcombe, Mike; Smallwood, Rod; Qwarnstrom, Eva			Introducing Spatial Information into Predictive NF-kappa B Modelling - An Agent-Based Approach	PLOS ONE			English	Article							REL PROTEINS; SIMULATION	Nature is governed by local interactions among lower-level sub-units, whether at the cell, organ, organism, or colony level. Adaptive system behaviour emerges via these interactions, which integrate the activity of the sub-units. To understand the system level it is necessary to understand the underlying local interactions. Successful models of local interactions at different levels of biological organisation, including epithelial tissue and ant colonies, have demonstrated the benefits of such 'agent-based' modelling [1-4]. Here we present an agent-based approach to modelling a crucial biological system the intracellular NF-kappa B signalling pathway. The pathway is vital to immune response regulation, and is fundamental to basic survival in a range of species [5-7]. Alterations in pathway regulation underlie a variety of diseases, including atherosclerosis and arthritis. Our modelling of individual molecules, receptors and genes provides a more comprehensive outline of regulatory network mechanisms than previously possible with equation-based approaches [8]. The method also permits consideration of structural parameters in pathway regulation; here we predict that inhibition of NF-kappa B is directly affected by actin filaments of the cytoskeleton sequestering excess inhibitors, therefore regulating steady-state and feedback behaviour.	[Pogson, Mark; Holcombe, Mike; Smallwood, Rod] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Qwarnstrom, Eva] Univ Sheffield, Sect Infect Immun & Inflammat, Unit Cell Biol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Pogson, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	m.holcombe@dcs.shef.ac.uk	Smallwood, Rod/C-5583-2011; Pogson, Mark/D-9558-2016	Pogson, Mark/0000-0002-2116-7200; Smallwood, Rod/0000-0003-0134-0632	EPSRC research studentship; BBSRC [BB/C515798/1]; Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056] Funding Source: researchfish	EPSRC research studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by an EPSRC research studentship and by BBSRC Grant BB/C515798/1.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Are AF, 2000, EXP CELL RES, V256, P533, DOI 10.1006/excr.2000.4830; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Balanescu T., 1999, J UNIVERS COMPUT SCI, V5, P494; BEG AA, 1992, GENE DEV, V6, P2664; BURRAGE K, 2003, P HONG KONG C SCI CO; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Holcombe M, 2003, BIOSYSTEMS, V68, P223, DOI 10.1016/S0303-2647(02)00098-9; Jackson D, 2004, BIOSYSTEMS, V76, P101, DOI 10.1016/j.biosystems.2004.05.028; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; McMinn P, 2004, SOFTW TEST VERIF REL, V14, P105, DOI 10.1002/stvr.294; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; TAUSSIG R, 2002, NATURE, V420, P703; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200	22	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2367	10.1371/journal.pone.0002367	http://dx.doi.org/10.1371/journal.pone.0002367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523553	Green Published, Green Accepted, gold			2022-12-27	WOS:000262614300053
J	Saenz, FE; Balu, B; Smith, J; Mendonca, SR; Adams, JH				Saenz, Fabian E.; Balu, Bharath; Smith, Jonah; Mendonca, Sarita R.; Adams, John H.			The Transmembrane Isoform of Plasmodium falciparum MAEBL Is Essential for the Invasion of Anopheles Salivary Glands	PLOS ONE			English	Article								Malaria transmission depends on infective stages in the mosquito salivary glands. Plasmodium sporozoites that mature in midgut oocysts must traverse the hemocoel and invade the mosquito salivary glands in a process thought to be mediated by parasite ligands. MAEBL, a homologue of the transmembrane EBP ligands essential in merozoite invasion, is expressed abundantly in midgut sporozoites. Alternative splicing generates different MAEBL isoforms and so it is unclear what form is functionally essential. To identify the MAEBL isoform required for P. falciparum (NF54) sporozoite invasion of salivary glands, we created knockout and allelic replacements each carrying CDS of a single MAEBL isoform. Only the transmembrane form of MAEBL is essential and is the first P. falciparum ligand validated as essential for invasion of Anopheles salivary glands. MAEBL is the first P. falciparum ligand experimentally determined to be essential for this important step in the life cycle where the vector becomes infectious for transmitting sporozoites to people. With an increasing emphasis on advancing vector-based transgenic methods for suppression of malaria, it is important that this type of study, using modern molecular genetic tools, is done with the agent of the human disease. Understanding what P. falciparum sporozoite ligands are critical for mosquito transmission will help validate targets for vector-based transmission-blocking strategies.	[Saenz, Fabian E.; Balu, Bharath; Mendonca, Sarita R.; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA; [Saenz, Fabian E.; Smith, Jonah; Mendonca, Sarita R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN USA	State University System of Florida; University of South Florida; University of Notre Dame	Saenz, FE (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015; Saenz, Fabian E/X-8481-2018	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Saenz, Fabian E/0000-0001-6460-5373	National Institutes of Health [R01 AI33656]; University of Notre Dame [Kellogg fellowships]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Notre Dame; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health R01 AI33656 to JHA and Kellogg fellowships for University of Notre Dame graduate students to FES.	Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fu J, 2005, MOL BIOCHEM PARASIT, V141, P113, DOI 10.1016/j.molbiopara.2004.12.017; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935; Kappe SHI, 1998, P NATL ACAD SCI USA, V95, P1230, DOI 10.1073/pnas.95.3.1230; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Krettli AU, 2001, CURR BIOL, V11, pR409, DOI 10.1016/S0960-9822(01)00221-4; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; PONNUDURAI T, 1988, PARASITOL TODAY, V4, P319, DOI 10.1016/0169-4758(88)90114-7; Preiser P, 2004, INFECT IMMUN, V72, P3604, DOI 10.1128/IAI.72.6.3604-3608.2004; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Singh N, 2004, J MOL BIOL, V343, P589, DOI 10.1016/j.jmb.2004.08.047; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1	33	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2287	10.1371/journal.pone.0002287	http://dx.doi.org/10.1371/journal.pone.0002287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509478	Green Submitted, Green Published, gold			2022-12-27	WOS:000262268500029
J	Swinkels, DW; Girelli, D; Laarakkers, C; Kroot, J; Campostrini, N; Kemna, EHJM; Tjalsma, H				Swinkels, Dorine W.; Girelli, Domenico; Laarakkers, Coby; Kroot, Joyce; Campostrini, Natascia; Kemna, Erwin H. J. M.; Tjalsma, Harold			Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SERUM HEPCIDIN; IRON; QUANTIFICATION; INFLAMMATION; PLASMA; CANCER; ALPHA; REGULATOR; DISCOVERY	Assays for the detection of the iron regulatory hormone hepcidin in plasma or urine have not yet been widely available, whereas quantitative comparisons between hepcidin levels in these different matrices were thus far even impossible due to technical restrictions. To circumvent these limitations, we here describe several advances in time-of flight mass spectrometry (TOF MS), the most important of which concerned spiking of a synthetic hepcidin analogue as internal standard into serum and urine samples. This serves both as a control for experimental variation, such as recovery and matrix-dependent ionization and ion suppression, and at the same time allows value assignment to the measured hepcidin peak intensities. The assay improvements were clinically evaluated using samples from various patients groups and its relevance was further underscored by the significant correlation of serum hepcidin levels with serum iron indices in healthy individuals. Most importantly, this approach allowed kinetic studies as illustrated by the paired analyses of serum and urine samples, showing that more than 97% of the freely filtered serum hepcidin can be reabsorbed in the kidney. Thus, the here reported advances in TOF MS-based hepcidin measurements represent critical steps in the accurate quantification of hepcidin in various body fluids and pave the way for clinical studies on the kinetic behavior of hepcidin in both healthy and diseased states.	[Swinkels, Dorine W.; Laarakkers, Coby; Kroot, Joyce; Kemna, Erwin H. J. M.; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6525 ED Nijmegen, Netherlands; [Girelli, Domenico; Campostrini, Natascia] Univ Verona, Dept Clin & Expt Med, Sect Internal Med, Verona, Italy	Radboud University Nijmegen; University of Verona	Swinkels, DW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6525 ED Nijmegen, Netherlands.	D.Swinkels@akc.umcn.nl	Swinkels, Dorine W./H-8098-2014; Tjalsma, Harold/I-7146-2012; Girelli, Domenico/B-1183-2008	Swinkels, Dorine W./0000-0002-1040-9446; Girelli, Domenico/0000-0001-9684-1899	Telethon Italy [GGP06213]; Cariverona Foundation, Verona, Italy	Telethon Italy(Fondazione Telethon); Cariverona Foundation, Verona, Italy(Fondazione Cariverona)	This work was in part supported by grants from Telethon Italy (no. GGP06213) and the Cariverona Foundation, Verona, Italy (to D.G).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Bozzini C, 2008, BLOOD CELL MOL DIS, V40, P347, DOI 10.1016/j.bcmd.2007.10.001; Cohen SL, 2006, ANAL CHEM, V78, P4352, DOI 10.1021/ac052263n; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Dallalio G, 2003, BRIT J HAEMATOL, V122, P996, DOI 10.1046/j.1365-2141.2003.04516.x; FINCH CA, 1986, WESTERN J MED, V145, P657; GANZ T, 2006, HEMATOL-AM SOC HEMAT, V507, P29, DOI DOI 10.1182/ASHEDUCATION-2006.1.29; Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Jacobs EMG, 2005, ANAL BIOCHEM, V341, P241, DOI 10.1016/j.ab.2005.03.008; Kemna E, 2005, BLOOD, V106, P3268, DOI 10.1182/blood-2005-05-1873; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Melino S, 2005, J PEPT RES, V66, P65, DOI 10.1111/j.1747-0285.2006.00328.x; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324/haematol.10842; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peronnet E, 2006, PROTEOMICS, V6, P6288, DOI 10.1002/pmic.200600158; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; Song J, 2006, CLIN CHEM, V52, P1045, DOI 10.1373/clinchem.2005.065722; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; Tjalsma H, 2008, PROTEOM CLIN APPL, V2, P167, DOI 10.1002/prca.200780012; Tjalsma H, 2006, INT J CANCER, V119, P2127, DOI 10.1002/ijc.22116; Tolson J, 2004, LAB INVEST, V84, P845, DOI 10.1038/labinvest.3700097; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; van Dijk BAC, 2007, BLOOD, V109, P5525, DOI 10.1182/blood-2006-11-058560	37	171	176	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2706	10.1371/journal.pone.0002706	http://dx.doi.org/10.1371/journal.pone.0002706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628991	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200049
J	Zheng, XC; Zhang, HM; Yin, LJ; Wang, CR; Liu, Y; Zheng, P				Zheng, Xincheng; Zhang, Huiming; Yin, Lijie; Wang, Chyung-Ru; Liu, Yang; Zheng, Pan			Modulation of NKT Cell Development by B7-CD28 Interaction: An Expanding Horizon for Costimulation	PLOS ONE			English	Article								It has been demonstrated that the development of NKT cells requires CD1d. The contribution of costimulatory molecules in this process has not been studied. Here we show that in mice with targeted mutations of B7-1/2 and CD28, the TCR beta(+)alpha-Galcer/CD1d(+) (iV alpha 14 NKT) subset is significantly reduced in the thymus, spleen and liver. This is mainly due to decreased cell proliferation; although increased cell death in the thymi of CD28-deficient mice was also observed. Moreover, in the B7-1/2- and CD28-deficient mice, we found a decreased percentage of the CD4(-) NK1.1(+) subset and a correspondingly increased portion of the CD4(+)NK1.1(-) subset. In addition, the mice with a targeted mutation of either B7 or CD28 had a reduced susceptibility to Con A induced hepatitis, which is known to be mediated by NKT cells. Our results demonstrate that the development, maturation and function of NKT cell are modulated by the costimulatory pathway and thus expand the horizon of costimulation into NKT, which is widely viewed as a bridge between innate and adaptive immunity. As such, costimulation may modulate all major branches of cell-mediated immunity, including T cells, NK cells and NKT cells.	[Zheng, Xincheng; Zhang, Huiming; Yin, Lijie; Liu, Yang; Zheng, Pan] Univ Michigan, Dept Surg, Ctr Comprehens Canc, Program Mol Mech Dis, Ann Arbor, MI 48109 USA; [Zheng, Xincheng] OncoImmune Ltd, Columbus, OH USA; [Wang, Chyung-Ru] Univ Chicago, Dept Pathol, Chicago, IL USA	University of Michigan System; University of Michigan; University of Chicago	Zheng, XC (corresponding author), Univ Michigan, Dept Surg, Ctr Comprehens Canc, Program Mol Mech Dis, Ann Arbor, MI 48109 USA.	panz@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	NIH [AI 51342]; Department of Defense [DAMD17-03-1-0013, W81XWH-07-1-0169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043407, R01AI051342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by an NIH grant (AI 51342 to YL) and grants from the Department of Defense (DAMD17-03-1-0013 and W81XWH-07-1-0169 to PZ).	Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Eberl G, 1999, J IMMUNOL, V162, P6410; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Gao JX, 2002, J EXP MED, V195, P959, DOI 10.1084/jem.20011948; GAO JX, 2003, BLOOD; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Hammond KJL, 1999, EUR J IMMUNOL, V29, P3768, DOI 10.1002/(SICI)1521-4141(199911)29:11<3768::AID-IMMU3768>3.3.CO;2-7; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARDING FA, 1993, J EXP MED, V177, P1791, DOI 10.1084/jem.177.6.1791; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; ISSACHERGUI B, 1988, DIABETOLOGIA, V31, P675, DOI 10.1007/BF00278751; Jaruga B, 2003, J IMMUNOL, V171, P3233, DOI 10.4049/jimmunol.171.6.3233; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Louis H, 2002, GASTROENTEROLOGY, V122, P2001, DOI 10.1053/gast.2002.33620; MacDonald HR, 2002, CURR OPIN IMMUNOL, V14, P250, DOI 10.1016/S0952-7915(02)00329-1; MacDonald HR, 2002, SCIENCE, V296, P481, DOI 10.1126/science.1071492; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; NORTON SD, 1992, J IMMUNOL, V149, P1556; Pellicci DG, 2003, EUR J IMMUNOL, V33, P1816, DOI 10.1002/eji.200323894; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Swann J, 2004, IMMUNOL CELL BIOL, V82, P323, DOI 10.1111/j.1440-1711.2004.01254.x; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Van Dommelen SLH, 2004, IMMUNOL CELL BIOL, V82, P332, DOI 10.1111/j.0818-9641.2004.01261.x; Van Kaer L, 2004, IMMUNOL CELL BIOL, V82, P315, DOI 10.1111/j.0818-9641.2004.01252.x; Zheng XC, 2004, J IMMUNOL, V173, P2253, DOI 10.4049/jimmunol.173.4.2253	50	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2703	10.1371/journal.pone.0002703	http://dx.doi.org/10.1371/journal.pone.0002703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628995	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200046
J	Chodanowski, P; Grosdidier, A; Feytmans, E; Michielin, O				Chodanowski, Pierre; Grosdidier, Aurelien; Feytmans, Ernest; Michielin, Olivier			Local Alignment Refinement Using Structural Assessment	PLOS ONE			English	Article							PROTEIN-STRUCTURE; FREE-ENERGIES; MODELS; HOMOLOGY; ERRORS; DISCRIMINATION; CLASSIFICATION; RECOGNITION; PROGRESS	Homology modeling is the most commonly used technique to build a three-dimensional model for a protein sequence. It heavily relies on the quality of the sequence alignment between the protein to model and related proteins with a known three dimensional structure. Alignment quality can be assessed according to the physico-chemical properties of the three dimensional models it produces. In this work, we introduce fifteen predictors designed to evaluate the properties of the models obtained for various alignments. They consist of an energy value obtained from different force fields (CHARMM, ProsaII or ANOLEA) computed on residue selected around misaligned regions. These predictors were evaluated on ten challenging test cases. For each target, all possible ungapped alignments are generated and their corresponding models are computed and evaluated. The best predictor, retrieving the structural alignment for 9 out of 10 test cases, is based on the ANOLEA atomistic mean force potential and takes into account residues around misaligned secondary structure elements. The performance of the other predictors is significantly lower. This work shows that substantial improvement in local alignments can be obtained by careful assessment of the local structure of the resulting models.	[Chodanowski, Pierre; Grosdidier, Aurelien; Feytmans, Ernest; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Grosdidier, Aurelien; Michielin, Olivier] Ludwig Inst Canc Res, Epalinges, Switzerland; [Michielin, Olivier] CHU Vaudois, Ctr Pluridisciplin Oncol, Lausanne, Switzerland	Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chodanowski, P (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	Olivier.Michielin@isb-sib.ch	Michielin, Olivier/ABE-7924-2020	Grosdidier, Aurelien/0000-0001-9873-3461	Swiss National Science Foundation [3232B0-103172, 3200B0-103173]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the Swiss Institute of Bioinformatics and particularly Hamid Hussain-Khan for providing us assistance in exploiting the computational facilities of the Cluster versus Cancer Project (www.clusterVScancer.org) of the Lausanne University. We thank Vincent Zoete and Theres Fagerberg for interesting comments and careful reading of the manuscript. This work was supported by SCORE funds (3232B0-103172 and 3200B0-103173 to O. M.) from the Swiss National Science Foundation.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fleming PJ, 2006, PROTEIN SCI, V15, P1829, DOI 10.1110/ps.062305106; Gatchell DW, 2000, PROTEINS, V41, P518, DOI 10.1002/1097-0134(20001201)41:4<518::AID-PROT90>3.3.CO;2-Y; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARTIRENOM MA, 2003, MODELING PROTEIN STR; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; MELO F, UNPUB; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; POTTS JT, 1963, J BIOL CHEM, V238, P2593; Qiu J, 2006, PROTEINS, V62, P881, DOI 10.1002/prot.20854; READ RJ, 1984, BIOCHEMISTRY-US, V23, P6570, DOI 10.1021/bi00321a045; REIHER WE, 1985, THESIS HARVARD U CAM; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Sanchez R, 2000, METH MOL B, V143, P97; SAQI MAS, 1992, PROTEIN ENG, V5, P305, DOI 10.1093/protein/5.4.305; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; TANIUCHI H, 1971, J BIOL CHEM, V246, P2291; Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530; Venclovas C, 2003, PROTEINS, V53, P380, DOI 10.1002/prot.10591; Vorobjev YN, 2001, PROTEIN SCI, V10, P2498, DOI 10.1110/ps.ps.15501; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; WYCKOFF HW, 1970, J BIOL CHEM, V245, P305	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2645	10.1371/journal.pone.0002645	http://dx.doi.org/10.1371/journal.pone.0002645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612410	gold, Green Published, Green Submitted			2022-12-27	WOS:000264065800047
J	Dinh, TN; Nagahisa, K; Hirasawa, T; Furusawa, C; Shimizu, H				Dinh, Thai Nho; Nagahisa, Keisuke; Hirasawa, Takashi; Furusawa, Chikara; Shimizu, Hiroshi			Adaptation of Saccharomyces cerevisiae Cells to High Ethanol Concentration and Changes in Fatty Acid Composition of Membrane and Cell Size	PLOS ONE			English	Article								Background: Microorganisms can adapt to perturbations of the surrounding environment to grow. To analyze the adaptation process of the yeast Saccharomyces cerevisiae to a high ethanol concentration, repetitive cultivation was performed with a stepwise increase in the ethanol concentration in the culture medium. Methodology/Principal Findings: First, a laboratory strain of S. cerevisiae was cultivated in medium containing a low ethanol concentration, followed by repetitive cultivations. Then, the strain repeatedly cultivated in the low ethanol concentration was transferred to medium containing a high ethanol concentration and cultivated repeatedly in the same high-ethanol-concentration medium. When subjected to a stepwise increase in ethanol concentration with the repetitive cultivations, the yeast cells adapted to the high ethanol concentration; the specific growth rate of the adapted yeast strain did not decrease during repetitive cultivation in the medium containing the same ethanol concentration, while that of the non-adapted strain decreased during repetitive cultivation. A comparison of the fatty acid composition of the cell membrane showed that the contents in oleic acid (C(18:1)) in ethanol-adapted and non-adapted strains were similar, but the content of palmitic acid (C(16:0)) in the ethanol- adapted strains was lower than that in the non-adapted strain in media containing ethanol. Moreover, microscopic observation showed that the mother cells of the adapted yeast were significantly larger than those of the non-adapted strain. Conclusions: Our results suggest that activity of cell growth defined by specific growth rate of the yeast cells adapted to stepwise increase in ethanol concentration did not decrease during repetitive cultivation in high-ethanol-concentration medium. Moreover, fatty acid content of cell membrane and the size of ethanol-adapted yeast cells were changed during adaptation process. Those might be the typical phenotypes of yeast cells adapted to high ethanol concentration. In addition, the difference in sizes of the mother cell between the non-adapted and ethanol strains suggests that the cell size, cell cycle and adaptation to ethanol are thought to be closely correlated.	[Dinh, Thai Nho] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Osaka, Japan; [Nagahisa, Keisuke; Hirasawa, Takashi; Furusawa, Chikara; Shimizu, Hiroshi] Osaka Univ, Graduate Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan	Osaka University; Osaka University	Dinh, TN (corresponding author), Osaka Univ, Dept Biotechnol, Grad Sch Engn, Osaka, Japan.	shimizu@ist.osaka-u.ac.jp	Furusawa, Chikara/N-6103-2015; Hirasawa, Takashi/G-4458-2016; Shimizu, Hiroshi/C-3688-2017; Dinh, Thai/H-1340-2018; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Hirasawa, Takashi/0000-0002-5183-2953; Shimizu, Hiroshi/0000-0002-8986-0861; Dinh, Thai/0000-0001-7637-5288; Furusawa, Chikara/0000-0003-3554-4975	Japan Society for the Promotion of Science [18360395]; Ministry of Education, Culture, Sports, Science and Technology of Japan [19780061]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) to HS (18360395) from the Japan Society for the Promotion of Science and a Grant-in-Aid for Young Scientists (B) to TH (19780061) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported in part by "Global COE Program" and "Special Coordination Funds for Promoting Science and Technology: Yuragi Project" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ALEXANDRE H, 1994, FEMS MICROBIOL LETT, V124, P17, DOI 10.1016/0378-1097(94)90326-3; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; BEAVEN MJ, 1982, J GEN MICROBIOL, V128, P1447; Blanch H. W., 1997, BIOCH ENG; CALVERT GR, 1984, NATURE, V312, P61, DOI 10.1038/312061a0; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Hama S, 2004, BIOCHEM ENG J, V21, P155, DOI 10.1016/j.bej.2004.05.009; INGRAM LO, 1976, J BACTERIOL, V125, P670, DOI 10.1128/JB.125.2.670-678.1976; ISMAIL AA, 1971, FOLIA MICROBIOL, V16, P346, DOI 10.1007/BF02875751; Kajiwara S, 2000, BIOTECHNOL LETT, V22, P1839, DOI 10.1023/A:1005632522620; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; LLOYD D, 1993, YEAST, V9, P825, DOI 10.1002/yea.320090803; Maria JT, 2003, INT J FOOD MICROBIOL, V85, P127; MISHRA P, 1989, APPL MICROBIOL BIOT, V30, P294; THOMAS DS, 1978, ARCH MICROBIOL, V117, P239, DOI 10.1007/BF00738541; WALKERCAPRIOGLIO HM, 1990, APPL ENVIRON MICROB, V56, P2853, DOI 10.1128/AEM.56.9.2853-2857.1990; WALKERCAPRIOGLIO HM, 1985, APPL ENVIRON MICROB, V50, P685, DOI 10.1128/AEM.50.3.685-689.1985; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003	19	63	72	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2623	10.1371/journal.pone.0002623	http://dx.doi.org/10.1371/journal.pone.0002623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612424	gold, Green Published, Green Submitted			2022-12-27	WOS:000264065800025
J	Wu, YM; Ellis, RD; Shaffer, D; Fontes, E; Malkin, EM; Mahanty, S; Fay, MP; Narum, D; Rausch, K; Miles, AP; Aebig, J; Orcutt, A; Muratova, O; Song, GH; Lambert, L; Zhu, DM; Miura, K; Long, C; Saul, A; Miller, LH; Durbin, AP				Wu, Yimin; Ellis, Ruth D.; Shaffer, Donna; Fontes, Erica; Malkin, Elissa M.; Mahanty, Siddhartha; Fay, Michael P.; Narum, David; Rausch, Kelly; Miles, Aaron P.; Aebig, Joan; Orcutt, Andrew; Muratova, Olga; Song, Guanhong; Lambert, Lynn; Zhu, Daming; Miura, Kazutoyo; Long, Carole; Saul, Allan; Miller, Louis H.; Durbin, Anna P.			Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51	PLOS ONE			English	Article							ERYTHEMA-NODOSUM; PLASMODIUM-FALCIPARUM; IMMUNOGENICITY; ANTIGENS; PROTEIN; TARGET	Background: Pfs25 and Pvs25, surface proteins of mosquito stage of the malaria parasites P. falciparum and P. vivax, respectively, are leading candidates for vaccines preventing malaria transmission by mosquitoes. This single blinded, dose escalating, controlled Phase 1 study assessed the safety and immunogenicity of recombinant Pfs25 and Pvs25 formulated with Montanide ISA 51, a water-in-oil emulsion. Methodology/Principal Findings: The trial was conducted at The Johns Hopkins Center for Immunization Research, Washington DC, USA, between May 16, 2005-April 30, 2007. The trial was designed to enroll 72 healthy male and nonpregnant female volunteers into 1 group to receive adjuvant control and 6 groups to receive escalating doses of the vaccines. Due to unexpected reactogenicity, the vaccination was halted and only 36 volunteers were enrolled into 4 groups: 3 groups of 10 volunteers each were immunized with 5 mu g of Pfs25/ISA 51, 5 mu g of Pvs25/ISA 51, or 20 mu g of Pvs25/ISA 51, respectively. A fourth group of 6 volunteers received adjuvant control (PBS/ISA 51). Frequent local reactogenicity was observed. Systemic adverse events included two cases of erythema nodosum considered to be probably related to the combination of the antigen and the adjuvant. Significant antibody responses were detected in volunteers who completed the lowest scheduled doses of Pfs25/ISA 51. Serum anti-Pfs25 levels correlated with transmission blocking activity. Conclusion/Significance: It is feasible to induce transmission blocking immunity in humans using the Pfs25/ISA 51 vaccine, but these vaccines are unexpectedly reactogenic for further development. This is the first report that the formulation is associated with systemic adverse events including erythema nodosum.	[Wu, Yimin; Ellis, Ruth D.; Malkin, Elissa M.; Mahanty, Siddhartha; Narum, David; Rausch, Kelly; Miles, Aaron P.; Aebig, Joan; Orcutt, Andrew; Muratova, Olga; Song, Guanhong; Lambert, Lynn; Zhu, Daming; Miura, Kazutoyo; Long, Carole; Saul, Allan; Miller, Louis H.] NIAID, Malaria Vaccine Dev Branch, Rockville, MD USA; [Shaffer, Donna; Fontes, Erica; Durbin, Anna P.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD USA; [Fay, Michael P.] NIAID, Biostat Res Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wu, YM (corresponding author), NIAID, Malaria Vaccine Dev Branch, Rockville, MD USA.	yiwu@niaid.nih.gov; adurbin@jhsph.edu	Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; Fay, Michael P/A-2974-2008; Miura, Kazutoyo/AAY-9751-2020	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; Fay, Michael P/0000-0002-8643-9625; Miura, Kazutoyo/0000-0003-4455-2432; Narum, David/0000-0003-3041-5402; Mahanty, Siddhartha/0000-0003-1068-0524	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001007, ZIAAI000241, Z01AI000241, ZIGAI001047, Z01AI001047, Z01AI001020, Z01AI001007, ZIAAI001020] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funder played no role in study design, data collection and analysis, and manuscript preparation and submission.	Aucouturier J, 2006, VACCINE, V24, pS44, DOI 10.1016/j.vaccine.2005.01.116; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Carr A, 2003, J CLIN ONCOL, V21, P1015, DOI 10.1200/JCO.2003.02.124; CASTRESANAISLA CJ, 1993, J RHEUMATOL, V20, P1417; DIGIUSTO CA, 1986, LANCET, V2, P1042; GOOLSBY PL, 1989, NEW ENGL J MED, V321, P1198, DOI 10.1056/NEJM198910263211717; Gringeri A, 1998, J Hum Virol, V1, P293; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; Lehmann E. L., 1999, ELEMENTS LARGE SAMPL; LENGELER C, 2004, COCHRANE DB SYST REV, V3; Limsuwan A, 1998, VACCINE, V16, P142, DOI 10.1016/S0264-410X(97)88327-2; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miles AP, 2005, VACCINE, V23, P2530, DOI 10.1016/j.vaccine.2004.08.049; Miles AP, 2002, PROTEIN EXPRES PURIF, V25, P87, DOI 10.1006/prep.2001.1613; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Muderspach L, 2000, CLIN CANCER RES, V6, P3406; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; R Development Core Team, 2007, R LANG ENV STAT COMP; Requena L, 2007, SEMIN CUTAN MED SURG, V26, P114, DOI 10.1016/j.sder.2007.02.009; Robbins GK, 2003, AIDS, V17, P1121, DOI 10.1097/00002030-200305230-00002; ROGERSON SJ, 1990, BRIT MED J, V301, P345, DOI 10.1136/bmj.301.6747.345; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; SAUL A, 2008, EFFICACY MODEL MOSQU, P1; Saul A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000850; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; THOMSON BJ, 1985, SCOT MED J, V30, P173, DOI 10.1177/003693308503000310; TRAUGER RJ, 1995, J ACQ IMMUN DEF SYND, V2, P74; TSAI CW, 2005, J BIOTECHNOL; *WHO UNICEF ROLL B, 2005, WORLD MAL REP; Zou LL, 2003, VACCINE, V21, P1650, DOI 10.1016/S0264-410X(02)00701-6	35	232	251	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2636	10.1371/journal.pone.0002636	http://dx.doi.org/10.1371/journal.pone.0002636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612426	gold, Green Submitted, Green Published			2022-12-27	WOS:000264065800038
J	Abrantes, P; Dimopoulos, G; Grosso, AR; do Rosario, VE; Silveira, H				Abrantes, Patricia; Dimopoulos, George; Grosso, Ana Rita; do Rosario, Virgilio E.; Silveira, Henrique			Chloroquine Mediated Modulation of Anopheles gambiae Gene Expression	PLOS ONE			English	Article								Background: Plasmodium development in the mosquito is crucial for malaria transmission and depends on the parasite's interaction with a variety of cell types and specific mosquito factors that have both positive and negative effects on infection. Whereas the defensive response of the mosquito contributes to a decrease in parasite numbers during these stages, some components of the blood meal are known to favor infection, potentiating the risk of increased transmission. The presence of the antimalarial drug chloroquine in the mosquito's blood meal has been associated with an increase in Plasmodium infectivity for the mosquito, which is possibly caused by chloroquine interfering with the capacity of the mosquito to defend against the infection. Methodology/Principal Findings: In this study, we report a detailed survey of the Anopheles gambiae genes that are differentially regulated by the presence of chloroquine in the blood meal, using an A. gambiae cDNA microarray. The effect of chloroquine on transcript abundance was evaluated separately for non-infected and Plasmodium berghei-infected mosquitoes. Chloroquine was found to affect the abundance of transcripts that encode proteins involved in a variety of processes, including immunity, apoptosis, cytoskeleton and the response to oxidative stress. This pattern of differential gene expression may explain the weakened mosquito defense response which accounts for the increased infectivity observed in chloroquine-treated mosquitoes. Conclusions/Significance: The results of the present study suggest that chloroquine can interfere with several putative mosquito mechanisms of defense against Plasmodium at the level of gene expression and highlight the need for a better understanding of the impacts of antimalarial agents on parasite transmission.	[Abrantes, Patricia; do Rosario, Virgilio E.; Silveira, Henrique] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais LA UEI Mal, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Grosso, Ana Rita] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Grosso, Ana Rita] Univ Cambridge, Hutchison MRC Res Ctr, Dept Oncol, Cambridge, England	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade de Lisboa; University of Cambridge	Abrantes, P (corresponding author), Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais LA UEI Mal, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	patriciabrantes@netcabo.pt	Silveira, Henrique/G-2229-2011; Abrantes, Patrícia/G-2649-2019; Silveira, Henrique/AAB-4948-2022; Grosso, Ana Rita/I-6656-2013	Silveira, Henrique/0000-0002-7939-772X; Silveira, Henrique/0000-0002-7939-772X; Grosso, Ana Rita/0000-0001-6974-4209; Abrantes, Patricia/0000-0002-7484-2441; Dimopoulos, George/0000-0001-6755-8111	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/6346/2001]; Johns Hopkins Malaria Research Institute; National Institutes of Health/National Institute for Allergy and Infectious Disease [1R01AI061576-01A1]; The Ellison Medical Foundation;  [POCTI/35815/MGI/2000];  [POCTI/MGI/44905/2002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061576] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Johns Hopkins Malaria Research Institute; National Institutes of Health/National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); The Ellison Medical Foundation(Lawrence Ellison Foundation); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fundacao para a Ciencia e a Tecnologia grant to P.A. (SFRH/BD/6346/2001) and research funds from projects POCTI/35815/MGI/2000 and POCTI/MGI/44905/2002, the Johns Hopkins Malaria Research Institute, the National Institutes of Health/National Institute for Allergy and Infectious Disease 1R01AI061576-01A1, and The Ellison Medical Foundation.	Abrantes P, 2005, INSECT BIOCHEM MOLEC, V35, P1124, DOI 10.1016/j.ibmb.2005.05.003; Baton LA, 2004, PARASITOLOGY, V129, P663, DOI 10.1017/S0031182004005979; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bolstad B, 2005, BIOINFORMATICS COMPU; Bonizzi G, 1997, J IMMUNOL, V159, P5264; Chen Yan-ping, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P245; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Danielli A, 2005, CELL MICROBIOL, V7, P181, DOI 10.1111/j.1462-5822.2004.00445.x; DESBUQUOIS B, 1992, DIABETES METAB, V18, P104; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dudoit S, 2002, STAT SINICA, V12, P111; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hogh B, 1998, AM J TROP MED HYG, V58, P176, DOI 10.4269/ajtmh.1998.58.176; ICHIMORI K, 1990, PARASITOLOGY, V100, P377, DOI 10.1017/S0031182000078641; Jan JT, 2000, J VIROL, V74, P6425, DOI 10.1128/JVI.74.14.6425-6432.2000; Jeong JY, 2002, IMMUNOLOGY, V105, P83, DOI 10.1046/j.0019-2805.2001.01339.x; Kriventseva EV, 2005, GENOME RES, V15, P893, DOI 10.1101/gr.3756405; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Legssyer R, 2003, J INORG BIOCHEM, V94, P36, DOI 10.1016/S0162-0134(02)00633-5; Lopes LF, 2007, EXP PARASITOL, V115, P259, DOI 10.1016/j.exppara.2006.09.007; NEWMAN SL, 1994, J CLIN INVEST, V93, P1422, DOI 10.1172/JCI117119; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; PEIRIS JSM, 1988, AM J TROP MED HYG, V39, P26, DOI 10.4269/ajtmh.1988.39.26; R Development Core Team, 2005, R LANG ENV STAT COMP; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Silveira H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-84; SMYTH GK, 2003, LINEAR MODELS MICROA; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Vizioli J, 2001, P NATL ACAD SCI USA, V98, P12630, DOI 10.1073/pnas.221466798; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; *WHO, 2006, WHO LIB CAT PUBL DAT, P253; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Xu XJ, 2005, MOL BIOCHEM PARASIT, V142, P76, DOI 10.1016/j.molbiopara.2005.02.013; YANG YH, 2001, NORMALIZATION CDNA M; Zhang D, 2002, INSECT BIOCHEM MOLEC, V32, P579, DOI 10.1016/S0965-1748(01)00138-2	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2587	10.1371/journal.pone.0002587	http://dx.doi.org/10.1371/journal.pone.0002587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596975	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200046
J	Keil, MS; Lapedriza, A; Masip, D; Vitria, J				Keil, Matthias S.; Lapedriza, Agata; Masip, David; Vitria, Jordi			Preferred Spatial Frequencies for Human Face Processing Are Associated with Optimal Class Discrimination in the Machine	PLOS ONE			English	Article							NATURAL SCENES; RECOGNITION; RETINA; EXPLANATION; INFORMATION; STATISTICS; BRIGHTNESS; PERCEPTION; IMAGES; COST	Psychophysical studies suggest that humans preferentially use a narrow band of low spatial frequencies for face recognition. Here we asked whether artificial face recognition systems have an improved recognition performance at the same spatial frequencies as humans. To this end, we estimated recognition performance over a large database of face images by computing three discriminability measures: Fisher Linear Discriminant Analysis, Non-Parametric Discriminant Analysis, and Mutual Information. In order to address frequency dependence, discriminabilities were measured as a function of (filtered) image size. All three measures revealed a maximum at the same image sizes, where the spatial frequency content corresponds to the psychophysical found frequencies. Our results therefore support the notion that the critical band of spatial frequencies for face recognition in humans and machines follows from inherent properties of face images, and that the use of these frequencies is associated with optimal face recognition performance.	[Keil, Matthias S.] Univ Barcelona, Basic Psychol Dept, Fac Psychol, Barcelona, Spain; [Lapedriza, Agata] Autonomous Univ Barcelona, Comp Vision Ctr, Comp Sci Dept, Bellaterra, Spain; [Masip, David] Univ Oberta Catalunya, Dept Comp Sci, Barcelona, Spain; [Vitria, Jordi] Univ Barcelona, Dept Appl Math & Anal, Barcelona, Spain	University of Barcelona; Autonomous University of Barcelona; Centre de Visio per Computador (CVC); UOC Universitat Oberta de Catalunya; University of Barcelona	Keil, MS (corresponding author), Univ Barcelona, Basic Psychol Dept, Fac Psychol, Barcelona, Spain.	mats@cvc.uab.es	Vitria, Jordi/C-7072-2008; Vitrià, Jordi/AAF-9668-2020; Masip, David/B-1709-2009	Vitria, Jordi/0000-0003-1484-539X; Vitrià, Jordi/0000-0003-1484-539X; Lapedriza, Agata/0000-0002-5248-0443; Masip Rodo, David/0000-0001-7898-1847	Spanish Government; MCyT [SEJ2006-15095]; MEC [TIC2006-15308-C02-01]; CONSOLIDER-INGENIO 2010 [CSD2007-00018]	Spanish Government(Spanish GovernmentEuropean Commission); MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEC(European Commission); CONSOLIDER-INGENIO 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MSK was partially supported by a Juan de la Cierva post-doctoral contract from the Spanish Government. Further support was granted by the MCyT grant SEJ2006-15095, MEC grant TIC2006-15308-C02-01 and CONSOLIDER-INGENIO 2010 (CSD2007-00018).	ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; Duda R.O., 2000, PATTERN CLASSIFICATI; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; FUKUNAGA K, 1983, IEEE T PATTERN ANAL, V5, P671, DOI 10.1109/TPAMI.1983.4767461; FUKUNAGA K, 1990, INTRO STAT PATTERN; GUORONGXUAN, 2005, IEEE 7 WORKSH MULT S, P1; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; Keil MS, 2008, P ROY SOC B-BIOL SCI, V275, P2095, DOI 10.1098/rspb.2008.0486; KEINOSUKEFUKUNA, 1995, ELECT COMPUTER ENG T; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; LINSKER R, 1988, IEEE COMPUT, V21, P105, DOI DOI 10.1109/2.36; Lotto RB, 2000, P NATL ACAD SCI USA, V97, P12834, DOI 10.1073/pnas.210369597; Lotto RB, 1999, P NATL ACAD SCI USA, V96, P5245, DOI 10.1073/pnas.96.9.5245; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Nundy S, 2002, P NATL ACAD SCI USA, V99, P14482, DOI 10.1073/pnas.172520399; Ojanpaa H, 2003, VISION RES, V43, P2505, DOI 10.1016/S0042-6989(03)00459-0; PELI E, 1994, J OPT SOC AM A, V11, P1929, DOI 10.1364/JOSAA.11.001929; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71	36	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2590	10.1371/journal.pone.0002590	http://dx.doi.org/10.1371/journal.pone.0002590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596932	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200049
J	Corcoran, KE; Trzaska, KA; Fernandes, H; Bryan, M; Taborga, M; Srinivas, V; Packman, K; Patel, PS; Rameshwar, P				Corcoran, Kelly E.; Trzaska, Katarzyna A.; Fernandes, Helen; Bryan, Margarette; Taborga, Marcelo; Srinivas, Venkatesh; Packman, Kathryn; Patel, Prem S.; Rameshwar, Pranela			Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; NEUROKININ RECEPTORS; TUMOR-GROWTH; IN-VITRO; EXPRESSION; METASTASIS; FACTOR-1-ALPHA; ACTIVATION; RELEVANCE; TARGETS	Background: An understanding of BC cell (BCC) entry into bone marrow ( BM) at low tumor burden is limited when compared to highly metastatic events during heavy tumor burden. BCCs can achieve quiescence, without interfering with hematopoiesis. This occurs partly through the generation of gap junctions with BM stroma, located close to the endosteum. These events are partly mediated by the evolutionary conserved gene, Tac1. Methodogy/Principal Findings: This study focuses on the role of mesenchymal stem cells (MSCs), Tac1, SDF-1 and CXCR4 in BCC entry into BM. The model is established in studies with low numbers of tumor cells, and focuses on cancer cells with low metastatic and invasion potential. This allowed us to recapitulate early event, and to study cancer cells with low invasive potential, even when they are part of larger numbers of highly metastatic cells. A novel migration assay showed a facilitating role of MSCs in BCC migration across BM endothelial cells. siRNA and ectopic expression studies showed a central role for Tac1 and secondary roles for SDF-1 alpha and CXCR4. We also observed differences in the mechanisms between low invasive and highly metastatic cells. The in vitro studies were verified in xenogeneic mouse models that showed a preference for low invasive BCCs to BM, but comparable movement to lung and BM by highly metastatic BCCs. The expressions of Tac1 and production of SDF-1 alpha were verified in primary BCCs from paired samples of BM aspirates and peripheral blood. Conclusions/Significance: MSC facilitate BCC entry into BM, partly through Tac1-mediated regulation of SDF-1 alpha and CXCR4. We propose a particular population of BCC with preference for BM could be isolated for characterization. This population might be the subset that enter BM at an early time period, and could be responsible for cancer resurgence and resistance to current therapies.	[Corcoran, Kelly E.; Trzaska, Katarzyna A.; Bryan, Margarette; Taborga, Marcelo; Srinivas, Venkatesh; Rameshwar, Pranela] UMDNJ, New Jersey Med Sch, Dept Med, Newark, NJ USA; [Fernandes, Helen] UMDNJ, New Jersey Med Sch, Dept Pathol, Lab Med, Newark, NJ USA; [Packman, Kathryn] Hoffmann La Roche, Discovery Oncol, Nutley, NJ USA; [Patel, Prem S.] Brookdale Univ Hosp, Med Ctr, Div Trauma, Brooklyn, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Roche Holding	Corcoran, KE (corresponding author), UMDNJ, New Jersey Med Sch, Dept Med, Newark, NJ USA.	rameshwa@umdnj.edu						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Beaujouan JC, 2004, PEPTIDES, V25, P339, DOI 10.1016/j.peptides.2004.02.011; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; BIGIONI M, 2007, ANTI-CANCER DRUG, V16, P1083; Braun S, 2005, J CLIN ONCOL, V23, P1623, DOI 10.1200/JCO.2005.10.073; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Claps CM, 2005, CURR NEUROVASC RES, V2, P319, DOI 10.2174/156720205774322593; Corcoran KE, 2005, BIOL PROCED ONLINE, V7, P8, DOI 10.1251/bpo100; Corcoran KE, 2007, MOL CANCER RES, V5, P373, DOI 10.1158/1541-7786.MCR-06-0396; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; DONAHUE HJ, 2007, J MUSCULOSKEL NEURON, V3, P156; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Greco SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P1782, DOI 10.2741/1373; Holland JD, 2006, CANCER RES, V66, P4117, DOI 10.1158/0008-5472.CAN-05-1631; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kang HS, 2004, ARCH IMMUNOL THER EX, V52, P338; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Klein CA, 2004, CELL CYCLE, V3, P29; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; LACROIX M, 2007, BREAST CANC RES TREA, V83, P249; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Loo WTY, 2005, BIOMED PHARMACOTHER, V59, pS384, DOI 10.1016/S0753-3322(05)80084-8; Moharita AL, 2006, BLOOD, V108, P3245, DOI 10.1182/blood-2006-01-017459; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patel HJ, 2005, P NATL ACAD SCI USA, V102, P17436, DOI 10.1073/pnas.0506351102; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Rao G, 2004, CANCER RES, V64, P2874, DOI 10.1158/0008-5472.CAN-03-3121; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Sotiropoulou PA, 2006, STEM CELLS, V24, P1409, DOI 10.1634/stemcells.2005-0654; Taborga M, 2007, MINI-REV MED CHEM, V7, P245, DOI 10.2174/138955707780059826; Trosko JE, 2005, BIOMED PHARMACOTHER, V59, pS326, DOI 10.1016/S0753-3322(05)80065-4; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	42	119	125	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2563	10.1371/journal.pone.0002563	http://dx.doi.org/10.1371/journal.pone.0002563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575622	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000053
J	De Gennaro, L; Fratello, F; Marzano, C; Moroni, F; Curcio, G; Tempesta, D; Pellicciari, MC; Pirulli, C; Ferrara, M; Rossini, PM				De Gennaro, Luigi; Fratello, Fabiana; Marzano, Cristina; Moroni, Fabio; Curcio, Giuseppe; Tempesta, Daniela; Pellicciari, Maria Concetta; Pirulli, Cornelia; Ferrara, Michele; Rossini, Paolo Maria			Cortical Plasticity Induced by Transcranial Magnetic Stimulation during Wakefulness Affects Electroencephalogram Activity during Sleep	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; LONG-TERM POTENTIATION; HUMAN MOTOR CORTEX; EVOKED-POTENTIALS; EXCITABILITY; DEPRESSION; LTP; DEPRIVATION; EEG; TOPOGRAPHY	Background: Sleep electroencephalogram (EEG) brain oscillations in the low-frequency range show local signs of homeostatic regulation after learning. Such increases and decreases of slow wave activity are limited to the cortical regions involved in specific task performance during wakefulness. Here, we test the hypothesis that reorganization of motor cortex produced by long-term potentiation (LTP) affects EEG activity of this brain area during subsequent sleep. Methodology/Principal Findings: By pairing median nerve stimulation with transcranial magnetic stimulation over the contralateral motor cortex, one can potentiate the motor output, which is presumed to reflect plasticity of the neural circuitry. This paired associative stimulation increases M1 cortical excitability at interstimulus intervals of 25 ms. We compared the scalp distribution of sleep EEG power following paired associative stimulation at 25 ms to that following a control paradigm with 50 ms intervals. It is shown that the experimental manipulation by paired associative stimulation at 25 ms induces a 48% increase in amplitude of motor evoked potentials. This LTP-like potentiation, induced during waking, affects delta and theta EEG power in both REM and non-REM sleep, measured during the following night. Slow-wave activity increases in some frontal and prefrontal derivations and decreases at sites neighboring and contralateral to the stimulated motor cortex. The magnitude of increased amplitudes of motor evoked potentials by the paired associative stimulation at 25 ms predicts enhancements of slow-wave activity in prefrontal regions. Conclusions/Significance: An LTP-like paradigm, presumably inducing increased synaptic strength, leads to changes in local sleep regulation, as indexed by EEG slow-wave activity. Enhancement and depression of slow-wave activity are interpreted in terms of a simultaneous activation of both excitatory and inhibitory circuits consequent to the paired associative stimulation at 25 ms.	[De Gennaro, Luigi; Fratello, Fabiana; Marzano, Cristina; Moroni, Fabio; Curcio, Giuseppe] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [De Gennaro, Luigi; Pellicciari, Maria Concetta; Pirulli, Cornelia] Hosp Fatebenefratelli, IRCCS Centro S Giovanni Dio, Brescia, Italy; [Curcio, Giuseppe; Rossini, Paolo Maria] IRCCS S Raffaele Pisana, Casa Cura S Raffaele Cassino, Rome, Italy; [Tempesta, Daniela] Univ Laquila, Fac Psychol, Lab Sleep Psychophysiol, Laquila, Italy; [Ferrara, Michele] Univ Laquila, Dept Internal Med & Publ Hlth, Laquila, Italy; [Rossini, Paolo Maria] Isola Tiberina, Hosp Fatebenefratelli, Dept Neurosci, AFaR, Rome, Italy; [Rossini, Paolo Maria] Univ Campus Biomed, Neurol Clin, Rome, Italy	Sapienza University Rome; IRCCS Fatebenefratelli; IRCCS San Raffaele Pisana; University of L'Aquila; University of L'Aquila; University Campus Bio-Medico - Rome Italy	De Gennaro, L (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	luigi.degennaro@uniroma1.it	Ferrara, Michele/AAB-7574-2022; Curcio, Giuseppe/M-1635-2014; Rossini, Paolo M./D-4994-2013; De Gennaro, Luigi/L-8711-2015; Tempesta, Daniela/AAB-7539-2022; Pirulli, Cornelia/K-1518-2016; Pellicciari, Maria Concetta/A-6815-2012	Ferrara, Michele/0000-0003-2304-7576; Rossini, Paolo M./0000-0003-2665-534X; De Gennaro, Luigi/0000-0003-3613-6631; Tempesta, Daniela/0000-0002-6942-5336; Pirulli, Cornelia/0000-0003-1865-5833; Pellicciari, Maria Concetta/0000-0003-2455-8220; Moroni, Fabio/0000-0003-0587-0614; Curcio, Giuseppe/0000-0003-2248-781X	MUR [PRIN 2006-2006062871]	MUR(Ministry of Education, Universities and Research (MIUR))	This work is supported by the M.U.R. grant "PRIN 2006-2006062871" (to LDG).	Andersen P, 1977, Ciba Found Symp, P87; Bergmann TO, 2008, EUR J NEUROSCI, V27, P2241, DOI 10.1111/j.1460-9568.2008.06178.x; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1992, J SLEEP RES, V1, P63, DOI 10.1111/j.1365-2869.1992.tb00013.x; BRUNNER DP, 1993, SLEEP, V16, P100, DOI 10.1093/sleep/16.2.100; Buonomano DV, 1998, J NEUROPHYSIOL, V80, P1765, DOI 10.1152/jn.1998.80.4.1765; Classen Joseph, 2004, Suppl Clin Neurophysiol, V57, P563; Crupi D, 2008, BRAIN RES BULL, V75, P107, DOI 10.1016/j.brainresbull.2007.07.029; Enomoto H, 2001, CLIN NEUROPHYSIOL, V112, P2154, DOI 10.1016/S1388-2457(01)00667-8; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Ferrara M, 2002, CEREB CORTEX, V12, P737, DOI 10.1093/cercor/12.7.737; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Fratello F, 2006, CLIN NEUROPHYSIOL, V117, P2667, DOI 10.1016/j.clinph.2006.07.315; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2000, J NEUROPHYSIOL, V84, P1888, DOI 10.1152/jn.2000.84.4.1888; Huber R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000276; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Ishikawa S, 2007, CLIN NEUROPHYSIOL, V118, P1033, DOI 10.1016/j.clinph.2007.02.003; Litvak V, 2007, EUR J NEUROSCI, V25, P2862, DOI 10.1111/j.1460-9568.2007.05531.x; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MARIORENZI R, 1991, ELECTROEN CLIN NEURO, V81, P90, DOI 10.1016/0168-5597(91)90002-F; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Murakami T, 2008, EXP BRAIN RES, V184, P339, DOI 10.1007/s00221-007-1103-0; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Oleksenko A.I., 1992, Journal of Sleep Research, V1, P40; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; RECHTSHAFFEN A, 1968, MANUAL STANDARDIZED; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Stefan K, 2004, J NEUROPHYSIOL, V92, P66, DOI 10.1152/jn.00383.2003; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2006, CEREB CORTEX, V16, P376, DOI 10.1093/cercorbhi116; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; TOBLER I, 1992, J SLEEP RES, V1, P125, DOI 10.1111/j.1365-2869.1992.tb00024.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsuji T, 2002, J PHYSIOL-LONDON, V540, P367, DOI 10.1113/jphysiol.2001.013504; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2002, J NEUROPHYSIOL, V88, P2280, DOI 10.1152/jn.00304.2002; Wawryko P, 2004, BRAIN RES, V1029, P1, DOI 10.1016/j.brainres.2004.09.019; Weise D, 2006, BRAIN, V129, P2709, DOI 10.1093/brain/awl221; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	50	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2483	10.1371/journal.pone.0002483	http://dx.doi.org/10.1371/journal.pone.0002483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575583	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000013
J	Lee, DW; Freitag, M; Selker, EU; Aramayo, R				Lee, Dong W.; Freitag, Michael; Selker, Eric U.; Aramayo, Rodolfo			A Cytosine Methyltransferase Homologue Is Essential for Sexual Development in Aspergillus nidulans	PLOS ONE			English	Article								Background: The genome defense processes RIP (repeat-induced point mutation) in the filamentous fungus Neurospora crassa, and MIP (methylation induced premeiotically) in the fungus Ascobolus immersus depend on proteins with DNA methyltransferase (DMT) domains. Nevertheless, these proteins, RID and Masc1, respectively, have not been demonstrated to have DMT activity. We discovered a close homologue in Aspergillus nidulans, a fungus thought to have no methylation and no genome defense system comparable to RIP or MIP. Principal Findings: We report the cloning and characterization of the DNA methyltransferase homologue A (dmtA) gene from Aspergillus nidulans. We found that the dmtA locus encodes both a sense (dmtA) and an anti-sense transcript (tmdA). Both transcripts are expressed in vegetative, conidial and sexual tissues. We determined that dmtA, but not tmdA, is required for early sexual development and formation of viable ascospores. We also tested if DNA methylation accumulated in any of the dmtA/tmdA mutants we constructed, and found that in both asexual and sexual tissues, these mutants, just like wild-type strains, appear devoid of DNA methylation. Conclusions/Significance: Our results demonstrate that a DMT homologue closely related to proteins implicated in RIP and MIP has an essential developmental function in a fungus that appears to lack both DNA methylation and RIP or MIP. It remains formally possible that DmtA is a bona fide DMT, responsible for trace, undetected DNA methylation that is restricted to a few cells or transient but our work supports the idea that the DMT domain present in the RID/Masc1/DmtA family has a previously undescribed function.	[Lee, Dong W.; Aramayo, Rodolfo] Texas A&M Univ, Dept Biol, Coll Sci, College Stn, TX 77843 USA; [Freitag, Michael; Selker, Eric U.] Univ Oregon, Inst Mol Biol, Dept Biol, Eugene, OR USA	Texas A&M University System; Texas A&M University College Station; University of Oregon	Lee, DW (corresponding author), Texas A&M Univ, Dept Biol, Coll Sci, College Stn, TX 77843 USA.	raramayo@tamu.edu		Aramayo, Rodolfo/0000-0001-9702-6204	U. S. Public Health Service [GM58770, GM35690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035690, R37GM035690, R01GM058770] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U. S. Public Health Service Grants GM58770 and GM35690 to R. A. and E. U. S., respectively.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; ARAMAYO R, 1993, EMBO J, V12, P2039, DOI 10.1002/j.1460-2075.1993.tb05853.x; ARAMAYO R, 1989, GENETICS, V122, P65; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Attard A, 2005, FUNGAL GENET BIOL, V42, P30, DOI 10.1016/j.fgb.2004.09.004; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bouhouche K, 2004, GENETICS, V167, P151, DOI 10.1534/genetics.167.1.151; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; CHRISTMAN JK, 1985, J BIOL CHEM, V260, P4059; Clutterbuck AJ, 2004, FUNGAL GENET BIOL, V41, P308, DOI 10.1016/j.fgb.2003.11.004; CLUTTERBUCK JC, 1974, BACTERIA BACTERIOPHA, P447; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; FREEDMAN T, 1993, GENETICS, V135, P357; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; GOYON C, 1989, MOL CELL BIOL, V9, P2818, DOI 10.1128/MCB.9.7.2818; Graia F, 2001, MOL MICROBIOL, V40, P586, DOI 10.1046/j.1365-2958.2001.02367.x; Hamann A, 2000, MOL GEN GENET, V263, P1061, DOI 10.1007/s004380050035; HAN D M, 1990, Korean Journal of Mycology, V18, P225; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Idnurm A, 2003, FUNGAL GENET BIOL, V39, P31, DOI 10.1016/S1087-1845(02)00588-1; JOHNSTONE IL, 1990, GENE, V90, P181, DOI 10.1016/0378-1119(90)90178-T; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KIRK KE, 1991, GENE DEV, V5, P2014, DOI 10.1101/gad.5.11.2014; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; LAW DJ, 1980, J BACTERIOL, V144, P509, DOI 10.1128/JB.144.2.509-517.1980; Leonhardt H., 1993, DNA methylation: molecular biology and biological significance., P109; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Malagnac F, 1997, CELL, V91, P281, DOI 10.1016/S0092-8674(00)80410-9; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mautino MR, 1998, J THEOR BIOL, V192, P61, DOI 10.1006/jtbi.1997.0608; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428; Nicosia MGL, 2001, MOL MICROBIOL, V39, P1330; Nielsen ML, 2001, MOL GENET GENOMICS, V265, P883, DOI 10.1007/s004380100484; NOYERWEIDNER M, 1993, DNA METHYLATION MOL, P39; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; Pratt RJ, 2002, FUNGAL GENET BIOL, V37, P56, DOI 10.1016/S1087-1845(02)00032-4; PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Rosa AL, 2004, MUTAT RES-FUND MOL M, V548, P85, DOI 10.1016/j.mrfmmm.2004.01.001; Sambrook J., 2002, MOL CLONING LAB MANU; SELKER EU, 1987, MOL CELL BIOL, V7, P1032, DOI 10.1128/MCB.7.3.1032; SELKER EU, 1985, P NATL ACAD SCI USA, V82, P8114, DOI 10.1073/pnas.82.23.8114; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; SELKER EU, 1990, TRENDS BIOCHEM SCI, V15, P103, DOI 10.1016/0968-0004(90)90193-F; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; Steigele S, 2005, NUCLEIC ACIDS RES, V33, P5034, DOI 10.1093/nar/gki804; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; TAMAME M, 1988, MOL CELL BIOL, V8, P3043, DOI 10.1128/MCB.8.8.3043; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WESSLER SR, 1988, SCIENCE, V242, P399, DOI 10.1126/science.2845581; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470	78	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2531	10.1371/journal.pone.0002531	http://dx.doi.org/10.1371/journal.pone.0002531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575630	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000046
J	Molokhia, M; McKeigue, P; Curcin, V; Majeed, A				Molokhia, Mariam; McKeigue, Paul; Curcin, Vasa; Majeed, Azeem			Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991-2006	PLOS ONE			English	Article								Background: Statins are widely used as a cholesterol lowering medication, reduce cardiovascular mortality and morbidity in high risk patients; and only rarely cause serious adverse drug reactions (ADRs). UK primary care databases of morbidity and prescription data, which now cover several million people, have potential for more powerful analytical approaches to study ADRs including adjusting for confounders and examining temporal effects. Methods: Case-crossover design in detecting statin associated myopathy ADR in 93, 831 patients, using two independent primary care databases (1991-2006). We analysed risk by drug class, by disease code and cumulative year, exploring different cut-off exposure times and confounding by temporality. Results: Using a 12 and 26 week exposure period, large risk ratios (RR) are associated with all classes of statins and fibrates for myopathy: RR 10.6 (9.8-11.4) and 19.9 (17.6-22.6) respectively. At 26 weeks, the largest risks are with fluvastatin RR 33.3 (95% CI 16.8-66.0) and ciprofibrate (with previous statin use) RR 40.5 (95% CI 13.4-122.0). AT 12 weeks the differences between cerivastatin and atorvastatin RR for myopathy were found to be significant, RR 2.05 (95% CI 1.2-3.5), and for rosuvastatin and fluvastatin RR 3.0 (95% CI 1.6-5.7). After 12 months of statin initiation, the relative risk for myopathy for all statins and fibrates increased to 25.7 (95% CI 21.8-30.3). Furthermore, this signal was detected within 2 years of first events being recorded. Our data suggests an annual incidence of statin induced myopathy or myalgia of around 11.4 for 16, 591 patients or 689 per million per year. Conclusion: There may be differential risks associated with some classes of statin and fibrate. Myopathy related to statin or fibrate use may persist after a long exposure time (12 months or more). These methods could be applied for early detection of harmful drug side effects, using similar primary care diagnostic and prescribing data.	[Molokhia, Mariam] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [McKeigue, Paul] Univ Edinburgh, Med Sch, Publ Hlth Sci, Edinburgh, Midlothian, Scotland; [Curcin, Vasa] Imperial Coll London, Dept Comp, London, England; [Majeed, Azeem] Imperial Coll, Dept Primary Care & Social Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh; Imperial College London; Imperial College London	Molokhia, M (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	mariam.molokhia@lshtm.ac.uk		Curcin, Vasa/0000-0002-8308-2886; Majeed, Azeem/0000-0002-2357-9858	NCCRCD [Post-Doctoral Fellowship]; Department of Primary Care and Social Medicine at Imperial College; NIHR Biomedical Research Centre; EPSRC [EP/F059221/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F059221/1] Funding Source: researchfish	NCCRCD; Department of Primary Care and Social Medicine at Imperial College; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MM is supported by a Post-Doctoral Fellowship from the NCCRCD. The Department of Primary Care and Social Medicine at Imperial College is grateful for support from the NIHR Biomedical Research Centre Funding Scheme.	Aberra FN, 2005, CLIN GASTROENTEROL H, V3, P459, DOI 10.1016/S1542-3565(05)00020-0; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; ARMITAGE J, 2007, LANCET; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Black C, 2002, PHARMACOTHERAPY, V22, P1524, DOI 10.1592/phco.22.17.1524.34130; Department of Health (DoH), 2001, NAT SERV FRAM DIAB S; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Gaist D, 2001, EPIDEMIOLOGY, V12, P565, DOI 10.1097/00001648-200109000-00017; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Hebert C, 2007, PHARMACOEPIDEM DR S, V16, P845, DOI 10.1002/pds.1432; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majeed Azeem, 2004, Health Stat Q, P5; McClure DL, 2007, J CLIN EPIDEMIOL, V60, P812, DOI 10.1016/j.jclinepi.2006.11.006; Meier CR, 2004, DRUG SAFETY, V27, P203, DOI 10.2165/00002018-200427030-00005; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; National Center for AIDS/STD Control and Prevention Chinese Center for Disease Control and Prevention, 2007, PLANN NEW REM ARCH F, P1; National Institute for Health and Clinical Excellence (NICE), 2006, STAT PREV CARD EV PA; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rodriguez LAG, 1999, BRIT J CLIN PHARMACO, V48, P847; ROWE A, 2003, ISMB S, P225; Soininen K, 2006, BASIC CLIN PHARMACOL, V98, P51, DOI 10.1111/j.1742-7843.2006.pto_193.x; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; van der Linden PD, 1998, J CLIN EPIDEMIOL, V51, P703, DOI 10.1016/S0895-4356(98)00041-9; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; 2007, INFORSENSE KDE FACTS	27	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2522	10.1371/journal.pone.0002522	http://dx.doi.org/10.1371/journal.pone.0002522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575628	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000263288000038
J	Chai, GL; Li, L; Zhou, W; Wu, LP; Zhao, Y; Wang, DL; Lu, SL; Yu, Y; Wang, HY; McNutt, MA; Hu, YG; Chen, YQ; Yang, Y; Wu, X; Otterson, GA; Zhu, WG				Chai, Guolin; Li, Lian; Zhou, Wen; Wu, Lipeng; Zhao, Ying; Wang, Donglai; Lu, Shaoli; Yu, Yu; Wang, Haiying; McNutt, Michael A.; Hu, Ye-Guang; Chen, Yingqi; Yang, Yang; Wu, Xin; Otterson, Gregory A.; Zhu, Wei-Guo			HDAC Inhibitors Act with 5-aza-2 '-Deoxycytidine to Inhibit Cell Proliferation by Suppressing Removal of Incorporated Abases in Lung Cancer Cells	PLOS ONE			English	Article							DNA N-GLYCOSYLASE; ANTINEOPLASTIC ACTION; PROTEIN-KINASE; APOPTOSIS; ATR; EXPRESSION; 5-AZA-2-DEOXYCYTIDINE; METHYLTRANSFERASE; PATHWAY; METHYLATION	5-aza-2 '-deoxycytidine (5-aza-CdR) is used extensively as a demethylating agent and acts in concert with histone deacetylase inhibitors (HDACl) to induce apoptosis or inhibition of cell proliferation in human cancer cells. Whether the action of 5-aza-CdR in this synergistic effect results from demethylation by this agent is not yet clear. In this study we found that inhibition of cell proliferation was not observed when cells with knockdown of DNA methyltransferase 1 (DNMT1), or double knock down of DNMT1-DNMT3A or DNMT1-DNMT3B were treated with HDACl, implying that the demethylating function of 5-aza-CdR may be not involved in this synergistic effect. Further study showed that there was a causal relationship between 5-aza-CdR induced DNA damage and the amount of [H-3]-5-aza-CdR incorporated in DNA. However, incorporated [H-3]-5-aza-CdR gradually decreased when cells were incubated in [H-3]-5-aza-CdR free medium, indicating that 5-aza-CdR, which is an abnormal base, may be excluded by the cell repair system. It was of interest that HDACl significantly postponed the removal of the incorporated [H-3]-5-aza-CdR from DNA. Moreover, HDAC inhibitor showed selective synergy with nucleoside analog-induced DNA damage to inhibit cell proliferation, but showed no such effect with other DNA damage stresses such as gamma-ray and UV, etoposide or cisplatin. This study demonstrates that HDACl synergistically inhibits cell proliferation with nucleoside analogs by suppressing removal of incorporated harmful nucleotide analogs from DNA.	[Chai, Guolin; Li, Lian; Zhou, Wen; Wu, Lipeng; Zhao, Ying; Wang, Donglai; Lu, Shaoli; Yu, Yu; Wang, Haiying; Chen, Yingqi; Yang, Yang; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China; [Hu, Ye-Guang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Wu, Xin; Otterson, Gregory A.] Ohio State Univ, Comprehensive Canc Ctr, Dept Internal Med, Div Hematol Oncol, Columbus, OH USA	Peking University; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chai, GL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	zhuweiguo@bjmu.edu.cn	zhu, wei-guo/E-1334-2012; Zhou, Wen/A-5763-2010; Wu, Xin/B-2244-2010	Zhou, Wen/0000-0002-5496-5815; Yang, Yang/0000-0002-8737-590X; Zhu, Wei-Guo/0000-0001-8385-6581; Wang, Haiying/0000-0001-7729-0649	National Natural Science Foundation of China [30425017, 30670417, 30621002]; Ministry of Science and Technology of China [2005CB522403, 2006AA02Z101, 2006CB910300, B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study is supported by National Natural Science Foundation of China (No.30425017, 30670417 and 30621002), and grants (2005CB522403, 2006AA02Z101, 2006CB910300 and B07001) from the Ministry of Science and Technology of China.	Achanta G, 2001, CANCER RES, V61, P8723; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CANMAN CE, 1992, P NATL ACAD SCI USA, V89, P10474, DOI 10.1073/pnas.89.21.10474; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; Cline SD, 2003, NAT REV MOL CELL BIO, V4, P361, DOI 10.1038/nrm1101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Dai ZY, 2006, BIOCHEM BIOPH RES CO, V351, P455, DOI 10.1016/j.bbrc.2006.10.055; DINCALCI M, 1985, CANCER RES, V45, P3197; Dizdaroglu M, 1996, NUCLEIC ACIDS RES, V24, P418, DOI 10.1093/nar/24.3.418; Eggert A, 2001, CANCER RES, V61, P1314; ELLERHORST JA, 1993, BRIT J CANCER, V67, P209, DOI 10.1038/bjc.1993.41; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; FURTH JJ, 1968, CANCER RES, V28, P2061; Gomyo Y, 2004, ONCOGENE, V23, P6779, DOI 10.1038/sj.onc.1207381; GRAHAM FL, 1970, CANCER RES, V30, P2636; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Harada K, 2002, CANCER RES, V62, P5897; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Hurtubise A, 2006, CANCER CHEMOTH PHARM, V58, P618, DOI 10.1007/s00280-006-0225-6; INGRAHAM HA, 1980, CANCER RES, V40, P998; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LONN U, 1990, INT J CANCER, V45, P494, DOI 10.1002/ijc.2910450321; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Primeau M, 2003, INT J CANCER, V103, P177, DOI 10.1002/ijc.10789; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Steiner FA, 2005, ONCOGENE, V24, P2386, DOI 10.1038/sj.onc.1208376; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; VESELY J, 1977, CANCER RES, V37, P3684; Villar-Garea A, 2003, CANCER RES, V63, P4984; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Wang H, 2008, J BIOL CHEM, V283, P2564, DOI 10.1074/jbc.M702454200; WARNER HR, 1980, J BACTERIOL, V141, P680, DOI 10.1128/JB.141.2.680-686.1980; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970; Zhu WG, 2001, CANCER RES, V61, P1327; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	66	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2445	10.1371/journal.pone.0002445	http://dx.doi.org/10.1371/journal.pone.0002445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560576	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700030
J	Edelweiss, E; Balandin, TG; Ivanova, JL; Lutsenko, GV; Leonova, OG; Popenko, VI; Sapozhnikov, AM; Deyev, SM				Edelweiss, Evelina; Balandin, Taras G.; Ivanova, Julia L.; Lutsenko, Gennady V.; Leonova, Olga G.; Popenko, Vladimir I.; Sapozhnikov, Alexander M.; Deyev, Sergey M.			Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells	PLOS ONE			English	Article							RIBONUCLEASE INHIBITOR; CYTOTOXIC RIBONUCLEASE; GOLD PROBES; IN-VITRO; BARSTAR; SELECTION; ANTIBODY; VECTOR; RNA; SUSCEPTIBILITY	Background: RNases are currently studied as non-mutagenic alternatives to the harmful DNA-damaging anticancer drugs commonly used in clinical practice. Many mammalian RNases are not potent toxins due to the strong inhibition by ribonuclease inhibitor (RI) presented in the cytoplasm of mammalian cells. Methodology/Principal Findings: In search of new effective anticancer RNases we studied the effects of barnase, a ribonuclease from Bacillus amyloliquefaciens, on human cancer cells. We found that barnase is resistant to RI. In MTT cell viability assay, barnase was cytotoxic to human carcinoma cell lines with half-inhibitory concentrations (IC50) ranging from 0.2 to 13 mu M and to leukemia cell lines with IC50 values ranging from 2.4 to 82 mu M. Also, we characterized the cytotoxic effects of barnase-based immunoRNase scFv 4D5-dibarnase, which consists of two barnase molecules serially fused to the single-chain variable fragment (scFv) of humanized antibody 4D5 that recognizes the extracellular domain of cancer marker HER2. The scFv 4D5-dibarnase specifically bound to HER2-positive cells and was internalized via receptor-mediated endocytosis. The intracellular localization of internalized scFv 4D5-dibarnase was determined by electronic microscopy. The cytotoxic effect of scFv 4D5-dibarnase on HER2-positive human ovarian carcinoma SKOV-3 cells (IC50 = 1.8 nM) was three orders of magnitude greater than that of barnase alone. Both barnase and scFv 4D5-dibarnase induced apoptosis in SKOV-3 cells accompanied by internucleosomal chromatin fragmentation, membrane blebbing, the appearance of phosphatidylserine on the outer leaflet of the plasma membrane, and the activation of caspase-3. Conclusions/Significance: These results demonstrate that barnase is a potent toxic agent for targeting to cancer cells.	[Edelweiss, Evelina; Balandin, Taras G.; Lutsenko, Gennady V.; Sapozhnikov, Alexander M.; Deyev, Sergey M.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Ivanova, Julia L.; Leonova, Olga G.; Popenko, Vladimir I.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Deyev, Sergey M.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Edelweiss, E (corresponding author), Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	edelweiss.evelina@gmail.com; deyev@ibch.ru	Sapozhnikov, Alexander M/J-8704-2018; Lutsenko, Gennady/AAQ-2786-2021; Deyev, Sergey M/F-8191-2014	Deyev, Sergey M/0000-0002-3952-0631; Popenko, Vladimir/0000-0002-2108-0658; Sapozhnikov, Alexander/0000-0002-4934-677X	Russian Foundation for Basic research [07-02-00649, 07-04-00584, 06-04-49686-a]; SNSF [IB73AO-110842/1]; Program Molecular and Cell Biology RAS	Russian Foundation for Basic research(Russian Foundation for Basic Research (RFBR)); SNSF(Swiss National Science Foundation (SNSF)); Program Molecular and Cell Biology RAS	This work was supported by grants from the Russian Foundation for Basic research (Nos. 07-02-00649, 07-04-00584, 06-04-49686-a), SNSF (No. IB73AO-110842/1), and the Program Molecular and Cell Biology RAS.	Ardelt B, 2007, CELL CYCLE, V6, P3097, DOI 10.4161/cc.6.24.5045; Becerril B, 1999, BIOCHEM BIOPH RES CO, V255, P386, DOI 10.1006/bbrc.1999.0177; Bracale A, 2002, BIOCHEM J, V362, P553, DOI 10.1042/0264-6021:3620553; Chan SDH, 1996, ANAL BIOCHEM, V242, P214, DOI 10.1006/abio.1996.0455; CHO SW, 1989, ANAL BIOCHEM, V176, P175, DOI 10.1016/0003-2697(89)90289-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Choudhury A, 2004, Breast Dis, V20, P25; Colombo L, 1997, PLANT CELL, V9, P703, DOI 10.1105/tpc.9.5.703; Custers JBM, 1997, PLANT MOL BIOL, V35, P689, DOI 10.1023/A:1005846527674; De Lorenzo C, 2004, CANCER RES, V64, P4870; De Lorenzo C, 2002, FEBS LETT, V516, P208, DOI 10.1016/S0014-5793(02)02527-9; Dean GS, 1998, CLIN CANCER RES, V4, P2545; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Deyev SM, 1998, MOL GEN GENET, V259, P379, DOI 10.1007/s004380050825; DREXLER HG, 2001, MYELOID LEUKEMIA CEL, P632; Erickson HA, 2006, PROTEIN ENG DES SEL, V19, P37, DOI 10.1093/protein/gzi073; Fukumoto H, 1999, INT J CANCER, V82, P759, DOI 10.1002/(SICI)1097-0215(19990827)82:5<759::AID-IJC22>3.0.CO;2-H; Futami J, 2001, BIOCHEMISTRY-US, V40, P7518, DOI 10.1021/bi010248g; GOLDMAN MHS, 1994, EMBO J, V13, P2976, DOI 10.1002/j.1460-2075.1994.tb06596.x; Haigis MC, 2003, NUCLEIC ACIDS RES, V31, P1024, DOI 10.1093/nar/gkg163; Haigis MC, 2002, J BIOL CHEM, V277, P11576, DOI 10.1074/jbc.M112227200; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1972, PREP BIOCHEM, V2, P229; HARTLEY RW, 1997, RIBONUCLEASES STRUCT, P00051; Hellstrom I, 2001, CANCER RES, V61, P2420; Ilinskaya ON, 1997, TOXICOLOGY, V120, P55, DOI 10.1016/S0300-483X(97)03639-1; Iordanov MS, 2000, CANCER RES, V60, P1983; Johnson RJ, 2007, J MOL BIOL, V368, P434, DOI 10.1016/j.jmb.2007.02.005; Jucovic M, 1996, P NATL ACAD SCI USA, V93, P2343, DOI 10.1073/pnas.93.6.2343; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lanteri M, 2005, BREAST CANCER RES, V7, pR487, DOI 10.1186/bcr1034; Lee JE, 2008, BIODRUGS, V22, P53, DOI 10.2165/00063030-200822010-00006; Leland PA, 1998, P NATL ACAD SCI USA, V95, P10407, DOI 10.1073/pnas.95.18.10407; Leuchtenberger S, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.16.e76; LORENZO C, 2007, FEBS LETT, V581, P296; Makarov AA, 2003, FEBS LETT, V540, P15, DOI 10.1016/S0014-5793(03)00225-4; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEWTON DL, 1992, J BIOL CHEM, V267, P19572; NITTA K, 1994, CANCER RES, V54, P928; PRIOR TI, 1992, BIOCHEMISTRY-US, V31, P3555, DOI 10.1021/bi00129a001; Prior TI, 1996, BIOCONJUGATE CHEM, V7, P23, DOI 10.1021/bc9500655; Qin Q, 2005, J BIOCHEM MOL BIOL, V38, P41; Ragupathi G, 1996, CANCER IMMUNOL IMMUN, V43, P152, DOI 10.1007/s002620050316; RUSHIZKY GW, 1963, BIOCHEMISTRY-US, V2, P787, DOI 10.1021/bi00904a028; Rybak SM, 1999, EXP CELL RES, V253, P325, DOI 10.1006/excr.1999.4718; RYBAK SM, 1991, J BIOL CHEM, V266, P21202; Saxena SK, 2002, J BIOL CHEM, V277, P15142, DOI 10.1074/jbc.M108115200; Schreiber G, 2000, METH MOL B, V160, P213; Schulga A, 1998, PROTEIN ENG, V11, P775, DOI 10.1093/protein/11.9.775; Sevcik J, 2002, J BIOL CHEM, V277, P47325, DOI 10.1074/jbc.M208425200; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; SLOT JW, 1981, J CELL BIOL, V90, P533, DOI 10.1083/jcb.90.2.533; Smith MR, 1999, EXP CELL RES, V247, P220, DOI 10.1006/excr.1998.4317; Suzuki M, 1999, NAT BIOTECHNOL, V17, P265, DOI 10.1038/7010; UTSUGI T, 1991, CANCER RES, V51, P3062; Van Poucke K., 2001, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V66, P591; Viola M, 2005, INT J ONCOL, V27, P1071; Wang LC, 2001, P NATL ACAD SCI USA, V98, P7684, DOI 10.1073/pnas.121069998; Willuda J, 1999, CANCER RES, V59, P5758; WU YN, 1995, J BIOL CHEM, V270, P17476, DOI 10.1074/jbc.270.29.17476; WU YN, 1993, J BIOL CHEM, V268, P10686; Yang G, 2004, J BIOL CHEM, V279, P4339, DOI 10.1074/jbc.M311153200; Yazynin S, 1999, FEBS LETT, V452, P351, DOI 10.1016/S0014-5793(99)00661-4; Zelenikhin PV, 2005, MOL BIOL+, V39, P404, DOI 10.1007/s11008-005-0055-3	65	65	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2434	10.1371/journal.pone.0002434	http://dx.doi.org/10.1371/journal.pone.0002434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560598	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700019
J	Wood-Kaczmar, A; Gandhi, S; Yao, Z; Abramov, ASY; Miljan, EA; Keen, G; Stanyer, L; Hargreaves, I; Klupsch, K; Deas, E; Downward, J; Mansfield, L; Jat, P; Taylor, J; Heales, S; Duchen, MR; Latchman, D; Tabrizi, SJ; Wood, NW				Wood-Kaczmar, Alison; Gandhi, Sonia; Yao, Zhi; Abramov, Andrey S. Y.; Miljan, Erik A.; Keen, Gregory; Stanyer, Lee; Hargreaves, Iain; Klupsch, Kristina; Deas, Emma; Downward, Julian; Mansfield, Louise; Jat, Parmjit; Taylor, Joanne; Heales, Simon; Duchen, Michael R.; Latchman, David; Tabrizi, Sarah J.; Wood, Nicholas W.			PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons	PLOS ONE			English	Article							DROSOPHILA-PARKIN MUTANTS; OXIDATIVE STRESS; GENE-EXPRESSION; MUTATIONS; DISEASE; GLUTATHIONE; APOPTOSIS; INACTIVATION; DYSFUNCTION; PROTECTS	Parkinson's disease (PD) is a common age-related neurodegenerative disease and it is critical to develop models which recapitulate the pathogenic process including the effect of the ageing process. Although the pathogenesis of sporadic PD is unknown, the identification of the mendelian genetic factor PINK1 has provided new mechanistic insights. In order to investigate the role of PINK1 in Parkinson's disease, we studied PINK1 loss of function in human and primary mouse neurons. Using RNAi, we created stable PINK1 knockdown in human dopaminergic neurons differentiated from foetal ventral mesencephalon stem cells, as well as in an immortalised human neuroblastoma cell line. We sought to validate our findings in primary neurons derived from a transgenic PINK1 knockout mouse. For the first time we demonstrate an age dependent neurodegenerative phenotype in human and mouse neurons. PINK1 deficiency leads to reduced long-term viability in human neurons, which die via the mitochondrial apoptosis pathway. Human neurons lacking PINK1 demonstrate features of marked oxidative stress with widespread mitochondrial dysfunction and abnormal mitochondrial morphology. We report that PINK1 plays a neuroprotective role in the mitochondria of mammalian neurons, especially against stress such as staurosporine. In addition we provide evidence that cellular compensatory mechanisms such as mitochondrial biogenesis and upregulation of lysosomal degradation pathways occur in PINK1 deficiency. The phenotypic effects of PINK1 loss-of function described here in mammalian neurons provides mechanistic insight into the age-related degeneration of nigral dopaminergic neurons seen in PD.	[Wood-Kaczmar, Alison; Gandhi, Sonia; Yao, Zhi; Stanyer, Lee; Deas, Emma; Heales, Simon; Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Gandhi, Sonia; Latchman, David] Inst Child Hlth, Med Mol Biol Unit, London, England; [Abramov, Andrey S. Y.; Duchen, Michael R.] UCL, Dept Physiol, London, England; [Miljan, Erik A.] ReNeuron Ltd, Guildford, Surrey, England; [Keen, Gregory; Taylor, Joanne] Eisai London Res Lab Ltd, London, England; [Hargreaves, Iain; Heales, Simon] Natl Hosp Neurol & Neurosurg, Neurometabol Unit, London, England; [Klupsch, Kristina; Downward, Julian] Canc Res United Kingdom, London, England; [Mansfield, Louise; Jat, Parmjit; Tabrizi, Sarah J.] Inst Neurol, Dept Neurodegenerat Dis, London, England; [Latchman, David] Univ London, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Eisai Co Ltd; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Cancer Research UK; University of London; University College London; University of London; University College London; University of London	Wood-Kaczmar, A (corresponding author), Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucl.ac.uk	Downward, Julian/A-3251-2012; Hargreaves, Iain/AAJ-6757-2020; Abramov, Andrey Y/H-9053-2012; Deas, Emma/A-6755-2010; Wood, Nicholas W/C-2505-2009; duchen, michael/A-2116-2009; Miljan, Erik/AAH-7424-2020; Abramov, Andrey/AAC-6712-2019; Yao, Zhi/B-9047-2013; YAO, Zhi/C-6096-2009; Waldvogel, Henry/D-6691-2012	Abramov, Andrey Y/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; duchen, michael/0000-0003-2548-4294; Abramov, Andrey/0000-0002-7646-7235; Yao, Zhi/0000-0001-6432-5734; Downward, Julian/0000-0002-2331-4729; Tabrizi, Sarah/0000-0003-2716-2045; Waldvogel, Henry/0000-0003-2165-8568	MRC UK; Wellcome Trust [research Training Fellowship]; MRC [G0601943, G0400000, G0700877] Funding Source: UKRI; Medical Research Council [G0400000, G0700877, G0601943] Funding Source: researchfish	MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MRC UK program grant, Wellcome Trust research Training Fellowship	Abou-Sleiman PM, 2006, ANN NEUROL, V60, P414, DOI 10.1002/ana.20960; Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; BOGAERTS V, 2007, GENES BRAIN BEHAV; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Clark IE, 2006, NATURE; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; GANDHI S, 2006, BRAIN; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074; Grunewald A, 2007, NEUROGENETICS, V8, P103, DOI 10.1007/s10048-006-0072-y; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Ibanez P, 2006, BRAIN, V129, P686, DOI 10.1093/brain/awl005; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; PARK J, 2006, NATURE; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; PLUNFAVREAU H, 2007, NAT CELL BIOL; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Taymans JM, 2006, J NEUROCHEM, V98, P951, DOI 10.1111/j.1471-4159.2006.03919.x; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; WANG HL, 2007, NEUROBIOL DIS; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhou HX, 2007, INT J BIOL SCI, V3, P242; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	63	264	274	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2455	10.1371/journal.pone.0002455	http://dx.doi.org/10.1371/journal.pone.0002455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560593	Green Published, Green Accepted, gold			2022-12-27	WOS:000263280700037
J	Xin, DD; Hu, L; Kong, XY				Xin, Dedong; Hu, Landian; Kong, Xiangyin			Alternative Promoters Influence Alternative Splicing at the Genomic Level	PLOS ONE			English	Article								Background: More and more experiments have shown that transcription and mRNA processing are not two independent events but are tightly coupled to each other. Both promoter and transcription rate were found to influence alternative splicing. More than half of human genes have alternative promoters, but it is still not clear why there are so many alternative promoters and what their biological roles are. Methodology/Principal Findings: In this study, we explored whether there is a functional correlation between alternative promoters and alternative splicing by a genome-wide analysis of human and mouse genes. We constructed a large data set of genes with alternative promoter and alternative splicing annotations. By analyzing these genes, we showed that genes with alternative promoters tended to demonstrate alternative splicing compare to genes with single promoter, and, genes with more alternative promoters tend to have more alternative splicing variants. Furthermore, transcripts from different alternative promoters tended to splice differently. Conclusions/Significance: Thus at the genomic level, alternative promoters are positively correlated with alternative splicing.	[Xin, Dedong; Hu, Landian; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xin, Dedong; Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Xin, DD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	xykong@sibs.ac.cn			National High Technology Research and Development Program of China [2006AA02Z330, 2006AA02A301]; National Basic Research Program of China [2007CB512202, 2007CB512100, 2004CB518603]; China Postdoctoral Science Foundation [20060400685]; National Natural Science Foundation of China, Key Program [30530450]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-74]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China, Key Program(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work is supported by the National High Technology Research and Development Program of China (863 Pro-gram) (2006AA02Z330, 2006AA02A301), the National Basic Research Program of China (973 program) (No. 2007CB512202, 2007CB512100, 2004CB518603), the China Postdoctoral Science Foundation (NO.20060400685), the National Natural Science Foundation of China, Key Program (No.30530450), and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX1-YW-R-74).	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Jiang ZH, 2000, MOL CELL BIOL, V20, P4036, DOI 10.1128/MCB.20.11.4036-4048.2000; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2; Kim N, 2005, GENOME RES, V15, P566, DOI 10.1101/gr.3030405; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2003, J VIROL, V77, P7459, DOI 10.1128/JVI.77.13.7459-7466.2003; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Venables JP, 2002, CURR OPIN GENET DEV, V12, P615, DOI 10.1016/S0959-437X(02)00347-7; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	36	48	52	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2377	10.1371/journal.pone.0002377	http://dx.doi.org/10.1371/journal.pone.0002377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560582	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700002
J	Li, SF; Li, JH; Cheng, J; Zhou, BR; Tong, X; Dong, XB; Wang, ZX; Hu, QG; Chen, M; Hua, ZC				Li, Shufeng; Li, Jiahuang; Cheng, Jian; Zhou, Bingrong; Tong, Xin; Dong, Xiangbai; Wang, Zixing; Hu, Qingang; Chen, Meng; Hua, Zi-Chun			Non-Syndromic Tooth Agenesis in Two Chinese Families Associated with Novel Missense Mutations in the TNF Domain of EDA (Ectodysplasin A)	PLOS ONE			English	Article								Here we report two unrelated Chinese families with congenital missing teeth inherited in an X-linked manner. We mapped the affected locus to chromosome Xp11-Xq21 in one family. In the defined region, both families were found to have novel missense mutations in the ectodysplasin-A (EDA) gene. The mutation of c.947A > G caused the D316G substitution of the EDA protein. The mutation of c.1013C > T found in the other family resulted in the Thr to Met mutation at position 338 of EDA. The EDA gene has been reported responsible for X-linked hypohidrotic ectodermal dysplasia (XLHED) in humans characterized by impaired development of hair, eccrine sweat glands, and teeth. In contrast, all the affected individuals in the two families that we studied here had normal hair and skin. Structural analysis suggests that these two novel mutants may account for the milder phenotype by affecting the stability of EDA trimers. Our results indicate that these novel missense mutations in EDA are associated with the isolated tooth agenesis and provide preliminary explanation for the abnormal clinical phenotype at a molecular structural level.	[Li, Shufeng; Li, Jiahuang; Cheng, Jian; Zhou, Bingrong; Tong, Xin; Dong, Xiangbai; Wang, Zixing; Hu, Qingang; Chen, Meng; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing Stomatol Hosp, Nanjing 210008, Peoples R China	Nanjing University	Li, SF (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing Stomatol Hosp, Nanjing 210008, Peoples R China.	zchua@nju.edu.cn			Chinese National Nature Sciences Foundation [30730030, 30425009]; Jiangsu Provincial Nature Sciences Foundation [BK2007715]	Chinese National Nature Sciences Foundation; Jiangsu Provincial Nature Sciences Foundation	The project was supported by grants from the Chinese National Nature Sciences Foundation (30730030, 30425009) and Jiangsu Provincial Nature Sciences Foundation (BK2007715) to Zi-Chun Hua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz S, 1993, J Clin Pediatr Dent, V17, P105; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Elomaa O, 2001, HUM MOL GENET, V10, P953, DOI 10.1093/hmg/10.9.953; Ezer S, 1999, HUM MOL GENET, V8, P2079, DOI 10.1093/hmg/8.11.2079; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Jumlongras D, 2004, HUM GENET, V114, P242, DOI 10.1007/s00439-003-1066-6; Kapadia H, 2006, EUR J HUM GENET, V14, P403, DOI 10.1038/sj.ejhg.5201574; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; MACKENZIE A, 1991, DEVELOPMENT, V111, P269; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; SLAVKIN HC, 1998, MOL BASIS EPITHELIAL, P15; Stimson J M, 1997, J Clin Pediatr Dent, V21, P269; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tao R, 2006, J HUM GENET, V51, P498, DOI 10.1007/s10038-006-0389-2; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Vieira AR, 2003, J DENT RES, V82, P162, DOI 10.1177/154405910308200303; Visinoni AF, 2003, AM J MED GENET A, V122A, P51, DOI 10.1002/ajmg.a.20276	31	28	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2396	10.1371/journal.pone.0002396	http://dx.doi.org/10.1371/journal.pone.0002396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545687	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800034
J	Tsakiridu, DO; Vidal, AF; Valdes, FV; Llaneza, MLJ; Uria, JAV; Rodriguez, MC; Sanchez, CL; Folgosa, MB; Ollero, MJF				Ojer Tsakiridu, Domingo; Franco Vidal, Amalia; Vazquez Valdes, Fernando; Junquera Llaneza, Maria Luisa; Varela Uria, Jose Antonio; Cuesta Rodriguez, Mar; Lopez Sanchez, Carmen; Busto Folgosa, Margarita; Fernandez Ollero, Maria Jesus			Factors Associated with Induced Abortion in Women Prostitutes in Asturias (Spain)	PLOS ONE			English	Article							SEX WORKERS; CONDOM PROMOTION; TRIAL; CONTRACEPTION; MADAGASCAR; CLIENTS; NEED	Background: The aim is to investigate the factors that might be associated with the presence of induced abortion (IA) in women prostitutes in Asturias (Spain). Methodology/Principal Findings: Cross-sectional descriptive study by self-completion questionnaire of 212 women prostitutes who attended the three Sexually Transmitted Disease Clinics in Asturias, between January-December 2003. The questionnaire was designed to investigate the women's perceived knowledge (what they claimed to know), their real knowledge (what they really knew), the use of contraceptive methods and socio-demographic variables. Multivariate analysis was carried out. 92% of the participants were immigrants. 76% were practising at brothel. 37.6% (95% CI: 30.7-44.4%) reported to have undergone at least one IA during their life. According to the logistic regression the "presence of IA'' was directly associated with the variables "number of pregnancies''(OR:65.82;95%IC:7.73-560.14) and "years of practising prostitution''(OR:1.13;95%CI:0.99-1.29);and inversely associated with "children''(0=no children; 1=one or more children; OR:0.005;95%CI:0.000-0.057), "women's age''(OR:0.89;95%CI:0.82-0.97) and "real contraceptive knowledge''(OR:0.50;95%CI:0.34-0.75). Married women wer(e) more likely to have undergone an IA (OR:2.74;95%IC:1.05-7.13). No association with "perceived contraceptive knowledge'' was found. Conclusions/Significance: The characteristics more closely linked to the reproductive history of the women (such as "pregnancies'', "children''), together with the "real contraceptive knowledge'' and the "time practising prostitution'' explain the presence of IA better than factors more closely linked to the conditions in which the women practise prostitution ("place of activity'', "other activities compatible with prostitution'', "use of safe method in commercial relation''). It is possible that IA is being used as a birth control method, hypothesis suggested by the inverse association observed between the variable "children'' and the "presence of IA''. Therefore, the promotion of the use of safe contraceptive methods should be a high-priority. If the real contraceptive knowledge was measured correctly, all strategies to increase it would be justified because it was inversely associated with the presence of IA.	[Ojer Tsakiridu, Domingo] Ctr Salud La Felguera, La Felguera, Spain; [Franco Vidal, Amalia] Hosp Univ Cent Asturias, Serv Calidad, Oviedo, Spain; [Vazquez Valdes, Fernando] Hosp Monte Naranco, Serv Microbiol, Oviedo, Spain; [Junquera Llaneza, Maria Luisa; Cuesta Rodriguez, Mar] Hosp Monte Naranco, Unidad ITS, Oviedo, Spain; [Varela Uria, Jose Antonio; Lopez Sanchez, Carmen] Ambulatorio Pumarin, Unidad ITS, Gijon, Spain; [Busto Folgosa, Margarita; Fernandez Ollero, Maria Jesus] CEREDA, Med Mundo Asturias, Oviedo, Spain	Central University Hospital Asturias	Tsakiridu, DO (corresponding author), Ctr Salud La Felguera, La Felguera, Spain.	domingoelena@telefonica.net	Vazquez, Fernando/ABG-7531-2020					Belza María José, 2004, Gac Sanit, V18, P177, DOI 10.1157/13063093; Chakraborty A. K., 1994, Journal of Communicable Diseases, V26, P161; *CONS SAN SERV SOC, 1995, PLAN SAL AST; CORTINA JB, 1996, BALACH CORTINA JDOCU, P159; Delvaux T, 2003, REPROD HEALTH MATTER, V11, P88, DOI 10.1016/S0968-8080(03)02163-3; Elmore-Meegan M, 2004, REPROD HEALTH MATTER, V12, P50, DOI 10.1016/S0968-8080(04)23125-1; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Feldblum PJ, 2005, SEX TRANSM INFECT, V81, P166, DOI 10.1136/sti.2004.010074; FORTUNY A, 1998, OBSTETRICIA, P283; *GAB EST SOC, 1992, COND VID PROST AST C; Geelhoed DW, 2002, TROP MED INT HEALTH, V7, P708, DOI 10.1046/j.1365-3156.2002.00912.x; *GOB PRINC AST, 2000, PLAN SAL AST OBJ IND; Guillaume A, 2002, INT FAM PLAN PERSPEC, V28, P159, DOI 10.2307/3088259; Hoke TH, 2007, SEX TRANSM INFECT, V83, P448, DOI 10.1136/sti.2006.024612; *I NAC EST, 1999, ENC FEC AF 1999; Ikechebelu J I, 2005, J Obstet Gynaecol, V25, P792, DOI 10.1080/01443610500328231; JIMENEZ RA, 1999, ESTUDIO PROSTITUCION; *MIN SAN CONS, 2000, DIR GEN SAL PUBL CON; MOLINA R, 2001, ABORTION DEV WORD, P57; Okunlola M A, 2006, J Obstet Gynaecol, V26, P353, DOI 10.1080/01443610600613516; Orji EO, 2005, EUR J CONTRACEP REPR, V10, P244, DOI 10.1080/08927010500241767; PAIEWONSKY D, 2001, ABORTION DEV WORD, P131; Pal D., 2003, Journal of Communicable Diseases, V35, P90; PEDROSA JLB, 1999, THESIS U BARCELONA; PICKERING H, 1992, SOC SCI MED, V34, P75, DOI 10.1016/0277-9536(92)90069-3; SANCHEZ GL, 1992, IMPULSO, V27, P14; SHAH HI, 1999, ANN TECHNICAL REPOT, P239; VANWESENBEECK I, 2001, ANN REW SEX RES, V10, P242; Verster A, 2001, AIDS CARE, V13, P367, DOI 10.1080/09540120120044017; ZAMUDIO L, 2001, ABORTION DEV WORD, P407; 1994, PROG HUM REPROD RES, V29, P6; 2003, PLAN SALUD ASTURIAS	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2358	10.1371/journal.pone.0002358	http://dx.doi.org/10.1371/journal.pone.0002358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523646	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300045
J	Lafourcade, C; Sobo, K; Kieffer-Jaquinod, S; Garin, J; van der Goot, FG				Lafourcade, Celine; Sobo, Komla; Kieffer-Jaquinod, Sylvie; Garin, Jerome; van der Goot, F. Gisou			Regulation of the V-ATPase along the Endocytic Pathway Occurs through Reversible Subunit Association and Membrane Localization	PLOS ONE			English	Article								The lumen of endosomal organelles becomes increasingly acidic when going from the cell surface to lysosomes. Luminal pH thereby regulates important processes such as the release of internalized ligands from their receptor or the activation of lysosomal enzymes. The main player in endosomal acidification is the vacuolar ATPase (V-ATPase), a multi-subunit transmembrane complex that pumps protons from the cytoplasm to the lumen of organelles, or to the outside of the cell. The active V-ATPase is composed of two multi-subunit domains, the transmembrane V(0) and the cytoplasmic V(1). Here we found that the ratio of membrane associated V(1)/Vo varies along the endocytic pathway, the relative abundance of V(1) being higher on late endosomes than on early endosomes, providing an explanation for the higher acidity of late endosomes. We also found that all membrane-bound V-ATPase subunits were associated with detergent resistant membranes (DRM) isolated from late endosomes, raising the possibility that association with lipid-raft like domains also plays a role in regulating the activity of the proton pump. In support of this, we found that treatment of cells with U18666A, a drug that leads to the accumulation of cholesterol in late endosomes, affected acidification of late endosome. Altogether our findings indicate that the activity of the vATPase in the endocytic pathway is regulated both by reversible association/dissociation and the interaction with specific lipid environments.	[Lafourcade, Celine; Sobo, Komla; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Kieffer-Jaquinod, Sylvie; Garin, Jerome] INSERM U880, Lab Etude Dynamique Proteomes, IRTSV, CEA, DSV, Grenoble, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lafourcade, C (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X	Swiss National Science foundation; Novartis Consumer Health Foundation; Roche Research Foundation [post-doctoral fellowship]; Howard Hughes Medical Institute [International Fellow]	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Consumer Health Foundation; Roche Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Swiss National Science foundation and from a grant from Novartis Consumer Health Foundation to G.v.d.G. C.L is a recipient of a Roche Research Foundation post-doctoral fellowship. G.v.d.G is an international Fellow of the Howard Hughes Medical Institute.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Blonder J, 2004, ELECTROPHORESIS, V25, P1307, DOI 10.1002/elps.200405891; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Brown D, 2000, J EXP BIOL, V203, P137; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Dawson K, 2008, EUKARYOT CELL, V7, P926, DOI 10.1128/EC.00037-08; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Dixon N, 2004, BBA-BIOMEMBRANES, V1665, P177, DOI 10.1016/j.bbamem.2004.08.001; Dixon N, 2008, BIOPHYS J, V94, P506, DOI 10.1529/biophysj.107.111781; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; HINTON A, 2007, V ATPASE FUNCTIONS N; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 2007, J BIOENERG BIOMEMBR; Karsan A, 2005, J PROTEOME RES, V4, P349, DOI 10.1021/pr049824w; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; MARSHANSKY V, 2008, CURR OPIN CELL BIOL; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Roy CR, 2005, NAT IMMUNOL, V6, P546, DOI 10.1038/ni0605-546; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van der Goot FG, 1997, ELECTROPHORESIS, V18, P2689, DOI 10.1002/elps.1150181426; Van Dyke Rebecca W, 2004, BMC Physiol, V4, P1, DOI 10.1186/1472-6793-4-1; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yoshinaka K, 2004, NEUROSCI LETT, V363, P168, DOI 10.1016/j.neulet.2004.04.002	74	136	141	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2758	10.1371/journal.pone.0002758	http://dx.doi.org/10.1371/journal.pone.0002758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648502	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900028
J	Matz, C; Webb, JS; Schupp, PJ; Phang, SY; Penesyan, A; Egan, S; Steinberg, P; Kjelleberg, S				Matz, Carsten; Webb, Jeremy S.; Schupp, Peter J.; Phang, Shui Yen; Penesyan, Anahit; Egan, Suhelen; Steinberg, Peter; Kjelleberg, Staffan			Marine Biofilm Bacteria Evade Eukaryotic Predation by Targeted Chemical Defense	PLOS ONE			English	Article								Many plants and animals are defended from predation or herbivory by inhibitory secondary metabolites, which in the marine environment are very common among sessile organisms. Among bacteria, where there is the greatest metabolic potential, little is known about chemical defenses against bacterivorous consumers. An emerging hypothesis is that sessile bacterial communities organized as biofilms serve as bacterial refuge from predation. By testing growth and survival of two common bacterivorous nanoflagellates, we find evidence that chemically mediated resistance against protozoan predators is common among biofilm populations in a diverse set of marine bacteria. Using bioassay-guided chemical and genetic analysis, we identified one of the most effective antiprotozoal compounds as violacein, an alkaloid that we demonstrate is produced predominately within biofilm cells. Nanomolar concentrations of violacein inhibit protozoan feeding by inducing a conserved eukaryotic cell death program. Such biofilm-specific chemical defenses could contribute to the successful persistence of biofilm bacteria in various environments and provide the ecological and evolutionary context for a number of eukaryote-targeting bacterial metabolites.	[Matz, Carsten; Phang, Shui Yen; Penesyan, Anahit; Egan, Suhelen; Kjelleberg, Staffan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Matz, Carsten] Helmholtz Ctr Infect Res, Div Cell a& Immune Biol, Braunschweig, Germany; [Webb, Jeremy S.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Schupp, Peter J.] Univ Guam, Marine Lab, Mangilao, GU USA; [Steinberg, Peter] Univ New S Wales, Ctr Marine BioInnovat, Sch Biol, Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Helmholtz Association; Helmholtz-Center for Infection Research; University of Southampton; University of Guam; University of New South Wales Sydney	Matz, C (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	carsten.matz@helmholtz-hzi.de	Schupp, Peter j/D-3296-2015; Kjelleberg, Staffan/AAB-4641-2020; Kjelleberg, Staffan/C-9229-2015; Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012	Kjelleberg, Staffan/0000-0003-4271-6413; Kjelleberg, Staffan/0000-0003-4271-6413; Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Webb, Jeremy/0000-0003-2068-8589; Egan, Suhelen/0000-0003-3286-4279; Schupp, Peter Josef/0000-0003-4831-2751; Steinberg, Peter/0000-0002-1781-0726	German Research Foundation; Alexander von Humboldt Foundation; Australian Research Council; Australian Cooperative Research Centre for Environmental Biotechnology; Centre for Marine Bio-Innovation of the University of New South Wales	German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Australian Research Council(Australian Research Council); Australian Cooperative Research Centre for Environmental Biotechnology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Centre for Marine Bio-Innovation of the University of New South Wales	This research was supported by grants from the German Research Foundation (to C.M.), the Alexander von Humboldt Foundation (to P.J.S.), the Australian Research Council (to S.K.), the Australian Cooperative Research Centre for Environmental Biotechnology (to S.K. and C.M.) and by the Centre for Marine Bio-Innovation of the University of New South Wales.	August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; CHRZANOWSKI TH, 1990, LIMNOL OCEANOGR, V35, P1429, DOI 10.4319/lo.1990.35.7.1429; CORPE WA, 1953, J BACTERIOL, V66, P470, DOI 10.1128/JB.66.4.470-477.1953; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Egan S, 2002, ENVIRON MICROBIOL, V4, P433, DOI 10.1046/j.1462-2920.2002.00322.x; Egan S, 2000, ENVIRON MICROBIOL, V2, P343, DOI 10.1046/j.1462-2920.2000.00107.x; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; FENCHEL T, 1987, ECOLOGY PROTOZOA BIO; Ferreira CV, 2004, BLOOD, V104, P1459, DOI 10.1182/blood-2004-02-0594; Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P25; Halda-Alija L, 1999, CAN J MICROBIOL, V45, P879, DOI 10.1139/cjm-45-10-879; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hay ME, 2002, J CHEM ECOL, V28, P2001, DOI 10.1023/A:1020797827806; HAY ME, 1988, ANNU REV ECOL SYST, V19, P111, DOI 10.1146/annurev.es.19.110188.000551; Hild E, 2000, J BACTERIOL, V182, P6964, DOI 10.1128/JB.182.24.6964-6974.2000; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; JENSEN PR, 1994, ANNU REV MICROBIOL, V48, P559, DOI 10.1146/annurev.mi.48.100194.003015; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kiorboe T, 2003, APPL ENVIRON MICROB, V69, P3036, DOI 10.1128/AEM.69.6.3036-3047.2003; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Longford SR, 2007, AQUAT MICROB ECOL, V48, P217, DOI 10.3354/ame048217; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Nakamura Y, 2002, BIOCHEM ENG J, V12, P79, DOI 10.1016/S1369-703X(02)00079-7; Parry JD, 2004, ADV APPL MICROBIOL, V54, P167, DOI 10.1016/S0065-2164(04)54007-8; PATTERSON DJ, FLAGELLATES UNITY DI, P269; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Pernthaler J, 1996, AQUAT MICROB ECOL, V10, P255, DOI 10.3354/ame010255; Rao D, 2007, APPL ENVIRON MICROB, V73, P7844, DOI 10.1128/AEM.01543-07; Rao D, 2006, APPL ENVIRON MICROB, V72, P5547, DOI 10.1128/AEM.00449-06; Rhoades D.F., 1979, HERBIVORES THEIR INT, P1; RIVEROS R, 1988, ARQ BIOL TECNOL, V31, P475; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; VAATANEN P, 1976, W A DENOTTBECK F SCI, V1, P1; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x	51	146	150	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2744	10.1371/journal.pone.0002744	http://dx.doi.org/10.1371/journal.pone.0002744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648491	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000264302900015
J	Barribeau, SM; Villinger, J; Waldman, B				Barribeau, Seth M.; Villinger, Jandouwe; Waldman, Bruce			Major Histocompatibility Complex Based Resistance to a Common Bacterial Pathogen of Amphibians	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; EMERGING INFECTIOUS-DISEASE; CLASS IIB ALLELES; IMMUNE-SYSTEM; AEROMONAS-HYDROPHILA; FITNESS CONSEQUENCES; POPULATION DECLINES; MHC POLYMORPHISM; SIZE VARIABILITY; ATLANTIC SALMON	Given their well-developed systems of innate and adaptive immunity, global population declines of amphibians are particularly perplexing. To investigate the role of the major histocompatibilty complex (MHC) in conferring pathogen resistance, we challenged Xenopus laevis tadpoles bearing different combinations of four MHC haplotypes (f, g, j, and r) with the bacterial pathogen Aeromonas hydrophila in two experiments. In the first, we exposed ff, fg, gg, gj, and jj tadpoles, obtained from breeding MHC homozygous parents, to one of three doses of A. hydrophila or heat-killed bacteria as a control. In the second, we exposed ff, fg, fr, gg, rg, and rr tadpoles, obtained from breeding MHC heterozygous parents and subsequently genotyped by PCR, to A. hydrophila, heat-killed bacteria or media alone as controls. We thereby determined whether the same patterns of MHC resistance emerged within as among families, independent of non-MHC heritable differences. Tadpoles with r or g MHC haplotypes were more likely to die than were those with f or j haplotypes. Growth rates varied among MHC types, independent of exposure dose. Heterozygous individuals with both susceptible and resistant haplotypes were intermediate to either homozygous genotype in both size and survival. The effect of the MHC on growth and survival was consistent between experiments and across families. MHC alleles differentially confer resistance to, or tolerance of, the bacterial pathogen, which affects tadpoles' growth and survival.	[Barribeau, Seth M.; Villinger, Jandouwe; Waldman, Bruce] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	University of Canterbury	Barribeau, SM (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	seth.barribeau@emory.edu; jandouwe@gmail.com; waldmanb@lincoln.ac.nz	Waldman, Bruce/A-1269-2009; Barribeau, Seth M/C-3977-2011; Villinger, Jandouwe/ABH-2172-2020	Waldman, Bruce/0000-0003-0006-5333; Barribeau, Seth M/0000-0001-6643-0562; Villinger, Jandouwe/0000-0002-5097-6605	Marsden Grant of New Zealand	Marsden Grant of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by the Marsden Grant of New Zealand (to BW). No funding agency was involved in the design or interpretation of this study.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; BROCKELMAN WY, 1969, ECOLOGY, V50, P632, DOI 10.2307/1936252; Carey C, 2000, ENVIRON HEALTH PERSP, V108, P143, DOI 10.2307/3454639; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; CRUMP ML, 1981, AM NAT, V117, P724, DOI 10.1086/283755; CRUMP ML, 1984, COPEIA, P302, DOI 10.2307/1445185; Cunningham AA, 1996, PHILOS T ROY SOC B, V351, P1539, DOI 10.1098/rstb.1996.0140; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Dziminski MA, 2006, J EVOLUTION BIOL, V19, P144, DOI 10.1111/j.1420-9101.2005.00978.x; Dziminski MA, 2005, OECOLOGIA, V146, P98, DOI 10.1007/s00442-005-0177-2; Edwards Scott V., 1996, P214; Flajnik MF, 1999, J IMMUNOL, V163, P3826; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; FRYE FL, 1985, J AM VET MED ASSOC, V187, P1223; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Gervasi SS, 2008, FUNCT ECOL, V22, P100, DOI 10.1111/j.1365-2435.2007.01340.x; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; HAZEN TC, 1978, APPL ENVIRON MICROB, V36, P731, DOI 10.1128/AEM.36.5.731-738.1978; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HIRD DW, 1981, LAB ANIM SCI, V31, P166; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; HUGHES AL, 1991, CONSERV BIOL, V5, P249, DOI 10.1111/j.1523-1739.1991.tb00130.x; KAPLAN RH, 1984, AM NAT, V123, P393, DOI 10.1086/284211; KAPLAN RH, 1980, EVOLUTION, V34, P51, DOI 10.1111/j.1558-5646.1980.tb04788.x; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Lewis K, 1998, J THEOR BIOL, V193, P359, DOI 10.1006/jtbi.1998.0725; Linder G, 2003, AMPHIBIAN DECLINE IN; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Liu Y, 2002, DEV COMP IMMUNOL, V26, P735, DOI 10.1016/S0145-305X(02)00034-4; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Mauel MJ, 2002, J VET DIAGN INVEST, V14, P431, DOI 10.1177/104063870201400515; McClelland EE, 2003, INFECT IMMUN, V71, P2079, DOI 10.1128/IAI.71.4.2079-2086.2003; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Miller KM, 2004, ENVIRON BIOL FISH, V69, P307, DOI 10.1023/B:EBFI.0000022874.48341.0f; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; NYMAN S, 1986, J HERPETOL, V20, P196, DOI 10.2307/1563944; Pearman PB, 2004, J WILDLIFE DIS, V40, P660, DOI 10.7589/0090-3558-40.4.660; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rollins-Smith LA, 2006, DEV COMP IMMUNOL, V30, P831, DOI 10.1016/j.dci.2005.10.005; RUSSELL FH, 1898, JAMA-J AM MED ASSOC, V30, P1442; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamouza R, 2002, HUM IMMUNOL, V63, P194, DOI 10.1016/S0198-8859(01)00378-0; Taylor Sharon K., 2001, P159; Taylor SK, 1999, J WILDLIFE DIS, V35, P536, DOI 10.7589/0090-3558-35.3.536; Todd BD, 2007, AM NAT, V170, P793, DOI 10.1086/521958; TRAVIS J, 1984, ECOLOGY, V65, P1155, DOI 10.2307/1938323; VILLINGER J, 2007, THESIS U CANTERBURY; Villinger J, 2008, P ROY SOC B-BIOL SCI, V275, P1225, DOI 10.1098/rspb.2008.0022; Waldman B, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P394; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; WILBUR HM, 1982, ECOLOGY, V63, P278, DOI 10.2307/1938942; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; WILBUR HM, 1976, ECOLOGY, V57, P1289, DOI 10.2307/1935053	80	35	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2692	10.1371/journal.pone.0002692	http://dx.doi.org/10.1371/journal.pone.0002692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629002	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200035
J	Genoud, T; Cruz, MTS; Kulisic, T; Sparla, F; Fankhauser, C; Metraux, JP				Genoud, Thierry; Cruz, Marcela Trevino Santa; Kulisic, Tea; Sparla, Francesca; Fankhauser, Christian; Metraux, Jean-Pierre			The Protein Phosphatase 7 Regulates Phytochrome Signaling in Arabidopsis	PLOS ONE			English	Article							BLUE-LIGHT RECEPTORS; TRANSCRIPTION FACTOR; CROSS-TALK; PP7; CRYPTOCHROME; GENE; PHOTORECEPTORS; TRANSDUCTION; EXPRESSION; RESPONSES	The psi2 mutant of Arabidopsis displays amplification of the responses controlled by the red/far red light photoreceptors phytochrome A (phyA) and phytochrome B (phyB) but no apparent defect in blue light perception. We found that loss-of-function alleles of the protein phosphatase 7 (AtPP7) are responsible for the light hypersensitivity in psi2 demonstrating that AtPP7 controls the levels of phytochrome signaling. Plants expressing reduced levels of AtPP7 mRNA display reduced blue-light induced cryptochrome signaling but no noticeable deficiency in phytochrome signaling. Our genetic analysis suggests that phytochrome signaling is enhanced in the AtPP7 loss of function alleles, including in blue light, which masks the reduced cryptochrome signaling. AtPP7 has been found to interact both in yeast and in planta assays with nucleotide-diphosphate kinase 2 (NDPK2), a positive regulator of phytochrome signals. Analysis of ndpk2-psi2 double mutants suggests that NDPK2 plays a critical role in the AtPP7 regulation of the phytochrome pathway and identifies NDPK2 as an upstream element involved in the modulation of the salicylic acid (SA)-dependent defense pathway by light. Thus, cryptochrome-and phytochrome-specific light signals synchronously control their relative contribution to the regulation of plant development. Interestingly, PP7 and NDPK are also components of animal light signaling systems.	[Genoud, Thierry; Fankhauser, Christian] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Cruz, Marcela Trevino Santa] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL USA; [Kulisic, Tea] Univ Split, Fac Chem Technol, Dept Biochem, Split, Croatia; [Sparla, Francesca] Univ Bologna, Dept Biol, Lab Plant Physiol, Bologna, Italy; [Metraux, Jean-Pierre] Univ Fribourg, Dept Biol, Unit Plant Biol, Fribourg, Switzerland	University of Lausanne; State University System of Florida; Florida Gulf Coast University; University of Split; University of Bologna; University of Fribourg	Genoud, T (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	thierry.genoud@unil.ch	Fankhauser, Christian/C-4291-2018; Bilusic, Tea/E-2689-2017; Metraux, Jean-Pierre JP/C-1111-2012; Fankhauser, Christian/ABE-8757-2021	Fankhauser, Christian/0000-0003-4719-5901; Bilusic, Tea/0000-0001-8834-9562; Fankhauser, Christian/0000-0003-4719-5901; Sparla, Francesca/0000-0002-2103-4870	Swiss National Science Foundation [3100A0-104224]; HFSP [RGY0016/2004-C]; Swiss Federal Commission of Scholarships for Foreign Students	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HFSP(Human Frontier Science Program); Swiss Federal Commission of Scholarships for Foreign Students	Swiss National Science Foundation (grant 3100A0-104224 to J.P.M.) HFSP (grant RGY0016/2004-C to C.F.) Swiss Federal Commission of Scholarships for Foreign Students	Andreeva AV, 1998, BIOCHEM MOL BIOL INT, V44, P703; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BECKER DM, 1994, CURRENT PROTOCOLS MO; Bolter B, 2007, PLANTA, V226, P1059, DOI 10.1007/s00425-007-0549-4; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Fankhauser C, 2004, PLANT J, V39, P747, DOI 10.1111/j.1365-313X.2004.02148.x; FEDOROFF NV, 1993, PLANT J, V3, P273, DOI 10.1046/j.1365-313X.1993.t01-15-00999.x; Franklin KA, 2003, PLANT CELL, V15, P1981, DOI 10.1105/tpc.015164; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; Genoud T, 1998, PLANT CELL, V10, P889, DOI 10.1105/tpc.10.6.889; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hsieh HL, 2000, GENE DEV, V14, P1958; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kang XJ, 2005, PLANT CELL, V17, P822, DOI 10.1105/tpc.104.029165; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kutuzov MA, 2001, BIOCHEM BIOPH RES CO, V289, P634, DOI 10.1006/bbrc.2001.6020; Kutuzov MA, 1998, FEBS LETT, V440, P147, DOI 10.1016/S0014-5793(98)01428-8; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; Liu HT, 2007, PLANT CELL ENVIRON, V30, P156, DOI 10.1111/j.1365-3040.2006.01613.x; Long Deborah, 1998, V82, P315; Miller JH, EXPT MOL GENETICS; Mira-Rodado V, 2007, J EXP BOT, V58, P2595, DOI 10.1093/jxb/erm087; Moller SG, 2003, PLANT CELL, V15, P1111, DOI 10.1105/tpc.008649; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Neff MM, 2000, GENE DEV, V14, P257; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Sharrock RA, 2003, PLANT MOL BIOL, V52, P135, DOI 10.1023/A:1023901718508; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Swarup R, 2002, PLANT MOL BIOL, V49, P411; WANG H, 2002, ARABIDOPSIS BOOK; Ward JM, 2005, PLANT CELL, V17, P475, DOI 10.1105/tpc.104.027722; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Zhang H, 1997, BBA-GENE STRUCT EXPR, V1353, P199, DOI 10.1016/S0167-4781(97)00096-1	56	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2699	10.1371/journal.pone.0002699	http://dx.doi.org/10.1371/journal.pone.0002699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628957	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200042
J	Singh, R; Lemire, J; Mailloux, RJ; Appanna, VD				Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.			A Novel Strategy Involved Anti-Oxidative Defense: The Conversion of NADH into NADPH by a Metabolic Network	PLOS ONE			English	Article								The reduced nicotinamide adenine dinucleotide phosphate (NADPH) is pivotal to the cellular anti-oxidative defence strategies in most organisms. Although its production mediated by different enzyme systems has been relatively well-studied, metabolic networks dedicated to the biogenesis of NADPH have not been fully characterized. In this report, a metabolic pathway that promotes the conversion of reduced nicotinamide adenine dinucleotide (NADH), a pro-oxidant into NADPH has been uncovered in Pseudomonas fluorescens exposed to oxidative stress. Enzymes such as pyruvate carboxylase (PC), malic enzyme (ME), malate dehydrogenase (MDH), malate synthase (MS), and isocitrate lyase (ICL) that are involved in disparate metabolic modules, converged to create a metabolic network aimed at the transformation of NADH into NADPH. The downregulation of phosphoenol carboxykinase (PEPCK) and the upregulation of pyruvate kinase (PK) ensured that this metabolic cycle fixed NADH into NADPH to combat the oxidative stress triggered by the menadione insult. This is the first demonstration of a metabolic network invoked to generate NADPH from NADH, a process that may be very effective in combating oxidative stress as the increase of an anti-oxidant is coupled to the decrease of a pro-oxidant.	[Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Singh, R (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca		Appanna, Vasu/0000-0002-0138-5665; Mailloux, Ryan/0000-0003-3986-9830	Northern Ontario Heritage Fund; Ontario Center of Excellence	Northern Ontario Heritage Fund; Ontario Center of Excellence	This project was funded by Northern Ontario Heritage Fund and Ontario Center of Excellence.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2008, CURR MED CHEM, V15, P650; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Maia L, 2007, J BIOL INORG CHEM, V12, P777, DOI 10.1007/s00775-007-0229-7; Mailloux RJ, 2008, ELECTROPHORESIS, V29, P1484, DOI 10.1002/elps.200700697; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Marino D, 2007, PLANTA, V225, P413, DOI 10.1007/s00425-006-0354-5; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Minard KI, 2005, J BIOL CHEM, V280, P39890, DOI 10.1074/jbc.M509461200; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; SATTERLEE J, 1991, BIOCHIM BIOPHYS ACTA, V1079, P247, DOI 10.1016/0167-4838(91)90065-8; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Sugiyama N, 1997, PHYTOCHEMISTRY, V44, P571, DOI 10.1016/S0031-9422(96)00629-2; Tuttle SW, 2007, J BIOL CHEM, V282, P36790, DOI 10.1074/jbc.M700327200; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yoshihara T, 2001, J HISTOCHEM CYTOCHEM, V49, P1123, DOI 10.1177/002215540104900906; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P1766, DOI 10.1073/pnas.90.5.1766	26	94	96	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2682	10.1371/journal.pone.0002682	http://dx.doi.org/10.1371/journal.pone.0002682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628998	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200026
J	Arede, N; Tavares, AT				Arede, Natacha; Tavares, Ana T.			Modified Whole-Mount In situ Hybridization Protocol for the Detection of Transgene Expression in Electroporated Chick Embryos	PLOS ONE			English	Article								Background: In vivo electroporation has been extensively used as an effective means of DNA transfer for analyzing gene function as well as gene regulation in developmental systems. In any of these two types of studies, the correct spatial and temporal expression of the electroporated transgene can only be accurately assessed by in situ hybridization. Methodology/Principal Findings: While analyzing transgene expression in electroporated chicken embryos, we verified that transgene riboprobes cross-hybridized with the exogenous plasmid DNA when embryos were processed by conventional whole-mount in situ hybridization (WISH). Conclusions/Significance: Here we describe a modification to the WISH protocol that is essential to prevent DNA cross-hybridization and to specifically detect transgene mRNA transcripts in electroporated embryos. Our optimized WISH procedure can be applied not only to electroporated chick embryos but also to other embryos or adult tissues that have been transfected with large amounts of reporter- or expression construct DNA.	[Arede, Natacha; Tavares, Ana T.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Instituto Gulbenkian de Ciencia	Arede, N (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	atavares@igc.gulbenkian.pt	Tavares, Ana Teresa/I-3086-2013	Tavares, Ana Teresa/0000-0002-3495-5513	Fundacao para a Ciencia e a Tecnologia (FCT)/FEDER [POCI/SAU-MMO/59725/2004, SFRH/BPD/20434/2004]; Centro de Biologia do Desenvolvimento; IGC/Fundacao Calouste Gulbenkian	Fundacao para a Ciencia e a Tecnologia (FCT)/FEDER(Portuguese Foundation for Science and TechnologyEuropean Commission); Centro de Biologia do Desenvolvimento; IGC/Fundacao Calouste Gulbenkian	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT)/FEDER (POCI/SAU-MMO/59725/2004), Centro de Biologia do Desenvolvimento, and IGC/Fundacao Calouste Gulbenkian. A. T. Tavares was supported by FCT (SFRH/BPD/20434/2004).	Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CASEY J, 1977, NUCLEIC ACIDS RES, V4, P1539, DOI 10.1093/nar/4.5.1539; Corbo JC, 1997, DEVELOPMENT, V124, P589; Echeverri K, 2003, DEV DYNAM, V226, P418, DOI 10.1002/dvdy.10238; Eide FF, 2000, FEBS LETT, V486, P29, DOI 10.1016/S0014-5793(00)02124-4; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Isaka Y, 2007, EXPERT OPIN DRUG DEL, V4, P561, DOI 10.1517/17425247.4.5.561; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Kamdar K P, 1995, Methods Mol Biol, V48, P239; Liguori GL, 2003, DEV BIOL, V264, P537, DOI 10.1016/j.ydbio.2003.08.023; Nakamura H, 2004, MECH DEVELOP, V121, P1137, DOI 10.1016/j.mod.2004.05.013; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P326; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Tavares AT, 2007, DEVELOPMENT, V134, P2051, DOI 10.1242/dev.000901; Teh C, 2003, BIOTECHNIQUES, V35, P950, DOI 10.2144/03355st02; Uchikawa M, 2004, MECH DEVELOP, V121, P1145, DOI 10.1016/j.mod.2004.05.009; Wilkinson D.G., 1992, SITU HYBRIDIZATION P, P1; Yomogida K, 2002, BIOL REPROD, V67, P712, DOI 10.1095/biolreprod.101.001743	21	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2638	10.1371/journal.pone.0002638	http://dx.doi.org/10.1371/journal.pone.0002638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612382	Green Submitted, gold, Green Published			2022-12-27	WOS:000264065800040
J	Palmer, C; Duan, XB; Hawley, S; Scholler, N; Thorpe, JD; Sahota, RA; Wong, MQ; Wray, A; Bergan, LA; Drescher, CW; McIntosh, MW; Brown, PO; Nelson, BH; Urban, N				Palmer, Chana; Duan, Xiaobo; Hawley, Sarah; Scholler, Nathalie; Thorpe, Jason D.; Sahota, Rob A.; Wong, May Q.; Wray, Andrew; Bergan, Lindsay A.; Drescher, Charles W.; McIntosh, Martin W.; Brown, Patrick O.; Nelson, Brad H.; Urban, Nicole			Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer	PLOS ONE			English	Article								Background: Epithelial ovarian cancer is a significant cause of mortality both in the United States and worldwide, due largely to the high proportion of cases that present at a late stage, when survival is extremely poor. Early detection of epithelial ovarian cancer, and of the serous subtype in particular, is a promising strategy for saving lives. The low prevalence of ovarian cancer makes the development of an adequately sensitive and specific test based on blood markers very challenging. We evaluated the performance of a set of candidate blood markers and combinations of these markers in detecting serous ovarian cancer. Methods and Findings: We selected 14 candidate blood markers of serous ovarian cancer for which assays were available to measure their levels in serum or plasma, based on our analysis of global gene expression data and on literature searches. We evaluated the performance of these candidate markers individually and in combination by measuring them in overlapping sets of serum ( or plasma) samples from women with clinically detectable ovarian cancer and women without ovarian cancer. Based on sensitivity at high specificity, we determined that 4 of the 14 candidate markers-MUC16, WFDC2, MSLN and MMP7-warrant further evaluation in precious serum specimens collected months to years prior to clinical diagnosis to assess their utility in early detection. We also reported differences in the performance of these candidate blood markers across histological types of epithelial ovarian cancer. Conclusions: By systematically analyzing the performance of candidate blood markers of ovarian cancer in distinguishing women with clinically apparent ovarian cancer from women without ovarian cancer, we identified a set of serum markers with adequate performance to warrant testing for their ability to identify ovarian cancer months to years prior to clinical diagnosis. We argued for the importance of sensitivity at high specificity and of magnitude of difference in marker levels between cases and controls as performance metrics and demonstrated the importance of stratifying analyses by histological type of ovarian cancer. Also, we discussed the limitations of studies (like this one) that use samples obtained from symptomatic women to assess potential utility in detection of disease months to years prior to clinical detection.	[Palmer, Chana; Hawley, Sarah] Canary Fdn, Sci Programs, San Jose, CA USA; [Duan, Xiaobo; Sahota, Rob A.; Wong, May Q.; Wray, Andrew; Nelson, Brad H.] Trev & Joyce Deeley Res Ctr, British Columbia Canc Agcy, Victoria, BC, Canada; [Scholler, Nathalie] Univ Penn, Sch Med, Philadelphia, PA USA; [Thorpe, Jason D.; Bergan, Lindsay A.; Drescher, Charles W.; McIntosh, Martin W.; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA USA	British Columbia Cancer Agency; University of Pennsylvania; Fred Hutchinson Cancer Center; Stanford University	Palmer, C (corresponding author), Canary Fdn, Sci Programs, San Jose, CA USA.	nurban@fhcrc.org	Nelson, Brad H/K-2622-2014	Nelson, Brad/0000-0002-4445-5539	Canary Foundation; Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer [P50 CA83636]; NIH/NCI [1 RO1 CA75494]; British Columbia Cancer Foundation; Howard Hughes Medical Institute [investigator]; NATIONAL CANCER INSTITUTE [R01CA075494, P50CA083636] Funding Source: NIH RePORTER	Canary Foundation; Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); British Columbia Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for generous funding from the Canary Foundation, the Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer (P50 CA83636, N.U.), NIH/NCI Grant 1 RO1 CA75494 (QUEST), and the British Columbia Cancer Foundation. POB is an investigator of the Howard Hughes Medical Institute. CP and SJH are employees of the Canary Foundation and were involved in design of the study, analysis and interpretation of the data, and preparation of the manuscript.	AGARWAL R, 2007, AM J OBSTET GYNECOL, V348, pE341; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bjorge T, 2004, BRIT J CANCER, V91, P1829, DOI 10.1038/sj.bjc.6602199; Cass R, 2005, OBSTET GYNECOL, V106, P1327, DOI 10.1097/01.AOG.0000187892.78392.3f; Dupont J, 2004, J CLIN ONCOL, V22, P3330, DOI 10.1200/JCO.2004.09.112; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Hellstrom I, 2003, CANCER RES, V63, P3695; JACOBS I, 1988, LANCET, V1, P268; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kioi M, 2006, CANCER-AM CANCER SOC, V107, P1407, DOI 10.1002/cncr.22134; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; McIntosh MW, 2004, GYNECOL ONCOL, V95, P9, DOI 10.1016/j.ygyno.2004.07.039; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2005, EPIDEMIOLOGY, V16, P598, DOI 10.1097/01.ede.0000173041.03470.8b; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Ries LAG, 2007, SEER SURVIVAL MONOGR, P133; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Scholler N, 2008, CLIN CANCER RES, V14, P2647, DOI 10.1158/1078-0432.CCR-07-1442; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; So J, 2004, GYNECOL ONCOL, V95, P314, DOI 10.1016/j.ygyno.2004.08.001; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Surveillance E and End Results ( SEER) Program, 2007, SEER STAT DAT INC SE; Tanimoto H, 1999, TUMOR BIOL, V20, P88, DOI 10.1159/000030051; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; van Haaften-Day C, 2001, CANCER-AM CANCER SOC, V92, P2837, DOI 10.1002/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO;2-5; Venkatraman ES, 1996, BIOMETRIKA, V83, P835, DOI 10.1093/biomet/83.4.835; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; ZURAWSKI VR, 1988, INT J CANCER, V42, P677, DOI 10.1002/ijc.2910420507	36	66	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2633	10.1371/journal.pone.0002633	http://dx.doi.org/10.1371/journal.pone.0002633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612378	gold, Green Published, Green Submitted			2022-12-27	WOS:000264065800035
J	Togbe, D; de Sousa, PL; Fauconnier, M; Boissay, V; Fick, L; Scheu, S; Pfeffer, K; Menard, R; Grau, GE; Doan, BT; Beloeil, JC; Renia, L; Hansen, AM; Ball, HJ; Hunt, NH; Ryffel, B; Quesniaux, VFJ				Togbe, Dieudonnee; de Sousa, Paulo Loureiro; Fauconnier, Mathilde; Boissay, Victorine; Fick, Lizette; Scheu, Stefanie; Pfeffer, Klaus; Menard, Robert; Grau, Georges E.; Doan, Bich-Thuy; Beloeil, Jean Claude; Renia, Laurent; Hansen, Anna M.; Ball, Helen J.; Hunt, Nicholas H.; Ryffel, Bernhard; Quesniaux, Valerie F. J.			Both Functional LT beta Receptor and TNF Receptor 2 Are Required for the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article								Background: TNF-related lymphotoxin alpha (LT alpha) is essential for the development of Plasmodium berghei ANKA (PbA)-induced experimental cerebral malaria (ECM). The pathway involved has been attributed to TNFR2. Here we show a second arm of LT alpha-signaling essential for ECM development through LT beta-R, receptor of LT alpha 1 beta 2 heterotrimer. Methodology/Principal Findings: LT beta R deficient mice did not develop the neurological signs seen in PbA induced ECM but died at three weeks with high parasitaemia and severe anemia like LT alpha beta deficient mice. Resistance of LT alpha beta or LT beta R deficient mice correlated with unaltered cerebral microcirculation and absence of ischemia, as documented by magnetic resonance imaging and angiography, associated with lack of microvascular obstruction, while wild-type mice developed distinct microvascular pathology. Recruitment and activation of perforin(+) CD8(+) T cells, and their ICAM-1 expression were clearly attenuated in the brain of resistant mice. An essential contribution of LIGHT, another LT beta R ligand, could be excluded, as LIGHT deficient mice rapidly succumbed to ECM. Conclusions/Significance: LT beta R expressed on radioresistant resident stromal, probably endothelial cells, rather than hematopoietic cells, are essential for the development of ECM, as assessed by hematopoietic reconstitution experiment. Therefore, the data suggest that both functional LT beta R and TNFR2 signaling are required and non-redundant for the development of microvascular pathology resulting in fatal ECM.	[Togbe, Dieudonnee; Fauconnier, Mathilde; Boissay, Victorine; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, Orleans, France; [de Sousa, Paulo Loureiro; Doan, Bich-Thuy; Beloeil, Jean Claude] CNRS CBM, Orleans, France; [Fick, Lizette] Inst Infect Dis & Mol Med, Cape Town, South Africa; [Scheu, Stefanie; Pfeffer, Klaus] Univ Duesseldorf, Dusseldorf, Germany; [Menard, Robert] Pasteur Inst Paris, Paris, France; [Grau, Georges E.; Renia, Laurent; Hansen, Anna M.; Ball, Helen J.; Hunt, Nicholas H.] Univ Sydney, Dept Pathol, Camperdown, NSW, Australia; [Renia, Laurent] Inserm, U567, Paris, France	Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); University of Cape Town; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Togbe, D (corresponding author), Univ Orleans, Orleans, France.	bryffel@cnrs-orleans.fr; quesniaux@cnrs-orleans.fr	Hunt, Nick H/A-3636-2011; Scheu, Stefanie/H-3670-2019; Ball, Helen J/A-4242-2010; Grau, Georges/AGR-7139-2022; Togbe, Dieudonnee/AAE-1135-2020; Renia, Laurent/E-2117-2011; , Beloeil/I-5451-2014	Scheu, Stefanie/0000-0002-9707-8191; Ball, Helen J/0000-0003-3733-9748; Grau, Georges/0000-0002-0442-0462; Togbe, Dieudonnee/0000-0001-6658-414X; Renia, Laurent/0000-0003-0349-1557; , Beloeil/0000-0002-1474-3898; DOAN, Bich-Thuy/0000-0002-7148-9515; Pfeffer, Klaus/0000-0002-5652-6330	CNRS; MIE from the French Research Minister; European FP6 MPCM project	CNRS(Centre National de la Recherche Scientifique (CNRS)); MIE from the French Research Minister; European FP6 MPCM project	Work supported by CNRS, the interdisciplinary program MIE from the French Research Minister, and European FP6 MPCM project.	Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gimenez F, 2003, CELL MOL LIFE SCI, V60, P1623, DOI 10.1007/s00018-003-2347-x; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1988, IMMUNOLOGY, V65, P501; Hall N, 2005, CURR OPIN GENET DEV, V15, P609, DOI 10.1016/j.gde.2005.09.001; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; Kuprash DV, 1999, J IMMUNOL, V163, P6575; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Muller M, 1996, MOL MED, V2, P247, DOI 10.1007/BF03401621; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rudin W, 1997, AM J PATHOL, V150, P257; Ryffel B, 1997, J IMMUNOL, V158, P2126; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stoelcker B, 2002, INFECT IMMUN, V70, P5857, DOI 10.1128/IAI.70.10.5857-5859.2002; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; Voza T, 2005, INFECT IMMUN, V73, P4777, DOI 10.1128/IAI.73.8.4777-4786.2005; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Wunderlich F, 2005, MICROBES INFECT, V7, P399, DOI 10.1016/j.micinf.2004.11.016	50	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2608	10.1371/journal.pone.0002608	http://dx.doi.org/10.1371/journal.pone.0002608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612394	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800014
J	Kalita, MK; Nandal, UK; Pattnaik, A; Sivalingam, A; Ramasamy, G; Kumar, M; Raghava, GPS; Gupta, D				Kalita, Mridul K.; Nandal, Umesh K.; Pattnaik, Ansuman; Sivalingam, Anandhan; Ramasamy, Gowthaman; Kumar, Manish; Raghava, Gajendra P. S.; Gupta, Dinesh			CyclinPred: A SVM-Based Method for Predicting Cyclin Protein Sequences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CELL-CYCLE; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; COUPLED RECEPTORS; NEURAL-NETWORKS; MESSENGER-RNA; GENE; FOLD; MATURATION	Functional annotation of protein sequences with low similarity to well characterized protein sequences is a major challenge of computational biology in the post genomic era. The cyclin protein family is once such important family of proteins which consists of sequences with low sequence similarity making discovery of novel cyclins and establishing orthologous relationships amongst the cyclins, a difficult task. The currently identified cyclin motifs and cyclin associated domains do not represent all of the identified and characterized cyclin sequences. We describe a Support Vector Machine (SVM) based classifier, CyclinPred, which can predict cyclin sequences with high efficiency. The SVM classifier was trained with features of selected cyclin and non cyclin protein sequences. The training features of the protein sequences include amino acid composition, dipeptide composition, secondary structure composition and PSI-BLAST generated Position Specific Scoring Matrix (PSSM) profiles. Results obtained from Leave-One-Out cross validation or jackknife test, self consistency and holdout tests prove that the SVM classifier trained with features of PSSM profile was more accurate than the classifiers based on either of the other features alone or hybrids of these features. A cyclin prediction server-CyclinPred has been setup based on SVM model trained with PSSM profiles. CyclinPred prediction results prove that the method may be used as a cyclin prediction tool, complementing conventional cyclin prediction methods.	[Kalita, Mridul K.; Nandal, Umesh K.; Pattnaik, Ansuman; Sivalingam, Anandhan; Ramasamy, Gowthaman; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India; [Kumar, Manish; Raghava, Gajendra P. S.] Inst Microb Technol, Bioinformat Ctr, Chandigarh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kalita, MK (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Kumar, Manish/AGP-1250-2022; Gupta, Dinesh/C-1079-2009; Raghava, Gajendra/B-1717-2009; Gupta, Dinesh/AAW-4243-2020; Raghava, Gajendra P.S./AAA-2413-2022	Kumar, Manish/0000-0002-7936-9892; Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835; Raghava, Gajendra P.S./0000-0002-8902-2876	Department of Biotechnology (DBT, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India)	The work was supported by Department of Biotechnology (DBT, India) grant award to DG.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bazan JF, 1996, PROTEINS, V24, P1; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bock JR, 2001, BIOINFORMATICS, V17, P455, DOI 10.1093/bioinformatics/17.5.455; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Busuttil Steven, 2004, Genome Inform, V15, P191; Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P946, DOI 10.1093/nar/22.6.946; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NICHOLAS J, 1992, NATURE, V355, P362, DOI 10.1038/355362a0; Nieduszynski CA, 2002, GENOME BIOL, V3; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; RECZKO M, 1994, NUCLEIC ACIDS RES, V22, P3616; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Scholkopf B., 1999, ADV KERNEL METHODS S; Shepherd AJ, 1999, PROTEIN SCI, V8, P1045, DOI 10.1110/ps.8.5.1045; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Vlahovicek K, 2005, NUCLEIC ACIDS RES, V33, pD223; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yuan Z, 2002, PROTEINS, V48, P566, DOI 10.1002/prot.10176; Zhang QD, 2005, BIOINFORMATICS, V21, P2370, DOI 10.1093/bioinformatics/bti358	46	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2605	10.1371/journal.pone.0002605	http://dx.doi.org/10.1371/journal.pone.0002605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596929	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200058
J	Wei, Y; Qu, MH; Wang, XS; Chen, L; Wang, DL; Liu, Y; Hua, Q; He, RQ				Wei, Yan; Qu, Mei-Hua; Wang, Xing-Sheng; Chen, Lan; Wang, Dong-Liang; Liu, Ying; Hua, Qian; He, Rong-Qiao			Binding to the Minor Groove of the Double-Strand, Tau Protein Prevents DNA from Damage by Peroxidation	PLOS ONE			English	Article								Tau, an important microtubule associated protein, has been found to bind to DNA, and to be localized in the nuclei of both neurons and some non-neuronal cells. Here, using electrophoretic mobility shifting assay ( EMSA) in the presence of DNA with different chain-lengths, we observed that tau protein favored binding to a 13 bp or a longer polynucleotide. The results from atomic force microscopy also showed that tau protein preferred a 13 bp polynucleotide to a 12 bp or shorter polynucleotide. In a competitive assay, a minor groove binder distamycin A was able to replace the bound tau from the DNA double helix, indicating that tau protein binds to the minor groove. Tau protein was able to protect the double-strand from digestion in the presence of DNase I that was bound to the minor groove. On the other hand, a major groove binder methyl green as a negative competitor exhibited little effect on the retardation of tau-DNA complex in EMSA. This further indicates the DNA minor groove as the binding site for tau protein. EMSA with truncated tau proteins showed that both the proline-rich domain ( PRD) and the microtubule-binding domain ( MTBD) contributed to the interaction with DNA; that is to say, both PRD and MTBD bound to the minor groove of DNA and bent the double-strand, as observed by electron microscopy. To investigate whether tau protein is able to prevent DNA from the impairment by hydroxyl free radical, the chemiluminescence emitted by the phen-Cu/H2O2/ascorbate was measured. The emission intensity of the luminescence was markedly decreased when tau protein was present, suggesting a significant protection of DNA from the damage in the presence of hydroxyl free radical.	[Wei, Yan; Qu, Mei-Hua; Wang, Xing-Sheng; Chen, Lan; Wang, Dong-Liang; Liu, Ying; Hua, Qian; He, Rong-Qiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Wei, Yan; Wang, Dong-Liang; He, Rong-Qiao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Hua, Qian] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing University of Chinese Medicine	Wei, Y (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn	Qu, Mei-Hua/ABE-5521-2020; Liu, Ying/D-8933-2013	Qu, Mei-Hua/0000-0003-2464-6773; Liu, Ying/0000-0003-0802-3832	NSFC [90206041]; 973-Project [2006CB500703, 2006CB911003]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-119-1]	NSFC(National Natural Science Foundation of China (NSFC)); 973-Project(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	The work was supported by NSFC (90206041), 973-Project (2006CB500703 and 2006CB911003), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-119-1).	Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; ARCAMONE FM, 1989, J MED CHEM, V32, P774, DOI 10.1021/jm00124a008; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; BRUCE A, 2002, MOL BIOL CELL, P381; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CORCES VG, 1980, EUR J BIOCHEM, V105, P7; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; Delacourte A, 1997, INT REV CYTOL, V171, P167; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GREENWOOD JA, 1995, EXP CELL RES, V220, P332, DOI 10.1006/excr.1995.1323; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Johnson GVW, 2002, J ALZHEIMERS DIS, V4, P375, DOI 10.3233/JAD-2002-4505; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; KUMAR KA, 1992, J BIOL CHEM, V260, P24824; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Li FX, 2008, PROG BIOCHEM BIOPHYS, V35, P393; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; Li W, 2005, BBA-GEN SUBJECTS, V1726, P280, DOI 10.1016/j.bbagen.2005.08.014; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Ma WJ, 1998, J PHOTOCH PHOTOBIO B, V44, P63, DOI 10.1016/S1011-1344(98)00120-1; Michaelis ML, 2002, J MOL NEUROSCI, V19, P289, DOI 10.1385/JMN:19:3:289; Mitsouras K, 2002, MOL CELL BIOL, V22, P4390, DOI 10.1128/MCB.22.12.4390-4401.2002; MORAGA DM, 1993, J NEUROCHEM, V61, P979, DOI 10.1111/j.1471-4159.1993.tb03611.x; MORTON RE, 1992, ANAL BIOCHEM, V204, P332, DOI 10.1016/0003-2697(92)90248-6; Nie Chun Lai, 2007, BMC Neurosci, V8, P9, DOI 10.1186/1471-2202-8-9; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425; PORSCHKE D, 1991, J MOL BIOL, V222, P423, DOI 10.1016/0022-2836(91)90220-Z; PUTNAM FW, 1953, PROTEINS, P893; Qu MH, 2004, NEUROREPORT, V15, P2723; RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K; Rogers Faye A., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P319, DOI 10.2174/1568011054222300; Roy KB, 1996, INDIAN J BIOCHEM BIO, V33, P83; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Tuite E, 1997, EUR J BIOCHEM, V243, P482, DOI 10.1111/j.1432-1033.1997.0482a.x; Wang XS, 2006, PROTEIN PEPTIDE LETT, V13, P679, DOI 10.2174/092986606777790566; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; WISEMAN H, 1995, CANCER LETT, V93, P113, DOI 10.1016/0304-3835(95)03792-U; Wojtuszewski K, 2004, PROTEIN SCI, V13, P2416, DOI 10.1110/ps.04730204; YAMAUCHI PS, 1993, BIOCHEM BIOPH RES CO, V190, P710, DOI 10.1006/bbrc.1993.1107	51	85	86	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2600	10.1371/journal.pone.0002600	http://dx.doi.org/10.1371/journal.pone.0002600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596978	gold, Green Submitted, Green Published			2022-12-27	WOS:000263288200053
J	Amsili, S; Zer, H; Hinderlich, S; Krause, S; Becker-Cohen, M; MacArthur, DG; North, KN; Mitrani-Rosenbaum, S				Amsili, Shira; Zer, Hagit; Hinderlich, Stephan; Krause, Sabine; Becker-Cohen, Michal; MacArthur, Daniel G.; North, Kathryn N.; Mitrani-Rosenbaum, Stella			UDP-N-Acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle?	PLOS ONE			English	Article								Background: Hereditary inclusion body myopathy (HIBM) is a rare neuromuscular disorder caused by mutations in GNE, the key enzyme in the biosynthetic pathway of sialic acid. While the mechanism leading from GNE mutations to the HIBM phenotype is not yet understood, we searched for proteins potentially interacting with GNE, which could give some insights about novel putative biological functions of GNE in muscle. Methodology/Principal Findings: We used a Surface Plasmon Resonance (SPR)-Biosensor based assay to search for potential GNE interactors in anion exchanged fractions of human skeletal muscle primary culture cell lysate. Analysis of the positive fractions by in vitro binding assay revealed alpha-actinin 1 as a potential interactor of GNE. The direct interaction of the two proteins was assessed in vitro by SPR-Biosensor based kinetics analysis and in a cellular environment by a coimmunoprecipitation assay in GNE overexpressing 293T cells. Furthermore, immunohistochemistry on stretched mouse muscle suggest that both GNE and a-actinin 1 localize to an overlapping but not identical region of the myofibrillar apparatus centered on the Z line. Conclusions/Significance: The interaction of GNE with alpha-actinin 1 might point to its involvement in alpha-actinin mediated processes. In addition these studies illustrate for the first time the expression of the non-muscle form of alpha-actinin, alpha-actinin 1, in mature skeletal muscle tissue, opening novel avenues for its specific function in the sarcomere. Although no significant difference could be detected in the binding kinetics of alpha-actinin 1 with either wild type or mutant GNE in our SPR biosensor based analysis, further investigation is needed to determine whether and how the interaction of GNE with alpha-actinin 1 in skeletal muscle is relevant to the putative muscle-specific function of alpha-actinin 1, and to the muscle-restricted pathology of HIBM.	[Amsili, Shira; Becker-Cohen, Michal; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Zer, Hagit] Hebrew Univ Jerusalem, Inst Life Sci, Biacore Lab, Interdept Equipment Unit, Jerusalem, Israel; [Hinderlich, Stephan] Charite, Campus Benjamin Franklin, Berlin, Germany; [Hinderlich, Stephan] Inst Biochem & Molekularbiol, Berlin, Germany; [Hinderlich, Stephan] Fachbereich Life Sci & Technol, Tech Fachhochschule Berlin, Berlin, Germany; [Krause, Sabine] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Neurol Klin & Poliklin, Munich, Germany; [MacArthur, Daniel G.; North, Kathryn N.] Univ Sydney, Childrens Hosp Westmead, Inst Neuromuscular Res, Fac Med, Sydney, NSW, Australia	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Sydney	Amsili, S (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	stella@cc.huji.ac.il	North, Kathryn N/K-6476-2012; Krause, Sabine/AAJ-1163-2020; MacArthur, Daniel/E-3275-2010	North, Kathryn N/0000-0003-0841-8009; Krause, Sabine/0000-0002-3141-886X; MacArthur, Daniel/0000-0002-5771-2290; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709	German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel; Association Francaise contre les Myopathies (AFM); Israel Science Foundation (ISF)	German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel(German-Israeli Foundation for Scientific Research and Development); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was supported by grants from the German-Israeli Foundation for Research and Development (GIF), Jerusalem, Israel (SM-R;SH;SK), from the Association Francaise contre les Myopathies (AFM) (SM-R) and from the Israel Science Foundation (ISF) (SM-R).	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Argov Zohar, 1998, Current Opinion in Rheumatology, V10, P543, DOI 10.1097/00002281-199811000-00006; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Broccolini A, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9252; Catimel B, 2005, J PROTEOME RES, V4, P1646, DOI 10.1021/pr050132x; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; ENDO T, 1984, J CELL BIOL, V99, P2322, DOI 10.1083/jcb.99.6.2322; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kelly DF, 2006, J MOL BIOL, V357, P562, DOI 10.1016/j.jmb.2005.12.076; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; Malicdan MCV, 2007, HUM MOL GENET, V16, P115, DOI 10.1093/hmg/ddl446; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; Roden LD, 1996, BIOCHEM BIOPH RES CO, V225, P1073, DOI 10.1006/bbrc.1996.1297; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Tomimitsu H, 2004, NEUROLOGY, V62, P1607, DOI 10.1212/01.WNL.0000123115.23652.6C; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519	33	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2477	10.1371/journal.pone.0002477	http://dx.doi.org/10.1371/journal.pone.0002477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560563	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700050
J	Burke, T; Page, B; Van Dyk, G; Millspaugh, J; Slotow, R				Burke, Tarryne; Page, Bruce; Van Dyk, Gus; Millspaugh, Josh; Slotow, Rob			Risk and Ethical Concerns of Hunting Male Elephant: Behavioural and Physiological Assays of the Remaining Elephants	PLOS ONE			English	Article								Background: Hunting of male African elephants may pose ethical and risk concerns, particularly given their status as a charismatic species of high touristic value, yet which are capable of both killing people and damaging infrastructure. Methodology/Principal Findings: We quantified the effect of hunts of male elephants on (1) risk of attack or damage (11 hunts), and (2) behavioural (movement dynamics) and physiological (stress hormone metabolite concentrations) responses (4 hunts) in Pilanesberg National Park. For eleven hunts, there were no subsequent attacks on people or infrastructure, and elephants did not break out of the fenced reserve. For three focal hunts, there was an initial flight response by bulls present at the hunting site, but their movements stabilised the day after the hunt event. Animals not present at the hunt (both bulls and herds) did not show movement responses. Physiologically, hunting elephant bulls increased faecal stress hormone levels (corticosterone metabolites) in both those bulls that were present at the hunts (for up to four days post-hunt) and in the broader bull and breeding herd population (for up to one month post-hunt). Conclusions/Significance: As all responses were relatively minor, hunting male elephants is ethically acceptable when considering effects on the remaining elephant population; however bulls should be hunted when alone. Hunting is feasible in relatively small enclosed reserves without major risk of attack, damage, or breakout. Physiological stress assays were more effective than behavioural responses in detecting effects of human intervention. Similar studies should evaluate intervention consequences, inform and improve best practice, and should be widely applied by management agencies.	[Burke, Tarryne; Page, Bruce; Van Dyk, Gus; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa; [Millspaugh, Josh] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA	University of Kwazulu Natal; University of Missouri System; University of Missouri Columbia	Burke, T (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Amarula Elephant Res Programme, Durban, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020; Page, Bruce R/G-1245-2010	Page, Bruce R/0000-0001-7979-5229; Slotow, Rob/0000-0001-9469-1508	PPC Cement; Amarula (Distell),; National Research Foundation [2053623]; University of KwaZulu-Natal; Missouri University South African Partnerships Program; MU Alumni Association	PPC Cement; Amarula (Distell),; National Research Foundation; University of KwaZulu-Natal; Missouri University South African Partnerships Program; MU Alumni Association	PPC Cement, Amarula (Distell), National Research Foundation (GUN: 2053623), University of KwaZulu-Natal, Missouri University South African Partnerships Program and the MU Alumni Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks J. P. H., 1988, VELD TYPES S AFRICA; BOONZAAIER W. W., 2000, PILANESBERG NATL PAR; BREYTENBACH G, 2001, KOEDOE, V44, P105; BROWN IRF, 1979, COMP BIOCHEM PHYS A, V62, P899, DOI 10.1016/0300-9629(79)90025-2; Creedy J, 2002, J ECON SURV, V16, P1, DOI 10.1111/1467-6419.00158; CUMMING D, 2005, 11 WWFSARPO; Dalmau A, 2007, J WILDLIFE MANAGE, V71, P190, DOI 10.2193/2005-492; DEVILLIERS MS, 1995, P ROY SOC B-BIOL SCI, V262, P215, DOI 10.1098/rspb.1995.0198; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Eltringham S. K., 1977, East African Wildlife Journal, V15, P19; HALLMARTIN AJ, 1987, S AFR J SCI, V83, P616; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Irwin L.L., 1979, P199; Kilpatrick HJ, 1999, WILDLIFE SOC B, V27, P433; KNOKE D, 1980, QUANTITATIVE APPL SO, P9; LANGBAUER WR, 1991, J EXP BIOL, V157, P35; Lecocq Y, 1997, WILDLIFE SOC B, V25, P215; LOTTER HPP, ASSESSMENT IN PRESS, P307; MARTIN RB, 1996, ELEPHANT MANAGEMENT; MBENGA E, 2004, THESIS U KWAZULU NAT; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Millspaugh JJ, 2000, J WILDLIFE MANAGE, V64, P994, DOI 10.2307/3803209; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2003, WILDLIFE SOC B, V31, P399; Millspaugh JJ, 2001, WILDLIFE SOC B, V29, P899; Millspaugh JJ, 2007, J WILDLIFE MANAGE, V71, P1257, DOI 10.2193/2006-015; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; MORGANTINI LE, 1985, J RANGE MANAGE, V38, P77, DOI 10.2307/3899339; Peterson MN, 2004, WILDLIFE SOC B, V32, P310, DOI 10.2193/0091-7648(2004)32[310:AAFDTS]2.0.CO;2; Poole J.H., 1995, DIFFERENCES SEXES, P331; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; Pretorius Y., 2004, THESIS U KWAZULU NAT; Reynolds PC, 2001, TOURISM MANAGE, V22, P31, DOI 10.1016/S0261-5177(00)00018-2; Roy C, 2001, J WILDLIFE MANAGE, V65, P808, DOI 10.2307/3803030; Sapolsky R.M., 1987, P291; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R., 2001, Koedoe, V44, P85; Sokal R. R, 1981, BIOMETRY; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; Western D., 1989, PACHYDERM, V12, P42; Whyte IJ, 1993, PACHYDERM, V16, P72; Zar JH, 1999, BIOSTATISTICAL ANAL	43	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2417	10.1371/journal.pone.0002417	http://dx.doi.org/10.1371/journal.pone.0002417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560517	Green Submitted, gold, Green Published			2022-12-27	WOS:000263280700006
J	Abdoul, H; Mallet, V; Pol, S; Fontanet, A				Abdoul, Hendy; Mallet, Vincent; Pol, Stanislas; Fontanet, Arnaud			Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype	PLOS ONE			English	Article								We examined the association between serum alpha-fetoprotein (AFP) level and sustained virological response (SVR) in 93 chronic hepatitis C patients. The SVR rate was much higher among patients with serum AFP levels below rather than above the median value (5.7 ng/ml) (58.7% and 19.2%, respectively; P < 0.0001). Serum AFP should be added to the list of factors predictive of treatment response in chronic hepatitis C.	[Abdoul, Hendy; Fontanet, Arnaud] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Mallet, Vincent; Pol, Stanislas] Univ Paris 05, Hop Cochin, APHP, Unite Hepatol, INSERM U567, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Abdoul, H (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	fontanet@pasteur.fr	; Mallet, Vincent/G-4623-2011	, arnaud/0000-0002-5239-6110; Mallet, Vincent/0000-0003-2219-9201				Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; DABEVA MD, 1993, AM J PATHOL, V143, P1606; GERMAIN L, 1988, CANCER RES, V48, P368; Gupta S, 2003, ANN INTERN MED, V139, P46, DOI 10.7326/0003-4819-139-1-200307010-00012; HALBRECHT I, 1956, NATURE, V178, P794, DOI 10.1038/178794a0; Males S, 2007, ANTIVIR THER, V12, P797; Poynard T, 2000, HEPATOLOGY, V31, P211, DOI 10.1002/hep.510310131; SHIOJIRI N, 1991, CANCER RES, V51, P2611; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tsamandas AC, 2006, LIVER INT, V26, P817, DOI 10.1111/j.1478-3231.2006.01306.x; Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65	12	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2391	10.1371/journal.pone.0002391	http://dx.doi.org/10.1371/journal.pone.0002391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545682	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800030
J	MacKenzie, JJ; Gomez, ND; Bhattacharjee, S; Mann, S; Haldar, K				MacKenzie, Julia J.; Gomez, Noe D.; Bhattacharjee, Souvik; Mann, Shaina; Haldar, Kasturi			A Plasmodium falciparum Host-Targeting Motif Functions in Export during Blood Stage Infection of the Rodent Malarial Parasite Plasmodium berghei	PLOS ONE			English	Article								Plasmodium falciparum (P. falciparum) secretes hundreds of proteins-including major virulence proteins-into the host erythrocyte. In order to reach the host cytoplasm, most P. falciparum proteins contain an N terminal host-targeting (HT) motif composed of 11 amino acids. In silico analyses have suggested that the HT motif is conserved throughout the Plasmodium species but experimental evidence only exists for P. falciparum. Here, we show that in the rodent malaria parasite Plasmodium berghei (P. berghei) a reporter-like green fluorescent protein expressed by the parasite can be exported to the erythrocyte cytoplasm in a HT-specific manner. This provides the first experimental proof that the HT motif can function as a signal for protein delivery to the erythrocyte across Plasmodium species. Further, it suggests that P. berghei may serve as a model for validation of P. falciparum secretome proteins. We also show that tubovesicular membranes extend from the vacuolar parasite into the erythrocyte cytoplasm and speculate that these structures may facilitate protein export to the erythrocyte.	[MacKenzie, Julia J.; Gomez, Noe D.; Bhattacharjee, Souvik; Mann, Shaina; Haldar, Kasturi] Northwestern Univ, Dept Pathol & Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	MacKenzie, JJ (corresponding author), Northwestern Univ, Dept Pathol & Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	k-haldar@northwestern.edu	Haldar, Kasturi/C-6685-2014		Alliance for Graduate Education and the Professoriate - AGEP;  [R01HL069630];  [R01AI039071];  [P01-PPG 5P01HL078826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069630, P01HL078826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039071] Funding Source: NIH RePORTER	Alliance for Graduate Education and the Professoriate - AGEP; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the following grants: Haldar (R01HL069630, R01AI039071, P01-PPG 5P01HL078826); Gomez (Alliance for Graduate Education and the Professoriate - AGEP).	Bhattacharjee S, 2008, BLOOD, V111, P2418, DOI 10.1182/blood-2007-09-115279; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Haldar K, 2006, NAT REV MICROBIOL, V4, P922, DOI 10.1038/nrmicro1549; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; Wiser Mark F., 1999, Novartis Foundation Symposium, V226, P199; WISER MF, 1999, NOVART FDN SYMP, V226, P211	18	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2405	10.1371/journal.pone.0002405	http://dx.doi.org/10.1371/journal.pone.0002405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545649	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800043
J	Miura, P; Andrews, M; Holcik, M; Jasmin, BJ				Miura, Pedro; Andrews, Meghan; Holcik, Martin; Jasmin, Bernard J.			IRES-Mediated Translation of Utrophin A Is Enhanced by Glucocorticoid Treatment in Skeletal Muscle Cells	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; PROTEIN MESSENGER-RNA; TRANS-ACTING FACTOR; LONG-TERM BENEFIT; MDX MICE; DEPENDENT TRANSLATION; GENE-TRANSFER; UP-REGULATION; DOUBLE-BLIND	Glucocorticoids are currently the only drug treatment recognized to benefit Duchenne muscular dystrophy (DMD) patients. The nature of the mechanisms underlying the beneficial effects remains incompletely understood but may involve an increase in the expression of utrophin. Here, we show that treatment of myotubes with 6 alpha-methylprednisolone-21 sodium succinate (PDN) results in enhanced expression of utrophin A without concomitant increases in mRNA levels thereby suggesting that translational regulation contributes to the increase. In agreement with this, we show that PDN treatment of cells transfected with monocistronic reporter constructs harbouring the utrophin A 5'UTR, causes an increase in reporter protein expression while leaving levels of reporter mRNAs unchanged. Using bicistronic reporter assays, we further demonstrate that PDN enhances activity of an Internal Ribosome Entry Site (IRES) located within the utrophin A 5'UTR. Analysis of polysomes demonstrate that PDN causes an overall reduction in polysome-associated mRNAs indicating that global translation rates are depressed under these conditions. Importantly, PDN causes an increase in the polysome association of endogenous utrophin A mRNAs and reporter mRNAs harbouring the utrophin A 5'UTR. Additional experiments identified a distinct region within the utrophin A 5'UTR that contains the inducible IRES activity. Together, these studies demonstrate that a translational regulatory mechanism involving increased IRES activation mediates, at least partially, the enhanced expression of utrophin A in muscle cells treated with glucocorticoids. Targeting the utrophin A IRES may thus offer an important and novel therapeutic avenue for developing drugs appropriate for DMD patients.	[Miura, Pedro; Jasmin, Bernard J.] Univ Ottawa, Dept Cellular & Mol Med, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Andrews, Meghan; Holcik, Martin] Childrens Hosp E Ontario, Apoptosis Res Ctr, Ottawa, ON, Canada; [Jasmin, Bernard J.] Ottawa Hosp, Ottawa Hlth Res Inst, Mol Med Program, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Miura, P (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ctr Neuromuscular Dis, Ottawa, ON, Canada.	jasmin@uottawa.ca	Holcik, Martin/E-5372-2011; Holcik, Martin/AAC-6660-2019; Miura, Pedro/N-4604-2013	Holcik, Martin/0000-0002-1922-5299; Miura, Pedro/0000-0002-8434-5027	L'Association Francaise contre les Myopathies; Canadian Institutes of Health Research (CIHR) [Canada Graduate Scholarships Doctoral Award]; Muscular Dystrophy Association-USA; CHEO	L'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association-USA(Muscular Dystrophy Association); CHEO	This work was supported by grants from the L'Association Francaise contre les Myopathies (AFM) (to B.J.J.), the Canadian Institutes of Health Research (CIHR) (to B.J.J. and M.H.), the Muscular Dystrophy Association-USA (to B.J.J.), and a CHEO feasibility grant (to M.H. and B.J.J.). P.M. was supported by a fellowship from AFM during the course of this work, and is a recipient of a CIHR Canada Graduate Scholarships Doctoral Award.	Ambuhl PM, 1999, J CLIN INVEST, V103, P429, DOI 10.1172/JCI2913; Biggar WD, 2001, J PEDIATR-US, V138, P45, DOI 10.1067/mpd.2001.109601; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Bonet-Kerrache A, 2005, BIOCHEM J, V391, P261, DOI 10.1042/BJ20050024; Bonifati MD, 2000, MUSCLE NERVE, V23, P1344, DOI 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.3.CO;2-6; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Campbell Craig, 2003, BMC Neurol, V3, P7, DOI 10.1186/1471-2377-3-7; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; COLSON P, 1992, AM J PHYSIOL, V263, pE1054; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; Courdier-Fruh I, 2003, NEUROMUSCULAR DISORD, V13, P699, DOI 10.1016/S0960-8966(03)00117-2; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Devarajan P, 2000, AM J PHYSIOL-RENAL, V279, pF1132, DOI 10.1152/ajprenal.2000.279.6.F1132; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Fisher I, 2005, FASEB J, V19, P834, DOI 10.1096/fj.04-2511fje; Galy B, 1999, CANCER RES, V59, P165; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Gramolini AO, 1999, J NEUROPATH EXP NEUR, V58, P235, DOI 10.1097/00005072-199903000-00003; Gramolini AO, 1997, J BIOL CHEM, V272, P8117, DOI 10.1074/jbc.272.13.8117; Henis-Korenblit S, 2002, P NATL ACAD SCI USA, V99, P5400, DOI 10.1073/pnas.082102499; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kim YK, 2000, J MOL BIOL, V304, P119, DOI 10.1006/jmbi.2000.4179; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; LO CV, 1995, CALCIFIED TISSUE INT, V56, P109; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nordsborg N, 2005, J PHYSIOL-LONDON, V567, P583, DOI 10.1113/jphysiol.2005.087031; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; PONTA H, 1985, P NATL ACAD SCI USA, V82, P1020, DOI 10.1073/pnas.82.4.1020; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; SARANTOS P, 1994, AM J SURG, V167, P8, DOI 10.1016/0002-9610(94)90047-7; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2002, J BIOL CHEM, V277, P2525, DOI 10.1074/jbc.M105935200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE1185, DOI 10.1152/ajpendo.2000.279.5.E1185; Shah OJ, 2000, BIOCHEM J, V347, P389, DOI 10.1042/0264-6021:3470389; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; VERDI JM, 1990, J BIOL CHEM, V265, P20314; Warnakulasuriyarachchi D, 2004, J BIOL CHEM, V279, P17148, DOI 10.1074/jbc.M308737200; Wehling-Henricks M, 2004, NEUROMUSCULAR DISORD, V14, P483, DOI 10.1016/j.nmd.2004.04.008; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200	58	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2309	10.1371/journal.pone.0002309	http://dx.doi.org/10.1371/journal.pone.0002309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545658	gold, Green Published			2022-12-27	WOS:000263248800001
J	Park, JY; Cho, MO; Leonard, S; Calder, B; Mian, IS; Kim, WH; Wijnhoven, S; van Steeg, H; Mitchell, J; van der Horst, GTJ; Hoeijmakers, J; Cohen, P; Vijg, J; Suh, Y				Park, Jung Yoon; Cho, Mi-Ook; Leonard, Shanique; Calder, Brent; Mian, I. Saira; Kim, Woo Ho; Wijnhoven, Susan; van Steeg, Harry; Mitchell, James; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan; Cohen, Pinchas; Vijg, Jan; Suh, Yousin			Homeostatic Imbalance between Apoptosis and Cell Renewal in the Liver of Premature Aging Xpd(TTD) Mice	PLOS ONE			English	Article							DNA-REPAIR; GENOMIC INSTABILITY; SOMATIC MUTATIONS; LIFE-SPAN; P53; GENE; DEFICIENT; FAS; MECHANISMS; PATHWAYS	Unrepaired or misrepaired DNA damage has been implicated as a causal factor in cancer and aging. Xpd(TTD) mice, harboring defects in nucleotide excision repair and transcription due to a mutation in the Xpd gene (R722W), display severe symptoms of premature aging but have a reduced incidence of cancer. To gain further insight into the molecular basis of the mutant-specific manifestation of age-related phenotypes, we used comparative microarray analysis of young and old female livers to discover gene expression signatures distinguishing Xpd(TTD) mice from their age-matched wild type controls. We found a transcription signature of increased apoptosis in the Xpd(TTD) mice, which was confirmed by in situ immunohistochemical analysis and found to be accompanied by increased proliferation. However, apoptosis rate exceeded the rate of proliferation, resulting in homeostatic imbalance. Interestingly, a metabolic response signature was observed involving decreased energy metabolism and reduced IGF-1 signaling, a major modulator of life span. We conclude that while the increased apoptotic response to endogenous DNA damage contributes to the accelerated aging phenotypes and the reduced cancer incidence observed in the Xpd(TTD) mice, the signature of reduced energy metabolism is likely to reflect a compensatory adjustment to limit the increased genotoxic stress in these mutants. These results support a general model for premature aging in DNA repair deficient mice based on cellular responses to DNA damage that impair normal tissue homeostasis.	[Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Leonard, Shanique] Univ Texas, Hlth Sci Ctr San Antonio, Barshop Inst Longevity & Aging Stud, Dept Physiol, San Antonio, TX USA; [Calder, Brent; Vijg, Jan] Buck Inst Age Res, Novato, CA USA; [Mian, I. Saira] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Wijnhoven, Susan; van Steeg, Harry] Natl Inst Publ Hlth & Env, Lab Toxicol, Pathol & Genet, Bilthoven, Netherlands; [Mitchell, James; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan] Erasmus MC, MGC Dept Cell Biol & Genet, Rotterdam, Netherlands; [Cohen, Pinchas] Univ Calif Los Angeles, Los Angeles, CA USA; [Park, Jung Yoon; Cho, Mi-Ook; Suh, Yousin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Health San Antonio; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Seoul National University (SNU); Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine	Park, JY (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	ysuh@aecom.yu.edu	Hoeijmakers, Jan/AAX-6972-2021; van der Horst, Gijsbertus TJ/E-3661-2015; Kim, Wooho/G-3703-2011	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; 	US National Institute of Health [RO1 AG024391, RO3 AG023292, PO1 AG17242, RO1AG20438, UO1ES11044]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG023292, R01AG020438, R01AG024391, P01AG017242] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institute of Health (RO1 AG024391 and RO3 AG023292) awarded to YS, and (PO1 AG17242, RO1AG20438, UO1ES11044) awarded to JV.	Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Bohr VA, 2005, DNA REPAIR, V4, P293, DOI 10.1016/j.dnarep.2004.09.010; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Desagher S, 2005, J BIOL CHEM, V280, P5693, DOI 10.1074/jbc.M408971200; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Giese H, 1999, ONCOGENE, V18, P1257, DOI 10.1038/sj.onc.1202404; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liedtke C, 2004, J HEPATOL, V40, P874, DOI 10.1016/j.jhep.2004.02.020; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Papaconstantinou J, 2005, MECH AGEING DEV, V126, P692, DOI 10.1016/j.mad.2005.01.002; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Suh Y, 2006, ANTIOXID REDOX SIGN, V8, P559, DOI 10.1089/ars.2006.8.559; Suh YS, 2000, CANCER RES, V60, P5067; van de Ven M, 2007, MECH AGEING DEV, V128, P58, DOI 10.1016/j.mad.2006.11.011; van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vijg J, 2006, NATURE, V440, P874, DOI 10.1038/440874a; Vijg J, 2005, AGING CELL, V4, P331, DOI 10.1111/j.1474-9726.2005.00179.x; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753	42	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2346	10.1371/journal.pone.0002346	http://dx.doi.org/10.1371/journal.pone.0002346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545656	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800008
J	Buck, M				Buck, Martina			Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures	PLOS ONE			English	Article							LIVER-CANCER; C/EBP-BETA; GROWTH-FACTOR; LOW-DENSITY; CELL-LINE; EXPRESSION; ACTIVATION; PHOSPHORYLATION; BINDING; ENTRY	Background: Hepatitis C virus (HCV) infection afflicts about 170 million individuals worldwide. However, the HCV life cycle is only partially understood because it has not been possible to infect normal human hepatocytes in culture. The current Huh-7 systems use cloned, synthetic HCV RNA expressed in hepatocellular carcinoma cells to produce virions, but these cells cannot be infected with naturally occurring HCV obtained from infected patients. Methodology/Principal Findings: Here, we describe a human hepatocyte culture permissible to the direct infection with naturally occurring HCV genotypes 1, 2, 3 and 4 in the blood of HCV-infected patients. The culture system mimics the biology and kinetics of HCV infection in humans, and produces infectious virions that can infect naive human hepatocytes. Conclusions/Significance: This culture system should complement the existing systems, and may facilitate the understanding of the HCV life cycle, its effects in the natural host cell, the hepatocyte, as well as the development of novel therapeutics and vaccines.	[Buck, Martina] Univ Calif, Dept Med & Moores Canc Ctr, La Jolla, CA USA; [Buck, Martina] VA Healthcare Ctr, Dept Med, San Diego, CA USA	University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif, Dept Med & Moores Canc Ctr, La Jolla, CA USA.	mbuck@ucsd.edu			National Institutes of Health [R37-DK-46071, DK-38652, CA-96932]; Department of Veterans Affairs; Medical Research Foundation, University of California, San Diego; National Cancer Institute [Howard Temin Award]; NATIONAL CANCER INSTITUTE [K01CA096932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Medical Research Foundation, University of California, San Diego; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (R37-DK-46071, DK-38652, and CA-96932), the Department of Veterans Affairs (Merit Review) and the Medical Research Foundation, University of California, San Diego. M.B. is a recipient of the Howard Temin Award from the National Cancer Institute. None of these funders had any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; Buck M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001372; Cho MK, 2003, HEPATOLOGY, V37, P686, DOI 10.1053/jhep.2003.50078; CHUNG R, 2007, AASLD, P306; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; De Vos R, 2002, J HEPATOL, V37, P370, DOI 10.1016/S0168-8278(02)00236-2; Durantel D, 2007, J HEPATOL, V46, P1, DOI 10.1016/j.jhep.2006.10.005; Fournier C, 1998, J GEN VIROL, V79, P2367, DOI 10.1099/0022-1317-79-10-2367; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; HEPATITIS C, WKLY EPIDEMIOL REC, V72, P341; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jung CR, 2006, HEPATOLOGY, V43, P1042, DOI 10.1002/hep.21137; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149; Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9; MIYAMOTO H, 1992, J GEN VIROL, V73, P715, DOI 10.1099/0022-1317-73-3-715; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Mueller S, 2006, GASTROENTEROLOGY, V130, P2229, DOI 10.1053/j.gastro.2006.05.006; Murakami K, 2006, VIROLOGY, V351, P381, DOI 10.1016/j.virol.2006.03.038; Nagao K, 2005, INT J MOL MED, V15, P683; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Patel Keyur, 2005, Clin Liver Dis, V9, P399, DOI 10.1016/j.cld.2005.05.007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shimizu YK, 1996, HEPATOLOGY, V23, P205; Shimotohno K, 2000, SEMIN CANCER BIOL, V10, P233, DOI 10.1006/scbi.2000.0322; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; *US DEP HHS, 2004, 045491 US DEP HLTH H, P61; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Williams BRG, 2003, SCIENCE, V300, P1100, DOI 10.1126/science.1085277; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Yokoo H, 2004, HEPATOLOGY, V40, P609, DOI 10.1002/hep.20372; Zhao XP, 2002, J CLIN INVEST, V109, P221, DOI 10.1172/JCI13011; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	60	51	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2660	10.1371/journal.pone.0002660	http://dx.doi.org/10.1371/journal.pone.0002660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628977	Green Submitted, Green Published, gold			2022-12-27	WOS:000264057200006
J	Doostzadeh, J; Shokralla, S; Absalan, F; Jalili, R; Mohandessi, S; Langston, JW; Davis, RW; Ronaghi, M; Gharizadeh, B				Doostzadeh, Julie; Shokralla, Shadi; Absalan, Farnaz; Jalili, Roxana; Mohandessi, Sharareh; Langston, James W.; Davis, Ronald W.; Ronaghi, Mostafa; Gharizadeh, Baback			High Throughput Automated Allele Frequency Estimation by Pyrosequencing	PLOS ONE			English	Article								Pyrosequencing is a DNA sequencing method based on the principle of sequencing-by-synthesis and pyrophosphate detection through a series of enzymatic reactions. This bioluminometric, real-time DNA sequencing technique offers unique applications that are cost-effective and user-friendly. In this study, we have combined a number of methods to develop an accurate, robust and cost efficient method to determine allele frequencies in large populations for association studies. The assay offers the advantage of minimal systemic sampling errors, uses a general biotin amplification approach, and replaces dTTP for dATP-apha-thio to avoid non-uniform higher peaks in order to increase accuracy. We demonstrate that this newly developed assay is a robust, cost-effective, accurate and reproducible approach for large-scale genotyping of DNA pools. We also discuss potential improvements of the software for more accurate allele frequency analysis.	[Doostzadeh, Julie; Mohandessi, Sharareh; Langston, James W.] Parkinsons Inst, Sunnyvale, CA USA; [Shokralla, Shadi; Jalili, Roxana; Davis, Ronald W.; Ronaghi, Mostafa; Gharizadeh, Baback] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA USA; [Absalan, Farnaz] Princeton Univ, Dept Mol Biol, Princeton, NJ USA	Stanford University; Princeton University	Doostzadeh, J (corresponding author), Parkinsons Inst, Sunnyvale, CA USA.	baback@stanford.edu			National Institutes of Health [R01HG003571, R01HG00205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG003571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants from National Institutes of Health R01HG003571 and R01HG00205	Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Farkas DH, 1996, ARCH PATHOL LAB MED, V120, P591; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Gruber JD, 2002, HUM GENET, V110, P395, DOI 10.1007/s00439-002-0722-6; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Lavebratt C, 2004, HUM MUTAT, V23, P92, DOI 10.1002/humu.10292; Neve B, 2002, BIOTECHNIQUES, V32, P1138, DOI 10.2144/02325dd03; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04	11	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2693	10.1371/journal.pone.0002693	http://dx.doi.org/10.1371/journal.pone.0002693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628978	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200036
J	Fischer, NO; Tok, JBH; Tarasow, TM				Fischer, Nicholas O.; Tok, Jeffrey B. -H.; Tarasow, Theodore M.			Massively Parallel Interrogation of Aptamer Sequence, Structure and Function	PLOS ONE			English	Article								Background: Optimization of high affinity reagents is a significant bottleneck in medicine and the life sciences. The ability to synthetically create thousands of permutations of a lead high-affinity reagent and survey the properties of individual permutations in parallel could potentially relieve this bottleneck. Aptamers are single stranded oligonucleotides affinity reagents isolated by in vitro selection processes and as a class have been shown to bind a wide variety of target molecules. Methodology/Principal Findings: High density DNA microarray technology was used to synthesize, in situ, arrays of approximately 3,900 aptamer sequence permutations in triplicate. These sequences were interrogated on-chip for their ability to bind the fluorescently-labeled cognate target, immunoglobulin E, resulting in the parallel execution of thousands of experiments. Fluorescence intensity at each array feature was well resolved and shown to be a function of the sequence present. The data demonstrated high intra- and inter-chip correlation between the same features as well as among the sequence triplicates within a single array. Consistent with aptamer mediated IgE binding, fluorescence intensity correlated strongly with specific aptamer sequences and the concentration of IgE applied to the array. Conclusion and Significance: The massively parallel sequence-function analyses provided by this approach confirmed the importance of a consensus sequence found in all 21 of the original IgE aptamer sequences and support a common stem: loop structure as being the secondary structure underlying IgE binding. The microarray application, data and results presented illustrate an efficient, high information content approach to optimizing aptamer function. It also provides a foundation from which to better understand and manipulate this important class of high affinity biomolecules.	[Fischer, Nicholas O.; Tok, Jeffrey B. -H.] Lawrence Livermore Natl Lab, Chem Mat Earth & Life Sci Directorate, Livermore, CA 94550 USA; [Tarasow, Theodore M.] Tethys Biosci Inc, Emeryville, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Fischer, NO (corresponding author), Lawrence Livermore Natl Lab, Chem Mat Earth & Life Sci Directorate, Livermore, CA 94550 USA.	ttarasow@tethysbio.com	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390	Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory; Tethys Bioscience	Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory; Tethys Bioscience	This work was supported by the Biosecurity and Nanosciecnes Laboratory at Lawrence Livermore National Laboratory and by Tethys Bioscience. Sponsors reviewed and approved manuscript.	Bock C, 2004, PROTEOMICS, V4, P609, DOI 10.1002/pmic.200300631; Brody EN, 1999, MOL DIAGN, V4, P381, DOI 10.1016/S1084-8592(99)80014-9; Cho EJ, 2006, ANAL CHIM ACTA, V564, P82, DOI 10.1016/j.aca.2005.12.038; Collett JR, 2005, METHODS, V37, P4, DOI 10.1016/j.ymeth.2005.05.009; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 1999, CURR OPIN STRUC BIOL, V9, P324, DOI 10.1016/S0959-440X(99)80043-8; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; Hamula CLA, 2006, TRAC-TREND ANAL CHEM, V25, P681, DOI 10.1016/j.trac.2006.05.007; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Katilius E, 2007, NUCLEIC ACIDS RES, V35, P7626, DOI 10.1093/nar/gkm922; Liu JW, 2006, ANGEW CHEM INT EDIT, V45, P90, DOI 10.1002/anie.200502589; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Proske D, 2005, APPL MICROBIOL BIOT, V69, P367, DOI 10.1007/s00253-005-0193-5; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wiegand TW, 1996, J IMMUNOL, V157, P221; Xiao Y, 2005, ANGEW CHEM INT EDIT, V44, P5456, DOI 10.1002/anie.200500989; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2720	10.1371/journal.pone.0002720	http://dx.doi.org/10.1371/journal.pone.0002720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628955	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200058
J	Nienhaus, A; Schablon, A; Diel, R				Nienhaus, Albert; Schablon, Anja; Diel, Roland			Interferon-Gamma Release Assay for the Diagnosis of Latent TB Infection - Analysis of Discordant Results, when Compared to the Tuberculin Skin Test	PLOS ONE			English	Article							HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; OCCUPATIONAL RISK; RECOMMENDATIONS; DISEASE; BCG	Background: With the Interferon-c release assays (IGRA) a new method for the diagnosis of latent tuberculosis infections (LTBI) is available. Due to the lack of a gold standard for the diagnosis of LTBI, the IGRA is compared to the Mantoux Tuberculin Skin Test (TST), which yields discordant results in varying numbers. Therefore we assessed to which extent discordant results can be explained by potential risk factors such as age, BCG vaccination and migration. Methods and Findings: In this pooled analysis, two German studies evaluating the Quantiferon-Gold In-Tube test (QFT) by comparison with the TST (RT23 of SSI) were combined and logistic regressions for potential risk factors for TST+/QFT- as well as THT2/QFT+ discordance were calculated. The analysis comprises 1,033 participants. Discordant results were observed in 15.4%, most of them being TST+/QFT- combinations. BCG vaccination or migration explained 85.1% of all TST+/QFT- discordance. Age explained 49.1% of all TST-/QFT+ discordance. Agreement between the two tests was 95.6% in German-born persons younger than 40 years and not BCG-vaccinated. Conclusions: After adjustment for potential risk factors for positive or negative TST results, agreement of QFT and TST is excellent with little potential that the TST is more likely to detect old infections than the QFT. In surveillance programs for LTBI in high-income, low TB incidence countries like Germany the QFT is especially suited for persons with BCG vaccination or migrants due to better specificity and in older persons due to its superior sensitivity.	[Nienhaus, Albert; Schablon, Anja] Inst Statutory Accid Insurance & Prevent Hlth & W, Dept Occupat Hlth Res, Hamburg, Germany; [Diel, Roland] Univ Dusseldorf, Inst Med Sociol, Sch Publ Hlth, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Nienhaus, A (corresponding author), Inst Statutory Accid Insurance & Prevent Hlth & W, Dept Occupat Hlth Res, Hamburg, Germany.	albert.nienhaus@bgw-online.de						Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barsegian V, 2008, J HOSP INFECT, V69, P69, DOI 10.1016/j.jhin.2008.02.009; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Diel R, 2007, Pneumologie, V61, P440, DOI 10.1055/s-2007-959219; Diel R, 2006, EUR RESPIR J, V28, P16, DOI 10.1183/09031936.06.00107005; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Franken WPJ, 2007, CLIN VACCINE IMMUNOL, V14, P477, DOI 10.1128/CVI.00463-06; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Infuso A, 2006, Euro Surveill, V11, P6, DOI 10.2807/esm.11.03.00604-en; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Keskiner R, 2004, INFECT CONT HOSP EP, V25, P1067, DOI 10.1086/502345; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; MANTOUX MC, 1912, PRESSE MED, V20, P146; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nahid Payam, 2006, Proc Am Thorac Soc, V3, P103, DOI 10.1513/pats.200511-119JH; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2005, Indian J Med Microbiol, V23, P151; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Robert Koch-Institut (RKI), 2002, EPIDEM B, V07, P49; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; *SIM GUTL, 1988, PRAX KLIN PNEUMOL, V42, P423; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; World Health Organization, 2008, GLOB TUB CONTR SURV; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	33	93	97	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2665	10.1371/journal.pone.0002665	http://dx.doi.org/10.1371/journal.pone.0002665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628829	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200011
J	Matarese, V				Matarese, Valerie			Relationship between Quality and Editorial Leadership of Biomedical Research Journals: A Comparative Study of Italian and UK Journals	PLOS ONE			English	Article							MEDICAL JOURNALS; IMPACT; REGISTRATION; COMMITTEE; TRIALS	Background: The quality of biomedical reporting is guided by statements of several organizations. Although not all journals adhere to these guidelines, those that do demonstrate "editorial leadership'' in their author community. To investigate a possible relationship between editorial leadership and journal quality, research journals from two European countries, one Anglophone and one non-Anglophone, were studied and compared. Quality was measured on a panel of bibliometric parameters while editorial leadership was evaluated from journals' instructions to authors. Methodology/Principal Findings: The study considered all 76 Italian journals indexed in Medline and 76 randomly chosen UK journals; only journals both edited and published in these countries were studied. Compared to UK journals, Italian journals published fewer papers (median, 60 vs. 93; p = 0.006), less often had online archives ( 43 vs. 74; p < 0.001) and had lower median values of impact factor (1.2 vs. 2.7, p < 0.001) and SCImago journal rank (0.09 vs. 0.25, p < 0.001). Regarding editorial leadership, Italian journals less frequently required manuscripts to specify competing interests ( p < 0.001), authors' contributions (p = 0.005), funding (p < 0.001), informed consent (p < 0.001), ethics committee review (p < 0.001). No Italian journal adhered to COPE or the CONSORT and QUOROM statements nor required clinical trial registration, while these characteristics were observed in 15%-43% of UK journals (p < 0.001). At multiple regression, editorial leadership predicted 37.1%-49.9% of the variance in journal quality defined by citation statistics (p < 0.0001); confounding variables inherent to a cross-cultural comparison had a relatively small contribution, explaining an additional 6.2%-13.8% of the variance. Conclusions/Significance: Journals from Italy scored worse for quality and editorial leadership than did their UK counterparts. Editorial leadership predicted quality for the entire set of journals. Greater appreciation of international initiatives to improve biomedical reporting may help low-quality journals achieve higher status.	[Matarese, Valerie] UpTo Infotechnol, Vidor, TV, Italy		Matarese, V (corresponding author), UpTo Infotechnol, Vidor, TV, Italy.	vmatarese@uptoit.org	Matarese, Valerie/ABE-1606-2020	Matarese, Valerie/0000-0003-2687-194X				Abbott A, 2006, NATURE, V440, P264, DOI 10.1038/440264a; Altman D, 2007, LANCET, V370, P1494, DOI 10.1016/S0140-6736(07)61635-3; Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; [Anonymous], INT COMMITTEE MED J; BECKER SO, 2003, 839 CESIFO; *COMM PUBL ETH, GUID GOOD PUBL PRACT; *COUNC SCI ED, ED POL STAT; Davidoff F, 2001, ANN INTERN MED, V135, P463, DOI 10.7326/0003-4819-135-6-200109180-00016; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; *EUR COMM, 2007, KEY FIG 2007 EUR RES; European Commission, 2000, EUR RES AR SCI TECHN; Falagas ME, 2006, CAN MED ASSOC J, V175, P1389, DOI 10.1503/cmaj.060361; FALAGAS ME, 2008, FASEB J         0411; Habibzadeh F, 2006, CROAT MED J, V47, P181; Habibzadeh F, 2005, B WORLD HEALTH ORGAN, V83, P404; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Marusic A, 1999, CROAT MED J, V40, P508; Marusic A, 2002, CROAT MED J, V43, P1; Marusic M, 2004, INT MICROBIOL, V7, P143; Marusic M, 2001, CROAT MED J, V42, P113; Mela GS, 2003, EUR RADIOL, V13, P657, DOI 10.1007/s00330-002-1640-7; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Negrini S, 2007, Eura Medicophys, V43, P299; OROFIADJEI D, 2006, PLOS MED, V3, pE359; PESCATORI M, 2000, TECH COLOPROCTOL, V4, P127; Schriger DL, 2006, ANN EMERG MED, V48, P743, DOI 10.1016/j.annemergmed.2006.03.028; Schroter S, 2006, J MED ETHICS, V32, P718, DOI 10.1136/jme.2005.015115; Scuderi Gabriella, 2004, Ann Ist Super Sanita, V40, P495; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192; Ugolini D, 2003, SCIENTOMETRICS, V56, P345, DOI 10.1023/A:1022326820017; Ugolini D, 2005, EUR J CANCER, V41, P485, DOI 10.1016/j.ejca.2004.11.008; WAGER E, 2007, MED GEN MED, V9, P16; WAGNER CS, 2001, MR13570WB RAND	35	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2512	10.1371/journal.pone.0002512	http://dx.doi.org/10.1371/journal.pone.0002512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596938	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200002
J	Stein, A; Aloy, P				Stein, Amelie; Aloy, Patrick			Contextual Specificity in Peptide-Mediated Protein Interactions	PLOS ONE			English	Article								Most biological processes are regulated through complex networks of transient protein interactions where a globular domain in one protein recognizes a linear peptide from another, creating a relatively small contact interface. Although sufficient to ensure binding, these linear motifs alone are usually too short to achieve the high specificity observed, and additional contacts are often encoded in the residues surrounding the motif (i.e. the context). Here, we systematically identified all instances of peptide-mediated protein interactions of known three-dimensional structure and used them to investigate the individual contribution of motif and context to the global binding energy. We found that, on average, the context is responsible for roughly 20% of the binding and plays a crucial role in determining interaction specificity, by either improving the affinity with the native partner or impeding non-native interactions. We also studied and quantified the topological and energetic variability of interaction interfaces, finding a much higher heterogeneity in the context residues than in the consensus binding motifs. Our analysis partially reveals the molecular mechanisms responsible for the dynamic nature of peptide-mediated interactions, and suggests a global evolutionary mechanism to maximise the binding specificity. Finally, we investigated the viability of non-native interactions and highlight cases of potential cross-reaction that might compensate for individual protein failure and establish backup circuits to increase the robustness of cell networks.	[Stein, Amelie; Aloy, Patrick] BSC, IRB, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Stein, A (corresponding author), BSC, IRB, Barcelona, Spain.	patrick.aloy@irbbarcelona.org	Aloy, Patrick/AAB-3538-2019; Stein, Amelie/K-1417-2019	Stein, Amelie/0000-0002-5862-1681; Aloy, Patrick/0000-0002-3557-0236	Spanish Ministerio de Educacion y Ciencia [BIO2007-62426, PSE-010000-2007-1]; ICREA Funding Source: Custom	Spanish Ministerio de Educacion y Ciencia(Spanish Government); ICREA(ICREA)	This work has been supported by the Spanish Ministerio de Educacion y Ciencia through the grants BIO2007-62426 and PSE-010000-2007-1.	Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Egea PF, 2000, FEBS LETT, V476, P62, DOI 10.1016/S0014-5793(00)01672-0; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Folkertsma S, 2007, MOL ENDOCRINOL, V21, P30, DOI 10.1210/me.2006-0072; Freund C, 2002, EMBO J, V21, P5985, DOI 10.1093/emboj/cdf602; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mahajan A, 2005, J AM CHEM SOC, V127, P14572, DOI 10.1021/ja054538m; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	44	116	117	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2524	10.1371/journal.pone.0002524	http://dx.doi.org/10.1371/journal.pone.0002524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596940	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200004
J	Ancuta, P; Kamat, A; Kunstman, KJ; Kim, EY; Autissier, P; Wurcel, A; Zaman, T; Stone, D; Mefford, M; Morgello, S; Singer, EJ; Wolinsky, SM; Gabuzda, D				Ancuta, Petronela; Kamat, Anupa; Kunstman, Kevin J.; Kim, Eun-Young; Autissier, Patrick; Wurcel, Alysse; Zaman, Tauheed; Stone, David; Mefford, Megan; Morgello, Susan; Singer, Elyse J.; Wolinsky, Steven M.; Gabuzda, Dana			Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients	PLOS ONE			English	Article								Elevated plasma lipopolysaccharide (LPS), an indicator of microbial translocation from the gut, is a likely cause of systemic immune activation in chronic HIV infection. LPS induces monocyte activation and trafficking into brain, which are key mechanisms in the pathogenesis of HIV-associated dementia (HAD). To determine whether high LPS levels are associated with increased monocyte activation and HAD, we obtained peripheral blood samples from AIDS patients and examined plasma LPS by Limulus amebocyte lysate (LAL) assay, peripheral blood monocytes by FACS, and soluble markers of monocyte activation by ELISA. Purified monocytes were isolated by FACS sorting, and HIV DNA and RNA levels were quantified by real time PCR. Circulating monocytes expressed high levels of the activation markers CD69 and HLA-DR, and harbored low levels of HIV compared to CD4(+) T-cells. High plasma LPS levels were associated with increased plasma sCD14 and LPS-binding protein (LBP) levels, and low endotoxin core antibody levels. LPS levels were higher in HAD patients compared to control groups, and were associated with HAD independently of plasma viral load and CD4 counts. LPS levels were higher in AIDS patients using intravenous heroin and/or ethanol, or with Hepatitis C virus (HCV) co-infection, compared to control groups. These results suggest a role for elevated LPS levels in driving monocyte activation in AIDS, thereby contributing to the pathogenesis of HAD, and provide evidence that cofactors linked to substance abuse and HCV co-infection influence these processes.	[Ancuta, Petronela; Kamat, Anupa; Mefford, Megan; Gabuzda, Dana] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Kunstman, Kevin J.; Kim, Eun-Young; Wolinsky, Steven M.] Northwestern Univ, Med Sch, Chicago, IL USA; [Autissier, Patrick] Beth Israel Deaconess Med Ctr, Boston, MA USA; [Wurcel, Alysse; Zaman, Tauheed; Stone, David] Lemuel Shattuck Hosp, Jamaica Plain, MA USA; [Morgello, Susan] Mount Sinai Med Ctr, New York, NY USA; [Singer, Elyse J.] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Northwestern University; Harvard University; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Ancuta, P (corresponding author), Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA.	dana_gabuzda@dfci.harvard.edu	Wurcel, Alysse/AAZ-6132-2020; Wurcel, Alysse/AAC-5372-2019; Wolinsky, Steven/B-2893-2012	Wurcel, Alysse/0000-0002-8255-8387; Mefford, Megan/0000-0003-4441-7134; Ancuta, Petronela/0000-0003-1922-5640; Wolinsky, Steven/0000-0002-9625-6697; Kim, Eunyoung/0000-0002-7436-7396	NIH [DA016549, MH083588]; Fonds de la Recherche en Sante Quebec (FRSQ); French National Institute of Health and Medical Research (INSERM); Harvard Center for AIDS Research; DFCI/Harvard Center for Cancer Research; NNTC [MH 59745, NS38841, MH59656, NS54591, MH59724];  [NS060611]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083588, R24MH059745, R24MH059724, R24MH059656, U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016549, R21DA026322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Harvard Center for AIDS Research; DFCI/Harvard Center for Cancer Research; NNTC; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH DA016549 and MH083588. P.A. was supported in part by Fonds de la Recherche en Sante Quebec (FRSQ) and the French National Institute of Health and Medical Research (INSERM). M.M. was supported in part by NS060611. Core facilities were supported by the Harvard Center for AIDS Research and DFCI/Harvard Center for Cancer Research grants. NNTC sites were supported by MH 59745, NS38841, MH59656, NS54591, and MH59724.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Almodovar S, 2007, VIROLOGY, V369, P35, DOI 10.1016/j.virol.2007.07.010; Amirayan-Chevillard N, 2000, CLIN EXP IMMUNOL, V120, P107, DOI 10.1046/j.1365-2249.2000.01201.x; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2006, J IMMUNOL, V176, P5760, DOI 10.4049/jimmunol.176.10.5760; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Asakura E, 1997, IMMUNOPHARMACOLOGY, V37, P7, DOI 10.1016/S0162-3109(96)00165-8; Bouwman FH, 1998, NEUROLOGY, V50, P1814, DOI 10.1212/WNL.50.6.1814; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chapoval AI, 1998, J LEUKOCYTE BIOL, V63, P245, DOI 10.1002/jlb.63.2.245; Cherner M, 2007, J NEUROVIROL, V13, P23, DOI 10.1080/13550280601089175; COHEN IR, 1966, SCIENCE, V152, P1257, DOI 10.1126/science.152.3726.1257; CROWE S, 2003, J LEUKOCYTE BIOL, V21, P21; Davidson DJ, 2006, J IMMUNOL, V177, P8202, DOI 10.4049/jimmunol.177.11.8202; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Gartner S, 2002, J NEUROVIROL, V8, P69, DOI 10.1080/13550280290049525; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hutchinson SJ, 1997, QJM-MON J ASSOC PHYS, V90, P685, DOI 10.1093/qjmed/90.11.685; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kapadia F, 2005, CLIN INFECT DIS, V41, P1027, DOI 10.1086/433175; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kusdra L, 2002, AIDS, V16, P31, DOI 10.1097/00002030-200201040-00005; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Lien E, 1998, BLOOD, V92, P2084, DOI 10.1182/blood.V92.6.2084.418k26_2084_2092; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Morgello S, 2005, SEMIN LIVER DIS, V25, P118, DOI 10.1055/s-2005-864787; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Parsons TD, 2006, AIDS, V20, P1591, DOI 10.1097/01.aids.0000238404.16121.47; Peng XH, 2001, J IMMUNOL, V167, P3677, DOI 10.4049/jimmunol.167.7.3677; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rankine EL, 2006, EUR J NEUROSCI, V24, P77, DOI 10.1111/j.1460-9568.2006.04891.x; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Ryan LA, 2001, J INFECT DIS, V184, P699, DOI 10.1086/323036; SHEN YN, 1994, CLIN DIAGN LAB IMMUN, V1, P531, DOI 10.1128/CDLI.1.5.531-537.1994; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; van Marle G, 2002, AIDS, V16, P1905, DOI 10.1097/00002030-200209270-00007; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	64	362	373	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2516	10.1371/journal.pone.0002516	http://dx.doi.org/10.1371/journal.pone.0002516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575590	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000033
J	McDermott, SR; Kliman, RM				McDermott, Shannon R.; Kliman, Richard M.			Estimation of Isolation Times of the Island Species in the Drosophila simulans Complex from Multilocus DNA Sequence Data	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; NATURAL-SELECTION; DIVERGENCE; GENE; POLYMORPHISM; POPULATION; STERILITY; LINKAGE; RECOMBINATION; CHROMOSOME	Background: The Drosophila simulans species complex continues to serve as an important model system for the study of new species formation. The complex is comprised of the cosmopolitan species, D. simulans, and two island endemics, D. mauritiana and D. sechellia. A substantial amount of effort has gone into reconstructing the natural history of the complex, in part to infer the context in which functional divergence among the species has arisen. In this regard, a key parameter to be estimated is the initial isolation time (t) of each island species. Loci in regions of low recombination have lower divergence within the complex than do other loci, yet divergence from D. melanogaster is similar for both classes. This might reflect gene flow of the low-recombination loci subsequent to initial isolation, but it might also reflect differential effects of changing population size on the two recombination classes of loci when the low-recombination loci are subject to genetic hitchhiking or pseudohitchhiking Methodology/Principal Findings: New DNA sequence variation data for 17 loci corroborate the prior observation from 13 loci that DNA sequence divergence is reduced in genes of low recombination. Two models are presented to estimate t and other relevant parameters (substitution rate correction factors in lineages leading to the island species and, in the case of the 4-parameter model, the ratio of ancestral to extant effective population size) from the multilocus DNA sequence data. Conclusions/Significance: In general, it appears that both island species were isolated at about the same time, here estimated at -250,000 years ago. It also appears that the difference in divergence patterns of genes in regions of low and higher recombination can be reconciled by allowing a modestly larger effective population size for the ancestral population than for extant D. simulans.	[McDermott, Shannon R.; Kliman, Richard M.] Cedar Crest Muhlenberg Coll, Dept Biol Sci, Allentown, PA USA		McDermott, SR (corresponding author), Cedar Crest Muhlenberg Coll, Dept Biol Sci, Allentown, PA USA.	rmkliman@cedarcrest.edu			NIH [R15HG002456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG002456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The work was supported by NIH grant R15HG002456 to RMK. The sponsors were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Barbash DA, 2007, GENETICS, V176, P543, DOI 10.1534/genetics.107.072827; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; BIRKY CW, 1988, P NATL ACAD SCI USA, V85, P6414, DOI 10.1073/pnas.85.17.6414; Caccone A, 1996, MOL BIOL EVOL, V13, P1224, DOI 10.1093/oxfordjournals.molbev.a025688; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Comeron JM, 2008, HEREDITY, V100, P19, DOI 10.1038/sj.hdy.6801059; COYNE JA, 1994, J HERED, V85, P224, DOI 10.1093/oxfordjournals.jhered.a111440; Gillespie JH, 2000, GENETICS, V155, P909; Hellmann I, 2003, AM J HUM GENET, V72, P1527, DOI 10.1086/375657; Hey J, 2002, GENETICS, V160, P595; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Kliman RM, 2000, GENETICS, V156, P1913; LLOPART A, 2008, J MOL EVOL; Macpherson JM, 2007, GENETICS, V177, P2083, DOI 10.1534/genetics.107.080226; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noor MAF, 2003, GENETICA, V118, P51, DOI 10.1023/A:1022983023900; Ometto L, 2006, BIOL LETT-UK, V2, P604, DOI 10.1098/rsbl.2006.0521; PALOPOLI MF, 1994, GENETICS, V138, P329; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Tao Y, 2003, EVOLUTION, V57, P2580; Throckmorton L.H., 1975, P421; Ting CT, 2000, P NATL ACAD SCI USA, V97, P5313, DOI 10.1073/pnas.090541597; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; True JR, 1996, GENETICS, V142, P819; Wall JD, 2002, GENETICS, V162, P203; Wang RL, 1997, GENETICS, V147, P1091; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	32	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2442	10.1371/journal.pone.0002442	http://dx.doi.org/10.1371/journal.pone.0002442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560591	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700027
J	Penkov, D; Palazzolo, M; Mondino, A; Blasi, F				Penkov, Dmitry; Palazzolo, Martina; Mondino, Anna; Blasi, Francesco			Cytosolic Sequestration of Prep1 Influences Early Stages of T Cell Development	PLOS ONE			English	Article								Objective: Prep1 and Pbx2 are the main homeodomain DNA-binding proteins of the TALE (three amino acid loop extension) family expressed in the thymus. We previously reported reduced Pbx2 expression and defective thymocyte maturation in Prep1 hypomorphic mice. To further investigate the role of this homeodomain DNA-binding protein in T cell development, we generated transgenic mice expressing the N-terminal fragment of Pbx1 (Pbx1NT) under the control of the Lck proximal promoter. Principal Findings: Pbx1NT causes Prep1 cytosolic sequestration, abolishes Prep1-dependent DNA-binding activity and results in reduced Pbx2 expression in developing thymocytes. Transgenic thymi reveal increased numbers of CD4(-) CD8(-) CD44(-) (DN3 and DN4) thymocytes, due to a higher frequency of DN2 and DN4 Pbx1NT thymocytes in the S phase. Transgenic thymocytes however do not accumulate at later stages, as revealed by a normal representation of CD4/CD8 double positive and single positive thymocytes, due to a higher rate of apoptotic cell death of DN4 Pbx1NT thymocytes. Conclusion: The results obtained by genetic (Prep1 hypomorphic) and functional (Pbx1NT transgenic) inactivation of Prep1 support nonredundant roles for this homeodomain protein during different stages of T cell development.	[Penkov, Dmitry; Palazzolo, Martina; Blasi, Francesco] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Mol Genet Unit, Milan, Italy; [Mondino, Anna] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Lymphocyte Activat Unit, Milan, Italy; [Blasi, Francesco] Inst Mol Oncol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IFOM - FIRC Institute of Molecular Oncology	Penkov, D (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Mol Genet Unit, Milan, Italy.	mondino.anna@hsr.it; blasi.francesco@hsr.it	Mondino, Anna/K-9434-2016	Mondino, Anna/0000-0003-0833-6927; Blasi, Francesco/0000-0001-9406-1784	Telethon Italia Onlus; AIRC (Italian Association for Cancer Research); FEBS [fellowship]	Telethon Italia Onlus(Fondazione Telethon); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); FEBS	This work was supported by Telethon Italia Onlus and AIRC (Italian Association for Cancer Research). D. Penkov received a fellowship from FEBS.	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Berthelsen J, 1996, J BIOL CHEM, V271, P3822; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Longobardi E, 2003, J BIOL CHEM, V278, P39235, DOI 10.1074/jbc.M304704200; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105	13	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2424	10.1371/journal.pone.0002424	http://dx.doi.org/10.1371/journal.pone.0002424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560600	Green Submitted, gold, Green Published			2022-12-27	WOS:000263280700010
J	Llop-Guevara, A; Colangelo, M; Chu, DK; Moore, CL; Stieber, NA; Walker, TD; Goncharova, S; Coyle, AJ; Lundblad, LKA; O'Byrne, PM; Lovric, M; Jordana, M				Llop-Guevara, Alba; Colangelo, Marc; Chu, Derek K.; Moore, Cheryl Lynn; Stieber, Nicole A.; Walker, Tina D.; Goncharova, Susanna; Coyle, Anthony J.; Lundblad, Lennart K. A.; O'Byrne, Paul M.; Lovric, Miroslav; Jordana, Manel			In Vivo-to-In Silico Iterations to Investigate Aeroallergen-Host Interactions	PLOS ONE			English	Article								Background: Allergic asthma is a complex process arising out of the interaction between the immune system and aeroallergens. Yet, the relationship between aeroallergen exposure, allergic sensitization and disease remains unclear. This knowledge is essential to gain further insight into the origin and evolution of allergic diseases. The objective of this research is to develop a computational view of the interaction between aeroallergens and the host by investigating the impact of dose and length of aeroallergen exposure on allergic sensitization and allergic disease outcomes, mainly airway inflammation and to a lesser extent lung dysfunction and airway remodeling. Methods and Principal Findings: BALB/C mice were exposed intranasally to a range of concentrations of the most pervasive aeroallergen worldwide, house dust mite (HDM), for up to a quarter of their lifespan (20 weeks). Actual biological data delineating the kinetics, nature and extent of responses for local (airway inflammation) and systemic (HDM-specific immunoglobulins) events were obtained. Mathematical equations for each outcome were developed, evaluated, refined through several iterations involving in vivo experimentation, and validated. The models accurately predicted the original biological data and simulated an extensive array of previously unknown responses, eliciting two- and three-dimensional models. Our data demonstrate the non-linearity of the relationship between aeroallergen exposure and either allergic sensitization or airway inflammation, identify thresholds, behaviours and maximal responsiveness for each outcome, and examine inter-variable relationships. Conclusions: This research provides a novel way to visualize allergic responses in vivo and establishes a basic experimental platform upon which additional variables and perturbations can be incorporated into the system.	[Llop-Guevara, Alba; Colangelo, Marc; Chu, Derek K.; Moore, Cheryl Lynn; Stieber, Nicole A.; Walker, Tina D.; Goncharova, Susanna; Coyle, Anthony J.; Jordana, Manel] McMaster Univ, Ctr Gene Therapeut, Div Resp Dis & Allergy, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Coyle, Anthony J.] MedImmune Inc, Dept Inflammat & Autoimmun, Gaithersburg, MD USA; [O'Byrne, Paul M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lovric, Miroslav] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Lundblad, Lennart K. A.] Univ Vermont, Vermont Lung Ctr, Burlington, VT USA	McMaster University; AstraZeneca; Medimmune; McMaster University; McMaster University; University of Vermont	Llop-Guevara, A (corresponding author), McMaster Univ, Ctr Gene Therapeut, Div Resp Dis & Allergy, Dept Pathol & Mol Med, Hamilton, ON, Canada.	jordanam@mcmaster.ca	T, E/HII-8943-2022	Llop-Guevara, Alba/0000-0002-7913-9472; O'Byrne, Paul/0000-0003-0979-281X; Lundblad, Lennart/0000-0002-1749-8242; Chu, Derek/0000-0001-8269-4496	Canadian Institutes for Health Research (CIHR); MedImmune Inc; LaCaixa-ICCS (Spain) [scholarship]; Ontario Graduate Scholarship; Senior Canada Research Chair	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MedImmune Inc(AstraZenecaMedimmune); LaCaixa-ICCS (Spain); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Senior Canada Research Chair	This research was supported by the Canadian Institutes for Health Research (CIHR) and MedImmune Inc. AL-G holds a LaCaixa-ICCS scholarship (Spain) and MC is supported by an Ontario Graduate Scholarship. MJ is a Senior Canada Research Chair.	An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Cates Elizabeth C., 2007, V14, P42, DOI 10.1159/000107054; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Cohen IR, 2007, IMMUNOL REV, V216, P232; Custis NJ, 2003, CLIN EXP ALLERGY, V33, P986, DOI 10.1046/j.1365-2222.2003.01706.x; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Deisboeck TS, 2005, MED HYPOTHESES, V65, P785, DOI 10.1016/j.mehy.2005.04.014; FATTOUH R, 2008, AM J RESP CRIT CARE; Greenspan NS, 2007, NAT IMMUNOL, V8, P5, DOI 10.1038/ni0107-5; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Oberkampf W.L., 2002, VERIFICATION VALIDAT; Oberkampf WL, 2006, J COMPUT PHYS, V217, P5, DOI 10.1016/j.jcp.2006.03.037; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Sakaguchi M, 1996, J ALLERGY CLIN IMMUN, V97, P1040, DOI 10.1016/S0091-6749(96)70255-5; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Sporik R, 2001, THORAX, V56, P58; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Tovey ER, 2003, ALLERGY, V58, P790, DOI 10.1034/j.1398-9995.2003.00228.x; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7	37	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2426	10.1371/journal.pone.0002426	http://dx.doi.org/10.1371/journal.pone.0002426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545674	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800057
J	Challen, GA; Goodell, MA				Challen, Grant A.; Goodell, Margaret A.			Promiscuous Expression of H2B-GFP Transgene in Hematopoietic Stem Cells	PLOS ONE			English	Article							FLUORESCENT PROTEIN; LOCATION; REVEAL; RESIDE; NICHE; GENE; H3	Background: The study of adult stem cells relies on the ability to isolate them using complex combinations of markers for flow cytometry. A recent study has used a tetracycline-regulatable H2B-GFP transgenic mouse model analogous to BrdU pulse-chase methods to fluorescently label quiescent skin stem cells in vivo. In this study, we sought to use these mice to fluorescently label hematopoietic stem cells to study niche interactions. Methods and Findings: We crossed the H2B-GFP mice to mice carrying a tetracycline-regulated transactivator protein. When these mice were administered doxycycline, we observed a gradual decrease in total bone marrow GFP(+) cells over 12 weeks but the hematopoietic stem cell population remained largely GFP(+) (> 85%). In histological bone sections, the long-term GFP label-retaining cells tended to concentrate at the endosteal surface and competitive transplantation assays showed that the majority of hematopoietic stem cell activity was contained in the GFP(+) cell fraction. However, in response to stimulation with 5-fluorouracil, the hematopoietic stem cells of the crossed mice still retained a high level of GFP expression when it was anticipated the label should be lost when the cells divide. Upon further review, it was determined that the founder H2B-GFP mice showed spurious expression of the transgene at high levels in the hematopoietic stem cell population, thus the observed response of hematopoietic stem cells in the double transgenic mice to doxycycline was due to aberrant expression of the transgene and not the correct tetracycline-regulatable system. Conclusions: We observed promiscuous expression of the H2B-GFP transgene in the hematopoietic stem cell compartment of the bone marrow. This leaky expression prohibits the use of this model to study hematopoietic stem cells in vivo and careful characterization for each organ must be done if this transgenic system is to be used to isolate other prospective tissue stem cells.	[Challen, Grant A.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Challen, Grant A.] Monash Univ, Clayton, Vic, Australia	Baylor College of Medicine; Monash University	Challen, GA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	Australian National Health and Medical Research Council (NHMRC) [CJ Martin Fellowship]; Leukemia and Lymphoma Society [fellow]; NIH [HL081007, EB005173, DK58192]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.A.C. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship. M. A. G. was a fellow of the Leukemia and Lymphoma Society. This work was also supported by NIH grants HL081007, EB005173, and DK58192.	Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Hanazono Y, 2002, J GENE MED, V4, P470, DOI 10.1002/jgm.307; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Klopotowska D, 2008, NEUROCHEM INT, V52, P221, DOI 10.1016/j.neuint.2007.05.014; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Torbett BE, 2002, J GENE MED, V4, P478, DOI 10.1002/jgm.323; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301	24	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2357	10.1371/journal.pone.0002357	http://dx.doi.org/10.1371/journal.pone.0002357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523660	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300044
J	Soanes, DM; Alam, I; Cornell, M; Wong, HM; Hedeler, C; Paton, NW; Rattray, M; Hubbard, SJ; Oliver, SG; Talbot, NJ				Soanes, Darren M.; Alam, Intikhab; Cornell, Mike; Wong, Han Min; Hedeler, Cornelia; Paton, Norman W.; Rattray, Magnus; Hubbard, Simon J.; Oliver, Stephen G.; Talbot, Nicholas J.			Comparative Genome Analysis of Filamentous Fungi Reveals Gene Family Expansions Associated with Fungal Pathogenesis	PLOS ONE			English	Article							MAGNAPORTHE-GRISEA; ASPERGILLUS-NIDULANS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PATHOGENICITY GENES; GALACTOSE-OXIDASE; MOLECULAR-BIOLOGY; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; USTILAGO-MAYDIS	Fungi and oomycetes are the causal agents of many of the most serious diseases of plants. Here we report a detailed comparative analysis of the genome sequences of thirty-six species of fungi and oomycetes, including seven plant pathogenic species, that aims to explore the common genetic features associated with plant disease-causing species. The predicted translational products of each genome have been clustered into groups of potential orthologues using Markov Chain Clustering and the data integrated into the e-Fungi object-oriented data warehouse (http://www.e-fungi.org.uk/). Analysis of the species distribution of members of these clusters has identified proteins that are specific to filamentous fungal species and a group of proteins found only in plant pathogens. By comparing the gene inventories of filamentous, ascomycetous phytopathogenic and free-living species of fungi, we have identified a set of gene families that appear to have expanded during the evolution of phytopathogens and may therefore serve important roles in plant disease. We have also characterised the predicted set of secreted proteins encoded by each genome and identified a set of protein families which are significantly over-represented in the secretomes of plant pathogenic fungi, including putative effector proteins that might perturb host cell biology during plant infection. The results demonstrate the potential of comparative genome analysis for exploring the evolution of eukaryotic microbial pathogenesis.	[Soanes, Darren M.; Wong, Han Min; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Alam, Intikhab; Cornell, Mike; Hedeler, Cornelia; Paton, Norman W.; Rattray, Magnus] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Hubbard, Simon J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Exeter; University of Manchester; University of Manchester; University of Cambridge	Soanes, DM (corresponding author), Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter, Devon, England.	N.J.Talbot@exeter.ac.uk	Rattray, Magnus/B-4393-2009; Talbot, Nicholas J/I-5618-2019; Oliver, Stephen/AAQ-5992-2021; Talbot, Nicholas J/I-9584-2014; Rattray, Magnus/AAE-3297-2021; Hubbard, Simon J/B-9006-2009	Rattray, Magnus/0000-0001-8196-5565; Talbot, Nicholas J/0000-0001-6434-7757; Oliver, Stephen/0000-0003-3410-6439; Talbot, Nicholas J/0000-0001-6434-7757; Rattray, Magnus/0000-0001-8196-5565; Alam, Intikhab/0000-0001-5306-847X; Paton, Norman/0000-0003-2008-6617; Hubbard, Simon/0000-0002-8601-9524	Biotechnology and Biological Sciences Research Council (BBSRC).; Biotechnology and Biological Sciences Research Council [BBS/B/17166, BBS/B/17174] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC).(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge the financial support of the Biotechnology and Biological Sciences Research Council (BBSRC). The development of e-Fungi has been funded by the BBSRC Bioinformatics and e-Science programme II.	ALAM I, 2007, J INTEGRATIVE BIOINF, V4, P69; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldwin TK, 2006, MOL PLANT MICROBE IN, V19, P1451, DOI 10.1094/MPMI-19-1451; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolker M, 2001, MICROBIOL-SGM, V147, P1395, DOI 10.1099/00221287-147-6-1395; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chauvaux S, 2001, J BACTERIOL, V183, P6551, DOI 10.1128/JB.183.22.6551-6557.2001; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Colovos C, 1998, STRUCTURE, V6, P1329, DOI 10.1016/S0969-2126(98)00132-4; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dijkgraaf GJP, 1996, YEAST, V12, P683, DOI 10.1002/(SICI)1097-0061(19960615)12:7<683::AID-YEA959>3.0.CO;2-8; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FISCHER R, 1995, J CELL BIOL, V128, P485, DOI 10.1083/jcb.128.4.485; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Han WD, 2003, ENDOCR-RELAT CANCER, V10, P217, DOI 10.1677/erc.0.0100217; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hedeler C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-426; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kanamori T, 2005, FEMS MICROBIOL LETT, V245, P61, DOI 10.1016/j.femsle.2005.02.023; Kang SC, 1995, MOL PLANT MICROBE IN, V8, P939, DOI 10.1094/MPMI-8-0939; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kawano T, 2003, PLANT CELL REP, V21, P829, DOI 10.1007/s00299-003-0591-z; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Le Nours J, 2003, PROTEIN SCI, V12, P1195, DOI 10.1110/ps.0300103; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; MCPHERSON MJ, 1992, J BIOL CHEM, V267, P8146; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Ohno S., 1970, P1; OLIVER R, 1995, MICROBIOL-UK, V141, P1, DOI 10.1099/00221287-141-1-1; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perez-Martin J, 2006, MOL GENET GENOMICS, V276, P211, DOI 10.1007/s00438-006-0152-6; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Poggeler S, 2004, EUKARYOT CELL, V3, P232, DOI 10.1128/EC.3.1.232-240.2004; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; REDDY CA, 1994, FEMS MICROBIOL REV, V13, P137, DOI 10.1016/0168-6445(94)90077-9; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SAUPE S, 1995, GENE, V162, P135, DOI 10.1016/0378-1119(95)00272-8; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Silakowski B, 1998, J BACTERIOL, V180, P1241, DOI 10.1128/JB.180.5.1241-1247.1998; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Soanes DM, 2006, MOL PLANT PATHOL, V7, P61, DOI 10.1111/J.1364-3703.2005.00317.X; Solomon PS, 2004, MOL MICROBIOL, V53, P1065, DOI 10.1111/j.1365-2958.2004.04178.x; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Sweeney MJ, 1999, FEMS MICROBIOL LETT, V175, P149, DOI 10.1111/j.1574-6968.1999.tb13614.x; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tani M, 2000, J BIOL CHEM, V275, P11229, DOI 10.1074/jbc.275.15.11229; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tucker SL, 2004, PLANT CELL, V16, P1575, DOI 10.1105/tpc.021279; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Tunlid A, 2002, CURR OPIN MICROBIOL, V5, P513, DOI 10.1016/S1369-5274(02)00355-7; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van den Brink HJM, 1998, FUNGAL GENET BIOL, V23, P1, DOI 10.1006/fgbi.1997.1021; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WAY M, 1995, J CELL SCI, V108, P3155; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xu JR, 2006, ANNU REV PHYTOPATHOL, V44, P337, DOI 10.1146/annurev.phyto.44.070505.143412; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426	116	134	140	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2300	10.1371/journal.pone.0002300	http://dx.doi.org/10.1371/journal.pone.0002300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523684	gold, Green Submitted, Green Published			2022-12-27	WOS:000262614300011
J	Streitz, M; Noutsias, M; Volkmer, R; Rohde, M; Brestrich, G; Block, A; Klippert, K; Kotsch, K; Ay, B; Hummel, M; Kuhl, U; Lassner, D; Schultheiss, HP; Volk, HD; Kern, F				Streitz, Mathias; Noutsias, Michel; Volkmer, Rudolf; Rohde, Maria; Brestrich, Gordon; Block, Andrea; Klippert, Katrin; Kotsch, Katja; Ay, Bernhard; Hummel, Michael; Kuehl, Uwe; Lassner, Dirk; Schultheiss, Heinz-Peter; Volk, Hans-Dieter; Kern, Florian			NS1 Specific CD8(+) T-Cells with Effector Function and TRBV11 Dominance in a Patient with Parvovirus B19 Associated Inflammatory Cardiomyopathy	PLOS ONE			English	Article								Background: Parvovirus B19 (B19V) is the most commonly detected virus in endomyocardial biopsies (EMBs) from patients with inflammatory cardiomyopathy (DCMi). Despite the importance of T-cells in antiviral defense, little is known about the role of B19V specific T-cells in this entity. Methodology and Principal Findings: An exceptionally high B19V viral load in EMBs (115,091 viral copies/mg nucleic acids), peripheral blood mononuclear cells (PBMCs) and serum was measured in a DCMi patient at initial presentation, suggesting B19V viremia. The B19V viral load in EMBs had decreased substantially 6 and 12 months afterwards, and was not traceable in PBMCs and the serum at these times. Using pools of overlapping peptides spanning the whole B19V proteome, strong CD8(+) T-cell responses were elicited to the 10-amico-acid peptides SALKLAIYKA (19.7% of all CD8(+) cells) and QSALKLAIYK (10%) and additional weaker responses to GLCPHCINVG (0.71%) and LLHTDFEQVM (0.06%). Real-time RT-PCR of IFN gamma secretion-assay-enriched T-cells responding to the peptides, SALKLAIYKA and GLCPHCINVG, revealed a disproportionately high T-cell receptor Vbeta (TRBV) 11 expression in this population. Furthermore, dominant expression of type-1 (IFN gamma, IL2, IL27 and Tbet) and of cytotoxic T-cell markers (Perforin and Granzyme B) was found, whereas gene expression indicating type-2 (IL4, GATA3) and regulatory T-cells (FoxP3) was low. Conclusions: Our results indicate that B19V Ag-specific CD8(+) T-cells with effector function are involved in B19V associated DCMi. In particular, a dominant role of TRBV11 and type-1/CTL effector cells in the T-cell mediated antiviral immune response is suggested. The persistence of B19V in the endomyocardium is a likely antigen source for the maintenance of CD8(+) T-cell responses to the identified epitopes.	[Streitz, Mathias; Volkmer, Rudolf; Brestrich, Gordon; Klippert, Katrin; Kotsch, Katja; Ay, Bernhard; Volk, Hans-Dieter; Kern, Florian] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Noutsias, Michel; Rohde, Maria; Block, Andrea; Kuehl, Uwe; Schultheiss, Heinz-Peter] Charite Universitaatsmed Berlin, Dept Cardiol & Pneumonol, Berlin, Germany; [Hummel, Michael] Charite, Inst Pathol, Berlin, Germany; [Lassner, Dirk] Inst Cardiac Diagnost & Therapy, Berlin, Germany; [Kern, Florian] Brighton & Sussex Med Sch, Div Med, Brighton, E Sussex, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Brighton; University of Sussex	Streitz, M (corresponding author), Charite, Inst Med Immunol, D-13353 Berlin, Germany.	michel.noutsias@charite.de	Noutsias, Michel/AAM-4006-2021; volk, hans-dieter/AAV-8053-2021; Kotsch, Katja/AAG-2597-2021; Kern, Florian/AAE-6784-2022	volk, hans-dieter/0000-0002-7743-6668; Kern, Florian/0000-0002-0368-8408; Noutsias, Michel/0000-0002-9066-5262; Lassner, Dirk/0000-0003-0815-7013; Kuhl, Uwe/0000-0002-2476-0050; Volkmer, Rudolf/0000-0003-4710-1143; Brestrich, Gordon/0000-0002-1306-5474	DFG [SFB TR19, TPB1, TPB2, TP Z1]	DFG(German Research Foundation (DFG))	These investigations were supported by the DFG through the SFB TR19 (TPB1 to RVE and FK; TPB2 to MN, MH and HDV; and TP Z1 to UK and HPS).	ARETZ HT, 1987, HUM PATHOL, V18, P619; Baughman KL, 2006, CIRCULATION, V113, P593, DOI 10.1161/CIRCULATIONAHA.105.589663; Bialek K, 2003, ANAL BIOANAL CHEM, V376, P1006, DOI 10.1007/s00216-003-1876-3; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Caforio ALP, 2007, EUR HEART J, V28, P1326, DOI 10.1093/eurheartj/ehm076; COSSART YE, 1975, LANCET, V1, P72; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Isa A, 2005, PLOS MED, V2, P1280, DOI 10.1371/journal.pmed.0020343; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kasprowicz V, 2006, J VIROL, V80, P6697, DOI 10.1128/JVI.02388-05; Kasprowicz V, 2006, J VIROL, V80, P11209, DOI 10.1128/JVI.01173-06; Kern F, 1998, NAT MED, V4, P975, DOI 10.1038/nm0898-975; Kuhl U, 2005, CIRCULATION, V112, P1965, DOI 10.1161/CIRCULATIONAHA.105.548156; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Kuhl U, 2003, CIRCULATION, V108, P945, DOI 10.1161/01.CIR.0000085168.02782.2C; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; Lehmann HW, 2003, ARTHRITIS RHEUM, V48, P1631, DOI 10.1002/art.10979; Liefeldt L, 2005, J MED VIROL, V75, P161, DOI 10.1002/jmv.20251; Liu PP, 2001, CIRCULATION, V104, P1076, DOI 10.1161/hc3401.095198; Mahrholdt H, 2006, CIRCULATION, V114, P1581, DOI 10.1161/CIRCULATIONAHA.105.606509; Mitchell LA, 2001, J MED MICROBIOL, V50, P627, DOI 10.1099/0022-1317-50-7-627; Modrow S, 2002, PATHOL BIOL, V50, P326, DOI 10.1016/S0369-8114(02)00302-4; Norbeck O, 2005, J VIROL, V79, P12117, DOI 10.1128/JVI.79.18.12117-12121.2005; Norja P, 2006, P NATL ACAD SCI USA, V103, P7450, DOI 10.1073/pnas.0602259103; Noutsias M, 1999, CIRCULATION, V99, P2124, DOI 10.1161/01.CIR.99.16.2124; Noutsias Michel, 2003, Heart Fail Monit, V3, P127; Noutsias M, 2002, MED SCI MONITOR, V8, pMT59; Pankuweit S, 2003, HUM PATHOL, V34, P497, DOI 10.1016/S0046-8177(03)00078-9; Pfrepper KI, 2005, J VET MED B, V52, P362, DOI 10.1111/j.1439-0450.2005.00874.x; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840	33	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2361	10.1371/journal.pone.0002361	http://dx.doi.org/10.1371/journal.pone.0002361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523634	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000262614300048
J	Li, YH; Rowland, C; Xiromerisiou, G; Lagier, RJ; Schrodi, SJ; Dradiotis, E; Ross, D; Bui, N; Catanese, J; Aggelakis, K; Grupe, A; Hadjigeorgiou, G				Li, Yonghong; Rowland, Charles; Xiromerisiou, Georgia; Lagier, Robert J.; Schrodi, Steven J.; Dradiotis, Efthimios; Ross, David; Bui, Nam; Catanese, Joseph; Aggelakis, Konstantinos; Grupe, Andrew; Hadjigeorgiou, Georgios			Neither Replication nor Simulation Supports a Role for the Axon Guidance Pathway in the Genetics of Parkinson's Disease	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; LRRK2 G2019S; POLYMORPHISMS; RISK; SUSCEPTIBILITY; IDENTIFICATION; SAMPLES; SEMA5A	Susceptibility to sporadic Parkinson's disease (PD) is thought to be influenced by both genetic and environmental factors and their interaction with each other. Statistical models including multiple variants in axon guidance pathway genes have recently been purported to be capable of predicting PD risk, survival free of the disease and age at disease onset; however the specific models have not undergone independent validation. Here we tested the best proposed risk panel of 23 single nucleotide polymorphisms (SNPs) in two PD sample sets, with a total of 525 cases and 518 controls. By single marker analysis, only one marker was significantly associated with PD risk in one of our sample sets (rs6692804: P = 0.03). Multi-marker analysis using the reported model found a mild association in one sample set (two sided P = 0.049, odds ratio for each score change = 1.07) but no significance in the other (two sided P = 0.98, odds ratio = 1), a stark contrast to the reported strong association with PD risk (P = 4.64 x 10(-38), odds ratio as high as 90.8). Following a procedure similar to that used to build the reported model, simulated multi-marker models containing SNPs from randomly chosen genes in a genome wide PD dataset produced P-values that were highly significant and indistinguishable from similar models where disease status was permuted (3.13 x 10(-23) to 4.90 x 10(-64)), demonstrating the potential for overfitting in the model building process. Together, these results challenge the robustness of the reported panel of genetic markers to predict PD risk in particular and a role of the axon guidance pathway in PD genetics in general.	[Li, Yonghong; Rowland, Charles; Lagier, Robert J.; Schrodi, Steven J.; Ross, David; Bui, Nam; Catanese, Joseph; Grupe, Andrew] Celera, Alameda, CA USA; [Xiromerisiou, Georgia; Dradiotis, Efthimios; Aggelakis, Konstantinos; Hadjigeorgiou, Georgios] Univ Thessaly, Med Sch, Dept Neurol, Larisa, Greece; [Hadjigeorgiou, Georgios] CERETETH, Inst Biomed Res & Technol, Larisa, Greece	University of Thessaly	Li, YH (corresponding author), Celera, Alameda, CA USA.	yonghong.li@celera.com	Schrodi, Steven J./O-4288-2019; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Schrodi, Steven J./0000-0003-2304-8528; Xiromerisiou, Georgia/0000-0001-7162-3588; Li, Yonghong/0000-0001-7326-0717	Celera	Celera	This work was partly supported by Celera.	Bialecka M, 2006, NEUROSCI LETT, V399, P121, DOI 10.1016/j.neulet.2006.01.038; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Elbaz A, 2006, LANCET NEUROL, V5, P917, DOI 10.1016/S1474-4422(06)70579-8; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Li Y, 2008, NEUROBIOL DIS, V29, P293, DOI 10.1016/j.nbd.2007.09.001; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Shiffman D, 2006, CURR OPIN MOL THER, V8, P493; Shriner D, 2007, SCIENCE, V316, P1840; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; WANG K, 2007, AM J HUM GENET; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Xiromerisiou G, 2007, NEUROSCI LETT, V415, P59, DOI 10.1016/j.neulet.2006.12.038; Xiromerisiou G, 2007, EUR J NEUROL, V14, P7, DOI 10.1111/j.1468-1331.2006.01551.x; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang J, 2005, EUR NEUROL, V53, P15, DOI 10.1159/000082956	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2707	10.1371/journal.pone.0002707	http://dx.doi.org/10.1371/journal.pone.0002707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628988	gold, Green Published			2022-12-27	WOS:000264057200050
J	Prost, MA; Jahn, A; Floyd, S; Mvula, H; Mwaiyeghele, E; Mwinuka, V; Mhango, T; Crampin, AC; McGrath, N; Fine, PEM; Glynn, JR				Prost, Marc-Andre; Jahn, Andreas; Floyd, Sian; Mvula, Hazzie; Mwaiyeghele, Eleneus; Mwinuka, Venance; Mhango, Thomas; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Glynn, Judith R.			Implication of New WHO Growth Standards on Identification of Risk Factors and Estimated Prevalence of Malnutrition in Rural Malawian Infants	PLOS ONE			English	Article								Background: The World Health Organization (WHO) released new Child Growth Standards in 2006 to replace the current National Center for Health Statistics (NCHS) growth reference. We assessed how switching from the NCHS to the newly released WHO Growth Standards affects the estimated prevalence of wasting, underweight and stunting, and the pattern of risk factors identified. Methodology/Principal Findings: Data were drawn from a village-informant driven Demographic Surveillance System in Northern Malawi. Children (n = 1328) were visited twice at 0-4 months and 11-15 months. Data were collected on the demographic and socio-economic environment of the child, health history, maternal and child anthropometry and child feeding practices. Weight-for-length, weight-for-age and length-for-age were derived in z-scores using the two growth references. In early infancy, prevalence estimates were 2.9, 6.1, and 8.5 fold higher for stunting, underweight, and wasting respectively using the WHO standards compared to NCHS reference (p < 0.001 for all). At one year, prevalence estimates for wasting and stunting did not differ significantly according to reference used, but the prevalence of underweight was half that with the NCHS reference (p < 0.001). Patterns of risk factors were similar with the two growth references for all outcomes at one year although the strength of association was higher with WHO standards. Conclusions/Significance: Differences in prevalence estimates differed in magnitude but not direction from previous studies. The scale of these differences depends on the population's nutritional status thus it should not be assumed a priori. The increase in estimated prevalence of wasting in early infancy has implications for feeding programs targeting lactating mothers and ante-natal multiple micronutrients supplementation to tackle small birth size. Risk factors identified using WHO standards remain comparable with findings based on the NCHS reference in similar settings. Further research should aim to identify whether the young infants additionally diagnosed as malnourished by this new standard are more appropriate targets for interventions than those identified with the NCHS reference.	[Prost, Marc-Andre; Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, London WC1E 7HT, England; [Jahn, Andreas; Mvula, Hazzie; Mwaiyeghele, Eleneus; Mwinuka, Venance; Mhango, Thomas; Crampin, Amelia C.; McGrath, Nuala] Karonga Prevent Study, Chilumba, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Prost, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol & Populat Hlth Dept, Keppel St, London WC1E 7HT, England.	marco@thepep.net	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust; UK Department of Health [Public Health Career Scientist award]	Wellcome Trust(Wellcome TrustEuropean Commission); UK Department of Health	This work was supported in full by funds from the Wellcome Trust. JRG was supported in part by the UK Department of Health (Public Health Career Scientist award). The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON MA, 1995, B WORLD HEALTH ORGAN, V73, P165; COLLINS S, 2000, ASSESSMENT NUTR STAT, P8; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; De Onis M, 2004, J PEDIATR-US, V144, P461, DOI 10.1016/j.jpeds.2003.12.034; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Espo M, 2002, ACTA PAEDIATR, V91, P1364, DOI 10.1111/j.1651-2227.2002.tb02835.x; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Hotz C, 2001, EUR J CLIN NUTR, V55, P841, DOI 10.1038/sj.ejcn.1601239; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; *MAL NAT STAT OFF, 2005, MAL DEM HLTH SURV 20, P163; Maleta K, 2003, PAEDIATR PERINAT EP, V17, P384, DOI 10.1046/j.1365-3016.2003.00519.x; Maleta K, 2003, ARCH DIS CHILD, V88, P574, DOI 10.1136/adc.88.7.574; Maleta K, 2003, ACTA PAEDIATR, V92, P491, DOI 10.1111/j.1651-2227.2003.tb00584.x; Onyango AW, 2007, J NUTR, V137, P149, DOI 10.1093/jn/137.1.149; *ORC MACR, 2006, NUTR YOUNG CHILDR MO, P18; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; The World Health Organization, 1995, PHYS STAT US INT ANT, P364; UNICEF, 2003, STAT WORLDS CHILDR 2; UNICEF, 2006, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 1997, STAT WORLDS CHILDR 1; *WHO, 2006, WHO ANTR 2005 SOFTW; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2001, OPT DUR EXCL BREASTF	27	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2684	10.1371/journal.pone.0002684	http://dx.doi.org/10.1371/journal.pone.0002684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628980	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000264057200028
J	Garamszegi, LZ; Eens, M; Torok, J				Garamszegi, Laszlo Zsolt; Eens, Marcel; Toeroek, Janos			Birds Reveal their Personality when Singing	PLOS ONE			English	Article							COLLARED FLYCATCHER; FEMALE CHOICE; FITNESS CONSEQUENCES; EXPLORATORY-BEHAVIOR; AVIAN PERSONALITIES; SEXUAL SELECTION; WILLOW WARBLER; PREDATION RISK; LIFE-HISTORY; SONG	Background: Individual differences in social behaviour may have consequences for mate choice and sexual signalling, because partners should develop preferences for personalities that maximize reproductive output. Here we propose that behavioural traits involved in sexual advertisement may serve as good indicators of personality, which is fundamental for sexual selection to operate on temperament. Bird song has a prominent and well-established role in sexual selection, and it displays considerable variation among individuals with a potentially strong personality component. Therefore, we predicted that features of song would correlate with estimates of personality. Methodology/Principal Findings: In a field study of free-living male collared flycatchers, Ficedula albicollis, we characterised personality based on the exploration of an altered breeding environment, and based on the risk taken when a potential predator was approaching during a simulated territorial interaction. We found that explorative and risk-taker individuals consistently sang at lower song posts than shy individuals in the presence of a human observer. Moreover, males from lower posts established pair-bonds relatively faster than males from higher posts. Conclusions/Significance: Our results may demonstrate that risk taking during singing correlates with risk taking during aggression and with exploration, thus personality may be manifested in different contexts involving sexual advertisement. These findings are in accordance with the hypothesis that the male's balance between investment in reproduction and risk taking is reflected in sexual displays, and it may be important information for choosy females that seek partners with personality traits enhancing breeding success.	[Garamszegi, Laszlo Zsolt; Eens, Marcel] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Toeroek, Janos] Eotvos Lorand Univ, Dept Syst Zool & Ecol, Budapest, Hungary	University of Antwerp; Eotvos Lorand University	Garamszegi, LZ (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	laszlo.garamszegi@ua.ac.be	Garamszegi, Laszlo/M-1488-2015; Eens, Marcel/AAC-8466-2020; Garamszegi, Laszlo Z/B-5089-2011; Torok, Janos/C-6144-2008	Garamszegi, Laszlo/0000-0001-8920-2183; Torok, Janos/0000-0002-4799-5522	FWO Flanders (Belgium) [post-doc fellowship]; University of Antwerp; National Scientific Research Fund, Hungary [T049678, T049650]	FWO Flanders (Belgium)(FWO); University of Antwerp; National Scientific Research Fund, Hungary	During this study LZG received a post-doc fellowship from the FWO Flanders (Belgium). ME was supported by the University of Antwerp and FWO Flanders (Belgium). The fieldwork was supported by the National Scientific Research Fund, Hungary (grants: T049678 and T049650).	Andersson Malte, 1994; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; BENSCH S, 1992, ANIM BEHAV, V44, P301, DOI 10.1016/0003-3472(92)90036-9; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Bradbury Jack W., 1998, pi; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Cramp S., 1994, BIRDS W PALEARCTIC; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; DOWSETTLEMAIRE F, 1979, IBIS, V121, P453, DOI 10.1111/j.1474-919X.1979.tb06685.x; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; Forstmeier W, 2002, P ROY SOC B-BIOL SCI, V269, P1479, DOI 10.1098/rspb.2002.2039; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Garamszegi LZ, 2007, BEHAV ECOL, V18, P1001, DOI 10.1093/beheco/arm069; Garamszegi LZ, 2006, BEHAV ECOL, V17, P399, DOI 10.1093/beheco/arj042; Garamszegi LZ, 2005, BEHAV ECOL, V16, P580, DOI 10.1093/beheco/ari029; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; Gil D, 2000, BEHAV ECOL SOCIOBIOL, V47, P319, DOI 10.1007/s002650050672; Gil D, 2000, BEHAVIOUR, V137, P759, DOI 10.1163/156853900502330; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griskevicius V, 2007, J PERS SOC PSYCHOL, V93, P85, DOI 10.1037/0022-3514.93.1.85; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; Hale AM, 2004, WILSON BULL, V116, P167, DOI 10.1676/04-015; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HEGYI G, 2008, NATURWISSEN IN PRESS; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; Lundberg A, 1992, PIED FLYCATCHER; Miller GF, 2007, Q REV BIOL, V82, P97, DOI 10.1086/517857; Moller AP, 2008, BEHAV ECOL, V19, P41, DOI 10.1093/beheco/arm098; Moller AP, 2006, BEHAV ECOL, V17, P155, DOI 10.1093/beheco/arj010; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Parker TH, 2006, BIRD STUDY, V53, P253, DOI 10.1080/00063650609461440; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; REID ML, 1990, ANIMAL BEHAV, V40; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; Searcy William A., 1996, P454; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; TOROK J, 1988, J ANIM ECOL, V57, P251, DOI 10.2307/4776; Wiley R. H., 1982, ACOUSTIC COMMUNICATI, P131; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	58	73	75	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2647	10.1371/journal.pone.0002647	http://dx.doi.org/10.1371/journal.pone.0002647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612388	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000264065800049
J	Nowotny, T; Levi, R; Selverston, AI				Nowotny, Thomas; Levi, Rafael; Selverston, Allen I.			Probing the Dynamics of Identified Neurons with a Data-Driven Modeling Approach	PLOS ONE			English	Article								In controlling animal behavior the nervous system has to perform within the operational limits set by the requirements of each specific behavior. The implications for the corresponding range of suitable network, single neuron, and ion channel properties have remained elusive. In this article we approach the question of how well-constrained properties of neuronal systems may be on the neuronal level. We used large data sets of the activity of isolated invertebrate identified cells and built an accurate conductance-based model for this cell type using customized automated parameter estimation techniques. By direct inspection of the data we found that the variability of the neurons is larger when they are isolated from the circuit than when in the intact system. Furthermore, the responses of the neurons to perturbations appear to be more consistent than their autonomous behavior under stationary conditions. In the developed model, the constraints on different parameters that enforce appropriate model dynamics vary widely from some very tightly controlled parameters to others that are almost arbitrary. The model also allows predictions for the effect of blocking selected ionic currents and to prove that the origin of irregular dynamics in the neuron model is proper chaoticity and that this chaoticity is typical in an appropriate sense. Our results indicate that data driven models are useful tools for the in-depth analysis of neuronal dynamics. The better consistency of responses to perturbations, in the real neurons as well as in the model, suggests a paradigm shift away from measuring autonomous dynamics alone towards protocols of controlled perturbations. Our predictions for the impact of channel blockers on the neuronal dynamics and the proof of chaoticity underscore the wide scope of our approach.	[Nowotny, Thomas] Univ Sussex, Dept Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Levi, Rafael] Univ Autonoma Madrid, Escuela Politech Superior, Madrid, Spain; [Selverston, Allen I.] Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA USA	University of Sussex; Autonomous University of Madrid; University of California System; University of California San Diego	Nowotny, T (corresponding author), Univ Sussex, Dept Informat, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England.	T.Nowotny@sussex.ac.uk	Levi, Rafael/Q-8176-2018; Nowotny, Thomas/C-3883-2012	Levi, Rafael/0000-0002-0144-2295; Nowotny, Thomas/0000-0002-4451-915X	Research Councils of the UK; BBSRC; NSF/NIH; Spanish ministry of education and science; community of Madrid;  [RCUK fellowship];  [BB/F005113/1];  [RO1 NS050945];  [MEC BFU2006-07902/BFI];  [CAM S-SEM-0255-2006]; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050945] Funding Source: NIH RePORTER; BBSRC [BB/F005113/1] Funding Source: UKRI	Research Councils of the UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish ministry of education and science(Spanish Government); community of Madrid(Comunidad de Madrid); ; ; ; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partially funded by the Research Councils of the UK under an RCUK fellowship, the BBSRC, grant BB/F005113/1, the NSF/NIH, Grant No. RO1 NS050945, the Spanish ministry of education and science, grant MEC BFU2006-07902/BFI, and the community of Madrid, grant CAM S-SEM-0255-2006. Other than supporting the work financially with research grants, the funding bodies had no role in this work.	Abarbanel HDI, 1996, NEURAL COMPUT, V8, P1567, DOI 10.1162/neco.1996.8.8.1567; Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; ANDERSON WW, 1981, J EXP ZOOL, V216, P187, DOI 10.1002/jez.1402160121; BAL T, 1994, J NEUROSCI, V14, P3019; Baro DJ, 1997, J NEUROSCI, V17, P6597; BENETTIN G, 1978, CR ACAD SCI A MATH, V286, P431; BIDAUT M, 1980, J NEUROPHYSIOL, V44, P1089, DOI 10.1152/jn.1980.44.6.1089; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Bullock T., 1965, STRUCTURE FUNCTION N; Carelli PV, 2005, J NEUROPHYSIOL, V94, P1169, DOI 10.1152/jn.00070.2005; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; De Schutter E, 2005, TRENDS NEUROSCI, V28, P562, DOI 10.1016/j.tins.2005.08.002; EAGER MA, 2007, CONSTRAINING NEURAL; Elson RC, 1999, J NEUROPHYSIOL, V82, P115, DOI 10.1152/jn.1999.82.1.115; Falcke M, 2000, BIOL CYBERN, V82, P517, DOI 10.1007/s004220050604; FOSTER WR, 1993, J NEUROPHYSIOL, V70, P2502, DOI 10.1152/jn.1993.70.6.2502; Giorgilli A., 1980, MECCANICA, V15, P9, DOI 10.1007/BF02128236; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P341, DOI 10.1152/jn.1992.67.2.341; GOLOWASCH J, 1990, CHARACTERIZATION STO; Gruhn M, 2005, J NEUROPHYSIOL, V94, P2888, DOI 10.1152/jn.00434.2005; Guckenheimer J, 1997, J COMPUT NEUROSCI, V4, P257, DOI 10.1023/A:1008871803040; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; GUTENKUNST RN, 2007, ANN NY ACAD SCI; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harris-Warrick RM, 1998, ANN NY ACAD SCI, V860, P155, DOI 10.1111/j.1749-6632.1998.tb09046.x; Haufler D, 2007, NEUROCOMPUTING, V70, P1605, DOI 10.1016/j.neucom.2006.10.041; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Hobbs KH, 2008, J NEUROPHYSIOL, V99, P1871, DOI 10.1152/jn.00032.2008; HORBELT W, 2000, ANAL NONLINEAR DIFFE, P152; Hoyle G., 1977, IDENTIFIED NEURONS B; Huerta R, 2000, BIOL CYBERN, V82, P85, DOI 10.1007/PL00007963; Huys QJM, 2006, J NEUROPHYSIOL, V96, P872, DOI 10.1152/jn.00079.2006; Johnson BR, 2003, J NEUROPHYSIOL, V90, P631, DOI 10.1152/jn.00037.2003; JOHNSON BR, 1990, J NEUROSCI, V10, P2066; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Levi R, 2003, NEUROSCIENCE, V118, P283, DOI 10.1016/S0306-4522(02)00973-9; Liu Z, 1998, J NEUROSCI, V18, P2309; Lopez-Aguado L, 2002, J NEUROPHYSIOL, V88, P2809, DOI 10.1152/jn.00183.2002; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; Mizrahi A, 2001, J NEUROSCI, V21, P7331, DOI 10.1523/JNEUROSCI.21-18-07331.2001; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; Nowotny T, 2006, J NEUROSCI METH, V158, P287, DOI 10.1016/j.jneumeth.2006.05.034; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Prinz AA, 2003, J NEUROSCI, V23, P943; ROSS WN, 1989, P NATL ACAD SCI USA, V86, P1679, DOI 10.1073/pnas.86.5.1679; RUSSELL DF, 1976, BRAIN RES, V101, P582, DOI 10.1016/0006-8993(76)90482-0; Sakaguchi H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.027201; SCHMIDT J, 1992, J EXP BIOL, V171, P329; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; Selverston AI, 2000, J PHYSIOLOGY-PARIS, V94, P357, DOI 10.1016/S0928-4257(00)01101-3; Soto-Trevino C, 2005, J NEUROPHYSIOL, V94, P590, DOI 10.1152/jn.00013.2005; STRETTON AO, 1968, SCIENCE, V162, P132, DOI 10.1126/science.162.3849.132; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Szucs A, 2001, J NEUROPHYSIOL, V85, P1623, DOI 10.1152/jn.2001.85.4.1623; Szucs A, 2006, J NEUROBIOL, V66, P1584, DOI 10.1002/neu.20325; Thoby-Brisson M, 2000, J NEUROPHYSIOL, V84, P596, DOI 10.1152/jn.2000.84.1.596; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2107, DOI 10.1152/jn.00026.2006; TOKUDA I, 2002, PARAMETER ESTIMATION; Traub R. D., 1991, NEURAL NETWORKS HIPP; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Vanier MC, 1999, J COMPUT NEUROSCI, V7, P149, DOI 10.1023/A:1008972005316; Varona P, 2001, NEURAL NETWORKS, V14, P865, DOI 10.1016/S0893-6080(01)00046-6; Varona P, 2001, BIOL CYBERN, V84, P91, DOI 10.1007/s004220000198; Weaver CM, 2006, NEUROCOMPUTING, V69, P1053, DOI 10.1016/j.neucom.2005.12.044; Willms AR, 1999, J COMPUT NEUROSCI, V6, P145, DOI 10.1023/A:1008880518515; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	87	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2627	10.1371/journal.pone.0002627	http://dx.doi.org/10.1371/journal.pone.0002627			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612435	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264065800029
J	Siawaya, JFD; Roberts, T; Babb, C; Black, G; Golakai, HJ; Stanley, K; Bapela, NB; Hoal, E; Parida, S; van Helden, P; Walzl, G				Siawaya, Joel Fleury Djoba; Roberts, Teri; Babb, Chantal; Black, Gillian; Golakai, Hawa Jande; Stanley, Kim; Bapela, Nchinya Bennedict; Hoal, Eileen; Parida, Shreemanta; van Helden, Paul; Walzl, Gerhard			An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays	PLOS ONE			English	Article							HOST-DEFENSE; HUMAN PLASMA; IMMUNOASSAY; QUANTITATION; KITS	The recent introduction of fluorescent bead-based technology, allowing the measurement of multiples analytes in a single 25-50 mu l sample has revolutionized the study of cytokine responses. However, such multiplex approaches may compromise the ability of these assays to accurately measure actual cytokine levels. This study evaluates the performance of three commercially available multiplex cytokine fluorescent bead-based immunoassays (Bio-Rad's Cytokine 17-plex kit; LINCO Inc's 29-plex kit; and RnD System's Fluorokine-Multi Analyte Profiling ( MAP) base kit A and B). The LINCO Inc kit was found to be the most sensitive assay for measuring concentrations of multiple recombinant cytokines in samples that had been spiked with serial dilutions of the standard provided by the manufacturer, followed respectively by the RnD Fluorokine- (MAP) and Bio-Rad 17-plex kits. A positive correlation was found in the levels of IFN-gamma measured in antigen stimulated whole blood culture supernatants by the LINCO Inc 29-plex, RnD Fluorokine-( MAP) and RnD system IFN-gamma Quantikine ELISA kits across a panel of controls and stimulated samples. Researchers should take the limitation of such multiplexed assays into account when planning experiments and the most appropriate use for these tests may currently be as screening tools for the selection of promising markers for analysis by more sensitive techniques.	[Siawaya, Joel Fleury Djoba; Roberts, Teri; Babb, Chantal; Black, Gillian; Golakai, Hawa Jande; Stanley, Kim; Bapela, Nchinya Bennedict; Hoal, Eileen; van Helden, Paul; Walzl, Gerhard] Univ Stellenbosch Cape Town, Div Human Genet & Mol Biol, Dept Biomed Sci, Stellenbosch, South Africa; [Parida, Shreemanta] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany	Max Planck Society	Siawaya, JFD (corresponding author), Univ Stellenbosch Cape Town, Div Human Genet & Mol Biol, Dept Biomed Sci, Stellenbosch, South Africa.	joe@sun.ac.za	de Villiers, Chantal Babb/AAL-3787-2021; Siawaya, Joel Fleury Djoba/N-3156-2019; Walzl, Gerhard/N-6371-2016	de Villiers, Chantal Babb/0000-0003-1334-1819; Siawaya, Joel Fleury Djoba/0000-0002-0369-0153; Hoal, Eileen/0000-0002-6444-5688; Walzl, Gerhard/0000-0003-2487-125X; Parida, Shreemanta K/0000-0003-2129-6691; Black, Gillian/0000-0002-5081-274X	South African DST/NFR; Bill and Melinda Gates Foundation [37772]; South African MRC; Stellenbosch University	South African DST/NFR(Research Council of Norway); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stellenbosch University	JFDS and BB are supported by the South African DST/NFR. GB, KS, HJG, SP and GW are supported by the Bill and Melinda Gates Foundation through Grand Challenges in Global Health Grant 37772. TR is supported by the South African MRC and Stellenbosch University.	Coutinho HM, 2005, J INFECT DIS, V192, P528, DOI 10.1086/430929; de Jager W, 2006, METHODS, V38, P294, DOI 10.1016/j.ymeth.2005.11.008; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; Dieli F, 2000, SCAND J IMMUNOL, V52, P96; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; ENITAN D, 2005, INTENS CARE MED, V30, P1415; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073; Jiang B, 2003, CLIN DIAGN LAB IMMUN, V10, P995, DOI 10.1128/CDLI.10.6.995-1001.2003; KATHRYN L, 2001, CYTOMETRY, V45, P27; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Liu MY, 2005, CLIN CHEM, V51, P1102, DOI 10.1373/clinchem.2004.047084; Maggio M, 2006, J ANDROL, V27, P725, DOI 10.2164/jandrol.106.000141; Martins TB, 2004, CLIN DIAGN LAB IMMUN, V11, P325, DOI 10.1128/CDLI.11.2.325-329.2004; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; PROBST MCO, 2003, LAB MED, V27, P182; Stenger S, 2001, ANN RHEUM DIS, V60, pIII43; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277	18	124	129	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2535	10.1371/journal.pone.0002535	http://dx.doi.org/10.1371/journal.pone.0002535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596971	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200007
J	Gibbs, AJ; Ohshima, K; Phillips, MJ; Gibbs, MJ				Gibbs, Adrian J.; Ohshima, Kazusato; Phillips, Matthew J.; Gibbs, Mark J.			The Prehistory of Potyviruses: Their Initial Radiation Was during the Dawn of Agriculture	PLOS ONE			English	Article							MOLECULAR EVOLUTION; CLIMATE-CHANGE; DNA-SEQUENCES; VIRUS; COEVOLUTION; RATES; DIVERSITY; SPREAD; PLANTS; GENE	Background: Potyviruses are found world wide, are spread by probing aphids and cause considerable crop damage. Potyvirus is one of the two largest plant virus genera and contains about 15% of all named plant virus species. When and why did the potyviruses become so numerous? Here we answer the first question and discuss the other. Methods and Findings: We have inferred the phylogenies of the partial coat protein gene sequences of about 50 potyviruses, and studied in detail the phylogenies of some using various methods and evolutionary models. Their phylogenies have been calibrated using historical isolation and outbreak events: the plum pox virus epidemic which swept through Europe in the 20th century, incursions of potyviruses into Australia after agriculture was established by European colonists, the likely transport of cowpea aphid-borne mosaic virus in cowpea seed from Africa to the Americas with the 16th century slave trade and the similar transport of papaya ringspot virus from India to the Americas. Conclusions/Significance: Our studies indicate that the partial coat protein genes of potyviruses have an evolutionary rate of about 1.15x10(-4) nucleotide substitutions/site/year, and the initial radiation of the potyviruses occurred only about 6,600 years ago, and hence coincided with the dawn of agriculture. We discuss the ways in which agriculture may have triggered the prehistoric emergence of potyviruses and fostered their speciation.	[Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga, Japan; [Phillips, Matthew J.] Australian Natl Univ, Fac Sci, Sch Bot & Zool, Canberra, ACT, Australia	Saga University; Australian National University		adrian_j_gibbs@hotmail.com	Phillips, Matthew J/J-1365-2012	Phillips, Matthew J/0000-0003-1532-449X				Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], 1994, POTYVIRIDAE; [Anonymous], 1962, CONSPECTUS APHIDS VE; Bateson MF, 2002, J GEN VIROL, V83, P2575, DOI 10.1099/0022-1317-83-10-2575; BATESON MF, 1994, J GEN VIROL, V75, P3547, DOI 10.1099/0022-1317-75-12-3547; Bawden FC, 1955, ANN APPL BIOL, V42, P140, DOI 10.1111/j.1744-7348.1955.tb02419.x; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; BRAND RJ, 1993, ARCH VIROL, V128, P29, DOI 10.1007/BF01309786; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; CHAN SY, 1992, J VIROL, V66, P2057, DOI 10.1128/JVI.66.4.2057-2066.1992; Coulibaly S, 2002, THEOR APPL GENET, V104, P358, DOI 10.1007/s001220100740; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DIAMOND J, 1997, GUNS GERMS STEELS SH; Diamond J., 2011, COLLAPSE SOC CHOOSE; Domingo E., 1999, ORIGIN EVOLUTION VIR, P263; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy S, 2008, J VIROL, V82, P957, DOI 10.1128/JVI.01929-07; Fara Patricia, 2003, SEX BOT EMPIRE STORY; FARGETTE D, 2008, J VIROL, V82, DOI DOI 10.1128/JVI.012506-012507; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; French R.L., 2002, WHEAT STREAK MOSAIC; Gascoigne J., 1994, JOSEPH BANKS ENGLISH; GIBBS AJ, 2008, ARCH VIROLO IN PRESS; GIBBS AJ, 2008, ORIGIN EVOL IN PRESS; Gibbs MJ, 2007, ARCH VIROL, V152, P11, DOI 10.1007/s00705-006-0834-8; GUILDING L, 1825, ACCOUNT BOTANIC GARD; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGGETT P, 1959, AM ANTIQUITY, V25, P267, DOI 10.2307/277449; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HENZELL T, 2007, AUSTR AGR ITS HIT CH; Hill John, 1768, HORTUS KEWENSIS SIST; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Jackson AP, 2004, MOL BIOL EVOL, V21, P45, DOI 10.1093/molbev/msg232; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Kenneth F, 2000, CAMBRIDGE WORLD HIST; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Levy L.E., 2000, PLUM POX POTYVIRUS D; Lovejoy Paul E., 2000, TRANSFORMATIONS SLAV; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McKinney H.H., 1937, 442 USDA, P1; MERRILL ED, 1954, BOT COOKS VOYAGES; MILIUS S, 1999, SCI NEWS, V156, P325; Mill Arthur W, 1915, ANN MISSOURI BOT GAR, V2. 1, P185, DOI DOI 10.2307/2990033; Nascimento AVS, 2006, ARCH VIROL, V151, P1797, DOI 10.1007/s00705-006-0755-6; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; *PALEOCLIM, 2015, PALEOCLIM DAT; Pappu HR, 1997, ARCH VIROL, V142, P1919, DOI 10.1007/s007050050211; Perez-Losada M, 2006, J VIROL, V80, P5663, DOI 10.1128/JVI.00056-06; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; PURCIFULL D, 1984, DESCRIPTIONS PLANT V, V292, P4; PURSEGLOVE JW, 1966, TROPICAL CROPS DICOT; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241; ROBAGLIA C, 1989, J GEN VIROL, V70, P935, DOI 10.1099/0022-1317-70-4-935; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tan ZY, 2005, J GEN VIROL, V86, P501, DOI 10.1099/vir.0.80540-0; Thomas H., 1997, SLAVE TRADE HIST ATL; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; Von Dohlen CD, 2000, BIOL J LINN SOC, V71, P689, DOI 10.1006/bijl.2000.0470; Wace N., 1985, PESTS PARASITES MIGR, P3; Wallis CM, 2007, J GEN VIROL, V88, P2839, DOI 10.1099/vir.0.82814-0; Ward C. W., 1995, MOL BASIS VIRUS EVOL, P477; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	76	125	130	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2523	10.1371/journal.pone.0002523	http://dx.doi.org/10.1371/journal.pone.0002523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575612	Green Published, gold			2022-12-27	WOS:000263288000039
J	Hwang, NS; Varghese, S; Elisseeff, J				Hwang, Nathaniel S.; Varghese, Shyni; Elisseeff, Jennifer			Derivation of Chondrogenically-Committed Cells from Human Embryonic Cells for Cartilage Tissue Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO CHONDROGENESIS; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE; GENE-EXPRESSION; DIFFERENTIATION; CHONDROCYTES; HYDROGELS; CULTURE; GROWTH	Background: Heterogeneous and uncontrolled differentiation of human embryonic stem cells (hESCs) in embryoid bodies (EBs) limits the potential use of hESCs for cell-based therapies. More efficient strategies are needed for the commitment and differentiation of hESCs to produce a homogeneous population of specific cell types for tissue regeneration applications. Methodology/Principal Findings: We report here that significant chondrocytic commitment of feeder-free cultured human embryonic stem cells (FF-hESCs), as determined by gene expression and immunostaining analysis, was induced by co-culture with primary chondrocytes. Furthermore, a dynamic expression profile of chondrocyte-specific genes was observed during monolayer expansion of the chondrogenically-committed cells. Chondrogenically-committed cells synergistically responded to transforming growth factor-beta 1 (TGF-beta 1) and beta 1-integrin activating antibody by increasing tissue mass in pellet culture. In addition, when encapsulated in hydrogels, these cells formed cartilage tissue both in vitro and in vivo. In contrast, the absence of chondrocyte co-culture did not result in an expandable cell population from FF-hESCs. Conclusions/Significance: The direct chondrocytic commitment of FF-hESCs can be induced by morphogenetic factors from chondrocytes without EB formation and homogenous cartilage tissue can be formed in vitro and in vivo.	[Hwang, Nathaniel S.; Varghese, Shyni; Elisseeff, Jennifer] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hwang, NS (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010; Hwang, Nathaniel/AAI-3333-2020	Elisseeff, Jennifer/0000-0002-5066-1996; 	Johns Hopkins University (JHU)-Technion Joint Program; Arthritis Foundation	Johns Hopkins University (JHU)-Technion Joint Program(Johns Hopkins University); Arthritis Foundation	This work was supported by funding from the Johns Hopkins University (JHU)-Technion Joint Program and the Arthritis Foundation.	Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; DAngelo M, 1997, J BONE MINER RES, V12, P1368, DOI 10.1359/jbmr.1997.12.9.1368; De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450; Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295; Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Furman BD, 2006, J ORTHOP TRAUMA, V20, P719, DOI 10.1097/01.bot.0000211160.05864.14; Gillogly SD, 2006, J ORTHOP SPORT PHYS, V36, P751, DOI 10.2519/jospt.2006.2409; Hegert C, 2002, J CELL SCI, V115, P4617, DOI 10.1242/jcs.00171; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052; Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kim MS, 2005, STEM CELLS, V23, P113, DOI 10.1634/stemcells.2004-0110; Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; LaPrade RF, 1999, JAMA-J AM MED ASSOC, V281, P876, DOI 10.1001/jama.281.10.876; Lee J, 2007, BIOTECHNOL APPL BIOC, V48, P149, DOI 10.1042/BA20060233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52; SOLURSH M, 1975, DEV BIOL, V44, P278, DOI 10.1016/0012-1606(75)90398-X; Song L, 2004, CYTOTHERAPY, V6, P596, DOI 10.1080/14653240410005276-1; Takahashi I, 2003, EUR J CELL BIOL, V82, P182, DOI 10.1078/0171-9335-00307; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Vacanti V, 2005, J CELL PHYSIOL, V205, P194, DOI 10.1002/jcp.20376; Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275	45	96	102	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2498	10.1371/journal.pone.0002498	http://dx.doi.org/10.1371/journal.pone.0002498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575581	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000021
J	Takata, N; Hirase, H				Takata, Norio; Hirase, Hajime			Cortical Layer 1 and Layer 2/3 Astrocytes Exhibit Distinct Calcium Dynamics In Vivo	PLOS ONE			English	Article								Cumulative evidence supports bidirectional interactions between astrocytes and neurons, suggesting glial involvement of neuronal information processing in the brain. Cytosolic calcium (Ca2+) concentration is important for astrocytes as Ca2+ surges co-occur with gliotransmission and neurotransmitter reception. Cerebral cortex is organized in layers which are characterized by distinct cytoarchitecture. We asked if astrocyte-dominant layer 1 (L1) of the somatosensory cortex was different from layer 2/3 (L2/3) in spontaneous astrocytic Ca2+ activity and if it was influenced by background neural activity. Using a two-photon laser scanning microscope, we compared spontaneous Ca2+ activity of astrocytic somata and processes in L1 and L2/3 of anesthetized mature rat somatosensory cortex. We also assessed the contribution of background neural activity to the spontaneous astrocytic Ca2+ dynamics by investigating two distinct EEG states("synchronized'' vs. "desynchronized'' states). We found that astrocytes in L1 had nearly twice higher Ca2+ activity than L2/3. Furthermore, Ca2+ fluctuations of processes within an astrocyte were independent in L1 while those in L2/3 were synchronous. Pharmacological blockades of metabotropic receptors for glutamate, ATP, and acetylcholine, as well as suppression of action potentials did not have a significant effect on the spontaneous somatic Ca2+ activity. These results suggest that spontaneous astrocytic Ca2+ surges occurred in large part intrinsically, rather than neural activity-driven. Our findings propose a new functional segregation of layer 1 and 2/3 that is defined by autonomous astrocytic activity.	[Takata, Norio; Hirase, Hajime] RIKEN, Brain Sci Inst, Hirase Res Unit, Neuronal Circuit & Mech Res Grp, Wako, Saitama, Japan	RIKEN	Takata, N (corresponding author), RIKEN, Brain Sci Inst, Hirase Res Unit, Neuronal Circuit & Mech Res Grp, Wako, Saitama, Japan.	takata@brain.riken.jp; hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905	MEXT of Japan [18053026]; Grant-in-Aid for Young Scientists; HFSP [RGY0073/2006]; RIKEN Brain Science Institute	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); HFSP(Human Frontier Science Program); RIKEN Brain Science Institute	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the MEXT of Japan (grant number: 18053026) (H.H.), Grant-in-Aid for Young Scientists (B) (N.T.), HFSP (RGY0073/2006) (H.H.) and RIKEN Brain Science Institute internal research fund (H.H.).	Aguado F, 2002, J NEUROSCI, V22, P9430; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Amzica F, 1999, J NEUROPHYSIOL, V82, P2731, DOI 10.1152/jn.1999.82.5.2731; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Binns KE, 2001, NEUROPHARMACOLOGY, V40, P639, DOI 10.1016/S0028-3908(00)00202-1; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Deitmer JW, 2006, GLIA, V54, P639, DOI 10.1002/glia.20428; Ding S, 2007, J NEUROSCI, V27, P10674, DOI 10.1523/JNEUROSCI.2001-07.2007; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; FLEISCHHAUER K, 1979, ANAT EMBRYOL, V156, P269, DOI 10.1007/BF00299627; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KUDO Y, 1993, BIOIMAGES, V1, P159; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Mechawar N, 2000, J COMP NEUROL, V428, P305, DOI 10.1002/1096-9861(20001211)428:2<305::AID-CNE9>3.0.CO;2-Y; Mishima T, 2007, J NEUROSCI METH, V166, P32, DOI 10.1016/j.jneumeth.2007.06.021; Moller C, 2007, COGN SYST RES, V8, P28, DOI 10.1016/j.cogsys.2006.07.001; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Perea G, 2005, CELL CALCIUM, V38, P375, DOI 10.1016/j.ceca.2005.06.015; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Schipke CG, 2008, CELL CALCIUM, V43, P285, DOI 10.1016/j.ceca.2007.06.002; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shipp S, 2007, CURR BIOL, V17, pR443, DOI 10.1016/j.cub.2007.03.044; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Verkhratsky A., 2007, GLIAL NEUROBIOLOGY T; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	47	106	107	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2525	10.1371/journal.pone.0002525	http://dx.doi.org/10.1371/journal.pone.0002525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575586	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000040
J	Shen, WL; Hao, JJ; Tian, CA; Ren, JM; Yang, L; Li, XS; Luo, C; Cotma, CW; Liu, JK				Shen, Weili; Hao, Jiejie; Tian, Chuan; Ren, Jinmin; Yang, Lu; Li, Xuesen; Luo, Cheng; Cotma, Carl W.; Liu, Jiankang			A Combination of Nutriments Improves Mitochondrial Biogenesis and Function in Skeletal Muscle of Type 2 Diabetic Goto-Kakizaki Rats	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; FREE FATTY-ACIDS; BETA-CELL MASS; INSULIN-SECRETION; METABOLIC ANTIOXIDANT; PPAR-GAMMA; GLUCOSE; DYSFUNCTION; CARNITINE; PIOGLITAZONE	Background: Recent evidence indicates that insulin resistance in skeletal muscle may be related to reduce mitochondrial number and oxidation capacity. However, it is not known whether increasing mitochondrial number and function improves insulin resistance. In the present study, we investigated the effects of a combination of nutrients on insulin resistance and mitochondrial biogenesis/function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. Methodology/Principal Findings: We demonstrated that defect of glucose and lipid metabolism is associated with low mitochondrial content and reduced mitochondrial enzyme activity in skeletal muscle of the diabetic Goto-Kakizaki rats. The treatment of combination of R-alpha-lipoic acid, acetyl-L-carnitine, nicotinamide, and biotin effectively improved glucose tolerance, decreased the basal insulin secretion and the level of circulating free fatty acid (FFA), and prevented the reduction of mitochondrial biogenesis in skeletal muscle. The nutrients treatment also significantly increased mRNA levels of genes involved in lipid metabolism, including peroxisome proliferator-activated receptor-alpha (Ppar alpha), peroxisome proliferator activated receptor-delta (Ppar delta), and carnitine palmitoyl transferase-1 (Mcpt-1) and activity of mitochondrial complex I and II in skeletal muscle. All of these effects of mitochondrial nutrients are comparable to that of the antidiabetic drug, pioglitazone. In addition, the treatment with nutrients, unlike pioglitazone, did not cause body weight gain. Conclusions/Significance: These data suggest that a combination of mitochondrial targeting nutrients may improve skeletal mitochondrial dysfunction and exert hypoglycemic effects, without causing weight gain.	[Shen, Weili; Hao, Jiejie; Tian, Chuan; Ren, Jinmin; Yang, Lu; Li, Xuesen; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Hao, Jiejie; Tian, Chuan; Li, Xuesen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cotma, Carl W.; Liu, Jiankang] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Irvine	Shen, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China.	j.liu@uci.edu	Luo, Cheng/C-2849-2013; Liu, Jiankang/A-1610-2011	Luo, Cheng/0000-0003-2193-3670; Shen, Weili/0000-0002-3088-8245	Pujiang Talent Award [05PJ14104]; Science and Technology Commission of Shanghai Municipality [04dz14007]; Chinese Academy of Sciences	Pujiang Talent Award; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Pujiang Talent Award (05PJ14104) and the Diabetes Research Grant from the Science and Technology Commission of Shanghai Municipality (04dz14007), and the grant by the Chinese Academy of Sciences. The sponsors has no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ames BN, 2003, ALZ DIS ASSOC DIS, V17, pS54, DOI 10.1097/00002093-200304002-00007; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; AMES BN, 2006, NUTRIGENOMICS DISCOV, P277; ANSTALL HB, 1965, CLIN CHEM, V11, P741; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; BONNARD C, 2008, J CLIN INVEST; Dachicourt N, 1998, EUR J PHARMACOL, V361, P243, DOI 10.1016/S0014-2999(98)00718-3; Estrada DE, 1996, DIABETES, V45, P1798, DOI 10.2337/diabetes.45.12.1798; Ghosh S, 2007, MOL PHARMACOL, V71, P1695, DOI 10.1124/mol.106.033845; Giancaterini A, 2000, METABOLISM, V49, P704, DOI 10.1053/meta.2000.6250; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; Harrison WA, 2004, ACCIDENT ANAL PREV, V36, P885, DOI 10.1016/j.aap.2003.09.004; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Janssen U, 2004, J NEPHROL, V17, P769; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Liu CC, 2005, BRIT J NUTR, V94, P595, DOI 10.1079/BJN20051541; LIU J, 2007, NEUROCHEM RES; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo C, 2006, J BIOCHEM BIOPH METH, V68, P101, DOI 10.1016/j.jbbm.2006.04.003; Maru S, 2005, DIABETES CARE, V28, P20, DOI 10.2337/diacare.28.1.20; MCCAMAN RE, 1966, J BIOL CHEM, V241, P930; McCarty MF, 2005, MED HYPOTHESES, V64, P399, DOI 10.1016/j.mehy.2004.03.034; MENSINK M, 2007, INT J OBES LOND; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195, DOI 10.3233/jad-2007-12210; Packer L, 1997, Adv Pharmacol, V38, P79; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; Palmeira CM, 1999, FEBS LETT, V458, P103, DOI 10.1016/S0014-5793(99)01144-8; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; REAVEN GM, 1988, AM J PHYSIOL, V254, pE23, DOI 10.1152/ajpendo.1988.254.1.E23; REGOUW BJM, 1971, CLIN CHIM ACTA, V31, P187, DOI 10.1016/0009-8981(71)90377-9; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Satoh K, 2005, BIOL PHARM BULL, V28, P2092, DOI 10.1248/bpb.28.2092; Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4; Shima K, 1998, DIABETES RES CLIN PR, V41, P1, DOI 10.1016/S0168-8227(98)00061-8; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; SUGIYAMA Y, 1990, ARZNEIMITTEL-FORSCH, V40-1, P263; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; TSUJI K, 1988, METABOLISM, V37, P1040, DOI 10.1016/0026-0495(88)90064-9; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Velykyi M. M., 1996, Ukrainskii Biokhimicheskii Zhurnal, V68, P109; Walczak R, 2003, NAT MED, V9, P1348, DOI 10.1038/nm1103-1348; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yamanaka M, 2007, DIABETES OBES METAB, V9, P879, DOI 10.1111/j.1463-1326.2006.00675.x; Zempleni J, 1997, J NUTR, V127, P1776, DOI 10.1093/jn/127.9.1776	57	55	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2328	10.1371/journal.pone.0002328	http://dx.doi.org/10.1371/journal.pone.0002328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523557	Green Published, gold			2022-12-27	WOS:000262614300023
J	Hartl, D; Rohe, M; Mao, L; Staufenbiel, M; Zabel, C; Klose, J				Hartl, Daniela; Rohe, Michael; Mao, Lei; Staufenbiel, Matthias; Zabel, Claus; Klose, Joachim			Impairment of Adolescent Hippocampal Plasticity in a Mouse Model for Alzheimer's Disease Precedes Disease Phenotype	PLOS ONE			English	Article								The amyloid precursor protein (APP) was assumed to be an important neuron-morphoregulatory protein and plays a central role in Alzheimer's disease (AD) pathology. In the study presented here, we analyzed the APP-transgenic mouse model APP23 using 2-dimensional gel electrophoresis technology in combination with DIGE and mass spectrometry. We investigated cortex and hippocampus of transgenic and wildtype mice at 1, 2, 7 and 15 months of age. Furthermore, cortices of 16 days old embryos were analyzed. When comparing the protein patterns of APP23 with wildtype mice, we detected a relatively large number of altered protein spots at all age stages and brain regions examined which largely preceded the occurrence of amyloid plaques. Interestingly, in hippocampus of adolescent, two-month old mice, a considerable peak in the number of protein changes was observed. Moreover, when protein patterns were compared longitudinally between age stages, we found that a large number of proteins were altered in wildtype mice. Those alterations were largely absent in hippocampus of APP23 mice at two months of age although not in other stages compared. Apparently, the large difference in the hippocampal protein patterns between two-month old APP23 and wildtype mice was caused by the absence of distinct developmental changes in the hippocampal proteome of APP23 mice. In summary, the absence of developmental proteome alterations as well as a down-regulation of proteins related to plasticity suggest the disturption of a normally occurring peak of hippocampal plasticity during adolescence in APP23 mice. Our findings are in line with the observation that AD is preceded by a clinically silent period of several years to decades. We also demonstrate that it is of utmost importance to analyze different brain regions and different age stages to obtain information about disease-causing mechanisms.	[Hartl, Daniela; Mao, Lei; Zabel, Claus; Klose, Joachim] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Rohe, Michael] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Staufenbiel, Matthias] Novartis Inst Biomed Res, Basel, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Novartis	Hartl, D (corresponding author), Charite, Inst Human Genet, D-13353 Berlin, Germany.	claus.zabel@charite.de			German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program	German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program(Federal Ministry of Education & Research (BMBF))	This work was supported by the German ministry for education and research (BMBF) within the German National Genome Research Network (NGFN2) program.	Alpar A, 2006, INT J DEV NEUROSCI, V24, P133, DOI 10.1016/j.ijdevneu.2005.11.008; Arendt T, 2005, PROG BRAIN RES, V147, P355, DOI 10.1016/S0079-6123(04)47025-3; Arendt T, 2003, PROG NEUROBIOL, V71, P83, DOI 10.1016/j.pneurobio.2003.09.007; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Bornemann KD, 2000, ANN NY ACAD SCI, V908, P260; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Capetillo-Zarate E, 2006, BRAIN, V129, P2992, DOI 10.1093/brain/awl176; Diedrich M, 2008, PROTEOMICS, V8, P1266, DOI 10.1002/pmic.200700754; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Hefner K, 2007, BEHAV BRAIN RES, V176, P210, DOI 10.1016/j.bbr.2006.10.001; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mao L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001218; MASLIAH E, 1992, BRAIN RES, V593, P323, DOI 10.1016/0006-8993(92)91329-D; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Small D H, 1999, J Alzheimers Dis, V1, P275; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sturchler-Pierrat C, 2000, ANN NY ACAD SCI, V920, P134; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Tsuji T, 2002, NEUROCHEM RES, V27, P1245, DOI 10.1023/A:1020941929414; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Vloeberghs E, 2006, NEUROSCI LETT, V407, P6, DOI 10.1016/j.neulet.2006.07.060; ZABEL C, 2007, METHODS MOL IN PRESS; Zabel C, 2008, EXPERT REV PROTEOMIC, V5, P187, DOI 10.1586/14789450.5.2.187; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	45	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2759	10.1371/journal.pone.0002759	http://dx.doi.org/10.1371/journal.pone.0002759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648492	gold, Green Published, Green Accepted			2022-12-27	WOS:000264302900029
J	Verdoni, AM; Smith, RS; Ikeda, A; Ikeda, S				Verdoni, Angela M.; Smith, Richard S.; Ikeda, Akihiro; Ikeda, Sakae			Defects in Actin Dynamics Lead to an Autoinflammatory Condition through the Upregulation of CXCL5	PLOS ONE			English	Article								Background: Destrin (DSTN) is a member of the ADF/cofilin family of proteins and is an important regulator of actin dynamics. The primary function of destrin is to depolymerize filamentous actin into its monomeric form and promote filament severing. While progress has been made in understanding the biochemical functions of the ADF/cofilin proteins, the study of an animal model for cells deficient for DSTN provides an opportunity to investigate the physiological processes regulated by proper actin dynamics in vivo. A spontaneous mouse mutant, corneal disease 1(corn1), is deficient for DSTN, which causes epithelial hyperproliferation and neovascularization in the cornea. Dstn(corn1) mice exhibit an actin dynamics defect in the cornea as evidenced by the formation of actin stress fibers in the epithelial cells. Previously, we observed a significant infiltration of leukocytes into the cornea of Dstn(corn1) mice as well as the upregulation of proinflammatory molecules. In this study, we sought to characterize this inflammatory condition and explore the physiological mechanism through which a loss of Dstn function leads to inflammation. Methodology/Principal Findings: Through immunofluorescent analyses, we observed a significant recruitment of neutrophils and macrophages to the Dstn(corn1) cornea, demonstrating that the innate immune system is spontaneously activated in this mutant. The inflammatory chemokine, CXCL5, was ectopically expressed in the corneal epithelial cells of Dstn corn1 mice, and targeting of the receptor for this chemokine inhibited neutrophil recruitment. An inflammatory reaction was not observed in the cornea of allelic mutant strain, Dstn(corn1-2J), which has a milder defect in actin dynamics in the corneal epithelial cells. Conclusions/Significance: This study shows that severe defects in actin dynamics lead to an autoinflammatory condition that is mediated by the expression of CXC chemokines.	[Verdoni, Angela M.; Ikeda, Akihiro; Ikeda, Sakae] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Smith, Richard S.] Jackson Lab, Bar Harbor, ME USA	University of Wisconsin System; University of Wisconsin Madison; Jackson Laboratory	Verdoni, AM (corresponding author), Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA.	aikeda@wisc.edu		Ikeda, Akihiro/0000-0001-8440-3891	National Institutes of Health [EY011837, EY016108];  [T32 GM07133]; NATIONAL EYE INSTITUTE [R01EY016108, R01EY011837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: National Institutes of Health (NIH; EY011837, EY016108); Support for AMV was provided by the Predoctoral Training Program in Genetics (T32 GM07133). Funders did not play a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	APPELBERG R, 1989, CLIN EXP IMMUNOL, V78, P478; APPELBERG R, 1992, CLIN EXP IMMUNOL, V89, P120; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Feniger-Barish R, 2000, BLOOD, V95, P1551, DOI 10.1182/blood.V95.5.1551.005a36_1551_1559; Galon J, 2000, CURR OPIN IMMUNOL, V12, P479, DOI 10.1016/S0952-7915(00)00124-2; GAZZANIGA S, 2007, J INVEST DERMATOL; Gerberick GF, 2002, TOXICOL SCI, V68, P420, DOI 10.1093/toxsci/68.2.420; Goncalves AS, 2002, SCAND J IMMUNOL, V55, P585, DOI 10.1046/j.1365-3083.2002.01097.x; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hall LR, 1999, J IMMUNOL, V163, P4970; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; IIDA K, 1993, GENE, V124, P115; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Lu PR, 2007, CORNEA, V26, P199, DOI 10.1097/01.ico.0000248385.16896.34; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; MASON DY, 1989, J CLIN PATHOL, V42, P1194, DOI 10.1136/jcp.42.11.1194; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MURAO S, 1988, P NATL ACAD SCI USA, V85, P1232, DOI 10.1073/pnas.85.4.1232; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Ono S, 1998, J BIOL CHEM, V273, P3778, DOI 10.1074/jbc.273.6.3778; PEAKMAN M, 1993, J IMMUNOL METHODS, V158, P87, DOI 10.1016/0022-1759(93)90261-5; PETKOVA SB, 2008, PHYSL GENOM IN PRESS; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1016/S0022-4804(02)00020-3; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Su YJ, 2005, J IMMUNOL, V175, P5396, DOI 10.4049/jimmunol.175.8.5396; Suzuki S, 2002, BLOOD, V99, P1863, DOI 10.1182/blood.V99.5.1863.h8001863_1863_1865; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Verdoni AM, 2008, PHYSIOL GENOMICS, V34, P9, DOI 10.1152/physiolgenomics.00285.2007; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Wuyts A, 1996, J IMMUNOL, V157, P1736; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280; Zhou JH, 2005, MOL VIS, V11, P414	63	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2701	10.1371/journal.pone.0002701	http://dx.doi.org/10.1371/journal.pone.0002701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628996	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200044
J	Kim, E; Graham, LE				Kim, Eunsoo; Graham, Linda E.			EEF2 Analysis Challenges the Monophyly of Archaeplastida and Chromalveolata	PLOS ONE			English	Article							RED ALGAE; COMPLETE SEQUENCE; PHYLOGENETIC ANALYSIS; EVOLUTIONARY RELATIONSHIPS; EUKARYOTIC PHYLOGENY; CYANOPHORA-PARADOXA; PLASTID ORIGINS; SINGLE ORIGIN; COMMON ORIGIN; MISSING DATA	Background: Classification of eukaryotes provides a fundamental phylogenetic framework for ecological, medical, and industrial research. In recent years eukaryotes have been classified into six major supergroups: Amoebozoa, Archaeplastida, Chromalveolata, Excavata, Opisthokonta, and Rhizaria. According to this supergroup classification, Archaeplastida and Chromalveolata each arose from a single plastid-generating endosymbiotic event involving a cyanobacterium (Archaeplastida) or red alga (Chromalveolata). Although the plastids within members of the Archaeplastida and Chromalveolata share some features, no nucleocytoplasmic synapomorphies supporting these supergroups are currently known. Methodology/Principal Findings: This study was designed to test the validity of the Archaeplastida and Chromalveolata through the analysis of nucleus-encoded eukaryotic translation elongation factor 2 (EEF2) and cytosolic heat-shock protein of 70 kDa (HSP70) sequences generated from the glaucophyte Cyanophora paradoxa, the cryptophytes Goniomonas truncata and Guillardia theta, the katablepharid Leucocryptos marina, the rhizarian Thaumatomonas sp. and the green alga Mesostigma viride. The HSP70 phylogeny was largely unresolved except for certain well- established groups. In contrast, EEF2 phylogeny recovered many well- established eukaryotic groups and, most interestingly, revealed a well- supported clade composed of cryptophytes, katablepharids, haptophytes, rhodophytes, and Viridiplantae (green algae and land plants). This clade is further supported by the presence of a two amino acid signature within EEF2, which appears to have arisen from amino acid replacement before the common origin of these eukaryotic groups. Conclusions/Significance: Our EEF2 analysis strongly refutes the monophyly of the Archaeplastida and the Chromalveolata, adding to a growing body of evidence that limits the utility of these supergroups. In view of EEF2 phylogeny and other morphological evidence, we discuss the possibility of an alternative eukaryotic supergroup.	[Kim, Eunsoo; Graham, Linda E.] University of Wisconsin-Madison, Dept Bot, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Kim, E (corresponding author), University of Wisconsin-Madison, Dept Bot, Madison, WI USA.	eunsookim@dal.ca			National Science Foundation [MCB-9977903]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-9977903 from the National Science Foundation. The grant was used to purchase supplies for molecular sequencing.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; Bachvaroff TR, 2005, MOL BIOL EVOL, V22, P1772, DOI 10.1093/molbev/msi172; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Bhattacharya D, 2006, CURR BIOL, V16, pR1017, DOI 10.1016/j.cub.2006.11.021; BISBY FA, 2007, SPECIES 2000; Bodyl A, 2005, J PHYCOL, V41, P712, DOI 10.1111/j.1529-8817.2005.00091.x; Bodyl A, 2007, TRENDS MICROBIOL, V15, P295, DOI 10.1016/j.tim.2007.05.002; Bodyl A, 2006, EUR J PHYCOL, V41, P435, DOI 10.1080/09670260600961080; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bucknam J, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-26; Burger G, 1999, PLANT CELL, V11, P1675, DOI 10.1105/tpc.11.9.1675; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Clay B, 1999, PROTIST, V150, P43, DOI 10.1016/S1434-4610(99)70008-8; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; DOMOZYCH DS, 1992, PROTOPLASMA, V167, P19, DOI 10.1007/BF01353577; DOMOZYCH DS, 1981, J CELL SCI, V52, P351; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Germot A, 1999, J EUKARYOT MICROBIOL, V46, P116, DOI 10.1111/j.1550-7408.1999.tb04594.x; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Graham LE, 2000, ALGAE; Grzebyk D, 2004, SCIENCE, V306, P2191, DOI 10.1126/science.1105297; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; GUPTA RS, 1993, J MOL EVOL, V37, P573; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Inagaki Y, 2004, SYST BIOL, V53, P582, DOI 10.1080/10635150490468756; Jarvis P, 2001, BBA-MOL CELL RES, V1541, P64, DOI 10.1016/S0167-4889(01)00147-1; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Keeling Patrick J, 2004, Science, V306, P2191; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; KIM E, 2008, CHLOROPLAST IN PRESS; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; Kohler S, 2005, PARASITOL RES, V96, P258, DOI 10.1007/s00436-005-1338-2; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Larkum AWD, 2007, TRENDS PLANT SCI, V12, P189, DOI 10.1016/j.tplants.2007.03.011; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; LEE RE, 1992, BRIT PHYCOL J, V27, P369, DOI 10.1080/00071619200650311; LEE RE, 1991, J PHYCOL, V27, P505, DOI 10.1111/j.0022-3646.1991.00505.x; Loffelhardt W, 1997, PLANT SYST EVOL, P149; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; Marin B, 2005, PROTIST, V156, P425, DOI 10.1016/j.protis.2005.09.001; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; MCFADDEN GI, 1994, EUR J PHYCOL, V29, P29, DOI 10.1080/09670269400650451; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Moriya M, 2002, PROTIST, V153, P143, DOI 10.1078/1434-4610-00093; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Nowack ECM, 2008, CURR BIOL, V18, P410, DOI 10.1016/j.cub.2008.02.051; Nozaki H, 2005, J PHYCOL, V41, P652, DOI 10.1111/j.1529-8817.2005.00079.x; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; O'Kelly Charles J., 1993, P269; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; PATTERSON DJ, 2000, LINEAGES EUKARYOTES; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rissler HM, 2005, PLANT CELL PHYSIOL, V46, P416, DOI 10.1093/pcp/pci054; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Sanchez-Puerta MV, 2007, MOL PHYLOGENET EVOL, V44, P885, DOI 10.1016/j.ympev.2007.03.003; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, J MOL EVOL, V57, P408, DOI 10.1007/s00239-003-2490-x; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Steiner JM, 2005, PLANT J, V44, P646, DOI 10.1111/j.1365-313X.2005.02559.x; Stiller JW, 2007, TRENDS PLANT SCI, V12, P391, DOI 10.1016/j.tplants.2007.08.002; Stiller JW, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-71; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Stiller JW, 2003, J PHYCOL, V39, P95, DOI 10.1046/j.1529-8817.2003.02070.x; Stiller JW, 2001, J MOL EVOL, V52, P527, DOI 10.1007/s002390010183; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Stoebe B, 1998, PLANT MOL BIOL REP, V16, P243, DOI 10.1023/A:1007568326120; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Takishita K, 2008, GENE, V410, P26, DOI 10.1016/j.gene.2007.11.008; Theissen U, 2006, CURR BIOL, V16, pR1016, DOI 10.1016/j.cub.2006.11.020; Tomova C, 2006, BIOL CELL, V98, P535, DOI 10.1042/BC20060028; VORS N, 1992, EUR J PROTISTOL, V28, P369, DOI 10.1016/S0932-4739(11)80001-5; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	104	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2621	10.1371/journal.pone.0002621	http://dx.doi.org/10.1371/journal.pone.0002621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612431	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800023
J	Takagi, H; Sato, MJ; Yanagida, T; Ueda, M				Takagi, Hiroaki; Sato, Masayuki J.; Yanagida, Toshio; Ueda, Masahiro			Functional Analysis of Spontaneous Cell Movement under Different Physiological Conditions	PLOS ONE			English	Article								Cells can show not only spontaneous movement but also tactic responses to environmental signals. Since the former can be regarded as the basis to realize the latter, playing essential roles in various cellular functions, it is important to investigate spontaneous movement quantitatively at different physiological conditions in relation to a cell's physiological functions. For that purpose, we observed a series of spontaneous movements by Dictyostelium cells at different developmental periods by using a single cell tracking system. Using statistical analysis of these traced data, we found that cells showed complex dynamics with anomalous diffusion and that their velocity distribution had power-law tails in all conditions. Furthermore, as development proceeded, average velocity and persistency of the movement increased and as too did the exponential behavior in the velocity distribution. Based on these results, we succeeded in applying a generalized Langevin model to the experimental data. With this model, we discuss the relation of spontaneous cell movement to cellular physiological function and its relevance to behavioral strategies for cell survival.	[Takagi, Hiroaki; Sato, Masayuki J.; Yanagida, Toshio; Ueda, Masahiro] Osaka Univ, Labs Nanobiol, Grad Sch Frontier Biosci, Osaka, Japan; [Takagi, Hiroaki] Nara Med Univ, Sch Med, Dept Phys, Nara, Japan; [Takagi, Hiroaki; Sato, Masayuki J.; Ueda, Masahiro] CREST, Japan Sci & Technol Agcy JST, Osaka, Japan	Osaka University; Nara Medical University; Japan Science & Technology Agency (JST)	Takagi, H (corresponding author), Osaka Univ, Labs Nanobiol, Grad Sch Frontier Biosci, Osaka, Japan.	takagi@naramed-u.ac.jp		Ueda, Masahiro/0000-0002-9354-3404	MEXT, Japan; JSPS, Japan [19870020, Research Fellowships]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Leading Project, MEXT, Japan. H.T. is supported by Grant-in-Aid for Young Scientists (Start-up, no. 19870020), JSPS, Japan. M.S. is supported by Research Fellowships, JSPS, Japan.	Bray D., 2000, CELL MOVEMENTS MOL M; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Dormann D, 2006, CURR OPIN GENET DEV, V16, P367, DOI 10.1016/j.gde.2006.06.003; DUNN GA, 1987, J CELL SCI, P81; Miyoshi H, 2003, PROTOPLASMA, V222, P175, DOI 10.1007/s00709-003-0013-7; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Shenderov AD, 1997, BIOPHYS J, V72, P2382, DOI 10.1016/S0006-3495(97)78883-0; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	11	104	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2648	10.1371/journal.pone.0002648	http://dx.doi.org/10.1371/journal.pone.0002648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612377	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800050
J	Ohta, H; Xu, S; Moriya, T; Iigo, M; Watanabe, T; Nakahata, N; Chisaka, H; Hanita, T; Matsuda, T; Ohura, T; Kimura, Y; Yaegashi, N; Tsuchiya, S; Tei, H; Okamura, K				Ohta, Hidenobu; Xu, Shanhai; Moriya, Takahiro; Iigo, Masayuki; Watanabe, Tatsuya; Nakahata, Norimichi; Chisaka, Hiroshi; Hanita, Takushi; Matsuda, Tadashi; Ohura, Toshihiro; Kimura, Yoshitaka; Yaegashi, Nobuo; Tsuchiya, Shigeru; Tei, Hajime; Okamura, Kunihiro			Maternal Feeding Controls Fetal Biological Clock	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SUPRACHIASMATIC NUCLEUS; NURSING MOTHERS; CONSTANT LIGHT; EXPRESSION; GENES; BRAIN; COORDINATION; OSCILLATIONS; ENDOCRINE	Background: It is widely accepted that circadian physiological rhythms of the fetus are affected by oscillators in the maternal brain that are coupled to the environmental light-dark (LD) cycle. Methodology/Principal Findings: To study the link between fetal and maternal biological clocks, we investigated the effects of cycles of maternal food availability on the rhythms of Per1 gene expression in the fetal suprachiasmatic nucleus (SCN) and liver using a transgenic rat model whose tissues express luciferase in vitro. Although the maternal SCN remained phase-locked to the LD cycle, maternal restricted feeding phase-advanced the fetal SCN and liver by 5 and 7 hours respectively within the 22-day pregnancy. Conclusions/Significance: Our results demonstrate that maternal feeding entrains the fetal SCN and liver independently of both the maternal SCN and the LD cycle. This indicates that maternal-feeding signals can be more influential for the fetal SCN and particular organ oscillators than hormonal signals controlled by the maternal SCN, suggesting the importance of a regular maternal feeding schedule for appropriate fetal molecular clockwork during pregnancy.	[Ohta, Hidenobu; Xu, Shanhai; Watanabe, Tatsuya; Chisaka, Hiroshi; Hanita, Takushi; Matsuda, Tadashi; Okamura, Kunihiro] Tohoku Univ Hosp, Ctr Perinatal Med, Sendai, Miyagi, Japan; [Ohta, Hidenobu; Xu, Shanhai; Chisaka, Hiroshi; Yaegashi, Nobuo; Okamura, Kunihiro] Tohoku Univ Hosp, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Ohta, Hidenobu; Watanabe, Tatsuya; Hanita, Takushi; Matsuda, Tadashi; Ohura, Toshihiro; Tsuchiya, Shigeru] Tohoku Univ Hosp, Dept Pediat, Sendai, Miyagi, Japan; [Moriya, Takahiro; Nakahata, Norimichi] Tohoku Univ, Grad Sch Pharm Sci, Dept Cellular Signaling, Sendai, Miyagi, Japan; [Iigo, Masayuki] Utsunomiya Univ, Fac Agr, Dept Appl Biochem, Tochigi, Japan; [Kimura, Yoshitaka] Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi, Japan; [Tei, Hajime] Mitsubishi Kagaku Inst Life Sci, Res Grp Chronogenom, Tokyo, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Utsunomiya University; Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Ohta, H (corresponding author), Tohoku Univ Hosp, Ctr Perinatal Med, Sendai, Miyagi, Japan.	hideohta@mail.tains.tohoku.ac.jp	Iigo, Masayuki/I-7110-2013		Ministry of Education, Science, Sports and Culture [Grants-in-Aid for Scientific Research]; Ministry of Health, Labour and Welfare; Kanzawa Medical Research Foundation	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation)	Grants-in-Aid for Scientific Research (to H.O.) from the Ministry of Education, Science, Sports and Culture and from the Ministry of Health, Labour and Welfare; a grant from Kanzawa Medical Research Foundation (to H.O.)	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; [Anonymous], [No title captured], DOI [10.1126/science.284.5423.2177, DOI 10.1126/SCIENCE.284.5423.2177]; Burgoon PW, 2004, J COMP PHYSIOL A, V190, P167, DOI 10.1007/s00359-003-0486-z; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVIS FC, 1988, J COMP PHYSIOL A, V162, P601, DOI 10.1007/BF01342635; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Kennaway DJ, 2002, TRENDS ENDOCRIN MET, V13, P398, DOI 10.1016/S1043-2760(02)00692-6; Kovacikova Z, 2006, J BIOL RHYTHM, V21, P140, DOI 10.1177/0748730405285876; Li XD, 2005, DEV BRAIN RES, V158, P31, DOI 10.1016/j.devbrainres.2005.05.005; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; Mirmiran M, 2000, SEMIN PERINATOL, V24, P247, DOI 10.1053/sper.2000.8593; Ohta H, 2003, EUR J NEUROSCI, V17, P1628, DOI 10.1046/j.1460-9568.2003.02584.x; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Parraguez VH, 1996, ENDOCRINOLOGY, V137, P2355, DOI 10.1210/en.137.6.2355; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; REPPERT SM, 1986, ENDOCRINOLOGY, V119, P1763, DOI 10.1210/endo-119-4-1763; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; SHIBATA S, 1987, DEV BRAIN RES, V34, P311, DOI 10.1016/0165-3806(87)90220-3; Shimomura H, 2001, EUR J NEUROSCI, V13, P687, DOI 10.1046/j.0953-816x.2000.01438.x; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; WEAVER DR, 1986, BRAIN RES DEV BRAIN, V46, P291; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	32	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2601	10.1371/journal.pone.0002601	http://dx.doi.org/10.1371/journal.pone.0002601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596966	gold, Green Submitted, Green Published			2022-12-27	WOS:000263288200054
J	Snaddon, JL; Turner, EC; Foster, WA				Snaddon, Jake L.; Turner, Edgar C.; Foster, William A.			Children's Perceptions of Rainforest Biodiversity: Which Animals Have the Lion's Share of Environmental Awareness?	PLOS ONE			English	Article							BUTTERFLIES; CONSERVATION; EXTINCTION	Globally, natural ecosystems are being lost to agricultural land at an unprecedented rate. This land-use often results in significant reductions in abundance and diversity of the flora and fauna as well as alterations in their composition. Despite this, there is little public perception of which taxa are most important in terms of their total biomass, biodiversity or the ecosystem services they perform. Such awareness is important for conservation, as without appreciation of their value and conservation status, species are unlikely to receive adequate conservation protection. We investigated children's perceptions of rainforest biodiversity by asking primary-age children, visiting the University Museum of Zoology, Cambridge to draw their ideal rainforest. By recording the frequency at which children drew different climatic, structural, vegetative and faunal components of the rainforest, we were able to quantify children's understanding of a rainforest environment. We investigated children's perceptions of rainforest biodiversity by comparing the relative numbers of the taxa drawn with the actual contributions made by these taxa to total rainforest biomass and global biodiversity. We found that children have a sophisticated view of the rainforest, incorporating many habitat features and a diverse range of animals. However, some taxa were over-represented (particularly mammals, birds and reptiles) and others under-represented (particularly insects and annelids) relative to their contribution to total biomass and species richness. Scientists and naturalists must continue to emphasise the diversity and functional importance of lesser-known taxa through public communication and outdoor events to aid invertebrate conservation and to ensure that future generations are inspired to become naturalists themselves.	[Snaddon, Jake L.; Turner, Edgar C.; Foster, William A.] Univ Cambridge, Dept Zool, Cambridge, England; [Turner, Edgar C.] Bedfordshire, Cambridgeshire Wildlife Trusts, Northamptonshire & Peterborough Wildlife Trusts, Bedford, England	University of Cambridge	Snaddon, JL (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ect23@cam.ac.uk	Snaddon, Jake Lanion/C-8800-2011	Snaddon, Jake Lanion/0000-0003-3549-5472; Turner, Edgar/0000-0003-2715-2234				Balmford A, 2002, SCIENCE, V295, P2367; Barraza L, 1999, ENVIRON EDUC RES, V5, P49, DOI DOI 10.1080/1350462990050103; Barrow L.H., 2002, J ELEMENTARY SCI ED, V14, P53, DOI [DOI 10.1007/BF03173848, 10.1007/BF03173848]; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; CHEESMAN OD, 2007, INSECT CONSERVATION; Chen S. H., 1998, P NATL SCI COUNCIL D, V8, P55; Dumbrell AJ, 2005, BIOL CONSERV, V125, P123, DOI 10.1016/j.biocon.2005.02.016; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Fontaine B, 2007, BIOL CONSERV, V139, P167, DOI 10.1016/j.biocon.2007.06.012; GREAVES E, 1993, J BIOL EDUC, V27, P189, DOI 10.1080/00219266.1993.9655332; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grimaldi David, 2005, pi; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Leather SR, 2008, INSECT CONSERV DIVER, V1, P1, DOI 10.1111/j.1752-4598.2007.00009.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Matthews RW, 1997, ANNU REV ENTOMOL, V42, P269, DOI 10.1146/annurev.ento.42.1.269; MCGAVIN GC, 2000, INSECTS SPIDERS OTHE; Measham TG, 2006, ENVIRON MANAGE, V38, P426, DOI 10.1007/s00267-005-0205-3; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Prokop P, 2008, INT J SCI EDUC, V30, P431, DOI 10.1080/09500690701206686; Pyle R. M., 1993, THUNDER TREE LESSONS; Samways M.J., 2005, INSECT DIVERSITY CON; Shepardson DP, 2007, J RES SCI TEACH, V44, P327, DOI 10.1002/tea.20161; Shepardson DP, 2002, INT J SCI EDUC, V24, P627, DOI 10.1080/09500690110074765; Shepardson DP, 1997, J RES SCI TEACH, V34, P873, DOI 10.1002/(SICI)1098-2736(199711)34:9<873::AID-TEA3>3.0.CO;2-R; Snaddon JL, 2007, ENVIRON CONSERV, V34, P33, DOI 10.1017/S0376892907003669; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; STROMMEN E, 1995, J RES SCI TEACH, V32, P683, DOI 10.1002/tea.3660320704; Tarlowski A, 2006, COGNITIVE DEV, V21, P249, DOI 10.1016/j.cogdev.2006.02.001; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Tomkins S, 2007, J BIOL EDUC, V41, P150, DOI 10.1080/00219266.2007.9656090; Tunnicliffe SD, 1999, J BIOL EDUC, V33, P142, DOI 10.1080/00219266.1999.9655654; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; WILSON E O, 1992; Wilson E.O, 1990, SUCCESS DOMINANCE EC	37	59	63	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2579	10.1371/journal.pone.0002579	http://dx.doi.org/10.1371/journal.pone.0002579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596931	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000263288200043
J	Qi, Z; Miller, GW; Voit, EO				Qi, Zhen; Miller, Gary W.; Voit, Eberhard O.			Computational Systems Analysis of Dopamine Metabolism	PLOS ONE			English	Article							PARKINSONS-DISEASE; MONOAMINE-OXIDASE; ACETYLCHOLINE-RECEPTORS; ALPHA-SYNUCLEIN; MOUSE MODEL; MICE; IRON; LOCOMOTION; LAW; CATECHOLAMINES	A prominent feature of Parkinson's disease (PD) is the loss of dopamine in the striatum, and many therapeutic interventions for the disease are aimed at restoring dopamine signaling. Dopamine signaling includes the synthesis, storage, release, and recycling of dopamine in the presynaptic terminal and activation of pre- and post-synaptic receptors and various downstream signaling cascades. As an aid that might facilitate our understanding of dopamine dynamics in the pathogenesis and treatment in PD, we have begun to merge currently available information and expert knowledge regarding presynaptic dopamine homeostasis into a computational model, following the guidelines of biochemical systems theory. After subjecting our model to mathematical diagnosis and analysis, we made direct comparisons between model predictions and experimental observations and found that the model exhibited a high degree of predictive capacity with respect to genetic and pharmacological changes in gene expression or function. Our results suggest potential approaches to restoring the dopamine imbalance and the associated generation of oxidative stress. While the proposed model of dopamine metabolism is preliminary, future extensions and refinements may eventually serve as an in silico platform for prescreening potential therapeutics, identifying immediate side effects, screening for biomarkers, and assessing the impact of risk factors of the disease.	[Qi, Zhen; Voit, Eberhard O.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Qi, Zhen; Miller, Gary W.] Emory Univ, Rollins Sch Publ Hlth, Dept Env & Occupat Hlth, Atlanta, GA USA; [Qi, Zhen; Miller, Gary W.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Emory University; Rollins School Public Health; Emory University	Qi, Z (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	eberhard.voit@bme.gatech.edu	Qi, Zhen/A-6273-2011		Woodruff Health Science Center; NIH [U54-ES012068]; Georgia Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870, U54ES012068] Funding Source: NIH RePORTER	Woodruff Health Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Woodruff Health Science Center Fund grant, NIH grant number U54-ES012068, and an endowment from the Georgia Research Alliance.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Alves R, 2004, PROTEINS, V56, P354, DOI 10.1002/prot.20110; Andersen JK, 2004, J ALZHEIMERS DIS, V6, pS47; ANTON AH, 1964, J PHARMACOL EXP THER, V145, P326; Barbano PE, 2007, P NATL ACAD SCI USA, V104, P19169, DOI 10.1073/pnas.0709955104; BARBEAU A, 1961, ARCH NEUROL-CHICAGO, V4, P97, DOI 10.1001/archneur.1961.00450070099011; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; CARLSSON A, 1959, PHARMACOL REV, V11, P490; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen K, 2004, J BIOL CHEM, V279, P39645, DOI 10.1074/jbc.M405550200; Colebrooke RE, 2006, EUR J NEUROSCI, V24, P2622, DOI 10.1111/j.1460-9568.2006.05143.x; Doudet DJ, 1997, EUR J PHARMACOL, V334, P31, DOI 10.1016/S0014-2999(97)01157-6; Faucheux BA, 2003, J NEUROCHEM, V86, P1142, DOI 10.1046/j.1471-4159.2003.01923.x; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Fernandez HH, 2007, CLIN NEUROPHARMACOL, V30, P150, DOI 10.1097/01.WNF.0000240956.49315.BE; Fumagalli F, 1998, Adv Pharmacol, V42, P179; Gesi M, 2001, PHARMACOL TOXICOL, V89, P217, DOI 10.1034/j.1600-0773.2001.d01-151.x; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Goldman AI, 2007, GRAZER PHILOS STUD, V74, P1; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Hakansson K, 2004, PARKINSONISM RELAT D, V10, P281, DOI 10.1016/j.parkreldis.2004.02.010; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Huotari M, 2002, J PHARMACOL EXP THER, V303, P1309, DOI 10.1124/jpet.102.043042; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JUSTICE JB, 1988, J NEUROSCI METH, V22, P239, DOI 10.1016/0165-0270(88)90045-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur D, 2007, NEUROBIOL AGING, V28, P907, DOI 10.1016/j.neurobiolaging.2006.04.003; Kaushik P, 2007, J COMPUT NEUROSCI, V22, P147, DOI 10.1007/s10827-006-0004-8; Kawahara K, 2008, J BIOL CHEM, V283, P6979, DOI 10.1074/jbc.M710418200; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Leung TW, 2006, INT J STROKE, V1, P20, DOI 10.1111/j.1747-4949.2005.00014.x; Lindskog M, 2006, PLOS COMPUT BIOL, V2, P1045, DOI 10.1371/journal.pcbi.0020119; Matsunaga J, 1999, J BIOL CHEM, V274, P3268, DOI 10.1074/jbc.274.6.3268; Mooslehner KA, 2001, MOL CELL BIOL, V21, P5321, DOI 10.1128/MCB.21.16.5321-5331.2001; NAPOLITANO A, 1995, EUR J PHARMACOL, V273, P215, DOI 10.1016/0014-2999(94)00682-W; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Phillips JM, 2006, EUR J NEUROSCI, V23, P151, DOI 10.1111/j.1460-9568.2005.04550.x; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; SANO I, 1959, BIOCHIM BIOPHYS ACTA, V32, P586, DOI 10.1016/0006-3002(59)90652-3; SATO K, 1994, NEUROSCI LETT, V173, P59, DOI 10.1016/0304-3940(94)90149-X; SAVAGEAU MA, 1987, MATH BIOSCI, V87, P83, DOI 10.1016/0025-5564(87)90035-6; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P370, DOI 10.1016/S0022-5193(69)80027-5; SAVAGEAU MA, 1969, J THEOR BIOL, V25, P365, DOI 10.1016/S0022-5193(69)80026-3; SAVAGEAU MA, 1970, J THEOR BIOL, V26, P215, DOI 10.1016/S0022-5193(70)80013-3; SAVAGEAU MA, 1976, BIOCHEMICAL SYSTEMS, P199; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; SCHULZ AR, 1994, ENZYME KINETICS; Shoulson I, 1998, ANN NEUROL, V44, pS160, DOI 10.1002/ana.410440724; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Stocchi F, 2006, NEUROLOGY, V67, pS24, DOI 10.1212/WNL.67.7_suppl_2.S24; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Sun YF, 2001, ACTA PHARMACOL SIN, V22, P243; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; TORRES NV, 2002, PATHWAY ANAL OPTIMIZ, pP14; Tyce G M, 1990, J Neural Transm Suppl, V29, P233; Voit EO, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3454323; VOIT EO, 1993, ENVIRONMETRICS, V4, P153, DOI 10.1002/env.3170040203; Voit EO, 2004, BIOINFORMATICS, V20, P1670, DOI 10.1093/bioinformatics/bth140; VOIT EO, 2000, COMPUTATIONAL ANAL B, pR12; VOIT EO, 1991, CONONICAL NONLINEAR, pR11; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Yuan Hong, 2007, Neurosci Bull, V23, P125, DOI 10.1007/s12264-007-0018-x	65	53	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2444	10.1371/journal.pone.0002444	http://dx.doi.org/10.1371/journal.pone.0002444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18568086	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700029
J	Mollenbeck, M; Zhou, Y; Cavalcanti, ARO; Jonsson, F; Higgins, BP; Chang, WJ; Juranek, S; Doak, TG; Rozenberg, G; Lipps, HJ; Landweber, LF				Moellenbeck, Matthias; Zhou, Yi; Cavalcanti, Andre R. O.; Joensson, Franziska; Higgins, Brian P.; Chang, Wei-Jen; Juranek, Stefan; Doak, Thomas G.; Rozenberg, Grzegorz; Lipps, Hans J.; Landweber, Laura F.			The Pathway to Detangle a Scrambled Gene	PLOS ONE			English	Article							DEVELOPMENTAL GENOME REARRANGEMENTS; MACRONUCLEAR DEVELOPMENT; DNA DELETION; SMALL RNAS; EVOLUTION; EXCISION; ELIMINATION; TETRAHYMENA; DIMINUTION; MECHANISM	Background: Programmed DNA elimination and reorganization frequently occur during cellular differentiation. Development of the somatic macronucleus in some ciliates presents an extreme case, involving excision of internal eliminated sequences (IESs) that interrupt coding DNA segments (macronuclear destined sequences, MDSs), as well as removal of transposon-like elements and extensive genome fragmentation, leading to 98% genome reduction in Stylonychia lemnae. Approximately 20-30% of the genes are estimated to be scrambled in the germline micronucleus, with coding segment order permuted and present in either orientation on micronuclear chromosomes. Massive genome rearrangements are therefore critical for development. Methodology/Principal Findings: To understand the process of DNA deletion and reorganization during macronuclear development, we examined the population of DNA molecules during assembly of different scrambled genes in two related organisms in a developmental time-course by PCR. The data suggest that removal of conventional IESs usually occurs first, accompanied by a surprising level of error at this step. The complex events of inversion and translocation seem to occur after repair and excision of all conventional IESs and via multiple pathways. Conclusions/Significance: This study reveals a temporal order of DNA rearrangements during the processing of a scrambled gene, with simpler events usually preceding more complex ones. The surprising observation of a hidden layer of errors, absent from the mature macronucleus but present during development, also underscores the need for repair or screening of incorrectly-assembled DNA molecules.	[Moellenbeck, Matthias; Joensson, Franziska; Juranek, Stefan; Lipps, Hans J.] Univ Witten Herdecke, Inst Cell Biol, Witten, Germany; [Zhou, Yi; Cavalcanti, Andre R. O.; Higgins, Brian P.; Chang, Wei-Jen; Doak, Thomas G.; Landweber, Laura F.] Princeton Univ, Princeton, NJ USA; [Rozenberg, Grzegorz] Leiden Univ, Inst Advanced Comp Sci, Leiden, Netherlands	Witten Herdecke University; Princeton University; Leiden University; Leiden University - Excl LUMC	Mollenbeck, M (corresponding author), Univ Witten Herdecke, Inst Cell Biol, Witten, Germany.	lfl@Princeton.edu	Cavalcanti, Andre RO/H-9777-2013; Chang, Wei-Jen/AAT-3303-2021	Cavalcanti, Andre RO/0000-0001-8708-6932; Chang, Wei-Jen/0000-0002-8065-2281; Doak, Thomas/0000-0001-5487-553X	NSF [0121422, 0622112]; NIH [GM59708]; DFG; Alfried Krupp von Bohlen und Halbach Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Alfried Krupp von Bohlen und Halbach Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the NSF (0121422 and 0622112) and NIH (GM59708) to L.F.L. and the DFG and Alfried Krupp von Bohlen und Halbach Foundations to H.J.L.	AMMERMANN D, 1974, CHROMOSOMA, V45, P401, DOI 10.1007/BF00283386; Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BEERMANN S, 1977, CHROMOSOMA, V60, P297, DOI 10.1007/BF00292858; BORST P, 1991, IMMUNOPARASITOL TOD, pA29, DOI 10.1016/S0167-5699(05)80009-X; Cavalcanti ARO, 2006, NAT COMP SER, P349, DOI 10.1007/3-540-30296-4_22; Cavalcanti ARO, 2005, NUCLEIC ACIDS RES, V33, pD396, DOI 10.1093/nar/gki130; Cavalcanti ARO, 2004, PROTIST, V155, P311, DOI 10.1078/1434461041844196; Cavalcanti ARO, 2004, BIOINFORMATICS, V20, P800, DOI 10.1093/bioinformatics/bth003; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chang WJ, 2006, GENE, V368, P72, DOI 10.1016/j.gene.2005.10.008; Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Doak TG, 2003, TRENDS GENET, V19, P603, DOI 10.1016/j.tig.2003.09.013; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Ehrenfeucht A., 2002, Mathematical Structures in Computer Science, V12, P113, DOI 10.1017/S0960129501003516; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Gerbi S.A., 1986, Results and Problems in Cell Differentiation, V13, P71; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Juranek SA, 2005, EUKARYOT CELL, V4, P1934, DOI 10.1128/EC.4.11.1934-1941.2005; Juranek SA, 2007, INT REV CYTOL, V262, P219, DOI 10.1016/S0074-7696(07)62005-1; KLOBUTCHER LA, 1993, GENE DEV, V7, P84, DOI 10.1101/gad.7.1.84; KRAUT H, 1986, INT REV CYTOL, V99, P1; Kuo SY, 2006, MOL BIOL EVOL, V23, P4, DOI 10.1093/molbev/msj017; Landweber LF, 2000, P NATL ACAD SCI USA, V97, P3298, DOI 10.1073/pnas.040574697; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber M, 1996, CURR BIOL, V6, P134, DOI 10.1016/S0960-9822(02)00443-8; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Meyer E, 1996, CELL, V87, P9, DOI 10.1016/S0092-8674(00)81317-3; Meyer E, 2002, ADV GENET, V46, P305; MITCHAM JL, 1992, GENE DEV, V6, P788, DOI 10.1101/gad.6.5.788; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2006, J MOL EVOL, V63, P69, DOI 10.1007/s00239-005-0166-4; Muller F, 2000, INT J PARASITOL, V30, P391, DOI 10.1016/S0020-7519(99)00199-X; Myrick KV, 2002, GENE, V284, P125, DOI 10.1016/S0378-1119(02)00384-0; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Paschka AG, 2005, GENE, V359, P81, DOI 10.1016/j.gene.2005.06.024; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; PRESCOTT DM, 1992, DEV GENET, V13, P66, DOI 10.1002/dvg.1020130111; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Tobler H., 1986, Results and Problems in Cell Differentiation, V13, P1; Vanhamme L, 2001, TRENDS PARASITOL, V17, P338, DOI 10.1016/S1471-4922(01)01922-5; Wen JP, 1996, NUCLEIC ACIDS RES, V24, P4415, DOI 10.1093/nar/24.22.4415; Wong LC, 2006, MOL BIOL EVOL, V23, P756, DOI 10.1093/molbev/msj089; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yao MC, 1996, TRENDS GENET, V12, P26, DOI 10.1016/0168-9525(96)81385-0	52	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2330	10.1371/journal.pone.0002330	http://dx.doi.org/10.1371/journal.pone.0002330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523559	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300025
J	Edwards, YJK; Bryson, K; Jones, DT				Edwards, Yvonne J. K.; Bryson, Kevin; Jones, David T.			A Meta-Analysis of Microarray Gene Expression in Mouse Stem Cells: Redefining Stemness	PLOS ONE			English	Article							ALTERNATIVE PROMOTERS; MOLECULAR SIGNATURE; DNA METHYLATION; CHROMATIN; DATABASE; BIOLOGY	Background: While much progress has been made in understanding stem cell (SC) function, a complete description of the molecular mechanisms regulating SCs is not yet established. This lack of knowledge is a major barrier holding back the discovery of therapeutic uses of SCs. We investigated the value of a novel meta-analysis of microarray gene expression in mouse SCs to aid the elucidation of regulatory mechanisms common to SCs and particular SC types. Methodology/Principal Findings: We added value to previously published microarray gene expression data by characterizing the promoter type likely to regulate transcription. Promoters of up-regulated genes in SCs were characterized in terms of alternative promoter (AP) usage and CpG-richness, with the aim of correlating features known to affect transcriptional control with SC function. We found that SCs have a higher proportion of up-regulated genes using CpG-rich promoters compared with the negative controls. Comparing subsets of SC type with the controls a slightly different story unfolds. The differences between the proliferating adult SCs and the embryonic SCs versus the negative controls are statistically significant. Whilst the difference between the quiescent adult SCs compared with the negative controls is not. On examination of AP usage, no difference was observed between SCs and the controls. However, comparing the subsets of SC type with the controls, the quiescent adult SCs are found to up-regulate a larger proportion of genes that have APs compared to the controls and the converse is true for the proliferating adult SCs and the embryonic SCs. Conclusions/Significance: These findings suggest that looking at features associated with control of transcription is a promising future approach for characterizing "stemness'' and that further investigations of stemness could benefit from separate considerations of different SC states. For example, "proliferating-stemness'' is shown here, in terms of promoter usage, to be distinct from "quiescent-stemness''.	[Edwards, Yvonne J. K.; Bryson, Kevin; Jones, David T.] UCL, Dept Comp Sci, Bioinformat Grp, London, England	University of London; University College London	Edwards, YJK (corresponding author), UCL, Dept Comp Sci, Bioinformat Grp, London, England.	d.jones@cs.ucl.ac.uk		Bryson, Kevin/0000-0002-1163-6368; Edwards, Yvonne/0000-0001-8505-3168	Wellcome Trust [GR066745MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust Functional Genomics Initiative on Stem Cells (grant number: GR066745MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fortunel NO, 2003, SCIENCE, V302, P393; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Ivanova NB, 2003, SCIENCE, V302; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2712	10.1371/journal.pone.0002712	http://dx.doi.org/10.1371/journal.pone.0002712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628962	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264057200055
J	Koelsch, S; Kilches, S; Steinbeis, N; Schelinski, S				Koelsch, Stefan; Kilches, Simone; Steinbeis, Nikolaus; Schelinski, Stefanie			Effects of Unexpected Chords and of Performer's Expression on Brain Responses and Electrodermal Activity	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MUSIC; EXPECTANCY; ERP; LANGUAGE; EMOTION; RULES	Background: There is lack of neuroscientific studies investigating music processing with naturalistic stimuli, and brain responses to real music are, thus, largely unknown. Methodology/Principal Findings: This study investigates event-related brain potentials (ERPs), skin conductance responses (SCRs) and heart rate (HR) elicited by unexpected chords of piano sonatas as they were originally arranged by composers, and as they were played by professional pianists. From the musical excerpts played by the pianists ( with emotional expression), we also created versions without variations in tempo and loudness ( without musical expression) to investigate effects of musical expression on ERPs and SCRs. Compared to expected chords, unexpected chords elicited an early right anterior negativity (ERAN, reflecting music-syntactic processing) and an N5 ( reflecting processing of meaning information) in the ERPs, as well as clear changes in the SCRs ( reflecting that unexpected chords also elicited emotional responses). The ERAN was not influenced by emotional expression, whereas N5 potentials elicited by chords in general ( regardless of their chord function) differed between the expressive and the non-expressive condition. Conclusions/Significance: These results show that the neural mechanisms of music-syntactic processing operate independently of the emotional qualities of a stimulus, justifying the use of stimuli without emotional expression to investigate the cognitive processing of musical structure. Moreover, the data indicate that musical expression affects the neural mechanisms underlying the processing of musical meaning. Our data are the first to reveal influences of musical performance on ERPs and SCRs, and to show physiological responses to unexpected chords in naturalistic music.	[Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton, E Sussex, England; [Koelsch, Stefan; Kilches, Simone; Steinbeis, Nikolaus; Schelinski, Stefanie] Max Planck Inst Human Cognit & Brain Sci, Junior Res Grp Neurocognit Music, Leipzig, Germany	University of Sussex; Max Planck Society	Koelsch, S (corresponding author), Univ Sussex, Dept Psychol, Brighton, E Sussex, England.	koelsch@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020		German Research Foundation (Deutsche Forschungsgemeinschaft) [KO 2266/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft) through grant KO 2266/2-1. The Deutsche Forschungsgemeinschaft played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Juslin P.N., 2008, BEHAV BRAIN IN PRESS; Juslin P. N., 2003, MUSIC EMOTION THEORY, P309; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, J COGNITIVE NEUROSCI, V17, P1565, DOI 10.1162/089892905774597290; KOELSCH S, 2005, CURRENT OPINION NEUR, V15, P1; KOELSCH S, 2008, PSYCHOPHYSI IN PRESS; KOELSCH S, 2008, BRAIN RES IN PRESS; Koelsch S, 2007, PSYCHOPHYSIOLOGY, V44, P476, DOI 10.1111/j.1469-8986.2007.00517.x; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Leino S, 2007, BRAIN RES, V1142, P169, DOI 10.1016/j.brainres.2007.01.049; LOUI P, 2005, COG BRAIN RES, V25, P589; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Poulin-Charronnat B, 2006, J COGNITIVE NEUROSCI, V18, P1545, DOI 10.1162/jocn.2006.18.9.1545; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2002, PERCEPT PSYCHOPHYS, V64, P640, DOI 10.3758/BF03194732	32	59	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2631	10.1371/journal.pone.0002631	http://dx.doi.org/10.1371/journal.pone.0002631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18612459	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800033
J	Madsen, BE; Ramos, EM; Boulard, M; Duda, K; Overgaard, J; Nordsmark, M; Wiuf, C; Hansen, LL				Madsen, Bo Eskerod; Ramos, Eliana Marisa; Boulard, Mathieu; Duda, Katarzyna; Overgaard, Jens; Nordsmark, Marianne; Wiuf, Carsten; Hansen, Lise Lotte			Germline Mutation in RNASEL Predicts Increased Risk of Head and Neck, Uterine Cervix and Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER; HUMAN-PAPILLOMAVIRUS; 2-5A-DEPENDENT RNASE; PROTEIN-SYNTHESIS; GENETIC-ANALYSIS; ASSOCIATION; EXPRESSION; INHIBITOR; APOPTOSIS	The Background: Ribonuclease L (RNASEL), encoding the 29-59-oligoadenylate (2-5A)-dependent RNase L, is a key enzyme in the interferon induced antiviral and anti-proliferate pathway. Mutations in RNASEL segregate with the disease in prostate cancer families and specific genotypes are associated with an increased risk of prostate cancer. Infection by human papillomavirus (HPV) is the major risk factor for uterine cervix cancer and for a subset of head and neck squamous cell carcinomas (HNSCC). HPV, Epstein Barr virus (EBV) and sequences from mouse mammary tumor virus ( MMTV) have been detected in breast tumors, and the presence of integrated SV40 T/t antigen in breast carcinomas correlates with an aggressive phenotype and poor prognosis. A genetic predisposition could explain why some viral infections persist and induce cancer, while others disappear spontaneously. This points at RNASEL as a strong susceptibility gene. Methodology/Principal Findings: To evaluate the implication of an abnormal activity of RNase L in the onset and development of viral induced cancers, the study was initiated by searching for germline mutations in patients diagnosed with uterine cervix cancer. The rationale behind is that close to 100% of the cervix cancer patients have a persistent HPV infection, and if a defective RNase L were responsible for the lack of ability to clear the HPV infection, we would expect to find a wide spectrum of mutations in these patients, leading to a decreased RNase L activity. The HPV genotype was established in tumor DNA from 42 patients diagnosed with carcinoma of the uterine cervix and somatic tissue from these patients was analyzed for mutations by direct sequencing of all coding and regulatory regions of RNASEL. Fifteen mutations, including still uncharacterized, were identified. The genotype frequencies of selected single nucleotide polymorphisms (SNPs) established in the cervix cancer patients were compared between 382 patients with head and neck squamous cell carcinomas (HNSCC), 199 patients with primary unilateral breast cancer and 502 healthy Danish control individuals. We found that the genotype frequencies of only one of the 15 mutations, the yet uncharacterized 5'UTR mutation rs3738579 differed significantly between cancer patients and control individuals (P-value: 4.43 x 10(-5)). Conclusion/Significance: In conclusion, we have discovered an increased risk, a heterozygous advantage and thereby a protective effect linked to the RNASEL SNP rs3738579. This effect is found for patients diagnosed with carcinoma of the uterine cervix, HNSCC, and breast cancer thus pointing at RNASEL as a general marker for cancer risk and not restricted to familial prostate cancer.	[Ramos, Eliana Marisa; Boulard, Mathieu; Duda, Katarzyna; Hansen, Lise Lotte] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Madsen, Bo Eskerod; Wiuf, Carsten] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark; [Overgaard, Jens; Nordsmark, Marianne] Univ Hosp Aarhus, Dept Expt Clin Oncol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Madsen, BE (corresponding author), Univ Aarhus, Inst Human Genet, Aarhus, Denmark.	Lotte@humgen.au.dk	Hansen, Lise Lotte/I-3377-2016; Wiuf, Carsten/H-6320-2011; Boulard, Matthieu/H-8923-2017	Hansen, Lise Lotte/0000-0001-7915-2506; Wiuf, Carsten/0000-0002-1302-4445; Boulard, Matthieu/0000-0001-5135-8529	The Danish Cancer Research Foundation; The Danish Medical Research Council; The Novo Nordic; The John and Birthe Meyer; The Boje Benzon; The Aarhus University Research; The A.P. Moller and Wife Foundations; Frits, Georg and Marie Cecilie Gluds grant; The Danish Cancer Society	The Danish Cancer Research Foundation; The Danish Medical Research Council(Danish Medical Research Council); The Novo Nordic; The John and Birthe Meyer; The Boje Benzon; The Aarhus University Research; The A.P. Moller and Wife Foundations; Frits, Georg and Marie Cecilie Gluds grant; The Danish Cancer Society(Danish Cancer Society)	Financial support was provided by The Danish Cancer Research Foundation, The Danish Medical Research Council, The Novo Nordic, The John and Birthe Meyer, The Boje Benzon, The Aarhus University Research and The A.P. Moller and Wife Foundations and Frits, Georg and Marie Cecilie Gluds grant. The Danish Cancer Society supported C.W.	An HJ, 2004, MOD PATHOL; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartsch DK, 2005, INT J CANCER, V117, P718, DOI 10.1002/ijc.21254; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Choi YL, 2007, TUMOR BIOL, V28, P327, DOI 10.1159/000124238; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Halder A, 2005, INDIAN J MED RES, V122, P434; Hansen LL, 1998, APMIS, V106, P371, DOI 10.1111/j.1699-0463.1998.tb01359.x; Hansen LL, 1998, CANCER RES, V58, P2166; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Hoglund M, 2002, CANCER RES, V62, P2675; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kruger S, 2005, LANCET ONCOL, V6, P566, DOI 10.1016/S1470-2045(05)70253-9; Kubbutat MHG, 1998, TRENDS MICROBIOL, V6, P173, DOI 10.1016/S0966-842X(98)01267-0; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; Li HH, 2006, CLIN CANCER RES, V12, P5713, DOI 10.1158/1078-0432.CCR-05-2799; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Liang SL, 2006, IUBMB LIFE, V58, P508, DOI 10.1080/15216540600838232; LILIENFELD AM, 1955, CANCER, V8, P875, DOI 10.1002/1097-0142(1955)8:5<875::AID-CNCR2820080504>3.0.CO;2-Z; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Maier C, 2005, BRIT J CANCER, V92, P1159, DOI 10.1038/sj.bjc.6602401; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Naik S, 1998, NUCLEIC ACIDS RES, V26, P1522, DOI 10.1093/nar/26.6.1522; Nakazato H, 2003, BRIT J CANCER, V89, P691, DOI 10.1038/sj.bjc.6601075; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patmore HS, 2004, BRIT J CANCER, V90, P1976, DOI 10.1038/sj.bjc.6601756; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Rennert H, 2005, CANCER EPIDEM BIOMAR, V14, P949, DOI 10.1158/1055-9965.EPI-04-0637; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; Rokman A, 2002, AM J HUM GENET, V70, P1299, DOI 10.1086/340450; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Sevinc A, 2004, ANTICANCER RES, V24, P2547; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Thomas M, 1996, ONCOGENE, V13, P265; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Wiklund F, 2004, CLIN CANCER RES, V10, P7150, DOI 10.1158/1078-0432.CCR-04-0982; Xiang Y, 2003, CANCER RES, V63, P6795; Zhou AM, 2005, J INTERF CYTOK RES, V25, P595, DOI 10.1089/jir.2005.25.595; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	54	38	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2492	10.1371/journal.pone.0002492	http://dx.doi.org/10.1371/journal.pone.0002492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575592	Green Published, gold			2022-12-27	WOS:000263288000017
J	Balleza, E; Alvarez-Buylla, ER; Chaos, A; Kauffman, S; Shmulevich, I; Aldana, M				Balleza, Enrique; Alvarez-Buylla, Elena R.; Chaos, Alvaro; Kauffman, Stuart; Shmulevich, Ilya; Aldana, Maximino			Critical Dynamics in Genetic Regulatory Networks: Examples from Four Kingdoms	PLOS ONE			English	Article							EXPRESSION; MODELS; ROBUSTNESS; EVOLUTION; BEHAVIOR; CRP	The coordinated expression of the different genes in an organism is essential to sustain functionality under the random external perturbations to which the organism might be subjected. To cope with such external variability, the global dynamics of the genetic network must possess two central properties. (a) It must be robust enough as to guarantee stability under a broad range of external conditions, and (b) it must be flexible enough to recognize and integrate specific external signals that may help the organism to change and adapt to different environments. This compromise between robustness and adaptability has been observed in dynamical systems operating at the brink of a phase transition between order and chaos. Such systems are termed critical. Thus, criticality, a precise, measurable, and well characterized property of dynamical systems, makes it possible for robustness and adaptability to coexist in living organisms. In this work we investigate the dynamical properties of the gene transcription networks reported for S. cerevisiae, E. coli, and B. subtilis, as well as the network of segment polarity genes of D. melanogaster, and the network of flower development of A. thaliana. We use hundreds of microarray experiments to infer the nature of the regulatory interactions among genes, and implement these data into the Boolean models of the genetic networks. Our results show that, to the best of the current experimental data available, the five networks under study indeed operate close to criticality. The generality of this result suggests that criticality at the genetic level might constitute a fundamental evolutionary mechanism that generates the great diversity of dynamically robust living forms that we observe around us.	[Balleza, Enrique; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Alvarez-Buylla, Elena R.; Chaos, Alvaro] Univ Nacl Autonoma Mexico, Inst Ecol, San Nicolas de Los Garza, Mexico; [Kauffman, Stuart] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Calgary; Institute for Systems Biology (ISB)	Balleza, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico.	max@fis.unam.mx	Balleza, Enrique/GZG-2287-2022; Aldana, Maximino/D-9372-2017	Balleza, Enrique/0000-0003-0769-7130; Aldana, Maximino/0000-0002-3419-6641; Alvarez-Buylla Roces, Maria Elena/0000-0002-7938-6473	National Institute of Health [GM070600, GM072855, P50 GM076547]; CONACyT [P47836-F, CO1.41848/A-1, CO1.0538/A-1, CO1.0435.B-1]; PAPIIT-UNAM [IN112407-3, IN230002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM072855, R21GM070600] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of Health grants GM070600 (I.S. and S.A.K.), GM072855 (I.S.), and P50 GM076547 (I.S.), CONACyT grants P47836-F (M.A.), CO1.41848/A-1, CO1.0538/A-1 and CO1.0435.B-1 (E.R.A.B.), and PAPIIT-UNAM grants IN112407-3 (M.A.) and IN230002 (E.R.A.B.). E.B. and A.C. acknowledge CONACyT for Ph.D. scholarships.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Arakawa A, 2006, NAT PHYS, V2, P373, DOI 10.1038/nphys323; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079; Chialvo DR, 2006, NAT PHYS, V2, P301, DOI 10.1038/nphys300; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; DERRIDA B, 1986, EUROPHYS LETT, V2, P739, DOI 10.1209/0295-5075/2/10/001; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Harrelson GL, 2002, ATHLET THER TODAY, V7, P23, DOI 10.1123/att.7.5.23; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heimpel M, 1997, NATURE, V388, P865, DOI 10.1038/42232; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Just W, 2004, PHYSICA D, V197, P211, DOI 10.1016/j.physd.2004.07.002; Karlsson F, 2007, PHYSICA A, V384, P747, DOI 10.1016/j.physa.2007.05.050; KAUFFMAN S, HOME UNIVERSE; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Kioussis D, 2005, NATURE, V435, P579, DOI 10.1038/435579a; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Mendoza L, 2000, J THEOR BIOL, V204, P311, DOI 10.1006/jtbi.2000.2014; Nehaniv CL, 2003, BIOSYSTEMS, V69, P77, DOI 10.1016/S0303-2647(02)00130-2; Nikolajewa S, 2007, BIOSYSTEMS, V90, P40, DOI 10.1016/j.biosystems.2006.06.007; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Ostojic S, 2006, NATURE, V439, P828, DOI 10.1038/nature04549; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Peters O, 2006, NAT PHYS, V2, P393, DOI 10.1038/nphys314; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Shmulevich I, 2003, P NATL ACAD SCI USA, V100, P10734, DOI 10.1073/pnas.1534782100; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Wagner GP., 2005, ROBUSTNESS EVOLVABIL; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Yuh Chiou-Hwa, 2001, P73; Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005	50	127	128	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2456	10.1371/journal.pone.0002456	http://dx.doi.org/10.1371/journal.pone.0002456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560561	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700038
J	Naseem, R; Webb, M				Naseem, Riffat; Webb, Michelle			Analysis of the DNA Binding Activity of BRCA1 and Its Modulation by the Tumour Suppressor p53	PLOS ONE			English	Article								Background: The breast cancer susceptibility protein, BRCA1 functions to maintain the integrity of the genome. The exact mechanisms by which it does so, however, remain unclear. The ability of BRCA1 to bind directly to DNA suggests a more direct role. However, little research has been conducted to understand the functional relevance of this characteristic of BRCA1. In this study we examine the DNA substrate specificity of BRCA1 and how this may be controlled by one of its interacting partners, p53. Methodology/Principal Findings: Using competition gel retardation assays we have examined the ability of residues 230534 of BRCA1 to discriminate between different synthetic DNA substrates that mimic those recognised by the DNA damage response i.e. four-way junction DNA, mismatch containing DNA, bulge containing DNA and linear DNA. Of those tested the highest affinity observed was for four-way junction DNA, with a 20 fold excess of each of the other synthetic DNA's unable to compete for any of the bound BRCA1 230-534. We also observed a higher affinity for C: C and bulge containing DNA compared to linear duplex and G: T containing DNA. BRCA1 230-534 also has interaction sites for the tumour suppressor p53 and we show that titration of this complex into the DNA binding assays significantly reduces the affinity of BRCA1 for DNA. Conclusions/Significance: In this paper we show that BRCA1 can discriminate between different types of DNA damage and we discuss the implications of this with respect to its function in DNA repair. We also show that the DNA binding activity can be inhibited by the tumour suppressor p53 and suggest that this may prevent genome destabilizing events such as HR between non-homologous sequences.	[Naseem, Riffat] Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales; [Webb, Michelle] Univ Manchester, Sch Med, Ctr Mol Med, Manchester, Lancs, England	Cardiff University; University of Manchester	Naseem, R (corresponding author), Cardiff Univ, Sch Med, Dept Med Biochem & Immunol, Cardiff, S Glam, Wales.	michelle.webb@manchester.ac.uk		Webb, Michelle/0000-0002-3228-7558	BBSRC	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the BBSRC. They had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen GC, 2001, BIOCHEM BIOPH RES CO, V284, P507, DOI 10.1006/bbrc.2001.5003; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; Degtyareva N, 2001, J BIOL CHEM, V276, P8778, DOI 10.1074/jbc.M006795200; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; Foray N, 2003, EMBO J, V22, P2860, DOI 10.1093/emboj/cdg274; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; KOONIN VF, 1996, NAT GENET, V13, P266; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Linke SP, 2003, CANCER RES, V63, P2596; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Moynahan ME, 2001, CANCER RES, V61, P4842; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sturdy A, 2004, J MOL BIOL, V340, P469, DOI 10.1016/j.jmb.2004.05.005; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yun S, 2004, NUCLEIC ACIDS RES, V32, P6479, DOI 10.1093/nar/gkh986; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2336	10.1371/journal.pone.0002336	http://dx.doi.org/10.1371/journal.pone.0002336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545657	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800006
J	Roberge, C; Blanchet, S; Dodson, JJ; Guderley, H; Bernatchez, L				Roberge, Christian; Blanchet, Simon; Dodson, Julian J.; Guderley, Helga; Bernatchez, Louis			Disturbance of Social Hierarchy by an Invasive Species: A Gene Transcription Study	PLOS ONE			English	Article								Background: Ecological and evolutionary changes in native populations facing invasion by exotic species are increasingly reported. Recently, it has been shown that competition with exotic rainbow trout (Oncorhynchus mykiss) disrupts dominance hierarchies within groups of native Atlantic salmon (Salmo salar). The genetic and molecular actors underlying phenotypic plasticity are poorly understood. Methodology: Here, we aimed at identifying the genetic and molecular actors contributing to this plastic loss of dominance hierarchies as well as at identifying genes implicated in behaviours related to social dominance. By using microarrays, we compared the genome-wide gene transcription profiles in brains of dominant versus subordinate juvenile Atlantic salmon in presence or absence of a competitive rainbow trout. Principal Findings: Adding the trout competitor resulted in dominant and subordinate salmon being more similar, both behaviourally and at the level of brain gene transcription patterns. Genes for which transcription levels differed between dominant and subordinate salmon in the absence of exotic trout were mainly over-expressed in dominant salmon and included genes implicated in protein turnover, neuronal structural change and oxygen transport. Conclusions/Significance: Our study provides one of the few examples demonstrating a close interplay between behavioural plasticity and gene transcription, therefore contributing to the understanding of the molecular mechanisms underlying these processes in an ecologically relevant context.	[Roberge, Christian; Blanchet, Simon; Dodson, Julian J.; Guderley, Helga; Bernatchez, Louis] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Blanchet, Simon] Univ Paul Sabatier, CNRS, Lab Evol Diversite Biol, Toulouse, France	Laval University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Roberge, C (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	christian.roberge.1@ulaval.ca	Blanchet, Simon/A-2313-2010; Blanchet, Simon/D-4850-2013; Blanchet, Simon/AAA-5871-2019	Blanchet, Simon/0000-0002-3843-589X; Blanchet, Simon/0000-0002-3843-589X; Bernatchez, Louis/0000-0002-8085-9709	Science and Engineering Research Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) [scholarship]	Science and Engineering Research Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT)	This work was supported by a research grant from Science and Engineering Research Canada (NSERC strategic program) to L.B., H.G. and J.J. Dodson, and by a scholarship from the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) to C.R. This study is a contribution to the research programmes of the CIRSA (Centre Inter-universitaire de Recherche sur le Saumon Atlantique), the RAQ (Reseau Aquaculture Quebec) as well as of Quebec-Ocean.	Aubin-Horth N, 2005, J HERED, V96, P261, DOI 10.1093/jhered/esi030; Aubin-Horth N, 2007, MOL ECOL, V16, P1349, DOI 10.1111/j.1365-294X.2007.03249.x; BENNETT E, 1994, J NEUROCHEM, V63, P1616; Blanchet S, 2007, OECOLOGIA, V152, P569, DOI 10.1007/s00442-007-0668-4; Chiavegatto S, 2003, HORM BEHAV, V44, P233, DOI 10.1016/j.yhbeh.2003.02.002; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Crawford SS, 2008, REV FISH BIOL FISHER, V18, P313, DOI 10.1007/s11160-007-9079-1; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Draghici S., 2003, DATA ANAL TOOLS DNA; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Garant D, 2003, EVOLUTION, V57, P1133; Gilmour KM, 2005, INTEGR COMP BIOL, V45, P263, DOI 10.1093/icb/45.2.263; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2003, J NEUROBIOL, V54, P272, DOI 10.1002/neu.10172; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lund SG, 2000, J EXP BIOL, V203, P2219; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; METCALFE NB, 1989, PROC R SOC SER B-BIO, V236, P7, DOI 10.1098/rspb.1989.0009; Miczek KA, 2003, HORM BEHAV, V44, P242, DOI 10.1016/j.yhbeh.2003.04.002; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Overli O, 1999, BRAIN BEHAV EVOLUT, V54, P263, DOI 10.1159/000006627; Owens IPF, 2006, TRENDS ECOL EVOL, V21, P356, DOI 10.1016/j.tree.2006.03.014; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Roberge C, 2007, MOL IMMUNOL, V44, P1374, DOI 10.1016/j.molimm.2006.05.005; Sloman KA, 2002, CAN J ZOOL, V80, P1221, DOI [10.1139/z02-105, 10.1139/Z02-105]; Sneddon LU, 2005, PHYSIOL BIOCHEM ZOOL, V78, P695, DOI 10.1086/432141; Sorensen C, 2007, BRAIN BEHAV EVOLUT, V70, P239, DOI 10.1159/000105487; SPECKNER W, 1989, J EXP BIOL, V141, P133; St-Cyr J, 2008, MOL ECOL, V17, P1850, DOI 10.1111/j.1365-294X.2008.03696.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Trainor BC, 2007, BEHAV BRAIN RES, V179, P314, DOI 10.1016/j.bbr.2007.02.014; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZAR JH, 1999, STAT INTRO USING R	49	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2408	10.1371/journal.pone.0002408	http://dx.doi.org/10.1371/journal.pone.0002408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545706	Green Submitted, gold, Green Published			2022-12-27	WOS:000263248800046
J	Surcel, A; Koshland, D; Ma, H; Simpson, RT				Surcel, Alexandra; Koshland, Douglas; Ma, Hong; Simpson, Robert T.			Cohesin Interaction with Centromeric Minichromosomes Shows a Multi-Complex Rod-Shaped Structure	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; COILED-COIL TETRAMER; SMC PROTEINS; IN-VIVO; DNA; CONDENSIN; YEAST; COMPACTION; BINDING; IDENTIFICATION	Cohesin is the protein complex responsible for maintaining sister chromatid cohesion. Cohesin interacts with centromeres and specific loci along chromosome arms known as Chromosome Attachment Regions (CARs). The cohesin holocomplex contains four subunits. Two of them, Smc1p (Structural maintenance of chromosome 1 protein) and Smc3p, are long coiled-coil proteins, which heterodimerize with each other at one end. They are joined together at the other end by a third subunit, Scc1p, which also binds to the fourth subunit, Scc3p. How cohesin interacts with chromosomes is not known, although several models have been proposed, in part on the basis of in vitro assembly of purified cohesin proteins. To be able to observe in vivo cohesin-chromatin interactions, we have modified a Minichromosome Affinity Purification (MAP) method to isolate a CAR-containing centromeric minichromosome attached to in vivo assembled cohesin. Transmission Electron Microscopy (TEM) analysis of these minichromosomes suggests that cohesin assumes a rod shape and interacts with replicated minichromosome at one end of that rod. Additionally, our data implies that more than one cohesin molecule interacts with each pair of replicated minichromsomes. These molecules seem to be packed into a single thick rod, suggesting that the Smc1p and Smc3p subunits may interact extensively.	[Surcel, Alexandra; Ma, Hong; Simpson, Robert T.] Penn State Univ, Huck Inst Life Sci, Intercoll Grad Program in Cell & Dev Biol, University Pk, PA USA; [Koshland, Douglas] Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD USA; [Ma, Hong] Penn State Univ, Dept Biol, University Pk, PA USA; [Simpson, Robert T.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Institution for Science; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Surcel, A (corresponding author), Penn State Univ, Huck Inst Life Sci, Intercoll Grad Program in Cell & Dev Biol, University Pk, PA USA.	hxm16@psu.edu			NIH; Department of Biochemistry and Molecular Biology; Huck Institutes of the Life Sciences, Department of Biology, the Pennsylvania State University; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biochemistry and Molecular Biology; Huck Institutes of the Life Sciences, Department of Biology, the Pennsylvania State University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding was provided by a NIH grant to R.T.S., by the Department of Biochemistry and Molecular Biology to A. S., and by the Huck Institutes of the Life Sciences, and the Department of Biology, the Pennsylvania State University, to H.M. Additional support was provided by the Howard Hughes Medical Institute to D.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Bazett-Jones DP, 2002, MOL CELL, V9, P1183, DOI 10.1016/S1097-2765(02)00546-4; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Burgess SA, 2004, J STRUCT BIOL, V146, P205, DOI 10.1016/j.jsb.2003.10.005; Case RB, 2004, SCIENCE, V305, P222, DOI 10.1126/science.1098225; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Deng YQ, 2006, STRUCTURE, V14, P247, DOI 10.1016/j.str.2005.10.010; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Gilliland WD, 2005, CELL, V123, P371, DOI 10.1016/j.cell.2005.10.018; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Ohbayashi T, 2007, BIOCHEM BIOPH RES CO, V356, P699, DOI 10.1016/j.bbrc.2007.03.037; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Wang X, 2001, NUCLEIC ACIDS RES, V29, P1943, DOI 10.1093/nar/29.9.1943; White GE, 2006, J STRUCT BIOL, V154, P111, DOI 10.1016/j.jsb.2006.01.001; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002	43	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2453	10.1371/journal.pone.0002453	http://dx.doi.org/10.1371/journal.pone.0002453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545699	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800060
J	Yeka, A; Dorsey, G; Kamya, MR; Talisuna, A; Lugemwa, M; Rwakimari, JB; Staedke, SG; Rosenthal, PJ; Wabwire-Mangen, F; Bukirwa, H				Yeka, Adoke; Dorsey, Grant; Kamya, Moses R.; Talisuna, Ambrose; Lugemwa, Myers; Rwakimari, John Bosco; Staedke, Sarah G.; Rosenthal, Philip J.; Wabwire-Mangen, Fred; Bukirwa, Hasifa			Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLUS SULFADOXINE-PYRIMETHAMINE; POPULATION PHARMACOKINETICS; COMBINATION THERAPY; AMODIAQUINE; EFFICACY; CHILDREN; ARTESUNATE; SAFETY; ARTEMISININ	Background: Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria. However, AL has several limitations, including a twice-daily dosing regimen, recommendation for administration with fatty food, and a high risk of reinfection soon after therapy in high transmission areas. Dihydroartemisinin-piperaquine (DP) is a new alternative artemisinin-based combination therapy that is dosed once daily and has a long post-treatment prophylactic effect. We compared the efficacy and safety of AL with DP in Kanungu, an area of moderate malaria transmission. Methodology/Principal Findings: Patients aged 6 months to 10 years with uncomplicated falciparum malaria were randomized to therapy and followed for 42 days. Genotyping was used to distinguish recrudescence from new infection. Of 414 patients enrolled, 408 completed follow-up. Compared to patients treated with artemether-lumefantrine, patients treated with dihydroartemisinin-piperaquine had a significantly lower risk of recurrent parasitaemia (33.2% vs. 12.2%; risk difference = 20.9%, 95% CI 13.0-28.8%) but no statistically significant difference in the risk of treatment failure due to recrudescence (5.8% vs. 2.0%; risk difference = 3.8%, 95% CI -0.2-7.8%). Patients treated with dihydroartemisinin-piperaquine also had a lower risk of developing gametocytaemia after therapy (4.2% vs. 10.6%, p = 0.01). Both drugs were safe and well tolerated. Conclusions/Significance: DP is highly efficacious, and operationally preferable to AL because of a less intensive dosing schedule and requirements. Dihydroartemisinin-piperaquine should be considered for a role in the antimalarial treatment policy of Uganda.	[Yeka, Adoke; Bukirwa, Hasifa] Uganda Malaria Surveillance Project, Kampala, Uganda; [Dorsey, Grant; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Med Sch, Kampala, Uganda; [Talisuna, Ambrose; Lugemwa, Myers; Rwakimari, John Bosco] Minist Hlth, Kampala, Uganda; [Staedke, Sarah G.] London Sch Hyg & Trop Med, London, England; [Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	University of California System; University of California San Francisco; Makerere University; University of London; London School of Hygiene & Tropical Medicine; Makerere University	Yeka, A (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	hbukirwa@muucsf.org			Centers for Disease Control [U50/CCU925122-01]; Department for International Development (DFID)	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department for International Development (DFID)	This investigation received financial support from the Centers for Disease Control under Cooperative Agreement Number U50/CCU925122-01 and from the Department for International Development (DFID). Dihydroartemisinin-piperaquine study drugs were provided free of charge by Holleypharm, China. Artemethe lumefantrine was provided free of charge by the Uganda Ministry of Health. The funders had no involvement in the study design, data collection, data analysis, data interpretation, in the writing of the paper, or in the decision to submit it for publication. The funding source had no involvement in the authors' work.	Arrow KJ, 2005, NEW ENGL J MED, V353, P333, DOI 10.1056/NEJMp058168; Ashley EA, 2005, CLIN INFECT DIS, V41, P425, DOI 10.1086/432011; Ashley EA, 2004, J INFECT DIS, V190, P1773, DOI 10.1086/425015; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Denis MB, 2002, CLIN INFECT DIS, V35, P1469, DOI 10.1086/344647; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Hien TT, 2004, LANCET, V363, P18, DOI 10.1016/S0140-6736(03)15163-X; Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI 10.1111/j.1365-2125.2003.02004.x; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; *WHO, 2006, WHOHTMMAL20061108; *WHO, 2007, GLOB AMDP DAT AFR; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	24	112	113	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2390	10.1371/journal.pone.0002390	http://dx.doi.org/10.1371/journal.pone.0002390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545692	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800029
J	Ross, EA; Freeman, S; Zhao, Y; Dhanjal, TS; Ross, EJ; Lax, S; Ahmed, Z; Hou, TZ; Kalia, N; Egginton, S; Nash, G; Watson, SP; Frampton, J; Buckley, CD				Ross, Ewan A.; Freeman, Sylvie; Zhao, Yan; Dhanjal, Tarvinder S.; Ross, Emma J.; Lax, Sian; Ahmed, Zubair; Hou, Tie Zheng; Kalia, Neena; Egginton, Stuart; Nash, Gerard; Watson, Steve P.; Frampton, Jon; Buckley, Christopher D.			A Novel Role for PECAM-1 (CD31) in Regulating Haematopoietic Progenitor Cell Compartmentalization between the Peripheral Blood and Bone Marrow	PLOS ONE			English	Article								Although the expression of PECAM-1 (CD31) on vascular and haematopoietic cells within the bone marrow microenvironment has been recognized for some time, its physiological role within this niche remains unexplored. In this study we show that PECAM-1 influences steady state hematopoietic stem cell (HSC) progenitor numbers in the peripheral blood but not the bone marrow compartment. PECAM-1(-/-) mice have higher levels of HSC progenitors in the blood compared to their littermate controls. We show that PECAM-1 is required on both progenitors and bone marrow vascular cells in order for efficient transition between the blood and bone marrow to occur. We have identified key roles for PECAM-1 in both the regulation of HSC migration to the chemokine CXCL12, as well as maintaining levels of the matrix degrading enzyme MMP-9 in the bone marrow vascular niche. Using intravital microscopy and adoptive transfer of either wild type (WT) or PECAM-1(-/-) bone marrow precursors, we demonstrate that the increase in HSC progenitors in the blood is due in part to a reduced ability to migrate from blood to the bone marrow vascular niche. These findings suggest a novel role for PECAM-1 as a regulator of resting homeostatic progenitor cell numbers in the blood	[Ross, Ewan A.; Ross, Emma J.; Lax, Sian; Hou, Tie Zheng; Buckley, Christopher D.] Univ Birmingham, MRC, Ctr Immune Regulat, Rheumatol Res Grp, Birmingham, W Midlands, England; [Freeman, Sylvie; Frampton, Jon] Univ Birmingham, MRC, Ctr Immune Regulat, Div Immun & Infect, Birmingham, W Midlands, England; [Zhao, Yan; Dhanjal, Tarvinder S.; Kalia, Neena; Nash, Gerard; Watson, Steve P.] Univ Birmingham, Ctr Cardiovascul Stud, Birmingham, W Midlands, England; [Ahmed, Zubair] Univ Birmingham, Mol Neurosci Grp, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ross, EA (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Rheumatol Res Grp, Birmingham, W Midlands, England.	c.d.buckley@bham.ac.uk	Nash, Gerard B/E-4182-2010; Buckley, Christopher/AAN-6378-2021; Watson, Stephen P/Q-6292-2016; HOU, TIEZHENG/B-4848-2015	Nash, Gerard B/0000-0002-5935-2831; Buckley, Christopher/0000-0001-6924-6402; Watson, Stephen P/0000-0002-7846-7423; Lax, Sian/0000-0002-0248-8973; Ross, Ewan/0000-0001-5733-9361; Freeman, Sylvie/0000-0003-1869-180X; KALIA, NEENA/0000-0003-2960-7829; Egginton, Stuart/0000-0002-3084-9692	Leukaemia Research Fund; Arthritis Research Campaign; MRC [G0300102] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [C19491] Funding Source: researchfish; Medical Research Council [G0300102, G9818340B] Funding Source: researchfish	Leukaemia Research Fund; Arthritis Research Campaign(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Leukaemia Research Fund and Arthritis Research Campaign.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bird IN, 1999, J CELL SCI, V112, P1989; BROXMEYER HE, 2007, ANN N Y ACAD SCI; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; GLODEK AM, 2007, LEUKEMIA; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com; Ilan N, 2001, DEV BIOL, V232, P219, DOI 10.1006/dbio.2001.0186; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; Lee S, 2000, STEM CELLS, V18, P281, DOI 10.1634/stemcells.18-4-281; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Ling V, 1997, EUR J IMMUNOL, V27, P509, DOI 10.1002/eji.1830270223; Luu NT, 2003, J VASC RES, V40, P467, DOI 10.1159/000074296; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Nakamura Y, 2004, EXP HEMATOL, V32, P390, DOI 10.1016/j.exphem.2004.01.004; Nelissen I, 2002, J LEUKOCYTE BIOL, V71, P89; Newman PJ, 1997, J CLIN INVEST, V100, pS25; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Rainger GE, 1997, CURR BIOL, V7, P316, DOI 10.1016/S0960-9822(06)00155-2; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sagawa K, 1997, J BIOL CHEM, V272, P31086, DOI 10.1074/jbc.272.49.31086; SLIEKER WAT, 1993, INT IMMUNOL, V5, P1093, DOI 10.1093/intimm/5.9.1093; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Voermans C, 2000, STEM CELLS, V18, P435, DOI 10.1634/stemcells.18-6-435; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; WATT SM, 1993, BLOOD, V82, P2649; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wong MX, 2005, J CLIN IMMUNOL, V25, P19, DOI 10.1007/s10875-005-0354-7; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; WU Y, 2007, BLOOD; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yong KL, 1998, BLOOD, V91, P1196, DOI 10.1182/blood.V91.4.1196; ZICHA D, 1991, J CELL SCI, V99, P769; [No title captured]	57	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2338	10.1371/journal.pone.0002338	http://dx.doi.org/10.1371/journal.pone.0002338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523558	Green Published, gold, Green Accepted			2022-12-27	WOS:000262614300031
J	Takayama, H; Chelikani, P; Reeves, PJ; Zhang, SG; Khorana, HG				Takayama, Hidehito; Chelikani, Prashen; Reeves, Philip J.; Zhang, Shuguang; Khorana, H. Gobind			High-Level Expression, Single-Step Immunoaffinity Purification and Characterization of Human Tetraspanin Membrane Protein CD81	PLOS ONE			English	Article								The study of membrane protein structure and function requires their high-level expression and purification in fully functional form. We previously used a tetracycline-inducible stable mammalian cell line, HEK293S-TetR, for regulated high-level expression of G-protein coupled receptors. We here report successfully using this method for high-level expression of de novo oligo-DNA assembled human CD81 gene. CD81 is a member of the vital tetraspanin membrane protein family. It has recently been identified as the putative receptor for the Hepatitis C Virus envelope E2 glycoprotein (HCV-E2). In this study we used a single-step rho-1D4-affinity purification method to obtain > 95% purity from HEK293S-TetR-inducible stable cell lines. Using ELISA assay we determined that the affinity of the purified CD81 receptor for HCV-E2 protein is 3.8 +/- 1.2 nM. Using fluorescent confocal microscopy we showed that the inducibly overexpressed CD81 receptor in HEK293S-TetR cells is correctly located on the plasma membrane. We demonstrated that the combination of high-level expression of CD81 with efficient single-step immunoaffinity purification is a useful method for obtaining large quantities of CD81 membrane receptor suitable for detailed structural analyses of this elusive tetraspanin protein. Furthermore, this simple single-step immunoaffinity purification to high purity of membrane protein could be useful broadly for other membrane protein purifications, thus accelerating the determination of structures for large numbers of difficult-to-obtain membrane proteins.	[Takayama, Hidehito; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Takayama, Hidehito] Mitsubishi Chem Corp, Yokohama, Kanagawa, Japan; [Chelikani, Prashen; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA USA; [Chelikani, Prashen; Khorana, H. Gobind] MIT, Dept Chem, Cambridge, MA USA; [Reeves, Philip J.] Univ Essex, Dept Biol Sci, Colchester, Essex, England	Massachusetts Institute of Technology (MIT); Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Essex	Takayama, H (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Shuguang@mit.edu; khorana@mit.edu		Chelikani, Prashen/0000-0003-1129-7957; Zhang, Shuguang/0000-0002-3856-3752	Mitsubishi Chemical Corporation, Japan [fellowship]; NIH [RO1-EY11716]; American Heart Association [Postdoctoral Fellowship]; University of Manitoba, Canada; John Simon Guggenheim [fellowship]; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER	Mitsubishi Chemical Corporation, Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Manitoba, Canada; John Simon Guggenheim; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported here was supported by unrestricted grants from Mitsubishi Chemical Corporation, Japan to SZ; RO1-EY11716 (NIH) to HGK, and an American Heart Association Postdoctoral Fellowship to PC. HT was supported by a fellowship from Mitsubishi Chemical Corporation. PC acknowledges support from the University of Manitoba, Canada. SZ gratefully acknowledges the John Simon Guggenheim fellowship to provide freedom to pursue frontiers of research.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; DUBUISSON J, 2008, CELL MICROBIOL  0103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GARCIAESPAFIA A, 2008, GENOMICS        0219; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kusnezow W, 2003, J MOL RECOGNIT, V16, P165, DOI 10.1002/jmr.625; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	22	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2314	10.1371/journal.pone.0002314	http://dx.doi.org/10.1371/journal.pone.0002314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523555	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300017
J	Rossner, MJ; Oster, H; Wichert, SP; Reinecke, L; Wehr, MC; Reinecke, J; Eichele, G; Taneja, R; Nave, KA				Rossner, Moritz J.; Oster, Henrik; Wichert, Sven P.; Reinecke, Lisa; Wehr, Michael C.; Reinecke, Johannes; Eichele, Gregor; Taneja, Reshma; Nave, Klaus-Armin			Disturbed Clockwork Resetting in Sharp-1 and Sharp-2 Single and Double Mutant Mice	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; SLEEP PHASE SYNDROME; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; DROSOPHILA; ORANGE; BMAL1; CELLS; METABOLISM; COMPONENT	Background: The circadian system provides the basis to anticipate and cope with daily recurrent challenges to maintain the organisms' homeostasis. De-synchronization of circadian feedback oscillators in humans causes 'jet lag', likely contributes to sleep-, psychiatric-, metabolic disorders and even cancer. However, the molecular mechanisms leading to the disintegration of tissue-specific clocks are complex and not well understood. Methodology/Principal Findings: Based on their circadian expression and cell culture experiments, the basic Helix-Loop-Helix (bHLH) transcription factors SHARP-1(Dec2) and SHARP-2(Stra13/Dec1) were proposed as novel negative regulators of the molecular clock. To address their function in vivo, we generated Sharp-1 and Sharp-2 single and double mutant mice. Our experiments reveal critical roles for both factors in regulating period length, tissue-specific control of clock gene expression and entrainment to external cues. Light-pulse experiments and rapid delays of the light-dark cycle (experimental jet lag) unravel complementary functions for SHARP-1 and SHARP-2 in controlling activity phase resetting kinetics. Moreover, we show that SHARP-1 and 2 can serve dual functions as repressors and co-activators of mammalian clock gene expression in a context-specific manner. This correlates with increased amplitudes of Per2 expression in the cortex and liver and a decrease in the suprachiasmatic nucleus (SCN) of double mutant mice. Conclusions/Significance: The existence of separate mechanisms regulating phase of entrainment, rhythm amplitude and period length has been postulated before. The differential effects of Sharp-deficiency on rhythmicity and behavioral re-entrainment, coupled to tissue-dependent regulatory functions, provide a new mechanistic basis to further understand the complex process of clock synchronizations.	[Rossner, Moritz J.; Wichert, Sven P.; Reinecke, Lisa; Wehr, Michael C.; Reinecke, Johannes; Nave, Klaus-Armin] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Oster, Henrik; Eichele, Gregor] Max Planck Inst Biophys Chem, Gottingen, Germany; [Taneja, Reshma] Mount Sinai Sch Med, New York, NY USA	Max Planck Society; Max Planck Society; Icahn School of Medicine at Mount Sinai	Rossner, MJ (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	rossner@em.mpg.de	Wehr, Michael/J-7989-2019; Nave, Klaus-Armin/C-8883-2011; Oster, Henrik/D-2335-2013; Oster, Henrik/O-4426-2019; Taneja, Reshma/F-9658-2014	Wehr, Michael/0000-0003-1770-8323; Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068; Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177; Rossner, Moritz/0000-0002-0667-3420	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [Emmy Noether fellowship]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Gesellschaft (M.J.R., K.-A.N. and G.E.) and an Emmy Noether fellowship of the Deutsche Forschungsgemeinschaft (H.O.).	Albrecht U, 2001, BEHAV BRAIN RES, V125, P89, DOI 10.1016/S0166-4328(01)00288-1; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Li YX, 2004, BIOCHEM J, V382, P895, DOI 10.1042/BJ20040592; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Mrosovsky N, 1996, CHRONOBIOL INT, V13, P387, DOI 10.3109/07420529609012662; NAKASHIMA A, 2008, MOL CELL BIOL; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richier B, 2008, J BIOL RHYTHM, V23, P103, DOI 10.1177/0748730407313817; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schwab MH, 1998, J NEUROSCI, V18, P1408; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	41	75	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2762	10.1371/journal.pone.0002762	http://dx.doi.org/10.1371/journal.pone.0002762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648504	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900032
J	Kilian, M; Poulsen, K; Blomqvist, T; Havarstein, LS; Bek-Thomsen, M; Tettelin, H; Sorensen, UBS				Kilian, Mogens; Poulsen, Knud; Blomqvist, Trinelise; Havarstein, Leiv S.; Bek-Thomsen, Malene; Tettelin, Herve; Sorensen, Uffe B. S.			Evolution of Streptococcus pneumoniae and Its Close Commensal Relatives	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; GROUP-O-ANTIGEN; GENETIC-TRANSFORMATION; C-POLYSACCHARIDE; NUCLEOTIDE-SEQUENCE; DNA HYBRIDIZATION; VIRULENCE FACTOR; MITIS GROUP; S-MITIS; SP-NOV	Streptococcus pneumoniae is a member of the Mitis group of streptococci which, according to 16S rRNA-sequence based phylogenetic reconstruction, includes 12 species. While other species of this group are considered prototypes of commensal bacteria, S. pneumoniae is among the most frequent microbial killers worldwide. Population genetic analysis of 118 strains, supported by demonstration of a distinct cell wall carbohydrate structure and competence pheromone sequence signature, shows that S. pneumoniae is one of several hundred evolutionary lineages forming a cluster separate from Streptococcus oralis and Streptococcus infantis. The remaining lineages of this distinct cluster are commensals previously collectively referred to as Streptococcus mitis and each represent separate species by traditional taxonomic standard. Virulence genes including the operon for capsule polysaccharide synthesis and genes encoding IgA1 protease, pneumolysin, and autolysin were randomly distributed among S. mitis lineages. Estimates of the evolutionary age of the lineages, the identical location of remnants of virulence genes in the genomes of commensal strains, the pattern of genome reductions, and the proportion of unique genes and their origin support the model that the entire cluster of S. pneumoniae, S. pseudopneumoniae, and S. mitis lineages evolved from pneumococcus-like bacteria presumably pathogenic to the common immediate ancestor of hominoids. During their adaptation to a commensal life style, most of the lineages gradually lost the majority of genes determining virulence and became genetically distinct due to sexual isolation in their respective hosts.	[Kilian, Mogens; Poulsen, Knud; Bek-Thomsen, Malene; Sorensen, Uffe B. S.] Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark; [Blomqvist, Trinelise; Havarstein, Leiv S.] Norwegian Univ Life Sci, Dept Chem, Biotechnol & Food Sci, As, Norway; [Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD USA	Aarhus University; Norwegian University of Life Sciences; University System of Maryland; University of Maryland Baltimore	Kilian, M (corresponding author), Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark.	kilian@microbiology.au		Kilian, Mogens/0000-0002-5861-0472; Havarstein, Leiv Sigve/0000-0001-8250-4322; Sorensen, Uffe B. Skov/0000-0002-6777-054X	Carlsberg foundation; Velux foundation; Karen Elise Jensen foundation; Faculty of Health Sciences, University of Aarhus	Carlsberg foundation(Carlsberg Foundation); Velux foundation(Velux Fonden); Karen Elise Jensen foundation; Faculty of Health Sciences, University of Aarhus	This research was financed by unconditional grants from the Carlsberg, Velux, and Karen Elise Jensen foundations, and from the Faculty of Health Sciences, University of Aarhus.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bergstrom N, 2003, EUR J BIOCHEM, V270, P2157, DOI 10.1046/j.1432-1033.2003.03569.x; Bergstrom N, 2000, EUR J BIOCHEM, V267, P7147, DOI 10.1046/j.1432-1327.2000.01821.x-i2; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Carlsson J, 1968, Odontol Revy, V19, P137; Carvalho MGS, 2003, J CLIN MICROBIOL, V41, P4415, DOI 10.1128/JCM.41.9.4415-4417.2003; CASHION P, 1977, ANAL BIOCHEM, V81, P461, DOI 10.1016/0003-2697(77)90720-5; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; CLAVERYS JP, 1983, P NATL ACAD SCI-BIOL, V80, P5956, DOI 10.1073/pnas.80.19.5956; DELEY J, 1970, EUR J BIOCHEM, V12, P133; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; ESCARA JF, 1980, BIOPOLYMERS, V19, P1315, DOI 10.1002/bip.1980.360190708; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; GILLESPIE SH, 1993, INFECT IMMUN, V61, P3076, DOI 10.1128/IAI.61.7.3076-3077.1993; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Hashimoto JQ, 2003, J BACTERIOL, V185, P966, DOI 10.1128/JB.185.3.966-972.2003; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; HOHWY J, 1995, ORAL MICROBIOL IMMUN, V10, P19, DOI 10.1111/j.1399-302X.1995.tb00113.x; Hoshino T, 2005, J CLIN MICROBIOL, V43, P6073, DOI 10.1128/JCM.43.12.6073-6085.2005; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Jumas-Bilak E, 1998, MOL MICROBIOL, V27, P99, DOI 10.1046/j.1365-2958.1998.00661.x; KAWAMURA S, 1992, J BIOL CHEM, V267, P7359; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Kawamura Y, 1998, INT J SYST BACTERIOL, V48, P921, DOI 10.1099/00207713-48-3-921; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; KILIAN M, 1995, PEDIATR RES, V38, P182, DOI 10.1203/00006450-199508000-00008; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Knutsen E, 2006, J BACTERIOL, V188, P8307, DOI 10.1128/JB.00850-06; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morrison DA, 1997, MICROB DRUG RESIST, V3, P27, DOI 10.1089/mdr.1997.3.27; Neeleman C, 2004, J CLIN MICROBIOL, V42, P4355, DOI 10.1128/JCM.42.9.4355-4357.2004; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SanchezBeato AR, 1997, J BACTERIOL, V179, P2459, DOI 10.1128/jb.179.7.2459-2463.1997; Takenouchi-Ohkubo N, 2006, MICROBIOL-SGM, V152, P2171, DOI 10.1099/mic.0.28801-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; WALKER JA, 1987, INFECT IMMUN, V55, P1184, DOI 10.1128/IAI.55.5.1184-1189.1987; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Weiser JN, 2003, P NATL ACAD SCI USA, V100, P4215, DOI 10.1073/pnas.0637469100; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Yoshida Y, 2006, J BACTERIOL, V188, P4125, DOI 10.1128/JB.01843-05; [No title captured]	67	208	210	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2683	10.1371/journal.pone.0002683	http://dx.doi.org/10.1371/journal.pone.0002683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628950	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200027
J	Pauly, T; Ratliff, M; Pietrowski, E; Neugebauer, R; Schlicksupp, A; Kirsch, J; Kuhse, J				Pauly, Thorsten; Ratliff, Miriam; Pietrowski, Eweline; Neugebauer, Rainer; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Activity-Dependent Shedding of the NMDA Receptor Glycine Binding Site by Matrix Metalloproteinase 3: A PUTATIVE Mechanism of Postsynaptic Plasticity	PLOS ONE			English	Article								Functional and structural alterations of clustered postsynaptic ligand gated ion channels in neuronal cells are thought to contribute to synaptic plasticity and memory formation in the human brain. Here, we describe a novel molecular mechanism for structural alterations of NR1 subunits of the NMDA receptor. In cultured rat spinal cord neurons, chronic NMDA receptor stimulation induces disappearance of extracellular epitopes of NMDA receptor NR1 subunits, which was prevented by inhibiting matrix metalloproteinases (MMPs). Immunoblotting revealed the digestion of solubilized NR1 subunits by MMP-3 and identified a fragment of about 60 kDa as MMPs-activity-dependent cleavage product of the NR1 subunit in cultured neurons. The expression of MMP-3 in the spinal cord culture was shown by immunoblotting and immunofluorescence microscopy. Recombinant NR1 glycine binding protein was used to identify MMP-3 cleavage sites within the extracellular S1 and S2-domains. N-terminal sequencing and site-directed mutagenesis revealed S542 and L790 as two putative major MMP-3 cleavage sites of the NR1 subunit. In conclusion, our data indicate that MMPs, and in particular MMP-3, are involved in the activity dependent alteration of NMDA receptor structure at postsynaptic membrane specializations in the CNS.	[Pauly, Thorsten] Univ Ulm, Dept Anat & Cellular Neurobiol, Ulm, Germany; [Ratliff, Miriam; Pietrowski, Eweline; Neugebauer, Rainer; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Univ Heidelberg, Dept Anat & Cell Biol, Heidelberg, Germany	Ulm University; Ruprecht Karls University Heidelberg	Pauly, T (corresponding author), Univ Ulm, Dept Anat & Cellular Neurobiol, Ulm, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019	Ratliff, Miriam/0000-0002-9464-6544	Deutsche Forschungsgemeinschaft [SFB 497, 577/1, 856/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank the Deutsche Forschungsgemeinschaft for supporting this work (SFB 497, Forschergruppe FOR 577/1 and DFG Grant Ku 856/6-1). The sponsors did not contribute to the design or conduct of the study.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Arendt Y, 2007, FEBS LETT, V581, P4723, DOI 10.1016/j.febslet.2007.08.069; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; EGUCHI T, 2008, MOL CELL BIOL   0102; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; Hilgenberg LGW, 2002, MOL CELL NEUROSCI, V19, P97, DOI 10.1006/mcne.2001.1056; Holmes KD, 2002, J BIOL CHEM, V277, P1457, DOI 10.1074/jbc.M107809200; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim YS, 2005, J NEUROSCI, V25, P3701, DOI 10.1523/JNEUROSCI.4346-04.2005; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neugebauer R, 2003, BIOCHEM BIOPH RES CO, V305, P476, DOI 10.1016/S0006-291X(03)00768-X; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Pauly T, 2005, NEUROSCIENCE, V131, P99, DOI 10.1016/j.neuroscience.2004.10.039; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Reeves TM, 2003, J NEUROSCI, V23, P10182; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Si-Tayeb K, 2006, AM J PATHOL, V169, P1390, DOI 10.2353/ajpath.2006.060005; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; VanSaun M, 2000, J NEUROBIOL, V44, P369, DOI 10.1002/1097-4695(20000905)44:3<369::AID-NEU7>3.3.CO;2-Q; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wetzel M, 2003, EUR J NEUROSCI, V18, P1050, DOI 10.1046/j.1460-9568.2003.02838.x	36	38	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2681	10.1371/journal.pone.0002681	http://dx.doi.org/10.1371/journal.pone.0002681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18629001	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200025
J	Connell, TG; Ritz, N; Paxton, GA; Buttery, JP; Curtis, N; Ranganathan, SC				Connell, Tom G.; Ritz, Nicole; Paxton, Georgia A.; Buttery, Jim P.; Curtis, Nigel; Ranganathan, Sarath C.			A Three-Way Comparison of Tuberculin Skin Testing, QuantiFERON-TB Gold and T-SPOT. TB in Children	PLOS ONE			English	Article							BLOOD INTERFERON-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; RELEASE ASSAYS; INFECTION; DIAGNOSIS; SENSITIVITY; TOOLS	Background: There are limited data comparing the performance of the two commercially available interferon gamma (IFN-gamma) release assays ( IGRAs) for the diagnosis of tuberculosis ( TB) in children. We compared QuantiFERON-TB gold In Tube (QFT-IT), T-SPOT. TB and the tuberculin skin test (TST) in children at risk for latent TB infection or TB disease. Methods and Findings: The results of both IGRAs were compared with diagnosis assigned by TST-based criteria and assessed in relation to TB contact history. Results from the TST and at least one assay were available for 96 of 100 children. Agreement between QFT-IT and T-SPOT. TB was high (93% agreement, kappa = 0.83). QFT-IT and T-SPOT. TB tests were positive in 8 (89%) and 9 (100%) children with suspected active TB disease. There was moderate agreement between TST and either QFT-IT (75%, kappa = 0.50) or T-SPOT. TB ( 75%, kappa = 0.51). Among 38 children with TST-defined latent TB infection, QFT-IT gold and T-SPOT. TB assays were positive in 47% and 39% respectively. Three TST-negative children were positive by at least one IGRA. Children with a TB contact were more likely than children without a TB contact to have a positive IGRA (QFT-IT LR 3.9; T-SPOT. TB LR 3.9) and a positive TST (LR 1.4). Multivariate linear regression analysis showed that the magnitude of both TST induration and IGRA IFN-gamma responses was significantly influenced by TB contact history, but only the TST was influenced by age. Conclusions: Although a high level of agreement between the IGRAs was observed, they are commonly discordant with the TST. The correct interpretation of a negative assay in a child with a positive skin test in clinical practice remains challenging and highlights the need for longitudinal studies to determine the negative predictive value of IGRAs.	[Connell, Tom G.; Ritz, Nicole; Buttery, Jim P.; Curtis, Nigel; Ranganathan, Sarath C.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia; [Connell, Tom G.; Ritz, Nicole; Buttery, Jim P.; Curtis, Nigel; Ranganathan, Sarath C.] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Victoria, Australia; [Connell, Tom G.; Ritz, Nicole; Buttery, Jim P.; Curtis, Nigel] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Victoria, Australia; [Paxton, Georgia A.] Royal Childrens Hosp Melbourne, Dept Gen Med, Immigrant Hlth Serv, Victoria, Australia; [Ranganathan, Sarath C.] Royal Childrens Hosp Melbourne, Dept Thoracic Med, Victoria, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	Connell, TG (corresponding author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.	nigel.curtis@rch.org.au	Curtis, Nigel/B-3491-2012; Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019	Curtis, Nigel/0000-0003-3446-4594; Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Paxton, Georgia/0000-0003-2314-9812; Ranganathan, Sarath/0000-0002-6975-0307	John Burge Trust Victoria; European Society of Paediatric Infectious Diseases [fellowship]; Nossal [fellowship]; Institute of Global Health; Swiss National Science Foundation	John Burge Trust Victoria; European Society of Paediatric Infectious Diseases; Nossal; Institute of Global Health; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a grant from the John Burge Trust Victoria. Tom G Connell is supported by fellowship awards from the European Society of Paediatric Infectious Diseases and the Nossal. Institute of Global Health. Nicole Ritz is supported by fellowship awards from the Swiss National Science Foundation and the European Society of Paediatric Infectious Diseases. Funding bodies had no role in data analysis or in the preparation of the manuscript.	Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Carvalho ACC, 2007, J INFECTION, V55, P164, DOI 10.1016/j.jinf.2007.02.004; Cehovin A, 2007, CLIN VACCINE IMMUNOL, V14, P796, DOI 10.1128/CVI.00093-07; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Curtis N, 2006, THORAX, V61, P920; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Haimi-Cohen Y, 2001, CLIN INFECT DIS, V33, P1786, DOI 10.1086/323984; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Higuchi K, 2007, RESPIROLOGY, V12, P88, DOI 10.1111/j.1440-1843.2006.01000.x; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Kimura M, 2005, INT J TUBERC LUNG D, V9, P853; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; LANDIS JR, 1977, BIOMETRICS, V33, P174; LEYTEN EM, 2007, CLIN VACCINE IMMUNOL; Mahomed H, 2006, INT J TUBERC LUNG D, V10, P310; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mori T, 2007, INT J TUBERC LUNG D, V11, P1021; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Suzuki K, 2004, KEKKAKU, V79, P200; TAYLOR RE, 2007, ARCH DIS CHILD	36	143	148	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2624	10.1371/journal.pone.0002624	http://dx.doi.org/10.1371/journal.pone.0002624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612425	Green Published, gold			2022-12-27	WOS:000264065800026
J	Krach, S; Hegel, F; Wrede, B; Sagerer, G; Binkofski, F; Kircher, T				Krach, Soeren; Hegel, Frank; Wrede, Britta; Sagerer, Gerhard; Binkofski, Ferdinand; Kircher, Tilo			Can Machines Think? Interaction and Perspective Taking with Robots Investigated via fMRI	PLOS ONE			English	Article							NEURAL BASIS; SELF-CONSCIOUSNESS; MIND; ATTRIBUTION; COOPERATION; INTENTIONS; SIMULATION; PRECUNEUS; OTHERS; PEOPLE	Background: When our PC goes on strike again we tend to curse it as if it were a human being. Why and under which circumstances do we attribute human-like properties to machines? Although humans increasingly interact directly with machines it remains unclear whether humans implicitly attribute intentions to them and, if so, whether such interactions resemble human-human interactions on a neural level. In social cognitive neuroscience the ability to attribute intentions and desires to others is being referred to as having a Theory of Mind (ToM). With the present study we investigated whether an increase of human-likeness of interaction partners modulates the participants' ToM associated cortical activity. Methodology/Principal Findings: By means of functional magnetic resonance imaging (subjects n = 20) we investigated cortical activity modulation during highly interactive human-robot game. Increasing degrees of human-likeness for the game partner were introduced by means of a computer partner, a functional robot, an anthropomorphic robot and a human partner. The classical iterated prisoner's dilemma game was applied as experimental task which allowed for an implicit detection of ToM associated cortical activity. During the experiment participants always played against a random sequence unknowingly to them. Irrespective of the surmised interaction partners' responses participants indicated having experienced more fun and competition in the interaction with increasing human-like features of their partners. Parametric modulation of the functional imaging data revealed a highly significant linear increase of cortical activity in the medial frontal cortex as well as in the right temporo-parietal junction in correspondence with the increase of human-likeness of the interaction partner (computer<functional robot<anthropomorphic robot<human). Conclusions/Significance: Both regions correlating with the degree of human-likeness, the medial frontal cortex and the right temporo-parietal junction, have been associated with Theory-of-Mind. The results demonstrate that the tendency to build a model of another's mind linearly increases with its perceived human-likeness. Moreover, the present data provides first evidence of a contribution of higher human cognitive functions such as ToM in direct interactions with artificial robots. Our results shed light on the long-lasting psychological and philosophical debate regarding human-machine interaction and the question of what makes humans being perceived as human.	[Krach, Soeren; Kircher, Tilo] Rhein Westfal TH Aachen, Dept Psychiat, Aachen, Germany; [Krach, Soeren] Rhein Westfal TH Aachen, ICCR BIOMAT, Cent Serv Facil Funct Imaging, Aachen, Germany; [Hegel, Frank; Wrede, Britta; Sagerer, Gerhard] Bielefeld Univ, Tech Fac, Cognitive Interact Technol, Bielefeld, Germany; [Binkofski, Ferdinand] Univ Hosp Schleswig Holstein, Dept Neurol, Lubeck, Germany; [Binkofski, Ferdinand] Univ Med Ctr, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany; [Kircher, Tilo] Wilhelm Johnen Strasse, Forschungszentrum Julich, Brain Imaging Ctr W BICW, Julich, Germany	RWTH Aachen University; RWTH Aachen University; University of Bielefeld; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Research Center Julich	Krach, S (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat, Aachen, Germany.	skrach@ukaachen.de	Kircher, Tilo/AAT-6480-2020; Binkofski, Ferdinand/S-6997-2017	Kircher, Tilo/0000-0002-2514-2625; Binkofski, Ferdinand/0000-0002-6750-943X; Krach, Soren/0000-0002-4834-8378	EU funded IP-project COGNIRON; German Research Foundation (DFG); BMBF [01GW0751]	EU funded IP-project COGNIRON; German Research Foundation (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work has been supported by the EU funded IP-project COGNIRON, the German Research Foundation (DFG) within the SFB 673 Alignment in Communication, Project C2 (Communicating Emotions) and the BMBF project 01GW0751 Mirror Neurons.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Brickenkamp R., 2002, AUFMERKSAMKEITS BELA; BRUCE A, 2001, P AAAI FALL S EM INT; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; BUTTERWORTH G., 1991, NATURAL THEORIES MIN, P223; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavanna AE, 2007, CNS SPECTRUMS, V12, P545, DOI 10.1017/S1092852900021295; Dautenhahn K., 2002, COGNITIVE SYSTEMS RE, V3, P397, DOI [10.1016/S1389-0417(02)00050-5, DOI 10.1016/S1389-0417(02)00050-5]; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Dennett Daniel C., 1987, INTENTIONAL STANCE; DISALVO CF, 2002, ALL ROBOTS NOT CREAT; Dresher M., 1961, THEORY APPL; DUFFY B, 2004, ROBOT BEING; Duffy BR, 2003, ROBOT AUTON SYST, V42, P177, DOI 10.1016/S0921-8890(02)00374-3; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; FOERSTER H, 1997, WISSEN GEWISSEN; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Frith C, 1996, PHILOS T R SOC B, V351, P1505, DOI 10.1098/rstb.1996.0136; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fukui H, 2006, NEUROIMAGE, V32, P913, DOI 10.1016/j.neuroimage.2006.03.039; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; GHAZANFAR AA, 2008, NATURE NEUROSCIENCE, V11; GOCKLEY R, 2006, INTERACTIONS MOODY R, P186; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Goetz J, 2003, RO-MAN 2003: 12TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P55; Hegel F, 2006, IEEE-RAS INT C HUMAN, P56, DOI 10.1109/ICHR.2006.321363; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jung Y, 2004, EFFECTS PHYS EMBODIM, P80; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Kircher TTJ, 2003, CONSCIOUS COGN, V12, P656, DOI 10.1016/S1053-8100(03)00071-0; Langton SRH, 2000, Q J EXP PSYCHOL-A, V53, P825, DOI 10.1080/027249800410562; LEHRL S, 2007, MEHRFACHWAHL WORTSCH; Leslie A.M., 1994, MAPPING MIND DOMAIN, P119, DOI [10.1017/cbo9780511752902.006, DOI 10.1017/CBO9780511752902.006]; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Leube DT, 2003, CONSCIOUS COGN, V12, P597, DOI 10.1016/S1053-8100(03)00079-5; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCarthy J., 1979, PHILOS PERSPECTIVES, P1; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Morewedge CK, 2007, J PERS SOC PSYCHOL, V93, P1, DOI 10.1037/0022-3514.93.1.1; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Talairach J., 1988, COPLANAR STEREOTAXIC; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Wood Gaby, 2002, LIVING DOLLS MAGICAL	61	196	198	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2597	10.1371/journal.pone.0002597	http://dx.doi.org/10.1371/journal.pone.0002597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612463	Green Published, gold			2022-12-27	WOS:000264065800010
J	Pellegatti, P; Raffaghello, L; Bianchi, G; Piccardi, F; Pistoia, V; Di Virgilio, F				Pellegatti, Patrizia; Raffaghello, Lizzia; Bianchi, Giovanna; Piccardi, Federica; Pistoia, Vito; Di Virgilio, Francesco			Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase	PLOS ONE			English	Article								Background: There is growing awareness that tumour cells build up a "self-advantageous'' microenvironment that reduces effectiveness of anti-tumour immune response. While many different immunosuppressive mechanisms are likely to come into play, recent evidence suggests that extracellular adenosine acting at A2A receptors may have a major role in down-modulating the immune response as cancerous tissues contain elevated levels of adenosine and adenosine break-down products. While there is no doubt that all cells possess plasma membrane adenosine transporters that mediate adenosine uptake and may also allow its release, it is now clear that most of extracellularly-generated adenosine originates from the catabolism of extracellular ATP. Methodology/Principal Findings: Measurement of extracellular ATP is generally performed in cell supernatants by HPLC or soluble luciferin-luciferase assay, thus it generally turns out to be laborious and inaccurate. We have engineered a chimeric plasma membrane-targeted luciferase that allows in vivo real-time imaging of extracellular ATP. With this novel probe we have measured the ATP concentration within the tumour microenvironment of several experimentally-induced tumours. Conclusions/Significance: Our results show that ATP in the tumour interstitium is in the hundrends micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targeted luciferase allows in vivo detection of high extracellular ATP concentration at tumour sites. On the contrary, tumour-free tissues show undetectable extracellular ATP levels. Extracellular ATP may be crucial for the tumour not only as a stimulus for growth but also as a source of an immunosuppressive agent such as adenosine. Our approach offers a new tool for the investigation of the biochemical composition of tumour milieu and for development of novel therapies based on the modulation of extracellular purine-based signalling.	[Pellegatti, Patrizia; Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, ICSI, I-44100 Ferrara, Italy; [Raffaghello, Lizzia; Bianchi, Giovanna; Pistoia, Vito] Giannina Gaslini Inst, Lab Oncol, Genoa, Italy; [Piccardi, Federica] Ist Tumori, Anim Res Facil, Genoa, Italy	University of Ferrara; University of Genoa; IRCCS Istituto Giannina Gaslini	Pellegatti, P (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, ICSI, I-44100 Ferrara, Italy.	fdv@unife.it	Di Virgilio, Francesco/J-3754-2018; Pellegatti, Patrizia/A-1891-2011; DI VIRGILIO, Francesco/O-4634-2019; Bianchi, Giovanna/J-5904-2016	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Bianchi, Giovanna/0000-0002-0888-3616; Raffaghello, Lizzia/0000-0003-2357-0607	Italian Association for Cancer Research; Telethon of Italy [GGP06070]; Italian Space Agency (ASI-OSMA); Italian Ministry of University and Scientific Research (PRIN); Commission of European Communities [HEALTH-F2-2007-202231]; University of Ferrara; Fondazione Italiana per la Lotta al Neuroblastoma [fellowship]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); Italian Space Agency (ASI-OSMA)(Agenzia Spaziale Italiana (ASI)); Italian Ministry of University and Scientific Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Commission of European Communities(European Commission); University of Ferrara; Fondazione Italiana per la Lotta al Neuroblastoma	This research was supported by grants from the Italian Association for Cancer Research (to F.D.V. and V. P.), Telethon of Italy (n. GGP06070), the Italian Space Agency (ASI-OSMA), the Italian Ministry of University and Scientific Research (PRIN), the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231), and institutional funds from the University of Ferrara. Dr. Lizzia Raffaghello is a recipient of a fellowship from Fondazione Italiana per la Lotta al Neuroblastoma.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Buffon A, 2007, BBA-GEN SUBJECTS, V1770, P1259, DOI 10.1016/j.bbagen.2007.05.004; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; FISCHER S, 1995, MOL BRAIN RES, V28, P141, DOI 10.1016/0169-328X(94)00193-I; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gourine AV, 2007, J PHYSIOL-LONDON, V585, P305, DOI 10.1113/jphysiol.2007.143933; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Grant MB, 1999, CIRC RES, V85, P699, DOI 10.1161/01.RES.85.8.699; Gu BJ, 2006, BLOOD, V107, P4946, DOI 10.1182/blood-2005-07-2994; Harrison LH, 2000, ANN THORAC SURG, V70, P407, DOI 10.1016/S0003-4975(00)01557-5; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Marteau F, 2005, BLOOD, V106, P3860, DOI 10.1182/blood-2005-05-1843; Morrone FB, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-226; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Viola A, 2007, SEMIN CANCER BIOL, V17, P309, DOI 10.1016/j.semcancer.2007.06.005	27	444	450	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2599	10.1371/journal.pone.0002599	http://dx.doi.org/10.1371/journal.pone.0002599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612415	gold, Green Submitted, Green Published			2022-12-27	WOS:000264065800012
J	Buchholz, K; Rahlfs, S; Schirmer, RH; Becker, K; Matuschewski, K				Buchholz, Kathrin; Rahlfs, Stefan; Schirmer, R. Heiner; Becker, Katja; Matuschewski, Kai			Depletion of Plasmodium berghei Plasmoredoxin Reveals a Non-Essential Role for Life Cycle Progression of the Malaria Parasite	PLOS ONE			English	Article								Proliferation of the pathogenic Plasmodium asexual blood stages in host erythrocytes requires an exquisite capacity to protect the malaria parasite against oxidative stress. This function is achieved by a complex antioxidant defence system composed of redox-active proteins and low MW antioxidants. Here, we disrupted the P. berghei plasmoredoxin gene that encodes a parasite-specific 22 kDa member of the thioredoxin superfamily. The successful generation of plasmoredoxin knockout mutants in the rodent model malaria parasite and phenotypic analysis during life cycle progression revealed a non-vital role in vivo. Our findings suggest that plasmoredoxin fulfils a specialized and dispensable role for Plasmodium and highlights the need for target validation to inform drug development strategies.	[Buchholz, Kathrin; Rahlfs, Stefan; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, Giessen, Germany; [Buchholz, Kathrin; Schirmer, R. Heiner] Univ Heidelberg, Biochem Ctr, Heidelberg, Germany; [Buchholz, Kathrin; Matuschewski, Kai] Heidelberg Univ, Sch Med, Dept Parasitol, Heidelberg, Germany	Justus Liebig University Giessen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Buchholz, K (corresponding author), Univ Giessen, Interdisciplinary Res Ctr, Giessen, Germany.	becker.katja@gmx.de; Kai.Matuschewski@med.uni-heidelberg.de	Buchholz, Kathrin/O-3217-2017	Matuschewski, Kai/0000-0001-6147-8591	Deutsche Forschungsgemeinschaft;  [SFB 544];  [B2];  [B10];  [BE1540/4-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; ; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 544, B2 and B10 as well as BE1540/4-4).	Becker K, 2005, MOLECULAR APPROACHES TO MALARIA, P365; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Boucher IW, 2006, MOL MICROBIOL, V61, P948, DOI 10.1111/j.1365-2958.2006.05303.x; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Collinson EJ, 2002, J BIOL CHEM, V277, P16712, DOI 10.1074/jbc.M111686200; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; JANSE CJ, 1994, INT J PARASITOL, V24, P589, DOI 10.1016/0020-7519(94)90150-3; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MUELLER EGD, 1991, J BIOL CHEM, V43, P9194; Muller S, 2003, REDOX REP, V8, P251, DOI 10.1179/135100003225002853; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Nickel C, 2005, BIOL CHEM, V386, P1129, DOI 10.1515/BC.2005.129; Nickel C, 2006, ANTIOXID REDOX SIGN, V8, P1227, DOI 10.1089/ars.2006.8.1227; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Ortenberg R, 2004, P NATL ACAD SCI USA, V101, P7439, DOI 10.1073/pnas.0401965101; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rahlfs S, 2006, MINI-REV MED CHEM, V6, P163, DOI 10.2174/138955706775475911; Rahlfs S, 2003, REDOX REP, V8, P246, DOI 10.1179/135100003225002844; Rahlfs S, 2002, CELL MOL LIFE SCI, V59, P1024, DOI 10.1007/s00018-002-8484-9; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; RUSSEL M, 1988, P NATL ACAD SCI USA, V85, P990, DOI 10.1073/pnas.85.4.990; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Thathy Vandana, 2002, Methods Mol Med, V72, P317, DOI 10.1385/1-59259-271-6:317; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618	36	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2474	10.1371/journal.pone.0002474	http://dx.doi.org/10.1371/journal.pone.0002474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575607	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000006
J	Dalmasso, G; Nguyen, HTT; Yan, YT; Charrier-Hisamuddin, L; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Yan, Yutao; Charrier-Hisamuddin, Laetitia; Sitaraman, Shanthi V.; Merlin, Didier			Butyrate Transcriptionally Enhances Peptide Transporter PepT1 Expression and Activity	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; NHE3 GENE PROMOTER; NF-KAPPA-B; HPEPT1 EXPRESSION; HUMAN INTESTINE; COLONIC-MUCOSA; RAT; CANCER; LOCALIZATION; METABOLISM	Background: PepT1, an intestinal epithelial apical di/tripeptide transporter, is normally expressed in the small intestine and induced in colon during chronic inflammation. This study aimed at investigating PepT1 regulation by butyrate, a short-chain fatty acid produced by commensal bacteria and accumulated inside inflamed colonocyte. Results: We found that butyrate treatment of human intestinal epithelial Caco2-BBE cells increased human PepT1 (hPepT1) promoter activity in a dose- and time-dependent manner, with maximal activity observed in cells treated with 5 mM butyrate for 24 h. Under this condition, hPepT1 promoter activity, mRNA and protein expression levels were increased as assessed by luciferase assay, real-time RT-PCR and Western blot, respectively. hPepT1 transport activity was accordingly increased by similar to 2.5-fold. Butyrate did not alter hPepT1 mRNA half-life indicating that butyrate acts at the transcriptional level. Molecular analyses revealed that Cdx2 is the most important transcription factor for butyrate-induced increase of hPepT1 expression and activity in Caco2-BBE cells. Butyrate-activated Cdx2 binding to hPepT1 promoter was confirmed by gel shift and chromatin immunoprecipitation. Moreover, Caco2-BBE cells overexpressing Cdx2 exhibited greater hPepT1 expression level than wild-type cells. Finally, treatment of mice with 5 mM butyrate added to drinking water for 24 h increased colonic PepT1 mRNA and protein expression levels, as well as enhanced PepT1 transport activity in colonic apical membranes vesicles. Conclusions: Collectively, our results demonstrate that butyrate increases PepT1 expression and activity in colonic epithelial cells, which provides a new understanding of PepT1 regulation during chronic inflammation.	[Dalmasso, Guillaume; Nguyen, Hang Thi Thu; Yan, Yutao; Charrier-Hisamuddin, Laetitia; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA	Emory University	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	nguye9@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK061941-02, RO1-DK55850]; Crohn's and Colitis Foundation of America [research fellowship, carrier development award]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061941, R01DK055850, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health of Diabetes and Digestive and Kidney Diseases under a center grant (R24-DK-064399), RO1-DK061941-02 (to D. Merlin), RO1-DK55850 (to S. Sitaraman). G. Dalmasso and Y. Yan are recipient of a research fellowship award from the Crohn's and Colitis Foundation of America. L. Charrier-Hisamuddin is a recipient of a carrier development award from the Crohn's and Colitis Foundation of America.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; BOEDIGER WE, 1996, GUT, V38, P792; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Charrier L, 2006, LAB INVEST, V86, P490, DOI 10.1038/labinvest.3700413; CLAUSEN MR, 1994, GASTROENTEROLOGY, V106, P423, DOI 10.1016/0016-5085(94)90601-7; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Daly K, 2005, BIOCHEM SOC T, V33, P733, DOI 10.1042/BST0330733; DANIEL H, 1991, J BIOL CHEM, V266, P19917; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Den Hond E, 1998, GASTROENTEROLOGY, V115, P584; Domon-Dell C, 2002, GUT, V50, P525, DOI 10.1136/gut.50.4.525; Engelhardt W V, 1989, Acta Vet Scand Suppl, V86, P103; Fei YJ, 1998, PROG NUCLEIC ACID RE, V58, P239; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Kiela PR, 2007, AM J PHYSIOL-CELL PH, V293, pC64, DOI 10.1152/ajpcell.00277.2006; Kiela PR, 2001, AM J PHYSIOL-GASTR L, V281, pG947, DOI 10.1152/ajpgi.2001.281.4.G947; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; MCINTYRE A, 1993, GUT, V34, P386, DOI 10.1136/gut.34.3.386; Merlin D, 1998, J CLIN INVEST, V102, P2011, DOI 10.1172/JCI4179; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mutoh H, 2005, INT J DEV BIOL, V49, P867, DOI 10.1387/ijdb.052016hm; Nduati V, 2007, J BIOL CHEM, V282, P1359, DOI 10.1074/jbc.M604267200; Ogihara H, 1999, HISTOCHEM J, V31, P169, DOI 10.1023/A:1003515413550; Ogihara H, 1996, BIOCHEM BIOPH RES CO, V220, P848, DOI 10.1006/bbrc.1996.0493; ROEDIGER WEW, 1980, LANCET, V2, P712; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94; Sai Y, 1996, FEBS LETT, V392, P25, DOI 10.1016/0014-5793(96)00778-8; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Shah P, 2006, BRAIN RES, V1107, P13, DOI 10.1016/j.brainres.2006.05.097; Shi B, 2006, J SURG RES, V136, P38, DOI 10.1016/j.jss.2006.05.025; Shi B, 2006, DIGEST DIS SCI, V51, P2087, DOI 10.1007/s10620-005-9067-z; Shimakura J, 2005, AM J PHYSIOL-GASTR L, V289, pG471, DOI 10.1152/ajpgi.00025.2005; Shimakura J, 2006, BIOCHEM PHARMACOL, V71, P1581, DOI 10.1016/j.bcp.2006.03.001; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Smith DE, 1998, PHARM RES-DORDR, V15, P1244, DOI 10.1023/A:1011996009332; Tanaka N, 1998, SURF REV LETT, V5, P723, DOI 10.1142/S0218625X98001092; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thu Nguyen HT, 2007, AM J PHYSIOL-GASTR L, V293, pG1155, DOI 10.1152/ajpgi.00334.2007; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; WRONG O, 1965, CLIN SCI, V28, P357; Zeissig S, 2007, GASTROENTEROLOGY, V132, P236, DOI 10.1053/j.gastro.2006.10.033; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922	53	69	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2476	10.1371/journal.pone.0002476	http://dx.doi.org/10.1371/journal.pone.0002476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575574	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000008
J	Elisaphenko, EA; Kolesnikov, NN; Shevchenko, AI; Rogozin, IB; Nesterova, TB; Brockdorff, N; Zakian, SM				Elisaphenko, Eugeny A.; Kolesnikov, Nikolay N.; Shevchenko, Alexander I.; Rogozin, Igor B.; Nesterova, Tatyana B.; Brockdorff, Neil; Zakian, Suren M.			A Dual Origin of the Xist Gene from a Protein-Coding Gene and a Set of Transposable Elements	PLOS ONE			English	Article								X-chromosome inactivation, which occurs in female eutherian mammals is controlled by a complex X-linked locus termed the X-inactivation center (XIC). Previously it was proposed that genes of the XIC evolved, at least in part, as a result of pseudogenization of protein-coding genes. In this study we show that the key XIC gene Xist, which displays fragmentary homology to a protein-coding gene Lnx3, emerged de novo in early eutherians by integration of mobile elements which gave rise to simple tandem repeats. The Xist gene promoter region and four out of ten exons found in eutherians retain homology to exons of the Lnx3 gene. The remaining six Xist exons including those with simple tandem repeats detectable in their structure have similarity to different transposable elements. Integration of mobile elements into Xist accompanies the overall evolution of the gene and presumably continues in contemporary eutherian species. Additionally we showed that the combination of remnants of protein-coding sequences and mobile elements is not unique to the Xist gene and is found in other XIC genes producing non-coding nuclear RNA.	[Elisaphenko, Eugeny A.; Kolesnikov, Nikolay N.; Shevchenko, Alexander I.; Rogozin, Igor B.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Dept, Novosibirsk 630090, Russia; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA; [Nesterova, Tatyana B.] Imperial Coll, Fac Med, Clin Sci Ctr, Med Res Council, London, England; [Brockdorff, Neil] Univ Oxford, Dept Biochem, Oxford, England	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	Elisaphenko, EA (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Dept, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Elisaphenko, Eugeny/V-5115-2018; Shevchenko, Alexander I./T-3400-2018; Kolesnikov, Nikolay/N-7569-2015; Zakian, Suren/J-2196-2018; Elisafenko, Eugeny/AAD-5901-2020	Kolesnikov, Nikolay/0000-0001-7005-0888; Elisafenko, Eugeny/0000-0002-3204-8178; Zakian, Suren/0000-0003-2448-6511; Nesterova, Tatyana/0000-0001-7740-4386; Rogozin, Igor/0000-0003-0802-4851; Brockdorff, Neil/0000-0003-4838-2653	Russian Foundation for Fundamental Research [06-04-48337-a, 08-04-00346-a]; Russian Academy of Sciences [10.8]; Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS; MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: researchfish	Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Russian Foundation for Fundamental Research (grants no. 06-04-48337-a and 08-04-00346-a), Russian Academy of Sciences foundation program for Molecular and Cellular Biology and by grant 10.8 from the Interdisciplinary Integration Project of the Siberian Division of the Russian Academy of Sciences. I.B.R. was supported in part by the Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Britten RJ, 2004, P NATL ACAD SCI USA, V101, P16825, DOI 10.1073/pnas.0406985101; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Brown CJ, 1996, SOMAT CELL MOLEC GEN, V22, P403, DOI 10.1007/BF02369896; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Elnitski L, 2002, GENOMICS, V80, P681, DOI 10.1006/geno.2002.7018; Glazko GV, 2005, TRENDS GENET, V21, P89, DOI 10.1016/j.tig.2004.12.006; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shevchenko AI, 2007, CHROMOSOME RES, V15, P127, DOI 10.1007/s10577-006-1115-9; Smit A.F.A., REPEATMASKER; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yen ZC, 2007, GENOMICS, V90, P453, DOI 10.1016/j.ygeno.2007.07.002	28	117	123	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2521	10.1371/journal.pone.0002521	http://dx.doi.org/10.1371/journal.pone.0002521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575625	gold, Green Submitted, Green Published			2022-12-27	WOS:000263288000037
J	Tarasov, KV; Tarasova, YS; Tam, WL; Riordon, DR; Elliott, ST; Kania, G; Li, JL; Yamanaka, S; Crider, DG; Testa, G; Li, RA; Lim, B; Stewart, CL; Liu, Y; Van Eyk, JE; Wersto, RP; Wobus, AM; Boheler, KR				Tarasov, Kirill V.; Tarasova, Yelena S.; Tam, Wai Leong; Riordon, Daniel R.; Elliott, Steven T.; Kania, Gabriela; Li, Jinliang; Yamanaka, Satoshi; Crider, David G.; Testa, Gianluca; Li, Ronald A.; Lim, Bing; Stewart, Colin L.; Liu, Yie; Van Eyk, Jennifer E.; Wersto, Robert P.; Wobus, Anna M.; Boheler, Kenneth R.			B-MYB Is Essential for Normal Cell Cycle Progression and Chromosomal Stability of Embryonic Stem Cells	PLOS ONE			English	Article								Background: The transcription factor B-Myb is present in all proliferating cells, and in mice engineered to remove this gene, embryos die in utero just after implantation due to inner cell mass defects. This lethal phenotype has generally been attributed to a proliferation defect in the cell cycle phase of G1. Methodology/Principal Findings: In the present study, we show that the major cell cycle defect in murine embryonic stem (mES) cells occurs in G2/M. Specifically, knockdown of B-Myb by short-hairpin RNAs results in delayed transit through G2/M, severe mitotic spindle and centrosome defects, and in polyploidy. Moreover, many euploid mES cells that are transiently deficient in B-Myb become aneuploid and can no longer be considered viable. Knockdown of B-Myb in mES cells also decreases Oct4 RNA and protein abundance, while over-expression of B-MYB modestly up-regulates pou5f1 gene expression. The coordinated changes in B-Myb and Oct4 expression are due, at least partly, to the ability of B-Myb to directly modulate pou5f1 gene promoter activity in vitro. Ultimately, the loss of B-Myb and associated loss of Oct4 lead to an increase in early markers of differentiation prior to the activation of caspase-mediated programmed cell death. Conclusions/Significance: Appropriate B-Myb expression is critical to the maintenance of chromosomally stable and pluripotent ES cells, but its absence promotes chromosomal instability that results in either aneuploidy or differentiation-associated cell death.	[Tarasov, Kirill V.; Tarasova, Yelena S.; Riordon, Daniel R.; Li, Jinliang; Yamanaka, Satoshi; Crider, David G.; Testa, Gianluca; Boheler, Kenneth R.] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; [Tam, Wai Leong; Lim, Bing] Genome Inst Singapore, Singapore, Singapore; [Elliott, Steven T.; Van Eyk, Jennifer E.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Kania, Gabriela; Wobus, Anna M.] Leibniz Inst Plant Genet & Crop Plant Res, In vitro Differentiat Grp, Gatersleben, Germany; [Li, Ronald A.] Univ Calif Davis, Stem Cell Inst, Lab Stem Cell Engn & Bioelectricity, Davis, CA USA; [Lim, Bing] Harvard Med Sch, Harvard Inst Med, Boston, MA USA; [Stewart, Colin L.] NCI, Canc & Dev Biol Lab, Frederick, MD USA; [Liu, Yie] NIH, NIA, Lab Mol Genet, Baltimore, MD USA; [Wersto, Robert P.] NIH, NIA, Flow Cytometry Grp, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Johns Hopkins University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of California System; University of California Davis; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tarasov, KV (corresponding author), NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA.	bohelerk@grc.nia.nih.gov	Liu, Yie/AAO-2092-2020; Tam, Wai Leong/P-1497-2019; Kania, Gabriela/E-8715-2017; /AAB-9217-2021; Li, Ronald/E-9833-2010	Tam, Wai Leong/0000-0003-2365-5264; Kania, Gabriela/0000-0003-3788-4594; Li, Jinliang/0000-0002-3018-0570; Tarasov, Kirill/0000-0001-7799-4670	Intramural Research Program of the NIA/NIH [R01 HL72857]; German Research Foundation [Wo 503/3-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085434, R01HL072857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000847, Z01AG000618] Funding Source: NIH RePORTER	Intramural Research Program of the NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIA/NIH (KRB, RPW), the German Research Foundation (Wo 503/3-3: AMW), and NIH grants (R01 HL72857: RAL).	Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Davidson CJ, 2005, GENETICS, V169, P215, DOI 10.1534/genetics.104.034132; Debiak M, 2004, DNA REPAIR, V3, P359, DOI 10.1016/j.dnarep.2003.11.013; Elliott ST, 2004, PROTEOMICS, V4, P3813, DOI 10.1002/pmic.200300820; Garcia P, 2006, J CELL SCI, V119, P1483, DOI 10.1242/jcs.02870; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Grassilli E, 1999, CANCER RES, V59, P2451; Iwai N, 2001, ONCOGENE, V20, P1425, DOI 10.1038/sj.onc.1204236; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Johnson LR, 2002, J BIOL CHEM, V277, P4088, DOI 10.1074/jbc.M105112200; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Li XL, 2002, MOL CELL BIOL, V22, P3663, DOI 10.1128/MCB.22.11.3663-3673.2002; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; Manak R, 2007, NAT CELL BIOL, V9, P581, DOI 10.1038/ncb1580; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; SNOW MHL, 1978, J EMBRYOL EXP MORPH, V47, P39; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; TARASOV KV, 2008, CELLS TISSUES ORGANS, V27; Tarasova YS, 2006, EMBRYONIC STEM CELLS, P130; Tashiro S, 2004, J BIOL CHEM, V279, P17715, DOI 10.1074/jbc.M310561200; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang YS, 2005, P NATL ACAD SCI USA, V102, P10256, DOI 10.1073/pnas.0504635102; Wersto RP, 1998, J VIROL, V72, P9491, DOI 10.1128/JVI.72.12.9491-9502.1998; Wobus A M, 2002, Methods Mol Biol, V185, P127; WOBUS AM, 1994, IN VITRO CELL DEV-AN, V30A, P425; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	42	75	75	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2478	10.1371/journal.pone.0002478	http://dx.doi.org/10.1371/journal.pone.0002478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575582	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000009
J	Ciani, AC; Cermelli, P; Zanzotto, G				Ciani, Andrea Camperio; Cermelli, Paolo; Zanzotto, Giovanni			Sexually Antagonistic Selection in Human Male Homosexuality	PLOS ONE			English	Article							BIRTH-ORDER; ORIENTATION; CONFLICT; EVOLUTION; LINKAGE; FAMILY; CHROMOSOME; SPECIATION; BEHAVIOR; INSECTS	Several lines of evidence indicate the existence of genetic factors influencing male homosexuality and bisexuality. In spite of its relatively low frequency, the stable permanence in all human populations of this apparently detrimental trait constitutes a puzzling 'Darwinian paradox'. Furthermore, several studies have pointed out relevant asymmetries in the distribution of both male homosexuality and of female fecundity in the parental lines of homosexual vs. heterosexual males. A number of hypotheses have attempted to give an evolutionary explanation for the long-standing persistence of this trait, and for its asymmetric distribution in family lines; however a satisfactory understanding of the population genetics of male homosexuality is lacking at present. We perform a systematic mathematical analysis of the propagation and equilibrium of the putative genetic factors for male homosexuality in the population, based on the selection equation for one or two diallelic loci and Bayesian statistics for pedigree investigation. We show that only the two-locus genetic model with at least one locus on the X chromosome, and in which gene expression is sexually antagonistic (increasing female fitness but decreasing male fitness), accounts for all known empirical data. Our results help clarify the basic evolutionary dynamics of male homosexuality, establishing this as a clearly ascertained sexually antagonistic human trait.	[Ciani, Andrea Camperio] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Cermelli, Paolo] Univ Turin, Dipartimento Mat, Turin, Italy; [Zanzotto, Giovanni] Univ Padua, Dipartimento Metodi Modelli Mat Sci Appl, Padua, Italy	University of Padua; University of Turin; University of Padua	Ciani, AC (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	andrea.camperio@unipd.it	Cermelli, Paolo/C-7042-2011; Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799; Cermelli, Paolo/0000-0002-2181-8800				Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist G., 2005, SEXUAL CONFLICTS; Bailey JM, 1999, BEHAV GENET, V29, P79, DOI 10.1023/A:1021652204405; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CIANI AC, 2008, MALE HOMOSEXUALITY P; CIANI AC, 2008, SEX MED IN PRESS; Dawkins Richard, 1976, SELFISH GENE; Dawood K, 2000, ARCH SEX BEHAV, V29, P155, DOI 10.1023/A:1001955721992; EDWARDS AWF, 2000, FDN MATH GENETICS; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Gavrilets S, 2006, P ROY SOC B-BIOL SCI, V273, P3031, DOI 10.1098/rspb.2006.3684; GETZ WM, 1993, J THEOR BIOL, V162, P515, DOI 10.1006/jtbi.1993.1102; Hamer D., 1994, SCI DESIRE SEARCH GA; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; Hofbauer J., 1988, THEORY EVOLUTION DYN; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; HUTCHINSON GE, 1959, AM NAT, V93, P81, DOI 10.1086/282059; IEMMOLA F, 2008, ARCH SEX BE IN PRESS; Judson O., 2003, TATIANAS SEX ADVICE; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; MACINTYRE F, 1993, BIOSYSTEMS, V31, P223, DOI 10.1016/0303-2647(93)90051-D; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; McKnight J., 1997, STRAIGHT SCI HOMOSEX; Miller EM, 2000, ARCH SEX BEHAV, V29, P1, DOI 10.1023/A:1001836320541; Muscarella F, 2000, J HOMOSEXUAL, V40, P51, DOI 10.1300/J082v40n01_03; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Oliver B, 2004, BIOESSAYS, V26, P543, DOI 10.1002/bies.20034; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; PARKER GA, 1979, INSECTS, P123; Pattatucci AM, 1998, HUM BIOL, V70, P367; Pillard RC, 1998, HUM BIOL, V70, P347; PILLARD RC, 1981, ARCH SEX BEHAV, V10, P465, DOI 10.1007/BF01541437; PILLARD RC, 1982, ARCH SEX BEHAV, V11, P511, DOI 10.1007/BF01542476; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Rice G, 1999, SCIENCE, V284, P665, DOI 10.1126/science.284.5414.665; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Savolainen V, 2007, NATURE, V445, P158, DOI 10.1038/445158b; TRIVERS RL, 1974, AM ZOOL, V14, P249; Trivers RL., 1972, SEXUAL SELECTION DES; VANDERLAAN DP, 2007, ARCH SEX BEHAV; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; WEINRICH J, 1987, SEXUAL LANDSCAPES; Wilson E.O., 1975, P1	49	51	51	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2282	10.1371/journal.pone.0002282	http://dx.doi.org/10.1371/journal.pone.0002282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560521	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700001
J	Skov, V; Glintborg, D; Knudsen, S; Tan, Q; Jensen, T; Kruse, TA; Beck-Nielsen, H; Hojlund, K				Skov, Vibe; Glintborg, Dorte; Knudsen, Steen; Tan, Qihua; Jensen, Thomas; Kruse, Torben A.; Beck-Nielsen, Henning; Hojlund, Kurt			Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome	PLOS ONE			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ROSIGLITAZONE TREATMENT; GENE-EXPRESSION; MICROARRAY DATA; ADIPOSE-TISSUE; PPAR-GAMMA; AMP KINASE; METABOLISM; WOMEN	Insulin resistance is a common metabolic abnormality in women with PCOS and leads to an elevated risk of type 2 diabetes. Studies have shown that thiazolidinediones (TZDs) improve metabolic disturbances in PCOS patients. We hypothesized that the effect of TZDs in PCOS is, in part, mediated by changes in the transcriptional profile of muscle favoring insulin sensitivity. Using Affymetrix microarrays, we examined the effect of pioglitazone (30 mg/day for 16 weeks) on gene expression in skeletal muscle of 10 obese women with PCOS metabolically characterized by a euglycemic-hyperinsulinemic clamp. Moreover, we explored gene expression changes between these PCOS patients before treatment and 13 healthy women. Treatment with pioglitazone improved insulin-stimulated glucose metabolism and plasma adiponectin, and reduced fasting serum insulin (all P<0.05). Global pathway analysis using Gene Map Annotator and Pathway Profiler (GenMAPP 2.1) and Gene Set Enrichment Analysis (GSEA 2.0.1) revealed a significant upregulation of genes representing mitochondrial oxidative phosphorylation (OXPHOS), ribosomal proteins, mRNA processing reactome, translation factors, and proteasome degradation in PCOS after pioglitazone therapy. Quantitative real-time PCR suggested that upregulation of OXPHOS genes was mediated by an increase in PGC-1a expression (P<0.05). Pretreatment expression of genes representing OXPHOS and ribosomal proteins was down-regulated in PCOS patients compared to healthy women. These data indicate that pioglitazone therapy restores insulin sensitivity, in part, by a coordinated upregulation of genes involved in mitochondrial OXPHOS and ribosomal protein biosynthesis in muscle in PCOS. These transcriptional effects of pioglitazone may contribute to prevent the onset of type 2 diabetes in these women.	[Skov, Vibe; Tan, Qihua; Kruse, Torben A.] Univ So Denmark, Dept Biochem Genet & Pharmacol, Odense Univ Hosp, Odense, Denmark; [Glintborg, Dorte; Beck-Nielsen, Henning; Hojlund, Kurt] Odense Univ Hosp, Diabetes Res Ctr, Dept Endocrinol, Odense, Denmark; [Knudsen, Steen; Jensen, Thomas] Med Prognosis Inst Aps, Horsholm, Denmark; [Tan, Qihua] Univ So Denmark, Inst Publ Hlth, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Skov, V (corresponding author), Univ So Denmark, Dept Biochem Genet & Pharmacol, Odense Univ Hosp, Odense, Denmark.	vibe.skov@ouh.regionsyddanmark.dk; k.hojlund@dadlnet.dk	Tan, Qihua/AAG-2582-2019; Tan, Qihua/F-1349-2015; Glintborg, Dorte/AAE-3676-2019	Tan, Qihua/0000-0003-3194-0030; Tan, Qihua/0000-0003-3194-0030; Glintborg, Dorte/0000-0002-8338-8025	Novo Nordisk Foundation; Danish Diabetes Association; Danish Medical Research Council	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from the Novo Nordisk Foundation, the Danish Diabetes Association, and the Danish Medical Research Council.	Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Barazzoni R, 2004, CURR OPIN CLIN NUTR, V7, P97, DOI 10.1097/00075197-200401000-00015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Brettenthaler N, 2004, J CLIN ENDOCR METAB, V89, P3835, DOI 10.1210/jc.2003-031737; Brunmair B, 2001, DIABETES, V50, P2309, DOI 10.2337/diabetes.50.10.2309; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Glintborg D, 2006, FERTIL STERIL, V86, P385, DOI 10.1016/j.fertnstert.2005.12.067; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jove M, 2004, J LIPID RES, V45, P113, DOI 10.1194/jlr.M300208-JLR200; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lessard SJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE251, DOI 10.1152/ajpendo.00096.2005; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Miyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pagel-Langenickel I, 2007, AM J PHYSIOL-HEART C, V293, pH2659, DOI 10.1152/ajpheart.00782.2007; Pasquali R, 2006, EUR J ENDOCRINOL, V154, P763, DOI 10.1530/eje.1.02156; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275; Sreenivasulu K., 2002, Gene Expression Patterns, V2, P51, DOI 10.1016/S0925-4773(02)00357-X; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	51	64	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2466	10.1371/journal.pone.0002466	http://dx.doi.org/10.1371/journal.pone.0002466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560589	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700047
J	Agudelo-Romero, P; Carbonell, P; Perez-Amador, MA; Elena, SF				Agudelo-Romero, Patricia; Carbonell, Pablo; Perez-Amador, Miguel A.; Elena, Santiago F.			Virus Adaptation by Manipulation of Host's Gene Expression	PLOS ONE			English	Article							LONG-DISTANCE MOVEMENT; TURNIP-MOSAIC-VIRUS; ARABIDOPSIS RTM1; INFECTION; MICROARRAY; EVOLUTION; RADIATION; COMMUNITY; PROTEINS; BACTERIA	Viruses adapt to their hosts by evading defense mechanisms and taking over cellular metabolism for their own benefit. Alterations in cell metabolism as well as side-effects of antiviral responses contribute to symptoms development and virulence. Sometimes, a virus may spill over from its usual host species into a novel one, where usually will fail to successfully infect and further transmit to new host. However, in some cases, the virus transmits and persists after fixing beneficial mutations that allow for a better exploitation of the new host. This situation would represent a case for a new emerging virus. Here we report results from an evolution experiment in which a plant virus was allowed to infect and evolve on a naive host. After 17 serial passages, the viral genome has accumulated only five changes, three of which were non-synonymous. An amino acid substitution in the viral VPg protein was responsible for the appearance of symptoms, whereas one substitution in the viral P3 protein the epistatically contributed to exacerbate severity. DNA microarray analyses show that the evolved and ancestral viruses affect the global patterns of host gene expression in radically different ways. A major difference is that genes involved in stress and pathogen response are not activated upon infection with the evolved virus, suggesting that selection has favored viral strategies to escape from host defenses.	[Agudelo-Romero, Patricia; Carbonell, Pablo; Perez-Amador, Miguel A.; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Elena, SF (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain.	sfelena@ibmcp.upv.es	Agudelo-Romero, Patricia/K-4625-2015; Elena, Santiago F./A-4191-2011; Carbonell-Bejerano, Pablo/AAX-3509-2021; Perez-Amador, Miguel A./J-7123-2012; Carbonell-Bejerano, Pablo/L-6699-2017	Agudelo-Romero, Patricia/0000-0002-3703-4111; Elena, Santiago F./0000-0001-8249-5593; Carbonell-Bejerano, Pablo/0000-0002-7266-9665; Perez-Amador, Miguel A./0000-0003-4518-3544; Carbonell-Bejerano, Pablo/0000-0002-7266-9665	Spanish MEC-FEDER [BFU2006-14819-C02-01/BMC]; Generalitat Valenciana [ACOMP07/263]; EMBO Young Investigator Program; Spanish Ministerio de Educacion y Ciencia [fellowships]	Spanish MEC-FEDER(Spanish GovernmentEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants BFU2006-14819-C02-01/BMC (Spanish MEC-FEDER), ACOMP07/263 (Generalitat Valenciana), and the EMBO Young Investigator Program to SFE. PAR and PC received fellowships from the Spanish Ministerio de Educacion y Ciencia.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; Al-Shahrour F, 2005, BIOINFORMATICS, V21, P2988, DOI 10.1093/bioinformatics/bti457; [Anonymous], 1994, POTYVIRIDAE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bosinger SE, 2004, J IMMUNOL, V173, P6858, DOI 10.4049/jimmunol.173.11.6858; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Bueso E, 2007, PLANT J, V52, P1052, DOI 10.1111/j.1365-313X.2007.03305.x; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Carrasco P, 2007, J VIROL METHODS, V139, P181, DOI 10.1016/j.jviromet.2006.09.020; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chisholm ST, 2000, P NATL ACAD SCI USA, V97, P489, DOI 10.1073/pnas.97.1.489; Chisholm ST, 2001, PLANT PHYSIOL, V127, P1667, DOI 10.1104/pp.010479; Choi IR, 2005, J GEN VIROL, V86, P2605, DOI 10.1099/vir.0.81081-0; DOLJA VV, 1992, P NATL ACAD SCI USA, V89, P10208, DOI 10.1073/pnas.89.21.10208; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Grinde B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-24; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Ishihara T, 2004, PLANT CELL PHYSIOL, V45, P470, DOI 10.1093/pcp/pch057; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KLECZKOWSKI A, 1950, J GEN MICROBIOL, V4, P53, DOI 10.1099/00221287-4-1-53; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Martinez I, 2007, J GEN VIROL, V88, P570, DOI 10.1099/vir.0.82187-0; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; ONATESANCHEZ L, 2007, PLANT PHYSIOL, V128, P1313; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Sambrook J., 2001, MOL CLONING LAB MANU; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; Tilman D., 1982, Monographs in Population Biology, pi; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	63	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2397	10.1371/journal.pone.0002397	http://dx.doi.org/10.1371/journal.pone.0002397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545680	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800035
J	Polonelli, L; Ponton, J; Elguezabal, N; Moragues, MD; Casoli, C; Pilotti, E; Ronzi, P; Dobroff, AS; Rodrigues, EG; Juliano, MA; Maffei, DL; Magliani, W; Conti, S; Travassos, LR				Polonelli, Luciano; Ponton, Jose; Elguezabal, Natalia; Dolores Moragues, Maria; Casoli, Claudio; Pilotti, Elisabetta; Ronzi, Paola; Dobroff, Andrey S.; Rodrigues, Elaine G.; Juliano, Maria A.; Maffei, Domenico Leonardo; Magliani, Walter; Conti, Stefania; Travassos, Luiz R.			Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODIES; MONOCLONAL-ANTIBODY; THERAPEUTIC ACTIVITY; SYNTHETIC PEPTIDE; CANDIDA-ALBICANS; IN-VITRO; ANTIIDIOTYPIC ANTIBODIES; HIV-1 REPLICATION; HEAVY-CHAIN; CELLS	Background: Complementarity-determining regions (CDRs) are immunoglobulin (Ig) hypervariable domains that determine specific antibody (Ab) binding. We have shown that synthetic CDR-related peptides and many decapeptides spanning the variable region of a recombinant yeast killer toxin-like antiidiotypic Ab are candidacidal in vitro. An alanine-substituted decapeptide from the variable region of this Ab displayed increased cytotoxicity in vitro and/or therapeutic effects in vivo against various bacteria, fungi, protozoa and viruses. The possibility that isolated CDRs, represented by short synthetic peptides, may display antimicrobial, antiviral and antitumor activities irrespective of Ab specificity for a given antigen is addressed here. Methodology/Principal Findings: CDR-based synthetic peptides of murine and human monoclonal Abs directed to: a) a protein epitope of Candida albicans cell wall stress mannoprotein; b) a synthetic peptide containing well-characterized B-cell and T-cell epitopes; c) a carbohydrate blood group A substance, showed differential inhibitory activities in vitro, ex vivo and/or in vivo against C. albicans, HIV-1 and B16F10-Nex2 melanoma cells, conceivably involving different mechanisms of action. Antitumor activities involved peptide-induced caspase-dependent apoptosis. Engineered peptides, obtained by alanine substitution of Ig CDR sequences, and used as surrogates of natural point mutations, showed further differential increased/unaltered/decreased antimicrobial, antiviral and/or antitumor activities. The inhibitory effects observed were largely independent of the specificity of the native Ab and involved chiefly germline encoded CDR1 and CDR2 of light and heavy chains. Conclusions/Significance: The high frequency of bioactive peptides based on CDRs suggests that Ig molecules are sources of an unlimited number of sequences potentially active against infectious agents and tumor cells. The easy production and low cost of small sized synthetic peptides representing Ig CDRs and the possibility of peptide engineering and chemical optimization associated to new delivery mechanisms are expected to give rise to a new generation of therapeutic agents.	[Polonelli, Luciano; Maffei, Domenico Leonardo; Magliani, Walter; Conti, Stefania] Univ Parma, Sez Microbiol, Dipartimento Patol, I-43100 Parma, Italy; [Ponton, Jose; Elguezabal, Natalia] Univ Basque Country, Fac Med Odontol, Dept Inmunol, Microbiol Parasitol, Bilbao, Spain; [Dolores Moragues, Maria] Univ Basque Country, Dept Enfermeria I, Bilbao, Spain; [Casoli, Claudio; Ronzi, Paola] Univ Milan, Dipartimento Sci Cliniche L Sacco, Sez Malattie Infettive Immunopatol, Milan, Italy; [Pilotti, Elisabetta] Univ Studi Parma, Dipartimento Clin Med, Nefrol Sci Prev, Parma, Italy; [Dobroff, Andrey S.; Rodrigues, Elaine G.; Travassos, Luiz R.] Univ Fed Sao Paulo, Departamento Microbiol, Imunol Parasitol, Unidade Oncol Expt, Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil	University of Parma; University of Basque Country; University of Basque Country; University of Milan; University of Parma; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Polonelli, L (corresponding author), Univ Parma, Sez Microbiol, Dipartimento Patol, I-43100 Parma, Italy.	luiztravassos@gmail.com	Rodrigues, Elaine Guadelupe/ABB-6632-2021; Elguezabal, Natalia/ABF-8199-2021; Conti, Stefania/N-3558-2015; Rodrigues, Elaine G/H-3688-2014; Moragues, Maria D/F-5264-2010; Dobroff, Andrey/A-9814-2016; Travassos, Luiz R/J-3631-2012; Travassos, Luiz/V-2467-2019	Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; Conti, Stefania/0000-0001-9973-8352; Moragues, Maria D/0000-0002-7272-8610; Dobroff, Andrey/0000-0003-2162-9951; Elguezabal, Natalia/0000-0002-8765-5477	Department of Education, Universities and Research, Basque Goverment [IT-264-07]; FAPESP, Sao Paulo, Brazil [06/50634-2]; Istituto Superiore di Sanita, National Research Project on A.I.D.S. [50G.30, 40D.14]; Cariparma Banking Foundation [2004.0190]; Brazilian National Research Council [research fellowship]	Department of Education, Universities and Research, Basque Goverment; FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Istituto Superiore di Sanita, National Research Project on A.I.D.S.; Cariparma Banking Foundation; Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Department of Education, Universities and Research, Basque Goverment (grant IT-264-07), FAPESP 06/50634-2 grant, Sao Paulo, Brazil; Istituto Superiore di Sanita, National Research Project on A.I.D.S. (grants 50G.30 and 40D.14, ELVIS Italian Network on LTNP), and the Cariparma Banking Foundation (grant 2004.0190). Funding agencies had no role in the design and development of the research work. LRT and EGR are recipients of a research fellowship from the Brazilian National Research Council (CNPq).	Barcellini W, 2000, J LEUKOCYTE BIOL, V68, P693; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; Bourgeois C, 1998, J VIROL, V72, P807, DOI 10.1128/JVI.72.1.807-810.1998; Brena S, 2007, INFECT IMMUN, V75, P3680, DOI 10.1128/IAI.01840-06; Casoli C, 2000, BLOOD, V95, P2760, DOI 10.1182/blood.V95.9.2760.009k04_2760_2769; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; Cenci E, 2002, INFECT IMMUN, V70, P2375, DOI 10.1128/IAI.70.5.2375-2382.2002; Conti S, 1998, J INFECT DIS, V177, P807, DOI 10.1086/517815; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; de Soultrait VR, 2003, CURR MED CHEM, V10, P1765; Dorfman T, 2006, J BIOL CHEM, V281, P28529, DOI 10.1074/jbc.M602732200; Eisenhardt SU, 2007, BLOOD, V109, P3521, DOI 10.1182/blood-2006-03-007179; Feng Y, 1998, J BIOL CHEM, V273, P5625, DOI 10.1074/jbc.273.10.5625; Fiori PL, 2006, J ANTIMICROB CHEMOTH, V57, P891, DOI 10.1093/jac/dkl051; GRANT S, 1992, CANCER RES, V52, P6270; Huther A, 2007, AIDS REV, V9, P208; Jackson NAC, 1999, J GEN VIROL, V80, P225, DOI 10.1099/0022-1317-80-1-225; Kabat E. A., 1991, NIH PUBLICATION; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Magliani W, 1997, NAT BIOTECHNOL, V15, P155, DOI 10.1038/nbt0297-155; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; NICKERSON KG, 1995, J BIOL CHEM, V270, P12457, DOI 10.1074/jbc.270.21.12457; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Omaetxebarria MJ, 2005, CURR MOL MED, V5, P393, DOI 10.2174/1566524054022521; PADLAN EA, 1995, FASEB J, V9, P133, DOI 10.1096/fasebj.9.1.7821752; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; POLONELLI L, 1993, SCAND J IMMUNOL, V37, P105, DOI 10.1111/j.1365-3083.1993.tb01671.x; Polonelli L, 1996, J IMMUNOL, V156, P1880; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Sagot MA, 2000, MOL IMMUNOL, V37, P423, DOI 10.1016/S0161-5890(00)00060-2; Sambrook J.E.F., 1989, MOL CLONING LAB MANU, P1659; Sevilla MJ, 2006, INFECT IMMUN, V74, P3042, DOI 10.1128/IAI.74.5.3042-3045.2006; Sforca ML, 2005, BIOCHEMISTRY-US, V44, P6440, DOI 10.1021/bi0475323; Travassos LR, 2004, J ANTIMICROB CHEMOTH, V54, P956, DOI 10.1093/jac/dkh430; Tuteja R, 1999, IMMUNOLOGY, V97, P1, DOI 10.1046/j.1365-2567.1999.00743.x; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; WILLIAMS WV, 1991, J BIOL CHEM, V266, P5182; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	45	58	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2371	10.1371/journal.pone.0002371	http://dx.doi.org/10.1371/journal.pone.0002371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545659	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800013
J	Rokia-Mille, SB; Tinette, S; Engler, G; Arthaud, L; Tares, S; Robichon, A				Rokia-Mille, Selim Ben; Tinette, Sylvette; Engler, Gilbert; Arthaud, Laury; Tares, Sophie; Robichon, Alain			Continued Neurogenesis in Adult Drosophila as a Mechanism for Recruiting Environmental Cue-Dependent Variants	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; BEHAVIOR POLYMORPHISM; SIZE VARIATION; BODY-SIZE; MELANOGASTER; PROLIFERATION; GENE; TIME; EXPRESSION; RECEPTORS	Background: The skills used by winged insects to explore their environment are strongly dependent upon the integration of neurosensory information comprising visual, acoustic and olfactory signals. The neuronal architecture of the wing contains a vast array of different sensors which might convey information to the brain in order to guide the trajectories during flight. In Drosophila, the wing sensory cells are either chemoreceptors or mechanoreceptors and some of these sensors have as yet unknown functions. The axons of these two functionally distinct types of neurons are entangled, generating a single nerve. This simple and accessible coincidental signaling circuitry in Drosophila constitutes an excellent model system to investigate the developmental variability in relation to natural behavioral polymorphisms. Methodology/Principal Findings: A fluorescent marker was generated in neurons at all stages of the Drosophila life cycle using a highly efficient and controlled genetic recombination system that can be induced in dividing precursor cells (MARCM system, flybase web site). It allows fluorescent signals in axons only when the neuroblasts and/or neuronal cell precursors like SOP (sensory organ precursors) undergo division during the precedent steps. We first show that a robust neurogenesis continues in the wing after the adults emerge from the pupae followed by an extensive axonal growth. Arguments are presented to suggest that this wing neurogenesis in the newborn adult flies was influenced by genetic determinants such as the frequency dependent for gene and by environmental cues such as population density. Conclusions: We demonstrate that the neuronal architecture in the adult Drosophila wing is unfinished when the flies emerge from their pupae. This unexpected developmental step might be crucial for generating non-heritable variants and phenotypic plasticity. This might therefore constitute an advantage in an unstable ecological system and explain much regarding the ability of Drosophila to robustly adapt to their environment.	[Rokia-Mille, Selim Ben; Tinette, Sylvette; Engler, Gilbert; Arthaud, Laury; Tares, Sophie; Robichon, Alain] Univ Nice Sophia Antipolis, CNRS, INRA, Dept Biol & Biot Interact, Sophia Antipolis, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Rokia-Mille, SB (corresponding author), Univ Nice Sophia Antipolis, CNRS, INRA, Dept Biol & Biot Interact, Sophia Antipolis, France.	robichon@antibes.inra.fr	TARES, Sophie/AAV-1494-2020	TARES, Sophie/0000-0002-1311-1207; robichon, alain/0000-0003-1075-9646	CNRS (Centre National de Recherche Scientifique); INRA; ANR [2700009]	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INRA; ANR(French National Research Agency (ANR))	This work was supported by CNRS (Centre National de Recherche Scientifique) and a grant from INRA (department of sante des plantes et environnement)and ANR grant 2700009.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; BRADLEY BP, 1980, GENETICS, V95, P1033; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Cayre M, 2005, EUR J NEUROSCI, V21, P2893, DOI 10.1111/j.1460-9568.2005.04153.x; Cayre M, 2007, CHEM SENSES, V32, P385, DOI 10.1093/chemse/bjm010; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Debat V, 2003, EVOLUTION, V57, P2773, DOI 10.1111/j.0014-3820.2003.tb01519.x; DEBELLE JS, 1989, GENETICS, V123, P157; DeMoed GH, 1997, GENET RES, V70, P35, DOI 10.1017/S0016672397002930; DICKINSON MH, 1987, J NEUROSCI, V7, P4201; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fowler K, 2002, P ROY SOC B-BIOL SCI, V269, P677, DOI 10.1098/rspb.2001.1931; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Galindo K, 2001, GENETICS, V159, P1059; GEBHARDT MD, 1992, GENET RES, V60, P87, DOI 10.1017/S0016672300030780; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Karan D, 2000, EVOLUTION, V54, P1035, DOI 10.1111/j.0014-3820.2000.tb00103.x; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leopold P, 2004, CELL, V119, P4, DOI 10.1016/j.cell.2004.09.024; Malaterre J, 2003, J NEUROBIOL, V56, P387, DOI 10.1002/neu.10244; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; MURRAY MA, 1984, DEV BIOL, V104, P259, DOI 10.1016/0012-1606(84)90082-4; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PALKA J, 1986, J NEUROSCI, V6, P1822; PALKA J, 1993, J NEUROBIOL, V24, P788, DOI 10.1002/neu.480240607; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Scotto-Lomassese S, 2002, CURR BIOL, V12, P1001, DOI 10.1016/S0960-9822(02)00889-8; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Sherman A, 2004, J EXP BIOL, V207, P133, DOI 10.1242/jeb.00731; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Tinette S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-65; Wajnberg E, 1998, J INSECT PHYSIOL, V44, P437, DOI 10.1016/S0022-1910(98)00032-8; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zwaan BJ, 2000, HEREDITY, V84, P338, DOI 10.1046/j.1365-2540.2000.00677.x	56	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2395	10.1371/journal.pone.0002395	http://dx.doi.org/10.1371/journal.pone.0002395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545694	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800033
J	Massaro, M; Starling-Windhof, A; Briskie, JV; Martin, TE				Massaro, Melanie; Starling-Windhof, Amanda; Briskie, James V.; Martin, Thomas E.			Introduced Mammalian Predators Induce Behavioural Changes in Parental Care in an Endemic New Zealand Bird	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; POOR KNIGHTS ISLANDS; NEST PREDATION; CONTEMPORARY EVOLUTION; CONSERVATION BIOLOGY; AVIAN EXTINCTION; OCEANIC ISLANDS; CLUTCH SIZE; INCUBATION; TEMPERATURE	The introduction of predatory mammals to oceanic islands has led to the extinction of many endemic birds. Although introduced predators should favour changes that reduce predation risk in surviving bird species, the ability of island birds to respond to such novel changes remains unstudied. We tested whether novel predation risk imposed by introduced mammalian predators has altered the parental behaviour of the endemic New Zealand bellbird (Anthornis melanura). We examined parental behaviour of bellbirds at three woodland sites in New Zealand that differed in predation risk: 1) a mainland site with exotic predators present (high predation risk), 2) a mainland site with exotic predators experimentally removed (low risk recently) and, 3) an off-shore island where exotic predators were never introduced (low risk always). We also compared parental behaviour of bellbirds with two closely related Tasmanian honeyeaters (Phylidonyris spp.) that evolved with native nest predators (high risk always). Increased nest predation risk has been postulated to favour reduced parental activity, and we tested whether island bellbirds responded to variation in predation risk. We found that females spent more time on the nest per incubating bout with increased risk of predation, a strategy that minimised activity at the nest during incubation. Parental activity during the nestling period, measured as number of feeding visits/hr, also decreased with increasing nest predation risk across sites, and was lowest among the honeyeaters in Tasmania that evolved with native predators. These results demonstrate that some island birds are able to respond to increased risk of predation by novel predators in ways that appear adaptive. We suggest that conservation efforts may be more effective if they take advantage of the ability of island birds to respond to novel predators, especially when the elimination of exotic predators is not possible.	[Massaro, Melanie; Starling-Windhof, Amanda; Briskie, James V.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Martin, Thomas E.] Univ Montana, USGS Montana Cooperat Wildlife Res Unit, Missoula, MT USA	University of Canterbury; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Massaro, M (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	melanie.massaro@canterbury.ac.nz	Martin, Thomas E/F-6016-2011; Massaro, Melanie/P-4791-2017	Martin, Thomas E/0000-0002-4028-4867; , Amanda/0000-0003-2483-3886; Massaro, Melanie/0000-0001-9039-1268	Percy Sladen Fund; Brian Mason Trust; Association for the Study of Animal Behaviour; University of Canterbury [postdoctoral fellowships]; Foundation for Research, Science and Technology [UOCX0601]	Percy Sladen Fund; Brian Mason Trust; Association for the Study of Animal Behaviour; University of Canterbury; Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This research was financially supported by grants from the Percy Sladen Fund, the Brian Mason Trust, the Association for the Study of Animal Behaviour and the University of Canterbury to J. Briskie, as well as postdoctoral fellowships from the University of Canterbury and the Foundation for Research, Science and Technology (UOCX0601) to M. Massaro.	Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; BARTLE J A, 1987, Notornis, V34, P253; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Clarke RH, 2000, EMU, V100, P115, DOI 10.1071/MU9843; CLARKE RH, 1999, AUSTR J ECOLOGY, V204, P604; Conway CJ, 2000, EVOLUTION, V54, P670; de Lange PJ, 1999, NEW ZEAL J BOT, V37, P433, DOI 10.1080/0028825X.1999.9512646; DIAMOND JM, 1981, SCIENCE, V211, P499, DOI 10.1126/science.211.4481.499; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Doligez B, 2003, ECOLOGY, V84, P2582, DOI 10.1890/02-3116; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; Duncan RP, 2004, GLOBAL ECOL BIOGEOGR, V13, P509, DOI 10.1111/j.1466-822X.2004.00132.x; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Ferretti V, 2005, P ROY SOC B-BIOL SCI, V272, P769, DOI 10.1098/rspb.2004.3039; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Heather B., 2005, FIELD GUIDE BIRDS NZ; HENSLER GL, 1981, WILSON BULL, V93, P42; HIGGINS PJ, 2001, HDB AUSTR NZ ANTARTI, V5; Holdaway Richard N., 1999, P189; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; Martin TE, 2002, P ROY SOC B-BIOL SCI, V269, P309, DOI 10.1098/rspb.2001.1879; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MAYFIELD HF, 1975, WILSON BULL, V87, P456; MCFARLAND DC, 1986, EMU, V86, P161, DOI 10.1071/MU9860161; Muchai M, 2005, J AVIAN BIOL, V36, P110, DOI 10.1111/j.0908-8857.2005.03312.x; ODonnell CFJ, 1996, NEW ZEAL J ZOOL, V23, P279, DOI 10.1080/03014223.1996.9518086; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; RECHER H F, 1977, Emu, V77, P136; Roff Derek A., 1992; SAGAR PM, 1985, NEW ZEAL J ZOOL, V12, P643, DOI 10.1080/03014223.1985.10428314; SAUER JR, 1989, J WILDLIFE MANAGE, V53, P137, DOI 10.2307/3801320; Saunders A, 2001, BIOL CONSERV, V99, P109, DOI 10.1016/S0006-3207(00)00192-0; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; SMITH TB, 1995, CONSERV BIOL, V9, P107, DOI 10.1046/j.1523-1739.1995.09010107.x; STARLING A, THESIS U CANTERBURY; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Taylor SS, 2007, J EVOLUTION BIOL, V20, P2035, DOI 10.1111/j.1420-9101.2007.01362.x; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; WEATHERS WW, 1989, CONDOR, V91, P628, DOI 10.2307/1368113; WORTHY TH, 2002, LOST WORLD MOA BLOOM	55	69	70	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2331	10.1371/journal.pone.0002331	http://dx.doi.org/10.1371/journal.pone.0002331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523640	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300026
J	Nieberding, CM; de Vos, H; Schneider, MV; Lassance, JM; Estramil, N; Andersson, J; Bang, J; Hedenstrom, E; Lofstedt, C; Brakefield, PM				Nieberding, Caroline M.; de Vos, Helene; Schneider, Maria V.; Lassance, Jean-Marc; Estramil, Natalia; Andersson, Jimmy; Bang, Joakim; Hedenstroem, Erik; Loefstedt, Christer; Brakefield, Paul M.			The Male Sex Pheromone of the Butterfly Bicyclus anynana: Towards an Evolutionary Analysis	PLOS ONE			English	Article							COLIAS-PHILODICE LEPIDOPTERA; ORIENTAL FRUIT MOTHS; HELIOTHIS-VIRESCENS; EVO-DEVO; MATE CHOICE; IDENTIFICATION; EURYTHEME; GENETICS; BIOSYNTHESIS; SELECTION	Background: Female sex pheromones attracting mating partners over long distances are a major determinant of reproductive isolation and speciation in Lepidoptera. Males can also produce sex pheromones but their study, particularly in butterflies, has received little attention. A detailed comparison of sex pheromones in male butterflies with those of female moths would reveal patterns of conservation versus novelty in the associated behaviours, biosynthetic pathways, compounds, scent-releasing structures and receiving systems. Here we assess whether the African butterfly Bicyclus anynana, for which genetic, genomic, phylogenetic, ecological and ethological tools are available, represents a relevant model to contribute to such comparative studies. Methodology/Principal Findings: Using a multidisciplinary approach, we determined the chemical composition of the male sex pheromone (MSP) in the African butterfly B. anynana, and demonstrated its behavioural activity. First, we identified three compounds forming the presumptive MSP, namely (Z)-9-tetradecenol (Z9-14:OH), hexadecanal (16:Ald) and 6,10,14-trimethylpentadecan-2-ol (6,10,14-trime-15-2-ol), and produced by the male secondary sexual structures, the androconia. Second, we described the male courtship sequence and found that males with artificially reduced amounts of MSP have a reduced mating success in semi-field conditions. Finally, we could restore the mating success of these males by perfuming them with the synthetic MSP. Conclusions/Significance: This study provides one of the first integrative analyses of a MSP in butterflies. The toolkit it has developed will enable the investigation of the type of information about male quality that is conveyed by the MSP in intraspecific communication. Interestingly, the chemical structure of B. anynana MSP is similar to some sex pheromones of female moths making a direct comparison of pheromone biosynthesis between male butterflies and female moths relevant to future research. Such a comparison will in turn contribute to understanding the evolution of sex pheromone production and reception in butterflies.	[Nieberding, Caroline M.; de Vos, Helene; Schneider, Maria V.; Estramil, Natalia; Brakefield, Paul M.] Leiden Univ, Evolutionary Biol Grp, Inst Biol, Leiden, Netherlands; [Nieberding, Caroline M.] Univ Liege, Inst Botany, Zoogeographical Res Unit, Liege, Belgium; [Lassance, Jean-Marc; Loefstedt, Christer] Lund Univ, Dept Ecol, Lund, Sweden; [Andersson, Jimmy; Bang, Joakim; Hedenstroem, Erik] Mid Sweden Univ, Dept Nat Sci, Chem Lab, Sundsvall, Sweden	Leiden University; Leiden University - Excl LUMC; University of Liege; Lund University; Mid-Sweden University	Nieberding, CM (corresponding author), Leiden Univ, Evolutionary Biol Grp, Inst Biol, Leiden, Netherlands.	c.m.nieberding@biology.leidenuniv.nl	Schneider, Maria Victoria/E-6317-2010; Lassance, Jean-Marc/AAF-3933-2020; Löfstedt, Christer/G-2016-2014	Lassance, Jean-Marc/0000-0002-3675-6956; Löfstedt, Christer/0000-0002-3116-6922; Estramil, Natalia/0000-0002-7487-7062; Schneider, Maria Victoria/0000-0002-7114-2060	Marie Curie [FP6-2005-Mobility-5 nr039083]; Belgian "Fonds National de la Recherche Scientifique"; Swedish Council; Leiden University	Marie Curie(European Commission); Belgian "Fonds National de la Recherche Scientifique"(Fonds de la Recherche Scientifique - FNRS); Swedish Council(Swedish Research Council); Leiden University	Marie Curie International European Fellowship to C.N. (FP6-2005-Mobility-5 nr039083); Belgian "Fonds National de la Recherche Scientifique" to C.N (mandat Chargee de Recherches); European objective 1 the region of South Forest Countries to E.H., the Swedish Council (Lansstyrelsen i Vasternorrlands lan to E.H., VR and Formas grants to C.L.); Leiden University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; [Anonymous], 2014, PHEROMONES ANIMAL BE; BAKER TC, 1981, SCIENCE, V214, P1359, DOI 10.1126/science.214.4527.1359; Beldade P, 2008, HEREDITY, V100, P150, DOI 10.1038/sj.hdy.6800934; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Bigiani A, 2005, REV PHYSIOL BIOCH P, V154, P1, DOI 10.1007/s10254-004-0038-0; BIRCH MC, 1990, ANNU REV ENTOMOL, V35, P25, DOI 10.1146/annurev.en.35.010190.000325; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 2001, J EVOLUTION BIOL, V14, P148, DOI 10.1046/j.1420-9101.2001.00248.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brakefield PM, 2003, ANNU REV ECOL EVOL S, V34, P633, DOI 10.1146/annurev.ecolsys.34.011802.132425; BROOKS CJW, 1973, ANAL CHEM, V45, P896, DOI 10.1021/ac60328a033; BUSER HR, 1983, ANAL CHEM, V55, P818, DOI 10.1021/ac00257a003; Choi MY, 2005, ARCH INSECT BIOCHEM, V59, P53, DOI 10.1002/arch.20051; Condamin M., 1973, MONOGRAPHIE GENRE BI; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; DESS DB, 1983, J ORG CHEM, V48, P4155, DOI 10.1021/jo00170a070; DUSSOURD DE, 1991, P NATL ACAD SCI USA, V88, P9224, DOI 10.1073/pnas.88.20.9224; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; Groot AT, 2004, J CHEM ECOL, V30, P2495, DOI 10.1007/s10886-004-7946-y; GRULA JW, 1980, J CHEM ECOL, V6, P241, DOI 10.1007/BF00987543; HEATH RR, 1992, J CHEM ECOL, V18, P441, DOI 10.1007/BF00994243; Hedenstrom E, 2002, J CHEM SOC PERK T 1, P1810, DOI 10.1039/b201395a; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; Iyengar VK, 2001, BEHAV ECOL SOCIOBIOL, V49, P283, DOI 10.1007/s002650000292; JACQUIN E, 1991, J CHEM ECOL, V17, P239, DOI 10.1007/BF00994436; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; Jurenka R.A., 2003, P53, DOI 10.1016/B978-012107151-6/50005-0; Kemp DJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1017, DOI 10.1007/s00265-007-0529-5; Kimura T, 1999, APPL ENTOMOL ZOOL, V34, P147, DOI 10.1303/aez.34.147; LARSEN T, 1999, BUTTERFLIES W AFRICA; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; LINN CE, 1989, CHEM SENSES, V14, P421, DOI 10.1093/chemse/14.3.421; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; Lofstedt C., 1991, Chemoecology, V2, P20, DOI 10.1007/BF01240662; Lundh M, 1996, TETRAHEDRON-ASYMMETR, V7, P3277, DOI 10.1016/0957-4166(96)00428-4; Mori K, 2004, TOP CURR CHEM, V239, P1, DOI 10.1007/b95448; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; MYERS J, 1972, AM ZOOL, V12, P545; Nishida R, 1996, J CHEM ECOL, V22, P949, DOI 10.1007/BF02029947; NISHIDA R, 1982, J CHEM ECOL, V8, P947, DOI 10.1007/BF00987661; Phelan P. Larry, 1997, P240, DOI 10.1017/CBO9780511721946.015; PHELAN PL, 1986, J CHEM ECOL, V12, P135, DOI 10.1007/BF01045597; PLISKE TE, 1969, SCIENCE, V164, P1170, DOI 10.1126/science.164.3884.1170; Rafaeli A, 2005, ENTOMOL EXP APPL, V115, P7, DOI 10.1111/j.1570-7458.2005.00292.x; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P14599, DOI 10.1073/pnas.1233767100; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; SAPPINGTON TW, 1990, J CHEM ECOL, V16, P2755, DOI 10.1007/BF00988084; SAPPINGTON TW, 1990, P NATL ACAD SCI USA, V87, P6132, DOI 10.1073/pnas.87.16.6132; SAPPINGTON TW, 1990, J CHEM ECOL, V16, P2771, DOI 10.1007/BF00988085; Sasaerila Y, 2003, CHEMOECOLOGY, V13, P89, DOI 10.1007/s00049-003-0233-5; SCHNEIDER MV, 1998, THESIS U ROME TORVER; Sheck AL, 2006, J EVOLUTION BIOL, V19, P600, DOI 10.1111/j.1420-9101.2005.00999.x; SHIELDS O, 1976, Journal of Research on the Lepidoptera, V15, P132; Svensson GP, 2002, J CHEM ECOL, V28, P1447, DOI 10.1023/A:1016204820674; Svensson M, 1996, BIOL REV, V71, P113, DOI 10.1111/j.1469-185X.1996.tb00743.x; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; TAYLOR OR, 1973, ANN ENTOMOL SOC AM, V66, P621, DOI 10.1093/aesa/66.3.621; TEAL PEA, 1989, J CHEM ECOL, V15, P413, DOI 10.1007/BF02027801; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vane-Wright D, 2004, NATURE, V428, P477, DOI 10.1038/428477a; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Wahlberg N, 2006, SYST BIOL, V55, P703, DOI 10.1080/10635150600913235	71	104	107	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2751	10.1371/journal.pone.0002751	http://dx.doi.org/10.1371/journal.pone.0002751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648495	Green Published, gold			2022-12-27	WOS:000264302900022
J	Zhao, M; Amiel, SA; Ajami, S; Jiang, J; Rela, M; Heaton, N; Huang, GC				Zhao, Min; Amiel, Stephanie A.; Ajami, Sanaz; Jiang, Jie; Rela, Mohamed; Heaton, Nigel; Huang, Guo Cai			Amelioration of Streptozotocin-Induced Diabetes in Mice with Cells Derived from Human Marrow Stromal Cells	PLOS ONE			English	Article								Background: Pluri-potent bone marrow stromal cells (MSCs) provide an attractive opportunity to generate unlimited glucose-responsive insulin-producing cells for the treatment of diabetes. We explored the potential for human MSCs (hMSCs) to be differentiated into glucose-responsive cells through a non-viral genetic reprogramming approach. Methods and Findings: Two hMSC lines were transfected with three genes: PDX-1, NeuroD1 and Ngn3 without subsequent selection, followed by differentiation induction in vitro and transplantation into diabetic mice. Human MSCs expressed mRNAs of the archetypal stem cell markers: Sox2, Oct4, Nanog and CD34, and the endocrine cell markers: PDX-1, NeuroD1, Ngn3, and Nkx6.1. Following gene transfection and differentiation induction, hMSCs expressed insulin in vitro, but were not glucose regulated. After transplantation, hMSCs differentiated further and similar to 12.5% of the grafted cells expressed insulin. The graft bearing kidneys contained mRNA of insulin and other key genes required for the functions of beta cells. Mice transplanted with manipulated hMSCs showed reduced blood glucose levels (from 18.9+/-0.75 to 7.63+/-1.63 mM). 13 of the 16 mice became normoglycaemic (6.9+/-0.64 mM), despite the failure to detect the expression of SUR1, a K(+)-ATP channel component required for regulation of insulin secretion. Conclusions: Our data confirm that hMSCs can be induced to express insulin sufficient to reduce blood glucose in a diabetic mouse model. Our triple gene approach has created cells that seem less glucose responsive in vitro but which become more efficient after transplantation. The maturation process requires further study, particularly the in vivo factors influencing the differentiation, in order to scale up for clinical purposes.	[Zhao, Min; Amiel, Stephanie A.; Ajami, Sanaz; Huang, Guo Cai] Kings Coll London, Sch Med, Diabet Res Grp, London WC2R 2LS, England; [Jiang, Jie] Kings Coll London, Sch Med, Dept Haematol Med, London, England; [Rela, Mohamed; Heaton, Nigel] Kings Coll Hosp, Inst Liver Studies, London, England	University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Zhao, M (corresponding author), Kings Coll London, Sch Med, Diabet Res Grp, London WC2R 2LS, England.	guo.huang@kcl.ac.uk	Heaton, Nigel/AAK-8363-2020		King's College Hospital Charity Trust; Juvenile Diabetes Research Foundation International [1-2004-357]; Medical Research Council [G0600698B] Funding Source: researchfish	King's College Hospital Charity Trust; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by funding from King's College Hospital Charity Trust and partially by a research grants from Juvenile Diabetes Research Foundation International: 1-2004-357. The funding bodies and authors do not have conflict of interest with this publication.	Armanios M, 2005, COLD SH Q B, V70, P205, DOI 10.1101/sqb.2005.70.030; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Butler AE, 2007, DIABETES, V56, P1810, DOI 10.2337/db06-1385; Corti S, 2002, J NEUROSCI RES, V70, P721, DOI 10.1002/jnr.10455; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gumus-Akay G, 2007, GENET MOL RES, V6, P41; HALL PA, 1988, J PATHOL, V154, P223, DOI 10.1002/path.1711540305; HOBBS SM, 1997, ARTIFICAL DNA UNPUB; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Iwata H, 2007, FRONT BIOSCI, V12, P4157, DOI 10.2741/2377; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kobune M, 2003, EXP HEMATOL, V31, P715, DOI 10.1016/S0301-472X(03)00177-2; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; MacFarlane WM, 1999, J BIOL CHEM, V274, P34059, DOI 10.1074/jbc.274.48.34059; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Pascucci L, 2006, VET DERMATOL, V17, P244, DOI 10.1111/j.1365-3164.2006.00527.x; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rajagopal J, 2003, SCIENCE, V299, P363; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sharma A, 1999, MOL CELL BIOL, V19, P704; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Tayaramma T, 2006, STEM CELLS, V24, P2858, DOI 10.1634/stemcells.2006-0109; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Zhao M, 2005, DIABETOLOGIA, V48, P2051, DOI 10.1007/s00125-005-1888-y; Zhao M, 2002, TRANSPLANTATION, V73, P1454, DOI 10.1097/00007890-200205150-00015; Zhao M, 2007, J ENDOCRINOL, V195, P407, DOI 10.1677/JOE-07-0436; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	48	35	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2666	10.1371/journal.pone.0002666	http://dx.doi.org/10.1371/journal.pone.0002666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628974	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200012
J	Rubins, KH; Hensley, LE; Bell, GW; Wang, CL; Lefkowitz, EJ; Brown, PO; Relman, DA				Rubins, Kathleen H.; Hensley, Lisa E.; Bell, George W.; Wang, Chunlin; Lefkowitz, Elliot J.; Brown, Patrick O.; Relman, David A.			Comparative Analysis of Viral Gene Expression Programs during Poxvirus Infection: A Transcriptional Map of the Vaccinia and Monkeypox Genomes	PLOS ONE			English	Article								Background: Poxviruses engage in a complex and intricate dialogue with host cells as part of their strategy for replication. However, relatively little molecular detail is available with which to understand the mechanisms behind this dialogue. Methodology/Principal Findings: We designed a specialized microarray that contains probes specific to all predicted ORFs in the Monkeypox Zaire (MPXV) and Vaccinia Western Reserve (VACV) genomes, as well as >18,000 human genes, and used this tool to characterize MPXV and VACV gene expression responses in vitro during the course of primary infection of human monocytes, primary human fibroblasts and HeLa cells. The two viral transcriptomes show distinct features of temporal regulation and species-specific gene expression, and provide an early foundation for understanding global gene expression responses during poxvirus infection. Conclusions/Significance: The results provide a temporal map of the transcriptome of each virus during infection, enabling us to compare viral gene expression across species, and classify expression patterns of previously uncharacterized ORFs.	[Rubins, Kathleen H.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA; [Rubins, Kathleen H.; Brown, Patrick O.] Stanford Univ, Sch Med, Biochem, Stanford, CA USA; [Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA USA; [Hensley, Lisa E.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Bell, George W.] Whitehead Inst Biomed Res, Cambridge, MA USA; [Wang, Chunlin; Lefkowitz, Elliot J.; Relman, David A.] Univ Alabama Birmingham, Birmingham, AL USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Stanford Univ, Sch Med, Dept Med, Palo Alto, CA USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Alabama System; University of Alabama Birmingham; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rubins, KH (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA.	rubins@wi.mit.edu	Pacific-Southwest, RCE/B-6155-2009	Relman, David A./0000-0001-8331-1354; Lefkowitz, Elliot/0000-0002-4748-4925; Hensley, Lisa/0000-0003-1188-4342	NIH [AI54922, AI065359]; DARPA [N65236-99-1-5428]; Horn Foundation; Howard Hughes Medical Institute [Investigator]; NIH/NIAID Viral Bioinformatics Resource Center [HHSN266200400036C]; National Biodefense Analysis and Countermeasures Center/Department of Homeland security [HSHQDC-05-X-00301, HSHQDC-05-X-00035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054922, U54AI065359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Horn Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIAID Viral Bioinformatics Resource Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Biodefense Analysis and Countermeasures Center/Department of Homeland security(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation was supported by NIH Grant AI54922 (D.A.R. and P.O.B.), AI065359 (K.H.R and D.A.R.), DARPA Grant N65236-99-1-5428 (D.A.R.), and a gift from the Horn Foundation (D.A.R. and P.O.B.), as well as the Howard Hughes Medical Institute (P.O.B.). P.O.B. is an Investigator of the Howard Hughes Medical Institute. E.J.L. was supported by the NIH/NIAID Viral Bioinformatics Resource Center, Contract No. HHSN266200400036C. Work at USAMRIID was funded by National Biodefense Analysis and Countermeasures Center/Department of Homeland security contracts #HSHQDC-05-X-00301 and HSHQDC-05-X-00035. None of the funding agencies were involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript. The US Army Medical Research Institute and the National Biodefense Analysis and Countermeasures Center reviewed and approved the manuscript. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army.	Aguilar J S, 2005, Methods Mol Biol, V292, P423; Aguilar JS, 2006, VIROLOGY, V348, P233, DOI 10.1016/j.virol.2005.12.036; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; BALDICK CJ, 1993, J VIROL, V67, P3515, DOI 10.1128/JVI.67.6.3515-3527.1993; BALDICK CJ, 1992, J VIROL, V66, P4710, DOI 10.1128/JVI.66.8.4710-4719.1992; BOONE RF, 1978, J VIROL, V26, P554, DOI 10.1128/JVI.26.3.554-569.1978; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; CUMMINGS CA, MADBUG AUTOMATED MIC; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; DAVISON AJ, 1989, J MOL BIOL, V210, P771, DOI 10.1016/0022-2836(89)90108-3; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Ehlers A, 2002, BIOINFORMATICS, V18, P1544, DOI 10.1093/bioinformatics/18.11.1544; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; ESPOSITO JJ, SEQUENCING CODING RE; Heidari M, 2008, VIRUS GENES, V36, P383, DOI 10.1007/s11262-008-0203-7; Herrero J, 2002, J PROTEOME RES, V1, P467, DOI 10.1021/pr025521v; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Jahrling PB, 1996, ARCH VIROL, P135; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; MOSS B, 2001, VIROLOGY, P2849; Mukinda VBK, 1997, LANCET, V349, P1449, DOI 10.1016/S0140-6736(05)63725-7; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; ODA KI, 1967, J MOL BIOL, V27, P395, DOI 10.1016/0022-2836(67)90047-2; PAOLETTI E, 1977, J VIROL, V23, P608, DOI 10.1128/JVI.23.3.608-615.1977; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Shchelkunov SN, 2002, VIROLOGY, V297, P172, DOI 10.1006/viro.2002.1446; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; SMITH GL, 1991, J GEN VIROL, V72, P1349, DOI 10.1099/0022-1317-72-6-1349; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; 1997, MMWR MORB MORTAL WKL, V46, P304; VIRAL ORTHOLOGOUS CL; 1996, MMWR MORB MORTAL WKL, V46, P1168; VACCINIA WR SEQUENCE	41	37	39	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2628	10.1371/journal.pone.0002628	http://dx.doi.org/10.1371/journal.pone.0002628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612436	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800030
J	Schwab, U; Seppanen-Laakso, T; Yetukuri, L; Agren, J; Kolehmainen, M; Laaksonen, DE; Ruskeepaa, AL; Gylling, H; Uusitupa, M; Oresic, M				Schwab, Ursula; Seppanen-Laakso, Tuulikki; Yetukuri, Laxman; Agren, Jyrki; Kolehmainen, Marjukka; Laaksonen, David E.; Ruskeepaa, Anna-Liisa; Gylling, Helena; Uusitupa, Matti; Oresic, Matej		GENOBIN Study Grp	Triacylglycerol Fatty Acid Composition in Diet-Induced Weight Loss in Subjects with Abnormal Glucose Metabolism - the GENOBIN Study	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INSULIN SENSITIVITY; MASS-SPECTROMETRY; SERUM-LIPIDS; MULTIPLE PRECURSOR; PLASMA; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; CHOLESTEROL; ADIPOSE	Background: The effect of weight loss on different plasma lipid subclasses at the molecular level is unknown. The aim of this study was to examine whether a diet-induced weight reduction result in changes in the extended plasma lipid profiles (lipidome) in subjects with features of metabolic syndrome in a 33-week intervention. Methodology/Principal Findings: Plasma samples of 9 subjects in the weight reduction group and 10 subjects in the control group were analyzed using mass spectrometry based lipidomic and fatty acid analyses. Body weight decreased in the weight reduction group by 7.8 +/- 2.9% (p<0.01). Most of the serum triacylglycerols and phosphatidylcholines were reduced. The decrease in triacylglycerols affected predominantly the saturated short chain fatty acids. This decrease of saturated short chain fatty acid containing triacylglycerols correlated with the increase of insulin sensitivity. However, levels of several longer chain fatty acids, including arachidonic and docosahexanoic acid, were not affected by weight loss. Levels of other lipids known to be associated with obesity such as sphingolipids and lysophosphatidylcholines were not altered by weight reduction. Conclusions/Significance: Diet-induced weight loss caused significant changes in global lipid profiles in subjects with abnormal glucose metabolism. The observed changes may affect insulin sensitivity and glucose metabolism in these subjects.	[Schwab, Ursula; Kolehmainen, Marjukka; Gylling, Helena; Uusitupa, Matti] Univ Kuopio, Dept Clin Nutr & Food, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland; [Schwab, Ursula; Gylling, Helena] Kuopio Univ Hosp, Kuopio, Finland; [Seppanen-Laakso, Tuulikki; Yetukuri, Laxman; Ruskeepaa, Anna-Liisa; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Agren, Jyrki; Laaksonen, David E.] Univ Kuopio, Dept Physiol, Kuopio, Finland; [Laaksonen, David E.] Kuopio Univ Hosp, Dept Med, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; VTT Technical Research Center Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Schwab, U (corresponding author), Univ Kuopio, Dept Clin Nutr & Food, Sch Publ Hlth & Clin Nutr, FIN-70211 Kuopio, Finland.	ursula.schwab@uku.fi; matej.oresic@vtt.fi	Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Oresic, Matej/0000-0002-2856-9165; 	Sigrid Juselius foundation, the Academy of Finland [209445, 211497]; EVO [5179, 5198]	Sigrid Juselius foundation, the Academy of Finland(Academy of FinlandSigrid Juselius Foundation); EVO	The study was financially supported by grants from Sigrid Juselius foundation, the Academy of Finland (no. 209445, no. 211497), and EVO funding (no. 5179, no. 5198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren JJ, 2006, CLIN CHIM ACTA, V366, P309, DOI 10.1016/j.cca.2005.11.006; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; KOLEHMAINEN M, 2007, INT J OBESITY, DOI DOI 10.1038/SJ.IJ0.0803718; Krauss RM, 2000, CIRCULATION, V102, P2284; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; LAITINEN JH, 1993, J AM DIET ASSOC, V93, P276, DOI 10.1016/0002-8223(93)91552-2; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MATSUDA Y, 1993, CIRC RES, V72, P1103, DOI 10.1161/01.RES.72.5.1103; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Medina-Gomez G, 2005, DIABETES, V54, P1706, DOI 10.2337/diabetes.54.6.1706; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mehta D, 2005, AM J PHYSIOL-LUNG C, V289, pL174, DOI 10.1152/ajplung.00165.2005; Metz JA, 2000, ARCH INTERN MED, V160, P2150, DOI 10.1001/archinte.160.14.2150; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Murugesan G, 1996, J CLIN INVEST, V97, P2736, DOI 10.1172/JCI118728; Nelson J, 2006, AM J EPIDEMIOL, V163, P903, DOI 10.1093/aje/kwj140; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; RABINI RA, 1994, DIABETES, V43, P915, DOI 10.2337/diabetes.43.7.915; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sarkkinen E, 1996, EUR J CLIN NUTR, V50, P592; SCHMIDT K, 1992, BIOCHEM BIOPH RES CO, V182, P302, DOI 10.1016/S0006-291X(05)80145-7; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Seppanen-Laakso T, 2002, ANAL CHIM ACTA, V465, P39, DOI 10.1016/S0003-2670(02)00397-5; SHALINA S, 2000, GLIA, V30, P92; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storlien LH, 1996, DIABETOLOGIA, V39, P621, DOI 10.1007/BF00418533; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Sweeney G, 1996, CLIN INVEST MED, V19, P243; Tremblay AJ, 2004, METABOLISM, V53, P310, DOI 10.1016/j.metabol.2003.10.011; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Willett W., 2012, NUTR EPIDEMIOLOGY; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632	52	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2630	10.1371/journal.pone.0002630	http://dx.doi.org/10.1371/journal.pone.0002630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612464	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800032
J	Bunnell, TM; Jaeger, MA; Fitzsimons, DP; Prins, KW; Ervasti, JM				Bunnell, Tina M.; Jaeger, Michele A.; Fitzsimons, Daniel P.; Prins, Kurt W.; Ervasti, James M.			Destabilization of the Dystrophin-Glycoprotein Complex without Functional Deficits in alpha-Dystrobrevin Null Muscle	PLOS ONE			English	Article								alpha-Dystrobrevin is a component of the dystrophin-glycoprotein complex (DGC) and is thought to have both structural and signaling roles in skeletal muscle. Mice deficient for alpha-dystrobrevin (adbn(-/-)) exhibit extensive myofiber degeneration and neuromuscular junction abnormalities. However, the biochemical stability of the DGC and the functional performance of adbn(-/-) muscle have not been characterized. Here we show that the biochemical association between dystrophin and beta-dystroglycan is compromised in adbn(-/-) skeletal muscle, suggesting that alpha-dystrobrevin plays a structural role in stabilizing the DGC. However, despite muscle cell death and DGC destabilization, costamere organization and physiological performance is normal in adbn(-/-) skeletal muscle. Our results demonstrate that myofiber degeneration alone does not cause functional deficits and suggests that more complex pathological factors contribute to the development of muscle weakness in muscular dystrophy.	[Bunnell, Tina M.; Prins, Kurt W.; Ervasti, James M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Jaeger, Michele A.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Fitzsimons, Daniel P.] Univ Wisconsin, Dept Physiol, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bunnell, TM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	jervasti@umn.edu	Ervasti, James/AAZ-4786-2020	Prins, Kurt/0000-0002-0364-6742	AHA [predoctoral fellowship]; NIH [AR049899, AR042423]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042423, R01AR049899] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by an AHA predoctoral fellowship to M.A.J and NIH grants AR049899 and AR042423 to J.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; CARLSON CG, 1990, MUSCLE NERVE, V13, P480, DOI 10.1002/mus.880130603; Chao DS, 1998, J NEUROCHEM, V71, P784; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; DWYER TM, 1995, FEBS LETT, V375, P91, DOI 10.1016/0014-5793(95)01176-F; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; GORDON T, 1988, MUSCLE NERVE, V11, P819, DOI 10.1002/mus.880110804; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hack AA, 2000, J CELL SCI, V113, P2535; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; MARTINEZ P, 2007, MOL BIOL CELL, V18, P2904; MCCULLAGH KJ, 2007, NEUROMUSCUL DISORD; Mizuno Y, 2001, P NATL ACAD SCI USA, V98, P6156, DOI 10.1073/pnas.111153298; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; O'Neill A, 2002, MOL BIOL CELL, V13, P2347, DOI 10.1091/mbc.01-12-0576; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Poon E, 2002, J BIOL CHEM, V277, P3433, DOI 10.1074/jbc.M105273200; Reed P, 2005, NEUROMUSCULAR DISORD, V15, P552, DOI 10.1016/j.nmd.2005.03.007; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; Sasaoka T, 2003, NEUROMUSCULAR DISORD, V13, P193, DOI 10.1016/S0960-8966(02)00220-1; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Warner LE, 2002, HUM MOL GENET, V11, P1095, DOI 10.1093/hmg/11.9.1095; Williams MW, 1999, J CELL BIOL, V144, P1259, DOI 10.1083/jcb.144.6.1259; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033	44	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2604	10.1371/journal.pone.0002604	http://dx.doi.org/10.1371/journal.pone.0002604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596960	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200057
J	Roh, M; Franco, OE; Hayward, SW; van der Meer, R; Abdulkadir, SA				Roh, Meejeon; Franco, Omar E.; Hayward, Simon W.; van der Meer, Riet; Abdulkadir, Sarki A.			A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial Cells	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; ANEUPLOIDY; PIM-1; EXPRESSION; CANCER; P53; OVEREXPRESSION; SUPPRESSION; PROGRESSION; PROTEIN	Background: Polyploidy is a prominent feature of many human cancers, and it has long been hypothesized that polyploidy may contribute to tumorigenesis by promoting genomic instability. In this study, we investigated whether polyploidy per se induced by a relevant oncogene can promote genomic instability and tumorigenicity in human epithelial cells. Principal Findings: When the oncogenic serine-threonine kinase Pim-1 is overexpressed in immortalized, non-tumorigenic human prostate and mammary epithelial cells, these cells gradually converted to polyploidy and became tumorigenic. To assess the contribution of polyploidy to tumorigenicity, we obtained sorted, matched populations of diploid and polyploid cells expressing equivalent levels of the Pim-1 protein. Spectral karyotyping revealed evidence of emerging numerical and structural chromosomal abnormalities in polyploid cells, supporting the proposition that polyploidy promotes chromosomal instability. Polyploid cells displayed an intact p53/p21 pathway, indicating that the viability of polyploid cells in this system is not dependent on the inactivation of the p53 signaling pathway. Remarkably, only the sorted polyploid cells were tumorigenic in vitro and in vivo. Conclusions: Our results support the notion that polyploidy can promote chromosomal instability and the initiation of tumorigenesis in human epithelial cells.	[Roh, Meejeon; van der Meer, Riet; Abdulkadir, Sarki A.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Roh, M (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.	sarki.abdulkadir@vanderbilt.edu		Hayward, Simon/0000-0002-6059-6550	National Cancer Institute [RO1CA123484]; NATIONAL CANCER INSTITUTE [R01CA123484] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Cancer Institute grant RO1CA123484. Sponsors had no role in the design, collection, analysis or interpretation of data or preparation, review or approval of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Ai H, 2001, LARYNGOSCOPE, V111, P1853, DOI 10.1097/00005537-200110000-00034; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; BUTZ K, 1995, ONCOGENE, V10, P927; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Cardoso J, 2006, CANCER RES, V66, P2514, DOI 10.1158/0008-5472.CAN-05-2407; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; DEITCH AD, 1993, CANCER, V72, P1692, DOI 10.1002/1097-0142(19930901)72:5<1692::AID-CNCR2820720533>3.0.CO;2-8; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Doak SH, 2004, MUTAT RES-FUND MOL M, V547, P133, DOI 10.1016/j.mrfmmm.2003.12.009; Duensing S, 2003, CRIT REV EUKAR GENE, V13, P9, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.20; Duesberg P, 2005, SCIENCE, V307, P41; Duesberg P, 2003, CELL CYCLE, V2, P202, DOI 10.4161/cc.2.3.382; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; FORSSLUND G, 1990, CANCER RES, V50, P4281; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Jung YJ, 2007, EUR J HAEMATOL, V78, P131, DOI 10.1111/j.1600-0609.2006.00791.x; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Li Q, 1999, MOL CELL BIOL, V19, P5339; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Mendelin J, 1999, LAB INVEST, V79, P387; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Mogal AP, 2007, J BIOL CHEM, V282, P25790, DOI 10.1074/jbc.M702438200; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; OTTESEN GL, 1995, BRIT J CANCER, V72, P832, DOI 10.1038/bjc.1995.421; Pihan GA, 2003, CANCER RES, V63, P1398; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Roh M, 2005, J BIOL CHEM, V280, P40568, DOI 10.1074/jbc.M509369200; Roh M, 2003, CANCER RES, V63, P8079; Sagulenko E, 2007, CANCER LETT, V257, P65, DOI 10.1016/j.canlet.2007.07.003; Thomas M, 1996, ONCOGENE, V13, P471; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; Visscher DW, 1996, CANCER, V77, P315, DOI 10.1002/(SICI)1097-0142(19960115)77:2<315::AID-CNCR14>3.0.CO;2-4; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410	47	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2572	10.1371/journal.pone.0002572	http://dx.doi.org/10.1371/journal.pone.0002572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596907	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200037
J	Saayman, S; Barichievy, S; Capovilla, A; Morris, KV; Arbuthnot, P; Weinberg, MS				Saayman, Sheena; Barichievy, Samantha; Capovilla, Alexio; Morris, Kevin V.; Arbuthnot, Patrick; Weinberg, Marc S.			The Efficacy of Generating Three Independent Anti-HIV-1 siRNAs from a Single U6 RNA Pol III-Expressed Long Hairpin RNA	PLOS ONE			English	Article								RNA Interference (RNAi) effectors have been used to inhibit rogue RNAs in mammalian cells. However, rapidly evolving sequences such as the human immunodeficiency virus type 1 (HIV-1) require multiple targeting approaches to prevent the emergence of escape variants. Expressed long hairpin RNAs (lhRNAs) have recently been used as a strategy to produce multiple short interfering RNAs (siRNAs) targeted to highly variant sequences. We aimed to characterize the ability of expressed lhRNAs to generate independent siRNAs that silence three non-contiguous HIV-1 sites by designing lhRNAs comprising different combinations of siRNA-encoding sequences. All lhRNAs were capable of silencing individual target sequences. However, silencing efficiency together with concentrations of individual lhRNA-derived siRNAs diminished from the stem base (first position) towards the loop side of the hairpin. Silencing efficacy against HIV-1 was primarily mediated by siRNA sequences located at the base of the stem. Improvements could be made to first and second position siRNAs by adjusting spacing arrangements at their junction, but silencing of third position siRNAs remained largely ineffective. Although lhRNAs offer advantages for combinatorial RNAi, we show that good silencing efficacy across the span of the lhRNA duplex is difficult to achieve with sequences that encode more than two adjacent independent siRNAs.	[Saayman, Sheena; Barichievy, Samantha; Arbuthnot, Patrick; Weinberg, Marc S.] Univ Witwatersrand, Dept Mol Med & Haematol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa; [Capovilla, Alexio] Univ Witwatersrand, Dept Mol Med & Haematol, HIV Pathogenesis Lab, Johannesburg, South Africa; [Morris, Kevin V.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA USA	University of Witwatersrand; University of Witwatersrand; Scripps Research Institute	Saayman, S (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Antiviral Gene Therapy Res Unit, Johannesburg, South Africa.	marc.weinberg@wits.ac.za	Weinberg, Marc/B-4669-2009; morris, kevin v/B-5481-2011	Weinberg, Marc/0000-0002-1997-2171; Morris, Kevin/0000-0002-0157-0553	Ernst and Ethel Eriksen Trust [postgraduate scholarship]; German Academic Exchange; National Research Foundation (NRF); Medical Research Council (MRC); Poliomyelitis Research Foundation (PRF); Sixth Research Framework Programme of the European Union, Project RIGHT [LSHB-CT-2004-005276]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084406] Funding Source: NIH RePORTER	Ernst and Ethel Eriksen Trust; German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); National Research Foundation (NRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Poliomyelitis Research Foundation (PRF); Sixth Research Framework Programme of the European Union, Project RIGHT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SS holds a postgraduate scholarship from the Ernst and Ethel Eriksen Trust and German Academic Exchange (DAAD). This work was supported by grants from the National Research Foundation (NRF), Medical Research Council (MRC), Poliomyelitis Research Foundation (PRF), and from funding under the Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004-005276).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akashi H, 2005, MOL BIOSYST, V1, P382, DOI 10.1039/b510159j; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Barichievy S, 2007, OLIGONUCLEOTIDES, V17, P419, DOI 10.1089/oli.2007.0095; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Castanotto D, 2002, RNA, V8, P1454, DOI 10.1017/S1355838202021362; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Diallo M, 2003, OLIGONUCLEOTIDES, V13, P381, DOI 10.1089/154545703322617069; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; Grimm D, 2007, MOL THER, V15, P878, DOI 10.1038/sj.mt.6300116; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Henry SD, 2006, MOL THER, V14, P485, DOI 10.1016/j.ymthe.2006.04.012; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee SK, 2005, BLOOD, V106, P818, DOI 10.1182/blood-2004-10-3959; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu YP, 2007, NUCLEIC ACIDS RES, V35, P5683, DOI 10.1093/nar/gkm596; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Nishida K, 2006, IEEJ T ELECTR ELECTR, V1, P80, DOI 10.1002/tee.20012; Park WS, 2002, NUCLEIC ACIDS RES, V30, P4830, DOI 10.1093/nar/gkf627; Passman M, 2000, BIOCHEM BIOPH RES CO, V268, P728, DOI 10.1006/bbrc.2000.2209; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Robbins MA, 2006, NAT BIOTECHNOL, V24, P566, DOI 10.1038/nbt1206; Sano M, 2008, MOL THER, V16, P170, DOI 10.1038/sj.mt.6300298; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Strat A, 2006, NUCLEIC ACIDS RES, V34, P3803, DOI 10.1093/nar/gkl532; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tran N, 2004, FEBS LETT, V573, P127, DOI 10.1016/j.febslet.2004.07.075; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Weinberg MS, 2007, MOL THER, V15, P534, DOI 10.1038/sj.mt.6300077; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Xia XG, 2006, BIOTECHNIQUES, V41, P64, DOI 10.2144/000112198; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	49	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2602	10.1371/journal.pone.0002602	http://dx.doi.org/10.1371/journal.pone.0002602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596982	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200055
J	Zetola, NM; Grijalva, CG; Gertler, S; Hare, CB; Kaplan, B; Dowling, T; Colfax, G; Katz, MH; Klausner, JD				Zetola, Nicola M.; Grijalva, Carlos G.; Gertler, Sarah; Hare, C. Bradley; Kaplan, Beth; Dowling, Teri; Colfax, Grant; Katz, Mitchell H.; Klausner, Jeffrey D.			Simplifying Consent for HIV Testing Is Associated with an Increase in HIV Testing and Case Detection in Highest Risk Groups, San Francisco January 2003-June 2007	PLOS ONE			English	Article								Background: Populations at highest risk for HIV infection face multiple barriers to HIV testing. To facilitate HIV testing procedures, the San Francisco General Hospital Medical Center eliminated required written patient consent for HIV testing in its medical settings in May 2006. To describe the change in HIV testing rates in different hospital settings and populations after the change in HIV testing policy in the SFDH medical center, we performed an observational study using interrupted time series analysis. Methods: Data from all patients aged 18 years and older seen from January 2003 through June 2007 at the San Francisco Department of Public Health (SFDPH) medical care system were included in the analysis. The monthly HIV testing rate per 1000 hadpatient-visits was calculated for the overall population and stratified by hospital setting, age, sex, race/ethnicity, homelessness status, insurance status and primary language. Results: By June 2007, the average monthly rate of HIV tests per 1000 patient-visits increased 4.38 (CI, 2.17-6.60, p < 0.001) over the number predicted if the policy change had not occurred (representing a 44% increase). The monthly average number of new positive HIV tests increased from 8.9 (CI, 6.3-11.5) to 14.9 (CI, 10.6-19.2, p < 0.001), representing a 67% increase. Although increases in HIV testing were seen in all populations, populations at highest risk for HIV infection, particularly men, the homeless, and the uninsured experienced the highest increases in monthly HIV testing rates after the policy change. Conclusions: The elimination of the requirement for written consent in May 2006 was associated with a significant and sustained increase in HIV testing rates and HIV case detection in the SFDPH medical center. Populations facing the higher barriers to HIV testing had the highest increases in HIV testing rates and case detection in response to the policy change.	[Zetola, Nicola M.; Klausner, Jeffrey D.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; [Grijalva, Carlos G.] Vanderbilt Univ, Sch Med, Dept Preventive Med, Nashville, TN USA; [Gertler, Sarah] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Hare, C. Bradley] Univ Calif San Francisco, Positive Hlth Program, San Francisco, CA USA; [Kaplan, Beth] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA USA; [Dowling, Teri; Colfax, Grant; Katz, Mitchell H.; Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health	Zetola, NM (corresponding author), Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA.	nzetola@gmail.com		Grijalva, Carlos/0000-0002-2329-7797	General Clinical Research Center at San Francisco General Hospital; Division of Research Resources, National Institutes of Health [5-MO1-RR00083]; California HIV Research Program [CH05-SMCHC-612]; San Francisco Department of Public Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000083] Funding Source: NIH RePORTER	General Clinical Research Center at San Francisco General Hospital(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); California HIV Research Program; San Francisco Department of Public Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was carried out in part through the General Clinical Research Center at San Francisco General Hospital, supported by Grant 5-MO1-RR00083 from the Division of Research Resources, National Institutes of Health, by the California HIV Research Program Grant CH05-SMCHC-612 and the San Francisco Department of Public Health. In the past 12 months Dr. Klausner has received funding for research or educational purposes from Gen-Probe, Inc., and Gilead Sciences, Inc.	[Anonymous], 2006, MMWR RECOMM REP; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cook T.C., 1979, QUASIEXPERIMENTATION; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Kellock DJ, 1998, INT J STD AIDS, V9, P263, DOI 10.1258/0956462981922188; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Troccoli K, 2002, OBSTET GYNECOL, V100, P420, DOI 10.1016/S0029-7844(02)02120-8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zetola NM, 2007, JAMA-J AM MED ASSOC, V297, P1061, DOI 10.1001/jama.297.10.1061	12	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2591	10.1371/journal.pone.0002591	http://dx.doi.org/10.1371/journal.pone.0002591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596933	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200050
J	Bueti, D; van Dongen, EV; Walsh, V				Bueti, Domenica; van Dongen, Eelco V.; Walsh, Vincent			The Role of Superior Temporal Cortex in Auditory Timing	PLOS ONE			English	Article							TIME PERCEPTION; NEURAL REPRESENTATION; BRAIN ACTIVATION; INTERNAL CLOCK; VISUAL-CORTEX; BASAL GANGLIA; DURATION; INTERVALS; SYSTEMS; MOTOR	Recently, there has been upsurge of interest in the neural mechanisms of time perception. A central question is whether the representation of time is distributed over brain regions as a function of stimulus modality, task and length of the duration used or whether it is centralized in a single specific and supramodal network. The answers seem to be converging on the former, and many areas not primarily considered as temporal processing areas remain to be investigated in the temporal domain. Here we asked whether the superior temporal gyrus, an auditory modality specific area, is involved in processing of auditory timing. Repetitive transcranial magnetic stimulation was applied over left and right superior temporal gyri while participants performed either a temporal or a frequency discrimination task of single tones. A significant decrease in performance accuracy was observed after stimulation of the right superior temporal gyrus, in addition to an increase in response uncertainty as measured by the Just Noticeable Difference. The results are specific to auditory temporal processing and performance on the frequency task was not affected. Our results further support the idea of distributed temporal processing and speak in favor of the existence of modality specific temporal regions in the human brain.	[Bueti, Domenica; van Dongen, Eelco V.] UCL, Inst Cognit Neurosci, London, England; [Walsh, Vincent] UCL, Dept Psychol, London, England	University of London; University College London; University of London; University College London	Bueti, D (corresponding author), UCL, Inst Cognit Neurosci, London, England.	domenica.bueti@googlemail.com	van Dongen, Eelco V/G-4232-2010; Bueti, Domenica/E-7627-2014	van Dongen, Eelco V/0000-0002-2031-8759; Bueti, Domenica/0000-0001-6660-7241	Leverhulme Trust; Royal Society	Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London)	Domenica Bueti was supported by the Leverhulme Trust; Vincent Walsh was supported by the Royal Society.	Alexander I, 2005, COGN NEUROPSYCHOL, V22, P306, DOI 10.1080/02643290442000356; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bengtsson SL, 2005, EUR J NEUROSCI, V22, P3255, DOI 10.1111/j.1460-9568.2005.04517.x; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Grondin S, 1996, PERCEPT PSYCHOPHYS, V58, P424, DOI 10.3758/BF03206818; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kudo K, 2004, NEUROIMAGE, V22, P1291, DOI 10.1016/j.neuroimage.2004.03.043; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Melgire M, 2005, BRAIN COGNITION, V58, P119, DOI 10.1016/j.bandc.2004.09.013; MERCHANT H, 2007, J NEUROPHYSIOL; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Penhune VB, 1999, NEUROPSYCHOLOGIA, V37, P315, DOI 10.1016/S0028-3932(98)00075-X; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rao SM, 1997, J NEUROSCI, V17, P5528; Sakai K, 1999, J NEUROSCI, V19, P10074; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, BRADFORD BOOKS, P1; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	45	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2481	10.1371/journal.pone.0002481	http://dx.doi.org/10.1371/journal.pone.0002481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575615	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000011
J	Desmond, C; Bland, RM; Boyce, G; Coovadia, HM; Coutsoudis, A; Rollins, N; Newell, ML				Desmond, Chris; Bland, Ruth M.; Boyce, Gerard; Coovadia, Hoosen M.; Coutsoudis, Anna; Rollins, Nigel; Newell, Marie-Louise			Scaling-Up Exclusive Breastfeeding Support Programmes: The Example of KwaZulu-Natal	PLOS ONE			English	Article							CHILD HIV TRANSMISSION; UNINFECTED WOMEN; PREVALENCE; HEALTH	Background: Exclusive breastfeeding (EBF) for six months is the mainstay of global child health and the preferred feeding option for HIV-infected mothers for whom replacement feeding is inappropriate. Promotion of community-level EBF requires effective personnel and management to ensure quality counselling and support for women. We present a costing and cost effectiveness analysis of a successful intervention to promote EBF in high HIV prevalence area in South Africa, and implications for scale-up in the province of KwaZulu-Natal. Methods and Findings: The costing of the intervention as implemented was calculated, in addition to the modelling of the costs and outcomes associated with running the intervention at provincial level under three different scenarios: full intervention (per protocol), simplified version (half the number of visits compared to the full intervention; more clinic compared to home visits) and basic version (one third the number of visits compared to the full intervention; all clinic and no home visits). Implementation of the full scenario costs R95 million ($14 million) per annum; the simplified version R47 million ($7 million) and the basic version R4 million ($2 million). Although the cost of the basic scenario is less than one tenth of the cost of the simplified scenario, modelled effectiveness of the full and simplified versions suggest they would be 10 times more effective compared to the basic intervention. A further analysis modelled the costs per increased month of EBF due to each intervention: R337 ($ 48), R206 ($29), and R616 ($88) for the full, simplified and basic scenarios respectively. In addition to the average cost effectiveness the incremental cost effectiveness ratios associated with moving from the less effective scenarios to the more effective scenarios were calculated and reported: Nothing - Basic R616 ($88), Basic Simplified R162 ($23) and Simplified - Full R879 ($126). Conclusions: The simplified scenario, with a combination of clinic and home visits, is the most efficient in terms of cost per increased month of EBF and has the lowest incremental cost effectiveness ratio.	[Desmond, Chris; Boyce, Gerard] Human Sci Res Council, Durban, South Africa; [Bland, Ruth M.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Stud, Somkhele, South Africa; [Bland, Ruth M.] Glasgow Univ, Div Dev Med, Glasgow, Lanark, Scotland; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Ctr HIV AIDS Network, Somkhele, South Africa; [Coutsoudis, Anna; Rollins, Nigel] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Somkhele, South Africa; [Newell, Marie-Louise] UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England	Human Sciences Research Council-South Africa; University of Kwazulu Natal; University of Glasgow; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London	Desmond, C (corresponding author), Human Sci Res Council, Durban, South Africa.	rbland@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268	Wellcome Trust [063009/Z/00/2]; Africa Centre [050534, 077760Z/05/B]	Wellcome Trust(Wellcome TrustEuropean Commission); Africa Centre	Wellcome Trust supported this study (Grant #063009/Z/00/2) and the Africa Centre (Grant #050534 and #077760Z/05/B).	BLAND R, 2008, AIDS IN PRESS; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2007, B WORLD HEALTH ORGAN, V85, P289, DOI 10.2471/BLT.06.032441; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Chopra M, 2002, SAMJ S AFR MED J, V92, P298; COOVADIA H, 2007, LANCET, V369, P1607; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; CREEK T, 2006, ROLE INFANT FEEDING; Drummond MF, 2015, METHODS EC EVALUATIO; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; *KWAZULU NAT PROV, 2006, PROV SAL SCAL FACS C; *KWAZULU NAT PROV, 2003, PROT PHAS IMPL COMPR; LATHAM MC, 2001, CURRENT STATUS PROTE; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Rice BD, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-160; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; SKORDIS J, 2000, J HLTH EC, V21, P405; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Taha TE, 2006, B WORLD HEALTH ORGAN, V84, P546, DOI 10.2471/BLT.05.027664; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; *UNAIDS WHO, 2005, AIDS EP UPD; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; *WHO, 2002, NUTR AD EXCL BREASTF; *WHO UNICEF UNAIDS, 2000, HIV INF FEED COUNS T; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization & Unicef, 1993, BREASTF COUNS TRAIN	29	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2454	10.1371/journal.pone.0002454	http://dx.doi.org/10.1371/journal.pone.0002454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560596	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000263280700036
J	Destouches, D; El Khoury, D; Hamma-Kourbali, Y; Krust, B; Albanese, P; Katsoris, P; Guichard, G; Briand, JP; Courty, J; Hovanessian, AG				Destouches, Damien; El Khoury, Diala; Hamma-Kourbali, Yamina; Krust, Bernard; Albanese, Patricia; Katsoris, Panagiotis; Guichard, Gilles; Briand, Jean Paul; Courty, Jose; Hovanessian, Ara G.			Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin	PLOS ONE			English	Article							PENTAMERIC PSEUDOPEPTIDE HB-19; BINDING PROTEIN; IN-VIVO; HIV; PLEIOTROPHIN; INHIBITION; PARTICLES; INDUCTION; ANCHORAGE; MEMBRANE	Background: Emerging evidences suggest that nucleolin expressed on the cell surface is implicated in growth of tumor cells and angiogenesis. Nucleolin is one of the major proteins of the nucleolus, but it is also expressed on the cell surface where is serves as a binding protein for variety of ligands implicated in cell proliferation, differentiation, adhesion, mitogenesis and angiogenesis. Methodology/Principal Findings: By using a specific antagonist that binds the C-terminal tail of nucleolin, the HB-19 pseudopeptide, here we show that the growth of tumor cells and angiogenesis are suppressed in various in vitro and in vivo experimental models. HB-19 inhibited colony formation in soft agar of tumor cell lines, impaired migration of endothelial cells and formation of capillary-like structures in collagen gel, and reduced blood vessel branching in the chick embryo chorioallantoic membrane. In athymic nude mice, HB-19 treatment markedly suppressed the progression of established human breast tumor cell xenografts in nude mice, and in some cases eliminated measurable tumors while displaying no toxicity to normal tissue. This potent antitumoral effect is attributed to the direct inhibitory action of HB-19 on both tumor and endothelial cells by blocking and down regulating surface nucleolin, but without any apparent effect on nucleolar nucleolin. Conclusion/Significance: Our results illustrate the dual inhibitory action of HB-19 on the tumor development and the neovascularization process, thus validating the cell-surface expressed nucleolin as a strategic target for an effective cancer drug. Consequently, the HB-19 pseudopeptide provides a unique candidate to consider for innovative cancer therapy.	[Destouches, Damien; Hamma-Kourbali, Yamina; Albanese, Patricia; Courty, Jose] Univ Paris Est, CNRS, UMR 7149, Creteil, France; [El Khoury, Diala; Krust, Bernard; Hovanessian, Ara G.] Univ Paris 05, CNRS UPR 2228, Paris, France; [Katsoris, Panagiotis] Univ Patras, Lab Mol Pharmacol, Patras, Greece; [Guichard, Gilles; Briand, Jean Paul] Inst Biol Mol Cellulaire, CNRS UPR 9021, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; University of Patras	Destouches, D (corresponding author), Univ Paris Est, CNRS, UMR 7149, Creteil, France.	ara.hovanessian@univ-paris5.fr	Courty, Jose/Q-3702-2018; GUICHARD, Gilles/I-3858-2016; Destouches, Damien/R-2430-2018; Hamma-Kourbali, Yamina/R-3692-2018	GUICHARD, Gilles/0000-0002-2584-7502; Destouches, Damien/0000-0003-4959-2580; Hamma-Kourbali, Yamina/0000-0002-2754-8928	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation (ANR:EMBP)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation (ANR:EMBP)(French National Research Agency (ANR))	This work was supported by "Centre National de la Recherche Scientifique" (CNRS) and "Agence Nationale de la Recherche: Emergence et Maturation de projets de Biotechnologie a fort Potentiel de valorisation" (ANR:EMBP), France. D.E.K was supported in part by CNRS, Lebanon.	Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bernard-Pierrot I, 2002, J BIOL CHEM, V277, P32071, DOI 10.1074/jbc.M202747200; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Folkman J, 2007, BLOOD, V110, P2786, DOI 10.1182/blood-2007-08-102178; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fu ZM, 2005, J PROTEOME RES, V4, P1583, DOI 10.1021/pr0501158; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Grinstein E, 2002, J EXP MED, V196, P1067, DOI 10.1084/jem.20011053; Grinstein E, 2006, J BIOL CHEM, V281, P22223, DOI 10.1074/jbc.M513335200; Haemmerling GJ, 2006, CELL CYCLE, V5, P509, DOI 10.4161/cc.5.5.2517; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Re RN, 2006, BIOESSAYS, V28, P943, DOI 10.1002/bies.20459; Ribatti D, 2007, LEUKEMIA, V21, P1606, DOI 10.1038/sj.leu.2404756; Ribatti D, 2007, HISTOL HISTOPATHOL, V22, P285, DOI 10.14670/HH-22.285; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; STEPANOVA V, 2008, BLOOD IN PRESS; STORCK S, 2007, SUBCELL BIOCH, V41; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tanaka Shinji, 2006, Int J Clin Oncol, V11, P82, DOI 10.1007/s10147-006-0566-5; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Ugrinova I, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-66; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200	48	117	126	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2518	10.1371/journal.pone.0002518	http://dx.doi.org/10.1371/journal.pone.0002518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560571	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700062
J	Perfettini, JL; Nardacci, R; Bourouba, M; Subra, F; Gros, L; Seror, C; Manic, G; Rosselli, F; Amendola, A; Masdehors, P; Chessa, L; Novelli, G; Ojcius, DM; Siwicki, JK; Chechlinska, M; Auclair, C; Regueiro, JR; de The, H; Gougeon, ML; Piacentini, M; Kroemer, G				Perfettini, Jean-Luc; Nardacci, Roberta; Bourouba, Mehdi; Subra, Frederic; Gros, Laurent; Seror, Claire; Manic, Gwenola; Rosselli, Filippo; Amendola, Alessandra; Masdehors, Peggy; Chessa, Luciana; Novelli, Giuseppe; Ojcius, David M.; Siwicki, Jan Konrad; Chechlinska, Magdalena; Auclair, Christian; Regueiro, Jose R.; de The, Hugues; Gougeon, Marie-Lise; Piacentini, Mauro; Kroemer, Guido			Critical Involvement of the ATM-Dependent DNA Damage Response in the Apoptotic Demise of HIV-1-Elicited Syncytia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; GLYCOPROTEIN COMPLEX; HIV-1 INFECTION; P53; INDUCTION; ACTIVATION; NBS1; PHOSPHORYLATION; REPLICATION; INTEGRATION	DNA damage can activate the oncosuppressor protein ataxia telangiectasia mutated (ATM), which phosphorylates the histone H2AX within characteristic DNA damage foci. Here, we show that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitro. This was accompanied by aggregation of ATM in discrete nuclear foci that also contained phospho-histone H2AX. DNA damage foci containing phosphorylated ATM and H2AX were detectable in syncytia present in the brain or lymph nodes from patients with HIV-1 infection, as well as in a fraction of blood leukocytes, correlating with viral status. Knockdown of ATM or of its obligate activating factor NBS1 (Nijmegen breakage syndrome 1 protein), as well as pharmacological inhibition of ATM with KU-55933, inhibited H2AX phosphorylation and prevented Env-elicited syncytia from undergoing apoptosis. ATM was found indispensable for the activation of MAP kinase p38, which catalyzes the activating phosphorylation of p53 on serine 46, thereby causing p53 dependent apoptosis. Both wild type HIV-1 and an HIV-1 mutant lacking integrase activity induced syncytial apoptosis, which could be suppressed by inhibiting ATM. HIV-1-infected T lymphoblasts from patients with inactivating ATM or NBS1 mutations also exhibited reduced syncytial apoptosis. Altogether these results indicate that apoptosis induced by a fusogenic HIV-1 Env follows a pro-apoptotic pathway involving the sequential activation of ATM, p38MAPK and p53.	[Perfettini, Jean-Luc; Bourouba, Mehdi; Seror, Claire; Manic, Gwenola; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Nardacci, Roberta; Amendola, Alessandra; Piacentini, Mauro] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Subra, Frederic; Gros, Laurent; Auclair, Christian] Ecole Normale Superieure Cachan, CNRS UMR 8113 LBPA, Cachan, France; [Rosselli, Filippo] Inst Gustave Roussy, CNRS FRE2939, Villejuif, France; [Masdehors, Peggy; Gougeon, Marie-Lise] Inst Pasteur, Dept Infect & Epidemiol, Biotherapy & Vaccine Unit, Paris, France; [Chessa, Luciana] Univ Roma La Sapienza, Fac Med 2, Rome, Italy; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol & Diagnos Imag, Rome, Italy; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Siwicki, Jan Konrad; Chechlinska, Magdalena] M Sklodowska Curie Memorial Canc Ctr, Inst Oncol, Dept Immunol, Warsaw, Poland; [Regueiro, Jose R.] Univ Complutense, Fac Med, Madrid, Spain; [de The, Hugues] Univ Paris 07, Hop St Louis, CNRS UPR 9051, Paris, France; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; IRCCS Lazzaro Spallanzani; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Sapienza University Rome; University of Rome Tor Vergata; University of California System; University of California Merced; Maria Sklodowska-Curie National Research Institute of Oncology; Complutense University of Madrid; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Rome Tor Vergata	Perfettini, JL (corresponding author), Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France.	kroemer@igr.fr	Chechlinska, Magdalena/AAB-9059-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Regueiro, José R./B-5499-2014; Filippo, Rosselli/AAO-6393-2020; Novelli, Giuseppe/GQB-3329-2022; Amendola, Alessandra/ABC-2753-2021; Amendola, Alessandra/K-8835-2016; Kroemer, Guido/AAY-9859-2020; Bourouba, Mehdi/AAC-3615-2020; KROEMER, Guido/B-4263-2013; Piacentini, Mauro/I-2411-2016; Manic, Gwenola/J-8496-2018; Nardacci, Roberta/K-6555-2016; Chechlinska, Magdalena/ABB-9653-2020; Ojcius, David/ABE-6557-2020; PERFETTINI, Jean-Luc/N-4699-2017	Chechlinska, Magdalena/0000-0001-6139-1234; Novelli, Giuseppe/0000-0002-7781-602X; Regueiro, José R./0000-0001-8442-7762; Filippo, Rosselli/0000-0003-1080-5745; Novelli, Giuseppe/0000-0002-7781-602X; Amendola, Alessandra/0000-0002-7063-0222; Amendola, Alessandra/0000-0002-7063-0222; KROEMER, Guido/0000-0002-9334-4405; Piacentini, Mauro/0000-0003-2919-1296; Nardacci, Roberta/0000-0002-9209-1207; PERFETTINI, Jean-Luc/0000-0002-2427-2604; Manic, Gwenola/0000-0003-3759-8029; Ojcius, David/0000-0003-1461-4495; Siwicki, Jan Konrad/0000-0002-5083-3022	LNC; ANRS; Sidaction; European Commission; Istituto Superiore di Sanita [N40F60]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	LNC; ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; European Commission(European CommissionEuropean Commission Joint Research Centre); Istituto Superiore di Sanita; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work has been supported by a special grant from LNC, as well as grants by ANRS, Sidaction and the European Commission (RIGHT, ACTIVE P53, ApoSys) (to G.K.), Istituto Superiore di Sanita (N40F60, Ricerca Corrente e Finalizzate Ministerio della Salute, COFIN from MIUR and AIRC).	Agarwal RP, 1997, MUTAT RES-GEN TOX EN, V390, P223, DOI 10.1016/S1383-5718(97)00014-4; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Brown EJ, 2003, CELL CYCLE, V2, P188, DOI 10.4161/cc.2.3.395; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Camerini D, 2000, J VIROL, V74, P3196, DOI 10.1128/JVI.74.7.3196-3204.2000; Castedo M, 2005, BIOCHEM BIOPH RES CO, V331, P701, DOI 10.1016/j.bbrc.2005.03.188; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Cook JE, 2005, ANN NEUROL, V57, P795, DOI 10.1002/ana.20479; Costes SV, 2007, PLOS COMPUT BIOL, V3, P1477, DOI 10.1371/journal.pcbi.0030155; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daniel R, 2003, P NATL ACAD SCI USA, V100, P4778, DOI 10.1073/pnas.0730887100; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Difilippantonio S, 2007, J EXP MED, V204, P1003, DOI 10.1084/jem.20070319; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Ferri KF, 2000, EXP CELL RES, V261, P119, DOI 10.1006/excr.2000.5062; Garden GA, 2004, FASEB J, V18, P1141, DOI 10.1096/fj.04-1676fje; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gougeon ML, 2005, CELL DEATH DIFFER, V12, P845, DOI 10.1038/sj.cdd.4401616; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Hamers FF, 2004, LANCET, V364, P83, DOI 10.1016/S0140-6736(04)16594-X; Jayadev S, 2007, J NEUROIMMUNE PHARM, V2, P359, DOI 10.1007/s11481-007-9095-x; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kopka J, 2002, PEDIATR RES, V52, P475, DOI [10.1203/01.0000028056.74614.E0, 10.1203/00006450-200210000-00004]; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Nardacci R, 2005, AM J PATHOL, V167, P695, DOI 10.1016/S0002-9440(10)62044-5; Nunnari G, 2005, VIROLOGY, V335, P177, DOI 10.1016/j.virol.2005.02.015; PANTALEO G, 1995, NAT MED, V1, P118, DOI 10.1038/nm0295-118; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Perfettini JL, 2004, J EXP MED, V199, P629, DOI 10.1084/jem.20031216; Rivero-Carmena M, 2000, INT IMMUNOL, V12, P927, DOI 10.1093/intimm/12.6.927; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Saito H, 2002, GYNECOL OBSTET INVES, V53, P46, DOI 10.1159/000049424; Scheller C, 2001, VIROLOGY, V282, P48, DOI 10.1006/viro.2000.0811; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siwicki JK, 2003, EXP CELL RES, V287, P178, DOI 10.1016/S0014-4827(03)00140-X; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wyen C, 2004, JAIDS-J ACQ IMM DEF, V37, P1263, DOI 10.1097/01.qai.0000136093.47316.f3; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	54	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2458	10.1371/journal.pone.0002458	http://dx.doi.org/10.1371/journal.pone.0002458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560558	Green Published, gold			2022-12-27	WOS:000263280700039
J	Garcia-Contreras, R; Zhang, XS; Kim, Y; Wood, TK				Garcia-Contreras, Rodolfo; Zhang, Xue-Song; Kim, Younghoon; Wood, Thomas K.			Protein Translation and Cell Death: The Role of Rare tRNAs in Biofilm Formation and in Activating Dormant Phage Killer Genes	PLOS ONE			English	Article								We discovered previously that the small Escherichia coli proteins Hha (hemolysin expression modulating protein) and the adjacent, poorly-characterized YbaJ are important for biofilm formation; however, their roles have been nebulous. Biofilms are intricate communities in which cell signaling often converts single cells into primitive tissues. Here we show that Hha decreases biofilm formation dramatically by repressing the transcription of rare codon tRNAs which serves to inhibit fimbriae production and by repressing to some extent transcription of fimbrial genes fimA and ihfA. In vivo binding studies show Hha binds to the rare codon tRNAs argU, ileX, ileY, and proL and to two prophage clusters D1P12 and CP4-57. Real-time PCR corroborated that Hha represses argU and proL, and Hha type I fimbriae repression is abolished by the addition of extra copies of argU, ileY, and proL. The repression of transcription of rare codon tRNAs by Hha also leads to cell lysis and biofilm dispersal due to activation of prophage lytic genes rzpD, yfjZ, appY, and alpA and due to induction of ClpP/ClpX proteases which activate toxins by degrading antitoxins. YbaJ serves to mediate the toxicity of Hha. Hence, we have identified that a single protein (Hha) can control biofilm formation by limiting fimbriae production as well as by controlling cell death. The mechanism used by Hha is the control of translation via the availability of rare codon tRNAs which reduces fimbriae production and activates prophage lytic genes. Therefore, Hha acts as a toxin in conjunction with co-transcribed YbaJ (TomB) that attenuates Hha toxicity.	[Garcia-Contreras, Rodolfo; Zhang, Xue-Song; Kim, Younghoon; Wood, Thomas K.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Wood, Thomas K.] Texas A&M Univ, Dept Biol, College Stn, TX USA; [Wood, Thomas K.] Texas A&M Univ, Zachry Dept Civil Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Garcia-Contreras, R (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	Thomas.Wood@chemail.tamu.edu	Garcia-Contreras, Rodolfo/AAI-3548-2020; Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Wood, Thomas/0000-0002-6258-529X; Zhang, Xue-Song/0000-0001-5080-0098	NIH [5R01EB003872-05]; ARO [W911NF-06-1-0408]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARO; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH (5R01EB003872-05) and the ARO (W911NF-06-1-0408). The funding agencies did not participate in the work.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balsalobre C, 1999, J BACTERIOL, V181, P3018, DOI 10.1128/JB.181.10.3018-3024.1999; BANSAL T, 2007, INFECT IMMUN; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BLANCO A, 1991, FEMS MICROBIOL LETT, V81, P221; Brown JM, 2003, J BACTERIOL, V185, P6600, DOI 10.1128/JB.185.22.6600-6608.2003; CARMONA M, 1993, MOL MICROBIOL, V9, P1011, DOI 10.1111/j.1365-2958.1993.tb01230.x; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Delgado-Olivares L, 2006, BIOCHIMIE, V88, P793, DOI 10.1016/j.biochi.2006.01.007; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dobrindt U, 2002, MOL GENET GENOMICS, V267, P370, DOI 10.1007/s00438-002-0668-3; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; DORMAN CJ, 1987, J BACTERIOL, V169, P3840, DOI 10.1128/jb.169.8.3840-3843.1987; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; Forns N, 2005, FEMS MICROBIOL LETT, V251, P75, DOI 10.1016/j.femsle.2005.07.027; Frumerie C, 2005, VIROLOGY, V332, P284, DOI 10.1016/j.virol.2004.11.015; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; GODESSART N, 1988, J GEN MICROBIOL, V134, P2779; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; KAWULA TH, 1991, J BACTERIOL, V173, P4116, DOI 10.1128/jb.173.13.4116-4123.1991; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOHNO K, 1994, J BIOCHEM-TOKYO, V115, P1113, DOI 10.1093/oxfordjournals.jbchem.a124466; Leathart JBS, 1998, MOL MICROBIOL, V28, P371, DOI 10.1046/j.1365-2958.1998.00802.x; Lee J, 2007, J MOL BIOL, V373, P11, DOI 10.1016/j.jmb.2007.07.037; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Madrid C, 2007, MOL MICROBIOL, V63, P7, DOI 10.1111/j.1365-2958.2006.05497.x; Maeda T, 2008, MICROB BIOTECHNOL, V1, P30, DOI 10.1111/j.1751-7915.2007.00003.x; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mai-Prochnow A, 2004, APPL ENVIRON MICROB, V70, P3232, DOI 10.1128/AEM.70.6.3232-3238.2004; MIKULSKIS AV, 1994, MOL MICROBIOL, V11, P77, DOI 10.1111/j.1365-2958.1994.tb00291.x; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; MIRELMAN D, 1980, J CLIN MICROBIOL, V11, P328, DOI 10.1128/JCM.11.4.328-331.1980; Mourino M, 1996, INFECT IMMUN, V64, P2881; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Ren DC, 2005, APPL ENVIRON MICROB, V71, P4022, DOI 10.1128/AEM.71.7.4022-4034.2005; Ren DC, 2004, BIOTECHNOL BIOENG, V88, P630, DOI 10.1002/bit.20259; Ritter A, 1997, MOL MICROBIOL, V25, P871, DOI 10.1111/j.1365-2958.1997.mmi517.x; SAIER MH, 1995, FEBS LETT, V362, P1, DOI 10.1016/0014-5793(95)00185-C; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schembri MA, 1998, MOL GEN GENET, V259, P336, DOI 10.1007/s004380050820; Schembri MA, 2002, MOL GENET GENOMICS, V267, P721, DOI 10.1007/s00438-002-0705-2; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Srividhya KV, 2007, J BIOSCIENCES, V32, P979, DOI 10.1007/s12038-007-0097-x; SWENSON DL, 1994, MOL GEN GENET, V244, P216, DOI 10.1007/BF00283525; Tamini Y, 2004, INVEST OPHTH VIS SCI, V45, P3904, DOI 10.1167/iovs.04-0628; Tinker JK, 2000, INFECT IMMUN, V68, P3305, DOI 10.1128/IAI.68.6.3305-3313.2000; Tinker JK, 2001, MOL MICROBIOL, V40, P757, DOI 10.1046/j.1365-2958.2001.02430.x; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; VIVERO A, 2007, J BACTERIOL; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; YEH KS, 1995, J BACTERIOL, V177, P6861, DOI 10.1128/jb.177.23.6861-6865.1995; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	77	82	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2394	10.1371/journal.pone.0002394	http://dx.doi.org/10.1371/journal.pone.0002394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545668	Green Published, gold			2022-12-27	WOS:000263248800032
J	Hatori, M; Le, H; Vollmers, C; Keding, SR; Tanaka, N; Schmedt, C; Jegla, T; Panda, S				Hatori, Megumi; Le, Hiep; Vollmers, Christopher; Keding, Sheena Racheal; Tanaka, Nobushige; Schmedt, Christian; Jegla, Timothy; Panda, Satchidananda			Inducible Ablation of Melanopsin-Expressing Retinal Ganglion Cells Reveals Their Central Role in Non-Image Forming Visual Responses	PLOS ONE			English	Article								Rod/cone photoreceptors of the outer retina and the melanopsin-expressing retinal ganglion cells ( mRGCs) of the inner retina mediate non-image forming visual responses including entrainment of the circadian clock to the ambient light, the pupillary light reflex ( PLR), and light modulation of activity. Targeted deletion of the melanopsin gene attenuates these adaptive responses with no apparent change in the development and morphology of the mRGCs. Comprehensive identification of mRGCs and knowledge of their specific roles in image-forming and non-image forming photoresponses are currently lacking. We used a Cre-dependent GFP expression strategy in mice to genetically label the mRGCs. This revealed that only a subset of mRGCs express enough immunocytochemically detectable levels of melanopsin. We also used a Cre-inducible diphtheria toxin receptor ( iDTR) expression approach to express the DTR in mRGCs. mRGCs develop normally, but can be acutely ablated upon diphtheria toxin administration. The mRGC-ablated mice exhibited normal outer retinal function. However, they completely lacked non-image forming visual responses such as circadian photoentrainment, light modulation of activity, and PLR. These results point to the mRGCs as the site of functional integration of the rod/cone and melanopsin phototransduction pathways and as the primary anatomical site for the divergence of image-forming and non-image forming photoresponses in mammals.	[Hatori, Megumi; Le, Hiep; Vollmers, Christopher; Keding, Sheena Racheal; Tanaka, Nobushige; Panda, Satchidananda] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Schmedt, Christian] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Jegla, Timothy] Scripps Res Inst, Inst Childhood & Neglected Dis, Dept Cell Biol, La Jolla, CA USA	Salk Institute; Novartis; Scripps Research Institute	Hatori, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu	Buch, Thorsten/P-1659-2019; Panda, Satchidananda/J-6891-2012; Waisman, Ari/C-7383-2015; Hatori, Megumi/GTY-3770-2022	Buch, Thorsten/0000-0002-2236-9074; Waisman, Ari/0000-0003-4304-8234; Jegla, Timothy/0000-0001-8616-2390; Hatori, Megumi/0000-0001-7888-158X	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH [EY016807]; GNF; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; Dana Foundation; Whitehall Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GNF; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MH, HL, CV, SK, and SP were supported by Pew Scholars Program in Biomedical Sciences, Dana Foundation, Whitehall Foundation and NIH grant EY016807. CS and TJ were supported by funding from GNF. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; CRAWLEY JN, 2000, WHATS WRONG MY MOUSE, P65; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; De Haro L, 2006, J BIOL RHYTHM, V21, P507, DOI 10.1177/0748730406294767; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Panda S, 2007, NEURON, V53, P619, DOI 10.1016/j.neuron.2007.02.017; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Van Gelder RN, 2005, METHOD ENZYMOL, V393, P746, DOI 10.1016/S0076-6879(05)93039-5	41	205	206	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2451	10.1371/journal.pone.0002451	http://dx.doi.org/10.1371/journal.pone.0002451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545654	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800059
J	Hoehl, S; Wiese, L; Striano, T				Hoehl, Stefanie; Wiese, Lisa; Striano, Tricia			Young Infants' Neural Processing of Objects Is Affected by Eye Gaze Direction and Emotional Expression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FACIAL EXPRESSIONS; SPECIES FOLLOW; FACE; ATTENTION; RECOGNITION; AMYGDALA; BRAIN; FEAR; POTENTIALS	Eye gaze is an important social cue which is used to determine another person's focus of attention and intention to communicate. In combination with a fearful facial expression eye gaze can also signal threat in the environment. The ability to detect and understand others' social signals is essential in order to avoid danger and enable social evaluation. It has been a matter of debate when infants are able to use gaze cues and emotional facial expressions in reference to external objects. Here we demonstrate that by 3 months of age the infant brain differentially responds to objects as a function of how other people are reacting to them. Using event-related electrical brain potentials (ERPs), we show that an indicator of infants' attention is enhanced by an adult's expression of fear toward an unfamiliar object. The infant brain showed an increased Negative central (Nc) component toward objects that had been previously cued by an adult's eye gaze and frightened facial expression. Our results further suggest that infants' sensitivity cannot be due to a general arousal elicited by a frightened face with eye gaze directed at an object. The neural attention system of 3 month old infants is sensitive to an adult's eye gaze direction in combination with a fearful expression. This early capacity may lay the foundation for the development of more sophisticated social skills such as social referencing, language, and theory of mind.	[Hoehl, Stefanie; Wiese, Lisa] Max Planck Inst Human Cognit & Brain Sci, Neurocognit & Dev Grp, Leipzig, Germany; [Striano, Tricia] CUNY, Hunter Coll, New York, NY USA	Max Planck Society; City University of New York (CUNY) System; Hunter College (CUNY)	Hoehl, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Neurocognit & Dev Grp, Leipzig, Germany.	tstriano@hunter.cuny.edu	Hoehl, Stefanie/N-2452-2014	Hoehl, Stefanie/0000-0003-0472-0374	Federal Ministry of Education [Sofja Kovalevskaja Award]; Alexander von Humboldt Foundation [Sofja Kovalevskaja Award]	Federal Ministry of Education; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This research was supported by the Sofja Kovalevskaja Award granted by the Alexander von Humboldt Foundation and donated by the Federal Ministry of Education to T.S.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Casey BJ, 1997, DEV PSYCHOBIOL, V30, P61, DOI 10.1002/(SICI)1098-2302(199701)30:1<61::AID-DEV6>3.3.CO;2-B; COURCHESNE E, 1981, CHILD DEV, V52, P804, DOI 10.2307/1129080; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; CSIBRA G, BRIT J DEV IN PRESS; Csibra G, 2006, ATTENTION PERFORM, P249; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; FEINMAN S, 1992, SOCIAL REFERENCING S; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; Grossmann T, 2007, BRAIN COGNITION, V64, P30, DOI 10.1016/j.bandc.2006.10.002; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; HOEHL S, CHILD DEV IN PRESS; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Latane B., 1970, UNRESPONSIVE BYSTAND; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Leppanen JM, 2006, ADV CHILD DEV BEHAV, V34, P207, DOI 10.1016/S0065-2407(06)80008-X; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Moses LJ, 2001, CHILD DEV, V72, P718, DOI 10.1111/1467-8624.00311; Mumme DL, 2003, CHILD DEV, V74, P221, DOI 10.1111/1467-8624.00532; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; Nelson CA, 1998, PERCEPTUAL DEV VISUA, P287; Nelson Charles A., 1994, P269; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Prentice DA, 1996, ADV EXP SOC PSYCHOL, V28, P161, DOI 10.1016/S0065-2601(08)60238-5; Reid VM, 2007, EUR J DEV PSYCHOL, V4, P100, DOI 10.1080/17405620601005648; Reid VM, 2005, EUR J NEUROSCI, V21, P1763, DOI 10.1111/j.1460-9568.2005.03986.x; Reid VM, 2004, NEUROREPORT, V15, P2553, DOI 10.1097/00001756-200411150-00025; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; Striano T, 2006, SOC COGN AFFECT NEUR, V1, P87, DOI 10.1093/scan/nsl008; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; WALDEN TA, 1988, CHILD DEV, V59, P1230, DOI 10.2307/1130486; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; Woodward AL, 2003, DEVELOPMENTAL SCI, V6, P297, DOI 10.1111/1467-7687.00286	51	65	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2389	10.1371/journal.pone.0002389	http://dx.doi.org/10.1371/journal.pone.0002389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545689	gold, Green Published			2022-12-27	WOS:000263248800028
J	Iwai, Y; Hemmi, H; Mizenina, O; Kuroda, S; Suda, K; Steinman, RM				Iwai, Yoshiko; Hemmi, Hiroaki; Mizenina, Olga; Kuroda, Shoko; Suda, Koji; Steinman, Ralph M.			An IFN-gamma-IL-18 Signaling Loop Accelerates Memory CD8(+) T Cell Proliferation	PLOS ONE			English	Article								Rapid proliferation is one of the important features of memory CD8(+) T cells, ensuring rapid clearance of reinfection. Although several cytokines such as IL-15 and IL-7 regulate relatively slow homeostatic proliferation of memory T cells during the maintenance phase, it is unknown how memory T cells can proliferate more quickly than naive T cells upon antigen stimulation. To examine antigen-specific CD8(+) T cell proliferation in recall responses in vivo, we targeted a model antigen, ovalbumin(OVA), to DEC-205(+) dendritic cells (DCs) with a CD40 maturation stimulus. This led to the induction of functional memory CD8(+) T cells, which showed rapid proliferation and multiple cytokine production (IFN-gamma, IL-2, TNF-alpha) during the secondary challenge to DC-targeted antigen. Upon antigen-presentation, IL-18, an IFN-gamma-inducing factor, accumulated at the DC:T cell synapse. Surprisingly, IFN-gamma receptors were required to augment IL-18 production from DCs. Mice genetically deficient for IL-18 or IFN-gamma-receptor 1 also showed delayed expansion of memory CD8(+) T cells in vivo. These results indicate that a positive regulatory loop involving IFN-gamma and IL-18 signaling contributes to the accelerated memory CD8(+) T cell proliferation during a recall response to antigen presented by DCs.	[Iwai, Yoshiko; Hemmi, Hiroaki; Mizenina, Olga; Suda, Koji; Steinman, Ralph M.] Rockefeller Univ, Lab Cellular Immunol & Physiol, New York, NY 10021 USA; [Iwai, Yoshiko; Hemmi, Hiroaki; Kuroda, Shoko] Tokyo Med & Dental Univ, Med Res Inst, MTT Program, Tokyo, Japan	Rockefeller University; Tokyo Medical & Dental University (TMDU)	Iwai, Y (corresponding author), Rockefeller Univ, Lab Cellular Immunol & Physiol, 1230 York Ave, New York, NY 10021 USA.	steinma@mail.rockefeller.edu	Steinman, Ralph/F-7729-2012		NIH [AI40874, AI 54523]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS [Postdoctoral Fellowship]; Uehara Memorial Foundation [Research Fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523, R01AI040874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (AI40874 and AI 54523 to R.M. Steinman) and is funded in part by a grant from the Center for AIDS vaccine discovery and the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. Y. Iwai was the recipient of the JSPS Postdoctoral Fellowship for Research Abroad, and of the Uehara Memorial Foundation Research Fellowship.	Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; ISHIKAWA H, 1993, P NATL ACAD SCI USA, V90, P8204, DOI 10.1073/pnas.90.17.8204; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Rubartelli A., 1997, UNUSUAL SECRETORY PA, P87, DOI [10.1007/978-3-662-22581-3_3, DOI 10.1007/978-3-662-22581-3_3]; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Surh CD, 2006, IMMUNOL REV, V211, P154, DOI 10.1111/j.0105-2896.2006.00401.x; Tough DF, 2001, J IMMUNOL, V166, P6007, DOI 10.4049/jimmunol.166.10.6007; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	37	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2404	10.1371/journal.pone.0002404	http://dx.doi.org/10.1371/journal.pone.0002404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545704	gold, Green Submitted, Green Published			2022-12-27	WOS:000263248800042
J	McGrath, J; Iwazaki, T; Eyles, D; Burne, T; Cui, XY; Ko, P; Matsumoto, I				McGrath, John; Iwazaki, Takeshi; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline; Matsumoto, Izuru			Protein Expression in the Nucleus Accumbens of Rats Exposed to Developmental Vitamin D Deficiency	PLOS ONE			English	Article							ADULT-RAT; GENE-EXPRESSION; ALTERS; SCHIZOPHRENIA; NEUROTENSIN; DOPAMINE; HYPERLOCOMOTION; PATHWAYS; CORTEX; SEASON	Introduction: Developmental vitamin D (DVD) deficiency is a candidate risk factor for schizophrenia. Animal models have confirmed that DVD deficiency is associated with a range of altered genomic, proteomic, structural and behavioural outcomes in the rat. Because the nucleus accumbens has been implicated in neuropsychiatric disorders, in the current study we examined protein expression in this region in adult rats exposed to DVD deficiency Methods: Female Sprague Dawley rats were maintained on a vitamin D deficient diet for 6 weeks, mated and allowed to give birth, after which a diet containing vitamin D was reintroduced. Male adult offspring (n = 8) were compared to control male (n = 8). 2-D gel electrophoresis-based proteomics and mass spectroscopy were used to investigate differential protein expression. Results: There were 35 spots, mapped to 33 unique proteins, which were significantly different between the two groups. Of these, 22 were down-regulated and 13 up-regulated. The fold changes were uniformly small, with the largest FC being -1.67. Within the significantly different spots, three calcium binding proteins (calbindin1, calbindin2 and hippocalcin) were altered. Other proteins associated with DVD deficiency related to mitochondrial function, and the dynamin-like proteins. Conclusions: Developmental vitamin D deficiency was associated with subtle changes in protein expression in the nucleus accumbens. Disruptions in pathways related to calcium-binding proteins and mitochondrial function may underlie some of the behavioural features associated with animal models of developmental vitamin D deficiency	[McGrath, John; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Richlands, Australia; [McGrath, John] Univ Queensland, Dept Psychiat, St Lucia, Qld, Australia; [McGrath, John; Eyles, Darryl; Burne, Thomas; Cui, Xiaoying; Ko, Pauline] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Iwazaki, Takeshi; Matsumoto, Izuru] Univ Sydney, Dept Pathol, Sydney, NSW, Australia; [Matsumoto, Izuru] Asahiyama Hosp, Dept Psychiat, Sapporo, Hokkaido, Japan	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Sydney	McGrath, J (corresponding author), Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Richlands, Australia.	john_mcgrath@qcmhr.uq.edu.au	Eyles, Darryl W/X-3386-2018; McGrath, John Joseph/G-5493-2010; Burne, Thomas H/C-5656-2009	Eyles, Darryl W/0000-0002-5023-7095; McGrath, John Joseph/0000-0002-4792-6068; Burne, Thomas H/0000-0003-3502-9789	National Health and Medical Research Council; Schizophrenia Research Institute	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute	This project was supported by the National Health and Medical Research Council and the Schizophrenia Research Institute. Neither agency had any further role in study design, analysis and interpretation of data, writing of the report or decision to submit the manuscript for publication.	ALEXANDERKAUFMA.A, 2005, DIFFERENTIAL PROTEIN; Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Andrade EC, 2007, CURR OPIN MOL THER, V9, P270; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Cheng SS, 2006, INT J ADV MANUF TECH, V28, P142, DOI 10.1007/s00170-004-2330-1; Christakos S, 2007, J STEROID BIOCHEM, V103, P405, DOI 10.1016/j.jsbmb.2006.12.079; Cui XY, 2007, INT J DEV NEUROSCI, V25, P227, DOI 10.1016/j.ijdevneu.2007.03.006; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Escamilla M, 2007, PHARMACOGENOMICS, V8, P691, DOI 10.2217/14622416.8.7.691; Eyles D, 2007, J STEROID BIOCHEM, V103, P538, DOI 10.1016/j.jsbmb.2006.12.096; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Ferraro L, 2007, BRAIN RES REV, V55, P144, DOI 10.1016/j.brainresrev.2007.03.006; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Joseph MH, 2003, NEUROSCI BIOBEHAV R, V27, P527, DOI 10.1016/j.neubiorev.2003.09.001; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Ko P, 2004, DEV BRAIN RES, V153, P61, DOI 10.1016/j.devbrainres.2004.07.013; Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017; Lauer M, 2001, J NEURAL TRANSM, V108, P645, DOI 10.1007/s007020170042; Lee BD, 2007, PSYCHIAT RES, V150, P1, DOI 10.1016/j.psychres.2006.06.001; Lewis DA, 2007, INT REV NEUROBIOL, V78, P109, DOI 10.1016/S0074-7742(06)78004-7; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; MEREDITH GE, 2008, BRAIN STRUCTURE FUNC; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Oliveira V, 2005, FEBS J, V272, P2978, DOI 10.1111/j.1742-4658.2005.04692.x; Paspalas CD, 2006, EUR J NEUROSCI, V24, P1395, DOI 10.1111/j.1460-9568.2006.05023.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Saha S, 2006, ACTA PSYCHIAT SCAND, V114, P36, DOI 10.1111/j.1600-0447.2005.00742.x; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; SCORRANO L, 2007, NOVART FDN SYMP, V287, P55; Scorrano Luca, 2007, Novartis Found Symp, V287, P47; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thompson TL, 1997, NEUROSCI LETT, V229, P145, DOI 10.1016/S0304-3940(97)00450-3; Vawter MP, 2004, NEUROCHEM RES, V29, P1245, DOI 10.1023/B:NERE.0000023611.99452.47; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Zhou WX, 2002, MOL BRAIN RES, V100, P75, DOI 10.1016/S0169-328X(02)00134-1	50	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2383	10.1371/journal.pone.0002383	http://dx.doi.org/10.1371/journal.pone.0002383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545652	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800022
J	Beck, IM; Ruckert, R; Brandt, K; Mueller, MS; Sadowski, T; Brauer, R; Schirmacher, P; Mentlein, R; Sedlacek, R				Beck, Inken M.; Rueckert, Rene; Brandt, Katja; Mueller, Markus S.; Sadowski, Thorsten; Brauer, Rena; Schirmacher, Peter; Mentlein, Rolf; Sedlacek, Radislav			MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses	PLOS ONE			English	Article								Matrix metalloproteinase-19 (MMP19) affects cell proliferation, adhesion, and migration in vitro but its physiological role in vivo is poorly understood. To determine the function of MMP19, we generated mice deficient for MMP19 by disrupting the catalytic domain of mmp19 gene. Although MMP19-deficient mice do not show overt developmental and morphological abnormalities they display a distinct physiological phenotype. In a model of contact hypersensitivity (CHS) MMP19-deficient mice showed impaired T cell-mediated immune reaction that was characterized by limited influx of inflammatory cells, low proliferation of keratinocytes, and reduced number of activated CD8(+) T cells in draining lymph nodes. In the inflamed tissue, the low number of CD8(+) T cells in MMP19-deficient mice correlated with low amounts of proinflammatory cytokines, especially lymphotactin and interferon-inducible T cell a chemoattractant (I-TAC). Further analyses showed that T cell populations in the blood of immature, unsensitized mice were diminished and that this alteration originated from an altered maturation of thymocytes. In the thymus, thymocytes exhibited low proliferation rates and the number of CD4(+) CD8(+) double-positive cells was remarkably augmented. Based on the phenotype of MMP19-deficient mice we propose that MMP19 is an important factor in cutaneous immune responses and influences the development of T cells.	[Beck, Inken M.] Inst Biotechnol, Prague, Czech Republic; [Beck, Inken M.; Sedlacek, Radislav] Inst Mol Genet, Prague, Czech Republic; [Rueckert, Rene; Brandt, Katja] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany; [Mueller, Markus S.] Swiss Trop Inst, Basel, Switzerland; [Sadowski, Thorsten] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany; [Brauer, Rena; Sedlacek, Radislav] Univ Kiel, Dept Biochem, Kiel, Germany; [Schirmacher, Peter] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Mentlein, Rolf] Univ Kiel, Dept Anat, Kiel, Germany	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Forschungszentrum Borstel; University of Basel; Swiss Tropical & Public Health Institute; Sanofi-Aventis; University of Kiel; Ruprecht Karls University Heidelberg; University of Kiel	Beck, IM (corresponding author), Inst Biotechnol, Prague, Czech Republic.	radislav.sedlacek@img.cas.cz	Mentlein, Rolf/B-1613-2010; Sedlacek, Radislav/G-4408-2014; Beck, Inken/G-4416-2014	Mentlein, Rolf/0000-0002-6350-3911; Brauer, Rena/0000-0002-5900-4853	DFG [SE 878/2-1, SFB617-A8]	DFG(German Research Foundation (DFG))	This work was supported by grants SE 878/2-1 and SFB617-A8 (R.S.) from DFG. The findings and conclusions of this report are those of the authors and do not represent the views of DFG. The authors have no conflicting financial interests.	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Aoudjit F, 1997, INT J CANCER, V71, P71, DOI 10.1002/(SICI)1097-0215(19970328)71:1<71::AID-IJC13>3.3.CO;2-O; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Behera AK, 2005, INFECT IMMUN, V73, P126, DOI 10.1128/IAI.73.1.126-134.2005; Blachere NE, 2006, J IMMUNOL, V176, P7288, DOI 10.4049/jimmunol.176.12.7288; Bouloc A, 1998, J INVEST DERMATOL, V111, P44, DOI 10.1046/j.1523-1747.1998.00236.x; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Brandt K, 2003, J INVEST DERMATOL, V121, P1379, DOI 10.1046/j.1523-1747.2003.12603.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cossins J, 1996, BIOCHEM BIOPH RES CO, V228, P494, DOI 10.1006/bbrc.1996.1688; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dilulio NA, 1999, EUR J IMMUNOL, V29, P3485, DOI 10.1002/(SICI)1521-4141(199911)29:11<3485::AID-IMMU3485>3.0.CO;2-B; Djonov V, 2001, J PATHOL, V195, P147, DOI 10.1002/path.927; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Gorbachev AV, 2001, IMMUNOL RES, V24, P69, DOI 10.1385/IR:24:1:69; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Haidl ID, 2006, SCAND J IMMUNOL, V64, P280, DOI 10.1111/j.1365-3083.2006.01820.x; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hogan B, 1994, MANIPULATING MOUSE E; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kolb C, 1999, EXP CELL RES, V250, P122, DOI 10.1006/excr.1999.4493; Kolb C, 1997, IMMUNOL LETT, V57, P83, DOI 10.1016/S0165-2478(97)00057-6; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; Lopez CB, 1998, INT ARCH ALLERGY IMM, V117, P194, DOI 10.1159/000024010; MACATONIA SE, 1986, IMMUNOLOGY, V59, P509; Masuda K, 2005, CLIN EXP IMMUNOL, V140, P213, DOI 10.1111/j.1365-2249.2005.02752.x; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mizumoto N, 2001, IMMUNOBIOLOGY, V204, P477, DOI 10.1078/0171-2985-00057; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Mueller MS, 2000, GENE, V252, P27, DOI 10.1016/S0378-1119(00)00236-5; Mueller MS, 2000, GENE, V256, P101, DOI 10.1016/S0378-1119(00)00369-3; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Nakae S, 2001, INT IMMUNOL, V13, P1471, DOI 10.1093/intimm/13.12.1471; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Saint-Mezard P, 2005, J INVEST DERMATOL, V124, P562, DOI 10.1111/j.0022-202X.2005.23567.x; Saint-Mezard P, 2003, J INVEST DERMATOL, V120, P641, DOI 10.1046/j.1523-1747.2003.12093.x; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Schroen DJ, 1996, CELL IMMUNOL, V167, P141, DOI 10.1006/cimm.1996.0018; Sedlacek R, 1998, IMMUNOBIOLOGY, V198, P408, DOI 10.1016/S0171-2985(98)80049-1; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stracke JO, 2000, FEBS LETT, V478, P52, DOI 10.1016/S0014-5793(00)01819-6; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; Tensen CP, 1999, J INVEST DERMATOL, V112, P716, DOI 10.1046/j.1523-1747.1999.00581.x; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Warner RL, 2001, AM J PATHOL, V158, P2139, DOI 10.1016/S0002-9440(10)64685-8; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	75	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2343	10.1371/journal.pone.0002343	http://dx.doi.org/10.1371/journal.pone.0002343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523579	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300036
J	Fouchet, D; O'Brien, J; Pontier, D				Fouchet, David; O'Brien, John; Pontier, Dominique			Visiting Sick People: Is It Really Detrimental to Our Health?	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MATERNAL ANTIBODIES; NATURAL IMMUNITY; CHILDREN; VACCINE; MALARIA; DISEASE; TRANSMISSION; REINFECTION; INFECTIONS	Intuitively, keeping ones distance from a source of infection would appear to be the best way to limit the occurrence of disease. However, this overlooks the importance of repeated infections in maintaining efficient immune defenses. When acquired immunity has partly waned, re-exposure to the pathogenic agent may lead to mild disease that boosts the immune system. This prevents the total loss of immunity that would lead to classical disease in cases of re-infection. Here, using a mathematical model, we show that avoiding the pathogenic agent is detrimental in some situations, e. g. for pathogens that are highly transmissible, are not excessively lethal and that induce rapidly waning immunity. Reducing exposure to pathogenic agents is among the objectives of most, if not all, public health measures. A better understanding of the factors influencing the severity of a disease is required before applying measures that reduce the circulation of pathogenic agents.	[Fouchet, David; Pontier, Dominique] Univ Lyon, CNRS, UMR Biometrie & Biol Evolut 5558, Lyon, France; [O'Brien, John] Trinity Coll Dublin, Zool Dept, Dublin, Ireland	Centre National de la Recherche Scientifique (CNRS); Trinity College Dublin	Fouchet, D (corresponding author), Univ Lyon, CNRS, UMR Biometrie & Biol Evolut 5558, Lyon, France.	fouchet@biomserv.univ-lyon1.fr		Pontier, Dominique/0000-0003-4700-3543	ANR SEST programme Pathocenoses et emergence des maladies transmissibles: un concept unificateur mis a l'epreuve sur des pathologies exemplaires	ANR SEST programme Pathocenoses et emergence des maladies transmissibles: un concept unificateur mis a l'epreuve sur des pathologies exemplaires(French National Research Agency (ANR))	DF and DP thank the ANR SEST programme Pathocenoses et emergence des maladies transmissibles: un concept unificateur mis a l'epreuve sur des pathologies exemplaires for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2006, LANCET INFECT DIS, V6, P112, DOI 10.1016/S1473-3099(06)70384-X; Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Ausiello CM, 1999, INFECT IMMUN, V67, P4064, DOI 10.1128/IAI.67.8.4064-4071.1999; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Bunimovich-Mendrazitsky S, 2005, J THEOR BIOL, V237, P302, DOI 10.1016/j.jtbi.2005.04.017; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; COULSON BS, 1992, J CLIN MICROBIOL, V30, P1678, DOI 10.1128/JCM.30.7.1678-1684.1992; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fouchet D, 2007, J R SOC INTERFACE, V4, P479, DOI 10.1098/rsif.2006.0189; Gomes MGM, 2005, J THEOR BIOL, V236, P111, DOI 10.1016/j.jtbi.2005.03.001; Leino T, 2000, EPIDEMIOL INFECT, V125, P583, DOI 10.1017/S0950268800004799; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Miller E, 1997, BIOLOGICALS, V25, P137, DOI 10.1006/biol.1997.0072; Moulton LH, 1998, J INFECT DIS, V178, P1562, DOI 10.1086/314504; Narita M, 1998, CLIN DIAGN LAB IMMUN, V5, P799, DOI 10.1128/CDLI.5.6.799-803.1998; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; THELU J, 1991, J CLIN MICROBIOL, V29, P510, DOI 10.1128/JCM.29.3.510-518.1991; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2299	10.1371/journal.pone.0002299	http://dx.doi.org/10.1371/journal.pone.0002299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523551	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300010
J	Singh, LN; Hannenhalli, S				Singh, Larry N.; Hannenhalli, Sridhar			Functional Diversification of Paralogous Transcription Factors via Divergence in DNA Binding Site Motif and in Expression	PLOS ONE			English	Article							GENE-EXPRESSION; DUPLICATE GENES; EVOLUTION; MOUSE; SELECTION; PROFILES; DATABASE; PATTERN; FOXA2; RATES	Background: Gene duplication is a major driver of evolutionary innovation as it allows for an organism to elaborate its existing biological functions via specialization or diversification of initially redundant gene paralogs. Gene function can diversify in several ways. Transcription factor gene paralogs in particular, can diversify either by changes in their tissue-specific expression pattern or by changes in the DNA binding sitemotif recognized by their protein product, which in turn alters their gene targets. The relationship between these two modes of functional diversification of transcription factor paralogs has not been previously investigated, and is essential for understanding adaptive evolution of transcription factor gene families. Findings: Based on a large set of human paralogous transcription factor pairs, we show that when the DNA binding site motifs of transcription factor paralogs are similar, the expressions of the genes that encode the paralogs have diverged, so in general, at most one of the paralogs is highly expressed in a tissue. Moreover, paralogs with diverged DNA binding site motifs tend to be diverged in their function. Conversely, two paralogs that are highly expressed in a tissue tend to have dissimilar DNA binding site motifs. We have also found that in general, within a paralogous family, tissue-specific decrease in gene expression is more frequent than what is expected by chance. Conclusions: While previous investigations of paralogous gene diversification have only considered coding sequence divergence, by explicitly quantifying divergence in DNA binding site motif, our work presents a new paradigm for investigating functional diversification. Consistent with evolutionary expectation, our quantitative analysis suggests that paralogous transcription factors have survived extinction in part, either through diversification of their DNA binding site motifs or through alterations in their tissue-specific expression levels.	[Singh, Larry N.; Hannenhalli, Sridhar] Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania	Singh, LN (corresponding author), Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA.	sridharh@pcbi.upenn.edu	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864	NIH [R21]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH R21 (PI Hannenhalli)	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bartolome C, 2005, GENETICS, V169, P1495, DOI 10.1534/genetics.104.033068; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Harrison AP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-195; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nadeau JH, 1997, GENETICS, V147, P1259; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Ohno S., 1970, EVOLUTION GENE DUPLI; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Wagner A, 2002, GENOME BIOL, V3; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wilcox RR, 2001, FUNDAMENTALS MODERN; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	43	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2345	10.1371/journal.pone.0002345	http://dx.doi.org/10.1371/journal.pone.0002345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523562	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300038
J	Sordino, P; Andreakis, N; Brown, ER; Leccia, NI; Squarzoni, P; Tarallo, R; Alfano, C; Caputi, L; D'Ambrosio, P; Daniele, P; D'Aniello, E; D'Aniello, S; Maiella, S; Miraglia, V; Russo, MT; Sorrenti, G; Branno, M; Cariello, L; Cirino, P; Locascio, A; Spagnuolo, A; Zanetti, L; Ristoratore, F				Sordino, Paolo; Andreakis, Nikos; Brown, Euan R.; Leccia, Nicola I.; Squarzoni, Paola; Tarallo, Raffaella; Alfano, Christian; Caputi, Luigi; D'Ambrosio, Palmira; Daniele, Paola; D'Aniello, Enrico; D'Aniello, Salvatore; Maiella, Sylvie; Miraglia, Valentina; Russo, Monia Teresa; Sorrenti, Gerarda; Branno, Margherita; Cariello, Lucio; Cirino, Paola; Locascio, Annamaria; Spagnuolo, Antonietta; Zanetti, Laura; Ristoratore, Filomena			Natural Variation of Model Mutant Phenotypes in Ciona intestinalis	PLOS ONE			English	Article							NERVOUS-SYSTEM; GERMLINE TRANSGENESIS; MICROSATELLITE LOCI; ALLELIC FREQUENCIES; TRANSPOSON MINOS; SENSORY ORGANS; POPULATIONS; MUTATIONS; LARVA; TRANSMISSION	Background: The study of ascidians (Chordata, Tunicata) has made a considerable contribution to our understanding of the origin and evolution of basal chordates. To provide further information to support forward genetics in Ciona intestinalis, we used a combination of natural variation and neutral population genetics as an approach for the systematic identification of new mutations. In addition to the significance of developmental variation for phenotype-driven studies, this approach can encompass important implications in evolutionary and population biology. Methodology/Principal Findings: Here, we report a preliminary survey for naturally occurring mutations in three geographically interconnected populations of C. intestinalis. The influence of historical, geographical and environmental factors on the distribution of abnormal phenotypes was assessed by means of 12 microsatellites. We identified 37 possible mutant loci with stereotyped defects in embryonic development that segregate in a way typical of recessive alleles. Local populations were found to differ in genetic organization and frequency distribution of phenotypic classes. Conclusions/Significance: Natural genetic polymorphism of C. intestinalis constitutes a valuable source of phenotypes for studying embryonic development in ascidians. Correlating genetic structure and the occurrence of abnormal phenotypes is a crucial focus for understanding the selective forces that shape natural finite populations, and may provide insights of great importance into the evolutionary mechanisms that generate animal diversity.	[Sordino, Paolo; Andreakis, Nikos; Leccia, Nicola I.; Squarzoni, Paola; Tarallo, Raffaella; Alfano, Christian; Caputi, Luigi; D'Ambrosio, Palmira; Daniele, Paola; D'Aniello, Enrico; D'Aniello, Salvatore; Maiella, Sylvie; Miraglia, Valentina; Russo, Monia Teresa; Sorrenti, Gerarda; Branno, Margherita; Cariello, Lucio; Locascio, Annamaria; Spagnuolo, Antonietta; Zanetti, Laura; Ristoratore, Filomena] Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, Naples, Italy; [Brown, Euan R.] Staz Zoolo Anton Dohrn, Lab Neurobiol, Naples, Italy; [Leccia, Nicola I.] G Rummo Hosp, Benevento, Italy; [Alfano, Christian] Tigem Telethon Inst Genet & Med, Naples, Italy; [D'Aniello, Salvatore] Univ Barcelona, Dept Genet, Barcelona, Spain; [Maiella, Sylvie] Inst Pasteur, Paris, France; [Sorrenti, Gerarda] CNR, Inst Marine Sci, Lesina, Italy; [Cirino, Paola] Staz Zool Anton Dohrn, Serv Marine Resources Res, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Stazione Zoologica Anton Dohrn di Napoli	Sordino, P (corresponding author), Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, Naples, Italy.	sordino@szn.it	caputi, Luigi/H-9304-2012; Daniele, Paola/AAB-9604-2019; Andreakis, Nikos/A-4010-2010; Locascio, Annamaria/E-8714-2015; Russo, Monia Teresa/AGI-3134-2022; Brown, Euan R/A-5558-2008; Brown, Euan Robert/I-2389-2019; russo, monia t/Q-5774-2016; CNR, Ismar/P-1247-2014	Daniele, Paola/0000-0001-5640-4184; Andreakis, Nikos/0000-0001-7120-4279; Locascio, Annamaria/0000-0001-6956-2157; Brown, Euan R/0000-0002-5995-834X; Brown, Euan Robert/0000-0002-5995-834X; russo, monia t/0000-0003-2001-5384; Caputi, Luigi/0000-0002-5724-1943; Cirino, Paola/0000-0002-0688-4199; Spagnuolo, Antonietta/0000-0001-6660-071X; D'Aniello, Enrico/0000-0002-2627-0477; CNR, Ismar/0000-0001-5351-1486	European Union; Italian Ministry of University and Research [24/C08c]	European Union(European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Union (Network of Excellence, Marine Genomics Europe, WP36 The genetic identity of species) (PS, NA) and the Italian Ministry of University and Research (24/C08c) (PS, GS).	Andreakis N, 2007, MOL ECOL NOTES, V7, P610, DOI 10.1111/j.1471-8286.2006.01649.x; Awazu S, 2007, GENESIS, V45, P307, DOI 10.1002/dvg.20290; Berrill N. J., 1950, TUNICATA ACCOUNT BRI; Berrill NJ, 1931, PHILOS T R SOC LON B, V219, P281, DOI 10.1098/rstb.1931.0006; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; Boffelli D, 2004, GENOME RES, V14, P2406, DOI 10.1101/gr.3199704; Brown ER, 2005, EUR J NEUROSCI, V22, P2541, DOI 10.1111/j.1460-9568.2005.04420.x; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Caputi L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-39; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CIRINO P, 2002, LAB CULTURE ASCIDIAN; Colson I, 2002, MOL ECOL, V11, P1311, DOI 10.1046/j.1365-294X.2002.01549.x; De Santis R, 2001, BIOLOGY OF ASCIDIANS, P14; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deschet K, 2004, CURR BIOL, V14, pR408, DOI 10.1016/j.cub.2004.05.029; Deschet K, 2003, GENESIS, V35, P248, DOI 10.1002/gene.10195; Fields S, 2005, SCIENCE, V307, P1885, DOI 10.1126/science.1108872; Haffter P, 1996, DEVELOPMENT, V123, P1; Hendrickson C, 2004, METHOD CELL BIOL, V74, P143; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Jeffery WR, 2004, EVOL DEV, V6, P170, DOI 10.1111/j.1525-142X.2004.04022.x; Jiang D, 2005, CURR BIOL, V15, P79; Jiang D, 2005, J EXP BIOL, V208, P433, DOI 10.1242/jeb.01420; Kano S, 2001, MAR BIOTECHNOL, V3, P58, DOI 10.1007/s101260000048; Kano S, 2006, ZOOL SCI, V23, P31, DOI 10.2108/zsj.23.31; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; Kowalewsky A., 1866, Mem. Acad. Imp. St. Petersbourg, Vtom. x, P1; Locascio A, 1999, DEVELOPMENT, V126, P4737; Matsumoto M., 1992, Zoological Science (Tokyo), V9, P1304; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Matsuoka T, 2004, DEV GROWTH DIFFER, V46, P249; McCune AR, 2002, SCIENCE, V296, P2398, DOI 10.1126/science.1071757; Meinertzhagen IA, 2004, ANNU REV NEUROSCI, V27, P453, DOI 10.1146/annurev.neuro.27.070203.144255; Moody R, 1999, MOL GEN GENET, V262, P199, DOI 10.1007/s004380051075; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; NEI M, 1978, GENETICS, V89, P583; Noramly S, 2005, MECH DEVELOP, V122, P273, DOI 10.1016/j.mod.2004.11.001; OHMORI H, 1977, J PHYSIOL-LONDON, V269, P221, DOI 10.1113/jphysiol.1977.sp011900; PAPADOPOULOU C, 1977, MAR POLLUT BULL, V8, P229, DOI 10.1016/0025-326X(77)90431-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETERSEN JK, 1995, J EXP MAR BIOL ECOL, V186, P89, DOI 10.1016/0022-0981(94)00157-9; Procaccini G, 2000, MOL ECOL, V9, P1924, DOI 10.1046/j.1365-294x.2000.01071-4.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riisgard HU, 1998, OPHELIA, V49, P1; Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Satoh N., 1994, DEV BIOL ASCIDIANS; SCHMIDTKE J, 1980, BIOCHEM GENET, V18, P503, DOI 10.1007/BF00484397; Schultz ST, 1999, P NATL ACAD SCI USA, V96, P11393, DOI 10.1073/pnas.96.20.11393; Shimeld SM, 2006, DEV DYNAM, V235, P1543, DOI 10.1002/dvdy.20792; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; Sordino P, 2001, PHILOS T R SOC B, V356, P1573, DOI 10.1098/rstb.2001.0919; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Suzuki MM, 2005, J MOL EVOL, V61, P627, DOI 10.1007/s00239-005-0009-3; TAKAHATA N, 1979, P NATL ACAD SCI USA, V76, P5813, DOI 10.1073/pnas.76.11.5813; Theodorakis CW, 1997, ECOTOXICOLOGY, V6, P335, DOI 10.1023/A:1018695231565; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Whitehead A, 2003, MOL ECOL, V12, P2817, DOI 10.1046/j.1365-294X.2003.01933.x; Whittaker JR, 1997, AM ZOOL, V37, P237; Zega G, 2006, J EXP BIOL, V209, P3405, DOI 10.1242/jeb.02421	69	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2344	10.1371/journal.pone.0002344	http://dx.doi.org/10.1371/journal.pone.0002344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523552	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300037
J	de Heering, A; Rossion, B				de Heering, Adelaide; Rossion, Bruno			Prolonged Visual Experience in Adulthood Modulates Holistic Face Perception	PLOS ONE			English	Article							OTHER-RACE FACES; OWN-RACE; RECOGNITION; INVERSION; AGE; MEMORY; BIAS	Background: Using the well-known composite illusion as a marker of the holistic perception of faces, we tested how prolonged visual experience with a specific population of faces (4- to 6-year-old children) modulates the face perception system in adulthood. Methodology/Principal Findings: We report a face composite effect that is larger for adult than children faces in a group of adults without experience with children faces ("children-face novices''), while it is of equal magnitude for adults and children faces in a population of preschool teachers ("children-face experts''). When considering preschool teachers only, we observed a significant correlation between the number of years of experience with children faces and the differential face composite effect between children and adults faces. Participants with at least 10 years of qualitative experience with children faces had a larger composite face effect for children than adult faces. Conclusions/Significance: Overall, these observations indicate that even in adulthood face processes can be reshaped qualitatively, presumably to facilitate efficient processing of the differential morphological features of the frequently encountered population of faces.	[de Heering, Adelaide; Rossion, Bruno] Catholic Univ Louvain, Unite Cognit & Dev, B-1348 Louvain, Ottignies, Belgium	Universite Catholique Louvain	de Heering, A (corresponding author), Catholic Univ Louvain, Unite Cognit & Dev, B-1348 Louvain, Ottignies, Belgium.	adelaide.deheering@uclouvain.be; bruno.rossion@uclouvain.be	de Heering, Adelaide/A-6482-2017	de Heering, Adelaide/0000-0001-5843-7406; Rossion, Bruno/0000-0002-1845-3935	Belgian National Fund for Scientific Research (FNRS)	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	AH and BR are supported by the Belgian National Fund for Scientific Research (FNRS).	Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; HOLE GJ, 1994, PERCEPTION, V23, P65, DOI 10.1068/p230065; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; KUEFNER D, J EXPT PSYC IN PRESS; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; POLK TA, 1995, NATURE, V376, P648, DOI 10.1038/376648a0; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; VALENTINE T, 1986, ACTA PSYCHOL, V61, P259, DOI 10.1016/0001-6918(86)90085-5; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	27	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2317	10.1371/journal.pone.0002317	http://dx.doi.org/10.1371/journal.pone.0002317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509528	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500045
J	Iwata, Y; Suzuki, K; Wakuda, T; Seki, N; Thanseem, I; Matsuzaki, H; Mamiya, T; Ueki, T; Mikawa, S; Sasaki, T; Suda, S; Yamamoto, S; Tsuchiya, KJ; Sugihara, G; Nakamura, K; Sato, K; Takei, N; Hashimoto, K; Mori, N				Iwata, Yasuhide; Suzuki, Katsuaki; Wakuda, Tomoyasu; Seki, Norihito; Thanseem, Ismail; Matsuzaki, Hideo; Mamiya, Takayoshi; Ueki, Takatoshi; Mikawa, Sumiko; Sasaki, Takeshi; Suda, Shiro; Yamamoto, Shigeyuki; Tsuchiya, Kenji J.; Sugihara, Genichi; Nakamura, Kazuhiko; Sato, Kohji; Takei, Nori; Hashimoto, Kenji; Mori, Norio			Irradiation in Adulthood as a New Model of Schizophrenia	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; STEM-CELL; OBSTETRIC COMPLICATIONS; SPECTRUM DISORDERS; IONIZING-RADIATION; DENTATE GYRUS; BRAIN; MICE; METHAMPHETAMINE	Background: Epidemiological studies suggest that radiation exposure may be a potential risk factor for schizophrenia in adult humans. Here, we investigated whether adult irradiation in rats caused behavioral abnormalities relevant to schizophrenia. Methodology/Principal Findings: A total dose of 15-Gy irradiation in six fractionations during 3 weeks was exposed to the forebrain including the subventricular zone (SVZ) and subgranular zone (SGZ) with male rats in the prone position. Behavioral, immunohistochemical, and neurochemical studies were performed three months after fractionated ionizing irradiation. Three months after fractionated ionizing irradiation, the total numbers of BrdU-positive cells in both the SVZ and SGZ zones of irradiated rats were significantly lower than those of control (sham-irradiated) rats. Hyperactivity after administration of the dopaminergic agonist methamphetamine, but not the N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine, was significantly enhanced in the irradiated rats although spontaneous locomotion in the irradiated rats was significantly lower than that of controls. Behavioral abnormalities including auditory sensory gating deficits, social interaction deficits, and working memory deficits were observed in the irradiated rats. Conclusion/Significance: The present study suggests that irradiation in adulthood caused behavioral abnormalities relevant to schizophrenia, and that reduction of adult neurogenesis by irradiation may be associated with schizophrenia-like behaviors in rats.	[Iwata, Yasuhide; Suzuki, Katsuaki; Wakuda, Tomoyasu; Suda, Shiro; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Ueki, Takatoshi; Mikawa, Sumiko; Sasaki, Takeshi; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Anat, Shizuoka, Japan; [Seki, Norihito; Thanseem, Ismail; Yamamoto, Shigeyuki; Tsuchiya, Kenji J.; Sugihara, Genichi; Takei, Nori] Hamamatsu Univ Sch Med, Mental Dev Res Ctr, Shizuoka, Japan; [Matsuzaki, Hideo] Osaka Univ, Grad Sch Med, Mental Dev Res Ctr, Osaka, Japan; [Mamiya, Takayoshi] Meijo Univ, Fac Pharm Sci, Dept Chem Pharm, Nagoya, Aichi, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forensic Mental Hlth, Div Clin Neurosci, Chiba, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Meijo University; Chiba University	Iwata, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan.	iwata@hama-med.ac.jp; hashimoto@faculty.chiba-u.jp	MATSUZAKI, HIDEO/AAE-5246-2020; Takei, Nori/GWZ-7464-2022; Tsuchiya, Kenji J./I-9123-2019; Takei, Nori/AAC-8578-2019; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tsuchiya, Kenji J./0000-0002-1314-4199; Hashimoto, Kenji/0000-0002-8892-0439; Wakuda, Tomoyasu/0000-0002-1924-8167; Suzuki, Katsuaki/0000-0003-0446-3355	Japan Society for the Promotion of Science [19209039, 15209036, 19390301]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (#19209039 and #15209036; to N.M. and #19390301; to K.H.) from the Japan Society for the Promotion of Science. These fundings had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Byrne TN, 2005, CURR OPIN NEUROL, V18, P662, DOI 10.1097/01.wco.0000191511.52745.99; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Eriksson PS, 2006, EXP NEUROL, V199, P26, DOI 10.1016/j.expneurol.2005.10.017; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Geddes JR, 1999, SCHIZOPHRENIA BULL, V25, P413, DOI 10.1093/oxfordjournals.schbul.a033389; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; GUNDERSEN HJ, 1989, J MICROSC-OXFORD, V147, P229; HASHIMOTO K, 2008, EUR NEUROPS IN PRESS; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Juan L, 2006, SYNAPSE, V60, P56, DOI 10.1002/syn.20275; Loganovsky KN, 2005, WORLD J BIOL PSYCHIA, V6, P212, DOI 10.1080/15622970510029876; LOGANOVSKY KN, 2005, SCHIZOPHR B, V26, P751; Matsumoto H, 2001, PSYCHOL MED, V31, P907, DOI 10.1017/S0033291701003944; Miyakawa T, 1996, MOL BRAIN RES, V37, P145; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nakane Y., 1986, PSYCHIATRIC CASE REG, P26; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Tani K, 2001, BRIT J PHARMACOL, V134, P1411, DOI 10.1038/sj.bjp.0704370; Toro CT, 2007, SCHIZOPHR RES, V90, P1, DOI 10.1016/j.schres.2006.09.030; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	35	31	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2283	10.1371/journal.pone.0002283	http://dx.doi.org/10.1371/journal.pone.0002283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509473	Green Submitted, Green Published, gold			2022-12-27	WOS:000262268500026
J	Martinez, GQ; Maduke, M				Martinez, Gilbert Q.; Maduke, Merritt			A Cytoplasmic Domain Mutation in ClC-Kb Affects Long-Distance Communication Across the Membrane	PLOS ONE			English	Article								Background: ClC-Kb and ClC-Ka are homologous chloride channels that facilitate chloride homeostasis in the kidney and inner ear. Disruption of ClC-Kb leads to Bartter's Syndrome, a kidney disease. A point mutation in ClC-Kb, R538P, linked to Bartter's Syndrome and located in the C-terminal cytoplasmic domain was hypothesized to alter electrophysiological properties due to its proximity to an important membrane-embedded helix. Methodology/Principal Findings: Two-electrode voltage clamp experiments were used to examine the electrophysiological properties of the mutation R538P in both ClC-Kb and ClC-Ka. R538P selectively abolishes extracellular calcium activation of ClC-Kb but not ClC-Ka. In attempting to determine the reason for this specificity, we hypothesized that the ClC-Kb C-terminal domain had either a different oligomeric status or dimerization interface than that of ClC-Ka, for which a crystal structure has been published. We purified a recombinant protein corresponding to the ClC-Kb C-terminal domain and used multi-angle light scattering together with a cysteine-crosslinking approach to show that the dimerization interface is conserved between the ClC-Kb and ClC-Ka C-terminal domains, despite the fact that there are several differences in the amino acids that occur at this interface. Conclusions: The R538P mutation in ClC-Kb, which leads to Bartter's Syndrome, abolishes calcium activation of the channel. This suggests that a significant conformational change - ranging from the cytoplasmic side of the protein to the extracellular side of the protein - is involved in the Ca(2+)-activation process for ClC-Kb, and shows that the cytoplasmic domain is important for the channel's electrophysiological properties. In the highly similar ClC-Ka (90% identical), the R538P mutation does not affect activation by extracellular Ca(2+). This selective outcome indicates that ClC-Ka and ClC-Kb differ in how conformational changes are translated to the extracellular domain, despite the fact that the cytoplasmic domains share the same quaternary structure.	[Martinez, Gilbert Q.; Maduke, Merritt] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Martinez, GQ (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	maduke@stanford.edu		Maduke, Merritt/0000-0001-7787-306X	American Heart Association [0435056N]; Mathers Foundation	American Heart Association(American Heart Association); Mathers Foundation	This work was supported by the American Heart Association (0435056N) and the Mathers Foundation.	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Beck CL, 1996, P NATL ACAD SCI USA, V93, P11248, DOI 10.1073/pnas.93.20.11248; Carr G, 2003, BIOCHEM BIOPH RES CO, V310, P600, DOI 10.1016/j.bbrc.2003.09.057; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Cox JPD, 1999, J BONE MINER RES, V14, P1536, DOI 10.1359/jbmr.1999.14.9.1536; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2002, CURR OPIN STRUC BIOL, V12, P531, DOI 10.1016/S0959-440X(02)00358-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Fukuyama S, 2004, J CLIN ENDOCR METAB, V89, P5847, DOI 10.1210/jc.2004-0775; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Heils Armin, 2005, Adv Neurol, V95, P265; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Jeck N, 2000, PEDIATR RES, V48, P754, DOI 10.1203/00006450-200012000-00009; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1995, SOC GEN PHY, V50, P149; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KONDO Y, 1988, AM J PHYSIOL, V254, pF232, DOI 10.1152/ajprenal.1988.254.2.F232; Konrad M, 2000, J AM SOC NEPHROL, V11, P1449, DOI 10.1681/ASN.V1181449; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Mupanomunda MM, 2000, AM J PHYSIOL-RENAL, V278, pF644, DOI 10.1152/ajprenal.2000.278.4.F644; Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004; Nozu K, 2008, J MED GENET, V45, P182, DOI 10.1136/jmg.2007.052944; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Rodriguez-Soriano J, 2005, PEDIATR NEPHROL, V20, P891, DOI 10.1007/s00467-005-1867-z; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Stogmann E, 2006, NEUROGENETICS, V7, P265, DOI 10.1007/s10048-006-0057-x; Uchida S, 2005, ANNU REV PHYSIOL, V67, P759, DOI 10.1146/annurev.physiol.67.032003.153547; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Zelikovic I, 2003, KIDNEY INT, V63, P24, DOI 10.1046/j.1523-1755.2003.00730.x; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605	59	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2746	10.1371/journal.pone.0002746	http://dx.doi.org/10.1371/journal.pone.0002746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648499	gold, Green Submitted, Green Published			2022-12-27	WOS:000264302900017
J	van Aerde, KI; Heistek, TS; Mansvelder, HD				van Aerde, Karlijn I.; Heistek, Tim S.; Mansvelder, Huibert D.			Prelimbic and Infralimbic Prefrontal Cortex Interact during Fast Network Oscillations	PLOS ONE			English	Article								Background: The medial prefrontal cortex has been implicated in a variety of cognitive and executive processes such as decision making and working memory. The medial prefrontal cortex of rodents consists of several areas including the prelimbic and infralimbic cortex that are thought to be involved in different aspects of cognitive performance. Despite the distinct roles in cognitive behavior that have been attributed to prelimbic and infralimbic cortex, little is known about neuronal network functioning of these areas, and whether these networks show any interaction during fast network oscillations. Methodology/Principal Findings: Here we show that fast network oscillations in rat infralimbic cortex slices occur at higher frequencies and with higher power than oscillations in prelimbic cortex. The difference in oscillation frequency disappeared when prelimbic and infralimbic cortex were disconnected. Conclusions/Significance: Our data indicate that neuronal networks of prelimbic and infralimbic cortex can sustain fast network oscillations independent of each other, but suggest that neuronal networks of prelimbic and infralimbic cortex are interacting during these oscillations.	[van Aerde, Karlijn I.; Heistek, Tim S.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Aerde, KI (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Amsterdam, Netherlands.	huibert.mansvelder@cncr.vu.nl	Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	Dutch Medical Research Council [912.04.022, 917.76.360]; Royal Netherlands Academy of Arts and Sciences; NeuroBsik	Dutch Medical Research Council(Danish Medical Research Council); Royal Netherlands Academy of Arts and Sciences; NeuroBsik	This work was supported by grants from the Dutch Medical Research Council (912.04.022, 917.76.360) and the Royal Netherlands Academy of Arts and Sciences to HDM, and by NeuroBsik (www.neurobsik.nl). They did not have any influence on the study performed.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Marquis JP, 2007, EUR J NEUROSCI, V25, P559, DOI 10.1111/j.1460-9568.2006.05295.x; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; Paulsen O, 2006, J NEUROSCI, V26, P1661, DOI 10.1523/JNEUROSCI.3737-05a.2006; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; RAGOZZINO M, 2007, ANN N Y ACAD SCI; Shimono K, 2000, J NEUROSCI, V20, P8462, DOI 10.1523/JNEUROSCI.20-22-08462.2000; Shimono K, 2001, NEUROCOMPUTING, V38, P899, DOI 10.1016/S0925-2312(01)00392-7; STERIADE M, 1990, J NEUROSCI, V10, P2560; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; VANDENOEVER MC, 2008, NATURE NEUR IN PRESS; VANEDEN CG, 1985, J COMP NEUROL, V241, P253, DOI 10.1002/cne.902410302	32	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2725	10.1371/journal.pone.0002725	http://dx.doi.org/10.1371/journal.pone.0002725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628964	Green Submitted, Green Published, gold			2022-12-27	WOS:000264057200063
J	Chiang, YJ; Hsiao, SJ; Yver, D; Cushman, SW; Tessarollo, L; Smith, S; Hodes, RJ				Chiang, Y. Jeffrey; Hsiao, Susan J.; Yver, Dena; Cushman, Samuel W.; Tessarollo, Lino; Smith, Susan; Hodes, Richard J.			Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development	PLOS ONE			English	Article							SISTER TELOMERE ASSOCIATION; REPEAT-BINDING FACTOR-1; POLY(ADP-RIBOSE) POLYMERASE; LENGTH MAINTENANCE; IRAP; TRF1; REQUIREMENTS; EXPRESSION; CONTAINS; ACCEPTOR	Tankyrases are proteins with poly(ADP-ribose) polymerase activity. Human tankyrases post-translationally modify multiple proteins involved in processes including maintenance of telomere length, sister telomere association, and trafficking of glut4-containing vesicles. To date, however, little is known about in vivo functions for tankyrases. We recently reported that body size was significantly reduced in mice deficient for tankyrase 2, but that these mice otherwise appeared developmentally normal. In the present study, we report generation of tankyrase 1-deficient and tankyrase 1 and 2 double-deficient mice, and use of these mutant strains to systematically assess candidate functions of tankyrase 1 and tankyrase 2 in vivo. No defects were observed in development, telomere length maintenance, or cell cycle regulation in tankyrase 1 or tankyrase 2 knockout mice. In contrast to viability and normal development of mice singly deficient in either tankyrase, deficiency in both tankyrase 1 and tankyrase 2 results in embryonic lethality by day 10, indicating that there is substantial redundancy between tankyrase 1 and tankyrase 2, but that tankyrase function is essential for embryonic development.	[Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD USA; [Hsiao, Susan J.; Smith, Susan] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY USA; [Yver, Dena; Cushman, Samuel W.] NIDDKD, NIH, Bethesda, MD USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chiang, YJ (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov		Smith, Susan/0000-0002-8213-5915	NIH [GM07238, RO1 CA95099]; National Institutes of Health (NIH), National Cancer Institute; NATIONAL CANCER INSTITUTE [ZICBC010904, Z01BC009255, ZIABC009405, R01CA095099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.J.H. was supported by the NIH Predoctoral Training Grant (GM07238). S.S. was supported by the NIH (RO1 CA95099). This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute.	Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baerlocher GM, 2002, CYTOMETRY, V47, P89, DOI 10.1002/cyto.10053; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; CHANG P, 2005, NAT CELL BIOL; Chang W, 2005, BIOCHEM J, V391, P177, DOI 10.1042/BJ20050885; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; GLIEMANN J, 1984, BIOCHIM BIOPHYS ACTA, V804, P68, DOI 10.1016/0167-4889(84)90100-9; Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Kuimov AN, 2001, GENES IMMUN, V2, P52, DOI 10.1038/sj.gene.6363722; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Tessarollo L, 2000, METH MOL B, V158, P47; Xu XL, 1998, DEVELOPMENT, V125, P753; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793	30	113	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2639	10.1371/journal.pone.0002639	http://dx.doi.org/10.1371/journal.pone.0002639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612384	Green Submitted, gold, Green Published			2022-12-27	WOS:000264065800041
J	Klompas, M; Haney, G; Church, D; Lazarus, R; Hou, XL; Platt, R				Klompas, Michael; Haney, Gillian; Church, Daniel; Lazarus, Ross; Hou, Xuanlin; Platt, Richard			Automated Identification of Acute Hepatitis B Using Electronic Medical Record Data to Facilitate Public Health Surveillance	PLOS ONE			English	Article								Background: Automatic identification of notifiable diseases from electronic medical records can potentially improve the timeliness and completeness of public health surveillance. We describe the development and implementation of an algorithm for prospective surveillance of patients with acute hepatitis B using electronic medical record data. Methods: Initial algorithms were created by adapting Centers for Disease Control and Prevention diagnostic criteria for acute hepatitis B into electronic terms. The algorithms were tested by applying them to ambulatory electronic medical record data spanning 1990 to May 2006. A physician reviewer classified each case identified as acute or chronic infection. Additional criteria were added to algorithms in serial fashion to improve accuracy. The best algorithm was validated by applying it to prospective electronic medical record data from June 2006 through April 2008. Completeness of case capture was assessed by comparison with state health department records. Findings: A final algorithm including a positive hepatitis B specific test, elevated transaminases and bilirubin, absence of prior positive hepatitis B tests, and absence of an ICD9 code for chronic hepatitis B identified 112/113 patients with acute hepatitis B ( sensitivity 97.4%, 95% confidence interval 94-100%; specificity 93.8%, 95% confidence interval 87-100%). Application of this algorithm to prospective electronic medical record data identified 8 cases without false positives. These included 4 patients that had not been reported to the health department. There were no known cases of acute hepatitis B missed by the algorithm. Conclusions: An algorithm using codified electronic medical record data can reliably detect acute hepatitis B. The completeness of public health surveillance may be improved by automatically identifying notifiable diseases from electronic medical record data.	[Klompas, Michael; Platt, Richard] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; [Klompas, Michael; Lazarus, Ross; Hou, Xuanlin; Platt, Richard] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Haney, Gillian; Church, Daniel] Massachusetts Dept Publ Hlth, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Department of Public Health	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019	lazarus, ross/0000-0003-3939-1961	Centers for Disease Control and Prevention [PH000238D]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by grant PH000238D from the Centers for Disease Control and Prevention. The funding organization had no role in the study design, data collection, analysis, interpretation, writing or submission of this manuscript.	DAVIS GL, 1985, ANN INTERN MED, V102, P762, DOI 10.7326/0003-4819-102-6-762; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Effler P, 1999, JAMA-J AM MED ASSOC, V282, P1845, DOI 10.1001/jama.282.19.1845; Gonzalez R, 2006, TRANSFUSION, V46, P1138, DOI 10.1111/j.1537-2995.2006.00863.x; Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29; Klompas M., 2008, Morbidity and Mortality Weekly Report, V57, P373; Klompas M., 2007, ADV DIS SURV, V3, P1; Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x; McHugh L. A., 2008, Morbidity and Mortality Weekly Report, V57, P42; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Panackal AA, 2002, EMERG INFECT DIS, V8, P685, DOI 10.3201/eid0807.010493; Poulos Roslyn G, 2004, Commun Dis Intell Q Rep, V28, P392; Ramsay ME, 1998, VACCINE, V16, pS76, DOI 10.1016/S0264-410X(98)00303-X; van De Garde EMW, 2007, J CLIN EPIDEMIOL, V60, P834, DOI 10.1016/j.jclinepi.2006.10.018; Ward M, 2005, Euro Surveill, V10, P7, DOI 10.2807/esm.10.01.00513-en; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; Weber B, 2005, J CLIN VIROL, V32, P67, DOI 10.1016/j.jcv.2004.09.018	17	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2626	10.1371/journal.pone.0002626	http://dx.doi.org/10.1371/journal.pone.0002626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612462	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800028
J	Fox, AS; Shelton, SE; Oakes, TR; Davidson, RJ; Kalin, NH				Fox, Andrew S.; Shelton, Steven E.; Oakes, Terrence R.; Davidson, Richard J.; Kalin, Ned H.			Trait-Like Brain Activity during Adolescence Predicts Anxious Temperament in Primates	PLOS ONE			English	Article							PERFORMANCE EVALUATION; BEHAVIORAL-INHIBITION; HIGH-RESOLUTION; RHESUS-MONKEYS; PET SCANNER; ANXIETY; AMYGDALA; EMOTION; REGISTRATION; MICROPET	Early theorists (Freud and Darwin) speculated that extremely shy children, or those with anxious temperament, were likely to have anxiety problems as adults. More recent studies demonstrate that these children have heightened responses to potentially threatening situations reacting with intense defensive responses that are characterized by behavioral inhibition (BI) (inhibited motor behavior and decreased vocalizations) and physiological arousal. Confirming the earlier impressions, data now demonstrate that children with this disposition are at increased risk to develop anxiety, depression, and comorbid substance abuse. Additional key features of anxious temperament are that it appears at a young age, it is a stable characteristic of individuals, and even in non-threatening environments it is associated with increased psychic anxiety and somatic tension. To understand the neural underpinnings of anxious temperament, we performed imaging studies with 18-fluoro-deoxyglucose (FDG) high-resolution Positron Emission Tomography (PET) in young rhesus monkeys. Rhesus monkeys were used because they provide a well validated model of anxious temperament for studies that cannot be performed in human children. Imaging the same animal in stressful and secure contexts, we examined the relation between regional metabolic brain activity and a trait-like measure of anxious temperament that encompasses measures of BI and pituitary-adrenal reactivity. Regardless of context, results demonstrated a trait-like pattern of brain activity (amygdala, bed nucleus of stria terminalis, hippocampus, and periaqueductal gray) that is predictive of individual phenotypic differences. Importantly, individuals with extreme anxious temperament also displayed increased activity of this circuit when assessed in the security of their home environment. These findings suggest that increased activity of this circuit early in life mediates the childhood temperamental risk to develop anxiety and depression. In addition, the findings provide an explanation for why individuals with anxious temperament have difficulty relaxing in environments that others perceive as non-stressful.	[Fox, Andrew S.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Shelton, Steven E.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin Madison, Dept Psychiat, Madison, WI USA; [Fox, Andrew S.; Oakes, Terrence R.; Davidson, Richard J.; Kalin, Ned H.] Univ Wisconsin Madison, Waisman Lab Brain Imaging & Behavior, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fox, AS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	nkalin@wisc.edu		Kalin, Ned/0000-0003-1184-0868; Davidson, Richard/0000-0002-8506-4964	HealthEmotions Research Institute and Meriter Hospital [MH046729, MH052354, MH069315]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046729, P50MH052354, P50MH069315] Funding Source: NIH RePORTER	HealthEmotions Research Institute and Meriter Hospital; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants MH046729, MH052354, MH069315, The HealthEmotions Research Institute and Meriter Hospital.	BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Biederman J, 2001, AM J PSYCHIAT, V158, P1673, DOI 10.1176/appi.ajp.158.10.1673; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Chatziioannou AF, 1999, J NUCL MED, V40, P1164; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DREVETS WC, 1992, SCIENCE, V256, P1696, DOI 10.1126/science.256.5064.1696; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Farquhar TH, 1998, IEEE T MED IMAGING, V17, P1073, DOI 10.1109/42.746722; Fox AS, 2005, P NATL ACAD SCI USA, V102, P4176, DOI 10.1073/pnas.0409470102; Fox NA, 2005, ANNU REV PSYCHOL, V56, P235, DOI 10.1146/annurev.psych.55.090902.141532; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jernigan TL, 2003, HUM BRAIN MAPP, V19, P90, DOI 10.1002/hbm.10108; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kagan J, 2008, DEV PSYCHOBIOL, V50, P4, DOI 10.1002/dev.20267; Kalin NH, 2005, BIOL PSYCHIAT, V58, P796, DOI 10.1016/j.biopsych.2005.05.021; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702; Knoess C, 2003, EUR J NUCL MED MOL I, V30, P737, DOI 10.1007/s00259-002-1052-6; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Paxinos G., 2000, RHESUS MONKEY BRAIN; PHELPS ME, 1978, J NUCL MED, V19, P1311; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	35	110	111	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2570	10.1371/journal.pone.0002570	http://dx.doi.org/10.1371/journal.pone.0002570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IM	18596957	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200035
J	Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Haemmerle, M; Rainer, C; Deisenhammer, F; Schocke, M; Berger, T; Reindl, M				Kuenz, Bettina; Lutterotti, Andreas; Ehling, Rainer; Gneiss, Claudia; Haemmerle, Monika; Rainer, Carolyn; Deisenhammer, Florian; Schocke, Michael; Berger, Thomas; Reindl, Markus			Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis	PLOS ONE			English	Article								Background: There is accumulating evidence from immunological, pathological and therapeutic studies that B cells are key components in the pathophysiology of multiple sclerosis (MS). Methodology/Principal Findings: In this prospective study we have for the first time investigated the differences in the inflammatory response between relapsing and progressive MS by comparing cerebrospinal fluid (CSF) cell profiles from patients at the onset of the disease (clinically isolated syndrome, CIS), relapsing-remitting (RR) and chronic progressive (CP) MS by flow cytometry. As controls we have used patients with other neurological diseases. We have found a statistically significant accumulation of CSF mature B cells (CD19+CD138-) and plasma blasts (CD19+CD138+) in CIS and RRMS. Both B cell populations were, however, not significantly increased in CPMS. Further, this accumulation of B cells correlated with acute brain inflammation measured by magnetic resonance imaging and with inflammatory CSF parameters such as the number of CSF leukocytes, intrathecal immunoglobulin M and G synthesis and intrathecal production of matrix metalloproteinase (MMP)-9 and the B cell chemokine CxCL-13. Conclusions: Our data support an important role of CSF B cells in acute brain inflammation in CIS and RRMS.	[Kuenz, Bettina; Lutterotti, Andreas; Ehling, Rainer; Gneiss, Claudia; Haemmerle, Monika; Rainer, Carolyn; Deisenhammer, Florian; Berger, Thomas; Reindl, Markus] Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria; [Schocke, Michael] Innsbruck Med Univ, Dept Radiol 1, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Kuenz, B (corresponding author), Innsbruck Med Univ, Dept Clin Neurol, Innsbruck, Austria.	markus.reindl@i-med.ac.at	Berger, Thomas U/HGA-3594-2022; Reindl, Markus/ABE-5880-2020; Schocke, Michael/AAC-3666-2020	Haemmerle, Monika/0000-0003-3145-0541; Reindl, Markus/0000-0003-2817-1402	Gemeinnuetzige Hertiestiftung (Frankfurt, Germany); Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University; Schering-Berlex (Germany, USA)	Gemeinnuetzige Hertiestiftung (Frankfurt, Germany); Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University; Schering-Berlex (Germany, USA)	This study was supported by research grants of the Gemeinnuetzige Hertiestiftung (Frankfurt, Germany), the Interdisciplinary Center for Research and Treatment (IFTZ) of Innsbruck Medical University and Schering-Berlex (Germany, USA). The sponsors or funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cepok S, 2003, ARCH NEUROL-CHICAGO, V60, P849, DOI 10.1001/archneur.60.6.849; Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195; Cepok S, 2006, J NEUROIMMUNOL, V180, P33, DOI 10.1016/j.jneuroim.2006.06.031; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; Di Girolamo N, 1998, EUR J IMMUNOL, V28, P1773, DOI 10.1002/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Liuzzi GM, 2002, MULT SCLER, V8, P222, DOI 10.1191/1352458502ms800oa; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Magliozzi R, 2004, J NEUROIMMUNOL, V148, P11, DOI 10.1016/j.jneuroim.2003.10.056; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qin YF, 1998, J CLIN INVEST, V102, P1045, DOI 10.1172/JCI3568; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Trocme C, 1998, J BIOL CHEM, V273, P20677, DOI 10.1074/jbc.273.32.20677; Uccelli A, 2005, TRENDS IMMUNOL, V26, P254, DOI 10.1016/j.it.2005.02.009; Yong VW, 1998, TRENDS NEUROSCI, V21, P75	39	85	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2559	10.1371/journal.pone.0002559	http://dx.doi.org/10.1371/journal.pone.0002559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596942	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200026
J	Kondilis, BK; Kiriaze, IJ; Athanasoulia, AP; Falagas, ME				Kondilis, Barbara K.; Kiriaze, Ismene J.; Athanasoulia, Anastasia P.; Falagas, Matthew E.			Mapping Health Literacy Research in the European Union: A Bibliometric Analysis	PLOS ONE			English	Article							RESEARCH PRODUCTIVITY; BIOMEDICAL-RESEARCH; READABILITY; ENGLISH; SPANISH; WRITTEN	Background: To examine and compare the research productivity on selected fields related to health literacy of the current members of the European Union, the four candidate countries waiting to join the EU, Norway, Switzerland, and the United States. Methodology/Principal findings: A bibliometric analysis (1991-2005). Data sources included papers published by authors from each country separately. The 25 European countries produce less than 1/3 health literacy research when compared to the U.S. (13,710 and 49,523 articles were published by authors with main affiliation in the European Union and the four candidate countries, and the U. S., respectively). The Netherlands and Sweden (followed by Germany, Italy, and France) are the European countries with the highest number of research published in fields related to health literacy. After adjustment for population Sweden, Finland, and Norway, were on the top of the relevant list. In addition, Sweden, Finland, and Ireland, were on the top of the list of countries regarding research productivity on the selected fields after adjustment for gross domestic product (GDP). Conclusions/Significance: Inequalities in research published on the topic of health literacy exist among Europe, Norway, Switzerland, and the U. S. More research may need to be done in all areas of health literacy in Europe and the potential detrimental effects of this gap should be further investigated.	[Kondilis, Barbara K.; Kiriaze, Ismene J.; Athanasoulia, Anastasia P.; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Kondilis, Barbara K.; Kiriaze, Ismene J.] Hellenic American Univ, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA USA	Alfa Institute Of Biomedical Sciences; Tufts University	Kondilis, BK (corresponding author), Alfa Inst Biomed Sci, Athens, Greece.	m.falagas@aibs.gr			Marie Curie Reintegration Grant [518711]	Marie Curie Reintegration Grant(European Commission)	This research was made possible through a Marie Curie Reintegration Grant (#518711).	Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; Christmann S., 2005, EUROHEALTHNET; Coey L, 1996, J CLIN NURS, V5, P359, DOI 10.1111/j.1365-2702.1996.tb00268.x; Commission of the European Communities, 2002, EEUR 2005 INF SOC AL; Contreras A, 1999, J HEALTH COMMUN, V4, P21, DOI 10.1080/108107399127066; *CTR HLTH CAR STRA, FACT SHEETS HLTH LIT; DIXON E, 1990, NURS OUTLOOK, V38, P278; *EUR COMM, 2002, QUAL CIRT HLTH REL W; European Commission, 2001, ELEARNING ACT PLAN D; Falagas ME, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-56; Kickbusch IS, 2001, HEALTH PROMOT INT, V16, P289, DOI 10.1093/heapro/16.3.289; Kondilis BK, 2006, EUR J PUBLIC HEALTH, V16, P113, DOI 10.1093/eurpub/cki204; Kusec Sanja, 2003, Stud Health Technol Inform, V95, P655; Leyva M, 2005, AMBUL PEDIATR, V5, P56, DOI 10.1367/A04-093R.1; Mastilica M, 2005, BMJ-BRIT MED J, V331, P223, DOI 10.1136/bmj.331.7510.223; Mierzewski P, 2005, BRIT MED J, V331, P226, DOI 10.1136/bmj.331.7510.226; Mika VS, 2005, FAM COMMUNITY HEALTH, V28, P351, DOI 10.1097/00003727-200510000-00007; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P183, DOI 10.1093/heapro/15.3.183; Paris A, 2005, PRESSE MED, V34, P13, DOI 10.1016/S0755-4982(05)83877-1; Rudd R.E., 1999, ANN REV ADULT LEARNI; Soteriades ES, 2005, BRIT MED J, V331, P192, DOI 10.1136/bmj.331.7510.192; Vergidis PI, 2005, EUR J CLIN MICROBIOL, V24, P342, DOI 10.1007/s10096-005-1306-x; WILSON P, 2004, EHEALTH C CORK IR; Young D, 2004, AM J HEALTH-SYST PH, V61, P986, DOI 10.1093/ajhp/61.10.986; 2005, TAKING HLTH LIT SERI, V366, P95	27	40	40	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2519	10.1371/journal.pone.0002519	http://dx.doi.org/10.1371/journal.pone.0002519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406IK	18575594	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288000035
J	Stahl, JE; Kreke, JE; Malek, FAA; Schaefer, AJ; Vacanti, J				Stahl, James E.; Kreke, Jennifer E.; Malek, Fawaz Ali Abdul; Schaefer, Andrew J.; Vacanti, Joseph			Consequences of Cold-Ischemia Time on Primary Nonfunction and Patient and Graft Survival in Liver Transplantation: A Meta-Analysis	PLOS ONE			English	Article								Introduction: The ability to preserve organs prior to transplant is essential to the organ allocation process. Objective: The purpose of this study is to describe the functional relationship between cold-ischemia time (CIT) and primary nonfunction (PNF), patient and graft survival in liver transplant. Methods: To identify relevant articles Medline, EMBASE and the Cochrane database, including the non-English literature identified in these databases, was searched from 1966 to April 2008. Two independent reviewers screened and extracted the data. CIT was analyzed both as a continuous variable and stratified by clinically relevant intervals. Nondichotomous variables were weighted by sample size. Percent variables were weighted by the inverse of the binomial variance. Results: Twenty-six studies met criteria. Functionally, PNF% = -6.678281+ 0.9134701*CIT Mean+0.1250879*(CIT Mean -9.89535)(Lambda)2-0.0067663*(CIT Mean -9.89535)(Lambda)3, r2 = .625,, p < .0001. Mean patient survival: 93% (1 month), 88% (3 months), 83% (6 months) and 83% (12 months). Mean graft survival: 85.9% (1 month), 80.5% (3 months), 78.1% (6 months) and 76.8% (12 months). Maximum patient and graft survival occurred with CITs between 7.5-12.5 hrs at each survival interval. PNF was also significantly correlated with ICU time, % first time grafts and % immunologic mismatches. Conclusion: The results of this work imply that CIT may be the most important pre-transplant information needed in the decision to accept an organ.	[Stahl, James E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Inst Technol Assessment, Boston, MA 02115 USA; [Stahl, James E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Stahl, James E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Kreke, Jennifer E.; Schaefer, Andrew J.] Univ Pittsburgh, Dept Industrial Engn, Pittsburgh, PA USA; [Schaefer, Andrew J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Malek, Fawaz Ali Abdul] Univ Kuwait, Industrial & Management Syst Engn Dept, Kuwait, Kuwait; [Vacanti, Joseph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat Surg, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kuwait University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stahl, JE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Inst Technol Assessment, Boston, MA 02115 USA.	Jstahl@partners.org			National Science Foundation [DMI-0223084]; National Institutes of Health [R01-HS09694, 1K08HS011637-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS011637, R01HS009694] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The authors of this paper did not receive any commercial funding for this project. Supported by grant DMI-0223084 from the National Science Foundation and partially by grants R01-HS09694 and 1K08HS011637-01A1 from the National Institutes of Health.	ADAM R, 1992, LANCET, V340, P1373, DOI 10.1016/0140-6736(92)92559-X; ADAM R, 1993, TRANSPLANT P, V25, P1653; ADAM R, 1995, TRANSPLANT P, V27, P1181; ADAM R, 1991, TRANSPLANT P, V23, P2374; Bennett-Guerrero E, 2001, ARCH SURG-CHICAGO, V136, P1177, DOI 10.1001/archsurg.136.10.1177; Brooks BK, 1996, TRANSPLANTATION, V62, P1784, DOI 10.1097/00007890-199612270-00017; BURDELSKI M, 1987, TRANSPLANT P, V19, P3838; Cacclarelli TV, 1999, TRANSPLANTATION, V68, P650, DOI 10.1097/00007890-199909150-00010; CALMUS Y, 1995, GASTROENTEROLOGY, V108, P1510, DOI 10.1016/0016-5085(95)90701-7; CARRARO P, 1995, CLIN CHEM, V41, P471; Cavallari A, 2003, LIVER TRANSPLANT, V9, P814, DOI 10.1053/jlts.2003.50161; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; CILLO U, 1994, TRANSPLANT P, V26, P3599; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; COFER JB, 1990, TRANSPLANTATION, V49, P1088, DOI 10.1097/00007890-199006000-00012; COFER JB, 1992, TRANSPLANTATION, V53, P995, DOI 10.1097/00007890-199205000-00006; COLLINS GM, 1969, LANCET, V2, P1219, DOI 10.1016/S0140-6736(69)90753-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deschenes M, 1998, TRANSPLANTATION, V66, P302, DOI 10.1097/00007890-199808150-00005; Dette K, 1997, TRANSPL P, V29, P376, DOI 10.1016/S0041-1345(96)00126-1; Fernandez-Merino J, 2003, TRANSPLANT P, V35, P1439, DOI 10.1016/S0041-1345(03)00480-9; FURUKAWA H, 1991, TRANSPLANTATION, V51, P1000, DOI 10.1097/00007890-199105000-00013; FURUKAWA H, 1991, TRANSPLANT P, V23, P1550; GARCIAVALDECASA.JC, 1991, TRANSPLANT INT, V5, P77; GARCIAVALDECASAS JC, 1992, TRANSPLANT P, V24, P130; GONZALEZ FX, 1994, HEPATOLOGY, V20, P565, DOI 10.1002/hep.1840200304; GREIG PD, 1990, TRANSPLANT P, V22, P2072; Gruenberger T, 1996, Transpl Int, V9 Suppl 1, pS132, DOI 10.1111/j.1432-2277.1996.tb01589.x; HALLER GW, 1995, TRANSPLANT P, V27, P1192; Imagawa DK, 1996, TRANSPLANTATION, V61, P1605, DOI 10.1097/00007890-199606150-00010; Jain Ashok, 2006, Exp Clin Transplant, V4, P451; Kang KJ, 2002, TRANSPLANT P, V34, P2659, DOI 10.1016/S0041-1345(02)03465-6; KUSS R, 1992, ILLUSTRATED HIST ORG; MAKOWKA L, 1987, TRANSPLANT P, V19, P2378; Maring JK, 1997, CLIN TRANSPLANT, V11, P373; MENASCHE P, 1994, EUR J CARDIO-THORAC, V8, P207, DOI 10.1016/1010-7940(94)90117-1; MOR E, 1992, TRANSPLANTATION, V53, P383, DOI 10.1097/00007890-199202010-00022; Nardo B, 2005, TRANSPL P, V37, P320, DOI 10.1016/j.transproceed.2004.11.028; Nardo B, 2001, TRANSPLANT P, V33, P870, DOI 10.1016/S0041-1345(00)02357-5; OELLERICH M, 1993, TRANSPLANT P, V25, P1116; Ohkohchi N, 2002, TRANSPLANT P, V34, P2670, DOI 10.1016/S0041-1345(02)03370-5; OLTHOFF KM, 1990, TRANSPLANTATION, V49, P284, DOI 10.1097/00007890-199002000-00012; Pedotti P, 2004, TRANSPLANTATION, V77, P1540, DOI 10.1097/01.TP.0000132278.00441.CF; Pettiti D, 1994, METAANALYSIS DECISIO; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024; PLOEG RJ, 1993, TRANSPLANT P, V25, P3031; Stahl JE, 2005, MED DECIS MAKING, V25, P35, DOI 10.1177/0272989X04273137; STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410; STRATTA RJ, 1990, TRANSPLANTATION, V50, P438, DOI 10.1097/00007890-199009000-00015; TAKAYA S, 1995, TRANSPLANT P, V27, P1862; TODO S, 1989, JAMA-J AM MED ASSOC, V261, P711, DOI 10.1001/jama.261.5.711; Totsuka E, 2002, SURG TODAY, V32, P792, DOI 10.1007/s005950200152; Trotter JF, 2004, JAMA-J AM MED ASSOC, V291, P1871, DOI 10.1001/jama.291.15.1871; WAHLBERG JA, 1987, TRANSPLANTATION, V43, P5, DOI 10.1097/00007890-198701000-00002; WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030; Woodside KJ, 1998, CLIN TRANSPLANT, V12, P43; YANAGA K, 1989, TRANSPLANT INT, V2, P137; [No title captured]	59	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2468	10.1371/journal.pone.0002468	http://dx.doi.org/10.1371/journal.pone.0002468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575623	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000263288000001
J	Saeed, U; Durgadoss, L; Valli, RK; Joshi, DC; Joshi, PG; Ravindranath, V				Saeed, Uzma; Durgadoss, Lalitha; Valli, R. Khader; Joshi, Dinesh C.; Joshi, Preeti G.; Ravindranath, Vijayalakshmi			Knockdown of Cytosolic Glutaredoxin 1 Leads to Loss of Mitochondrial Membrane Potential: Implication in Neurodegenerative Diseases	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; EXCITATORY AMINO-ACID; COMPLEX-I; THIOLTRANSFERASE GLUTAREDOXIN; CONSTITUTIVE EXPRESSION; MIXED DISULFIDES; MOTOR-NEURONS; CALF THYMUS; GLUTATHIONE; THIOREDOXIN	Mitochondrial dysfunction including that caused by oxidative stress has been implicated in the pathogenesis of neurodegenerative diseases. Glutaredoxin 1 (Grx1), a cytosolic thiol disulfide oxido-reductase, reduces glutathionylated proteins to protein thiols and helps maintain redox status of proteins during oxidative stress. Grx1 downregulation aggravates mitochondrial dysfunction in animal models of neurodegenerative diseases, such as Parkinson's and motor neuron disease. We examined the mechanism underlying the regulation of mitochondrial function by Grx1. Downregulation of Grx1 by shRNA results in loss of mitochondrial membrane potential (MMP), which is prevented by the thiol antioxidant, alpha-lipoic acid, or by cyclosporine A, an inhibitor of mitochondrial permeability transition. The thiol groups of voltage dependent anion channel (VDAC), an outer membrane protein in mitochondria but not adenosine nucleotide translocase (ANT), an inner membrane protein, are oxidized when Grx1 is downregulated. We then examined the effect of beta-N-oxalyl amino-L-alanine (L-BOAA), an excitatory amino acid implicated in neurolathyrism (a type of motor neuron disease), that causes mitochondrial dysfunction. Exposure of cells to L-BOAA resulted in loss of MMP, which was prevented by overexpression of Grx1. Grx1 expression is regulated by estrogen in the CNS and treatment of SH-SY5Y cells with estrogen upregulated Grx1 and protected from L-BOAA mediated MMP loss. Our studies demonstrate that Grx1, a cytosolic oxidoreductase, helps maintain mitochondrial integrity and prevents MMP loss caused by oxidative insult. Further, downregulation of Grx1 leads to mitochondrial dysfunction through oxidative modification of the outer membrane protein, VDAC, providing support for the critical role of Grx1 in maintenance of MMP.	[Saeed, Uzma; Durgadoss, Lalitha; Valli, R. Khader; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India; [Joshi, Dinesh C.; Joshi, Preeti G.] National Inst Mental Hlth & Neurosci, Dept Biophys, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Saeed, U (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India.	vijir@nbrc.ac.in		Joshi, Dinesh/0000-0003-1158-7890	National Brain Research Center, Manesar, Haryana, India	National Brain Research Center, Manesar, Haryana, India	The work done in this study was funded by the National Brain Research Center, Manesar, Haryana, India.	Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Balijepalli S, 1999, NEUROSCI LETT, V272, P203, DOI 10.1016/S0304-3940(99)00593-5; Bambrick LL, 2008, BRAIN RES, V1188, P9, DOI 10.1016/j.brainres.2007.10.045; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Borgne-Sanchez A, 2007, CELL DEATH DIFFER, V14, P422, DOI 10.1038/sj.cdd.4402018; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Diwakar L, 2007, NEUROCHEM INT, V51, P37, DOI 10.1016/j.neuint.2007.03.008; Diwakar L, 2007, NEUROCHEM INT, V50, P418, DOI 10.1016/j.neuint.2006.09.014; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fernando MR, 2006, FASEB J, V20, P2645, DOI 10.1096/fj.06-5919fje; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Haouzi D, 2002, APOPTOSIS, V7, P395, DOI 10.1023/A:1020026923038; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Joensson Thomas J., 2007, V44, P115; Karunakaran S, 2007, BRAIN RES, V1185, P8, DOI 10.1016/j.brainres.2007.09.019; Kenchappa RS, 2004, FASEB J, V18, P1102, DOI 10.1096/fj.03-1075fje; Kenchappa RS, 2003, FASEB J, V17, P717, DOI 10.1096/fj.02-0771fje; Kenchappa RS, 2002, J NEUROSCI, V22, P8402; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kim R, 2005, ONCOL REP, V14, P595; Ludolph AC, 1996, J NEUROL SCI, V139, P53, DOI 10.1016/0022-510X(96)00122-0; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1979, P NATL ACAD SCI USA, V76, P2158, DOI 10.1073/pnas.76.5.2158; MANNERVIK B, 1975, BIOCHEM J, V149, P785, DOI 10.1042/bj1490785; MIEYAL JJ, 1995, GLUTATHIONYL SPECIFI, P305; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; ROSS SM, 1989, J NEUROCHEM, V53, P710, DOI 10.1111/j.1471-4159.1989.tb11762.x; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sen I, 2008, NEUROCHEM INT, V52, P247, DOI 10.1016/j.neuint.2007.06.028; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; Sriram K, 1998, J NEUROSCI, V18, P10287; Sriram K, 1997, BRAIN RES, V749, P44, DOI 10.1016/S0006-8993(96)01271-1; Wells W W, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P149; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang ZQ, 2007, MOL BIOL CELL, V18, P4681, DOI 10.1091/mbc.E06-12-1161	47	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2459	10.1371/journal.pone.0002459	http://dx.doi.org/10.1371/journal.pone.0002459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560520	Green Submitted, Green Published, gold			2022-12-27	WOS:000263280700040
J	Li, JX; Wu, HB; Hong, J; Xu, XQ; Yang, HL; Wu, BX; Wang, YP; Zhu, JH; Lai, R; Jiang, XG; Lin, DH; Prescott, MC; Rees, HH				Li, Jianxu; Wu, Hongbing; Hong, Jing; Xu, Xueqing; Yang, Hailong; Wu, Bingxian; Wang, Yipeng; Zhu, Jianhua; Lai, Ren; Jiang, Xinguo; Lin, Donghai; Prescott, Mark C.; Rees, Huw H.			Odorranalectin Is a Small Peptide Lectin with Potential for Drug Delivery and Targeting	PLOS ONE			English	Article								Background: Lectins are sugar-binding proteins that specifically recognize sugar complexes. Based on the specificity of protein-sugar interactions, different lectins could be used as carrier molecules to target drugs specifically to different cells which express different glycan arrays. In spite of lectin's interesting biological potential for drug targeting and delivery, a potential disadvantage of natural lectins may be large size molecules that results in immunogenicity and toxicity. Smaller peptides which can mimic the function of lectins are promising candidates for drug targeting. Principal Findings: Small peptide with lectin-like behavior was screened from amphibian skin secretions and its structure and function were studied by NMR, NMR-titration, SPR and mutant analysis. A lectin-like peptide named odorranalectin was identified from skin secretions of Odorrana grahami. It was composed of 17 aa with a sequence of YASPKCFRYPNGVLACT. L-fucose could specifically inhibit the haemagglutination induced by odorranalectin. (125)I-odorranalectin was stable in mice plasma. In experimental mouse models, odorranalectin was proved to mainly conjugate to liver, spleen and lung after i.v. administration. Odorranalectin showed extremely low toxicity and immunogenicity in mice. The small size and single disulfide bridge of odorranalectin make it easy to manipulate for developing as a drug targeting system. The cyclic peptide of odorranalectin disclosed by solution NMR study adopts a beta-turn conformation stabilized by one intramolecular disulfide bond between Cys6-Cys16 and three hydrogen bonds between Phe7-Ala15, Tyr9-Val13, Tyr9-Gly12. Residues K5, C6, F7, C16 and T17 consist of the binding site of L-fucose on odorranalectin determined by NMR titration and mutant analysis. The structure of odorranalectin in bound form is more stable than in free form. Conclusion: These findings identify the smallest lectin so far, and show the application potential of odorranalectin for drug delivery and targeting. It also disclosed a new strategy of amphibian anti-infection.	[Li, Jianxu; Xu, Xueqing; Yang, Hailong; Wang, Yipeng; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [Wu, Hongbing; Wu, Bingxian; Zhu, Jianhua; Jiang, Xinguo] Fudan Univ, Sch Pharm, Shanghai, Peoples R China; [Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China; [Prescott, Mark C.; Rees, Huw H.] Univ Liverpool, Sch Biol Sci, Liverpool, Merseyside, England; [Li, Jianxu; Hong, Jing; Xu, Xueqing; Wang, Yipeng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Liverpool; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, JX (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn; xgjiang@shmu.edu.cn; dhlin@mail.shcnc.ac.cn	Li, Jianxu/I-5723-2013; Wang, Yipeng/AAA-1499-2020; yang, hailong/GXH-9625-2022	Wang, Yipeng/0000-0003-1385-4470; 	Ministry of Science and Technology of the People's Republic of China [2007AA02Z192]; Chinese Academy of Sciences [KSCX2-YW-G-024, KSCX2-YW-R-20]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by 2007AA02Z192 from the Ministry of Science and Technology of the People's Republic of China, and KSCX2-YW-G-024, KSCX2-YW-R-20 from the Chinese Academy of Sciences.	BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bies C, 2004, ADV DRUG DELIVER REV, V56, P425, DOI 10.1016/j.addr.2003.10.030; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; KAWAGISHI H, 1994, FEBS LETT, V340, P56, DOI 10.1016/0014-5793(94)80172-X; Kobayashi Y, 2004, J BIOL CHEM, V279, P53048, DOI 10.1074/jbc.M407997200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lehr CM, 2004, ADV DRUG DELIVER REV, V56, P419, DOI 10.1016/j.addr.2003.10.013; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Nadesalingam J, 2005, J IMMUNOL, V175, P1785, DOI 10.4049/jimmunol.175.3.1785; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Robinson MA, 2004, P NATL ACAD SCI USA, V101, P14527, DOI 10.1073/pnas.0303574101; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949; SHORE A, 1959, J PHARMACOL EXP THER, V127, P182; Sobal G, 2004, NUCL MED BIOL, V31, P381, DOI 10.1016/j.nucmedbio.2003.10.010; Tchernychev B, 1996, FEBS LETT, V397, P139, DOI 10.1016/S0014-5793(96)01154-4; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; WESTERHOFF HV, 1995, EUR J BIOCHEM, V228, P257; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu XQ, 2006, TOXICON, V47, P459, DOI 10.1016/j.toxicon.2006.01.002; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	60	66	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2381	10.1371/journal.pone.0002381	http://dx.doi.org/10.1371/journal.pone.0002381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18584053	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800021
J	Grosman, AH; Janssen, A; de Brito, EF; Cordeiro, EG; Colares, F; Fonseca, JO; Lima, ER; Pallini, A; Sabelis, MW				Grosman, Amir H.; Janssen, Arne; de Brito, Elaine F.; Cordeiro, Eduardo G.; Colares, Felipe; Fonseca, Juliana Oliveira; Lima, Eraldo R.; Pallini, Angelo; Sabelis, Maurice W.			Parasitoid Increases Survival of Its Pupae by Inducing Hosts to Fight Predators	PLOS ONE			English	Article							HORNWORM MANDUCA-SEXTA; TOBACCO HORNWORM; ADAPTIVE-CHANGES; BEHAVIOR; MANIPULATION; WASP; TEMPERATURE; EVOLUTION; SELECTION	Many true parasites and parasitoids modify the behaviour of their host, and these changes are thought to be to the benefit of the parasites. However, field tests of this hypothesis are scarce, and it is often unclear whether the host or the parasite profits from the behavioural changes, or even if parasitism is a cause or consequence of the behaviour. We show that braconid parasitoids (Glyptapanteles sp.) induce their caterpillar host (Thyrinteina leucocerae) to behave as a bodyguard of the parasitoid pupae. After parasitoid larvae exit from the host to pupate, the host stops feeding, remains close to the pupae, knocks off predators with violent head-swings, and dies before reaching adulthood. Unparasitized caterpillars do not show these behaviours. In the field, the presence of bodyguard hosts resulted in a two-fold reduction in mortality of parasitoid pupae. Hence, the behaviour appears to be parasitoid-induced and confers benefits exclusively to the parasitoid.	[Grosman, Amir H.; Janssen, Arne; Sabelis, Maurice W.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, Amsterdam, Netherlands; [de Brito, Elaine F.; Cordeiro, Eduardo G.; Colares, Felipe; Fonseca, Juliana Oliveira; Lima, Eraldo R.; Pallini, Angelo] Univ Fed Vicosa, Dept Animal Biol, Sect Agr Entomol, Vicosa, MG, Brazil	University of Amsterdam; Universidade Federal de Vicosa	Grosman, AH (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, Amsterdam, Netherlands.	Janssen@science.uva.nl	Lima, Eraldo R/B-6675-2008; Lima, Eraldo R/S-9585-2018; Janssen, Arne/B-2657-2009; Pallini, Angelo/F-7791-2012	Lima, Eraldo R/0000-0003-4446-5435; Janssen, Arne/0000-0001-5075-5303; Pallini, Angelo/0000-0003-3752-3545	NWO-WOTRO [W 84-520]; CAPES [scholarship]; CNPq; FAPEMIG	NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	A.H. Grosman was supported by NWO-WOTRO grant no. W 84-520, A.J. received a scholarship from CAPES (PVE), A.P. was supported by CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2000, CAN J ZOOL, V78, P1580, DOI 10.1139/cjz-78-9-1580; Adamo SA, 2005, ARCH INSECT BIOCHEM, V60, P185, DOI 10.1002/arch.20068; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Adamo SA, 1997, J EXP BIOL, V200, P117; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; BECKAGE NE, 1978, ENTOMOL EXP APPL, V23, P139, DOI 10.1007/BF00290629; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; CARNEY WP, 1969, AM MIDL NAT, V82, P605, DOI 10.2307/2423801; Cezilly F., 2005, Behavioural Processes, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; COMBES C, 1991, AM NAT, V138, P866, DOI 10.1086/285257; Crawley M.J., 2007, R BOOK; Dawkins R., 1982, pi; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; Gelman DB, 1998, J INSECT PHYSIOL, V44, P833, DOI 10.1016/S0022-1910(98)00015-8; Gelman DB, 1999, ARCH INSECT BIOCHEM, V40, P17, DOI 10.1002/(SICI)1520-6327(1999)40:1&lt;17::AID-ARCH3&gt;3.0.CO;2-#; Godfray H. C. J., 1994, MONOGRAPHS BEHAV ECO; HOHORST W, 1961, NATURWISSENSCHAFTEN, V48, P229, DOI 10.1007/BF00597502; Miles CI, 2000, J EXP BIOL, V203, P1689; Moore J., 2002, OXFORD SERIES ECOLOG, P338; Mouritsen KN, 2003, INT J PARASITOL, V33, P1043, DOI 10.1016/S0020-7519(03)00178-4; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; MULLER CB, 1994, ANIM BEHAV, V48, P961, DOI 10.1006/anbe.1994.1321; Ponton F, 2006, NATURE, V440, P756, DOI 10.1038/440756a; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; Poulin R, 2005, BEHAV PROCESS, V68, P241, DOI 10.1016/j.beproc.2004.07.011; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; SCHNEIDER G, 1971, NATURWISSENSCHAFTEN, V58, P327, DOI 10.1007/BF00624750; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WICKLER W, 1976, Z TIERPSYCHOL, V42, P206; [No title captured]	39	78	81	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2276	10.1371/journal.pone.0002276	http://dx.doi.org/10.1371/journal.pone.0002276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523578	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300005
J	Moleon, M; Almaraz, P; Sanchez-Zapata, JA				Moleon, Marcos; Almaraz, Pablo; Sanchez-Zapata, Jose A.			An Emerging Infectious Disease Triggering Large-Scale Hyperpredation	PLOS ONE			English	Article							VIRAL HEMORRHAGIC-DISEASE; WILD RABBIT; POPULATION; PREDATION; EMERGENCE; DENSITY; DECLINE; BIRDS	Hyperpredation refers to an enhanced predation pressure on a secondary prey due to either an increase in the abundance of a predator population or a sudden drop in the abundance of the main prey. This scarcely documented mechanism has been previously studied in scenarios in which the introduction of a feral prey caused overexploitation of native prey. Here we provide evidence of a previously unreported link between Emergent Infectious Diseases (EIDs) and hyperpredation on a predator-prey community. We show how a viral outbreak caused the population collapse of a host prey at a large spatial scale, which subsequently promoted higher-than-normal predation intensity on a second prey from shared predators. Thus, the disease left a population dynamic fingerprint both in the primary host prey, through direct mortality from the disease, and indirectly in the secondary prey, through hyperpredation. This resulted in synchronized prey population dynamics at a large spatio-temporal scale. We therefore provide evidence for a novel mechanism by which EIDs can disrupt a predator-prey interaction from the individual behavior to the population dynamics. This mechanism can pose a further threat	[Moleon, Marcos] Univ Granada, Dept Biol Anim, Granada, Spain; [Almaraz, Pablo] Consejo Superior Investigac Cient, Estac Biol Donana, Seville, Spain; [Sanchez-Zapata, Jose A.] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Miguel Hernandez de Elche	Moleon, M (corresponding author), Univ Granada, Dept Biol Anim, Granada, Spain.	mmoleonpaiz@hotmail.com	Almaraz, Pablo/A-3683-2014; Moleón, Marcos/K-2875-2014; Sanchez-Zapata, Jose Antonio/H-1413-2015	Almaraz, Pablo/0000-0003-1416-2695; Moleón, Marcos/0000-0002-3126-619X; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953	Spanish Ministerio de Educacion y Ciencia;  [CGL-2006-10689/BOS]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); 	MM and JASZ were partially supported by a project of the Spanish Ministerio de Educacion y Ciencia (reference CGL-2006-10689/BOS).	Almaraz P, 2004, ECOL LETT, V7, P547, DOI 10.1111/j.1461-0248.2004.00612.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANGELSTAM P, 1985, HOLARCTIC ECOL, V8, P285; [Anonymous], 1999, BIOL WILDLIFE MEDITE; BOSTFORD LW, 1983, CAN J FISH AQUAT SCI, V40, P337; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 1998, MODEL SELECTION INFE; Calvete C, 2002, VET REC, V150, P776, DOI 10.1136/vr.150.25.776; Calvete C, 2006, CONSERV BIOL, V20, P1232, DOI 10.1111/j.1523-1739.2006.00371.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Clark J. S, 2007, MODELS ECOLOGICAL DA; Courchamp F, 2000, J ANIM ECOL, V69, P154, DOI 10.1046/j.1365-2656.2000.00383.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; DURBIN B, 2001, TIME SERIES ANAL STA; FERNANDEZ C, 1993, REV ECOL-TERRE VIE, V48, P323; Gelman A., 2004, BAYESIAN DATA ANAL; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Kristan WB, 2003, ECOLOGY, V84, P2432, DOI 10.1890/02-0448; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Madrono A., 2004, LIBRO ROJO AVES ESPA; MOLEON M., 2007, BIODIVERSIDAD CONSER, P743; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Robert PC, 2004, MONTE CARLO STAT MET; Roemer GW, 2001, ANIM CONSERV, V4, P307, DOI 10.1017/S1367943001001366; Royama T., 1992, ANAL POPULATION ECOL; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Tong H, 1990, NONLINEAR TIME SERIE; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Villafuerte R, 1995, MAMMALIA, V59, P651, DOI 10.1515/mamm.1995.59.4.651; VIRGOS E, BIODIVERS C IN PRESS; Whelan CJ, 2003, EVOL ECOL RES, V5, P329	33	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2307	10.1371/journal.pone.0002307	http://dx.doi.org/10.1371/journal.pone.0002307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523587	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300014
J	Zeeuwen, PLJM; de Jongh, GJ; Rodijk-Olthuis, D; Kamsteeg, M; Verhoosel, RM; van Rossum, MM; Hiemstra, PS; Schalkwijk, J				Zeeuwen, Patrick L. J. M.; de Jongh, Gys J.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Verhoosel, Renate M.; van Rossum, Michelle M.; Hiemstra, Pieter S.; Schalkwijk, Joost			Genetically Programmed Differences in Epidermal Host Defense between Psoriasis and Atopic Dermatitis Patients	PLOS ONE			English	Article								In the past decades, chronic inflammatory diseases such as psoriasis, atopic dermatitis, asthma, Crohn's disease and celiac disease were generally regarded as immune-mediated conditions involving activated T-cells and proinflammatory cytokines produced by these cells. This paradigm has recently been challenged by the finding that mutations and polymorphisms in epithelium-expressed genes involved in physical barrier function or innate immunity, are risk factors of these conditions. We used a functional genomics approach to analyze cultured keratinocytes from patients with psoriasis or atopic dermatitis and healthy controls. First passage primary cells derived from non-lesional skin were stimulated with pro-inflammatory cytokines, and expression of a panel of 55 genes associated with epidermal differentiation and cutaneous inflammation was measured by quantitative PCR. A subset of these genes was analyzed at the protein level. Using cluster analysis and multivariate analysis of variance we identified groups of genes that were differentially expressed, and could, depending on the stimulus, provide a disease-specific gene expression signature. We found particularly large differences in expression levels of innate immunity genes between keratinocytes from psoriasis patients and atopic dermatitis patients. Our findings indicate that cell-autonomous differences exist between cultured keratinocytes of psoriasis and atopic dermatitis patients, which we interpret to be genetically determined. We hypothesize that polymorphisms of innate immunity genes both with signaling and effector functions are coadapted, each with balancing advantages and disadvantages. In the case of psoriasis, high expression levels of antimicrobial proteins genes putatively confer increased protection against microbial infection, but the biological cost could be a beneficial system gone awry, leading to overt inflammatory disease.	[Zeeuwen, Patrick L. J. M.; de Jongh, Gys J.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; van Rossum, Michelle M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Skin Biol & Expt Dermatol, NL-6525 ED Nijmegen, Netherlands; [Verhoosel, Renate M.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zeeuwen, PLJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Skin Biol & Expt Dermatol, NL-6525 ED Nijmegen, Netherlands.	P.Zeeuwen@ncmls.ru.nl; J.Schalkwijk@ncmls.ru.nl	Schalkwijk, Joost/R-7509-2019; Kamsteeg, M./L-4422-2015; Hiemstra, Pieter S/K-8587-2018; Zeeuwen, Patrick/N-1779-2013; /V-8478-2019; Schalkwijk, Joost/N-1774-2013; Rossum, M.M./L-4614-2015	Schalkwijk, Joost/0000-0002-1308-1319; Hiemstra, Pieter S/0000-0002-0238-5982; Zeeuwen, Patrick/0000-0002-6878-2438; 				Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Franssen MEJ, 2005, J INVEST DERMATOL, V124, P373, DOI 10.1111/j.0022-202X.2004.23612.x; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Kamsteeg M, 2007, J INVEST DERMATOL, V127, P1786, DOI 10.1038/sj.jid.5700752; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Nickoloff BJ, 2006, TRENDS MOL MED, V12, P102, DOI 10.1016/j.molmed.2006.01.001; NICKOLOFF BJ, 1989, BRIT J DERMATOL, V121, P161, DOI 10.1111/j.1365-2133.1989.tb01795.x; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLANIRAN AK, 1995, ARCH DERMATOL RES, V287, P231, DOI 10.1007/BF01105071; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Vandermeeren M, 2001, ARCH DERMATOL RES, V293, P343, DOI 10.1007/s004030100238; vanRuissen F, 1996, J CELL PHYSIOL, V168, P442; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	33	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2301	10.1371/journal.pone.0002301	http://dx.doi.org/10.1371/journal.pone.0002301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523683	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300012
J	Lange, TS; Kim, KK; Singh, RK; Strongin, RM; McCourt, CK; Brard, L				Lange, Thilo S.; Kim, Kyu Kwang; Singh, Rakesh K.; Strongin, Robert M.; McCourt, Carolyn K.; Brard, Laurent			Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-BINDING; CLEAVING PROPERTIES; CYCLE CONTROL; MAP KINASE; COMPLEXES; APOPTOSIS; PROLIFERATION; COPPER(II); ACTIVATION; CARCINOMA	Background: In this pioneer study to the biological activity of organometallic compound Iron(III)-salophene (Fe-SP) the specific effects of Fe-SP on viability, morphology, proliferation, and cell-cycle progression on platinum-resistant ovarian cancer cell lines were investigated. Methodology/Principal Findings: Fe-SP displayed selective cytotoxicity against SKOV-3 and OVCAR-3 (ovarian epithelial adenocarcinoma) cell lines at concentrations between 100 nM and 1 mu M, while the viability of HeLa cells (epithelial cervix adenocarcinoma) or primary lung or skin fibroblasts was not affected. SKOV-3 cells in contrast to fibroblasts after treatment with Fe-SP revealed apparent hallmarks of apoptosis including densely stained nuclear granular bodies within fragmented nuclei, highly condensed chromatin and chromatin fragmentation. Fe-SP treatment led to the activation of markers of the extrinsic (Caspase-8) and intrinsic (Caspase-9) pathway of apoptosis as well as of executioner Caspase-3 while PARP-1 was deactivated. Fe-SP exerted effects as an anti-proliferative agent with an IC50 value of 300 nM and caused delayed progression of cells through S-phase phase of the cell cycle resulting in a complete S-phase arrest. When intra-peritoneally applied to rats Fe-SP did not show any systemic toxicity at concentrations that in preliminary trials were determined to be chemotherapeutic relevant doses in a rat ovarian cancer cell model. Conclusion/Significance: The present report suggests that Fe-SP is a potent growth-suppressing agent in vitro for cell lines derived from ovarian cancer and a potential therapeutic drug to treat such tumors in vivo.	[Lange, Thilo S.; Kim, Kyu Kwang; Singh, Rakesh K.; McCourt, Carolyn K.; Brard, Laurent] Brown Univ, Women & Infants Hosp RI, Warren Alpert Med Sch,Mol Therapeut Lab, Program Womens Oncol,Dept Obstet & Gynecol, Providence, RI 02912 USA; [Lange, Thilo S.] Brown Univ, Dept Biol & Med, Providence, RI USA; [Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR USA	Brown University; Women & Infants Hospital Rhode Island; Brown University; Portland State University	Lange, TS (corresponding author), Brown Univ, Women & Infants Hosp RI, Warren Alpert Med Sch,Mol Therapeut Lab, Program Womens Oncol,Dept Obstet & Gynecol, Providence, RI 02912 USA.	lbrard@wihri.org	Strongin, Robert M./F-1026-2010	Brard, Laurent/0000-0003-0065-1826	Brown University [Seed Grant]; NICHD [K12 HD043447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043447] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER	Brown University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Brown University Seed Grant and a NICHD, K12 HD043447 BIRCWH Scholar Grant to Dr. Brard.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Alpturk O, 2006, P NATL ACAD SCI USA, V103, P9756, DOI 10.1073/pnas.0603758103; *AM CANC SOC, 2007, CANC FACTS FIG 2007; Bi CF, 2001, SYN REACT INORG MET, V31, P219, DOI 10.1081/SIM-100002041; Birkenkamp KU, 1999, LEUKEMIA, V13, P1037, DOI 10.1038/sj.leu.2401447; BURROWS CJ, 1994, ACCOUNTS CHEM RES, V27, P295, DOI 10.1021/ar00046a002; Cerchiaro G, 2005, J INORG BIOCHEM, V99, P1433, DOI 10.1016/j.jinorgbio.2005.03.013; CREASY LE, 1896, 256 EC TEMPL CHAMB, V9; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P213, DOI 10.1016/S1040-8428(02)00039-2; Doctrow SR, 2002, J MED CHEM, V45, P4549, DOI 10.1021/jm020207y; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Gust R, 2004, J MED CHEM, V47, P5837, DOI 10.1021/jm040763n; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Heintz APM, 2003, INT J GYNECOL OBSTET, V83, P135, DOI 10.1016/S0020-7292(03)90118-4; Huang RL, 2005, BIOCHEM PHARMACOL, V69, P1009, DOI 10.1016/j.bcp.2005.01.001; KOEHLAR CSW, 2001, CHEM CHRONICLES, V10, P61; KOPFMAIER P, 1994, EUR J CLIN PHARMACOL, V47, P1, DOI 10.1007/BF00193472; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Lange TS, 2007, CHEM BIOL DRUG DES, V70, P302, DOI 10.1111/j.1747-0285.2007.00567.x; LIU ZX, 1994, ARCH BIOCHEM BIOPHYS, V315, P74, DOI 10.1006/abbi.1994.1473; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Mandal SS, 1997, BIOCONJUGATE CHEM, V8, P798, DOI 10.1021/bc970121x; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PINES J, 1999, NATL CELL BIOL, V1, P73; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Routier S, 1999, NUCLEIC ACIDS RES, V27, P4160, DOI 10.1093/nar/27.21.4160; Routier S, 1997, BIOCONJUGATE CHEM, V8, P789, DOI 10.1021/bc970131y; Routier S, 1996, BIOORGAN MED CHEM, V4, P1185, DOI 10.1016/0968-0896(96)00082-X; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shishodia S, 2007, BIOCHEM PHARMACOL, V74, P118, DOI 10.1016/j.bcp.2007.03.026; Shrivastava HY, 2005, FREE RADICAL BIO MED, V38, P58, DOI 10.1016/j.freeradbiomed.2004.09.029; Singh RK, 2008, LETT ORG CHEM, V5, P103; SINGH RK, 2008, GYN ONC IN PRESS; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Woldemariam GA, 2008, J INORG BIOCHEM, V102, P740, DOI 10.1016/j.jinorgbio.2007.11.008; Zhong X, 2007, BIOORG MED CHEM LETT, V17, P3774, DOI 10.1016/j.bmcl.2007.04.006	43	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2303	10.1371/journal.pone.0002303	http://dx.doi.org/10.1371/journal.pone.0002303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509533	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500038
J	van der Sande, M; Teunis, P; Sabel, R				van der Sande, Marianne; Teunis, Peter; Sabel, Rob			Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population	PLOS ONE			English	Article								Background: Governments are preparing for a potential influenza pandemic. Therefore they need data to assess the possible impact of interventions. Face-masks worn by the general population could be an accessible and affordable intervention, if effective when worn under routine circumstances. Methodology: We assessed transmission reduction potential provided by personal respirators, surgical masks and home-made masks when worn during a variety of activities by healthy volunteers and a simulated patient. Principal Findings: All types of masks reduced aerosol exposure, relatively stable over time, unaffected by duration of wear or type of activity, but with a high degree of individual variation. Personal respirators were more efficient than surgical masks, which were more efficient than home-made masks. Regardless of mask type, children were less well protected. Outward protection (mask wearing by a mechanical head) was less effective than inward protection (mask wearing by healthy volunteers). Conclusions/Significance: Any type of general mask use is likely to decrease viral exposure and infection risk on a population level, in spite of imperfect fit and imperfect adherence, personal respirators providing most protection. Masks worn by patients may not offer as great a degree of protection against aerosol transmission.	[van der Sande, Marianne; Teunis, Peter] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Teunis, Peter] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Glob Hlth, Atlanta, GA USA; [Sabel, Rob] Netherlands Org Appl Sci Res TNO, Rijswijk, Netherlands	Netherlands National Institute for Public Health & the Environment; Emory University; Rollins School Public Health; Netherlands Organization Applied Science Research	van der Sande, M (corresponding author), Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands.	marianne.van.der.sande@rivm.nl		van der Sande, Marianne AB/0000-0002-4778-6739	Netherlands Ministry of Health, Welfare and Sports	Netherlands Ministry of Health, Welfare and Sports	The study was funded by the Netherlands Ministry of Health, Welfare and Sports. The sponsor had no role in design and conduct of the study, in the collection, analysis and interpretation, nor in the preparation, review or approval of the manuscript.	Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; DIEKMAN O, 2000, WILEY SERIES MATH CO; Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Pourbohloul B, 2005, EMERG INFECT DIS, V11, P1249; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Wilder-Smith Annelies, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P481; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730	16	254	261	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2618	10.1371/journal.pone.0002618	http://dx.doi.org/10.1371/journal.pone.0002618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612429	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800020
J	He, XS; Holmes, TH; Sasaki, S; Jaimes, MC; Kemble, GW; Dekker, CL; Arvin, AM; Greenberg, HB				He, Xiao-Song; Holmes, Tyson H.; Sasaki, Sanae; Jaimes, Maria C.; Kemble, George W.; Dekker, Cornelia L.; Arvin, Ann M.; Greenberg, Harry B.			Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; VIRUS INFECTION; NK CELLS; IMMUNE-RESPONSES; LIVE; CHILDREN; ADULTS; VACCINATION; SAFETY	Background: Factors affecting immune responses to influenza vaccines have not been studied systematically. We hypothesized that T-cell and antibody responses to the vaccines are functions of pre-existing host immunity against influenza antigens. Methodology/Principal Findings: During the 2004 and 2005 influenza seasons, we have collected data on cellular and humoral immune reactivity to influenza virus in blood samples collected before and after immunization with inactivated or live attenuated influenza vaccines in healthy children and adults. We first used cross-validated lasso regression on the 2004 dataset to identify a group of candidate baseline correlates with T-cell and antibody responses to vaccines, defined as fold-increase in influenza-specific T-cells and serum HAI titer after vaccination. The following baseline parameters were examined: percentages of influenza-reactive IFN-gamma(+) cells in T and NK cell subsets, percentages of influenza-specific memory B-cells, HAI titer, age, and type of vaccine. The candidate baseline correlates were then tested with the independent 2005 dataset. Baseline percentage of influenza-specific IFN-gamma(+) CD4 T-cells was identified as a significant correlate of CD4 and CD8 T- cell responses, with lower baseline levels associated with larger T- cell responses. Baseline HAI titer and vaccine type were identified as significant correlates for HAI response, with lower baseline levels and the inactivated vaccine associated with larger HAI responses. Previously we reported that baseline levels of CD56(dim) NK reactivity against influenza virus inversely correlated with the immediate T- cell response to vaccination, and that NK reactivity induced by influenza virus depended on IL-2 produced by influenza-specific memory T- cells. Taken together these results suggest a novel mechanism for the homeostasis of virus-specific T- cells, which involves interaction between memory helper T-cells, CD56(dim) NK and DC. Significance: These results demonstrate that assessment of baseline biomarkers may predict immunologic outcome of influenza vaccination and may reveal some of the mechanisms responsible for variable immune responses following vaccination and natural infection.	[He, Xiao-Song; Sasaki, Sanae; Jaimes, Maria C.; Greenberg, Harry B.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [He, Xiao-Song; Sasaki, Sanae; Jaimes, Maria C.; Greenberg, Harry B.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Holmes, Tyson H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Biostat, Stanford, CA USA; [Kemble, George W.; Arvin, Ann M.] MedImmune Vaccines, Mountain View, CA USA; [Dekker, Cornelia L.; Arvin, Ann M.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA; [Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; AstraZeneca; Medimmune; Stanford University; Stanford University	He, XS (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	xiaosong@Stanford.edu		greenberg, harry/0000-0002-2128-9080	(National Center for Research Resources), National Institutes of Health [U19 AI057229, M01 RR-00070]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	(National Center for Research Resources), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	U19 AI057229 and M01 RR-00070 (National Center for Research Resources), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Belshe RB, 2004, CLIN INFECT DIS, V39, P920, DOI 10.1086/423001; Belshe RB, 2001, PHILOS T ROY SOC B, V356, P1947, DOI 10.1098/rstb.2001.0982; BELSHE RB, 2004, VACCINES; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Bot A, 1996, J VIROL, V70, P5668, DOI 10.1128/JVI.70.8.5668-5672.1996; Couch R B, 2003, Dev Biol (Basel), V115, P25; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; ENNIS FA, 1981, LANCET, V2, P891; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; GRUBER WC, 1990, AM J DIS CHILD, V144, P595, DOI 10.1001/archpedi.1990.02150290089035; Gruber WC, 1996, J INFECT DIS, V173, P1313, DOI 10.1093/infdis/173.6.1313; Harrell FE, 2001, REGRESSION MODELING; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; He XS, 2004, J CLIN INVEST, V114, P1812, DOI 10.1172/JCI200422797; He XS, 2003, J INFECT DIS, V187, P1075, DOI 10.1086/368218; HE XS, 2008, J INFECT DIS; HOLM S, 1979, SCAND J STAT, V43, P223; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; KILBOURNE ED, 1999, VACCINES, P531; Kutza J, 1996, CLIN DIAGN LAB IMMUN, V3, P105, DOI 10.1128/CDLI.3.1.105-108.1996; Lamb RA, 2001, FIELDS VIROLOGY, P1533; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; Liu BX, 2004, J GEN VIROL, V85, P423, DOI 10.1099/vir.0.19596-0; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MILLIKEN G, 1998, ANAL MESSY DATA DESI; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Mysliwska J, 2004, EXP GERONTOL, V39, P1447, DOI 10.1016/j.exger.2004.08.005; NAGLER A, 1989, J IMMUNOL, V143, P3183; NETER J, 1996, APPL LINEAR STAT MOD, P724; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Perez OD, 2006, IMMUNOL REV, V210, P208, DOI 10.1111/j.0105-2896.2006.00364.x; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SCHAPIRO JM, 1990, J MED VIROL, V30, P196, DOI 10.1002/jmv.1890300310; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Zar JH, 1999, BIOSTATISTICAL ANAL; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	53	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2574	10.1371/journal.pone.0002574	http://dx.doi.org/10.1371/journal.pone.0002574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596908	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200039
J	Wei, B; Chen, Z; Zhang, X; Feldman, M; Dong, XZ; Doran, R; Zhao, BL; Yin, WX; Kotlikoff, MI; Ji, GJ				Wei, Bin; Chen, Zheng; Zhang, Xu; Feldman, Morris; Dong, Xian-zhi; Doran, Robert; Zhao, Bao-Lu; Yin, Wen-xuan; Kotlikoff, Michael I.; Ji, Guangju			Nitric Oxide Mediates Stretch-Induced Ca2+Release via Activation of Phosphatidylinositol 3-Kinase-Akt Pathway in Smooth Muscle	PLOS ONE			English	Article								Background: Hollow smooth muscle organs such as the bladder undergo significant changes in wall tension associated with filling and distension, with attendant changes in muscle tone. Our previous study indicated that stretch induces Ca2+ release occurs in the form of Ca2+ sparks and Ca2+ waves in urinary bladder myocytes. While, the mechanism underlying stretch-induced Ca2+ release in smooth muscle is unknown. Methodology/Principal Findings: We examined the transduction mechanism linking cell stretch to Ca2+ release. The probability and frequency of Ca2+ sparks induced by stretch were closely related to the extent of cell extension and the time that the stretch was maintained. Experiments in tissues and single myocytes indicated that mechanical stretch significantly increases the production of nitric oxide (NO) and the amplitude and duration of muscle contraction. Stretch-induced Ca2+ sparks and contractility increases were abrogated by the NO inhibitor L-NAME and were also absent in eNOS knockout mice. Furthermore, exposure of eNOS null mice to exogenously generated NO induced Ca2+ sparks. The soluble guanylyl cyclase inhibitor ODQ did not inhibit SICR, but this process was effectively blocked by the PI3 kinase inhibitors LY494002 and wortmannin; the phosphorylation of Akt and eNOS were up-regulated by 204 +/- 28.6% and 258 +/- 36.8% by stretch, respectively. Moreover, stretch significantly increased the eNOS protein expression level. Conclusions/Significance: Taking together, these results suggest that stretch-induced Ca2+ release is NO dependent, resulting from the activation of PI3K/Akt pathway in smooth muscle.	[Wei, Bin; Chen, Zheng; Zhang, Xu; Dong, Xian-zhi; Zhao, Bao-Lu; Yin, Wen-xuan; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Feldman, Morris; Doran, Robert; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Cornell University	Wei, B (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China.	mik7@cornell.edu; gj28@ibp.ac.cn	Wei, Bin/M-2017-2014; chen, zheng/J-4600-2014	chen, zheng/0000-0003-2161-6106; Ji, Guangju/0000-0001-8626-3490; , zheng/0000-0001-7129-6644	National Institute of Health [DK072277, HL045239]; National Foundation of Science and Technology [30670505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072277] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health Grants NIH DK072277 and HL045239 (to M.I.K.), National Foundation of Science and Technology #30670505 (to G.J.J.).	Alvarez BV, 1999, CIRC RES, V85, P716, DOI 10.1161/01.RES.85.8.716; ANNUNZIATO L, 2006, AM J PHYSIOL-CELL PH, V290, pC233; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; Cao YL, 2005, METHOD ENZYMOL, V396, P77, DOI 10.1016/S0076-6879(05)96008-4; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Dikalov S, 2005, METHOD ENZYMOL, V396, P597, DOI 10.1016/S0076-6879(05)96052-7; Eu JP, 1999, BIOCHEM PHARMACOL, V57, P1079, DOI 10.1016/S0006-2952(98)00360-8; Fritz N, 2007, J CELL SCI, V120, P3784, DOI 10.1242/jcs.009415; Hidalgo C, 2005, PHILOS T R SOC B, V360, P2237, DOI 10.1098/rstb.2005.1759; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Ji GJ, 2004, J GEN PHYSIOL, V123, P377, DOI 10.1085/jgp.200308999; Ji GJ, 2002, J GEN PHYSIOL, V119, P533, DOI 10.1085/jgp.20028514; KIRBER MT, 1988, PFLUG ARCH EUR J PHY, V412, P339, DOI 10.1007/BF01907549; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nowicki PT, 2007, J PEDIATR-US, V150, P40, DOI 10.1016/j.jpeds.2006.09.029; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Secondo A, 2006, AM J PHYSIOL-CELL PH, V290, pC233, DOI 10.1152/ajpcell.00231.2005; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; van der Wees CGC, 2006, PFLUG ARCH EUR J PHY, V451, P588, DOI 10.1007/s00424-005-1402-x; Wellner M C, 1993, EXS, V66, P93; WELLNER MC, 1994, J PHYSIOL-LONDON, V480, P439, DOI 10.1113/jphysiol.1994.sp020373; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2526	10.1371/journal.pone.0002526	http://dx.doi.org/10.1371/journal.pone.0002526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575589	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000041
J	Finkelstein, M; Bakker, V; Doak, DF; Sullivan, B; Lewison, R; Satterthwaite, WH; McIntyre, PB; Wolf, S; Priddel, D; Arnold, JM; Henry, RW; Sievert, P; Croxall, J				Finkelstein, Myra; Bakker, Victoria; Doak, Daniel F.; Sullivan, Ben; Lewison, Rebecca; Satterthwaite, William H.; McIntyre, Peter B.; Wolf, Shaye; Priddel, David; Arnold, Jennifer M.; Henry, Robert W.; Sievert, Paul; Croxall, John			Evaluating the Potential Effectiveness of Compensatory Mitigation Strategies for Marine Bycatch	PLOS ONE			English	Article								Conservationists are continually seeking new strategies to reverse population declines and safeguard against species extinctions. Here we evaluate the potential efficacy of a recently proposed approach to offset a major anthropogenic threat to many marine vertebrates: incidental bycatch in commercial fisheries operations. This new approach, compensatory mitigation for marine bycatch (CMMB), is conceived as a way to replace or reduce mandated restrictions on fishing activities with compensatory activities (e. g., removal of introduced predators from islands) funded by levies placed on fishers. While efforts are underway to bring CMMB into policy discussions, to date there has not been a detailed evaluation of CMMB's potential as a conservation tool, and in particular, a list of necessary and sufficient criteria that CMMB must meet to be an effective conservation strategy. Here we present a list of criteria to assess CMMB that are tied to critical ecological aspects of the species targeted for conservation, the range of possible mitigation activities, and the multi-species impact of fisheries bycatch. We conclude that, overall, CMMB has little potential for benefit and a substantial potential for harm if implemented to solve most fisheries bycatch problems. In particular, CMMB is likely to be effective only when applied to short-lived and highly-fecund species (not the characteristics of most bycatch-impacted species) and to fisheries that take few non-target species, and especially few non-seabird species (not the characteristics of most fisheries). Thus, CMMB appears to have limited application and should only be implemented after rigorous appraisal on a case-specific basis; otherwise it has the potential to accelerate declines of marine species currently threatened by fisheries bycatch.	[Finkelstein, Myra; Bakker, Victoria; Henry, Robert W.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Doak, Daniel F.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY USA; [Sullivan, Ben] BirdLife Int Glob Seabird Programme, C Australian Antarctic Div, Kingston, Tas, Australia; [Lewison, Rebecca] San Diego State Univ, Biol Dept, San Diego, CA USA; [Satterthwaite, William H.] Univ Calif Santa Cruz, Appl Math & Stat, Santa Cruz, CA USA; [McIntyre, Peter B.] Univ Michigan, Sch Nat Resources & Env, Ann Arbor, MI USA; [Wolf, Shaye] Ctr Biol Diversity, San Francisco, CA USA; [Priddel, David] Dept Env & Climate Change, Hurstville, NSW, Australia; [Arnold, Jennifer M.] Penn State Univ, Div Sci, Reading, PA USA; [Sievert, Paul] Univ Massachusetts Amherst, Massachusetts Cooperative Fish & Wildlife Res Unit, US Geological Survey, Amherst, MA USA; [Croxall, John] BirdLife Int Glob Seabird Programme, Cambridge, England	University of California System; University of California Santa Cruz; University of Wyoming; Australian Antarctic Division; BirdLife International; California State University System; San Diego State University; University of California System; University of California Santa Cruz; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Massachusetts System; University of Massachusetts Amherst; BirdLife International	Finkelstein, M (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	myraf@ucsc.edu		Satterthwaite, William/0000-0002-0436-7390; Lewison, Rebecca/0000-0003-3065-2926	David H. Smith Conservation Research Fellowship	David H. Smith Conservation Research Fellowship	M. Finkelstein, V. Bakker, and P.B. McIntyre were supported by the David H. Smith Conservation Research Fellowship.	Abrams PA, 2002, AM NAT, V160, P293, DOI 10.1086/341521; *AGDEH, 2005, STRAT ASS E TUN BILL, P56; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Arnold JM, 2006, ECOL APPL, V16, P419, DOI 10.1890/03-5340; Awkerman JA, 2006, BIOL CONSERV, V133, P483, DOI 10.1016/j.biocon.2006.07.010; Bache SJ, 2003, OCEAN COAST MANAGE, V46, P103, DOI 10.1016/S0964-5691(02)00123-0; Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bull LS, 2007, FISH FISH, V8, P31, DOI 10.1111/j.1467-2979.2007.00234.x; CADE TJ, 1988, PEREGRINE FALCON POP, P949; Carrier JC, 1998, FISH RES, V39, P209, DOI 10.1016/S0165-7836(98)00184-2; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Cowell R, 2003, GEOFORUM, V34, P343, DOI 10.1016/S0016-7185(02)00081-7; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; CROXALL JP, 1984, STATUS CONSERVATION, P778; CROXALL JP, 1991, BIRD POPULATION STUD, P272; Cuthbert R, 2004, BIOL CONSERV, V117, P483, DOI 10.1016/j.biocon.2003.08.007; Cuthbert R, 2002, IBIS, V144, P423, DOI 10.1046/j.1474-919X.2002.00071.x; DIETRICH KS, 2003, THESIS U WASHINGTON, P119; DOAK D, 1994, ECOL APPL, V4, P446, DOI 10.2307/1941949; Doak D, 2007, FRONT ECOL ENVIRON, V5, P350, DOI 10.1890/1540-9295(2007)5[350:CMFMBW]2.0.CO;2; Doak DF, 1995, CONSERV BIOL, V9, P1370, DOI 10.1046/j.1523-1739.1995.09061370.x; Donlan CJ, 2008, BIOL INVASIONS, V10, P1053, DOI 10.1007/s10530-007-9183-0; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eden S, 1999, AREA, V31, P151, DOI 10.1111/j.1475-4762.1999.tb00180.x; Gilman E, 2007, BIOL CONSERV, V139, P19, DOI 10.1016/j.biocon.2007.06.002; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hunter CM, 2000, ECOL MODEL, V134, P299, DOI 10.1016/S0304-3800(00)00344-6; Hunter CM, 2005, J ANIM ECOL, V74, P589, DOI 10.1111/j.1365-2656.2005.00929.x; *JOINT NAT CONS CO, 2006, ALB PETR S ATL CONS, P94; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Julian F, 1998, FISH B-NOAA, V96, P271; Kaplan IC, 2007, T AM FISH SOC, V136, P392, DOI 10.1577/T05-301.1; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Kauffman MJ, 2004, AM NAT, V164, P582, DOI 10.1086/424763; KEITT BS, 2005, ISLA GUADALUPE RESTA, P219; Kelleher K., 2005, DISCARDS WORLDS MARI, P470; Kentula ME, 2000, ECOL ENG, V15, P199, DOI 10.1016/S0925-8574(00)00076-8; Kesler DC, 2007, BIOL CONSERV, V136, P520, DOI 10.1016/j.biocon.2006.12.023; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koons DN, 2006, ECOL MODEL, V197, P418, DOI 10.1016/j.ecolmodel.2006.03.034; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lewison RL, 2003, CONSERV BIOL, V17, P1089, DOI 10.1046/j.1523-1739.2003.02057.x; Miller TJ, 2006, CAN J FISH AQUAT SCI, V63, P1878, DOI 10.1139/F06-075; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; PECKHAM SH, 2007, PLOS ONE, V10, P1; Priddel D, 2006, BIOL CONSERV, V128, P412, DOI 10.1016/j.biocon.2005.10.007; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Race MS, 1996, ECOL APPL, V6, P94, DOI 10.2307/2269556; Read AJ, 2007, BIOL CONSERV, V135, P155, DOI 10.1016/j.biocon.2006.10.030; Romanov EV, 2002, FISH B-NOAA, V100, P90; *SC CCAMLR, 2000, 19 M SCI COMM HOB SC, P239; SCHREIBER RW, 1980, BIOSCIENCE, V30, P742, DOI 10.2307/1308334; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; STOBUTZKI I, 2006, EC BYC SPEC WORK GRO, P34; Stobutzki IC, 2002, FISH B-NOAA, V100, P800; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Weimerskirch H, 1999, BIOL CONSERV, V87, P273, DOI 10.1016/S0006-3207(98)00039-1; Whittow G. Causey, 1993, Birds of North America, V66, P1; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Wilkinson Ian, 2003, P192; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2; Witmer GW, 2007, WILDLIFE RES, V34, P108, DOI 10.1071/WR06006	68	34	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2480	10.1371/journal.pone.0002480	http://dx.doi.org/10.1371/journal.pone.0002480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560568	Green Published, gold			2022-12-27	WOS:000263280700051
J	Giri, PK; Schorey, JS				Giri, Pramod K.; Schorey, Jeffrey S.			Exosomes Derived from M-Bovis BCG Infected Macrophages Activate Antigen-Specific CD4(+) and CD8(+) T Cells In Vitro and In Vivo	PLOS ONE			English	Article								Activation of both CD4(+) and CD8(+) T cells is required for an effective immune response to an M. tuberculosis infection. However, infected macrophages are poor antigen presenting cells and may be spatially separated from recruited T cells, thus limiting antigen presentation within a granuloma. Our previous studies showed that infected macrophages release from cells small membrane-bound vesicles called exosomes which contain mycobacterial lipid components and showed that these exosomes could stimulate a pro-inflammatory response in naive macrophages. In the present study we demonstrate that exosomes stimulate both CD4+ and CD8+ splenic T cells isolated from mycobacteria-sensitized mice. Although the exosomes contain MHC I and II as well as costimulatory molecules, maximum stimulation of T cells required prior incubation of exosomes with antigen presenting cells. Exosomes isolated from M. bovis and M. tuberculosis infected macrophages also stimulated activation and maturation of mouse bone marrow-derived dendritic cells. Interestingly, intranasal administration of mice with exosomes isolated from M. bovis BCG infected macrophages induce the generation of memory CD4+ and CD8+ T cells. The isolated T cells also produced IFN-gamma upon restimulation with BCG antigens. The release of exosomes from infected macrophages may overcome some of the defects in antigen presentation associated with mycobacterial infections and we suggest that exosomes may be a promising M. tuberculosis vaccine candidate.	[Giri, Pramod K.; Schorey, Jeffrey S.] Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA	University of Notre Dame	Giri, PK (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Ctr Global Hlth & Infect Dis, Notre Dame, IN 46556 USA.	Schorey.1@nd.edu			National Institute of Allergy and Infectious Diseases [AI056979, AI052439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056979, R01AI052439] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through grants AI056979 and AI052439 from the National Institute of Allergy and Infectious Diseases (JSS).	Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Amigorena S, 2000, MEDICINA-BUENOS AIRE, V60, P51; Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; ANDERSEN P, 1994, IMMUNOBIOLOGY, V191, P537, DOI 10.1016/S0171-2985(11)80460-2; Andre F, 2004, ANN ONCOL, V15, P141, DOI 10.1093/annonc/mdh918; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; Chang ST, 2005, P NATL ACAD SCI USA, V102, P4530, DOI 10.1073/pnas.0500362102; Chaput N, 2006, J LEUKOCYTE BIOL, V80, P471, DOI 10.1189/jlb.0206094; Colino J, 2007, INFECT IMMUN, V75, P220, DOI 10.1128/IAI.01217-06; COSULICH ME, 1987, P NATL ACAD SCI USA, V84, P4205, DOI 10.1073/pnas.84.12.4205; Dorer DE, 2007, CELL MICROBIOL, V9, P544, DOI 10.1111/j.1462-5822.2006.00810.x; Esser MT, 2003, VACCINE, V21, P419, DOI 10.1016/S0264-410X(02)00407-3; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GERCKEN J, 1994, INFECT IMMUN, V62, P3472, DOI 10.1128/IAI.62.8.3472-3478.1994; Harding CV, 2003, CURR OPIN IMMUNOL, V15, P112, DOI 10.1016/S0952-7915(02)00008-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sable SB, 2007, CLIN IMMUNOL, V122, P239, DOI 10.1016/j.clim.2006.10.010; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wieckowski E, 2006, IMMUNOL RES, V36, P247, DOI 10.1385/IR:36:1:247; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30	40	167	180	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2461	10.1371/journal.pone.0002461	http://dx.doi.org/10.1371/journal.pone.0002461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560543	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700042
J	West, JB; Sobek, A; Ehleringer, JR				West, Jason B.; Sobek, Adam; Ehleringer, James R.			A Simplified GIS Approach to Modeling Global Leaf Water Isoscapes	PLOS ONE			English	Article							OXYGEN-ISOTOPE RATIOS; STABLE-ISOTOPES; STOMATAL SENSITIVITY; ATMOSPHERIC CO2; DELTA-D; 3-DIMENSIONAL SYNTHESIS; INTERSPECIFIC VARIATION; TERRESTRIAL VEGETATION; MECHANISTIC MODEL; O-18 ENRICHMENT	The stable hydrogen (delta H-2) and oxygen (delta O-18) isotope ratios of organic and inorganic materials record biological and physical processes through the effects of substrate isotopic composition and fractionations that occur as reactions proceed. At large scales, these processes can exhibit spatial predictability because of the effects of coherent climatic patterns over the Earth's surface. Attempts to model spatial variation in the stable isotope ratios of water have been made for decades. Leaf water has a particular importance for some applications, including plant organic materials that record spatial and temporal climate variability and that may be a source of food for migrating animals. It is also an important source of the variability in the isotopic composition of atmospheric gases. Although efforts to model global-scale leaf water isotope ratio spatial variation have been made (especially of delta O-18), significant uncertainty remains in models and their execution across spatial domains. We introduce here a Geographic Information System (GIS) approach to the generation of global, spatially-explicit isotope landscapes ( = isoscapes) of "climate normal'' leaf water isotope ratios. We evaluate the approach and the resulting products by comparison with simulation model outputs and point measurements, where obtainable, over the Earth's surface. The isoscapes were generated using biophysical models of isotope fractionation and spatially continuous precipitation isotope and climate layers as input model drivers. Leaf water delta O-18 isoscapes produced here generally agreed with latitudinal averages from GCM/biophysical model products, as well as mean values from point measurements. These results show global-scale spatial coherence in leaf water isotope ratios, similar to that observed for precipitation and validate the GIS approach to modeling leaf water isotopes. These results demonstrate that relatively simple models of leaf water enrichment combined with spatially continuous precipitation isotope ratio and climate data layers yield accurate global leaf water estimates applicable to important questions in ecology and atmospheric science.	[West, Jason B.; Ehleringer, James R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sobek, Adam] Univ Utah, Dept Geography, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	West, JB (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jwest@biology.utah.edu	West, Jason B/G-8833-2012; Ehleringer, James/G-1780-2010	West, Jason/0000-0002-7811-8020	Office of National Drug Control Policy (ONDCP); Technical Support Working Group (TSWG); Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy [DE-FG03-00ER63012]	Office of National Drug Control Policy (ONDCP); Technical Support Working Group (TSWG); Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE))	Financial support was provided by the Office of National Drug Control Policy (ONDCP), the Technical Support Working Group (TSWG), and the Terrestrial Carbon Processes (TCP) program by the office of Science (BER), U.S. Department of Energy under Grant No. DE-FG03-00ER63012.	Addington RN, 2004, TREE PHYSIOL, V24, P561, DOI 10.1093/treephys/24.5.561; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2004, PLANT CELL ENVIRON, V27, P107, DOI 10.1046/j.0016-8025.2003.01132.x; Barbour MM, 2004, OECOLOGIA, V138, P426, DOI 10.1007/s00442-003-1449-3; Barnard RL, 2007, PLANT CELL ENVIRON, V30, P539, DOI 10.1111/j.1365-3040.2007.01654.x; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Brandes E, 2007, PLANT CELL ENVIRON, V30, P113, DOI 10.1111/j.1365-3040.2006.01609.x; Brooks JR, 2002, J AGR FOOD CHEM, V50, P6413, DOI 10.1021/jf020594k; Buckley TN, 2005, NEW PHYTOL, V168, P275, DOI 10.1111/j.1469-8137.2005.01543.x; Bunn AG, 2006, EARTH INTERACT, V10; Cappa CD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003597; Casale JF, 2005, J FORENSIC SCI, V50, P1315; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5873, DOI 10.1029/96JD02361; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Coplen TB, 2002, PURE APPL CHEM, V74, P1987, DOI 10.1351/pac200274101987; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; CUNTZ M, 2003, J GEOPHYS RES, V108; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Darling WG, 2004, QUATERNARY SCI REV, V23, P743, DOI 10.1016/j.quascirev.2003.06.016; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P219, DOI 10.1007/BF01323191; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; Ewers BE, 2005, PLANT CELL ENVIRON, V28, P660, DOI 10.1111/j.1365-3040.2005.01312.x; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; Farquhar GD, 2005, FUNCT PLANT BIOL, V32, P293, DOI 10.1071/FP04232; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Farquhar GD, 2003, PLANT CELL ENVIRON, V26, P801; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; Formica VA, 2004, ECOLOGY, V85, P1125, DOI 10.1890/03-0029; FRANCEY RJ, 1987, NATURE, V327, P495, DOI 10.1038/327495a0; Gan KS, 2003, PLANT CELL ENVIRON, V26, P1479, DOI 10.1046/j.1365-3040.2003.01070.x; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Hansson S, 1997, ECOLOGY, V78, P2249, DOI 10.2307/2265961; Helliker BR, 2000, P NATL ACAD SCI USA, V97, P7894, DOI 10.1073/pnas.97.14.7894; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hoffmann G, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002059; JACOB H, 1991, TELLUS B, V43, P291, DOI 10.1034/j.1600-0889.1991.t01-2-00003.x; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; KEELING RF, 1995, REV GEOPHYS, V33, P1253, DOI 10.1029/95RG00438; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lai CH, 2006, CURR OPIN OBSTET GYN, V18, P29; Lee H, 2006, TELLUS B, V58, P293, DOI 10.1111/j.1600-0889.2006.00191.x; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Liu WG, 2005, ORG GEOCHEM, V36, P851, DOI 10.1016/j.orggeochem.2005.01.006; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Lohammar T., 1980, Ecological Bulletins, V32, P505; LUO YH, 1992, PLANT PHYSIOL, V99, P348, DOI 10.1104/pp.99.1.348; Maherali H, 2003, PLANT CELL ENVIRON, V26, P1297, DOI 10.1046/j.1365-3040.2003.01054.x; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423, DOI 10.1051/jcp/1971681423; Masarie KA, 2001, J GEOPHYS RES-ATMOS, V106, P20445, DOI 10.1029/2000JD000023; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; MERLIVAT L, 1978, J CHEM PHYS, V69, P2864, DOI 10.1063/1.436884; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Ogee J, 2007, PLANT CELL ENVIRON, V30, P367, DOI 10.1111/j.1365-3040.2006.01621.x; Ogrinc N, 2003, ANAL BIOANAL CHEM, V376, P424, DOI 10.1007/s00216-003-1804-6; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Pearcy R. W., 1989, Plant physiological ecology: field methods and instrumentation.; Riley WJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001878; Roden JS, 1999, PLANT PHYSIOL, V120, P1165, DOI 10.1104/pp.120.4.1165; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Rossmann A, 2001, FOOD REV INT, V17, P347, DOI 10.1081/FRI-100104704; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Scott RL, 2006, GLOBAL CHANGE BIOL, V12, P311, DOI 10.1111/j.1365-2486.2005.01093.x; Seibt U, 2006, PLANT CELL ENVIRON, V29, P928, DOI 10.1111/j.1365-3040.2005.01474.x; Smita Joshi, 2006, AIDS Res Ther, V3, P4, DOI 10.1186/1742-6405-3-4; Strong M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028307; Terwilliger VJ, 2002, GEOCHIM COSMOCHIM AC, V66, P3887, DOI 10.1016/S0016-7037(02)00964-X; Tsujimura M, 2007, J HYDROL, V333, P35, DOI 10.1016/j.jhydrol.2006.07.025; Wang LB, 2005, REMOTE SENS ENVIRON, V95, P453, DOI 10.1016/j.rse.2005.01.006; Wang XF, 1998, GLOBAL CHANGE BIOL, V4, P835, DOI 10.1046/j.1365-2486.1998.00197.x; Welker JM, 2000, HYDROL PROCESS, V14, P1449, DOI [10.1002/1099-1085(20000615)14:8<1449::AID-HYP993>3.0.CO;2-7, 10.1002/1099-1085(20000615)14:8&lt;1449::AID-HYP993&gt;3.0.CO;2-7]; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; WEST JB, 2007, J AGR FOOD CHEM; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; YAKIR D, 1989, GEOCHIM COSMOCHIM AC, V53, P2769, DOI 10.1016/0016-7037(89)90147-6; YAKIR D, 1994, PLANT CELL ENVIRON, V17, P73, DOI 10.1111/j.1365-3040.1994.tb00267.x; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; YAKIR D, 1990, PLANT CELL ENVIRON, V13, P49, DOI 10.1111/j.1365-3040.1990.tb01298.x; Yoshimura K, 2006, GLOBAL PLANET CHANGE, V51, P90, DOI 10.1016/j.gloplacha.2005.12.007; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510	89	77	78	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2447	10.1371/journal.pone.0002447	http://dx.doi.org/10.1371/journal.pone.0002447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560592	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700032
J	Galli, S; Arciuch, VGA; Poderoso, C; Converso, DP; Zhou, QQ; Joffe, EBD; Cadenas, E; Boczkowski, J; Carreras, MC; Poderoso, JJ				Galli, Soledad; Antico Arciuch, Valeria Gabriela; Poderoso, Cecilia; Converso, Daniela Paola; Zhou, Qiongqiong; de Kier Joffe, Elisa Bal; Cadenas, Enrique; Boczkowski, Jorge; Carreras, Maria Cecilia; Poderoso, Juan Jose			Tumor Cell Phenotype Is Sustained by Selective MAPK Oxidation in Mitochondria	PLOS ONE			English	Article							CYSTEINE-SULFINIC ACID; ACTIVATED PROTEIN-KINASES; OXIDE SYNTHASE ACTIVITY; N-TERMINAL KINASE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; SITE CYSTEINE; APOPTOSIS; PROLIFERATION; PEROXIREDOXIN	Mitochondria are major cellular sources of hydrogen peroxide (H2O2), the production of which is modulated by oxygen availability and the mitochondrial energy state. An increase of steady-state cell H2O2 concentration is able to control the transition from proliferating to quiescent phenotypes and to signal the end of proliferation; in tumor cells thereby, low H2O2 due to defective mitochondrial metabolism can contribute to sustain proliferation. Mitogen-activated protein kinases (MAPKs) orchestrate signal transduction and recent data indicate that are present in mitochondria and regulated by the redox state. On these bases, we investigated the mechanistic connection of tumor mitochondrial dysfunction, H2O2 yield, and activation of MAPKs in LP07 murine tumor cells with confocal microscopy, in vivo imaging and directed mutagenesis. Two redox conditions were examined: low 1 mu M H2O2 increased cell proliferation in ERK1/2-dependent manner whereas high 50 mu M H2O2 arrested cell cycle by p38 and JNK1/2 activation. Regarding the experimental conditions as a three-compartment model (mitochondria, cytosol, and nuclei), the different responses depended on MAPKs preferential traffic to mitochondria, where a selective activation of either ERK1/2 or p38-JNK1/2 by co-localized upstream kinases (MAPKKs) facilitated their further passage to nuclei. As assessed by mass spectra, MAPKs activation and efficient binding to cognate MAPKKs resulted from oxidation of conserved ERK1/2 or p38-JNK1/2 cysteine domains to sulfinic and sulfonic acids at a definite H2O2 level. Like this, high H2O2 or directed mutation of redox-sensitive ERK2 Cys(214) impeded binding to MEK1/2, caused ERK2 retention in mitochondria and restricted shuttle to nuclei. It is surmised that selective cysteine oxidations adjust the electrostatic forces that participate in a particular MAPK-MAPKK interaction. Considering that tumor mitochondria are dysfunctional, their inability to increase H2O2 yield should disrupt synchronized MAPK oxidations and the regulation of cell cycle leading cells to remain in a proliferating phenotype.	[Galli, Soledad; Antico Arciuch, Valeria Gabriela; Converso, Daniela Paola; Carreras, Maria Cecilia; Poderoso, Juan Jose] Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Poderoso, Cecilia] Univ Buenos Aires, Fac Med, Dept Human Biochem, Buenos Aires, DF, Argentina; [Zhou, Qiongqiong; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [de Kier Joffe, Elisa Bal] Univ Buenos Aires, Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina; [Boczkowski, Jorge] Hop Bichat Claude Bernard, Unite INSERM 700, Paris, France; [Carreras, Maria Cecilia] Univ Buenos Aires, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina; [Poderoso, Juan Jose] Univ Buenos Aires, Univ Hosp, Dept Med, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Southern California; University of Buenos Aires; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Buenos Aires; University of Buenos Aires	Galli, S (corresponding author), Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Boczkowski, Jorge/S-7474-2018	Boczkowski, Jorge/0000-0001-6619-5785	Fundacion Perez Companc, University of Buenos Aires [M073]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [5495]; Agencia Nacional para la Promocion Cientifica y Tecnologica [8468]; NIH [5R01AG016718]	Fundacion Perez Companc, University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from Fundacion Perez Companc, University of Buenos Aires (Ubacyt M073), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (PIP 5495), Agencia Nacional para la Promocion Cientifica y Tecnologica (Foncyt, PICT 8468), and NIH (NIA) 5R01AG016718.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOVERIS A, 2000, NITRIC OXIDE BIOL PA, P355; Boveris A, 1997, OXYGEN GENE EXPRESSI, P1; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen DB, 2003, MOL CELL ENDOCRINOL, V200, P141, DOI 10.1016/S0303-7207(02)00379-9; Chodosh LA, 2002, NEW ENGL J MED, V347, P134, DOI 10.1056/NEJMcibr020712; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dougherty CJ, 2004, FASEB J, V18, P1060, DOI 10.1096/fj.04-1505com; Galli S, 2003, CANCER RES, V63, P6370; Heerdt BG, 2003, CANCER RES, V63, P6311; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Jacob C, 2006, BIOL CHEM, V387, P1385, DOI 10.1515/BC.2006.174; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623; Kreft M, 2004, COMPUT METH PROG BIO, V74, P63, DOI 10.1016/S0169-2607(03)00071-3; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lou YW, 2008, FEBS J, V275, P69, DOI 10.1111/j.1742-4658.2007.06173.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pantano C, 2003, J BIOL CHEM, V278, P44091, DOI 10.1074/jbc.M308487200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Riobo NA, 2002, J BIOL CHEM, V277, P42447, DOI 10.1074/jbc.M204580200; Robinson MJ, 2002, J BIOL CHEM, V277, P5094, DOI 10.1074/jbc.M110935200; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Urtreger AJ, 2001, INT J ONCOL, V18, P639; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	54	50	51	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2379	10.1371/journal.pone.0002379	http://dx.doi.org/10.1371/journal.pone.0002379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545666	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800019
J	Jamieson, SE; de Roubaix, LA; Cortina-Borja, M; Tan, HK; Mui, EJ; Cordell, HJ; Kirisits, MJ; Miller, EN; Peacock, CS; Hargrave, AC; Coyne, JJ; Boyer, K; Bessieres, MH; Buffolano, W; Ferret, N; Franck, J; Kieffer, F; Meier, P; Nowakowska, DE; Paul, M; Peyron, F; Stray-Pedersen, B; Prusa, AR; Thulliez, P; Wallon, M; Petersen, E; McLeod, R; Gilbert, RE; Blackwell, JM				Jamieson, Sarra E.; de Roubaix, Lee-Anne; Cortina-Borja, Mario; Tan, Hooi Kuan; Mui, Ernest J.; Cordell, Heather J.; Kirisits, Michael J.; Miller, E. Nancy; Peacock, Christopher S.; Hargrave, Aubrey C.; Coyne, Jessica J.; Boyer, Kenneth; Bessieres, Marie-Helene; Buffolano, Wilma; Ferret, Nicole; Franck, Jacqueline; Kieffer, Francois; Meier, Paul; Nowakowska, Dorota E.; Paul, Malgorzata; Peyron, Francois; Stray-Pedersen, Babill; Prusa, Andrea-Romana; Thulliez, Philippe; Wallon, Martine; Petersen, Eskild; McLeod, Rima; Gilbert, Ruth E.; Blackwell, Jenefer M.			Genetic and Epigenetic Factors at COL2A1 and ABCA4 Influence Clinical Outcome in Congenital Toxoplasmosis	PLOS ONE			English	Article								Background: Primary Toxoplasma gondii infection during pregnancy can be transmitted to the fetus. At birth, infected infants may have intracranial calcification, hydrocephalus, and retinochoroiditis, and new ocular lesions can occur at any age after birth. Not all children who acquire infection in utero develop these clinical signs of disease. Whilst severity of disease is influenced by trimester in which infection is acquired by the mother, other factors including genetic predisposition may contribute. Methods and Findings: In 457 mother-child pairs from Europe, and 149 child/parent trios from North America, we show that ocular and brain disease in congenital toxoplasmosis associate with polymorphisms in ABCA4 encoding ATP-binding cassette transporter, subfamily A, member 4. Polymorphisms at COL2A1 encoding type II collagen associate only with ocular disease. Both loci showed unusual inheritance patterns for the disease allele when comparing outcomes in heterozygous affected children with outcomes in affected children of heterozygous mothers. Modeling suggested either an effect of mother's genotype, or parent-of-origin effects. Experimental studies showed that both ABCA4 and COL2A1 show isoform-specific epigenetic modifications consistent with imprinting. Conclusions: These associations between clinical outcomes of congenital toxoplasmosis and polymorphisms at ABCA4 and COL2A1 provide novel insight into the molecular pathways that can be affected by congenital infection with this parasite.	[Jamieson, Sarra E.; de Roubaix, Lee-Anne; Cordell, Heather J.; Miller, E. Nancy; Peacock, Christopher S.; Blackwell, Jenefer M.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Cortina-Borja, Mario; Tan, Hooi Kuan; Gilbert, Ruth E.] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Mui, Ernest J.; Kirisits, Michael J.; Hargrave, Aubrey C.; Coyne, Jessica J.; McLeod, Rima] Univ Chicago, Michael Reese Hosp & Med Ctr, Dept Ophthalmol, Med, Pediat, Committees on Immunol, Mol Med, & Genet, Chicago, IL USA; [Cordell, Heather J.] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Boyer, Kenneth] Rush Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Chicago, IL USA; [Bessieres, Marie-Helene] CHU Rangueil, Serv Parasitol Mycol, Toulouse, France; [Buffolano, Wilma] Univ Naples Federico 2, Dept Paediat, Naples, Italy; [Ferret, Nicole] Hop Archet II, Serv Parasitol Mycol, Nice, France; [Franck, Jacqueline] CHU Timone, Serv Parasitol, Marseille, France; [Kieffer, Francois] Inst Puericulture, Dept Paediat, Paris, France; [Meier, Paul] Columbia Univ, Dept Biostat, New York, NY USA; [Nowakowska, Dorota E.] Med Univ, Dept Fetal Maternal Med & Gynecol, Lodz, Poland; [Paul, Malgorzata] Univ Med Sci, Dept & Clin Trop & Parasit Dis, Poznan, Poland; [Peyron, Francois; Wallon, Martine] Hop Croix Rousse, Serv Parasitol, Hospices Civils Lyon, Lyon, France; [Stray-Pedersen, Babill] Univ Oslo, Dept Obstet & Gynaecol, Rikshospitalet Radiumhospitalet, Oslo, Norway; [Prusa, Andrea-Romana] Med Univ Vienna, Dept Pediat, Div Neonatol, Congenit Disorders & Intens Care, Vienna, Austria; [Thulliez, Philippe] Inst Puericulture, Toxoplasmosis Lab, Paris, France; [Petersen, Eskild] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Michael Reese Hospital & Medical Center; University of Chicago; Newcastle University - UK; Rush University; CHU de Toulouse; University of Naples Federico II; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Columbia University; CHU Lyon; University of Oslo; Medical University of Vienna; Aarhus University	Jamieson, SE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.	jmb37@cam.ac.uk	Borja, Mario Cortina/A-3847-2009; Wallon, martine/D-1340-2013; Peacock, Christopher/A-4052-2012; Blackwell, Jenefer M/H-3015-2015	Borja, Mario Cortina/0000-0003-0627-2624; Wallon, martine/0000-0001-8285-8550; Gilbert, Ruth/0000-0001-9347-2709; Cordell, Heather/0000-0002-1879-5572; Miller, Eric/0000-0002-0650-714X	EU [BMH4-CT98-3927, QLG5-CT2000-00846]; Department of Health, UK; NIH [16945 01-20, 27530 01-20, 4328 01-11, 071319-01]; FDA RFA [8-86 01-2]; March of Dimes [6-528 01-4]; The Research to Prevent Blindness Foundation; United Airlines Foundation; Hyatt Hotels Foundation; The French Consulate in Chicago; Michael Reese Medical Center Foundation; The Buchannan Family Foundation	EU(European Commission); Department of Health, UK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA RFA; March of Dimes(March of Dimes); The Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); United Airlines Foundation; Hyatt Hotels Foundation; The French Consulate in Chicago; Michael Reese Medical Center Foundation; The Buchannan Family Foundation	The epidemiology, clinical evaluation and sample collection for the EMSCOT study was funded by EU grants BMH4-CT98-3927 and QLG5-CT2000-00846. Research at the ICH, University College London, benefits from Research and Development funding from the Department of Health, UK. The clinical evaluation, sample collection and preparation, and parts of the genotyping for the NCCCTS cohort were funded by NIH RO1s NIAID TMP 16945 01-20;27530 01-20; 4328 01-11;071319-01; FDA RFA 8-86 01-2; March of Dimes 6-528 01-4; The Research to Prevent Blindness Foundation: United Airlines Foundation; and Hyatt Hotels Foundation. Genetic studies for both cohorts were principally funded by the Guide Dogs for the Blind Association in the UK. Additional support for the NCCCTS study was provided by: The French Consulate in Chicago, Michael Reese Medical Center Foundation, The Buchannan Family Foundation, and gifts from the Kieweit, Blackmon, Brennan, Koshland, Langel, Morel, Rosenstein, Kapnick, Cussen, Taub, Samuel and Rooney-Alden families. Complimentary travel for families visiting Chicago was provided by Foundations of American, Braniff, United, Southwest, Air Canada, Horizon, Brittish, and Pan American Airlines and Angel Flight. None of these funding agencies had any role in design or conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; BENEVENTO J, 2008, ARCH OPTHAL IN PRESS; Bhongsatiern J, 2005, J NEUROCHEM, V92, P1277, DOI 10.1111/j.1471-4159.2004.02941.x; Binquet C, 2003, EPIDEMIOL INFECT, V131, P1157, DOI 10.1017/S0950268803001316; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Ducroq D, 2002, AM J HUM GENET, V71, P1480, DOI 10.1086/344829; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Eckert GU, 2007, EYE, V21, P746, DOI 10.1038/sj.eye.6702319; FREEMAN K, 2008, PAEDIATRICS IN PRESS; Gilbert R, 2003, BJOG-INT J OBSTET GY, V110, P112, DOI 10.1016/S1470-0328(02)02325-X; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gras L, 2005, ACTA PAEDIATR, V94, P1721, DOI 10.1080/08035250500251999; HEDRICK PW, 1987, GENETICS, V117, P331; Hitchins MP, 2002, MAMM GENOME, V13, P686, DOI 10.1007/s00335-002-3028-z; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; Ihanamaki T, 2002, EUR J OPHTHALMOL, V12, P450, DOI 10.1177/112067210201200602; Ihanamaki T, 2001, EXP EYE RES, V72, P423, DOI 10.1006/exer.2000.0972; Kamei Y, 2007, FEBS LETT, V581, P91, DOI 10.1016/j.febslet.2006.12.002; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; Kodjikian L, 2006, GRAEF ARCH CLIN EXP, V244, P14, DOI 10.1007/s00417-005-1164-3; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Mack DG, 1999, INT J PARASITOL, V29, P1351, DOI 10.1016/S0020-7519(99)00152-6; Mauget-Faysse M, 2006, RETINA-J RET VIT DIS, V26, P396, DOI 10.1097/00006982-200604000-00003; MCAULEY J, 1994, CLIN INFECT DIS, V18, P38, DOI 10.1093/clinids/18.1.38; McLeod R, 2006, CLIN INFECT DIS, V42, P1383, DOI 10.1086/501360; Molestina RE, 2005, J CELL SCI, V118, P5785, DOI 10.1242/jcs.02709; Molestina RE, 2005, CELL MICROBIOL, V7, P351, DOI 10.1111/j.1462-5822.2004.00463.x; Orefice JL, 2007, BRIT J OPHTHALMOL, V91, P773, DOI 10.1136/bjo.2006.108068; REMINGTON JS, 2005, INFECT DIS FETUS NEW, P947; Richards AJ, 2005, INVEST OPHTH VIS SCI, V46, P663, DOI 10.1167/iovs.04-1017; Richards AJ, 2006, HUM MUTAT, V27, P696, DOI 10.1002/humu.20347; Rose PS, 2005, AM J MED GENET A, V138A, P199, DOI 10.1002/ajmg.a.30955; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Savontaus M, 1997, INVEST OPHTH VIS SCI, V38, P930; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Tachikawa M, 2005, J NEUROCHEM, V95, P294, DOI 10.1111/j.1471-4159.2005.03369.x; Thiebaut R, 2007, LANCET, V369, P115, DOI 10.1016/S0140-6736(07)60072-5; van den Oord EJCG, 2000, AM J HUM GENET, V66, P335, DOI 10.1086/302708; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500	50	89	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2285	10.1371/journal.pone.0002285	http://dx.doi.org/10.1371/journal.pone.0002285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523590	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300006
J	Pask, AJ; McInnes, KJ; Webb, DR; Short, RV				Pask, Andrew J.; McInnes, Kerry J.; Webb, David R.; Short, Roger V.			Topical Oestrogen Keratinises The Human Foreskin and May Help Prevent HIV Infection	PLOS ONE			English	Article								With the growing incidence of HIV, there is a desperate need to develop simple, cheap and effective new ways of preventing HIV infection. Male circumcision reduces the risk of infection by about 60%, probably because of the removal of the Langerhans cells which are abundant in the inner foreskin and are the primary route by which HIV enters the penis. Langerhans cells form a vital part of the body's natural defence against HIV and only cause infection when they are exposed to high levels of HIV virions. Rather than removing this natural defence mechanism by circumcision, it may be better to enhance it by thickening the layer of keratin overlying the Langerhans cells, thereby reducing the viral load to which they are exposed. We have investigated the ability of topically administered oestrogen to induce keratinization of the epithelium of the inner foreskin. Histochemically, the whole of the foreskin is richly supplied with oestrogen receptors. The epithelium of the inner foreskin, like the vagina, responds within 24 hours to the topical administration of oestriol by keratinization, and the response persists for at least 5 days after the cessation of the treatment. Oestriol, a cheap, readily available natural oestrogen metabolite, rapidly keratinizes the inner foreskin, the site of HIV entry into the penis. This thickening of the overlying protective layer of keratin should reduce the exposure of the underlying Langerhans cells to HIV virions. This simple treatment could become an adjunct or alternative to surgical circumcision for reducing the incidence of HIV infection in men.	[Pask, Andrew J.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [McInnes, Kerry J.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Webb, David R.] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Webb, David R.] Austin Hlth, Heidelberg, Vic, Australia; [Short, Roger V.] Univ Melbourne, Fac Med, Dent & Hlth Sci, Melbourne, Vic, Australia	University of Melbourne; Prince Henry's Institute of Medical Research; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Pask, AJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	r.short@unimelb.edu.au	McInnes, Kerry/B-7893-2011	Pask, Andrew/0000-0002-1900-2263	National Health and Medical Research Council [RD Wright Fellowship]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a National Health and Medical Research Council RD Wright Fellowship to AJP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DEVINCENZI I, 1992, BRIT MED J, V304, P809; GERBALDO D, 1991, MATURITAS, V13, P269, DOI 10.1016/0378-5122(91)90235-I; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Kelley Charlotte, 2007, Urol Nurs, V27, P40; Luna L, 1992, HISTOPATHOLOGIC METH; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Morris BJ, 2007, BIOESSAYS, V29, P1147, DOI 10.1002/bies.20654; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Quinn TC, 2007, CURR OPIN INFECT DIS, V20, P33, DOI 10.1097/QCO.0b013e328012c5bc; Robinson D, 2003, UROLOGY, V62, P45, DOI 10.1016/S0090-4295(03)00676-9; Schwartz O, 2007, NAT MED, V13, P245, DOI 10.1038/nm0307-245; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Wu WX, 2000, AM J PHYSIOL-CELL PH, V278, pC190, DOI 10.1152/ajpcell.2000.278.1.C190	20	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2308	10.1371/journal.pone.0002308	http://dx.doi.org/10.1371/journal.pone.0002308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523637	gold, Green Published			2022-12-27	WOS:000262614300015
J	Cao, RH; Jensen, LDE; Soll, I; Hauptmann, G; Cao, YH				Cao, Renhai; Jensen, Lasse Dahl Ejby; Soell, Iris; Hauptmann, Giselbert; Cao, Yihai			Hypoxia-Induced Retinal Angiogenesis in Zebrafish as a Model to Study Retinopathy	PLOS ONE			English	Article							VASCULAR-PERMEABILITY FACTOR; INHIBITS TUMOR-GROWTH; CELLS; LYMPHANGIOGENESIS; BLOCKADE; VESSELS; FENESTRATIONS; EXPRESSION; PROMOTE; PROTEIN	Mechanistic understanding and defining novel therapeutic targets of diabetic retinopathy and age-related macular degeneration (AMD) have been hampered by a lack of appropriate adult animal models. Here we describe a simple and highly reproducible adult fli-EGFP transgenic zebrafish model to study retinal angiogenesis. The retinal vasculature in the adult zebrafish is highly organized and hypoxia-induced neovascularization occurs in a predictable area of capillary plexuses. New retinal vessels and vascular sprouts can be accurately measured and quantified. Orally active anti-VEGF agents including sunitinib and ZM323881 effectively block hypoxia-induced retinal neovascularization. Intriguingly, blockage of the Notch signaling pathway by the inhibitor DAPT under hypoxia, results in a high density of arterial sprouting in all optical arteries. The Notch suppression-induced arterial sprouting is dependent on tissue hypoxia. However, in the presence of DAPT substantial endothelial tip cell formation was detected only in optic capillary plexuses under normoxia. These findings suggest that hypoxia shifts the vascular targets of Notch inhibitors. Our findings for the first time show a clinically relevant retinal angiogenesis model in adult zebrafish, which might serve as a platform for studying mechanisms of retinal angiogenesis, for defining novel therapeutic targets, and for screening of novel antiangiogenic drugs.	[Cao, Renhai; Jensen, Lasse Dahl Ejby; Cao, Yihai] Karolinska Inst, Dept Microbiol, Stockholm, Sweden; [Soell, Iris; Hauptmann, Giselbert] Sodertorns Univ Coll, Sch Life Sci, Huddinge, Sweden; [Soell, Iris; Hauptmann, Giselbert] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet; Sodertorn University; Karolinska Institutet	Cao, RH (corresponding author), Karolinska Inst, Dept Microbiol, Stockholm, Sweden.	yihai.cao@ki.se		Jensen, Lasse/0000-0003-2338-357X; Hauptmann, Giselbert/0000-0002-1205-1011	Swedish Research Council; Swedish Heart and Lung Foundation; Swedish Cancer Foundation; Karolinska Institute; Soderberg Foundation; EU [504743, 013811]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Foundation; Karolinska Institute(Karolinska Institutet); Soderberg Foundation; EU(European Commission)	Yihai Cao's laboratory is supported by research grants from the Swedish Research Council, the Swedish Heart and Lung Foundation, the Swedish Cancer Foundation, the Karolinska Institute fund, the Soderberg Foundation, the EU integrated projects of Angiotargeting (Contract No. 504743), and VascuPlug (Contract No. STRP 013811). The Swedish Research Council further supports Y. Cao.	Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Eriksson A, 2003, CIRCULATION, V107, P1532, DOI 10.1161/01.CIR.0000055324.34758.32; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferris FL, 2004, NEW ENGL J MED, V351, P2863, DOI 10.1056/NEJMe048316; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gardner TW, 2007, NAT MED, V13, P131, DOI 10.1038/nm0207-131; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	44	104	109	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2748	10.1371/journal.pone.0002748	http://dx.doi.org/10.1371/journal.pone.0002748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648503	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900019
J	Coolen, M; Nicolle, D; Plouhinec, JL; Gombault, A; Sauka-Spengler, T; Menuet, A; Pieau, C; Mazan, S				Coolen, Marion; Nicolle, Delphine; Plouhinec, Jean-Louis; Gombault, Aurelie; Sauka-Spengler, Tatjana; Menuet, Arnaud; Pieau, Claude; Mazan, Sylvie			Molecular Characterization of the Gastrula in the Turtle Emys orbicularis: An Evolutionary Perspective on Gastrulation	PLOS ONE			English	Article								Due to the presence of a blastopore as in amphibians, the turtle has been suggested to exemplify a transition form from an amphibian-to an avian-type gastrulation pattern. In order to test this hypothesis and gain insight into the emergence of the unique characteristics of amniotes during gastrulation, we have performed the first molecular characterization of the gastrula in a reptile, the turtle Emys orbicularis. The study of Brachyury, Lim1, Otx2 and Otx5 expression patterns points to a highly conserved dynamic of expression with amniote model organisms and makes it possible to identify the site of mesoderm internalization, which is a long-standing issue in reptiles. Analysis of Brachyury expression also highlights the presence of two distinct phases, less easily recognizable in model organisms and respectively characterized by an early ring-shaped and a later bilateral symmetrical territory. Systematic comparisons with tetrapod model organisms lead to new insights into the relationships of the blastopore/blastoporal plate system shared by all reptiles, with the blastopore of amphibians and the primitive streak of birds and mammals. The biphasic Brachyury expression pattern is also consistent with recent models of emergence of bilateral symmetry, which raises the question of its evolutionary significance.	[Coolen, Marion; Nicolle, Delphine; Plouhinec, Jean-Louis; Gombault, Aurelie; Sauka-Spengler, Tatjana; Menuet, Arnaud; Mazan, Sylvie] CNRS, Dev & Evolut Vertebres, UMR 6218, F-45071 Orleans, France; [Pieau, Claude] Univ Pierre Marie Curie Paris 6 & 7, CNRS, Inst Jacques Monod, UMR7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Coolen, M (corresponding author), CNRS, Dev & Evolut Vertebres, UMR 6218, F-45071 Orleans, France.	mazan@cnrs-orleans.fr		Sauka-Spengler, Tatjana/0000-0001-9289-0263; Coolen, Marion/0000-0001-5658-5296	Universite Paris Sud; Universite d'Orleans; CNRS; Ministere de la Recherche [PhD fellowships]	Universite Paris Sud; Universite d'Orleans; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by funds from the Universite Paris Sud, Universite d'Orleans and CNRS. J.L P. and T.S.S. were recipients of PhD fellowships from the Ministere de la Recherche and M.C from CNRS.	ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Arendt D, 1999, MECH DEVELOP, V81, P3, DOI 10.1016/S0925-4773(98)00226-3; BALLYCUIF L, 1995, MECH DEVELOP, V49, P49, DOI 10.1016/0925-4773(94)00301-3; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Coolen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000374; del Pino EM, 2007, P NATL ACAD SCI USA, V104, P11882, DOI 10.1073/pnas.0705092104; Dorizzi M, 1996, DIFFERENTIATION, V60, P193, DOI 10.1046/j.1432-0436.1996.6040193.x; Fritzenwanker JH, 2007, DEV BIOL, V310, P264, DOI 10.1016/j.ydbio.2007.07.029; GAUTHIER JA, 1988, PHYLOGENY CLASSIFICA, V1, P103; Gilland E.H., 2004, P205; GUYOT G, 1994, ANN SCI NAT ZOOL, V15, P115; Holland PWH, 1995, DEVELOPMENT, V121, P4283; Ibrahim H, 2001, DEV BIOL, V240, P108, DOI 10.1006/dbio.2001.0459; Keller R., 2004, P171; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kraus Y, 2007, CURR BIOL, V17, pR874, DOI 10.1016/j.cub.2007.08.017; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Meinhardt H, 2004, NAT REV NEUROSCI, V5, P502, DOI 10.1038/nrn1410; Meinhardt H, 2006, DEV DYNAM, V235, P2907, DOI 10.1002/dvdy.20952; MITSUKURI, 1896, J COLL SCI IMP U TOK, V10, P1; Moya IM, 2007, DEV BIOL, V304, P467, DOI 10.1016/j.ydbio.2006.12.036; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; NAYAR MC, 1966, INDIAN JEXPBIO, P131; PANNESE M, 1995, DEVELOPMENT, V121, P707; PASTEELS J, 1937, REPTILES ARCH BIOL, P105; Peichel CL, 2005, DEV DYNAM, V234, P815, DOI 10.1002/dvdy.20564; Perea-Gomez A, 2001, DEVELOPMENT, V128, P753; Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Rhinn M, 1998, DEVELOPMENT, V125, P845; Sauka-Spengler T, 2003, DEV BIOL, V263, P296, DOI 10.1016/j.ydbio.2003.07.009; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; STERN CD, 2004, GASTRULATION CELLS E, P219; Taira M, 1997, P NATL ACAD SCI USA, V94, P895, DOI 10.1073/pnas.94.3.895; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Viebahn C, 2002, DEVELOPMENT, V129, P2355; Vignali R, 2000, MECH DEVELOP, V96, P3, DOI 10.1016/S0925-4773(00)00367-1; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207	45	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2676	10.1371/journal.pone.0002676	http://dx.doi.org/10.1371/journal.pone.0002676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628985	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000264057200021
J	Eriksson, D; Tompa, T; Roland, PE				Eriksson, David; Tompa, Tamas; Roland, Per E.			Non-Linear Population Firing Rates and Voltage Sensitive Dye Signals in Visual Areas 17 and 18 to Short Duration Stimuli	PLOS ONE			English	Article							RECEPTIVE-FIELD ORGANIZATION; RETINAL GANGLION-CELLS; AXON FLUORESCENCE; IN-VIVO; NEURONS; CORTEX; DYNAMICS; RESPONSES; REPRESENTATION; ARCHITECTURE	Visual stimuli of short duration seem to persist longer after the stimulus offset than stimuli of longer duration. This visual persistence must have a physiological explanation. In ferrets exposed to stimuli of different durations we measured the relative changes in the membrane potentials with a voltage sensitive dye and the action potentials of populations of neurons in the upper layers of areas 17 and 18. For durations less than 100 ms, the timing and amplitude of the firing and membrane potentials showed several non-linear effects. The ON response became truncated, the OFF response progressively reduced, and the timing of the OFF responses progressively delayed the shorter the stimulus duration. The offset of the stimulus elicited a sudden and strong negativity in the time derivative of the dye signal. All these non-linearities could be explained by the stimulus offset inducing a sudden inhibition in layers II-III as indicated by the strongly negative time derivative of the dye signal. Despite the non-linear behavior of the layer II-III neurons the sum of the action potentials, integrated from the peak of the ON response to the peak of the OFF response, was almost linearly related to the stimulus duration.	[Eriksson, David; Tompa, Tamas; Roland, Per E.] Karolinska Inst, Dept Neurosci, Solna, Sweden	Karolinska Institutet	Eriksson, D (corresponding author), Karolinska Inst, Dept Neurosci, Solna, Sweden.	per.roland@ki.se	Eriksson, David/E-2064-2012		Swedish Science Council	Swedish Science Council	This work was supported by a grant from the Swedish Science Council to P.E.R.	AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; AHMED B, 2008, CORTICAL DYNAMICS EN; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Anderson JC, 2002, J COMP NEUROL, V443, P56, DOI 10.1002/cne.10100; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BULLIER J, 1980, J COMP NEUROL, V193, P913, DOI 10.1002/cne.901930407; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; COLHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183; COLONNIER M, 1981, ELECT MISCROSCOPIC A; DAVILA HV, 1973, NATURE-NEW BIOL, V241, P159, DOI 10.1038/newbio241159a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; DUYSEN J, 1985, VISION RES, V25, P171, DOI 10.1016/0042-6989(85)90110-5; Duysens J, 1996, VISION RES, V36, P3243, DOI 10.1016/0042-6989(96)00040-5; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P37, DOI 10.1016/0028-3932(70)90024-2; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Galifret Y, 2006, CR BIOL, V329, P369, DOI 10.1016/j.crvi.2006.03.008; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; HEGGELUND P, 1981, EXP BRAIN RES, V42, P99; HEGGELUND P, 1981, EXP BRAIN RES, V42, P89; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Innocenti GM, 2002, CEREB CORTEX, V12, P411, DOI 10.1093/cercor/12.4.411; JUNG R, 1960, STRUCTURE FUNCTION C, P204; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; KONNERTH A, 1986, NEUROSCI LETT, V66, P49, DOI 10.1016/0304-3940(86)90164-3; KONNERTH A, 1988, GLIA, V1, P225, DOI 10.1002/glia.440010308; KRATZ KE, 1990, INT J NEUROSCI, V52, P111, DOI 10.3109/00207459008994252; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LEVICK WR, 1970, J PHYSIOL-LONDON, V206, P677, DOI 10.1113/jphysiol.1970.sp009037; LEVRAM V, 1986, P NATL ACAD SCI USA, V83, P6651, DOI 10.1073/pnas.83.17.6651; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; LOWENSTEIN PR, 1991, J COMP NEUROL, V310, P253, DOI 10.1002/cne.903100209; LUNG JS, 1979, J COMP NEUROL, V184, P599; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Pernberg J, 1998, EUR J NEUROSCI, V10, P3596, DOI 10.1046/j.1460-9568.1998.00364.x; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; ROSS WN, 1977, J MEMBRANE BIOL, V33, P141, DOI 10.1007/BF01869514; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; SINGER W, 1974, EXP BRAIN RES, V19, P507; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1	57	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2673	10.1371/journal.pone.0002673	http://dx.doi.org/10.1371/journal.pone.0002673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628825	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200018
J	Konczak, J; Li, KY; Tuite, PJ; Poizner, H				Konczak, Juergen; Li, Kuan-yi; Tuite, Paul J.; Poizner, Howard			Haptic Perception of Object Curvature in Parkinson's Disease	PLOS ONE			English	Article								Background: The haptic perception of the curvature of an object is essential for adequate object manipulation and critical for our guidance of actions. This study investigated how the ability to perceive the curvature of an object is altered by Parkinson's disease (PD). Methodology/Principal Findings: Eight healthy subjects and 11 patients with mild to moderate PD had to judge, without vision, the curvature of a virtual "box'' created by a robotic manipulandum. Their hands were either moved passively along a defined curved path or they actively explored the curved curvature of a virtual wall. The curvature was either concave or convex (bulging to the left or right) and was judged in two locations of the hand workspace-a left workspace location, where the curved hand path was associated with curved shoulder and elbow joint paths, and a right workspace location in which these joint paths were nearly linear. After exploring the curvature of the virtual object, subjects had to judge whether the curvature was concave or convex. Based on these data, thresholds for curvature sensitivity were established. The main findings of the study are: First, 9 out 11 PD patients (82%) showed elevated thresholds for detecting convex curvatures in at least one test condition. The respective median threshold for the PD group was increased by 343% when compared to the control group. Second, when distal hand paths became less associated with proximal joint paths ( right workspace), haptic acuity was reduced substantially in both groups. Third, sensitivity to hand trajectory curvature was not improved during active exploration in either group. Conclusion/Significance: Our data demonstrate that PD is associated with a decreased acuity of the haptic sense, which may occur already at an early stage of the disease.	[Konczak, Juergen; Li, Kuan-yi] Univ Minnesota, Human Sensorimotor Control Lab, Minneapolis, MN 55455 USA; [Konczak, Juergen; Tuite, Paul J.] Univ Minnesota, Dept Neurol, Minneapolis, MN USA; [Poizner, Howard] Univ Calif San Diego, Inst Neural Computat, San Diego, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Konczak, J (corresponding author), Univ Minnesota, Human Sensorimotor Control Lab, Minneapolis, MN 55455 USA.	jkonczak@umn.edu	Konczak, Jürgen/J-4001-2019; Tuite, Paul/P-3164-2014	Konczak, Jürgen/0000-0002-4422-5610; Tuite, Paul/0000-0003-1413-7924	Academic Health Center at the University of Minnesota Medical School; University of Minnesota Medical Foundation; NIH [2 R01 NS 36449]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036449] Funding Source: NIH RePORTER	Academic Health Center at the University of Minnesota Medical School; University of Minnesota Medical Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the Academic Health Center at the University of Minnesota Medical School and the University of Minnesota Medical Foundation and by NIH grant# 2 R01 NS 36449 to UCSD.	Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529, DOI 10.1152/jn.1985.54.6.1529; Demirci M, 1997, ANN NEUROL, V41, P781, DOI 10.1002/ana.410410614; Fasse ED, 2000, BIOL CYBERN, V82, P69, DOI 10.1007/PL00007962; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gibson J.J., 1966, SENSES CONSIDERED PE; Goldscheider A., 1898, PHYSL MUSKELSINNES; Henriques DYP, 2005, J NEUROPHYSIOL, V93, P3036, DOI 10.1152/jn.00010.2005; Henriques DYP, 2004, J NEUROPHYSIOL, V91, P1808, DOI 10.1152/jn.00998.2003; Henriques DYP, 2003, EXP BRAIN RES, V150, P95, DOI 10.1007/s00221-003-1402-z; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Maschke M, 2005, J NEUROL NEUROSUR PS, V76, P569, DOI 10.1136/jnnp.2004.047324; Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230; Maschke M, 2006, MOVEMENT DISORD, V21, P1013, DOI 10.1002/mds.20876; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; O'Suilleabhain P, 2001, J NEUROL NEUROSUR PS, V71, P607, DOI 10.1136/jnnp.71.5.607; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pratorius B, 2003, NEUROSCI LETT, V346, P173, DOI 10.1016/S0304-3940(03)00582-2; Putzki N, 2006, MOVEMENT DISORD, V21, P754, DOI 10.1002/mds.20799; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; SCHNEIDER JS, 1987, NEUROLOGY, V37, P951, DOI 10.1212/WNL.37.6.951; SOECHTING JF, 1982, BRAIN RES, V248, P392, DOI 10.1016/0006-8993(82)90601-1; Song WL, 2004, SOMATOSENS MOT RES, V21, P177, DOI 10.1080/08990220400012422; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zia S, 2003, CLIN ANAT, V16, P241, DOI 10.1002/ca.10100; Zia S, 2002, CLIN ANAT, V15, P23, DOI 10.1002/ca.1087; Zia S, 2000, ANN NEUROL, V47, P218, DOI 10.1002/1531-8249(200002)47:2<218::AID-ANA12>3.3.CO;2-R	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2625	10.1371/journal.pone.0002625	http://dx.doi.org/10.1371/journal.pone.0002625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612466	Green Published, gold			2022-12-27	WOS:000264065800027
J	Pennings, JLA; Kimman, TG; Janssen, R				Pennings, Jeroen L. A.; Kimman, Tjeerd G.; Janssen, Riny			Identification of a Common Gene Expression Response in Different Lung Inflammatory Diseases in Rodents and Macaques	PLOS ONE			English	Article								To identify gene expression responses common to multiple pulmonary diseases we collected microarray data for acute lung inflammation models from 12 studies and used these in a meta-analysis. The data used include exposures to air pollutants; bacterial, viral, and parasitic infections; and allergic asthma models. Hierarchical clustering revealed a cluster of 383 upregulated genes with a common response. This cluster contained five subsets, each characterized by more specific functions such as inflammatory response, interferon-induced genes, immune signaling, or cell proliferation. Of these subsets, the inflammatory response was common to all models, interferon-induced responses were more pronounced in bacterial and viral models, and a cell division response was more prominent in parasitic and allergic models. A common cluster containing 157 moderately down-regulated genes was associated with the effects of tissue damage. Responses to influenza in macaques were weaker than in mice, reflecting differences in the degree of lung inflammation and/or virus replication. The existence of a common cluster shows that in vivo lung inflammation in response to various pathogens or exposures proceeds through shared molecular mechanisms.	[Pennings, Jeroen L. A.; Kimman, Tjeerd G.; Janssen, Riny] Natl Inst Publ Hlth & Environm, RIVM, Lab Hlth Protect Res, GBO, NL-3720 BA Bilthoven, Netherlands; [Kimman, Tjeerd G.] Cent Vet Inst, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm, RIVM, Lab Hlth Protect Res, GBO, NL-3720 BA Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl		Pennings, Jeroen L.A./0000-0002-9188-6358				Baken Kirsten A, 2006, J Immunotoxicol, V3, P227, DOI 10.1080/15476910601023602; Banus S, 2007, IMMUNOGENETICS, V59, P555, DOI 10.1007/s00251-007-0227-5; Banus S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-88; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Cohen MD, 2001, TOXICOL APPL PHARM, V171, P71, DOI 10.1006/taap.2000.9106; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong WM, 1996, EXP LUNG RES, V22, P577, DOI 10.3109/01902149609046043; Grundschober C, 2002, J BIOL CHEM, V277, P36715, DOI 10.1074/jbc.M203777200; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kloetzel PM, 2004, BBA-MOL CELL RES, V1695, P225, DOI 10.1016/j.bbamcr.2004.10.004; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kooter IM, 2005, INHAL TOXICOL, V17, P53, DOI 10.1080/08958370590885717; Kooter IM, 2007, J APPL PHYSIOL, V102, P1185, DOI 10.1152/japplphysiol.00796.2006; Kuperman DA, 2005, J ALLERGY CLIN IMMUN, V116, P305, DOI 10.1016/j.jaci.2005.03.024; Lewis CC, 2008, AM J RESP CRIT CARE, V177, P376, DOI 10.1164/rccm.200702-333OC; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; R Development Core Team, 2006, R LANG ENV STAT COMP; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Rosseau S, 2007, IMMUNOLOGY, V120, P380, DOI 10.1111/j.1365-2567.2006.02514.x; Schins RPF, 2004, TOXICOL APPL PHARM, V195, P1, DOI 10.1016/j.taap.2003.10.002; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	28	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2596	10.1371/journal.pone.0002596	http://dx.doi.org/10.1371/journal.pone.0002596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612392	Green Published, gold			2022-12-27	WOS:000264065800009
J	Kitamura, M; Nakashima, K; Kowashi, Y; Fujii, T; Shimauchi, H; Sasano, T; Furuuchi, T; Fukuda, M; Noguchi, T; Shibutani, T; Iwayama, Y; Takashiba, S; Kurihara, H; Ninomiya, M; Kido, JI; Nagata, T; Hamachi, T; Maeda, K; Hara, Y; Izumi, Y; Hirofuji, T; Imai, E; Omae, M; Watanuki, M; Murakami, S				Kitamura, Masahiro; Nakashima, Keisuke; Kowashi, Yusuke; Fujii, Takeo; Shimauchi, Hidetoshi; Sasano, Takashi; Furuuchi, Toshi; Fukuda, Mitsuo; Noguchi, Toshihide; Shibutani, Toshiaki; Iwayama, Yukio; Takashiba, Shogo; Kurihara, Hidemi; Ninomiya, Masami; Kido, Jun-ichi; Nagata, Toshihiko; Hamachi, Takafumi; Maeda, Katsumasa; Hara, Yoshitaka; Izumi, Yuichi; Hirofuji, Takao; Imai, Enyu; Omae, Masatoshi; Watanuki, Mitsuru; Murakami, Shinya			Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2: Randomized Controlled Phase II Clinical Trial	PLOS ONE			English	Article								Background: The options for medical use of signaling molecules as stimulators of tissue regeneration are currently limited. Preclinical evidence suggests that fibroblast growth factor (FGF)-2 can promote periodontal regeneration. This study aimed to clarify the activity of FGF-2 in stimulating regeneration of periodontal tissue lost by periodontitis and to evaluate the safety of such stimulation. Methodology/Principal Findings: We used recombinant human FGF-2 with 3% hydroxypropylcellulose (HPC) as vehicle and conducted a randomized double-blinded controlled trial involving 13 facilities. Subjects comprised 74 patients displaying a 2- or 3-walled vertical bone defect as measured >= 3 mm apical to the bone crest. Patients were randomly assigned to 4 groups: Group P, given HPC with no FGF-2; Group L, given HPC containing 0.03% FGF-2; Group M, given HPC containing 0.1% FGF-2; and Group H, given HPC containing 0.3% FGF-2. Each patient underwent flap operation during which we administered 200 mu L of the appropriate investigational drug to the bone defect. Before and for 36 weeks following administration, patients underwent periodontal tissue inspections and standardized radiography of the region under investigation. As a result, a significant difference (p = 0.021) in rate of increase in alveolar bone height was identified between Group P (23.92%) and Group H (58.62%) at 36 weeks. The linear increase in alveolar bone height at 36 weeks in Group P and H was 0.95 mm and 1.85 mm, respectively (p = 0.132). No serious adverse events attributable to the investigational drug were identified. Conclusions: Although no statistically significant differences were noted for gains in clinical attachment level and alveolar bone gain for FGF-2 groups versus Group P, the significant difference in rate of increase in alveolar bone height (p = 0.021) between Groups P and H at 36 weeks suggests that some efficacy could be expected from FGF-2 in stimulating regeneration of periodontal tissue in patients with periodontitis.	[Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Dent Hosp, Suita, Osaka, Japan; [Nakashima, Keisuke; Kowashi, Yusuke] Hlth Sci Univ Hokkaido, Dent Hosp, Ishikari, Hokkaido, Japan; [Fujii, Takeo] Hlth Sci Univ Hokkaido, Med & Dent Clin, Sapporo, Hokkaido, Japan; [Shimauchi, Hidetoshi; Sasano, Takashi; Furuuchi, Toshi] Tohoku Univ, Dent Hosp, Sendai, Miyagi, Japan; [Fukuda, Mitsuo; Noguchi, Toshihide] Aichi Gakuin Univ, Dent Hosp, Nagoya, Aichi, Japan; [Shibutani, Toshiaki; Iwayama, Yukio] Asahi Univ, Dent Hosp, Mizuho, Japan; [Takashiba, Shogo] Okayama Univ, Dent Hosp, Okayama, Japan; [Kurihara, Hidemi] Hiroshima Univ, Dent Hosp, Hiroshima, Japan; [Ninomiya, Masami; Kido, Jun-ichi; Nagata, Toshihiko] Tokushima Univ, Dent Hosp, Tokushima, Japan; [Hamachi, Takafumi; Maeda, Katsumasa] Kyushu Univ, Dent Hosp, Fukuoka, Japan; [Hara, Yoshitaka] Nagasaki Univ Hosp, Attached Sch Dent, Nagasaki, Japan; [Izumi, Yuichi] Kagoshima Univ, Dent Hosp, Kagoshima, Japan; [Hirofuji, Takao] Fukuoka Dent Coll Hosp, Fukuoka, Japan; [Imai, Enyu] Osaka Univ Hosp, Suita, Osaka, Japan; [Omae, Masatoshi] Izumisano Municipal Hosp, Rinku Gen Med Ctr, Izumisano, Japan; [Watanuki, Mitsuru] Kaken Pharm Co Ltd, Tokyo, Japan	Osaka University; Health Sciences University of Hokkaido; Health Sciences University of Hokkaido; Tohoku University; Aichi Gakuin University; Asahi University; Okayama University; Hiroshima University; Tokushima University; Kyushu University; Nagasaki University; Kagoshima University; Fukuoka Dental College (FDC); Osaka University; Kaken Pharmaceutical Co Ltd	Kitamura, M (corresponding author), Osaka Univ, Dent Hosp, Suita, Osaka, Japan.	ipshinya@dent.osaka-u.ac.jp	Takashiba, Shogo/C-9830-2010	Takashiba, Shogo/0000-0002-4712-6829; Fukuda, Mistuo/0000-0002-6584-6758; Murakami, Shinya/0000-0002-5230-452X	Kaken Pharmaceutical Co., Ltd.	Kaken Pharmaceutical Co., Ltd.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Kaken Pharmaceutical Co., Ltd., which proposed study protocol and was responsible for data collection and prespecified statistical analysis. Preparation of the manuscript was consigned to the authors and the views expressed in this article do not necessarily reflect those of Kaken Pharmaceutical Co., Ltd.	BOWERS GM, 1982, J PERIODONTOL, V53, P509, DOI 10.1902/jop.1982.53.8.509; CATON J, 1976, Journal of Clinical Periodontology, V3, P54, DOI 10.1111/j.1600-051X.1976.tb01850.x; EGELBERG J, 1987, J PERIODONTAL RES, V22, P233, DOI 10.1111/j.1600-0765.1987.tb01577.x; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129; GIBRAN NS, 1994, J SURG RES, V56, P226, DOI 10.1006/jsre.1994.1036; Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186; Kilic AR, 1997, J CLIN PERIODONTOL, V24, P372, DOI 10.1111/j.1600-051X.1997.tb00200.x; Kinane DF, 2001, PERIODONTOL 2000, V25, P8, DOI 10.1034/j.1600-0757.2001.22250102.x; Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103; LEDOUX D, 1991, PROG GROWTH FACTOR R, V4, P107; Lekic P, 2001, J PERIODONTAL RES, V36, P71, DOI 10.1034/j.1600-0765.2001.360202.x; LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240; LYNCH SE, 1989, J CLIN PERIODONTOL, V16, P545, DOI 10.1111/j.1600-051X.1989.tb02334.x; Miller S.C., 1950, TXB PERIODONTIA; Mohammed S, 1998, J PERIODONTAL RES, V33, P335, DOI 10.1111/j.1600-0765.1998.tb02208.x; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; Okumura M, 1996, BIOL PHARM BULL, V19, P530; RICHARD JL, 1995, DIABETES CARE, V18, P64, DOI 10.2337/diacare.18.1.64; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shimabukuro Y, 2005, J CELL PHYSIOL, V203, P557, DOI 10.1002/jcp.20256; SHIMABUKURO Y, 2008, MATRIX IN PRESS; Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290; SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001; Takayama S, 1997, J PERIODONTAL RES, V32, P667, DOI 10.1111/j.1600-0765.1997.tb00577.x; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618; TERASHIMA Y, 2008, J CELL PHYS IN PRESS; WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x; YU W, 1994, LASER SURG MED, V15, P281, DOI 10.1002/lsm.1900150308; Zetterstrom O, 1997, J CLIN PERIODONTOL, V24, P697, DOI 10.1111/j.1600-051X.1997.tb00252.x	37	133	137	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2611	10.1371/journal.pone.0002611	http://dx.doi.org/10.1371/journal.pone.0002611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596969	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200060
J	Lundby, A; Mutoh, H; Dimitrov, D; Akemann, W; Knopfel, T				Lundby, Alicia; Mutoh, Hiroki; Dimitrov, Dimitar; Akemann, Walther; Knopfel, Thomas			Engineering of a Genetically Encodable Fluorescent Voltage Sensor Exploiting Fast Ci-VSP Voltage-Sensing Movements	PLOS ONE			English	Article								Ci-VSP contains a voltage-sensing domain (VSD) homologous to that of voltage-gated potassium channels. Using charge displacement ('gating' current) measurements we show that voltage-sensing movements of this VSD can occur within 1 ms in mammalian membranes. Our analysis lead to development of a genetically encodable fluorescent protein voltage sensor (VSFP) in which the fast, voltage-dependent conformational changes of the Ci-VSP voltage sensor are transduced to similarly fast fluorescence read-outs.	[Lundby, Alicia; Mutoh, Hiroki; Dimitrov, Dimitar; Akemann, Walther; Knopfel, Thomas] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan; [Lundby, Alicia] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	RIKEN; Danmarks Grundforskningsfond; University of Copenhagen	Lundby, A (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama, Japan.	ricksteinhardt@berkeley.edu	Mutoh, Hiroki/D-5240-2009; Knöpfel, Thomas/B-1128-2008; Lundby, Alicia/H-3322-2013; Akemann, Walther/A-7593-2011	Knöpfel, Thomas/0000-0002-5718-0765; Akemann, Walther/0000-0002-4978-4665; Lundby, Alicia/0000-0002-1612-6041	RIKEN BSI; NIH [NS057631]; Danish Cardiovascular Research Academy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631] Funding Source: NIH RePORTER	RIKEN BSI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cardiovascular Research Academy; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by RIKEN BSI intramural funds, NIH grant NS057631 and a stipend from Danish Cardiovascular Research Academy to AL.	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; VILLALBAGALEA CA, 2008, BIOPHYS J, V94, P1362; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618	12	123	127	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2514	10.1371/journal.pone.0002514	http://dx.doi.org/10.1371/journal.pone.0002514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575613	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000031
J	Owusu-Agyei, S; Asante, KP; Owusu, R; Adjuik, M; Amenga-Etego, S; Dosoo, DK; Gyapong, J; Greenwood, B; Chandramohan, D				Owusu-Agyei, Seth; Asante, Kwaku Poku; Owusu, Ruth; Adjuik, Martin; Amenga-Etego, Stephen; Dosoo, David Kwame; Gyapong, John; Greenwood, Brian; Chandramohan, Daniel			An Open Label, Randomised Trial of Artesunate plus Amodiaquine, Artesunate plus Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria	PLOS ONE			English	Article								Background: Artesunate+amodiaquine (AS+AQ) and artemether-lumefantrine (AL) are now the most frequently recommended first line treatments for uncomplicated malaria in Africa. Artesunate+chlorproguanil-dapsone (AS+CD) was a potential alternative for treatment of uncomplicated malaria. A comparison of the efficacy and safety of these three drug combinations was necessary to make evidence based drug treatment policies. Methods: Five hundred and thirty-four, glucose-6-phosphate dehydrogenase (G6PD) normal children were randomised in blocks of 15 to the AS+AQ, AL or AS+CD groups. Administration of study drugs was supervised by project staff and the children were followed up at r home on days 1,2,3,7,14 and 28 post treatment. Parasitological and clinical failures and adverse events were compared between the study groups. Main Findings: In a per-protocol analysis, the parasitological and clinical failure rate at day 28 post treatment (PCF28) was lower in the AS+AQ group compared to the AL or AS+CD groups (corrected for re-infections: 6.6% vs 13.8% and 13.8% respectively, p = 0.08; uncorrected: 14.6% vs 27.6% and 28.1% respectively, p = 0.005). In the intention to treat analysis, the rate of early treatment failure was high in all three groups (AS+AQ 13.3%; AL 15.2%; and AS+CD 9.3%, p = 0.2) primarily due to vomiting. However, the PCF28 corrected for re-infection was lower, though not significantly, in the AS+AQ group compared to the AL or the AS+CD groups (AS+AQ 18.3%; AL 24.2%; AS+CD 20.8%, p = 0.4) The incidence of adverse events was comparable between the groups. Conclusions: AS+AQ is an appropriate first line treatment for uncomplicated malaria in Ghana and possibly in the neighbouring countries in West Africa. The effectiveness of AL in routine programme conditions needs to be studied further in West Africa. Trial Registration: ClinicalTrials.gov NCT00119145	[Owusu-Agyei, Seth; Asante, Kwaku Poku; Owusu, Ruth; Amenga-Etego, Stephen; Dosoo, David Kwame] Minist Hlth, Kintmapo Hlth Res Ctr, Kintampo, Ghana; [Owusu-Agyei, Seth; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, Infect & Trop Dis Dept, London, England; [Adjuik, Martin] Minist Hlth, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Gyapong, John] Minist Hlth, Hlth Res Unit, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Navrongo Health Research Center	Owusu-Agyei, S (corresponding author), Minist Hlth, Kintmapo Hlth Res Ctr, Kintampo, Ghana.	Daniel.chandramohan@lshtm.ac.uk		Gyapong, John/0000-0002-8415-1468; Owusu-Agyei, Seth/0000-0002-0807-1781	Gates Malaria Partnership of the London School of Hygiene and Tropical Medicine	Gates Malaria Partnership of the London School of Hygiene and Tropical Medicine	This study received financial support from the Gates Malaria Partnership of the London School of Hygiene and Tropical Medicine.	Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Guthmann JP, 2006, AM J TROP MED HYG, V75, P143, DOI 10.4269/ajtmh.2006.75.143; Koram KA, 2005, ACTA TROP, V95, P194, DOI 10.1016/j.actatropica.2005.06.018; Martensson A, 2005, CLIN INFECT DIS, V41, P1079, DOI 10.1086/444460; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; *WHO, 2001, WHOCDSRBM200135	8	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2530	10.1371/journal.pone.0002530	http://dx.doi.org/10.1371/journal.pone.0002530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575626	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000263288000045
J	Silva, N; Smith, WC				Silva, Nathan; Smith, William C.			Inverse Correlation of Population Similarity and Introduction Date for Invasive Ascidians	PLOS ONE			English	Article								The genomes of many marine invertebrates, including the purple sea urchin and the solitary ascidians Ciona intestinalis and Ciona savignyi, show exceptionally high levels of heterozygosity, implying that these populations are highly polymorphic. Analysis of the C. savignyi genome found little evidence to support an elevated mutation rate, but rather points to a large population size contributing to the polymorphism level. In the present study, the relative genetic polymorphism levels in sampled populations of ten different ascidian species were determined using a similarity index generated by AFLP analysis. The goal was to determine the range of polymorphism within the populations of different species, and to uncover factors that may contribute to the high level of polymorphism. We observe that, surprisingly, the levels of polymorphism within these species show a negative correlation with the reported age of invasive populations, and that closely related species show substantially different levels of genetic polymorphism. These findings show exceptions to the assumptions that invasive species start with a low level of genetic polymorphism that increases over time and that closely related species have similar levels of genetic polymorphism.	[Silva, Nathan; Smith, William C.] Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA; [Smith, William C.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Silva, N (corresponding author), Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA.	w_smith@lifesci.ucsb.edu			NIH [HD038701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by a grant from the NIH to WCS (HD038701).	[Anonymous], [No title captured]; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Blake T., 1999, J AGR GENOMICS, V4; Blum JC, 2007, J EXP MAR BIOL ECOL, V342, P5, DOI 10.1016/j.jembe.2006.10.010; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Cayer D., 1999, J SHELLFISH RES, V18, P327; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Han KP, 2002, MAR BIOTECHNOL, V4, P141, DOI 10.1007/s10126-001-0080-8; Innan H, 1999, GENETICS, V151, P1157; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert CC, 2003, MAR ECOL PROG SER, V259, P145, DOI 10.3354/meps259145; LAMBERT CC, 1967, BIOL BULL, V132, P222, DOI 10.2307/1539890; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; Ritter W.E., 1917, U CALIFORNIA PUBLICA, V16, P439; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Turon X, 2004, MOL PHYLOGENET EVOL, V33, P309, DOI 10.1016/j.ympev.2004.06.011; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wright S, 1978, VARIABILITY NATURAL; Yund PO, 2002, MAR BIOL, V141, P955, DOI 10.1007/s00227-002-0894-6	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2552	10.1371/journal.pone.0002552	http://dx.doi.org/10.1371/journal.pone.0002552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575620	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288000052
J	Lindner, A; Cairns, SD; Cunningham, CW				Lindner, Alberto; Cairns, Stephen D.; Cunningham, Clifford W.			From Offshore to Onshore: Multiple Origins of Shallow-Water Corals from Deep-Sea Ancestors	PLOS ONE			English	Article							LIKELIHOOD APPROACH; DIVERSITY; EVOLUTION; PATTERNS; HYDROZOA; COELENTERATA; DIVERGENCE; STATES; SHELF	Shallow-water tropical reefs and the deep sea represent the two most diverse marine environments. Understanding the origin and diversification of this biodiversity is a major quest in ecology and evolution. The most prominent and well-supported explanation, articulated since the first explorations of the deep sea, holds that benthic marine fauna originated in shallow, onshore environments, and diversified into deeper waters. In contrast, evidence that groups of marine organisms originated in the deep sea is limited, and the possibility that deep-water taxa have contributed to the formation of shallow-water communities remains untested with phylogenetic methods. Here we show that stylasterid corals (Cnidaria: Hydrozoa: Stylasteridae)-the second most diverse group of hard corals-originated and diversified extensively in the deep sea, and subsequently invaded shallow waters. Our phylogenetic results show that deep-water stylasterid corals have invaded the shallow-water tropics three times, with one additional invasion of the shallow-water temperate zone. Our results also show that anti-predatory innovations arose in the deep sea, but were not involved in the shallow-water invasions. These findings are the first robust evidence that an important group of tropical shallow-water marine animals evolved from deep-water ancestors.	[Lindner, Alberto] Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil; [Cairns, Stephen D.] Smithsonian Inst, Natl Museum Natural Hist, Washington, DC USA; [Cunningham, Clifford W.] Duke Univ, Biol Dept, Durham, NC USA	Universidade de Sao Paulo; Smithsonian Institution; Duke University	Lindner, A (corresponding author), Univ Sao Paulo, Ctr Biol Marinha, Sao Paulo, Brazil.	alindner@usp.br	Lindner, Alberto/E-1946-2013; Cunningham, Clifford/B-9807-2014	Lindner, Alberto/0000-0003-3288-0885; Cunningham, Clifford/0000-0002-5434-5122	National Science Foundation [DEB-9978086]; Society for Integrative and Comparative Biology [grant-in-aid of research]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX0917-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [06/02960-8/60327-0]	National Science Foundation(National Science Foundation (NSF)); Society for Integrative and Comparative Biology; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by a National Science Foundation grant (NSF PEET DEB-9978086) to CWC and SDC and by a Society for Integrative and Comparative Biology grant-in-aid of research, a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES BEX0917-0), and a postdoctoral fellowship and grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 06/02960-8/60327-0) to AL.	Allen J.A., 1983, P29; Bell R, 2002, J SCI MED SPORT, V5, P32, DOI 10.1016/S1440-2440(02)80295-X; Bernecker M., 1990, Facies, V22, P103, DOI 10.1007/BF02536947; BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; Briggs JC, 2004, J BIOGEOGR, V31, P525, DOI 10.1046/j.1365-2699.2003.00939.x; CACCHIONE DA, 1984, J SEDIMENT PETROL, V54, P1280; CAIRNS SD, 1983, B MAR SCI, V33, P427; CAIRNS SD, 1982, J NAT HIST, V16, P71, DOI 10.1080/00222938200770051; Cairns SD, 2007, B MAR SCI, V81, P311; Cairns Stephen D., 1992, Scientia Marina, V56, P125; CLARKE AH, 1962, DEEP-SEA RES, V9, P291, DOI 10.1016/0011-7471(62)90012-8; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; DAVIS RA, 1977, PRINCIPLES OCEANOGRA; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Govindarajan AF, 2005, MAR BIOL, V146, P213, DOI 10.1007/s00227-004-1434-3; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Hessler R., 1983, EVOLUTION TIME SPACE, P227; HESSLER RR, 1967, DEEP-SEA RES, V14, P65; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Lorz AN, 2003, J MAR BIOL ASSOC UK, V83, P785, DOI 10.1017/S002531540300780Xh; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Madsen F. J., 1961, Galathea Report, V4, P177; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MIGLIETTA MP, 2005, THESIS DUKE U; Miller KJ, 2004, AQUAT CONSERV, V14, P75, DOI 10.1002/aqc.597; Moseley H. N., 1880, NATURE, V21, P543; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STANLEY G D JR, 1988, Palaios, V3, P233; Stone RP, 2006, CORAL REEFS, V25, P229, DOI 10.1007/s00338-006-0091-z; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Vermeij G.J, 1987, EVOLUTION ESCALATION; WOLFF T, 1960, DEEP-SEA RES, V6, P95; Yuasa HJ, 2001, GENE, V279, P205, DOI 10.1016/S0378-1119(01)00755-7	46	93	96	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2429	10.1371/journal.pone.0002429	http://dx.doi.org/10.1371/journal.pone.0002429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560569	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700014
J	Albanese, A; Arosio, D; Terreni, M; Cereseto, A				Albanese, Alberto; Arosio, Daniele; Terreni, Mariaelena; Cereseto, Anna			HIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery	PLOS ONE			English	Article								Integration of the double-stranded DNA copy of the HIV-1 genome into host chromosomal DNA is a requirement for efficient viral replication. Integration preferentially occurs within active transcription units, however chromosomal site specificity does not correlate with any strong primary sequence. To investigate whether the nuclear architecture may affect viral integration we have developed an experimental system where HIV-1 viral particles can be visualized within the nuclear compartment. Fluorescently labeled HIV-1 virions were engineered by fusing integrase, the viral protein that catalyzes the integration reaction, to fluorescent proteins. Viral tests demonstrate that the infectivity of fluorescent virions, including the integration step, is not altered as compared to wild-type virus. 3-D confocal microscopy allowed a detailed analysis of the spatial and temporal distribution of the pre-integration complexes (PICs) within the nucleus at different moments following infection; the fluorescently labeled PICs preferentially distribute in decondensed areas of the chromatin with a striking positioning in the nuclear periphery, while heterochromatin regions are largely disfavored. These observations provide a first indication of how the nuclear architecture may initially orient the selection of retroviral integration sites.	[Albanese, Alberto; Terreni, Mariaelena; Cereseto, Anna] Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy; [Albanese, Alberto; Arosio, Daniele; Terreni, Mariaelena; Cereseto, Anna] Scuola Normale Superiore, CNR INFM, NEST, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Scuola Normale Superiore di Pisa	Albanese, A (corresponding author), Scuola Normale Super Pisa, Mol Biol Lab, Pisa, Italy.	d.arosio@sns.it; cereseto@sns.it	arosio, daniele/B-3160-2012	Cereseto, Anna/0000-0003-4453-2597	National Research Program on AIDS of the Istituto Superiore di Sanita; Fondazione Cassa di Risparmio di Pisa	National Research Program on AIDS of the Istituto Superiore di Sanita; Fondazione Cassa di Risparmio di Pisa	This work was supported by grants from the National Research Program on AIDS of the Istituto Superiore di Sanita and from the Fondazione Cassa di Risparmio di Pisa.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Bhattacharya D, 2006, BIOPHYS J, V91, P2326, DOI 10.1529/biophysj.105.079343; Brown P. O., 1997, P161; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Cereseto A, 2004, AIDS REV, V6, P13; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Crise B, 2005, J VIROL, V79, P12199, DOI 10.1128/JVI.79.19.12199-12204.2005; GOODENOW MM, 1987, J VIROL, V61, P2489, DOI 10.1128/JVI.61.8.2489-2498.1987; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Holmes-Son ML, 2000, J VIROL, V74, P11548, DOI 10.1128/JVI.74.24.11548-11556.2000; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; PANET A, 1977, CELL, V11, P933, DOI 10.1016/0092-8674(77)90304-X; ROBINSON HL, 1986, J VIROL, V57, P28, DOI 10.1128/JVI.57.1.28-36.1986; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; Taganov KD, 2004, J VIROL, V78, P5848, DOI 10.1128/JVI.78.11.5848-5855.2004; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Weidemann T, 2003, J MOL BIOL, V334, P229, DOI 10.1016/j.jmb.2003.08.063; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Zhang H, 1996, J VIROL, V70, P2809, DOI 10.1128/JVI.70.5.2809-2824.1996	42	91	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2413	10.1371/journal.pone.0002413	http://dx.doi.org/10.1371/journal.pone.0002413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545681	gold, Green Submitted, Green Published			2022-12-27	WOS:000263248800050
J	Bilal, E; Rabadan, R; Alexe, G; Fuku, N; Ueno, H; Nishigaki, Y; Fujita, Y; Ito, M; Arai, Y; Hirose, N; Ruckenstein, A; Bhanot, G; Tanaka, M				Bilal, Erhan; Rabadan, Raul; Alexe, Gabriela; Fuku, Noriyuki; Ueno, Hitomi; Nishigaki, Yutaka; Fujita, Yasunori; Ito, Masafumi; Arai, Yasumichi; Hirose, Nobuyoshi; Ruckenstein, Andrei; Bhanot, Gyan; Tanaka, Masashi			Mitochondrial DNA Haplogroup D4a Is a Marker for Extreme Longevity in Japan	PLOS ONE			English	Article							SELECTION; SUBUNITS; N9A	We report results from the analysis of complete mitochondrial DNA (mtDNA) sequences from 112 Japanese semi-supercentenarians (aged above 105 years) combined with previously published data from 96 patients in each of three nondisease phenotypes: centenarians (99-105 years of age), healthy non-obese males, obese young males and four disease phenotypes, diabetics with and without angiopathy, and Alzheimer's and Parkinson's disease patients. We analyze the correlation between mitochondrial polymorphisms and the longevity phenotype using two different methods. We first use an exhaustive algorithm to identify all maximal patterns of polymorphisms shared by at least five individuals and define a significance score for enrichment of the patterns in each phenotype relative to healthy normals. Our study confirms the correlations observed in a previous study showing enrichment of a hierarchy of haplogroups in the D clade for longevity. For the extreme longevity phenotype we see a single statistically significant signal: a progressive enrichment of certain "beneficial'' patterns in centenarians and semi-supercentenarians in the D4a haplogroup. We then use Principal Component Spectral Analysis of the SNP-SNP Covariance Matrix to compare the measured eigenvalues to a Null distribution of eigenvalues on Gaussian datasets to determine whether the correlations in the data (due to longevity) arises from some property of the mutations themselves or whether they are due to population structure. The conclusion is that the correlations are entirely due to population structure (phylogenetic tree). We find no signal for a functional mtDNA SNP correlated with longevity. The fact that the correlations are from the population structure suggests that hitch-hiking on autosomal events is a possible explanation for the observed correlations.	[Bilal, Erhan; Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA; [Rabadan, Raul; Bhanot, Gyan] Simons Ctr Syst Biol, Inst Advanced Study, Princeton, NJ USA; [Alexe, Gabriela] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fuku, Noriyuki; Ueno, Hitomi; Nishigaki, Yutaka; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan; [Fujita, Yasunori; Ito, Masafumi] Gifu Int Inst Biotechnol, Dept Longevity & Aging Res, Gifu, Japan; [Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Sch Med, Dept Geriat Med, Tokyo, Japan; [Ruckenstein, Andrei] Boston Univ, Dept Phys, Boston, MA USA; [Bhanot, Gyan] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Institute for Advanced Study - USA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tokyo Metropolitan Institute of Gerontology; Keio University; Boston University; Rutgers State University New Brunswick	Bilal, E (corresponding author), Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA.	mtanaka@tmig.or.jp	Rabadan, Raul/AAZ-7367-2020	Rabadan, Raul/0000-0001-7946-9255; Fuku, Noriyuki/0000-0001-7792-5835	Ministry of Education, Culture, Sports, Science, and Technology of Japan [A-15200051, C-18590317, B-18700541]; Third-Term Comprehensive 10-year Strategy for Cancer Control; Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan [17A-10]; Kao Research Council for the Study of Healthcare Science; Takeda Science Foundation [I-2007, II-2007]; Longevity Science of Ministry of Health, Labour, and Welfare of Japan; Cancer Institute of New Jersey; NJ Commission for Cancer Research; Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ; Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; National Institutes of Health	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third-Term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan; Kao Research Council for the Study of Healthcare Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Longevity Science of Ministry of Health, Labour, and Welfare of Japan; Cancer Institute of New Jersey; NJ Commission for Cancer Research; Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ; Simons Foundation; Ambrose Monell Foundation; Leon Levy Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Grants-in-Aid for Scientific Research (A-15200051 to MT and C-18590317 to YN), and a Grant-in-Aid for Young Scientists (B-18700541 to NF) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by a grant from the Third-Term Comprehensive 10-year Strategy for Cancer Control (to MT), by grant 17A-10 from the program Research Grants for Nervous and Mental Disorders of the Ministry of Health, Labour, and Welfare of Japan (to MT) as well as by a grant from Kao Research Council for the Study of Healthcare Science (to YN) and by grants from Takeda Science Foundation (I-2007 to MT and II-2007 to YN). The work of NH was supported by a grant for Longevity Science of Ministry of Health, Labour, and Welfare of Japan. The work of GB was supported by grants from the Cancer Institute of New Jersey and the NJ Commission for Cancer Research. The work of EB was supported by funds from the Center for Clinical and Translational Sciences at the Robert Wood Johnson Medical School, New Brunswick, NJ. RR was supported by the Simons Foundation, the Ambrose Monell Foundation, the Leon Levy Foundation, and the National Institutes of Health.	Alexe G, 2004, DISCRETE APPL MATH, V145, P11, DOI 10.1016/j.dam.2003.09.004; ALEXE G, 2007, PRINCIPAL COMP UNPUB; Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6; Alexe G, 2006, ANN OPER RES, V148, P189, DOI 10.1007/s10479-006-0084-x; Bandelt H.J., 2006, HUMAN MITOCHONDRIAL; Barrientos A, 2000, MOL BIOL EVOL, V17, P1508, DOI 10.1093/oxfordjournals.molbev.a026250; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Bayona-Bafaluy MP, 2005, MOL BIOL EVOL, V22, P716, DOI 10.1093/molbev/msi059; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; JOLIFFE T, 2002, PRINCIPAL COMPONENT; Kaufmann L., 1990, FINDING GROUPS DATA; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; WHO, 2006, WORLD HLTH REP	30	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2421	10.1371/journal.pone.0002421	http://dx.doi.org/10.1371/journal.pone.0002421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545700	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800056
J	Kishida, T				Kishida, Takushi			Pattern of the Divergence of Olfactory Receptor Genes during Tetrapod Evolution	PLOS ONE			English	Article								The olfactory receptor (OR) multigene family is responsible for the sense of smell in vertebrate species. OR genes are scattered widely in our chromosomes and constitute one of the largest gene families in eutherian genomes. Some previous studies revealed that eutherian OR genes diverged mainly during early mammalian evolution. However, the exact period when, and the ecological reason why eutherian ORs strongly diverged has remained unclear. In this study, I performed a strict data mining effort for marsupial opossum OR sequences and bootstrap analyses to estimate the periods of chromosomal migrations and gene duplications of OR genes during tetrapod evolution. The results indicate that chromosomal migrations occurred mainly during early vertebrate evolution before the monotreme-placental split, and that gene duplications occurred mainly during early mammalian evolution between the bird-mammal split and marsupial-placental split, coinciding with the reduction of opsin genes in primitive mammals. It could be thought that the previous chromosomal dispersal allowed the OR genes to subsequently expand easily, and the nocturnal adaptation of early mammals might have triggered the OR gene expansion.	Kyoto Univ, Dept Zool, Kyoto, Japan	Kyoto University	Kishida, T (corresponding author), Kyoto Univ, Dept Zool, Kyoto, Japan.	Takushi@kishida.mbox.media.kyoto-u.ac.jp	Kishida, Takushi/H-3381-2012	Kishida, Takushi/0000-0002-2220-7892				Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Aloni R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r88; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Grus WE, 2007, MOL BIOL EVOL, V24, P2153, DOI 10.1093/molbev/msm157; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; NEI M, 2000, MOL EVOLUTION PHYLOG, P175; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satoh G, 2005, GENESIS, V41, P47, DOI 10.1002/gene.20082; Suga H, 1999, FEBS LETT, V453, P346, DOI 10.1016/S0014-5793(99)00749-8; Suga H, 1997, FEBS LETT, V412, P540, DOI 10.1016/S0014-5793(97)00639-X; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535	32	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2385	10.1371/journal.pone.0002385	http://dx.doi.org/10.1371/journal.pone.0002385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18568087	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800024
J	Su, SK; Cai, F; Si, A; Zhang, SW; Tautz, J; Chen, SL				Su, Songkun; Cai, Fang; Si, Aung; Zhang, Shaowu; Tautz, Juergen; Chen, Shenglu			East Learns from West: Asiatic Honeybees Can Understand Dance Language of European Honeybees	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; APIS; BEHAVIOR; ANIMALS; BRAINS	The honeybee waggle dance, through which foragers advertise the existence and location of a food source to their hive mates, is acknowledged as the only known form of symbolic communication in an invertebrate. However, the suggestion, that different species of honeybee might possess distinct 'dialects' of the waggle dance, remains controversial. Furthermore, it remains unclear whether different species of honeybee can learn from and communicate with each other. This study reports experiments using a mixed-species colony that is composed of the Asiatic bee Apis cerana cerana (Acc), and the European bee Apis mellifera ligustica (Aml). Using video recordings made at an observation hive, we first confirm that Acc and Aml have significantly different dance dialects, even when made to forage in identical environments. When reared in the same colony, these two species are able to communicate with each other: Acc foragers could decode the dances of Aml to successfully locate an indicated food source. We believe that this is the first report of successful symbolic communication between two honeybee species; our study hints at the possibility of social learning between the two honeybee species, and at the existence of a learning component in the honeybee dance language.	[Su, Songkun; Cai, Fang; Zhang, Shaowu; Chen, Shenglu] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Si, Aung; Zhang, Shaowu] Australian Natl Univ, Ctr Excellence Vision Sci, Res Sch Biol Sci, Canberra, ACT, Australia; [Tautz, Juergen] Univ Wurzburg, Bioctr, BEE grp, Wurzburg, Germany	Zhejiang University; Australian National University; University of Wurzburg	Su, SK (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shaowu.zhang@anu.edu.au; slchen@zju.edu.cn		Si, Aung/0000-0001-8115-9176; Zhang, Shaowu/0000-0002-3551-5587	National Natural Science Foundation of China [30571409, 30671593]; ARC COE [CE0561903, DP-0450535]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARC COE(Australian Research Council)	This study was supported by the National Natural Science Foundation of China to SSK (No.30571409) and CSL (No.30671593), the ARC COE in Vision Science (CE0561903) and ARC DP-0450535 to SWZ.	Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; ATWAL AS, 1967, 21 INT BEEK C PREL S; Ayasse M, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P117; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; BOCH R, 1957, Z VERGL PHYSIOL, V40, P289, DOI 10.1007/BF00340572; Brockmann A, 2007, BRAIN BEHAV EVOLUT, V70, P125, DOI 10.1159/000102974; Chittka L, 2004, PLOS BIOL, V2, P898, DOI 10.1371/journal.pbio.0020216; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; DHALIWAL G S, 1970, Journal of Apicultural Research, V9, P53; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; DYER FC, 1991, BEHAV ECOL SOCIOBIOL, V28, P227, DOI 10.1007/BF00175094; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2003, BEE WORLD, V84, P5, DOI 10.1080/0005772X.2003.11099566; GOULD JL, 1987, AM NAT, V130, P317, DOI 10.1086/284713; Griffin AS, 2004, LEARN BEHAV, V32, P131; Heyes Cecilia. M., 1996, SOCIAL LEARNING ANIM; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; Johnson RN, 2002, J HERED, V93, P170, DOI 10.1093/jhered/93.3.170; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Nieh JC, 2000, J EXP BIOL, V203, P1573; OKU N, 1990, HONEYBEE SCI, V3, P121; OLDROYD BP, 1991, ANIM BEHAV, V42, P121, DOI 10.1016/S0003-3472(05)80612-8; POTICHOT S, 1993, ASIAN APICULTURE, P128; RINDERER TE, 1995, THEOR APPL GENET, V91, P727, DOI 10.1007/BF00220950; Sandeman DC, 1996, J EXP BIOL, V199, P2585; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; Sen Sarma M, 2004, J COMP PHYSIOL A, V190, P49, DOI 10.1007/s00359-003-0470-7; SHEPPARD WS, 1989, APIDOLOGIE, V20, P419, DOI 10.1051/apido:19890507; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Sokal R.R., 2012, BIOMETRY; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Su SK, 2005, APIDOLOGIE, V36, P389, DOI 10.1051/apido:2005026; Takenaka T, 1996, BIOSCI BIOTECH BIOCH, V60, P518, DOI 10.1271/bbb.60.518; Tan K, 2006, NATURWISSENSCHAFTEN, V93, P315, DOI 10.1007/s00114-006-0113-2; Tang Q.V., 1997, PRACTICAL STAT DPS D; Tautz J, 2004, PLOS BIOL, V2, P915, DOI 10.1371/journal.pbio.0020211; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; Tautz J, 1996, NATURE, V382, P32, DOI 10.1038/382032a0; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Winston, 1987, BIOL HONEYBEE; Zhang Shaowu, 2004, P41; Zhang SW, 2004, VISUAL NEUROSCIENCES, P1501	53	28	31	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2365	10.1371/journal.pone.0002365	http://dx.doi.org/10.1371/journal.pone.0002365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523550	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300051
J	Chen, M; Zhao, JZ; Collins, HL; Earle, ED; Cao, J; Shelton, AM				Chen, Mao; Zhao, Jian-Zhou; Collins, Hilda L.; Earle, Elizabeth D.; Cao, Jun; Shelton, Anthony M.			A Critical Assessment of the Effects of Bt Transgenic Plants on Parasitoids	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; PLUTELLA-XYLOSTELLA LEPIDOPTERA; DIADEGMA-INSULARE HYMENOPTERA; INSECT RESISTANCE; MARGINIVENTRIS HYMENOPTERA; SPODOPTERA-LITTORALIS; BRACONIDAE; FIELD; BROCCOLI	The ecological safety of transgenic insecticidal plants expressing crystal proteins (Cry toxins) from the bacterium Bacillus thuringiensis (Bt) continues to be debated. Much of the debate has focused on nontarget organisms, especially predators and parasitoids that help control populations of pest insects in many crops. Although many studies have been conducted on predators, few reports have examined parasitoids but some of them have reported negative impacts. None of the previous reports were able to clearly characterize the cause of the negative impact. In order to provide a critical assessment, we used a novel paradigm consisting of a strain of the insect pest, Plutella xylostella (herbivore), resistant to Cry1C and allowed it to feed on Bt plants and then become parasitized by Diadegma insulare, an important endoparasitoid of P. xylostella. Our results indicated that the parasitoid was exposed to a biologically active form of the Cy1C protein while in the host but was not harmed by such exposure. Parallel studies conducted with several commonly used insecticides indicated they significantly reduced parasitism rates on strains of P. xylostella resistant to these insecticides. These results provide the first clear evidence of the lack of hazard to a parasitoid by a Bt plant, compared to traditional insecticides, and describe a test to rigorously evaluate the risks Bt plants pose to predators and parasitoids.	[Chen, Mao; Zhao, Jian-Zhou; Collins, Hilda L.; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Earle, Elizabeth D.; Cao, Jun] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	Cornell University; Cornell University	Chen, M (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	ams5@cornell.edu		Zhao, Jianzhou/0000-0001-9136-2442	International Food Policy Research Institute; Program for Biosafety Systems	International Food Policy Research Institute(CGIAR); Program for Biosafety Systems	This work was supported in part by a grant from USAID through the International Food Policy Research Institute and the Program for Biosafety Systems. However, opinions in this manuscript do not necessarily reflect the views of the sponsor or funder.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Baur ME, 2003, BIOL CONTROL, V26, P325, DOI 10.1016/S1049-9644(02)00160-3; Bernal JS, 2002, J ENTOMOL SCI, V37, P27, DOI 10.18474/0749-8004-37.1.27; Brookes G., 2006, AgBioForum, V9, P139; Cao J, 1999, MOL BREEDING, V5, P131, DOI 10.1023/A:1009619924620; Cao J, 2002, THEOR APPL GENET, V105, P258, DOI 10.1007/s00122-002-0942-0; Chilcutt CF, 1999, BIOCONTROL SCI TECHN, V9, P435, DOI 10.1080/09583159929695; Desneux N, 2006, CHEMOSPHERE, V65, P1697, DOI 10.1016/j.chemosphere.2006.04.082; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Glare T.R., 2000, BACILLUS THURINGIENS; Hu GY, 1998, FLA ENTOMOL, V81, P526, DOI 10.2307/3495951; IDRIS AB, 1993, J ECON ENTOMOL, V86, P1196, DOI 10.1093/jee/86.4.1196; Liu Yu-Fang, 2006, Acta Entomologica Sinica, V49, P955; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Meissle Michael, 2004, IOBC-WPRS Bulletin, V27, P117; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1178, DOI 10.1603/0046-225X(2005)034[1178:FSAANE]2.0.CO;2; NORUSIS M, 2005, SPSS 13 0 ADV STAT P, P103; O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352; Prutz G, 2004, ENTOMOL EXP APPL, V111, P179, DOI 10.1111/j.0013-8703.2004.00166.x; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; SAFRAZ M, 2005, J APPL ENOTMOL, V129, P49; SALAMA HS, 1983, Z ANGEW ENTOMOL, V95, P425; Schoenly Kenneth G., 2003, Environmental Biosafety Research, V2, P181, DOI 10.1051/ebr:2003013; Schuler TH, 2004, J INSECT PHYSIOL, V50, P435, DOI 10.1016/j.jinsphys.2004.03.001; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; SHELTON AM, 2004, IMPROVING BIOL CONTR, P93; SRINIVASAN R, 2005, CURR SCI, V88, P1877; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tillman PG, 2000, J ECON ENTOMOL, V93, P1638, DOI 10.1603/0022-0493-93.6.1638; Vojtech E, 2005, TRANSGENIC RES, V14, P133, DOI 10.1007/s11248-005-2736-z; Walker GP, 2007, BIOL CONTROL, V40, P142, DOI 10.1016/j.biocontrol.2006.09.008; Xu JX, 2001, J ECON ENTOMOL, V94, P541, DOI 10.1603/0022-0493-94.2.541; Xu YY, 2004, BIOCONTROL SCI TECHN, V14, P713, DOI 10.1080/09583150410001682395; Zhao JZ, 2000, APPL ENVIRON MICROB, V66, P3784, DOI 10.1128/AEM.66.9.3784-3789.2000; Zhao JZ, 2006, J ECON ENTOMOL, V99, P176, DOI 10.1603/0022-0493(2006)099[0176:MODMLP]2.0.CO;2; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907; Zhao JZ, 2002, J ECON ENTOMOL, V95, P14, DOI 10.1603/0022-0493-95.1.14; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430; Zhao JZ, 2001, J ECON ENTOMOL, V94, P1547, DOI 10.1603/0022-0493-94.6.1547	44	73	80	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2284	10.1371/journal.pone.0002284	http://dx.doi.org/10.1371/journal.pone.0002284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18523682	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500027
J	Kim, KW; Moretti, L; Lu, B				Kim, Kwang Woon; Moretti, Luigi; Lu, Bo			M867, a Novel Selective Inhibitor of Caspase-3 Enhances Cell Death and Extends Tumor Growth Delay in Irradiated Lung Cancer Models	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; MAMMALIAN TARGET; FAS LIGAND; IN-VITRO; RADIATION; APOPTOSIS; SURVIVAL; INDUCTION; TUMORIGENESIS; EXPRESSION	Background: Lung cancer remains the leading cause of cancer death worldwide. Radioresistance of lung cancer cells results in unacceptable rate of loco-regional failure. Although radiation is known to induce apoptosis, our recent study showed that knockdown of pro-apoptotic proteins Bak and Bax resulted in an increase in autophagic cell death and lung cancer radiosensitivity in vitro. To further explore the potential of apoptosis inhibition as a way to sensitize lung cancer for therapy, we tested M867, a novel chemical and reversible caspase-3 inhibitor, in combination with ionizing radiation in vivo and in vitro. Methods and Findings: M867 reduced clonogenic survival in H460 lung cancer cells (DER = 1.27, p = 0.007) compared to the vehicle-treated treated cells. We found that administration of M867 with ionizing radiation in an in vivo mouse hind limb lung cancer model was well tolerated, and produced a significant tumor growth delay compared to radiation alone. A dramatic decrease in tumor vasculature was observed with M867 and radiation using von Willebrand factor staining. In addition, Ki67 index showed >5-fold reduction of tumor proliferation in the combination therapy group, despite the reduced levels of apoptosis observed with terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining. Radiosensitizing effect of M867 through inhibiting caspases was validated using caspase-3/-7 double-knockout (DKO) mouse embryonic fibroblasts (MEF) cell model. Consistent with our previous study, autophagy contributed to the mechanism of increased cell death, following inhibition of apoptosis. In addition, matrigel assay showed a decrease in in vitro endothelial tubule formation during the M867/radiation combination treatment. Conclusions: M867 enhances the cytotoxic effects of radiation on lung cancer and its vasculature both in vitro and in vivo. M867 has the potential to prolong tumor growth delay by inhibiting tumor proliferation. Clinical trials are needed to determine the potential of this combination therapy in patients with locally advanced lung cancer.	[Kim, Kwang Woon; Moretti, Luigi; Lu, Bo] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Radiat Oncol, Nashville, TN 37212 USA	Vanderbilt University	Kim, KW (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Radiat Oncol, Nashville, TN 37212 USA.	bo.lu@vanderbilt.edu	lu, bo/G-4573-2010		US National Cancer Institute (NCI) [1R01 CA125842-01A1]; NATIONAL CANCER INSTITUTE [R01CA125842] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the US National Cancer Institute (NCI) Grant 1R01 CA125842-01A1. The funders had no role in the design and conduct of the study, in the data collection, analysis and interpretation, and decision to publish, review, approval, or preparation of the manuscript.	Abend M, 2003, INT J RADIAT BIOL, V79, P927, DOI 10.1080/09553000310001632958; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Andriani F, 2006, NEOPLASIA, V8, P9, DOI 10.1593/neo.05517; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gdynia G, 2007, MOL CANCER RES, V5, P1232, DOI 10.1158/1541-7786.MCR-07-0343; Gorski DH, 1999, CANCER RES, V59, P3374; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; HALL HM, 1902, U CALIFORNIA PUBLICA, V1, P1; Hallahan DE, 1997, P NATL ACAD SCI USA, V94, P6432, DOI 10.1073/pnas.94.12.6432; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Han YX, 2005, BIOORG MED CHEM LETT, V15, P1173, DOI 10.1016/j.bmcl.2004.12.006; Hope AJ, 2006, INT J RADIAT ONCOL, V65, P112, DOI 10.1016/j.ijrobp.2005.11.046; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kuwano K, 2000, CHEST, V118, P451, DOI 10.1378/chest.118.2.451; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Methot N, 2004, J EXP MED, V199, P199, DOI 10.1084/jem.20031791; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nishio Kazuto, 1999, Current Opinion in Oncology, V11, P109, DOI 10.1097/00001622-199903000-00006; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ohta Y, 1996, CLIN CANCER RES, V2, P1411; Paglin S, 2001, CANCER RES, V61, P439; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Segura I, 2002, FASEB J, V16, DOI 10.1096/fj.01-0819com; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Thornton SC, 1996, CLIN EXP IMMUNOL, V103, P67, DOI 10.1046/j.1365-2249.1996.898598.x; Verheij M, 2000, CELL TISSUE RES, V301, P133, DOI 10.1007/s004410000188; Wang J, 2000, J CELL SCI, V113, P753; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798	45	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2275	10.1371/journal.pone.0002275	http://dx.doi.org/10.1371/journal.pone.0002275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509530	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500020
J	Fabian, P; McDevitt, JJ; DeHaan, WH; Fung, ROP; Cowling, BJ; Chan, KH; Leung, GM; Milton, DK				Fabian, Patricia; McDevitt, James J.; DeHaan, Wesley H.; Fung, Rita O. P.; Cowling, Benjamin J.; Chan, Kwok Hung; Leung, Gabriel M.; Milton, Donald K.			Influenza Virus in Human Exhaled Breath: An Observational Study	PLOS ONE			English	Article								Background: Recent studies suggest that humans exhale fine particles during tidal breathing but little is known of their composition, particularly during infection. Methodology/Principal Findings: We conducted a study of influenza infected patients to characterize influenza virus and particle concentrations in their exhaled breath. Patients presenting with influenza-like-illness, confirmed influenza A or B virus by rapid test, and onset within 3 days were recruited at three clinics in Hong Kong, China. We collected exhaled breath from each subject onto Teflon filters and measured exhaled particle concentrations using an optical particle counter. Filters were analyzed for influenza A and B viruses by quantitative polymerase chain reaction (qPCR). Twelve out of thirteen rapid test positive patients provided exhaled breath filter samples (7 subjects infected with influenza B virus and 5 subjects infected with influenza A virus). We detected influenza virus RNA in the exhaled breath of 4 (33%) subjects-three (60%) of the five patients infected with influenza A virus and one (14%) of the seven infected with influenza B virus. Exhaled influenza virus RNA generation rates ranged from <3.2 to 20 influenza virus RNA particles per minute. Over 87% of particles exhaled were under 1 mu m in diameter. Conclusions: These findings regarding influenza virus RNA suggest that influenza virus may be contained in fine particles generated during tidal breathing, and add to the body of literature suggesting that fine particle aerosols may play a role in influenza transmission.	[Fabian, Patricia; McDevitt, James J.; Milton, Donald K.] Univ Massachusetts, Dept Work Environm, Lowell, MA 01854 USA; [Fabian, Patricia; McDevitt, James J.; Milton, Donald K.] Harvard Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [DeHaan, Wesley H.] Pulmatrix Inc, Lexington, MA USA; [Fung, Rita O. P.; Cowling, Benjamin J.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Dept Community Med, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Peoples R China	University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong	Fabian, P (corresponding author), Univ Massachusetts, Dept Work Environm, Lowell, MA 01854 USA.	patricia_fabian@uml.edu	Milton, Donald K/G-3286-2010; Chan, Kwok Hung/ABD-5399-2021; Cowling, Benjamin John/C-4263-2009	Milton, Donald K/0000-0002-0550-7834; Cowling, Benjamin John/0000-0002-6297-7154; Leung, Gabriel/0000-0002-2503-6283; Fabian, M. Patricia/0000-0002-1658-3349	US Centers for Disease Control and Prevention [1U01CI000439-01, 1U01CI000446-01]; Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER) [04-C-ACE-HU]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000439, U01CI000446] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University Grants Committee; U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has received financial support from the US Centers for Disease Control and Prevention (cooperative grants #1U01CI000439-01 and #1U01CI000446-01), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR, and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). This work was also supported by the U.S. Federal Aviation Administration (FAA) Office of Aerospace Medicine through the Air Transportation Center of Excellence for Airliner Cabin Environment Research (ACER), Cooperative Agreements 04-C-ACE-HU. Although the FAA and CDC have sponsored this project, they neither endorse nor reject the findings of this research.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Andrewes CH, 1941, BRIT J EXP PATHOL, V22, P91; [Anonymous], PREPARING INFLUENZA; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; COUCH RB, 1970, AM J EPIDEMIOL, V91, P78, DOI 10.1093/oxfordjournals.aje.a121115; COUCH RB, 1966, BACTERIOL REV, V30, P517, DOI 10.1128/MMBR.30.3.517-529.1966; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P615; DUGUID J P, 1945, Edinb Med J, V52, P385; Edward DGF, 1943, J HYG-CAMBRIDGE, V43, P1, DOI 10.1017/S0022172400035828; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; FRANKOVA V, 1975, ACTA VIROL, V19, P29; Gebhart J., 1988, J AEROSOL MED, V1, P196; GERONE PJ, 1966, BACTERIOL REV, V30, P576, DOI 10.1128/MMBR.30.3.576-588.1966; Glover RE, 1941, BRIT J EXP PATHOL, V22, P98; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; KNIGHT V, 1965, ANN INTERN MED, V62, P1307, DOI 10.7326/0003-4819-62-6-1307; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; LOOSLI CG, 1970, ARCH ENVIRON HEALTH, V21, P332, DOI 10.1080/00039896.1970.10667248; LOOSLI CG, 1953, T ASSOC AM PHYSICIAN, V66, P222; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; MAIGETTER RZ, 1976, ENVIRON RES, V11, P386, DOI 10.1016/0013-9351(76)90100-6; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; SCHULMAN JL, 1967, J EXP MED, V125, P479, DOI 10.1084/jem.125.3.479; SCHULMAN JL, 1968, AM J PUBLIC HEALTH N, V58, P2092, DOI 10.2105/AJPH.58.11.2092; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; SNYDER MH, 1986, J INFECT DIS, V154, P709, DOI 10.1093/infdis/154.4.709; Squires S, 1975, J Antimicrob Chemother, V1, P35; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; *US DHHS, 2005, HHS PAND INFL PLAN; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008; Wells WF, 1955, AIR HYG ECOL STUDY D	42	334	351	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2691	10.1371/journal.pone.0002691	http://dx.doi.org/10.1371/journal.pone.0002691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628983	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200034
J	Jun, SH; Choi, B; Shahine, L; Westphal, LM; Behr, B; Pera, RAR; Wong, WH; Yao, MWM				Jun, Sunny H.; Choi, Bokyung; Shahine, Lora; Westphal, Lynn M.; Behr, Barry; Pera, Renee A. Reijo; Wong, Wing H.; Yao, Mylene W. M.			Defining Human Embryo Phenotypes by Cohort-Specific Prognostic Factors	PLOS ONE			English	Article							IN-VITRO-FERTILIZATION; STEM-CELL LINES; INTRACYTOPLASMIC SPERM INJECTION; FOLLICLE-STIMULATING-HORMONE; MORPHOLOGICAL ASSESSMENT; BLASTOCYST TRANSFER; PREDICTIVE-VALUE; OVARIAN RESERVE; PREGNANCY; FRAGMENTATION	Background: Hundreds of thousands of human embryos are cultured yearly at in vitro fertilization (IVF) centers worldwide, yet the vast majority fail to develop in culture or following transfer to the uterus. However, human embryo phenotypes have not been formally defined, and current criteria for embryo transfer largely focus on characteristics of individual embryos. We hypothesized that embryo cohort-specific variables describing sibling embryos as a group may predict developmental competence as measured by IVF cycle outcomes and serve to define human embryo phenotypes. Methodology/Principal Findings: We retrieved data for all 1117 IVF cycles performed in 2005 at Stanford University Medical Center, and further analyzed clinical data from the 665 fresh IVF, non-donor cycles and their associated 4144 embryos. Thirty variables representing patient characteristics, clinical diagnoses, treatment protocol, and embryo parameters were analyzed in an unbiased manner by regression tree models, based on dichotomous pregnancy outcomes defined by positive serum beta-human chorionic gonadotropin (beta-hCG). IVF cycle outcomes were most accurately predicted at similar to 70% by four non-redundant, embryo cohort-specific variables that, remarkably, were more informative than any measures of individual, transferred embryos: Total number of embryos, number of 8-cell embryos, rate (percentage) of cleavage arrest in the cohort and day 3 follicle stimulating hormone (FSH) level. While three of these variables captured the effects of other significant variables, only the rate of cleavage arrest was independent of any known variables. Conclusions/Significance: Our findings support defining human embryo phenotypes by non-redundant, prognostic variables that are specific to sibling embryos in a cohort.	[Jun, Sunny H.; Shahine, Lora; Westphal, Lynn M.; Behr, Barry; Pera, Renee A. Reijo; Yao, Mylene W. M.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Choi, Bokyung] Stanford Univ, Sch Humanities & Sci, Dept Appl Phys, Stanford, CA USA; [Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat, Ctr Human Embryo & Embryon Stem Cell Res & Educ, Stanford, CA USA; [Wong, Wing H.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Jun, SH (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	mylene.yao@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	NIH [HD057970, HD01249, GM067250]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057970] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.W.M.Y. received support from NIH HD057970 and HD01249; W.H.W. received support from NIH GM067250; R.A.R.P. received support from the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikani M, 1999, FERTIL STERIL, V71, P836, DOI 10.1016/S0015-0282(99)00092-8; ARTLEY JK, 1992, HUM REPROD, V7, P1014, DOI 10.1093/oxfordjournals.humrep.a137761; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Behr B, 1999, HUM REPROD, V14, P5, DOI 10.1093/humrep/14.1.5; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Ebner T, 2003, HUM REPROD UPDATE, V9, P251, DOI 10.1093/humupd/dmg021; Ebner T, 2001, FERTIL STERIL, V76, P281, DOI 10.1016/S0015-0282(01)01904-5; Fisch JD, 1999, FERTIL STERIL, V71, P750, DOI 10.1016/S0015-0282(98)00533-0; Friedman J.H., 1999, GREEDY FUNCTION APPR; Friedman J.H., 1999, STOCHASTIC GRADIENT; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; FRIEDMAN JH, 2002, TUTORIAL GETTING STA; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gardner DK, 1998, HUM REPROD, V13, P3434, DOI 10.1093/humrep/13.12.3434; Gardner DK, 2000, HUM REPROD, V15, P9; GIORGETTI C, 1995, HUM REPROD, V10, P2427; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; Jain T, 2004, FERTIL STERIL, V82, P180, DOI 10.1016/j.fertnstert.2003.11.045; Jun SH, 2006, FERTIL STERIL, V86, P825, DOI 10.1016/j.fertnstert.2006.03.043; Keltz MD, 2006, FERTIL STERIL, V86, P321, DOI 10.1016/j.fertnstert.2006.01.048; Lan KC, 2003, HUM REPROD, V18, P1299, DOI 10.1093/humrep/deg239; LANE M, 1992, HUM REPROD, V7, P558, DOI 10.1093/oxfordjournals.humrep.a137690; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Milki AA, 2002, FERTIL STERIL, V77, P1191, DOI 10.1016/S0015-0282(02)03104-7; Milki AA, 2000, FERTIL STERIL, V73, P126, DOI 10.1016/S0015-0282(99)00485-9; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Nagy ZP, 2003, FERTIL STERIL, V80, P67, DOI 10.1016/S0015-0282(03)00569-7; Neuber E, 2006, FERTIL STERIL, V85, P794, DOI 10.1016/j.fertnstert.2005.08.064; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; Racowsky C, 2000, FERTIL STERIL, V73, P558, DOI 10.1016/S0015-0282(99)00565-8; Racowsky C, 2002, THERIOGENOLOGY, V57, P87, DOI 10.1016/S0093-691X(01)00659-8; Rijnders PM, 1998, HUM REPROD, V13, P2869, DOI 10.1093/humrep/13.10.2869; SCOTT RT, 2007, FERTIL STERIL; Spyropoulou I, 1999, HUM REPROD, V14, P76, DOI 10.1093/humrep/14.1.76; Srouji SS, 2005, FERTIL STERIL, V84, P795, DOI 10.1016/j.fertnstert.2005.02.042; Stone BA, 2005, AM J OBSTET GYNECOL, V192, P2014, DOI 10.1016/j.ajog.2005.02.048; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Volpes A, 2004, FERTIL STERIL, V82, P1330, DOI 10.1016/j.fertnstert.2004.03.067; Watt AH, 2000, J ASSIST REPROD GEN, V17, P264, DOI 10.1023/A:1009458332567; 2006, FERTIL STERIL S, V86, pS51	45	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2562	10.1371/journal.pone.0002562	http://dx.doi.org/10.1371/journal.pone.0002562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596962	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200029
J	Dettenhofer, M; Zhou, F; Leder, P				Dettenhofer, Markus; Zhou, Fen; Leder, Philip			Formin 1-Isoform IV Deficient Cells Exhibit Defects in Cell Spreading and Focal Adhesion Formation	PLOS ONE			English	Article								Background: Regulation of the cytoskeleton is a central feature of cell migration. The formin family of proteins controls the rate of actin nucleation at its barbed end. Thus, formins are predicted to contribute to several important cell processes such as locomotion, membrane ruffling, vesicle endocytosis, and stress fiber formation and disassociation. Methodology/Principal Findings: In this study we investigated the functional role of Formin1-isoform4 (Fmn1-IV) by using genetically null primary cells that displayed augmented protrusive behaviour during wound healing and delayed cell spreading. Cells deficient of Fmn1-IV also showed reduced efficiency of focal adhesion formation. Additionally, we generated an enhanced green fluorescence protein (EGFP)-fused Fmn1-IV knock-in mouse to monitor the endogenous subcellular localization of Fmn1-IV. Its localization was found within the cytoplasm and along microtubules, yet it was largely excluded from adherens junctions. Conclusions/Significance: It was determined that Fmn1-IV, as an actin nucleator, contributes to protrusion of the cell's leading edge and focal adhesion formation, thus contributing to cell motility.	[Dettenhofer, Markus; Zhou, Fen; Leder, Philip] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dettenhofer, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mdettenh@genetics.med.harvard.edu	Dettenhofer, Markus/ABB-9840-2021	Dettenhofer, Markus/0000-0003-1972-7026	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding in part through the Howard Hughes Medical Institute.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Feierbach B, 2004, J CELL BIOL, V165, P697, DOI 10.1083/jcb.200403090; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; JACKSONGRUSBY L, 1992, GENE DEV, V6, P29, DOI 10.1101/gad.6.1.29; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; O'Rourke DA, 2000, J AM SOC NEPHROL, V11, P2212, DOI 10.1681/ASN.V11122212; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Takaishi K, 2000, BIOCHEM BIOPH RES CO, V274, P68, DOI 10.1006/bbrc.2000.3102; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; WynshawBoris A, 1997, MOL MED, V3, P372, DOI 10.1007/BF03401684; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamazaki D, 2007, J CELL SCI, V120, P86, DOI 10.1242/jcs.03311; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	40	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2497	10.1371/journal.pone.0002497	http://dx.doi.org/10.1371/journal.pone.0002497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560567	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700057
J	Faca, VM; Ventura, AP; Fitzgibbon, MP; Pereira-Faca, SR; Pitteri, SJ; Green, AE; Ireton, RC; Zhang, Q; Wang, H; O'Briant, KC; Drescher, CW; Schummer, M; McIntosh, MW; Knudsen, BS; Hanash, SM				Faca, Vitor M.; Ventura, Aviva P.; Fitzgibbon, Mathew P.; Pereira-Faca, Sandra R.; Pitteri, Sharon J.; Green, Ann E.; Ireton, Renee C.; Zhang, Qing; Wang, Hong; O'Briant, Kathy C.; Drescher, Charles W.; Schummer, Michel; McIntosh, Martin W.; Knudsen, Beatrice S.; Hanash, Samir M.			Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains	PLOS ONE			English	Article								Background: Elucidation of the repertoire of secreted and cell surface proteins of tumor cells is relevant to molecular diagnostics, tumor imaging and targeted therapies. We have characterized the cell surface proteome and the proteins released into the extra-cellular milieu of three ovarian cancer cell lines, CaOV3, OVCAR3 and ES2 and of ovarian tumor cells enriched from ascites fluid. Methodology and Findings: To differentiate proteins released into the media from protein constituents of media utilized for culture, cells were grown in the presence of [(13)C]-labeled lysine. A biotinylation-based approach was used to capture cell surface associated proteins. Our general experimental strategy consisted of fractionation of proteins from individual compartments followed by proteolytic digestion and LC-MS/MS analysis. In total, some 6,400 proteins were identified with high confidence across all specimens and fractions. Conclusions and Significance: Protein profiles of the cell lines had substantial similarity to the profiles of human ovarian cancer cells from ascites fluid and included protein markers known to be associated with ovarian cancer. Proteomic analysis indicated extensive shedding from extra-cellular domains of proteins expressed on the cell surface, and remarkably high secretion rates for some proteins (nanograms per million cells per hour). Cell surface and secreted proteins identified by in-depth proteomic profiling of ovarian cancer cells may provide new targets for diagnosis and therapy.	[Faca, Vitor M.; Ventura, Aviva P.; Fitzgibbon, Mathew P.; Pereira-Faca, Sandra R.; Pitteri, Sharon J.; Green, Ann E.; Ireton, Renee C.; Zhang, Qing; Wang, Hong; O'Briant, Kathy C.; Drescher, Charles W.; Schummer, Michel; McIntosh, Martin W.; Knudsen, Beatrice S.; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Faca, VM (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	shanash@fhcrc.org	Faça, Vitor M/A-3989-2013	Pitteri, Sharon/0000-0002-3119-873X; FACA, VITOR MARCEL/0000-0003-3205-7944	The Canary Foundation	The Canary Foundation	This study was funded by The Canary Foundation. The funding organization did not have any role in data collection or analysis, decision to publish, or preparation of the manuscript.	Aletti GD, 2007, MAYO CLIN PROC, V82, P751; An HJ, 2006, J PROTEOME RES, V5, P1082, DOI 10.1021/pr050461p; Bengtsson S, 2007, J PROTEOME RES, V6, P1440, DOI 10.1021/pr060593y; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; De Wever O, 2007, CLIN EXP METASTAS, V24, P685, DOI 10.1007/s10585-007-9104-8; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2007, BIOTECHNIQUES, V43, P279, DOI 10.2144/000112541; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goonewardene TI, 2007, LANCET ONCOL, V8, P813, DOI 10.1016/S1470-2045(07)70273-5; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; KARLAN BY, 1994, GYNECOL ONCOL, V53, P70; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LAU DHM, 1991, CANCER RES, V51, P5181; Lin YW, 2006, INT J GYNECOL CANCER, V16, P139, DOI 10.1111/j.1525-1438.2006.00475.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Maatta M, 2007, ANTICANCER RES, V27, P2753; Morita A, 2006, PROTEOMICS, V6, P5880, DOI 10.1002/pmic.200500708; Moshkovskii SA, 2005, PROTEOMICS, V5, P3790, DOI 10.1002/pmic.200401205; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Schwartz DR, 2002, CANCER RES, V62, P4722; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337	39	105	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2425	10.1371/journal.pone.0002425	http://dx.doi.org/10.1371/journal.pone.0002425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560578	gold, Green Published, Green Submitted			2022-12-27	WOS:000263280700011
J	Mutalima, N; Molyneux, E; Jaffe, H; Kamiza, S; Borgstein, E; Mkandawire, N; Liomba, G; Batumba, M; Lagos, D; Gratrix, F; Boshoff, C; Casabonne, D; Carpenter, LM; Newton, R				Mutalima, Nora; Molyneux, Elizabeth; Jaffe, Harold; Kamiza, Steve; Borgstein, Eric; Mkandawire, Nyengo; Liomba, George; Batumba, Mkume; Lagos, Dimitrios; Gratrix, Fiona; Boshoff, Chris; Casabonne, Delphine; Carpenter, Lucy M.; Newton, Robert			Associations between Burkitt Lymphoma among Children in Malawi and Infection with HIV, EBV and Malaria: Results from a Case-Control Study	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PLASMODIUM-FALCIPARUM; ANTIBODY-RESPONSES; CANCER; RISK; UGANDA; ADULTS; BLOOD	Background: Burkitt lymphoma, a childhood cancer common in parts of sub-Saharan Africa, has been associated with Epstein Barr Virus (EBV) and malaria, but its association with human immunodeficiency virus (HIV) is not clear. Methodology/Principal Findings: We conducted a case-control study of Burkitt lymphoma among children (aged <= 15 years) admitted to the pediatric oncology unit in Blantyre, Malawi between July 2005 and July 2006. Cases were 148 children diagnosed with Burkitt lymphoma and controls were 104 children admitted with non-malignant conditions or cancers other than hematological malignancies and Kaposi sarcoma. Interviews were conducted and serological samples tested for antibodies against HIV, EBV and malaria. Odds ratios for Burkitt lymphoma were estimated using unconditional logistic regression adjusting for sex, age, and residential district. Cases had a mean age of 7.1 years and 60% were male. Cases were more likely than controls to be HIV positive (Odds ratio (OR)) = 12.4, 95% Confidence Interval (CI) 1.3 to 116.2, p = 0.03). ORs for Burkitt lymphoma increased with increasing antibody titers against EBV (p = 0.001) and malaria (p = 0.01). Among HIV negative participants, cases were thirteen times more likely than controls to have raised levels of both EBV and malaria antibodies (OR = 13.2; 95% CI 3.8 to 46.6; p = 0.001). Reported use of mosquito nets was associated with a lower risk of Burkitt lymphoma (OR = 0.2, 95% CI, 0.03 to 0.9, p = 0.04). Conclusions: Our findings support prior evidence that EBV and malaria act jointly in the pathogenesis of Burkitt lymphoma, suggesting that malaria prevention may decrease the risk of Burkitt lymphoma. HIV may also play a role in the etiology of this childhood tumor.	[Mutalima, Nora; Jaffe, Harold; Carpenter, Lucy M.] Univ Oxford, Dept Publ Hlth, Oxford, England; [Molyneux, Elizabeth] Coll Med, Dept Pediat, Blantyre, Malawi; [Kamiza, Steve; Liomba, George] Coll Med, Dept Histopathol, Blantyre, Malawi; [Borgstein, Eric; Mkandawire, Nyengo] Coll Med, Dept Surg, Blantyre, Malawi; [Batumba, Mkume] Coll Med, Dept Ophthalmol, Blantyre, Malawi; [Lagos, Dimitrios; Gratrix, Fiona; Boshoff, Chris] UCL, Wolfson Inst Biomed Res, London, England; [Casabonne, Delphine] Univ Oxford, Canc Epidemiol Unit, Oxford, England; [Newton, Robert] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York, N Yorkshire, England	University of Oxford; University of Malawi; University of Malawi; University of Malawi; University of Malawi; University of London; University College London; University of Oxford; University of York - UK	Mutalima, N (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford, England.	nora.mutalima@gmail.com	Casabonne, Delphine/H-6425-2014	Lagos, Dimitris/0000-0003-0637-281X	Cancer Research UK; Medical Research Council [G0800168] Funding Source: researchfish; MRC [G0800168] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support for this work was provided by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKENJI TN, 1994, J PARASITOL, V80, P895, DOI 10.2307/3283437; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Akre O, 1999, INT J CANCER, V82, P1; BIGGAR RJ, 1979, INT J CANCER, V23, P330, DOI 10.1002/ijc.2910230310; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Carpenter LM, 2008, INT J CANCER, V122, P1319, DOI 10.1002/ijc.23254; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; DALLDORF G, 1964, PERSPECT BIOL MED, V7, P435; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Douek Daniel C., 2003, AIDS Reviews, V5, P172; DZAMALALA C, 2005, CANC EPIDEMIC MALAWI; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; GESER A, 1989, AM J EPIDEMIOL, V129, P740, DOI 10.1093/oxfordjournals.aje.a115189; GESER A, 1982, INT J CANCER, V29, P397, DOI 10.1002/ijc.2910290406; GESER A, 1985, BURKITTS LYMPHOMA HU, P205; HADDOW AJ, 1970, BURKITTS LYMPHOMA, P198; HENLE G, 1969, J NATL CANCER I, V43, P1147; Higgins CD, 2007, J INFECT DIS, V195, P474, DOI 10.1086/510854; IARC, 1997, IARC MON EV CARC RIS; *IARC, 2003, CANC AFR EP PREV, P427; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lazzi S, 1998, HUM PATHOL, V29, P1285, DOI 10.1016/S0046-8177(98)90258-1; LENGELER C, 1998, COCHRANE DB SYST REV; Mathanga DP, 2005, AM J TROP MED HYG, V73, P622, DOI 10.4269/ajtmh.2005.73.622; Mbulaiteye SM, 2006, J INFECT DIS, V193, P422, DOI 10.1086/499277; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; MORROW RH, 1974, CANCER RES, V34, P1211; MORROW RH, 1976, JNCI-J NATL CANCER I, V56, P479, DOI 10.1093/jnci/56.3.479; MORROW RH, 1976, CANCER RES, V36, P667; Morrow RH, 1982, CANCER EPIDEMIOL, V779-94; Moutschen M, 2007, VACCINE, V25, P4697, DOI 10.1016/j.vaccine.2007.04.008; National Statistics Office (Malawi) Measure DHS ORC Macro, 2005, MAL DEM HLTH SURV 20; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; Newton R, 2006, BRIT J CANCER, V94, P1504, DOI 10.1038/sj.bjc.6603100; OLWENY CLM, 1977, JNCI-J NATL CANCER I, V58, P1191, DOI 10.1093/jnci/58.5.1191; Parkin DM, 2000, AIDS, V14, P2929, DOI 10.1097/00002030-200012220-00015; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; SHIRAMIZU B, 1991, BLOOD, V77, P1516; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Slutsker L, 1996, AM J TROP MED HYG, V55, P71, DOI 10.4269/ajtmh.1996.55.71; *STATACORP REL 200, 2007, INT STAT 9 2 WIND VE; Verra F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000978; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Yamey G, 2000, BRIT MED J, V320, P1228, DOI 10.1136/bmj.320.7244.1228; [No title captured]	50	80	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2505	10.1371/journal.pone.0002505	http://dx.doi.org/10.1371/journal.pone.0002505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560562	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700061
J	Peterson, AT; Stewart, A; Mohamed, KI; Araujo, MB				Peterson, A. Townsend; Stewart, Aimee; Mohamed, Kamal I.; Araujo, Miguel B.			Shifting Global Invasive Potential of European Plants with Climate Change	PLOS ONE			English	Article								Global climate change and invasions by nonnative species rank among the top concerns for agents of biological loss in coming decades. Although each of these themes has seen considerable attention in the modeling and forecasting communities, their joint effects remain little explored and poorly understood. We developed ecological niche models for 1804 species from the European flora, which we projected globally to identify areas of potential distribution, both at present and across 4 scenarios of future (2055) climates. As expected from previous studies, projections based on the CGCM1 climate model were more extreme than those based on the HadCM3 model, and projections based on the a2 emissions scenario were more extreme than those based on the b2 emissions scenario. However, less expected were the highly nonlinear and contrasting projected changes in distributional areas among continents: increases in distributional potential in Europe often corresponded with decreases on other continents, and species seeing expanding potential on one continent often saw contracting potential on others. In conclusion, global climate change will have complex effects on invasive potential of plant species. The shifts and changes identified in this study suggest strongly that biological communities will see dramatic reorganizations in coming decades owing to shifting invasive potential by nonnative species.	[Peterson, A. Townsend; Stewart, Aimee] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Mohamed, Kamal I.] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY USA; [Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Biodivers & Evol Biol Dept, Madrid, Spain	University of Kansas; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; Consejo Superior de Investigaciones Cientificas (CSIC)	Peterson, AT (corresponding author), Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA.	town@ku.edu	Araújo, Miguel B/B-6117-2008; Peterson, A. Townsend/I-5697-2013	Araújo, Miguel B/0000-0002-5107-7265; Peterson, A. Townsend/0000-0003-0243-2379				Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2003, GLOBAL ECOL BIOGEOGR, V12, P5, DOI 10.1046/j.1466-822X.2003.00314.x; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; *CRIA, 2007, OPENMODELLER VERS; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Flato GM, 2000, CLIM DYNAM, V16, P451, DOI 10.1007/s003820050339; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hoffmann MH, 2001, FLORA, V196, P395, DOI 10.1016/S0367-2530(17)30076-2; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Iguchi K, 2004, T AM FISH SOC, V133, P845, DOI 10.1577/T03-172.1; IPCC, 2001, CLIM DAT ARCH; Jalas J., 1972, ATLAS FLORAE EUROPAE; Lahti Tapani, 1999, Acta Botanica Fennica, V162, P5; LAWTON JH, 1986, PHILOS T ROY SOC B, V314, P607, DOI 10.1098/rstb.1986.0076; Martin WK, 1996, EMU, V96, P166, DOI 10.1071/MU9960166; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; *NAS, 2002, PRED INV NON PLANTS; New M., 1997, 1961 1990 MEAN MONTH; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2004, CAN J ZOOL, V82, P851, DOI 10.1139/Z04-064; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PETERSON AT, 2005, CLIMATE CHANGE BIODI, P211; POPE VD, 2002, IMPACT NEW PHYS PARA; RICHARDSON DM, 1992, S AFR J SCI, V88, P380; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Skov F, 2000, TAXON, V49, P503, DOI 10.2307/1224346; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; *USDA, 2007, PLANTS DAT; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WILLIAMSON M, 1996, BIOLO INVASIONS	54	54	54	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2441	10.1371/journal.pone.0002441	http://dx.doi.org/10.1371/journal.pone.0002441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560572	Green Published, Green Submitted, gold			2022-12-27	WOS:000263280700026
J	Agarwal, V; Kommaddi, RP; Valli, K; Ryder, D; Hyde, TM; Kleinman, JE; Strobel, HW; Ravindranath, V				Agarwal, Varsha; Kommaddi, Reddy P.; Valli, Khader; Ryder, Daniel; Hyde, Thomas M.; Kleinman, Joel E.; Strobel, Henry W.; Ravindranath, Vijayalakshmi			Drug Metabolism in Human Brain: High Levels of Cytochrome P4503A43 in Brain and Metabolism of Anti-Anxiety Drug Alprazolam to Its Active Metabolite	PLOS ONE			English	Article								Cytochrome P450 (P450) is a super-family of drug metabolizing enzymes. P450 enzymes have dual function; they can metabolize drugs to pharmacologically inactive metabolites facilitating their excretion or biotransform them to pharmacologically active metabolites which may have longer half-life than the parent drug. The variable pharmacological response to psychoactive drugs typically seen in population groups is often not accountable by considering dissimilarities in hepatic metabolism. Metabolism in brain specific nuclei may play a role in pharmacological modulation of drugs acting on the CNS and help explain some of the diverse response to these drugs seen in patient population. P450 enzymes are also present in brain where drug metabolism can take place and modify therapeutic action of drugs at the site of action. We have earlier demonstrated an intrinsic difference in the biotransformation of alprazolam (ALP) in brain and liver, relatively more alpha-hydroxy alprazolam (alpha-OHALP) is formed in brain as compared to liver. In the present study we show that recombinant CYP3A43 metabolizes ALP to both alpha-OHALP and 4-hydroxy alprazolam (4-OHALP) while CYP3A4 metabolizes ALP predominantly to its inactive metabolite, 4-OHALP. The expression of CYP3A43 mRNA in human brain samples correlates with formation of relatively higher levels of alpha-OH ALP indicating that individuals who express higher levels of CYP3A43 in the brain would generate larger amounts of alpha-OHALP. Further, the expression of CYP3A43 was relatively higher in brain as compared to liver across different ethnic populations. Since CYP3A enzymes play a prominent role in the metabolism of drugs, the higher expression of CYP3A43 would generate metabolite profile of drugs differentially in human brain and thus impact the pharmacodynamics of psychoactive drugs at the site of action.	[Agarwal, Varsha; Kommaddi, Reddy P.; Valli, Khader; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India; [Ryder, Daniel; Strobel, Henry W.] Univ Texas, Med Sch, Dept Biochem & Mol Biol, Houston, TX USA; [Hyde, Thomas M.; Kleinman, Joel E.] NIMH, NIH, DIRP, Sect Neuropathol,Clin Brain Disorders Branch, Bethesda, MD USA	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); University of Texas System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Agarwal, V (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Nainwal Mode, Manesar, India.	vijir@nbrc.ac.in			National Institutes of Health [MH 70054]; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002903, ZICMH002903, R01MH070054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant MH 70054 to HWS and VR.	ANANDATHEERTHAVARADA HK, 1990, BRAIN RES, V536, P339, DOI 10.1016/0006-8993(90)90047-F; Chinta SJ, 2002, MOL BRAIN RES, V103, P49, DOI 10.1016/S0169-328X(02)00177-8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Domanski TL, 2001, MOL PHARMACOL, V59, P386, DOI 10.1124/mol.59.2.386; Fukasawa T, 2007, J CLIN PHARM THER, V32, P333, DOI 10.1111/j.1365-2710.2007.00829.x; Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002; GREENBLATT DJ, 1993, CLIN PHARMACOKINET, V24, P453, DOI 10.2165/00003088-199324060-00003; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Haining RL, 2007, PHARMACOL THERAPEUT, V113, P537, DOI 10.1016/j.pharmthera.2006.11.005; Hirota N, 2001, BIOPHARM DRUG DISPOS, V22, P53, DOI 10.1002/bdd.261; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Kevil CG, 1997, BIOCHEM BIOPH RES CO, V238, P277, DOI 10.1006/bbrc.1997.7284; Kommaddi RP, 2007, J NEUROCHEM, V102, P867, DOI 10.1111/j.1471-4159.2007.04599.x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; OZHEMIR V, 2000, PHARMACOGENETICS, V5, P373; Pai H. V., 2002, Pharmacogenomics Journal, V2, P243, DOI 10.1038/sj.tpj.6500115; Park JY, 2006, CLIN PHARMACOL THER, V79, P590, DOI 10.1016/j.clpt.2006.02.008; PARK JY, 2006, CLIN PHARMACOL THER, V6, P715; Ravindranath V, 2006, J NEURAL TRANSM-SUPP, P167; RAVINDRANATH V, 1989, BRAIN RES, V496, P331, DOI 10.1016/0006-8993(89)91083-4; SCHUETZ JD, 1993, J CLIN INVEST, V92, P1018, DOI 10.1172/JCI116607; SETHY VH, 1982, J PHARM PHARMACOL, V34, P115, DOI 10.1111/j.2042-7158.1982.tb04197.x; Wennerholm A, 2005, EUR J CLIN PHARMACOL, V61, P113, DOI 10.1007/s00228-004-0861-x; Westlind A, 2001, BIOCHEM BIOPH RES CO, V281, P1349, DOI 10.1006/bbrc.2001.4505; Williams ET, 2004, J PHARMACOL EXP THER, V311, P728, DOI 10.1124/jpet.104.068908	27	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2337	10.1371/journal.pone.0002337	http://dx.doi.org/10.1371/journal.pone.0002337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545703	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800007
J	Muller, M; Fink, K; Geisel, J; Kahl, F; Jilge, B; Reimann, J; Mach, N; Autenrieth, IB; Frick, JS				Mueller, Martina; Fink, Kerstin; Geisel, Julia; Kahl, Frauke; Jilge, Burghardt; Reimann, Joerg; Mach, Nicolas; Autenrieth, Ingo B.; Frick, Julia S.			Intestinal Colonization of IL-2 Deficient Mice with Non-Colitogenic B. vulgatus Prevents DC Maturation and T-Cell Polarization	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; INFLAMMATION; COLITIS; DISEASE; CCR7; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INTERLEUKIN-6; INHIBITION	Background: IL-2 deficient (IL-2(-/-)) mice mono-colonized with E. coli mpk develop colitis whereas IL-2(-/-)-mice mono-colonized with B. vulgatus mpk do not and are even protected from E. coli mpk induced colitis. Methodology/Principal Findings: We investigated if mono-colonization with E. coli mpk or B. vulgatus mpk differentially modulates distribution, activation and maturation of intestinal lamina propria (LP) dendritic cells (DC). LP DC in mice mono-colonized with protective B. vulgatus mpk or co-colonized with E. coli mpk/B. vulgatus mpk featured a semi-mature LP DC phenotype (CD40(lo)CD80(lo)MHC-IIhi) whereas mono-colonization with colitogenic E. coli mpk induced LP DC activation and maturation prior to onset of colitis. Accordingly, chemokine receptor (CCR) 7 surface expression was more strikingly enhanced in mesenteric lymph node DC from E. coli mpk than B. vulgatus mpk mono- or co-colonized mice. Mature but not semi-mature LP DC promoted Th1 polarization. As B. vulgatus mpk promotes differentiation of semi-mature DC presumably by IL-6, mRNA and protein expression of IL-6 was investigated in LP DC. The data demonstrated that IL-6 mRNA and protein was increased in LP DC of B. vulgatus mpk as compared to E. coli mpk mono- colonized IL-2(-/-)-mice. The B. vulgatus mpk mediated suppression of CCR7 expression and DC migration was abolished in IL-6(-/-)-DC in vitro. Conclusions/Significance: From this data we conclude that the B. vulgatus triggered IL-6 secretion by LP DC in absence of proinflammatory cytokines such as IL-12 or TNF-alpha induces a semi-mature LP DC phenotype, which might prevent T-cell activation and thereby the induction of colitis in IL-2(-/-)-mice. The data provide new evidence that IL-6 might act as an immune regulatory cytokine in the mucosa by targeting intestinal DC.	[Mueller, Martina; Fink, Kerstin; Geisel, Julia; Kahl, Frauke; Autenrieth, Ingo B.; Frick, Julia S.] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Jilge, Burghardt; Reimann, Joerg] Univ Ulm, Ulm, Germany; [Mach, Nicolas] Geneva Univ Hosp, Oncol Div, Geneva, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ulm University; University of Geneva	Muller, M (corresponding author), Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany.	julia-stefanie.frick@med.uni-tuebingen.de	mach, nicolas/AAZ-5302-2021	Frick, Julia-Stefanie/0000-0002-7662-7956	Deutsche Forschungsgemeinschaft [AU 103/13-2]; IZKF Tubingen (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Tubingen (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (AU 103/13-2) and the IZKF Tubingen (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Autenrieth IB, 1997, GUT, V41, P793, DOI 10.1136/gut.41.6.793; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Betti M, 2006, ANN ONCOL, V17, P235; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Frick JS, 2006, EUR J IMMUNOL, V36, P1537, DOI 10.1002/eji.200635840; Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kitamura H, 2005, IMMUNITY, V23, P491, DOI 10.1016/j.immuni.2005.09.010; Krajina T, 2004, EUR J IMMUNOL, V34, P705, DOI 10.1002/eji.200324463; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; Mach N, 2000, CANCER RES, V60, P3239; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; MANSHEIM BJ, 1978, J IMMUNOL, V120, P72; Moseman EA, 2004, J IMMUNOL, V173, P4433, DOI 10.4049/jimmunol.173.7.4433; NAIR BC, 1983, J PERIODONTAL RES, V18, P40, DOI 10.1111/j.1600-0765.1983.tb00333.x; Naito Y, 2004, INT J MOL MED, V14, P191; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sousa CRE, 2001, IMMUNITY, V14, P495; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Waidmann M, 2003, GASTROENTEROLOGY, V125, P162, DOI 10.1016/S0016-5085(03)00672-3; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Yanagihara S, 1998, J IMMUNOL, V161, P3096	40	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2376	10.1371/journal.pone.0002376	http://dx.doi.org/10.1371/journal.pone.0002376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545662	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800017
J	Shen, HB; Chou, JJ				Shen, Hongbin; Chou, James J.			MemBrain: Improving the Accuracy of Predicting Transmembrane Helices	PLOS ONE			English	Article								Prediction of transmembrane helices (TMH) in alpha helical membrane proteins provides valuable information about the protein topology when the high resolution structures are not available. Many predictors have been developed based on either amino acid hydrophobicity scale or pure statistical approaches. While these predictors perform reasonably well in identifying the number of TMHs in a protein, they are generally inaccurate in predicting the ends of TMHs, or TMHs of unusual length. To improve the accuracy of TMH detection, we developed a machine-learning based predictor, MemBrain, which integrates a number of modern bioinformatics approaches including sequence representation by multiple sequence alignment matrix, the optimized evidence-theoretic K-nearest neighbor prediction algorithm, fusion of multiple prediction window sizes, and classification by dynamic threshold. MemBrain demonstrates an overall improvement of about 20% in prediction accuracy, particularly, in predicting the ends of TMHs and TMHs that are shorter than 15 residues. It also has the capability to detect N-terminal signal peptides. The MemBrain predictor is a useful sequence-based analysis tool for functional and structural characterization of helical membrane proteins; it is freely available at http://chou.med.harvard.edu/bioinf/MemBrain/.	[Shen, Hongbin; Chou, James J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shen, HB (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	james_chou@hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIH and the Pew Scholars Program in the Biomedical Sciences	NIH and the Pew Scholars Program in the Biomedical Sciences	This work was supported by the NIH and the Pew Scholars Program in the Biomedical Sciences awarded to J.J.C.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 2004, BIOINFORMATICS, V20, P136, DOI 10.1093/bioinformatics/btg394; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; MAKIVIRTA A, 1991, COMPUT METH PROG BIO, V34, P139, DOI 10.1016/0169-2607(91)90039-V; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shafer G.A., 1976, MATH THEORY EVIDENCE; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411; Zhou HY, 2003, PROTEIN SCI, V12, P1547, DOI 10.1110/ps.0305103; Zouhal LM, 1998, IEEE T SYST MAN CY C, V28, P263, DOI 10.1109/5326.669565	26	90	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2399	10.1371/journal.pone.0002399	http://dx.doi.org/10.1371/journal.pone.0002399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545655	Green Published, gold, Green Submitted			2022-12-27	WOS:000263248800037
J	Ratnaparkhi, A; Lawless, GM; Schweizer, FE; Golshani, P; Jackson, GR				Ratnaparkhi, Anuradha; Lawless, George M.; Schweizer, Felix E.; Golshani, Peyman; Jackson, George R.			A Drosophila Model of ALS: Human ALS-Associated Mutation in VAP33A Suggests a Dominant Negative Mechanism	PLOS ONE			English	Article								ALS8 is caused by a dominant mutation in an evolutionarily conserved protein, VAPB (vesicle-associated membrane protein (VAMP)-associated membrane protein B)/ALS8). We have established a fly model of ALS8 using the corresponding mutation in Drosophila VAPB (dVAP33A) and examined the effects of this mutation on VAP function using genetic and morphological analyses. By simultaneously assessing the effects of VAP(wt) and VAP(P58S) on synaptic morphology and structure, we demonstrate that the phenotypes produced by neuronal expression of VAP(P58S) resemble VAP loss of function mutants and are opposite those of VAP overexpression, suggesting that VAP(P58S) may function as a dominant negative. This is brought about by aggregation of VAP(P58S) and recruitment of wild type VAP into these aggregates. Importantly, we also demonstrate that the ALS8 mutation in dVAP33A interferes with BMP signaling pathways at the neuromuscular junction, identifying a new mechanism underlying pathogenesis of ALS8. Furthermore, we show that mutant dVAP33A can serve as a powerful tool to identify genetic modifiers of VAPB. This new fly model of ALS, with its robust pathological phenotypes, should for the first time allow the power of unbiased screens in Drosophila to be applied to study of motor neuron diseases.	[Ratnaparkhi, Anuradha; Lawless, George M.; Golshani, Peyman; Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Schweizer, Felix E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ratnaparkhi, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	Grjackson@mednet.ucla.edu			NIH [NS046489]; American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH NS046489 and the American Health Assistance Foundation(G.R.J.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Frey D, 2000, J NEUROSCI, V20, P2534; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Italiano JE, 2001, INT REV CYTOL, V202, P1, DOI 10.1016/S0074-7696(01)02002-2; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	50	95	97	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2334	10.1371/journal.pone.0002334	http://dx.doi.org/10.1371/journal.pone.0002334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523548	Green Published, Green Submitted, gold			2022-12-27	WOS:000262614300029
J	Schooling, CM; Wenjie, S; Ho, SY; Chan, WM; Tham, MK; Ho, KS; Leung, GM; Lam, TH				Schooling, C. Mary; Wenjie, Sun; Ho, Sai Yin; Chan, Wai Man; Tham, May Ked; Ho, Kin Sang; Leung, Gabriel M.; Lam, Tai Hing			Moderate Alcohol Use and Mortality from Ischaemic Heart Disease: A Prospective Study in Older Chinese People	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MIDDLE-AGED MEN; HONG-KONG; COMPETING RISKS; BLOOD-PRESSURE; SOCIAL-STATUS; LUNG-CANCER; FOLLOW-UP; CONSUMPTION; METAANALYSIS	Background: Moderate alcohol use is generally associated with lower ischaemic heart disease (IHD) mortality but it is difficult to ascertain whether this is due to attributes of moderate alcohol users or the properties of alcohol itself. Evidence from populations with different patterns of alcohol use and IHD can provide crucial evidence. We assessed the association of moderate alcohol use with IHD mortality in older Chinese people from Hong Kong. Methodology: We used Cox regression to determine whether moderate alcohol use was associated with IHD mortality in a prospective, population-based cohort study of all 56167 attendees, aged 65 years or over, from July 1998 to December 2000 at all 18 Elderly Health Centers operated by the Department of Health in Hong Kong. Principal Findings: After a median follow-up of 4.2 years, there were 406 (188 in men, 218 in women) deaths from IHD in 54,090 subjects (96.3% successful follow-up). Moderate alcohol use in men was not associated with IHD mortality adjusted only for age [Hazard Ratio, HR 1.01 (95% CI 0.55 to 1.84) compared with never drinkers] or additionally adjusted for socioeconomic status and lifestyle. Almost all women were occasional drinkers and their current alcohol use was not significantly associated with IHD mortality [HR 0.88, (95% CI 0.51 to 1.53)]. Conclusions: Moderate alcohol use had no effect on IHD mortality in older Chinese men. Lack of replication of the usual protective effect of moderate alcohol use in a setting with a different pattern of alcohol use and IHD could be due to chance or could suggest that the protective effect of alcohol on IHD does not extend to all populations.	[Schooling, C. Mary; Wenjie, Sun; Ho, Sai Yin; Leung, Gabriel M.; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Wai Man; Tham, May Ked; Ho, Kin Sang] Gov Hong Kong Special Adm Region, Dept Hlth, Hong Kong, Peoples R China	University of Hong Kong	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk	Leung, Gabriel Matthew/C-4336-2009; Sun, Wenjie/I-7692-2013; Schooling, Catherine Mary/C-4386-2009; sun, wenjie/J-8928-2013; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283; Ho, Daniel Sai Yin/0000-0001-9485-0273; Schooling, Mary/0000-0001-9933-5887	Health Care & Promotion Fund Committee in Hong Kong [HSRC#S111016]	Health Care & Promotion Fund Committee in Hong Kong	This project was funded by the Health Care & Promotion Fund Committee in Hong Kong (Grant: HSRC#S111016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2002, STAT METHODS MED RES, V11, P203, DOI 10.1191/0962280202sm281ra; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813; Bartley M, 1999, SOC SCI MED, V49, P831, DOI 10.1016/S0277-9536(99)00192-6; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x; Deev A, 1998, ANN EPIDEMIOL, V8, P147, DOI 10.1016/S1047-2797(98)00004-0; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Doll R, 2005, INT J EPIDEMIOL, V34, P199, DOI 10.1093/ije/dyh369; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Fillmore KM, 1998, ADDICTION, V93, P183, DOI 10.1046/j.1360-0443.1998.9321834.x; Fuchs FD, 2004, AM J EPIDEMIOL, V160, P466, DOI 10.1093/aje/kwh229; Gronbaek M, 2003, J CARDIOVASC RISK, V10, P5, DOI 10.1097/00043798-200302000-00002; Gronbaek M, 2002, ANN NY ACAD SCI, V957, P16, DOI 10.1111/j.1749-6632.2002.tb02902.x; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Janghorbani M, 2003, ADDICTION, V98, P215, DOI 10.1046/j.1360-0443.2003.00268.x; Jiang R, 2003, AM J EPIDEMIOL, V158, P760, DOI 10.1093/aje/kwg221; Korte JE, 2002, AM J EPIDEMIOL, V155, P496, DOI 10.1093/aje/155.6.496; Kunst AE, 1999, AM J PUBLIC HEALTH, V89, P47, DOI 10.2105/AJPH.89.1.47; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; MARMOT MG, 1984, INT J EPIDEMIOL, V13, P160, DOI 10.1093/ije/13.2.160; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; Mortensen EL, 2006, SCAND J PSYCHOL, V47, P387, DOI 10.1111/j.1467-9450.2006.00520.x; Mukamal KJ, 2006, J AM GERIATR SOC, V54, P30, DOI 10.1111/j.1532-5415.2005.00561.x; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Serdula MK, 2004, AM J PREV MED, V26, P294, DOI 10.1016/j.amepre.2003.12.017; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; Strandberg AY, 2004, AM J CLIN NUTR, V80, P1366, DOI 10.1093/ajcn/80.5.1366; WONG SL, 1992, J EPIDEMIOL COMMUN H, V46, P148, DOI 10.1136/jech.46.2.148; Wray LA, 2005, J GERONTOL B-PSYCHOL, V60, P85; Xu WH, 2007, PREV MED, V45, P313, DOI 10.1016/j.ypmed.2007.05.015; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18	44	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2370	10.1371/journal.pone.0002370	http://dx.doi.org/10.1371/journal.pone.0002370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523644	Green Published, gold			2022-12-27	WOS:000262614300056
J	Patel, MS; Phillips, CB; Pearce, C; Kljakovic, M; Dugdale, P; Glasgow, N				Patel, Mahomed S.; Phillips, Christine B.; Pearce, Christopher; Kljakovic, Marjan; Dugdale, Paul; Glasgow, Nicholas			General Practice and Pandemic Influenza: A Framework for Planning and Comparison of Plans in Five Countries	PLOS ONE			English	Article							HEALTH-CARE; PREPAREDNESS; IMPROVEMENT; CHALLENGE; QUALITY; SYSTEMS	Background: Although primary health care, and in particular, general practice will be at the frontline in the response to pandemic influenza, there are no frameworks to guide systematic planning for this task or to appraise available plans for their relevance to general practice. We aimed to develop a framework that will facilitate planning for general practice, and used it to appraise pandemic plans from Australia, England, USA, New Zealand and Canada. Methodology/Principal Findings: We adapted the Haddon matrix to develop the framework, populating its cells through a multi-method study that incorporated the peer-reviewed and grey literature, interviews with general practitioners, practice nurses and senior decision-makers, and desktop simulation exercises. We used the framework to analyse 89 publicly-available jurisdictional plans at similar managerial levels in the five countries. The framework identifies four functional domains: clinical care for influenza and other needs, public health responsibilities, the internal environment and the macro-environment of general practice. No plan addressed all four domains. Most plans either ignored or were sketchy about noninfluenza clinical needs, and about the contribution of general practice to public health beyond surveillance. Collaborations between general practices were addressed in few plans, and inter-relationships with the broader health system, even less frequently. Conclusions: This is the first study to provide a framework to guide general practice planning for pandemic influenza. The framework helped identify critical shortcomings in available plans. Engaging general practice effectively in planning is challenging, particularly where governance structures for primary health care are weak. We identify implications for practice and for research.	[Patel, Mahomed S.; Phillips, Christine B.; Pearce, Christopher; Kljakovic, Marjan; Dugdale, Paul; Glasgow, Nicholas] Australian Natl Univ, Coll Med & Hlth Sci, Canberra, ACT, Australia	Australian National University	Patel, MS (corresponding author), Australian Natl Univ, Coll Med & Hlth Sci, Canberra, ACT, Australia.	Mahomed.Patel@anu.edu.au	Glasgow, Nicholas J/G-3521-2010; Pearce, Christopher/AAE-5967-2019; Dugdale, Paul/GYJ-7351-2022; Phillips, Christine/H-3041-2019	Glasgow, Nicholas J/0000-0002-1994-3565; Pearce, Christopher/0000-0002-3132-6033; Phillips, Christine/0000-0001-5602-3664; Dugdale, Paul/0000-0002-2315-5051; Patel, Mahomed/0000-0001-7671-1114	Australian National Health and Medical Research Committee	Australian National Health and Medical Research Committee	This study was funded by an Australian National Health and Medical Research Committee grant for Urgent Research in a Potential Avian Influenza-Induced Pandemic.	*AG SANT SERV SOC, 2007, MONTR PAND INFL PLAN; *AM COLL PHYS, 2006, HLTH CAR RESP PAND I; Anderson J, 2007, AUST FAM PHYSICIAN, V36, P257; *AR DEP HLTH HUM S, 2006, ARK RESP ARK PAND IN; *AZ DEP HLTH SERV, 2006, ARIZ INFL PAND RESP; Barnett DJ, 2005, ENVIRON HEALTH PERSP, V113, P561, DOI 10.1289/ehp.7491; Barnett DJ, 2005, PLOS MED, V2, P1235, DOI 10.1371/journal.pmed.0020359; *BATH N E SOM PRIM, 2006, BATH N E SOM MAJ INC; Beaumont M, 2007, EUR J CLIN MICROBIOL, V26, P819, DOI 10.1007/s10096-007-0377-2; Brammer T Lynnette, 2002, MMWR Surveill Summ, V51, P1; *BRENT TEACH PRIM, 2006, INFL PAND CONT PLAN; Butler-Jones D, 2007, CAN MED ASSOC J, V176, P36; *CA DEP HLTH, 2006, PAND INFL PREP RESP; *CALG HLTH REG, 2007, PAND INFL RESP PLAN; *CAMD PRIM CAR TRU, 2007, KEEP CAMD WORK MAN I; Campos-Outcalt D, 2005, J FAM PRACTICE, V54, P1045; Chan-Yeung M, 2003, BRIT MED J, V326, P850, DOI 10.1136/bmj.326.7394.850; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Coker R, 2006, LANCET, V368, P886, DOI 10.1016/S0140-6736(06)69209-X; *COLL FAM PHYS CAN, 2004, NAT PHYS SURV; Collins N, 2006, MED J AUSTRALIA, V185, pS66; *COUNT MAN DISTR H, 2007, PRACT PAND PLANN RES; Department of Health and Ageing, 2007, NAT PAND INFL EX EX; *DISTR COL DEP HLT, 2005, PAND INFL PREP PLAN; Elliot A J, 2006, Euro Surveill, V11, P249; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Fry CL, 2004, AUST NZ J PUBL HEAL, V28, P13, DOI 10.1111/j.1467-842X.2004.tb00625.x; Goh Lee Gan, 2006, Prim Care Respir J, V15, P222, DOI 10.1016/j.pcrj.2006.04.193; *GREENW TEACH PRIM, 2007, INFL PAND PLAN VERS; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Harris MF, 2007, MED J AUSTRALIA, V187, P104, DOI 10.5694/j.1326-5377.2007.tb01152.x; *HI STAT DEP HLTH, 2007, PAND INFL PREP RESP; Hogg W, 2006, CAN FAM PHYSICIAN, V52, P1255; Hogg W, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-181; *IND STAT DEP HLTH, 2005, PAND INFL PLAN; Kotalik J, 2005, BIOETHICS, V19, P422, DOI 10.1111/j.1467-8519.2005.00453.x; *LA DEP HLTH HOSP, 2006, STAT DRAFT PAND INFL; *LEIC COUNT RUTL P, 2006, PAND INFL CONT PLAN; *MA DEP PUBL HLTH, 2006, INFL PAND PREP PLAN; Meads G, 2006, HEALTH SERV MANAG RE, V19, P166, DOI 10.1258/095148406777888125; Moore Michael G, 2006, N S W Public Health Bull, V17, P135; Moore S, 2007, J EPIDEMIOL COMMUN H, V61, P282, DOI 10.1136/jech.2004.030783; Mosca I, 2006, HEALTH POLICY, V77, P113, DOI 10.1016/j.healthpol.2005.07.011; *N YORKSH YORK PRI, 2006, COMM INF CONTR PAND; Nelson C, 2007, ANNU REV PUBL HEALTH, V28, P1, DOI 10.1146/annurev.publhealth.28.021406.144054; New York State Department of Health, 2006, PAND INFL PLAN; *NSW HLTH, 2005, NSW HLTH INT PAND AC; *ONT MIN HLTH LONG, 2007, ONT HLTH PLAN INFL P; *OR DEP HLTH SERV, 2006, PUBL HLTH PAND INFL; PHILLIPS C, 2006, PANDEMIC INFLUENZA G; Phillips CB, 2007, MED J AUSTRALIA, V186, P355, DOI 10.5694/j.1326-5377.2007.tb00937.x; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; QUARANTELLI EL, MAJOR CRITERIA JUDGI; *RI DEP HLTH, 2006, PAND INFL PLAN; Runyan C W, 1998, Inj Prev, V4, P302; Schoen C, 2006, HEALTH AFFAIR, V25, pW555, DOI 10.1377/hlthaff.25.w555; Seid M, 2007, ANNU REV PUBL HEALTH, V28, P19, DOI 10.1146/annurev.publhealth.28.082206.094104; Seng SL, 2004, ANN ACAD MED SINGAP, V33, P623; Shaw KA, 2006, FAM PRACT, V23, P267, DOI 10.1093/fampra/cml014; *SUFF PRIM CAR TRU, 2007, PAND INFL CONT PLAN; *SURR PRIM CAR TRU, 2007, PAND INFL PLAN EX SU; *TASM DEP HLTH HUM, 2006, TASM HLTH ACT PLAN P; The Public Health Agency of Canada, 2006, CAN PAND INFL PLAN H; *U MINN CTR INF DI, 2007, PROM PRACT PAND PREP; *UK CAB OFF, 2007, UK RES HUM FLU PAND; *UK CAB OFF DEP HL, 2007, RESP PAND INFL ETH F; *UK DEP HLTH, 2007, PAND INFL GUID PRIM; *UK HLTH PROT AG, 2006, PAND INFL CONT PLAN; *UK HLTH PROT AG, 2007, DEP HLTH EX WINT WIL; *US DEP HLTH, 2005, HHS PAND INFL PLAN; *VA DEP HLTH, 2006, VIRG EM OP PLAN ATT; *VANC ISL HLTH AUT, 2006, PAND INFL PLAN; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; WHO, 2005, GLOB INFL PREP PLAN; WHO Interim Protocol, 2007, INT PROT RAP OP CONT; *WILTSH PRIM CAR T, 2007, PAND INFL OP RESP PL; 2006, SINGAPORE PEOPL 0723	78	37	37	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2269	10.1371/journal.pone.0002269	http://dx.doi.org/10.1371/journal.pone.0002269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509538	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500015
J	Akers, KG; Yang, Z; DelVecchio, DP; Reeb, BC; Romeo, RD; McEwen, BS; Tang, AC				Akers, Katherine G.; Yang, Zhen; DelVecchio, Dominic P.; Reeb, Bethany C.; Romeo, Russell D.; McEwen, Bruce S.; Tang, Akaysha C.			Social Competitiveness and Plasticity of Neuroendocrine Function in Old Age: Influence of Neonatal Novelty Exposure and Maternal Care Reliability	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; VISIBLE BURROW SYSTEM; MALE-RATS; SYNAPTIC PLASTICITY; AGGRESSIVE-BEHAVIOR; ALZHEIMERS-DISEASE; WATER COMPETITION; EARLY STIMULATION; FOOD-COMPETITION; BRAIN ASYMMETRY	Early experience is known to have a profound impact on brain and behavioral function later in life. Relatively few studies, however, have examined whether the effects of early experience remain detectable in the aging animal. Here, we examined the effects of neonatal novelty exposure, an early stimulation procedure, on late senescent rats' ability to win in social competition. During the first 3 weeks of life, half of each litter received daily 3-min exposures to a novel environment while the other half stayed in the home cage. At 24 months of age, pairs of rats competed against each other for exclusive access to chocolate rewards. We found that novelty-exposed rats won more rewards than home-staying rats, indicating that early experience exerts a life-long effect on this aspect of social dominance. Furthermore, novelty-exposed but not home-staying rats exhibited habituation of corticosterone release across repeated days of social competition testing, suggesting that early experience permanently enhances plasticity of the stress response system. Finally, we report a surprising finding that across individual rat families, greater effects of neonatal novelty exposure on stress response plasticity were found among families whose dams provided more reliable, instead of a greater total quantity of, maternal care.	[Akers, Katherine G.; Yang, Zhen; DelVecchio, Dominic P.; Reeb, Bethany C.; Tang, Akaysha C.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Tang, Akaysha C.] Univ New Mexico, Dept Neurosci, Albuquerque, NM USA; [Romeo, Russell D.] Barnard Coll, Dept Psychol & Neurosci, Behavior Program, New York, NY USA; [Romeo, Russell D.; McEwen, Bruce S.] Rockefeller Univ, Lab Neuroendocrinol, New York, NY USA	University of New Mexico; University of New Mexico; Rockefeller University	Akers, KG (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	akaysha@unm.edu	Akers, Katherine G./A-4537-2013; He, Robert/L-9441-2013; He, Hongbo/H-1815-2013; McEwen, Bruce/Z-1630-2019	Akers, Katherine G./0000-0002-4578-6575; 				Akers KG, 2006, EUR J NEUROSCI, V24, P547, DOI 10.1111/j.1460-9568.2006.04921.x; ALBERT FW, HORM BEHAV IN PRESS; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Baamonde C, 2002, STRESS, V5, P137, DOI 10.1080/10253890290027903; BAENNINGER LP, 1970, J COMP PHYSIOL PSYCH, P202; BECKER G, 1969, PSYCHON SCI, V15, P27, DOI 10.3758/BF03336179; BENTON D, 1982, AGGRESSIVE BEHAV, V8, P104, DOI 10.1002/1098-2337(1982)8:2<104::AID-AB2480080203>3.0.CO;2-W; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; BHATNAGAR S, 1995, J NEUROENDOCRINOL, V7, P97, DOI 10.1111/j.1365-2826.1995.tb00672.x; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; BRUCE RH, 1941, J COMP PSYCHOL, V31; Castles DL, 1998, ETHOLOGY, V104, P126; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chapillon P, 2002, DEV PSYCHOBIOL, V41, P373, DOI 10.1002/dev.10066; Cole MA, 2000, J NEUROENDOCRINOL, V12, P1034, DOI 10.1046/j.1365-2826.2000.00555.x; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; DALY M, 1973, BRIT J PSYCHOL, V64, P435, DOI 10.1111/j.2044-8295.1973.tb01370.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P1117, DOI 10.1016/0031-9384(90)90361-7; Denenberg VH, 1999, DEV PSYCHOBIOL, V34, P1, DOI 10.1002/(SICI)1098-2302(199901)34:1<1::AID-DEV2>3.0.CO;2-U; Dhabhar FS, 1997, NEUROENDOCRINOLOGY, V65, P360, DOI 10.1159/000127196; DIGBY L, 1995, BEHAV ECOL SOCIOBIOL, V37, P51, DOI 10.1007/BF00173899; DIJKSTRA H, 1992, PHYSIOL BEHAV, V51, P961, DOI 10.1016/0031-9384(92)90078-G; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; DREWS DR, 1977, PSYCHOL REC, V27, P331, DOI 10.1007/BF03394449; Everson-Rose SA, 2003, AM J EPIDEMIOL, V158, P1083, DOI 10.1093/aje/kwg263; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P233, DOI 10.1016/S0091-3057(02)00787-6; FILE SE, 1986, BEHAV BRAIN RES, V21, P195, DOI 10.1016/0166-4328(86)90237-8; FLANNELLY K, 1975, AGGRESSIVE BEHAV, V1, P331, DOI 10.1002/1098-2337(1975)1:4<331::AID-AB2480010406>3.0.CO;2-8; GENTSCH C, 1990, PSYCHOPHARMACOLOGY, V100, P530, DOI 10.1007/BF02244007; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Gonzalez Jatuff AS, 1999, STRESS, V3, P97; GUNNAR MR, 1989, DEV PSYCHOBIOL, V22, P221, DOI 10.1002/dev.420220304; Haller J, 2000, J NEUROENDOCRINOL, V12, P431; JOLY D, 1991, BEHAV PHARMACOL, V2, P205; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Kudielka BM, 2006, BIOL PSYCHOL, V72, P147, DOI 10.1016/j.biopsycho.2005.09.001; LEE MHS, 1974, ANIM BEHAV, V22, P679, DOI 10.1016/S0003-3472(74)80016-3; Lehmann J, 2002, NEUROBIOL AGING, V23, P457, DOI 10.1016/S0197-4580(01)00320-7; Lepley WM, 1937, J EXP PSYCHOL, V21, P194, DOI 10.1037/h0060095; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; LUCION A, 1994, INTEGR PHYS BEH SCI, V29, P415, DOI 10.1007/BF02691361; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2006, HORM BEHAV, V50, P667, DOI 10.1016/j.yhbeh.2006.06.015; Malatynska E, 2002, PHARMACOLOGY, V64, P8, DOI 10.1159/000056145; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MEANEY MJ, 1992, NEUROENDOCRINOLOGY, V55, P204, DOI 10.1159/000126116; MEANEY MJ, 1991, NEUROBIOL AGING, V12, P31, DOI 10.1016/0197-4580(91)90036-J; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEZEI TC, 1960, ARCH GEN PSYCHIAT, V3, P53; Mikics E, 2004, PSYCHONEUROENDOCRINO, V29, P618, DOI 10.1016/S0306-4530(03)00090-8; MITCHELL CL, 1991, BEHAV ECOL SOCIOBIOL, V28, P55, DOI 10.1007/BF00172139; MITCHELL JA, 1987, PHARMACOL BIOCHEM BE, V27, P707, DOI 10.1016/0091-3057(87)90198-5; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Nakazawa M, 2006, NEUROSCI LETT, V408, P119, DOI 10.1016/j.neulet.2006.08.064; NATELSON BH, 1988, PHYSIOL BEHAV, V43, P41, DOI 10.1016/0031-9384(88)90096-0; Neumann ID, 2005, NEUROSCIENCE, V132, P867, DOI 10.1016/j.neuroscience.2005.01.034; Parker KJ, 2006, P NATL ACAD SCI USA, V103, P3000, DOI 10.1073/pnas.0506571103; POPOVA NK, 1972, ANIM BEHAV, V20, P108, DOI 10.1016/S0003-3472(72)80179-9; Pryce CR, 2003, NEUROSCI BIOBEHAV R, V27, P57, DOI 10.1016/S0149-7634(03)00009-5; RAPAPORT PM, 1978, ANIM LEARN BEHAV, V6, P160, DOI 10.3758/BF03209595; Rosenthal Robert, 1984, ESSENTIALS BEHAV RES; ROWELL TE, 1974, BEHAV BIOL, V11, P131, DOI 10.1016/S0091-6773(74)90289-2; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sapolsky RM, 1992, STRESS AGING BRAIN M; SMOTHERMAN WP, 1983, DEV PSYCHOBIOL, V16, P169, DOI 10.1002/dev.420160303; STANTON ME, 1987, DEV PSYCHOBIOL, V20, P131, DOI 10.1002/dev.420200204; Stefanski V, 2001, J NEUROIMMUNOL, V114, P122, DOI 10.1016/S0165-5728(00)00464-1; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; SYME GJ, 1974, ANIM BEHAV, V22, P931, DOI 10.1016/0003-3472(74)90016-5; SYME GJ, 1974, ANIM BEHAV, V22, P486, DOI 10.1016/S0003-3472(74)80048-5; Tamashiro KLK, 2004, PHYSIOL BEHAV, V80, P683, DOI 10.1016/j.physbeh.2003.12.002; Tang AC, 2004, DEV PSYCHOBIOL, V44, P84, DOI 10.1002/dev.10158; Tang AC, 2003, J NEUROSCI, V23, P8254; Tang AC, 2002, HIPPOCAMPUS, V12, P398, DOI 10.1002/hipo.10017; Tang AC, 2001, LEARN MEMORY, V8, P257, DOI 10.1101/lm.43101; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; WILLIAMS DI, 1975, BEHAV BIOL, V13, P505, DOI 10.1016/S0091-6773(75)91149-9; Wilson RS, 2005, NEUROEPIDEMIOLOGY, V25, P8, DOI 10.1159/000085307; WINSLOW C. N., 1940, COMPAR PSYCHOL MONOGR, V15, P1; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008; Zou B, 2001, DEV BRAIN RES, V130, P1, DOI 10.1016/S0165-3806(01)00173-0	86	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2840	10.1371/journal.pone.0002840	http://dx.doi.org/10.1371/journal.pone.0002840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18641792	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300059
J	Cui, YJ; Li, YJ; Gorge, O; Platonov, ME; Yan, YF; Guo, ZB; Pourcel, C; Dentovskaya, SV; Balakhonov, SV; Wang, XY; Song, YJ; Anisimov, AP; Vergnaud, G; Yang, RF				Cui, Yujun; Li, Yanjun; Gorge, Olivier; Platonov, Mikhail E.; Yan, Yanfeng; Guo, Zhaobiao; Pourcel, Christine; Dentovskaya, Svetlana V.; Balakhonov, Sergey V.; Wang, Xiaoyi; Song, Yajun; Anisimov, Andrey P.; Vergnaud, Gilles; Yang, Ruifu			Insight into Microevolution of Yersinia pestis by Clustered Regularly Interspaced Short Palindromic Repeats	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; PLAGUE; IDENTIFICATION; DNA; DIVERSITY; GENETICS; PROVIDES; STRAINS; TOOLS	Background: Yersinia pestis, the pathogen of plague, has greatly influenced human history on a global scale. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR), an element participating in immunity against phages' invasion, is composed of short repeated sequences separated by unique spacers and provides the basis of the spoligotyping technology. In the present research, three CRISPR loci were analyzed in 125 strains of Y. pestis from 26 natural plague foci of China, the former Soviet Union and Mongolia were analyzed, for validating CRISPR-based genotyping method and better understanding adaptive microevolution of Y. pestis. Methodology/Principal Findings: Using PCR amplification, sequencing and online data processing, a high degree of genetic diversity was revealed in all three CRISPR elements. The distribution of spacers and their arrays in Y. pestis strains is strongly region and focus-specific, allowing the construction of a hypothetic evolutionary model of Y. pestis. This model suggests transmission route of microtus strains that encircled Takla Makan Desert and ZhunGer Basin. Starting from Tadjikistan, one branch passed through the Kunlun Mountains, and moved to the Qinghai-Tibet Plateau. Another branch went north via the Pamirs Plateau, the Tianshan Mountains, the Altai Mountains and the Inner Mongolian Plateau. Other Y. pestis lineages might be originated from certain areas along those routes. Conclusions/significance: CRISPR can provide important information for genotyping and evolutionary research of bacteria, which will help to trace the source of outbreaks. The resulting data will make possible the development of very low cost and high-resolution assays for the systematic typing of any new isolate.	[Cui, Yujun; Li, Yanjun; Yan, Yanfeng; Guo, Zhaobiao; Wang, Xiaoyi; Song, Yajun; Yang, Ruifu] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Gorge, Olivier; Pourcel, Christine; Vergnaud, Gilles] Univ Paris Sud 11, Inst Genet Microbiol, CNRS, UMR8621, Orsay, France; [Platonov, Mikhail E.; Dentovskaya, Svetlana V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol, Obolensk, Russia; [Balakhonov, Sergey V.] Antiplague Res Inst Siberia & Far East, Irkutsk, Russia; [Vergnaud, Gilles] DGA, D4S Mission Rech Innovat Sci, Bagneux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cui, YJ (corresponding author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	anisimov@obolensk.org; gilles.vergnaud@u-psud.fr; ruifuyang@gmail.com	Pourcel, Christine/E-4949-2017; Song, Yajun/F-3714-2011; Michael, Platonov/GZG-8615-2022; Vergnaud, Gilles/AAC-1162-2020; Song, Yajun/GQQ-0476-2022; Balakonov, Sergey/AAL-1726-2020; Cui, Yujun/E-7015-2012; Anisimov, Andrey P./H-5257-2012; Anisimov, Andrey P/D-2217-2009; Platonov, Mikhail E/S-1209-2016; Dentovskaya, Svetlana/F-4623-2017; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Song, Yajun/0000-0002-6628-2747; Vergnaud, Gilles/0000-0003-0913-194X; Song, Yajun/0000-0002-6628-2747; Balakonov, Sergey/0000-0003-4201-5828; Anisimov, Andrey P./0000-0002-5499-7999; Anisimov, Andrey P/0000-0002-5499-7999; Dentovskaya, Svetlana/0000-0002-1996-8949; Vergnaud, Gilles/0000-0003-0913-194X; Platonov, Mihail/0000-0003-3946-1755	National Science Fund of China for Distinguished Young Scholars [30525025]; Chinese National 863 Project [2006AA02Z438]; International Science and Technology Center [2426]	National Science Fund of China for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National 863 Project(National High Technology Research and Development Program of China); International Science and Technology Center	This research was founded by the National Science Fund of China for Distinguished Young Scholars (contract no. 30525025), the Chinese National 863 Project (contract no.2006AA02Z438), and the International Science and Technology Center (project no. 2426).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Barrangou R, 2002, APPL ENVIRON MICROB, V68, P2877, DOI 10.1128/AEM.68.6.2877-2884.2002; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Dai EH, 2005, RES MICROBIOL, V156, P785, DOI 10.1016/j.resmic.2005.02.012; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; DEVEAU H, 2007, J BACTERIOL; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Greenfield RA, 2002, AM J MED SCI, V323, P299, DOI 10.1097/00000441-200206000-00003; GRISSA I, 2007, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKM1360; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grygorczuk Sambor, 2002, Medycyna Pracy, V53, P343; GUIYOULE A, 1994, J CLIN MICROBIOL, V32, P634, DOI 10.1128/JCM.32.3.634-641.1994; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hai Rong, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P509; HORVATH P, 2007, J BACTERIOL; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; LUCIER TS, 1992, J BACTERIOL, V174, P2078, DOI 10.1128/JB.174.7.2078-2086.1992; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; SOREK R, 2007, NAT REV MICROBIOL; Tyson K, 1997, ARCH MICROBIOL, V168, P403, DOI 10.1007/s002030050515; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; Wheelis M, 2002, EMERG INFECT DIS, V8, P971, DOI 10.3201/eid0809.010536; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]; Zhou DS, 2004, MICROBES INFECT, V6, P1226, DOI 10.1016/j.micinf.2004.08.002; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	44	120	151	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2652	10.1371/journal.pone.0002652	http://dx.doi.org/10.1371/journal.pone.0002652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612419	gold, Green Published, Green Submitted			2022-12-27	WOS:000264065800054
J	Elemans, CPH; Mead, AF; Rome, LC; Goller, F				Elemans, Coen P. H.; Mead, Andrew F.; Rome, Lawrence C.; Goller, Franz			Superfast Vocal Muscles Control Song Production in Songbirds	PLOS ONE			English	Article							SYRINGEAL MUSCLES; POWER OUTPUT; BIRD; GENERATION; LATERALIZATION; DYNAMICS; PATTERN; DESIGN; SPEED; CODE	Birdsong is a widely used model for vocal learning and human speech, which exhibits high temporal and acoustic diversity. Rapid acoustic modulations are thought to arise from the vocal organ, the syrinx, by passive interactions between the two independent sound generators or intrinsic nonlinear dynamics of sound generating structures. Additionally, direct neuromuscular control could produce such rapid and precisely timed acoustic features if syringeal muscles exhibit rare superfast muscle contractile kinetics. However, no direct evidence exists that avian vocal muscles can produce modulations at such high rates. Here, we show that 1) syringeal muscles are active in phase with sound modulations during song over 200 Hz, 2) direct stimulation of the muscles in situ produces sound modulations at the frequency observed during singing, and that 3) syringeal muscles produce mechanical work at the required frequencies and up to 250 Hz in vitro. The twitch kinematics of these so-called superfast muscles are the fastest measured in any vertebrate muscle. Superfast vocal muscles enable birds to directly control the generation of many observed rapid acoustic changes and to actuate the millisecond precision of neural activity into precise temporal vocal control. Furthermore, birds now join the list of vertebrate classes in which superfast muscle kinetics evolved independently for acoustic communication.	[Elemans, Coen P. H.; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT USA; [Mead, Andrew F.; Rome, Lawrence C.] Univ Penn, Dept Biol, Philadelphia, PA USA; [Rome, Lawrence C.] Marine Biol Lab, Woods Hole, MA USA	Utah System of Higher Education; University of Utah; University of Pennsylvania; Marine Biological Laboratory - Woods Hole	Elemans, CPH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT USA.	coen@biology.sdu.dk		Elemans, Coen/0000-0001-6306-5715	NIH [DC04390, DC06876, AR38404-20, AR46125]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038404, R01AR046125, R29AR038404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876, R01DC004390] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by NIH DC04390 and DC06876 to FG, and NIH AR38404-20 and NIH AR46125 to LCR. The work was also supported by a grant from the Pennsylvania Department of Health to LCR. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Briggs MM, 2000, J EXP BIOL, V203, P2485; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; CLOSE RI, 1974, J PHYSIOL-LONDON, V236, P259, DOI 10.1113/jphysiol.1974.sp010434; Conley KE, 1996, NATURE, V383, P71, DOI 10.1038/383071a0; Elemans CPH, 2006, J EXP BIOL, V209, P965, DOI 10.1242/jeb.02066; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fine ML, 2001, J COMP PHYSIOL A, V187, P371, DOI 10.1007/s003590100209; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GOLLER F, 1995, NATURE, V373, P63, DOI 10.1038/373063a0; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Hoh JFY, 2005, ACTA PHYSIOL SCAND, V183, P133, DOI 10.1111/j.1365-201X.2004.01402.x; JOSEPHSON RK, 1985, J EXP BIOL, V114, P493; Larsen ON, 2002, J EXP BIOL, V205, P25; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Marler P., 2004, NATURES MUSIC SCI BI; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; NOTTEBOHM F, 1972, J EXP ZOOL, V179, P35, DOI 10.1002/jez.1401790104; NOWICKI S, 1986, SCIENCE, V231, P1297, DOI 10.1126/science.3945824; Parmentier E, 2003, P ROY SOC B-BIOL SCI, V270, P2301, DOI 10.1098/rspb.2003.2495; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Rome LC, 1996, P NATL ACAD SCI USA, V93, P8095, DOI 10.1073/pnas.93.15.8095; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0; Syme DA, 2002, INTEGR COMP BIOL, V42, P762, DOI 10.1093/icb/42.4.762; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; Trevisan MA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031908; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Wilden I., 1998, Bioacoustics, V9, P171; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; Young IS, 2001, P ROY SOC B-BIOL SCI, V268, P1965, DOI 10.1098/rspb.2001.1731; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	46	81	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2581	10.1371/journal.pone.0002581	http://dx.doi.org/10.1371/journal.pone.0002581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612467	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800002
J	Hiroi, M; Tanimura, T; Marion-Poll, F				Hiroi, Makoto; Tanimura, Teiichi; Marion-Poll, Frederic			Hedonic Taste in Drosophila Revealed by Olfactory Receptors Expressed in Taste Neurons	PLOS ONE			English	Article								Taste and olfaction are each tuned to a unique set of chemicals in the outside world, and their corresponding sensory spaces are mapped in different areas in the brain. This dichotomy matches categories of receptors detecting molecules either in the gaseous or in the liquid phase in terrestrial animals. However, in Drosophila olfactory and gustatory neurons express receptors which belong to the same family of 7-transmembrane domain proteins. Striking overlaps exist in their sequence structure and in their expression pattern, suggesting that there might be some functional commonalities between them. In this work, we tested the assumption that Drosophila olfactory receptor proteins are compatible with taste neurons by ectopically expressing an olfactory receptor (OR22a and OR83b) for which ligands are known. Using electrophysiological recordings, we show that the transformed taste neurons are excited by odor ligands as by their cognate tastants. The wiring of these neurons to the brain seems unchanged and no additional connections to the antennal lobe were detected. The odor ligands detected by the olfactory receptor acquire a new hedonic value, inducing appetitive or aversive behaviors depending on the categories of taste neurons in which they are expressed i.e. sugar- or bitter-sensing cells expressing either Gr5a or Gr66a receptors. Taste neurons expressing ectopic olfactory receptors can sense odors at close range either in the aerial phase or by contact, in a lipophilic phase. The responses of the transformed taste neurons to the odorant are similar to those obtained with tastants. The hedonic value attributed to tastants is directly linked to the taste neurons in which their receptors are expressed.	[Hiroi, Makoto; Marion-Poll, Frederic] AgroParisTech, UPMC, INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France; [Hiroi, Makoto; Tanimura, Teiichi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka, Japan	AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Kyushu University	Hiroi, M (corresponding author), AgroParisTech, UPMC, INRA, UMR Physiol Insecte Signalisat & Commun 1272, Versailles, France.	marion@versailles.inra.fr	Hiroi, Makoto/B-6834-2008; Frederic, Marion-Poll/I-1358-2019	Hiroi, Makoto/0000-0002-0136-5891; Frederic, Marion-Poll/0000-0001-6824-0180	French Ministry of Foreign Affairs; JSPS-INRA, under the Japan-France Research Cooperative Program; Ministry of Education, Culture, Sports and Technology of Japan; Direction Generale de l'Enseignement et de la Recherche of France	French Ministry of Foreign Affairs; JSPS-INRA, under the Japan-France Research Cooperative Program; Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direction Generale de l'Enseignement et de la Recherche of France	This work was supported by a grant from the French Ministry of Foreign Affairs to F.M.P. and to M.H., by a joint JSPS-INRA grant under the Japan-France Research Cooperative Program (T.T. and F.M.P.), by a grant from the Ministry of Education, Culture, Sports and Technology of Japan to T.T., and by a grant from the Direction Generale de l'Enseignement et de la Recherche of France to F.M.P.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; Ahamed A, 2001, CHEM SENSES, V26, P507, DOI 10.1093/chemse/26.5.507; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; del Campo ML, 2001, NATURE, V411, P186, DOI 10.1038/35075559; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; EIGENBRODE SD, 1995, ANNU REV ENTOMOL, V40, P171, DOI 10.1146/annurev.en.40.010195.001131; FALK R, 1975, NATURE, V254, P325, DOI 10.1038/254325a0; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galindo K, 2001, GENETICS, V159, P1059; Glendinning JI, 2001, J NEUROSCI, V21, P3688, DOI 10.1523/JNEUROSCI.21-10-03688.2001; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; HODGSON ES, 1954, ANAT REC, V120, P718; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Koganezawa M, 2002, CHEM SENSES, V27, P319, DOI 10.1093/chemse/27.4.319; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MITCHELL BK, 1994, J CHEM ECOL, V20, P753, DOI 10.1007/BF02059611; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; Ozaki M, 2003, CHEM SENSES, V28, P349, DOI 10.1093/chemse/28.4.349; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rogers SM, 2003, ADV INSECT PHYSIOL, V31, P141, DOI 10.1016/S0065-2806(03)31003-3; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; Silverman J, 1998, J INSECT BEHAV, V11, P93, DOI 10.1023/A:1020870601137; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; STADLER E, 1975, J COMP PHYSIOL, V104, P97; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tsuchihara K, 2005, CHEM SENSES, V30, P559, DOI 10.1093/chemse/bji049; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	67	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2610	10.1371/journal.pone.0002610	http://dx.doi.org/10.1371/journal.pone.0002610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612414	Green Published, gold			2022-12-27	WOS:000264065800016
J	Hooper, SD; Raes, J; Foerstner, KU; Harrington, ED; Dalevi, D; Bork, P				Hooper, Sean D.; Raes, Jeroen; Foerstner, Konrad U.; Harrington, Eoghan D.; Dalevi, Daniel; Bork, Peer			A Molecular Study of Microbe Transfer between Distant Environments	PLOS ONE			English	Article								Background: Environments and their organic content are generally not static and isolated, but in a constant state of exchange and interaction with each other. Through physical or biological processes, organisms, especially microbes, may be transferred between environments whose characteristics may be quite different. The transferred microbes may not survive in their new environment, but their DNA will be deposited. In this study, we compare two environmental sequencing projects to find molecular evidence of transfer of microbes over vast geographical distances. Methodology: By studying synonymous nucleotide composition, oligomer frequency and orthology between predicted genes in metagenomics data from two environments, terrestrial and aquatic, and by correlating with phylogenetic mappings, we find that both environments are likely to contain trace amounts of microbes which have been far removed from their original habitat. We also suggest a bias in direction from soil to sea, which is consistent with the cycles of planetary wind and water. Conclusions: Our findings support the Baas-Becking hypothesis formulated in 1934, which states that due to dispersion and population sizes, microbes are likely to be found in widely disparate environments. Furthermore, the availability of genetic material from distant environments is a possible font of novel gene functions for lateral gene transfer.	[Hooper, Sean D.] DOE JGI, Walnut Creek, CA USA; [Raes, Jeroen; Foerstner, Konrad U.; Harrington, Eoghan D.; Bork, Peer] EMBL, Heidelberg, Germany; [Dalevi, Daniel] Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA USA	United States Department of Energy (DOE); European Molecular Biology Laboratory (EMBL); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Hooper, SD (corresponding author), DOE JGI, Walnut Creek, CA USA.	bork@embl.de	Bork, Peer/F-1813-2013; Förstner, Konrad U./B-1531-2010; raes, jeroen/D-7835-2018	Bork, Peer/0000-0002-2627-833X; Förstner, Konrad U./0000-0002-1481-2996; raes, jeroen/0000-0002-1337-041X	EU 6th Framework Programme [LSHG-CT-2004-503567, LSHG-CT-2003-503265]	EU 6th Framework Programme(European Commission)	This work was supported by the EU 6th Framework Programme, Contract Nrs LSHG-CT-2004-503567 (GeneFun) and LSHG-CT-2003-503265 (BioSapiens). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAASBECKINGL, 1934, GEOBIOLOGIE INLEIDIN; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Dalevi D, 2006, BIOINFORMATICS, V22, P517, DOI 10.1093/bioinformatics/btk029; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Dufraigne C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni004; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Hooper SD, 2002, J MOL EVOL, V54, P365, DOI 10.1007/s00239-001-0051-8; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; KARLIN S, 1995, TRENDS GENET, V11, P283; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; OHNO S, 1988, P NATL ACAD SCI USA, V85, P9630, DOI 10.1073/pnas.85.24.9630; Powell B, 2005, MAR POLLUT BULL, V51, P149, DOI 10.1016/j.marpolbul.2004.10.047; Raes J, 2007, CURR OPIN MICROBIOL, V10, P490, DOI 10.1016/j.mib.2007.09.001; Shinn EA, 2003, ARCH ENVIRON HEALTH, V58, P498; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-163; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	32	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2607	10.1371/journal.pone.0002607	http://dx.doi.org/10.1371/journal.pone.0002607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612393	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000264065800013
J	Carwardine, J; Wilson, KA; Watts, M; Etter, A; Klein, CJ; Possingham, HP				Carwardine, Josie; Wilson, Kerrie A.; Watts, Matt; Etter, Andres; Klein, Carissa J.; Possingham, Hugh P.			Avoiding Costly Conservation Mistakes: The Importance of Defining Actions and Costs in Spatial Priority Setting	PLOS ONE			English	Article							CAPE FLORISTIC REGION; BIODIVERSITY HOTSPOT; OPPORTUNITY COSTS; AREAS; IRREPLACEABILITY; PRIORITIZATION; DISTRIBUTIONS; VULNERABILITY; SELECTION; DESIGN	Background: The typical mandate in conservation planning is to identify areas that represent biodiversity targets within the smallest possible area of land or sea, despite the fact that area may be a poor surrogate for the cost of many conservation actions. It is also common for priorities for conservation investment to be identified without regard to the particular conservation action that will be implemented. This demonstrates inadequate problem specification and may lead to inefficiency: the cost of alternative conservation actions can differ throughout a landscape, and may result in dissimilar conservation priorities. Methodology/Principal Findings: We investigate the importance of formulating conservation planning problems with objectives and cost data that relate to specific conservation actions. We identify priority areas in Australia for two alternative conservation actions: land acquisition and stewardship. Our analyses show that using the cost surrogate that most closely reflects the planned conservation action can cut the cost of achieving our biodiversity goals by half. We highlight spatial differences in relative priorities for land acquisition and stewardship in Australia, and provide a simple approach for determining which action should be undertaken where. Conclusions/Significance: Our study shows that a poorly posed conservation problem that fails to pre-specify the planned conservation action and incorporate cost a priori can lead to expensive mistakes. We can be more efficient in achieving conservation goals by clearly specifying our conservation objective and parameterising the problem with economic data that reflects this objective.	[Carwardine, Josie; Wilson, Kerrie A.; Watts, Matt; Etter, Andres; Klein, Carissa J.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Etter, Andres] Javeriana Univ, Fac Env & Rural Studies, Dept Territorial Processes & Human Settlements, Bogota, Colombia	University of Queensland; Pontificia Universidad Javeriana	Carwardine, J (corresponding author), Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	j.carwardine@uq.edu.au	Klein, Carissa J/F-1632-2011; Wilson, Kerrie A/C-8058-2009; Possingham, Hugh/B-1337-2008; Etter, Andrés/E-1860-2011; POSSINGHAM, HUGH/R-8310-2019; Wilson, Kerrie/W-4181-2019; Carwardine, Josie/A-5801-2011	Klein, Carissa J/0000-0002-6299-6451; Wilson, Kerrie A/0000-0002-0092-935X; Possingham, Hugh/0000-0001-7755-996X; Etter, Andrés/0000-0003-0665-9300; POSSINGHAM, HUGH/0000-0001-7755-996X; Wilson, Kerrie/0000-0002-0092-935X; Watts, Matthew/0000-0002-9094-1335	Australian Government; Department of Environment and Water Resources; CSRIO Australia; Australian Research Council; AEDA Commonwealth Environmental Research Facility	Australian Government(Australian GovernmentCGIAR); Department of Environment and Water Resources; CSRIO Australia; Australian Research Council(Australian Research Council); AEDA Commonwealth Environmental Research Facility	This work was supported by the Australian Government, Department of Environment and Water Resources (JC, KAW, MW, AE, CJK, HPP), CSRIO Australia (JC), the Australian Research Council (KAW, HPP) and the AEDA Commonwealth Environmental Research Facility (KAW, MW, CJP, HPP).	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Araujo MB, 2002, P ROY SOC B-BIOL SCI, V269, P1971, DOI 10.1098/rspb.2002.2121; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; *AUSTR BUR AGR RES, 2000, LAND VAL BROAD FARMS; *AUSTR BUR AGR RES, 2006, COST PRIC IND MULT; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; *BIRDS AUSTR, 2005, ATL AUSTR BIRDS; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Carwardine J, 2007, BIODIVERS CONSERV, V16, P245, DOI 10.1007/s10531-006-9055-4; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Chomitz KM, 2005, ENVIRON DEV ECON, V10, P293, DOI 10.1017/S1355770X05002081; Church R., 1974, PAP REG SCI ASS, V32, P101, DOI DOI 10.1007/BF01942293; *COMM AUSTR BUR RU, 2003, INT VEG COV VERS 1; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; Davis FW, 2006, ECOL SOC, V11; *DEP ENV WAT RES, 1999, DAT SPEC NAT ENV SIG; *DEP ENV WAT RES, 2005, AUSTR BIOG REG; *EX STEER COMM AUS, 2001, NAT VEG INF SYST NVI; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; Groom M.J., 2006, PRINCIPLES CONSERVAT; Hajkowicz S, 2005, ENVIRON MODELL SOFTW, V20, P1251, DOI 10.1016/j.envsoft.2004.08.009; HAJKOWICZ SA, 2002, VALUE RETURNS COSTS, P230; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Jacobi SK, 2007, ENVIRON MODEL ASSESS, V12, P91, DOI 10.1007/s10666-006-9046-6; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Naidoo R, 2006, CONSERV BIOL, V20, P490, DOI 10.1111/j.1523-1739.2006.00304.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Odling-Smee L, 2005, NATURE, V437, P614, DOI 10.1038/437614a; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Polasky S, 2001, LAND ECON, V77, P68, DOI 10.2307/3146981; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Possingham H. P., 2006, PRINCIPLES CONSERVAT, V3rd, P507, DOI DOI 10.1023/A:1006601319528; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham HP, 2007, CONSERV SCI PRACT, V1, P546, DOI 10.1002/9780470692400.ch45; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Pressey RL, 2001, BIOL CONSERV, V100, P355, DOI 10.1016/S0006-3207(01)00039-8; PRESSEY RL, 2002, PROG PHYS GEOGR, V26, P434; Reyers B, 2004, BIOL CONSERV, V118, P521, DOI 10.1016/j.biocon.2003.09.027; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Rissman AR, 2007, CONSERV BIOL, V21, P709, DOI 10.1111/j.1523-1739.2007.00660.x; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	55	132	134	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2586	10.1371/journal.pone.0002586	http://dx.doi.org/10.1371/journal.pone.0002586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596914	Green Submitted, Green Published, gold			2022-12-27	WOS:000263288200045
J	Doering, CJ; Rehak, R; Bonfield, S; Peloquin, JB; Stell, WK; Mema, SC; Sauve, Y; McRory, JE				Doering, Clinton J.; Rehak, Renata; Bonfield, Stephan; Peloquin, Jean B.; Stell, William K.; Mema, Silvina C.; Sauve, Yves; McRory, John E.			Modified Ca(v)1.4 Expression in the Cacna1f(nob2) Mouse Due to Alternative Splicing of an ETn Inserted in Exon 2	PLOS ONE			English	Article								The Cacna1f(nob2) mouse is reported to be a naturally occurring null mutation for the Ca(v)1.4 calcium channel gene and the phenotype of this mouse is not identical to that of the targeted gene knockout model. We found two mRNA species in the Cacna1f(nob2) mouse: approximately 90% of the mRNA represents a transcript with an in-frame stop codon within exon 2 of CACNA1F, while approximately 10% of the mRNA represents a transcript in which alternative splicing within the ETn element has removed the stop codon. This latter mRNA codes for full length Ca(v)1.4 protein, detectable by Western blot analysis that is predicted to differ from wild type Ca(v)1.4 protein in a region of approximately 22 amino acids in the N-terminal portion of the protein. Electrophysiological analysis with either mouse Ca(v)1.4(wt) or Ca(v)1.4(nob2) cDNA revealed that the alternatively spliced protein does not differ from wild type with respect to activation and inactivation characteristics; however, while the wild type N-terminus interacted with filamin proteins in a biochemical pull-down experiment, the alternatively spliced N-terminus did not. The Cacna1f(nob2) mouse electroretinogram displayed reduced b-wave and oscillatory potential amplitudes, and the retina was morphologically disorganized, with substantial reduction in thickness of the outer plexiform layer and sprouting of bipolar cell dendrites ectopically into the outer nuclear layer. Nevertheless, the spatial contrast sensitivity (optokinetic response) of Cacna1f(nob2) mice was generally similar to that of wild type mice. These results suggest the Cacna1f(nob2) mouse is not a CACNA1F knockout model. Rather, alternative splicing within the ETn element can lead to full-length Ca(v)1.4 protein, albeit at reduced levels, and the functional Ca(v)1.4 mutant may be incapable of interacting with cytoskeletal filamin proteins. These changes, do not alter the ability of the Cacna1f(nob2) mouse to detect and follow moving sine-wave gratings compared to their wild type counterparts.	[Doering, Clinton J.; Rehak, Renata; Peloquin, Jean B.; Stell, William K.; McRory, John E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Bonfield, Stephan; Stell, William K.] Univ Calgary, Cell Biol & Anat Surg, Calgary, AB, Canada; [Doering, Clinton J.; Bonfield, Stephan; Peloquin, Jean B.; Stell, William K.; McRory, John E.] Univ Calgary, Lions Ctr Retinal Degenerat Res, Calgary, AB, Canada; [Mema, Silvina C.; Sauve, Yves] Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta	Doering, CJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	McRoryj@ucalgary.ca	Mema, Silvina/J-5416-2019	Mema, Silvina/0000-0001-5895-9159	AHFMR [Studentships]; NSERC CGS [Discovery Grant]; University of Calgary [Killam Fellowship]; Lions Sight Centre Fund (University of Calgary); Canadian Institutes of Health Research [151145]; Alberta Heritage Foundation for Medical Research; Canadian National Institute for the Blind (CNIB); The Lena McLaughlin Foundation; Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration; Foundation Fighting Blindness	AHFMR(Alberta Heritage Foundation for Medical Research); NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary; Lions Sight Centre Fund (University of Calgary); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian National Institute for the Blind (CNIB); The Lena McLaughlin Foundation; Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration; Foundation Fighting Blindness(European Commission)	CJD and RR are supported by Studentships from AHFMR. CJD is also supported by NSERC CGS, and a Killam Fellowship from the University of Calgary. WKS and SB are supported by a Discovery Grant from NSERC to WKS, and the OptoMotry system was purchased with a grant from the Lions Sight Centre Fund (University of Calgary) to WKS. YS is supported by a Canadian Institutes of Health Research Grant (151145), an Alberta Heritage Foundation for Medical Research equipment grant, and grants from the Canadian National Institute for the Blind (CNIB) and The Lena McLaughlin Foundation (Mona & Rod McLennan); he is a recipient of the Barbara Tuck/MacPhee Family Vision Research Award in Macular Degeneration. SCM was supported by the Foundation Fighting Blindness Canada. JEM is supported by an Operating Grant from CIHR.	Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BONFIELD S, 2007, SPATIOTEMPORAL CONTR; Boycott KM, 2000, CAN J OPHTHALMOL, V35, P204, DOI 10.1016/S0008-4182(00)80031-9; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Doering CJ, 2007, CHANNELS, V1; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ekinci FJ, 1999, J BIOL CHEM, V274, P30322, DOI 10.1074/jbc.274.42.30322; GEORGIEV GP, 1984, EUR J BIOCHEM, V145, P203, DOI 10.1111/j.1432-1033.1984.tb08541.x; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Herrera R, 1998, EXP CELL RES, V238, P407, DOI 10.1006/excr.1997.3847; Hoda JC, 2006, J NEUROCHEM, V96, P1648, DOI 10.1111/j.1471-4159.2006.03678.x; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Hope CI, 2005, CLIN EXP OPHTHALMOL, V33, P129, DOI 10.1111/j.1442-9071.2005.00987.x; Jacobi FK, 2003, AM J OPHTHALMOL, V135, P733, DOI 10.1016/S0002-9394(02)02109-8; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Jalkanen R, 2007, INVEST OPHTH VIS SCI, V48, P2498, DOI 10.1167/iovs.06-1103; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Nakamura M, 2001, INVEST OPHTH VIS SCI, V42, P1610; Nusinowitz S, 2003, EXP EYE RES, V77, P627, DOI 10.1016/S0014-4835(03)00217-3; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Peloquin JB, 2007, NEUROSCIENCE, V150, P335, DOI 10.1016/j.neuroscience.2007.09.021; Petrecca K, 2000, J NEUROSCI, V20, P8736; PRAT AG, 1995, AM J PHYSIOL-CELL PH, V268, pC1552, DOI 10.1152/ajpcell.1995.268.6.C1552; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Schmidt H, 2000, J NEUROCHEM, V74, P414, DOI 10.1046/j.1471-4159.2000.0740414.x; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; SONIGO P, 1987, P NATL ACAD SCI USA, V84, P3768, DOI 10.1073/pnas.84.11.3768; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; TREMBLAY F, 1995, VISION RES, V35, P2383, DOI 10.1016/0042-6989(95)00006-L; Umeda T, 2001, J BIOCHEM, V130, P535, DOI 10.1093/oxfordjournals.jbchem.a003016; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; YU M, 2007, DOC OPHTHALMOL; Zeitz C, 2005, MOL VIS, V11, P179; Zito I, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9106	54	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2538	10.1371/journal.pone.0002538	http://dx.doi.org/10.1371/journal.pone.0002538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596967	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288200010
J	Ortega-Gutierrez, S; Leung, D; Ficarro, S; Peters, EC; Cravatt, BF				Ortega-Gutierrez, Silvia; Leung, Donmienne; Ficarro, Scott; Peters, Eric C.; Cravatt, Benjamin F.			Targeted Disruption of the PME-1 Gene Causes Loss of Demethylated PP2A and Perinatal Lethality in Mice	PLOS ONE			English	Article								Background: Phosphoprotein phosphatase 2A (PP2A), a major serine-threonine protein phosphatase in eukaryotes, is an oligomeric protein comprised of structural (A) and catalytic (C) subunits to which a variable regulatory subunit (B) can associate. The C subunit contains a methyl ester post-translational modification on its C-terminal leucine residue, which is removed by a specific methylesterase (PME-1). Methylesterification is thought to control the binding of different B subunits to AC dimers, but little is known about its physiological significance in vivo. Methodology/Principal Findings: Here, we show that targeted disruption of the PME-1 gene causes perinatal lethality in mice, a phenotype that correlates with a virtually complete loss of the demethylated form of PP2A in the nervous system and peripheral tissues. Interestingly, PP2A catalytic activity over a peptide substrate was dramatically reduced in PME-1(-/-) tissues, which also displayed alterations in phosphoproteome content. Conclusions: These findings suggest a role for the demethylated form of PP2A in maintenance of enzyme function and phosphorylation networks in vivo.	[Ortega-Gutierrez, Silvia; Leung, Donmienne; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Ortega-Gutierrez, Silvia; Leung, Donmienne; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA USA; [Ficarro, Scott; Peters, Eric C.] Genom Inst Novartis Fdn, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Novartis	Ortega-Gutierrez, S (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Ortega-Gutierrez, Silvia/ABC-7653-2021; Ortega-Gutierrez, Silvia/I-1935-2017; Peters, Eric/W-2739-2019	Ortega-Gutierrez, Silvia/0000-0002-0257-6754; 	National Institutes of Health [DA015197]; The Skaggs Institute for Chemical Biology; Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents; Fulbright Scholar program and the Spanish Ministry of Science and Education; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Skaggs Institute for Chemical Biology; Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents; Fulbright Scholar program and the Spanish Ministry of Science and Education; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants (DA015197; B.F.C.), The Skaggs Institute for Chemical Biology, the Helen L. Dorris Institute for the Study of Neurological and Psychiatric Disorders of Children and Adolescents and the Fulbright Scholar program and the Spanish Ministry of Science and Education (S.O.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAYLA X, 1994, J BIOL CHEM, V269, P15668; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gong CX, 2003, NEUROSCI LETT, V340, P107, DOI 10.1016/S0304-3940(03)00096-X; Gual P, 2001, ONCOGENE, V20, P156, DOI 10.1038/sj.onc.1204047; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Leulliot N, 2004, J BIOL CHEM, V279, P8351, DOI 10.1074/jbc.M311484200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Maiti T, 1997, J BIOL CHEM, V272, P18333, DOI 10.1074/jbc.272.29.18333; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Maton G, 2005, J CELL SCI, V118, P2485, DOI 10.1242/jcs.02370; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Oliver Carey J., 1998, Frontiers in Bioscience, V3, pD961; Ramakers GMJ, 2000, J BIOL CHEM, V275, P28682, DOI 10.1074/jbc.M003068200; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; ULLOA L, 1993, FEBS LETT, V330, P85, DOI 10.1016/0014-5793(93)80925-K; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; WEI GQ, 2001, P SOC PHOTO-OPT INS, V2, P1570; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu T, 1997, ARCH BIOCHEM BIOPHYS, V339, P210, DOI 10.1006/abbi.1996.9835	56	34	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2486	10.1371/journal.pone.0002486	http://dx.doi.org/10.1371/journal.pone.0002486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596935	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200001
J	Rodriguez-Feo, JA; Hellings, WE; Moll, FL; De Vries, JPPM; van Middelaar, BJ; Algra, A; Sluijter, J; Velema, E; van der Broek, T; Sessa, WC; De Kleijn, DPV; Pasterkamp, G				Rodriguez-Feo, Juan A.; Hellings, Willem E.; Moll, Frans L.; De Vries, Jean-Paul P. M.; van Middelaar, Ben J.; Algra, Ale; Sluijter, Joost; Velema, Evelyn; van der Broek, Theo; Sessa, William C.; De Kleijn, Dominique P. V.; Pasterkamp, Gerard			Caveolin-1 Influences Vascular Protease Activity and Is a Potential Stabilizing Factor in Human Atherosclerotic Disease	PLOS ONE			English	Article								Caveolin-1 (Cav-1) is a regulatory protein of the arterial wall, but its role in human atherosclerosis remains unknown. We have studied the relationships between Cav-1 abundance, atherosclerotic plaque characteristics and clinical manisfestations of atherosclerotic disease. We determined Cav-1 expression by western blotting in atherosclerotic plaques harvested from 378 subjects that underwent carotid endarterectomy. Cav-1 levels were significantly lower in carotid plaques than non-atherosclerotic vascular specimens. Low Cav-1 expression was associated with features of plaque instability such as large lipid core, thrombus formation, macrophage infiltration, high IL-6, IL-8 levels and elevated MMP-9 activity. Clinically, a downregulation of Cav-1 was observed in plaques obtained from men, patients with a history of myocardial infarction and restenotic lesions. Cav-1 levels above the median were associated with absence of new vascular events within 30 days after surgery [0% vs. 4%] and a trend towards lower incidence of new cardiovascular events during longer follow-up. Consistent with these clinical data, Cav-1 null mice revealed elevated intimal hyperplasia response following arterial injury that was significantly attenuated after MMP inhibition. Recombinant peptides mimicking Cav-1 scaffolding domain (Cavtratin) reduced gelatinase activity in cultured porcine arteries and impaired MMP-9 activity and COX-2 in LPS-challenged macrophages. Administration of Cavtratin strongly impaired flow-induced expansive remodeling in mice. This is the first study that identifies Cav-1 as a novel potential stabilizing factor in human atherosclerosis. Our findings support the hypothesis that local down-regulation of Cav-1 in atherosclerotic lesions contributes to plaque formation and/or instability accelerating the occurrence of adverse clinical outcomes. Therefore, given the large number of patients studied, we believe that Cav-1 may be considered as a novel target in the prevention of human atherosclerotic disease and the loss of Cav-1 may be a novel biomarker of vulnerable plaque with prognostic value.	[Rodriguez-Feo, Juan A.; van Middelaar, Ben J.; Sluijter, Joost; Velema, Evelyn; van der Broek, Theo; De Kleijn, Dominique P. V.; Pasterkamp, Gerard] Univ Med Ctr, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands; [Hellings, Willem E.; Moll, Frans L.] Univ Med Ctr, Dept Vasc Surg, Utrecht, Netherlands; [De Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Algra, Ale] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Algra, Ale] UMC Utrecht, Rudolf Magnus Inst, Dept Neurol, Utrecht, Netherlands; [Sessa, William C.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT USA; [De Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Yale University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Rodriguez-Feo, JA (corresponding author), Univ Med Ctr, Dept Cardiol, Expt Cardiol Lab, Utrecht, Netherlands.	g.pasterkamp@umcutrecht.nl	, van den Broek T/I-9651-2019; Sessa, William C/B-6844-2011	, van den Broek T/0000-0002-2781-5731; Sessa, William C/0000-0001-5759-1938; Sluijter, Joost/0000-0003-2088-9102	Netherlands Organization for Scientific Research [902-16-239, 902-26-213, 902-16-222]; Netherlands Heart Foundation [99-209]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation)	Netherlands Organization for Scientific Research grants 902-16-239, 902-26-213 and 902-16-222; Netherlands heart Foundation grant 99-209	Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Chow AK, 2007, J MOL CELL CARDIOL, V42, P896, DOI 10.1016/j.yjmcc.2007.01.008; de Kleijn DPV, 2001, FEBS LETT, V501, P37, DOI 10.1016/S0014-5793(01)02622-9; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Frank PG, 2004, CURR OPIN LIPIDOL, V15, P523, DOI 10.1097/00041433-200410000-00005; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GOLUB LM, 1987, J DENT RES, V66, P1310, DOI 10.1177/00220345870660080401; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Halliday A, 2004, LANCET, V363, P1491; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Hellings WE, 2007, TRENDS CARDIOVAS MED, V17, P162, DOI 10.1016/j.tcm.2007.03.006; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Jasmin JF, 2006, CIRCULATION, V114, P912, DOI 10.1161/CIRCULATIONAHA.106.634709; Karwowski JK, 1999, J SURG RES, V87, P122, DOI 10.1006/jsre.1999.5707; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; North American Symptomatic Carotid Endarterectomy Trial Collaborators, 1991, N ENGL J MED, V325, P445; Pasterkamp G, 2004, ARTERIOSCL THROM VAS, V24, P650, DOI 10.1161/01.ATV.0000120376.09047.fe; Rothwell PM, 2000, LANCET, V355, P19, DOI 10.1016/S0140-6736(99)04470-0; Schwencke C, 2005, CARDIOVASC RES, V68, P128, DOI 10.1016/j.cardiores.2005.05.004; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Smits PC, 1999, HEART, V82, P461, DOI 10.1136/hrt.82.4.461; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Verhoeven B, 2005, J VASC SURG, V42, P1075, DOI 10.1016/j.jvs.2005.08.009; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Watanabe T, 2004, LIFE SCI, V75, P1219, DOI 10.1016/j.lfs.2004.03.004; 1998, LANCET, V351, P1379	38	34	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2612	10.1371/journal.pone.0002612	http://dx.doi.org/10.1371/journal.pone.0002612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596970	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200061
J	Yu, K; Wang, ZM; Li, QZ; Wacholder, S; Hunter, DJ; Hoover, RN; Chanock, S; Thomas, G				Yu, Kai; Wang, Zhaoming; Li, Qizhai; Wacholder, Sholom; Hunter, David J.; Hoover, Robert N.; Chanock, Stephen; Thomas, Gilles			Population Substructure and Control Selection in Genome-Wide Association Studies	PLOS ONE			English	Article								Determination of the relevance of both demanding classical epidemiologic criteria for control selection and robust handling of population stratification ( PS) represents a major challenge in the design and analysis of genome-wide association studies (GWAS). Empirical data from two GWAS in European Americans of the Cancer Genetic Markers of Susceptibility (CGEMS) project were used to evaluate the impact of PS in studies with different control selection strategies. In each of the two original case-control studies nested in corresponding prospective cohorts, a minor confounding effect due to PS ( inflation factor lambda of 1.025 and 1.005) was observed. In contrast, when the control groups were exchanged to mimic a cost-effective but theoretically less desirable control selection strategy, the confounding effects were larger (lambda of 1.090 and 1.062). A panel of 12,898 autosomal SNPs common to both the Illumina and Affymetrix commercial platforms and with low local background linkage disequilibrium (pair-wise r(2)< 0.004) was selected to infer population substructure with principal component analysis. A novel permutation procedure was developed for the correction of PS that identified a smaller set of principal components and achieved a better control of type I error (to lambda of 1.032 and 1.006, respectively) than currently used methods. The overlap between sets of SNPs in the bottom 5% of p-values based on the new test and the test without PS correction was about 80%, with the majority of discordant SNPs having both ranks close to the threshold. Thus, for the CGEMS GWAS of prostate and breast cancer conducted in European Americans, PS does not appear to be a major problem in well-designed studies. A study using suboptimal controls can have acceptable type I error when an effective strategy for the correction of PS is employed.	[Yu, Kai; Wang, Zhaoming; Li, Qizhai; Wacholder, Sholom; Hunter, David J.; Hoover, Robert N.; Chanock, Stephen; Thomas, Gilles] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Wang, Zhaoming] Natl Canc Inst Frederick, SAIC Frederick Inc, Advanced Technol Program, Core Genotyping Facility, Frederick, MD USA; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Hunter, David J.] Harvard Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Harvard University; Harvard T.H. Chan School of Public Health	Yu, K (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yuka@mail.nih.gov	Wang, Zhaoming/R-5527-2018	Wang, Zhaoming/0000-0001-7556-3869	Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS [N01-CO-12400]; US NIH [CA65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; NATIONAL CANCER INSTITUTE [Z01CP010181] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. The Nurses' Health Studies (NHS) are supported by US NIH grants CA65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; COX DR, 1982, BIOMETRICS, V38, P541, DOI 10.2307/2530040; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hunter DJ, 2007, CANCER CAUSE CONTROL, V18, P479, DOI 10.1007/s10552-007-0118-y; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; KRUSKAL WILLIAM H., 1952, JOUR AMER STATIST ASSOC, V47, P583, DOI 10.2307/2280779; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P885; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	35	94	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2551	10.1371/journal.pone.0002551	http://dx.doi.org/10.1371/journal.pone.0002551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596976	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200019
J	Hensler, ME; Miyamoto, S; Nizet, V				Hensler, Mary E.; Miyamoto, Shigeki; Nizet, Victor			Group B Streptococcal beta-Hemolysin/Cytolysin Directly Impairs Cardiomyocyte Viability and Function	PLOS ONE			English	Article							CORONARY VASOCONSTRICTION; MYOCARDIAL-CONTRACTILITY; HEMOLYSIN; SEPSIS; AGALACTIAE; INFECTION; INJURY; ENDOCARDITIS; PATHOGENESIS; DYSFUNCTION	Background: Group B Streptococcus (GBS) is a leading cause of neonatal sepsis where myocardial dysfunction is an important contributor to poor outcome. Here we study the effects of the GBS pore-forming beta-hemolysin/cytolysin (Bh/c) exotoxin on cardiomyocyte viability, contractility, and calcium transients. Methodology/Principal Findings: HL-1 cardiomyocytes exposed to intact wild-type (WT) or isogenic Delta beta h/c mutant GBS, or to cell-free extracts from either strain, were assessed for viability by trypan blue exclusion and for apoptosis by TUNEL staining. Functionality of exposed cardiomyocytes was analyzed by visual quantitation of the rate and extent of contractility. Mitochondrial membrane polarization was measured in TMRE-loaded cells exposed to GBS beta h/c. Effects of GBS beta h/c on calcium transients were studied in fura-2AM-loaded primary rat ventricular cardiomyocytes. Exposure of HL-1 cardiomyocytes to either WT GBS or beta h/c extracts significantly reduced both rate and extent of contractility and later induced necrotic and apoptotic cell death. No effects on cardiomyocyte viability or function were observed after treatment with Delta beta h/c mutant bacteria or extracts. The beta h/c toxin was associated with complete and rapid loss of detectable calcium transients in primary neonatal rat ventricular cardiomyocytes and induced a loss of mitochondrial membrane polarization. These effects on viability and function were abrogated by the beta h/c inhibitor, dipalmitoyl phosphatidylcholine (DPPC). Conclusions/Significance: Our data show a rapid loss of cardiomyocyte viability and function induced by GBS beta h/c, and these deleterious effects are inhibited by DPPC, a normal constituent of human pulmonary surfactant. These findings have clinical implications for the cardiac dysfunction observed in neonatal GBS infections.	[Hensler, Mary E.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Miyamoto, Shigeki] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hensler, ME (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Miyamoto, Shigeki/L-4004-2019	Nizet, Victor/0000-0003-3847-0422	American Heart Association [Career Investigator Award]; NIH [HD051796]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051796] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an American Heart Association Career Investigator Award and NIH Grant HD051796 (both to VN).	Baltimore RS, 2007, SEMIN PERINATOL, V31, P33, DOI 10.1053/j.semperi.2007.01.005; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; delMoral T, 1996, PEDIATR RES, V40, P469; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; GALLAGHER PG, 1986, REV INFECT DIS, V8, P175; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Gibson RL, 1999, PEDIATR RES, V45, P626, DOI 10.1203/00006450-199905010-00003; Gottschalk B, 2006, J BACTERIOL, V188, P5984, DOI 10.1128/JB.00768-05; Grandel U, 2006, CRIT CARE MED, V34, P118, DOI 10.1097/01.CCM.0000190626.71045.16; Griffiths B B, 1992, Microbios, V69, P17; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Henneke P, 2006, SEMIN FETAL NEONAT M, V11, P333, DOI 10.1016/j.siny.2006.03.003; Hensler ME, 2005, J INFECT DIS, V191, P1287, DOI 10.1086/428946; Herting E, 1997, ARCH DIS CHILD-FETAL, V76, pF3, DOI 10.1136/fn.76.1.F3; Herting E, 2000, PEDIATRICS, V106, P957, DOI 10.1542/peds.106.5.957; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; MARCHLEWICZ BA, 1980, INFECT IMMUN, V30, P805; Maruyama R, 2006, AM J PHYSIOL-HEART C, V290, pH1493, DOI 10.1152/ajpheart.00669.2005; MENKE JA, 1979, J PEDIATR-US, V94, P467, DOI 10.1016/S0022-3476(79)80603-4; Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; PAYNE NR, 1988, PEDIATR INFECT DIS J, V7, P836; PEEVY KJ, 1985, PEDIATR RES, V19, P511, DOI 10.1203/00006450-198506000-00001; Pettersson K, 2007, SEMIN FETAL NEONAT M, V12, P193, DOI 10.1016/j.siny.2007.01.010; Pribble C G, 1991, ASAIO Trans, V37, P33, DOI 10.1097/00002480-199101000-00010; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Puliti M, 2000, J INFECT DIS, V182, P824, DOI 10.1086/315773; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Ring A, 2002, J INFECT DIS, V185, P1745, DOI 10.1086/340818; RUNKLE B, 1984, PEDIATR RES, V18, P874, DOI 10.1203/00006450-198409000-00014; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Sibelius U, 2003, CRIT CARE MED, V31, P683, DOI 10.1097/01.CCM.0000050072.69509.06; Sibelius U, 2000, CIRCULATION, V101, P78, DOI 10.1161/01.CIR.101.1.78; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; VonHunolstein C, 1997, INFECT IMMUN, V65, P4017, DOI 10.1128/IAI.65.10.4017-4021.1997; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003	42	25	26	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2446	10.1371/journal.pone.0002446	http://dx.doi.org/10.1371/journal.pone.0002446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560574	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700031
J	Kerse, N; Flicker, L; Pfaff, JJ; Draper, B; Lautenschlager, NT; Sim, M; Snowdon, J; Almeida, OP				Kerse, Ngaire; Flicker, Leon; Pfaff, Jon J.; Draper, Brian; Lautenschlager, Nicola T.; Sim, Moira; Snowdon, John; Almeida, Osvaldo P.			Falls, Depression and Antidepressants in Later Life: A Large Primary Care Appraisal	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; GENERAL-PRACTICE; RISK-FACTORS; PREVENTING FALLS; OLDER-PEOPLE; POPULATION; METAANALYSIS; MEDICATIONS; REGISTERS; ACCURACY	Background: Depression and falls are common and co-exist for older people. Safe management of each of these conditions is important to quality of life. Methods: A cross-sectional survey was used to examine medication use associated with injurious and non-injurious falls in 21,900 community-dwelling adults, aged 60 years or over from 383 Australian general practices recruited for the DEPS-GP Project. Falls and injury from falls, medication use, depressive symptoms (Primary Health Questionnaire (PHQ-9)), clinical morbidity, suicidal ideation and intent, health status (SF-12 Health Survey), demographic and lifestyle information was reported in a standardised survey. Findings: Respondents were 71.8 years (sd 7.7) of age and 58.4% were women. 24% 11% and 8% reported falls, fall related injury, and sought medical attention respectively. Antidepressant use (odds ratio, OR: 1.46; 95% confidence interval, 95% CI: 1.25, 1.70), questionable depression (5-14 on PHQ OR: 1.32, 95% CI: 1.13, 1.53) and clinically significant symptoms of depression (15 or more on PHQ OR: 1.70, 95% CI: 1.14, 1.50) were independently associated with multiple falls. SSRI use was associated with the highest risk of multiple falls (OR: 1.66, 95% CI: 1.36, 2.02) amongst all psychotropic medications. Similar associations were observed for injurious falls. Over 60% of those with four accumulated risk factors had multiple falls in the previous year (OR: 3.40, 95% CI: 1.79, 6.45); adjusted for other demographic and health factors. Interpretation: Antidepressant use (particularly SSRIs) was strongly associated with falls regardless of presence of depressive symptoms. Strategies to prevent falls should become a routine part of the management of older people with depression.	[Kerse, Ngaire] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Flicker, Leon; Pfaff, Jon J.; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Univ W Australia, W Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Draper, Brian] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Sim, Moira] Edith Cowan Univ, Sch Nursing, Grad Higher Degree Syst Program, Midwifery & Postgrad Med, Perth, WA, Australia; [Snowdon, John] Univ Sydney, Discipline Psychol Med, Sydney, NSW, Australia	University of Auckland; University of Western Australia; University of New South Wales Sydney; Edith Cowan University; University of Sydney	Kerse, N (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Fac Med & Hlth Sci, Auckland 1, New Zealand.	n.kerse@auckland.ac.nz	Kerse, Ngaire/AFF-8119-2022; Almeida, Osvaldo P./A-4925-2008; Sim, Moira/D-5120-2013; Flicker, Leon/A-9039-2008; Flicker, Leon/AAE-1530-2022	Almeida, Osvaldo P./0000-0002-8689-6199; Sim, Moira/0000-0001-5962-6639; Flicker, Leon/0000-0002-3650-0475; Lautenschlager, Nicola/0000-0003-4850-7794				Afifi M, 2006, SAUDI MED J, V27, P128; Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; *AUSTR BUR STAT, 1995, NATL HLTH SURV SF 36; Becker C, 2006, OSTEOPOROSIS INT, V17, P410, DOI 10.1007/s00198-005-0001-1; Bergland A, 2000, Physiother Res Int, V5, P33, DOI 10.1002/pri.182; BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165; Buchner DM, 1996, J GERONTOL A-BIOL, V51, pM297, DOI 10.1093/gerona/51A.6.M297; BURKER EJ, 1995, PSYCHOL AGING, V10, P104, DOI 10.1037/0882-7974.10.1.104; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; COBB JS, 1983, BRIT MED J, V287, P1434, DOI 10.1136/bmj.287.6403.1434; DIFFORD F, 1985, BRIT MED J, V290, P519, DOI 10.1136/bmj.290.6467.519; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Gillespie LD, 2006, COCHRANE DB SYST REV, P4; GRANEK E, 1987, J AM GERIATR SOC, V35, P503, DOI 10.1111/j.1532-5415.1987.tb01395.x; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hien LT, 2005, J AM GERIATR SOC, V53, P1290, DOI 10.1111/j.1532-5415.2005.53403.x; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Hull B P, 1999, Aust Fam Physician, V28, P55; Hybels CF, 2003, CLIN GERIATR MED, V19, P663, DOI 10.1016/S0749-0690(03)00042-9; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Oakley-Browne M., 2006, RAU HINENGARO NZ MEN; OCONNER P, 1988, NEW ENGL J MED, V338, P592; Pope D, 1996, J PUBLIC HEALTH MED, V18, P6, DOI 10.1093/oxfordjournals.pubmed.a024464; Raymont A., 2004, 1 MIN HLTH; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; ROBSON J, 1995, BRIT J GEN PRACT, V45, P463; SCRIVENER G, 1995, BRIT MED J, V311, P163, DOI 10.1136/bmj.311.6998.163; SHELDON MG, 1984, J ROY COLL GEN PRACT, V34, P269; Simonsick EM, 1999, J AM GERIATR SOC, V47, P672, DOI 10.1111/j.1532-5415.1999.tb01588.x; SINGH N, 2005, J GERONTOL, V768, pM76; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; THAPA PB, 1995, AM J EPIDEMIOL, V142, P202, DOI 10.1093/oxfordjournals.aje.a117619; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Whooley MA, 1999, ARCH INTERN MED, V159, P484, DOI 10.1001/archinte.159.5.484; Williamson MK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-42; World Health Organisation, 2005, FRUIT VEG HLTH JOINT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	102	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2423	10.1371/journal.pone.0002423	http://dx.doi.org/10.1371/journal.pone.0002423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560599	Green Published, gold			2022-12-27	WOS:000263280700009
J	Kuehl, HS; Elzner, C; Moebius, Y; Boesch, C; Walsh, PD				Kuehl, Hjalmar S.; Elzner, Caroline; Moebius, Yasmin; Boesch, Christophe; Walsh, Peter D.			The Price of Play: Self-Organized Infant Mortality Cycles in Chimpanzees	PLOS ONE			English	Article							TRANSMISSION; PARAMETERS; SEVERITY; DYNAMICS; PATTERNS; MEASLES; SPREAD; FOOD	Chimpanzees have been used extensively as a model system for laboratory research on infectious diseases. Ironically, we know next to nothing about disease dynamics in wild chimpanzee populations. Here, we analyze long-term demographic and behavioral data from two habituated chimpanzee communities in Tai National Park, Cote d'Ivoire, where previous work has shown respiratory pathogens to be an important source of infant mortality. In this paper we trace the effect of social connectivity on infant mortality dynamics. We focus on social play which, as the primary context of contact between young chimpanzees, may serve as a key venue for pathogen transmission. Infant abundance and mortality rates at Tai cycled regularly and in a way that was not well explained in terms of environmental forcing. Rather, infant mortality cycles appeared to self-organize in response to the ontogeny of social play. Each cycle started when the death of multiple infants in an outbreak synchronized the reproductive cycles of their mothers. A pulse of births predictably arrived about twelve months later, with social connectivity increasing over the following two years as the large birth cohort approached the peak of social play. The high social connectivity at this play peak then appeared to facilitate further outbreaks. Our results provide the first evidence that social play has a strong role in determining chimpanzee disease transmission risk and the first record of chimpanzee disease cycles similar to those seen in human children. They also lend more support to the view that infectious diseases are a major threat to the survival of remaining chimpanzee populations.	[Kuehl, Hjalmar S.; Elzner, Caroline; Moebius, Yasmin; Boesch, Christophe; Walsh, Peter D.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Kuehl, HS (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	kuehl@eva.mpg.de			Swiss National Science Foundation; Max Planck Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Swiss National Science Foundation funded long-term data collection for this study. Max Planck Society funded data collection and data analysis.	Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; ANDERSON R M, 1991; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Boesch C, 2000, CHIMPANZEES TAI FORE; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Brent L, 2003, BEHAVIOUR, V140, P209, DOI 10.1163/156853903321671505; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Crowcroft N S, 1999, Commun Dis Public Health, V2, P234; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; FORMENTY P, 1997, J INFECT DIS, V179, P120; GOG J, 2004, P R SOC, V269, P671; Hanamura S, 2008, PRIMATES, V49, P77, DOI 10.1007/s10329-007-0054-1; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lonsdorf EV, 2006, AM J PRIMATOL, V68, P897, DOI 10.1002/ajp.20296; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; MIKOLAJCZYK RT, 2007, EPIDEMIOL INFECT, P1; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pellegrini A. D., 2005, NATURE PLAY GREAT AP; Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; SCRIMSHAW NS, 2007, AM J CLIN NUTR, V66, pS464; Sugiyama Y, 2004, AM J PHYS ANTHROPOL, V124, P154, DOI 10.1002/ajpa.10345; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; WALD ER, 1988, J PEDIATR-US, V112, P540, DOI 10.1016/S0022-3476(88)80164-1; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; World Health Organization, 2007, WORLD HLTH REP 2007	44	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2440	10.1371/journal.pone.0002440	http://dx.doi.org/10.1371/journal.pone.0002440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	406FP	18560519	gold, Green Submitted, Green Published			2022-12-27	WOS:000263280700025
J	Yeo, TW; Lampah, DA; Gitawati, R; Tjitra, E; Kenangalem, E; Granger, DL; Weinberg, JB; Lopansri, BK; Price, RN; Celermajer, DS; Duffull, SB; Anstey, NM				Yeo, Tsin W.; Lampah, Daniel A.; Gitawati, Retno; Tjitra, Emiliana; Kenangalem, Enny; Granger, Donald L.; Weinberg, J. Brice; Lopansri, Bert K.; Price, Ric N.; Celermajer, David S.; Duffull, Stephen B.; Anstey, Nicholas M.			Safety Profile of L-Arginine Infusion in Moderately Severe Falciparum Malaria	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; NITRIC-OXIDE; CEREBRAL MALARIA; DYSFUNCTION; CHILDREN; HYPERKALEMIA; MANAGEMENT; THERAPY; HUMANS; TRIAL	Background: L-arginine infusion improves endothelial function in malaria but its safety profile has not been described in detail. We assessed clinical symptoms, hemodynamic status and biochemical parameters before and after a single L-arginine infusion in adults with moderately severe malaria. Methodology and Findings: In an ascending dose study, adjunctive intravenous L-arginine hydrochloride was infused over 30 minutes in doses of 3 g, 6 g and 12 g to three separate groups of 10 adults hospitalized with moderately severe Plasmodium falciparum malaria in addition to standard quinine therapy. Symptoms, vital signs and selected biochemical measurements were assessed before, during, and for 24 hours after infusion. No new or worsening symptoms developed apart from mild discomfort at the intravenous cannula site in two patients. There was a dose-response relationship between increasing mg/kg dose and the maximum decrease in systolic (rho = 0.463; Spearman's, p = 0.02) and diastolic blood pressure (r = 0.42; Pearson's, p = 0.02), and with the maximum increment in blood potassium (r = 0.70, p < 0.001) and maximum decrement in bicarbonate concentrations (r = 0.53, p = 0.003) and pH (r = 0.48, p = 0.007). At the highest dose (12 g), changes in blood pressure and electrolytes were not clinically significant, with a mean maximum decrease in mean arterial blood pressure of 6 mmHg (range: 0-11; p < 0.001), mean maximal increase in potassium of 0.5 mmol/L (range 0.2-0.7 mmol/L; p, 0.001), and mean maximal decrease in bicarbonate of 3 mEq/L (range 1-7; p < 0.01) without a significant change in pH. There was no significant dose-response relationship with blood phosphate, lactate, anion gap and glucose concentrations. All patients had an uncomplicated clinical recovery. Conclusions/Significance: Infusion of up to 12g of intravenous L-arginine hydrochloride over 30 minutes is well tolerated in adults with moderately severe malaria, with no clinically important changes in hemodynamic or biochemical status. Trials of adjunctive L-arginine can be extended to phase 2 studies in severe malaria. Trial Registration: ClinicalTrials.gov NCT00147368	[Yeo, Tsin W.; Price, Ric N.; Anstey, Nicholas M.] Charles Darwin Univ, Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT 0909, Australia; [Lampah, Daniel A.; Kenangalem, Enny] Natl Inst Hlth Res & Dev Res Program, Menzies Sch Hlth Res, Dist Minist Hlth, Timika, Papua, Indonesia; [Gitawati, Retno; Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Granger, Donald L.; Lopansri, Bert K.] Univ Utah, VA Med Ctr, Div Infect Dis, Salt Lake City, UT USA; [Weinberg, J. Brice] Duke Univ, Sch Med, VA Med Ctr, Div Hematol Oncol, Durham, NC USA; [Price, Ric N.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Price, Ric N.] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford, England; [Celermajer, David S.] Univ Sydney, Royal Prince Alfred Hosp, Dept Cardiol, Dept Med, Sydney, NSW, Australia; [Duffull, Stephen B.] Univ Otago, Sch Pharm, Dunedin, New Zealand	Charles Darwin University; Menzies School of Health Research; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Utah System of Higher Education; University of Utah; Duke University; University of Oxford; University of Sydney; University of Otago	Yeo, TW (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT 0909, Australia.	anstey@menzies.edu.au	Duffull, Stephen/ABF-8474-2020; Yeo, Tsin Wen/F-9505-2015	Duffull, Stephen/0000-0002-6545-9408; Price, Richard/0000-0003-2000-2874	Wellcome Trust [GR071614MA]; National Health and Medical Research Council of Australia [283321, 290208]; Tudor Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Tudor Foundation	The study was funded by the Wellcome Trust (ICRG GR071614MA), the National Health and Medical Research Council of Australia (NHMRC ICRG ID 283321 and NHMRC 290208) and the Tudor Foundation. The sponsors had no role in the design or conduct of the study.	Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; BAKER GL, 1991, SOUTH MED J, V84, P381, DOI 10.1097/00007611-199103000-00018; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bode-Boger SM, 1998, BRIT J CLIN PHARMACO, V46, P489, DOI 10.1046/j.1365-2125.1998.00803.x; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; BUSHINSKY DA, 1978, ANN INTERN MED, V89, P632, DOI 10.7326/0003-4819-89-5-632; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; DAVIS TME, 1993, T ROY SOC TROP MED H, V87, P49, DOI 10.1016/0035-9203(93)90416-N; DE CR, 1995, J CLIN INVEST, V96, P60; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DICKERMAN HW, 1964, AM J PHYSIOL, V206, P403, DOI 10.1152/ajplegacy.1964.206.2.403; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Faiz MA, 2005, LANCET, V366, P717; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Giugliano D, 1997, J CLIN INVEST, V99, P433, DOI 10.1172/JCI119177; HERTZ P, 1972, ARCH INTERN MED, V130, P778, DOI 10.1001/archinte.130.5.778; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Kalil AC, 2006, CRIT CARE MED, V34, P2719, DOI 10.1097/01.CCM.0000242757.26245.03; Koller-Strametz J, 1999, KIDNEY INT, V55, P1871, DOI 10.1046/j.1523-1755.1999.00415.x; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; LORENTE JA, 1993, CRIT CARE MED, V21, P1287, DOI 10.1097/00003246-199309000-00010; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MADDEN HP, 1988, J SURG RES, V44, P658, DOI 10.1016/0022-4804(88)90097-2; Maitland K, 2005, CLIN INFECT DIS, V40, P9, DOI 10.1086/426022; MASSARA F, 1980, J ENDOCRINOL INVEST, V3, P177, DOI 10.1007/BF03348247; MEHTA S, 1995, CIRCULATION, V92, P1539, DOI 10.1161/01.CIR.92.6.1539; Mohanty S, 2006, INDIAN J MED RES, V124, P245; NAKAKI T, 1990, LANCET, V336, P696, DOI 10.1016/0140-6736(90)92196-O; PALMER JP, 1975, DIABETES, V24, P735, DOI 10.2337/diabetes.24.8.735; Pasvol G, 2005, INFECT DIS CLIN N AM, V19, P211, DOI 10.1016/j.idc.2004.10.007; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Schlaich MP, 2000, CLIN SCI, V99, P293, DOI 10.1042/CS20000041; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; TIWARY CM, 1973, NEW ENGL J MED, V288, P218; Tjitra E, 2001, AM J TROP MED HYG, V65, P309, DOI 10.4269/ajtmh.2001.65.309; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; YEO TW, 2008, J INFECT DI IN PRESS	41	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2347	10.1371/journal.pone.0002347	http://dx.doi.org/10.1371/journal.pone.0002347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545693	Green Submitted, Green Published, gold			2022-12-27	WOS:000263248800009
J	Elsea, CR; Roberts, DA; Druker, BJ; Wood, LJ				Elsea, Collin R.; Roberts, Daniel A.; Druker, Brian J.; Wood, Lisa J.			Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal Activity	PLOS ONE			English	Article								Cancer patients undergoing treatment with systemic cancer chemotherapy drugs often experience debilitating fatigue similar to sickness behavior, a normal response to infection or tissue damage caused by the production of the inflammatory cytokines IL-1 beta, TNF-alpha, and IL-6. The p38 mitogen activated protein kinase (p38 MAPK) plays a central role in the production of these cytokines and consequently the development of sickness behavior. Targeted inhibitors of p38 MAPK can reduce systemic inflammatory cytokine production and the development of sickness behavior. Several systemic cancer chemotherapy drugs have been shown to stimulate inflammatory cytokine production, yet whether this response is related to a common ability to activate p38 MAPK is not known and is the focus of this study. This understanding may present the possibility of using p38 MAPK inhibitors to reduce chemotherapy-induced inflammatory cytokine production and consequently treatment-related fatigue. One caveat of this approach is a potential reduction in chemotherapeutic efficacy as some believe that p38 MAPK activity is required for chemotherapy-induced cytotoxicity of tumor cells. The purpose of this study was to demonstrate proof of principal that p38 MAPK inhibition can block chemotherapy-induced inflammatory cytokine production without inhibiting drug-induced cytotoxicity using murine peritoneal macrophages and Lewis Lung Carcinoma (LLC1) cells as model cell systems. Using these cells we assessed the requirement of etoposide, doxorubicin, 5-flourouracil, and docetaxel for p38 MAPK in inflammatory cytokine production and cytotoxicity. Study findings demonstrate that clinically relevant doses of etoposide, doxorubicin, and 5-FU activated p38 MAPK in both macrophages and LLC1 cells. In contrast, docetaxel failed to activate p38 MAPK in either cell type. Activation of p38 MAPK mediated the drug's effects on inflammatory cytokine production in macrophages but not LLC1 cytotoxicity and this was confirmed with inhibitor studies.	[Elsea, Collin R.; Roberts, Daniel A.; Wood, Lisa J.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Druker, Brian J.] Howard Hughes Med Inst, Boston, MA USA; [Druker, Brian J.] Oregon Hlth & Sci Univ, Canc Inst, Div Hematol & Med Oncol, Portland, OR USA; [Wood, Lisa J.] Oregon Hlth & Sci Univ, Canc Inst, Sch Med, Dept Radiat Med, Portland, OR USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Elsea, CR (corresponding author), Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA.	woodl@ohsu.edu		Wood, Lisa/0000-0003-1145-3649; Druker, Brian/0000-0001-8331-8206	National Institute of Nursing Research Exploratory Nursing Research Center [1P20NR07807-03]; American Cancer Society; NATIONAL INSTITUTE OF NURSING RESEARCH [P20NR007807] Funding Source: NIH RePORTER	National Institute of Nursing Research Exploratory Nursing Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported in part by pilot funding awarded to L.J.W. from the National Institute of Nursing Research Exploratory Nursing Research Center Grant 1P20NR07807-03, which was awarded to L.M.N. L.J.W is a recipient of an American Cancer Society Research Scholar Grant. Funding agencies were not involved in the design, conduct, data collection, analysis, data interpretation, or preparation, review, or approval of the manuscript.	Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; BORUT BSP, 2004, PAIN, V107, P7; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Bryniarski K, 1996, IMMUNOPHARMACOLOGY, V34, P73, DOI 10.1016/0162-3109(96)00130-0; BURKHART CA, 1994, CANCER RES, V54, P5779; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; CHRISTENSEN LV, 1992, J ORAL REHABIL, V19, P39, DOI 10.1111/j.1365-2842.1992.tb01589.x; de Vries P, 2000, EXP HEMATOL, V28, P916, DOI 10.1016/S0301-472X(00)00493-8; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Harden LM, 2006, PHYSIOL BEHAV, V89, P146, DOI 10.1016/j.physbeh.2006.05.016; Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4; HUANG Y, 2007, NEUROBIOL AGING; JACOBSEN S, 1993, SCAND J RHEUMATOL, V22, P69, DOI 10.3109/03009749309095118; Janicki-Deverts D, 2007, BRAIN BEHAV IMMUN, V21, P301, DOI 10.1016/j.bbi.2006.09.002; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Ma SF, 2007, KIDNEY INT, V72, P1474, DOI 10.1038/sj.ki.5002556; MANTHEY CL, 1993, J EXP MED, V178, P695, DOI 10.1084/jem.178.2.695; Moos PJ, 1999, J IMMUNOL, V162, P467; Moos PJ, 1998, P NATL ACAD SCI USA, V95, P3896, DOI 10.1073/pnas.95.7.3896; Morse SMJ, 2006, BIOTECHNIQUES, V40, P54, DOI 10.2144/000112100; Muhl H, 1999, EUR J IMMUNOL, V29, P3225, DOI 10.1002/(SICI)1521-4141(199910)29:10<3225::AID-IMMU3225>3.0.CO;2-0; Offidani M, 2004, EUR J HAEMATOL, V72, P403, DOI 10.1111/j.1600-0609.2004.00238.x; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Peifer C, 2006, CURR TOP MED CHEM, V6, P113, DOI 10.2174/156802606775270323; POGREBNIAK HW, 1991, SURGERY, V110, P231; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; SALEEM A, 1995, CELL GROWTH DIFFER, V6, P1651; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Shishodia S, 1997, INT J IMMUNOPHARMACO, V19, P683; Shishodia S, 1998, IMMUNOL LETT, V61, P179, DOI 10.1016/S0165-2478(98)00017-0; SINGH RK, 1991, IMMUNOL LETT, V28, P127, DOI 10.1016/0165-2478(91)90110-V; SINGH RK, 1991, NAT IMMUN CELL GROW, V10, P105; SODHI A, 1992, IMMUNOL LETT, V34, P183, DOI 10.1016/0165-2478(92)90211-6; SURESH A, 1991, IMMUNOL LETT, V30, P93, DOI 10.1016/0165-2478(91)90095-R; TEELING JL, 2007, BRAIN BEHAV IMMUN; THOMPSON DS, 1995, CLIN PHARMACOL THER, V57, P499, DOI 10.1016/0009-9236(95)90034-9; Ujhazy P, 2003, CANCER IMMUNOL IMMUN, V52, P463, DOI 10.1007/s00262-003-0391-x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953; Wang LCS, 2006, ONCOL RES, V16, P1; White CM, 1998, CANCER IMMUNOL IMMUN, V46, P104, DOI 10.1007/s002620050468; WILLETTE AA, 2007, BRAIN BEHAV IMMUN; Wood LJ, 2006, ONCOL NURS FORUM, V33, P535, DOI 10.1188/06.ONF.535-542; WOOD LJ, 2006, BIOL RES NURS, P7; Zaks-Zilberman M, 2001, CYTOKINE, V15, P156, DOI 10.1006/cyto.2001.0935; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	53	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2355	10.1371/journal.pone.0002355	http://dx.doi.org/10.1371/journal.pone.0002355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523641	Green Published, gold, Green Submitted			2022-12-27	WOS:000262614300042
J	Zhang, W; Liu, S; Zhou, YQ				Zhang, Wei; Liu, Song; Zhou, Yaoqi			SP5: Improving Protein Fold Recognition by Using Torsion Angle Profiles and Profile-Based Gap Penalty Model	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; HIDDEN MARKOV-MODELS; SOLVENT ACCESSIBILITY; STRUCTURE ALIGNMENT; LOCAL-STRUCTURE; SEQUENCE; DATABASE; SERVER; IDENTIFICATION; INFORMATION	How to recognize the structural fold of a protein is one of the challenges in protein structure prediction. We have developed a series of single (non-consensus) methods (SPARKS, SP2, SP3, SP4) that are based on weighted matching of two to four sequence and structure-based profiles. There is a robust improvement of the accuracy and sensitivity of fold recognition as the number of matching profiles increases. Here, we introduce a new profile-profile comparison term based on real-value dihedral torsion angles. Together with updated real-value solvent accessibility profile and a new variable gap-penalty model based on fractional power of insertion/deletion profiles, the new method (SP5) leads to a robust improvement over previous SP method. There is a 2% absolute increase (5% relative improvement) in alignment accuracy over SP4 based on two independent benchmarks. Moreover, SP5 makes 7% absolute increase (22% relative improvement) in success rate of recognizing correct structural folds, and 32% relative improvement in model accuracy of models within the same fold in Lindahl benchmark. In addition, modeling accuracy of top-1 ranked models is improved by 12% over SP4 for the difficult targets in CASP 7 test set. These results highlight the importance of harnessing predicted structural properties in challenging remote-homolog recognition. The SP5 server is available at http://sparks.informatics.iupui.edu.	[Zhang, Wei; Zhou, Yaoqi] Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA; [Zhang, Wei] Inst Appl Phys & Computat Math, Beijing, Peoples R China; [Liu, Song] SUNY Buffalo, Univ Buffalo, Center of Excellence Bioinformat & Life Sci, Dept Biostat, Buffalo, NY USA; [Liu, Song] Roswell Park Canc Inst, Dept Biostat, Buffalo, NY USA; [Liu, Song] SUNY Buffalo, Univ Buffalo, Howard Hughes Med Inst, Dept Physiol & Biophys, Buffalo, NY USA	Indiana University System; Indiana University-Purdue University Indianapolis; Chinese Academy of Sciences; Institute of Applied Physics & Computational Mathematics - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, W (corresponding author), Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA.	yqzhou@iupui.edu	Zhou, Yaoqi/B-3284-2009	Zhou, Yaoqi/0000-0002-9958-5699	NIH;  [R01 GM 966049];  [R01 GM 068530]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (R01 GM 966049 and R01 GM 068530).	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Domingues FS, 2000, J MOL BIOL, V297, P1003, DOI 10.1006/jmbi.2000.3615; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etchebest C, 2004, SILICO BIOL, V4, P31; Fischer D, 1996, Pac Symp Biocomput, P300; Goonesekere NCW, 2004, NUCLEIC ACIDS RES, V32, P2838, DOI 10.1093/nar/gkh610; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANG HS, 1993, J MOL BIOL, V229, P448, DOI 10.1006/jmbi.1993.1045; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kihara D, 2003, J MOL BIOL, V334, P793, DOI 10.1016/j.jmb.2003.10.027; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; LESK AM, 1986, PROTEIN ENG, V1, P77, DOI 10.1093/protein/1.1.77; Lindahl E, 2000, J MOL BIOL, V295, P613, DOI 10.1006/jmbi.1999.3377; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Madhusudhan MS, 2006, PROTEIN ENG DES SEL, V19, P129, DOI 10.1093/protein/gzj005; MARKSTEIN P, 2007, IMPROVEMENT PROTEIN, V6; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Terashi G, 2007, PROTEINS, V69, P98, DOI 10.1002/prot.21785; Tress M, 2005, PROTEINS, V61, P27, DOI 10.1002/prot.20720; Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319; XU J, 2003, PAC S BIOCOMPUT, V8, P264; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649; Zhou HY, 2007, PROTEIN SCI, V16, P947, DOI 10.1110/ps.062597307; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	55	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2325	10.1371/journal.pone.0002325	http://dx.doi.org/10.1371/journal.pone.0002325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523556	Green Published, gold			2022-12-27	WOS:000262614300020
J	Derelle, E; Ferraz, C; Escande, ML; Eychenie, S; Cooke, R; Piganeau, G; Desdevises, Y; Bellec, L; Moreau, H; Grimsley, N				Derelle, Evelyne; Ferraz, Conchita; Escande, Marie-Line; Eychenie, Sophie; Cooke, Richard; Piganeau, Gwenael; Desdevises, Yves; Bellec, Laure; Moreau, Herve; Grimsley, Nigel			Life-Cycle and Genome of OtV5, a Large DNA Virus of the Pelagic Marine Unicellular Green Alga Ostreococcus tauri	PLOS ONE			English	Article								Large DNA viruses are ubiquitous, infecting diverse organisms ranging from algae to man, and have probably evolved from an ancient common ancestor. In aquatic environments, such algal viruses control blooms and shape the evolution of biodiversity in phytoplankton, but little is known about their biological functions. We show that Ostreococcus tauri, the smallest known marine photosynthetic eukaryote, whose genome is completely characterized, is a host for large DNA viruses, and present an analysis of the life-cycle and 186,234 bp long linear genome of OtV5. OtV5 is a lytic phycodnavirus which unexpectedly does not degrade its host chromosomes before the host cell bursts. Analysis of its complete genome sequence confirmed that it lacks expected site-specific endonucleases, and revealed the presence of 16 genes whose predicted functions are novel to this group of viruses. OtV5 carries at least one predicted gene whose protein closely resembles its host counterpart and several other host-like sequences, suggesting that horizontal gene transfers between host and viral genomes may occur frequently on an evolutionary scale. Fifty seven percent of the 268 predicted proteins present no similarities with any known protein in Genbank, underlining the wealth of undiscovered biological diversity present in oceanic viruses, which are estimated to harbour 200Mt of carbon.	[Derelle, Evelyne; Escande, Marie-Line; Piganeau, Gwenael; Desdevises, Yves; Bellec, Laure; Moreau, Herve; Grimsley, Nigel] Univ Paris 06, Lab Arago, Banyuls Sur Mer, France; [Derelle, Evelyne; Escande, Marie-Line; Piganeau, Gwenael; Moreau, Herve; Grimsley, Nigel] Lab Arago, CNRS, UMR7628, Banyuls sur Mer, France; [Ferraz, Conchita; Eychenie, Sophie] Genopole Montpellier Languedoc Roussillon, Inst Genet Humaine, UPR1142, Montpellier, France; [Cooke, Richard] Genopole Languedoc Roussillon, Genome Dev Plantes, UMR5096, Perpignan, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Derelle, E (corresponding author), Univ Paris 06, Lab Arago, Banyuls Sur Mer, France.	nigel.grimsley@obs-banyuls.fr	Desdevises, Yves/D-5528-2011; Desdevises, Yves/AAH-2097-2019; Desdevises, Yves/H-5334-2019; Grimsley, Nigel/O-1359-2015; Piganeau, Gwenael V/C-7600-2011	Desdevises, Yves/0000-0001-9774-0336; Desdevises, Yves/0000-0001-9774-0336; Grimsley, Nigel/0000-0001-9323-417X; Piganeau, Gwenael V/0000-0002-9992-4187; bellec, laure/0000-0002-1954-9867; Cooke, Richard/0000-0001-6335-1092; Derelle, Evelyne/0000-0002-1499-4240	Agence National de Recherche [PICOVIR]; European Network of Excellence Marine Genomics Europe [GOCE-CT-2004-505403]; GDR 1928 Genomique des Populations	Agence National de Recherche(French National Research Agency (ANR)); European Network of Excellence Marine Genomics Europe; GDR 1928 Genomique des Populations	This work was supported partly by an Agence National de Recherche grant PICOVIR (coordinator N.G.), partly by the European Network of Excellence Marine Genomics Europe (no. GOCE-CT-2004-505403, coordinator H.M.) and the isolation of new strains was partly supported by a GDR 1928 Genomique des Populations grant to G. P.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agarkova IV, 2006, J VIROL, V80, P8114, DOI 10.1128/JVI.00486-06; Allen MJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Attoui H, 2006, J GEN VIROL, V87, P1375, DOI 10.1099/vir.0.81584-0; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Bratbak G, 1996, J MARINE SYST, V9, P75, DOI 10.1016/0924-7963(96)00018-8; Brown CM, 2007, ENVIRON MICROBIOL, V9, P2720, DOI 10.1111/j.1462-2920.2007.01384.x; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; BUTCHER RW, 1952, J MAR BIOL ASSOC UK, V31, P175, DOI 10.1017/S0025315400003751; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CHEN F, 1995, APPL ENVIRON MICROB, V61, P1274, DOI 10.1128/AEM.61.4.1274-1278.1995; Cho KY, 1996, MOL MICROBIOL, V22, P1025, DOI 10.1046/j.1365-2958.1996.01524.x; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; COTTRELL MT, 1991, MAR ECOL PROG SER, V78, P1, DOI 10.3354/meps078001; COTTRELL MT, 1995, APPL ENVIRON MICROB, V61, P3088, DOI 10.1128/AEM.61.8.3088-3091.1995; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Countway PD, 2006, APPL ENVIRON MICROB, V72, P2496, DOI 10.1128/AEM.72.4.2496-2506.2006; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Delaroque N, 2003, J MOL EVOL, V57, P613, DOI 10.1007/s00239-003-2501-y; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; KOHL DH, 1988, P NATL ACAD SCI USA, V85, P2036, DOI 10.1073/pnas.85.7.2036; La Scola B, 2003, SCIENCE, V299, P2033; Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; MEAD JR, 1988, J PARASITOL, V74, P366, DOI 10.2307/3282039; Nagasaki Keizo, 2005, Uirusu, V55, P127, DOI 10.2222/jsv.55.127; O'Kelly CJ, 2003, J PHYCOL, V39, P850, DOI 10.1046/j.1529-8817.2003.02201.x; Oliveira IC, 2001, BRAZ J MED BIOL RES, V34, P567, DOI 10.1590/S0100-879X2001000500003; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4; Piganeau G, 2007, GENE, V406, P184, DOI 10.1016/j.gene.2007.09.015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pringle CR, 1998, ARCH VIROL, V143, P203, DOI 10.1007/s007050050280; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; ROHOZINSKI J, 1989, VIROLOGY, V168, P363, DOI 10.1016/0042-6822(89)90277-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Schroeder DC, 2003, APPL ENVIRON MICROB, V69, P2484, DOI 10.1128/AEM.69.5.2484-2490.2003; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Simek K, 2007, ENVIRON MICROBIOL, V9, P789, DOI 10.1111/j.1462-2920.2006.01201.x; STRASSER P, 1991, VIROLOGY, V180, P763, DOI 10.1016/0042-6822(91)90089-T; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRASK BJ, 1982, CYTOMETRY, V2, P258; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049; WATERS RE, 1982, J GEN VIROL, V63, P199, DOI 10.1099/0022-1317-63-1-199; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; XIA YN, 1986, MOL CELL BIOL, V6, P1430, DOI 10.1128/MCB.6.5.1430; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Zhang R, 2007, ENVIRON MICROBIOL, V9, P3008, DOI 10.1111/j.1462-2920.2007.01410.x; ZHANG YP, 1994, VIROLOGY, V202, P1079, DOI 10.1006/viro.1994.1444	90	88	89	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2250	10.1371/journal.pone.0002250	http://dx.doi.org/10.1371/journal.pone.0002250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509524	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500004
J	Harris, CM; Travis, JMJ; Harwood, J				Harris, Catriona M.; Travis, Justin M. J.; Harwood, John			Evaluating the Influence of Epidemiological Parameters and Host Ecology on the Spread of Phocine Distemper Virus through Populations of Harbour Seals	PLOS ONE			English	Article							SPATIAL DYNAMICS; COMMON SEALS; VITULINA; EPIZOOTIOLOGY; TRANSMISSION; PATTERNS; DISEASE; NORTH	Background: Outbreaks of phocine distemper virus (PDV) in Europe during 1988 and 2002 were responsible for the death of around 23,000 and 30,000 harbour seals, respectively. These epidemics, particularly the one in 2002, provided an unusual opportunity to estimate epidemic parameters for a wildlife disease. There were marked regional differences in the values of some parameters both within and between epidemics. Methodology and Principal Findings: We used an individual-based model of seal movement that allowed us to incorporate realistic representations of space, time and animal behaviour into a traditional epidemiological modelling framework. We explored the potential influence of a range of ecological (foraging trip duration, time of epidemic onset, population size) and epidemiological (length of infectious period, contact rate between infectious and susceptible individuals, case mortality) parameters on four readily-measurable epidemic characteristics (number of dead individuals, duration of epidemic, peak mortality date and prevalence) and on the probability that an epidemic would occur in a particular region. We analysed the outputs as if they were the results of a series of virtual experiments, using Generalised Linear Modelling. All six variables had a significant effect on the probability that an epidemic would be recognised as an unusual mortality event by human observers. Conclusions: Regional and temporal variation in contact rate was the most likely cause of the observed differences between the two epidemics. This variation could be a consequence of differences in the way individuals divide their time between land and sea at different times of the year.	[Harris, Catriona M.; Harwood, John] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Harris, Catriona M.; Harwood, John] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [Travis, Justin M. J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of St Andrews; University of St Andrews; University of Aberdeen	Harris, CM (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	catriona@mcs.st-and.ac.uk	Travis, Justin/B-8571-2014	Travis, Justin/0000-0002-5785-4272; Harris, Catriona/0000-0001-9198-2414	UK Natural Environment Research Council	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Catriona Harris was supported by a grant from the UK Natural Environment Research Council. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript	BAKER JR, 1992, SCI TOTAL ENVIRON, V115, P1, DOI 10.1016/0048-9697(92)90027-P; BRASSEUR SM, 2003, MANAGEMENT N SEA HAR, P27; COLIZZA V, J THEORETIC IN PRESS; COSBY SL, 1988, NATURE, V336, P115, DOI 10.1038/336115b0; De Koeijer A, 1998, B MATH BIOL, V60, P585, DOI 10.1006/bulm.1997.0030; DESWART RL, 1995, THESIS ERASMUS U ROT; DIETZ R, 1989, AMBIO, V18, P258; Doran RJ, 2005, PREV VET MED, V70, P133, DOI 10.1016/j.prevetmed.2005.03.002; DUCK CD, 2006, STATUS BRIT COMMON S; EVERARD K, 2004, THESIS U ST ANDREWS; Fuks H, 2001, DISCRETE DYN NAT SOC, V6, P191, DOI 10.1155/S1026022601000206; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Green DG, 2005, ECOL COMPLEX, V2, P117, DOI 10.1016/j.ecocom.2004.11.006; GRENFELL BT, 1992, SCI TOTAL ENVIRON, V115, P15, DOI 10.1016/0048-9697(92)90029-R; Hall AJ, 2006, BIOL CONSERV, V131, P221, DOI 10.1016/j.biocon.2006.04.008; HALL AJ, 1992, SCI TOTAL ENVIRON, V115, P31, DOI 10.1016/0048-9697(92)90030-V; HARDER T, 1990, J VET MED B, V37, P641, DOI 10.1111/j.1439-0450.1990.tb01109.x; Harding KC, 2002, ECOL LETT, V5, P727, DOI 10.1046/j.1461-0248.2002.00390.x; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; Harkonen T, 2001, CAN J ZOOL, V79, P2115, DOI 10.1139/cjz-79-12-2115; HARKONEN T, 1990, Z SAUGETIERKD, V55, P233; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Harwood J., 1990, Ocean Challenge, V1, P4; HEIDEJORGENSEN MP, 1992, DIS AQUAT ORGAN, V13, P37, DOI 10.3354/dao013037; HEIDEJORGENSEN MP, 1992, J APPL ECOL, V29, P99, DOI 10.2307/2404353; Hess G.R., 2002, P102; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; KENNEDY S, 1990, VET REC, V127, P563; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; LONERGAN ME, DIS AQUATIC IN PRESS; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; Reineking Bettina, 2002, Wadden Sea Newsletter, V2, P3; Ross PS, 2002, HUM ECOL RISK ASSESS, V8, P277, DOI 10.1080/20028091056917; SHARPLES RJ, 2005, DISTRIBUTION MOVEMEN; SHARPLES RJ, 2004, DISTRIBUTION MOVEMEN; SHARPLES RJ, 2005, THESIS U ST ANDREWS; Shirley MDF, 2003, ECOL MODEL, V167, P139, DOI 10.1016/S0304-3800(03)00167-4; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; THOMPSON PM, 1992, SCI TOTAL ENVIRON, V115, P57, DOI 10.1016/0048-9697(92)90032-N; Thompson PM, 2002, VET REC, V151, P609, DOI 10.1136/vr.151.20.609; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; THOMPSON PM, 1990, J APPL ECOL, V27, P924, DOI 10.2307/2404387	44	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2710	10.1371/journal.pone.0002710	http://dx.doi.org/10.1371/journal.pone.0002710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628992	Green Submitted, Green Published, gold			2022-12-27	WOS:000264057200053
J	Schrempf, A; Heinze, J				Schrempf, Alexandra; Heinze, Juergen			Mating with Stressed Males Increases the Fitness of Ant Queens	PLOS ONE			English	Article							LONGEVITY; EVOLUTION; PROTEINS; BIOLOGY	Background: According to sexual conflict theory, males can increase their own fitness by transferring substances during copulation that increase the short-term fecundity of their mating partners at the cost of the future life expectancy and re-mating capability of the latter. In contrast, sexual cooperation is expected in social insects. Mating indeed positively affects life span and fecundity of young queens of the male-polymorphic ant Cardiocondyla obscurior, even though males neither provide nuptial gifts nor any other care but leave their mates immediately after copulation and die shortly thereafter. Principal Findings: Here, we show that mating with winged disperser males has a significantly stronger impact on life span and reproductive success of young queens of C. obscurior than mating with wingless fighter males. Conclusions: Winged males are reared mostly under stressful environmental conditions, which force young queens to disperse and found their own societies independently. In contrast, queens that mate with wingless males under favourable conditions usually start reproducing in the safety of the established maternal nest. Our study suggests that males of C. obscurior have evolved mechanisms to posthumously assist young queens during colony founding under adverse ecological conditions.	[Schrempf, Alexandra; Heinze, Juergen] Univ Regensburg, Regensburg, Germany	University of Regensburg	Schrempf, A (corresponding author), Univ Regensburg, Regensburg, Germany.	alexandra.schrempf@biologie.uni-regensburg.de			German Science Foundation (DFG) [SCHR 1135-1-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	We thank the German Science Foundation (DFG) for financial support (SCHR 1135-1-1).	ARNQVIST G, 2005, SEXUAL CONFLICT, P330; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Colonello NA, 2005, APIDOLOGIE, V36, P231, DOI 10.1051/apido:2005012; Cremer S, 2003, CURR BIOL, V13, P219, DOI 10.1016/S0960-9822(03)00012-5; Du Y, 2007, EUR J ENTOMOL, V104, P243, DOI 10.14411/eje.2007.038; Heinze J, 2006, INSECT SOC, V53, P1, DOI 10.1007/s00040-005-0847-4; Heinze J, 2005, STUD NEOTROP FAUNA E, V40, P187, DOI 10.1080/01650520500175250; Holldobler B., 1990, pi; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liana M, 2005, EXP APPL ACAROL, V35, P173, DOI 10.1007/s10493-004-4301-5; Mercier JL, 2007, INSECT SOC, V54, P403, DOI 10.1007/s00040-007-0960-7; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Simmons L. W., 2001, MG BEH ECOL; Tucic N, 1996, J EVOLUTION BIOL, V9, P485, DOI 10.1046/j.1420-9101.1996.9040485.x	16	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2592	10.1371/journal.pone.0002592	http://dx.doi.org/10.1371/journal.pone.0002592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596983	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200051
J	Lindholm, E; Bakhtadze, E; Cilio, C; Agardh, E; Groop, L; Agardh, CD				Lindholm, Eero; Bakhtadze, Ekaterina; Cilio, Corrado; Agardh, Elisabet; Groop, Leif; Agardh, Carl-David			Association between LTA, TNF and AGER Polymorphisms and Late Diabetic Complications	PLOS ONE			English	Article								Background: Several candidate genes on the short arm of chromosome 6 including the HLA locus, TNF, LTA and AGER could be associated with late diabetic complications. The aim of our study was therefore to explore whether polymorphisms (TNF 308 G -> A, LTA T60N C -> A and AGER -374 T -> A) in these genes alone or together (as haplotypes) increased the risk for diabetic complications. Methodology/Principal Findings: The studied polymorphisms were genotyped in 742 type 1 and 2957 type 2 diabetic patients as well as in 206 non-diabetic control subjects. The Haploview program was used to analyze putative linkage disequilibrium between studied polymorphisms. The TNF, LTA and AGER polymorphisms were associated with the HLA-DQB1 risk genotypes. The AGER -374 A allele was more common in type 1 diabetic patients with than without diabetic nephropathy (31.2 vs. 28.4%, p=0.007). In a logistic regression analysis, the LTA but not the AGER polymorphism was associated with diabetic nephropathy (OR 2.55[1.11-5.86], p=0.03). The AGER -374 A allele was associated with increased risk of sight threatening retinopathy in type 2 diabetic patients (1.65[1.11-2.45], p=0.01) and also with increased risk for macrovascular disease in type 1 diabetic patients (OR 2.05[1.19-3.54], p=0.01), but with decreased risk for macrovascular disease in type 2 diabetic patients (OR 0.66[0.49-0.90], p=0.009). The TNF A allele was associated with increased risk for macrovascular complications in type 2 (OR 1.53 [1.04-2.25], p=0.03, but not in type 1 diabetic patients. Conclusions/Significance: The association between diabetic complications and LTA, TNF and AGER polymorphisms is complex, with partly different alleles conferring susceptibility in type 1 and type 2 diabetic patients. We can not exclude the possibility that the genes are part of a large haplotype block that also includes HLA-DQB1 risk genotypes.	[Lindholm, Eero; Bakhtadze, Ekaterina; Cilio, Corrado; Agardh, Elisabet; Groop, Leif; Agardh, Carl-David] Lund Univ, Univ Hosp MAS, Dept Clin Sci, Lund, Sweden	Lund University; Skane University Hospital	Lindholm, E (corresponding author), Lund Univ, Univ Hosp MAS, Dept Clin Sci, Lund, Sweden.	Eero.Lindholm@med.lu.se		Lindholm, Eero/0000-0002-8869-681X	Skane County Council Research and Development Foundation; Medical Research Council of Lundberg	Skane County Council Research and Development Foundation; Medical Research Council of Lundberg	This study was supported by Skane County Council Research and Development Foundation and the Medical Research Council of Lundberg.	Agardh D, 1996, DIABETOLOGIA, V39, P1313, DOI 10.1007/s001250050575; ASSELBERGS FW, 2006, CLIN SCI LOND; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernard V, 2003, CLIN CHEM LAB MED, V41, P511, DOI 10.1515/CCLM.2003.077; DAHLEN GH, 1993, EUR J IMMUNOGENET, V20, P95, DOI 10.1111/j.1744-313X.1993.tb00098.x; Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961; dos Santos KG, 2005, MOL GENET METAB, V85, P149, DOI 10.1016/j.ymgme.2005.02.010; Dyck R, 2003, AM J NEPHROL, V23, P178, DOI 10.1159/000070747; Falcone C, 2005, CLIN CHIM ACTA, V354, P111, DOI 10.1016/j.cccn.2004.11.021; GUSTAVSSON C, 2007, J DIABETES IN PRESS; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2002, AM J PATHOL, V160, P1683, DOI 10.1016/S0002-9440(10)61115-7; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P974, DOI 10.1111/j.1471-8286.2006.01456.x; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Kumaramanickavel A, 2001, DIABETES RES CLIN PR, V54, P89, DOI 10.1016/S0168-8227(01)00269-8; Laki J, 2007, MOL IMMUNOL, V44, P648, DOI 10.1016/j.molimm.2006.01.011; Li HY, 2003, J CLIN ENDOCR METAB, V88, P2767, DOI 10.1210/jc.2002-020506; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lindholm E, 2006, DIABETOLOGIA, V49, P2745, DOI 10.1007/s00125-006-0412-3; Makhatadze NJ, 1998, HUM IMMUNOL, V59, P571, DOI 10.1016/S0198-8859(98)00056-1; Manchanda PK, 2006, CLIN CHIM ACTA, V370, P152, DOI 10.1016/j.cca.2006.02.002; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Noble JA, 1996, AM J HUM GENET, V59, P1134; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Padovani JC, 2000, THROMB RES, V100, P263, DOI 10.1016/S0049-3848(00)00315-7; Pettersson-Fernholm K, 2003, DIABETES, V52, P891, DOI 10.2337/diabetes.52.3.891; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Single RM, 2002, GENET EPIDEMIOL, V22, P186, DOI 10.1002/gepi.0163; Um JY, 2003, J MOL NEUROSCI, V21, P167, DOI 10.1385/JMN:21:2:167; Vlassara H, 2003, MT SINAI J MED, V70, P232; Wang YY, 2005, NEPHROL DIAL TRANSPL, V20, P2733, DOI 10.1093/ndt/gfi101; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zeggini E, 2005, DIABETOLOGIA, V48, P2013, DOI 10.1007/s00125-005-1902-4	34	68	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2546	10.1371/journal.pone.0002546	http://dx.doi.org/10.1371/journal.pone.0002546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18575614	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288000049
J	Miozzi, L; Piro, RM; Rosa, F; Ala, U; Silengo, L; Di Cunto, F; Provero, P				Miozzi, Laura; Piro, Rosario Michael; Rosa, Fabio; Ala, Ugo; Silengo, Lorenzo; Di Cunto, Ferdinando; Provero, Paolo			Functional Annotation and Identification of Candidate Disease Genes by Computational Analysis of Normal Tissue Gene Expression Data	PLOS ONE			English	Article							MUTATIONS; MICROARRAY; FAMILIES; GENOME	Background: High-throughput gene expression data can predict gene function through the "guilt by association'' principle: coexpressed genes are likely to be functionally associated. Methodology/Principal Findings: We analyzed publicly available expression data on normal human tissues. The analysis is based on the integration of data obtained with two experimental platforms (microarrays and SAGE) and of various measures of dissimilarity between expression profiles. The building blocks of the procedure are the Ranked Coexpression Groups (RCG), small sets of tightly coexpressed genes which are analyzed in terms of functional annotation. Functionally characterized RCGs are selected by means of the majority rule and used to predict new functional annotations. Functionally characterized RCGs are enriched in groups of genes associated to similar phenotypes. We exploit this fact to find new candidate disease genes for many OMIM phenotypes of unknown molecular origin. Conclusions/Significance: We predict new functional annotations for many human genes, showing that the integration of different data sets and coexpression measures significantly improves the scope of the results. Combining gene expression data, functional annotation and known phenotype-gene associations we provide candidate genes for several genetic diseases of unknown molecular basis.	[Miozzi, Laura] CNR, Inst Plant Virol, I-10126 Turin, Italy; [Piro, Rosario Michael; Ala, Ugo; Silengo, Lorenzo; Di Cunto, Ferdinando; Provero, Paolo] Univ Turin, Mol Biotechnol Ctr, Dept Genet, Biol & Biochem, Turin, Italy; [Rosa, Fabio] ISI Fdn, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Turin	Miozzi, L (corresponding author), CNR, Inst Plant Virol, I-10126 Turin, Italy.	paolo.provero@unito.it	Piro, Rosario M./AAT-6937-2020; Miozzi, Laura/AAY-2139-2020; Di Cunto, Ferdinando/K-5575-2016; Miozzi, Laura/AAW-9296-2021; Rosa, Fabio/AGI-6840-2022; Ala, Ugo/K-2029-2016; Provero, Paolo/AAC-1930-2019	Piro, Rosario M./0000-0002-3066-7397; Miozzi, Laura/0000-0003-0410-8230; Miozzi, Laura/0000-0003-0410-8230; Rosa, Fabio/0000-0002-8335-4482; Ala, Ugo/0000-0001-5408-6397; di cunto, ferdinando/0000-0001-9367-6357	Regione Piemonte CIPE Program; Italian Ministry of University and Research; CRT Foundation, Turin [Lagrange Fellowship]	Regione Piemonte CIPE Program(Regione Piemonte); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CRT Foundation, Turin	This work was funded by the Regione Piemonte CIPE Program to LS and by the Italian Ministry of University and Research through the FIRB program to FDC and PP. LM and PP were partially supported by a Lagrange Fellowship of the CRT Foundation, Turin. The funders did not play any active role in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	[Anonymous], ONLINE MENDELIAN INH; [Anonymous], GENE ONTOLOGY; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garvey SM, 2006, ANN HUM GENET, V70, P414, DOI 10.1111/j.1469-1809.2005.00252.x; Griffith OL, 2005, GENOMICS, V86, P476, DOI 10.1016/j.ygeno.2005.06.009; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Michaelides M, 2005, BRIT J OPHTHALMOL, V89, P198, DOI 10.1136/bjo.2004.050773; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; STEINLEIN O, 1992, GENOMICS, V12, P69, DOI 10.1016/0888-7543(92)90408-K; Sulko J, 2005, AM J MED GENET A, V137A, P292, DOI 10.1002/ajmg.a.30881; Udar N, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9109; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; COMP GENE EXPRESSION; CANC GENOME ANATOMY; SAGE LIB FINDER	28	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2439	10.1371/journal.pone.0002439	http://dx.doi.org/10.1371/journal.pone.0002439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560577	gold, Green Published			2022-12-27	WOS:000263280700024
J	Pattyn, E; Verhee, A; Uyttendaele, I; Piessevaux, J; Timmerman, E; Gevaert, K; Vandekerckhove, J; Peelman, F; Tavernier, J				Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan			HyperISGylation of Old World Monkey ISG15 in Human Cells	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; ANTIVIRAL MOLECULE; STIMULATED GENE-15; ACTIVATING ENZYME; E2 ENZYME; INTERFERON; CONJUGATION; IDENTIFICATION; VIRUS; ISGYLATION	Background: ISG15 is an Ubiquitin-like protein, highly induced by Type I Interferons. Upon the cooperative activity of specific Ubiquitinating enzymes, ISG15 can be conjugated to its substrates. Increasing evidence points to a role for protein ISGylation in anti-viral and anti-tumoral defense. Principal Findings: We identified ISG15 from Old World Monkeys (OWm) as a hyper-efficient protein modifier. Western blot analysis visualized more efficient conjugation of OWmISG15 relative to HuISG15 in human (Hu), monkey and mouse (Mo) cell-lines. Moreover, the substrates of OWmISG15 identified upon Tandem Affinity Purification followed by LC-MS/MS identification largely outnumbered these of HuISG15 itself. Several Ubiquitin-Conjugating enzymes were identified as novel ISGylated substrates. Introduction of a N89D mutation in HuISG15 improved its ISGylation capacity, and additional Q31K/T33A/D133N mutations yielded a HuISG15 variant with an ISGylation efficiency comparable to OWmISG15. Homology modeling and structural superposition situate N89 in the interaction interface with the Activating enzyme. Analysis of the UbE1L residues in this interface revealed a striking homology between OWmUbE1L and HuUbE1, the Activating enzyme of Ubiquitin. In line with this observation, we found efficient activation of AgmISG15, but not HuISG15 or MoISG15, by HuUbE1, thus providing a likely explanation for OWm hyperISGylation. Conclusions: This study discloses the poor conjugation competence of HuISG15 compared to OWmISG15 and maps the critical determinants for efficient conjugation. HyperISGylation may greatly assist ISGylation studies and may enhance its function as positive regulator of Interferon-related immune responses or as anti-tumoral modulator.	[Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan] VIB, Dept Med Prot Res, Ghent, Belgium; [Pattyn, Els; Verhee, Annick; Uyttendaele, Isabel; Piessevaux, Julie; Timmerman, Evy; Gevaert, Kris; Vandekerckhove, Joel; Peelman, Frank; Tavernier, Jan] Univ Ghent, Dept Biochem, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Pattyn, E (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	Jan.Tavernier@UGent.be	Gevaert, Kris/D-6489-2017; Tavernier, Jan/AAG-3636-2019; Gevaert, Kris/AAE-4212-2019; Gevaert, Kris/H-3637-2013	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283	Fund for Scientific Research-Flanders [3G003106, 3G007606]; Ghent University [GOA 12051401]; European Union Interaction Proteome	Fund for Scientific Research-Flanders(FWO); Ghent University(Ghent University); European Union Interaction Proteome(European Commission)	This work was supported by grants from the Fund for Scientific Research-Flanders (N 3G003106 and 3G007606 and a personal grant to IU), grant IUAP-6 N P6:28 and from Ghent University (GOA 12051401). KG and JV acknowledge support by research grants from the Fund for Scientific Research- Flanders and the European Union Interaction Proteome (6th Framework Program).	Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BAZZIGHER L, 1992, VIROLOGY, V186, P154, DOI 10.1016/0042-6822(92)90069-2; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; Catic A, 2005, TRENDS BIOCHEM SCI, V30, P600, DOI 10.1016/j.tibs.2005.09.002; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; Gevaert K, 2002, MOL CELL PROTEOMICS, V1, P896, DOI 10.1074/mcp.M200061-MCP200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; GRAHAM RW, 1989, MOL CELL BIOL, V9, P268, DOI 10.1128/MCB.9.1.268; Haas A.L., 2006, PROTEIN DEGRADATION; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; LINDNER HA, 2007, ARCH BIOCH BIOPHYS; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McDade TW, 1999, AM J HUM BIOL, V11, P705, DOI 10.1002/(SICI)1520-6300(199911/12)11:6<705::AID-AJHB1>3.0.CO;2-G; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Okamoto Y, 2003, CANCER RES, V63, P4167; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Pitha-Rowe I, 2004, J BIOL CHEM, V279, P18178, DOI 10.1074/jbc.M309259200; Potter JL, 1999, J BIOL CHEM, V274, P25061, DOI 10.1074/jbc.274.35.25061; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; STAES A, 2008, PROTEOMICS; Takeuchi T, 2005, J BIOCHEM, V138, P711, DOI 10.1093/jb/mvi172; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhang Xu, 2007, Fudan Xuebao (Yixueban), V34, P580; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	62	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2427	10.1371/journal.pone.0002427	http://dx.doi.org/10.1371/journal.pone.0002427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560560	Green Published, gold, Green Submitted			2022-12-27	WOS:000263280700012
J	Fisher, AC; DeLisa, MP				Fisher, Adam C.; DeLisa, Matthew P.			Laboratory Evolution of Fast-Folding Green Fluorescent Protein Using Secretory Pathway Quality Control	PLOS ONE			English	Article								Green fluorescent protein (GFP) has undergone a long history of optimization to become one of the most popular proteins in all of cell biology. It is thermally and chemically robust and produces a pronounced fluorescent phenotype when expressed in cells of all types. Recently, a superfolder GFP was engineered with increased resistance to denaturation and improved folding kinetics. Here we report that unlike other well-folded variants of GFP (e. g., GFPmut2), superfolder GFP was spared from elimination when targeted for secretion via the SecYEG translocase. This prompted us to hypothesize that the folding quality control inherent to this secretory pathway could be used as a platform for engineering similar 'superfolded' proteins. To test this, we targeted a combinatorial library of GFPmut2 variants to the SecYEG translocase and isolated several superfolded variants that accumulated in the cytoplasm due to their enhanced folding properties. Each of these GFP variants exhibited much faster folding kinetics than the parental GFPmut2 protein and one of these, designated superfast GFP, folded at a rate that even exceeded superfolder GFP. Remarkably, these GFP variants exhibited little to no loss in specific fluorescence activity relative to GFPmut2, suggesting that the process of superfolding can be accomplished without altering the proteins' normal function. Overall, we demonstrate that laboratory evolution combined with secretory pathway quality control enables sampling of largely unexplored amino-acid sequences for the discovery of artificial, high-performance proteins with properties that are unparalleled in their naturally occurring analogues.	[Fisher, Adam C.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University	Fisher, AC (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation CAREER Award [0449080]; NYSTAR James D. Watson Investigator Award	National Science Foundation CAREER Award(National Science Foundation (NSF)); NYSTAR James D. Watson Investigator Award	This work was supported by a National Science Foundation CAREER Award (BES #0449080) and a NYSTAR James D. Watson Investigator Award (both to MPD).	Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2004, J BACTERIOL, V186, P7467, DOI 10.1128/JB.186.22.7467-7473.2004; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; GENTZ R, 1988, J BACTERIOL, V170, P2212, DOI 10.1128/jb.170.5.2212-2220.1988; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jackson SE, 2006, EXPERT REV PROTEOMIC, V3, P545, DOI 10.1586/14789450.3.5.545; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; Lansbury PT, 2001, NAT BIOTECHNOL, V19, P112, DOI 10.1038/84355; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; Liu JW, 2006, PROTEIN EXPRES PURIF, V47, P258, DOI 10.1016/j.pep.2005.11.019; Lu CH, 2004, BIOTECHNOL PROGR, V20, P1634, DOI 10.1021/bp049751l; Maxwell KL, 1999, PROTEIN SCI, V8, P1908, DOI 10.1110/ps.8.9.1908; MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107; MEERMAN HJ, 1994, ANN NY ACAD SCI, V721, P292, DOI 10.1111/j.1749-6632.1994.tb47402.x; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schlicht M, 2006, APPL ENVIRON MICROB, V72, P5637, DOI 10.1128/AEM.00739-06; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Vendruscolo M, 2007, NATURE, V449, P555, DOI 10.1038/449555a; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; WEISS JB, 1990, J BACTERIOL, V172, P3023, DOI 10.1128/jb.172.6.3023-3029.1990; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	46	53	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2351	10.1371/journal.pone.0002351	http://dx.doi.org/10.1371/journal.pone.0002351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545653	gold, Green Published, Green Submitted			2022-12-27	WOS:000263248800011
J	Greene, JM; Burwitz, BJ; Blasky, AJ; Mattila, TL; Hong, JJ; Rakasz, EG; Wiseman, RW; Hasenkrug, KJ; Skinner, PJ; O'Connor, SL; O'Connor, DH				Greene, Justin M.; Burwitz, Benjamin J.; Blasky, Alex J.; Mattila, Teresa L.; Hong, Jung Joo; Rakasz, Eva G.; Wiseman, Roger W.; Hasenkrug, Kim J.; Skinner, Pamela J.; O'Connor, Shelby L.; O'Connor, David H.			Allogeneic Lymphocytes Persist and Traffic in Feral MHC-Matched Mauritian Cynomolgus Macaques	PLOS ONE			English	Article								Background: Thus far, live attenuated SIV has been the most successful method for vaccinating macaques against pathogenic SIV challenge; however, it is not clear what mechanisms are responsible for this protection. Adoptive transfer studies in mice have been integral to understanding live attenuated vaccine protection in models like Friend virus. Previous adoptive transfers in primates have failed as transferred cells are typically cleared within hours after transfer. Methodology/Principal Findings: Here we describe adoptive transfer studies in Mauritian origin cynomolgus macaques (MCM), a non-human primate model with limited MHC diversity. Cells transferred between unrelated MHC-matched macaques persist for at least fourteen days but are rejected within 36 hours in MHC-mismatched macaques. Cells trafficked from the blood to peripheral lymphoid tissues within 12 hours of transfer. Conclusions/Significance: MHC-matched MCM provide the first viable primate model for adoptive transfer studies. Because macaques infected with SIV are the best model for HIV/AIDS pathogenesis, we can now directly study the correlates of protective immune responses to AIDS viruses. For example, plasma viral loads following pathogenic SIV challenge are reduced by several orders of magnitude in macaques previously immunized with attenuated SIV. Adoptive transfer of lymphocyte subpopulations from vaccinated donors into SIV-naive animals may define the immune mechanisms responsible for protection and guide future vaccine development.	[Greene, Justin M.; Burwitz, Benjamin J.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Blasky, Alex J.; Rakasz, Eva G.; Wiseman, Roger W.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Mattila, Teresa L.; Hong, Jung Joo; Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN USA; [Hasenkrug, Kim J.] NIH, NIAID, Rocky Mountain Lab, Lab Persistent Viral Dis, Hamilton, MT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Greene, JM (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	doconnor@primate.wisc.edu	Rakasz, Eva G/H-9197-2019	o'connor, david/0000-0003-2139-470X; Skinner, Pamela/0000-0003-3388-1687	International AIDS Vaccine Initiative (IAVI) [133-JH10]; NIH [1R21AI068488-01A2, RR021745-01A1]; National Center for Research Resources (NCRR) [P51 RR000167]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR021745, C06RR015459, P51RR000167, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000753, ZIAAI001100, R21AI068488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by International AIDS Vaccine Initiative (IAVI) grant 133-JH10; and NIH grants 1R21AI068488-01A2 and RR021745-01A1. This publication was made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01.	Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Berger C, 2004, BLOOD, V103, P1261, DOI 10.1182/blood-2003-08-2908; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bernstein WB, 2004, CLIN IMMUNOL, V111, P262, DOI 10.1016/j.clim.2004.03.004; BEX F, 1994, BLOOD, V84, P3317; Chea S, 2005, J VIROL, V79, P3748, DOI 10.1128/JVI.79.6.3748-3757.2005; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; de Groot N, 2004, J IMMUNOL, V172, P6152, DOI 10.4049/jimmunol.172.10.6152; DeMaria MA, 2000, EUR J HAEMATOL, V65, P245, DOI 10.1034/j.1600-0609.2000.065004245.x; Dittmer U, 1999, J VIROL, V73, P3753, DOI 10.1128/JVI.73.5.3753-3757.1999; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Dittmer Ulf, 2001, Current Molecular Medicine (Hilversum), V1, P431, DOI 10.2174/1566524013363591; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Hasenkrug KJ, 2007, FRONT BIOSCI-LANDMRK, V12, P1544, DOI 10.2741/2167; HOFFMANN C, 2007, BR J HAEMATOL; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Johnson RP, 2002, VACCINE, V20, P1985, DOI 10.1016/S0264-410X(02)00083-X; JOSEPH A, 2008, J VIROL; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; KESTLER HW, 1988, NATURE, V331, P619, DOI 10.1038/331619a0; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; McKinney DM, 1999, J IMMUNOL, V163, P861; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; O'Connor SL, 2007, IMMUNOGENETICS, V59, P449, DOI 10.1007/s00251-007-0209-7; Onlamoon N, 2007, J MED PRIMATOL, V36, P206, DOI 10.1111/j.1600-0684.2007.00238.x; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1998, BLOOD, V92, P198, DOI 10.1182/blood.V92.1.198.413k13_198_206; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SLEZAK SE, 1989, J IMMUNOL METHODS, V117, P205, DOI 10.1016/0022-1759(89)90142-7; Tan R, 1998, AIDS, V12, P2240; Tan RS, 1999, BLOOD, V93, P1506, DOI 10.1182/blood.V93.5.1506.405a38_1506_1510; Villinger F, 2002, BLOOD, V99, P590, DOI 10.1182/blood.V99.2.590; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker RE, 2000, BLOOD, V96, P467; Watanabe ME, 2003, NAT MED, V9, P376, DOI 10.1038/nm0403-376b; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	47	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2384	10.1371/journal.pone.0002384	http://dx.doi.org/10.1371/journal.pone.0002384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	405UD	18545705	gold, Green Published			2022-12-27	WOS:000263248800023
J	Liao, AP; Petrof, EO; Kuppireddi, S; Zhao, Y; Xia, YL; Claud, EC; Sun, J				Liao, Anne P.; Petrof, Elaine O.; Kuppireddi, Sumalatha; Zhao, Yun; Xia, Yinglin; Claud, Erika C.; Sun, Jun			Salmonella Type III Effector AvrA Stabilizes Cell Tight Junctions to Inhibit Inflammation in Intestinal Epithelial Cells	PLOS ONE			English	Article								Salmonella Typhimurium is a major cause of human gastroenteritis. The Salmonella type III secretory system secretes virulence proteins, called effectors. Effectors are responsible for the alteration of tight junction (TJ) structure and function in intestinal epithelial cells. AvrA is a newly described bacterial effector found in Salmonella. We report here that AvrA expression stabilizes cell permeability and tight junctions in intestinal epithelial cells. Cells colonized with an AvrA-deficient bacterial strain (AvrA(-)) displayed decreased cell permeability, disruption of TJs, and an increased inflammatory response. Western blot data showed that TJ proteins, such as ZO-1, claudin-1, decreased after AvrA- colonization for only 1 hour. In contrast, cells colonized with AvrA- sufficient bacteria maintained cell permeability with stabilized TJ structure. This difference was confirmed in vivo. Fluorescent tracer studies showed increased fluorescence in the blood of mice infected with AvrA- compared to those infected with the AvrA- sufficient strains. AvrA- disrupted TJ structure and function and increased inflammation in vivo, compared to the AvrA- sufficient strain. Additionally, AvrA overexpression increased TJ protein expression when transfected into colonic epithelial cells. An intriguing aspect of this study is that AvrA stabilized TJs, even though the other TTSS proteins, SopB, SopE, and SopE2, are known to disrupt TJs. AvrA may play a role in stabilizing TJs and balancing the opposing action of other bacterial effectors. Our findings indicate an important role for the bacterial effector AvrA in regulation of intestinal epithelial cell TJs during inflammation. The role of AvrA represents a highly refined bacterial strategy that helps the bacteria survive in the host and dampen the inflammatory response.	[Liao, Anne P.; Kuppireddi, Sumalatha; Zhao, Yun; Xia, Yinglin; Sun, Jun] Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY 14627 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Div Infect Dis, GI Dis Res Unit, Kingston, ON, Canada; [Claud, Erika C.] Univ Chicago, Med Ctr, Dept Paediat, Chicago, IL USA	University of Rochester; Queens University - Canada; University of Chicago; University of Chicago Medical Center	Liao, AP (corresponding author), Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY 14627 USA.	jun_sun@umrc.rochester.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK;  [KO1 DK075386]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK KO1 DK075386 to J. S. The funder played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Ben-Barak Z, 2006, INT J MED MICROBIOL, V296, P25, DOI 10.1016/j.ijmm.2005.08.004; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; FINLAY BB, 1990, J INFECT DIS, V162, P1096, DOI 10.1093/infdis/162.5.1096; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Huang FC, 2004, INFECT IMMUN, V72, P5052, DOI 10.1128/IAI.72.9.5052-5062.2004; JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995; Jepson MA, 2000, INFECT IMMUN, V68, P7202, DOI 10.1128/IAI.68.12.7202-7208.2000; Kohler H, 2007, AM J PHYSIOL-GASTR L, V293, pG178, DOI 10.1152/ajpgi.00535.2006; Landau D, 2006, CURR OPIN NEPHROL HY, V15, P425, DOI 10.1097/01.mnh.0000232883.43093.76; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Reed KA, 2002, J BIOL CHEM, V277, P13346, DOI 10.1074/jbc.M200149200; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Streckel W, 2004, MOL NUTR FOOD RES, V48, P496, DOI 10.1002/mnfr.200400035; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Tafazoli F, 2003, INFECT IMMUN, V71, P872, DOI 10.1128/IAI.71.2.872-881.2003; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Turner JR, 2000, AM J PHYSIOL-CELL PH, V279, pC1918, DOI 10.1152/ajpcell.2000.279.6.C1918; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	41	85	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2369	10.1371/journal.pone.0002369	http://dx.doi.org/10.1371/journal.pone.0002369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523661	gold, Green Published, Green Submitted			2022-12-27	WOS:000262614300055
J	Berno, V; Amazit, L; Hinojos, C; Zhong, J; Mancini, MG; Sharp, ZD; Mancini, MA				Berno, Valeria; Amazit, Larbi; Hinojos, Cruz; Zhong, Jeannie; Mancini, Maureen G.; Sharp, Zelton Dave; Mancini, Michael A.			Activation of Estrogen Receptor-alpha by E2 or EGF Induces Temporally Distinct Patterns of Large-Scale Chromatin Modification and mRNA Transcription	PLOS ONE			English	Article								Estrogen receptor-alpha (ER) transcription function is regulated in a ligand-dependent (e. g., estradiol, E2) or ligand-independent (e. g., growth factors) manner. Our laboratory seeks to understand these two modes of action. Using a cell line that contains a visible prolactin enhancer/promoter array (PRL-HeLa) regulated by ER, we analyzed ER response to E2 and EGF by quantifying image-based results. Data show differential recruitment of GFP-ER to the array, with the AF1 domain playing a vital role in EGF-mediated responsiveness. Temporal analyses of large-scale chromatin dynamics, and accumulation of array-localized reporter mRNA over 24 hours showed that the EGF response consists of a single pulse of reporter mRNA accumulation concomitant with transient increase in array decondensation. Estradiol induced a novel cyclical pattern of mRNA accumulation with a sustained increase in array decondensation. Collectively, our work shows that there is a stimuli-specific pattern of large-scale chromatin modification and transcript levels by ER.	[Berno, Valeria; Amazit, Larbi; Hinojos, Cruz; Zhong, Jeannie; Mancini, Maureen G.; Mancini, Michael A.] Baylor Coll Med, Houston, TX 77030 USA; [Sharp, Zelton Dave] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Berno, V (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	mancini@bcm.tmc.edu	Berno, Valeria/AAN-3997-2020	Berno, Valeria/0000-0001-5848-494X	NIH [DK55622]; Department of Defense Synergistic Idea Award [GRANT00210313]; Center for Reproductive Biology [HD-07495]; Baylor College of Medicine Dan L. Duncan Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Synergistic Idea Award; Center for Reproductive Biology; Baylor College of Medicine Dan L. Duncan Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH grants DK55622 (M.A.M.), and a Department of Defense Synergistic Idea Award GRANT00210313 to MAM and ZDS; Integrated Microscopy Core support was provided by HD-07495 (Center for Reproductive Biology, B.W. O'Malley) and the Baylor College of Medicine Dan L. Duncan Cancer Center.	Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Britton DJ, 2006, BREAST CANCER RES TR, V96, P131, DOI 10.1007/s10549-005-9070-2; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CARRILLO AJ, 1987, ENDOCRINOLOGY, V121, P1993, DOI 10.1210/endo-121-6-1993; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; FEY EG, 1986, J CELL SCI, P99; Gee JMW, 2005, BREAST CANCER RES, V7, P187, DOI 10.1186/bcr1289; Gorski S, 2005, J CELL SCI, V118, P4083, DOI 10.1242/jcs.02596; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lipfert L, 2006, MOL ENDOCRINOL, V20, P516, DOI 10.1210/me.2005-0190; Manfroid I, 2005, MOL CELL ENDOCRINOL, V229, P127, DOI 10.1016/j.mce.2004.08.009; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Murphy L, 2004, CLIN CANCER RES, V10, P1354, DOI 10.1158/1078-0432.CCR-03-0112; Murphy LC, 2004, CLIN CANCER RES, V10, P5902, DOI 10.1158/1078-0432.CCR-04-0191; Osborne CK, 2003, BREAST, V12, P362, DOI 10.1016/S0960-9776(03)00137-1; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Shav-Tal Y, 2006, EMBO J, V25, P3469, DOI 10.1038/sj.emboj.7601226; SHOPLAND RLS, APPL RNA FISH VISUAL; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stenoien DL, 2000, J CELL BIOCHEM, P99; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Takahashi T, 2005, ENDOCRINOLOGY, V146, P4082, DOI 10.1210/en.2005-0302; Voogt J L, 2001, Prog Brain Res, V133, P173; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Weitsman GE, 2006, CANCER RES, V66, P10162, DOI 10.1158/0008-5472.CAN-05-4111	51	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2286	10.1371/journal.pone.0002286	http://dx.doi.org/10.1371/journal.pone.0002286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509470	gold, Green Published, Green Submitted			2022-12-27	WOS:000262268500028
J	McNally, BA; Trgovcich, J; Maul, GG; Liu, Y; Zheng, P				McNally, Beth A.; Trgovcich, Joanne; Maul, Gerd G.; Liu, Yang; Zheng, Pan			A Role for Cytoplasmic PML in Cellular Resistance to Viral Infection	PLOS ONE			English	Article								PML gene was discovered as a fusion partner with retinoic acid receptor (RAR) alpha in the t(15:17) chromosomal translocation associated with acute promyelocytic leukemia (APL). Nuclear PML protein has been implicated in cell growth, tumor suppression, apoptosis, transcriptional regulation, chromatin remodeling, DNA repair, and anti-viral defense. The localization pattern of promyelocytic leukemia (PML) protein is drastically altered during viral infection. This alteration is traditionally viewed as a viral strategy to promote viral replication. Although multiple PML splice variants exist, we demonstrate that the ratio of a subset of cytoplasmic PML isoforms lacking exons 5 & 6 is enriched in cells exposed to herpes simplex virus-1 (HSV-1). In particular, we demonstrate that a PML isoform lacking exons 5 & 6, called PML Ib, mediates the intrinsic cellular defense against HSV-1 via the cytoplasmic sequestration of the infected cell protein (ICP) 0 of HSV-1. The results herein highlight the importance of cytoplasmic PML and call for an alternative, although not necessarily exclusive, interpretation regarding the redistribution of PML that is seen in virally infected cells.	[McNally, Beth A.; Trgovcich, Joanne; Liu, Yang; Zheng, Pan] Ohio State Univ, Med Ctr, Dept Pathol, Div Canc Immunol, Columbus, OH 43210 USA; [McNally, Beth A.; Liu, Yang; Zheng, Pan] Univ Michigan, Comprehensive Canc Ctr, Dept Surg, Program Mol Mechanism Dis, Ann Arbor, MI USA; [Maul, Gerd G.] Wistar Inst Anat & Biol, Philadelphia, PA USA	University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; The Wistar Institute	McNally, BA (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Div Canc Immunol, Columbus, OH 43210 USA.	panz@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institute of Health [CA82355]; Department of Defense [DAMD 17-03-1-0013]; NATIONAL CANCER INSTITUTE [R01CA082355] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by Grants from the National Institute of Health (CA82355 to PZ) and Department of Defense (DAMD 17-03-1-0013 to PZ).	Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Ahn JH, 1997, J VIROL, V71, P4599, DOI 10.1128/JVI.71.6.4599-4613.1997; Bell P, 2000, J VIROL, V74, P5329, DOI 10.1128/JVI.74.11.5329-5336.2000; Bell P, 2000, J VIROL, V74, P11800, DOI 10.1128/JVI.74.24.11800-11810.2000; Bellodi C, 2006, CELL CYCLE, V5, P2688, DOI 10.4161/cc.5.22.3504; Blondel D, 2002, ONCOGENE, V21, P7957, DOI 10.1038/sj.onc.1205931; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Borden KLB, 1998, J VIROL, V72, P758, DOI 10.1128/JVI.72.1.758-766.1998; Boulware SL, 2000, J GEN VIROL, V81, P1773, DOI 10.1099/0022-1317-81-7-1773; Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Burkham J, 2001, J VIROL, V75, P2353, DOI 10.1128/JVI.75.5.2353-2367.2001; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Ehmann GL, 2000, VIROLOGY, V267, P335, DOI 10.1006/viro.1999.0147; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; EVERETT RD, 1987, ANTICANCER RES, V7, P589; Everett RD, 2004, J VIROL, V78, P11411, DOI 10.1128/JVI.78.20.11411-11415.2004; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; FAGIOLI M, 1992, ONCOGENE, V7, P1083; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HARDWICKE MA, 1994, J VIROL, V68, P4797, DOI 10.1128/JVI.68.8.4797-4810.1994; HARDY WR, 1994, J VIROL, V68, P7790, DOI 10.1128/JVI.68.12.7790-7799.1994; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lopez P, 2002, J VIROL, V76, P9355, DOI 10.1128/JVI.76.18.9355-9367.2002; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Phelan A, 1997, J GEN VIROL, V78, P3327, DOI 10.1099/0022-1317-78-12-3327; PRESTON CM, 1976, J GEN VIROL, V33, P471, DOI 10.1099/0022-1317-33-3-471; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; ROLLER RJ, 1992, J VIROL, V66, P3624, DOI 10.1128/JVI.66.6.3624-3632.1992; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; STUURMAN N, 1992, J CELL SCI, V101, P773; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	66	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2277	10.1371/journal.pone.0002277	http://dx.doi.org/10.1371/journal.pone.0002277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509536	Green Submitted, gold, Green Published			2022-12-27	WOS:000262268500021
J	Moron, B; Bethune, MT; Comino, I; Manyani, H; Ferragud, M; Lopez, MC; Cebolla, A; Khosla, C; Sousa, C				Moron, Belen; Bethune, Michael T.; Comino, Isabel; Manyani, Hamid; Ferragud, Marina; Lopez, Manuel Carlos; Cebolla, Angel; Khosla, Chaitan; Sousa, Carolina			Toward the Assessment of Food Toxicity for Celiac Patients: Characterization of Monoclonal Antibodies to a Main Immunogenic Gluten Peptide	PLOS ONE			English	Article							COMBINATION ENZYME THERAPY; GLIADIN PEPTIDES; RATIONAL DESIGN; T-CELLS; DISEASE; SAFE; INTERLEUKIN-15; INTOLERANCE; EXPRESSION; THRESHOLD	Background and Aims: Celiac disease is a permanent intolerance to gluten prolamins from wheat, barley, rye and, in some patients, oats. Partially digested gluten peptides produced in the digestive tract cause inflammation of the small intestine. High throughput, immune-based assays using monoclonal antibodies specific for these immunotoxic peptides would facilitate their detection in food and enable monitoring of their enzymatic detoxification. Two monoclonal antibodies, G12 and A1, were developed against a highly immunotoxic 33-mer peptide. The potential of each antibody for quantifying food toxicity for celiac patients was studied. Methods: Epitope preferences of G12 and A1 antibodies were determined by ELISA with gluten-derived peptide variants of recombinant, synthetic or enzymatic origin. Results: The recognition sequences of G12 and A1 antibodies were hexameric and heptameric epitopes, respectively. Although G12 affinity for the 33-mer was superior to A1, the sensitivity for gluten detection was higher for A1. This observation correlated to the higher number of A1 epitopes found in prolamins than G12 epitopes. Activation of T cell from gluten digested by glutenases decreased equivalently to the detection of intact peptides by A1 antibody. Peptide recognition of A1 included gliadin peptides involved in the both the adaptive and innate immunological response in celiac disease. Conclusions: The sensitivity and epitope preferences of the A1 antibody resulted to be useful to detect gluten relevant peptides to infer the potential toxicity of food for celiac patients as well as to monitor peptide modifications by transglutaminase 2 or glutenases.	[Moron, Belen; Comino, Isabel; Manyani, Hamid; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Moron, Belen; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA USA; [Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA USA; [Ferragud, Marina; Cebolla, Angel] Biomedal SL, Seville, Spain; [Lopez, Manuel Carlos] CSIC, Inst Parasitol Biomed Lopez Neyra, Dept Biol Mol, Granada, Spain; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA USA	University of Sevilla; Stanford University; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Stanford University	Moron, B (corresponding author), Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain.	csoumar@us.es	Lopez, Manuel/Z-5641-2019; Manyani, Hamid/AFE-8060-2022; Manyani, Hamid/AAE-9636-2022	Sousa Martin, Carolina/0000-0002-9235-9496; Manyani Charroudi, Hamid/0000-0001-6129-2092; Lopez, Manuel Carlos/0000-0003-0002-3678; Khosla, Chaitan/0000-0001-6529-495X; Moron, Belen/0000-0003-4815-7536	Asociacion de Celiacos de Madrid; Corporacion Tecnologica de Andalucia; Agencia de Innovacion y Desarrollo de Andalucia; Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica [BFU2007-64999, RICET-RD06/0021-0014]; Consejo Andaluz de Colegios Oficiales de Farmaceuticos [fellowship]	Asociacion de Celiacos de Madrid; Corporacion Tecnologica de Andalucia; Agencia de Innovacion y Desarrollo de Andalucia; Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica; Consejo Andaluz de Colegios Oficiales de Farmaceuticos	This work was supported by the Asociacion de Celiacos de Madrid (to Carolina Sousa), by the CTA (Corporacion Tecnologica de Andalucia) and IDEA (Agencia de Innovacion y Desarrollo de Andalucia) (to Angel Cebolla) and by grants BFU2007-64999 from Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica (Miniterio de Educacion y Ciencia) and RICET-RD06/0021-0014, Spain (to Manuel C. Lopez). Belen Moron was supported by a fellowship from Consejo Andaluz de Colegios Oficiales de Farmaceuticos. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bernardo D, 2007, GUT, V56, P889, DOI 10.1136/gut.2006.118265; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Cerf-Bensussan N, 2007, GUT, V56, P157, DOI 10.1136/gut.2005.090498; Collin P, 2004, ALIMENT PHARM THER, V19, P1277, DOI 10.1111/j.1365-2036.2004.01961.x; ELLIS HJ, 1994, INT ARCH ALLERGY IMM, V104, P308, DOI 10.1159/000236683; ELLIS HJ, 1990, CLIN CHIM ACTA, V189, P123, DOI 10.1016/0009-8981(90)90082-4; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Khosla C, 2005, GASTROENTEROLOGY, V129, P1362, DOI 10.1053/j.gastro.2005.08.044; Kumar V, 2001, CLIN DIAGN LAB IMMUN, V8, P678, DOI 10.1128/CDLI.8.4.678-685.2001; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Robins G, 2005, CURR OPIN GASTROEN, V21, P152, DOI 10.1097/01.mog.0000153312.05457.8d; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Shewry P., 1992, COELIAC DIS, P305; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Skovbjerg H, 2004, BBA-MOL BASIS DIS, V1690, P220, DOI 10.1016/j.bbadis.2004.06.009; Sollid LM, 2005, NAT CLIN PRACT GASTR, V2, P140, DOI 10.1038/ncpgasthep0111; Spaenij-Dekking EHA, 2004, GUT, V53, P1267, DOI 10.1136/gut.2003.037952; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Stern M, 2001, EUR J GASTROEN HEPAT, V13, P741, DOI 10.1097/00042737-200106000-00023; *TEPN BIOS, GLUT ASS KIT QUANT D; Valdes I, 2003, EUR J GASTROEN HEPAT, V15, P465, DOI 10.1097/01.meg.0000059119.41030.df; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Vora H, 2007, BIOTECHNOL BIOENG, V98, P177, DOI 10.1002/bit.21423; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c	41	123	129	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2294	10.1371/journal.pone.0002294	http://dx.doi.org/10.1371/journal.pone.0002294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509534	Green Published, gold			2022-12-27	WOS:000262268500033
J	Chiou, SH; Kao, CL; Chen, YW; Chien, CS; Hung, SC; Lo, JF; Chen, YJ; Ku, HH; Hsu, MT; Wong, TT				Chiou, Shih-Hwa; Kao, Chung-Lan; Chen, Yi-Wei; Chien, Chien-Shu; Hung, Shih-Chieh; Lo, Jeng-Fan; Chen, Yann-Jang; Ku, Hung-Hai; Hsu, Ming-Ta; Wong, Tai-Tong			Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/Rhabdoid Tumor	PLOS ONE			English	Article								Atypical teratoid/rhabdoid tumor (AT/RT) is an extremely malignant neoplasm in the central nervous system (CNS) which occurs in infancy and childhood. Recent studies suggested that CD133 could be considered a marker for brain cancer stemlike cells (CSCs). However, the role of CD133 in AT/RT has never been investigated. Herein we report the isolation of CD133-positive cells (CD133(+)), found to have the potential to differentiate into three germ layer tissues, from tissues of nine AT/RT patients. The migration/invasion/malignancy and radioresistant capabilities of CD133(+) were significantly augmented when compared to CD133(-). The clinical data showed that the amount of CD133(+) in AT/RTs correlated positively with the degree of resistance to radiation therapy. Using cDNA microarray analysis, the genotoxic -response profiles of CD133(+) and CD133(-) irradiated with 10 Gy ionizing radiation (IR) were analyzed 0.5, 2, 6, 12 and 24 h post-IR. We then validated these microarray data and showed increased phosphorylation after IR of p-ATM, p-RAD17, and p-CHX2 as well as increased expression of BCL-2 protein in CD133(+) compared to CD133(-). Furthermore, we found that CD133(+) can effectively resist IR with cisplatin-and/or TRAIL-induced apoptosis. Immunohistochemical analysis confirmed the up-regulated expression of p-ATM and BCL-2 proteins in IR-treated CD133(+) xenotransgrafts in SCID mice but not in IR-treated CD133(-). Importantly, the effect of IR in CD133(+) transplanted mice can be significantly improved by a combination of BCL-2 siRNA with debromohymenialdisine, an inhibitor of checkpoint kinases. In sum, this is the first report indicating that CD133(+) AT/RT cells demonstrate the characteristics of CSCs. The IR-resistant and anti-apoptotic properties in CD133(+) may reflect the clinical refractory malignancy of AT/RTs and thus the activated p-ATM pathway and BCL-2 expression in CD133(+) could be possible targets to improve future treatment of deadly diseases like AT/RT.	[Chiou, Shih-Hwa; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Kao, Chung-Lan] Natl Yang Ming Univ, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Yi-Wei] Taipei Vet Gen Hosp, Dept Phys Med & Rehab, Taipei, Taiwan; [Wong, Tai-Tong] Natl Yang Ming Univ, Dept Phys Med & Rehab, Taipei, Taiwan; [Chiou, Shih-Hwa; Chien, Chien-Shu; Lo, Jeng-Fan] Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan; [Chen, Yann-Jang; Hsu, Ming-Ta; Wong, Tai-Tong] Natl Yang Ming Univ, Canc Ctr, Taipei, Taiwan; [Ku, Hung-Hai] Taipei Vet Gen Hosp, Neurol Inst, Sect Neuropediat Surg, Taipei, Taiwan; [Chiou, Shih-Hwa; Kao, Chung-Lan; Chen, Yi-Wei; Hung, Shih-Chieh] Natl Yang Ming Univ, Neurol Inst, Sect Neuropediat Surg, Taipei, Taiwan; Natl Yang Ming Univ, Inst Oral Biol, Taipei, Taiwan; Natl Yang Ming Univ, VYM Genomic Res Ctr, Taipei, Taiwan; Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan; Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chiou, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	shchiou@vghtpe.gov.tw	Chen, Yi/HIR-2608-2022; Chien, Chian-Shiu/AAT-3192-2020; Lo, Jeng-Fan/AAE-9626-2020; Lo, Jeng-Fan/ABB-2820-2020	Lo, Jeng-Fan/0000-0001-7188-9140; Lo, Jeng-Fan/0000-0001-7188-9140; Wong, Tai-Tong/0000-0003-4075-6227	National Science Council [NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024]; Taipei Veterans General Hospital [V96C1-151, V96E1-004, V96ER2-016, V96E2-010]; Joint Projects of UTVGH [VGHUST96-P1-07]; VGHUST96-P1-07; Yen-Tjing-Ling Medical Foundation; Taipei City Hospital [96001-62-014, 96001-62-018, 96002-62-092]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint Projects of UTVGH; VGHUST96-P1-07; Yen-Tjing-Ling Medical Foundation; Taipei City Hospital; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024), Taipei Veterans General Hospital (V96C1-151, V96E1-004, V96ER2-016, V96E2-010), the Joint Projects of UTVGH (VGHUST96-P1-07), Yen-Tjing-Ling Medical Foundation, Taipei City Hospital (96001-62-014, 96001-62-018, 96002-62-092), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan.	BAO S, 2006, ACTA NEUROCHIR WIEN, V139, P961; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BERGMANN M, 1997, PRIMARY MALIGNANT RH; BIEGEL JA, 1992, GENE CHROMOSOME CANC, V5, P104, DOI 10.1002/gcc.2870050203; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Biegel JA, 1999, CANCER RES, V59, P74; BIEGEL JA, 1989, NEW ENGL J MED, V321, P906; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; CHEN YW, 2006, INT J RADIAT ONCOL, V64, P3843; Cheng YC, 2005, ACTA RADIOL, V46, P89, DOI 10.1080/02841850510020987; Chiou SH, 2006, J IMMUNOL, V177, P6199, DOI 10.4049/jimmunol.177.9.6199; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Hilden JM, 2004, J CLIN ONCOL, V22, P2877, DOI 10.1200/jco.2004.07.073; Ho DMT, 2000, ACTA NEUROPATHOL, V99, P482, DOI 10.1007/s004010051149; Kao CL, 2005, MODERN PATHOL, V18, P769, DOI 10.1038/modpathol.3800270; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Nix P, 2005, BRIT J CANCER, V92, P2185, DOI 10.1038/sj.bjc.6602647; Packer RJ, 2002, J PEDIAT HEMATOL ONC, V24, P337, DOI 10.1097/00043426-200206000-00004; Parwani AV, 2005, CANCER CYTOPATHOL, V105, P65, DOI 10.1002/cncr.20872; Peng CH, 2008, EUR NEUROPSYCHOPHARM, V18, P128, DOI 10.1016/j.euroneuro.2007.05.002; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; Schwartz JL, 2007, INT J RADIAT BIOL, V83, P153, DOI 10.1080/09553000601146949; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weiss E, 1998, INT J RADIAT ONCOL, V41, P1013, DOI 10.1016/S0360-3016(98)00106-0; Wong TT, 2005, CANCER, V104, P2156, DOI 10.1002/cncr.21430; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zgheib O, 2005, RADIOTHER ONCOL, V76, P119, DOI 10.1016/j.radonc.2005.06.026	45	95	96	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2090	10.1371/journal.pone.0002090	http://dx.doi.org/10.1371/journal.pone.0002090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18509505	gold, Green Published			2022-12-27	WOS:000261642400013
J	Skibola, CF; Bracci, PM; Halperin, E; Nieters, A; Hubbard, A; Paynter, RA; Skibola, DR; Agana, L; Becker, N; Tressler, P; Forrest, MS; Sankararaman, S; Conde, L; Holly, EA; Smith, MT				Skibola, Christine F.; Bracci, Paige M.; Halperin, Eran; Nieters, Alexandra; Hubbard, Alan; Paynter, Randi A.; Skibola, Danica R.; Agana, Luz; Becker, Nikolaus; Tressler, Patrick; Forrest, Matthew S.; Sankararaman, Sriram; Conde, Lucia; Holly, Elizabeth A.; Smith, Martyn T.			Polymorphisms in the Estrogen Receptor 1 and Vitamin C and Matrix Metalloproteinase Gene Families Are Associated with Susceptibility to Lymphoma	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; HAPLOTYPE RECONSTRUCTION; CYTOCHROME-P450 17A1; TUMOR INVASION; RISK; DATABASE; CANCER; BIOSYNTHESIS; INHIBITORS; EXPRESSION	Background: Non-Hodgkin lymphoma (NHL) is the fifth most common cancer in the U. S. and few causes have been identified. Genetic association studies may help identify environmental risk factors and enhance our understanding of disease mechanisms. Methodology/Principal Findings: 768 coding and haplotype tagging SNPs in 146 genes were examined using Illumina GoldenGate technology in a large population-based case-control study of NHL in the San Francisco Bay Area (1,292 cases 1,375 controls are included here). Statistical analyses were restricted to HIV-participants of white non-Hispanic origin. Genes involved in steroidogenesis, immune function, cell signaling, sunlight exposure, xenobiotic metabolism/oxidative stress, energy balance, and uptake and metabolism of cholesterol, folate and vitamin C were investigated. Sixteen SNPs in eight pathways and nine haplotypes were associated with NHL after correction for multiple testing at the adjusted q<0.10 level. Eight SNPs were tested in an independent case-control study of lymphoma in Germany ( 494 NHL cases and 494 matched controls). Novel associations with common variants in estrogen receptor 1 (ESR1) and in the vitamin C receptor and matrix metalloproteinase gene families were observed. Four ESR1 SNPs were associated with follicular lymphoma (FL) in the U. S. study, with rs3020314 remaining associated with reduced risk of FL after multiple testing adjustments [odds ratio (OR)=0.42, 95% confidence interval (CI) = 0.23-0.77) and replication in the German study (OR = 0.24, 95% CI = 0.06-0.94). Several SNPs and haplotypes in the matrix metalloproteinase-3 (MMP3) and MMP9 genes and in the vitamin C receptor genes, solute carrier family 23 member 1 (SLC23A1) and SLC23A2, showed associations with NHL risk. Conclusions/Significance: Our findings suggest a role for estrogen, vitamin C and matrix metalloproteinases in the pathogenesis of NHL that will require further validation.	[Skibola, Christine F.; Hubbard, Alan; Paynter, Randi A.; Skibola, Danica R.; Agana, Luz; Conde, Lucia; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Bracci, Paige M.; Holly, Elizabeth A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Halperin, Eran; Sankararaman, Sriram; Conde, Lucia] Int Comp Sci Inst, Berkeley, CA USA; [Nieters, Alexandra; Becker, Nikolaus] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Tressler, Patrick] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Forrest, Matthew S.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Francisco; Wellcome Trust Sanger Institute	Skibola, CF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	chrisfs@berkeley.edu	Conde, Lucia/D-9295-2011; Paynter, Randi/X-7689-2019	Paynter, Randi/0000-0003-2326-7659; Forrest, Matthew/0000-0002-2141-0303; Conde, Lucia/0000-0001-5180-543X	NIH [CA122663, CA104862, CA45614, CA89745, CA87014]; German Jose Carreras Leukaemia foundation [DJCLS_R04/08]; NATIONAL CANCER INSTITUTE [R01CA122663, R03CA089745, R01CA045614, R01CA087014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Jose Carreras Leukaemia foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant numbers CA122663 (CFS), CA104862 (MTS) and CA45614, CA89745, CA87014 (EAH), and the German Jose Carreras Leukaemia foundation (DJCLS_R04/08) (AN).	Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker N, 2004, LEUKEMIA RES, V28, P713, DOI 10.1016/j.leukres.2003.11.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad J, 1976, Sykepleien, V63, P1198; Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069; Breslow NE, 1980, STAT METHODS CANC RE; BRODIE AMH, 1976, J STEROID BIOCHEM, V7, P787, DOI 10.1016/0022-4731(76)90180-1; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Catani MV, 2005, NUTR REV, V63, P81, DOI 10.1111/j.1753-4887.2005.tb00125.x; Chang ET, 2005, CANCER EPIDEM BIOMAR, V14, P512, DOI 10.1158/1055-9965.EPI-04-0451; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; Cohen JI, 2005, BRIT J CANCER, V92, P1593, DOI 10.1038/sj.bjc.6602561; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Forrest MS, 2006, BRIT J HAEMATOL, V134, P180, DOI 10.1111/j.1365-2141.2006.06141.x; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P921, DOI 10.1158/1055-9965.EPI-05-0866; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gallagher CJ, 2007, DIABETES, V56, P675, DOI 10.2337/db06-0303; Greendale GA, 2006, AM J MED, V119, P79, DOI 10.1016/j.amjmed.2006.07.011; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Harakeh S, 2007, ANTICANCER RES, V27, P289; Hartge P, 2006, CANCER CAUSE CONTROL, V17, P1045, DOI 10.1007/s10552-006-0040-8; HARUKI Y, 1983, Tokai Journal of Experimental and Clinical Medicine, V8, P31; Holly EA, 2003, AM J EPIDEMIOL, V158, P432, DOI 10.1093/aje/kwg174; Holly EA, 1999, AM J EPIDEMIOL, V150, P375, DOI 10.1093/oxfordjournals.aje.a010017; JAFFE ESH, 1998, HEMATOPATHOLOGY LOP; Karyotou K, 2005, ARCH BIOCHEM BIOPHYS, V434, P248, DOI 10.1016/j.abb.2004.11.003; Kuittinen O, 2003, EUR J HAEMATOL, V71, P91, DOI 10.1034/j.1600-0609.2003.00101.x; Kuo SM, 2004, J NUTR, V134, P2216; LEE JS, 2008, AM J EPIDEMIOL; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lightfoot TJ, 2005, CANCER EPIDEM BIOMAR, V14, P2999, DOI 10.1158/1055-9965.EPI-05-0515; Lightfoot TJ, 2006, HAEMATOLOGICA, V91, P1222; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; Phillips C, 2007, MOL BIOTECHNOL, V35, P65, DOI 10.1385/MB:35:1:65; Purdue MP, 2007, CANCER CAUSE CONTROL, V18, P989, DOI 10.1007/s10552-007-9039-z; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ribatti D, 2004, STEM CELLS DEV, V13, P484, DOI 10.1089/1547328042417354; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Rui LX, 2006, CURR MOL MED, V6, P291, DOI 10.2174/156652406776894563; SATO H, 1992, ONCOGENE, V7, P77; SAVINI I, 2007, AMINO ACIDS; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skibola CF, 2005, CANCER EPIDEM BIOMAR, V14, P2391, DOI 10.1158/1055-9965.EPI-05-0343; Skibola CF, 2005, BRIT J HAEMATOL, V129, P618, DOI 10.1111/j.1365-2141.2005.05505.x; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Skibola CF, 2004, BLOOD, V104, P2155, DOI 10.1182/blood-2004-02-0557; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Skibola CF, 2007, CANCER EPIDEM BIOMAR, V16, P392, DOI 10.1158/1055-9965.EPI-06-1081; Skibola DR, 2005, CANCER EPIDEM BIOMAR, V14, P1251, DOI 10.1158/1055-9965.EPI-04-0895; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stavrou I, 2006, HUM REPROD, V21, P554, DOI 10.1093/humrep/dei326; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Talamini R, 2006, INT J CANCER, V118, P2871, DOI 10.1002/ijc.21737; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thurmond TS, 2000, ENDOCRINOLOGY, V141, P2309, DOI 10.1210/en.141.7.2309; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Willett EV, 2005, BRIT J CANCER, V93, P811, DOI 10.1038/sj.bjc.6602762; Yang C, 2002, ONCOGENE, V21, P2854, DOI 10.1038/sj.onc.1205386; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021	68	67	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2816	10.1371/journal.pone.0002816	http://dx.doi.org/10.1371/journal.pone.0002816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18636124	Green Published, gold			2022-12-27	WOS:000264304300035
J	Peccoud, J; Blauvelt, MF; Cai, Y; Cooper, KL; Crasta, O; DeLalla, EC; Evans, C; Folkerts, O; Lyons, BM; Mane, SP; Shelton, R; Sweede, MA; Waldon, SA				Peccoud, Jean; Blauvelt, Megan F.; Cai, Yizhi; Cooper, Kristal L.; Crasta, Oswald; DeLalla, Emily C.; Evans, Clive; Folkerts, Otto; Lyons, Blair M.; Mane, Shrinivasrao P.; Shelton, Rebecca; Sweede, Matthew A.; Waldon, Sally A.			Targeted Development of Registries of Biological Parts	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; GENE SYNTHESIS; DESIGN	Background: The design and construction of novel biological systems by combining basic building blocks represents a dominant paradigm in synthetic biology. Creating and maintaining a database of these building blocks is a way to streamline the fabrication of complex constructs. The Registry of Standard Biological Parts (Registry) is the most advanced implementation of this idea. Methods/Principal Findings: By analyzing inclusion relationships between the sequences of the Registry entries, we build a network that can be related to the Registry abstraction hierarchy. The distribution of entry reuse and complexity was extracted from this network. The collection of clones associated with the database entries was also analyzed. The plasmid inserts were amplified and sequenced. The sequences of 162 inserts could be confirmed experimentally but unexpected discrepancies have also been identified. Conclusions/Significance: Organizational guidelines are proposed to help design and manage this new type of scientific resources. In particular, it appears necessary to compare the cost of ensuring the integrity of database entries and associated biological samples with their value to the users. The initial strategy that permits including any combination of parts irrespective of its potential value leads to an exponential and economically unsustainable growth that may be detrimental to the quality and long-term value of the resource to its users.	[Peccoud, Jean; Blauvelt, Megan F.; Cai, Yizhi; Cooper, Kristal L.; Crasta, Oswald; DeLalla, Emily C.; Evans, Clive; Folkerts, Otto; Lyons, Blair M.; Mane, Shrinivasrao P.; Shelton, Rebecca; Sweede, Matthew A.; Waldon, Sally A.] Virginia Bioinformat Inst, Blacksburg, VA USA		Peccoud, J (corresponding author), Virginia Bioinformat Inst, Blacksburg, VA USA.	peccoud@vt.edu	Cai, Yizhi/A-3550-2010; Peccoud, Jean/A-2374-2008	Cai, Yizhi/0000-0003-1663-2865; Peccoud, Jean/0000-0001-7649-6127; Mane, Shrinivasrao/0000-0003-4123-624X	Commonwealth of Virginia Research Initiative; Genetics, Bioinformatics, and Computational Biology program at Virginia Tech [fellowship]; Bradley Department of Electrical and Computer Engineering [fellowship]	Commonwealth of Virginia Research Initiative; Genetics, Bioinformatics, and Computational Biology program at Virginia Tech; Bradley Department of Electrical and Computer Engineering	This work was supported by the Commonwealth of Virginia Research Initiative. YC was supported by a fellowship from the Genetics, Bioinformatics, and Computational Biology program at Virginia Tech. RS was supported by a fellowship from the Bradley Department of Electrical and Computer Engineering. None of the sponsors were involved in the design of this work or analysis of the data	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Arkin AP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-114; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Goodman C, 2008, NAT CHEM BIOL, V4, P13, DOI 10.1038/nchembio0108-13; Haynes Karmella A, 2008, J Biol Eng, V2, P8, DOI 10.1186/1754-1611-2-8; Henkel J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100161; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jabasini M, 2002, ELECTROPHORESIS, V23, P1537, DOI 10.1002/1522-2683(200205)23:10<1537::AID-ELPS1537>3.0.CO;2-E; Kong DS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm121; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Peccoud J, 2007, M S-MED SCI, V23, P551, DOI 10.1051/medsci/2007235551; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wu G, 2006, J BIOTECHNOL, V124, P496, DOI 10.1016/j.jbiotec.2006.01.015	28	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2671	10.1371/journal.pone.0002671	http://dx.doi.org/10.1371/journal.pone.0002671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628824	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200016
J	Sasidharan, R; Smith, A; Gerstein, M				Sasidharan, Rajkumar; Smith, Andrew; Gerstein, Mark			Transmembrane Protein Oxygen Content and Compartmentalization of Cells	PLOS ONE			English	Article								Recently, there was a report that explored the oxygen content of transmembrane proteins over macroevolutionary time scales where the authors observed a correlation between the geological time of appearance of compartmentalized cells with atmospheric oxygen concentration. The authors predicted, characterized and correlated the differences in the structure and composition of transmembrane proteins from the three kingdoms of life with atmospheric oxygen concentrations in geological timescale. They hypothesized that transmembrane proteins in ancient taxa were selectively excluding oxygen and as this constraint relaxed over time with increase in the levels of atmospheric oxygen the size and number of communication-related transmembrane proteins increased. In summary, they concluded that compartmentalized and non-compartmentalized cells can be distinguished by how oxygen is partitioned at the proteome level. They derived this conclusion from an analysis of 19 taxa. We extended their analysis on a larger sample of taxa comprising 309 eubacterial, 34 archaeal, and 30 eukaryotic complete proteomes and observed that one can not absolutely separate the two groups of cells based on partition of oxygen in their membrane proteins. In addition, the origin of compartmentalized cells is likely to have been driven by an innovation than happened 2700 million years ago in the membrane composition of cells that led to the evolution of endocytosis and exocytosis rather than due to the rise in concentration of atmospheric oxygen.	[Sasidharan, Rajkumar; Smith, Andrew; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Smith, Andrew; Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Interdept Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Yale University; Yale University	Sasidharan, R (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.gerstein@yale.edu			Yale CEGS [P50 HG02357]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER	Yale CEGS; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Yale CEGS Grant# P50 HG02357 (06-10)	Acquisti C, 2007, NATURE, V445, P47, DOI 10.1038/nature05450; Aravind L, 2006, CURR OPIN STRUC BIOL, V16, P409, DOI 10.1016/j.sbi.2006.04.006; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; HOLLAND HD, 1990, AM J SCI, V290A, P1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Sagan L, 1967, J Theor Biol, V14, P255; Studholme DJ, 2004, FEMS MICROBIOL LETT, V236, P333, DOI 10.1016/j.femsle.2004.06.007; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Williams RJP, 2007, J R SOC INTERFACE, V4, P1049, DOI 10.1098/rsif.2007.0225	10	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2726	10.1371/journal.pone.0002726	http://dx.doi.org/10.1371/journal.pone.0002726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628944	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200064
J	Wang, XJ; Lavrov, DV				Wang, Xiujuan; Lavrov, Dennis V.			Seventeen New Complete mtDNA Sequences Reveal Extensive Mitochondrial Genome Evolution within the Demospongiae	PLOS ONE			English	Article							TRANSFER-RNA GENES; INTRON GAIN; PROTEIN; PHYLOGENY; ENVIRONMENT; DIVERSITY; PORIFERA; PROGRAM; SPONGES; BIOLOGY	Two major transitions in animal evolution - the origins of multicellularity and bilaterality-correlate with major changes in mitochondrial DNA (mtDNA) organization. Demosponges, the largest class in the phylum Porifera, underwent only the first of these transitions and their mitochondrial genomes display a peculiar combination of ancestral and animal-specific features. To get an insight into the evolution of mitochondrial genomes within the Demospongiae, we determined 17 new mtDNA sequences from this group and analyzing them with five previously published sequences. Our analysis revealed that all demosponge mtDNAs are 16- to 25-kbp circular molecules, containing 13 - 15 protein genes, 2 rRNA genes, and 2 - 27 tRNA genes. All but four pairs of sampled genomes had unique gene orders, with the number of shared gene boundaries ranging from 1 to 41. Although most demosponge species displayed low rates of mitochondrial sequence evolution, a significant acceleration in evolutionary rates occurred in the G1 group (orders Dendroceratida, Dictyoceratida, and Verticillitida). Large variation in mtDNA organization was also observed within the G0 group (order Homosclerophorida) including gene rearrangements, loss of tRNA genes, and the presence of two introns in Plakortis angulospiculatus. While introns are rare in modern-day demosponge mtDNA, we inferred that at least one intron was present in cox1 of the common ancestor of all demosponges. Our study uncovered an extensive mitochondrial genomic diversity within the Demospongiae. Although all sampled mitochondrial genomes retained some ancestral features, including a minimally modified genetic code, conserved structures of tRNA genes, and presence of multiple non-coding regions, they vary considerably in their size, gene content, gene order, and the rates of sequence evolution. Some of the changes in demosponge mtDNA, such as the loss of tRNA genes and the appearance of hairpin-containing repetitive elements, occurred in parallel in several lineages and suggest general trends in demosponge mtDNA evolution.	[Wang, Xiujuan; Lavrov, Dennis V.] Dept Ecol Evolut & Organismal Biol, Ames, IA USA		Wang, XJ (corresponding author), Dept Ecol Evolut & Organismal Biol, Ames, IA USA.	dlavrov@iastate.edu	Lavrov, Dennis/V-3699-2019	Lavrov, Dennis/0000-0002-2745-1704	College of Liberal Arts and Sciences at Iowa State University	College of Liberal Arts and Sciences at Iowa State University	The funding for this work came from the College of Liberal Arts and Sciences at Iowa State University.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beagley CT, 1995, PROG CELL R, V5, P149; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Erpenbeck D, 2007, MOL BIOL EVOL, V24, P19, DOI 10.1093/molbev/msl154; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; GOLDERER G, 1995, J BACTERIOL, V177, P5994, DOI 10.1128/jb.177.20.5994-5996.1995; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hooper J. N. A., 2002, SYSTEMA PORIFERA, DOI [10.1007/978-1-4615-0747-5_3, DOI 10.1007/978-1-4615-0747-5_3]; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2005, SYST BIOL, V54, P651, DOI 10.1080/10635150500221044; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Lavrov DV, 2005, TRENDS GENET, V21, P129, DOI 10.1016/j.tig.2005.01.004; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Pearson W R, 1994, Methods Mol Biol, V25, P365; Pisera A, 2006, CAN J ZOOL, V84, P242, DOI 10.1139/Z05-169; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Roy SW, 2007, MOL BIOL EVOL, V24, P1579, DOI 10.1093/molbev/msm082; Roy SW, 2006, MOL BIOL EVOL, V23, P2259, DOI 10.1093/molbev/msl098; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shao ZY, 2006, GENE, V381, P92, DOI 10.1016/j.gene.2006.06.021; SMITH AE, 1968, J MOL BIOL, V38, P241, DOI 10.1016/0022-2836(68)90409-9; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; SOLLAS WJ, 1885, SCI P R DUBLIN SOC, V5, P12; Sullivan James C, 2006, Genome Inform, V17, P219; VACELET J, 1995, NATURE, V373, P333, DOI 10.1038/373333a0; Van Soest R.W.M., 2005, WORLD PORIFERA DATAB; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Wolstenholme DR, 1992, CURR OPIN GENET DEV, V2, P918, DOI 10.1016/S0959-437X(05)80116-9; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	52	76	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2723	10.1371/journal.pone.0002723	http://dx.doi.org/10.1371/journal.pone.0002723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18628961	Green Published, gold, Green Submitted			2022-12-27	WOS:000264057200061
J	Ahmad, F; Banerjee, SK; Lage, ML; Huang, XN; Smith, SH; Saba, S; Rager, J; Conner, DA; Janczewski, AM; Tobita, K; Tinney, JP; Moskowitz, IP; Perez-Atayde, AR; Keller, BB; Mathier, MA; Shroff, SG; Seidman, CE; Seidman, JG				Ahmad, Ferhaan; Banerjee, Sanjay K.; Lage, Michele L.; Huang, Xueyin N.; Smith, Stephen H.; Saba, Samir; Rager, Jennifer; Conner, David A.; Janczewski, Andrzej M.; Tobita, Kimimasa; Tinney, Joseph P.; Moskowitz, Ivan P.; Perez-Atayde, Antonio R.; Keller, Bradley B.; Mathier, Michael A.; Shroff, Sanjeev G.; Seidman, Christine E.; Seidman, J. G.			The Role of Cardiac Troponin T Quantity and Function in Cardiac Development and Dilated Cardiomyopathy	PLOS ONE			English	Article								Background: Hypertrophic (HCM) and dilated (DCM) cardiomyopathies result from sarcomeric protein mutations, including cardiac troponin T (cTnT, TNNT2). We determined whether TNNT2 mutations cause cardiomyopathies by altering cTnT function or quantity; whether the severity of DCM is related to the ratio of mutant to wildtype cTnT; whether Ca(2+) desensitization occurs in DCM; and whether absence of cTnT impairs early embryonic cardiogenesis. Methods and Findings: We ablated Tnnt2 to produce heterozygous Tnnt2(+/-) mice, and crossbreeding produced homozygous null Tnnt2(-/-) embryos. We also generated transgenic mice overexpressing wildtype (TG(WT)) or DCM mutant (TG(K210 Delta)) Tnnt2. Crossbreeding produced mice lacking one allele of Tnnt2, but carrying wildtype ( Tnnt2(+/-)/TG(WT)) or mutant (Tnnt2(+/-)/ TG(K210 Delta)) transgenes. Tnnt2(+/-) mice relative to wildtype had significantly reduced transcript (0.82 +/- 0.06[SD] vs. 1.00 +/- 0.12 arbitrary units; p = 0.025), but not protein (1.01 +/- 0.20 vs. 1.00 +/- 0.13 arbitrary units; p = 0.44). Tnnt2(+/-) mice had normal hearts ( histology, mass, left ventricular end diastolic diameter [LVEDD], fractional shortening [FS]). Moreover, whereas Tnnt2(+/-)/TGK(210 Delta) mice had severe DCM, TGK(210 Delta) mice had only mild DCM (FS 18 +/- 4 vs. 29 +/- 7%; p<0.01). The difference in severity of DCM may be attributable to a greater ratio of mutant to wildtype Tnnt2 transcript in Tnnt2(+/-)/TGK(210 Delta) relative to TGK(210 Delta) mice (2.42 +/- 0.08, p = 0.03). Tnnt2(+/-)/TGK(210 Delta) muscle showed Ca(2+) desensitization (pCa(50) = 5.34 +/- 0.08 vs. 5.58 +/- 0.03 at sarcomere length 1.9 mu m, p<0.01), but no difference in maximum force generation. Day 9.5 Tnnt2(-/-) embryos had normally looped hearts, but thin ventricular walls, large pericardial effusions, noncontractile hearts, and severely disorganized sarcomeres. Conclusions: Absence of one Tnnt2 allele leads to a mild deficit in transcript but not protein, leading to a normal cardiac phenotype. DCM results from abnormal function of a mutant protein, which is associated with myocyte Ca(2+) desensitization. The severity of DCM depends on the ratio of mutant to wildtype Tnnt2 transcript. cTnT is essential for sarcomere formation, but normal embryonic heart looping occurs without contractile activity.	[Ahmad, Ferhaan; Banerjee, Sanjay K.; Lage, Michele L.; Huang, Xueyin N.; Saba, Samir; Rager, Jennifer; Mathier, Michael A.] Univ Pittsburgh, Dept Med, Cardiovasc Inst, Pittsburgh, PA 15260 USA; [Ahmad, Ferhaan] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Ahmad, Ferhaan; Conner, David A.; Seidman, Christine E.; Seidman, J. G.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Boston, MA USA; [Smith, Stephen H.; Janczewski, Andrzej M.; Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Tobita, Kimimasa; Tinney, Joseph P.; Keller, Bradley B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Moskowitz, Ivan P.; Perez-Atayde, Antonio R.] Childrens Hosp, Dept Pathol, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Boston Children's Hospital	Ahmad, F (corresponding author), Univ Pittsburgh, Dept Med, Cardiovasc Inst, 930 Scaife Hall, Pittsburgh, PA 15260 USA.	ahmadf@upmc.edu	Banerjee, Sanjay/F-2677-2019	Janczewski, Andrzej/0000-0001-7209-7188; Banerjee, Sanjay/0000-0002-0008-0480; Ahmad, Ferhaan/0000-0003-2877-4641; Tobita, Kimimasa/0000-0001-5435-8436; Moskowitz, Ivan/0000-0003-0014-4963; Banerjee, Sanjay k/0000-0002-0044-0984	American Heart Association [Postdoctoral Fellowships]; Hillgrove Foundation [Postdoctoral Fellowships]; Howard Hughes Medical Institute; McGinnis Chair Endowment Funds; Cardiovascular Institute of the University of Pittsburgh	American Heart Association(American Heart Association); Hillgrove Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); McGinnis Chair Endowment Funds; Cardiovascular Institute of the University of Pittsburgh	This work was supported by an American Heart Association Scientist Development Grant (FA), American Heart Association and Hillgrove Foundation Postdoctoral Fellowships (SKB), the Howard Hughes Medical Institute (FA, DAC, IPM, CES, JGS), and McGinnis Chair Endowment Funds (SGS). We thank Barry London, M.D., Ph.D., Director, Cardiovascular Institute of the University of Pittsburgh, for institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Ahmad F, 2005, CIRCULATION, V112, P3140, DOI 10.1161/CIRCULATIONAHA.105.550806; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Blanchard EM, 1997, CIRC RES, V81, P1005; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; GULICK J, 1991, J BIOL CHEM, V266, P9180; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Henderson SA, 2004, CIRC RES, V95, P604, DOI 10.1161/01.RES.0000142316.08250.68; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Huang XP, 1999, CIRC RES, V84, P1; Hurtado C, 2005, J MOL CELL CARDIOL, V38, P647, DOI 10.1016/j.yjmcc.2005.02.007; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Rethinasamy P, 1998, CIRC RES, V82, P116; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Sirenko SG, 2006, J PHYSIOL-LONDON, V575, P201, DOI 10.1113/jphysiol.2006.107557; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	33	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2642	10.1371/journal.pone.0002642	http://dx.doi.org/10.1371/journal.pone.0002642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612386	Green Accepted, Green Published, gold			2022-12-27	WOS:000264065800044
J	El-Bchiri, J; Guilloux, A; Dartigues, P; Loire, E; Mercier, D; Buhard, O; Sobhani, I; de la Grange, P; Auboeuf, D; Praz, F; Flejou, JF; Duval, A				El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Loire, Etienne; Mercier, Dominique; Buhard, Olivier; Sobhani, Iradj; de la Grange, Pierre; Auboeuf, Didier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex			Nonsense-Mediated mRNA Decay Impacts MSI-Driven Carcinogenesis and Anti-Tumor Immunity in Colorectal Cancers	PLOS ONE			English	Article								Nonsense-mediated mRNA Decay (NMD) degrades mutant mRNAs containing premature termination codon (PTC-mRNAs). Here we evaluate the consequence of NMD activity in colorectal cancers (CRCs) showing microsatellite instability (MSI) whose progression is associated with the accumulation of PTC-mRNAs encoding immunogenic proteins due to frameshift mutations in coding repeat sequences. Inhibition of UPF1, one of the major NMD factors, was achieved by siRNA in the HCT116 MSI CRC cell line and the resulting changes in gene expression were studied using expression microarrays. The impact of NMD activity was also investigated in primary MSI CRCs by quantifying the expression of several mRNAs relative to their mutational status and to endogenous UPF1 and UPF2 expression. Host immunity developed against MSI cancer cells was appreciated by quantifying the number of CD3 epsilon-positive tumor-infiltrating lymphocytes (TILs). UPF1 silencing led to the up-regulation of 1251 genes in HCT116, among which a proportion of them (i.e. 38%) significantly higher than expected by chance contained a coding microsatellite (P < 2 x 10-(16)). In MSI primary CRCs, UPF1 was significantly over-expressed compared to normal adjacent mucosa (P < 0.002). Our data provided evidence for differential decay of PTC-mRNAs compared to wild-type that was positively correlated to UPF1 endogenous expression level (P = 0.02). A negative effect of UPF1 and UPF2 expression on the host's anti-tumor response was observed (P < 0.01). Overall, our results show that NMD deeply influences MSI-driven tumorigenesis at the molecular level and indicate a functional negative impact of this system on anti- tumor immunity whose intensity has been recurrently shown to be an independent factor of favorable outcome in CRCs.	[El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Mercier, Dominique; Buhard, Olivier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex] INSERM, UMR S893, Team Microsatellite Instabil & Canc 13, Paris, France; [El-Bchiri, Jamila; Guilloux, Agathe; Dartigues, Peggy; Mercier, Dominique; Buhard, Olivier; Praz, Francoise; Flejou, Jean-Francois; Duval, Alex] Univ Paris 06, UPMC, UMR S893, Paris, France; [Loire, Etienne] Univ Paris 06, UPMC, Atelier Bioinformat, Paris, France; [Loire, Etienne] Univ Paris 06, UPMC, Inst Jacques Monod, UMR 7592, Paris, France; [Sobhani, Iradj] CHU Henri Mondor, Dept GastroEnterol, Creteil, France; [de la Grange, Pierre; Auboeuf, Didier] Hop St Louis, INSERM, U685, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	El-Bchiri, J (corresponding author), INSERM, UMR S893, Team Microsatellite Instabil & Canc 13, Paris, France.	alex.duval@cephb.fr	PRAZ, Françoise/A-7291-2008; Auboeuf, Didier/M-4610-2014; Guilloux, Agathe/T-2577-2017; PRAZ, Françoise/AAF-7761-2020	PRAZ, Françoise/0000-0002-5353-8889; PRAZ, Françoise/0000-0002-5353-8889; Auboeuf, Didier/0000-0002-3757-0002; loire, etienne/0000-0002-3465-7727; de la Grange, Pierre/0000-0001-6361-1878	Association pour la Recherche contre le Cancer [3946]; Ministere Francais de la Recherche [fellowship]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere Francais de la Recherche(Ministry of Research, France)	This work was partly supported by grants from the Association pour la Recherche contre le Cancer (credit number 3946). JEB, EL and PDLG were recipients of a fellowship from the Ministere Francais de la Recherche (MRT).	Anczukow O, 2008, HUM MUTAT, V29, P65, DOI 10.1002/humu.20590; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Brennetot C, 2005, INT J CANCER, V113, P446, DOI 10.1002/ijc.20586; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2005, HUM MOL GENET, V14, P2435, DOI 10.1093/hmg/ddi245; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Ishikawa T, 2003, CANCER RES, V63, P5564; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; LOTHE RA, 1993, CANCER RES, V53, P5849; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Meyer C, 2005, P NATL ACAD SCI USA, V102, P449, DOI 10.1073/pnas.0406994102; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; SHI T, 2003, MOL CELL, V12, P1187; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; You KT, 2007, PLOS BIOL, V5, P1098, DOI 10.1371/journal.pbio.0050109	28	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2583	10.1371/journal.pone.0002583	http://dx.doi.org/10.1371/journal.pone.0002583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612427	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800004
J	Ivanoff, J; Branning, P; Marois, R				Ivanoff, Jason; Branning, Philip; Marois, Rene			fMRI Evidence for a Dual Process Account of the Speed-Accuracy Tradeoff in Decision-Making	PLOS ONE			English	Article								Background: The speed and accuracy of decision-making have a well-known trading relationship: hasty decisions are more prone to errors while careful, accurate judgments take more time. Despite the pervasiveness of this speed-accuracy trade-off (SAT) in decision-making, its neural basis is still unknown. Methodology/Principal Findings: Using functional magnetic resonance imaging ( fMRI) we show that emphasizing the speed of a perceptual decision at the expense of its accuracy lowers the amount of evidence-related activity in lateral prefrontal cortex. Moreover, this speed-accuracy difference in lateral prefrontal cortex activity correlates with the speed-accuracy difference in the decision criterion metric of signal detection theory. We also show that the same instructions increase baseline activity in a dorso-medial cortical area involved in the internal generation of actions. Conclusions/Significance: These findings suggest that the SAT is neurally implemented by modulating not only the amount of externally-derived sensory evidence used to make a decision, but also the internal urge to make a response. We propose that these processes combine to control the temporal dynamics of the speed-accuracy trade-off in decision-making.	[Ivanoff, Jason; Branning, Philip; Marois, Rene] Vanderbilt Univ, Dept Psychol, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA	Vanderbilt University	Ivanoff, J (corresponding author), Vanderbilt Univ, Dept Psychol, Ctr Integrat & Cognit Neurosci, Nashville, TN 37240 USA.	J.Ivanoff@smu.ca; rene.marois@vanderbilt.edu			NIMH [R01 MH70776, fellowship]; NSERC (Canada); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIMH grant R01 MH70776 to R.M. and an NSERC (Canada) fellowship to J.I. The funding agencies played no role in the design and conduct of the study.	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Alkadhi H, 2002, NEUROREPORT, V13, P2065, DOI 10.1097/00001756-200211150-00015; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2005, J COGNITIVE NEUROSCI, V17, P1367, DOI 10.1162/0898929054985400; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2004, J NEUROSCI, V24, P8847, DOI 10.1523/JNEUROSCI.2513-04.2004; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bunge SA, 2005, J NEUROSCI, V25, P10347, DOI 10.1523/JNEUROSCI.2937-05.2005; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Diederich A, 2006, PERCEPT PSYCHOPHYS, V68, P194, DOI 10.3758/BF03193669; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GODSCHALK M, 1985, BEHAV BRAIN RES, V18, P143, DOI 10.1016/0166-4328(85)90070-1; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GRICE GR, 1982, J EXP PSYCHOL GEN, V111, P135, DOI 10.1037/0096-3445.111.1.135; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Indovina I, 2001, NEUROIMAGE, V13, P1027, DOI 10.1006/nimg.2001.0776; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kantowitz B.H., 1974, HUMAN INFORMATION PR, P41; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Laming DR, 1968, INFORM THEORY CHOICE; Lau H, 2006, NEUROIMAGE, V29, P446, DOI 10.1016/j.neuroimage.2005.07.050; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce RD, 1986, RESPONSE TIMES THEIR; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Macmillan N. A., 1991, DETECTION THEORY USE; Marois R, 2006, PSYCHOL RES-PSYCH FO, V70, P436, DOI 10.1007/s00426-005-0022-6; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2002, PSYCHON B REV, V9, P278, DOI 10.3758/BF03196283; Ratcliff R, 2001, NAT NEUROSCI, V4, P336, DOI 10.1038/85956; RATCLIFF R, 1988, PSYCHOL REV, V95, P238, DOI 10.1037/0033-295X.95.2.238; Ratcliff R, 2006, COGNITIVE PSYCHOL, V53, P195, DOI 10.1016/j.cogpsych.2005.10.002; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rinkenauer G, 2004, J EXP PSYCHOL GEN, V133, P261, DOI 10.1037/0096-3445.133.2.261; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Rorie AE, 2005, TRENDS COGN SCI, V9, P41, DOI 10.1016/j.tics.2004.12.007; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tremblay P, 2006, NEUROIMAGE, V33, P947, DOI 10.1016/j.neuroimage.2006.07.041; van Eimeren T, 2006, NEUROIMAGE, V29, P286, DOI 10.1016/j.neuroimage.2005.07.014; WATAMANIUK SNJ, 1992, VISION RES, V32, P2341, DOI 10.1016/0042-6989(92)90097-3; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858, DOI 10.1152/jn.2001.85.5.1858; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245; WOOD CC, 1976, PERCEPT PSYCHOPHYS, V19, P92, DOI 10.3758/BF03199392; Zhang JX, 2004, NEUROIMAGE, V23, P596, DOI 10.1016/j.neuroimage.2004.06.006; Zysset S, 2006, NEUROIMAGE, V31, P1380, DOI 10.1016/j.neuroimage.2006.01.017	93	123	133	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2635	10.1371/journal.pone.0002635	http://dx.doi.org/10.1371/journal.pone.0002635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612380	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800037
J	Roumier, A; Pascual, O; Bechade, C; Wakselman, S; Poncer, JC; Real, E; Triller, A; Bessis, A				Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Poncer, Jean-Christophe; Real, Eleonore; Triller, Antoine; Bessis, Alain			Prenatal Activation of Microglia Induces Delayed Impairment of Glutamatergic Synaptic Function	PLOS ONE			English	Article							FETAL-BRAIN-DEVELOPMENT; MATERNAL INFLUENZA INFECTION; NMDA RECEPTORS; KILLER-CELL; INFLAMMATION; SYNAPSES; EXPRESSION; NEURONS; DAMAGE; AMPA	Background: Epidemiological studies have linked maternal infection during pregnancy to later development of neuropsychiatric disorders in the offspring. In mice, experimental inflammation during embryonic development impairs behavioral and cognitive performances in adulthood. Synaptic dysfunctions may be at the origin of cognitive impairments, however the link between prenatal inflammation and synaptic defects remains to be established. Methodology/Principal Findings: In this study, we show that prenatal alteration of microglial function, including inflammation, induces delayed synaptic dysfunction in the adult. DAP12 is a microglial signaling protein expressed around birth, mutations of which in the human induces the Nasu-Hakola disease, characterized by early dementia. We presently report that synaptic excitatory currents in mice bearing a loss-of-function mutation in the DAP12 gene (DAP12(KI) mice) display enhanced relative contribution of AMPA. Furthermore, neurons from DAP12(KI) P0 pups cultured without microglia develop similar synaptic alterations, suggesting that a prenatal dysfunction of microglia may impact synaptic function in the adult. As we observed that DAP12(KI) microglia overexpress genes for IL1 beta, IL6 and NOS2, which are inflammatory proteins, we analyzed the impact of a pharmacologically-induced prenatal inflammation on synaptic function. Maternal injection of lipopolysaccharides induced activation of microglia at birth and alteration of glutamatergic synapses in the adult offspring. Finally, neurons cultured from neonates born to inflamed mothers and cultured without microglia also displayed altered neuronal activity. Conclusion/Significance: Our results demonstrate that prenatal inflammation is sufficient to induce synaptic alterations with delay. We propose that these alterations triggered by prenatal activation of microglia provide a cellular basis for the neuropsychiatric defects induced by prenatal inflammation.	[Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Real, Eleonore; Triller, Antoine; Bessis, Alain] INSERM, U789, Lab Biol Cellulaire Synapse, Paris, France; [Roumier, Anne; Pascual, Olivier; Bechade, Catherine; Wakselman, Shirley; Real, Eleonore; Triller, Antoine; Bessis, Alain] Dept Biol, Ecole Normale Superieure, Paris, France; [Poncer, Jean-Christophe] INSERM, U839, Avenir Team Plasticity Cortical Networks & Epil, Paris, France; [Poncer, Jean-Christophe] Univ Pierre Marie Curie Paris 6, IFR83, Paris, France; [Bessis, Alain] CNRS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Roumier, A (corresponding author), INSERM, U789, Lab Biol Cellulaire Synapse, Paris, France.	alain.bessis@ens.fr	Pascual, Olivier/E-9533-2017; Poncer, Jean Christophe/R-6362-2016; Pascual, Olivier/AAE-1449-2020; Roumier, Anne/AAG-5878-2021; Bechade, Catherine/K-5528-2017	Pascual, Olivier/0000-0002-5730-9880; Poncer, Jean Christophe/0000-0001-5729-3009; Pascual, Olivier/0000-0002-5730-9880; Roumier, Anne/0000-0002-1369-9231; Real, Dr Eleonore/0000-0002-5523-4408; Bechade, Catherine/0000-0003-2070-2993; TRILLER, Antoine/0000-0002-7530-1233; Bessis, Alain/0000-0001-8362-6874	Fondation pour la Recherche Medicale and of Region Ile-de-France [fellow]; Agence Nationale pour la Recherche [fellow]; Institut de Recherche sur la moelle epiniere et l'Encephale (IRME)	Fondation pour la Recherche Medicale and of Region Ile-de-France; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut de Recherche sur la moelle epiniere et l'Encephale (IRME)	A.R. was a fellow of Fondation pour la Recherche Medicale and of Region Ile-de-France. S.W. was a fellow of Agence Nationale pour la Recherche. Grants received from: Agence Nationale pour la Recherche (ANR-Maladies Rares), Institut de Recherche sur la moelle epiniere et l'Encephale (IRME).	ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; CIARANELLO AL, 1995, ANNU REV NEUROSCI, V18, P101, DOI 10.1146/annurev.ne.18.030195.000533; Dalmau I, 1997, J COMP NEUROL, V377, P70; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gilmore JH, 2003, J NEUROIMMUNOL, V138, P49, DOI 10.1016/S0165-5728(03)00095-X; Golan HM, 2005, NEUROPHARMACOLOGY, V48, P903, DOI 10.1016/j.neuropharm.2004.12.023; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Jonakait GM, 2007, INT J DEV NEUROSCI, V25, P415, DOI 10.1016/j.ijdevneu.2007.08.017; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Lewis DA, 2008, NEUROPSYCHOPHARMACOL, V33, P141, DOI 10.1038/sj.npp.1301563; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Peters A., 1990, FINE STRUCTURE NERVO, V3rd Edn; Rao A, 1998, J NEUROSCI, V18, P1217; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi LM, 2005, INT J DEV NEUROSCI, V23, P299, DOI 10.1016/j.ijdevneu.2004.05.005; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Zujovic V, 2005, J NEUROSCI RES, V82, P581, DOI 10.1002/jnr.20676	45	100	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2595	10.1371/journal.pone.0002595	http://dx.doi.org/10.1371/journal.pone.0002595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18612411	Green Published, gold, Green Submitted			2022-12-27	WOS:000264065800008
J	dos Santos, NR; Williame, M; Gachet, S; Cormier, F; Janin, A; Weih, D; Weih, F; Ghysdael, J				dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Janin, Anne; Weih, Debra; Weih, Falk; Ghysdael, Jacques			RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOTOXIN-BETA-RECEPTOR; MULTIORGAN INFLAMMATION; DIFFERENTIAL REGULATION; TARGETED DISRUPTION; SIGNALING PATHWAY; TRANSGENIC MICE; THYMIC MEDULLA; ACTIVATION	Background: The Rel/NF-kappa B transcription factors are often activated in solid or hematological malignancies. In most cases, NF-kappa B activation is found in malignant cells and results from activation of the canonical NF-kappa B pathway, leading to RelA and/or c-Rel activation. Recently, NF-kappa B activity in inflammatory cells infiltrating solid tumors has been shown to contribute to solid tumor initiation and progression. Noncanonical NF-kappa B activation, which leads to RelB activation, has also been reported in breast carcinoma, prostate cancer, and lymphoid leukemia. Methodology/Principal Findings: Here we report a novel role for RelB in stromal cells that promote T-cell leukemogenesis. RelB deficiency delayed leukemia onset in the TEL-JAK2 transgenic mouse model of human T acute lymphoblastic leukemia. Bone marrow chimeric mouse experiments showed that RelB is not required in the hematopoietic compartment. In contrast, RelB plays a role in radio-resistant stromal cells to accelerate leukemia onset and increase disease severity. Conclusions/Significance: The present results are the first to uncover a role for RelB in the crosstalk between non-hematopoietic stromal cells and leukemic cells. Thus, besides its previously reported role intrinsic to specific cancer cells, the noncanonical NF-kappa B pathway may also play a pro-oncogenic role in cancer microenvironmental cells.	[dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Ghysdael, Jacques] Ctr Rech, Inst Curie, Orsay, France; [dos Santos, Nuno R.; Williame, Maryvonne; Gachet, Stephanie; Cormier, Francoise; Ghysdael, Jacques] CNRS UMR146, Orsay, France; [Janin, Anne] Univ Paris 07, Hop Saint Louis, INSERM Unite 728, Paris, France; [Weih, Debra; Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	dos Santos, NR (corresponding author), Ctr Rech, Inst Curie, Orsay, France.	jacques.ghysdael@curie.u-psud.fr	GHYSDAEL, Jacques/F-3377-2013; dos Santos, Nuno Rodrigues/F-4411-2012	dos Santos, Nuno Rodrigues/0000-0001-7347-2592; Cormier, Francoise/0000-0002-6904-5122; GACHET, Stephanie/0000-0003-0491-9949	Ligue Nationale contre le Cancer (Equipe labelisee Ligue); Association for International Cancer Research (AICR) [postdoctoral fellowships]; Institut National du Cancer (INCa); Centre National de la Recherche Scientifique (CNRS); Institut Curie [postdoctoral fellowships]; Ministere de l'Education Nationale et de la Recherche (MENR) [pre-doctoral fellowship]	Ligue Nationale contre le Cancer (Equipe labelisee Ligue)(Ligue nationale contre le cancer); Association for International Cancer Research (AICR); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ministere de l'Education Nationale et de la Recherche (MENR)	This work was supported by funds from the Ligue Nationale contre le Cancer (Equipe labelisee Ligue), Association for International Cancer Research (AICR), Institut National du Cancer (INCa), Centre National de la Recherche Scientifique (CNRS) and Institut Curie. N.R.d.S. is a recipient of postdoctoral fellowships from AICR and Institut Curie. S.G. is a recipient of a pre-doctoral fellowship from the Ministere de l'Education Nationale et de la Recherche (MENR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; Barata JT, 2005, LEUKEMIA LYMPHOMA, V46, P483, DOI 10.1080/10428190400027852; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Carrasco D, 1996, EMBO J, V15, P3640, DOI 10.1002/j.1460-2075.1996.tb00733.x; Carron C, 2000, BLOOD, V95, P3891; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DeKoning J, 1997, J IMMUNOL, V158, P2558; Demicco EG, 2005, MOL CELL BIOL, V25, P10136, DOI 10.1128/MCB.25.22.10136-10147.2005; Derbinski J, 2005, TRENDS IMMUNOL, V26, P503, DOI 10.1016/j.it.2005.07.006; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; dos Santos NR, 2007, BLOOD, V109, P3972, DOI 10.1182/blood-2006-09-048801; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hare KJ, 2000, J IMMUNOL, V165, P2410, DOI 10.4049/jimmunol.165.5.2410; Hare KJ, 1998, J IMMUNOL, V160, P3666; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heino M, 2000, EUR J IMMUNOL, V30, P1884, DOI 10.1002/1521-4141(200007)30:7<1884::AID-IMMU1884>3.0.CO;2-P; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kordes U, 2000, LEUKEMIA, V14, P399, DOI 10.1038/sj.leu.2401705; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; LO D, 1992, AM J PATHOL, V141, P1237; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Naquet P, 1999, SEMIN IMMUNOL, V11, P47, DOI 10.1006/smim.1998.0149; O'Neil J, 2003, BLOOD, V102, P2593, DOI 10.1182/blood-2003-01-0090; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; PALMER DB, 1993, DEV IMMUNOL, V3, P175, DOI 10.1155/1993/56290; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Scupoli MT, 2007, HAEMATOLOGICA, V92, P264, DOI 10.3324/haematol.10356; Scupoli MT, 2003, HAEMATOLOGICA, V88, P1229; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Weih F, 1996, J IMMUNOL, V157, P3974; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Winter SS, 2001, BRIT J HAEMATOL, V115, P862, DOI 10.1046/j.1365-2141.2001.03182.x; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; Zhu MZ, 2007, J IMMUNOL, V179, P8069, DOI 10.4049/jimmunol.179.12.8069	59	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2555	10.1371/journal.pone.0002555	http://dx.doi.org/10.1371/journal.pone.0002555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18596915	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200022
J	Navis, M; Matas, DE; Rachinger, A; Koning, FA; van Swieten, P; Kootstra, NA; Schuitemaker, H				Navis, Marjon; Matas, Diana Edo; Rachinger, Andrea; Koning, Fransje A.; van Swieten, Peter; Kootstra, Neeltje A.; Schuitemaker, Hanneke			Molecular Evolution of Human Immunodeficiency Virus Type 1 upon Transmission between Human Leukocyte Antigen Disparate Donor-Recipient Pairs	PLOS ONE			English	Article							T-CELL RESPONSES; ESCAPE VARIANTS; GENETIC-VARIATION; IMMUNE-RESPONSES; HIV-1 INFECTION; VIRAL ESCAPE; IN-VIVO; REVERSION; GAG; LYMPHOCYTES	Background: To address evolution of HIV-1 after transmission, we studied sequence dynamics in and outside predicted epitopes of cytotoxic T lymphocytes (CTL) in subtype B HIV-1 variants that were isolated from 5 therapy-naive horizontal HLA-disparate donor-recipient pairs from the Amsterdam Cohort Studies on HIV-1 infection and AIDS. Methodology/Principal Findings: In the first weeks after transmission, the majority of donor-derived mutations in and outside donor-HLA-restricted epitopes in Gag, Env, and Nef, were preserved in the recipient. Reversion to the HIV-1 subtype B consensus sequence of mutations in-and outside donor-HLA-restricted CTL epitopes, and new mutations away from the consensus B sequence mostly within recipient-HLA-restricted epitopes, contributed equally to the early sequence changes. In the subsequent period (1-2 years) after transmission, still only a low number of both reverting and forward mutations had occurred. During subsequent long-term follow-up, sequence dynamics were dominated by forward mutations, mostly (50-85%) in recipient-HLA-restricted CTL epitopes. At the end of long-term follow-up, on average 43% of the transmitted CTL escape mutations in donor-HLA-restricted epitopes had reverted to the subtype B consensus sequence. Conclusions/Significance: The relatively high proportion of long-term preserved mutations after transmission points to a lack of back selection even in the absence of CTL pressure, which may lead to an accumulating loss of critical CTL epitopes. Our data are supportive for a continuous adaptation of HIV-1 to host immune pressures which may have implications for vaccine design.	[Navis, Marjon; Matas, Diana Edo; Rachinger, Andrea; Koning, Fransje A.; van Swieten, Peter; Kootstra, Neeltje A.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect Dis & Immun Amsterdam CINIMA,Landstein, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Navis, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect Dis & Immun Amsterdam CINIMA,Landstein, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.schuitemaker@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754	Landsteiner Foundation for Blood Transfusion Research [0317]; Netherlands AIDS fund [6006]; Sanquin Netherlands Blood Supply Foundation; Academic Medical Center Amsterdam; The Netherlands Organization for Scientific Research [901-02-222, 916.36.024]	Landsteiner Foundation for Blood Transfusion Research; Netherlands AIDS fund; Sanquin Netherlands Blood Supply Foundation; Academic Medical Center Amsterdam; The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	MN is financially supported by Landsteiner Foundation for Blood Transfusion Research (grant 0317), DEM is financially supported by the Netherlands AIDS fund (grant 6006) and the Sanquin Netherlands Blood Supply Foundation, AR is supported by Academic Medical Center Amsterdam, FAK and NK are financially supported by The Netherlands Organization for Scientific Research (grants 901-02-222 and 916.36.024, respectively). None of the funders of the here described study had a role in the design or conduct of the study, nor in the collection, analysis, or interpretation of the data, and also not in the preparation, review, or approval of the manuscript. The Amsterdam Cohort Studies are financially supported by the Netherlands National Institute for Public Health and the Environment.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altman JD, 2004, NAT MED, V10, P229, DOI 10.1038/nm0304-229; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Blaak H, 1997, J INFECT DIS, V176, P1383, DOI 10.1086/517327; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Coffin JM, 1996, AIDS, V10, pS75; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jansen CA, 2005, EUR J IMMUNOL, V35, P150, DOI 10.1002/eji.200425487; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kent SJ, 1997, J INFECT DIS, V176, P1188, DOI 10.1086/514112; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KOENIG WJ, 1995, PLAST RECONSTR SURG, V95, P1; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; *LOS AL NAT LAB, 2006, LAUR060036 LOS AL NA; Milicic A, 2005, J VIROL, V79, P13953, DOI 10.1128/JVI.79.22.13953-13962.2005; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6024, DOI 10.1073/pnas.87.16.6024; Peyerl FW, 2003, J VIROL, V77, P12572, DOI 10.1128/JVI.77.23.12572-12578.2003; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pillay T, 2005, J VIROL, V79, P12100, DOI 10.1128/JVI.79.18.12100-12105.2005; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Merino V, 2005, J IMMUNOL, V175, P6976, DOI 10.4049/jimmunol.175.10.6976; Sanchez-Merino V, 2008, J INFECT DIS, V197, P300, DOI 10.1086/524845; Scheliens IMM, 2008, AIDS, V22, P33, DOI 10.1097/QAD.0b013e3282f15622; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Smith Stephen M, 2004, Retrovirology, V1, P8, DOI 10.1186/1742-4690-1-8; Swofford DL, 2002, PAUP PHYLOGENETIC AN; vantWout AB, 1997, J CLIN INVEST, V100, P2325, DOI 10.1172/JCI119771; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wout ABVT, 1998, AIDS, V12, P1169, DOI 10.1097/00002030-199810000-00009; Yeh WW, 2006, J VIROL, V80, P8168, DOI 10.1128/JVI.00068-06	57	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2008	3	6							e2422	10.1371/journal.pone.0002422	http://dx.doi.org/10.1371/journal.pone.0002422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406FP	18560583	Green Submitted, gold, Green Published			2022-12-27	WOS:000263280700008
J	Braun, A; McArdle, J; Jones, J; Nechaev, V; Zalewski, C; Brewer, C; Drayna, D				Braun, Allen; McArdle, Joe; Jones, Jennifer; Nechaev, Vladimir; Zalewski, Christopher; Brewer, Carmen; Drayna, Dennis			Tune Deafness: Processing Melodic Errors Outside of Conscious Awareness as Reflected by Components of the Auditory ERP	PLOS ONE			English	Article							CONGENITAL AMUSIA; FREQUENCY; RECOGNITION; KNOWLEDGE; GENETICS; HEARING; CORTEX; P300	Tune deafness (TD) is a central auditory processing disorder characterized by the inability to discriminate pitch, reproduce melodies or to recognize deviations in melodic structure, in spite of normal hearing. The cause of the disorder is unknown. To identify a pathophysiological marker, we ascertained a group of severely affected TD patients using the Distorted Tunes Test, an ecologically valid task with a longstanding history, and used electrophysiological methods to characterize the brain's responses to correct and incorrect melodic sequences. As expected, we identified a neural correlate of patients' unawareness of melodic distortions: deviant notes modulated long-latency auditory evoked potentials and elicited a mismatch negativity in controls but not in affected subjects. However a robust P300 was elicited by deviant notes, suggesting that, as in blindsight, TD subjects process stimuli that they cannot consciously perceive. Given the high heritability of TD, these patients may make it possible to use genetic methods to study cellular and molecular mechanisms underlying conscious awareness.	[Braun, Allen; McArdle, Joe; Nechaev, Vladimir] Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD USA; [Jones, Jennifer; Drayna, Dennis] NIH, National Inst Deafness & Other Commun Disorders, Sect Syst Biol Commun Disorders, Bethesda, MD USA; [Zalewski, Christopher; Brewer, Carmen] NIH, Natl Inst Deafness & Other Commun Disorders, Audiol Unit, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Braun, A (corresponding author), Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD USA.	brauna@nidcd.nih.gov			Intramural Program of the National Institute on Deafness and other Communications Disroders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000031, ZIADC000046, Z01DC000031, ZIADC000064, Z01DC000064, Z01DC000046] Funding Source: NIH RePORTER	Intramural Program of the National Institute on Deafness and other Communications Disroders; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Intramural Program of the National Institute on Deafness and other Communications Disroders.	Alain C, 1999, PSYCHOPHYSIOLOGY, V36, P737, DOI 10.1111/1469-8986.3660737; Allen J, 2000, PERCEPT PSYCHOPHYS, V62, P1383, DOI 10.3758/BF03212140; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Brattico E, 2006, BRAIN RES, V1117, P162, DOI 10.1016/j.brainres.2006.08.023; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Garde MM, 2000, CORTEX, V36, P71, DOI 10.1016/S0010-9452(08)70837-2; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; JOHNSON R, 2008, ADV PSYCHOPHYSIOLOGY, P69; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Koelsch S, 2003, J COGNITIVE NEUROSCI, V15, P1149, DOI 10.1162/089892903322598111; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; *NEUR INC, 1998, NEUR; Nittono H, 2000, BIOL PSYCHOL, V52, P1, DOI 10.1016/S0301-0511(99)00042-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALLER KA, 1992, PSYCHOPHYSIOLOGY, V29, P202, DOI 10.1111/j.1469-8986.1992.tb01686.x; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; SCHACTER DL, 1992, P NATL ACAD SCI USA, V89, P11113, DOI 10.1073/pnas.89.23.11113; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Weiskrantz L, 2003, PROG BRAIN RES, V144, P229, DOI 10.1016/S0079-6123(03)14401-6	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2008	3	6							e2349	10.1371/journal.pone.0002349	http://dx.doi.org/10.1371/journal.pone.0002349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	405UD	18545651	Green Published, Green Submitted, gold			2022-12-27	WOS:000263248800010
J	Baverstock, K; Ronkko, M				Baverstock, Keith; Ronkko, Mauno			Epigenetic Regulation of the Mammalian Cell	PLOS ONE			English	Article							INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; GENE-EXPRESSION; CHROMATIN; NETWORK; ORGANIZATION; EXPOSURE; DOMAINS; ISSUES; YEAST	Background: Understanding how mammalian cells are regulated epigenetically to express phenotype is a priority. The cellular phenotypic transition, induced by ionising radiation, from a normal cell to the genomic instability phenotype, where the ability to replicate the genotype accurately is compromised, illustrates important features of epigenetic regulation. Based on this phenomenon and earlier work we propose a model to describe the mammalian cell as a self assembled open system operating in an environment that includes its genotype, neighbouring cells and beyond. Phenotype is represented by high dimensional attractors, evolutionarily conditioned for stability and robustness and contingent on rules of engagement between gene products encoded in the genetic network. Methodology/Findings: We describe how this system functions and note the indeterminacy and fluidity of its internal workings which place it in the logical reasoning framework of predicative logic. We find that the hypothesis is supported by evidence from cell and molecular biology. Conclusions: Epigenetic regulation and memory are fundamentally physical, as opposed to chemical, processes and the transition to genomic instability is an important feature of mammalian cells with probable fundamental relevance to speciation and carcinogenesis. A source of evolutionarily selectable variation, in terms of the rules of engagement between gene products, is seen as more likely to have greater prominence than genetic variation in an evolutionary context. As this epigenetic variation is based on attractor states phenotypic changes are not gradual; a phenotypic transition can involve the changed contribution of several gene products in a single step.	[Baverstock, Keith] Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland; [Ronkko, Mauno] Univ Kuopio, Dept Comp Sci, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Baverstock, K (corresponding author), Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland.	keith.baverstock@uku.fi; mauno.ronkko@uku.fi						Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Back R.-J., 1998, REFINEMENT CALCULUS; Barber RC, 2006, MUTAT RES-FUND MOL M, V598, P50, DOI 10.1016/j.mrfmmm.2006.01.009; Bateson P, 2002, J GENET, V81, P49, DOI 10.1007/BF02715900; Baverstock K, 2000, MUTAT RES-FUND MOL M, V454, P89, DOI 10.1016/S0027-5107(00)00100-7; BAVERSTOCK KF, 1991, INT J RADIAT BIOL, V60, P581, DOI 10.1080/09553009114552421; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bouffler SD, 2006, RADIAT RES, V165, P249, DOI 10.1667/RR3506.1; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DELBRUCK M, 1949, UNITES BIOL DOUEES C, P33; DUPRE J, 2008, CONSTITUENTS LIFE; ELSASSER WM, 1981, J THEOR BIOL, V89, P131, DOI 10.1016/0022-5193(81)90182-X; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li L, 2003, CANCER RES, V63, P2733; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Mayr E., 2002, WHAT EVOLUTION IS; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; NANNEY DL, 1958, P NATL ACAD SCI USA, V44, P712, DOI 10.1073/pnas.44.7.712; O'Malley MA, 2005, BIOESSAYS, V27, P1270, DOI 10.1002/bies.20323; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Rosen R, 1991, LIFE ITSELF COMPREHE; Rosen R., 2000, ESSAYS LIFE ITSELF; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Schrodinger E, 1944, WHAT IS LIFE; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarski A., 1955, PAC J MATH, V5, P285, DOI DOI 10.2140/PJM.1955.5.285; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watson A, 2004, MOL BIOL CELL, V15, P851, DOI 10.1091/mbc.E03-08-0569; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	63	28	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2290	10.1371/journal.pone.0002290	http://dx.doi.org/10.1371/journal.pone.0002290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523589	Green Submitted, Green Published, gold			2022-12-27	WOS:000262614300008
J	Muttukrishna, S; Suri, S; Groome, N; Jauniaux, E				Muttukrishna, Shanthi; Suri, Sangeeta; Groome, Nigel; Jauniaux, Eric			Relationships between TGF beta Proteins and Oxygen Concentrations Inside the First Trimester Human Gestational Sac	PLOS ONE			English	Article							ACTIVIN-A; OXIDATIVE STRESS; GROWTH-FACTOR; INHIBIN-A; IN-VITRO; TROPHOBLAST INVASION; FLUID COMPARTMENTS; ANGIOGENIC FACTORS; TYROSINE KINASE-1; HUMAN PLACENTA	In early pregnancy, the O-2 gradient between the maternal circulation and the gestational sac tissues modulates trophoblast biological functions. The aim was to evaluate if placental partial pressure of oxygen (PaO2) modulates in vivo synthesis of specific placental proteins inside the first trimester gestational sac. Matched samples of peripheral venous blood, blood from the placental bed (PB), coelomic fluid (CF) and placental tissue were obtained in 37 normal pregnancies at 6-12 weeks gestation. PaO2 was measured in PB and CF using an IRMA blood gas monitor. Inhibin A, activin A, sEng, PlGF, sFlt-1 and free VEGF concentrations were measured in all samples. HSP 70 was measured in placental extracts. ANOVA showed similar to 60% increase in PB PaO2 (P=0.02) between after 10 weeks gestation. Unpaired Student's T-test between two groups (6-9 weeks vs 9-12 weeks) shows a significant increase in MS Activin A (P=0.001), CF activin A (P < 0.001), MS P1GF (P=0.001), CF PIGF (P < 0.001), MS sFLT-1 (P=0.03), CF sFLT-1 (P=0.01), HSP 70 in placental extracts (P=0.04) and a significant decrease in PB inhibin A levels (P < 0.001) and PB sFLT-1 (P=0.02). Multiple correlation analysis showed a significant negative correlation between PB inhibin A levels and gestation (r= -0.45, P < 0.05) and PB PaO2 (r= -.5, P=0.008) and also between sFLT-1 and PB PaO2 (P=0.03). There was a positive correlation (P < 0.01) between PIGF, sEng and VEGF levels in the placental extracts. Our results indicate a direct relationship in the early intrauterine PaO2 in vivo and inhibin A and sFLT-1 concentrations confirming our hypothesis that specific placental proteins are regulated by intrauterine O-2 tension.	[Muttukrishna, Shanthi; Suri, Sangeeta; Jauniaux, Eric] UCL, EGA, Inst Womens Hlth, London, England; [Groome, Nigel] Oxford Brookes Univ, Sch Biol & Mol Sci, Oxford, England	University of London; University College London; Oxford Brookes University	Muttukrishna, S (corresponding author), UCL, EGA, Inst Womens Hlth, London, England.	s.muttukrishna@ucl.ac.uk			UCLH	UCLH	UCLH charities for early pregnancy	Baumann MU, 2007, MOL ASPECTS MED, V28, P227, DOI 10.1016/j.mam.2007.04.002; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Jauniaux E, 2005, J CLIN ENDOCR METAB, V90, P1171, DOI 10.1210/jc.2004-1513; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, HUM REPROD UPDATE, V6, P268, DOI 10.1093/humupd/6.3.268; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kaufmann Peter, 1994, P441; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lyall F, 2001, AM J PATHOL, V158, P1713, DOI 10.1016/S0002-9440(10)64127-2; Maeshima K, 2004, ENDOCRINOLOGY, V145, P3739, DOI 10.1210/en.2004-0213; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2004, SEMIN REPROD MED, V 22, P227, DOI 10.1055/s-2004-831898; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; MUTTUKRISHNA S, 1995, CLIN ENDOCRINOL, V42, P391, DOI 10.1111/j.1365-2265.1995.tb02648.x; Muttukrishna S, 2002, HUM REPROD, V17, P3072, DOI 10.1093/humrep/17.12.3072; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Robertson W B, 1985, Obstet Gynecol Annu, V14, P411; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Venkatesha S, 2006, NAT MED, V12, P862, DOI 10.1038/nm0706-862c; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4	40	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2302	10.1371/journal.pone.0002302	http://dx.doi.org/10.1371/journal.pone.0002302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523681	Green Submitted, gold, Green Published			2022-12-27	WOS:000262614300013
J	Fang, LQ; de Vlas, SJ; Liang, S; Looman, CWN; Gong, P; Xu, B; Yan, L; Yang, H; Richardus, JH; Cao, WC				Fang, Li-Qun; de Vlas, Sake J.; Liang, Song; Looman, Caspar W. N.; Gong, Peng; Xu, Bing; Yan, Lei; Yang, Hong; Richardus, Jan Hendrik; Cao, Wu-Chun			Environmental Factors Contributing to the Spread of H5N1 Avian Influenza in Mainland China	PLOS ONE			English	Article								Background: Since late 2003, highly pathogenic avian influenza (HPAI) outbreaks caused by infection with H5N1 virus has led to the deaths of millions of poultry and more than 10 thousands of wild birds, and as of 18-March 2008, at least 373 laboratory-confirmed human infections with 236 fatalities, have occurred. The unrestrained worldwide spread of this disease has caused great anxiety about the potential of another global pandemic. However, the effect of environmental factors influencing the spread of HPAI H5N1 virus is unclear. Methodology/Principal Findings: A database including incident dates and locations was developed for 128 confirmed HPAI H5N1 outbreaks in poultry and wild birds, as well as 21 human cases in mainland China during 2004-2006. These data, together with information on wild bird migration, poultry densities, and environmental variables (water bodies, wetlands, transportation routes, main cities, precipitation and elevation), were integrated into a Geographical Information System (GIS). A case-control design was used to identify the environmental factors associated with the incidence of the disease. Multivariate logistic regression analysis indicated that minimal distance to the nearest national highway, annual precipitation and the interaction between minimal distance to the nearest lake and wetland, were important predictive environmental variables for the risk of HPAI. A risk map was constructed based on these factors. Conclusions/Significance: Our study indicates that environmental factors contribute to the spread of the disease. The risk map can be used to target countermeasures to stop further spread of the HPAI H5N1 at its source.	[Fang, Li-Qun; Yan, Lei; Yang, Hong; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Fang, Li-Qun; de Vlas, Sake J.; Looman, Caspar W. N.; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Liang, Song] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA; [Gong, Peng] Beijing Normal Univ, Chinese Acad Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Gong, Peng] Univ Calif, Dept Env Sci Policy & Management, Berkeley, CA USA; [Xu, Bing] Univ Utah, Dept Geography, Salt Lake City, UT USA	Beijing Institute of Microbiology & Epidemiology; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; Ohio State University; Beijing Normal University; Chinese Academy of Sciences; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah	Fang, LQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn	Gong, Peng/AAM-1516-2021; Xu, Bing/C-7732-2015; Fang, Li-Qun/GWD-0296-2022; Richardus, Jan Hendrik/AAE-1278-2021	Gong, Peng/0000-0003-1513-3765; Richardus, Jan Hendrik/0000-0003-0564-6313; de Vlas, Sake J./0000-0002-1830-5668	National Science Fund for Distinguished Young Scholars [30725032]; National Natural Science Foundation of China [30590374]; Commission of the European Community [003824]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Commission of the European Community(European Commission)	This study was supported by grants from the National Science Fund for Distinguished Young Scholars (No. 30725032), National Natural Science Foundation of China (No. 30590374) and the Commission of the European Community, as part of the project Effective and Acceptable Strategies for the Control of SARS and New Emerging Infections in China and Europe (No. 003824). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, OPTIMAL BIRD MIGRATI, P331; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; *FOOD AGR ORG UN, 2007, DAT POULTR WOLD; Harder B., 2005, SCI NEWS, V168, P171; Hoyo J., 1996, HDB BIRDS WORLD, V3; Hoyo JD, 1996, HDB BIRDS WORLD, V1; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; *MIN AGR CHIN, 2007, REP AN INF DIS; *MIN AGR CHIN, 2007, OFF VET B; *MIN RAILW CHIN, 1982, REG TRANSP RAILR FRE; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; *RAMS CONV SECR, 2005, INF SHEET RAMS WETL; Shaw S. P., 1956, 39 US FISH WILDL SER; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WHO, 2021, CUM NUMB CONF HUM CA; *WHO, 2004, WAT ZOON; World Health Organization, 2006, DIR IND FACT FAC SPR; *WORLD ORG AN HLTH, 2008, SUMM IMM NOT FOLL UP; *WORLD ORG AN HLTH, 2008, AV INFL FACTS FIG; ZHANG F, 1997, BIRD MIGRATION CHINA; 2007, LENCET INFECT DIS, V7, P175	27	120	130	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2268	10.1371/journal.pone.0002268	http://dx.doi.org/10.1371/journal.pone.0002268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509468	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500014
J	Luo, ZL; Zhao, XJ; Zhang, SG				Luo, Zhongli; Zhao, Xiaojun; Zhang, Shuguang			Structural Dynamic of a Self-Assembling Peptide d-EAK16 Made of Only D-Amino Acids	PLOS ONE			English	Article							BETA-SHEET; ALPHA-HELIX; CONFORMATIONAL TRANSITIONS; COMPLEMENTARY OLIGOPEPTIDE; PROTEIN; RECOGNITION; CONVERSION; BINDING; MODEL	We here report systematic study of structural dynamics of a 16-residue self-assembling peptide d-EAK16 made of only D-amino acids. We compare these results with its chiral counterpart L-form, I-EAK16. Circular dichroism was used to follow the structural dynamics under various temperature and pH conditions. At 25 degrees C the d-EAK16 peptide displayed a typical beta-sheet spectrum. Upon increasing the temperature above 70 degrees C, there was a spectrum shift as the 218 nm valley widens toward 210 nm. Above 80 degrees C, the d-EAK16 peptide transformed into a typical alpha-helix CD spectrum without going through a detectable random-coil intermediate. When increasing the temperature from 4 degrees C to 110 degrees C then cooling back from 110 degrees C to 4 degrees C, there was a hysteresis: the secondary structure from beta-sheet to alpha-helix and then from alpha-helix to beta-sheet occurred. d-EAK16 formed an alpha-helical conformation at pH0.76 and pH12 but formed a beta-sheet at neutral pH. The effects of various pH conditions, ionic strength and denaturing agents were also noted. Since D-form peptides are resistant to natural enzyme degradation, such drastic structural changes may be exploited for fabricating molecular sensors to detect minute environmental changes. This provides insight into the behaviors of self-assembling peptides made of D-amino acids and points the way to designing new peptide materials for biomedical engineering and nanobiotechnology.	[Luo, Zhongli; Zhao, Xiaojun; Zhang, Shuguang] Sichuan Univ, W China Hosp, Lab Nanobiomed Technol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Luo, ZL (corresponding author), Sichuan Univ, W China Hosp, Lab Nanobiomed Technol, Chengdu 610064, Sichuan, Peoples R China.	shuguang@mit.edu		Luo, Zhongli/0000-0003-4041-7807; Zhang, Shuguang/0000-0002-3856-3752	China National 985 project at Sichuan University	China National 985 project at Sichuan University	This work was supported through the China National 985 project at Sichuan University. SZ is a founder of 3-DMatrix USA and receives stock options. SZ is also a founder of NZ3, USA and receive stock options. SZ is also scientific advisor for 3DM-Japan, NZ3, Inc. and receive consulting fees.	Altman M, 2000, PROTEIN SCI, V9, P1095, DOI 10.1110/ps.9.6.1095; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Branden C., 1999, INTRO PROTEIN STRUCT; Buschmann H, 2000, ANGEW CHEM INT EDIT, V39, P4033, DOI 10.1002/1521-3773(20001117)39:22<4033::AID-ANIE4033>3.0.CO;2-2; Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w; Chin J, 1999, NATURE, V401, P254, DOI 10.1038/45751; Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008; Ciani B, 2002, J BIOL CHEM, V277, P10150, DOI 10.1074/jbc.M107663200; DADO GP, 1993, J AM CHEM SOC, V115, P12609, DOI 10.1021/ja00079a060; FASMAN GD, 1994, P NATL ACAD SCI USA, V91, P11232, DOI 10.1073/pnas.91.23.11232; FLOURET G, 1965, J AM CHEM SOC, V87, P3775, DOI 10.1021/ja01094a045; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Kauffmann E, 2001, P NATL ACAD SCI USA, V98, P6646, DOI 10.1073/pnas.101122898; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; KURODA Y, 1995, J AM CHEM SOC, V117, P10950, DOI 10.1021/ja00149a018; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; MASON S, 1988, CHEM SOC REV, V17, P347, DOI 10.1039/cs9881700347; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; MONTELIONE GT, 1986, P NATL ACAD SCI USA, V83, P8594, DOI 10.1073/pnas.83.22.8594; MUTTER M, 1990, ANGEW CHEM INT EDIT, V29, P185, DOI 10.1002/anie.199001851; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; SHEMYAKI.MM, 1967, NATURE, V213, P412, DOI 10.1038/213412a0; Stanger HE, 2001, P NATL ACAD SCI USA, V98, P12015, DOI 10.1073/pnas.211536998; STEWART JM, 1965, NATURE, V206, P619, DOI 10.1038/206619b0; Still WC, 1996, ACCOUNTS CHEM RES, V29, P155, DOI 10.1021/ar950166i; Takahashi Y, 1999, BIOORGAN MED CHEM, V7, P177, DOI 10.1016/S0968-0896(98)00236-3; VOGLER K, 1965, HELV CHIM ACTA, V48, P1407, DOI 10.1002/hlca.19650480621; Yashima E, 1999, NATURE, V399, P449, DOI 10.1038/20900; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0; ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang XX, 1997, CHEM REV, V97, P3313, DOI 10.1021/cr960144p	45	61	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2364	10.1371/journal.pone.0002364	http://dx.doi.org/10.1371/journal.pone.0002364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509542	Green Published, gold			2022-12-27	WOS:000262268500049
J	Coussens, M; Maresh, JG; Yanagimachi, R; Maeda, G; Allsopp, R				Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard			Sirt1 Deficiency Attenuates Spermatogenesis and Germ Cell Function	PLOS ONE			English	Article								In mammals, Sirt1, a member of the sirtuin family of proteins, functions as a nicotinamide adenine dinucleotide-dependent protein deactylase, and has important physiological roles, including the regulation of glucose metabolism, cell survival, and mitochondrial respiration. The initial investigations of Sirt1 deficient mice have revealed a phenotype that includes a reduced lifespan, small size, and an increased frequency of abnormal sperm. We have now performed a detailed analysis of the molecular and functional effects of Sirt1 deficiency in the germ line of Sirt1 knock-out (-/-) mice. We find that Sirt1 deficiency markedly attenuates spermatogenesis, but not oogenesis. Numbers of mature sperm and spermatogenic precursors, as early as d15.5 of development, are significantly reduced (similar to 2-10-fold less; P <= 0.004) in numbers in Sirt1-/- mice, whereas Sirt1 deficiency did not effect the efficiency oocyte production following superovulation of female mice. Furthermore, the proportion of mature sperm with elevated DNA damage (similar to 7.5% of total epididymal sperm; P = 0.02) was significantly increased in adult Sirt1-/- males. Analysis of global gene expression by microarray analysis in Sirt1 deficient testis revealed dysregulated expression of 85 genes, which were enriched (P < 0.05) for genes involved in spermatogenesis and protein sumoylation. To assess the function of Sirt1 deficient germ cells, we compared the efficiency of generating embryos and viable offspring in in vitro fertilization (IVF) experiments using gametes from Sirt1-/- and sibling Sirt1+/- mice. While viable animals were derived in both Sirt1-/- X wild type and Sirt1-/- X Sirt1-/- crosses, the efficiency of producing both 2-cell zygotes and viable offspring was diminished when IVF was performed with Sirt1-/- sperm and/or oocytes. Together, these data support an important role for Sirt1 in spermatogenesis, including spermatogenic stem cells, as well as germ cell function.	[Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Coussens, Matthew; Allsopp, Richard] Univ Hawaii, Inst Biogen Res, Honolulu, HI USA	University of Hawaii System; University of Hawaii System	Coussens, M (corresponding author), Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.	allsopp@hawaii.edu		Whitman, Mary/0000-0001-6297-7499	NIH [P20 RR16467-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant P20 RR16467-05 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; ASHBURNER M, NAT GENET, V25, P25; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Coussens M, 2006, BIOL REPROD, V75, P785, DOI 10.1095/biolreprod.106.052167; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; HOPPE PC, 1973, BIOL REPROD, V8, P420, DOI 10.1093/biolreprod/8.4.420; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nagy A., 2002, MANIPULATING MOUSE E; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; WELCH JE, 1990, BIOL REPROD, V43, P569, DOI 10.1095/biolreprod43.4.569; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	34	129	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1571	10.1371/journal.pone.0001571	http://dx.doi.org/10.1371/journal.pone.0001571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18612420	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900010
J	Wang, X; Sun, Q; McGrath, SD; Mardis, ER; Soloway, PD; Clark, AG				Wang, Xu; Sun, Qi; McGrath, Sean D.; Mardis, Elaine R.; Soloway, Paul D.; Clark, Andrew G.			Transcriptome-Wide Identification of Novel Imprinted Genes in Neonatal Mouse Brain	PLOS ONE			English	Article								Imprinted genes display differential allelic expression in a manner that depends on the sex of the transmitting parent. The degree of imprinting is often tissue-specific and/or developmental stage-specific, and may be altered in some diseases including cancer. Here we applied Illumina/Solexa sequencing of the transcriptomes of reciprocal F1 mouse neonatal brains and identified 26 genes with parent-of-origin dependent differential allelic expression. Allele-specific Pyrosequencing verified 17 of them, including three novel imprinted genes. The known and novel imprinted genes all are found in proximity to previously reported differentially methylated regions (DMRs). Ten genes known to be imprinted in placenta had sufficient expression levels to attain a read depth that provided statistical power to detect imprinting, and yet all were consistent with non-imprinting in our transcript count data for neonatal brain. Three closely linked and reciprocally imprinted gene pairs were also discovered, and their pattern of expression suggests transcriptional interference. Despite the coverage of more than 5000 genes, this scan only identified three novel imprinted refseq genes in neonatal brain, suggesting that this tissue is nearly exhaustively characterized. This approach has the potential to yield an complete catalog of imprinted genes after application to multiple tissues and developmental stages, shedding light on the mechanism, bioinformatic prediction, and evolution of imprinted genes and diseases associated with genomic imprinting.	[Wang, Xu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Sun, Qi] Cornell Univ, Life Sci Core Lab Ctr, Computat Biol Serv Unit, Ithaca, NY 14853 USA; [McGrath, Sean D.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63130 USA; [Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Washington University (WUSTL); Cornell University	Wang, X (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ac347@cornell.edu	Wang, Xu/B-4587-2008; Soloway, Paul/T-8243-2019; McGrath, Sean David/AAT-3540-2020; Mardis, Elaine/W-2202-2019; Tang, Shuang/F-9115-2014	Wang, Xu/0000-0002-7594-5004; McGrath, Sean David/0000-0001-9064-8449; Soloway, Paul/0000-0003-1967-0437; Tang, Shuang/0000-0002-3084-0903; Zheng, Zhi-Ming/0000-0001-5547-7912; Clark, Andrew/0000-0001-7159-8511	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 79006, R01 CA095713, CA 95713, CA 94141, R01 CA094141] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BJORNSSON HT, 2008, GENOME RES; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chrast R, 2000, GENOME RES, V10, P2006, DOI 10.1101/gr.10.12.2006; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davies W, 2004, GENE EXPR PATTERNS, V4, P741, DOI 10.1016/j.modgep.2004.03.008; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Evans HK, 2005, MOL BIOL EVOL, V22, P1740, DOI 10.1093/molbev/msi165; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kikyo N, 1997, DEV BIOL, V190, P66, DOI 10.1006/dbio.1997.8681; Kim J, 2000, GENOME RES, V10, P1138, DOI 10.1101/gr.10.8.1138; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Lehmann EL, 2005, TESTING STAT HYPOTHE, pxiv; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Matoba R, 2000, GENE, V241, P125, DOI 10.1016/S0378-1119(99)00457-6; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mergenthaler S, 2001, AM J HUM GENET, V68, P543, DOI 10.1086/318192; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Paulsen M, 1998, HUM MOL GENET, V7, P1149, DOI 10.1093/hmg/7.7.1149; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Sado T, 2001, DEVELOPMENT, V128, P1275; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; STORER BE, 1990, J AM STAT ASSOC, V85, P146, DOI 10.2307/2289537; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Weinstein LS, 2000, AM J PHYSIOL-RENAL, V278, pF507, DOI 10.1152/ajprenal.2000.278.4.F507; Wilcox R.R., 2003, APPLYING CONT STAT T, DOI [10.1016/B978-012751541-0/50029-8, DOI 10.1016/B978-012751541-0/50029-8, DOI 10.1198/TECH.2004.S233]; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Yamazawa K, 2008, AM J MED GENET A, V146A, P514, DOI 10.1002/ajmg.a.32125; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	74	250	262	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2008	3	12							e3839	10.1371/journal.pone.0003839	http://dx.doi.org/10.1371/journal.pone.0003839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YO	18596939	gold, Green Published, Green Submitted			2022-12-27	WOS:000265452200001
